@prefix ns1: <https://1145.am/db/> .
@prefix org: <http://www.w3.org/ns/org#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://1145.am/db/2171269/Norsat_International> a org:Organization ;
    ns1:basedInLowRaw "Great White North" ;
    ns1:buyer <https://1145.am/db/2171269/Sinclair_Technologies_Holdings_Inc_Acquisition> ;
    ns1:description "Broadband communications products" ;
    ns1:documentDate "2011-01-21T13:05:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Money talks: Hughes Communications reported for sale; Suddenlink closes offering; Norsat snags Sinclair" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/money-talks-hughes-communications-reported-for-sale-suddenlink-closes-offering-norsat-snags> ;
    ns1:foundName "Norsat International" ;
    ns1:industry "broadband communications products" ;
    ns1:name "Norsat International" ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2176980/Grupo_Televisa> a org:Organization ;
    ns1:basedInHighGeoName "Mexico" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3996063/about.rdf> ;
    ns1:basedInHighRaw "Mexico" ;
    ns1:buyer <https://1145.am/db/2176980/Cablemas_Acquisition> ;
    ns1:documentDate "2011-04-04T14:06:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Liberty Global chases Ziggo ahead of IPO; Televisa buys Cablemas" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/liberty-global-chases-ziggo-ahead-ipo-televisa-buys-cablemas> ;
    ns1:foundName "Grupo Televisa" ;
    ns1:name "Grupo Televisa" ;
    ns1:sameAsMedium <https://1145.am/db/1267792/Grupo_Televisa>,
        <https://1145.am/db/1454711/Grupo_Televisa>,
        <https://1145.am/db/1574258/Grupo_Televisa>,
        <https://1145.am/db/1577770/Grupo_Televisa>,
        <https://1145.am/db/1682757/Grupo_Televisa>,
        <https://1145.am/db/1702592/Grupo_Televisa>,
        <https://1145.am/db/2161554/Grupo_Televisa>,
        <https://1145.am/db/2163754/Grupo_Televisa>,
        <https://1145.am/db/2602679/Grupo_Televisa>,
        <https://1145.am/db/2669703/Grupo_Televisa>,
        <https://1145.am/db/286426/Grupo_Televisa>,
        <https://1145.am/db/306767/Grupo_Televisa>,
        <https://1145.am/db/306797/Grupo_Televisa>,
        <https://1145.am/db/4145/Grupo_Televisa>,
        <https://1145.am/db/468280/Grupo_Televisa>,
        <https://1145.am/db/474437/Grupo_Televisa>,
        <https://1145.am/db/5447/Grupo_Televisa>,
        <https://1145.am/db/680714/Grupo_Televisa>,
        <https://1145.am/db/795773/Grupo_Televisa>,
        <https://1145.am/db/798046/Grupo_Televisa> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2176980/Liberty_Global> a org:Organization ;
    ns1:basedInLowRaw "Ireland",
        "Netherlands" ;
    ns1:buyer <https://1145.am/db/2176980/Unitymedia_Acquisition>,
        <https://1145.am/db/2176980/Ziggo_Acquisition> ;
    ns1:description "telecommunications" ;
    ns1:documentDate "2011-04-04T14:06:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Liberty Global chases Ziggo ahead of IPO; Televisa buys Cablemas" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/liberty-global-chases-ziggo-ahead-ipo-televisa-buys-cablemas> ;
    ns1:foundName "Liberty",
        "Liberty Global" ;
    ns1:name "Liberty",
        "Liberty Global" ;
    ns1:sameAsHigh <https://1145.am/db/134497/Liberty_Global>,
        <https://1145.am/db/2157622/Liberty_Global> ;
    ns1:sameAsMedium <https://1145.am/db/107126/Liberty_Global>,
        <https://1145.am/db/1156497/Liberty_Global>,
        <https://1145.am/db/152932/Liberty_Global>,
        <https://1145.am/db/1671318/Liberty_Global>,
        <https://1145.am/db/1728614/Liberty_Global>,
        <https://1145.am/db/1738986/Liberty_Global>,
        <https://1145.am/db/1805873/Liberty_Global>,
        <https://1145.am/db/1818979/Liberty_Global>,
        <https://1145.am/db/1833725/Liberty_Global>,
        <https://1145.am/db/1845917/Liberty_Global>,
        <https://1145.am/db/1893343/Liberty_Global>,
        <https://1145.am/db/2039070/Liberty_Global>,
        <https://1145.am/db/2073902/Liberty_Global>,
        <https://1145.am/db/2075472/Liberty_Global>,
        <https://1145.am/db/2157150/Liberty_Global>,
        <https://1145.am/db/2157765/Liberty_Global>,
        <https://1145.am/db/2157827/Liberty_Global>,
        <https://1145.am/db/2160105/Liberty_Global>,
        <https://1145.am/db/2162033/Liberty_Global>,
        <https://1145.am/db/2162111/Liberty_Global>,
        <https://1145.am/db/2163468/Liberty_Global>,
        <https://1145.am/db/2163543/Liberty_Global>,
        <https://1145.am/db/2166095/Liberty_Global>,
        <https://1145.am/db/2167342/Liberty_Global>,
        <https://1145.am/db/2168072/Liberty_Global>,
        <https://1145.am/db/2168142/Liberty_Global>,
        <https://1145.am/db/2169415/Liberty_Global>,
        <https://1145.am/db/2171943/Liberty_Global>,
        <https://1145.am/db/2173439/Liberty_Global>,
        <https://1145.am/db/2174251/Liberty_Global>,
        <https://1145.am/db/2174257/Liberty_Global>,
        <https://1145.am/db/2174290/Liberty_Global>,
        <https://1145.am/db/2176131/Liberty_Global>,
        <https://1145.am/db/2177533/Liberty_Global>,
        <https://1145.am/db/2177585/Liberty_Global>,
        <https://1145.am/db/2178040/Liberty_Global>,
        <https://1145.am/db/2262/Liberty_Global>,
        <https://1145.am/db/2604744/Liberty_Global>,
        <https://1145.am/db/2611263/Liberty_Global>,
        <https://1145.am/db/2614160/Liberty_Global>,
        <https://1145.am/db/2617635/Liberty_Global>,
        <https://1145.am/db/2620281/Liberty_Global>,
        <https://1145.am/db/2620455/Liberty_Global>,
        <https://1145.am/db/2620768/Liberty_Global>,
        <https://1145.am/db/2625170/Liberty_Global>,
        <https://1145.am/db/2646466/Liberty_Global>,
        <https://1145.am/db/2650809/Liberty_Global>,
        <https://1145.am/db/2650894/Liberty_Global>,
        <https://1145.am/db/2650978/Liberty_Global>,
        <https://1145.am/db/2651116/Liberty_Global>,
        <https://1145.am/db/2652362/Liberty_Global>,
        <https://1145.am/db/2655783/Liberty_Global>,
        <https://1145.am/db/2660906/Liberty_Global>,
        <https://1145.am/db/2660907/Liberty_Global>,
        <https://1145.am/db/2661991/Liberty_Global>,
        <https://1145.am/db/2663184/Liberty_Global>,
        <https://1145.am/db/2664151/Liberty_Global>,
        <https://1145.am/db/2665348/Liberty_Global>,
        <https://1145.am/db/2665363/Liberty_Global>,
        <https://1145.am/db/2666378/Liberty_Global>,
        <https://1145.am/db/2667355/Liberty_Global>,
        <https://1145.am/db/2671912/Liberty_Global>,
        <https://1145.am/db/2678973/Liberty_Global>,
        <https://1145.am/db/2680056/Liberty_Global>,
        <https://1145.am/db/2680826/Liberty_Global>,
        <https://1145.am/db/2758/Liberty_Global>,
        <https://1145.am/db/2820/Liberty_Global>,
        <https://1145.am/db/337315/Liberty_Global>,
        <https://1145.am/db/366239/Liberty_Global>,
        <https://1145.am/db/366788/Liberty_Global>,
        <https://1145.am/db/3702/Liberty_Global>,
        <https://1145.am/db/489558/Liberty_Global>,
        <https://1145.am/db/80982/Liberty_Global_Plc>,
        <https://1145.am/db/85758/Liberty_Global>,
        <https://1145.am/db/87741/Liberty_Global>,
        <https://1145.am/db/87823/Liberty_Global>,
        <https://1145.am/db/882636/Liberty_Global>,
        <https://1145.am/db/917819/Liberty_Global_Plc>,
        <https://1145.am/db/919160/Liberty_Global_Plc>,
        <https://1145.am/db/945663/Liberty_Global>,
        <https://1145.am/db/947184/Liberty_Global> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2177634/Dish_Network> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2177634/Blockbuster_Acquisition> ;
    ns1:description "satellite provider" ;
    ns1:documentDate "2011-04-11T12:01:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dish-Blockbuster deal gets DoJ, FTC approval" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/dish-blockbuster-deal-gets-doj-ftc-approval> ;
    ns1:foundName "Dish Network" ;
    ns1:industry "satellite provider" ;
    ns1:name "Dish Network" ;
    ns1:sameAsHigh <https://1145.am/db/1414969/Dish_Network_Corp>,
        <https://1145.am/db/1828852/Dish_Network>,
        <https://1145.am/db/1871585/Dish_Network>,
        <https://1145.am/db/2057379/Dish_Network>,
        <https://1145.am/db/2080036/Dish_Network>,
        <https://1145.am/db/2156911/Dish_Network>,
        <https://1145.am/db/2158102/Dish_Network>,
        <https://1145.am/db/2158505/Dish_Network>,
        <https://1145.am/db/2161463/Dish_Network>,
        <https://1145.am/db/2162239/Dish_Network>,
        <https://1145.am/db/2162920/Dish_Network>,
        <https://1145.am/db/2162989/Dish_Network>,
        <https://1145.am/db/2165021/Dish_Network>,
        <https://1145.am/db/2168509/Dish_Network>,
        <https://1145.am/db/2170437/Dish_Network>,
        <https://1145.am/db/2170857/Dish_Network>,
        <https://1145.am/db/2171982/Dish_Network>,
        <https://1145.am/db/2172101/Dish_Network>,
        <https://1145.am/db/2172901/Dish_Network>,
        <https://1145.am/db/2172911/Echostar_Dish>,
        <https://1145.am/db/2173675/Dish_Network>,
        <https://1145.am/db/2174986/Dish_Network>,
        <https://1145.am/db/2175716/Dish_Network>,
        <https://1145.am/db/2176115/Dish_Network>,
        <https://1145.am/db/2179082/Dish_Network>,
        <https://1145.am/db/2602950/Dish_Network>,
        <https://1145.am/db/2614911/Dish_Network>,
        <https://1145.am/db/2628816/Dish_Network>,
        <https://1145.am/db/2628938/Dish_Network>,
        <https://1145.am/db/2629786/Dish>,
        <https://1145.am/db/2631623/Dish_Network>,
        <https://1145.am/db/2638870/Dish_Network>,
        <https://1145.am/db/2640032/Dish_Network>,
        <https://1145.am/db/2640950/Dish_Network>,
        <https://1145.am/db/2648932/Dish_Network>,
        <https://1145.am/db/2668987/Dish_Network>,
        <https://1145.am/db/2671555/Dish_Networks>,
        <https://1145.am/db/2672784/Dish_Network>,
        <https://1145.am/db/2678734/Dish_Network>,
        <https://1145.am/db/2678781/Dish_Network>,
        <https://1145.am/db/2684574/Dish_Network>,
        <https://1145.am/db/2686210/Dish_Network>,
        <https://1145.am/db/2686325/Dish_Network>,
        <https://1145.am/db/611270/Dish_Network_Corporation> ;
    ns1:sameAsMedium <https://1145.am/db/1468719/Dish_Network_Corporation>,
        <https://1145.am/db/1889015/Dish_Network>,
        <https://1145.am/db/2158518/Dish_Network>,
        <https://1145.am/db/2159439/Dish_Network>,
        <https://1145.am/db/2162970/Dish_Network>,
        <https://1145.am/db/2167939/Dish_Network>,
        <https://1145.am/db/2175144/Dish_Network>,
        <https://1145.am/db/2598817/Dish_Network>,
        <https://1145.am/db/2614751/Dish_Network>,
        <https://1145.am/db/2626526/Dish_Network>,
        <https://1145.am/db/2627221/Dish_Network>,
        <https://1145.am/db/2629788/Dish_Network>,
        <https://1145.am/db/2634015/Dish_Network>,
        <https://1145.am/db/2638859/Dish_Network>,
        <https://1145.am/db/2644908/Dish_Network>,
        <https://1145.am/db/2645879/Dish_Network>,
        <https://1145.am/db/2646574/Dish_Network>,
        <https://1145.am/db/2646848/Dish_Network>,
        <https://1145.am/db/2646856/Dish_Network>,
        <https://1145.am/db/2654198/Dish_Network>,
        <https://1145.am/db/2655140/Dish_Network>,
        <https://1145.am/db/2656030/Dish_Network>,
        <https://1145.am/db/2656081/Dish_Network>,
        <https://1145.am/db/2661405/Dish_Network>,
        <https://1145.am/db/2661443/Dish_Network>,
        <https://1145.am/db/2662335/Dish_Network>,
        <https://1145.am/db/2662471/Dish_Network>,
        <https://1145.am/db/2666088/Dish_Network>,
        <https://1145.am/db/2667137/Dish_Network>,
        <https://1145.am/db/2669942/Dish_Network>,
        <https://1145.am/db/2672780/Dish_Network>,
        <https://1145.am/db/2672787/Dish_Network>,
        <https://1145.am/db/2672793/Dish_Network>,
        <https://1145.am/db/2674444/Dish_Network>,
        <https://1145.am/db/2675179/Dish_Network>,
        <https://1145.am/db/2676378/Dish_Network>,
        <https://1145.am/db/2677542/Dish_Network>,
        <https://1145.am/db/2678731/Dish_Network>,
        <https://1145.am/db/2681702/Dish_Network>,
        <https://1145.am/db/2685132/Dish_Network>,
        <https://1145.am/db/2686073/Dish_Network>,
        <https://1145.am/db/444153/Dish_Network_Corporation> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2217392/Aetna> a org:Organization ;
    ns1:basedInLowRaw "NYSE" ;
    ns1:buyer <https://1145.am/db/2217392/Axolotl_Acquisition>,
        <https://1145.am/db/2217392/Medicity_Acquisition> ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "Aetna" ;
    ns1:industry "Health Care" ;
    ns1:name "Aetna" ;
    ns1:sameAsHigh <https://1145.am/db/1034341/Anthem_Inc>,
        <https://1145.am/db/1895841/Aetna>,
        <https://1145.am/db/1967603/Anthem>,
        <https://1145.am/db/2182699/Aetna>,
        <https://1145.am/db/2184713/Aetna>,
        <https://1145.am/db/2184928/Aetna>,
        <https://1145.am/db/2185068/Anthem>,
        <https://1145.am/db/2185374/Aetna>,
        <https://1145.am/db/2185835/Aetna>,
        <https://1145.am/db/2185852/Anthem>,
        <https://1145.am/db/2186574/Aetna>,
        <https://1145.am/db/2187269/Anthem>,
        <https://1145.am/db/218855/Anthem_Inc>,
        <https://1145.am/db/2189163/Anthem>,
        <https://1145.am/db/2190031/Aetna>,
        <https://1145.am/db/2190760/Aetna>,
        <https://1145.am/db/2190907/Aetna>,
        <https://1145.am/db/2191214/Aetna>,
        <https://1145.am/db/2191753/Aetna>,
        <https://1145.am/db/2192294/Aetna>,
        <https://1145.am/db/2193300/Aetna>,
        <https://1145.am/db/2193303/Aetna>,
        <https://1145.am/db/2194225/Aetna>,
        <https://1145.am/db/2194895/Aetna>,
        <https://1145.am/db/2194913/Aetna>,
        <https://1145.am/db/2195393/Anthem>,
        <https://1145.am/db/2195406/Anthem>,
        <https://1145.am/db/2195461/Aetna>,
        <https://1145.am/db/2197679/Anthem>,
        <https://1145.am/db/2198190/Aetna>,
        <https://1145.am/db/2198190/Anthem>,
        <https://1145.am/db/2203367/Aetna>,
        <https://1145.am/db/2203587/Anthem>,
        <https://1145.am/db/2207608/Aetna>,
        <https://1145.am/db/2212804/Aetna>,
        <https://1145.am/db/2212804/Anthem>,
        <https://1145.am/db/2214130/Aetna>,
        <https://1145.am/db/2214135/Aetna>,
        <https://1145.am/db/2218776/Aetna>,
        <https://1145.am/db/2220698/Aetna>,
        <https://1145.am/db/2240693/Aetna>,
        <https://1145.am/db/2241120/Aetna>,
        <https://1145.am/db/2245024/Aetna>,
        <https://1145.am/db/2247439/Aetna>,
        <https://1145.am/db/2250503/Aetna>,
        <https://1145.am/db/2253170/Aetna>,
        <https://1145.am/db/2253537/Anthem>,
        <https://1145.am/db/2254700/Aetna>,
        <https://1145.am/db/2254720/Aetna>,
        <https://1145.am/db/2255490/Aetna>,
        <https://1145.am/db/2255659/Anthem>,
        <https://1145.am/db/2256114/Aetna>,
        <https://1145.am/db/2256344/Aetna>,
        <https://1145.am/db/2256365/Aetna>,
        <https://1145.am/db/2256412/Aetna>,
        <https://1145.am/db/2262557/Aetna_Anthem_Or>,
        <https://1145.am/db/2262569/Anthem>,
        <https://1145.am/db/2262593/Anthem>,
        <https://1145.am/db/2263385/Aetna>,
        <https://1145.am/db/2263392/Aetna>,
        <https://1145.am/db/2263421/Aetna>,
        <https://1145.am/db/2263445/Aetna>,
        <https://1145.am/db/2264287/Aetna>,
        <https://1145.am/db/2264295/Aetna>,
        <https://1145.am/db/2264927/Aetna>,
        <https://1145.am/db/2264927/Anthem>,
        <https://1145.am/db/2266016/Aetna>,
        <https://1145.am/db/2266806/Aetna>,
        <https://1145.am/db/2266972/Aetna>,
        <https://1145.am/db/2266972/Anthem>,
        <https://1145.am/db/2267801/Aetna>,
        <https://1145.am/db/2267830/Aetna>,
        <https://1145.am/db/2267830/Anthem>,
        <https://1145.am/db/2268568/Aetna>,
        <https://1145.am/db/2269230/Aetna>,
        <https://1145.am/db/2269267/Aetna>,
        <https://1145.am/db/2270653/Aetna>,
        <https://1145.am/db/2272244/Aetna>,
        <https://1145.am/db/2274757/Aetna>,
        <https://1145.am/db/2275398/Aetna>,
        <https://1145.am/db/2276152/Aetna>,
        <https://1145.am/db/2276163/Aetna>,
        <https://1145.am/db/2277343/Aetna>,
        <https://1145.am/db/2277482/Aetna>,
        <https://1145.am/db/2278456/Aetna>,
        <https://1145.am/db/2362850/Aetna>,
        <https://1145.am/db/2559244/Aetna>,
        <https://1145.am/db/2574470/Aetna>,
        <https://1145.am/db/2575500/Aetna>,
        <https://1145.am/db/2584713/Aetna>,
        <https://1145.am/db/285168/Anthem_Inc>,
        <https://1145.am/db/365544/Anthem_Inc>,
        <https://1145.am/db/389816/Anthem_Inc>,
        <https://1145.am/db/458330/Anthem_Blue_Cross_And_Blue_Shield>,
        <https://1145.am/db/772389/Anthem>,
        <https://1145.am/db/774919/Anthem>,
        <https://1145.am/db/830914/Anthem_Blue_Cross_And_Blue_Shield>,
        <https://1145.am/db/831414/Anthem_Blue_Cross_And_Blue_Shield> ;
    ns1:sameAsMedium <https://1145.am/db/2190847/Aetna>,
        <https://1145.am/db/2192282/Aetna>,
        <https://1145.am/db/2197211/Aetna>,
        <https://1145.am/db/2197483/Aetna>,
        <https://1145.am/db/2208704/Aetna>,
        <https://1145.am/db/2213068/Aetna>,
        <https://1145.am/db/2215199/Aetna>,
        <https://1145.am/db/2216382/Aetna>,
        <https://1145.am/db/2223863/Aetna>,
        <https://1145.am/db/2224155/Aetna>,
        <https://1145.am/db/2227027/Aetna>,
        <https://1145.am/db/2232883/Aetna>,
        <https://1145.am/db/2233496/Aetna>,
        <https://1145.am/db/2243700/Aetna>,
        <https://1145.am/db/2250666/Aetna>,
        <https://1145.am/db/2255256/Aetna>,
        <https://1145.am/db/2256300/Aetna>,
        <https://1145.am/db/2256346/Aetna>,
        <https://1145.am/db/2259863/Aetna>,
        <https://1145.am/db/2260831/Aetna>,
        <https://1145.am/db/2261705/Aetna>,
        <https://1145.am/db/2263365/Aetna>,
        <https://1145.am/db/2263407/Aetna>,
        <https://1145.am/db/2263450/Aetna>,
        <https://1145.am/db/2263968/Aetna_Inc>,
        <https://1145.am/db/2266104/Aetna>,
        <https://1145.am/db/2267796/Aetna>,
        <https://1145.am/db/2270165/Aetna>,
        <https://1145.am/db/2270379/Aetna>,
        <https://1145.am/db/2275755/Aetna>,
        <https://1145.am/db/2276552/Aetna>,
        <https://1145.am/db/2276969/Aetna>,
        <https://1145.am/db/2277989/Aetna>,
        <https://1145.am/db/2278258/Aetna>,
        <https://1145.am/db/2278449/Aetna>,
        <https://1145.am/db/2576016/Aetna> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2217392/Genstar_Capital> a org:Organization ;
    ns1:buyer <https://1145.am/db/2217392/Axolotl_Acquisition>,
        <https://1145.am/db/2217392/Evolution_Benefits_Acquisition> ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "Genstar Capital" ;
    ns1:name "Genstar Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1065061/Genstar_Capital>,
        <https://1145.am/db/1073728/Genstar_Capital>,
        <https://1145.am/db/1131366/Genstar_Capital>,
        <https://1145.am/db/1131734/Genstar_Capital>,
        <https://1145.am/db/1240910/Genstar_Capital>,
        <https://1145.am/db/1241686/Genstar_Capital>,
        <https://1145.am/db/1856827/Genstar_Capital>,
        <https://1145.am/db/2250518/Genstar_Capital>,
        <https://1145.am/db/2290651/Genstar_Capital>,
        <https://1145.am/db/2308033/Genstar_Capital>,
        <https://1145.am/db/2314081/Genstar_Capital>,
        <https://1145.am/db/2329414/Genstar_Capital>,
        <https://1145.am/db/2332522/Genstar_Capital>,
        <https://1145.am/db/2333447/Genstar_Capital>,
        <https://1145.am/db/2333453/Genstar_Capital_Llc>,
        <https://1145.am/db/2333454/Genstar_Capital>,
        <https://1145.am/db/2336420/Genstar_Capital>,
        <https://1145.am/db/254889/Genstar_Capital>,
        <https://1145.am/db/306817/Genstar_Capital>,
        <https://1145.am/db/350722/Genstar_Capital>,
        <https://1145.am/db/371588/Genstar_Capital>,
        <https://1145.am/db/371597/Genstar_Capital>,
        <https://1145.am/db/430134/Genstar_Capital>,
        <https://1145.am/db/441693/Genstar_Capital_Llc>,
        <https://1145.am/db/473107/Genstar_Capital>,
        <https://1145.am/db/713389/Genstar_Capital>,
        <https://1145.am/db/940663/Genstar_Capital_Llc> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2217392/Harris_Corporation> a org:Organization ;
    ns1:basedInLowRaw "Tenn" ;
    ns1:buyer <https://1145.am/db/2217392/Carefx_Acquisition> ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "Harris Corporation" ;
    ns1:name "Harris Corporation" ;
    ns1:sameAsMedium <https://1145.am/db/1022618/Harris>,
        <https://1145.am/db/1026534/Harris>,
        <https://1145.am/db/1951248/Harris>,
        <https://1145.am/db/2175573/Harris>,
        <https://1145.am/db/2183721/Harris>,
        <https://1145.am/db/2217400/Harris_Corp>,
        <https://1145.am/db/2237260/Harris_Corporation>,
        <https://1145.am/db/2453885/Harris_Corp>,
        <https://1145.am/db/2622319/Harris>,
        <https://1145.am/db/262897/Harris>,
        <https://1145.am/db/2635111/Harris>,
        <https://1145.am/db/2636070/Harris>,
        <https://1145.am/db/597671/Harris>,
        <https://1145.am/db/736873/Harris>,
        <https://1145.am/db/758622/Harris>,
        <https://1145.am/db/867572/Harris>,
        <https://1145.am/db/871411/Harris>,
        <https://1145.am/db/958805/Harris> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2217392/Ingenix> a org:Organization ;
    ns1:buyer <https://1145.am/db/2217392/Axolotl_Acquisition> ;
    ns1:description "health care" ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "Ingenix" ;
    ns1:name "Ingenix" ;
    ns1:sameAsHigh <https://1145.am/db/1175729/Innovage>,
        <https://1145.am/db/1234545/Innovaccer_Inc>,
        <https://1145.am/db/1387011/Innovaccer_Inc>,
        <https://1145.am/db/2187613/Innovaccer>,
        <https://1145.am/db/2199924/Ingenix>,
        <https://1145.am/db/2204518/Ingenix>,
        <https://1145.am/db/2204532/Ingenix>,
        <https://1145.am/db/2205543/Ingenix>,
        <https://1145.am/db/2205570/Ingenix>,
        <https://1145.am/db/2224570/Ingenix>,
        <https://1145.am/db/2227908/Ingenix>,
        <https://1145.am/db/2231160/Ingenix>,
        <https://1145.am/db/2239159/Ingenix>,
        <https://1145.am/db/2239161/Ingenix>,
        <https://1145.am/db/2249469/Ingenious_Med>,
        <https://1145.am/db/2251157/Ingenix>,
        <https://1145.am/db/2252305/Ingenix>,
        <https://1145.am/db/2252311/Ingenix>,
        <https://1145.am/db/2252318/Ingenix>,
        <https://1145.am/db/2262258/Ingenix>,
        <https://1145.am/db/631896/Innovacare>,
        <https://1145.am/db/700180/Innovaccer_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2203459/Ingenix>,
        <https://1145.am/db/2203473/Ingenix>,
        <https://1145.am/db/2203476/Ingenix>,
        <https://1145.am/db/2218433/Ingenix>,
        <https://1145.am/db/2225094/Ingenix>,
        <https://1145.am/db/2227885/Ingenix>,
        <https://1145.am/db/2237749/Ingenix>,
        <https://1145.am/db/2249263/Ingenix>,
        <https://1145.am/db/2250964/Ingenix>,
        <https://1145.am/db/2251336/Ingenix>,
        <https://1145.am/db/2262219/Ingenix>,
        <https://1145.am/db/2338799/Ingenix>,
        <https://1145.am/db/2344145/Ingenix>,
        <https://1145.am/db/2355125/Ingenix>,
        <https://1145.am/db/2581316/Ingenix>,
        <https://1145.am/db/2595379/Ingenix> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2217392/Merge_Healthcare> a org:Organization ;
    ns1:buyer <https://1145.am/db/2217392/Axolotl_Acquisition>,
        <https://1145.am/db/2217392/Evolution_Benefits_Acquisition> ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "Merge Healthcare" ;
    ns1:industry "Healthcare" ;
    ns1:name "Merge Healthcare" ;
    ns1:sameAsHigh <https://1145.am/db/1794140/Merge_Healthcare>,
        <https://1145.am/db/2191010/Healthcare_Merger_Corp>,
        <https://1145.am/db/2208793/Merge_Healthcare>,
        <https://1145.am/db/2210943/Merge_Healthcare_Incorporated>,
        <https://1145.am/db/2215743/Merge_Healthcare>,
        <https://1145.am/db/2218232/Merge_Healthcare>,
        <https://1145.am/db/2220594/Merge_Healthcare_Incorporated>,
        <https://1145.am/db/2223856/Merge_Healthcare_Incorporated>,
        <https://1145.am/db/2227227/Merge_Healthcare>,
        <https://1145.am/db/2228200/Merge_Healthcare_Incorporated>,
        <https://1145.am/db/2228238/Merge_Healthcare>,
        <https://1145.am/db/2232213/Merge_Healthcare>,
        <https://1145.am/db/2247957/Merge_Healthcare_Incorporated>,
        <https://1145.am/db/2250510/Merge_Healthcare_Incorporated>,
        <https://1145.am/db/2251973/Merge_Healthcare_Incorporated>,
        <https://1145.am/db/2320562/Merge_Healthcare>,
        <https://1145.am/db/2326099/Merge_Healthcare>,
        <https://1145.am/db/2326226/Merge_Healthcare>,
        <https://1145.am/db/2365055/Merge_Healthcare_Incorporated> ;
    ns1:sameAsMedium <https://1145.am/db/2205410/Merge_Healthcare>,
        <https://1145.am/db/2266051/Merge_Healthcare> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2217392/The_Raymond_James_Health_Care_Investment_Banking_Group> a org:Organization ;
    ns1:basedInHighGeoName "Nashville" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4644585/about.rdf> ;
    ns1:basedInHighRaw "NASHVILLE, Tenn." ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "The Raymond James Health Care Investment Banking Group" ;
    ns1:name "The Raymond James Health Care Investment Banking Group" ;
    ns1:participant <https://1145.am/db/2217392/Carefx_Acquisition> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2217392/United_Health_Group> a org:Organization ;
    ns1:description "health care" ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "United Health Group" ;
    ns1:industry "health care" ;
    ns1:name "United Health Group" ;
    ns1:participant <https://1145.am/db/2217392/Axolotl_Acquisition>,
        <https://1145.am/db/2217392/Evolution_Benefits_Acquisition>,
        <https://1145.am/db/2217392/Medicity_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/1022548/Unitedhealth_Group>,
        <https://1145.am/db/1026354/Unitedhealth_Group>,
        <https://1145.am/db/1254499/Unitedhealth_Group_Inc>,
        <https://1145.am/db/1354365/Unitedhealth_Group>,
        <https://1145.am/db/1356907/Unitedhealth_Group>,
        <https://1145.am/db/1364380/Unitedhealth_Group>,
        <https://1145.am/db/1391784/Unitedhealth_Group>,
        <https://1145.am/db/1391989/Unitedhealth>,
        <https://1145.am/db/1436644/Unitedhealth_Group>,
        <https://1145.am/db/1571015/Unitedhealth_Group>,
        <https://1145.am/db/1571171/Unitedhealth_Group>,
        <https://1145.am/db/160729/Unitedhealth_Group>,
        <https://1145.am/db/1667595/Unitedhealth>,
        <https://1145.am/db/1954915/Unitedhealth_Group>,
        <https://1145.am/db/2028335/Unitedhealth_Group>,
        <https://1145.am/db/2049606/Unitedhealth_Group>,
        <https://1145.am/db/2083123/Unitedhealth_Group>,
        <https://1145.am/db/2130702/Unitedhealth_Group>,
        <https://1145.am/db/2180529/Unitedhealth_Group>,
        <https://1145.am/db/2180553/Unitedhealth_Group>,
        <https://1145.am/db/2180768/Unitedhealth>,
        <https://1145.am/db/2180897/Unitedhealth>,
        <https://1145.am/db/2181035/Unitedhealth_Group>,
        <https://1145.am/db/2181105/Unitedhealth>,
        <https://1145.am/db/2181147/Unitedhealth_Group>,
        <https://1145.am/db/2181308/Unitedhealth_Group>,
        <https://1145.am/db/2181373/Unitedhealth_Group>,
        <https://1145.am/db/2181653/Unitedhealth_Group>,
        <https://1145.am/db/2181684/Unitedhealth_Group>,
        <https://1145.am/db/2181938/Unitedhealth>,
        <https://1145.am/db/2182152/Unitedhealth_Group>,
        <https://1145.am/db/2182352/Unitedhealth_Group>,
        <https://1145.am/db/2182463/Unitedhealth_Group>,
        <https://1145.am/db/2182610/Unitedhealth>,
        <https://1145.am/db/2182802/Unitedhealth_Group>,
        <https://1145.am/db/2182831/Unitedhealth_Group>,
        <https://1145.am/db/2183391/Unitedhealth_Group>,
        <https://1145.am/db/2183421/Unitedhealth_Group>,
        <https://1145.am/db/2183552/Unitedhealth_Group>,
        <https://1145.am/db/2183796/Unitedhealth_Group>,
        <https://1145.am/db/2183817/Unitedhealth_Group>,
        <https://1145.am/db/2184755/Unitedhealth_Group>,
        <https://1145.am/db/2185092/Unitedhealth_Group>,
        <https://1145.am/db/2185112/Unite_Us>,
        <https://1145.am/db/2185225/Unitedhealth_Group>,
        <https://1145.am/db/2186308/Unitedhealth>,
        <https://1145.am/db/2187572/Unitedhealth_Group>,
        <https://1145.am/db/2187990/Unitedhealth_Group>,
        <https://1145.am/db/2188214/Unitedhealth_Group>,
        <https://1145.am/db/2188220/Unitedhealth>,
        <https://1145.am/db/2188517/Unitedhealth_Group>,
        <https://1145.am/db/2188611/Unitedhealth_Group>,
        <https://1145.am/db/2188811/Unitedhealth_Group>,
        <https://1145.am/db/2189567/Unitedhealth_Group>,
        <https://1145.am/db/2189838/Unitedhealth>,
        <https://1145.am/db/2190569/Unitedhealth_Group>,
        <https://1145.am/db/2190597/Unitedhealth_Group>,
        <https://1145.am/db/2190680/Unitedhealth_Group>,
        <https://1145.am/db/2190774/Unitedhealth_Group>,
        <https://1145.am/db/2191220/Unitedhealth_Group>,
        <https://1145.am/db/2191396/Unitedhealth_Group>,
        <https://1145.am/db/2191526/Unitedhealth>,
        <https://1145.am/db/2191861/Unitedhealth_Group>,
        <https://1145.am/db/2191889/Unc_Health_Care>,
        <https://1145.am/db/2192253/Unitedhealth>,
        <https://1145.am/db/2192387/Unc_Health_Care>,
        <https://1145.am/db/2193901/Unitedhealth>,
        <https://1145.am/db/2194297/Unitedhealth_Group>,
        <https://1145.am/db/2194402/Unitedhealth>,
        <https://1145.am/db/2195452/Unitedhealth>,
        <https://1145.am/db/2196086/Unitedhealth>,
        <https://1145.am/db/2196375/Unitedhealth>,
        <https://1145.am/db/2196727/Unite_Us>,
        <https://1145.am/db/2196817/Unitedhealthcare>,
        <https://1145.am/db/2196854/Unitedhealth_Group>,
        <https://1145.am/db/2197239/Unitedhealthcare>,
        <https://1145.am/db/2197483/Unitedhealth>,
        <https://1145.am/db/2197514/Unitedhealth_Group>,
        <https://1145.am/db/2197584/Unitedhealth>,
        <https://1145.am/db/2197594/Unitedhealth_Group>,
        <https://1145.am/db/2197594/Unitedhealthcare>,
        <https://1145.am/db/2197606/Unitedhealth_Group>,
        <https://1145.am/db/2197622/Unitedhealth>,
        <https://1145.am/db/2198022/Unitedhealth_Group>,
        <https://1145.am/db/2198485/Unitedhealth>,
        <https://1145.am/db/2198684/Unitedhealthcare>,
        <https://1145.am/db/2198780/Unitedhealthcare>,
        <https://1145.am/db/2200045/Unitedhealth>,
        <https://1145.am/db/2200393/Unitedhealth>,
        <https://1145.am/db/2203819/Universal_Health_Services>,
        <https://1145.am/db/2204430/Unitedhealth_Group>,
        <https://1145.am/db/2204532/Unitedhealth_Group>,
        <https://1145.am/db/2206182/Unitedhealthcare>,
        <https://1145.am/db/2206309/Unitedhealth_Group>,
        <https://1145.am/db/2206594/Unitedhealth_Group>,
        <https://1145.am/db/2206608/Unitedhealth_Group>,
        <https://1145.am/db/2207608/Unitedhealth>,
        <https://1145.am/db/2208151/Unitedhealth_Group>,
        <https://1145.am/db/2209468/Universal_American>,
        <https://1145.am/db/2209784/Unitedhealthcare>,
        <https://1145.am/db/2210456/Unitedhealth_Group>,
        <https://1145.am/db/2212478/Unitedhealth_Group>,
        <https://1145.am/db/2212733/Unitedhealth_Group>,
        <https://1145.am/db/2213034/Unitedhealthcare>,
        <https://1145.am/db/2213068/Unitedhealth_Group>,
        <https://1145.am/db/2214077/Unitedhealthcare>,
        <https://1145.am/db/2215612/Unitedhealth_Group>,
        <https://1145.am/db/2217258/Unitedhealth_Group>,
        <https://1145.am/db/2220760/Unitedhealth_Group>,
        <https://1145.am/db/2226852/Unitedhealth_Group>,
        <https://1145.am/db/2227726/United_Healthcare>,
        <https://1145.am/db/2232709/Unitedhealth_Group>,
        <https://1145.am/db/2233048/Unitedhealthcare>,
        <https://1145.am/db/223485/Unitedhealth_Group_Inc>,
        <https://1145.am/db/2236360/Universal_Health_Services>,
        <https://1145.am/db/2236804/Universal_Health_Services>,
        <https://1145.am/db/2237077/Universal_Health_Services>,
        <https://1145.am/db/2237084/Unitedhealth_Group>,
        <https://1145.am/db/2237207/Unitedhealth_Group>,
        <https://1145.am/db/2239301/Unitedhealth_Group>,
        <https://1145.am/db/2239312/Unitedhealthcare>,
        <https://1145.am/db/2241363/Unitedhealth_Group>,
        <https://1145.am/db/2242495/Unitedhealth_Group>,
        <https://1145.am/db/2243356/Unitedhealthcare>,
        <https://1145.am/db/2244766/Unitedhealth_Group>,
        <https://1145.am/db/2244766/Unitedhealthcare>,
        <https://1145.am/db/2247567/Unitedhealthcare>,
        <https://1145.am/db/2248326/Unitedhealthcare>,
        <https://1145.am/db/2252315/Unitedhealthcare>,
        <https://1145.am/db/2254239/Universal_American>,
        <https://1145.am/db/2257167/Unitedhealthcare>,
        <https://1145.am/db/2258043/Unitedhealth_Group>,
        <https://1145.am/db/2258190/Unitedhealth_Group_Inc>,
        <https://1145.am/db/2258197/Unitedhealth>,
        <https://1145.am/db/2259040/Unitedhealthcare>,
        <https://1145.am/db/2259066/Unitedhealth>,
        <https://1145.am/db/2259620/Unitedhealth_Group>,
        <https://1145.am/db/2259793/Unitedhealthcare>,
        <https://1145.am/db/2259794/Unitedhealth_Group>,
        <https://1145.am/db/2259889/Unitedhealth_Group>,
        <https://1145.am/db/2262482/Unitedhealthcare>,
        <https://1145.am/db/2262506/Unitedhealth_Group>,
        <https://1145.am/db/2262569/Unitedhealth>,
        <https://1145.am/db/2263948/Unitedhealth_Group>,
        <https://1145.am/db/2264287/Unitedhealth>,
        <https://1145.am/db/2264321/Unitedhealth>,
        <https://1145.am/db/2264331/Unitedhealth>,
        <https://1145.am/db/2264343/Unitedhealth_Group>,
        <https://1145.am/db/2264884/Unitedhealth_Group>,
        <https://1145.am/db/2264927/Unitedhealth_Group>,
        <https://1145.am/db/2265037/Unitedhealthcare>,
        <https://1145.am/db/2265186/Unitedhealth>,
        <https://1145.am/db/2265406/Universal_Health_Services_Inc>,
        <https://1145.am/db/2266823/Unitedhealthcare>,
        <https://1145.am/db/2266832/Unitedhealthcare>,
        <https://1145.am/db/2268942/Universal_American>,
        <https://1145.am/db/2269237/Unitedhealthcare>,
        <https://1145.am/db/2270148/Unitedhealthcare>,
        <https://1145.am/db/2270480/Unitedhealth_Group_Inc>,
        <https://1145.am/db/2270493/Unitedhealth>,
        <https://1145.am/db/2272155/Unitedhealth>,
        <https://1145.am/db/2272246/Unitedhealth>,
        <https://1145.am/db/2272935/Unitedhealthcare>,
        <https://1145.am/db/2272943/Unitedhealth>,
        <https://1145.am/db/2274867/Unitedhealth_Group>,
        <https://1145.am/db/2275239/Unitedhealthcare>,
        <https://1145.am/db/2276237/Unitedhealth>,
        <https://1145.am/db/2276300/Universal_American>,
        <https://1145.am/db/2277175/Unitedhealthcare>,
        <https://1145.am/db/2277567/Unitedhealth_Group>,
        <https://1145.am/db/2294005/Unitedhealth_Group>,
        <https://1145.am/db/2570115/Unitedhealth>,
        <https://1145.am/db/2574865/Unitedhealth>,
        <https://1145.am/db/2581317/Unitedhealthcare>,
        <https://1145.am/db/2585688/Universal_Health_Services>,
        <https://1145.am/db/2595811/Unitedhealth_Group>,
        <https://1145.am/db/2595811/Unitedhealthcare>,
        <https://1145.am/db/2785756/Unitedhealth_Group>,
        <https://1145.am/db/2785876/United_Medical_Systems_Inc>,
        <https://1145.am/db/390496/Unitedhealth_Group>,
        <https://1145.am/db/490907/Unifihealth>,
        <https://1145.am/db/516698/United_Health_Group>,
        <https://1145.am/db/517694/United_Health_Group>,
        <https://1145.am/db/857593/Unitedhealth_Group>,
        <https://1145.am/db/858955/Unitedhealth_Group>,
        <https://1145.am/db/912123/Unitedhealth_Group>,
        <https://1145.am/db/937763/Unitedhealth_Group>,
        <https://1145.am/db/940193/Unitedhealth_Group>,
        <https://1145.am/db/941337/Unitedhealth_Group>,
        <https://1145.am/db/941949/Unitedhealth_Group>,
        <https://1145.am/db/942335/Unitedhealth_Group>,
        <https://1145.am/db/943526/Unitedhealth_Group>,
        <https://1145.am/db/958110/Unitedhealth_Group_Inc> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2223795/Investment_Airwatch_Airwatch_Inova_Health_System_Telemedicine_Institute_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-06-02T19:09:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "ATLANTA & FALLS CHURCH, Va.- (BUSINESS WIRE) -AirWatch, a global leader in enterprise-grade smartphone and mobile device management (MDM) software, and Inova Health System, Northern Virginia's leading not-for-profit healthcare provider that serves more than 1 million people each year, today announce AirWatch's $ 100,000 gift to Inova for its Telemedicine Institute's Mobility Programs." ;
    ns1:documentTitle "AirWatch Provides a $100,000 Gift to Inova Health System to Fund Telemedicine Institute's Mobility Programs" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/airwatch-provides-a-100-000-gift-to-inova-health-system-to-fund-telemedicine-institute-s> ;
    ns1:foundName "gift" ;
    ns1:name "gift" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2223795/Airwatch>,
        <https://1145.am/db/2223795/Inova_Health_System>,
        <https://1145.am/db/2223795/Telemedicine_Institute> ;
    ns1:valueRaw "$ 100,000" ;
    ns1:whereGeoName "Virginia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6254928/about.rdf> ;
    ns1:whereRaw "Va" .

<https://1145.am/db/2227037/Camden_Partners> a org:Organization ;
    ns1:basedInLowRaw "ST. LOUIS" ;
    ns1:documentDate "2011-07-19T13:30:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Essence Group Closes $61 Million Private Investment Round" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/essence-group-closes-61-million-private-investment-round> ;
    ns1:foundName "Camden Partners" ;
    ns1:investor <https://1145.am/db/2227037/Investment_Camden_Partners_Essence_Group_Holdings_Corporation_Kleiner_Perkins_Caufield___Byers_Completed> ;
    ns1:name "Camden Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1850642/Camden_Partners>,
        <https://1145.am/db/2295941/Camden_Partners>,
        <https://1145.am/db/2330405/Camden_Partners> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2232720/Aurora_(wis)_Health_Care> a org:Organization ;
    ns1:basedInHighGeoName "Wisconsin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5279468/about.rdf> ;
    ns1:basedInHighRaw "Wisconsin" ;
    ns1:buyer <https://1145.am/db/2232720/Acquisition_Aurora_(wis)_Health_Care_Completed>,
        <https://1145.am/db/2232720/Merger_Aurora_(wis)_Health_Care_Aurora_(wis)_Health_Care_Completed> ;
    ns1:documentDate "2011-08-05T15:39:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Doctors charged with $58M in false Medicare, Medicaid billing; DaVita's physician relationships under investigation;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/doctors-charged-58m-false-medicare-medicaid-billing-davita-s-physician-relationships> ;
    ns1:foundName "Aurora",
        "Aurora (Wis.) Health Care" ;
    ns1:industry "Health Care" ;
    ns1:name "Aurora",
        "Aurora (Wis.) Health Care" ;
    ns1:sameAsHigh <https://1145.am/db/2181415/Advocate_Aurora_Health>,
        <https://1145.am/db/2182589/Advocate_Aurora_Health>,
        <https://1145.am/db/2182838/Advocate_Aurora_Health>,
        <https://1145.am/db/2186408/Advocate_Aurora_Health>,
        <https://1145.am/db/2190887/Aurora_Health_Care>,
        <https://1145.am/db/2197868/Aurora_Health_Care>,
        <https://1145.am/db/2198186/Aurora_Health_Care>,
        <https://1145.am/db/2198798/Advocate_Aurora_Enterprises>,
        <https://1145.am/db/2198798/Advocate_Aurora_Health_System>,
        <https://1145.am/db/2259269/Aurora_Health_Care>,
        <https://1145.am/db/2541598/Aurora_Healthcare_Communications> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2232720/Us_Attorneys_Office_For_The_District_Of_Colorado> a org:Organization ;
    ns1:basedInHighGeoName "Denver" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5419384/about.rdf> ;
    ns1:basedInHighRaw "Denver" ;
    ns1:buyer <https://1145.am/db/2232720/Davita_Bankruptcy> ;
    ns1:documentDate "2011-08-05T15:39:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Doctors charged with $58M in false Medicare, Medicaid billing; DaVita's physician relationships under investigation;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/doctors-charged-58m-false-medicare-medicaid-billing-davita-s-physician-relationships> ;
    ns1:foundName "U.S. Attorney's Office for the District of Colorado" ;
    ns1:name "U.S. Attorney's Office for the District of Colorado" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2233192/Dlp_Healthcare> a org:Organization ;
    ns1:basedInHighGeoName "Durham County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4464374/about.rdf> ;
    ns1:basedInHighRaw "DURHAM, N.C." ;
    ns1:buyer <https://1145.am/db/2233192/Operations_Acquisition_Dlp_Healthcare_Duke_University_Health_System_Medcath_Partners_Medcath_Partners_Completed>,
        <https://1145.am/db/2233192/Operations_Acquisition_Dlp_Healthcare_Medcath_Partners_Medcath_Partners_Completed> ;
    ns1:description "Healthcare" ;
    ns1:documentDate "2011-05-05T12:21:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DLP Healthcare Acquires Operations of MedCath Partners" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/dlp-healthcare-acquires-operations-medcath-partners> ;
    ns1:foundName "DLP Healthcare, LLC" ;
    ns1:industry "Healthcare" ;
    ns1:name "DLP Healthcare" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2233192/Duke_University_Health_System> a org:Organization ;
    ns1:basedInHighGeoName "Durham County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4464374/about.rdf> ;
    ns1:basedInHighRaw "DURHAM, N.C." ;
    ns1:description "Business Development" ;
    ns1:documentDate "2011-05-05T12:21:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DLP Healthcare Acquires Operations of MedCath Partners" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/dlp-healthcare-acquires-operations-medcath-partners> ;
    ns1:foundName "Duke University Health System" ;
    ns1:industry "Healthcare" ;
    ns1:name "Duke University Health System" ;
    ns1:participant <https://1145.am/db/2233192/Operations_Acquisition_Dlp_Healthcare_Duke_University_Health_System_Medcath_Partners_Medcath_Partners_Completed> ;
    ns1:sameAsHigh <https://1145.am/db/2232938/Duke_Lifepoint_Healthcare>,
        <https://1145.am/db/2245916/Duke_Lifepoint_Healthcare>,
        <https://1145.am/db/2248992/Duke_Lifepoint_Healthcare>,
        <https://1145.am/db/2249673/Duke_Lifepoint_Healthcare>,
        <https://1145.am/db/2249743/Duke_Lifepoint_Healthcare>,
        <https://1145.am/db/2249785/Duke_Lifepoint>,
        <https://1145.am/db/2253336/Duke_Lifepoint_Healthcare>,
        <https://1145.am/db/2264655/Duke_Lifepoint_Healthcare> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2233192/Medcath_Partners> a org:Organization ;
    ns1:basedInHighGeoName "North Carolina" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4482348/about.rdf> ;
    ns1:basedInHighRaw "North Carolina" ;
    ns1:basedInLowRaw "North Carolina" ;
    ns1:description "providing cardiac catheterization services" ;
    ns1:documentDate "2011-05-05T12:21:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DLP Healthcare Acquires Operations of MedCath Partners" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/dlp-healthcare-acquires-operations-medcath-partners> ;
    ns1:foundName "MedCath Corporation",
        "MedCath Partners, LLC" ;
    ns1:industry "Healthcare" ;
    ns1:name "MedCath Corporation",
        "MedCath Partners" ;
    ns1:participant <https://1145.am/db/2233192/Operations_Acquisition_Dlp_Healthcare_Duke_University_Health_System_Medcath_Partners_Medcath_Partners_Completed>,
        <https://1145.am/db/2233192/Operations_Acquisition_Dlp_Healthcare_Medcath_Partners_Medcath_Partners_Completed> ;
    ns1:sameAsHigh <https://1145.am/db/1046324/Med-Metrix>,
        <https://1145.am/db/1087131/Medicx_Health>,
        <https://1145.am/db/1115650/Medimpact>,
        <https://1145.am/db/1117462/Medimpact>,
        <https://1145.am/db/1306345/Us_Medical_Management>,
        <https://1145.am/db/1450179/Medrina>,
        <https://1145.am/db/1498534/Medicotec>,
        <https://1145.am/db/1563786/Medstar_Health>,
        <https://1145.am/db/1638911/Medusind>,
        <https://1145.am/db/1638924/Medusind>,
        <https://1145.am/db/1639110/Medusind>,
        <https://1145.am/db/1640076/Medusind>,
        <https://1145.am/db/1751275/Medloop>,
        <https://1145.am/db/1754080/Medwing>,
        <https://1145.am/db/1936344/Medwing>,
        <https://1145.am/db/1999524/Medsitter>,
        <https://1145.am/db/2183366/Medstar_Health>,
        <https://1145.am/db/2217409/Medecision>,
        <https://1145.am/db/2218738/Medxt>,
        <https://1145.am/db/2225233/Medcath_Corp>,
        <https://1145.am/db/2226571/Medicasoft>,
        <https://1145.am/db/2232238/Medicasoft>,
        <https://1145.am/db/2233150/Medcath_Corporation>,
        <https://1145.am/db/2234389/Meddata>,
        <https://1145.am/db/2236183/Medrium>,
        <https://1145.am/db/2240083/Med-Metrix_Llc>,
        <https://1145.am/db/2240453/Meddata_Inc>,
        <https://1145.am/db/2241024/Medcath_Corp>,
        <https://1145.am/db/2248383/Medhost>,
        <https://1145.am/db/2250313/Medcath_Corporation>,
        <https://1145.am/db/2250901/Medibank>,
        <https://1145.am/db/2252534/Medcath>,
        <https://1145.am/db/2268068/Medcath>,
        <https://1145.am/db/2297592/Relievant_Medsystems>,
        <https://1145.am/db/2309536/Medtecheart>,
        <https://1145.am/db/2567342/Medicx_Health>,
        <https://1145.am/db/506243/Med-Metrix>,
        <https://1145.am/db/563776/Medsitter>,
        <https://1145.am/db/572855/Medsr>,
        <https://1145.am/db/689460/Medzero>,
        <https://1145.am/db/710972/Medecision>,
        <https://1145.am/db/751402/Medevolve>,
        <https://1145.am/db/875857/Medecision>,
        <https://1145.am/db/911064/Medme_Health>,
        <https://1145.am/db/935872/Medstar_Health>,
        <https://1145.am/db/936578/Medstar_Health>,
        <https://1145.am/db/956779/Us_Medical_Management> ;
    ns1:sameAsMedium <https://1145.am/db/2231785/Medcath>,
        <https://1145.am/db/2233152/Medcath>,
        <https://1145.am/db/2236695/Medcath_Corp> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2233822/The_Physicians_Foundation> a org:Organization ;
    ns1:basedInHighGeoName "Boston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4930956/about.rdf> ;
    ns1:basedInHighRaw "BOSTON" ;
    ns1:description "improving the quality of healthcare for all Americans" ;
    ns1:documentDate "2011-05-10T14:21:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "The Physicians Foundation Awards $1 Million Grant to Health Leads" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/physicians-foundation-awards-1-million-grant-to-health-leads> ;
    ns1:foundName "The Physicians Foundation" ;
    ns1:industry "nonprofit" ;
    ns1:name "The Physicians Foundation" ;
    ns1:participant <https://1145.am/db/2233822/Investment_Health_Leads_The_Physicians_Foundation_Completed> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2234558/Accel_Partners> a org:Organization ;
    ns1:basedInLowRaw "SUNNYVALE, Calif" ;
    ns1:description "investment" ;
    ns1:documentDate "2011-08-17T12:20:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Centrify Secures $16M in Financing to Expand Distribution and Extend Its On-Premise and Cloud Security Offerings" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/centrify-secures-16m-financing-to-expand-distribution-and-extend-its-premise-and-cloud> ;
    ns1:foundName "Accel Partners" ;
    ns1:investor <https://1145.am/db/2234558/Series_D_Investment_Accel_Partners_Centrify_Corporation_Invesco_Private_Capital_Index_Ventures_Mayfield_Fund_Sigma_Partners_Completed> ;
    ns1:name "Accel Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1061598/Accel>,
        <https://1145.am/db/1739942/Accel>,
        <https://1145.am/db/1751631/Accel>,
        <https://1145.am/db/1755304/Accel>,
        <https://1145.am/db/1761826/Accel>,
        <https://1145.am/db/1794049/Accel_Partners>,
        <https://1145.am/db/1795874/Accel_Partners>,
        <https://1145.am/db/1823919/Accel_Partners>,
        <https://1145.am/db/1826221/Accel_Partners>,
        <https://1145.am/db/1863185/Accel_Partners>,
        <https://1145.am/db/1870018/Accel_Partners>,
        <https://1145.am/db/1873748/Accel_Partners>,
        <https://1145.am/db/1874818/Accel_Partners>,
        <https://1145.am/db/1876914/Accel_Partners>,
        <https://1145.am/db/1877362/Accel_Partners>,
        <https://1145.am/db/1879023/Accel_Partners>,
        <https://1145.am/db/1889276/Accel_Partners>,
        <https://1145.am/db/1891530/Accel_Partners>,
        <https://1145.am/db/1892079/Accel_Partners>,
        <https://1145.am/db/1892598/Accel_Partners>,
        <https://1145.am/db/1905299/Accel_Partners>,
        <https://1145.am/db/1922037/Accel_Partners>,
        <https://1145.am/db/2072185/Accel>,
        <https://1145.am/db/2136225/Accel>,
        <https://1145.am/db/2662560/Accel_Partners>,
        <https://1145.am/db/884192/Accel> ;
    ns1:sameAsMedium <https://1145.am/db/1203939/Accel_Partners>,
        <https://1145.am/db/1694757/Accel_Partners>,
        <https://1145.am/db/1698644/Accel_Partners>,
        <https://1145.am/db/1703668/Accel_Partners>,
        <https://1145.am/db/1718432/Accel_Partners>,
        <https://1145.am/db/1719381/Accel_Partners>,
        <https://1145.am/db/1719392/Accel_Partners>,
        <https://1145.am/db/1719619/Accel_Partners>,
        <https://1145.am/db/1726477/Accel_Partners>,
        <https://1145.am/db/1729726/Accel_Partners>,
        <https://1145.am/db/1731295/Accel_Partners>,
        <https://1145.am/db/1735722/Accel_Partners>,
        <https://1145.am/db/1739832/Accel_Partners>,
        <https://1145.am/db/1739928/Accel_Partners>,
        <https://1145.am/db/1750438/Accel_Partners>,
        <https://1145.am/db/1754375/Accel_Partners>,
        <https://1145.am/db/1760696/Accel_Partners>,
        <https://1145.am/db/1766853/Accel_Partners>,
        <https://1145.am/db/1769352/Accel_Partners>,
        <https://1145.am/db/1770578/Accel_Partners>,
        <https://1145.am/db/1770635/Accel_Partners>,
        <https://1145.am/db/1772141/Accel_Partners>,
        <https://1145.am/db/1778667/Accel_Partners>,
        <https://1145.am/db/1779994/Accel_Partners>,
        <https://1145.am/db/1781980/Accel_Partners>,
        <https://1145.am/db/1782022/Accel_Partners>,
        <https://1145.am/db/1788999/Accel_Partners>,
        <https://1145.am/db/1791642/Accel_Partners>,
        <https://1145.am/db/1792423/Accel_Partners>,
        <https://1145.am/db/1792567/Accel_Partners>,
        <https://1145.am/db/1793780/Accel_Partners>,
        <https://1145.am/db/1794115/Accel_Partners>,
        <https://1145.am/db/1795063/Accel_Partners>,
        <https://1145.am/db/1795934/Accel_Partners>,
        <https://1145.am/db/1797968/Accel_Partners>,
        <https://1145.am/db/1799888/Accel_Partners>,
        <https://1145.am/db/1800153/Accel_Partners>,
        <https://1145.am/db/1801835/Accel_Partners>,
        <https://1145.am/db/1802441/Accel_Partners>,
        <https://1145.am/db/1803063/Accel_Partners>,
        <https://1145.am/db/1803251/Accel_Partners>,
        <https://1145.am/db/1805397/Accel_Partners>,
        <https://1145.am/db/1807391/Accel_Partners>,
        <https://1145.am/db/1807542/Accel_Partners>,
        <https://1145.am/db/1817857/Accel_Partners>,
        <https://1145.am/db/1823287/Accel_Partners>,
        <https://1145.am/db/1826465/Accel_Partners>,
        <https://1145.am/db/1826922/Accel_Partners>,
        <https://1145.am/db/1827053/Accel_Partners>,
        <https://1145.am/db/1827381/Accel_Partners>,
        <https://1145.am/db/1828128/Accel_Partners>,
        <https://1145.am/db/1828915/Accel_Partners>,
        <https://1145.am/db/1828979/Accel_Partners>,
        <https://1145.am/db/1829059/Accel_Partners>,
        <https://1145.am/db/1829266/Accel_Partners>,
        <https://1145.am/db/1830003/Accel_Partners>,
        <https://1145.am/db/1830127/Accel_Partners>,
        <https://1145.am/db/1830647/Accel_Partners>,
        <https://1145.am/db/1831440/Accel_Partners>,
        <https://1145.am/db/1831558/Accel_Partners>,
        <https://1145.am/db/1831747/Accel_Partners>,
        <https://1145.am/db/1834734/Accel_Partners>,
        <https://1145.am/db/1835922/Accel_Partners>,
        <https://1145.am/db/1838070/Accel_Partners>,
        <https://1145.am/db/1838531/Accel_Partners>,
        <https://1145.am/db/1838745/Accel_Partners>,
        <https://1145.am/db/1844931/Accel_Partners>,
        <https://1145.am/db/1844999/Accel_Partners>,
        <https://1145.am/db/1845114/Accel_Partners>,
        <https://1145.am/db/1845414/Accel_Partners>,
        <https://1145.am/db/1848225/Accel_Partners>,
        <https://1145.am/db/1848512/Accel_Partners>,
        <https://1145.am/db/1849355/Accel_Partners>,
        <https://1145.am/db/1850222/Accel_Partners>,
        <https://1145.am/db/1852187/Accel_Partners>,
        <https://1145.am/db/1852312/Accel_Partners>,
        <https://1145.am/db/1852745/Accel_Partners>,
        <https://1145.am/db/1852777/Accel_Partners>,
        <https://1145.am/db/1853278/Accel_Partners>,
        <https://1145.am/db/1854050/Accel_Partners>,
        <https://1145.am/db/1854347/Accel_Partners>,
        <https://1145.am/db/1854723/Accel_Partners>,
        <https://1145.am/db/1854971/Accel_Partners>,
        <https://1145.am/db/1856327/Accel_Partners>,
        <https://1145.am/db/1858102/Accel_Partners>,
        <https://1145.am/db/1858521/Accel_Partners>,
        <https://1145.am/db/1858646/Accel_Partners>,
        <https://1145.am/db/1862878/Accel_Partners>,
        <https://1145.am/db/1863164/Accel_Partners>,
        <https://1145.am/db/1863297/Accel_Partners>,
        <https://1145.am/db/1863426/Accel_Partners>,
        <https://1145.am/db/1863500/Accel_Partners>,
        <https://1145.am/db/1864169/Accel_Partners>,
        <https://1145.am/db/1864637/Accel_Partners>,
        <https://1145.am/db/1867084/Accel_Partners>,
        <https://1145.am/db/1868153/Accel_Partners>,
        <https://1145.am/db/1869525/Accel_Partners>,
        <https://1145.am/db/1870106/Accel_Partners>,
        <https://1145.am/db/1872343/Accel_Partners>,
        <https://1145.am/db/1872837/Accel_Partners>,
        <https://1145.am/db/1872947/Accel_Partners>,
        <https://1145.am/db/1873188/Accel_Partners>,
        <https://1145.am/db/1873728/Accel_Partners>,
        <https://1145.am/db/1875163/Accel_Partners>,
        <https://1145.am/db/1875703/Accel_Partners>,
        <https://1145.am/db/1876344/Accel_Partners>,
        <https://1145.am/db/1877236/Accel_Partners>,
        <https://1145.am/db/1878874/Accel_Partners>,
        <https://1145.am/db/1878978/Accel_Partners>,
        <https://1145.am/db/1879128/Accel_Partners>,
        <https://1145.am/db/1879759/Accel_Partners>,
        <https://1145.am/db/1881065/Accel_Partners>,
        <https://1145.am/db/1881652/Accel_Partners>,
        <https://1145.am/db/1881939/Accel_Partners>,
        <https://1145.am/db/1882621/Accel_Partners>,
        <https://1145.am/db/1882686/Accel_Partners>,
        <https://1145.am/db/1883769/Accel_Partners>,
        <https://1145.am/db/1884165/Accel_Partners>,
        <https://1145.am/db/1884349/Accel_Partners>,
        <https://1145.am/db/1889935/Accel_Partners>,
        <https://1145.am/db/1890886/Accel_Partners>,
        <https://1145.am/db/1891545/Accel_Partners>,
        <https://1145.am/db/1892354/Accel_Partners>,
        <https://1145.am/db/1893324/Accel_Partners>,
        <https://1145.am/db/1895183/Accel_Partners>,
        <https://1145.am/db/1895903/Accel_Partners>,
        <https://1145.am/db/1900812/Accel_Partners>,
        <https://1145.am/db/1900904/Accel_Partners>,
        <https://1145.am/db/1901295/Accel_Partners>,
        <https://1145.am/db/1907690/Accel_Partners>,
        <https://1145.am/db/1910484/Accel_Partners>,
        <https://1145.am/db/1912139/Accel_Partners>,
        <https://1145.am/db/1915168/Accel_Partners>,
        <https://1145.am/db/1915994/Accel_Partners>,
        <https://1145.am/db/1917671/Accel_Partners>,
        <https://1145.am/db/1920184/Accel_Partners>,
        <https://1145.am/db/1921374/Accel_Partners>,
        <https://1145.am/db/2173938/Accel_Partners>,
        <https://1145.am/db/2251834/Accel_Partners>,
        <https://1145.am/db/2570138/Accel_Partners>,
        <https://1145.am/db/2635849/Accel_Partners>,
        <https://1145.am/db/2638432/Accel_Partners>,
        <https://1145.am/db/412403/Accel_Partners>,
        <https://1145.am/db/415316/Accel_Partners> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2234558/Invesco_Private_Capital> a org:Organization ;
    ns1:basedInLowRaw "SUNNYVALE, Calif" ;
    ns1:documentDate "2011-08-17T12:20:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Centrify Secures $16M in Financing to Expand Distribution and Extend Its On-Premise and Cloud Security Offerings" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/centrify-secures-16m-financing-to-expand-distribution-and-extend-its-premise-and-cloud> ;
    ns1:foundName "INVESCO Private Capital" ;
    ns1:investor <https://1145.am/db/2234558/Series_D_Investment_Accel_Partners_Centrify_Corporation_Invesco_Private_Capital_Index_Ventures_Mayfield_Fund_Sigma_Partners_Completed> ;
    ns1:name "INVESCO Private Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1007161/Invesco_Private_Capital>,
        <https://1145.am/db/1081175/Invesco_Private_Capital>,
        <https://1145.am/db/1082613/Invesco_Private_Capital>,
        <https://1145.am/db/1765392/Invesco_Private_Capital>,
        <https://1145.am/db/1921869/Invesco_Private_Capital> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2234558/Mayfield_Fund> a org:Organization ;
    ns1:basedInLowRaw "SUNNYVALE, Calif" ;
    ns1:description "investment" ;
    ns1:documentDate "2011-08-17T12:20:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Centrify Secures $16M in Financing to Expand Distribution and Extend Its On-Premise and Cloud Security Offerings" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/centrify-secures-16m-financing-to-expand-distribution-and-extend-its-premise-and-cloud> ;
    ns1:foundName "Mayfield Fund" ;
    ns1:investor <https://1145.am/db/2234558/Series_D_Investment_Accel_Partners_Centrify_Corporation_Invesco_Private_Capital_Index_Ventures_Mayfield_Fund_Sigma_Partners_Completed> ;
    ns1:name "Mayfield Fund" ;
    ns1:sameAsHigh <https://1145.am/db/1106214/Mayfield_Humboldt_Fund>,
        <https://1145.am/db/1140730/Mayfield_Fund>,
        <https://1145.am/db/1713187/Mayfield_Fund>,
        <https://1145.am/db/1767995/Mayfield_Fund>,
        <https://1145.am/db/1828087/Mayfield_Fund>,
        <https://1145.am/db/1834982/Mayfield_Fund>,
        <https://1145.am/db/862760/Mayfield_Fund>,
        <https://1145.am/db/862851/Mayfield_Fund>,
        <https://1145.am/db/951514/Mayfield_India>,
        <https://1145.am/db/952832/Mayfield_India> ;
    ns1:sameAsMedium <https://1145.am/db/1269968/Mayfield_Fund>,
        <https://1145.am/db/1579373/Mayfield_Fund>,
        <https://1145.am/db/1667921/Mayfield_Fund>,
        <https://1145.am/db/1697005/Mayfield_Fund>,
        <https://1145.am/db/1707189/Mayfield_Fund>,
        <https://1145.am/db/1711300/Mayfield_Fund>,
        <https://1145.am/db/1712527/Mayfield_Fund>,
        <https://1145.am/db/1719392/Mayfield_Fund>,
        <https://1145.am/db/1721393/Mayfield_Fund>,
        <https://1145.am/db/1738731/Mayfield_Fund>,
        <https://1145.am/db/1741188/Mayfield_Fund>,
        <https://1145.am/db/1750685/Mayfield_Fund>,
        <https://1145.am/db/1756727/Mayfield_Fund>,
        <https://1145.am/db/1783231/Mayfield_Fund>,
        <https://1145.am/db/1788138/Mayfield_Fund>,
        <https://1145.am/db/1808677/Mayfield_Fund>,
        <https://1145.am/db/1824212/Mayfield_Fund>,
        <https://1145.am/db/1826053/Mayfield_Fund>,
        <https://1145.am/db/1828729/Mayfield_Fund>,
        <https://1145.am/db/1829257/Mayfield_Fund>,
        <https://1145.am/db/1834392/Mayfield_Fund>,
        <https://1145.am/db/1836065/Mayfield_Fund>,
        <https://1145.am/db/1838365/Mayfield_Fund>,
        <https://1145.am/db/1842872/Mayfield_Fund>,
        <https://1145.am/db/1849906/Mayfield_Fund>,
        <https://1145.am/db/1850812/Mayfield_Fund>,
        <https://1145.am/db/1854203/Mayfield_Fund>,
        <https://1145.am/db/1856424/Mayfield_Fund>,
        <https://1145.am/db/1859246/Mayfield_Fund>,
        <https://1145.am/db/1863384/Mayfield_Fund>,
        <https://1145.am/db/1870715/Mayfield_Fund>,
        <https://1145.am/db/1872463/Mayfield_Fund>,
        <https://1145.am/db/1877243/Mayfield_Fund>,
        <https://1145.am/db/1881065/Mayfield_Fund>,
        <https://1145.am/db/1882598/Mayfield_Fund>,
        <https://1145.am/db/1886261/Mayfield_Fund>,
        <https://1145.am/db/1889961/Mayfield_Fund>,
        <https://1145.am/db/1891542/Mayfield_Fund>,
        <https://1145.am/db/1891543/Mayfield_Fund>,
        <https://1145.am/db/1894848/Mayfield_Fund>,
        <https://1145.am/db/1914136/Mayfield_Fund>,
        <https://1145.am/db/1919724/Mayfield_Fund>,
        <https://1145.am/db/2174824/Mayfield_Fund>,
        <https://1145.am/db/2206261/Mayfield_Fund>,
        <https://1145.am/db/2206263/Mayfield_Fund>,
        <https://1145.am/db/2438872/Mayfield_Fund>,
        <https://1145.am/db/471967/Mayfield_Fund> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2234558/Sigma_Partners> a org:Organization ;
    ns1:basedInLowRaw "SUNNYVALE, Calif" ;
    ns1:description "investment" ;
    ns1:documentDate "2011-08-17T12:20:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Centrify Secures $16M in Financing to Expand Distribution and Extend Its On-Premise and Cloud Security Offerings" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/centrify-secures-16m-financing-to-expand-distribution-and-extend-its-premise-and-cloud> ;
    ns1:foundName "Sigma Partners" ;
    ns1:investor <https://1145.am/db/2234558/Series_D_Investment_Accel_Partners_Centrify_Corporation_Invesco_Private_Capital_Index_Ventures_Mayfield_Fund_Sigma_Partners_Completed> ;
    ns1:name "Sigma Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1696236/Sigma_Partners>,
        <https://1145.am/db/1700857/Sigma_Partners>,
        <https://1145.am/db/1825267/Sigma_Partners>,
        <https://1145.am/db/1835647/Sigma_Partners>,
        <https://1145.am/db/1841598/Sigma_Partners>,
        <https://1145.am/db/1846783/Sigma_Partners>,
        <https://1145.am/db/1849310/Sigma_Partners>,
        <https://1145.am/db/1862549/Sigma_Partners>,
        <https://1145.am/db/1871777/Sigma_Partners>,
        <https://1145.am/db/1873931/Sigma_Partners>,
        <https://1145.am/db/1886915/Sigma_Partners>,
        <https://1145.am/db/1896251/Sigma_Partners>,
        <https://1145.am/db/1907281/Sigma_Partners>,
        <https://1145.am/db/1913148/Sigma_Partners> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2235176/First_5_La> a org:Organization ;
    ns1:basedInHighGeoName "California" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:basedInHighRaw "California" ;
    ns1:documentDate "2011-08-18T16:20:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Valley Presbyterian Hospital Wins Grant for Breastfeeding Support" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/valley-presbyterian-hospital-wins-grant-for-breastfeeding-support> ;
    ns1:foundName "First 5 LA" ;
    ns1:investor <https://1145.am/db/2235176/Investment_First_5_La_Valley_Presbyterian_Hospital_Has_Not_Happened> ;
    ns1:name "First 5 LA" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2239374/Carraway_Medical_Systems_Llc> a org:Organization ;
    ns1:basedInLowRaw "AL" ;
    ns1:buyer <https://1145.am/db/2239374/Chilton_Medical_Center_Acquisition> ;
    ns1:description "Healthcare" ;
    ns1:documentDate "2011-03-03T23:20:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SunLink Health Systems, Inc. Announces the Lease of Its Chilton Medical Center" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/sunlink-health-systems-inc-announces-lease-its-chilton-medical-center> ;
    ns1:foundName "Carraway Medical Systems, LLC" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2239374/Chilton_Medical_Center_Acquisition> ;
    ns1:name "Carraway Medical Systems, LLC" ;
    ns1:participant <https://1145.am/db/2239374/Chilton_Medical_Center_Acquisition> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2239375/Health_Foundation_Of_South_Florida> a org:Organization ;
    ns1:basedInHighGeoName "Miami" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4164138/about.rdf> ;
    ns1:basedInHighRaw "MIAMI" ;
    ns1:documentDate "2011-03-04T12:20:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Institute for Child & Family Health (ICFH) Awarded $100,000 From Health Foundation of South Florida" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/institute-for-child-family-health-icfh-awarded-100-000-from-health-foundation-south> ;
    ns1:foundName "Health Foundation of South Florida" ;
    ns1:investor <https://1145.am/db/2239375/Investment_Health_Foundation_Of_South_Florida_Institute_For_Child_And_Family_Health_Has_Not_Happened> ;
    ns1:name "Health Foundation of South Florida" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2240085/Genesis_Healthcare_Corporation_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-03-07T22:20:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The company intends to use the net proceeds from these offerings to finance a portion of the purchase of its previously announced acquisition of substantially all of the real estate assets of privately - owned Genesis HealthCare Corporation for a price of $ 2.4 billion." ;
    ns1:documentTitle "Health Care REIT, Inc. Completes $2.1 Billion in Concurrent Offerings of Common Stock and Cumulative Convertible Perpetual" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/health-care-reit-inc-completes-2-1-billion-concurrent-offerings-common-stock-and> ;
    ns1:foundName "acquisition",
        "purchase" ;
    ns1:name "acquisition",
        "purchase" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2240085/Genesis_Healthcare_Corporation> ;
    ns1:targetName "Genesis HealthCare Corporation" ;
    ns1:valueRaw "$ 2.4 billion" .

<https://1145.am/db/2240085/Health_Care_Reit> a org:Organization ;
    ns1:basedInHighGeoName "Toledo" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5174035/about.rdf> ;
    ns1:basedInHighRaw "TOLEDO, Ohio" ;
    ns1:buyer <https://1145.am/db/2240085/Ipo_Health_Care_Reit_Completed> ;
    ns1:documentDate "2011-03-07T22:20:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Health Care REIT, Inc. Completes $2.1 Billion in Concurrent Offerings of Common Stock and Cumulative Convertible Perpetual" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/health-care-reit-inc-completes-2-1-billion-concurrent-offerings-common-stock-and> ;
    ns1:foundName "Health Care REIT, Inc." ;
    ns1:name "Health Care REIT" ;
    ns1:sameAsMedium <https://1145.am/db/2231360/Health_Care_Reit>,
        <https://1145.am/db/2232416/Health_Care_Reit>,
        <https://1145.am/db/2236815/Health_Care_Reit>,
        <https://1145.am/db/2238687/Health_Care_Reit>,
        <https://1145.am/db/2238691/Health_Care_Reit>,
        <https://1145.am/db/2246571/Health_Care_Reit>,
        <https://1145.am/db/2248737/Health_Care_Reit>,
        <https://1145.am/db/2251600/Health_Care_Reit>,
        <https://1145.am/db/2252099/Health_Care_Reit>,
        <https://1145.am/db/2265064/Health_Care_Reit> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2246449/Promedica_Health_System> a org:Organization ;
    ns1:basedInHighGeoName "Ohio",
        "Toledo" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5165418/about.rdf>,
        <https://sws.geonames.org/5174035/about.rdf> ;
    ns1:basedInHighRaw "Ohio",
        "Toledo, Ohio" ;
    ns1:buyer <https://1145.am/db/2246449/St_Lukes_Hospital_Control_Acquisition> ;
    ns1:description "health care",
        "healthcare" ;
    ns1:documentDate "2011-01-07T14:47:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "FTC and Ohio Attorney General Challenge ProMedica's Acquisition of St. Luke's Hospital" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/ftc-and-ohio-attorney-general-challenge-promedica-s-acquisition-st-luke-s-hospital> ;
    ns1:foundName "ProMedica",
        "ProMedica Health System, Inc." ;
    ns1:industry "Healthcare",
        "health care" ;
    ns1:name "ProMedica",
        "ProMedica Health System" ;
    ns1:sameAsHigh <https://1145.am/db/2180683/Promedica_Health_System>,
        <https://1145.am/db/2188819/Promedica_Health_System>,
        <https://1145.am/db/2198437/Promedica>,
        <https://1145.am/db/2235838/Promedica>,
        <https://1145.am/db/2246455/Promedica_Health_System>,
        <https://1145.am/db/2254907/Promedica>,
        <https://1145.am/db/2259150/Promedica>,
        <https://1145.am/db/2276051/Promedica>,
        <https://1145.am/db/2295407/Promedica>,
        <https://1145.am/db/975089/Promaxo> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2247240/Blueocean_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:documentDate "2011-07-05T14:20:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MyoPowers Closes Series B Investment of CHF 16 Million" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/myopowers-closes-series-b-investment-chf-16-million> ;
    ns1:foundName "BlueOcean Ventures" ;
    ns1:investor <https://1145.am/db/2247240/Series_B_Investment_Blueocean_Ventures_Gran_Plasa_Sa_Initiative_Capital_Romandie_Myopowers_Medical_Technologies_Sa_Novartis_Venture_Funds_Truffle_Capital_Completed> ;
    ns1:name "BlueOcean Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2292300/Blueocean_Ventures> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2247240/Gran_Plasa_Sa> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:documentDate "2011-07-05T14:20:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MyoPowers Closes Series B Investment of CHF 16 Million" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/myopowers-closes-series-b-investment-chf-16-million> ;
    ns1:foundName "Gran Plasa SA" ;
    ns1:investor <https://1145.am/db/2247240/Series_B_Investment_Blueocean_Ventures_Gran_Plasa_Sa_Initiative_Capital_Romandie_Myopowers_Medical_Technologies_Sa_Novartis_Venture_Funds_Truffle_Capital_Completed> ;
    ns1:name "Gran Plasa SA" ;
    ns1:sameAsMedium <https://1145.am/db/2292300/Gran_Plasa> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2247240/Truffle_Capital> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:documentDate "2011-07-05T14:20:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MyoPowers Closes Series B Investment of CHF 16 Million" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/myopowers-closes-series-b-investment-chf-16-million> ;
    ns1:foundName "Truffle Capital" ;
    ns1:investor <https://1145.am/db/2247240/Series_B_Investment_Blueocean_Ventures_Gran_Plasa_Sa_Initiative_Capital_Romandie_Myopowers_Medical_Technologies_Sa_Novartis_Venture_Funds_Truffle_Capital_Completed> ;
    ns1:name "Truffle Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1790627/Truffle_Capital>,
        <https://1145.am/db/1911696/Truffle_Capital>,
        <https://1145.am/db/2154535/Truffle_Capital>,
        <https://1145.am/db/2292300/Truffle_Capital>,
        <https://1145.am/db/2315943/Truffle_Capital>,
        <https://1145.am/db/2315957/Truffle_Capital>,
        <https://1145.am/db/2327256/Truffle_Capital>,
        <https://1145.am/db/2332658/Truffle_Capital>,
        <https://1145.am/db/2332659/Truffle_Capital>,
        <https://1145.am/db/2362455/Truffle_Capital> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2258082/Blue_Cross_Blue_Shield_Of_Michigan> a org:Organization ;
    ns1:basedInLowRaw "Michigan" ;
    ns1:buyer <https://1145.am/db/2258082/Acquisition_Blue_Cross_Blue_Shield_Of_Michigan_Independence_Blue_Cross_Has_Not_Happened> ;
    ns1:description "Medicaid coverage" ;
    ns1:documentDate "2011-08-12T02:10:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blues plans spend $170M to expand into Medicaid" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/blues-plans-spend-170m-to-expand-into-medicaid> ;
    ns1:foundName "Blue Cross Blue Shield of Michigan" ;
    ns1:industry "health care" ;
    ns1:name "Blue Cross Blue Shield of Michigan" ;
    ns1:sameAsHigh <https://1145.am/db/2181234/Blue_Cross_Blue_Shield_Of_Massachusetts>,
        <https://1145.am/db/2267701/Blue_Cross_Blue_Shield_Of_Michigan>,
        <https://1145.am/db/402970/Blue_Cross_Blue_Shield_Of_Michigan> ;
    ns1:sameAsMedium <https://1145.am/db/2180704/Blue_Cross_Blue_Shield_Of_Michigan>,
        <https://1145.am/db/2258956/Blue_Cross_Blue_Shield_Of_Michigan>,
        <https://1145.am/db/2259922/Blue_Cross_Blue_Shield_Of_Michigan>,
        <https://1145.am/db/2260694/Blue_Cross_Blue_Shield_Of_Michigan> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2258082/Independence_Blue_Cross> a org:Organization ;
    ns1:basedInLowRaw "Michigan",
        "Philadelphia" ;
    ns1:buyer <https://1145.am/db/2258082/Acquisition_Blue_Cross_Blue_Shield_Of_Michigan_Independence_Blue_Cross_Has_Not_Happened>,
        <https://1145.am/db/2258082/Amerihealth_Acquisition> ;
    ns1:description "health care" ;
    ns1:documentDate "2011-08-12T02:10:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blues plans spend $170M to expand into Medicaid" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/blues-plans-spend-170m-to-expand-into-medicaid> ;
    ns1:foundName "Independence",
        "Independence Blue Cross" ;
    ns1:industry "health care" ;
    ns1:name "Independence",
        "Independence Blue Cross" ;
    ns1:sameAsHigh <https://1145.am/db/2208110/Independence_Blue_Cross>,
        <https://1145.am/db/2213777/Independence_Blue_Cross>,
        <https://1145.am/db/2214452/Independence_Blue_Cross>,
        <https://1145.am/db/2231871/Independence_Blue_Cross>,
        <https://1145.am/db/2263068/Independence_Blue_Cross>,
        <https://1145.am/db/2267701/Independence_Blue_Cross>,
        <https://1145.am/db/2269235/Independence_Blue_Cross> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2258082/Michigan_Blues> a org:Organization ;
    ns1:basedInLowRaw "Americans" ;
    ns1:buyer <https://1145.am/db/2258082/Amerihealth_Acquisition> ;
    ns1:documentDate "2011-08-12T02:10:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blues plans spend $170M to expand into Medicaid" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/blues-plans-spend-170m-to-expand-into-medicaid> ;
    ns1:foundName "Michigan Blues" ;
    ns1:industry "healthcare" ;
    ns1:name "Michigan Blues" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2289564/Investment_Plus:_Nexstim_Oy_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-26T12:42:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "PLUS: Nexstim Oy has closed a 11.4 million round of financing." ;
    ns1:documentTitle "CSA Medical snares $10M in first round" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/csa-medical-snares-10m-first-round> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2289564/Plus:_Nexstim_Oy> ;
    ns1:valueRaw "11.4 million" ;
    ns1:whereGeoName "Baltimore County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4347790/about.rdf> ;
    ns1:whereRaw "Baltimore" .

<https://1145.am/db/2289564/New_Markets_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Baltimore" ;
    ns1:documentDate "2011-01-26T12:42:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CSA Medical snares $10M in first round" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/csa-medical-snares-10m-first-round> ;
    ns1:foundName "New Markets Venture Partners" ;
    ns1:investor <https://1145.am/db/2289564/Preferred_Stock_Investment_Csa_Medical_New_Markets_Venture_Partners_Completed> ;
    ns1:name "New Markets Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1119554/New_Markets_Venture_Partners>,
        <https://1145.am/db/1699998/New_Markets_Venture_Partners>,
        <https://1145.am/db/1750968/New_Market_Venture_Partners>,
        <https://1145.am/db/1817564/New_Markets_Venture_Partners>,
        <https://1145.am/db/1829316/New_Markets_Venture_Partners>,
        <https://1145.am/db/1853417/New_Markets_Venture_Partners>,
        <https://1145.am/db/400838/New_Markets_Venture_Partners>,
        <https://1145.am/db/488751/New_Markets_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289564/Series_D_Investment_Raindance_Technologies_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-26T12:42:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "ALSO: Lexington, MA - based RainDance Technologies has raised a $ 37.5 million Series D led by a pair of high-profile life science venture groups, giving it some extra cash to help advance its genomic research tools." ;
    ns1:documentTitle "CSA Medical snares $10M in first round" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/csa-medical-snares-10m-first-round> ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2289564/Raindance_Technologies> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "$ 37.5 million" ;
    ns1:whereGeoName "Baltimore County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4347790/about.rdf> ;
    ns1:whereRaw "Baltimore" .

<https://1145.am/db/2289591/Investment_Glaukos_Corp_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-02-07T14:05:59+00:00"^^xsd:dateTime ;
    ns1:documentExtract "ALSO: Palo Alto - based Glaukos Corp. has raised $ 29.5 million in a fifth round of venture capital funding to support development of a device that can be implanted to treat glaucoma." ;
    ns1:documentTitle "Cellnovo lands $48M for diabetes management system" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cellnovo-lands-48m-for-diabetes-management-system> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2289591/Glaukos_Corp> ;
    ns1:valueRaw "$ 29.5 million" ;
    ns1:whereGeoName "London" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:whereRaw "London" .

<https://1145.am/db/2289940/First_Alliance___Capital_Invest> a org:Organization ;
    ns1:basedInLowRaw "Europe" ;
    ns1:description "first-timers" ;
    ns1:documentDate "2011-03-02T12:55:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CardioFocus raises $30.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiofocus-raises-30-6m> ;
    ns1:foundName "First Alliance & Capital Invest" ;
    ns1:investor <https://1145.am/db/2289940/Investment_Cardiofocus_First_Alliance___Capital_Invest_Fletcher_Spaght_Ventures_Manatuck_Hill_Partners_Has_Not_Happened> ;
    ns1:name "First Alliance & Capital Invest" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289940/Fletcher_Spaght_Ventures> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:documentDate "2011-03-02T12:55:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CardioFocus raises $30.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiofocus-raises-30-6m> ;
    ns1:foundName "Fletcher Spaght Ventures" ;
    ns1:investor <https://1145.am/db/2289940/Investment_Cardiofocus_First_Alliance___Capital_Invest_Fletcher_Spaght_Ventures_Manatuck_Hill_Partners_Has_Not_Happened> ;
    ns1:name "Fletcher Spaght Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2292313/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2296640/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2306163/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2324756/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358640/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358658/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2364827/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365444/Fletcher_Spaght_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289940/Investment_Retina_Implant_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-03-02T12:55:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "ALSO: Retina Implant, which manufactures subretinal implants, has raised $ 18 million in venture capital funds." ;
    ns1:documentTitle "CardioFocus raises $30.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiofocus-raises-30-6m> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2289940/Retina_Implant> ;
    ns1:valueRaw "$ 18 million" ;
    ns1:whereGeoName "Marlborough" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4943170/about.rdf> ;
    ns1:whereRaw "Marlborough, MA" .

<https://1145.am/db/2289940/Manatuck_Hill_Partners> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:documentDate "2011-03-02T12:55:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CardioFocus raises $30.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiofocus-raises-30-6m> ;
    ns1:foundName "Manatuck Hill Partners" ;
    ns1:investor <https://1145.am/db/2289940/Investment_Cardiofocus_First_Alliance___Capital_Invest_Fletcher_Spaght_Ventures_Manatuck_Hill_Partners_Has_Not_Happened> ;
    ns1:name "Manatuck Hill Partners" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290405/Battelle_Ventures> a org:Organization ;
    ns1:description "equity financing" ;
    ns1:documentDate "2011-03-18T01:13:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Finance, GE Capital give $20M senior credit facility to NeoVista" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/oxford-finance-ge-capital-give-20m-senior-credit-facility-to-neovista> ;
    ns1:foundName "Battelle Ventures" ;
    ns1:investor <https://1145.am/db/2290405/Equity_Investment_Battelle_Ventures_Bionanomatrix_Domain_Associates_Gund_Investment_Corporation_Innovation_Valley_Partners_Kt_Venture_Group_Completed> ;
    ns1:name "Battelle Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2325346/Battelle_Ventures>,
        <https://1145.am/db/2328781/Battelle_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2302124/Battelle_Ventures>,
        <https://1145.am/db/2302732/Battelle_Ventures>,
        <https://1145.am/db/2357981/Battelle_Ventures>,
        <https://1145.am/db/2447220/Battelle_Ventures>,
        <https://1145.am/db/2454251/Battelle_Ventures_Lp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290405/Domain_Associates> a org:Organization ;
    ns1:description "equity financing" ;
    ns1:documentDate "2011-03-18T01:13:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Finance, GE Capital give $20M senior credit facility to NeoVista" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/oxford-finance-ge-capital-give-20m-senior-credit-facility-to-neovista> ;
    ns1:foundName "Domain Associates" ;
    ns1:investor <https://1145.am/db/2290405/Equity_Investment_Battelle_Ventures_Bionanomatrix_Domain_Associates_Gund_Investment_Corporation_Innovation_Valley_Partners_Kt_Venture_Group_Completed> ;
    ns1:name "Domain Associates" ;
    ns1:sameAsHigh <https://1145.am/db/2289515/Domain_Associates>,
        <https://1145.am/db/2303642/Domain_Associates>,
        <https://1145.am/db/2304587/Domain_Associates>,
        <https://1145.am/db/2330075/Domain_Associates>,
        <https://1145.am/db/2330539/Domain_Associates>,
        <https://1145.am/db/2352170/Domain_Associates>,
        <https://1145.am/db/2354899/Domain_Associates>,
        <https://1145.am/db/2361625/Domain_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1859331/Domain_Associates>,
        <https://1145.am/db/2153759/Domain_Associates>,
        <https://1145.am/db/2155032/Domain_Associates>,
        <https://1145.am/db/2155189/Domain_Associates>,
        <https://1145.am/db/2289819/Domain_Associates>,
        <https://1145.am/db/2294753/Domain_Associates>,
        <https://1145.am/db/2296841/Domain_Associates>,
        <https://1145.am/db/2297408/Domain_Associates>,
        <https://1145.am/db/2299776/Domain_Associates>,
        <https://1145.am/db/2300270/Domain_Associates>,
        <https://1145.am/db/2300293/Domain_Associates>,
        <https://1145.am/db/2300337/Domain_Associates>,
        <https://1145.am/db/2300455/Domain_Associates>,
        <https://1145.am/db/2302292/Domain_Associates_Llc>,
        <https://1145.am/db/2302508/Domain_Associates>,
        <https://1145.am/db/2303641/Domain_Associates>,
        <https://1145.am/db/2303793/Domain_Associates>,
        <https://1145.am/db/2304578/Domain_Associates>,
        <https://1145.am/db/2305524/Domain_Associates>,
        <https://1145.am/db/2305530/Domain_Associates>,
        <https://1145.am/db/2305706/Domain_Associates>,
        <https://1145.am/db/2305713/Domain_Associates>,
        <https://1145.am/db/2305729/Domain_Associates>,
        <https://1145.am/db/2306290/Domain_Associates_Llc>,
        <https://1145.am/db/2306873/Domain_Associates>,
        <https://1145.am/db/2307237/Domain_Associates>,
        <https://1145.am/db/2307644/Domain_Associates>,
        <https://1145.am/db/2309809/Domain_Associates>,
        <https://1145.am/db/2310073/Domain_Associates>,
        <https://1145.am/db/2311099/Domain_Associates>,
        <https://1145.am/db/2311221/Domain_Associates>,
        <https://1145.am/db/2312051/Domain_Associates>,
        <https://1145.am/db/2312120/Domain_Associates>,
        <https://1145.am/db/2312297/Domain_Associates>,
        <https://1145.am/db/2313171/Domain_Associates>,
        <https://1145.am/db/2316210/Domain_Associates>,
        <https://1145.am/db/2316214/Domain_Associates>,
        <https://1145.am/db/2317145/Domain_Associates>,
        <https://1145.am/db/2317951/Domain_Associates>,
        <https://1145.am/db/2318934/Domain_Associates>,
        <https://1145.am/db/2320925/Domain_Associates>,
        <https://1145.am/db/2322231/Domain_Associates>,
        <https://1145.am/db/2326423/Domain_Associates>,
        <https://1145.am/db/2326430/Domain_Associates_Llc>,
        <https://1145.am/db/2328030/Domain_Associates_Llc>,
        <https://1145.am/db/2328034/Domain_Associates_Llc>,
        <https://1145.am/db/2330549/Domain_Associates>,
        <https://1145.am/db/2331026/Domain_Associates>,
        <https://1145.am/db/2331047/Domain_Associates>,
        <https://1145.am/db/2331784/Domain_Associates>,
        <https://1145.am/db/2336221/Domain_Associates>,
        <https://1145.am/db/2340284/Domain_Associates>,
        <https://1145.am/db/2340634/Domain_Associates>,
        <https://1145.am/db/2341764/Domain_Associates>,
        <https://1145.am/db/2343206/Domain_Associates>,
        <https://1145.am/db/2344090/Domain_Associates>,
        <https://1145.am/db/2344092/Domain_Associates>,
        <https://1145.am/db/2344100/Domain_Associates>,
        <https://1145.am/db/2344782/Domain_Associates>,
        <https://1145.am/db/2347984/Domain_Associates>,
        <https://1145.am/db/2349143/Domain_Associates>,
        <https://1145.am/db/2349753/Domain_Associates>,
        <https://1145.am/db/2350044/Domain_Associates>,
        <https://1145.am/db/2352167/Domain_Associates>,
        <https://1145.am/db/2352808/Domain_Associates>,
        <https://1145.am/db/2354903/Domain_Associates>,
        <https://1145.am/db/2355936/Domain_Associates>,
        <https://1145.am/db/2355938/Domain_Associates>,
        <https://1145.am/db/2356301/Domain_Associates>,
        <https://1145.am/db/2357325/Domain_Associates>,
        <https://1145.am/db/2357981/Domain_Associates>,
        <https://1145.am/db/2358541/Domain_Associates>,
        <https://1145.am/db/2358883/Domain_Associates>,
        <https://1145.am/db/2362278/Domain_Associates>,
        <https://1145.am/db/2365700/Domain_Associates>,
        <https://1145.am/db/2366128/Domain_Associates>,
        <https://1145.am/db/2366133/Domain_Associates>,
        <https://1145.am/db/2366187/Domain_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290405/Innovation_Valley_Partners> a org:Organization ;
    ns1:description "equity financing" ;
    ns1:documentDate "2011-03-18T01:13:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Finance, GE Capital give $20M senior credit facility to NeoVista" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/oxford-finance-ge-capital-give-20m-senior-credit-facility-to-neovista> ;
    ns1:foundName "Innovation Valley Partners" ;
    ns1:investor <https://1145.am/db/2290405/Equity_Investment_Battelle_Ventures_Bionanomatrix_Domain_Associates_Gund_Investment_Corporation_Innovation_Valley_Partners_Kt_Venture_Group_Completed> ;
    ns1:name "Innovation Valley Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2325346/Innovation_Valley_Partners>,
        <https://1145.am/db/2328781/Innovation_Valley_Partners>,
        <https://1145.am/db/2454251/Innovation_Valley_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/2302124/Innovation_Valley_Partners>,
        <https://1145.am/db/2302732/Innovation_Valley_Partners>,
        <https://1145.am/db/2357981/Innovation_Valley_Partners>,
        <https://1145.am/db/2447220/Innovation_Valley_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290405/Investment_Neovista_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-03-18T01:13:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Sumitomo subsidiary Oxford Finance Corporation has joined GE Capital, Healthcare Financial Services in closing a $ 20 million round of debt financing for NeoVista." ;
    ns1:documentTitle "Oxford Finance, GE Capital give $20M senior credit facility to NeoVista" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/oxford-finance-ge-capital-give-20m-senior-credit-facility-to-neovista> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2290405/Neovista> ;
    ns1:valueRaw "$ 20 million" ;
    ns1:whereGeoName "Newark" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5376803/about.rdf> ;
    ns1:whereRaw "Newark, CA" .

<https://1145.am/db/2290405/Kt_Venture_Group> a org:Organization ;
    ns1:description "equity financing" ;
    ns1:documentDate "2011-03-18T01:13:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Finance, GE Capital give $20M senior credit facility to NeoVista" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/oxford-finance-ge-capital-give-20m-senior-credit-facility-to-neovista> ;
    ns1:foundName "KT Venture Group" ;
    ns1:investor <https://1145.am/db/2290405/Equity_Investment_Battelle_Ventures_Bionanomatrix_Domain_Associates_Gund_Investment_Corporation_Innovation_Valley_Partners_Kt_Venture_Group_Completed> ;
    ns1:name "KT Venture Group" ;
    ns1:sameAsHigh <https://1145.am/db/1739124/Ksd_Capital>,
        <https://1145.am/db/1763410/Ksd_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2325346/Kt_Venture_Group>,
        <https://1145.am/db/2325378/Kt_Venture_Group>,
        <https://1145.am/db/2357981/Kt_Venture_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2291344/Accuitive_Medical_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Aliso Viejo" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5323163/about.rdf> ;
    ns1:basedInHighRaw "Aliso Viejo" ;
    ns1:documentDate "2011-05-12T13:06:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "WaveTec Vision secures $15.9M; EU to apply new hazardous materials regs to medical devices;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/wavetec-vision-secures-15-9m-eu-to-apply-new-hazardous-materials-regs-to-medical> ;
    ns1:foundName "Accuitive Medical Ventures" ;
    ns1:investor <https://1145.am/db/2291344/Series_D_Investment_Accuitive_Medical_Ventures_De_Novo_Ventures_Gund_Investment_Corporation_Versant_Ventures_Completed> ;
    ns1:name "Accuitive Medical Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2292334/Accuitive_Medical_Ventures>,
        <https://1145.am/db/2292353/Accuitive_Medical_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2291344/De_Novo_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Aliso Viejo" ;
    ns1:documentDate "2011-05-12T13:06:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "WaveTec Vision secures $15.9M; EU to apply new hazardous materials regs to medical devices;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/wavetec-vision-secures-15-9m-eu-to-apply-new-hazardous-materials-regs-to-medical> ;
    ns1:foundName "De Novo Ventures" ;
    ns1:investor <https://1145.am/db/2291344/Series_D_Investment_Accuitive_Medical_Ventures_De_Novo_Ventures_Gund_Investment_Corporation_Versant_Ventures_Completed> ;
    ns1:name "De Novo Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2202763/De_Novo_Ventures>,
        <https://1145.am/db/2288209/De_Novo_Ventures>,
        <https://1145.am/db/2289585/De_Novo_Ventures>,
        <https://1145.am/db/2300455/De_Novo_Ventures>,
        <https://1145.am/db/2319658/De_Novo_Ventures>,
        <https://1145.am/db/2343723/De_Novo_Ventures>,
        <https://1145.am/db/2343724/De_Novo_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339295/Novo_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Swiss" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-05-03T15:32:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Delenex extends its A round to CHF 30.2 million" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/delenex-extends-its-a-round-to-chf-30-2-million> ;
    ns1:foundName "Novo Ventures" ;
    ns1:investor <https://1145.am/db/2339295/Series_A_Investment_Biomedinvest_Delenex_Hbm_Biocapital_Hbm_Bioventures_Novo_Ventures_Sv_Life_Sciences_Vi_Partners_Completed> ;
    ns1:name "Novo Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2309507/Novo_A_S>,
        <https://1145.am/db/2313143/Novo_Ventures>,
        <https://1145.am/db/2343966/Novo_Ventures>,
        <https://1145.am/db/2345268/Novo_A_S>,
        <https://1145.am/db/2354899/Novo_Ventures>,
        <https://1145.am/db/2364505/Novo_A_S>,
        <https://1145.am/db/2570481/Novo_Ventures>,
        <https://1145.am/db/2570483/Novo_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2251548/Novo_Ventures>,
        <https://1145.am/db/2284476/Novo_Ventures>,
        <https://1145.am/db/2326903/Novo_Ventures>,
        <https://1145.am/db/2330664/Novo_Ventures>,
        <https://1145.am/db/2330668/Novo_Ventures>,
        <https://1145.am/db/2336221/Novo_Ventures>,
        <https://1145.am/db/2350044/Novo_Ventures>,
        <https://1145.am/db/2352508/Novo_Ventures>,
        <https://1145.am/db/2353098/Novo_Ventures>,
        <https://1145.am/db/2353588/Novo_Ventures>,
        <https://1145.am/db/2353598/Novo_Ventures>,
        <https://1145.am/db/2353608/Novo_Ventures>,
        <https://1145.am/db/2354296/Novo_Ventures>,
        <https://1145.am/db/2354903/Novo_Ventures>,
        <https://1145.am/db/2356124/Novo_Ventures>,
        <https://1145.am/db/2358496/Novo_Ventures>,
        <https://1145.am/db/2358502/Novo_Ventures>,
        <https://1145.am/db/2361065/Novo_Ventures>,
        <https://1145.am/db/2362533/Novo_Ventures>,
        <https://1145.am/db/2363510/Novo_Ventures>,
        <https://1145.am/db/2365103/Novo_Ventures>,
        <https://1145.am/db/2370694/Novo_Ventures>,
        <https://1145.am/db/2371165/Novo_Ventures>,
        <https://1145.am/db/2371166/Novo_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339616/Golden_Seeds> a org:Organization ;
    ns1:basedInHighGeoName "Pittsburgh" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5206379/about.rdf> ;
    ns1:basedInHighRaw "Pittsburgh" ;
    ns1:description "angel investing" ;
    ns1:documentDate "2011-01-20T15:50:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cognition Therapeutics Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cognition-therapeutics-completes-2-5m-series-a1-financing-to-advance-alzheimer-s-disease> ;
    ns1:foundName "Golden Seeds" ;
    ns1:investor <https://1145.am/db/2339616/Series_A1_Investment_Cognition_Therapeutics_Inc_Golden_Seeds_Innovation_Works_M5invest_Ogden_Cap_Associates_Pittsburgh_Life_Sciences_Greenhouse_Tmc_Investment_Company_The_Breedlove_Limited_Family_Partnership_Completed> ;
    ns1:name "Golden Seeds" ;
    ns1:sameAsHigh <https://1145.am/db/1864609/Common_Angels> ;
    ns1:sameAsMedium <https://1145.am/db/1334108/Golden_Seeds>,
        <https://1145.am/db/1713906/Golden_Seeds>,
        <https://1145.am/db/1736646/Golden_Seeds>,
        <https://1145.am/db/1822737/Golden_Seeds>,
        <https://1145.am/db/1873676/Golden_Seeds>,
        <https://1145.am/db/1889112/Golden_Seeds>,
        <https://1145.am/db/1892363/Golden_Seeds>,
        <https://1145.am/db/2295771/Golden_Seeds>,
        <https://1145.am/db/2299828/Golden_Seeds_Llc>,
        <https://1145.am/db/2362638/Golden_Seeds>,
        <https://1145.am/db/2597020/Golden_Seeds>,
        <https://1145.am/db/417590/Golden_Seeds>,
        <https://1145.am/db/614070/Golden_Seeds> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339616/Innovation_Works> a org:Organization ;
    ns1:basedInHighGeoName "Pittsburgh" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5206379/about.rdf> ;
    ns1:basedInHighRaw "Pittsburgh" ;
    ns1:documentDate "2011-01-20T15:50:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cognition Therapeutics Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cognition-therapeutics-completes-2-5m-series-a1-financing-to-advance-alzheimer-s-disease> ;
    ns1:foundName "Innovation Works" ;
    ns1:investor <https://1145.am/db/2339616/Series_A1_Investment_Cognition_Therapeutics_Inc_Golden_Seeds_Innovation_Works_M5invest_Ogden_Cap_Associates_Pittsburgh_Life_Sciences_Greenhouse_Tmc_Investment_Company_The_Breedlove_Limited_Family_Partnership_Completed> ;
    ns1:name "Innovation Works" ;
    ns1:sameAsMedium <https://1145.am/db/1829897/Innovation_Works>,
        <https://1145.am/db/1840663/Innovation_Works>,
        <https://1145.am/db/1852951/Innovation_Works>,
        <https://1145.am/db/1858481/Innovation_Works>,
        <https://1145.am/db/2250293/Innovation_Works>,
        <https://1145.am/db/668230/Innovation_Works>,
        <https://1145.am/db/668965/Innovation_Works>,
        <https://1145.am/db/837927/Innovation_Works> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339616/M5invest> a org:Organization ;
    ns1:basedInLowRaw "PITTSBURGH" ;
    ns1:description "angel investing" ;
    ns1:documentDate "2011-01-20T15:50:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cognition Therapeutics Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cognition-therapeutics-completes-2-5m-series-a1-financing-to-advance-alzheimer-s-disease> ;
    ns1:foundName "M5Invest" ;
    ns1:investor <https://1145.am/db/2339616/Series_A1_Investment_Cognition_Therapeutics_Inc_Golden_Seeds_Innovation_Works_M5invest_Ogden_Cap_Associates_Pittsburgh_Life_Sciences_Greenhouse_Tmc_Investment_Company_The_Breedlove_Limited_Family_Partnership_Completed> ;
    ns1:name "M5Invest" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339616/Ogden_Cap_Associates> a org:Organization ;
    ns1:basedInLowRaw "PITTSBURGH" ;
    ns1:description "angel investing" ;
    ns1:documentDate "2011-01-20T15:50:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cognition Therapeutics Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cognition-therapeutics-completes-2-5m-series-a1-financing-to-advance-alzheimer-s-disease> ;
    ns1:foundName "Ogden CAP Associates" ;
    ns1:investor <https://1145.am/db/2339616/Series_A1_Investment_Cognition_Therapeutics_Inc_Golden_Seeds_Innovation_Works_M5invest_Ogden_Cap_Associates_Pittsburgh_Life_Sciences_Greenhouse_Tmc_Investment_Company_The_Breedlove_Limited_Family_Partnership_Completed> ;
    ns1:name "Ogden CAP Associates" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339616/Pittsburgh_Life_Sciences_Greenhouse> a org:Organization ;
    ns1:basedInLowRaw "PITTSBURGH" ;
    ns1:documentDate "2011-01-20T15:50:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cognition Therapeutics Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cognition-therapeutics-completes-2-5m-series-a1-financing-to-advance-alzheimer-s-disease> ;
    ns1:foundName "the Pittsburgh Life Sciences Greenhouse" ;
    ns1:investor <https://1145.am/db/2339616/Series_A1_Investment_Cognition_Therapeutics_Inc_Golden_Seeds_Innovation_Works_M5invest_Ogden_Cap_Associates_Pittsburgh_Life_Sciences_Greenhouse_Tmc_Investment_Company_The_Breedlove_Limited_Family_Partnership_Completed> ;
    ns1:name "Pittsburgh Life Sciences Greenhouse" ;
    ns1:sameAsMedium <https://1145.am/db/2250293/The_Pittsburgh_Life_Sciences_Greenhouse>,
        <https://1145.am/db/2332620/Pittsburgh_Life_Sciences_Greenhouse>,
        <https://1145.am/db/2332637/Pittsburgh_Life_Sciences_Greenhouse>,
        <https://1145.am/db/542334/Pittsburgh_Life_Science_Greenhouse>,
        <https://1145.am/db/572381/Pittsburgh_Life_Science_Greenhouse> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339616/The_Breedlove_Limited_Family_Partnership> a org:Organization ;
    ns1:basedInHighGeoName "Pittsburgh" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5206379/about.rdf> ;
    ns1:basedInHighRaw "Pittsburgh" ;
    ns1:description "angel investing" ;
    ns1:documentDate "2011-01-20T15:50:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cognition Therapeutics Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cognition-therapeutics-completes-2-5m-series-a1-financing-to-advance-alzheimer-s-disease> ;
    ns1:foundName "The Breedlove Limited Family Partnership" ;
    ns1:investor <https://1145.am/db/2339616/Series_A1_Investment_Cognition_Therapeutics_Inc_Golden_Seeds_Innovation_Works_M5invest_Ogden_Cap_Associates_Pittsburgh_Life_Sciences_Greenhouse_Tmc_Investment_Company_The_Breedlove_Limited_Family_Partnership_Completed> ;
    ns1:name "The Breedlove Limited Family Partnership" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339616/Tmc_Investment_Company> a org:Organization ;
    ns1:basedInHighGeoName "Pittsburgh" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5206379/about.rdf> ;
    ns1:basedInHighRaw "Pittsburgh" ;
    ns1:description "investment" ;
    ns1:documentDate "2011-01-20T15:50:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cognition Therapeutics Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cognition-therapeutics-completes-2-5m-series-a1-financing-to-advance-alzheimer-s-disease> ;
    ns1:foundName "TMC Investment Company" ;
    ns1:investor <https://1145.am/db/2339616/Series_A1_Investment_Cognition_Therapeutics_Inc_Golden_Seeds_Innovation_Works_M5invest_Ogden_Cap_Associates_Pittsburgh_Life_Sciences_Greenhouse_Tmc_Investment_Company_The_Breedlove_Limited_Family_Partnership_Completed> ;
    ns1:name "TMC Investment Company" ;
    ns1:sameAsHigh <https://1145.am/db/1182849/Tm_Capital>,
        <https://1145.am/db/1286333/Tgvest_Capital>,
        <https://1145.am/db/1360313/Mbm_Capital>,
        <https://1145.am/db/1433134/Ttv_Capital>,
        <https://1145.am/db/1705217/M8_Capital>,
        <https://1145.am/db/1711782/3one4_Capital>,
        <https://1145.am/db/1734866/Tmt_Investments>,
        <https://1145.am/db/1735269/Tmt_Investments>,
        <https://1145.am/db/1747851/3one4_Capital>,
        <https://1145.am/db/1758117/Tal_Capital>,
        <https://1145.am/db/1763437/Tlcom_Capital>,
        <https://1145.am/db/1763934/3one4_Capital>,
        <https://1145.am/db/1792421/Tr_Capital>,
        <https://1145.am/db/1847713/M8_Capital>,
        <https://1145.am/db/1887836/Mk_Capital>,
        <https://1145.am/db/2378855/Transom_Capital_Group>,
        <https://1145.am/db/2402253/Transom_Capital_Group>,
        <https://1145.am/db/2788032/Ttv_Capital>,
        <https://1145.am/db/413034/Tt_Capital_Partners>,
        <https://1145.am/db/593902/Ttv_Capital>,
        <https://1145.am/db/644860/Tygh_Capital_Management>,
        <https://1145.am/db/812250/Ttv_Capital>,
        <https://1145.am/db/884830/Tsv_Capital>,
        <https://1145.am/db/962091/Ttv_Capital>,
        <https://1145.am/db/963819/Ttv_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340172/Argonaut_Private_Equity> a org:Organization ;
    ns1:basedInLowRaw "SANTA CLARA, Calif" ;
    ns1:documentDate "2011-05-06T13:21:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crown Bioscience, Inc. Announces Closing of Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crown-bioscience-inc-announces-closing-of-series-c-financing> ;
    ns1:foundName "Argonaut Private Equity" ;
    ns1:investor <https://1145.am/db/2340172/Series_C_Investment_Argonaut_Private_Equity_Cdib_Capital_Investment_Cid_Group_Crci_Crown_Bioscience_Ibt_Orbimed_Advisors_Caduceus_Asia_Partners_Fund_Qiming_Venture_Partners_Completed> ;
    ns1:name "Argonaut Private Equity" ;
    ns1:sameAsMedium <https://1145.am/db/1000776/Argonaut_Private_Equity>,
        <https://1145.am/db/1031589/Argonaut_Private_Equity>,
        <https://1145.am/db/1032005/Argonaut_Private_Equity>,
        <https://1145.am/db/282214/Argonaut_Private_Equity>,
        <https://1145.am/db/457148/Argonaut_Private_Equity>,
        <https://1145.am/db/457662/Argonaut_Private_Equity>,
        <https://1145.am/db/459130/Argonaut_Private_Equity>,
        <https://1145.am/db/816150/Argonaut_Private_Equity>,
        <https://1145.am/db/818265/Argonaut_Private_Equity>,
        <https://1145.am/db/820804/Argonaut_Private_Equity>,
        <https://1145.am/db/823712/Argonaut_Private_Equity> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340172/Cdib_Capital_Investment> a org:Organization ;
    ns1:basedInLowRaw "SANTA CLARA" ;
    ns1:documentDate "2011-05-06T13:21:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crown Bioscience, Inc. Announces Closing of Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crown-bioscience-inc-announces-closing-of-series-c-financing> ;
    ns1:foundName "CDIB Capital Investment" ;
    ns1:investor <https://1145.am/db/2340172/Series_C_Investment_Argonaut_Private_Equity_Cdib_Capital_Investment_Cid_Group_Crci_Crown_Bioscience_Ibt_Orbimed_Advisors_Caduceus_Asia_Partners_Fund_Qiming_Venture_Partners_Completed> ;
    ns1:name "CDIB Capital Investment" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340172/Cid_Group> a org:Organization ;
    ns1:basedInLowRaw "SANTA CLARA" ;
    ns1:documentDate "2011-05-06T13:21:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crown Bioscience, Inc. Announces Closing of Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crown-bioscience-inc-announces-closing-of-series-c-financing> ;
    ns1:foundName "CID Group" ;
    ns1:investor <https://1145.am/db/2340172/Series_C_Investment_Argonaut_Private_Equity_Cdib_Capital_Investment_Cid_Group_Crci_Crown_Bioscience_Ibt_Orbimed_Advisors_Caduceus_Asia_Partners_Fund_Qiming_Venture_Partners_Completed> ;
    ns1:name "CID Group" ;
    ns1:sameAsMedium <https://1145.am/db/1730430/Cid_Group>,
        <https://1145.am/db/1797695/Cid_Group>,
        <https://1145.am/db/1802889/Cid_Group>,
        <https://1145.am/db/1848616/Cid_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340172/Crci> a org:Organization ;
    ns1:basedInHighGeoName "Santa Clara" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3537906/about.rdf> ;
    ns1:basedInHighRaw "SANTA CLARA" ;
    ns1:documentDate "2011-05-06T13:21:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crown Bioscience, Inc. Announces Closing of Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crown-bioscience-inc-announces-closing-of-series-c-financing> ;
    ns1:foundName "CRCI" ;
    ns1:investor <https://1145.am/db/2340172/Series_C_Investment_Argonaut_Private_Equity_Cdib_Capital_Investment_Cid_Group_Crci_Crown_Bioscience_Ibt_Orbimed_Advisors_Caduceus_Asia_Partners_Fund_Qiming_Venture_Partners_Completed> ;
    ns1:name "CRCI" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340172/Ibt> a org:Organization ;
    ns1:basedInLowRaw "SANTA CLARA" ;
    ns1:documentDate "2011-05-06T13:21:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crown Bioscience, Inc. Announces Closing of Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crown-bioscience-inc-announces-closing-of-series-c-financing> ;
    ns1:foundName "IBT" ;
    ns1:investor <https://1145.am/db/2340172/Series_C_Investment_Argonaut_Private_Equity_Cdib_Capital_Investment_Cid_Group_Crci_Crown_Bioscience_Ibt_Orbimed_Advisors_Caduceus_Asia_Partners_Fund_Qiming_Venture_Partners_Completed> ;
    ns1:name "IBT" ;
    ns1:sameAsMedium <https://1145.am/db/2369984/Ibt> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340172/Orbimed_Advisors_Caduceus_Asia_Partners_Fund> a org:Organization ;
    ns1:basedInLowRaw "SANTA CLARA, Calif" ;
    ns1:documentDate "2011-05-06T13:21:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crown Bioscience, Inc. Announces Closing of Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crown-bioscience-inc-announces-closing-of-series-c-financing> ;
    ns1:foundName "Caduceus Asia Partners Fund",
        "OrbiMed Advisors Caduceus Asia Partners Fund" ;
    ns1:investor <https://1145.am/db/2340172/Series_C_Investment_Argonaut_Private_Equity_Cdib_Capital_Investment_Cid_Group_Crci_Crown_Bioscience_Ibt_Orbimed_Advisors_Caduceus_Asia_Partners_Fund_Qiming_Venture_Partners_Completed> ;
    ns1:name "Caduceus Asia Partners Fund",
        "OrbiMed Advisors Caduceus Asia Partners Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2362278/Orbimed_Advisors_Caduceus_Asia_Partners_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340172/Qiming_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2011-05-06T13:21:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crown Bioscience, Inc. Announces Closing of Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crown-bioscience-inc-announces-closing-of-series-c-financing> ;
    ns1:foundName "Qiming Venture Partners" ;
    ns1:investor <https://1145.am/db/2340172/Series_C_Investment_Argonaut_Private_Equity_Cdib_Capital_Investment_Cid_Group_Crci_Crown_Bioscience_Ibt_Orbimed_Advisors_Caduceus_Asia_Partners_Fund_Qiming_Venture_Partners_Completed> ;
    ns1:name "Qiming Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1041075/Qiming_Venture_Partners>,
        <https://1145.am/db/1081888/Qiming_Venture_Partners>,
        <https://1145.am/db/1127018/Qiming_Venture_Partners>,
        <https://1145.am/db/1245682/Qiming_Venture_Partners>,
        <https://1145.am/db/1298702/Qiming_Venture_Partners>,
        <https://1145.am/db/1338458/Qiming_Venture_Partners_Usa>,
        <https://1145.am/db/1409504/Qiming_Venture_Partners>,
        <https://1145.am/db/1690914/Qiming_Venture_Partners>,
        <https://1145.am/db/1721480/Qiming_Venture_Partners>,
        <https://1145.am/db/1737267/Qiming_Venture_Partners>,
        <https://1145.am/db/1762844/Qiming_Venture_Partners>,
        <https://1145.am/db/1772310/Qiming_Venture_Partners>,
        <https://1145.am/db/1787190/Qiming_Venture_Partners>,
        <https://1145.am/db/1797999/Qiming_Venture_Partners>,
        <https://1145.am/db/1816476/Qiming_Venture_Partners>,
        <https://1145.am/db/1847010/Qiming_Venture_Partners>,
        <https://1145.am/db/1858346/Qiming_Venture_Partners>,
        <https://1145.am/db/1975490/Qiming_Venture_Partners_Usa>,
        <https://1145.am/db/2062003/Qiming_Venture_Partners_Usa>,
        <https://1145.am/db/2063986/Qiming_Venture_Partners>,
        <https://1145.am/db/2153728/Qiming_Venture_Partners_Usa>,
        <https://1145.am/db/2154341/Qiming_Venture_Partners>,
        <https://1145.am/db/2155730/Qiming_Venture_Partners>,
        <https://1145.am/db/2198776/Qiming_Venture_Partners>,
        <https://1145.am/db/2280922/Qiming_Venture_Partners>,
        <https://1145.am/db/2285621/Qiming_Venture_Partners>,
        <https://1145.am/db/2287244/Qiming_Venture_Partners_Usa>,
        <https://1145.am/db/2297157/Qiming_Venture_Partners>,
        <https://1145.am/db/2298954/Qiming_Venture_Partners>,
        <https://1145.am/db/2349845/Qiming_Venture_Partners>,
        <https://1145.am/db/2542366/Qiming_Venture_Partners>,
        <https://1145.am/db/2543363/Qiming_Venture_Partners>,
        <https://1145.am/db/2543365/Qiming_Venture_Partners>,
        <https://1145.am/db/2549519/Qiming_Venture_Partners>,
        <https://1145.am/db/2549521/Qiming_Venture_Partners>,
        <https://1145.am/db/2552636/Qiming_Venture_Partners>,
        <https://1145.am/db/2732060/Qiming_Venture_Partners>,
        <https://1145.am/db/293715/Qiming_Venture_Partners>,
        <https://1145.am/db/359185/Qiming_Venture_Partners>,
        <https://1145.am/db/4142/Qiming_Venture_Partners_Usa>,
        <https://1145.am/db/498954/Qiming_Venture_Partners>,
        <https://1145.am/db/593670/Qiming_Venture_Partners>,
        <https://1145.am/db/647107/Qiming_Venture_Partners>,
        <https://1145.am/db/689223/Qiming_Venture_Partners>,
        <https://1145.am/db/732702/Qiming_Venture_Partners>,
        <https://1145.am/db/734448/Qiming_Venture_Partners_Usa>,
        <https://1145.am/db/742173/Qiming_Venture_Partners>,
        <https://1145.am/db/768063/Qiming_Venture_Partners_Usa>,
        <https://1145.am/db/921164/Qiming_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340429/Acadia_Woods> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2011-01-25T13:21:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RainDance Technologies Raises $37.5 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/raindance-technologies-raises-37-5-million-series-d-financing> ;
    ns1:foundName "Acadia Woods, LLC" ;
    ns1:investor <https://1145.am/db/2340429/Series_D_Investment_Acadia_Woods_Alloy_Ventures_Mohr_Davidow_Ventures_Quaker_Bioventures_Raindance_Technologies_Completed> ;
    ns1:name "Acadia Woods" ;
    ns1:sameAsHigh <https://1145.am/db/1322396/Acadia_Woods_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1830311/Acadia_Woods>,
        <https://1145.am/db/1858293/Acadia_Woods>,
        <https://1145.am/db/2315049/Acadia_Woods>,
        <https://1145.am/db/2340423/Acadia_Woods> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340429/Alloy_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-01-25T13:21:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RainDance Technologies Raises $37.5 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/raindance-technologies-raises-37-5-million-series-d-financing> ;
    ns1:foundName "Alloy Ventures" ;
    ns1:investor <https://1145.am/db/2340429/Series_D_Investment_Acadia_Woods_Alloy_Ventures_Mohr_Davidow_Ventures_Quaker_Bioventures_Raindance_Technologies_Completed> ;
    ns1:name "Alloy Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1867543/Alloy_Ventures>,
        <https://1145.am/db/1868178/Alloy_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1719145/Alloy_Ventures>,
        <https://1145.am/db/1730063/Alloy_Ventures>,
        <https://1145.am/db/1886915/Alloy_Ventures>,
        <https://1145.am/db/1893956/Alloy_Ventures>,
        <https://1145.am/db/1898419/Alloy_Ventures>,
        <https://1145.am/db/2291809/Alloy_Ventures>,
        <https://1145.am/db/2292797/Alloy_Ventures>,
        <https://1145.am/db/2321216/Alloy_Ventures>,
        <https://1145.am/db/2324195/Alloy_Ventures>,
        <https://1145.am/db/2324226/Alloy_Ventures>,
        <https://1145.am/db/2328338/Alloy_Ventures>,
        <https://1145.am/db/2332944/Alloy_Ventures>,
        <https://1145.am/db/2340423/Alloy_Ventures>,
        <https://1145.am/db/2575044/Alloy_Ventures>,
        <https://1145.am/db/2636386/Alloy_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340429/Quaker_Bioventures> a org:Organization ;
    ns1:description "Investing in companies" ;
    ns1:documentDate "2011-01-25T13:21:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RainDance Technologies Raises $37.5 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/raindance-technologies-raises-37-5-million-series-d-financing> ;
    ns1:foundName "Quaker BioVentures" ;
    ns1:investor <https://1145.am/db/2340429/Series_D_Investment_Acadia_Woods_Alloy_Ventures_Mohr_Davidow_Ventures_Quaker_Bioventures_Raindance_Technologies_Completed> ;
    ns1:name "Quaker BioVentures" ;
    ns1:sameAsHigh <https://1145.am/db/2302192/Quaker_Bioventures>,
        <https://1145.am/db/2309809/Quaker_Bioventures>,
        <https://1145.am/db/2312792/Quaker_Bioventures>,
        <https://1145.am/db/2320853/Quaker_Bioventures>,
        <https://1145.am/db/2332631/Quaker_Bioventures>,
        <https://1145.am/db/2349717/Quaker_Bioventures>,
        <https://1145.am/db/2365171/Quaker_Bioventures> ;
    ns1:sameAsMedium <https://1145.am/db/2217039/Quaker_Bioventures>,
        <https://1145.am/db/2291872/Quaker_Bioventures>,
        <https://1145.am/db/2303458/Quaker_Bioventures>,
        <https://1145.am/db/2303641/Quaker_Bioventures>,
        <https://1145.am/db/2303642/Quaker_Bioventures>,
        <https://1145.am/db/2305610/Quaker_Bioventures>,
        <https://1145.am/db/2305615/Quaker_Bioventures>,
        <https://1145.am/db/2305625/Quaker_Bioventures>,
        <https://1145.am/db/2310123/Quaker_Bioventures>,
        <https://1145.am/db/2311099/Quaker_Bioventures>,
        <https://1145.am/db/2317849/Quaker_Bioventures>,
        <https://1145.am/db/2317961/Quaker_Bioventures>,
        <https://1145.am/db/2319360/Quaker_Bioventures>,
        <https://1145.am/db/2320852/Quaker_Bioventures>,
        <https://1145.am/db/2330549/Quaker_Bioventures>,
        <https://1145.am/db/2332021/Quaker_Bioventures>,
        <https://1145.am/db/2332626/Quaker_Bioventures>,
        <https://1145.am/db/2340423/Quaker_Bioventures>,
        <https://1145.am/db/2349722/Quaker_Bioventures>,
        <https://1145.am/db/2352808/Quaker_Bioventures>,
        <https://1145.am/db/2355936/Quaker_Bioventures>,
        <https://1145.am/db/2355938/Quaker_Bioventures>,
        <https://1145.am/db/2363464/Quaker_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341068/Adams_Street_Partners> a org:Organization ;
    ns1:basedInHighGeoName "Evanston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4891382/about.rdf> ;
    ns1:basedInHighRaw "EVANSTON, Ill." ;
    ns1:documentDate "2011-05-11T12:18:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $18 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-18-million-series-a-financing> ;
    ns1:foundName "Adams Street Partners" ;
    ns1:investor <https://1145.am/db/2341068/Series_A_Investment_Adams_Street_Partners_Druid_Bioventures_Genesys_Capital_Pathocapital_Lundbeck_Takeda_Venture_Latterell_Venture_Partners_Naurex_Inc_Pathocapital_Lundbeck_Takeda_Ventures_Inc_Shire_Completed> ;
    ns1:name "Adams Street Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1151052/Adams_Street_Partners>,
        <https://1145.am/db/1163164/Adams_Street_Partners>,
        <https://1145.am/db/1166225/Adams_Street_Partners>,
        <https://1145.am/db/1248471/Adams_Street_Partners>,
        <https://1145.am/db/1249040/Adams_Street_Partners>,
        <https://1145.am/db/1351661/Adams_Street_Partners>,
        <https://1145.am/db/1352625/Adams_Street_Partners>,
        <https://1145.am/db/1352945/Adams_Street_Partners>,
        <https://1145.am/db/1354185/Adams_Street_Partners>,
        <https://1145.am/db/1369238/Adams_Street_Partners>,
        <https://1145.am/db/1369876/Adams_Street_Partners>,
        <https://1145.am/db/1395257/Adams_Street_Partners>,
        <https://1145.am/db/1480201/Adams_Street_Partners>,
        <https://1145.am/db/1528582/Adams_Street_Partners>,
        <https://1145.am/db/1747870/Adams_Street_Partners>,
        <https://1145.am/db/1749294/Adams_Street_Partners>,
        <https://1145.am/db/1755127/Adams_Street_Partners>,
        <https://1145.am/db/1796380/Adams_Street_Partners>,
        <https://1145.am/db/1823041/Adams_Street_Partners>,
        <https://1145.am/db/1843607/Adams_Street_Partners>,
        <https://1145.am/db/1844474/Adams_Street_Partners>,
        <https://1145.am/db/1845463/Adams_Street_Partners>,
        <https://1145.am/db/1846040/Adams_Street_Partners>,
        <https://1145.am/db/1847894/Adams_Street_Partners>,
        <https://1145.am/db/1864601/Adams_Street_Partners>,
        <https://1145.am/db/1880209/Adams_Street_Partners>,
        <https://1145.am/db/1886915/Adams_Street_Partners>,
        <https://1145.am/db/1902164/Adams_Street_Partners>,
        <https://1145.am/db/1932511/Adams_Street_Partners>,
        <https://1145.am/db/2257512/Adams_Street_Partners>,
        <https://1145.am/db/2294721/Adams_Street_Partners>,
        <https://1145.am/db/2308828/Adams_Street_Partners>,
        <https://1145.am/db/2308841/Adams_Street_Partners>,
        <https://1145.am/db/2329550/Adams_Street_Partners>,
        <https://1145.am/db/2331820/Adams_Street_Partners>,
        <https://1145.am/db/2335743/Adams_Street_Partners>,
        <https://1145.am/db/2337166/Adams_Street_Partners>,
        <https://1145.am/db/2341074/Adams_Street_Partners>,
        <https://1145.am/db/2357487/Adams_Street_Partners>,
        <https://1145.am/db/2366519/Adams_Street_Partners>,
        <https://1145.am/db/2369359/Adams_Street_Partners>,
        <https://1145.am/db/2370694/Adams_Street_Partners>,
        <https://1145.am/db/396100/Adams_Street_Partners>,
        <https://1145.am/db/731028/Adams_Street_Partners>,
        <https://1145.am/db/936906/Adams_Street_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341068/Druid_Bioventures> a org:Organization ;
    ns1:basedInHighGeoName "Evanston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4891382/about.rdf> ;
    ns1:basedInHighRaw "EVANSTON, Ill." ;
    ns1:description "Investing in medical research" ;
    ns1:documentDate "2011-05-11T12:18:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $18 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-18-million-series-a-financing> ;
    ns1:foundName "Druid BioVentures" ;
    ns1:investor <https://1145.am/db/2341068/Series_A_Investment_Adams_Street_Partners_Druid_Bioventures_Genesys_Capital_Pathocapital_Lundbeck_Takeda_Venture_Latterell_Venture_Partners_Naurex_Inc_Pathocapital_Lundbeck_Takeda_Ventures_Inc_Shire_Completed> ;
    ns1:name "Druid BioVentures" ;
    ns1:sameAsMedium <https://1145.am/db/2341074/Druid_Bioventures>,
        <https://1145.am/db/2357487/Druid_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341068/Genesys_Capital_Pathocapital_Lundbeck_Takeda_Venture> a org:Organization ;
    ns1:basedInLowRaw "Ill" ;
    ns1:description "Investing",
        "venture capital" ;
    ns1:documentDate "2011-05-11T12:18:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $18 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-18-million-series-a-financing> ;
    ns1:foundName "Genesys Capital",
        "Genesys Capital, PathoCapital, Lundbeck, Takeda Ventures, Inc." ;
    ns1:investor <https://1145.am/db/2341068/Series_A_Investment_Adams_Street_Partners_Druid_Bioventures_Genesys_Capital_Pathocapital_Lundbeck_Takeda_Venture_Latterell_Venture_Partners_Naurex_Inc_Pathocapital_Lundbeck_Takeda_Ventures_Inc_Shire_Completed> ;
    ns1:name "Genesys Capital",
        "Genesys Capital, PathoCapital, Lundbeck, Takeda Venture" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341068/Latterell_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Ill" ;
    ns1:documentDate "2011-05-11T12:18:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $18 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-18-million-series-a-financing> ;
    ns1:foundName "Latterell Venture Partners" ;
    ns1:investor <https://1145.am/db/2341068/Series_A_Investment_Adams_Street_Partners_Druid_Bioventures_Genesys_Capital_Pathocapital_Lundbeck_Takeda_Venture_Latterell_Venture_Partners_Naurex_Inc_Pathocapital_Lundbeck_Takeda_Ventures_Inc_Shire_Completed> ;
    ns1:name "Latterell Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2223193/Latterell_Venture_Partners>,
        <https://1145.am/db/2257512/Latterell_Venture_Partners>,
        <https://1145.am/db/2308828/Latterell_Venture_Partners>,
        <https://1145.am/db/2308841/Latterell_Venture_Partners>,
        <https://1145.am/db/2312120/Latterell_Venture_Partners>,
        <https://1145.am/db/2319658/Latterell_Venture_Partners>,
        <https://1145.am/db/2324226/Latterell_Venture_Partners>,
        <https://1145.am/db/2329531/Latterell_Venture_Partners>,
        <https://1145.am/db/2341074/Latterell_Venture_Partners>,
        <https://1145.am/db/2345568/Latterell_Venture_Partners>,
        <https://1145.am/db/2349717/Latterell_Venture_Partners>,
        <https://1145.am/db/2349722/Latterell_Venture_Partners>,
        <https://1145.am/db/2357487/Latterell_Venture_Partners>,
        <https://1145.am/db/2365171/Latterell_Venture_Partners>,
        <https://1145.am/db/2366693/Latterell_Venture_Partners>,
        <https://1145.am/db/2366700/Latterell_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341068/Pathocapital_Lundbeck_Takeda_Ventures_Inc> a org:Organization ;
    ns1:basedInLowRaw "Ill" ;
    ns1:documentDate "2011-05-11T12:18:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $18 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-18-million-series-a-financing> ;
    ns1:foundName "Lundbeck, Takeda Ventures, Inc.",
        "PathoCapital",
        "PathoCapital, Lundbeck, Takeda Ventures, Inc." ;
    ns1:investor <https://1145.am/db/2341068/Series_A_Investment_Adams_Street_Partners_Druid_Bioventures_Genesys_Capital_Pathocapital_Lundbeck_Takeda_Venture_Latterell_Venture_Partners_Naurex_Inc_Pathocapital_Lundbeck_Takeda_Ventures_Inc_Shire_Completed> ;
    ns1:name "Lundbeck, Takeda Ventures, Inc.",
        "PathoCapital",
        "PathoCapital, Lundbeck, Takeda Ventures, Inc." ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341377/King_Pharmaceuticals> a org:Organization ;
    ns1:basedInHighGeoName "San Mateo County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5392427/about.rdf> ;
    ns1:basedInHighRaw "SAN MATEO" ;
    ns1:description "abuse-resistant prescription pain medications" ;
    ns1:documentDate "2011-01-28T14:09:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pain Therapeutics Receives $5,000,000 Payment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pain-therapeutics-receives-5-000-000-payment> ;
    ns1:foundName "King Pharmaceuticals, Inc" ;
    ns1:industry "pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2341377/Investment_King_Pharmaceuticals_Pain_Therapeutics_Completed> ;
    ns1:name "King Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2303132/King_Pharmaceuticals>,
        <https://1145.am/db/2304228/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2309924/King_Pharmaceuticals>,
        <https://1145.am/db/2311359/King_Pharmaceuticals>,
        <https://1145.am/db/2316576/King_Pharmaceuticals>,
        <https://1145.am/db/2316578/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2317595/King_Pharmaceuticals>,
        <https://1145.am/db/2317597/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318689/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318984/King_Pharmaceuticals>,
        <https://1145.am/db/2320998/King_Pharmaceuticals>,
        <https://1145.am/db/2321010/King_Pharmaceuticals>,
        <https://1145.am/db/2322039/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322272/King_Pharmaceuticals>,
        <https://1145.am/db/2325296/King_Pharmaceuticals>,
        <https://1145.am/db/2326314/King_Pharmaceuticals>,
        <https://1145.am/db/2326323/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2327224/King_Pharmaceuticals>,
        <https://1145.am/db/2330766/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330774/King_Pharmaceuticals>,
        <https://1145.am/db/2339627/King_Pharmaceuticals>,
        <https://1145.am/db/2339633/King_Pharmaceuticals>,
        <https://1145.am/db/2341372/King_Pharmaceuticals>,
        <https://1145.am/db/2351730/King_Pharmaceuticals>,
        <https://1145.am/db/2354914/King_Pharmaceuticals>,
        <https://1145.am/db/2355472/King_Pharmaceuticals>,
        <https://1145.am/db/2362851/King_Pharmaceuticals>,
        <https://1145.am/db/2367283/King_Pharmaceuticals>,
        <https://1145.am/db/2537542/King_Pharmaceuticals>,
        <https://1145.am/db/2539292/King_Pharmaceuticals>,
        <https://1145.am/db/2539298/King_Pharmaceuticals>,
        <https://1145.am/db/2541548/King_Pharmaceuticals>,
        <https://1145.am/db/2542509/King_Pharmaceuticals>,
        <https://1145.am/db/2543554/King_Pharmaceuticals>,
        <https://1145.am/db/2547068/King_Pharmaceuticals>,
        <https://1145.am/db/2549687/King_Pharmaceuticals>,
        <https://1145.am/db/2550685/King_Pharmaceuticals_Plant>,
        <https://1145.am/db/2563450/King_Pharmaceuticals>,
        <https://1145.am/db/2571798/King_Pharmaceuticals>,
        <https://1145.am/db/2575505/King_Pharmaceuticals>,
        <https://1145.am/db/2580401/King_Pharmaceuticals>,
        <https://1145.am/db/2581331/King_Pharmaceuticals>,
        <https://1145.am/db/2581334/King_Pharmaceuticals>,
        <https://1145.am/db/2581339/King_Pharmaceuticals>,
        <https://1145.am/db/2582343/King_Pharmaceuticals>,
        <https://1145.am/db/2583242/King_Pharmaceuticals>,
        <https://1145.am/db/2586763/King_Pharmaceuticals>,
        <https://1145.am/db/2587387/King_Pharmaceutical>,
        <https://1145.am/db/2588134/King_Pharmaceuticals>,
        <https://1145.am/db/2589055/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2592975/King_Pharmaceuticals>,
        <https://1145.am/db/2592977/King_Pharmaceuticals>,
        <https://1145.am/db/2592980/King_Pharmaceuticals>,
        <https://1145.am/db/2592990/King_Pharmaceuticals>,
        <https://1145.am/db/2592992/King_Pharmaceuticals>,
        <https://1145.am/db/2595320/King_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2327609/King_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342445/Ascension_Health_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Bedford, MA" ;
    ns1:documentDate "2011-02-03T15:22:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ocular Therapeutix garners $14M for mid-stage eye drug trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ocular-therapeutix-garners-14m-for-mid-stage-eye-drug-trials> ;
    ns1:foundName "Ascension Health Ventures" ;
    ns1:investor <https://1145.am/db/2342445/Investment_Ascension_Health_Ventures_Ocular_Therapeutix_Polaris_Venture_Partners_Sv_Life_Sciences_Versant_Ventures_Completed> ;
    ns1:name "Ascension Health Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1887797/Ascension_Health_Ventures>,
        <https://1145.am/db/2289616/Ascension_Health_Ventures>,
        <https://1145.am/db/2343467/Ascension_Health_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342445/Polaris_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Bedford, MA" ;
    ns1:documentDate "2011-02-03T15:22:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ocular Therapeutix garners $14M for mid-stage eye drug trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ocular-therapeutix-garners-14m-for-mid-stage-eye-drug-trials> ;
    ns1:foundName "Polaris Venture Partners" ;
    ns1:investor <https://1145.am/db/2342445/Investment_Ascension_Health_Ventures_Ocular_Therapeutix_Polaris_Venture_Partners_Sv_Life_Sciences_Versant_Ventures_Completed> ;
    ns1:name "Polaris Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1701903/Polaris_Venture_Partners>,
        <https://1145.am/db/1708291/Polaris_Venture_Partners>,
        <https://1145.am/db/1830502/Polaris_Venture_Partners>,
        <https://1145.am/db/1870436/Polaris_Venture_Partners>,
        <https://1145.am/db/1877606/Polaris_Venture_Partners>,
        <https://1145.am/db/1897450/Polaris_Venture_Partners>,
        <https://1145.am/db/1909651/Polaris_Venture_Partners>,
        <https://1145.am/db/2174824/Polaris_Venture_Partners>,
        <https://1145.am/db/2292800/Polaris_Venture_Partners>,
        <https://1145.am/db/2302116/Polaris_Venture_Partners>,
        <https://1145.am/db/2303656/Polaris_Venture_Partners>,
        <https://1145.am/db/2303675/Polaris_Venture_Partners>,
        <https://1145.am/db/2313401/Polaris_Venture_Partners>,
        <https://1145.am/db/2313405/Polaris_Venture_Partners>,
        <https://1145.am/db/2314380/Polaris_Venture_Partners>,
        <https://1145.am/db/2315289/Polaris_Venture_Partners>,
        <https://1145.am/db/2323586/Polaris_Venture_Partners>,
        <https://1145.am/db/2324431/Polaris_Venture_Partners>,
        <https://1145.am/db/2331763/Polaris_Venture_Partners>,
        <https://1145.am/db/2337571/Polaris_Venture_Partners>,
        <https://1145.am/db/2337577/Polaris_Venture_Partners>,
        <https://1145.am/db/2338373/Polaris_Venture_Partners>,
        <https://1145.am/db/2339127/Polaris_Venture_Partners>,
        <https://1145.am/db/2339128/Polaris_Venture_Partners>,
        <https://1145.am/db/2342862/Polaris_Venture_Partners>,
        <https://1145.am/db/2343210/Polaris_Venture_Partners>,
        <https://1145.am/db/2344256/Polaris_Venture_Partners>,
        <https://1145.am/db/2345224/Polaris_Venture_Partners>,
        <https://1145.am/db/2347102/Polaris_Venture_Partners>,
        <https://1145.am/db/2348448/Polaris_Venture_Partners>,
        <https://1145.am/db/2350034/Polaris_Venture_Partners>,
        <https://1145.am/db/2352414/Polaris_Venture_Partners>,
        <https://1145.am/db/2354806/Polaris_Venture_Partners>,
        <https://1145.am/db/2365296/Polaris_Venture_Partners>,
        <https://1145.am/db/2365300/Polaris_Venture_Partners>,
        <https://1145.am/db/2366654/Polaris_Venture_Partners>,
        <https://1145.am/db/2367497/Polaris_Venture_Partners>,
        <https://1145.am/db/2440024/Polaris_Venture_Partners>,
        <https://1145.am/db/2450515/Polaris_Venture_Partners>,
        <https://1145.am/db/2546216/Polaris_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345206/Clinipace_Worldwide> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:buyer <https://1145.am/db/2345206/Pfc_Pharma_Focus_Ltd_Subsidiaries_Acquisition>,
        <https://1145.am/db/2345206/Subsidiaries_Acquisition_Clinipace_Worldwide_Pfc_Pharma_Focus_Ltd_Completed>,
        <https://1145.am/db/2345206/Subsidiaries_Merger_Clinipace_Worldwide_Clinipace_Worldwide_Pfc_Pharma_Focus_Ltd_Completed> ;
    ns1:description "clinical and product development services" ;
    ns1:documentDate "2011-05-23T13:55:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clinipace Worldwide Acquires Switzerland-Based PFC Pharma Focus Ltd." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clinipace-worldwide-acquires-switzerland-based-pfc-pharma-focus-ltd> ;
    ns1:foundName "Clinipace Worldwide" ;
    ns1:industry "Life Sciences" ;
    ns1:name "Clinipace Worldwide" ;
    ns1:protagonist <https://1145.am/db/2345206/Pfc_Pharma_Focus_Ltd_Subsidiaries_Acquisition>,
        <https://1145.am/db/2345206/Subsidiaries_Merger_Clinipace_Worldwide_Clinipace_Worldwide_Pfc_Pharma_Focus_Ltd_Completed> ;
    ns1:sameAsMedium <https://1145.am/db/2305367/Clinipace_Worldwide>,
        <https://1145.am/db/2307546/Clinipace_Worldwide>,
        <https://1145.am/db/2319640/Clinipace_Worldwide>,
        <https://1145.am/db/2321356/Clinipace_Worldwide>,
        <https://1145.am/db/2322803/Clinipace_Worldwide>,
        <https://1145.am/db/2323511/Clinipace_Worldwide>,
        <https://1145.am/db/2329111/Clinipace_Worldwide>,
        <https://1145.am/db/2332459/Clinipace_Worldwide>,
        <https://1145.am/db/2334020/Clinipace_Worldwide>,
        <https://1145.am/db/2339913/Clinipace_Worldwide>,
        <https://1145.am/db/2344639/Clinipace_Worldwide>,
        <https://1145.am/db/2353670/Clinipace_Worldwide>,
        <https://1145.am/db/2353671/Clinipace_Worldwide>,
        <https://1145.am/db/2353674/Clinipace_Worldwide>,
        <https://1145.am/db/2354137/Clinipace_Worldwide>,
        <https://1145.am/db/2363181/Clinipace_Worldwide>,
        <https://1145.am/db/2364127/Clinipace_Worldwide>,
        <https://1145.am/db/2365481/Clinipace_Worldwide> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/Brookside_Capital> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "equity financing" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "Brookside Capital" ;
    ns1:investor <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:name "Brookside Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1711300/Interwest_Partners>,
        <https://1145.am/db/1886261/Interwest_Partners>,
        <https://1145.am/db/2312792/Interwest>,
        <https://1145.am/db/2315289/Interwest_Partners>,
        <https://1145.am/db/2320852/Intersouth_Partners>,
        <https://1145.am/db/2325257/Interwest_Partners>,
        <https://1145.am/db/2326361/Interwest_Partners>,
        <https://1145.am/db/2326373/Interwest_Partners>,
        <https://1145.am/db/2328655/Intersouth_Partners>,
        <https://1145.am/db/2348754/Interwest_Partners>,
        <https://1145.am/db/2350199/Intersouth_Partners>,
        <https://1145.am/db/2350199/Interwest>,
        <https://1145.am/db/2578837/Intersouth_Partners>,
        <https://1145.am/db/317537/Starbridge_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2303098/Brookside_Capital>,
        <https://1145.am/db/2316391/Brookside_Capital>,
        <https://1145.am/db/2327685/Brookside_Capital>,
        <https://1145.am/db/2338126/Brookside_Capital>,
        <https://1145.am/db/2338127/Brookside_Capital>,
        <https://1145.am/db/2346063/Brookside_Capital>,
        <https://1145.am/db/2352172/Brookside_Capital>,
        <https://1145.am/db/2657684/Brookside_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/Ge_Capital_Healthcare_Financial_Services> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE",
        "CAMBRIDGE, Mass" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "GE Capital",
        "GE Capital, Healthcare Financial Services",
        "Healthcare Financial Services" ;
    ns1:investor <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:name "GE Capital",
        "GE Capital, Healthcare Financial Services",
        "Healthcare Financial Services" ;
    ns1:sameAsMedium <https://1145.am/db/2364404/Ge_Capital_Healthcare_Financial_Services> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/Healthcare_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "equity financing" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "HealthCare Ventures" ;
    ns1:investor <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:name "HealthCare Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1335924/Blue_Venture_Fund>,
        <https://1145.am/db/1336552/Blue_Venture_Fund>,
        <https://1145.am/db/1374213/Apollo_Health_Ventures>,
        <https://1145.am/db/1628978/Cvs_Health_Ventures>,
        <https://1145.am/db/2180772/7wireventures>,
        <https://1145.am/db/2281648/Medical_Excellence_Capital_Partners>,
        <https://1145.am/db/2282392/Pioneer_Healthcare_Partners>,
        <https://1145.am/db/2294753/Catalyst_Health_Ventures>,
        <https://1145.am/db/2298897/Healthlink_Capital>,
        <https://1145.am/db/2303251/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2303257/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2305524/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/230667/Red_Tree_Venture_Capital>,
        <https://1145.am/db/2309845/Healthcare_Ventures>,
        <https://1145.am/db/2311069/Healthcare_Ventures>,
        <https://1145.am/db/2311075/Healthcare_Ventures>,
        <https://1145.am/db/2321713/Healthcor_Partners_Management>,
        <https://1145.am/db/2323586/Healthcare_Ventures>,
        <https://1145.am/db/2329533/Essex_Woodlands_Healthcare_Ventures>,
        <https://1145.am/db/2329533/Gilde_Healthcare>,
        <https://1145.am/db/2330876/Healthcare_Venture>,
        <https://1145.am/db/2337166/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2340284/Catalyst_Health_Ventures>,
        <https://1145.am/db/2342611/Healthcap>,
        <https://1145.am/db/2347469/Healthcare_Ventures>,
        <https://1145.am/db/2347822/Healthcap>,
        <https://1145.am/db/2349717/Healthcare_Ventures>,
        <https://1145.am/db/2352820/Healthcare_Ventures>,
        <https://1145.am/db/2356567/Mp_Healthcare_Venture_Management_Inc>,
        <https://1145.am/db/2365279/Founders_Fund>,
        <https://1145.am/db/2365296/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2367497/Healthcare_Ventures>,
        <https://1145.am/db/2369086/Whitesun_Healthcare_Ventures>,
        <https://1145.am/db/348452/Inflect_Health>,
        <https://1145.am/db/662177/Apollo_Health_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2235852/Healthcare_Ventures>,
        <https://1145.am/db/2304650/Healthcare_Ventures>,
        <https://1145.am/db/2308148/Healthcare_Ventures>,
        <https://1145.am/db/2308887/Healthcare_Ventures>,
        <https://1145.am/db/2312192/Healthcare_Ventures>,
        <https://1145.am/db/2313405/Healthcare_Ventures>,
        <https://1145.am/db/2316601/Healthcare_Ventures>,
        <https://1145.am/db/2316605/Healthcare_Ventures>,
        <https://1145.am/db/2316823/Healthcare_Ventures>,
        <https://1145.am/db/2318657/Healthcare_Ventures>,
        <https://1145.am/db/2321097/Healthcare_Ventures>,
        <https://1145.am/db/2331639/Healthcare_Ventures>,
        <https://1145.am/db/2338373/Healthcare_Ventures>,
        <https://1145.am/db/2342269/Healthcare_Ventures>,
        <https://1145.am/db/2343202/Healthcare_Ventures>,
        <https://1145.am/db/2343210/Healthcare_Ventures>,
        <https://1145.am/db/2348486/Healthcare_Ventures>,
        <https://1145.am/db/2349722/Healthcare_Ventures>,
        <https://1145.am/db/2352814/Healthcare_Ventures>,
        <https://1145.am/db/2363510/Healthcare_Ventures>,
        <https://1145.am/db/2365138/Healthcare_Ventures>,
        <https://1145.am/db/2365171/Healthcare_Ventures>,
        <https://1145.am/db/2443170/Healthcare_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/Ipsen> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "Pharmaceutical" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "Ipsen Pharma SAS" ;
    ns1:industry "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:name "Ipsen" ;
    ns1:sameAsHigh <https://1145.am/db/1161944/Ipsen>,
        <https://1145.am/db/1161957/Ipsen>,
        <https://1145.am/db/1163844/Ipsen_Sa>,
        <https://1145.am/db/1163848/Ipsen>,
        <https://1145.am/db/1163855/Ipsen>,
        <https://1145.am/db/1167451/Ipsen_Sa>,
        <https://1145.am/db/1176544/Ipsen>,
        <https://1145.am/db/1200853/Ipsen_Sa>,
        <https://1145.am/db/1202151/Ipsen_Sa>,
        <https://1145.am/db/1276041/Ipsen>,
        <https://1145.am/db/1626341/Ipsen>,
        <https://1145.am/db/1633106/Ipsen_Sa>,
        <https://1145.am/db/1633169/Ipsen_Sa>,
        <https://1145.am/db/1644477/Ipsen>,
        <https://1145.am/db/1645222/Ipsen>,
        <https://1145.am/db/2152544/Ipsen>,
        <https://1145.am/db/2153682/Ipsen>,
        <https://1145.am/db/2153782/Ipsen>,
        <https://1145.am/db/2153982/Ipsen>,
        <https://1145.am/db/2154368/Ipsen>,
        <https://1145.am/db/2155620/Ipsen>,
        <https://1145.am/db/2288192/Ipsen>,
        <https://1145.am/db/2288500/Ipsen>,
        <https://1145.am/db/2301863/Ipsen>,
        <https://1145.am/db/2302740/Ipsen>,
        <https://1145.am/db/2302958/Ipsen>,
        <https://1145.am/db/2309378/Ipsen_Sa>,
        <https://1145.am/db/2329638/Ipsen>,
        <https://1145.am/db/2336604/Ipsen>,
        <https://1145.am/db/2336987/Ipsen>,
        <https://1145.am/db/2337102/Ipsen>,
        <https://1145.am/db/2337689/Ipsen>,
        <https://1145.am/db/2339031/Ipsen>,
        <https://1145.am/db/2343954/Ipsen>,
        <https://1145.am/db/2344680/Ipsen_Biopharmaceuticals_Inc>,
        <https://1145.am/db/2352361/Ipsen>,
        <https://1145.am/db/2354464/Ipsen>,
        <https://1145.am/db/2355419/Ipsen>,
        <https://1145.am/db/2360217/Ipsen>,
        <https://1145.am/db/2360232/Ipsen>,
        <https://1145.am/db/2364637/Ipsen>,
        <https://1145.am/db/2367100/Ipsen>,
        <https://1145.am/db/2367129/Ipsen>,
        <https://1145.am/db/2371455/Ipsen>,
        <https://1145.am/db/2539925/Ipsen>,
        <https://1145.am/db/2541727/Ipsen>,
        <https://1145.am/db/2544894/Ipsen>,
        <https://1145.am/db/2544901/Ipsen>,
        <https://1145.am/db/2565505/Ipsen_Group>,
        <https://1145.am/db/2567081/Ipsen>,
        <https://1145.am/db/534524/Ipsen>,
        <https://1145.am/db/538860/Ipsen>,
        <https://1145.am/db/586242/Ipsen>,
        <https://1145.am/db/835053/Ipsen> ;
    ns1:sameAsMedium <https://1145.am/db/1257196/Ipsen_Sa>,
        <https://1145.am/db/1257350/Ipsen_Sa>,
        <https://1145.am/db/2294817/Ipsen>,
        <https://1145.am/db/2295271/Ipsen>,
        <https://1145.am/db/2324027/Ipsen>,
        <https://1145.am/db/2332815/Ipsen>,
        <https://1145.am/db/2359873/Ipsen>,
        <https://1145.am/db/2369202/Ipsen>,
        <https://1145.am/db/2370067/Ipsen>,
        <https://1145.am/db/2561454/Ipsen>,
        <https://1145.am/db/772473/Ipsen>,
        <https://1145.am/db/773879/Ipsen> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/Mpm_Acquisition_Corp> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "unlisted public reporting shell company" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "MPM Acquisition Corp." ;
    ns1:name "MPM Acquisition Corp" ;
    ns1:protagonist <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/Mpm_Bio_Iv_Nvs_Strategic_Fund> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "What is the typical occupation of the person or organization that is described as typically involved in:" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "MPM Bio IV NVS Strategic Fund" ;
    ns1:investor <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:name "MPM Bio IV NVS Strategic Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2303833/Mpm_Bio_Iv_Nvs_Strategic_Fund_Lp>,
        <https://1145.am/db/2308887/Mpm_Bio_Iv_Nvs_Strategic_Fund>,
        <https://1145.am/db/2352172/Mpm_Bio_Iv_Nvs_Strategic_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/Nordic_Bioscience> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "Nordic Bioscience" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "Nordic Bioscience" ;
    ns1:investor <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:name "Nordic Bioscience" ;
    ns1:sameAsHigh <https://1145.am/db/2357883/Claus_Christiansen> ;
    ns1:sameAsMedium <https://1145.am/db/255858/Nordic_Bioscience> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/Saints_Capital> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "equity financing" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "Saints Capital" ;
    ns1:investor <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:name "Saints Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2295207/Saints_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1880532/Saints_Capital>,
        <https://1145.am/db/2251548/Saints_Capital>,
        <https://1145.am/db/2337293/Saints_Capital>,
        <https://1145.am/db/2579358/Saints_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/Scottish_Widows_Investment_Partnership> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "equity financing" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "Scottish Widows Investment Partnership" ;
    ns1:investor <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:name "Scottish Widows Investment Partnership" ;
    ns1:sameAsHigh <https://1145.am/db/2303814/Scottish_Widows_Investment_Partnership>,
        <https://1145.am/db/2309845/Scottish_Widows_Investment_Partnership> ;
    ns1:sameAsMedium <https://1145.am/db/2303810/Scottish_Widows_Investment_Partnership>,
        <https://1145.am/db/2308887/Scottish_Widows_Investment_Partnership> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/The_Wellcome_Trust> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:description "Research" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "The Wellcome Trust" ;
    ns1:investor <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:name "The Wellcome Trust" ;
    ns1:sameAsHigh <https://1145.am/db/2312120/Wellcome_Trust>,
        <https://1145.am/db/2338829/Wellcome_Trust>,
        <https://1145.am/db/2367399/The_Wellcome_Trust>,
        <https://1145.am/db/2369419/Wellcome_Trust>,
        <https://1145.am/db/240593/Wellcome_Trust>,
        <https://1145.am/db/2559928/Wellcome_Trust> ;
    ns1:sameAsMedium <https://1145.am/db/2308887/The_Wellcome_Trust>,
        <https://1145.am/db/2309845/The_Wellcome_Trust>,
        <https://1145.am/db/2312116/The_Wellcome_Trust>,
        <https://1145.am/db/2317122/The_Wellcome_Trust>,
        <https://1145.am/db/2318656/The_Wellcome_Trust>,
        <https://1145.am/db/2318657/The_Wellcome_Trust>,
        <https://1145.am/db/2328763/The_Wellcome_Trust>,
        <https://1145.am/db/2328769/The_Wellcome_Trust>,
        <https://1145.am/db/2329533/The_Wellcome_Trust>,
        <https://1145.am/db/2330867/The_Wellcome_Trust>,
        <https://1145.am/db/2339393/The_Wellcome_Trust> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346230/Finance_Wales> a org:Organization ;
    ns1:basedInHighGeoName "Wales" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2634895/about.rdf> ;
    ns1:basedInHighRaw "Wales" ;
    ns1:documentDate "2011-05-25T12:41:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Q Chip completes US$6 million funding round to expand its portfolio of drug formulations and establish a European facility" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/q-chip-completes-us-6-million-funding-round-to-expand-its-portfolio-of-drug-formulations> ;
    ns1:foundName "Finance Wales" ;
    ns1:investor <https://1145.am/db/2346230/Series_C_Investment_Finance_Wales_Limburg_Ventures_Nedermaas_Hightech_Ventures_Q_Chip_Limited_Completed> ;
    ns1:name "Finance Wales" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346230/Limburg_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Dutch" ;
    ns1:documentDate "2011-05-25T12:41:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Q Chip completes US$6 million funding round to expand its portfolio of drug formulations and establish a European facility" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/q-chip-completes-us-6-million-funding-round-to-expand-its-portfolio-of-drug-formulations> ;
    ns1:foundName "Limburg Ventures" ;
    ns1:investor <https://1145.am/db/2346230/Series_C_Investment_Finance_Wales_Limburg_Ventures_Nedermaas_Hightech_Ventures_Q_Chip_Limited_Completed> ;
    ns1:name "Limburg Ventures" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346230/Nedermaas_Hightech_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Dutch" ;
    ns1:documentDate "2011-05-25T12:41:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Q Chip completes US$6 million funding round to expand its portfolio of drug formulations and establish a European facility" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/q-chip-completes-us-6-million-funding-round-to-expand-its-portfolio-of-drug-formulations> ;
    ns1:foundName "Nedermaas Hightech Ventures" ;
    ns1:investor <https://1145.am/db/2346230/Series_C_Investment_Finance_Wales_Limburg_Ventures_Nedermaas_Hightech_Ventures_Q_Chip_Limited_Completed> ;
    ns1:name "Nedermaas Hightech Ventures" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346523/Eye-Drug_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-02-14T13:14:44+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Sanofi-Aventis is considering four deals for eye-drug for a total of 1 billion ($ 1.36 billion) in possible acquisitions, French newspaper Les Echos reports." ;
    ns1:documentTitle "Sanofi mulls $1.36B in eye drug deals as it nears Genzyme buy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sanofi-mulls-1-36b-eye-drug-deals-as-it-nears-genzyme-buy> ;
    ns1:foundName "acquisitions",
        "deals" ;
    ns1:name "acquisitions",
        "deals" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2346523/Eye-Drug> ;
    ns1:targetName "eye-drug" ;
    ns1:valueRaw "$ 1.36 billion",
        "1 billion" ;
    ns1:whereGeoName "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Israel" .

<https://1145.am/db/2346532/Alta_Partners_Asset_Management_Company> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:description "Investing",
        "venture capital" ;
    ns1:documentDate "2011-02-14T14:19:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Chimerix, Inc. Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/chimerix-inc-completes-45-million-financing-to-fund-further-development-of-novel-antiviral> ;
    ns1:foundName "Alta Partners",
        "Alta Partners, Asset Management Company",
        "Asset Management Company" ;
    ns1:investor <https://1145.am/db/2346532/Series_F_Investment_Alta_Partners_Asset_Management_Company_Canaan_Partners_Chimerix_Frazier_Healthcare_Ventures_Morningside_Group_New_Leaf_Venture_Partners_Pappas_Ventures_Sanderling_Ventures_Completed> ;
    ns1:name "Alta Partners",
        "Alta Partners, Asset Management Company",
        "Asset Management Company" ;
    ns1:sameAsHigh <https://1145.am/db/2120060/Altair_Capital>,
        <https://1145.am/db/884806/Alta_Park_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346532/Frazier_Healthcare_Ventures> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:description "investing" ;
    ns1:documentDate "2011-02-14T14:19:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Chimerix, Inc. Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/chimerix-inc-completes-45-million-financing-to-fund-further-development-of-novel-antiviral> ;
    ns1:foundName "Frazier Healthcare Ventures" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2346532/Series_F_Investment_Alta_Partners_Asset_Management_Company_Canaan_Partners_Chimerix_Frazier_Healthcare_Ventures_Morningside_Group_New_Leaf_Venture_Partners_Pappas_Ventures_Sanderling_Ventures_Completed> ;
    ns1:name "Frazier Healthcare Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1244886/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1245863/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1813040/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2152824/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2196903/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2245812/Frazier_Healthcare>,
        <https://1145.am/db/2278780/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2292109/Frazier_Healthcare>,
        <https://1145.am/db/2303250/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2307829/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2310795/Frazier_Healthcare>,
        <https://1145.am/db/2318577/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2327442/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2330075/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2330079/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2331784/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2335675/Frazier_Healthcare>,
        <https://1145.am/db/2335817/Frazier_Life_Sciences>,
        <https://1145.am/db/2338625/Frazier_Healthcare>,
        <https://1145.am/db/2338633/Frazier_Healthcare>,
        <https://1145.am/db/2339926/Frazier_Healthcare>,
        <https://1145.am/db/2340204/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2342352/Frazier_Healthcare>,
        <https://1145.am/db/2346542/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2351519/Frazier_Healthcare>,
        <https://1145.am/db/2356269/Frazier_Healthcare>,
        <https://1145.am/db/2356306/Frazier_Healthcare>,
        <https://1145.am/db/2361549/Frazier_Healthcare>,
        <https://1145.am/db/2361551/Frazier_Healthcare>,
        <https://1145.am/db/2365700/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2366187/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2368333/Frazier_Healthcare>,
        <https://1145.am/db/2553555/Frazier_Healthcare>,
        <https://1145.am/db/2592685/Frazier_Healthcare>,
        <https://1145.am/db/505366/Frazier_Healthcare_Partners>,
        <https://1145.am/db/699981/Frazier_Healthcare_Partners>,
        <https://1145.am/db/770024/Frazier_Healthcare_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1329605/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1374146/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2154276/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2189855/Frazier_Healthcare>,
        <https://1145.am/db/2294202/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2303251/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2303257/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2305524/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2307824/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2308855/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2310798/Frazier_Healthcare>,
        <https://1145.am/db/2311551/Frazier_Healthcare>,
        <https://1145.am/db/2316391/Frazier_Healthcare>,
        <https://1145.am/db/2318274/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318276/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318635/Frazier_Healthcare>,
        <https://1145.am/db/2321216/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2325326/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2326430/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2327441/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2334616/Frazier_Healthcare>,
        <https://1145.am/db/2334622/Frazier_Healthcare>,
        <https://1145.am/db/2334624/Frazier_Healthcare>,
        <https://1145.am/db/2335743/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2336032/Frazier_Healthcare>,
        <https://1145.am/db/2337166/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2339925/Frazier_Healthcare>,
        <https://1145.am/db/2340207/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2342629/Frazier_Healthcare>,
        <https://1145.am/db/2348754/Frazier_Healthcare>,
        <https://1145.am/db/2351520/Frazier_Healthcare>,
        <https://1145.am/db/2366700/Frazier_Healthcare>,
        <https://1145.am/db/2370761/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2537423/Frazier_Healthcare>,
        <https://1145.am/db/2584561/Frazier_Healthcare_Partners>,
        <https://1145.am/db/490601/Frazier_Healthcare_Partners>,
        <https://1145.am/db/578056/Frazier_Healthcare_Partners>,
        <https://1145.am/db/578059/Frazier_Healthcare_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346532/Morningside_Group> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:documentDate "2011-02-14T14:19:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Chimerix, Inc. Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/chimerix-inc-completes-45-million-financing-to-fund-further-development-of-novel-antiviral> ;
    ns1:foundName "Morningside Group" ;
    ns1:investor <https://1145.am/db/2346532/Series_F_Investment_Alta_Partners_Asset_Management_Company_Canaan_Partners_Chimerix_Frazier_Healthcare_Ventures_Morningside_Group_New_Leaf_Venture_Partners_Pappas_Ventures_Sanderling_Ventures_Completed> ;
    ns1:name "Morningside Group" ;
    ns1:sameAsMedium <https://1145.am/db/1739611/Morningside_Group>,
        <https://1145.am/db/1855817/Morningside_Group>,
        <https://1145.am/db/2190702/Morningside_Group>,
        <https://1145.am/db/2292616/Morningside_Group>,
        <https://1145.am/db/2325366/Morningside_Group>,
        <https://1145.am/db/2339427/Morningside_Groups>,
        <https://1145.am/db/2339428/Morningside_Groups>,
        <https://1145.am/db/2346542/Morningside_Group>,
        <https://1145.am/db/2346972/Morningside_Group>,
        <https://1145.am/db/2346973/Morningside_Group>,
        <https://1145.am/db/2347977/Morningside_Group>,
        <https://1145.am/db/2347983/Morningside_Group>,
        <https://1145.am/db/2353522/Morningside_Group>,
        <https://1145.am/db/2353525/Morningside_Group>,
        <https://1145.am/db/531354/Morningside_Group>,
        <https://1145.am/db/719976/Morningside_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346532/Sanderling_Ventures> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:description "investing" ;
    ns1:documentDate "2011-02-14T14:19:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Chimerix, Inc. Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/chimerix-inc-completes-45-million-financing-to-fund-further-development-of-novel-antiviral> ;
    ns1:foundName "Sanderling Ventures" ;
    ns1:investor <https://1145.am/db/2346532/Series_F_Investment_Alta_Partners_Asset_Management_Company_Canaan_Partners_Chimerix_Frazier_Healthcare_Ventures_Morningside_Group_New_Leaf_Venture_Partners_Pappas_Ventures_Sanderling_Ventures_Completed> ;
    ns1:name "Sanderling Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1007995/Capital_One_Ventures>,
        <https://1145.am/db/1010371/Capital_One_Ventures>,
        <https://1145.am/db/1061906/Agya_Ventures>,
        <https://1145.am/db/1068382/Oquirrh_Ventures>,
        <https://1145.am/db/1079459/137_Ventures>,
        <https://1145.am/db/1087308/Nexo_Ventures>,
        <https://1145.am/db/1091523/Nexo_Ventures>,
        <https://1145.am/db/1111458/Spring_Ventures>,
        <https://1145.am/db/1111951/Spring_Ventures>,
        <https://1145.am/db/1119661/Menlo_Ventures>,
        <https://1145.am/db/1122753/Menlo_Ventures>,
        <https://1145.am/db/1124122/Delphi_Ventures>,
        <https://1145.am/db/1130744/Coingecko_Ventures>,
        <https://1145.am/db/1138738/Ap_Ventures>,
        <https://1145.am/db/1138829/Sozo_Ventures>,
        <https://1145.am/db/1140806/Ap_Ventures>,
        <https://1145.am/db/1141082/Sozo_Ventures>,
        <https://1145.am/db/1150154/Finistere_Ventures>,
        <https://1145.am/db/1156304/Astellas_Venture_Management>,
        <https://1145.am/db/1195265/Alpha_Ascent_Ventures>,
        <https://1145.am/db/1197990/Proje_Ventures_Inc>,
        <https://1145.am/db/1202633/Alix_Ventures>,
        <https://1145.am/db/1202633/Fpv_Ventures>,
        <https://1145.am/db/1202770/Seae_Ventures>,
        <https://1145.am/db/1203099/Alix_Ventures>,
        <https://1145.am/db/1203099/Fpv_Ventures>,
        <https://1145.am/db/1203467/Seae_Ventures>,
        <https://1145.am/db/1204350/Allegion_Ventures>,
        <https://1145.am/db/1205708/Allegion_Ventures>,
        <https://1145.am/db/1208612/Ia_Ventures>,
        <https://1145.am/db/1247764/Allos_Ventures>,
        <https://1145.am/db/1248635/Allos_Ventures>,
        <https://1145.am/db/1249241/Ulu_Ventures>,
        <https://1145.am/db/1290854/Mistry_Ventures>,
        <https://1145.am/db/1291767/Mistry_Ventures>,
        <https://1145.am/db/1297175/Nextview_Ventures>,
        <https://1145.am/db/1297529/Nextview_Ventures>,
        <https://1145.am/db/1318775/Waycross_Ventures>,
        <https://1145.am/db/1319026/Waycross_Ventures>,
        <https://1145.am/db/1334395/Eir_Ventures>,
        <https://1145.am/db/1334395/Gu_Ventures>,
        <https://1145.am/db/1366307/Hscm_Ventures>,
        <https://1145.am/db/1366825/Hscm_Ventures>,
        <https://1145.am/db/1375182/Sevenx_Ventures>,
        <https://1145.am/db/1406211/Exor_Ventures>,
        <https://1145.am/db/1433134/Haymaker_Ventures>,
        <https://1145.am/db/1451918/Engage_Ventures>,
        <https://1145.am/db/1453960/At_One_Ventures>,
        <https://1145.am/db/1470525/Nextview_Ventures>,
        <https://1145.am/db/1490295/M13_Ventures>,
        <https://1145.am/db/1503198/Illuminate_Ventures>,
        <https://1145.am/db/1503204/Illuminate_Ventures>,
        <https://1145.am/db/1503205/Illuminate_Ventures>,
        <https://1145.am/db/1504977/Sogal_Ventures>,
        <https://1145.am/db/1504983/Element_Ventures>,
        <https://1145.am/db/1523935/Chui_Ventures>,
        <https://1145.am/db/1558423/Grand_Ventures>,
        <https://1145.am/db/1615580/Alpha_Wave_Ventures>,
        <https://1145.am/db/1659940/Credo_Ventures>,
        <https://1145.am/db/1697098/Trinity_Ventures>,
        <https://1145.am/db/1698200/Liquid2_Ventures>,
        <https://1145.am/db/1704356/Dcm_Ventures>,
        <https://1145.am/db/1708599/Promus_Ventures>,
        <https://1145.am/db/1708892/Gatecap_Ventures>,
        <https://1145.am/db/1717613/Trinity_Ventures>,
        <https://1145.am/db/1737539/C4_Ventures>,
        <https://1145.am/db/1738305/East_Ventures>,
        <https://1145.am/db/1740448/212_Ventures>,
        <https://1145.am/db/1743085/Eventures>,
        <https://1145.am/db/1744228/M12_Ventures>,
        <https://1145.am/db/1744629/Oneway_Ventures>,
        <https://1145.am/db/1746172/Prosus_Ventures>,
        <https://1145.am/db/1746463/Allegion_Ventures>,
        <https://1145.am/db/1746463/Pathbreaker_Ventures>,
        <https://1145.am/db/1746463/West_Ventures>,
        <https://1145.am/db/1747510/Frontline_Ventures>,
        <https://1145.am/db/1747745/East_Ventures>,
        <https://1145.am/db/1747847/East_Ventures>,
        <https://1145.am/db/1748318/Mehta_Ventures>,
        <https://1145.am/db/1748858/Prosus_Ventures>,
        <https://1145.am/db/1753648/Yl_Ventures>,
        <https://1145.am/db/1756445/Menlo_Ventures>,
        <https://1145.am/db/1757432/Evolv_Ventures>,
        <https://1145.am/db/1757706/Menlo_Ventures>,
        <https://1145.am/db/1758679/Hv_Ventures>,
        <https://1145.am/db/1758927/At_One_Ventures>,
        <https://1145.am/db/1758927/Inmotion_Ventures>,
        <https://1145.am/db/1759769/7pc_Ventures>,
        <https://1145.am/db/1760406/Alpha_Bridge_Ventures>,
        <https://1145.am/db/1761089/Prosus_Ventures>,
        <https://1145.am/db/1761247/Connect_Ventures>,
        <https://1145.am/db/1761347/Ia_Ventures>,
        <https://1145.am/db/1762125/Gron_Ventures>,
        <https://1145.am/db/1762896/Amity_Ventures>,
        <https://1145.am/db/1763652/C4_Ventures>,
        <https://1145.am/db/1764066/Avid_Ventures>,
        <https://1145.am/db/1765903/Cathexis_Ventures>,
        <https://1145.am/db/1766725/Eqt_Ventures>,
        <https://1145.am/db/1767814/Dcm_Ventures>,
        <https://1145.am/db/1768556/Valar_Ventures>,
        <https://1145.am/db/1769467/Trinity_Ventures>,
        <https://1145.am/db/1775794/Helion_Ventures>,
        <https://1145.am/db/1775950/United_Ventures>,
        <https://1145.am/db/1776620/Sogal_Ventures>,
        <https://1145.am/db/1777489/Check24_Ventures>,
        <https://1145.am/db/1777903/Menlo_Ventures>,
        <https://1145.am/db/1779277/Ia_Ventures>,
        <https://1145.am/db/1780319/Dcm_Ventures>,
        <https://1145.am/db/1780319/Morningside_Ventures>,
        <https://1145.am/db/1789460/Capnamic_Ventures>,
        <https://1145.am/db/1789594/Partech_Ventures>,
        <https://1145.am/db/1790116/Dcm_Ventures>,
        <https://1145.am/db/1791642/Ia_Ventures>,
        <https://1145.am/db/1793575/Trinity_Ventures>,
        <https://1145.am/db/1794794/Placid_Ventures>,
        <https://1145.am/db/1794996/Idg_Ventures>,
        <https://1145.am/db/1808409/Trinity_Ventures>,
        <https://1145.am/db/1810437/Menlo_Ventures>,
        <https://1145.am/db/1813873/Valar_Ventures>,
        <https://1145.am/db/1815038/Ine_Ventures>,
        <https://1145.am/db/1820911/Horizon_Ventures>,
        <https://1145.am/db/1823954/Ia_Ventures>,
        <https://1145.am/db/1827409/Plus_Ventures>,
        <https://1145.am/db/1836989/Morgenthaler_Ventures>,
        <https://1145.am/db/1839836/Morgenthaler_Ventures>,
        <https://1145.am/db/1840889/Connect_Ventures>,
        <https://1145.am/db/1844180/Sherpa_Ventures>,
        <https://1145.am/db/1846679/Connect_Ventures>,
        <https://1145.am/db/1847463/Trinity_Ventures>,
        <https://1145.am/db/1850876/Partech_Ventures>,
        <https://1145.am/db/1853156/Idg_Ventures>,
        <https://1145.am/db/1855137/Lool_Ventures>,
        <https://1145.am/db/1858481/Xg_Ventures>,
        <https://1145.am/db/1866409/Menlo_Ventures>,
        <https://1145.am/db/1879023/Revolution_Ventures>,
        <https://1145.am/db/1879069/Ascend_Ventures>,
        <https://1145.am/db/1886260/Trinity_Ventures>,
        <https://1145.am/db/1886771/Onset_Ventures>,
        <https://1145.am/db/1890208/Star_Ventures>,
        <https://1145.am/db/1893502/Nextview_Ventures>,
        <https://1145.am/db/1894610/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1896364/Nextview_Ventures>,
        <https://1145.am/db/1898837/Trinity_Ventures>,
        <https://1145.am/db/1935365/Ac_Venture>,
        <https://1145.am/db/1942254/Audeo_Ventures>,
        <https://1145.am/db/196586/H_L_Ventures>,
        <https://1145.am/db/2003542/Valo_Ventures>,
        <https://1145.am/db/2017126/Stellar_Ventures>,
        <https://1145.am/db/2017188/Techpro_Ventures>,
        <https://1145.am/db/2023596/Ret_Ventures>,
        <https://1145.am/db/2052534/Level_Ventures>,
        <https://1145.am/db/2075625/Horizon_Ventures>,
        <https://1145.am/db/2133628/Prelude_Ventures>,
        <https://1145.am/db/2150240/Utiliti_Ventures>,
        <https://1145.am/db/2153423/Borealis_Ventures>,
        <https://1145.am/db/2196875/Maverick_Ventures>,
        <https://1145.am/db/2304637/Ampersand_Ventures>,
        <https://1145.am/db/2307644/Morgenthaler_Ventures>,
        <https://1145.am/db/2309005/Epic_Ventures>,
        <https://1145.am/db/2311075/Morgenthaler_Ventures>,
        <https://1145.am/db/2311595/Clarus_Ventures>,
        <https://1145.am/db/2315279/123_Ventures>,
        <https://1145.am/db/2317455/Rk_Venture_Group>,
        <https://1145.am/db/2320476/Astellas_Venture_Management>,
        <https://1145.am/db/2323586/Morgenthaler_Ventures>,
        <https://1145.am/db/2330876/Aberdare_Ventures>,
        <https://1145.am/db/2337971/Rho_Ventures>,
        <https://1145.am/db/2339732/Morningside_Ventures>,
        <https://1145.am/db/2342937/Morgenthaler_Ventures>,
        <https://1145.am/db/2358640/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358658/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2369785/Enso_Ventures>,
        <https://1145.am/db/2369872/Arcus_Ventures>,
        <https://1145.am/db/2370582/Astellas_Venture_Management>,
        <https://1145.am/db/2423622/Tdk_Ventures_Inc>,
        <https://1145.am/db/2587938/Rho_Ventures>,
        <https://1145.am/db/2604027/Nxt_Ventures>,
        <https://1145.am/db/2611628/Yl_Ventures>,
        <https://1145.am/db/2700208/Highsage_Ventures>,
        <https://1145.am/db/2717146/Allos_Ventures>,
        <https://1145.am/db/2799006/Stellantis_Ventures>,
        <https://1145.am/db/309011/Oca_Ventures>,
        <https://1145.am/db/309011/Seae_Ventures>,
        <https://1145.am/db/350275/Artis_Ventures>,
        <https://1145.am/db/364168/Grotech_Ventures>,
        <https://1145.am/db/429084/Capital_One_Ventures>,
        <https://1145.am/db/438400/Nextview_Ventures>,
        <https://1145.am/db/471253/Arch_Ventures>,
        <https://1145.am/db/490458/Molex_Ventures_Llc>,
        <https://1145.am/db/491313/Oca_Ventures>,
        <https://1145.am/db/509930/Arka_Ventures>,
        <https://1145.am/db/539571/Oca_Ventures>,
        <https://1145.am/db/587045/Creacion_Ventures>,
        <https://1145.am/db/591613/Creacion_Ventures>,
        <https://1145.am/db/594487/Highsage_Ventures>,
        <https://1145.am/db/601951/Ia_Ventures>,
        <https://1145.am/db/623441/Ascension_Ventures>,
        <https://1145.am/db/626473/Se_Ventures>,
        <https://1145.am/db/643962/Pathfinder_Ventures_Inc>,
        <https://1145.am/db/662514/Tdk_Ventures_Inc>,
        <https://1145.am/db/668624/Trinity_Ventures>,
        <https://1145.am/db/693216/Springtide_Ventures>,
        <https://1145.am/db/696617/Gsv_Ventures>,
        <https://1145.am/db/701859/Tdk_Ventures>,
        <https://1145.am/db/708697/Iu_Ventures>,
        <https://1145.am/db/731691/Co-Win_Ventures>,
        <https://1145.am/db/734916/Valar_Ventures>,
        <https://1145.am/db/75445/Droia_Ventures>,
        <https://1145.am/db/768089/Alix_Ventures>,
        <https://1145.am/db/769568/Artis_Ventures>,
        <https://1145.am/db/770705/Morningside_Ventures>,
        <https://1145.am/db/792608/Nextcoast_Ventures>,
        <https://1145.am/db/815550/Prosus_Ventures>,
        <https://1145.am/db/854084/Tegna_Ventures>,
        <https://1145.am/db/867116/Forever_Ventures>,
        <https://1145.am/db/867116/Lavrock_Ventures>,
        <https://1145.am/db/868933/Prosus_Ventures>,
        <https://1145.am/db/869652/Lavrock_Ventures>,
        <https://1145.am/db/882636/Prosus_Ventures>,
        <https://1145.am/db/886445/Eqt_Ventures>,
        <https://1145.am/db/886722/At_One_Ventures>,
        <https://1145.am/db/893076/Teamworthy_Ventures>,
        <https://1145.am/db/893076/Trium_Venture_Partners>,
        <https://1145.am/db/893316/Teamworthy_Ventures>,
        <https://1145.am/db/893316/Trium_Venture_Partners>,
        <https://1145.am/db/893416/Joseph_Ventures>,
        <https://1145.am/db/894336/Joseph_Ventures>,
        <https://1145.am/db/896550/Prelude_Ventures>,
        <https://1145.am/db/897410/Prelude_Ventures>,
        <https://1145.am/db/903689/Co-Win_Ventures>,
        <https://1145.am/db/903761/Tengro_Ventures>,
        <https://1145.am/db/911551/Astanor_Ventures>,
        <https://1145.am/db/935242/Cobalt_Ventures>,
        <https://1145.am/db/935686/Lool_Ventures>,
        <https://1145.am/db/941871/Eshelman_Ventures>,
        <https://1145.am/db/944358/Cortado_Ventures>,
        <https://1145.am/db/951514/Axilor_Ventures>,
        <https://1145.am/db/952832/Axilor_Ventures>,
        <https://1145.am/db/962870/Sozo_Ventures_Crv>,
        <https://1145.am/db/973424/Kawn_Ventures>,
        <https://1145.am/db/993478/Highgate_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2228252/Sanderling_Ventures>,
        <https://1145.am/db/2273257/Sanderling_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2289884/Sanderling_Ventures>,
        <https://1145.am/db/2299881/Sanderling_Ventures>,
        <https://1145.am/db/2305739/Sanderling_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2318941/Sanderling_Ventures>,
        <https://1145.am/db/2323103/Sanderling_Ventures>,
        <https://1145.am/db/2327212/Sanderling_Ventures>,
        <https://1145.am/db/2327227/Sanderling_Ventures>,
        <https://1145.am/db/2327638/Sanderling_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338237/Sanderling_Ventures>,
        <https://1145.am/db/2346542/Sanderling_Ventures>,
        <https://1145.am/db/2347594/Sanderling_Ventures>,
        <https://1145.am/db/2352831/Sanderling_Ventures>,
        <https://1145.am/db/2364301/Sanderling_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346534/Aberdare_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:description "private placement financing" ;
    ns1:documentDate "2011-02-14T14:20:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Conatus Pharmaceuticals Inc. Completes $20 Million Series B Private Placement Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/conatus-pharmaceuticals-inc-completes-20-million-series-b-private-placement-financing> ;
    ns1:foundName "Aberdare Ventures" ;
    ns1:investor <https://1145.am/db/2346534/Preferred_Stock_Investment_Aberdare_Ventures_Advent_Venture_Partners_Agechem_Venture_Fund_Bay_City_Capital_Conatus_Pharmaceuticals_Inc_Gilde_Healthcare_Partners_Roche_Venture_Fund_Completed> ;
    ns1:name "Aberdare Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2365296/Auriga_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1856457/Aberdare_Ventures>,
        <https://1145.am/db/1857326/Aberdare_Ventures>,
        <https://1145.am/db/2292334/Aberdare_Ventures>,
        <https://1145.am/db/2292353/Aberdare_Ventures>,
        <https://1145.am/db/2307565/Aberdare_Ventures>,
        <https://1145.am/db/2318708/Aberdare_Ventures>,
        <https://1145.am/db/2323531/Aberdare_Ventures>,
        <https://1145.am/db/2329550/Aberdare_Ventures>,
        <https://1145.am/db/2330876/Aberdare_Ventures>,
        <https://1145.am/db/2343723/Aberdare_Ventures>,
        <https://1145.am/db/2343724/Aberdare_Ventures>,
        <https://1145.am/db/2343744/Aberdare_Ventures>,
        <https://1145.am/db/2350491/Aberdare_Ventures>,
        <https://1145.am/db/2362035/Aberdare_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346534/Advent_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:description "private placement financing" ;
    ns1:documentDate "2011-02-14T14:20:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Conatus Pharmaceuticals Inc. Completes $20 Million Series B Private Placement Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/conatus-pharmaceuticals-inc-completes-20-million-series-b-private-placement-financing> ;
    ns1:foundName "Advent Venture Partners" ;
    ns1:investor <https://1145.am/db/2346534/Preferred_Stock_Investment_Aberdare_Ventures_Advent_Venture_Partners_Agechem_Venture_Fund_Bay_City_Capital_Conatus_Pharmaceuticals_Inc_Gilde_Healthcare_Partners_Roche_Venture_Fund_Completed> ;
    ns1:name "Advent Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2352566/Advent_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1699773/Advent_Venture_Partners_Llp>,
        <https://1145.am/db/1828930/Advent_Venture_Partners>,
        <https://1145.am/db/1873136/Advent_Venture_Partners>,
        <https://1145.am/db/1875469/Advent_Venture_Partners>,
        <https://1145.am/db/1879760/Advent_Venture_Partners>,
        <https://1145.am/db/1895619/Advent_Venture_Partners>,
        <https://1145.am/db/1895903/Advent_Venture_Partners>,
        <https://1145.am/db/1910490/Advent_Venture_Partners>,
        <https://1145.am/db/1919816/Advent_Venture_Partners>,
        <https://1145.am/db/2303656/Advent_Venture_Partners>,
        <https://1145.am/db/2314546/Advent_Venture_Partners>,
        <https://1145.am/db/2322622/Advent_Venture_Partners>,
        <https://1145.am/db/2331935/Advent_Venture_Partners>,
        <https://1145.am/db/2331946/Advent_Venture_Partners>,
        <https://1145.am/db/2362736/Advent_Venture_Partners>,
        <https://1145.am/db/2365819/Advent_Venture_Partners>,
        <https://1145.am/db/2638432/Advent_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346534/Gilde_Healthcare_Partners> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:description "private placement financing" ;
    ns1:documentDate "2011-02-14T14:20:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Conatus Pharmaceuticals Inc. Completes $20 Million Series B Private Placement Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/conatus-pharmaceuticals-inc-completes-20-million-series-b-private-placement-financing> ;
    ns1:foundName "Gilde Healthcare Partners" ;
    ns1:investor <https://1145.am/db/2346534/Preferred_Stock_Investment_Aberdare_Ventures_Advent_Venture_Partners_Agechem_Venture_Fund_Bay_City_Capital_Conatus_Pharmaceuticals_Inc_Gilde_Healthcare_Partners_Roche_Venture_Fund_Completed> ;
    ns1:name "Gilde Healthcare Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1130666/Gilde_Healthcare> ;
    ns1:sameAsMedium <https://1145.am/db/1281079/Gilde_Healthcare>,
        <https://1145.am/db/1281647/Gilde_Healthcare>,
        <https://1145.am/db/1619849/Gilde_Healthcare>,
        <https://1145.am/db/2153641/Gilde_Healthcare>,
        <https://1145.am/db/2153646/Gilde_Healthcare>,
        <https://1145.am/db/2154438/Gilde_Healthcare>,
        <https://1145.am/db/2285850/Gilde_Healthcare>,
        <https://1145.am/db/2289349/Gilde_Healthcare>,
        <https://1145.am/db/2294667/Gilde_Healthcare_Service>,
        <https://1145.am/db/2296209/Gilde_Healthcare>,
        <https://1145.am/db/2299080/Gilde_Healthcare>,
        <https://1145.am/db/2299342/Gilde_Healthcare>,
        <https://1145.am/db/2299386/Gilde_Healthcare_Partners>,
        <https://1145.am/db/2301160/Gilde_Healthcare>,
        <https://1145.am/db/2302380/Gilde_Healthcare_Partners>,
        <https://1145.am/db/2308952/Gilde_Healthcare_Partners>,
        <https://1145.am/db/2308959/Gilde_Healthcare_Partners>,
        <https://1145.am/db/2309490/Gilde_Healthcare_Partners>,
        <https://1145.am/db/2318829/Gilde_Healthcare_Partners>,
        <https://1145.am/db/2329533/Gilde_Healthcare>,
        <https://1145.am/db/2329870/Gilde_Healthcare_Partners>,
        <https://1145.am/db/2329919/Gilde_Healthcare_Partners>,
        <https://1145.am/db/2338079/Gilde_Healthcare>,
        <https://1145.am/db/2349048/Gilde_Healthcare>,
        <https://1145.am/db/2349301/Gilde_Healthcare_Partners>,
        <https://1145.am/db/2352566/Gilde_Healthcare_Partners>,
        <https://1145.am/db/2356685/Gilde_Healthcare_Partners>,
        <https://1145.am/db/2358747/Gilde_Healthcare_Partners>,
        <https://1145.am/db/2362148/Gilde_Healthcare>,
        <https://1145.am/db/2362156/Gilde_Healthcare>,
        <https://1145.am/db/2369953/Gilde_Healthcare>,
        <https://1145.am/db/2369987/Gilde_Healthcare>,
        <https://1145.am/db/770705/Gilde_Healthcare> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346534/Roche_Venture_Fund> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:description "private placement financing" ;
    ns1:documentDate "2011-02-14T14:20:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Conatus Pharmaceuticals Inc. Completes $20 Million Series B Private Placement Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/conatus-pharmaceuticals-inc-completes-20-million-series-b-private-placement-financing> ;
    ns1:foundName "Roche Venture Fund" ;
    ns1:investor <https://1145.am/db/2346534/Preferred_Stock_Investment_Aberdare_Ventures_Advent_Venture_Partners_Agechem_Venture_Fund_Bay_City_Capital_Conatus_Pharmaceuticals_Inc_Gilde_Healthcare_Partners_Roche_Venture_Fund_Completed> ;
    ns1:name "Roche Venture Fund" ;
    ns1:sameAsHigh <https://1145.am/db/2308834/Roche_Investments_Usa_Inc>,
        <https://1145.am/db/2313985/Roche_Venture_Fund>,
        <https://1145.am/db/2336333/Roche_Venture_Fund>,
        <https://1145.am/db/2337958/Roche_Venture_Fund>,
        <https://1145.am/db/2337974/Roche_Venture_Fund>,
        <https://1145.am/db/2343301/Roche_Venture_Fund>,
        <https://1145.am/db/2349143/Roche_Venture_Fund>,
        <https://1145.am/db/2352203/Roche_Venture_Fund>,
        <https://1145.am/db/2352204/Roche_Venture_Fund>,
        <https://1145.am/db/2352216/Roche_Venture_Fund>,
        <https://1145.am/db/2352436/Roche_Venture_Fund>,
        <https://1145.am/db/2352442/Roche_Venture_Fund>,
        <https://1145.am/db/2363396/Roche_Venture_Fund>,
        <https://1145.am/db/2367549/Roche_Venture_Fund>,
        <https://1145.am/db/829447/Roche_Venture_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2299180/Roche_($_Rhhby)_Venture_Fund>,
        <https://1145.am/db/2302731/Roche_Venture_Fund>,
        <https://1145.am/db/2306549/Roche_Venture_Fund>,
        <https://1145.am/db/2317779/Roche_Venture_Fund>,
        <https://1145.am/db/2326222/Roche_Venture_Fund>,
        <https://1145.am/db/2327441/Roche_Venture_Fund>,
        <https://1145.am/db/2327442/Roche_Venture_Fund>,
        <https://1145.am/db/2330668/Roche_Venture_Fund>,
        <https://1145.am/db/2336328/Roche_Venture_Fund>,
        <https://1145.am/db/2336335/Roche_Venture_Fund>,
        <https://1145.am/db/2355043/Roche_Venture_Fund>,
        <https://1145.am/db/2358496/Roche_Venture_Fund>,
        <https://1145.am/db/2358502/Roche_Venture_Fund>,
        <https://1145.am/db/2362533/Roche_Venture_Fund>,
        <https://1145.am/db/2362715/Roche_Venture_Fund>,
        <https://1145.am/db/2364249/Roche_Venture_Fund>,
        <https://1145.am/db/2364255/Roche_Venture_Fund>,
        <https://1145.am/db/2364283/Roche_Venture_Fund>,
        <https://1145.am/db/2365748/Roche_Venture_Fund>,
        <https://1145.am/db/2370694/Roche_Venture_Fund>,
        <https://1145.am/db/2371169/Roche_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347574/Abalis_Finance_Ag> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:description "Business" ;
    ns1:documentDate "2011-02-16T15:52:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Activaero Raises  5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/activaero-raises-%E2%82%AC-5-0-million-6-8-million-a-second-closing-series-a-round-led-by-lsp> ;
    ns1:foundName "Abalis Finance AG" ;
    ns1:investor <https://1145.am/db/2347574/Investment_Abalis_Finance_Ag_Activaero_Gmbh_Biomedpartners_Ag_Lsp_Life_Sciences_Partners_Medventure_Partners_Gmbh_Vi_Partners_Ag_Vesalius_Biocapital_I_Sicar_Sa_Completed> ;
    ns1:name "Abalis Finance AG" ;
    ns1:sameAsMedium <https://1145.am/db/2324792/Abalis_Finance_Ag> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347574/Lsp_Life_Sciences_Partners> a org:Organization ;
    ns1:basedInHighGeoName "Amsterdam" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2759794/about.rdf> ;
    ns1:basedInHighRaw "Amsterdam" ;
    ns1:description "Business",
        "raising money" ;
    ns1:documentDate "2011-02-16T15:52:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Activaero Raises  5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/activaero-raises-%E2%82%AC-5-0-million-6-8-million-a-second-closing-series-a-round-led-by-lsp> ;
    ns1:foundName "LSP",
        "LSP Life Sciences Partners of Amsterdam, the Netherlands" ;
    ns1:industry "Life Sciences" ;
    ns1:investor <https://1145.am/db/2347574/Investment_Abalis_Finance_Ag_Activaero_Gmbh_Biomedpartners_Ag_Lsp_Life_Sciences_Partners_Medventure_Partners_Gmbh_Vi_Partners_Ag_Vesalius_Biocapital_I_Sicar_Sa_Completed> ;
    ns1:name "LSP",
        "LSP Life Sciences Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2311395/LSP>,
        <https://1145.am/db/2311570/LSP>,
        <https://1145.am/db/2317934/Lsp_(life_Science_Partners)>,
        <https://1145.am/db/2336810/Lsp_5>,
        <https://1145.am/db/2337308/Lsp_5>,
        <https://1145.am/db/2351224/LSP>,
        <https://1145.am/db/2356290/LSP>,
        <https://1145.am/db/2363907/LSP> ;
    ns1:sameAsMedium <https://1145.am/db/2299180/Lsp_Life_Sciences_Partners>,
        <https://1145.am/db/2325831/Lsp_Life_Science_Partners>,
        <https://1145.am/db/2337043/Lsp_Life_Sciences_Partners>,
        <https://1145.am/db/2370764/Lsp_Life_Sciences_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347574/Medventure_Partners_Gmbh> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:description "Business" ;
    ns1:documentDate "2011-02-16T15:52:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Activaero Raises  5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/activaero-raises-%E2%82%AC-5-0-million-6-8-million-a-second-closing-series-a-round-led-by-lsp> ;
    ns1:foundName "MedVenture Partners GmbH" ;
    ns1:investor <https://1145.am/db/2347574/Investment_Abalis_Finance_Ag_Activaero_Gmbh_Biomedpartners_Ag_Lsp_Life_Sciences_Partners_Medventure_Partners_Gmbh_Vi_Partners_Ag_Vesalius_Biocapital_I_Sicar_Sa_Completed> ;
    ns1:name "MedVenture Partners GmbH" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347574/Vesalius_Biocapital_I_Sicar_Sa> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:description "Business" ;
    ns1:documentDate "2011-02-16T15:52:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Activaero Raises  5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/activaero-raises-%E2%82%AC-5-0-million-6-8-million-a-second-closing-series-a-round-led-by-lsp> ;
    ns1:foundName "Vesalius Biocapital I SICAR S.A." ;
    ns1:investor <https://1145.am/db/2347574/Investment_Abalis_Finance_Ag_Activaero_Gmbh_Biomedpartners_Ag_Lsp_Life_Sciences_Partners_Medventure_Partners_Gmbh_Vi_Partners_Ag_Vesalius_Biocapital_I_Sicar_Sa_Completed> ;
    ns1:name "Vesalius Biocapital I SICAR S.A." ;
    ns1:sameAsHigh <https://1145.am/db/2324792/Vesalius_Biocapital_I_Sicar_Sa> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348331/Life_Sciences_Partners> a org:Organization ;
    ns1:basedInLowRaw "Netherlands" ;
    ns1:documentDate "2011-06-01T15:36:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sapiens raises  13m in a Series A financing to fund the development of a novel deep brain stimulation system" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sapiens-raises-%E2%82%AC-13m-a-series-a-financing-to-fund-development-of-a-novel-deep-brain> ;
    ns1:foundName "Life Sciences Partners" ;
    ns1:investor <https://1145.am/db/2348331/Series_A_Investment_Edmond_De_Rothschild_Investment_Partners_Life_Sciences_Partners_Sapiens_Steering_Brain_Stimulation_Gmbh___Sapiens_Wellington_Partners_Completed> ;
    ns1:name "Life Sciences Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1857633/Life_Sciences_Partners>,
        <https://1145.am/db/2289408/Life_Science_Partners>,
        <https://1145.am/db/2291851/Life_Sciences_Partners>,
        <https://1145.am/db/2292345/Life_Sciences_Partners>,
        <https://1145.am/db/2301093/Life_Sciences_Partners>,
        <https://1145.am/db/2301966/Life_Sciences_Partners>,
        <https://1145.am/db/2302541/Life_Sciences_Partners>,
        <https://1145.am/db/2302549/Life_Sciences_Partners>,
        <https://1145.am/db/2306885/Life_Sciences_Partners>,
        <https://1145.am/db/2310922/Life_Sciences_Partners>,
        <https://1145.am/db/2313915/Life_Sciences_Partners>,
        <https://1145.am/db/2324015/Life_Sciences_Partners>,
        <https://1145.am/db/2331946/Life_Science_Partners>,
        <https://1145.am/db/2331946/Life_Sciences_Partners>,
        <https://1145.am/db/2353607/Life_Sciences_Partners>,
        <https://1145.am/db/2353610/Life_Sciences_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348331/Wellington_Partners> a org:Organization ;
    ns1:basedInLowRaw "Netherlands" ;
    ns1:documentDate "2011-06-01T15:36:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sapiens raises  13m in a Series A financing to fund the development of a novel deep brain stimulation system" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sapiens-raises-%E2%82%AC-13m-a-series-a-financing-to-fund-development-of-a-novel-deep-brain> ;
    ns1:foundName "Wellington Partners" ;
    ns1:investor <https://1145.am/db/2348331/Series_A_Investment_Edmond_De_Rothschild_Investment_Partners_Life_Sciences_Partners_Sapiens_Steering_Brain_Stimulation_Gmbh___Sapiens_Wellington_Partners_Completed> ;
    ns1:name "Wellington Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1680280/Wellington_Partners>,
        <https://1145.am/db/1742188/Wellington_Partners>,
        <https://1145.am/db/1742782/Wellington_Partners>,
        <https://1145.am/db/1764682/Wellington_Partners>,
        <https://1145.am/db/1769525/Wellington_Partners>,
        <https://1145.am/db/1793936/Wellington_Partners>,
        <https://1145.am/db/1817949/Wellington_Partners>,
        <https://1145.am/db/1821883/Wellington_Partners>,
        <https://1145.am/db/1828037/Wellington_Partners>,
        <https://1145.am/db/1829991/Wellington_Partners>,
        <https://1145.am/db/1833958/Wellington_Partners>,
        <https://1145.am/db/1834220/Wellington_Partners>,
        <https://1145.am/db/1846466/Wellington_Partners>,
        <https://1145.am/db/1848420/Wellington_Partners>,
        <https://1145.am/db/1854186/Wellington_Partners>,
        <https://1145.am/db/1856207/Wellington_Partners>,
        <https://1145.am/db/1864259/Wellington_Partners>,
        <https://1145.am/db/1868569/Wellington_Partners>,
        <https://1145.am/db/1875469/Wellington_Partners>,
        <https://1145.am/db/1879760/Wellington_Partners>,
        <https://1145.am/db/1881652/Wellington_Partners>,
        <https://1145.am/db/1883959/Wellington_Partners>,
        <https://1145.am/db/1887703/Wellington_Partners>,
        <https://1145.am/db/1893512/Wellington_Partners>,
        <https://1145.am/db/1901284/Wellington_Partners>,
        <https://1145.am/db/1905277/Wellington_Partners>,
        <https://1145.am/db/2151950/Wellington_Partners>,
        <https://1145.am/db/2288440/Wellington_Partners>,
        <https://1145.am/db/2289349/Wellington_Partners>,
        <https://1145.am/db/2295712/Wellington_Partners>,
        <https://1145.am/db/2296842/Wellington_Partners>,
        <https://1145.am/db/2298846/Wellington_Partners>,
        <https://1145.am/db/2323700/Wellington_Partners>,
        <https://1145.am/db/2323705/Wellington_Partners>,
        <https://1145.am/db/2331736/Wellington_Partners>,
        <https://1145.am/db/2332658/Wellington_Partners>,
        <https://1145.am/db/2332659/Wellington_Partners>,
        <https://1145.am/db/2338929/Wellington_Partners>,
        <https://1145.am/db/2341942/Wellington_Partners>,
        <https://1145.am/db/2342582/Wellington_Partners>,
        <https://1145.am/db/2349301/Wellington_Partners>,
        <https://1145.am/db/2351191/Wellington_Partners>,
        <https://1145.am/db/2351192/Wellington_Partners>,
        <https://1145.am/db/2351312/Wellington_Partners>,
        <https://1145.am/db/2351879/Wellington_Partners>,
        <https://1145.am/db/2351883/Wellington_Partners>,
        <https://1145.am/db/2359443/Wellington_Partners>,
        <https://1145.am/db/2361113/Wellington_Partners>,
        <https://1145.am/db/2363262/Wellington_Partners>,
        <https://1145.am/db/2363274/Wellington_Partners>,
        <https://1145.am/db/2363275/Wellington_Partners>,
        <https://1145.am/db/2536547/Wellington_Partners>,
        <https://1145.am/db/2562086/Wellington_Partners>,
        <https://1145.am/db/2569491/Wellington_Partners>,
        <https://1145.am/db/2580665/Wellington_Partners>,
        <https://1145.am/db/530060/Wellington_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350720/Orbimed> a org:Organization ;
    ns1:description "Series A Financing" ;
    ns1:documentDate "2011-02-28T16:41:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arsanis, Inc Announces Series A Financing with OrbiMed Advisors, Polaris Venture Partners and SV Life Sciences" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/arsanis-inc-announces-series-a-financing-orbimed-advisors-polaris-venture-partners-and-sv> ;
    ns1:foundName "OrbiMed" ;
    ns1:investor <https://1145.am/db/2350720/Series_A_Investment_Arsanis_Inc_Orbimed_Sv_Life_Sciences_Has_Not_Happened> ;
    ns1:name "OrbiMed" ;
    ns1:sameAsHigh <https://1145.am/db/1426073/Orbimed>,
        <https://1145.am/db/1426943/Orbimed>,
        <https://1145.am/db/1809007/Orbimed_Advisors>,
        <https://1145.am/db/2080575/Orbimed>,
        <https://1145.am/db/2303098/Orbimed_Advisors>,
        <https://1145.am/db/2325257/Orbimed_Advisors>,
        <https://1145.am/db/2352807/Orbimed_Advisors>,
        <https://1145.am/db/2356420/Orbimed_Advisors>,
        <https://1145.am/db/2359468/Orbimed_Advisors>,
        <https://1145.am/db/428737/Orbimed_Advisors>,
        <https://1145.am/db/770684/Orbimed>,
        <https://1145.am/db/791742/Orbimed> ;
    ns1:sameAsMedium <https://1145.am/db/1004121/Orbimed>,
        <https://1145.am/db/1042080/Orbimed>,
        <https://1145.am/db/1086582/Orbimed>,
        <https://1145.am/db/1089269/Orbimed>,
        <https://1145.am/db/1140378/Orbimed>,
        <https://1145.am/db/1213048/Orbimed>,
        <https://1145.am/db/1334863/Orbimed>,
        <https://1145.am/db/1340338/Orbimed>,
        <https://1145.am/db/1608803/Orbimed>,
        <https://1145.am/db/1690914/Orbimed>,
        <https://1145.am/db/194149/Orbimed>,
        <https://1145.am/db/2032047/Orbimed>,
        <https://1145.am/db/2151717/Orbimed>,
        <https://1145.am/db/2192716/Orbimed>,
        <https://1145.am/db/2198716/Orbimed>,
        <https://1145.am/db/2280770/Orbimed>,
        <https://1145.am/db/2281204/Orbimed>,
        <https://1145.am/db/2281272/Orbimed>,
        <https://1145.am/db/2283935/Orbimed>,
        <https://1145.am/db/2286207/Orbimed>,
        <https://1145.am/db/2286245/Orbimed>,
        <https://1145.am/db/2286541/Orbimed>,
        <https://1145.am/db/2288436/Orbimed>,
        <https://1145.am/db/2288529/Orbimed>,
        <https://1145.am/db/2290069/Orbimed>,
        <https://1145.am/db/2290337/Orbimed>,
        <https://1145.am/db/2290766/Orbimed>,
        <https://1145.am/db/2292284/Orbimed>,
        <https://1145.am/db/2293503/Orbimed>,
        <https://1145.am/db/2293508/Orbimed>,
        <https://1145.am/db/2293540/Orbimed>,
        <https://1145.am/db/2293893/Orbimed>,
        <https://1145.am/db/2295525/Orbimed>,
        <https://1145.am/db/2295713/Orbimed>,
        <https://1145.am/db/2297224/Orbimed>,
        <https://1145.am/db/2297507/Orbimed>,
        <https://1145.am/db/2297514/Orbimed>,
        <https://1145.am/db/2297930/Orbimed>,
        <https://1145.am/db/2298642/Orbimed>,
        <https://1145.am/db/2299411/Orbimed>,
        <https://1145.am/db/2299645/Orbimed>,
        <https://1145.am/db/2300061/Orbimed>,
        <https://1145.am/db/2300653/Orbimed>,
        <https://1145.am/db/2301464/Orbimed>,
        <https://1145.am/db/2304258/Orbimed>,
        <https://1145.am/db/2318134/Orbimed>,
        <https://1145.am/db/2323243/Orbimed>,
        <https://1145.am/db/2330389/Orbimed>,
        <https://1145.am/db/2335764/Orbimed>,
        <https://1145.am/db/2337043/Orbimed>,
        <https://1145.am/db/2337667/Orbimed>,
        <https://1145.am/db/2340942/Orbimed>,
        <https://1145.am/db/2341484/Orbimed>,
        <https://1145.am/db/2341487/Orbimed>,
        <https://1145.am/db/2343545/Orbimed>,
        <https://1145.am/db/2344044/Orbimed>,
        <https://1145.am/db/2344045/Orbimed>,
        <https://1145.am/db/2347103/Orbimed>,
        <https://1145.am/db/2347885/Orbimed>,
        <https://1145.am/db/2348149/Orbimed>,
        <https://1145.am/db/2348857/Orbimed>,
        <https://1145.am/db/2349834/Orbimed>,
        <https://1145.am/db/2349838/Orbimed>,
        <https://1145.am/db/2353515/Orbimed>,
        <https://1145.am/db/2355023/Orbimed>,
        <https://1145.am/db/2361337/Orbimed>,
        <https://1145.am/db/2362768/Orbimed>,
        <https://1145.am/db/236388/Orbimed>,
        <https://1145.am/db/2363947/Orbimed>,
        <https://1145.am/db/2368872/Orbimed>,
        <https://1145.am/db/2369135/Orbimed>,
        <https://1145.am/db/2369140/Orbimed>,
        <https://1145.am/db/2369202/Orbimed>,
        <https://1145.am/db/2369548/Orbimed>,
        <https://1145.am/db/2369982/Orbimed>,
        <https://1145.am/db/2369999/Orbimed>,
        <https://1145.am/db/2370208/Orbimed>,
        <https://1145.am/db/2370295/Orbimed>,
        <https://1145.am/db/2370694/Orbimed>,
        <https://1145.am/db/2370782/Orbimed>,
        <https://1145.am/db/2370799/Orbimed>,
        <https://1145.am/db/2371160/Orbimed>,
        <https://1145.am/db/2371163/Orbimed>,
        <https://1145.am/db/2547469/Orbimed>,
        <https://1145.am/db/2548437/Orbimed>,
        <https://1145.am/db/2718732/Orbimed>,
        <https://1145.am/db/2787561/Orbimed>,
        <https://1145.am/db/402604/Orbimed>,
        <https://1145.am/db/474852/Orbimed>,
        <https://1145.am/db/581662/Orbimed>,
        <https://1145.am/db/583614/Orbimed>,
        <https://1145.am/db/676857/Orbimed>,
        <https://1145.am/db/713335/Orbimed>,
        <https://1145.am/db/714498/Orbimed>,
        <https://1145.am/db/867907/Orbimed>,
        <https://1145.am/db/912732/Orbimed> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351734/Mrieux_Dveloppement> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, MA" ;
    ns1:documentDate "2011-03-01T13:30:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NeuroPhage Pharmaceuticals closes $12.4M Series B round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/neurophage-pharmaceuticals-closes-12-4m-series-b-round-0> ;
    ns1:foundName "Mrieux Dveloppement" ;
    ns1:investor <https://1145.am/db/2351734/Series_B_Investment_Mrieux_Dveloppement_Neurophage_Pharmaceuticals_Shire_Llc_Completed> ;
    ns1:name "Mrieux Dveloppement" ;
    ns1:sameAsMedium <https://1145.am/db/2288936/Mrieux_Dveloppement>,
        <https://1145.am/db/2337294/Mrieux_Dveloppement>,
        <https://1145.am/db/2337976/Mrieux_Dveloppement>,
        <https://1145.am/db/2344202/Merieux_Developpement>,
        <https://1145.am/db/2344205/Merieux_Developpement>,
        <https://1145.am/db/2348350/Merieux_Developpement>,
        <https://1145.am/db/2354266/Mrieux_Dveloppement>,
        <https://1145.am/db/2354277/Mrieux_Dveloppement>,
        <https://1145.am/db/2361809/Merieux_Developpement> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352441/Genechem> a org:Organization ;
    ns1:documentDate "2011-06-10T14:41:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit bounces back from dropped IPO with $30M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-bounces-back-from-dropped-ipo-30m-round> ;
    ns1:foundName "Genechem" ;
    ns1:investor <https://1145.am/db/2352441/Investment_Ambit_Biosciences_Apposite_Capital_Gimv_Genechem_Horizon_Technology_Finance_Novaquest_Orbimed_Advisors_Perseus-Soros_Biopharmaceutical_Fund_Completed> ;
    ns1:name "Genechem" ;
    ns1:sameAsMedium <https://1145.am/db/2352436/Genechem>,
        <https://1145.am/db/2352442/Genechem> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352441/Gimv> a org:Organization ;
    ns1:documentDate "2011-06-10T14:41:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit bounces back from dropped IPO with $30M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-bounces-back-from-dropped-ipo-30m-round> ;
    ns1:foundName "GIMV" ;
    ns1:investor <https://1145.am/db/2352441/Investment_Ambit_Biosciences_Apposite_Capital_Gimv_Genechem_Horizon_Technology_Finance_Novaquest_Orbimed_Advisors_Perseus-Soros_Biopharmaceutical_Fund_Completed> ;
    ns1:name "GIMV" ;
    ns1:sameAsMedium <https://1145.am/db/1724232/Gimv>,
        <https://1145.am/db/1806589/Gimv>,
        <https://1145.am/db/1830149/Gimv>,
        <https://1145.am/db/1854030/Gimv>,
        <https://1145.am/db/1866824/Gimv>,
        <https://1145.am/db/1883525/Gimv>,
        <https://1145.am/db/1914674/Gimv>,
        <https://1145.am/db/1919300/Gimv>,
        <https://1145.am/db/2154009/Gimv>,
        <https://1145.am/db/2280718/Gimv>,
        <https://1145.am/db/2281044/Gimv>,
        <https://1145.am/db/2286782/Gimv>,
        <https://1145.am/db/2294771/Gimv>,
        <https://1145.am/db/2299772/Gimv>,
        <https://1145.am/db/2301160/Gimv>,
        <https://1145.am/db/2302541/Gimv>,
        <https://1145.am/db/2302549/Gimv>,
        <https://1145.am/db/2316478/Gimv>,
        <https://1145.am/db/2328763/Gimv>,
        <https://1145.am/db/2328769/Gimv>,
        <https://1145.am/db/2336923/Gimv>,
        <https://1145.am/db/2346030/Gimv>,
        <https://1145.am/db/2352436/Gimv>,
        <https://1145.am/db/2352442/Gimv>,
        <https://1145.am/db/2356685/Gimv>,
        <https://1145.am/db/2365748/Gimv> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352441/Horizon_Technology_Finance> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2011-06-10T14:41:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit bounces back from dropped IPO with $30M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-bounces-back-from-dropped-ipo-30m-round> ;
    ns1:foundName "Horizon Technology Finance" ;
    ns1:investor <https://1145.am/db/2352441/Investment_Ambit_Biosciences_Apposite_Capital_Gimv_Genechem_Horizon_Technology_Finance_Novaquest_Orbimed_Advisors_Perseus-Soros_Biopharmaceutical_Fund_Completed> ;
    ns1:name "Horizon Technology Finance" ;
    ns1:sameAsHigh <https://1145.am/db/1150175/Horizon_Technology_Finance_Corporation>,
        <https://1145.am/db/1151808/Horizon_Technology_Finance_Corporation>,
        <https://1145.am/db/1266128/Horizon_Technology_Finance_Corporation>,
        <https://1145.am/db/1681297/Horizon_Technology_Finance_Corporation>,
        <https://1145.am/db/1681297/Horizon_Technology_Finance_Management_Llc>,
        <https://1145.am/db/1686469/Horizon_Technology_Finance_Management_Llc>,
        <https://1145.am/db/1869820/Horizon_Technology_Finance>,
        <https://1145.am/db/2333086/Horizon_Technology_Finance_Corp>,
        <https://1145.am/db/2352198/Horizon_Technology_Finance_Corporation>,
        <https://1145.am/db/701748/Horizon_Technology_Finance_Corporation> ;
    ns1:sameAsMedium <https://1145.am/db/1586050/Horizon_Technology_Finance_Corporation>,
        <https://1145.am/db/1680912/Horizon_Technology_Finance_Management_Llc>,
        <https://1145.am/db/1686469/Horizon_Technology_Finance_Corporation>,
        <https://1145.am/db/1735738/Horizon_Technology_Finance_Corporation>,
        <https://1145.am/db/2055902/Horizon_Technology_Finance_Management_Llc>,
        <https://1145.am/db/2290453/Horizon_Technology_Finance>,
        <https://1145.am/db/2296810/Horizon_Technology_Finance>,
        <https://1145.am/db/2333089/Horizon_Technology_Finance_Corporation>,
        <https://1145.am/db/2352436/Horizon_Technology_Finance>,
        <https://1145.am/db/2352442/Horizon_Technology_Finance>,
        <https://1145.am/db/2358002/Horizon_Technology_Finance_Corporation>,
        <https://1145.am/db/2601283/Horizon_Technology_Finance_Corp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352441/Novaquest> a org:Organization ;
    ns1:documentDate "2011-06-10T14:41:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit bounces back from dropped IPO with $30M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-bounces-back-from-dropped-ipo-30m-round> ;
    ns1:foundName "NovaQuest" ;
    ns1:investor <https://1145.am/db/2352441/Investment_Ambit_Biosciences_Apposite_Capital_Gimv_Genechem_Horizon_Technology_Finance_Novaquest_Orbimed_Advisors_Perseus-Soros_Biopharmaceutical_Fund_Completed> ;
    ns1:name "NovaQuest" ;
    ns1:sameAsMedium <https://1145.am/db/2285722/Novaquest>,
        <https://1145.am/db/2310905/Novaquest>,
        <https://1145.am/db/2310907/Novaquest>,
        <https://1145.am/db/2316674/Novaquest>,
        <https://1145.am/db/2352436/Novaquest>,
        <https://1145.am/db/2352442/Novaquest>,
        <https://1145.am/db/2362594/Novaquest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352441/Orbimed_Advisors> a org:Organization ;
    ns1:description "Venture Capital" ;
    ns1:documentDate "2011-06-10T14:41:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit bounces back from dropped IPO with $30M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-bounces-back-from-dropped-ipo-30m-round> ;
    ns1:foundName "OrbiMed Advisors" ;
    ns1:investor <https://1145.am/db/2352441/Investment_Ambit_Biosciences_Apposite_Capital_Gimv_Genechem_Horizon_Technology_Finance_Novaquest_Orbimed_Advisors_Perseus-Soros_Biopharmaceutical_Fund_Completed> ;
    ns1:name "OrbiMed Advisors" ;
    ns1:sameAsHigh <https://1145.am/db/2337254/Orbimed_Advisors>,
        <https://1145.am/db/2352804/Orbimed_Advisors>,
        <https://1145.am/db/2363339/Orbimed_Advisors> ;
    ns1:sameAsMedium <https://1145.am/db/1665536/Orbimed_Advisors>,
        <https://1145.am/db/1809007/Orbimed_Advisors>,
        <https://1145.am/db/2198816/Orbimed_Advisors>,
        <https://1145.am/db/2245885/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2281230/Orbimed_Advisors>,
        <https://1145.am/db/2284506/Orbimed_Advisors>,
        <https://1145.am/db/2289056/Orbimed_Advisors>,
        <https://1145.am/db/2290078/Orbimed_Advisors>,
        <https://1145.am/db/2290200/Orbimed_Advisors>,
        <https://1145.am/db/2290444/Orbimed_Advisors>,
        <https://1145.am/db/2297604/Orbimed_Advisors>,
        <https://1145.am/db/2298956/Orbimed_Advisors>,
        <https://1145.am/db/2303098/Orbimed_Advisors>,
        <https://1145.am/db/2304242/Orbimed_Advisors>,
        <https://1145.am/db/2305656/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306251/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306705/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2309491/Orbimed_Advisors>,
        <https://1145.am/db/2310922/Orbimed_Advisors>,
        <https://1145.am/db/2312233/Orbimed_Advisors>,
        <https://1145.am/db/2317918/Orbimed_Advisors>,
        <https://1145.am/db/2318133/Orbimed_Advisors>,
        <https://1145.am/db/2318829/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2318832/Orbimed_Advisers>,
        <https://1145.am/db/2318851/Orbimed_Advisors>,
        <https://1145.am/db/2319338/Orbimed_Advisors>,
        <https://1145.am/db/2320914/Orbimed_Advisors>,
        <https://1145.am/db/2322345/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2324226/Orbimed_Advisors>,
        <https://1145.am/db/2325257/Orbimed_Advisors>,
        <https://1145.am/db/2325880/Orbimed_Advisors>,
        <https://1145.am/db/2328599/Orbimed_Advisors>,
        <https://1145.am/db/2328700/Orbimed_Advisors>,
        <https://1145.am/db/2329260/Orbimed_Advisors>,
        <https://1145.am/db/2330799/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2330920/Orbimed_Advisors>,
        <https://1145.am/db/2332120/Orbimed_Advisors>,
        <https://1145.am/db/2333495/Orbimed_Advisors>,
        <https://1145.am/db/2333504/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2333966/Orbimed_Advisors>,
        <https://1145.am/db/2335743/Orbimed_Advisors>,
        <https://1145.am/db/2336221/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2336503/Orbimed_Advisors>,
        <https://1145.am/db/2336505/Orbimed_Advisors>,
        <https://1145.am/db/2336524/Orbimed_Advisors>,
        <https://1145.am/db/2337166/Orbimed_Advisors>,
        <https://1145.am/db/2337250/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2339885/Orbimed_Advisors>,
        <https://1145.am/db/2339886/Orbimed_Advisors>,
        <https://1145.am/db/2342862/Orbimed_Advisors>,
        <https://1145.am/db/2342925/Orbimed_Advisors>,
        <https://1145.am/db/2342937/Orbimed_Advisors>,
        <https://1145.am/db/2343244/Orbimed_Advisors>,
        <https://1145.am/db/2344735/Orbimed_Advisors>,
        <https://1145.am/db/2344786/Orbimed_Advisors>,
        <https://1145.am/db/2345435/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345453/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345456/Orbimed_Advisors>,
        <https://1145.am/db/2346030/Orbimed_Advisors>,
        <https://1145.am/db/2350034/Orbimed_Advisors>,
        <https://1145.am/db/2350044/Orbimed_Advisors>,
        <https://1145.am/db/2352436/Orbimed_Advisors>,
        <https://1145.am/db/2352442/Orbimed_Advisors>,
        <https://1145.am/db/2352701/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2352807/Orbimed_Advisors>,
        <https://1145.am/db/2355034/Orbimed_Advisors>,
        <https://1145.am/db/2356297/Orbimed_Advisors>,
        <https://1145.am/db/2356420/Orbimed_Advisors>,
        <https://1145.am/db/2357253/Orbimed_Advisors>,
        <https://1145.am/db/2357256/Orbimed_Advisors>,
        <https://1145.am/db/2357858/Orbimed_Advisors>,
        <https://1145.am/db/2359125/Orbimed_Advisors>,
        <https://1145.am/db/2359468/Orbimed_Advisors>,
        <https://1145.am/db/2359864/Orbimed_Advisors>,
        <https://1145.am/db/2360174/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2361018/Orbimed_Advisors>,
        <https://1145.am/db/2361022/Orbimed_Advisors>,
        <https://1145.am/db/2361027/Orbimed_Advisors>,
        <https://1145.am/db/2362475/Orbimed_Advisors>,
        <https://1145.am/db/2362481/Orbimed_Advisors>,
        <https://1145.am/db/2365679/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2365868/Orbimed_Advisors>,
        <https://1145.am/db/2366519/Orbimed_Advisors>,
        <https://1145.am/db/2574232/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2583013/Orbimed_Advisors>,
        <https://1145.am/db/428737/Orbimed_Advisors>,
        <https://1145.am/db/456081/Orbimed_Advisors>,
        <https://1145.am/db/456089/Orbimed_Advisors>,
        <https://1145.am/db/458377/Orbimed_Advisors>,
        <https://1145.am/db/674484/Orbimed_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352441/Perseus-Soros_Biopharmaceutical_Fund> a org:Organization ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-06-10T14:41:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit bounces back from dropped IPO with $30M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-bounces-back-from-dropped-ipo-30m-round> ;
    ns1:foundName "Perseus-Soros Biopharmaceutical Fund" ;
    ns1:investor <https://1145.am/db/2352441/Investment_Ambit_Biosciences_Apposite_Capital_Gimv_Genechem_Horizon_Technology_Finance_Novaquest_Orbimed_Advisors_Perseus-Soros_Biopharmaceutical_Fund_Completed> ;
    ns1:name "Perseus-Soros Biopharmaceutical Fund" ;
    ns1:sameAsHigh <https://1145.am/db/2350780/Perseus_Soros_Biopharmaceutical_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2350779/Perseus_Soros_Biopharmaceutical_Fund>,
        <https://1145.am/db/2352436/Perseus-Soros_Biopharmaceutical_Fund>,
        <https://1145.am/db/2352442/Perseus-Soros_Biopharmaceutical_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354540/Healthcap> a org:Organization ;
    ns1:basedInLowRaw "European" ;
    ns1:description "European investor" ;
    ns1:documentDate "2011-06-20T14:33:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ultragenyx Announces Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ultragenyx-announces-series-a-financing> ;
    ns1:foundName "HealthCap" ;
    ns1:investor <https://1145.am/db/2354540/Series_A_Investment_Healthcap_Pappas_Ventures_Tpg_Biotech_And_Fidelity_Biosciences_Ultragenyx_Pharmaceutical_Inc_Completed> ;
    ns1:name "HealthCap" ;
    ns1:sameAsMedium <https://1145.am/db/1334395/Healthcap>,
        <https://1145.am/db/1669813/Healthcap>,
        <https://1145.am/db/2286782/Healthcap>,
        <https://1145.am/db/2291206/Healthcap>,
        <https://1145.am/db/2301093/Healthcap>,
        <https://1145.am/db/2315943/Healthcap>,
        <https://1145.am/db/2315957/Healthcap>,
        <https://1145.am/db/2336511/Healthcap>,
        <https://1145.am/db/2337599/Healthcap>,
        <https://1145.am/db/2342611/Healthcap>,
        <https://1145.am/db/2343545/Healthcap>,
        <https://1145.am/db/2347822/Healthcap>,
        <https://1145.am/db/2354537/Healthcap>,
        <https://1145.am/db/2357144/Healthcap>,
        <https://1145.am/db/2359562/Healthcap>,
        <https://1145.am/db/2364492/Healthcap>,
        <https://1145.am/db/2364517/Healthcap>,
        <https://1145.am/db/2368579/Healthcap> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354540/Tpg_Biotech_And_Fidelity_Biosciences> a org:Organization ;
    ns1:basedInHighGeoName "Novato" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5285048/about.rdf> ;
    ns1:basedInHighRaw "NOVATO, Calif" ;
    ns1:basedInLowRaw "NOVATO, Calif" ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-06-20T14:33:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ultragenyx Announces Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ultragenyx-announces-series-a-financing> ;
    ns1:foundName "Fidelity Biosciences",
        "TPG Biotech",
        "TPG Biotech and Fidelity Biosciences" ;
    ns1:industry "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2354540/Series_A_Investment_Healthcap_Pappas_Ventures_Tpg_Biotech_And_Fidelity_Biosciences_Ultragenyx_Pharmaceutical_Inc_Completed> ;
    ns1:name "Fidelity Biosciences",
        "TPG Biotech",
        "TPG Biotech and Fidelity Biosciences" ;
    ns1:sameAsHigh <https://1145.am/db/1747873/Tpg_Capital>,
        <https://1145.am/db/2305254/Tpg_Biotechnology>,
        <https://1145.am/db/2324301/Aegera_Therapeutics>,
        <https://1145.am/db/2350809/Aesrx>,
        <https://1145.am/db/2353771/Tpg_Biotech>,
        <https://1145.am/db/2353789/Tpg_Biotech>,
        <https://1145.am/db/2368351/Tpg_Biotech>,
        <https://1145.am/db/666234/Aipharma_Global> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355543/Deerfield_Management> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:documentDate "2011-06-21T14:25:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tesaro-announces-101-million-series-b-financing-for-advancement-and-expansion-of-oncology> ;
    ns1:foundName "Deerfield Management" ;
    ns1:investor <https://1145.am/db/2355543/Series_B_Investment_Deerfield_Management_Interwest_Partners_Kleiner_Perkins_Caufield___Byers_Leerink_Swann_New_Enterprise_Associates_Oracle_Partners_T_Rowe_Price_Pappas_Ventures_T_Rowe_Price_Pappas_Ventures_Tesaro_Completed> ;
    ns1:name "Deerfield Management" ;
    ns1:sameAsMedium <https://1145.am/db/1004121/Deerfield_Management_Company>,
        <https://1145.am/db/1006175/Deerfield_Management_Company>,
        <https://1145.am/db/1102553/Deerfield_Management>,
        <https://1145.am/db/1106975/Deerfield_Management>,
        <https://1145.am/db/1177932/Deerfield_Management_Company>,
        <https://1145.am/db/1217674/Deerfield_Management>,
        <https://1145.am/db/1219334/Deerfield_Management>,
        <https://1145.am/db/1219771/Deerfield_Management>,
        <https://1145.am/db/1232497/Deerfield_Management>,
        <https://1145.am/db/1269807/Deerfield_Management_Company>,
        <https://1145.am/db/1279924/Deerfield_Management_Company>,
        <https://1145.am/db/1326655/Deerfield_Management>,
        <https://1145.am/db/1326957/Deerfield_Management>,
        <https://1145.am/db/1411936/Deerfield_Management_Company>,
        <https://1145.am/db/1468795/Deerfield_Management>,
        <https://1145.am/db/1519613/Deerfield_Management>,
        <https://1145.am/db/1519799/Deerfield_Management>,
        <https://1145.am/db/1620209/Deerfield_Management>,
        <https://1145.am/db/1624707/Deerfield_Management>,
        <https://1145.am/db/1771229/Deerfield_Management_Company>,
        <https://1145.am/db/1969781/Deerfield_Management>,
        <https://1145.am/db/2036223/Deerfield_Management>,
        <https://1145.am/db/2049332/Deerfield_Management>,
        <https://1145.am/db/2069495/Deerfield_Management>,
        <https://1145.am/db/2114372/Deerfield_Management>,
        <https://1145.am/db/2182698/Deerfield_Management>,
        <https://1145.am/db/2185095/Deerfield_Management_Company>,
        <https://1145.am/db/2198647/Deerfield_Management>,
        <https://1145.am/db/2198816/Deerfield_Management_Company>,
        <https://1145.am/db/2214553/Deerfield_Management>,
        <https://1145.am/db/2293172/Deerfield_Management>,
        <https://1145.am/db/2295295/Deerfield_Management>,
        <https://1145.am/db/2298642/Deerfield_Management>,
        <https://1145.am/db/2299549/Deerfield_Management>,
        <https://1145.am/db/2299794/Deerfield_Management_Company>,
        <https://1145.am/db/2302751/Deerfield_Management>,
        <https://1145.am/db/2305700/Deerfield_Management>,
        <https://1145.am/db/2311805/Deerfield_Management>,
        <https://1145.am/db/2311833/Deerfield_Management>,
        <https://1145.am/db/2313135/Deerfield_Management>,
        <https://1145.am/db/2317927/Deerfield_Management>,
        <https://1145.am/db/2317937/Deerfield_Management>,
        <https://1145.am/db/2321950/Deerfield_Management>,
        <https://1145.am/db/2324112/Deerfield_Management>,
        <https://1145.am/db/2325221/Deerfield_Management>,
        <https://1145.am/db/2325880/Deerfield_Management_Company>,
        <https://1145.am/db/2327266/Deerfield_Management>,
        <https://1145.am/db/2328305/Deerfield_Management>,
        <https://1145.am/db/2328427/Deerfield_Management>,
        <https://1145.am/db/2328594/Deerfield_Management>,
        <https://1145.am/db/2331436/Deerfield_Management>,
        <https://1145.am/db/2336511/Deerfield_Management_Company>,
        <https://1145.am/db/2337599/Deerfield_Management_Company>,
        <https://1145.am/db/2342543/Deerfield_Management_Company>,
        <https://1145.am/db/2346773/Deerfield_Management_Company>,
        <https://1145.am/db/2346775/Deerfield_Management_Company>,
        <https://1145.am/db/2347552/Deerfield_Management_Company>,
        <https://1145.am/db/2348857/Deerfield_Management>,
        <https://1145.am/db/2349834/Deerfield_Management>,
        <https://1145.am/db/2355531/Deerfield_Management>,
        <https://1145.am/db/2359227/Deerfield_Management>,
        <https://1145.am/db/2359404/Deerfield_Management>,
        <https://1145.am/db/2360370/Deerfield_Management>,
        <https://1145.am/db/2361142/Deerfield_Management>,
        <https://1145.am/db/2361147/Deerfield_Management>,
        <https://1145.am/db/2362106/Deerfield_Management_Company>,
        <https://1145.am/db/2362453/Deerfield_Management>,
        <https://1145.am/db/2365724/Deerfield_Management_Company>,
        <https://1145.am/db/2366527/Deerfield_Management_Company>,
        <https://1145.am/db/2368667/Deerfield_Management>,
        <https://1145.am/db/2368723/Deerfield_Management>,
        <https://1145.am/db/2369202/Deerfield_Management>,
        <https://1145.am/db/2369304/Deerfield_Management_Company>,
        <https://1145.am/db/2369305/Deerfield_Management>,
        <https://1145.am/db/2370094/Deerfield_Management_Company>,
        <https://1145.am/db/2370436/Deerfield_Management>,
        <https://1145.am/db/2371160/Deerfield_Management_Company>,
        <https://1145.am/db/2371163/Deerfield_Management_Company>,
        <https://1145.am/db/2569551/Deerfield_Management>,
        <https://1145.am/db/2573058/Deerfield_Management>,
        <https://1145.am/db/2597025/Deerfield_Management_Company>,
        <https://1145.am/db/542015/Deerfield_Management_Company>,
        <https://1145.am/db/544859/Deerfield_Management_Company>,
        <https://1145.am/db/951064/Deerfield_Management_Company>,
        <https://1145.am/db/971622/Deerfield_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355543/Interwest_Partners> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-06-21T14:25:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tesaro-announces-101-million-series-b-financing-for-advancement-and-expansion-of-oncology> ;
    ns1:foundName "InterWest Partners" ;
    ns1:investor <https://1145.am/db/2355543/Series_B_Investment_Deerfield_Management_Interwest_Partners_Kleiner_Perkins_Caufield___Byers_Leerink_Swann_New_Enterprise_Associates_Oracle_Partners_T_Rowe_Price_Pappas_Ventures_T_Rowe_Price_Pappas_Ventures_Tesaro_Completed> ;
    ns1:name "InterWest Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1091554/Riverfront_Ventures>,
        <https://1145.am/db/1091576/Riverfront_Ventures>,
        <https://1145.am/db/1150154/Norwind_Capital>,
        <https://1145.am/db/1263825/Westbridge_Capital>,
        <https://1145.am/db/1334273/West_Hill_Capital>,
        <https://1145.am/db/1335021/West_Hill_Capital>,
        <https://1145.am/db/1339788/Northzone>,
        <https://1145.am/db/1343467/Stormbreaker_Ventures>,
        <https://1145.am/db/1355824/Shorewind_Capital>,
        <https://1145.am/db/1398917/Red_River_West>,
        <https://1145.am/db/1407496/Storm_Ventures>,
        <https://1145.am/db/1433429/North_Island_Ventures>,
        <https://1145.am/db/1508460/North_Island_Ventures>,
        <https://1145.am/db/168364/Riverfront_Ventures>,
        <https://1145.am/db/1695419/Northgate_Capital>,
        <https://1145.am/db/1696310/Northzone>,
        <https://1145.am/db/1706170/Storm_Ventures>,
        <https://1145.am/db/1708291/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1717023/North_Island_Ventures>,
        <https://1145.am/db/1722944/Wind_Ventures>,
        <https://1145.am/db/1735168/Northgate_Capital>,
        <https://1145.am/db/1738465/Northzone>,
        <https://1145.am/db/1749607/Northzone>,
        <https://1145.am/db/1751200/Storm_Ventures>,
        <https://1145.am/db/1751800/Northgate_Capital>,
        <https://1145.am/db/1753643/Westbridge_Capital>,
        <https://1145.am/db/1754080/Northzone>,
        <https://1145.am/db/1760985/Westbridge_Capital>,
        <https://1145.am/db/1762493/Westbridge>,
        <https://1145.am/db/1765673/Norwest>,
        <https://1145.am/db/1791628/Interwest_Partners>,
        <https://1145.am/db/1793458/Storm_Ventures>,
        <https://1145.am/db/1808484/Northgate_Capital>,
        <https://1145.am/db/1808735/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1818901/Northgate_Capital>,
        <https://1145.am/db/1824252/Northgate_Capital>,
        <https://1145.am/db/1830655/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1832969/Interwest_Partners>,
        <https://1145.am/db/1841022/Northgate_Capital>,
        <https://1145.am/db/1846718/Northwest_Venture_Partners>,
        <https://1145.am/db/1848921/Interwest_Partners>,
        <https://1145.am/db/1849310/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1854203/Storm_Ventures>,
        <https://1145.am/db/1854846/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1857632/Northgate_Capital>,
        <https://1145.am/db/1860345/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1862872/Interwest_Partners>,
        <https://1145.am/db/1863401/Interwest_Partners>,
        <https://1145.am/db/1870838/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1872490/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1881065/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1890261/Storm_Ventures>,
        <https://1145.am/db/1890619/Northgate_Capital>,
        <https://1145.am/db/1894848/Storm_Ventures>,
        <https://1145.am/db/1906336/North_Bridge_Venture_Partners>,
        <https://1145.am/db/1911080/Northbridge_Venture_Partners>,
        <https://1145.am/db/1991347/Loop_Ventures>,
        <https://1145.am/db/2294753/Interwest_Partners>,
        <https://1145.am/db/2304606/Interwest_Partners>,
        <https://1145.am/db/2305507/Interwest_Partners>,
        <https://1145.am/db/2309051/Warburg_Pincus>,
        <https://1145.am/db/2314380/Interwest_Partners>,
        <https://1145.am/db/2340284/Interwest_Partners>,
        <https://1145.am/db/2355531/Interwest_Partners>,
        <https://1145.am/db/2360647/Interwest_Partners>,
        <https://1145.am/db/2362453/Warburg_Pincus>,
        <https://1145.am/db/2370582/Interwest_Partners>,
        <https://1145.am/db/2606743/Pacificap>,
        <https://1145.am/db/2614160/North_Bridge_Venture_Partners>,
        <https://1145.am/db/474123/Northzone> ;
    ns1:sameAsMedium <https://1145.am/db/1697098/Interwest_Partners>,
        <https://1145.am/db/1711300/Interwest_Partners>,
        <https://1145.am/db/1717613/Interwest_Partners>,
        <https://1145.am/db/1792426/Interwest_Partners>,
        <https://1145.am/db/1831689/Interwest_Partners>,
        <https://1145.am/db/1840379/Interwest_Partners>,
        <https://1145.am/db/1842466/Interwest_Partners>,
        <https://1145.am/db/1842817/Interwest_Partners>,
        <https://1145.am/db/1847994/Interwest_Partners>,
        <https://1145.am/db/1853156/Interwest_Partners>,
        <https://1145.am/db/1853882/Interwest_Partners>,
        <https://1145.am/db/1860832/Interwest_Partners>,
        <https://1145.am/db/1864172/Interwest_Partners>,
        <https://1145.am/db/1866990/Interwest_Partners>,
        <https://1145.am/db/1881935/Interwest_Partners>,
        <https://1145.am/db/1882810/Interwest_Partners>,
        <https://1145.am/db/1883990/Interwest_Partners>,
        <https://1145.am/db/1886261/Interwest_Partners>,
        <https://1145.am/db/1891834/Interwest_Partners>,
        <https://1145.am/db/1906428/Interwest_Partners>,
        <https://1145.am/db/1911578/Interwest_Partners>,
        <https://1145.am/db/2155189/Interwest_Partners>,
        <https://1145.am/db/2218486/Interwest_Partners>,
        <https://1145.am/db/2242262/Interwest_Partners>,
        <https://1145.am/db/2242266/Interwest_Partners>,
        <https://1145.am/db/2296841/Interwest_Partners>,
        <https://1145.am/db/2301464/Interwest_Partners>,
        <https://1145.am/db/2301901/Interwest_Partners>,
        <https://1145.am/db/2302076/Interwest_Partners>,
        <https://1145.am/db/2302091/Interwest_Partners>,
        <https://1145.am/db/2302108/Interwest_Partners>,
        <https://1145.am/db/2302289/Interwest_Partners>,
        <https://1145.am/db/2304598/Interwest_Partners>,
        <https://1145.am/db/2305514/Interwest_Partners>,
        <https://1145.am/db/2310073/Interwest_Partners>,
        <https://1145.am/db/2313357/Interwest_Partners>,
        <https://1145.am/db/2314964/Interwest_Partners>,
        <https://1145.am/db/2315289/Interwest_Partners>,
        <https://1145.am/db/2317561/Interwest_Partners>,
        <https://1145.am/db/2317564/Interwest_Partners>,
        <https://1145.am/db/2317750/Interwest_Partners>,
        <https://1145.am/db/2317753/Interwest_Partners>,
        <https://1145.am/db/2319809/Interwest_Partners>,
        <https://1145.am/db/2325257/Interwest_Partners>,
        <https://1145.am/db/2326361/Interwest_Partners>,
        <https://1145.am/db/2326373/Interwest_Partners>,
        <https://1145.am/db/2332991/Interwest_Partners>,
        <https://1145.am/db/2339393/Interwest_Partners>,
        <https://1145.am/db/2340224/Interwest_Partners>,
        <https://1145.am/db/2348754/Interwest_Partners>,
        <https://1145.am/db/2349838/Interwest_Partners>,
        <https://1145.am/db/2358234/Interwest_Partners>,
        <https://1145.am/db/2447807/Interwest_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355543/Leerink_Swann> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-06-21T14:25:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tesaro-announces-101-million-series-b-financing-for-advancement-and-expansion-of-oncology> ;
    ns1:foundName "Leerink Swann" ;
    ns1:investor <https://1145.am/db/2355543/Series_B_Investment_Deerfield_Management_Interwest_Partners_Kleiner_Perkins_Caufield___Byers_Leerink_Swann_New_Enterprise_Associates_Oracle_Partners_T_Rowe_Price_Pappas_Ventures_T_Rowe_Price_Pappas_Ventures_Tesaro_Completed> ;
    ns1:name "Leerink Swann" ;
    ns1:sameAsHigh <https://1145.am/db/1004004/Kindred_Ventures>,
        <https://1145.am/db/1018112/S3_Ventures>,
        <https://1145.am/db/1018984/S3_Ventures>,
        <https://1145.am/db/1065192/Sevenx_Ventures>,
        <https://1145.am/db/1079459/Obvious_Ventures>,
        <https://1145.am/db/1081175/166_2nd>,
        <https://1145.am/db/1082613/166_2nd>,
        <https://1145.am/db/1086692/468_Capital>,
        <https://1145.am/db/1091554/Switch_Ventures>,
        <https://1145.am/db/1091576/Switch_Ventures>,
        <https://1145.am/db/1138998/First_Rate_Ventures>,
        <https://1145.am/db/1152929/Base_Ventures>,
        <https://1145.am/db/1232111/Upfront_Ventures>,
        <https://1145.am/db/1233008/M12>,
        <https://1145.am/db/1238474/M12>,
        <https://1145.am/db/1287465/Innovation_Endeavors>,
        <https://1145.am/db/1352190/Valar_Ventures>,
        <https://1145.am/db/1381832/Breakout_Ventures>,
        <https://1145.am/db/1381832/Coatue>,
        <https://1145.am/db/1382787/Breakout_Ventures>,
        <https://1145.am/db/1382787/Coatue>,
        <https://1145.am/db/1398917/Upfront_Ventures>,
        <https://1145.am/db/1406168/Kindred_Ventures>,
        <https://1145.am/db/1429403/Venture_Capital_Firm>,
        <https://1145.am/db/1499092/Sourcenext>,
        <https://1145.am/db/1526876/M13>,
        <https://1145.am/db/1528201/M13>,
        <https://1145.am/db/1545833/S3_Ventures>,
        <https://1145.am/db/1546945/S3_Ventures>,
        <https://1145.am/db/1557307/Am_Ventures>,
        <https://1145.am/db/1558854/Am_Ventures>,
        <https://1145.am/db/1575612/Snr_Vc>,
        <https://1145.am/db/1575612/V1_Vc>,
        <https://1145.am/db/1584937/Venture_Catalysts>,
        <https://1145.am/db/1614343/Partners_Group>,
        <https://1145.am/db/1664845/S3_Ventures>,
        <https://1145.am/db/1682224/M13>,
        <https://1145.am/db/1693658/Upfront_Ventures>,
        <https://1145.am/db/1701485/Aum_Ventures>,
        <https://1145.am/db/1705761/Obvious_Ventures>,
        <https://1145.am/db/1711784/Venture_Catalysts>,
        <https://1145.am/db/1712520/Vspring_Capital>,
        <https://1145.am/db/1719240/K3>,
        <https://1145.am/db/1722058/Upfront_Ventures>,
        <https://1145.am/db/1726625/Sourcenext>,
        <https://1145.am/db/1737467/Index>,
        <https://1145.am/db/1739763/Invent>,
        <https://1145.am/db/1743316/Founders_Fund>,
        <https://1145.am/db/1748890/Newgen_Vc>,
        <https://1145.am/db/1749533/Afore_Capital>,
        <https://1145.am/db/1751312/Kindred_Ventures>,
        <https://1145.am/db/1751916/S3_Ventures>,
        <https://1145.am/db/1753024/S28_Capital>,
        <https://1145.am/db/1753730/Strong_Ventures>,
        <https://1145.am/db/1757392/K5_Global>,
        <https://1145.am/db/1757788/Strong_Ventures>,
        <https://1145.am/db/1758221/Valar_Ventures>,
        <https://1145.am/db/1760608/Upfront_Ventures>,
        <https://1145.am/db/1761491/A16z>,
        <https://1145.am/db/1761520/Novator>,
        <https://1145.am/db/1761999/Coatue>,
        <https://1145.am/db/1765092/S28_Capital>,
        <https://1145.am/db/1765372/468_Capital>,
        <https://1145.am/db/1766096/Founders_Fund>,
        <https://1145.am/db/1770139/Morningside>,
        <https://1145.am/db/1788333/Outbound_Ventures>,
        <https://1145.am/db/1790953/Venture_Capital>,
        <https://1145.am/db/1791220/Capital-E>,
        <https://1145.am/db/1795198/K1_Capital>,
        <https://1145.am/db/1796199/Generation_Ventures>,
        <https://1145.am/db/1799113/Upfront_Ventures>,
        <https://1145.am/db/1806746/K2_Global>,
        <https://1145.am/db/1819543/Base_Ventures>,
        <https://1145.am/db/1820422/Valar_Ventures>,
        <https://1145.am/db/1829422/Founders_Fund>,
        <https://1145.am/db/1859652/A16z>,
        <https://1145.am/db/1859806/Strong_Ventures>,
        <https://1145.am/db/1871784/Founders_Fund>,
        <https://1145.am/db/1884049/S3_Ventures>,
        <https://1145.am/db/2008536/Incite_Ventures>,
        <https://1145.am/db/2023596/Building_Ventures>,
        <https://1145.am/db/2023596/Concrete_Ventures>,
        <https://1145.am/db/2058874/Founders_Fund>,
        <https://1145.am/db/2064584/Concrete_Ventures>,
        <https://1145.am/db/2073480/Sant_Ventures>,
        <https://1145.am/db/2100049/K5_Global>,
        <https://1145.am/db/2120116/Capital_T>,
        <https://1145.am/db/2138006/Innovation_Endeavors>,
        <https://1145.am/db/2176223/Sig_Capital>,
        <https://1145.am/db/2183141/Founders_Fund>,
        <https://1145.am/db/219754/Founders_Fund>,
        <https://1145.am/db/2292800/Ws_Investments>,
        <https://1145.am/db/2298916/Breakout_Ventures>,
        <https://1145.am/db/2301736/Sant_Ventures>,
        <https://1145.am/db/2303695/Sigvion_Capital>,
        <https://1145.am/db/2305610/Techno_Venture_Management>,
        <https://1145.am/db/2305615/Techno_Venture_Management>,
        <https://1145.am/db/2310170/Apposite>,
        <https://1145.am/db/2314573/3i>,
        <https://1145.am/db/2317918/Advanced_Technology_Ventures>,
        <https://1145.am/db/2317934/Sr_One>,
        <https://1145.am/db/2319874/Advanced_Technology_Ventures>,
        <https://1145.am/db/2341904/Advanced_Technology_Ventures>,
        <https://1145.am/db/2343722/Advanced_Technology_Ventures>,
        <https://1145.am/db/2343737/Advanced_Technology_Ventures>,
        <https://1145.am/db/2355531/Leerink_Swann>,
        <https://1145.am/db/2365104/Sr_One>,
        <https://1145.am/db/2365300/Sr_One>,
        <https://1145.am/db/2367204/Advanced_Technology_Ventures>,
        <https://1145.am/db/2595958/Sr_One>,
        <https://1145.am/db/2621506/D1>,
        <https://1145.am/db/336270/Sbi_Investment>,
        <https://1145.am/db/396305/Obvious_Ventures>,
        <https://1145.am/db/435691/Concrete_Ventures>,
        <https://1145.am/db/437556/Founders_Fund>,
        <https://1145.am/db/438632/Founders_Fund>,
        <https://1145.am/db/478867/Founders_Fund>,
        <https://1145.am/db/508145/Snz_Capital>,
        <https://1145.am/db/508161/Snz_Capital>,
        <https://1145.am/db/517818/Strong_Ventures>,
        <https://1145.am/db/539214/Sosv>,
        <https://1145.am/db/571520/G___M_Capital>,
        <https://1145.am/db/606173/Impellent_Ventures>,
        <https://1145.am/db/6743/S28_Capital>,
        <https://1145.am/db/676953/Upfront_Ventures>,
        <https://1145.am/db/678418/Sjf_Ventures>,
        <https://1145.am/db/678978/Inp_Capital>,
        <https://1145.am/db/683067/Lofty_Ventures>,
        <https://1145.am/db/690348/L37_Ventures>,
        <https://1145.am/db/700308/Afore_Capital>,
        <https://1145.am/db/714710/2b_Ahead_Ventures>,
        <https://1145.am/db/731044/Sempervirensvc>,
        <https://1145.am/db/733491/Build_Ventures>,
        <https://1145.am/db/749201/Trust_Ventures>,
        <https://1145.am/db/750485/A16z>,
        <https://1145.am/db/750849/Trust_Ventures>,
        <https://1145.am/db/753541/A16z>,
        <https://1145.am/db/768306/Coatue>,
        <https://1145.am/db/773235/Innovation_Endeavors>,
        <https://1145.am/db/815627/Xyz_Capital>,
        <https://1145.am/db/821222/Afore_Capital>,
        <https://1145.am/db/838181/Addition_Ventures>,
        <https://1145.am/db/840680/Afore_Capital>,
        <https://1145.am/db/846931/Myasiavc>,
        <https://1145.am/db/922498/Founders_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2200286/Leerink_Swann>,
        <https://1145.am/db/2244676/Leerink_Swann>,
        <https://1145.am/db/2337924/Leerink_Swann> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355543/Oracle_Partners> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-06-21T14:25:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tesaro-announces-101-million-series-b-financing-for-advancement-and-expansion-of-oncology> ;
    ns1:foundName "Oracle Partners" ;
    ns1:investor <https://1145.am/db/2355543/Series_B_Investment_Deerfield_Management_Interwest_Partners_Kleiner_Perkins_Caufield___Byers_Leerink_Swann_New_Enterprise_Associates_Oracle_Partners_T_Rowe_Price_Pappas_Ventures_T_Rowe_Price_Pappas_Ventures_Tesaro_Completed> ;
    ns1:name "Oracle Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2355531/Oracle_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355543/T_Rowe_Price_Pappas_Ventures> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:documentDate "2011-06-21T14:25:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tesaro-announces-101-million-series-b-financing-for-advancement-and-expansion-of-oncology> ;
    ns1:foundName "Pappas Ventures",
        "T. Rowe Price",
        "T. Rowe Price, Pappas Ventures" ;
    ns1:investor <https://1145.am/db/2355543/Series_B_Investment_Deerfield_Management_Interwest_Partners_Kleiner_Perkins_Caufield___Byers_Leerink_Swann_New_Enterprise_Associates_Oracle_Partners_T_Rowe_Price_Pappas_Ventures_T_Rowe_Price_Pappas_Ventures_Tesaro_Completed> ;
    ns1:name "Pappas Ventures",
        "T. Rowe Price",
        "T. Rowe Price, Pappas Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2355531/T_Rowe_Price_Pappas_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355904/William_K_Bowes_Jr> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:description "venture capitalist" ;
    ns1:documentDate "2011-03-15T11:19:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "US venture capitalist donates USD 2 million to Karolinska Institutet" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/us-venture-capitalist-donates-usd-2-million-to-karolinska-institutet> ;
    ns1:foundName "William K. Bowes, Jr." ;
    ns1:industry "venture capitalist" ;
    ns1:investor <https://1145.am/db/2355904/Investment_Karolinska_Institutet_William_K_Bowes_Jr_Completed> ;
    ns1:name "William K. Bowes, Jr." ;
    ns1:sameAsHigh <https://1145.am/db/2356903/William_K_Bowes_Jr> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358011/Investment_Synageva_Biopharma_Corp_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-03-21T14:33:12+00:00"^^xsd:dateTime ;
    ns1:documentExtract "LEXINGTON, Mass., Mar 21, 2011 (BUSINESS WIRE) - Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, announced today the closing of a $ 25 million private equity financing.",
        "Synageva BioPharma Announces Additional $ 25 Million Funding to Support Rare Disease Product Development." ;
    ns1:documentTitle "Synageva BioPharma Announces Additional $25 Million Funding to Support Rare Disease Product Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/synageva-biopharma-announces-additional-25-million-funding-to-support-rare-disease-product> ;
    ns1:foundName "Funding",
        "financing",
        "private equity" ;
    ns1:name "Funding",
        "financing",
        "private equity" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2358011/Synageva_Biopharma_Corp> ;
    ns1:targetDetails "private equity" ;
    ns1:valueRaw "$ 25 Million",
        "$ 25 million" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "Kingdom of Sweden" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:whereRaw "Sweden" .

<https://1145.am/db/2360090/Investment_Methylgene_Inc_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-03-25T12:38:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MethylGene Announces $ 34.5 Million Private Placement.",
        "MethylGene Inc. (TSX: MYG) announced today its intention to complete a private placement of $ 34.5 million." ;
    ns1:documentTitle "MethylGene Announces $34.5 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/methylgene-announces-34-5-million-private-placement> ;
    ns1:foundName "Private Placement",
        "private placement" ;
    ns1:name "Private Placement",
        "private placement" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2360090/Methylgene_Inc> ;
    ns1:valueRaw "$ 34.5 Million",
        "$ 34.5 million" ;
    ns1:when "2011-03-24T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "March 24, 2011" ;
    ns1:whereGeoName "Qubec" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6325494/about.rdf> ;
    ns1:whereRaw "QUEBEC" .

<https://1145.am/db/2360127/Esperante> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Sweden" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:basedInHighRaw "Sweden" ;
    ns1:description "financing" ;
    ns1:documentDate "2011-03-28T15:11:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Anergis Closes CHF 18 Million Series A Financing Round to Develop its Innovative Allergy Vaccines and Expands its Board of Direc" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anergis-closes-chf-18-million-series-a-financing-round-to-develop-its-innovative-allergy> ;
    ns1:foundName "Esperante" ;
    ns1:investor <https://1145.am/db/2360127/Series_A_Investment_Anergis_Sa_Biomedinvest_Esperante_Initiative_Capital_Romandie_Sunstone_Capital_Vinci_Capital-Renaissance_Pme_Completed> ;
    ns1:name "Esperante" ;
    ns1:sameAsMedium <https://1145.am/db/2360125/Esperante> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360127/Vinci_Capital-Renaissance_Pme> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:description "Investing in biotech" ;
    ns1:documentDate "2011-03-28T15:11:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Anergis Closes CHF 18 Million Series A Financing Round to Develop its Innovative Allergy Vaccines and Expands its Board of Direc" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anergis-closes-chf-18-million-series-a-financing-round-to-develop-its-innovative-allergy> ;
    ns1:foundName "Vinci Capital-Renaissance PME" ;
    ns1:investor <https://1145.am/db/2360127/Series_A_Investment_Anergis_Sa_Biomedinvest_Esperante_Initiative_Capital_Romandie_Sunstone_Capital_Vinci_Capital-Renaissance_Pme_Completed> ;
    ns1:name "Vinci Capital-Renaissance PME" ;
    ns1:sameAsMedium <https://1145.am/db/2323705/Vinci_Capital-Renaissance_Pme>,
        <https://1145.am/db/2331736/Vinci_Capital-Renaissance_Pme>,
        <https://1145.am/db/2332658/Vinci_Capital-Renaissance_Pme>,
        <https://1145.am/db/2332659/Vinci_Capital-Renaissance_Pme>,
        <https://1145.am/db/2360125/Vinci_Capital-Renaissance_Pme> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360852/Family_Foundation_Of_Business_Leader> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:documentDate "2011-07-08T16:00:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics For Promising Clinical Trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/family-foundation-of-business-leader-invests-4-55-million-northwest-biotherapeutics-for> ;
    ns1:foundName "Family Foundation of Business Leader" ;
    ns1:investor <https://1145.am/db/2360852/Investment_Family_Foundation_Of_Business_Leader_Northwest_Biotherapeutics_Completed> ;
    ns1:name "Family Foundation of Business Leader" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360852/Whitebox> a org:Organization ;
    ns1:basedInHighGeoName "Minnesota" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5037779/about.rdf> ;
    ns1:basedInHighRaw "Minnesota" ;
    ns1:documentDate "2011-07-08T16:00:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics For Promising Clinical Trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/family-foundation-of-business-leader-invests-4-55-million-northwest-biotherapeutics-for> ;
    ns1:foundName "Whitebox Advisors" ;
    ns1:investor <https://1145.am/db/2360852/Equity_Investment_Whitebox_Completed> ;
    ns1:name "Whitebox" ;
    ns1:sameAsMedium <https://1145.am/db/1757073/Whitebox>,
        <https://1145.am/db/1767675/Whitebox>,
        <https://1145.am/db/270903/Whitebox> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362871/Advanced_Technology_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:documentDate "2011-07-14T13:23:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verastem snags $32M for drugs against cancer stem cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/verastem-snags-32m-for-drugs-against-cancer-stem-cells> ;
    ns1:foundName "Advanced Technology Ventures" ;
    ns1:investor <https://1145.am/db/2362871/Series_B_Investment_Advanced_Technology_Ventures_Astellas_Venture_Management_Bessemer_Venture_Partners_Cardinal_Partners_Longwood_Founders_Fund_Mpm_Capital_Verastem_Completed> ;
    ns1:name "Advanced Technology Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1800080/Advanced_Technology_Ventures>,
        <https://1145.am/db/1830593/Advanced_Technology_Ventures>,
        <https://1145.am/db/1850376/Advanced_Technology_Ventures>,
        <https://1145.am/db/1854846/Advanced_Technology_Ventures>,
        <https://1145.am/db/1861352/Advanced_Technology_Ventures>,
        <https://1145.am/db/1872490/Advanced_Technology_Ventures>,
        <https://1145.am/db/2287777/Advanced_Technology_Ventures>,
        <https://1145.am/db/2291818/Advanced_Technology_Ventures>,
        <https://1145.am/db/2300322/Advanced_Technology_Ventures>,
        <https://1145.am/db/2316391/Advanced_Technology_Ventures>,
        <https://1145.am/db/2317467/Advanced_Technology_Ventures>,
        <https://1145.am/db/2317918/Advanced_Technology_Ventures>,
        <https://1145.am/db/2319874/Advanced_Technology_Ventures>,
        <https://1145.am/db/2322012/Advanced_Technology_Ventures>,
        <https://1145.am/db/2322022/Advanced_Technology_Ventures>,
        <https://1145.am/db/2328599/Advanced_Technology_Ventures>,
        <https://1145.am/db/2336313/Advanced_Technology_Ventures>,
        <https://1145.am/db/2338703/Advanced_Technology_Ventures>,
        <https://1145.am/db/2338704/Advanced_Technology_Ventures>,
        <https://1145.am/db/2341904/Advanced_Technology_Ventures>,
        <https://1145.am/db/2343722/Advanced_Technology_Ventures>,
        <https://1145.am/db/2343737/Advanced_Technology_Ventures>,
        <https://1145.am/db/2347389/Advanced_Technology_Ventures>,
        <https://1145.am/db/2360756/Advanced_Technology_Ventures>,
        <https://1145.am/db/2360758/Advanced_Technology_Ventures>,
        <https://1145.am/db/2362553/Advanced_Technology_Ventures>,
        <https://1145.am/db/2364939/Advanced_Technology_Ventures>,
        <https://1145.am/db/2367204/Advanced_Technology_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362871/Astellas_Venture_Management> a org:Organization ;
    ns1:basedInHighGeoName "Japan" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1861060/about.rdf> ;
    ns1:basedInHighRaw "Japan" ;
    ns1:documentDate "2011-07-14T13:23:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verastem snags $32M for drugs against cancer stem cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/verastem-snags-32m-for-drugs-against-cancer-stem-cells> ;
    ns1:foundName "Astellas Venture Management" ;
    ns1:investor <https://1145.am/db/2362871/Series_B_Investment_Advanced_Technology_Ventures_Astellas_Venture_Management_Bessemer_Venture_Partners_Cardinal_Partners_Longwood_Founders_Fund_Mpm_Capital_Verastem_Completed> ;
    ns1:name "Astellas Venture Management" ;
    ns1:sameAsMedium <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1156304/Astellas_Venture_Management>,
        <https://1145.am/db/1503058/Astellas_Venture_Management>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2318733/Astellas_Venture_Management>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2320476/Astellas_Venture_Management>,
        <https://1145.am/db/2329125/Astellas_Venture_Management>,
        <https://1145.am/db/2329131/Astellas_Venture_Management>,
        <https://1145.am/db/2357858/Astellas_Venture_Management>,
        <https://1145.am/db/2358430/Astellas_Venture_Management>,
        <https://1145.am/db/2358657/Astellas_Venture_Management>,
        <https://1145.am/db/2365138/Astellas_Venture_Management>,
        <https://1145.am/db/2365748/Astellas_Venture_Management>,
        <https://1145.am/db/2370582/Astellas_Venture_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362871/Bessemer_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-07-14T13:23:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verastem snags $32M for drugs against cancer stem cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/verastem-snags-32m-for-drugs-against-cancer-stem-cells> ;
    ns1:foundName "Bessemer Venture Partners" ;
    ns1:investor <https://1145.am/db/2362871/Series_B_Investment_Advanced_Technology_Ventures_Astellas_Venture_Management_Bessemer_Venture_Partners_Cardinal_Partners_Longwood_Founders_Fund_Mpm_Capital_Verastem_Completed> ;
    ns1:name "Bessemer Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1006362/Bessemer_Ventures>,
        <https://1145.am/db/1007121/Bessemer_Ventures>,
        <https://1145.am/db/1140521/Bessemer_Venture_Partners>,
        <https://1145.am/db/1150887/Bessemer_Venture_Partners>,
        <https://1145.am/db/1153184/Bessemer_Venture_Partners>,
        <https://1145.am/db/1168925/Bessemer_Venture_Partners>,
        <https://1145.am/db/1171251/Bessemer_Venture_Partners>,
        <https://1145.am/db/1287496/Bessemer_Venture_Partners>,
        <https://1145.am/db/1297270/Bessemer_Venture_Partners>,
        <https://1145.am/db/1298072/Bessemer_Venture_Partners>,
        <https://1145.am/db/1311917/Bessemer_Venture_Partners>,
        <https://1145.am/db/1412727/Bessemer_Venture_Partners>,
        <https://1145.am/db/1445566/Bessemer_Venture_Partners>,
        <https://1145.am/db/1449740/Bessemer_Venture_Partners>,
        <https://1145.am/db/1490295/Bessemer_Venture_Partners>,
        <https://1145.am/db/1667738/Bessemer_Venture_Partners>,
        <https://1145.am/db/1703633/Bessemer_Venture_Partners>,
        <https://1145.am/db/1726088/Bessemer_Venture_Partners>,
        <https://1145.am/db/1731036/Bessemer_Venture_Partners>,
        <https://1145.am/db/1735755/Bessemer_Venture_Partners>,
        <https://1145.am/db/1736811/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744676/Bessemer_Venture_Partners>,
        <https://1145.am/db/1748765/Bessemer_Venture_Partners>,
        <https://1145.am/db/1749643/Bessemer_Venture_Partners>,
        <https://1145.am/db/1750217/Bessemer_Venture_Partners>,
        <https://1145.am/db/1751506/Bessemer_Venture_Partners>,
        <https://1145.am/db/1751790/Bessemer_Venture_Partners>,
        <https://1145.am/db/1751800/Bessemer_Venture_Partners>,
        <https://1145.am/db/1756092/Bessemer_Venture_Partners>,
        <https://1145.am/db/1760614/Bessemer_Ventures>,
        <https://1145.am/db/1762343/Bessemer_Venture_Partners>,
        <https://1145.am/db/1763774/Bessemer_Venture_Partners>,
        <https://1145.am/db/1765092/Bessemer_Venture_Partners>,
        <https://1145.am/db/1765646/Bessemer_Venture_Partners>,
        <https://1145.am/db/1772381/Bessemer_Venture_Partners>,
        <https://1145.am/db/1774323/Bessemer_Venture_Partners>,
        <https://1145.am/db/1775794/Bessemer_Venture_Partners>,
        <https://1145.am/db/1778844/Bessemer_Venture_Partners>,
        <https://1145.am/db/1779320/Bessemer_Venture_Partners>,
        <https://1145.am/db/1780998/Bessemer_Venture_Partners>,
        <https://1145.am/db/1795531/Bessemer_Venture_Partners>,
        <https://1145.am/db/1797945/Bessemer_Venture_Partners>,
        <https://1145.am/db/1801088/Bessemer_Venture_Partners>,
        <https://1145.am/db/1802590/Bessemer_Venture_Partners>,
        <https://1145.am/db/1802834/Bessemer_Venture_Partners>,
        <https://1145.am/db/1808735/Bessemer_Venture_Partners>,
        <https://1145.am/db/1813337/Bessemer_Venture_Partners>,
        <https://1145.am/db/1819651/Bessemer_Venture_Partners>,
        <https://1145.am/db/1820660/Bessemer_Venture_Partners>,
        <https://1145.am/db/1823001/Bessemer_Venture_Partners>,
        <https://1145.am/db/1823041/Bessemer_Ventures>,
        <https://1145.am/db/1826794/Bessemer_Ventures_Partners>,
        <https://1145.am/db/1833296/Bessemer_Venture_Partners>,
        <https://1145.am/db/1839990/Bessemer_Venture_Partners>,
        <https://1145.am/db/1849606/Bessemer_Venture_Partners>,
        <https://1145.am/db/1851792/Bessemer_Venture_Partners>,
        <https://1145.am/db/1853292/Bessemer_Venture_Partners>,
        <https://1145.am/db/1860406/Bessemer_Venture_Partners>,
        <https://1145.am/db/1860637/Bessemer_Venture_Partners>,
        <https://1145.am/db/1866032/Bessemer_Venture_Partners>,
        <https://1145.am/db/1892105/Bessemer_Venture_Partners>,
        <https://1145.am/db/1893502/Bessemer_Venture_Partners>,
        <https://1145.am/db/1898837/Bessemer_Venture_Partners>,
        <https://1145.am/db/1904197/Bessemer_Venture_Partners>,
        <https://1145.am/db/1914189/Bessemer_Venture_Partners>,
        <https://1145.am/db/1917346/Bessemer_Venture_Partners>,
        <https://1145.am/db/1921374/Bessemer_Venture_Partners>,
        <https://1145.am/db/1947303/Bessemer_Venture_Partners>,
        <https://1145.am/db/1954147/Bessemer_Venture_Partners>,
        <https://1145.am/db/2013193/Bessemer_Venture_Partners>,
        <https://1145.am/db/2051110/Bessemer_Venture_Partners>,
        <https://1145.am/db/2059038/Bessemer_Venture_Partners>,
        <https://1145.am/db/2070098/Bessemer_Venture_Partners>,
        <https://1145.am/db/2125259/Bessemer_Venture_Partners>,
        <https://1145.am/db/2142825/Bessemer_Venture_Partners>,
        <https://1145.am/db/2181016/Bessemer_Venture_Partners>,
        <https://1145.am/db/221321/Bessemer_Venture_Partners>,
        <https://1145.am/db/2236188/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303251/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303257/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303675/Bessemer_Venture_Partners>,
        <https://1145.am/db/2317918/Bessemer_Venture_Partners>,
        <https://1145.am/db/2325326/Bessemer_Venture_Partners>,
        <https://1145.am/db/2338625/Bessemer_Venture_Partners>,
        <https://1145.am/db/2339925/Bessemer_Venture_Partners>,
        <https://1145.am/db/2349437/Bessemer_Venture_Partners>,
        <https://1145.am/db/2621506/Bessemer_Venture_Partners>,
        <https://1145.am/db/2766437/Bessemer_Venture_Partners>,
        <https://1145.am/db/293891/Bessemer_Venture_Partners>,
        <https://1145.am/db/325080/Bessemer_Venture_Partners>,
        <https://1145.am/db/472389/Bessemer_Venture_Partners>,
        <https://1145.am/db/473354/Bessemer_Venture_Partners>,
        <https://1145.am/db/507249/Bessemer_Venture_Partners>,
        <https://1145.am/db/508115/Bessemer_Venture_Partners>,
        <https://1145.am/db/511072/Bessemer_Venture_Partners>,
        <https://1145.am/db/513305/Bessemer_Venture_Partners>,
        <https://1145.am/db/575249/Bessemer_Venture_Partners>,
        <https://1145.am/db/606291/Bessemer_Venture_Partners>,
        <https://1145.am/db/676869/Bessemer_Venture_Partners>,
        <https://1145.am/db/678140/Bessemer_Venture_Partners>,
        <https://1145.am/db/694924/Bessemer_Venture_Partners>,
        <https://1145.am/db/803541/Bessemer_Venture_Partners>,
        <https://1145.am/db/8314/Bessemer_Venture_Partners>,
        <https://1145.am/db/847157/Bessemer_Venture_Partners>,
        <https://1145.am/db/862760/Bessemer_Venture_Partners>,
        <https://1145.am/db/862851/Bessemer_Venture_Partners>,
        <https://1145.am/db/884806/Bessemer_Venture_Partners>,
        <https://1145.am/db/924505/Bessemer_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1060146/Bessemer_Venture_Partners>,
        <https://1145.am/db/1061468/Bessemer_Venture_Partners>,
        <https://1145.am/db/1061911/Bessemer_Venture_Partners>,
        <https://1145.am/db/1064710/Bessemer_Venture_Partners>,
        <https://1145.am/db/1090262/Bessemer_Venture_Partners>,
        <https://1145.am/db/1480187/Bessemer_Venture_Partners>,
        <https://1145.am/db/1669991/Bessemer_Venture_Partners>,
        <https://1145.am/db/1697155/Bessemer_Venture_Partners>,
        <https://1145.am/db/1698509/Bessemer_Venture_Partners>,
        <https://1145.am/db/1706697/Bessemer_Venture_Partners>,
        <https://1145.am/db/1707187/Bessemer_Venture_Partners>,
        <https://1145.am/db/1712471/Bessemer_Venture_Partners>,
        <https://1145.am/db/1717313/Bessemer_Venture_Partners>,
        <https://1145.am/db/1718800/Bessemer_Venture_Partners>,
        <https://1145.am/db/1723948/Bessemer_Venture_Partners>,
        <https://1145.am/db/1725530/Bessemer_Venture_Partners>,
        <https://1145.am/db/1742802/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744158/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744201/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744656/Bessemer_Venture_Partners>,
        <https://1145.am/db/1752609/Bessemer_Venture_Partners>,
        <https://1145.am/db/1756150/Bessemer_Venture_Partners>,
        <https://1145.am/db/1756999/Bessemer_Venture_Partners>,
        <https://1145.am/db/1757845/Bessemer_Venture_Partners>,
        <https://1145.am/db/1758776/Bessemer_Venture_Partners>,
        <https://1145.am/db/1759851/Bessemer_Venture_Partners>,
        <https://1145.am/db/1759923/Bessemer_Venture_Partners>,
        <https://1145.am/db/1760213/Bessemer_Venture_Partners>,
        <https://1145.am/db/1763433/Bessemer_Venture_Partners>,
        <https://1145.am/db/1767075/Bessemer_Venture_Partners>,
        <https://1145.am/db/1771769/Bessemer_Venture_Partners>,
        <https://1145.am/db/1772047/Bessemer_Venture_Partners>,
        <https://1145.am/db/1776988/Bessemer_Venture_Partners>,
        <https://1145.am/db/1779634/Bessemer_Venture_Partners>,
        <https://1145.am/db/1800364/Bessemer_Venture_Partners>,
        <https://1145.am/db/1802034/Bessemer_Venture_Partners>,
        <https://1145.am/db/1806684/Bessemer_Venture_Partners>,
        <https://1145.am/db/1813349/Bessemer_Venture_Partners>,
        <https://1145.am/db/1814014/Bessemer_Venture_Partners>,
        <https://1145.am/db/1816701/Bessemer_Venture_Partners>,
        <https://1145.am/db/1818326/Bessemer_Venture_Partners>,
        <https://1145.am/db/1818535/Bessemer_Venture_Partners>,
        <https://1145.am/db/1821929/Bessemer_Venture_Partners>,
        <https://1145.am/db/1823415/Bessemer_Venture_Partners>,
        <https://1145.am/db/1825267/Bessemer_Venture_Partners>,
        <https://1145.am/db/1828092/Bessemer_Venture_Partners>,
        <https://1145.am/db/1836250/Bessemer_Venture_Partners>,
        <https://1145.am/db/1838678/Bessemer_Venture_Partners>,
        <https://1145.am/db/1843244/Bessemer_Venture_Partners>,
        <https://1145.am/db/1846957/Bessemer_Venture_Partners>,
        <https://1145.am/db/1847160/Bessemer_Venture_Partners>,
        <https://1145.am/db/1849046/Bessemer_Venture_Partners>,
        <https://1145.am/db/1849746/Bessemer_Venture_Partners>,
        <https://1145.am/db/1850076/Bessemer_Venture_Partners>,
        <https://1145.am/db/1850727/Bessemer_Venture_Partners>,
        <https://1145.am/db/1856085/Bessemer_Venture_Partners>,
        <https://1145.am/db/1857212/Bessemer_Venture_Partners>,
        <https://1145.am/db/1857278/Bessemer_Venture_Partners>,
        <https://1145.am/db/1859331/Bessemer_Venture_Partners>,
        <https://1145.am/db/1860367/Bessemer_Venture_Partners>,
        <https://1145.am/db/1861518/Bessemer_Venture_Partners>,
        <https://1145.am/db/1876003/Bessemer_Venture_Partners>,
        <https://1145.am/db/1883858/Bessemer_Venture_Partners>,
        <https://1145.am/db/1885320/Bessemer_Venture_Partners>,
        <https://1145.am/db/1885998/Bessemer_Venture_Partners>,
        <https://1145.am/db/1889732/Bessemer_Venture_Partners>,
        <https://1145.am/db/1910644/Bessemer_Venture_Partners>,
        <https://1145.am/db/1921599/Bessemer_Venture_Partners>,
        <https://1145.am/db/2011521/Bessemer_Venture_Partners>,
        <https://1145.am/db/2031790/Bessemer_Venture_Partners>,
        <https://1145.am/db/2043214/Bessemer_Venture_Partners>,
        <https://1145.am/db/207823/Bessemer_Venture_Partners>,
        <https://1145.am/db/2127786/Bessemer_Venture_Partners>,
        <https://1145.am/db/2141061/Bessemer_Venture_Partners>,
        <https://1145.am/db/2173983/Bessemer_Venture_Partners>,
        <https://1145.am/db/2194210/Bessemer_Venture_Partners>,
        <https://1145.am/db/2197248/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303250/Bessemer_Venture_Partners>,
        <https://1145.am/db/2311551/Bessemer_Venture_Partners>,
        <https://1145.am/db/2316356/Bessemer_Venture_Partners>,
        <https://1145.am/db/2324076/Bessemer_Venture_Partners>,
        <https://1145.am/db/2338633/Bessemer_Venture_Partners>,
        <https://1145.am/db/2339926/Bessemer_Venture_Partners>,
        <https://1145.am/db/2348448/Bessemer_Venture_Partners>,
        <https://1145.am/db/2351520/Bessemer_Venture_Partners>,
        <https://1145.am/db/2352414/Bessemer_Venture_Partners>,
        <https://1145.am/db/2353404/Bessemer_Venture_Partners>,
        <https://1145.am/db/2353415/Bessemer_Venture_Partners>,
        <https://1145.am/db/2363330/Bessemer_Venture_Partners>,
        <https://1145.am/db/2677219/Bessemer_Venture_Partners>,
        <https://1145.am/db/341984/Bessemer_Venture_Partners>,
        <https://1145.am/db/341990/Bessemer_Venture_Partners>,
        <https://1145.am/db/425262/Bessemer_Venture_Partners>,
        <https://1145.am/db/478025/Bessemer_Venture_Partners>,
        <https://1145.am/db/506309/Bessemer_Venture_Partners>,
        <https://1145.am/db/559318/Bessemer_Venture_Partners>,
        <https://1145.am/db/668230/Bessemer_Venture_Partners>,
        <https://1145.am/db/668965/Bessemer_Venture_Partners>,
        <https://1145.am/db/699860/Bessemer_Venture_Partners>,
        <https://1145.am/db/700171/Bessemer_Venture_Partners>,
        <https://1145.am/db/829118/Bessemer_Venture_Partners>,
        <https://1145.am/db/832264/Bessemer_Venture_Partners>,
        <https://1145.am/db/877618/Bessemer_Venture_Partners>,
        <https://1145.am/db/902390/Bessemer_Venture_Partners>,
        <https://1145.am/db/907582/Bessemer_Venture_Partners>,
        <https://1145.am/db/907975/Bessemer_Venture_Partners>,
        <https://1145.am/db/955858/Bessemer_Venture_Partners>,
        <https://1145.am/db/960320/Bessemer_Venture_Partners>,
        <https://1145.am/db/971418/Bessemer_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362871/Cardinal_Partners> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-07-14T13:23:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verastem snags $32M for drugs against cancer stem cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/verastem-snags-32m-for-drugs-against-cancer-stem-cells> ;
    ns1:foundName "Cardinal Partners" ;
    ns1:investor <https://1145.am/db/2362871/Series_B_Investment_Advanced_Technology_Ventures_Astellas_Venture_Management_Bessemer_Venture_Partners_Cardinal_Partners_Longwood_Founders_Fund_Mpm_Capital_Verastem_Completed> ;
    ns1:name "Cardinal Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1721548/Harmony_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2240575/Cardinal_Partners>,
        <https://1145.am/db/2313127/Cardinal_Partners>,
        <https://1145.am/db/2341764/Cardinal_Partners>,
        <https://1145.am/db/2344092/Cardinal_Partners>,
        <https://1145.am/db/2344100/Cardinal_Partners>,
        <https://1145.am/db/2353404/Cardinal_Partners>,
        <https://1145.am/db/2353415/Cardinal_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362871/Longwood_Founders_Fund> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:documentDate "2011-07-14T13:23:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verastem snags $32M for drugs against cancer stem cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/verastem-snags-32m-for-drugs-against-cancer-stem-cells> ;
    ns1:foundName "Longwood Founders Fund" ;
    ns1:investor <https://1145.am/db/2362871/Series_B_Investment_Advanced_Technology_Ventures_Astellas_Venture_Management_Bessemer_Venture_Partners_Cardinal_Partners_Longwood_Founders_Fund_Mpm_Capital_Verastem_Completed> ;
    ns1:name "Longwood Founders Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2353404/Longwood_Founders_Fund>,
        <https://1145.am/db/2353415/Longwood_Founders_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2363247/Hangzhou_Binjiang_Investment_Holding_Co_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "Peoples Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:description "private entrepreneurs" ;
    ns1:documentDate "2011-04-06T13:59:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "US-China Based Ascletis, Inc. Raises $100 Million from Private Chinese Investors for Specialty Therapeutics Venture" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/us-china-based-ascletis-inc-raises-100-million-from-private-chinese-investors-for-specialty> ;
    ns1:foundName "Hangzhou Binjiang Investment Holding Co., Ltd." ;
    ns1:investor <https://1145.am/db/2363247/Investment_Ascletis_Hangzhou_Binjiang_Investment_Holding_Co_Ltd_Completed> ;
    ns1:name "Hangzhou Binjiang Investment Holding Co., Ltd." ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2363871/Cowen_Healthcare_Royalty_Partners_Ii> a org:Organization ;
    ns1:description "Investing in pharmaceutical companies" ;
    ns1:documentDate "2011-07-19T15:19:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zogenix Closes $30 Million Royalty Financing With Cowen Healthcare Royalty Partners II Includes $1.5 Million Equity Investment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zogenix-closes-30-million-royalty-financing-cowen-healthcare-royalty-partners-ii-includes-1> ;
    ns1:foundName "Cowen Healthcare Royalty Partners II",
        "Cowen Healthcare Royalty Partners II, L.P." ;
    ns1:investor <https://1145.am/db/2363871/Royalty_Investment_Cowen_Healthcare_Royalty_Partners_Ii_Zogenix_Completed> ;
    ns1:name "Cowen Healthcare Royalty Partners II" ;
    ns1:sameAsMedium <https://1145.am/db/2295203/Cowen_Healthcare_Royalty_Partners>,
        <https://1145.am/db/2305646/Cowen_Healthcare_Royalty_Partners>,
        <https://1145.am/db/2347862/Cowen_Healthcare_Royalty_Partners_Lp>,
        <https://1145.am/db/2347870/Cowen_Healthcare_Royalty_Partners_Lp>,
        <https://1145.am/db/2536960/Cowen_Healthcare_Royalty_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364201/G_Force_Investments_Llc> a org:Organization ;
    ns1:basedInLowRaw "Wis." ;
    ns1:documentDate "2011-04-07T15:23:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cellular Dynamics Raises $30 Million to Expand Its Product Line of Human Stem Cells and Tissue Cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cellular-dynamics-raises-30-million-to-expand-its-product-line-of-human-stem-cells-and> ;
    ns1:foundName "G Force Investments LLC" ;
    ns1:investor <https://1145.am/db/2364201/Investment_Cellular_Dynamics_International_G_Force_Investments_Llc_Sam_Zells_Equity_Group_Investments_Llc_Sixth_Floor_Investors_Lp_Completed> ;
    ns1:name "G Force Investments LLC" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364201/Sam_Zells_Equity_Group_Investments_Llc> a org:Organization ;
    ns1:basedInLowRaw "Wis." ;
    ns1:documentDate "2011-04-07T15:23:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cellular Dynamics Raises $30 Million to Expand Its Product Line of Human Stem Cells and Tissue Cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cellular-dynamics-raises-30-million-to-expand-its-product-line-of-human-stem-cells-and> ;
    ns1:foundName "Sam Zell's Equity Group Investments LLC" ;
    ns1:investor <https://1145.am/db/2364201/Investment_Cellular_Dynamics_International_G_Force_Investments_Llc_Sam_Zells_Equity_Group_Investments_Llc_Sixth_Floor_Investors_Lp_Completed> ;
    ns1:name "Sam Zell's Equity Group Investments LLC" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364201/Sixth_Floor_Investors_Lp> a org:Organization ;
    ns1:basedInLowRaw "Wis." ;
    ns1:documentDate "2011-04-07T15:23:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cellular Dynamics Raises $30 Million to Expand Its Product Line of Human Stem Cells and Tissue Cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cellular-dynamics-raises-30-million-to-expand-its-product-line-of-human-stem-cells-and> ;
    ns1:foundName "Sixth Floor Investors",
        "Sixth Floor Investors LP" ;
    ns1:investor <https://1145.am/db/2364201/Investment_Cellular_Dynamics_International_G_Force_Investments_Llc_Sam_Zells_Equity_Group_Investments_Llc_Sixth_Floor_Investors_Lp_Completed> ;
    ns1:name "Sixth Floor Investors",
        "Sixth Floor Investors LP" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364216/Amgen> a org:Organization ;
    ns1:basedInLowRaw "Brazil" ;
    ns1:buyer <https://1145.am/db/2364216/Bergamo_Rights_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-04-08T13:09:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sanofi funds stalled Genzyme programs; Amgen broadens Brazilian reach;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sanofi-funds-stalled-genzyme-programs-amgen-broadens-brazilian-reach> ;
    ns1:foundName "Amgen" ;
    ns1:industry "pharma" ;
    ns1:name "Amgen" ;
    ns1:sameAsHigh <https://1145.am/db/1044120/Maat_Pharma>,
        <https://1145.am/db/1216593/Small_Pharma_Inc>,
        <https://1145.am/db/1252426/Amgen_Inc>,
        <https://1145.am/db/1254815/Amgen>,
        <https://1145.am/db/1258904/Amgen_Inc>,
        <https://1145.am/db/1262006/Amgen>,
        <https://1145.am/db/1387633/Maat_Pharma>,
        <https://1145.am/db/1388835/Maat_Pharma>,
        <https://1145.am/db/1434130/Amgen>,
        <https://1145.am/db/1464274/Ambrx_Biopharma_Inc>,
        <https://1145.am/db/1465418/Ambrx_Biopharma_Inc>,
        <https://1145.am/db/1488570/Amgen>,
        <https://1145.am/db/1541946/Amgen>,
        <https://1145.am/db/1568872/Amgen_Inc>,
        <https://1145.am/db/1573831/Amgen>,
        <https://1145.am/db/1614229/Nmd_Pharma>,
        <https://1145.am/db/1673901/Amgen>,
        <https://1145.am/db/198163/Amgen>,
        <https://1145.am/db/2043001/Amgen>,
        <https://1145.am/db/2100118/Small_Pharma_Inc>,
        <https://1145.am/db/2106270/Amgen>,
        <https://1145.am/db/2150271/Small_Pharma_Inc>,
        <https://1145.am/db/2153258/Amgen>,
        <https://1145.am/db/2154415/Amgen>,
        <https://1145.am/db/2155409/Amgen>,
        <https://1145.am/db/2155659/Amgen>,
        <https://1145.am/db/2282934/Amgen>,
        <https://1145.am/db/2283321/Amgen>,
        <https://1145.am/db/2285195/Amgen>,
        <https://1145.am/db/2285614/Amgen>,
        <https://1145.am/db/2285991/Amgen>,
        <https://1145.am/db/2286174/Amgen>,
        <https://1145.am/db/2293310/Biogen>,
        <https://1145.am/db/2312121/Amgen>,
        <https://1145.am/db/2313429/Amgen>,
        <https://1145.am/db/2318877/Amgen>,
        <https://1145.am/db/2320754/Amgen>,
        <https://1145.am/db/2322040/Amgen>,
        <https://1145.am/db/2327526/Amgen>,
        <https://1145.am/db/2329762/Amgen>,
        <https://1145.am/db/2337435/Amgen_Inc>,
        <https://1145.am/db/2338329/Amgen>,
        <https://1145.am/db/2338346/Amgen>,
        <https://1145.am/db/2340634/Amgen>,
        <https://1145.am/db/2343862/Amgen>,
        <https://1145.am/db/2344369/Amgen>,
        <https://1145.am/db/2347976/Amgen>,
        <https://1145.am/db/2349030/Amgen>,
        <https://1145.am/db/2349444/Amgen>,
        <https://1145.am/db/2350465/Amgen>,
        <https://1145.am/db/2350471/Amgen>,
        <https://1145.am/db/2353167/Amgen>,
        <https://1145.am/db/2354835/Amgen>,
        <https://1145.am/db/2355383/Amgen>,
        <https://1145.am/db/2355392/Amgen>,
        <https://1145.am/db/2357336/Amgen>,
        <https://1145.am/db/2357451/Amgen>,
        <https://1145.am/db/2359165/Amgen>,
        <https://1145.am/db/2359498/Amgen>,
        <https://1145.am/db/2360080/Amgen>,
        <https://1145.am/db/2361037/Amgen>,
        <https://1145.am/db/2362552/Amgen>,
        <https://1145.am/db/2367430/Amgen_Inc>,
        <https://1145.am/db/2368788/Amgen_Inc>,
        <https://1145.am/db/2370174/Amgen>,
        <https://1145.am/db/2370215/Amgen>,
        <https://1145.am/db/2370217/Amgen>,
        <https://1145.am/db/2538019/Amgen>,
        <https://1145.am/db/2539787/Amgen>,
        <https://1145.am/db/2540225/Amgen>,
        <https://1145.am/db/2548575/Amgen>,
        <https://1145.am/db/2553162/Amgen>,
        <https://1145.am/db/2554152/Amgen>,
        <https://1145.am/db/2556729/Amgen>,
        <https://1145.am/db/2557364/Amgen>,
        <https://1145.am/db/2561317/Amgen>,
        <https://1145.am/db/2566335/Amgen>,
        <https://1145.am/db/2567468/Amgen>,
        <https://1145.am/db/2567517/Amgen>,
        <https://1145.am/db/2567752/Biogen>,
        <https://1145.am/db/2567981/Amgen>,
        <https://1145.am/db/2572655/Amgen>,
        <https://1145.am/db/2573455/Amgen>,
        <https://1145.am/db/2575263/Amgen>,
        <https://1145.am/db/2575289/Amgen>,
        <https://1145.am/db/2577120/Amgen>,
        <https://1145.am/db/2578164/Amgen>,
        <https://1145.am/db/2579211/Amgen>,
        <https://1145.am/db/2580383/Amgen_Inc>,
        <https://1145.am/db/2581917/Amgen>,
        <https://1145.am/db/2583990/Amgen>,
        <https://1145.am/db/2586750/Amgen>,
        <https://1145.am/db/2587009/Amgen>,
        <https://1145.am/db/2587770/Amgen>,
        <https://1145.am/db/258901/Amgen_Inc>,
        <https://1145.am/db/2590988/Amgen_Inc>,
        <https://1145.am/db/2592618/Amgen>,
        <https://1145.am/db/2592924/Amgen>,
        <https://1145.am/db/2593426/Amgen>,
        <https://1145.am/db/2593433/Amgen_Inc>,
        <https://1145.am/db/2593973/Amgen>,
        <https://1145.am/db/2594292/Amgen>,
        <https://1145.am/db/2594298/Amgen>,
        <https://1145.am/db/2594347/Amgen>,
        <https://1145.am/db/2595020/Amgen>,
        <https://1145.am/db/2595549/Amgen>,
        <https://1145.am/db/2595608/Amgen>,
        <https://1145.am/db/2595930/Amgen>,
        <https://1145.am/db/2596467/Amgen>,
        <https://1145.am/db/2598066/Amgen>,
        <https://1145.am/db/2789236/Amgen>,
        <https://1145.am/db/531806/Amgen_Inc>,
        <https://1145.am/db/559746/Amgen>,
        <https://1145.am/db/829447/Nmd_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/1253935/Amgen>,
        <https://1145.am/db/1406211/Amgen>,
        <https://1145.am/db/1570839/Amgen_Inc>,
        <https://1145.am/db/1574155/Amgen>,
        <https://1145.am/db/1575688/Amgen_Inc>,
        <https://1145.am/db/1576668/Amgen_Inc>,
        <https://1145.am/db/1929668/Amgen>,
        <https://1145.am/db/1981398/Amgen>,
        <https://1145.am/db/2008430/Amgen_Inc>,
        <https://1145.am/db/2008790/Amgen>,
        <https://1145.am/db/2009117/Amgen_Inc>,
        <https://1145.am/db/2011679/Amgen>,
        <https://1145.am/db/2012933/Amgen_Inc>,
        <https://1145.am/db/2013008/Amgen_Inc>,
        <https://1145.am/db/2016970/Amgen>,
        <https://1145.am/db/2046726/Amgen>,
        <https://1145.am/db/2098829/Amgen>,
        <https://1145.am/db/2105082/Amgen>,
        <https://1145.am/db/2107919/Amgen>,
        <https://1145.am/db/2117067/Amgen>,
        <https://1145.am/db/2117986/Amgen>,
        <https://1145.am/db/2138386/Amgen>,
        <https://1145.am/db/2152715/Amgen>,
        <https://1145.am/db/2249776/Amgen_Inc>,
        <https://1145.am/db/2282387/Amgen>,
        <https://1145.am/db/2291231/Amgen>,
        <https://1145.am/db/2292224/Amgen>,
        <https://1145.am/db/2292876/Amgen>,
        <https://1145.am/db/2299349/Amgen>,
        <https://1145.am/db/2302052/Amgen>,
        <https://1145.am/db/2303414/Amgen>,
        <https://1145.am/db/2317845/Amgen>,
        <https://1145.am/db/2320759/Amgen>,
        <https://1145.am/db/2320765/Amgen>,
        <https://1145.am/db/2320771/Amgen>,
        <https://1145.am/db/2320775/Amgen>,
        <https://1145.am/db/2321459/Amgen>,
        <https://1145.am/db/2321989/Amgen>,
        <https://1145.am/db/2322632/Amgen>,
        <https://1145.am/db/2326533/Amgen>,
        <https://1145.am/db/2326559/Amgen>,
        <https://1145.am/db/2327547/Amgen>,
        <https://1145.am/db/2328748/Amgen>,
        <https://1145.am/db/2333460/Amgen>,
        <https://1145.am/db/2334046/Amgen>,
        <https://1145.am/db/2337433/Amgen>,
        <https://1145.am/db/2337848/Amgen>,
        <https://1145.am/db/2338027/Amgen>,
        <https://1145.am/db/2338828/Amgen>,
        <https://1145.am/db/2340408/Amgen>,
        <https://1145.am/db/2340669/Amgen>,
        <https://1145.am/db/2343511/Amgen>,
        <https://1145.am/db/2343601/Amgen>,
        <https://1145.am/db/2343780/Amgen>,
        <https://1145.am/db/2344631/Amgen>,
        <https://1145.am/db/2344864/Amgen>,
        <https://1145.am/db/2345191/Amgen>,
        <https://1145.am/db/2345783/Amgen>,
        <https://1145.am/db/2345886/Amgen>,
        <https://1145.am/db/2346293/Amgen>,
        <https://1145.am/db/2347966/Amgen>,
        <https://1145.am/db/2347970/Amgen>,
        <https://1145.am/db/2350029/Amgen>,
        <https://1145.am/db/2352800/Amgen>,
        <https://1145.am/db/2355378/Amgen>,
        <https://1145.am/db/2355427/Amgen>,
        <https://1145.am/db/2357269/Amgen>,
        <https://1145.am/db/2357271/Amgen>,
        <https://1145.am/db/2357303/Amgen>,
        <https://1145.am/db/2357454/Amgen>,
        <https://1145.am/db/2357920/Amgen>,
        <https://1145.am/db/2358934/Amgen>,
        <https://1145.am/db/2359462/Amgen>,
        <https://1145.am/db/2359481/Amgen>,
        <https://1145.am/db/2360086/Amgen>,
        <https://1145.am/db/2361971/Amgen>,
        <https://1145.am/db/2361972/Amgen>,
        <https://1145.am/db/2361973/Amgen>,
        <https://1145.am/db/2363673/Amgen>,
        <https://1145.am/db/2370120/Amgen>,
        <https://1145.am/db/2371301/Amgen>,
        <https://1145.am/db/2543232/Amgen>,
        <https://1145.am/db/2543655/Amgen>,
        <https://1145.am/db/2544701/Amgen>,
        <https://1145.am/db/2545663/Amgen>,
        <https://1145.am/db/2545765/Amgen>,
        <https://1145.am/db/2550685/Amgen>,
        <https://1145.am/db/2550884/Amgen>,
        <https://1145.am/db/2551883/Amgen>,
        <https://1145.am/db/2551884/Amgen>,
        <https://1145.am/db/2553564/Amgen>,
        <https://1145.am/db/2555175/Amgen>,
        <https://1145.am/db/2558012/Amgen>,
        <https://1145.am/db/2558039/Amgen>,
        <https://1145.am/db/2558051/Amgen>,
        <https://1145.am/db/2558418/Amgen>,
        <https://1145.am/db/2559077/Amgen>,
        <https://1145.am/db/2561305/Amgen>,
        <https://1145.am/db/2561325/Amgen>,
        <https://1145.am/db/2561650/Amgen>,
        <https://1145.am/db/2566348/Amgen>,
        <https://1145.am/db/2567960/Amgen>,
        <https://1145.am/db/2568005/Amgen>,
        <https://1145.am/db/2568075/Amgen>,
        <https://1145.am/db/2568519/Amgen>,
        <https://1145.am/db/2572535/Amgen>,
        <https://1145.am/db/2573903/Amgen>,
        <https://1145.am/db/2573924/Amgen>,
        <https://1145.am/db/2573976/Amgen>,
        <https://1145.am/db/2574586/Amgen>,
        <https://1145.am/db/2576018/Amgen>,
        <https://1145.am/db/2576242/Amgen>,
        <https://1145.am/db/2576498/Amgen>,
        <https://1145.am/db/2577110/Amgen>,
        <https://1145.am/db/2577115/Amgen>,
        <https://1145.am/db/2578110/Amgen>,
        <https://1145.am/db/2578286/Amgen>,
        <https://1145.am/db/2579278/Amgen>,
        <https://1145.am/db/2580209/Amgen>,
        <https://1145.am/db/2580211/Amgen>,
        <https://1145.am/db/2581309/Amgen>,
        <https://1145.am/db/2581359/Amgen>,
        <https://1145.am/db/2584352/Amgen>,
        <https://1145.am/db/2585068/Amgen>,
        <https://1145.am/db/2586068/Amgen>,
        <https://1145.am/db/2589106/Amgen>,
        <https://1145.am/db/2590194/Amgen>,
        <https://1145.am/db/2590989/Amgen>,
        <https://1145.am/db/2591587/Amgen>,
        <https://1145.am/db/2591594/Amgen>,
        <https://1145.am/db/2592573/Amgen>,
        <https://1145.am/db/2593423/Amgen>,
        <https://1145.am/db/2593434/Amgen>,
        <https://1145.am/db/2593465/Amgen>,
        <https://1145.am/db/2593681/Amgen>,
        <https://1145.am/db/2594099/Amgen>,
        <https://1145.am/db/2594285/Amgen>,
        <https://1145.am/db/2594990/Amgen>,
        <https://1145.am/db/2594993/Amgen>,
        <https://1145.am/db/2595564/Amgen>,
        <https://1145.am/db/2595587/Amgen>,
        <https://1145.am/db/2595605/Amgen>,
        <https://1145.am/db/2596819/Amgen>,
        <https://1145.am/db/2597499/Amgen>,
        <https://1145.am/db/2716207/Amgen>,
        <https://1145.am/db/2802001/Amgen> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364216/Cadila_Healthcare> a org:Organization ;
    ns1:basedInHighGeoName "Republic of India" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:basedInHighRaw "India" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-04-08T13:09:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sanofi funds stalled Genzyme programs; Amgen broadens Brazilian reach;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sanofi-funds-stalled-genzyme-programs-amgen-broadens-brazilian-reach> ;
    ns1:foundName "Cadila Healthcare" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2364216/Investment_Cadila_Healthcare_Has_Not_Happened> ;
    ns1:name "Cadila Healthcare" ;
    ns1:sameAsHigh <https://1145.am/db/2547130/Cadila_Healthcare> ;
    ns1:sameAsMedium <https://1145.am/db/2550590/Cadila_Healthcare> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365105/Sr_One> a org:Organization ;
    ns1:documentDate "2011-04-13T10:20:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "f-star raises 15M in a New Financing led by SR One" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/f-star-raises-%E2%82%AC15m-a-new-financing-led-by-sr-one> ;
    ns1:foundName "SR One" ;
    ns1:investor <https://1145.am/db/2365105/Investment_Sr_One_F-Star_Gmbh_Has_Not_Happened> ;
    ns1:name "SR One" ;
    ns1:sameAsMedium <https://1145.am/db/1169952/Sr_One>,
        <https://1145.am/db/1334624/Sr_One>,
        <https://1145.am/db/1949427/Sr_One>,
        <https://1145.am/db/2095130/Sr_One>,
        <https://1145.am/db/2110113/Sr_One>,
        <https://1145.am/db/2280707/Sr_One>,
        <https://1145.am/db/2305791/Sr_One>,
        <https://1145.am/db/2317934/Sr_One>,
        <https://1145.am/db/2317951/Sr_One>,
        <https://1145.am/db/2318310/Sr_One>,
        <https://1145.am/db/2326222/Sr_One_Ltd>,
        <https://1145.am/db/2327305/Sr_One>,
        <https://1145.am/db/2327488/Sr_One_Ltd>,
        <https://1145.am/db/2331763/Sr_One>,
        <https://1145.am/db/2336328/Sr_One>,
        <https://1145.am/db/2337571/Sr_One>,
        <https://1145.am/db/2337577/Sr_One>,
        <https://1145.am/db/2340096/Sr_One>,
        <https://1145.am/db/2341904/Sr_One>,
        <https://1145.am/db/2342084/Sr_One>,
        <https://1145.am/db/2342983/Sr_One>,
        <https://1145.am/db/2343301/Sr_One>,
        <https://1145.am/db/2345675/Sr_One>,
        <https://1145.am/db/2347482/Sr_One>,
        <https://1145.am/db/2347594/Sr_One>,
        <https://1145.am/db/2349233/Sr_One>,
        <https://1145.am/db/2350030/Sr_One>,
        <https://1145.am/db/2350364/Sr_One>,
        <https://1145.am/db/2353917/Sr_One>,
        <https://1145.am/db/2356402/Sr_One>,
        <https://1145.am/db/2356411/Sr_One>,
        <https://1145.am/db/2357676/Sr_One>,
        <https://1145.am/db/2357679/Sr_One>,
        <https://1145.am/db/2357682/Sr_One>,
        <https://1145.am/db/2358430/Sr_One>,
        <https://1145.am/db/2358860/Sr_One>,
        <https://1145.am/db/2359334/Sr_One>,
        <https://1145.am/db/2362533/Sr_One>,
        <https://1145.am/db/2362715/Sr_One>,
        <https://1145.am/db/2363947/Sr_One>,
        <https://1145.am/db/2363950/Sr_One>,
        <https://1145.am/db/2365103/Sr_One>,
        <https://1145.am/db/2365104/Sr_One>,
        <https://1145.am/db/2365296/Sr_One>,
        <https://1145.am/db/2365300/Sr_One>,
        <https://1145.am/db/2367549/Sr_One>,
        <https://1145.am/db/2368501/Sr_One>,
        <https://1145.am/db/2371191/Sr_One>,
        <https://1145.am/db/2371304/Sr_One>,
        <https://1145.am/db/2544138/Sr_One>,
        <https://1145.am/db/2544140/Sr_One>,
        <https://1145.am/db/2546216/Sr_One>,
        <https://1145.am/db/2573068/Sr_One>,
        <https://1145.am/db/2595958/Sr_One> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365344/Delaware_Crossing_Investor_Group> a org:Organization ;
    ns1:basedInHighGeoName "Philadelphia" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4560349/about.rdf> ;
    ns1:basedInHighRaw "Philadelphia" ;
    ns1:documentDate "2011-07-26T19:20:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novira Therapeutics, Inc. Completes Second Round of Seed Financing with Philadelphia Angel Syndicate" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/novira-therapeutics-inc-completes-second-round-of-seed-financing-philadelphia-angel> ;
    ns1:foundName "Delaware Crossing Investor Group" ;
    ns1:investor <https://1145.am/db/2365344/Seed_Investment_Delaware_Crossing_Investor_Group_Mid-Atlantic_Angel_Group_Fund_Ii_Novira_Therapeutics_Robin_Hood_Ventures_Completed> ;
    ns1:name "Delaware Crossing Investor Group" ;
    ns1:sameAsMedium <https://1145.am/db/2332322/Delaware_Crossing_Investment_Group>,
        <https://1145.am/db/2351683/Delaware_Crossing_Investment_Group>,
        <https://1145.am/db/2351684/Delaware_Crossing_Investment_Group>,
        <https://1145.am/db/2572398/Delaware_Crossing_Investment_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365344/Mid-Atlantic_Angel_Group_Fund_Ii> a org:Organization ;
    ns1:basedInLowRaw "RADNOR" ;
    ns1:documentDate "2011-07-26T19:20:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novira Therapeutics, Inc. Completes Second Round of Seed Financing with Philadelphia Angel Syndicate" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/novira-therapeutics-inc-completes-second-round-of-seed-financing-philadelphia-angel> ;
    ns1:foundName "Mid-Atlantic Angel Group Fund II" ;
    ns1:investor <https://1145.am/db/2365344/Seed_Investment_Delaware_Crossing_Investor_Group_Mid-Atlantic_Angel_Group_Fund_Ii_Novira_Therapeutics_Robin_Hood_Ventures_Completed> ;
    ns1:name "Mid-Atlantic Angel Group Fund II" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365344/Robin_Hood_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Philadelphia" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4560349/about.rdf> ;
    ns1:basedInHighRaw "Philadelphia" ;
    ns1:documentDate "2011-07-26T19:20:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novira Therapeutics, Inc. Completes Second Round of Seed Financing with Philadelphia Angel Syndicate" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/novira-therapeutics-inc-completes-second-round-of-seed-financing-philadelphia-angel> ;
    ns1:foundName "Robin Hood Ventures" ;
    ns1:investor <https://1145.am/db/2365344/Seed_Investment_Delaware_Crossing_Investor_Group_Mid-Atlantic_Angel_Group_Fund_Ii_Novira_Therapeutics_Robin_Hood_Ventures_Completed> ;
    ns1:name "Robin Hood Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1428361/Robin_Hood_Ventures>,
        <https://1145.am/db/1867522/Robin_Hood_Ventures>,
        <https://1145.am/db/2290410/Robin_Hood_Ventures>,
        <https://1145.am/db/2332322/Robin_Hood_Ventures>,
        <https://1145.am/db/2351683/Robin_Hood_Ventures>,
        <https://1145.am/db/2351684/Robin_Hood_Ventures>,
        <https://1145.am/db/2572398/Robin_Hood_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365376/Creathor_Venture_Fonds> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:documentDate "2011-07-28T11:27:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CEVEC Pharma Raises $8.5 Million to Commercialize Human-Cell Expression Platform for Proteins and Vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cevec-pharma-raises-8-5-million-to-commercialize-human-cell-expression-platform-for> ;
    ns1:foundName "Creathor Venture Fonds" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2365376/Investment_Cevec_Pharmaceuticals_Creathor_Venture_Fonds_Kfw_Bank_Kfw_Bank_Nrwbank_Completed> ;
    ns1:name "Creathor Venture Fonds" ;
    ns1:sameAsHigh <https://1145.am/db/2364776/Creathor_Venture_Fonds>,
        <https://1145.am/db/2537737/Creathor_Venture_Fonds> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365376/Erp_Startfonds> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:documentDate "2011-07-28T11:27:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CEVEC Pharma Raises $8.5 Million to Commercialize Human-Cell Expression Platform for Proteins and Vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cevec-pharma-raises-8-5-million-to-commercialize-human-cell-expression-platform-for> ;
    ns1:foundName "ERP Startfonds of KfW bank" ;
    ns1:investor <https://1145.am/db/2365376/Investment_Cevec_Pharmaceuticals_Creathor_Venture_Fonds_Kfw_Bank_Kfw_Bank_Nrwbank_Completed> ;
    ns1:name "ERP Startfonds" ;
    ns1:sameAsMedium <https://1145.am/db/2340185/Erp_Startfonds>,
        <https://1145.am/db/2341034/Erp_Startfonds>,
        <https://1145.am/db/2364776/Erp_Startfonds>,
        <https://1145.am/db/2537737/Erp_Startfonds> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365376/Kfw_Bank> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:documentDate "2011-07-28T11:27:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CEVEC Pharma Raises $8.5 Million to Commercialize Human-Cell Expression Platform for Proteins and Vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cevec-pharma-raises-8-5-million-to-commercialize-human-cell-expression-platform-for> ;
    ns1:foundName "ERP Startfonds of",
        "KfW bank" ;
    ns1:investor <https://1145.am/db/2365376/Investment_Cevec_Pharmaceuticals_Creathor_Venture_Fonds_Kfw_Bank_Kfw_Bank_Nrwbank_Completed> ;
    ns1:name "KfW bank" ;
    ns1:sameAsMedium <https://1145.am/db/2335381/Kfw_Bank>,
        <https://1145.am/db/2665382/Kfw_Bank>,
        <https://1145.am/db/900181/Kfw_Bank> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365376/Nrwbank> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:documentDate "2011-07-28T11:27:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CEVEC Pharma Raises $8.5 Million to Commercialize Human-Cell Expression Platform for Proteins and Vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cevec-pharma-raises-8-5-million-to-commercialize-human-cell-expression-platform-for> ;
    ns1:foundName "NRW.BANK" ;
    ns1:investor <https://1145.am/db/2365376/Investment_Cevec_Pharmaceuticals_Creathor_Venture_Fonds_Kfw_Bank_Kfw_Bank_Nrwbank_Completed> ;
    ns1:name "NRW.BANK" ;
    ns1:sameAsMedium <https://1145.am/db/1443192/Nrwbank>,
        <https://1145.am/db/1444350/Nrwbank>,
        <https://1145.am/db/1786289/Nrwbank>,
        <https://1145.am/db/1909578/Nrw_Bank>,
        <https://1145.am/db/2305628/Nrwbank>,
        <https://1145.am/db/2314674/Nrwbank>,
        <https://1145.am/db/2322062/Nrw_Bank>,
        <https://1145.am/db/2338929/Nrw_Bank>,
        <https://1145.am/db/2341942/Nrwbank>,
        <https://1145.am/db/2358030/Nrwbank>,
        <https://1145.am/db/2360425/Nrwbank>,
        <https://1145.am/db/2364776/Nrwbank>,
        <https://1145.am/db/2537737/Nrwbank>,
        <https://1145.am/db/2558803/Nrwbank>,
        <https://1145.am/db/2569491/Nrwbank>,
        <https://1145.am/db/3450/Nrwbank>,
        <https://1145.am/db/545842/Nrwbank> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365651/Series_G_Investment_Merrimack_Pharmaceuticals_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-14T14:31:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, MA, April 13, 2011 - Merrimack Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel treatments for cancer, today announced that it has raised $ 77 million in a Series G private financing with participation by new and existing investors.",
        "Merrimack Pharmaceuticals Raises $ 77 Million in Private Financing." ;
    ns1:documentTitle "Merrimack Pharmaceuticals Raises $77 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merrimack-pharmaceuticals-raises-77-million-private-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2365651/Merrimack_Pharmaceuticals> ;
    ns1:targetDetails "Series G" ;
    ns1:valueRaw "$ 77 Million",
        "$ 77 million" ;
    ns1:when "2011-04-13T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "April 13, 2011" ;
    ns1:whereRaw "Merrimack Pharmaceuticals Raises $ 77 Million in Private Financing" .

<https://1145.am/db/2365826/Alk_Abello> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "financing" ;
    ns1:documentDate "2011-01-05T14:22:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DBV Technologies closes $25.5 (19,4) million Series 'C' financing round including new investors InnoBio, Lundbeckfond Ven" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dbv-technologies-closes-25-5-eu19-4-million-series-c-financing-round-including-new> ;
    ns1:foundName "ALK Abello" ;
    ns1:investor <https://1145.am/db/2365826/Series_C_Investment_Alk_Abello_Alto_Invest_Dbv_Technologies_Innobio_Fund_Lundbeckfond_Ventures_Shire_Plc_Sofinnova_Partners_Completed> ;
    ns1:name "ALK Abello" ;
    ns1:sameAsMedium <https://1145.am/db/2366303/Alk_Abello> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365826/Alto_Invest> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:documentDate "2011-01-05T14:22:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DBV Technologies closes $25.5 (19,4) million Series 'C' financing round including new investors InnoBio, Lundbeckfond Ven" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dbv-technologies-closes-25-5-eu19-4-million-series-c-financing-round-including-new> ;
    ns1:foundName "ALTO Invest" ;
    ns1:investor <https://1145.am/db/2365826/Series_C_Investment_Alk_Abello_Alto_Invest_Dbv_Technologies_Innobio_Fund_Lundbeckfond_Ventures_Shire_Plc_Sofinnova_Partners_Completed> ;
    ns1:name "ALTO Invest" ;
    ns1:sameAsMedium <https://1145.am/db/1707918/Alto_Invest>,
        <https://1145.am/db/1793731/Alto_Invest>,
        <https://1145.am/db/2366303/Alto_Invest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365826/Innobio_Fund> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "Biotechnology" ;
    ns1:documentDate "2011-01-05T14:22:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DBV Technologies closes $25.5 (19,4) million Series 'C' financing round including new investors InnoBio, Lundbeckfond Ven" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dbv-technologies-closes-25-5-eu19-4-million-series-c-financing-round-including-new> ;
    ns1:foundName "InnoBio Fund" ;
    ns1:investor <https://1145.am/db/2365826/Series_C_Investment_Alk_Abello_Alto_Invest_Dbv_Technologies_Innobio_Fund_Lundbeckfond_Ventures_Shire_Plc_Sofinnova_Partners_Completed> ;
    ns1:name "InnoBio Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2351191/Innobio_Fund>,
        <https://1145.am/db/2351192/Innobio_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365826/Lundbeckfond_Ventures> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:documentDate "2011-01-05T14:22:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DBV Technologies closes $25.5 (19,4) million Series 'C' financing round including new investors InnoBio, Lundbeckfond Ven" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dbv-technologies-closes-25-5-eu19-4-million-series-c-financing-round-including-new> ;
    ns1:foundName "Lundbeckfond Ventures" ;
    ns1:investor <https://1145.am/db/2365826/Series_C_Investment_Alk_Abello_Alto_Invest_Dbv_Technologies_Innobio_Fund_Lundbeckfond_Ventures_Shire_Plc_Sofinnova_Partners_Completed> ;
    ns1:name "Lundbeckfond Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2296062/Lundbeckfonden_Ventures>,
        <https://1145.am/db/2300680/Lundbeckfond_Ventures>,
        <https://1145.am/db/2301536/Lundbeckfonden_Ventures>,
        <https://1145.am/db/2326981/Lundbeckfond_Ventures>,
        <https://1145.am/db/2336716/Lundbeckfond_Ventures>,
        <https://1145.am/db/2338527/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349048/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349050/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349405/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349406/Lundbeckfond_Ventures>,
        <https://1145.am/db/2352357/Lundbeckfond_Ventures>,
        <https://1145.am/db/2352361/Lundbeckfond_Ventures>,
        <https://1145.am/db/2353098/Lundbeckfond_Ventures>,
        <https://1145.am/db/2353917/Lundbeckfond_Ventures>,
        <https://1145.am/db/2354401/Lundbeckfond_Ventures>,
        <https://1145.am/db/2356402/Lundbeckfond_Ventures>,
        <https://1145.am/db/2356411/Lundbeckfond_Ventures>,
        <https://1145.am/db/2359401/Lundbeckfond_Ventures>,
        <https://1145.am/db/2362148/Lundbeckfond_Ventures>,
        <https://1145.am/db/2362156/Lundbeckfond_Ventures>,
        <https://1145.am/db/2363947/Lundbeckfond_Ventures>,
        <https://1145.am/db/2363950/Lundbeckfond_Ventures>,
        <https://1145.am/db/2364492/Lundbeckfond_Ventures>,
        <https://1145.am/db/2366303/Lundbeckfond_Ventures>,
        <https://1145.am/db/2369169/Lundbeckfond_Ventures>,
        <https://1145.am/db/2369953/Lundbeckfond_Ventures>,
        <https://1145.am/db/2544138/Lundbeckfond_Ventures>,
        <https://1145.am/db/2544140/Lundbeckfond_Ventures>,
        <https://1145.am/db/2573068/Lundbeckfond_Ventures>,
        <https://1145.am/db/281538/Lundbeckfonden_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365826/Sofinnova_Partners> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-01-05T14:22:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DBV Technologies closes $25.5 (19,4) million Series 'C' financing round including new investors InnoBio, Lundbeckfond Ven" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dbv-technologies-closes-25-5-eu19-4-million-series-c-financing-round-including-new> ;
    ns1:foundName "Sofinnova Partners" ;
    ns1:investor <https://1145.am/db/2365826/Series_C_Investment_Alk_Abello_Alto_Invest_Dbv_Technologies_Innobio_Fund_Lundbeckfond_Ventures_Shire_Plc_Sofinnova_Partners_Completed> ;
    ns1:name "Sofinnova Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1173960/Susa_Ventures>,
        <https://1145.am/db/1583413/Sofinnova_Partners>,
        <https://1145.am/db/1735325/Sofinnova_Partners>,
        <https://1145.am/db/1748318/Soma_Capital>,
        <https://1145.am/db/1758078/Sph_Ventures>,
        <https://1145.am/db/1773491/Sofinnova_Partners>,
        <https://1145.am/db/1780998/Shasta_Ventures>,
        <https://1145.am/db/1788126/Shasta_Ventures>,
        <https://1145.am/db/1805034/Soma_Capital>,
        <https://1145.am/db/1892777/Sofinnova_Partners>,
        <https://1145.am/db/1896235/Shasta_Ventures>,
        <https://1145.am/db/2282400/Sofinnova_Partners>,
        <https://1145.am/db/2295713/Sofinnova_Private_Capital_Vii>,
        <https://1145.am/db/2299758/Sofinnova_Partners>,
        <https://1145.am/db/2312051/Mitsui_Ventures>,
        <https://1145.am/db/2322646/Sofinnova_Partners>,
        <https://1145.am/db/2323100/Sofinnova_Partners>,
        <https://1145.am/db/2323102/Sofinnova_Partners>,
        <https://1145.am/db/2324034/Sofinnova_Partners>,
        <https://1145.am/db/2330876/Sofinnova_Partners>,
        <https://1145.am/db/2343301/Sofinnova_Partners>,
        <https://1145.am/db/2358268/Sofinnova_Partners>,
        <https://1145.am/db/2363593/Sofinnova_Partners>,
        <https://1145.am/db/2367549/Sofinnova_Partners>,
        <https://1145.am/db/2555540/Sofinnova_Partners>,
        <https://1145.am/db/438593/Susa_Ventures>,
        <https://1145.am/db/577785/Sofinnova_Partners>,
        <https://1145.am/db/751030/Sozo_Ventures>,
        <https://1145.am/db/810584/Sofinnova_Partners>,
        <https://1145.am/db/923004/Susa_Ventures>,
        <https://1145.am/db/959113/Shasta_Ventures>,
        <https://1145.am/db/960219/Shasta_Ventures>,
        <https://1145.am/db/960386/Susa_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1039135/Sofinnova_Partners>,
        <https://1145.am/db/1054859/Sofinnova_Partners>,
        <https://1145.am/db/1112260/Sofinnova_Partners>,
        <https://1145.am/db/1113007/Sofinnova_Partners>,
        <https://1145.am/db/1118732/Sofinnova_Partners>,
        <https://1145.am/db/1196006/Sofinnova_Partners>,
        <https://1145.am/db/1196618/Sofinnova_Partners>,
        <https://1145.am/db/1199155/Sofinnova_Partners>,
        <https://1145.am/db/1419128/Sofinnova_Partners>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490997/Sofinnova_Partners>,
        <https://1145.am/db/1584328/Sofinnova_Partners>,
        <https://1145.am/db/1618717/Sofinnova_Partners>,
        <https://1145.am/db/1619418/Sofinnova_Partners>,
        <https://1145.am/db/1707724/Sofinnova_Partners>,
        <https://1145.am/db/1722774/Sofinnova_Partners>,
        <https://1145.am/db/1802402/Sofinnova_Partners>,
        <https://1145.am/db/1876390/Sofinnova_Partners>,
        <https://1145.am/db/1919228/Sofinnova_Partners>,
        <https://1145.am/db/1928060/Sofinnova_Partners>,
        <https://1145.am/db/1975388/Sofinnova_Partners>,
        <https://1145.am/db/2066938/Sofinnova_Partners>,
        <https://1145.am/db/2075963/Sofinnova_Partners>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2152180/Sofinnova_Partners>,
        <https://1145.am/db/2153042/Sofinnova_Partners>,
        <https://1145.am/db/2153373/Sofinnova_Partners>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2280230/Sofinnova_Partners>,
        <https://1145.am/db/2282747/Sofinnova_Partners>,
        <https://1145.am/db/2286182/Sofinnova_Partners>,
        <https://1145.am/db/2286404/Sofinnova_Partners>,
        <https://1145.am/db/2288699/Sofinnova_Partners>,
        <https://1145.am/db/2291023/Sofinnova_Partners>,
        <https://1145.am/db/2291790/Sofinnova_Partners>,
        <https://1145.am/db/2294367/Sofinnova_Partners>,
        <https://1145.am/db/2294502/Sofinnova_Partners>,
        <https://1145.am/db/2297649/Sofinnova_Partners>,
        <https://1145.am/db/2298624/Sofinnova_Partners>,
        <https://1145.am/db/2298631/Sofinnova_Partners>,
        <https://1145.am/db/2298641/Sofinnova_Partners>,
        <https://1145.am/db/2302741/Sofinnova_Partners>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2303849/Sofinnova_Partners>,
        <https://1145.am/db/2306395/Sofinnova_Partners>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2321542/Sofinnova_Partners>,
        <https://1145.am/db/2323243/Sofinnova_Partners>,
        <https://1145.am/db/2324027/Sofinnova_Partners>,
        <https://1145.am/db/2325549/Sofinnova_Partners>,
        <https://1145.am/db/2327222/Sofinnova_Partners>,
        <https://1145.am/db/2328763/Sofinnova_Partners>,
        <https://1145.am/db/2328769/Sofinnova_Partners>,
        <https://1145.am/db/2328825/Sofinnova_Partners>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2335582/Sofinnova_Partners>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2336333/Sofinnova_Partners>,
        <https://1145.am/db/2336335/Sofinnova_Partners>,
        <https://1145.am/db/2339692/Sofinnova_Partners>,
        <https://1145.am/db/2343545/Sofinnova_Partners>,
        <https://1145.am/db/2349013/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2354296/Sofinnova_Partners>,
        <https://1145.am/db/2355740/Sofinnova_Partners>,
        <https://1145.am/db/2355741/Sofinnova_Partners>,
        <https://1145.am/db/2355885/Sofinnova_Partners>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2358269/Sofinnova_Partners>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/236357/Sofinnova_Partners>,
        <https://1145.am/db/2363597/Sofinnova_Partners>,
        <https://1145.am/db/2366303/Sofinnova_Partners>,
        <https://1145.am/db/2370118/Sofinnova_Partners>,
        <https://1145.am/db/2538923/Sofinnova_Partners>,
        <https://1145.am/db/2571050/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2578627/Sofinnova_Partners>,
        <https://1145.am/db/2765863/Sofinnova_Partners>,
        <https://1145.am/db/2765866/Sofinnova_Partners>,
        <https://1145.am/db/2765873/Sofinnova_Partners>,
        <https://1145.am/db/530060/Sofinnova_Partners>,
        <https://1145.am/db/555385/Sofinnova_Partners>,
        <https://1145.am/db/595282/Sofinnova_Partners>,
        <https://1145.am/db/602316/Sofinnova_Partners>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/695229/Sofinnova_Partners>,
        <https://1145.am/db/695704/Sofinnova_Partners>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/955355/Sofinnova_Partners>,
        <https://1145.am/db/992046/Sofinnova_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366539/Arch_Venture_Partners> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-04-20T11:04:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team New Financing Will Further A" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/bluebird-bio-secures-additional-30-million-financing-arch-venture-partners-joins-investor> ;
    ns1:foundName "ARCH Venture Partners" ;
    ns1:investor <https://1145.am/db/2366539/Investment_Arch_Venture_Partners_Easton_Capital_Investment_Group_Forbion_Capital_Partners_Tvm_Capital_Third_Rock_Ventures_Bluebird_Bio_Completed> ;
    ns1:name "ARCH Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1028744/Alpha_Wave_Ventures>,
        <https://1145.am/db/1029882/Alpha_Wave_Ventures>,
        <https://1145.am/db/1042554/Adara_Ventures>,
        <https://1145.am/db/1127410/Arca>,
        <https://1145.am/db/1151052/Adams_Street_Partners>,
        <https://1145.am/db/1269968/Avenue_Capital_Group>,
        <https://1145.am/db/1359473/Amboy_Street_Ventures>,
        <https://1145.am/db/1505630/Avenue_Growth_Partners>,
        <https://1145.am/db/1519613/Arch_Venture_Partners>,
        <https://1145.am/db/1519799/Arch_Venture_Partners>,
        <https://1145.am/db/1667738/Alteria_Capital>,
        <https://1145.am/db/1695849/Sapphire_Ventures>,
        <https://1145.am/db/1714553/Insignia_Ventures>,
        <https://1145.am/db/1723434/Alteria_Capital>,
        <https://1145.am/db/1741043/Sapphire_Ventures>,
        <https://1145.am/db/1741609/Adara_Ventures>,
        <https://1145.am/db/1742562/Insignia_Ventures>,
        <https://1145.am/db/1749316/Sapphire_Ventures_And_Alkeon>,
        <https://1145.am/db/1749645/Sapphire_Ventures>,
        <https://1145.am/db/1756326/Aspenwood_Ventures>,
        <https://1145.am/db/1758975/Sapphire_Ventures>,
        <https://1145.am/db/1759922/Allievo_Capital>,
        <https://1145.am/db/1759922/Elysian_Park_Ventures>,
        <https://1145.am/db/1762277/Affirma_Capital>,
        <https://1145.am/db/1766540/Great_Oaks_Capital>,
        <https://1145.am/db/1772282/Oakhouse_Partners>,
        <https://1145.am/db/1791220/Arch_Venture_Partners>,
        <https://1145.am/db/1796380/Adams_Street_Partners>,
        <https://1145.am/db/1799828/Arch_Venture_Partners>,
        <https://1145.am/db/1812681/Sapphire_Ventures>,
        <https://1145.am/db/1822403/Sapphire_Ventures>,
        <https://1145.am/db/1864601/Adams_Street_Partners>,
        <https://1145.am/db/1873252/Adams_Capital_Management>,
        <https://1145.am/db/1888995/Exa_Ventures>,
        <https://1145.am/db/1928208/Arch_Venture_Partners>,
        <https://1145.am/db/1928388/Alpha_Wave_Ventures>,
        <https://1145.am/db/2059371/Sapphire_Ventures>,
        <https://1145.am/db/2141055/Rosecliff_Ventures>,
        <https://1145.am/db/2151983/Arch_Venture_Partners>,
        <https://1145.am/db/2181184/Arch_Venture_Partners>,
        <https://1145.am/db/2305524/Arch_Venture_Partners>,
        <https://1145.am/db/2306529/Arch_Venture_Partners>,
        <https://1145.am/db/2308828/Adams_Street_Partners>,
        <https://1145.am/db/2308841/Adams_Street_Partners>,
        <https://1145.am/db/2318934/Arch_Venrock>,
        <https://1145.am/db/2324015/Esprit_Capital_Partners_Llp>,
        <https://1145.am/db/2330075/Arch_Venture_Partners>,
        <https://1145.am/db/2331868/Arch_Venture_Partners>,
        <https://1145.am/db/2332659/Aravis_Venture>,
        <https://1145.am/db/2336126/Arch_Venture_Partners>,
        <https://1145.am/db/2337166/Adams_Street_Partners>,
        <https://1145.am/db/2341599/Arch_Venture_Partners>,
        <https://1145.am/db/2355706/Aravis_Venture>,
        <https://1145.am/db/2358725/Arch_Venture_Partners>,
        <https://1145.am/db/2366519/Adams_Street_Partners>,
        <https://1145.am/db/2366536/Arch_Venture_Partners>,
        <https://1145.am/db/2454251/Battelle_Ventures_Lp>,
        <https://1145.am/db/396307/Sapphire_Ventures>,
        <https://1145.am/db/429179/Aspenwood_Ventures>,
        <https://1145.am/db/430553/Aspenwood_Ventures>,
        <https://1145.am/db/441490/Elysian_Park_Ventures>,
        <https://1145.am/db/441493/Elysian_Park_Ventures>,
        <https://1145.am/db/474123/Endeavor_Catalyst>,
        <https://1145.am/db/510279/Alteria_Capital>,
        <https://1145.am/db/564008/Alameda_Ventures>,
        <https://1145.am/db/593836/Sapphire_Ventures>,
        <https://1145.am/db/661275/Sapphire_Ventures>,
        <https://1145.am/db/682791/Congress_Avenue_Ventures>,
        <https://1145.am/db/684123/Congress_Avenue_Ventures>,
        <https://1145.am/db/749201/Congress_Avenue_Ventures>,
        <https://1145.am/db/769568/Arch_Venture_Partners>,
        <https://1145.am/db/773301/Alameda_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1042080/Arch_Venture_Partners>,
        <https://1145.am/db/1105790/Arch_Venture_Partners>,
        <https://1145.am/db/1108240/Arch_Venture_Partners>,
        <https://1145.am/db/1320499/Arch_Venture_Partners>,
        <https://1145.am/db/1334395/Arch_Venture_Partners>,
        <https://1145.am/db/1376077/Arch_Venture_Partners>,
        <https://1145.am/db/1406211/Arch_Venture_Partners>,
        <https://1145.am/db/1476658/Arch_Venture_Partners>,
        <https://1145.am/db/1553175/Arch_Venture_Partners>,
        <https://1145.am/db/1553459/Arch_Venture_Partners>,
        <https://1145.am/db/1582111/Arch_Venture_Partners>,
        <https://1145.am/db/1619794/Arch_Venture_Partners>,
        <https://1145.am/db/1663313/Arch_Venture_Partners>,
        <https://1145.am/db/1750401/Arch_Venture_Partners>,
        <https://1145.am/db/1984721/Arch_Venture_Partners>,
        <https://1145.am/db/2095032/Arch_Venture_Partners>,
        <https://1145.am/db/2280315/Arch_Venture_Partners>,
        <https://1145.am/db/2281905/Arch_Venture_Partners>,
        <https://1145.am/db/2282162/Arch_Venture_Partners>,
        <https://1145.am/db/2284585/Arch_Venture_Partners>,
        <https://1145.am/db/2292675/Arch_Venture_Partners>,
        <https://1145.am/db/2294815/Arch_Venture_Partners>,
        <https://1145.am/db/2296113/Arch_Venture_Partners>,
        <https://1145.am/db/2301122/Arch_Venture_Partners>,
        <https://1145.am/db/2302047/Arch_Venture_Partners>,
        <https://1145.am/db/2315446/Arch_Venture_Partners>,
        <https://1145.am/db/2328599/Arch_Venture_Partners>,
        <https://1145.am/db/2330712/Arch_Venture_Partners>,
        <https://1145.am/db/2330852/Arch_Venture_Partners>,
        <https://1145.am/db/2331754/Arch_Venture_Partners>,
        <https://1145.am/db/2335701/Arch_Venture_Partners>,
        <https://1145.am/db/2335714/Arch_Venture_Partners>,
        <https://1145.am/db/2335773/Arch_Venture_Partners>,
        <https://1145.am/db/2337140/Arch_Venture_Partners>,
        <https://1145.am/db/2339413/Arch_Venture_Partners>,
        <https://1145.am/db/2340344/Arch_Venture_Partners>,
        <https://1145.am/db/2340345/Arch_Venture_Partners>,
        <https://1145.am/db/2340348/Arch_Venture_Partners>,
        <https://1145.am/db/2345223/Arch_Venture_Partners>,
        <https://1145.am/db/2345769/Arch_Venture_Partners>,
        <https://1145.am/db/2347368/Arch_Venture_Partners>,
        <https://1145.am/db/2347469/Arch_Venture_Partners>,
        <https://1145.am/db/2348074/Arch_Venture_Partners>,
        <https://1145.am/db/2356066/Arch_Venture_Partners>,
        <https://1145.am/db/2357253/Arch_Venture_Partners>,
        <https://1145.am/db/2357256/Arch_Venture_Partners>,
        <https://1145.am/db/2359124/Arch_Venture_Partners>,
        <https://1145.am/db/2359447/Arch_Venture_Partners>,
        <https://1145.am/db/2359655/Arch_Venture_Partners>,
        <https://1145.am/db/2364332/Arch_Venture_Partners>,
        <https://1145.am/db/2364336/Arch_Venture_Partners>,
        <https://1145.am/db/2366654/Arch_Venture_Partners>,
        <https://1145.am/db/2368912/Arch_Venture_Partners>,
        <https://1145.am/db/2369000/Arch_Venture_Partners>,
        <https://1145.am/db/2369549/Arch_Venture_Partners>,
        <https://1145.am/db/2371167/Arch_Venture_Partners>,
        <https://1145.am/db/2592611/Arch_Venture_Partners>,
        <https://1145.am/db/430986/Arch_Venture_Partners>,
        <https://1145.am/db/531806/Arch_Venture_Partners>,
        <https://1145.am/db/847865/Arch_Venture_Partners>,
        <https://1145.am/db/900779/Arch_Venture_Partners>,
        <https://1145.am/db/900943/Arch_Venture_Partners>,
        <https://1145.am/db/922192/Arch_Venture_Partners>,
        <https://1145.am/db/944358/Arch_Venture_Partners>,
        <https://1145.am/db/979509/Arch_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366539/Easton_Capital_Investment_Group> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2011-04-20T11:04:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team New Financing Will Further A" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/bluebird-bio-secures-additional-30-million-financing-arch-venture-partners-joins-investor> ;
    ns1:foundName "Easton Capital Investment Group" ;
    ns1:investor <https://1145.am/db/2366539/Investment_Arch_Venture_Partners_Easton_Capital_Investment_Group_Forbion_Capital_Partners_Tvm_Capital_Third_Rock_Ventures_Bluebird_Bio_Completed> ;
    ns1:name "Easton Capital Investment Group" ;
    ns1:sameAsMedium <https://1145.am/db/2338373/Easton_Capital_Investment_Group>,
        <https://1145.am/db/2343210/Easton_Capital_Investment_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366539/Forbion_Capital_Partners> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2011-04-20T11:04:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team New Financing Will Further A" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/bluebird-bio-secures-additional-30-million-financing-arch-venture-partners-joins-investor> ;
    ns1:foundName "Forbion Capital Partners" ;
    ns1:investor <https://1145.am/db/2366539/Investment_Arch_Venture_Partners_Easton_Capital_Investment_Group_Forbion_Capital_Partners_Tvm_Capital_Third_Rock_Ventures_Bluebird_Bio_Completed> ;
    ns1:name "Forbion Capital Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2223193/Forbion_Capital_Partners>,
        <https://1145.am/db/2288529/Forbion_Capital_Partners>,
        <https://1145.am/db/2295207/Forbion_Capital_Partners>,
        <https://1145.am/db/2296065/Forbion_Capital_Partners>,
        <https://1145.am/db/2301966/Forbion_Capital_Partners>,
        <https://1145.am/db/2309865/Forbion_Capital_Partners>,
        <https://1145.am/db/2309872/Forbion_Capital_Partners>,
        <https://1145.am/db/2313401/Forbion_Capital_Partners>,
        <https://1145.am/db/2313410/Forbion_Capital_Partners>,
        <https://1145.am/db/2313915/Forbion_Capital_Partners>,
        <https://1145.am/db/2318829/Forbion_Capital_Partners>,
        <https://1145.am/db/2320503/Forbion_Capital_Partners>,
        <https://1145.am/db/2323586/Forbion_Capital_Partners>,
        <https://1145.am/db/2327009/Forbion_Capital_Partners>,
        <https://1145.am/db/2328040/Forbion_Capital_Partners>,
        <https://1145.am/db/2328763/Forbion_Capital_Partners>,
        <https://1145.am/db/2328769/Forbion_Capital_Partners>,
        <https://1145.am/db/2329919/Forbion_Capital_Partners>,
        <https://1145.am/db/2336126/Forbion_Capital_Partners>,
        <https://1145.am/db/2338373/Forbion_Capital_Partners>,
        <https://1145.am/db/2338987/Forbion_Capital_Partners>,
        <https://1145.am/db/2339427/Forbion_Capital_Partners>,
        <https://1145.am/db/2339428/Forbion_Capital_Partners>,
        <https://1145.am/db/2339932/Forbion_Capital_Partners>,
        <https://1145.am/db/2339933/Forbion_Capital_Partners>,
        <https://1145.am/db/2341942/Forbion_Capital_Partners>,
        <https://1145.am/db/2343202/Forbion_Capital_Partners>,
        <https://1145.am/db/2343210/Forbion_Capital_Partners>,
        <https://1145.am/db/2343244/Forbion_Capital_Partners>,
        <https://1145.am/db/2346397/Forbion_Capital_Partners>,
        <https://1145.am/db/2348506/Forbion_Capital_Partners>,
        <https://1145.am/db/2348523/Forbion_Capital_Partners>,
        <https://1145.am/db/2350101/Forbion_Capital_Partners>,
        <https://1145.am/db/2352566/Forbion_Capital_Partners>,
        <https://1145.am/db/2355511/Forbion_Capital_Partners>,
        <https://1145.am/db/2355512/Forbion_Capital_Partners>,
        <https://1145.am/db/2356989/Forbion_Capital_Partners>,
        <https://1145.am/db/2357941/Forbion_Capital_Partners>,
        <https://1145.am/db/2357956/Forbion_Capital_Partners>,
        <https://1145.am/db/2359960/Forbion_Capital_Partners>,
        <https://1145.am/db/2360313/Forbion_Capital_Partners>,
        <https://1145.am/db/2360317/Forbion_Capital_Partners>,
        <https://1145.am/db/2361390/Forbion_Capital_Partners>,
        <https://1145.am/db/2363593/Forbion_Capital_Partners>,
        <https://1145.am/db/2363597/Forbion_Capital_Partners>,
        <https://1145.am/db/2369872/Forbion_Capital_Partners>,
        <https://1145.am/db/2370054/Forbion_Capital_Partners>,
        <https://1145.am/db/2370056/Forbion_Capital_Partners>,
        <https://1145.am/db/2538923/Forbion_Capital_Partners>,
        <https://1145.am/db/2569491/Forbion_Capital_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366539/Tvm_Capital> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2011-04-20T11:04:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team New Financing Will Further A" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/bluebird-bio-secures-additional-30-million-financing-arch-venture-partners-joins-investor> ;
    ns1:foundName "TVM Capital" ;
    ns1:investor <https://1145.am/db/2366539/Investment_Arch_Venture_Partners_Easton_Capital_Investment_Group_Forbion_Capital_Partners_Tvm_Capital_Third_Rock_Ventures_Bluebird_Bio_Completed> ;
    ns1:name "TVM Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1919300/Tvm_Capital>,
        <https://1145.am/db/2289349/Tvm_Capital>,
        <https://1145.am/db/2298846/Tvm_Capital>,
        <https://1145.am/db/2303598/Tvm_Capital>,
        <https://1145.am/db/2314674/Tvm_Capital>,
        <https://1145.am/db/2317779/Tvm_Capital>,
        <https://1145.am/db/2322531/Tvm_Capital>,
        <https://1145.am/db/2323243/Tvm_Capital>,
        <https://1145.am/db/2325366/Tvm_Capital>,
        <https://1145.am/db/2326376/Tvm_Capital>,
        <https://1145.am/db/2327406/Tvm_Capital>,
        <https://1145.am/db/2336126/Tvm_Capital>,
        <https://1145.am/db/2347977/Tvm_Capital>,
        <https://1145.am/db/2347983/Tvm_Capital>,
        <https://1145.am/db/2352814/Tvm_Capital>,
        <https://1145.am/db/2352819/Tvm_Capital>,
        <https://1145.am/db/2352820/Tvm_Capital>,
        <https://1145.am/db/2353522/Tvm_Capital>,
        <https://1145.am/db/2353525/Tvm_Capital>,
        <https://1145.am/db/2353607/Tvm_Capital>,
        <https://1145.am/db/2353610/Tvm_Capital>,
        <https://1145.am/db/2358268/Tvm_Capital>,
        <https://1145.am/db/2358269/Tvm_Capital>,
        <https://1145.am/db/2365103/Tvm_Capital>,
        <https://1145.am/db/2564563/Tvm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366561/Arcus_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2011-04-20T16:19:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TRACON Pharmaceuticals Announces $22 Million Tranched Investment Led by JAFCO and Nextech to Fund TRC105 Phase 2 Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tracon-pharmaceuticals-announces-22-million-tranched-investment-led-by-jafco-and-nextech-to> ;
    ns1:foundName "Arcus Ventures" ;
    ns1:investor <https://1145.am/db/2366561/Investment_Arcus_Ventures_Bhp_Brookline_Investments_Jafco_Nextech_Invest_Tracon_Pharmaceuticals_Completed> ;
    ns1:name "Arcus Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2292800/Arcus_Ventures>,
        <https://1145.am/db/2325257/Arcus_Ventures>,
        <https://1145.am/db/2369872/Arcus_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366561/BHP> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2011-04-20T16:19:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TRACON Pharmaceuticals Announces $22 Million Tranched Investment Led by JAFCO and Nextech to Fund TRC105 Phase 2 Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tracon-pharmaceuticals-announces-22-million-tranched-investment-led-by-jafco-and-nextech-to> ;
    ns1:foundName "BHP" ;
    ns1:investor <https://1145.am/db/2366561/Investment_Arcus_Ventures_Bhp_Brookline_Investments_Jafco_Nextech_Invest_Tracon_Pharmaceuticals_Completed> ;
    ns1:name "BHP" ;
    ns1:sameAsMedium <https://1145.am/db/1512457/BHP>,
        <https://1145.am/db/1575759/BHP>,
        <https://1145.am/db/337295/BHP>,
        <https://1145.am/db/364354/BHP>,
        <https://1145.am/db/383710/BHP> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366561/Brookline_Investments> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:description "private venture round" ;
    ns1:documentDate "2011-04-20T16:19:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TRACON Pharmaceuticals Announces $22 Million Tranched Investment Led by JAFCO and Nextech to Fund TRC105 Phase 2 Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tracon-pharmaceuticals-announces-22-million-tranched-investment-led-by-jafco-and-nextech-to> ;
    ns1:foundName "Brookline",
        "Brookline Investments" ;
    ns1:investor <https://1145.am/db/2366561/Investment_Arcus_Ventures_Bhp_Brookline_Investments_Jafco_Nextech_Invest_Tracon_Pharmaceuticals_Completed> ;
    ns1:name "Brookline Investments" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366561/Jafco> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2011-04-20T16:19:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TRACON Pharmaceuticals Announces $22 Million Tranched Investment Led by JAFCO and Nextech to Fund TRC105 Phase 2 Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tracon-pharmaceuticals-announces-22-million-tranched-investment-led-by-jafco-and-nextech-to> ;
    ns1:foundName "JAFCO" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2366561/Investment_Arcus_Ventures_Bhp_Brookline_Investments_Jafco_Nextech_Invest_Tracon_Pharmaceuticals_Completed> ;
    ns1:name "JAFCO" ;
    ns1:sameAsHigh <https://1145.am/db/1453541/Jatenzo>,
        <https://1145.am/db/2316674/Jafco>,
        <https://1145.am/db/2317737/Jafco>,
        <https://1145.am/db/2551315/Jafco> ;
    ns1:sameAsMedium <https://1145.am/db/1010026/Jafco>,
        <https://1145.am/db/1719460/Jafco>,
        <https://1145.am/db/1752809/Jafco>,
        <https://1145.am/db/1797834/Jafco>,
        <https://1145.am/db/1821299/Jafco>,
        <https://1145.am/db/1872512/Jafco>,
        <https://1145.am/db/2055707/Jafco>,
        <https://1145.am/db/2312444/Jafco>,
        <https://1145.am/db/2326176/Jafco>,
        <https://1145.am/db/2330712/Jafco>,
        <https://1145.am/db/2330852/Jafco>,
        <https://1145.am/db/2331754/Jafco>,
        <https://1145.am/db/2350717/Jafco>,
        <https://1145.am/db/2354608/Jafco>,
        <https://1145.am/db/2354613/Jafco> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366744/Avalon_Ventures> a org:Organization ;
    ns1:basedInLowRaw "KANSAS CITY, Kan" ;
    ns1:documentDate "2011-01-07T14:54:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aratana Therapeutics Announces $20 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-therapeutics-announces-20-million-financing> ;
    ns1:foundName "Avalon Ventures" ;
    ns1:investor <https://1145.am/db/2366744/Series_A_Investment_Aratana_Therapeutics_Avalon_Ventures_Mpm_Capital_Completed> ;
    ns1:name "Avalon Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1731233/Avalon_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1783415/Avalon_Ventures>,
        <https://1145.am/db/1788701/Avalon_Ventures>,
        <https://1145.am/db/1830629/Avalon_Ventures>,
        <https://1145.am/db/1833567/Avalon_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1835195/Avalon_Ventures>,
        <https://1145.am/db/1837950/Avalon_Ventures>,
        <https://1145.am/db/1841070/Avalon_Ventures>,
        <https://1145.am/db/1853099/Avalon_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1872954/Avalon_Ventures>,
        <https://1145.am/db/1875916/Avalon_Ventures>,
        <https://1145.am/db/1889400/Avalon_Ventures>,
        <https://1145.am/db/1919661/Avalon_Ventures>,
        <https://1145.am/db/2156284/Avalon_Ventures>,
        <https://1145.am/db/2178960/Avalon_Ventures>,
        <https://1145.am/db/2293612/Avalon_Ventures>,
        <https://1145.am/db/2295967/Avalon_Ventures>,
        <https://1145.am/db/2298395/Avalon_Ventures>,
        <https://1145.am/db/2308758/Avalon_Ventures>,
        <https://1145.am/db/2321216/Avalon_Ventures>,
        <https://1145.am/db/2326130/Avalon_Ventures>,
        <https://1145.am/db/2326139/Avalon_Ventures>,
        <https://1145.am/db/2335943/Avalon_Ventures>,
        <https://1145.am/db/2336221/Avalon_Ventures>,
        <https://1145.am/db/2343765/Avalon_Ventures>,
        <https://1145.am/db/2345299/Avalon_Ventures>,
        <https://1145.am/db/2345318/Avalon_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2359510/Avalon_Ventures>,
        <https://1145.am/db/2362475/Avalon_Ventures>,
        <https://1145.am/db/2367673/Avalon_Ventures>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2367676/Avalon_Ventures>,
        <https://1145.am/db/2368351/Avalon_Ventures>,
        <https://1145.am/db/935242/Avalon_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366753/Longitude_Capital> a org:Organization ;
    ns1:basedInLowRaw "Chelsea, MA" ;
    ns1:documentDate "2011-01-10T12:12:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $20 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/civitas-therapeutics-secures-20-million-series-a-financing> ;
    ns1:foundName "Longitude Capital" ;
    ns1:investor <https://1145.am/db/2366753/Series_A_Investment_Canaan_Partners_Civitas_Therapeutics_Longitude_Capital_Completed> ;
    ns1:name "Longitude Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1467975/Longitude_Capital>,
        <https://1145.am/db/1482048/Longitude_Capital>,
        <https://1145.am/db/1503165/Longitude_Capital>,
        <https://1145.am/db/1519688/Longitude_Capital>,
        <https://1145.am/db/1520070/Longitude_Capital>,
        <https://1145.am/db/2075754/Longitude_Capital>,
        <https://1145.am/db/2152399/Longitude_Capital>,
        <https://1145.am/db/2155668/Longitude_Capital>,
        <https://1145.am/db/2182698/Longitude_Capital>,
        <https://1145.am/db/2198647/Longitude_Capital>,
        <https://1145.am/db/2288251/Longitude_Capital>,
        <https://1145.am/db/2290453/Longitude_Capital>,
        <https://1145.am/db/2297930/Longitude_Capital>,
        <https://1145.am/db/2298634/Longitude_Capital>,
        <https://1145.am/db/2300708/Longitude_Capital>,
        <https://1145.am/db/2330799/Longitude_Capital>,
        <https://1145.am/db/2337591/Longitude_Capital>,
        <https://1145.am/db/2338428/Longitude_Capital>,
        <https://1145.am/db/2339214/Longitude_Capital>,
        <https://1145.am/db/2339223/Longitude_Capital>,
        <https://1145.am/db/2340204/Longitude_Capital>,
        <https://1145.am/db/2340207/Longitude_Capital>,
        <https://1145.am/db/2351129/Longitude_Capital>,
        <https://1145.am/db/2352167/Longitude_Capital>,
        <https://1145.am/db/2352170/Longitude_Capital>,
        <https://1145.am/db/2365501/Longitude_Capital>,
        <https://1145.am/db/2368232/Longitude_Capital>,
        <https://1145.am/db/2369359/Longitude_Capital>,
        <https://1145.am/db/2564563/Longitude_Capital>,
        <https://1145.am/db/2583466/Longitude_Capital>,
        <https://1145.am/db/955355/Longitude_Capital>,
        <https://1145.am/db/958767/Longitude_Capital>,
        <https://1145.am/db/959519/Longitude_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366984/Venrock> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2011-01-10T15:12:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ACADIA Pharmaceuticals, Inc. (ACAD) Announces $15 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/acadia-pharmaceuticals-inc-acad-announces-15-million-private-placement> ;
    ns1:foundName "Venrock" ;
    ns1:investor <https://1145.am/db/2366984/Investment_Acadia_Pharmaceuticals_Inc_New_Enterprise_Associates_Has_Not_Happened> ;
    ns1:name "Venrock" ;
    ns1:sameAsMedium <https://1145.am/db/1263825/Venrock>,
        <https://1145.am/db/1700286/Venrock>,
        <https://1145.am/db/1718033/Venrock>,
        <https://1145.am/db/1719688/Venrock>,
        <https://1145.am/db/1735836/Venrock>,
        <https://1145.am/db/1736582/Venrock>,
        <https://1145.am/db/1746940/Venrock>,
        <https://1145.am/db/1750203/Venrock>,
        <https://1145.am/db/1757897/Venrock>,
        <https://1145.am/db/1758165/Venrock>,
        <https://1145.am/db/1793754/Venrock>,
        <https://1145.am/db/1796590/Venrock>,
        <https://1145.am/db/1801792/Venrock>,
        <https://1145.am/db/1821534/Venrock>,
        <https://1145.am/db/1828008/Venrock>,
        <https://1145.am/db/1829024/Venrock>,
        <https://1145.am/db/1830635/Venrock>,
        <https://1145.am/db/1834607/Venrock>,
        <https://1145.am/db/1835080/Venrock>,
        <https://1145.am/db/1846413/Venrock>,
        <https://1145.am/db/1848371/Venrock>,
        <https://1145.am/db/1856457/Venrock>,
        <https://1145.am/db/1870276/Venrock>,
        <https://1145.am/db/1870808/Venrock>,
        <https://1145.am/db/1877870/Venrock>,
        <https://1145.am/db/1881935/Venrock>,
        <https://1145.am/db/1889137/Venrock>,
        <https://1145.am/db/1891984/Venrock>,
        <https://1145.am/db/1895986/Venrock>,
        <https://1145.am/db/1903951/Venrock>,
        <https://1145.am/db/1911226/Venrock>,
        <https://1145.am/db/2242614/Venrock>,
        <https://1145.am/db/2282806/Venrock>,
        <https://1145.am/db/2290283/Venrock>,
        <https://1145.am/db/2291211/Venrock>,
        <https://1145.am/db/2291384/Venrock>,
        <https://1145.am/db/2296169/Venrock>,
        <https://1145.am/db/2296869/Venrock>,
        <https://1145.am/db/2298631/Venrock>,
        <https://1145.am/db/2299758/Venrock>,
        <https://1145.am/db/2303675/Venrock>,
        <https://1145.am/db/2307476/Venrock>,
        <https://1145.am/db/2317918/Venrock>,
        <https://1145.am/db/2326903/Venrock>,
        <https://1145.am/db/2327474/Venrock>,
        <https://1145.am/db/2328599/Venrock>,
        <https://1145.am/db/2331784/Venrock>,
        <https://1145.am/db/2335748/Venrock>,
        <https://1145.am/db/2338126/Venrock>,
        <https://1145.am/db/2338127/Venrock>,
        <https://1145.am/db/2339666/Venrock>,
        <https://1145.am/db/2340942/Venrock>,
        <https://1145.am/db/2345037/Venrock>,
        <https://1145.am/db/2345047/Venrock>,
        <https://1145.am/db/2348448/Venrock>,
        <https://1145.am/db/2348857/Venrock>,
        <https://1145.am/db/2349834/Venrock>,
        <https://1145.am/db/2350164/Venrock>,
        <https://1145.am/db/2350167/Venrock>,
        <https://1145.am/db/2352414/Venrock>,
        <https://1145.am/db/2356064/Venrock>,
        <https://1145.am/db/2358173/Venrock>,
        <https://1145.am/db/2359334/Venrock>,
        <https://1145.am/db/2360682/Venrock>,
        <https://1145.am/db/2366775/Venrock>,
        <https://1145.am/db/2368501/Venrock>,
        <https://1145.am/db/2370436/Venrock>,
        <https://1145.am/db/2371160/Venrock>,
        <https://1145.am/db/2371163/Venrock>,
        <https://1145.am/db/2538407/Venrock>,
        <https://1145.am/db/2569515/Venrock>,
        <https://1145.am/db/2569522/Venrock>,
        <https://1145.am/db/437679/Venrock>,
        <https://1145.am/db/676854/Venrock>,
        <https://1145.am/db/678071/Venrock>,
        <https://1145.am/db/773235/Venrock>,
        <https://1145.am/db/893359/Venrock>,
        <https://1145.am/db/894233/Venrock>,
        <https://1145.am/db/922552/Venrock>,
        <https://1145.am/db/923335/Venrock> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367022/Aisling_Capital> a org:Organization ;
    ns1:basedInLowRaw "CUPERTINO, Calif" ;
    ns1:documentDate "2011-01-12T12:55:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NextWave Pharmaceuticals Secures $45 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nextwave-pharmaceuticals-secures-45-million-financing> ;
    ns1:foundName "Aisling Capital" ;
    ns1:investor <https://1145.am/db/2367022/Series_C_Investment_Aisling_Capital_Bay_City_Capital_Fidelity_Biosciences_Kearny_Venture_Partners_Nextwave_Pharmaceuticals_Panorama_Capital_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Aisling Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1334160/Aisling_Capital>,
        <https://1145.am/db/1334934/Aisling_Capital>,
        <https://1145.am/db/1665536/Aisling_Capital>,
        <https://1145.am/db/2280707/Aisling_Capital>,
        <https://1145.am/db/2291277/Aisling_Capital>,
        <https://1145.am/db/2292103/Aisling_Capital>,
        <https://1145.am/db/2292800/Aisling_Capital>,
        <https://1145.am/db/2294156/Aisling_Capital>,
        <https://1145.am/db/2297408/Aisling_Capital>,
        <https://1145.am/db/2307476/Aisling_Capital>,
        <https://1145.am/db/2310940/Aisling_Capital>,
        <https://1145.am/db/2317775/Aisling_Capital>,
        <https://1145.am/db/2319433/Aisling_Capital>,
        <https://1145.am/db/2320852/Aisling_Capital>,
        <https://1145.am/db/2320853/Aisling_Capital>,
        <https://1145.am/db/2324244/Aisling_Capital>,
        <https://1145.am/db/2324255/Aisling_Capital>,
        <https://1145.am/db/2325553/Aisling_Capital>,
        <https://1145.am/db/2326576/Aisling_Capital>,
        <https://1145.am/db/2328388/Aisling_Capital>,
        <https://1145.am/db/2332753/Aisling_Capital>,
        <https://1145.am/db/2336503/Aisling_Capital>,
        <https://1145.am/db/2336505/Aisling_Capital>,
        <https://1145.am/db/2336524/Aisling_Capital>,
        <https://1145.am/db/2337250/Aisling_Capital>,
        <https://1145.am/db/2337254/Aisling_Capital>,
        <https://1145.am/db/2339214/Aisling_Capital>,
        <https://1145.am/db/2339223/Aisling_Capital>,
        <https://1145.am/db/2341595/Aisling_Capital>,
        <https://1145.am/db/2341599/Aisling_Capital>,
        <https://1145.am/db/2344735/Aisling_Capital>,
        <https://1145.am/db/2344739/Aisling_Capital>,
        <https://1145.am/db/2344874/Aisling_Capital>,
        <https://1145.am/db/2346030/Aisling_Capital>,
        <https://1145.am/db/2346293/Aisling_Capital>,
        <https://1145.am/db/2348754/Aisling_Capital>,
        <https://1145.am/db/2352059/Aisling_Capital>,
        <https://1145.am/db/2352167/Aisling_Capital>,
        <https://1145.am/db/2352170/Aisling_Capital>,
        <https://1145.am/db/2356297/Aisling_Capital>,
        <https://1145.am/db/2357356/Aisling_Capital>,
        <https://1145.am/db/2359185/Aisling_Capital>,
        <https://1145.am/db/2359468/Aisling_Capital>,
        <https://1145.am/db/2362736/Aisling_Capital>,
        <https://1145.am/db/2362737/Aisling_Capital>,
        <https://1145.am/db/2367023/Aisling_Capital>,
        <https://1145.am/db/2369304/Aisling_Capital>,
        <https://1145.am/db/2369305/Aisling_Capital>,
        <https://1145.am/db/2539913/Aisling_Capital>,
        <https://1145.am/db/2583013/Aisling_Capital>,
        <https://1145.am/db/2588372/Aisling_Capital>,
        <https://1145.am/db/2591606/Aisling_Capital>,
        <https://1145.am/db/802321/Aisling_Capital>,
        <https://1145.am/db/803398/Aisling_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367022/Fidelity_Biosciences> a org:Organization ;
    ns1:basedInHighGeoName "Cupertino" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5341145/about.rdf> ;
    ns1:basedInHighRaw "CUPERTINO, Calif" ;
    ns1:documentDate "2011-01-12T12:55:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NextWave Pharmaceuticals Secures $45 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nextwave-pharmaceuticals-secures-45-million-financing> ;
    ns1:foundName "Fidelity Biosciences" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2367022/Series_C_Investment_Aisling_Capital_Bay_City_Capital_Fidelity_Biosciences_Kearny_Venture_Partners_Nextwave_Pharmaceuticals_Panorama_Capital_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Fidelity Biosciences" ;
    ns1:sameAsHigh <https://1145.am/db/1019870/Moderna>,
        <https://1145.am/db/1028098/A2pg>,
        <https://1145.am/db/1028744/Apnimed>,
        <https://1145.am/db/1029882/Apnimed>,
        <https://1145.am/db/1041428/Dr>,
        <https://1145.am/db/1042161/Wellgistics>,
        <https://1145.am/db/1042221/Wellgistics>,
        <https://1145.am/db/1096114/Astorg>,
        <https://1145.am/db/1096677/Astorg>,
        <https://1145.am/db/1138447/Apnimed>,
        <https://1145.am/db/1139445/Apnimed>,
        <https://1145.am/db/1152269/Alpha-5>,
        <https://1145.am/db/1163849/Productlife_Group>,
        <https://1145.am/db/1172760/Apexigen>,
        <https://1145.am/db/1215735/Astorg>,
        <https://1145.am/db/1219810/Prokidney_Corp>,
        <https://1145.am/db/1271008/Reviral_Ltd>,
        <https://1145.am/db/1272754/Prokidney_Corp>,
        <https://1145.am/db/1294637/LTS>,
        <https://1145.am/db/1307202/Leo_Pharma>,
        <https://1145.am/db/1309648/Achrom>,
        <https://1145.am/db/1323486/Glo_Pharma>,
        <https://1145.am/db/1374672/Sp_Industries>,
        <https://1145.am/db/1384852/Moderna_Inc>,
        <https://1145.am/db/1391799/Pharnext>,
        <https://1145.am/db/1454905/Aquestive>,
        <https://1145.am/db/1505021/Pharmaceutics_International_Inc>,
        <https://1145.am/db/1540522/Atec>,
        <https://1145.am/db/1541946/Abiomed>,
        <https://1145.am/db/1562763/Indivior>,
        <https://1145.am/db/1613904/Apnimed_Inc>,
        <https://1145.am/db/1615580/Apnimed>,
        <https://1145.am/db/1617770/Pharnext_Sa>,
        <https://1145.am/db/1648815/Indevr>,
        <https://1145.am/db/1681016/Enveric_Biosciences>,
        <https://1145.am/db/1745685/Drugstoc>,
        <https://1145.am/db/1838777/Medikly>,
        <https://1145.am/db/1936167/Reviral_Ltd>,
        <https://1145.am/db/1962783/Ora_Inc>,
        <https://1145.am/db/2039692/Rk_Pharma_Inc>,
        <https://1145.am/db/2051589/Ora_Inc>,
        <https://1145.am/db/2060641/Abionyx_Pharma>,
        <https://1145.am/db/2073336/Ose>,
        <https://1145.am/db/2132018/Solutions>,
        <https://1145.am/db/2139917/Leo_Pharma>,
        <https://1145.am/db/2151848/D___D_Pharmatech>,
        <https://1145.am/db/2152469/Sobi003>,
        <https://1145.am/db/2152499/Highchem>,
        <https://1145.am/db/2152633/Themis>,
        <https://1145.am/db/2152849/Therachon>,
        <https://1145.am/db/2152901/Abcellera>,
        <https://1145.am/db/2154166/Leo_Pharma>,
        <https://1145.am/db/2154252/Phoremost>,
        <https://1145.am/db/2155490/Enterome>,
        <https://1145.am/db/2155631/Achillion>,
        <https://1145.am/db/2155863/Therachon>,
        <https://1145.am/db/2212420/Cel-Sci_Corporation>,
        <https://1145.am/db/2235873/M3_Usa>,
        <https://1145.am/db/2244405/Seek>,
        <https://1145.am/db/2281535/Eqt_Life_Sciences>,
        <https://1145.am/db/2281676/Apnimed>,
        <https://1145.am/db/2283559/Oric>,
        <https://1145.am/db/2283918/Indivior>,
        <https://1145.am/db/2286215/Pandion>,
        <https://1145.am/db/2289550/Well>,
        <https://1145.am/db/2290753/Medivir>,
        <https://1145.am/db/2294621/Pharmaceutics_International>,
        <https://1145.am/db/2296235/Apexigen>,
        <https://1145.am/db/2297631/Clarient>,
        <https://1145.am/db/2298376/Caprion>,
        <https://1145.am/db/2301879/Magen_Biosciences>,
        <https://1145.am/db/2302863/Amri>,
        <https://1145.am/db/2303412/Hologic>,
        <https://1145.am/db/2303415/Amevive>,
        <https://1145.am/db/2303612/Intradigm_Corporation>,
        <https://1145.am/db/2303675/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2303720/Covance>,
        <https://1145.am/db/2305572/Covance_Inc>,
        <https://1145.am/db/2305703/Pinnacle_Bioventures>,
        <https://1145.am/db/2306640/Atryn>,
        <https://1145.am/db/2306640/Leo_Pharma>,
        <https://1145.am/db/2306724/Dermatech_Pty_Ltd>,
        <https://1145.am/db/2306725/Prevalere_Life_Sciences_Inc>,
        <https://1145.am/db/2306946/Amatsigroup>,
        <https://1145.am/db/2307526/Bioserv_Corporation>,
        <https://1145.am/db/2307529/Bioserv>,
        <https://1145.am/db/2307714/GTCR>,
        <https://1145.am/db/2308069/Bionomics>,
        <https://1145.am/db/2308807/Etrials_Worldwide>,
        <https://1145.am/db/2309352/Epicept_Corporation>,
        <https://1145.am/db/2309696/Encap>,
        <https://1145.am/db/2309697/Encap>,
        <https://1145.am/db/2310799/Inventiv_Health>,
        <https://1145.am/db/2312191/Medigene_Ag>,
        <https://1145.am/db/2312788/Leo_Pharma>,
        <https://1145.am/db/2312797/Leo_Pharma_A_S>,
        <https://1145.am/db/2312994/Upm>,
        <https://1145.am/db/2313383/Company>,
        <https://1145.am/db/2314613/Advent_International>,
        <https://1145.am/db/2315373/Nitromed>,
        <https://1145.am/db/2315424/Covance_Inc>,
        <https://1145.am/db/2316707/Catalyst_Pharmaceutical>,
        <https://1145.am/db/2316856/Viranative_Ab>,
        <https://1145.am/db/2317006/Amri>,
        <https://1145.am/db/2317060/Ception>,
        <https://1145.am/db/2317144/Leo_Pharma>,
        <https://1145.am/db/2317334/Aesica>,
        <https://1145.am/db/2317369/Relthy>,
        <https://1145.am/db/2320351/Prochieve>,
        <https://1145.am/db/2320947/Nitromed>,
        <https://1145.am/db/2321635/Celator>,
        <https://1145.am/db/2322824/Amri>,
        <https://1145.am/db/2322826/Amri>,
        <https://1145.am/db/2323790/Amri>,
        <https://1145.am/db/2323861/Amri>,
        <https://1145.am/db/2324112/Nitromed>,
        <https://1145.am/db/2324118/Rem_Medical_Corporation>,
        <https://1145.am/db/2324350/Celmed_Biosciences_Inc>,
        <https://1145.am/db/2324394/Amdl>,
        <https://1145.am/db/2324985/Amri>,
        <https://1145.am/db/2325553/Fidelity_Biosciences>,
        <https://1145.am/db/2327076/Amri>,
        <https://1145.am/db/2327088/Covance>,
        <https://1145.am/db/2327241/Preotact_(r)>,
        <https://1145.am/db/2327258/Biocon_Limited>,
        <https://1145.am/db/2327374/Diamedica_Inc>,
        <https://1145.am/db/2327424/Innopharm>,
        <https://1145.am/db/2328008/Epicept_Corporation>,
        <https://1145.am/db/2328318/Medpointe>,
        <https://1145.am/db/2328713/Sepracor>,
        <https://1145.am/db/2329333/Biopharma_Services_Inc>,
        <https://1145.am/db/2330808/Sepracor>,
        <https://1145.am/db/2331911/Clarient>,
        <https://1145.am/db/2332005/R___d>,
        <https://1145.am/db/2332200/Compendia_Bioscience>,
        <https://1145.am/db/2332920/Nastech>,
        <https://1145.am/db/2333644/Targent>,
        <https://1145.am/db/2334020/Accovion>,
        <https://1145.am/db/2336287/Biomotiv>,
        <https://1145.am/db/2336355/Correvio>,
        <https://1145.am/db/2336625/Biota>,
        <https://1145.am/db/2336998/Medivation_Inc>,
        <https://1145.am/db/2337028/Medivation>,
        <https://1145.am/db/2337078/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2338888/Cerulean_Pharma>,
        <https://1145.am/db/2338939/Nuevolution_A_S>,
        <https://1145.am/db/2339816/Nuevolution_A_S>,
        <https://1145.am/db/2339997/(Appa)>,
        <https://1145.am/db/2340054/Amri>,
        <https://1145.am/db/2340115/Mission>,
        <https://1145.am/db/2340160/Intercell_Ag>,
        <https://1145.am/db/2340507/Rho>,
        <https://1145.am/db/2341572/Aesica>,
        <https://1145.am/db/2341869/Fidelity_Biosciences>,
        <https://1145.am/db/2341897/Fidelity_Biosciences>,
        <https://1145.am/db/2342581/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2342628/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2343325/Medivir>,
        <https://1145.am/db/2344595/Mabxience>,
        <https://1145.am/db/2347172/Medivir_Ab>,
        <https://1145.am/db/2347755/Leo_Pharma_Inc>,
        <https://1145.am/db/2348448/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2348675/Signum_Biosciences>,
        <https://1145.am/db/2349050/Fidelity_Biosciences>,
        <https://1145.am/db/2349373/Asmacure>,
        <https://1145.am/db/2349740/Signum_Biosciences_Inc>,
        <https://1145.am/db/2349983/Leading_Biosciences_Inc>,
        <https://1145.am/db/2349990/Aesica>,
        <https://1145.am/db/2350847/Covance>,
        <https://1145.am/db/2351198/(Ptc)>,
        <https://1145.am/db/2351259/Biotime_Inc>,
        <https://1145.am/db/2352414/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2353223/Medivation_Inc>,
        <https://1145.am/db/2355036/Moderna>,
        <https://1145.am/db/2355194/Moderna>,
        <https://1145.am/db/2356488/Cerulean_Pharma>,
        <https://1145.am/db/2358197/Biopharma_Services_Inc>,
        <https://1145.am/db/2358403/Pht_Corporation>,
        <https://1145.am/db/2358637/Eurand>,
        <https://1145.am/db/2358638/Eurand_Nv>,
        <https://1145.am/db/2358734/Prosidion>,
        <https://1145.am/db/2358953/Abgent>,
        <https://1145.am/db/2359025/Nectid>,
        <https://1145.am/db/2359113/Eurand_Nv>,
        <https://1145.am/db/2359380/Amri>,
        <https://1145.am/db/2359577/Geno>,
        <https://1145.am/db/2359670/Biotie>,
        <https://1145.am/db/2359951/Entremed>,
        <https://1145.am/db/2360371/Preglem>,
        <https://1145.am/db/2360702/Cominnex>,
        <https://1145.am/db/2360922/Nuevolution_A_S>,
        <https://1145.am/db/2361675/Amri>,
        <https://1145.am/db/2361747/Servier>,
        <https://1145.am/db/2361926/Pharm-Olam_International_Ltd>,
        <https://1145.am/db/2362453/Pharnext>,
        <https://1145.am/db/2362607/Abide_Therapeutics>,
        <https://1145.am/db/2363722/Moderna>,
        <https://1145.am/db/2363725/Moderna>,
        <https://1145.am/db/2367023/Fidelity_Biosciences>,
        <https://1145.am/db/2367298/Amri>,
        <https://1145.am/db/2368106/Obseva>,
        <https://1145.am/db/2368242/Symic>,
        <https://1145.am/db/2368257/Almirall>,
        <https://1145.am/db/2368329/Amri>,
        <https://1145.am/db/2368332/Amri>,
        <https://1145.am/db/2368333/R___d>,
        <https://1145.am/db/2368601/Promosome>,
        <https://1145.am/db/2368824/Almirall_Inc>,
        <https://1145.am/db/2369042/Abide_Therapeutics>,
        <https://1145.am/db/2369128/Aegerion>,
        <https://1145.am/db/2369269/R___d>,
        <https://1145.am/db/2369446/Presage_Biosciences>,
        <https://1145.am/db/2369490/Medivation>,
        <https://1145.am/db/2369708/Promedior>,
        <https://1145.am/db/2370156/Pharming_Group_Nv>,
        <https://1145.am/db/2370164/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2370265/Ose_Pharma>,
        <https://1145.am/db/2370267/Ose_Pharma>,
        <https://1145.am/db/2370437/MSD>,
        <https://1145.am/db/2370557/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2370579/Arvinas>,
        <https://1145.am/db/2370659/Nuevolution>,
        <https://1145.am/db/2370828/Nuevolution>,
        <https://1145.am/db/2371158/Moderna>,
        <https://1145.am/db/2371408/Business_Management>,
        <https://1145.am/db/2536140/Scinopharm>,
        <https://1145.am/db/2536209/TPG>,
        <https://1145.am/db/2536305/Radient>,
        <https://1145.am/db/2536469/Agila_Specialties>,
        <https://1145.am/db/2536473/Encap>,
        <https://1145.am/db/2536575/G___w>,
        <https://1145.am/db/2536576/G___w>,
        <https://1145.am/db/2536612/Pharmaceutics_International_Inc>,
        <https://1145.am/db/2536776/Oramed>,
        <https://1145.am/db/2538112/Pharmedium>,
        <https://1145.am/db/2539816/P___R_Group>,
        <https://1145.am/db/2539858/Aesica>,
        <https://1145.am/db/2539890/Scinopharm>,
        <https://1145.am/db/2540218/Amri>,
        <https://1145.am/db/2540222/Amri>,
        <https://1145.am/db/2540931/Accucaps>,
        <https://1145.am/db/2540931/Pharmtek>,
        <https://1145.am/db/2541419/Amri>,
        <https://1145.am/db/2541469/Agila_Specialties>,
        <https://1145.am/db/2542113/Profectus_Biosciences>,
        <https://1145.am/db/2542472/Aesica>,
        <https://1145.am/db/2543530/Covance>,
        <https://1145.am/db/2544087/Univercells>,
        <https://1145.am/db/2544258/C___O_Pharmaceutical_Technology>,
        <https://1145.am/db/2544596/Bioton>,
        <https://1145.am/db/2545125/Ascendis_Health>,
        <https://1145.am/db/2545545/Agila_Specialties>,
        <https://1145.am/db/2546430/Bal_Pharma>,
        <https://1145.am/db/2546892/Aphena>,
        <https://1145.am/db/2547568/Amec>,
        <https://1145.am/db/2548137/Innopharm>,
        <https://1145.am/db/2548674/Sepracor>,
        <https://1145.am/db/2548840/Btcp_Pharma_Llc>,
        <https://1145.am/db/2549082/British_Company>,
        <https://1145.am/db/2549201/Rexall_Health>,
        <https://1145.am/db/2550632/Amri>,
        <https://1145.am/db/2550638/Amri>,
        <https://1145.am/db/2553761/Mabxience>,
        <https://1145.am/db/2553978/Bioverativ>,
        <https://1145.am/db/2554838/Amri>,
        <https://1145.am/db/2555168/Prokidney>,
        <https://1145.am/db/2555326/Leo_Pharma>,
        <https://1145.am/db/2556356/Medivation>,
        <https://1145.am/db/2556744/Leo_Pharma>,
        <https://1145.am/db/2557034/West_Pharmaceutical>,
        <https://1145.am/db/2557482/Idifarma>,
        <https://1145.am/db/2558133/Lifehealth>,
        <https://1145.am/db/2559160/West_Pharmaceutical>,
        <https://1145.am/db/2560277/Aesica>,
        <https://1145.am/db/2560277/Consort>,
        <https://1145.am/db/2560766/Accucaps>,
        <https://1145.am/db/2560808/Novamedica>,
        <https://1145.am/db/2561121/Bioserv>,
        <https://1145.am/db/2562459/Eurand>,
        <https://1145.am/db/2563255/MSD>,
        <https://1145.am/db/2563772/Apiject>,
        <https://1145.am/db/2564003/Leo_Pharma>,
        <https://1145.am/db/2564490/Accucaps>,
        <https://1145.am/db/2564490/Pharmtek>,
        <https://1145.am/db/2565613/Servier>,
        <https://1145.am/db/2566037/Almirall>,
        <https://1145.am/db/2566348/Indivior>,
        <https://1145.am/db/2566348/Opiant>,
        <https://1145.am/db/2568711/West_Pharmaceutical>,
        <https://1145.am/db/2569107/Almirall_Sa>,
        <https://1145.am/db/2569356/Leo_Pharma_Inc>,
        <https://1145.am/db/2569393/R___d>,
        <https://1145.am/db/2570064/Aegerion>,
        <https://1145.am/db/2570177/Oramed>,
        <https://1145.am/db/2572329/Incivo>,
        <https://1145.am/db/2572567/Northera>,
        <https://1145.am/db/2573050/Amatsigroup>,
        <https://1145.am/db/2573913/TPG>,
        <https://1145.am/db/2575143/Almirall>,
        <https://1145.am/db/2576254/Fougera>,
        <https://1145.am/db/2576550/TPG>,
        <https://1145.am/db/2576923/Pharmgate>,
        <https://1145.am/db/2576925/Pharmgate>,
        <https://1145.am/db/2577894/Advance_Properties_Ood>,
        <https://1145.am/db/2578052/Advent_International>,
        <https://1145.am/db/2578052/United_Medical>,
        <https://1145.am/db/2578645/Almirall>,
        <https://1145.am/db/2578667/Almirall>,
        <https://1145.am/db/2578667/Fycompa>,
        <https://1145.am/db/2579211/Proximagen>,
        <https://1145.am/db/2581197/Irom_Pharmaceutical>,
        <https://1145.am/db/2581832/West>,
        <https://1145.am/db/2586253/United_Biosource_Corporation>,
        <https://1145.am/db/2586420/Acuform>,
        <https://1145.am/db/2587709/Pharmstandard>,
        <https://1145.am/db/2589178/Oriel>,
        <https://1145.am/db/2590195/Nectid>,
        <https://1145.am/db/2590489/Amatsigroup>,
        <https://1145.am/db/2590528/C___O_Pharmaceutical>,
        <https://1145.am/db/2590556/Nycomed_Us>,
        <https://1145.am/db/2590827/Affairs>,
        <https://1145.am/db/2591609/Pharmstandard>,
        <https://1145.am/db/2591622/Pharmstandard>,
        <https://1145.am/db/2593060/Inventiv_Health>,
        <https://1145.am/db/2593265/Leo_Pharma>,
        <https://1145.am/db/2594186/Agila_Specialties>,
        <https://1145.am/db/2594699/Osi>,
        <https://1145.am/db/2595688/Fougera>,
        <https://1145.am/db/2598181/Amri>,
        <https://1145.am/db/2739044/Moderna>,
        <https://1145.am/db/2791590/Civica>,
        <https://1145.am/db/295168/Orifarm>,
        <https://1145.am/db/317543/Productlife_Group>,
        <https://1145.am/db/423883/Sohm_Inc>,
        <https://1145.am/db/449041/Advent_International>,
        <https://1145.am/db/515764/Sohm_Inc>,
        <https://1145.am/db/561196/Pharnext_Sa>,
        <https://1145.am/db/618115/Sohm>,
        <https://1145.am/db/654792/Innobic>,
        <https://1145.am/db/676564/Alvotech>,
        <https://1145.am/db/716162/Pharnext_Sa>,
        <https://1145.am/db/806327/Pharma_Nobis_Llc>,
        <https://1145.am/db/807295/Pharma_Nobis_Llc>,
        <https://1145.am/db/834480/Pharnext_Sa>,
        <https://1145.am/db/835269/Grand_Pharmaceutical_Group_Limited>,
        <https://1145.am/db/837157/Leo_Pharma_Inc>,
        <https://1145.am/db/848323/Pharmaceutics_International_Inc>,
        <https://1145.am/db/872336/Sohm_Inc>,
        <https://1145.am/db/882142/Aim>,
        <https://1145.am/db/886663/Tha>,
        <https://1145.am/db/888994/Tha>,
        <https://1145.am/db/943000/Pharnext>,
        <https://1145.am/db/965490/Reviral_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/1801792/Fidelity_Biosciences>,
        <https://1145.am/db/1849746/Fidelity_Biosciences>,
        <https://1145.am/db/2223723/Fidelity_Biosciences>,
        <https://1145.am/db/2303275/Fidelity_Biosciences>,
        <https://1145.am/db/2304028/Fidelity_Biosciences>,
        <https://1145.am/db/2304044/Fidelity_Biosciences>,
        <https://1145.am/db/2306790/Fidelity_Biosciences>,
        <https://1145.am/db/2313305/Fidelity_Biosciences>,
        <https://1145.am/db/2316601/Fidelity_Biosciences>,
        <https://1145.am/db/2316605/Fidelity_Biosciences>,
        <https://1145.am/db/2317737/Fidelity_Biosciences>,
        <https://1145.am/db/2318905/Fidelity_Biosciences>,
        <https://1145.am/db/2326576/Fidelity_Biosciences>,
        <https://1145.am/db/2336890/Fidelity_Biosciences>,
        <https://1145.am/db/2337971/Fidelity_Biosciences>,
        <https://1145.am/db/2337972/Fidelity_Biosciences>,
        <https://1145.am/db/2339666/Fidelity_Biosciences>,
        <https://1145.am/db/2340581/Fidelity_Biosciences>,
        <https://1145.am/db/2342754/Fidelity_Biosciences>,
        <https://1145.am/db/2342768/Fidelity_Biosciences>,
        <https://1145.am/db/2342771/Fidelity_Biosciences>,
        <https://1145.am/db/2344017/Fidelity_Biosciences>,
        <https://1145.am/db/2348149/Fidelity_Biosciences>,
        <https://1145.am/db/2349048/Fidelity_Biosciences>,
        <https://1145.am/db/2350891/Fidelity_Biosciences>,
        <https://1145.am/db/2352349/Fidelity_Biosciences>,
        <https://1145.am/db/2352350/Fidelity_Biosciences>,
        <https://1145.am/db/2354537/Fidelity_Biosciences>,
        <https://1145.am/db/2356048/Fidelity_Biosciences>,
        <https://1145.am/db/2356124/Fidelity_Biosciences>,
        <https://1145.am/db/2357722/Fidelity_Biosciences>,
        <https://1145.am/db/2359227/Fidelity_Biosciences>,
        <https://1145.am/db/2359240/Fidelity_Biosciences>,
        <https://1145.am/db/2359287/Fidelity_Biosciences>,
        <https://1145.am/db/2359562/Fidelity_Biosciences>,
        <https://1145.am/db/2359683/Fidelity_Biosciences>,
        <https://1145.am/db/2361065/Fidelity_Biosciences>,
        <https://1145.am/db/2363510/Fidelity_Biosciences>,
        <https://1145.am/db/2366710/Fidelity_Biosciences>,
        <https://1145.am/db/2366712/Fidelity_Biosciences>,
        <https://1145.am/db/2367381/Fidelity_Biosciences>,
        <https://1145.am/db/2369644/Fidelity_Biosciences>,
        <https://1145.am/db/2549505/Fidelity_Biosciences>,
        <https://1145.am/db/2549507/Fidelity_Biosciences>,
        <https://1145.am/db/2551315/Fidelity_Biosciences>,
        <https://1145.am/db/2569831/Fidelity_Biosciences>,
        <https://1145.am/db/2587938/Fidelity_Biosciences>,
        <https://1145.am/db/2588372/Fidelity_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367022/Panorama_Capital> a org:Organization ;
    ns1:basedInLowRaw "CUPERTINO" ;
    ns1:documentDate "2011-01-12T12:55:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NextWave Pharmaceuticals Secures $45 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nextwave-pharmaceuticals-secures-45-million-financing> ;
    ns1:foundName "Panorama Capital" ;
    ns1:investor <https://1145.am/db/2367022/Series_C_Investment_Aisling_Capital_Bay_City_Capital_Fidelity_Biosciences_Kearny_Venture_Partners_Nextwave_Pharmaceuticals_Panorama_Capital_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Panorama Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1825633/Panorama_Capital>,
        <https://1145.am/db/1828663/Panorama_Capital>,
        <https://1145.am/db/1876447/Panorama_Capital>,
        <https://1145.am/db/1890839/Panorama_Capital>,
        <https://1145.am/db/1919845/Panorama_Capital>,
        <https://1145.am/db/1925950/Panorama_Capital>,
        <https://1145.am/db/2301824/Panorama_Capital>,
        <https://1145.am/db/2302890/Panorama_Capital>,
        <https://1145.am/db/2302897/Panorama_Capital>,
        <https://1145.am/db/2314964/Panorama_Capital>,
        <https://1145.am/db/2330799/Panorama_Capital>,
        <https://1145.am/db/2331700/Panorama_Capital>,
        <https://1145.am/db/2347076/Panorama_Capital>,
        <https://1145.am/db/2358234/Panorama_Capital>,
        <https://1145.am/db/2367023/Panorama_Capital>,
        <https://1145.am/db/2367026/Panorama_Capital>,
        <https://1145.am/db/2588372/Panorama_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367022/Sofinnova_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CUPERTINO, Calif" ;
    ns1:documentDate "2011-01-12T12:55:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NextWave Pharmaceuticals Secures $45 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nextwave-pharmaceuticals-secures-45-million-financing> ;
    ns1:foundName "Sofinnova Ventures" ;
    ns1:investor <https://1145.am/db/2367022/Series_C_Investment_Aisling_Capital_Bay_City_Capital_Fidelity_Biosciences_Kearny_Venture_Partners_Nextwave_Pharmaceuticals_Panorama_Capital_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Sofinnova Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1876390/Sofinnova_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2301093/Sofinnova_Ventures>,
        <https://1145.am/db/2303548/Sofinnova_Ventures>,
        <https://1145.am/db/2303560/Sofinnova_Ventures>,
        <https://1145.am/db/2304598/Sofinnova_Ventures>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305328/Sofinnova_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2310073/Sofinnova_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2311075/Sofinnova_Ventures>,
        <https://1145.am/db/2312051/Sofinnova_Ventures>,
        <https://1145.am/db/2313171/Sofinnova_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314964/Sofinnova_Ventures>,
        <https://1145.am/db/2317750/Sofinnova_Ventures>,
        <https://1145.am/db/2317753/Sofinnova_Ventures>,
        <https://1145.am/db/2322231/Sofinnova_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2324223/Sofinnova_Ventures>,
        <https://1145.am/db/2325549/Sofinnova_Ventures>,
        <https://1145.am/db/2328338/Sofinnova_Ventures>,
        <https://1145.am/db/2330799/Sofinnova_Ventures>,
        <https://1145.am/db/2330914/Sofinnova_Ventures>,
        <https://1145.am/db/2330920/Sofinnova_Ventures>,
        <https://1145.am/db/2331700/Sofinnova_Ventures>,
        <https://1145.am/db/2336102/Sofinnova_Ventures>,
        <https://1145.am/db/2336109/Sofinnova_Ventures>,
        <https://1145.am/db/2337140/Sofinnova_Ventures>,
        <https://1145.am/db/2339666/Sofinnova_Ventures>,
        <https://1145.am/db/2340542/Sofinnova_Ventures>,
        <https://1145.am/db/2340888/Sofinnova_Ventures>,
        <https://1145.am/db/2340890/Sofinnova_Ventures>,
        <https://1145.am/db/2341869/Sofinnova_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341897/Sofinnova_Ventures>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2345047/Sofinnova_Ventures>,
        <https://1145.am/db/2345262/Sofinnova_Ventures>,
        <https://1145.am/db/2348857/Sofinnova_Ventures>,
        <https://1145.am/db/2349013/Sofinnova_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2349834/Sofinnova_Ventures>,
        <https://1145.am/db/2350231/Sofinnova_Ventures>,
        <https://1145.am/db/2350855/Sofinnova_Ventures>,
        <https://1145.am/db/2352059/Sofinnova_Ventures>,
        <https://1145.am/db/2353771/Sofinnova_Ventures>,
        <https://1145.am/db/2353789/Sofinnova_Ventures>,
        <https://1145.am/db/2355183/Sofinnova_Ventures>,
        <https://1145.am/db/2357105/Sofinnova_Ventures>,
        <https://1145.am/db/2357356/Sofinnova_Ventures>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358234/Sofinnova_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2359124/Sofinnova_Ventures>,
        <https://1145.am/db/2360266/Sofinnova_Ventures>,
        <https://1145.am/db/2360647/Sofinnova_Ventures>,
        <https://1145.am/db/2362902/Sofinnova_Ventures>,
        <https://1145.am/db/2362909/Sofinnova_Ventures>,
        <https://1145.am/db/2362910/Sofinnova_Ventures>,
        <https://1145.am/db/2366710/Sofinnova_Ventures>,
        <https://1145.am/db/2366712/Sofinnova_Ventures>,
        <https://1145.am/db/2367023/Sofinnova_Ventures>,
        <https://1145.am/db/2368982/Sofinnova_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/2371163/Sofinnova_Ventures>,
        <https://1145.am/db/2569522/Sofinnova_Ventures>,
        <https://1145.am/db/2570520/Sofinnova_Ventures>,
        <https://1145.am/db/2570523/Sofinnova_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2578627/Sofinnova_Ventures>,
        <https://1145.am/db/2588372/Sofinnova_Ventures>,
        <https://1145.am/db/2592611/Sofinnova_Ventures>,
        <https://1145.am/db/2630808/Sofinnova_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367022/Vivo_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CUPERTINO, Calif" ;
    ns1:documentDate "2011-01-12T12:55:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NextWave Pharmaceuticals Secures $45 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nextwave-pharmaceuticals-secures-45-million-financing> ;
    ns1:foundName "Vivo Ventures" ;
    ns1:investor <https://1145.am/db/2367022/Series_C_Investment_Aisling_Capital_Bay_City_Capital_Fidelity_Biosciences_Kearny_Venture_Partners_Nextwave_Pharmaceuticals_Panorama_Capital_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Vivo Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2029866/Vivo_Ventures>,
        <https://1145.am/db/2233578/Vivo_Ventures>,
        <https://1145.am/db/2265965/Vivo_Ventures>,
        <https://1145.am/db/2302076/Vivo_Ventures>,
        <https://1145.am/db/2302091/Vivo_Ventures>,
        <https://1145.am/db/2302108/Vivo_Ventures>,
        <https://1145.am/db/2305507/Vivo_Ventures>,
        <https://1145.am/db/2305514/Vivo_Ventures>,
        <https://1145.am/db/2309163/Vivo_Ventures>,
        <https://1145.am/db/2310302/Vivo_Ventures>,
        <https://1145.am/db/2311353/Vivo_Ventures>,
        <https://1145.am/db/2318806/Vivo_Ventures>,
        <https://1145.am/db/2318851/Vivo_Ventures>,
        <https://1145.am/db/2319846/Vivo_Ventures>,
        <https://1145.am/db/2322989/Vivo_Ventures>,
        <https://1145.am/db/2322991/Vivo_Ventures>,
        <https://1145.am/db/2323001/Vivo_Ventures>,
        <https://1145.am/db/2326361/Vivo_Ventures>,
        <https://1145.am/db/2326373/Vivo_Ventures>,
        <https://1145.am/db/2330920/Vivo_Ventures>,
        <https://1145.am/db/2337166/Vivo_Ventures>,
        <https://1145.am/db/2339345/Vivo_Ventures>,
        <https://1145.am/db/2339516/Vivo_Ventures>,
        <https://1145.am/db/2341869/Vivo_Ventures>,
        <https://1145.am/db/2341897/Vivo_Ventures>,
        <https://1145.am/db/2347043/Vivo_Ventures>,
        <https://1145.am/db/2358806/Vivo_Ventures>,
        <https://1145.am/db/2366710/Vivo_Ventures>,
        <https://1145.am/db/2366712/Vivo_Ventures>,
        <https://1145.am/db/2367023/Vivo_Ventures>,
        <https://1145.am/db/2588372/Vivo_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367043/Illumina> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "DNA sequencing technology" ;
    ns1:documentDate "2011-04-26T14:47:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Nanopore raises $41M for DNA sequencing work; Biogen Idec ready to break ground on new manufacturing center;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/oxford-nanopore-raises-41m-for-dna-sequencing-work-biogen-idec-ready-to-break-ground-on-new> ;
    ns1:foundName "Illumina" ;
    ns1:investor <https://1145.am/db/2367043/Investment_Ip_Group_Illumina_Invesco_Perpetual_Lansdowne_Partners_Oxford_Nanopore_Redmile_Group_Completed> ;
    ns1:name "Illumina" ;
    ns1:sameAsHigh <https://1145.am/db/2154909/Illumina_Ventures>,
        <https://1145.am/db/2326094/Illumina>,
        <https://1145.am/db/2362865/454_Life_Sciences>,
        <https://1145.am/db/2586700/454_Life_Sciences> ;
    ns1:sameAsMedium <https://1145.am/db/1088221/Illumina>,
        <https://1145.am/db/1202370/Illumina>,
        <https://1145.am/db/1217641/Illumina>,
        <https://1145.am/db/1232202/Illumina>,
        <https://1145.am/db/1240041/Illumina>,
        <https://1145.am/db/1311389/Illumina_Inc>,
        <https://1145.am/db/1311396/Illumina_Inc>,
        <https://1145.am/db/1315507/Illumina_Inc>,
        <https://1145.am/db/1318170/Illumina>,
        <https://1145.am/db/1319284/Illumina>,
        <https://1145.am/db/1320955/Illumina_Inc>,
        <https://1145.am/db/1321949/Illumina>,
        <https://1145.am/db/1322003/Illumina>,
        <https://1145.am/db/1339613/Illumina>,
        <https://1145.am/db/1354365/Illumina>,
        <https://1145.am/db/1357046/Illumina>,
        <https://1145.am/db/1577865/Illumina_Inc>,
        <https://1145.am/db/1668177/Illumina>,
        <https://1145.am/db/1936140/Illumina>,
        <https://1145.am/db/1938875/Illumina_Inc>,
        <https://1145.am/db/1957816/Illumina>,
        <https://1145.am/db/1974886/Illumina_Inc>,
        <https://1145.am/db/2019335/Illumina_Inc>,
        <https://1145.am/db/2029590/Illumina>,
        <https://1145.am/db/2033324/Illumina_Inc>,
        <https://1145.am/db/2033519/Illumina>,
        <https://1145.am/db/2059502/Illumina>,
        <https://1145.am/db/2083048/Illumina>,
        <https://1145.am/db/2108020/Illumina>,
        <https://1145.am/db/2141011/Illumina>,
        <https://1145.am/db/2142556/Illumina>,
        <https://1145.am/db/2143979/Illumina_Inc>,
        <https://1145.am/db/2144305/Illumina>,
        <https://1145.am/db/2144771/Illumina>,
        <https://1145.am/db/2154499/Illumina>,
        <https://1145.am/db/2154543/Illumina>,
        <https://1145.am/db/2279139/Illumina>,
        <https://1145.am/db/2279826/Illumina>,
        <https://1145.am/db/2281780/Illumina>,
        <https://1145.am/db/2282604/Illumina>,
        <https://1145.am/db/2283089/Illumina>,
        <https://1145.am/db/2283331/Illumina>,
        <https://1145.am/db/2284367/Illumina>,
        <https://1145.am/db/2287956/Illumina>,
        <https://1145.am/db/2294885/Illumina>,
        <https://1145.am/db/2294891/Illumina>,
        <https://1145.am/db/2294967/Illumina>,
        <https://1145.am/db/2296025/Illumina>,
        <https://1145.am/db/2296164/Illumina>,
        <https://1145.am/db/2296171/Illumina>,
        <https://1145.am/db/2296180/Illumina>,
        <https://1145.am/db/2296600/Illumina>,
        <https://1145.am/db/2296675/Illumina>,
        <https://1145.am/db/2296788/Illumina>,
        <https://1145.am/db/2297131/Illumina>,
        <https://1145.am/db/2297472/Illumina>,
        <https://1145.am/db/2297593/Illumina>,
        <https://1145.am/db/2297619/Illumina>,
        <https://1145.am/db/2298070/Illumina>,
        <https://1145.am/db/2306511/Illumina>,
        <https://1145.am/db/2306516/Illumina>,
        <https://1145.am/db/2307596/Illumina>,
        <https://1145.am/db/2311597/Illumina_Uk_Ltd>,
        <https://1145.am/db/2319601/Illumina>,
        <https://1145.am/db/2319603/Illumina_Inc>,
        <https://1145.am/db/2319627/Illumina>,
        <https://1145.am/db/2320930/Illumina>,
        <https://1145.am/db/2321784/Illumina>,
        <https://1145.am/db/2322901/Illumina>,
        <https://1145.am/db/2323244/Illumina>,
        <https://1145.am/db/2326093/Illumina>,
        <https://1145.am/db/2326119/Illumina>,
        <https://1145.am/db/2328637/Illumina>,
        <https://1145.am/db/2329403/Illumina>,
        <https://1145.am/db/2329404/Illumina>,
        <https://1145.am/db/2330521/Illumina>,
        <https://1145.am/db/2336625/Illumina>,
        <https://1145.am/db/2336627/Illumina_Inc>,
        <https://1145.am/db/2345558/Illumina>,
        <https://1145.am/db/2353287/Illumina_Inc>,
        <https://1145.am/db/2355226/Illumina>,
        <https://1145.am/db/2357075/Illumina>,
        <https://1145.am/db/2359655/Illumina_Inc>,
        <https://1145.am/db/2360982/Illumina>,
        <https://1145.am/db/2360997/Illumina>,
        <https://1145.am/db/2360999/Illumina>,
        <https://1145.am/db/2361624/Illumina>,
        <https://1145.am/db/2361632/Illumina>,
        <https://1145.am/db/2361994/Illumina>,
        <https://1145.am/db/2361998/Illumina>,
        <https://1145.am/db/2362001/Illumina>,
        <https://1145.am/db/2362034/Illumina>,
        <https://1145.am/db/2362590/Illumina>,
        <https://1145.am/db/2367537/Illumina>,
        <https://1145.am/db/2367708/Illumina>,
        <https://1145.am/db/2368611/Illumina_Inc>,
        <https://1145.am/db/2370715/Illumina>,
        <https://1145.am/db/2541350/Illumina>,
        <https://1145.am/db/2541672/Illumina>,
        <https://1145.am/db/2541685/Illumina>,
        <https://1145.am/db/2568519/Illumina>,
        <https://1145.am/db/2571613/Illumina>,
        <https://1145.am/db/2572452/Illumina>,
        <https://1145.am/db/2573339/Illumina>,
        <https://1145.am/db/2574083/Illumina>,
        <https://1145.am/db/2574281/Illumina>,
        <https://1145.am/db/2575289/Illumina>,
        <https://1145.am/db/2592803/Illumina>,
        <https://1145.am/db/2593666/Illumina>,
        <https://1145.am/db/2593713/Illumina>,
        <https://1145.am/db/2597109/Illumina>,
        <https://1145.am/db/2597648/Illumina>,
        <https://1145.am/db/294376/Illumina_Inc>,
        <https://1145.am/db/310868/Illumina_Inc>,
        <https://1145.am/db/356690/Illumina_Inc>,
        <https://1145.am/db/376116/Illumina_Inc>,
        <https://1145.am/db/385241/Illumina_Inc>,
        <https://1145.am/db/422712/Illumina>,
        <https://1145.am/db/425834/Illumina_Inc>,
        <https://1145.am/db/492277/Illumina>,
        <https://1145.am/db/580608/Illumina>,
        <https://1145.am/db/625378/Illumina_Inc>,
        <https://1145.am/db/782644/Illumina>,
        <https://1145.am/db/785864/Illumina>,
        <https://1145.am/db/791066/Illumina>,
        <https://1145.am/db/791240/Illumina>,
        <https://1145.am/db/810365/Illumina>,
        <https://1145.am/db/875920/Illumina>,
        <https://1145.am/db/876576/Illumina> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367043/Invesco_Perpetual> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "undisclosed investors" ;
    ns1:documentDate "2011-04-26T14:47:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Nanopore raises $41M for DNA sequencing work; Biogen Idec ready to break ground on new manufacturing center;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/oxford-nanopore-raises-41m-for-dna-sequencing-work-biogen-idec-ready-to-break-ground-on-new> ;
    ns1:foundName "Invesco Perpetual" ;
    ns1:investor <https://1145.am/db/2367043/Investment_Ip_Group_Illumina_Invesco_Perpetual_Lansdowne_Partners_Oxford_Nanopore_Redmile_Group_Completed> ;
    ns1:name "Invesco Perpetual" ;
    ns1:sameAsHigh <https://1145.am/db/2311597/Invesco_Perpetual> ;
    ns1:sameAsMedium <https://1145.am/db/2302961/Invesco_Perpetual>,
        <https://1145.am/db/2302965/Invesco_Perpetual>,
        <https://1145.am/db/2304832/Invesco_Perpetual>,
        <https://1145.am/db/2304844/Invesco_Perpetual>,
        <https://1145.am/db/2318529/Invesco_Perpetual>,
        <https://1145.am/db/2318537/Invesco_Perpetual>,
        <https://1145.am/db/2339108/Invesco_Perpetual>,
        <https://1145.am/db/2339111/Invesco_Perpetual>,
        <https://1145.am/db/2340559/Invesco_Perpetual>,
        <https://1145.am/db/2341738/Invesco_Perpetual>,
        <https://1145.am/db/2341760/Invesco_Perpetual>,
        <https://1145.am/db/2348796/Invesco_Perpetual>,
        <https://1145.am/db/2363947/Invesco_Perpetual>,
        <https://1145.am/db/2363950/Invesco_Perpetual>,
        <https://1145.am/db/2366154/Invesco_Perpetual>,
        <https://1145.am/db/2366156/Invesco_Perpetual>,
        <https://1145.am/db/2366434/Invesco_Perpetual>,
        <https://1145.am/db/2544138/Invesco_Perpetual> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367043/Investment_Biogen_Idec_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-26T14:47:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Biogen Idec has lined up a builder for its planned 180,000-square-foot facility in Research Triangle Park." ;
    ns1:documentTitle "Oxford Nanopore raises $41M for DNA sequencing work; Biogen Idec ready to break ground on new manufacturing center;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/oxford-nanopore-raises-41m-for-dna-sequencing-work-biogen-idec-ready-to-break-ground-on-new> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2367043/Biogen_Idec> ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2367043/Ip_Group> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:documentDate "2011-04-26T14:47:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Nanopore raises $41M for DNA sequencing work; Biogen Idec ready to break ground on new manufacturing center;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/oxford-nanopore-raises-41m-for-dna-sequencing-work-biogen-idec-ready-to-break-ground-on-new> ;
    ns1:foundName "IP Group" ;
    ns1:investor <https://1145.am/db/2367043/Investment_Ip_Group_Illumina_Invesco_Perpetual_Lansdowne_Partners_Oxford_Nanopore_Redmile_Group_Completed> ;
    ns1:name "IP Group" ;
    ns1:sameAsMedium <https://1145.am/db/1050773/Ip_Group>,
        <https://1145.am/db/1052134/Ip_Group>,
        <https://1145.am/db/1326655/Ip_Group_Inc>,
        <https://1145.am/db/1326957/Ip_Group_Inc>,
        <https://1145.am/db/1520407/Ip_Group>,
        <https://1145.am/db/1743462/Ip_Group>,
        <https://1145.am/db/1743749/Ip_Group_Plc>,
        <https://1145.am/db/1805749/Ip_Group>,
        <https://1145.am/db/1951986/Ip_Group>,
        <https://1145.am/db/2002735/Ip_Group>,
        <https://1145.am/db/2297062/Ip_Group>,
        <https://1145.am/db/2311597/Ip_Group>,
        <https://1145.am/db/2318529/Ip_Group>,
        <https://1145.am/db/2356861/Ip_Group>,
        <https://1145.am/db/2356876/Ip_Group>,
        <https://1145.am/db/2356920/Ip_Group_Plc>,
        <https://1145.am/db/2367681/Ip_Group>,
        <https://1145.am/db/323567/Ip_Group>,
        <https://1145.am/db/881549/Ip_Group>,
        <https://1145.am/db/907465/Ip_Group_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367043/Lansdowne_Partners> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:documentDate "2011-04-26T14:47:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Nanopore raises $41M for DNA sequencing work; Biogen Idec ready to break ground on new manufacturing center;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/oxford-nanopore-raises-41m-for-dna-sequencing-work-biogen-idec-ready-to-break-ground-on-new> ;
    ns1:foundName "Lansdowne Partners" ;
    ns1:investor <https://1145.am/db/2367043/Investment_Ip_Group_Illumina_Invesco_Perpetual_Lansdowne_Partners_Oxford_Nanopore_Redmile_Group_Completed> ;
    ns1:name "Lansdowne Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1096686/Lansdowne_Partners>,
        <https://1145.am/db/1115173/Lansdowne_Partners>,
        <https://1145.am/db/1116381/Lansdowne_Partners>,
        <https://1145.am/db/1180710/Lansdowne_Partners>,
        <https://1145.am/db/1208698/Lansdowne_Partners>,
        <https://1145.am/db/2024457/Lansdowne_Partners>,
        <https://1145.am/db/2302961/Lansdowne_Partners>,
        <https://1145.am/db/2302965/Lansdowne_Partners>,
        <https://1145.am/db/2304844/Lansdowne_Partners>,
        <https://1145.am/db/2311597/Lansdowne_Partners>,
        <https://1145.am/db/2318529/Lansdowne_Partners>,
        <https://1145.am/db/2318537/Lansdowne_Partners>,
        <https://1145.am/db/797597/Lansdowne_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367043/Redmile_Group> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:documentDate "2011-04-26T14:47:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Nanopore raises $41M for DNA sequencing work; Biogen Idec ready to break ground on new manufacturing center;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/oxford-nanopore-raises-41m-for-dna-sequencing-work-biogen-idec-ready-to-break-ground-on-new> ;
    ns1:foundName "Redmile Group" ;
    ns1:investor <https://1145.am/db/2367043/Investment_Ip_Group_Illumina_Invesco_Perpetual_Lansdowne_Partners_Oxford_Nanopore_Redmile_Group_Completed> ;
    ns1:name "Redmile Group" ;
    ns1:sameAsMedium <https://1145.am/db/1086649/Redmile_Group>,
        <https://1145.am/db/1192327/Redmile_Group>,
        <https://1145.am/db/1533327/Redmile_Group>,
        <https://1145.am/db/1533685/Redmile_Group>,
        <https://1145.am/db/1752458/Redmile_Group>,
        <https://1145.am/db/1813216/Redmile_Group>,
        <https://1145.am/db/1822362/Redmile_Group>,
        <https://1145.am/db/1837663/Redmile_Group>,
        <https://1145.am/db/1984721/Redmile_Group>,
        <https://1145.am/db/2075963/Redmile_Group>,
        <https://1145.am/db/2080575/Redmile_Group>,
        <https://1145.am/db/2089412/Redmile_Group>,
        <https://1145.am/db/2152126/Redmile_Group>,
        <https://1145.am/db/2224478/Redmile_Group>,
        <https://1145.am/db/2236068/Redmile_Group>,
        <https://1145.am/db/2281211/Redmile_Group>,
        <https://1145.am/db/2285762/Redmile_Group>,
        <https://1145.am/db/2291414/Redmile_Group>,
        <https://1145.am/db/2291716/Redmile_Group>,
        <https://1145.am/db/2292160/Redmile_Group>,
        <https://1145.am/db/2307889/Redmile_Group>,
        <https://1145.am/db/2308540/Redmile_Group>,
        <https://1145.am/db/2321658/Redmile_Group>,
        <https://1145.am/db/2335748/Redmile_Group>,
        <https://1145.am/db/2341595/Redmile_Group>,
        <https://1145.am/db/2341599/Redmile_Group>,
        <https://1145.am/db/2360277/Redmile_Group>,
        <https://1145.am/db/2361695/Redmile_Group>,
        <https://1145.am/db/2362106/Redmile_Group>,
        <https://1145.am/db/2368070/Redmile_Group>,
        <https://1145.am/db/2369304/Redmile_Group>,
        <https://1145.am/db/2371160/Redmile_Group>,
        <https://1145.am/db/2371163/Redmile_Group>,
        <https://1145.am/db/2584561/Redmile_Group>,
        <https://1145.am/db/342182/Redmile_Group>,
        <https://1145.am/db/577785/Redmile_Group>,
        <https://1145.am/db/585936/Redmile_Group>,
        <https://1145.am/db/602316/Redmile_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367046/Athenian_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CINCINNATI, OH" ;
    ns1:documentDate "2011-04-26T15:53:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Akebia Completes $22M Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/akebia-completes-22m-series-b-financing> ;
    ns1:foundName "Athenian Venture Partners" ;
    ns1:investor <https://1145.am/db/2367046/Series_B_Investment_Agechem_Venture_Fund_Akebia_Therapeutics_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Venture_Fund_Sigvion_Capital_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Athenian Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2303695/Athenian_Venture_Partners>,
        <https://1145.am/db/2317737/Athenian_Venture_Partners>,
        <https://1145.am/db/2335764/Athenian_Venture_Partners>,
        <https://1145.am/db/2354752/Athenian_Venture_Partners>,
        <https://1145.am/db/2354770/Athenian_Venture_Partners>,
        <https://1145.am/db/2361588/Athenian_Venture_Partners>,
        <https://1145.am/db/2367047/Athenian_Venture_Partners>,
        <https://1145.am/db/2575232/Athenian_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367046/Sigvion_Capital> a org:Organization ;
    ns1:basedInLowRaw "OH" ;
    ns1:documentDate "2011-04-26T15:53:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Akebia Completes $22M Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/akebia-completes-22m-series-b-financing> ;
    ns1:foundName "Sigvion Capital" ;
    ns1:investor <https://1145.am/db/2367046/Series_B_Investment_Agechem_Venture_Fund_Akebia_Therapeutics_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Venture_Fund_Sigvion_Capital_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Sigvion Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2303695/Sigvion_Capital>,
        <https://1145.am/db/2321861/Sigvion_Capital>,
        <https://1145.am/db/2321870/Sigvion_Capital>,
        <https://1145.am/db/2367047/Sigvion_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367046/Triathlon_Medical_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Cincinnati" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4508722/about.rdf> ;
    ns1:basedInHighRaw "CINCINNATI, OH" ;
    ns1:documentDate "2011-04-26T15:53:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Akebia Completes $22M Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/akebia-completes-22m-series-b-financing> ;
    ns1:foundName "Triathlon Medical Ventures" ;
    ns1:industry "pharmaceutical discovery and development" ;
    ns1:investor <https://1145.am/db/2367046/Series_B_Investment_Agechem_Venture_Fund_Akebia_Therapeutics_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Venture_Fund_Sigvion_Capital_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Triathlon Medical Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2305713/Triathlon_Medical_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2303695/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2305706/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2326139/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2330775/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2335764/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2354752/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2354770/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2361588/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2367047/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2575232/Triathlon_Medical_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367046/Venture_Investors_Llc> a org:Organization ;
    ns1:basedInLowRaw "OH" ;
    ns1:documentDate "2011-04-26T15:53:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Akebia Completes $22M Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/akebia-completes-22m-series-b-financing> ;
    ns1:foundName "Venture",
        "Venture Investors, LLC" ;
    ns1:investor <https://1145.am/db/2367046/Series_B_Investment_Agechem_Venture_Fund_Akebia_Therapeutics_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Venture_Fund_Sigvion_Capital_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Venture Investors",
        "Venture Investors, LLC" ;
    ns1:sameAsMedium <https://1145.am/db/1105339/Venture_Investors>,
        <https://1145.am/db/2299743/Venture_Investors>,
        <https://1145.am/db/2301714/Venture_Investors>,
        <https://1145.am/db/2301715/Venture_Investors>,
        <https://1145.am/db/2303695/Venture_Investors_Llc>,
        <https://1145.am/db/2311076/Venture_Investors>,
        <https://1145.am/db/2321713/Venture_Investors>,
        <https://1145.am/db/2354752/Venture_Investors_Llc>,
        <https://1145.am/db/2354770/Venture_Investors_Llc>,
        <https://1145.am/db/2364827/Venture_Investors>,
        <https://1145.am/db/2365444/Venture_Investors>,
        <https://1145.am/db/2369504/Venture_Investors_Llc>,
        <https://1145.am/db/2556669/Venture_Investors_Llc>,
        <https://1145.am/db/2575232/Venture_Investors_Llc>,
        <https://1145.am/db/2583558/Venture_Investors_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367053/Investment_Scout_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-27T12:49:26+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Scout Diagnostics, a company targeting early diagnosis of Alzheimer's disease, recently received matching funds of $ 435,600 to support developing a laboratory test to detect and confirm Alzheimer's disease in its earliest stages." ;
    ns1:documentTitle "Potential diagnostic test for Alzheimer's would use cerebrospinal fluid" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/potential-diagnostic-test-for-alzheimer-s-would-use-cerebrospinal-fluid> ;
    ns1:foundName "received" ;
    ns1:name "received" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2367053/Scout> ;
    ns1:valueRaw "$ 435,600" ;
    ns1:whereGeoName "Kentucky" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6254925/about.rdf> ;
    ns1:whereRaw "Kentucky" .

<https://1145.am/db/2367218/Merck_Kgaa> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:documentDate "2011-01-12T20:16:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "VAXIMM Closes a CHF 7.8 Million Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vaximm-closes-a-chf-7-8-million-financing-round> ;
    ns1:foundName "Merck KGaA" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2367218/Investment_Bb_Biotech_Ventures_Biomedpartners_Merck_Kgaa_Merck_Serono_Ventures_Sunstone_Capital_Vaximm_Ag_Completed> ;
    ns1:name "Merck KGaA" ;
    ns1:sameAsHigh <https://1145.am/db/1145060/Merck>,
        <https://1145.am/db/1186122/Merck___Co>,
        <https://1145.am/db/1217756/Merck_Kgaa>,
        <https://1145.am/db/141850/Merck>,
        <https://1145.am/db/1451511/Merck___Co>,
        <https://1145.am/db/1514452/Merck_Kgaa>,
        <https://1145.am/db/1519366/Merck>,
        <https://1145.am/db/1522616/Merck>,
        <https://1145.am/db/154793/Merck>,
        <https://1145.am/db/1554738/Merck>,
        <https://1145.am/db/159841/Merck>,
        <https://1145.am/db/1966692/Merck_Kgaa>,
        <https://1145.am/db/1970288/Merck>,
        <https://1145.am/db/1970357/Merck>,
        <https://1145.am/db/1972206/Merck>,
        <https://1145.am/db/1998846/Germanys_Merck_Kgaa>,
        <https://1145.am/db/2010010/Merck___Co_Inc>,
        <https://1145.am/db/2040537/Merck>,
        <https://1145.am/db/2151833/Merck_Kgaa>,
        <https://1145.am/db/2151908/Merck_Kgaa>,
        <https://1145.am/db/2152045/Merck_Kgaa>,
        <https://1145.am/db/2152482/Merck>,
        <https://1145.am/db/2152633/Merck>,
        <https://1145.am/db/2152721/Merck>,
        <https://1145.am/db/2153637/Merck>,
        <https://1145.am/db/2153796/Merck>,
        <https://1145.am/db/2154708/Merck_Kgaa>,
        <https://1145.am/db/2154806/Merck>,
        <https://1145.am/db/2155194/Merck>,
        <https://1145.am/db/2155657/Merck>,
        <https://1145.am/db/2204455/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2217406/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/223588/Merck___Co_Inc>,
        <https://1145.am/db/223595/Merck___Co_Inc>,
        <https://1145.am/db/224121/Merck___Co_Inc>,
        <https://1145.am/db/2278879/Merck>,
        <https://1145.am/db/2279118/Merck>,
        <https://1145.am/db/2279238/Merck>,
        <https://1145.am/db/2280487/Merck___Co>,
        <https://1145.am/db/2281134/Merck>,
        <https://1145.am/db/2283230/Merck>,
        <https://1145.am/db/2284577/Merck>,
        <https://1145.am/db/2285024/Merck>,
        <https://1145.am/db/2285322/Merck>,
        <https://1145.am/db/2286215/Merck>,
        <https://1145.am/db/2286469/Merck>,
        <https://1145.am/db/2286759/Merck>,
        <https://1145.am/db/2287351/Merck>,
        <https://1145.am/db/2288192/Merck>,
        <https://1145.am/db/2288199/Merck>,
        <https://1145.am/db/2294623/Merck>,
        <https://1145.am/db/2298415/Merck_Kgaa>,
        <https://1145.am/db/2302117/Merck___Co_Inc>,
        <https://1145.am/db/2302462/Merck_Kgaa>,
        <https://1145.am/db/2302856/Merck_Kgaa>,
        <https://1145.am/db/2303618/Merck_Sharp___Dohme>,
        <https://1145.am/db/2303818/Merck_Kgaa>,
        <https://1145.am/db/2304609/Merck_Kgaa>,
        <https://1145.am/db/2304616/Merck___Co_Inc>,
        <https://1145.am/db/2304619/Merck___Co_Inc>,
        <https://1145.am/db/2305804/Merck>,
        <https://1145.am/db/2306238/Merck>,
        <https://1145.am/db/2307377/Merck_Kgaa>,
        <https://1145.am/db/2307669/Merck>,
        <https://1145.am/db/2310391/Merck>,
        <https://1145.am/db/2312786/Merck>,
        <https://1145.am/db/2312813/Merck>,
        <https://1145.am/db/2313223/Merck>,
        <https://1145.am/db/2316418/Merck___Co>,
        <https://1145.am/db/2316435/Merck___Co>,
        <https://1145.am/db/2316525/Merck>,
        <https://1145.am/db/2317494/Merck>,
        <https://1145.am/db/2317795/Merck_Kgaa>,
        <https://1145.am/db/2317895/Merck_Kgaa>,
        <https://1145.am/db/2318333/Merck_Kgaa>,
        <https://1145.am/db/2319111/Merck>,
        <https://1145.am/db/2319215/Merck_Kgaa>,
        <https://1145.am/db/2320352/Merck_Kgaa>,
        <https://1145.am/db/2320534/Merck_Kgaa>,
        <https://1145.am/db/2320820/Merck_Kgaa>,
        <https://1145.am/db/2321072/Merck___Co_Inc>,
        <https://1145.am/db/2323722/Merck___Co>,
        <https://1145.am/db/2325084/Merck>,
        <https://1145.am/db/2325864/Merck>,
        <https://1145.am/db/2326224/Merck___Co_Inc>,
        <https://1145.am/db/2326286/Merck>,
        <https://1145.am/db/2328359/Merck>,
        <https://1145.am/db/2328367/Merck>,
        <https://1145.am/db/2329586/Merck>,
        <https://1145.am/db/2329589/Merck___Co_Inc>,
        <https://1145.am/db/2329775/Merck_Kgaa>,
        <https://1145.am/db/2329787/Merck_Kgaa>,
        <https://1145.am/db/2330990/Merck_Kgaa>,
        <https://1145.am/db/2331199/Merck_Kgaa>,
        <https://1145.am/db/2331307/Merck_Kgaa>,
        <https://1145.am/db/2332096/Merck___Co_Inc>,
        <https://1145.am/db/2335784/Merck_Kgaa>,
        <https://1145.am/db/2335812/Merck_Kgaa>,
        <https://1145.am/db/2335824/Merck_Kgaa>,
        <https://1145.am/db/2337047/Merck>,
        <https://1145.am/db/2337245/Boston-Merck>,
        <https://1145.am/db/2337246/Merck>,
        <https://1145.am/db/2337247/Merck___Co_Inc>,
        <https://1145.am/db/2337402/Merck_Sharp___Dohme_Bv>,
        <https://1145.am/db/2338348/Merck>,
        <https://1145.am/db/2339972/Merck_Serono>,
        <https://1145.am/db/2340479/Merck_Kgaa>,
        <https://1145.am/db/2341435/Merck>,
        <https://1145.am/db/2342387/Merck_Kgaa>,
        <https://1145.am/db/2342487/Merck>,
        <https://1145.am/db/2343123/Merck>,
        <https://1145.am/db/2343159/Merck>,
        <https://1145.am/db/2343161/Merck>,
        <https://1145.am/db/2343358/Merck_Kgaa>,
        <https://1145.am/db/2343584/Merck>,
        <https://1145.am/db/2343585/Merck>,
        <https://1145.am/db/2344286/Merck___Co_Inc>,
        <https://1145.am/db/2344290/Merck___Co_Inc>,
        <https://1145.am/db/2344563/Merck>,
        <https://1145.am/db/2344564/Merck>,
        <https://1145.am/db/2344792/Merck>,
        <https://1145.am/db/2346099/Merck_Kgaa>,
        <https://1145.am/db/2347933/Merck_Kgaa>,
        <https://1145.am/db/2348683/Merck>,
        <https://1145.am/db/2349084/Merck>,
        <https://1145.am/db/2350145/Merck>,
        <https://1145.am/db/2350594/Merck_Kgaa>,
        <https://1145.am/db/2350594/Merck_Serono>,
        <https://1145.am/db/2350645/Merck_Kgaa>,
        <https://1145.am/db/2350687/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2350706/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2350881/Merck>,
        <https://1145.am/db/2351858/Merck_Kgaa>,
        <https://1145.am/db/2352882/Merck_Kgaa>,
        <https://1145.am/db/2352961/Merck>,
        <https://1145.am/db/2355245/Merck_Kgaa>,
        <https://1145.am/db/2355800/Merck>,
        <https://1145.am/db/2357401/Merck_Kgaa>,
        <https://1145.am/db/2358644/Merck>,
        <https://1145.am/db/2359414/Merck>,
        <https://1145.am/db/2360369/Merck_Kgaa>,
        <https://1145.am/db/2360455/Merck>,
        <https://1145.am/db/2360816/Merck_Kgaa>,
        <https://1145.am/db/2360819/Merck_Kgaa>,
        <https://1145.am/db/2361274/Merck>,
        <https://1145.am/db/2361352/Merck_Kgaa>,
        <https://1145.am/db/2361913/Merck>,
        <https://1145.am/db/2362994/Merck>,
        <https://1145.am/db/2363210/And_Merck>,
        <https://1145.am/db/2363211/Merck>,
        <https://1145.am/db/2363215/Merck>,
        <https://1145.am/db/2365367/Merck>,
        <https://1145.am/db/2367207/Merck_Kgaa>,
        <https://1145.am/db/2367613/Merck_Kgaa>,
        <https://1145.am/db/2368041/Merck>,
        <https://1145.am/db/2368712/Merck>,
        <https://1145.am/db/2368719/Merck>,
        <https://1145.am/db/2368808/Merck>,
        <https://1145.am/db/2369162/Merck>,
        <https://1145.am/db/2369441/Merck_Kgaa>,
        <https://1145.am/db/2369641/Merck>,
        <https://1145.am/db/2370722/Merck>,
        <https://1145.am/db/2371269/Merck_Kgaa>,
        <https://1145.am/db/2536301/Merck>,
        <https://1145.am/db/2537455/Merck>,
        <https://1145.am/db/2538076/Merck___Co>,
        <https://1145.am/db/2539243/Merck>,
        <https://1145.am/db/2539257/Merck>,
        <https://1145.am/db/2539515/Merck_Kgaa>,
        <https://1145.am/db/2539561/Merck>,
        <https://1145.am/db/2540776/Merck>,
        <https://1145.am/db/2541112/Merck_Kgaa>,
        <https://1145.am/db/2541756/Merck>,
        <https://1145.am/db/2542057/Merck>,
        <https://1145.am/db/2542499/Merck>,
        <https://1145.am/db/2542731/Merck>,
        <https://1145.am/db/2542740/Merck>,
        <https://1145.am/db/2544107/Merck_Kgaa>,
        <https://1145.am/db/2544235/Merck>,
        <https://1145.am/db/2544391/Merck>,
        <https://1145.am/db/2545522/Merck_Kgaa>,
        <https://1145.am/db/2545618/Merck_Kgaa>,
        <https://1145.am/db/2546209/And_Merck_Kgaa>,
        <https://1145.am/db/2548696/Merck>,
        <https://1145.am/db/2549220/Merck_Manufacturing_Division>,
        <https://1145.am/db/2549220/Merck___Co>,
        <https://1145.am/db/2551075/Merck_Kgaa>,
        <https://1145.am/db/2551126/Merck>,
        <https://1145.am/db/2552135/Merck_Kgaa>,
        <https://1145.am/db/2552707/Merck___Co_Inc>,
        <https://1145.am/db/2553766/Merck_Kgaa>,
        <https://1145.am/db/2553841/Merck_Kgaas_Merck_Serono>,
        <https://1145.am/db/2556052/Merck>,
        <https://1145.am/db/2557023/Merck_Serono>,
        <https://1145.am/db/2557506/Merck___Co>,
        <https://1145.am/db/2557870/Merck_Millipore>,
        <https://1145.am/db/2558101/Merck_Kgaa>,
        <https://1145.am/db/2558555/Merck___Co>,
        <https://1145.am/db/2558691/Merck>,
        <https://1145.am/db/2558927/Merck>,
        <https://1145.am/db/2558947/Merck_Sharp_And_Dohme>,
        <https://1145.am/db/2559298/Merck>,
        <https://1145.am/db/2559346/Merck_Kgaa>,
        <https://1145.am/db/2559511/Merck>,
        <https://1145.am/db/2559601/Merck>,
        <https://1145.am/db/2559783/Merck_Kgaa>,
        <https://1145.am/db/2559822/Merck>,
        <https://1145.am/db/2560113/Merck_Kgaa>,
        <https://1145.am/db/2560263/Merck_Kgaa>,
        <https://1145.am/db/2560758/Merck>,
        <https://1145.am/db/2561492/Merck_Kgaa>,
        <https://1145.am/db/2561650/Merck___Co>,
        <https://1145.am/db/2562041/Merck>,
        <https://1145.am/db/2563423/Merck>,
        <https://1145.am/db/2563450/Merck>,
        <https://1145.am/db/2564473/Merck_Kgaa>,
        <https://1145.am/db/2564583/Merck_Kgaa>,
        <https://1145.am/db/2565433/Merck>,
        <https://1145.am/db/2566424/Merck___Co>,
        <https://1145.am/db/2566606/Merck_Kgaa>,
        <https://1145.am/db/2566939/Merck>,
        <https://1145.am/db/2567245/Merck___Co>,
        <https://1145.am/db/2568284/Merck_Kgaa>,
        <https://1145.am/db/2568357/Merck>,
        <https://1145.am/db/2568495/Merck>,
        <https://1145.am/db/2568729/Merck___Co>,
        <https://1145.am/db/2568891/Merck_Kgaa>,
        <https://1145.am/db/2568903/Merck_Kgaa>,
        <https://1145.am/db/2569029/Merck_Serono>,
        <https://1145.am/db/2570392/Merck_Kgaa>,
        <https://1145.am/db/2570807/Merck_Kgaa>,
        <https://1145.am/db/2571023/Merck_Kgaa>,
        <https://1145.am/db/2571569/Merck>,
        <https://1145.am/db/2572436/Merck_Canada>,
        <https://1145.am/db/2572620/Merck>,
        <https://1145.am/db/2572634/Merck>,
        <https://1145.am/db/2572675/Merck___Co_Inc>,
        <https://1145.am/db/2573613/Merck_Kgaa>,
        <https://1145.am/db/2575021/Merck>,
        <https://1145.am/db/2575032/Merck>,
        <https://1145.am/db/2575427/Merck>,
        <https://1145.am/db/2575623/Merck_Kgaa>,
        <https://1145.am/db/2576127/Merck>,
        <https://1145.am/db/2576129/Merck_Sharp___Dohme_Bv>,
        <https://1145.am/db/2578485/Merck>,
        <https://1145.am/db/2579483/Merck>,
        <https://1145.am/db/2579763/Merck>,
        <https://1145.am/db/2580399/Merck>,
        <https://1145.am/db/2581295/Merck_Kgaa>,
        <https://1145.am/db/2581441/Merck_Kgaa>,
        <https://1145.am/db/2583045/Merck>,
        <https://1145.am/db/2583206/Merck_Consumer_Care>,
        <https://1145.am/db/2584116/Merck___Co_Inc>,
        <https://1145.am/db/2586198/Merck>,
        <https://1145.am/db/2586373/Merck>,
        <https://1145.am/db/2586732/Merck>,
        <https://1145.am/db/2586790/Merck>,
        <https://1145.am/db/2587758/Merck_Millipore>,
        <https://1145.am/db/2588111/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2588119/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2588121/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2590952/Merck_Kgaa>,
        <https://1145.am/db/2591137/Merck___Co_Inc>,
        <https://1145.am/db/2591395/Merck_Kgaa>,
        <https://1145.am/db/2591656/Merck___Co_Inc>,
        <https://1145.am/db/2592574/Merck>,
        <https://1145.am/db/2592875/Merck>,
        <https://1145.am/db/2592986/Merck>,
        <https://1145.am/db/2594591/Merck>,
        <https://1145.am/db/2594604/Merck>,
        <https://1145.am/db/2594687/Merck_Sharp_Dohme>,
        <https://1145.am/db/2595812/Merck>,
        <https://1145.am/db/2596015/Theramex>,
        <https://1145.am/db/2596156/Merck_Serono>,
        <https://1145.am/db/2596183/Merck_Kgaa>,
        <https://1145.am/db/2597131/Merck>,
        <https://1145.am/db/2597135/Merck_Serono>,
        <https://1145.am/db/2597451/Merck>,
        <https://1145.am/db/2598195/Merck_Kgaa>,
        <https://1145.am/db/2598430/Merck>,
        <https://1145.am/db/2598439/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598439/Merck_Sharp___Dohme_Corp>,
        <https://1145.am/db/2598446/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598446/Merck>,
        <https://1145.am/db/2598455/Merck>,
        <https://1145.am/db/2598458/Merck>,
        <https://1145.am/db/2598523/Merck>,
        <https://1145.am/db/275241/Merck>,
        <https://1145.am/db/335436/Merck_Kgaa>,
        <https://1145.am/db/508163/Merck>,
        <https://1145.am/db/512986/Merck>,
        <https://1145.am/db/514478/Merck>,
        <https://1145.am/db/514938/Merck___Co>,
        <https://1145.am/db/515012/Merck>,
        <https://1145.am/db/515636/Merck>,
        <https://1145.am/db/516867/Merck>,
        <https://1145.am/db/517460/Merck___Co_Inc>,
        <https://1145.am/db/518115/Merck>,
        <https://1145.am/db/539381/Merck>,
        <https://1145.am/db/540665/Merck_Kgaa>,
        <https://1145.am/db/545265/Merck___Co>,
        <https://1145.am/db/546225/Merck___Co>,
        <https://1145.am/db/550927/Merck>,
        <https://1145.am/db/555027/Merck___Co_Inc>,
        <https://1145.am/db/557111/Merck___Co_Inc>,
        <https://1145.am/db/580628/Merck>,
        <https://1145.am/db/602160/Merck>,
        <https://1145.am/db/607613/Merck>,
        <https://1145.am/db/626833/Merck>,
        <https://1145.am/db/641350/Merck>,
        <https://1145.am/db/701833/Healthcare_Business_Sector_Of_Merck_Kgaa>,
        <https://1145.am/db/708442/Merck>,
        <https://1145.am/db/746997/Merck_Kgaa>,
        <https://1145.am/db/866117/Merck> ;
    ns1:sameAsMedium <https://1145.am/db/1098407/Merck_Kgaa>,
        <https://1145.am/db/1149563/Merck>,
        <https://1145.am/db/1153272/Merck>,
        <https://1145.am/db/1153273/Merck>,
        <https://1145.am/db/1467892/Merck_Kgaa>,
        <https://1145.am/db/1524293/Merck>,
        <https://1145.am/db/1525563/Merck>,
        <https://1145.am/db/1570995/Merck>,
        <https://1145.am/db/1571146/Merck>,
        <https://1145.am/db/1635899/Merck>,
        <https://1145.am/db/1968247/Merck>,
        <https://1145.am/db/2220801/Merck_Kgaa>,
        <https://1145.am/db/2287767/Merck>,
        <https://1145.am/db/2293662/Merck>,
        <https://1145.am/db/2303087/Merck_Kgaa>,
        <https://1145.am/db/2304635/Merck>,
        <https://1145.am/db/2305972/Merck___Co>,
        <https://1145.am/db/2306562/Merck>,
        <https://1145.am/db/2306873/Merck_Kgaa>,
        <https://1145.am/db/2307697/Merck_Kgaa>,
        <https://1145.am/db/2309914/Merck>,
        <https://1145.am/db/2315288/Merck_Kgaa>,
        <https://1145.am/db/2317398/Merck>,
        <https://1145.am/db/2318574/Merck>,
        <https://1145.am/db/2325702/Merck___Co>,
        <https://1145.am/db/2329475/Merck>,
        <https://1145.am/db/2329795/Merck_Kgaa>,
        <https://1145.am/db/2330692/Merck___Co>,
        <https://1145.am/db/2331756/Merck>,
        <https://1145.am/db/2333619/Merck_Kgaa>,
        <https://1145.am/db/2337072/Merck>,
        <https://1145.am/db/2348727/Merck>,
        <https://1145.am/db/2356800/Merck>,
        <https://1145.am/db/2358017/Merck_Kgaa>,
        <https://1145.am/db/2358663/Merck>,
        <https://1145.am/db/2362458/Merck_Kgaa>,
        <https://1145.am/db/2368838/Merck>,
        <https://1145.am/db/2537077/Merck>,
        <https://1145.am/db/2540072/Merck_Kgaa>,
        <https://1145.am/db/2542394/Merck_Kgaa>,
        <https://1145.am/db/2545631/Merck>,
        <https://1145.am/db/2546686/Merck>,
        <https://1145.am/db/2551984/Merck>,
        <https://1145.am/db/2553618/Merck_Kgaa>,
        <https://1145.am/db/2554244/Merck>,
        <https://1145.am/db/2554269/Merck>,
        <https://1145.am/db/2562722/Merck___Co>,
        <https://1145.am/db/2565626/Merck_Kgaa>,
        <https://1145.am/db/2571683/Merck>,
        <https://1145.am/db/2575465/Merck_Kgaa>,
        <https://1145.am/db/2578046/Merck>,
        <https://1145.am/db/2587981/Merck>,
        <https://1145.am/db/2588540/Merck>,
        <https://1145.am/db/2590687/Merck>,
        <https://1145.am/db/2591687/Merck_Kgaa>,
        <https://1145.am/db/2592013/Merck>,
        <https://1145.am/db/2594711/Merck>,
        <https://1145.am/db/2596909/Merck>,
        <https://1145.am/db/2598420/Merck>,
        <https://1145.am/db/2598428/Merck>,
        <https://1145.am/db/420173/Merck>,
        <https://1145.am/db/510419/Merck>,
        <https://1145.am/db/511540/Merck>,
        <https://1145.am/db/678858/Merck>,
        <https://1145.am/db/680862/Merck>,
        <https://1145.am/db/769856/Merck>,
        <https://1145.am/db/868747/Merck>,
        <https://1145.am/db/884408/Merck_Kgaa>,
        <https://1145.am/db/990890/Merck> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367218/Merck_Serono_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:documentDate "2011-01-12T20:16:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "VAXIMM Closes a CHF 7.8 Million Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vaximm-closes-a-chf-7-8-million-financing-round> ;
    ns1:foundName "Merck Serono Ventures" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2367218/Investment_Bb_Biotech_Ventures_Biomedpartners_Merck_Kgaa_Merck_Serono_Ventures_Sunstone_Capital_Vaximm_Ag_Completed> ;
    ns1:name "Merck Serono Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1098407/Merck_Kgaa> ;
    ns1:sameAsMedium <https://1145.am/db/2307739/Merck_Serono_Ventures>,
        <https://1145.am/db/2364035/Merck_Serono_Ventures>,
        <https://1145.am/db/2365103/Merck_Serono_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2577419/Astellas_Pharma> a org:Organization ;
    ns1:basedInHighGeoName "Japan" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1861060/about.rdf> ;
    ns1:basedInHighRaw "Japan" ;
    ns1:buyer <https://1145.am/db/2577419/Osi_Pharmaceuticals_Acquisition> ;
    ns1:documentDate "2010-12-23T12:50:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dealmaking goes from mega to mini" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dealmaking-goes-from-mega-to-mini> ;
    ns1:foundName "Astellas Pharma" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Astellas Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1392122/Astrazeneca>,
        <https://1145.am/db/1633177/Astrazeneca>,
        <https://1145.am/db/171176/Astrazeneca>,
        <https://1145.am/db/172070/Astrazeneca>,
        <https://1145.am/db/173169/Astrazeneca>,
        <https://1145.am/db/1988637/Astellas_Pharma_Inc>,
        <https://1145.am/db/2010010/Astellas_Pharma_Inc>,
        <https://1145.am/db/2038202/Astellas_Pharma_Inc>,
        <https://1145.am/db/2071435/Astrazeneca>,
        <https://1145.am/db/2151794/Astrazeneca>,
        <https://1145.am/db/2154218/Astrazeneca>,
        <https://1145.am/db/2154845/Astellas_Pharma>,
        <https://1145.am/db/2201236/Astrazeneca>,
        <https://1145.am/db/2278880/Astrazeneca>,
        <https://1145.am/db/2279647/Astrazeneca>,
        <https://1145.am/db/2280668/Astrazeneca>,
        <https://1145.am/db/2282580/Astrazeneca>,
        <https://1145.am/db/2282957/Astrazeneca>,
        <https://1145.am/db/2283156/Astrazeneca>,
        <https://1145.am/db/2284338/Astrazeneca>,
        <https://1145.am/db/2285828/Astrazeneca>,
        <https://1145.am/db/2287488/Astrazeneca>,
        <https://1145.am/db/2290060/Astrazeneca>,
        <https://1145.am/db/2291200/Astellas_Pharma>,
        <https://1145.am/db/2292385/Astellas_Pharma>,
        <https://1145.am/db/2293132/Astrazeneca>,
        <https://1145.am/db/2299349/Astrazeneca>,
        <https://1145.am/db/2302618/Astellas_Pharma_Inc>,
        <https://1145.am/db/2303415/Astellas_Pharma>,
        <https://1145.am/db/2303920/Astrazeneca>,
        <https://1145.am/db/2304902/Astellas_Pharma>,
        <https://1145.am/db/2305152/Astrazeneca>,
        <https://1145.am/db/2305155/Astrazeneca>,
        <https://1145.am/db/2305866/Astrazeneca>,
        <https://1145.am/db/2306464/Asterand>,
        <https://1145.am/db/2306905/Astrazeneca>,
        <https://1145.am/db/2307059/Astrazeneca>,
        <https://1145.am/db/2307068/Astrazeneca>,
        <https://1145.am/db/2307834/Astrazeneca>,
        <https://1145.am/db/2310968/Astellas_Pharma_Inc>,
        <https://1145.am/db/2312088/Astellas_Pharma>,
        <https://1145.am/db/2312476/Astrazeneca>,
        <https://1145.am/db/2318484/Astrazeneca>,
        <https://1145.am/db/2318485/Astrazeneca>,
        <https://1145.am/db/2318609/Astrazeneca>,
        <https://1145.am/db/2319111/Astellas_Pharma>,
        <https://1145.am/db/2319208/Astellas_Pharma>,
        <https://1145.am/db/2319211/Astellas_Pharma_Inc>,
        <https://1145.am/db/2319675/Astrazeneca>,
        <https://1145.am/db/2325196/Astellas_Pharma_Inc>,
        <https://1145.am/db/2327304/Astellas_Pharma_Inc>,
        <https://1145.am/db/2328825/Ascendis_Pharma>,
        <https://1145.am/db/2331796/Astellas_Pharma_Inc>,
        <https://1145.am/db/2334131/Astrazeneca>,
        <https://1145.am/db/2335717/Astrazeneca>,
        <https://1145.am/db/2339206/Astrazeneca>,
        <https://1145.am/db/2342367/Astellas_Pharma>,
        <https://1145.am/db/2342722/Astrazeneca>,
        <https://1145.am/db/2343632/Astrazeneca>,
        <https://1145.am/db/2343892/Astrazeneca>,
        <https://1145.am/db/2343913/Astrazeneca>,
        <https://1145.am/db/2343920/Astrazeneca>,
        <https://1145.am/db/2344057/Astrazeneca>,
        <https://1145.am/db/2345187/Astrazeneca>,
        <https://1145.am/db/2345375/Astex_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345426/Astrazeneca>,
        <https://1145.am/db/2345983/Astrazeneca>,
        <https://1145.am/db/2345996/Astrazeneca>,
        <https://1145.am/db/2347800/Astrazeneca>,
        <https://1145.am/db/2347971/Astrazeneca>,
        <https://1145.am/db/2350134/Astellas_Pharma_Inc>,
        <https://1145.am/db/2352067/Astrazeneca>,
        <https://1145.am/db/2352525/Astrazeneca>,
        <https://1145.am/db/2352532/Astrazeneca>,
        <https://1145.am/db/2353153/Astrazeneca>,
        <https://1145.am/db/2353550/Astrazeneca>,
        <https://1145.am/db/2353551/Astrazeneca>,
        <https://1145.am/db/2354064/Astellas_Pharma_Inc>,
        <https://1145.am/db/2354086/Astellas_Pharma_Inc>,
        <https://1145.am/db/2354978/Astrazeneca>,
        <https://1145.am/db/2355029/Astrazeneca>,
        <https://1145.am/db/2356384/Astrazeneca>,
        <https://1145.am/db/2356965/Astellas_Pharma_Inc>,
        <https://1145.am/db/2357230/Astrazeneca>,
        <https://1145.am/db/2357962/Astellas_Pharma>,
        <https://1145.am/db/2358193/Astellas_Pharma_Inc>,
        <https://1145.am/db/2358734/Astellas_Pharma_Inc>,
        <https://1145.am/db/2358768/Astrazeneca>,
        <https://1145.am/db/2359439/Astrazeneca>,
        <https://1145.am/db/2359539/Astrazeneca>,
        <https://1145.am/db/2359745/Astellas_Pharma>,
        <https://1145.am/db/2360237/Astrazeneca>,
        <https://1145.am/db/2360371/Astellas_Pharma>,
        <https://1145.am/db/2360562/Astrazeneca>,
        <https://1145.am/db/2360683/Astrazeneca>,
        <https://1145.am/db/2362425/Astellas_Pharma_Inc>,
        <https://1145.am/db/2362667/Astrazeneca>,
        <https://1145.am/db/2362670/Astrazeneca>,
        <https://1145.am/db/2362966/Astrazeneca>,
        <https://1145.am/db/2363405/Astrazeneca>,
        <https://1145.am/db/2364184/Astex_Pharmaceuticals>,
        <https://1145.am/db/2364191/Astex_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364805/Astrazeneca>,
        <https://1145.am/db/2365403/Astrazeneca>,
        <https://1145.am/db/2366678/Astellas_Pharma_Inc>,
        <https://1145.am/db/2367645/Astrazeneca>,
        <https://1145.am/db/2367646/Astrazeneca>,
        <https://1145.am/db/2367730/Astellas_Pharma_Inc>,
        <https://1145.am/db/2367731/Astellas_Pharma>,
        <https://1145.am/db/2368632/Astrazeneca>,
        <https://1145.am/db/2368654/Astellas_Pharma>,
        <https://1145.am/db/2368742/Astrazeneca>,
        <https://1145.am/db/2368900/Astrazeneca>,
        <https://1145.am/db/2369491/Astrazeneca>,
        <https://1145.am/db/2369493/Astrazeneca>,
        <https://1145.am/db/2369520/Astellas_Pharma_Inc>,
        <https://1145.am/db/2369607/Astrazeneca>,
        <https://1145.am/db/2370174/Astrazeneca>,
        <https://1145.am/db/2370175/Astrazeneca>,
        <https://1145.am/db/2370409/Astellas_Pharma>,
        <https://1145.am/db/2371094/Astrazeneca>,
        <https://1145.am/db/2537410/Astrazeneca>,
        <https://1145.am/db/2538238/Astrazeneca>,
        <https://1145.am/db/2538239/Astrazeneca>,
        <https://1145.am/db/2538821/Astrazeneca>,
        <https://1145.am/db/2539508/Astrazeneca>,
        <https://1145.am/db/2539509/Astrazeneca>,
        <https://1145.am/db/2539517/Astrazeneca>,
        <https://1145.am/db/2540845/Astrazeneca>,
        <https://1145.am/db/2543372/Astellas_Pharma>,
        <https://1145.am/db/2543375/Astellas_Pharma_Inc>,
        <https://1145.am/db/2543378/Astellas_Pharma>,
        <https://1145.am/db/2544077/Astrazeneca>,
        <https://1145.am/db/2544536/Astrazeneca>,
        <https://1145.am/db/2545023/Astrazeneca>,
        <https://1145.am/db/2545426/Astrazeneca>,
        <https://1145.am/db/2545610/Astellas_Pharma>,
        <https://1145.am/db/2546143/Astrazeneca>,
        <https://1145.am/db/2546314/Astrazeneca>,
        <https://1145.am/db/2547386/Astrazeneca>,
        <https://1145.am/db/2547785/Astrazeneca>,
        <https://1145.am/db/2548384/Astrazeneca>,
        <https://1145.am/db/2549670/Astellas_Pharma>,
        <https://1145.am/db/2549890/Astrazeneca>,
        <https://1145.am/db/2550962/Astrazeneca>,
        <https://1145.am/db/2551557/Aslan_Pharmaceuticals>,
        <https://1145.am/db/2553162/Astrazeneca>,
        <https://1145.am/db/2553168/Astrazeneca>,
        <https://1145.am/db/2553619/Astellas_Pharma>,
        <https://1145.am/db/2554064/Astrazeneca>,
        <https://1145.am/db/2554933/Astrazeneca>,
        <https://1145.am/db/2555142/Astrazeneca>,
        <https://1145.am/db/2556522/Astrazeneca>,
        <https://1145.am/db/2556536/Astrazeneca>,
        <https://1145.am/db/2556928/Astrazeneca>,
        <https://1145.am/db/2557406/Astrazeneca>,
        <https://1145.am/db/2558118/Astrazeneca>,
        <https://1145.am/db/2558133/Astellas_Pharma>,
        <https://1145.am/db/2559469/Astrazeneca>,
        <https://1145.am/db/2560865/Astellas_Pharma>,
        <https://1145.am/db/2561319/Astrazeneca>,
        <https://1145.am/db/2562249/Astrazeneca>,
        <https://1145.am/db/2563422/Astellas_Pharma>,
        <https://1145.am/db/2566037/Astrazeneca>,
        <https://1145.am/db/2566038/Astellas_Pharma>,
        <https://1145.am/db/2566415/Astrazeneca>,
        <https://1145.am/db/2566926/Astrazeneca>,
        <https://1145.am/db/2566929/Astrazeneca>,
        <https://1145.am/db/2567518/Astrazeneca>,
        <https://1145.am/db/2568895/Astrazeneca>,
        <https://1145.am/db/2569075/Astrazeneca_Plc>,
        <https://1145.am/db/2569709/Astrazeneca>,
        <https://1145.am/db/2570586/Astrazeneca>,
        <https://1145.am/db/2570592/Astrazeneca>,
        <https://1145.am/db/257192/Astrazeneca_Plc>,
        <https://1145.am/db/2572938/Astrazeneca>,
        <https://1145.am/db/2573339/Astellas_Pharma>,
        <https://1145.am/db/2573463/Astrazeneca>,
        <https://1145.am/db/2573978/Astrazeneca>,
        <https://1145.am/db/2573984/Astrazeneca>,
        <https://1145.am/db/2574096/Astrazeneca>,
        <https://1145.am/db/2575176/Astrazeneca>,
        <https://1145.am/db/2575183/Astrazeneca>,
        <https://1145.am/db/2575270/Astrazeneca>,
        <https://1145.am/db/257625/Astrazeneca_Plc>,
        <https://1145.am/db/2577797/Astrazeneca>,
        <https://1145.am/db/2578213/Astrazeneca>,
        <https://1145.am/db/2578454/Astrazeneca>,
        <https://1145.am/db/2579507/Astrazeneca>,
        <https://1145.am/db/2579630/Astrazeneca>,
        <https://1145.am/db/2580038/Astrazeneca>,
        <https://1145.am/db/2580053/Astrazeneca>,
        <https://1145.am/db/2580491/Astrazeneca>,
        <https://1145.am/db/2580556/Astrazeneca>,
        <https://1145.am/db/2580632/Astrazeneca>,
        <https://1145.am/db/2580642/Astrazeneca>,
        <https://1145.am/db/2582242/Astrazeneca>,
        <https://1145.am/db/2583124/Astrazeneca>,
        <https://1145.am/db/2583402/Astellas_Pharma>,
        <https://1145.am/db/2586257/Astrazeneca>,
        <https://1145.am/db/2587500/Astrazeneca>,
        <https://1145.am/db/2588049/Astrazeneca>,
        <https://1145.am/db/2590009/Astrazeneca>,
        <https://1145.am/db/2590159/Astellas_Pharma_Inc>,
        <https://1145.am/db/2591384/Astrazeneca>,
        <https://1145.am/db/2591652/Astrazeneca>,
        <https://1145.am/db/2591691/Astrazeneca>,
        <https://1145.am/db/2592696/Astrazeneca>,
        <https://1145.am/db/2593265/Astrazeneca>,
        <https://1145.am/db/2594107/Astrazeneca>,
        <https://1145.am/db/2594183/Astex_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594184/Astex_Pharmaceuticals>,
        <https://1145.am/db/2594365/Astrazeneca>,
        <https://1145.am/db/2594602/Astellas_Pharma>,
        <https://1145.am/db/2595368/Astellas_Pharma>,
        <https://1145.am/db/2595413/Astellas_Pharma_Inc>,
        <https://1145.am/db/2595981/Astrazeneca>,
        <https://1145.am/db/2596046/Astrazeneca>,
        <https://1145.am/db/2596053/Astrazeneca>,
        <https://1145.am/db/2596838/Astex_Pharmaceuticals>,
        <https://1145.am/db/2597175/Astrazeneca>,
        <https://1145.am/db/2597935/Astellas_Pharma>,
        <https://1145.am/db/2789987/Astrazeneca>,
        <https://1145.am/db/340451/Astrazeneca>,
        <https://1145.am/db/340474/Astrazeneca>,
        <https://1145.am/db/381681/Astrazeneca_Plc>,
        <https://1145.am/db/488413/Astrazeneca>,
        <https://1145.am/db/510316/Astrazeneca>,
        <https://1145.am/db/624169/Astrazeneca> ;
    ns1:sameAsMedium <https://1145.am/db/1988943/Astellas_Pharma>,
        <https://1145.am/db/2280769/Astellas_Pharma>,
        <https://1145.am/db/2287015/Astellas_Pharma>,
        <https://1145.am/db/2304792/Astellas_Pharma_Us>,
        <https://1145.am/db/2337343/Astellas_Pharma_Us>,
        <https://1145.am/db/2347222/Astellas_Pharma_Inc>,
        <https://1145.am/db/2370015/Astellas_Pharma_Inc>,
        <https://1145.am/db/2370029/Astellas_Pharma_Inc>,
        <https://1145.am/db/2370041/Astellas_Pharma_Inc>,
        <https://1145.am/db/2557314/Astellas_Pharma>,
        <https://1145.am/db/2584750/Astellas_Pharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2577419/Novartis> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:buyer <https://1145.am/db/2577419/Alcon_Stake_Acquisition>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals_Acquisition> ;
    ns1:documentDate "2010-12-23T12:50:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dealmaking goes from mega to mini" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dealmaking-goes-from-mega-to-mini> ;
    ns1:foundName "Novartis" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Novartis" ;
    ns1:sameAsHigh <https://1145.am/db/1176158/Novartis>,
        <https://1145.am/db/1177562/Novartis>,
        <https://1145.am/db/131136/Novartis>,
        <https://1145.am/db/132002/Novartis>,
        <https://1145.am/db/1328753/Novartis>,
        <https://1145.am/db/1507918/Novartis_Ag>,
        <https://1145.am/db/156403/Novartis>,
        <https://1145.am/db/1567521/Novartis>,
        <https://1145.am/db/1578114/Novartis>,
        <https://1145.am/db/1628428/Novalgen_Ltd>,
        <https://1145.am/db/1629605/Novartis>,
        <https://1145.am/db/1629663/Novartis>,
        <https://1145.am/db/165056/Novartis>,
        <https://1145.am/db/176334/Novartis>,
        <https://1145.am/db/177096/Novartis>,
        <https://1145.am/db/1986468/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/2033677/Novartis>,
        <https://1145.am/db/2062728/Novan>,
        <https://1145.am/db/2107835/Novartis>,
        <https://1145.am/db/2129754/Novartis>,
        <https://1145.am/db/2152605/Novartis>,
        <https://1145.am/db/2152618/Novartis>,
        <https://1145.am/db/2153059/Novartis>,
        <https://1145.am/db/2154527/Novartis>,
        <https://1145.am/db/2155069/Novartis>,
        <https://1145.am/db/2155665/Novartis>,
        <https://1145.am/db/2190363/Novartis_Ag>,
        <https://1145.am/db/2194161/Novartis>,
        <https://1145.am/db/2279108/Novartis>,
        <https://1145.am/db/2279232/Novartis>,
        <https://1145.am/db/2279829/Novartis>,
        <https://1145.am/db/2280153/Novartis>,
        <https://1145.am/db/2280350/Novartis>,
        <https://1145.am/db/2283590/Novartis>,
        <https://1145.am/db/2283645/Novartis>,
        <https://1145.am/db/2285311/Novartis>,
        <https://1145.am/db/2286604/Novartis>,
        <https://1145.am/db/2288851/Novartis>,
        <https://1145.am/db/2289846/Novartis>,
        <https://1145.am/db/2290022/Novartis>,
        <https://1145.am/db/2293323/Novartis>,
        <https://1145.am/db/2293342/Novartis>,
        <https://1145.am/db/2293591/Novartis>,
        <https://1145.am/db/2294026/Novartis>,
        <https://1145.am/db/2294585/Novartis>,
        <https://1145.am/db/2296504/Novartis>,
        <https://1145.am/db/2296552/Novartis>,
        <https://1145.am/db/2298606/Novartis>,
        <https://1145.am/db/2301066/Novartis>,
        <https://1145.am/db/2301089/Novartis>,
        <https://1145.am/db/2301705/Novasep>,
        <https://1145.am/db/2301735/Novartis>,
        <https://1145.am/db/2301857/Novartis>,
        <https://1145.am/db/2302724/Novartis>,
        <https://1145.am/db/2302727/Novartis>,
        <https://1145.am/db/2303121/Novartis_Bioventures>,
        <https://1145.am/db/230344/Swiss_Drugmaker_Novartis>,
        <https://1145.am/db/2304113/Novartis>,
        <https://1145.am/db/2304373/Novartis>,
        <https://1145.am/db/2304374/Novartis>,
        <https://1145.am/db/2305192/Novartis>,
        <https://1145.am/db/2305244/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2307228/Novadel_Pharma_Inc>,
        <https://1145.am/db/2307347/Novartis>,
        <https://1145.am/db/2307847/Novartis>,
        <https://1145.am/db/2307863/Novartis>,
        <https://1145.am/db/2307998/Novartis>,
        <https://1145.am/db/2308010/Novartis>,
        <https://1145.am/db/2308298/Novartis>,
        <https://1145.am/db/2308765/Novartis>,
        <https://1145.am/db/2308812/Novartis>,
        <https://1145.am/db/2308946/Novartis_Ag>,
        <https://1145.am/db/2309065/Novartis_Intercell>,
        <https://1145.am/db/2310150/Novartis>,
        <https://1145.am/db/2312008/Novartis>,
        <https://1145.am/db/2312018/Novartis_International_Ag>,
        <https://1145.am/db/2312088/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2312436/Novartis>,
        <https://1145.am/db/2317845/Novadel>,
        <https://1145.am/db/2317949/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2317951/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2318994/Novadel>,
        <https://1145.am/db/2319412/Novartis>,
        <https://1145.am/db/2320828/Novartis>,
        <https://1145.am/db/2321067/Novartis>,
        <https://1145.am/db/2322266/Novartis>,
        <https://1145.am/db/2323188/Novartis>,
        <https://1145.am/db/2323692/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2325073/Novartis>,
        <https://1145.am/db/2325869/Novartis>,
        <https://1145.am/db/2326949/Novartis>,
        <https://1145.am/db/2327560/Novartis>,
        <https://1145.am/db/2329413/Novadel_Pharma_Inc>,
        <https://1145.am/db/2329475/Novadel_Pharma>,
        <https://1145.am/db/2329597/Novartis>,
        <https://1145.am/db/2330648/Novartis>,
        <https://1145.am/db/2331875/Novadel>,
        <https://1145.am/db/2332005/Novartis>,
        <https://1145.am/db/2332788/Novartis_Ag>,
        <https://1145.am/db/2332796/Novadel_Pharma_Inc>,
        <https://1145.am/db/2332872/Novartis>,
        <https://1145.am/db/2334206/Novartis>,
        <https://1145.am/db/2334645/Novast>,
        <https://1145.am/db/2336028/Novartis>,
        <https://1145.am/db/2336704/Novartis>,
        <https://1145.am/db/2339656/Novartis>,
        <https://1145.am/db/2339669/Novartis>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2340948/Novartis>,
        <https://1145.am/db/2344017/Novartis>,
        <https://1145.am/db/2344434/Novartis>,
        <https://1145.am/db/2346576/Novadel_Pharma_Inc>,
        <https://1145.am/db/2346629/Novartis>,
        <https://1145.am/db/2348176/Novartis>,
        <https://1145.am/db/2349068/Novartis>,
        <https://1145.am/db/2352045/Novartis>,
        <https://1145.am/db/2352046/Novartis>,
        <https://1145.am/db/2354148/Novartis>,
        <https://1145.am/db/2358273/Novartis>,
        <https://1145.am/db/2358297/Novartis>,
        <https://1145.am/db/2359165/Novartis>,
        <https://1145.am/db/2359179/Novartis>,
        <https://1145.am/db/2359915/Novadel_Pharma_Inc>,
        <https://1145.am/db/2360526/Novartis>,
        <https://1145.am/db/2360633/Novartis>,
        <https://1145.am/db/2362448/Novadel_Pharma_Inc>,
        <https://1145.am/db/2363618/Novartis_Uk>,
        <https://1145.am/db/2367118/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2367207/Novartis>,
        <https://1145.am/db/2367829/Novartis_International_Ag>,
        <https://1145.am/db/2367836/Novartis_International_Ag>,
        <https://1145.am/db/2367993/Novabay>,
        <https://1145.am/db/2368571/Novartis>,
        <https://1145.am/db/2368646/Novartis>,
        <https://1145.am/db/2368659/Novartis>,
        <https://1145.am/db/2369183/Novartis>,
        <https://1145.am/db/2369450/Novartis>,
        <https://1145.am/db/2369451/Novartis>,
        <https://1145.am/db/2369555/Swiss_Pharma_Giant_Novartis>,
        <https://1145.am/db/2369718/Novartis>,
        <https://1145.am/db/2370010/Novartis>,
        <https://1145.am/db/2370013/Novartis>,
        <https://1145.am/db/2370615/Novartis>,
        <https://1145.am/db/2370635/Novartis>,
        <https://1145.am/db/2371070/Novartis>,
        <https://1145.am/db/2371077/Novartis>,
        <https://1145.am/db/2371323/Novartis>,
        <https://1145.am/db/2371326/Novartis>,
        <https://1145.am/db/2434670/Novartis>,
        <https://1145.am/db/2536325/Novartis>,
        <https://1145.am/db/2536882/Novartis>,
        <https://1145.am/db/2536914/Novartis>,
        <https://1145.am/db/2537064/Novartis>,
        <https://1145.am/db/2537477/Novartis>,
        <https://1145.am/db/2537482/Novacea>,
        <https://1145.am/db/2538344/Novartis>,
        <https://1145.am/db/2538791/Novartis>,
        <https://1145.am/db/2539541/Novasep>,
        <https://1145.am/db/2539787/Novartis>,
        <https://1145.am/db/2539925/Novartis>,
        <https://1145.am/db/2540187/Novartis>,
        <https://1145.am/db/2541511/Novartis>,
        <https://1145.am/db/2542938/Novartis>,
        <https://1145.am/db/2543689/Novartis>,
        <https://1145.am/db/2544236/Novartis>,
        <https://1145.am/db/2544326/Novartis>,
        <https://1145.am/db/2545284/Novartis>,
        <https://1145.am/db/2545651/Novartis>,
        <https://1145.am/db/2545966/Novartis>,
        <https://1145.am/db/2545986/Novartis>,
        <https://1145.am/db/2546157/Novartis>,
        <https://1145.am/db/2546170/Novartis>,
        <https://1145.am/db/2546603/Novartis>,
        <https://1145.am/db/2547397/Novartis>,
        <https://1145.am/db/2548223/Novartis>,
        <https://1145.am/db/2548224/Novartis_Group>,
        <https://1145.am/db/2549043/Novartis>,
        <https://1145.am/db/2549631/Novast>,
        <https://1145.am/db/2550855/Novartis>,
        <https://1145.am/db/2551143/Novartis>,
        <https://1145.am/db/2551693/Novartis>,
        <https://1145.am/db/2551694/Novartis>,
        <https://1145.am/db/2552165/Novartis>,
        <https://1145.am/db/2552258/Novartis>,
        <https://1145.am/db/2553024/Novartis>,
        <https://1145.am/db/2553276/Novartis>,
        <https://1145.am/db/2553480/Novartis>,
        <https://1145.am/db/2553740/Novasep>,
        <https://1145.am/db/2553810/Novartis>,
        <https://1145.am/db/2553846/Novartis>,
        <https://1145.am/db/2554060/Novartis>,
        <https://1145.am/db/2554669/Novasep>,
        <https://1145.am/db/2555555/Novartis>,
        <https://1145.am/db/2555561/Novartis>,
        <https://1145.am/db/2556030/Novartis>,
        <https://1145.am/db/2556543/Novartis>,
        <https://1145.am/db/2557588/Novartis>,
        <https://1145.am/db/2558316/Novartis>,
        <https://1145.am/db/2558415/Novartis>,
        <https://1145.am/db/2558779/Novartis>,
        <https://1145.am/db/2558927/Novartis>,
        <https://1145.am/db/2559306/Novartis>,
        <https://1145.am/db/2559655/Novartis>,
        <https://1145.am/db/2559797/Novartis>,
        <https://1145.am/db/2559802/Novartis>,
        <https://1145.am/db/2559810/Switzerlands_Novartis>,
        <https://1145.am/db/2560023/Novartis>,
        <https://1145.am/db/2560079/Novartis>,
        <https://1145.am/db/2561162/Novasep>,
        <https://1145.am/db/2561268/Novartis>,
        <https://1145.am/db/2561541/Novartis>,
        <https://1145.am/db/2561955/Novartis>,
        <https://1145.am/db/2562202/Novartis>,
        <https://1145.am/db/2562695/Novartis>,
        <https://1145.am/db/2562951/Novartis>,
        <https://1145.am/db/2563497/Novartis>,
        <https://1145.am/db/2563987/Novartis>,
        <https://1145.am/db/2564141/Novartis>,
        <https://1145.am/db/2564268/Novartis>,
        <https://1145.am/db/2564695/Novartis>,
        <https://1145.am/db/2565142/Novartis>,
        <https://1145.am/db/2565794/Novartis>,
        <https://1145.am/db/2565844/Novartis>,
        <https://1145.am/db/2567283/Novartis>,
        <https://1145.am/db/2567300/Novartis>,
        <https://1145.am/db/2567942/Novartis>,
        <https://1145.am/db/2568308/Novartis>,
        <https://1145.am/db/2568932/Novartis>,
        <https://1145.am/db/2568968/Novartis>,
        <https://1145.am/db/2568973/Novartis>,
        <https://1145.am/db/2570214/Novartis>,
        <https://1145.am/db/2570791/Novartis>,
        <https://1145.am/db/2570932/Novartis>,
        <https://1145.am/db/2570937/Novartis_Uk>,
        <https://1145.am/db/2571513/Novartis>,
        <https://1145.am/db/2571519/Novartis>,
        <https://1145.am/db/2571527/Novartis>,
        <https://1145.am/db/2572713/Novartis>,
        <https://1145.am/db/2572904/Novartis_Group>,
        <https://1145.am/db/2572985/Novartis>,
        <https://1145.am/db/2573002/Novartis>,
        <https://1145.am/db/2573473/Novartis>,
        <https://1145.am/db/2573517/Novartis>,
        <https://1145.am/db/2573611/Novartis>,
        <https://1145.am/db/2574958/Novartis>,
        <https://1145.am/db/2575047/Novartis>,
        <https://1145.am/db/2575310/Novartis>,
        <https://1145.am/db/2575313/Novartis>,
        <https://1145.am/db/2575488/Novartis>,
        <https://1145.am/db/2575545/Novartis>,
        <https://1145.am/db/2575625/Novartis>,
        <https://1145.am/db/2575702/Novartis>,
        <https://1145.am/db/2575712/Novartis>,
        <https://1145.am/db/2575810/Novartis_Ag>,
        <https://1145.am/db/2575813/Novartis>,
        <https://1145.am/db/2576242/Novartis>,
        <https://1145.am/db/2576254/Novartis>,
        <https://1145.am/db/2576547/Novartis>,
        <https://1145.am/db/2576933/Novartis>,
        <https://1145.am/db/2577129/Novartis>,
        <https://1145.am/db/2577998/Novartis>,
        <https://1145.am/db/2579507/Novartis>,
        <https://1145.am/db/2579519/Novartis>,
        <https://1145.am/db/2580047/Novartis>,
        <https://1145.am/db/2580401/Novartis>,
        <https://1145.am/db/2580963/Novartis>,
        <https://1145.am/db/2581378/Novartis>,
        <https://1145.am/db/2581394/Novartis>,
        <https://1145.am/db/2581397/Novartis>,
        <https://1145.am/db/2581493/Novartis>,
        <https://1145.am/db/2581716/Novartis>,
        <https://1145.am/db/2582355/Novartis>,
        <https://1145.am/db/2582395/Novartis>,
        <https://1145.am/db/2582400/Novartis>,
        <https://1145.am/db/2582402/Novartis>,
        <https://1145.am/db/2582623/Novartis>,
        <https://1145.am/db/2582643/Novartis>,
        <https://1145.am/db/2583067/Novartis>,
        <https://1145.am/db/2584538/Novartis>,
        <https://1145.am/db/2585039/Novartis>,
        <https://1145.am/db/2585121/Novartis>,
        <https://1145.am/db/2586661/Novatis>,
        <https://1145.am/db/2586670/Novartis>,
        <https://1145.am/db/2587047/Novartis>,
        <https://1145.am/db/2587857/Novartis>,
        <https://1145.am/db/2588196/Novartis>,
        <https://1145.am/db/2589178/Novartis>,
        <https://1145.am/db/2589535/Novartis>,
        <https://1145.am/db/2591905/Novartis>,
        <https://1145.am/db/2592351/Novartis>,
        <https://1145.am/db/2592505/Novartis>,
        <https://1145.am/db/2592895/Novartis>,
        <https://1145.am/db/2592987/Novartis>,
        <https://1145.am/db/2593443/Novartis>,
        <https://1145.am/db/2594494/Novartis>,
        <https://1145.am/db/2594935/Novartis>,
        <https://1145.am/db/2594940/Novartis>,
        <https://1145.am/db/2595048/Novartis>,
        <https://1145.am/db/2595150/Novartis>,
        <https://1145.am/db/2595688/Novartis>,
        <https://1145.am/db/2596344/Novartis>,
        <https://1145.am/db/2597197/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2598636/Novartis>,
        <https://1145.am/db/2787530/Novartis>,
        <https://1145.am/db/282192/Novartis>,
        <https://1145.am/db/346162/Novartis>,
        <https://1145.am/db/488391/Novartis>,
        <https://1145.am/db/509708/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/595011/Novartis>,
        <https://1145.am/db/601300/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/637582/Novartis>,
        <https://1145.am/db/652831/Novartis>,
        <https://1145.am/db/661296/Novartis>,
        <https://1145.am/db/691279/Novartis>,
        <https://1145.am/db/712016/Novartis>,
        <https://1145.am/db/895235/Novan> ;
    ns1:sameAsMedium <https://1145.am/db/1151476/Novartis>,
        <https://1145.am/db/1629127/Novartis>,
        <https://1145.am/db/1630421/Novartis>,
        <https://1145.am/db/2033933/Novartis>,
        <https://1145.am/db/2036487/Novartis_Ag>,
        <https://1145.am/db/2065993/Novartis_Ag>,
        <https://1145.am/db/2076347/Novartis>,
        <https://1145.am/db/2155042/Novartis>,
        <https://1145.am/db/2186148/Novartis>,
        <https://1145.am/db/2290898/Novartis>,
        <https://1145.am/db/2291090/Novartis>,
        <https://1145.am/db/2291713/Novartis>,
        <https://1145.am/db/2293419/Novartis>,
        <https://1145.am/db/2294680/Novartis>,
        <https://1145.am/db/2299847/Novartis>,
        <https://1145.am/db/2307851/Novartis>,
        <https://1145.am/db/2309347/Novartis>,
        <https://1145.am/db/2321958/Novartis>,
        <https://1145.am/db/2325386/Novartis>,
        <https://1145.am/db/2332408/Novartis>,
        <https://1145.am/db/2333390/Novartis>,
        <https://1145.am/db/2336990/Novartis>,
        <https://1145.am/db/2337976/Novartis>,
        <https://1145.am/db/2342687/Novartis>,
        <https://1145.am/db/2343460/Novartis>,
        <https://1145.am/db/2352178/Novartis>,
        <https://1145.am/db/2358559/Novartis>,
        <https://1145.am/db/2358579/Novartis>,
        <https://1145.am/db/2361451/Novartis>,
        <https://1145.am/db/2369178/Novartis>,
        <https://1145.am/db/2371165/Novartis>,
        <https://1145.am/db/2371188/Novartis>,
        <https://1145.am/db/2371203/Novartis>,
        <https://1145.am/db/2536538/Novartis>,
        <https://1145.am/db/2537155/Novartis>,
        <https://1145.am/db/2544350/Novartis>,
        <https://1145.am/db/2544409/Novartis>,
        <https://1145.am/db/2550764/Novartis>,
        <https://1145.am/db/2551001/Novartis>,
        <https://1145.am/db/2551402/Novartis>,
        <https://1145.am/db/2552856/Novartis>,
        <https://1145.am/db/2553487/Novartis>,
        <https://1145.am/db/2557204/Novartis>,
        <https://1145.am/db/2560238/Novartis>,
        <https://1145.am/db/2562442/Novartis>,
        <https://1145.am/db/2565564/Novartis>,
        <https://1145.am/db/2566121/Novartis>,
        <https://1145.am/db/2568734/Novartis>,
        <https://1145.am/db/2569724/Novartis>,
        <https://1145.am/db/2570062/Novartis>,
        <https://1145.am/db/2570721/Novartis>,
        <https://1145.am/db/2571462/Novartis>,
        <https://1145.am/db/2573984/Novartis>,
        <https://1145.am/db/2574584/Novartis>,
        <https://1145.am/db/2574950/Novartis>,
        <https://1145.am/db/2575947/Novartis>,
        <https://1145.am/db/2576892/Novartis>,
        <https://1145.am/db/2578046/Novartis>,
        <https://1145.am/db/2579890/Novartis>,
        <https://1145.am/db/2581804/Novartis>,
        <https://1145.am/db/2582646/Novartis>,
        <https://1145.am/db/2583163/Novartis>,
        <https://1145.am/db/2584135/Novartis>,
        <https://1145.am/db/2584245/Novartis>,
        <https://1145.am/db/2587048/Novartis>,
        <https://1145.am/db/2587805/Novartis>,
        <https://1145.am/db/2588333/Novartis>,
        <https://1145.am/db/2588691/Novartis>,
        <https://1145.am/db/2589799/Novartis>,
        <https://1145.am/db/2590887/Novartis>,
        <https://1145.am/db/2593780/Novartis>,
        <https://1145.am/db/2595924/Novartis_Ag>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2577419/Sanofi-Aventis> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:buyer <https://1145.am/db/2577419/Chattem_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2010-12-23T12:50:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dealmaking goes from mega to mini" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dealmaking-goes-from-mega-to-mini> ;
    ns1:foundName "Sanofi-Aventis" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Sanofi-Aventis" ;
    ns1:sameAsHigh <https://1145.am/db/1110205/Sanofi_Sa>,
        <https://1145.am/db/1114745/Sanofi>,
        <https://1145.am/db/1116151/Sanofi>,
        <https://1145.am/db/1177954/Sanofi>,
        <https://1145.am/db/1252297/Sanofi>,
        <https://1145.am/db/1316541/Sanofi>,
        <https://1145.am/db/1317517/Sanofi>,
        <https://1145.am/db/137297/Sanofi>,
        <https://1145.am/db/138669/Sanofi>,
        <https://1145.am/db/1533327/Sanofi_Ventures>,
        <https://1145.am/db/1533685/Sanofi_Ventures>,
        <https://1145.am/db/1541946/Sanofi>,
        <https://1145.am/db/1548955/Sanofi>,
        <https://1145.am/db/1931929/Sanofi>,
        <https://1145.am/db/1935113/Sanofi>,
        <https://1145.am/db/194991/Sanofi>,
        <https://1145.am/db/195055/Sanofi>,
        <https://1145.am/db/1953742/Sanofi>,
        <https://1145.am/db/1985052/Sanofi>,
        <https://1145.am/db/2137147/Sanofi>,
        <https://1145.am/db/2152605/Sanofi>,
        <https://1145.am/db/2152611/Sanofi>,
        <https://1145.am/db/2154031/Sanofi>,
        <https://1145.am/db/2154432/Sanofi>,
        <https://1145.am/db/2154444/Sanofi>,
        <https://1145.am/db/2154660/Sanofi>,
        <https://1145.am/db/2154812/Sanofi>,
        <https://1145.am/db/2154850/Sanofi>,
        <https://1145.am/db/2155307/Sanofi>,
        <https://1145.am/db/2241046/Sanofi-Aventis>,
        <https://1145.am/db/2278957/Sanofi>,
        <https://1145.am/db/2279007/Sanofi>,
        <https://1145.am/db/2280255/Sanofi>,
        <https://1145.am/db/2282197/Sanofi>,
        <https://1145.am/db/2282344/Sanofi>,
        <https://1145.am/db/2285905/Sanofi>,
        <https://1145.am/db/2286521/Sanofi>,
        <https://1145.am/db/2286823/Sanofi>,
        <https://1145.am/db/2286894/Sanofi>,
        <https://1145.am/db/2287400/Sanofi>,
        <https://1145.am/db/2290842/Sanofi>,
        <https://1145.am/db/2293342/Sanofi>,
        <https://1145.am/db/2296552/Sanofi_Genzyme>,
        <https://1145.am/db/2297648/Sanofi>,
        <https://1145.am/db/2300140/Sanofi>,
        <https://1145.am/db/2301137/Sanofi>,
        <https://1145.am/db/2301170/Sanofi>,
        <https://1145.am/db/2303989/Sanofi-Aventis>,
        <https://1145.am/db/2303991/Sanofi-Aventis>,
        <https://1145.am/db/2303992/Sanofi-Aventis>,
        <https://1145.am/db/2304313/Sanofi-Aventis>,
        <https://1145.am/db/2304370/Sanofi>,
        <https://1145.am/db/2304646/Sanofi-Aventis>,
        <https://1145.am/db/2306290/Sanofi-Aventis>,
        <https://1145.am/db/2307903/Sanofi>,
        <https://1145.am/db/2308778/Sanofi-Aventis>,
        <https://1145.am/db/2308961/Sanofi-Aventis_Europe>,
        <https://1145.am/db/2309866/Sanofi>,
        <https://1145.am/db/2311677/Sanofi-Aventis_Us>,
        <https://1145.am/db/2312115/Sanofi-Aventis>,
        <https://1145.am/db/2313209/Sanofi-Aventis>,
        <https://1145.am/db/2313287/Sanofi-Aventis>,
        <https://1145.am/db/2315315/Sanofi-Aventis>,
        <https://1145.am/db/2319330/Sanofi-Aventis>,
        <https://1145.am/db/2319334/Sanofi>,
        <https://1145.am/db/2319764/Sanofi-Aventis_Us>,
        <https://1145.am/db/2319769/Sanofi>,
        <https://1145.am/db/2319773/Sanofi-Aventis_Us>,
        <https://1145.am/db/2319838/Sanofi-Aventis>,
        <https://1145.am/db/2320000/Sanofi-Aventis>,
        <https://1145.am/db/2321466/Sanofi-Aventis>,
        <https://1145.am/db/2321557/Sanofi-Aventis>,
        <https://1145.am/db/2322297/Sanofi-Aventis>,
        <https://1145.am/db/2322509/Sanofi-Aventis>,
        <https://1145.am/db/2324095/Sanofi-Aventis>,
        <https://1145.am/db/2325835/Sanofi-Aventis>,
        <https://1145.am/db/2326978/Sanofi>,
        <https://1145.am/db/2328712/Sanofi-Aventis>,
        <https://1145.am/db/2328729/Sanofi-Aventis>,
        <https://1145.am/db/2331206/Sanofi>,
        <https://1145.am/db/2333555/Sanofi>,
        <https://1145.am/db/2334183/Sanofi-Aventis>,
        <https://1145.am/db/2336075/Sanofi>,
        <https://1145.am/db/2336811/Sanofi>,
        <https://1145.am/db/2337279/Sanofi>,
        <https://1145.am/db/2337501/Sanofi>,
        <https://1145.am/db/2339639/Sanofi-Aventis>,
        <https://1145.am/db/2340923/Sanofi>,
        <https://1145.am/db/2341620/Sanofi>,
        <https://1145.am/db/2341792/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2341800/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2341959/Sanofi>,
        <https://1145.am/db/2342823/Sanofi>,
        <https://1145.am/db/2344788/Sanofi>,
        <https://1145.am/db/2344918/Sanofi>,
        <https://1145.am/db/2345128/Sanofi-Aventis>,
        <https://1145.am/db/2345144/Sanofi-Aventis>,
        <https://1145.am/db/2345275/Sanofi>,
        <https://1145.am/db/2345278/Sanofi>,
        <https://1145.am/db/2347557/Sanofi-Aventis>,
        <https://1145.am/db/2348041/Sanofi>,
        <https://1145.am/db/2350149/Sanofi>,
        <https://1145.am/db/2350156/Sanofi>,
        <https://1145.am/db/2350188/Sanofi>,
        <https://1145.am/db/2350290/Sanofi>,
        <https://1145.am/db/2353778/Sanofi-Aventis>,
        <https://1145.am/db/2354894/Sanofi>,
        <https://1145.am/db/2356384/Sanofi-Aventis>,
        <https://1145.am/db/2356453/Sanofi>,
        <https://1145.am/db/2358227/Sanofi>,
        <https://1145.am/db/2360382/Sanofi-Aventis>,
        <https://1145.am/db/2361756/Sanofi>,
        <https://1145.am/db/2361762/Sanofi-Aventis>,
        <https://1145.am/db/2362809/Sanofi-Aventis>,
        <https://1145.am/db/2362893/Sanofi>,
        <https://1145.am/db/2364295/Sanofi-Aventis>,
        <https://1145.am/db/2364717/Sanofi-Aventis>,
        <https://1145.am/db/2365152/Sanofi>,
        <https://1145.am/db/2366608/Sanofi-Aventis>,
        <https://1145.am/db/2366682/Sanofi>,
        <https://1145.am/db/2366691/Sanofi-Aventis>,
        <https://1145.am/db/2366935/Sanofi>,
        <https://1145.am/db/2367188/Sanofi>,
        <https://1145.am/db/2367537/Sanofi>,
        <https://1145.am/db/2368181/Sanofi_Group>,
        <https://1145.am/db/2369920/Sanofi>,
        <https://1145.am/db/2370852/Sanofi>,
        <https://1145.am/db/2370897/Sanofi>,
        <https://1145.am/db/2370991/Sanofi>,
        <https://1145.am/db/2536247/Sanofi>,
        <https://1145.am/db/2537459/Sanofi>,
        <https://1145.am/db/2537482/Sanofi-Aventis>,
        <https://1145.am/db/2538082/Sanofi>,
        <https://1145.am/db/2538595/Sanofi-Aventis>,
        <https://1145.am/db/2538666/Sanofi>,
        <https://1145.am/db/2538728/Sanofi>,
        <https://1145.am/db/2538761/Sanofi>,
        <https://1145.am/db/2539788/Sanofi>,
        <https://1145.am/db/2540527/Sanofi>,
        <https://1145.am/db/2541684/Sanofi>,
        <https://1145.am/db/2542471/Sanofi>,
        <https://1145.am/db/2542477/Sanofi>,
        <https://1145.am/db/2543989/Sanofi>,
        <https://1145.am/db/2544435/Sanofi>,
        <https://1145.am/db/2544525/Sanofi>,
        <https://1145.am/db/2544560/Sanofi>,
        <https://1145.am/db/2544596/Sanofi-Aventis>,
        <https://1145.am/db/2544788/Sanofi>,
        <https://1145.am/db/2546160/Sanofi>,
        <https://1145.am/db/2546321/Sanofi>,
        <https://1145.am/db/2546603/Sanofi-Aventis>,
        <https://1145.am/db/2546629/Sanofi-Aventis>,
        <https://1145.am/db/2547653/Sanofi-Aventis>,
        <https://1145.am/db/2548674/Sanofi-Aventis>,
        <https://1145.am/db/2548677/Sanofi-Aventis>,
        <https://1145.am/db/2549121/Sanofi-Aventis>,
        <https://1145.am/db/2549313/Sanofi_Pasteur>,
        <https://1145.am/db/2549862/Sanofi_India>,
        <https://1145.am/db/2549933/Sanofi>,
        <https://1145.am/db/2550420/Sanofi>,
        <https://1145.am/db/2550719/Sanofi>,
        <https://1145.am/db/2550743/Sanofi>,
        <https://1145.am/db/2550868/Sanofi>,
        <https://1145.am/db/2551966/Sanofi>,
        <https://1145.am/db/2552490/Sanofi>,
        <https://1145.am/db/2552794/Sanofi-Aventis>,
        <https://1145.am/db/2553131/Sanofi>,
        <https://1145.am/db/2553354/Sanofi-Aventis>,
        <https://1145.am/db/2553497/Sanofi>,
        <https://1145.am/db/2553799/Sanofi-Aventis>,
        <https://1145.am/db/2553978/Sanofi>,
        <https://1145.am/db/2554814/Sanofi>,
        <https://1145.am/db/2556017/Sanofi>,
        <https://1145.am/db/2557509/Sanofi>,
        <https://1145.am/db/2558115/Sanofi>,
        <https://1145.am/db/2558679/Sanofi>,
        <https://1145.am/db/2558927/Sanofi>,
        <https://1145.am/db/2559069/Sanofi-Aventis>,
        <https://1145.am/db/2559247/Sanofi>,
        <https://1145.am/db/2559471/Sanofi>,
        <https://1145.am/db/2560854/Sanofi>,
        <https://1145.am/db/2560886/Sanofi_Pasteur>,
        <https://1145.am/db/2561700/Sanofi>,
        <https://1145.am/db/2562230/Sanofi>,
        <https://1145.am/db/2562306/Sanofi>,
        <https://1145.am/db/2562482/Sanofi-Aventis>,
        <https://1145.am/db/2563447/Sanofi-Aventis>,
        <https://1145.am/db/2566057/Sanofi>,
        <https://1145.am/db/2566482/Sanofi>,
        <https://1145.am/db/2567475/Sanofi>,
        <https://1145.am/db/2567517/Sanofi>,
        <https://1145.am/db/2568031/Sanofi>,
        <https://1145.am/db/2568144/Sanofi>,
        <https://1145.am/db/2571093/Sanofi>,
        <https://1145.am/db/2571467/Sanofi>,
        <https://1145.am/db/2572739/Sanofi-Aventis>,
        <https://1145.am/db/2573878/Sanofi>,
        <https://1145.am/db/2574505/Sanofi-Aventis>,
        <https://1145.am/db/2575450/Sanofi-Aventis>,
        <https://1145.am/db/2575623/Sanofi-Aventis>,
        <https://1145.am/db/2576254/Sanofi>,
        <https://1145.am/db/2576512/Sanofi-Aventis>,
        <https://1145.am/db/2576516/Sanofi>,
        <https://1145.am/db/2578346/Sanofi>,
        <https://1145.am/db/2578503/Sanofi-Aventis>,
        <https://1145.am/db/2578550/Sanofi-Aventis>,
        <https://1145.am/db/2578745/Sanofi>,
        <https://1145.am/db/2581176/Sanofi>,
        <https://1145.am/db/2581325/Sanofi>,
        <https://1145.am/db/2581432/Sanofi>,
        <https://1145.am/db/2583301/Sanofi-Aventis>,
        <https://1145.am/db/2583302/Sanofi>,
        <https://1145.am/db/2585710/Sanofi>,
        <https://1145.am/db/2585746/Sanofi>,
        <https://1145.am/db/2586373/Sanofi>,
        <https://1145.am/db/2586657/Sanofi>,
        <https://1145.am/db/2586658/Sanofi>,
        <https://1145.am/db/2587087/Sanofi>,
        <https://1145.am/db/2588362/Sanofi>,
        <https://1145.am/db/2588622/Sanofi>,
        <https://1145.am/db/2589423/Sanofi>,
        <https://1145.am/db/2589657/Sanofi>,
        <https://1145.am/db/2590017/Sanofi-Aventis>,
        <https://1145.am/db/2590137/Sanofi-Aventis>,
        <https://1145.am/db/2591938/Sanofi>,
        <https://1145.am/db/2592083/Sanofi-Aventis>,
        <https://1145.am/db/2592093/Sanofi-Aventis>,
        <https://1145.am/db/2592987/Sanofi-Aventis>,
        <https://1145.am/db/2593103/Sanofi>,
        <https://1145.am/db/2593819/Sanofi-Aventis>,
        <https://1145.am/db/2594116/Sanofi>,
        <https://1145.am/db/2595039/Sanofi>,
        <https://1145.am/db/2595050/Sanofi>,
        <https://1145.am/db/2595051/Sanofi>,
        <https://1145.am/db/2595150/Sanofi>,
        <https://1145.am/db/2595303/Sanofi-Aventis>,
        <https://1145.am/db/2595389/Sanofi-Aventis_Sp_Z_Oo>,
        <https://1145.am/db/2595483/Sanofi>,
        <https://1145.am/db/2595685/Sanofi>,
        <https://1145.am/db/2596034/Sanofi-Aventis>,
        <https://1145.am/db/2597433/Sanofi>,
        <https://1145.am/db/2597899/Sanofi-Aventis>,
        <https://1145.am/db/2598231/Sanofi>,
        <https://1145.am/db/2598237/Sanofi>,
        <https://1145.am/db/2598478/Sanofi-Aventis>,
        <https://1145.am/db/2767240/Sanofi>,
        <https://1145.am/db/2790381/Sanofi>,
        <https://1145.am/db/364048/Sanofi>,
        <https://1145.am/db/389077/Sanofi>,
        <https://1145.am/db/389114/Sanofi>,
        <https://1145.am/db/389294/Sanofi>,
        <https://1145.am/db/389303/Sanofi>,
        <https://1145.am/db/389554/Sanofi>,
        <https://1145.am/db/389590/Sanofi>,
        <https://1145.am/db/455480/Sanofi>,
        <https://1145.am/db/460895/Sanofi_Sa>,
        <https://1145.am/db/471607/Sanofi>,
        <https://1145.am/db/601458/Sanofi>,
        <https://1145.am/db/627105/Sanofi>,
        <https://1145.am/db/664174/Sanofi>,
        <https://1145.am/db/664442/Sanofi>,
        <https://1145.am/db/700482/Sanofi_Sa>,
        <https://1145.am/db/708041/Sanofi_Sa>,
        <https://1145.am/db/712037/Sanofi>,
        <https://1145.am/db/713105/Sanofi_Sa>,
        <https://1145.am/db/713127/Sanofi_Sa>,
        <https://1145.am/db/913775/Sanofi> ;
    ns1:sameAsMedium <https://1145.am/db/2288560/Sanofi-Aventis>,
        <https://1145.am/db/2306662/Sanofi-Aventis_Us>,
        <https://1145.am/db/2350305/Sanofi-Aventis>,
        <https://1145.am/db/2546596/Sanofi-Aventis>,
        <https://1145.am/db/2548693/Sanofi-Aventis>,
        <https://1145.am/db/2550758/Sanofi-Aventis>,
        <https://1145.am/db/2592013/Sanofi-Aventis>,
        <https://1145.am/db/2597878/Sanofi-Aventis> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2591540/Aenova> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:foundName "Aenova" ;
    ns1:investor <https://1145.am/db/2591540/Skyepharma_Business_Investment> ;
    ns1:name "Aenova" ;
    ns1:sameAsHigh <https://1145.am/db/2302275/Alexza_Pharmaceuticals>,
        <https://1145.am/db/2302703/Avalon_Pharmaceuticals>,
        <https://1145.am/db/2307847/Altus_Pharmaceuticals>,
        <https://1145.am/db/2311551/Alnara_Pharmaceuticals>,
        <https://1145.am/db/2311701/Avalon_Pharmaceuticals>,
        <https://1145.am/db/2313433/Avalon_Pharmaceuticals>,
        <https://1145.am/db/2316410/Avalon_Pharmaceuticals>,
        <https://1145.am/db/2317819/Avalon_Pharmaceuticals>,
        <https://1145.am/db/2318828/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326883/Alnara_Pharmaceuticals>,
        <https://1145.am/db/2327418/Aeolus_Pharmaceuticals>,
        <https://1145.am/db/2331044/Altus_Pharmaceuticals>,
        <https://1145.am/db/2335728/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336966/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2339350/Alexza_Pharmaceuticals>,
        <https://1145.am/db/2342843/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342857/Affinium_Pharmaceuticals>,
        <https://1145.am/db/2347466/Amira_Pharmaceuticals>,
        <https://1145.am/db/2347486/Amira_Pharmaceuticals>,
        <https://1145.am/db/2347488/Amira>,
        <https://1145.am/db/2354144/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362966/Ardea>,
        <https://1145.am/db/2363530/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2550884/Alexion_Pharmaceuticals>,
        <https://1145.am/db/2588287/Alexza_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596128/Amira_Pharmaceuticals>,
        <https://1145.am/db/2596137/Amira_Pharmaceuticals>,
        <https://1145.am/db/2598400/Alexion_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2318420/Aenova>,
        <https://1145.am/db/2336555/Aenova>,
        <https://1145.am/db/2558073/Aenova>,
        <https://1145.am/db/2577241/Aenova>,
        <https://1145.am/db/2580123/Aenova>,
        <https://1145.am/db/2591584/Aenova>,
        <https://1145.am/db/2592707/Aenova> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2591540/Bankruptcy_Salix_Pharmaceuticals_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "bankruptcy" ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Gastrointestinal specialist Salix Pharmaceuticals saw its second-quarter profit beat analyst estimates on growing sales of its diarrhea drug Xifaxan." ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:vendor <https://1145.am/db/2591540/Salix_Pharmaceuticals> ;
    ns1:whereGeoName "Hungary" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/719819/about.rdf> ;
    ns1:whereRaw "Hungary" .

<https://1145.am/db/2591540/Gedeon_Richter> a org:Organization ;
    ns1:basedInHighGeoName "Hungary" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/719819/about.rdf> ;
    ns1:basedInHighRaw "Hungary" ;
    ns1:buyer <https://1145.am/db/2591540/Polpharma_Acquisition> ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:foundName "Gedeon Richter" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Gedeon Richter" ;
    ns1:sameAsHigh <https://1145.am/db/2341838/Richter>,
        <https://1145.am/db/2348232/Gedeon_Richter_Plc>,
        <https://1145.am/db/2366906/Gedeon_Richter_Plc>,
        <https://1145.am/db/2366906/Richter>,
        <https://1145.am/db/2367100/Gedeon_Richter_Plc>,
        <https://1145.am/db/2559783/Richter_Gedeon>,
        <https://1145.am/db/2561426/Gedeon_Richter>,
        <https://1145.am/db/2575183/Richter>,
        <https://1145.am/db/2596684/Gedeon_Richter>,
        <https://1145.am/db/92181/Gedeon_Richter> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2591540/Genefar> a org:Organization ;
    ns1:basedInHighGeoName "Hungary" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/719819/about.rdf> ;
    ns1:basedInHighRaw "Hungary" ;
    ns1:buyer <https://1145.am/db/2591540/Bankruptcy_Genefar_Completed>,
        <https://1145.am/db/2591540/Polpharma_Acquisition> ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:foundName "Genefar" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Genefar" ;
    ns1:sameAsHigh <https://1145.am/db/2311110/Genextra_Spa>,
        <https://1145.am/db/2311264/Generex_Biotechnology>,
        <https://1145.am/db/2319365/Pharma_Genexx_Sa>,
        <https://1145.am/db/2319368/Pharma_Genexx>,
        <https://1145.am/db/2321661/Geneweave>,
        <https://1145.am/db/2328729/Geneohm>,
        <https://1145.am/db/2538424/Geneweave>,
        <https://1145.am/db/2564042/Pharma_Genexx> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2591540/Zydus_Pharmaceuticals_And_Zynesher_Pharmaceuticals> a org:Organization ;
    ns1:buyer <https://1145.am/db/2591540/Unit_Acquisition_Kv_Pharmaceutical_Zydus_Pharmaceuticals_And_Zynesher_Pharmaceuticals_Completed> ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:foundName "Zydus Pharmaceuticals and Zynesher Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Zydus Pharmaceuticals and Zynesher Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2320498/Ziarco>,
        <https://1145.am/db/2342869/Ziarco>,
        <https://1145.am/db/2343918/Ziarco> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2592467/Actera> a org:Organization ;
    ns1:basedInLowRaw "Turkish" ;
    ns1:buyer <https://1145.am/db/2592467/Bilim_Ilac_Stake_Acquisition>,
        <https://1145.am/db/2592467/Stake_Acquisition_Actera_Has_Not_Happened> ;
    ns1:description "investments in the country" ;
    ns1:documentDate "2011-08-12T15:40:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Turkish private equity fund eyes stake in Bilim Ilac" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/turkish-private-equity-fund-eyes-stake-bilim-ilac> ;
    ns1:foundName "Actera" ;
    ns1:industry "drugmakers" ;
    ns1:investor <https://1145.am/db/2592467/Bilim_Ilac_Stake_Acquisition> ;
    ns1:name "Actera" ;
    ns1:sameAsHigh <https://1145.am/db/2302549/Actogenix_Nv>,
        <https://1145.am/db/2324308/Actelion>,
        <https://1145.am/db/2329567/Actogenix>,
        <https://1145.am/db/2332731/Actelion_Ltd>,
        <https://1145.am/db/2332736/Actelion_Ltd>,
        <https://1145.am/db/2335645/Actogenix>,
        <https://1145.am/db/2340158/Actelion>,
        <https://1145.am/db/2342789/Actelion_Pharmaceuticals_Ltd___Actelion>,
        <https://1145.am/db/2347970/Actelion>,
        <https://1145.am/db/2359634/Actelion>,
        <https://1145.am/db/2363251/Actelion>,
        <https://1145.am/db/2370009/Actelion>,
        <https://1145.am/db/2371313/Actelion>,
        <https://1145.am/db/2543863/Actelion_Pharmaceuticals>,
        <https://1145.am/db/2573110/Actelion>,
        <https://1145.am/db/2575552/Actelion>,
        <https://1145.am/db/2576815/Actelion>,
        <https://1145.am/db/2593442/Actelion> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2598807/Telepacific> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2598807/Business_Acquisition_Megapaths_Nextweb_Telepacific_Completed>,
        <https://1145.am/db/2598807/Clec_One_Communications_Acquisition>,
        <https://1145.am/db/2598807/Covad_Wireless_Acquisition> ;
    ns1:description "telecommunications" ;
    ns1:documentDate "2011-04-04T15:42:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TelePacific finishes acquisition of Covad's wireless unit" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/telepacific-finishes-acquisition-covad-s-wireless-unit> ;
    ns1:foundName "TelePacific" ;
    ns1:industry "telecom service provider" ;
    ns1:name "TelePacific" ;
    ns1:sameAsHigh <https://1145.am/db/1082931/Tele2>,
        <https://1145.am/db/1647595/Telecel_Group>,
        <https://1145.am/db/2122859/Telecable>,
        <https://1145.am/db/2606726/Telx>,
        <https://1145.am/db/2613397/Telcordia>,
        <https://1145.am/db/2616904/Telepacific>,
        <https://1145.am/db/2620256/Telcel>,
        <https://1145.am/db/2624429/Telepacific_Communications>,
        <https://1145.am/db/2635292/Telamon_Corporation>,
        <https://1145.am/db/2636895/Telcodr>,
        <https://1145.am/db/2642411/Tele2>,
        <https://1145.am/db/2654849/Tele2>,
        <https://1145.am/db/2655889/Tele2>,
        <https://1145.am/db/2656135/Tele2_Ab>,
        <https://1145.am/db/2656418/Tele2>,
        <https://1145.am/db/2656436/Tele2>,
        <https://1145.am/db/2656843/Complete_Telecom>,
        <https://1145.am/db/2658794/Telma>,
        <https://1145.am/db/2658934/Tele2>,
        <https://1145.am/db/2660246/Tele2>,
        <https://1145.am/db/2665526/Tele2_Ab>,
        <https://1145.am/db/2666401/Tele2>,
        <https://1145.am/db/2668781/Tele2>,
        <https://1145.am/db/2670712/Tele2>,
        <https://1145.am/db/2671912/Tele2>,
        <https://1145.am/db/2675065/Tele2>,
        <https://1145.am/db/2675362/Tele2>,
        <https://1145.am/db/2676000/Tele2tango>,
        <https://1145.am/db/689502/Telenium>,
        <https://1145.am/db/931110/Telenet> ;
    ns1:sameAsMedium <https://1145.am/db/2602984/Telepacific>,
        <https://1145.am/db/2604461/Telepacific>,
        <https://1145.am/db/2605994/Telepacific>,
        <https://1145.am/db/2607652/Telepacific>,
        <https://1145.am/db/2612097/Telepacific> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2602193/Equinix> a org:Organization ;
    ns1:basedInLowRaw "Brazil" ;
    ns1:buyer <https://1145.am/db/2602193/Alog_Data_Centers_Major_Stake_Investment> ;
    ns1:description "data center provider" ;
    ns1:documentDate "2011-04-27T11:10:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Equinix gains instant Latin American presence by completing its ALOG acquisition" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/equinix-gains-instant-latin-american-presence-by-completing-its-alog-acquisition> ;
    ns1:foundName "Equinix" ;
    ns1:industry "data center provider" ;
    ns1:investor <https://1145.am/db/2602193/Alog_Data_Centers_Major_Stake_Investment> ;
    ns1:name "Equinix" ;
    ns1:sameAsHigh <https://1145.am/db/1758707/Equinix>,
        <https://1145.am/db/1763759/Equinix>,
        <https://1145.am/db/1764056/Equinix>,
        <https://1145.am/db/1805752/Equinix>,
        <https://1145.am/db/1806962/Equinix>,
        <https://1145.am/db/2600161/Equinix>,
        <https://1145.am/db/2601884/Equinix>,
        <https://1145.am/db/2602464/Equinix>,
        <https://1145.am/db/2602786/Equinix>,
        <https://1145.am/db/2604151/Equinix>,
        <https://1145.am/db/2606711/Equinix>,
        <https://1145.am/db/2610230/Equinix>,
        <https://1145.am/db/2610349/Equinix>,
        <https://1145.am/db/2612445/Equinix>,
        <https://1145.am/db/2612463/Equinix>,
        <https://1145.am/db/2612782/Equinix>,
        <https://1145.am/db/2614389/Equinix>,
        <https://1145.am/db/2616014/Equinix>,
        <https://1145.am/db/2617606/Equinix>,
        <https://1145.am/db/2617960/Equinix>,
        <https://1145.am/db/2650919/Equinix>,
        <https://1145.am/db/2677412/Equinix> ;
    ns1:sameAsMedium <https://1145.am/db/2600734/Equinix_Inc>,
        <https://1145.am/db/2605652/Equinix>,
        <https://1145.am/db/2606114/Equinix>,
        <https://1145.am/db/2608867/Equinix>,
        <https://1145.am/db/2609467/Equinix>,
        <https://1145.am/db/2610406/Equinix>,
        <https://1145.am/db/2617457/Equinix>,
        <https://1145.am/db/2617480/Equinix>,
        <https://1145.am/db/2617767/Equinix>,
        <https://1145.am/db/2618189/Equinix>,
        <https://1145.am/db/2619522/Equinix>,
        <https://1145.am/db/2620979/Equinix> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2602193/Riverwood_Capital> a org:Organization ;
    ns1:basedInLowRaw "Brazil" ;
    ns1:description "private equity" ;
    ns1:documentDate "2011-04-27T11:10:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Equinix gains instant Latin American presence by completing its ALOG acquisition" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/equinix-gains-instant-latin-american-presence-by-completing-its-alog-acquisition> ;
    ns1:foundName "Riverwood Capital" ;
    ns1:industry "private equity" ;
    ns1:investor <https://1145.am/db/2602193/Alog_Data_Centers_Major_Stake_Investment> ;
    ns1:name "Riverwood Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1241259/Golden_Gate_Capital>,
        <https://1145.am/db/1318669/Eagletree_Capital>,
        <https://1145.am/db/155434/Golden_Gate_Capital>,
        <https://1145.am/db/1631042/Exeter_Street_Capital_Partners>,
        <https://1145.am/db/1837450/Riverwood_Capital>,
        <https://1145.am/db/1891928/Riverwood_Capital>,
        <https://1145.am/db/199500/Vance_Street_Capital>,
        <https://1145.am/db/2109794/Riverwood_Capital>,
        <https://1145.am/db/2151141/Centergate_Capital>,
        <https://1145.am/db/2668266/Golden_Gate_Capital>,
        <https://1145.am/db/336377/Oaktree_Capital_Group>,
        <https://1145.am/db/413383/Charter_Oak_Equity>,
        <https://1145.am/db/435888/Oaktree_Capital>,
        <https://1145.am/db/582350/Eagletree_Capital>,
        <https://1145.am/db/590254/Eagletree_Capital>,
        <https://1145.am/db/607097/Eagletree_Capital>,
        <https://1145.am/db/741241/Exeter_Street_Capital_Partners>,
        <https://1145.am/db/815640/Oaktree_Capital_Management> ;
    ns1:sameAsMedium <https://1145.am/db/1050767/Riverwood_Capital>,
        <https://1145.am/db/1052126/Riverwood_Capital>,
        <https://1145.am/db/1084279/Riverwood_Capital>,
        <https://1145.am/db/1468368/Riverwood_Capital>,
        <https://1145.am/db/1578326/Riverwood_Capital>,
        <https://1145.am/db/1695849/Riverwood_Capital>,
        <https://1145.am/db/1721106/Riverwood_Capital>,
        <https://1145.am/db/1736524/Riverwood_Capital>,
        <https://1145.am/db/1736737/Riverwood_Capital>,
        <https://1145.am/db/1739158/Riverwood_Capital>,
        <https://1145.am/db/1752966/Riverwood_Capital>,
        <https://1145.am/db/1756891/Riverwood_Capital>,
        <https://1145.am/db/1759124/Riverwood_Capital>,
        <https://1145.am/db/1787985/Riverwood_Capital>,
        <https://1145.am/db/1804680/Riverwood_Capital>,
        <https://1145.am/db/1809998/Riverwood_Capital>,
        <https://1145.am/db/1840999/Riverwood_Capital>,
        <https://1145.am/db/1861038/Riverwood_Capital>,
        <https://1145.am/db/2078071/Riverwood_Capital>,
        <https://1145.am/db/2095037/Riverwood_Capital>,
        <https://1145.am/db/2101910/Riverwood_Capital>,
        <https://1145.am/db/2617960/Riverwood_Capital>,
        <https://1145.am/db/346598/Riverwood_Capital>,
        <https://1145.am/db/386715/Riverwood_Capital> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2606756/Citrix_Systems> a org:Organization ;
    ns1:buyer <https://1145.am/db/2606756/Cloudcom_Acquisition> ;
    ns1:documentDate "2011-07-13T12:19:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Citrix acquires Cloud.com; Apple's bet on TV, home automation could be $100B opportunity" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/citrix-acquires-cloud-com-apple-s-bet-tv-home-automation-could-be-100b-opportunity> ;
    ns1:foundName "Citrix Systems" ;
    ns1:name "Citrix Systems" ;
    ns1:sameAsMedium <https://1145.am/db/1115849/Citrix_Systems_Inc>,
        <https://1145.am/db/1195454/Citrix_Systems>,
        <https://1145.am/db/1195467/Citrix_Systems>,
        <https://1145.am/db/1198430/Citrix_Systems>,
        <https://1145.am/db/1198449/Citrix_Systems>,
        <https://1145.am/db/1331374/Citrix_Systems_Inc>,
        <https://1145.am/db/1362244/Citrix_Systems_Inc>,
        <https://1145.am/db/1367464/Citrix_Systems_Inc>,
        <https://1145.am/db/1381944/Citrix_Systems>,
        <https://1145.am/db/1383068/Citrix_Systems>,
        <https://1145.am/db/1414854/Citrix_Systems>,
        <https://1145.am/db/1825611/Citrix_Systems>,
        <https://1145.am/db/1870015/Citrix_Systems>,
        <https://1145.am/db/1870286/Citrix_Systems>,
        <https://1145.am/db/1876258/Citrix_Systems>,
        <https://1145.am/db/1887457/Citrix_Systems>,
        <https://1145.am/db/1957833/Citrix_Systems>,
        <https://1145.am/db/199514/Citrix_Systems_Inc>,
        <https://1145.am/db/474402/Citrix_Systems_Inc>,
        <https://1145.am/db/526928/Citrix_Systems>,
        <https://1145.am/db/527525/Citrix_Systems>,
        <https://1145.am/db/713065/Citrix_Systems_Inc>,
        <https://1145.am/db/794087/Citrix_Systems_Inc>,
        <https://1145.am/db/795731/Citrix_Systems_Inc>,
        <https://1145.am/db/799269/Citrix_Systems_Inc>,
        <https://1145.am/db/799475/Citrix_Systems>,
        <https://1145.am/db/799510/Citrix_Systems>,
        <https://1145.am/db/800113/Citrix_Systems>,
        <https://1145.am/db/816382/Citrix_Systems>,
        <https://1145.am/db/817355/Citrix_Systems>,
        <https://1145.am/db/819057/Citrix_Systems>,
        <https://1145.am/db/821431/Citrix_Systems>,
        <https://1145.am/db/865126/Citrix_Systems>,
        <https://1145.am/db/995492/Citrix_Systems>,
        <https://1145.am/db/995801/Citrix_Systems> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2606756/Swisscom> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:documentDate "2011-07-13T12:19:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Citrix acquires Cloud.com; Apple's bet on TV, home automation could be $100B opportunity" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/citrix-acquires-cloud-com-apple-s-bet-tv-home-automation-could-be-100b-opportunity> ;
    ns1:foundName "Swisscom" ;
    ns1:industry "Telecom" ;
    ns1:investor <https://1145.am/db/2606756/Investment_Swisscom_Winterthur_Public_Utilities_Has_Not_Happened> ;
    ns1:name "Swisscom" ;
    ns1:sameAsHigh <https://1145.am/db/2165483/Swisscom>,
        <https://1145.am/db/2609703/Swisscom>,
        <https://1145.am/db/2656116/Swisscom>,
        <https://1145.am/db/2660142/Swisscom>,
        <https://1145.am/db/2666380/Swisscom>,
        <https://1145.am/db/2666452/Swisscom> ;
    ns1:sameAsMedium <https://1145.am/db/1734104/Swisscom>,
        <https://1145.am/db/1795465/Swisscom>,
        <https://1145.am/db/2002735/Swisscom>,
        <https://1145.am/db/2179270/Swisscom>,
        <https://1145.am/db/2605723/Swisscom>,
        <https://1145.am/db/2637785/Swisscom>,
        <https://1145.am/db/2651967/Swisscom>,
        <https://1145.am/db/2656778/Swisscom>,
        <https://1145.am/db/2657449/Swisscom>,
        <https://1145.am/db/2657903/Swisscom>,
        <https://1145.am/db/2664154/Swisscom>,
        <https://1145.am/db/2666782/Swisscom>,
        <https://1145.am/db/2671103/Swisscom>,
        <https://1145.am/db/2672951/Swisscom>,
        <https://1145.am/db/2674136/Swisscom>,
        <https://1145.am/db/2678636/Swisscom>,
        <https://1145.am/db/2680106/Swisscom>,
        <https://1145.am/db/802844/Swisscom> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2618630/Bragg_Group> a org:Organization ;
    ns1:basedInHighGeoName "Canada" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:basedInHighRaw "Canada" ;
    ns1:buyer <https://1145.am/db/2618630/The_Bahamas_Telecommunications_Company_Operations_Acquisition> ;
    ns1:documentDate "2011-02-23T15:46:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cable & Wireless to sell off its Bermuda business" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/cable-wireless-to-sell-off-its-bermuda-business> ;
    ns1:foundName "Bragg Group" ;
    ns1:industry "telco and cable operator" ;
    ns1:investor <https://1145.am/db/2618630/The_Bahamas_Telecommunications_Company_Operations_Acquisition> ;
    ns1:name "Bragg Group" ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2618630/Singtel> a org:Organization ;
    ns1:basedInLowRaw "Singapore" ;
    ns1:buyer <https://1145.am/db/2618630/The_Bahamas_Telecommunications_Company_Operations_Acquisition> ;
    ns1:description "business" ;
    ns1:documentDate "2011-02-23T15:46:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cable & Wireless to sell off its Bermuda business" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/cable-wireless-to-sell-off-its-bermuda-business> ;
    ns1:foundName "SingTel" ;
    ns1:industry "telecommunications" ;
    ns1:name "SingTel" ;
    ns1:sameAsHigh <https://1145.am/db/1784384/Singtel>,
        <https://1145.am/db/1793231/Singtel>,
        <https://1145.am/db/1824295/Singtel>,
        <https://1145.am/db/1826633/Singtel>,
        <https://1145.am/db/1847400/Singtel>,
        <https://1145.am/db/2614188/Singtel>,
        <https://1145.am/db/2663006/Singtel>,
        <https://1145.am/db/2663397/Singtel>,
        <https://1145.am/db/2667040/Singtel>,
        <https://1145.am/db/2670169/Singtel> ;
    ns1:sameAsMedium <https://1145.am/db/1735713/Singtel>,
        <https://1145.am/db/1768719/Singtel>,
        <https://1145.am/db/1895713/Singtel>,
        <https://1145.am/db/2613008/Singtel>,
        <https://1145.am/db/2642430/Singtel>,
        <https://1145.am/db/2651909/Singtel>,
        <https://1145.am/db/2659738/Singtel>,
        <https://1145.am/db/773083/Singtel> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2655542/HTC> a org:Organization ;
    ns1:basedInHighGeoName "Taiwan" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1668284/about.rdf> ;
    ns1:basedInHighRaw "Taiwan" ;
    ns1:buyer <https://1145.am/db/2655542/Saffron_Digital_Stake_Acquisition> ;
    ns1:description "handset maker" ;
    ns1:documentDate "2011-02-08T01:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Finnish operators lack power; HTC acquires multimedia player" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-finnish-operators-lack-power-htc-acquires-multimedia-player> ;
    ns1:foundName "HTC" ;
    ns1:industry "handset maker" ;
    ns1:name "HTC" ;
    ns1:sameAsHigh <https://1145.am/db/1763823/HTC>,
        <https://1145.am/db/1773437/HTC>,
        <https://1145.am/db/1795912/HTC>,
        <https://1145.am/db/1800784/HTC>,
        <https://1145.am/db/1854602/HTC>,
        <https://1145.am/db/1868477/HTC>,
        <https://1145.am/db/1883625/Htc_America_Holding>,
        <https://1145.am/db/1887516/HTC>,
        <https://1145.am/db/2661446/HTC>,
        <https://1145.am/db/2662006/HTC>,
        <https://1145.am/db/2667468/HTC>,
        <https://1145.am/db/2677536/HTC>,
        <https://1145.am/db/2686310/HTC> ;
    ns1:sameAsMedium <https://1145.am/db/1705316/HTC>,
        <https://1145.am/db/1769806/HTC>,
        <https://1145.am/db/1811519/HTC>,
        <https://1145.am/db/1812840/HTC>,
        <https://1145.am/db/1828050/HTC>,
        <https://1145.am/db/1833831/HTC>,
        <https://1145.am/db/1838906/HTC>,
        <https://1145.am/db/1878212/HTC>,
        <https://1145.am/db/1879817/HTC>,
        <https://1145.am/db/2623618/HTC>,
        <https://1145.am/db/2626210/HTC>,
        <https://1145.am/db/2638567/HTC>,
        <https://1145.am/db/2654050/HTC>,
        <https://1145.am/db/2656198/HTC>,
        <https://1145.am/db/2672736/HTC>,
        <https://1145.am/db/2676313/HTC>,
        <https://1145.am/db/2686485/HTC> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2655542/Inmarsat_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-02-08T01:00:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Harbinger has a 14 % stake in Inmarsat, after selling half its stake for $ 660m (484 million) in October.",
        "US investment fund Harbinger Capital plans to today sell out of UK satellite operator Inmarsat." ;
    ns1:documentTitle "Webwire: Finnish operators lack power; HTC acquires multimedia player" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-finnish-operators-lack-power-htc-acquires-multimedia-player> ;
    ns1:foundName "sell",
        "selling" ;
    ns1:name "sell",
        "selling" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2655542/Inmarsat> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Inmarsat" ;
    ns1:valueRaw "$ 35 million",
        "$ 660m",
        "25.7 million",
        "484 million" ;
    ns1:vendor <https://1145.am/db/2655542/Harbinger_Capital> ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2655542/Ipo_Aircel_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "ipo" ;
    ns1:documentDate "2011-02-08T01:00:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aircel, the largest supplier of in-flight Wi-Fi, has raised $ 35 million (25.7 million) in operational funding as it gears up for an expected IPO." ;
    ns1:documentTitle "Webwire: Finnish operators lack power; HTC acquires multimedia player" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-finnish-operators-lack-power-htc-acquires-multimedia-player> ;
    ns1:foundName "IPO" ;
    ns1:name "IPO" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 35 million",
        "25.7 million" ;
    ns1:vendor <https://1145.am/db/2655542/Aircel> ;
    ns1:whereGeoName "Asia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255147/about.rdf> ;
    ns1:whereRaw "Asian" .

<https://1145.am/db/2655543/Mobitel> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Bulgaria" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/732800/about.rdf> ;
    ns1:basedInHighRaw "Bulgaria" ;
    ns1:buyer <https://1145.am/db/2655543/Megalan_Network_Acquisition> ;
    ns1:description "telecommunications" ;
    ns1:documentDate "2011-02-07T01:09:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Telekom Austria completes Bulgaria buys" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/telekom-austria-completes-bulgaria-buys> ;
    ns1:foundName "Mobitel" ;
    ns1:name "Mobitel" ;
    ns1:sameAsHigh <https://1145.am/db/1050899/Mobilitie>,
        <https://1145.am/db/1052635/Mobilitie>,
        <https://1145.am/db/2656676/Mobinil>,
        <https://1145.am/db/2663040/Mobistar>,
        <https://1145.am/db/2671922/Mobily>,
        <https://1145.am/db/523372/Mobilitie>,
        <https://1145.am/db/980082/Mobilitie>,
        <https://1145.am/db/981234/Mobilitie> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2655543/Telekom_Austria> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Austria" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2782113/about.rdf> ;
    ns1:basedInHighRaw "Austria" ;
    ns1:buyer <https://1145.am/db/2655543/Megalan_Network_Acquisition> ;
    ns1:documentDate "2011-02-07T01:09:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Telekom Austria completes Bulgaria buys" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/telekom-austria-completes-bulgaria-buys> ;
    ns1:foundName "Telekom Austria" ;
    ns1:investor <https://1145.am/db/2655543/Megalan_Network_Acquisition> ;
    ns1:name "Telekom Austria" ;
    ns1:sameAsMedium <https://1145.am/db/2602090/Telekom_Austria>,
        <https://1145.am/db/2604431/Telekom_Austria>,
        <https://1145.am/db/2605931/Telekom_Austria>,
        <https://1145.am/db/2618513/Telekom_Austria>,
        <https://1145.am/db/2651042/Telekom_Austria>,
        <https://1145.am/db/2651160/Telekom_Austria>,
        <https://1145.am/db/2651945/Telekom_Austria>,
        <https://1145.am/db/2652154/Telekom_Austria>,
        <https://1145.am/db/2653166/Telekom_Austria>,
        <https://1145.am/db/2653226/Telekom_Austria>,
        <https://1145.am/db/2656752/Telekom_Austria>,
        <https://1145.am/db/2656762/Telekom_Austria>,
        <https://1145.am/db/2656789/Telekom_Austria>,
        <https://1145.am/db/2657412/Telekom_Austria>,
        <https://1145.am/db/2657527/Telekom_Austria>,
        <https://1145.am/db/2658798/Telekom_Austria>,
        <https://1145.am/db/2659815/Telekom_Austria>,
        <https://1145.am/db/2660600/Telekom_Austria>,
        <https://1145.am/db/2661611/Telekom_Austria>,
        <https://1145.am/db/2661617/Telekom_Austria>,
        <https://1145.am/db/2661700/Telekom_Austria>,
        <https://1145.am/db/2661995/Telekom_Austria>,
        <https://1145.am/db/2663033/Telekom_Austria>,
        <https://1145.am/db/2663148/Telekom_Austria>,
        <https://1145.am/db/2663194/Telekom_Austria>,
        <https://1145.am/db/2663209/Telekom_Austria>,
        <https://1145.am/db/2663829/Telekom_Austria>,
        <https://1145.am/db/2664160/Telekom_Austria>,
        <https://1145.am/db/2664170/Telekom_Austria>,
        <https://1145.am/db/2664571/Telekom_Austria>,
        <https://1145.am/db/2664763/Telekom_Austria>,
        <https://1145.am/db/2664764/Telekom_Austria>,
        <https://1145.am/db/2666035/Telekom_Austria>,
        <https://1145.am/db/2666259/Telekom_Austria>,
        <https://1145.am/db/2666433/Telekom_Austria>,
        <https://1145.am/db/2667860/Telekom_Austria>,
        <https://1145.am/db/2668551/Telekom_Austria>,
        <https://1145.am/db/2668605/Telekom_Austria>,
        <https://1145.am/db/2669274/Telekom_Austria>,
        <https://1145.am/db/2670771/Telekom_Austria>,
        <https://1145.am/db/2670951/Austria_Telekom>,
        <https://1145.am/db/2671742/Telekom_Austria>,
        <https://1145.am/db/2673112/Telekom_Austria>,
        <https://1145.am/db/2677414/Telekom_Austria>,
        <https://1145.am/db/2677900/Telekom_Austria>,
        <https://1145.am/db/2677917/Telekom_Austria>,
        <https://1145.am/db/2679072/Telekom_Austria>,
        <https://1145.am/db/2679767/Telekom_Austria>,
        <https://1145.am/db/2680123/Telekom_Austria>,
        <https://1145.am/db/2680892/Telekom_Austria> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2660593/Vimpelcom> a org:Organization ;
    ns1:basedInLowRaw "Russia" ;
    ns1:buyer <https://1145.am/db/2660593/Orascom_Telecom_Acquisition> ;
    ns1:description "business" ;
    ns1:documentDate "2011-03-18T18:05:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vimpelcom becomes global player through $20bn Wind merger" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/vimpelcom-becomes-global-player-through-20bn-wind-merger> ;
    ns1:foundName "Vimpelcom" ;
    ns1:name "Vimpelcom" ;
    ns1:sameAsHigh <https://1145.am/db/2651270/Vimpelcom>,
        <https://1145.am/db/2659780/Vimpelcom>,
        <https://1145.am/db/2663852/Vimpelcom>,
        <https://1145.am/db/2666405/Vimpelcom>,
        <https://1145.am/db/2666410/Vimpelcom>,
        <https://1145.am/db/2667506/Vimpelcom>,
        <https://1145.am/db/2670712/Vimpelcom> ;
    ns1:sameAsMedium <https://1145.am/db/1529511/Vimpelcom>,
        <https://1145.am/db/1530772/Vimpelcom>,
        <https://1145.am/db/1656234/Vimpelcom>,
        <https://1145.am/db/1659276/Vimpelcom>,
        <https://1145.am/db/1668852/Vimpelcom>,
        <https://1145.am/db/2141019/Vimpelcom>,
        <https://1145.am/db/2600327/Vimpelcom>,
        <https://1145.am/db/2602370/Vimpelcom>,
        <https://1145.am/db/2602398/Vimpelcom>,
        <https://1145.am/db/2607010/Vimpelcom>,
        <https://1145.am/db/2611520/Vimpelcom>,
        <https://1145.am/db/2625867/Vimpelcom>,
        <https://1145.am/db/2626593/Vimpelcom>,
        <https://1145.am/db/2628046/Vimpelcom>,
        <https://1145.am/db/2646871/Vimpelcom>,
        <https://1145.am/db/2646907/Vimpelcom>,
        <https://1145.am/db/2652389/Vimpelcom>,
        <https://1145.am/db/2652974/Vimpelcom>,
        <https://1145.am/db/2652985/Vimpelcom>,
        <https://1145.am/db/2653167/Vimpelcom>,
        <https://1145.am/db/2653171/Vimpelcom>,
        <https://1145.am/db/2653186/Vimpelcom>,
        <https://1145.am/db/2653225/Vimpelcom>,
        <https://1145.am/db/2653311/Vimpelcom>,
        <https://1145.am/db/2654657/Vimpelcom>,
        <https://1145.am/db/2654675/Vimpelcom>,
        <https://1145.am/db/2655477/Vimpelcom>,
        <https://1145.am/db/2655754/Vimpelcom>,
        <https://1145.am/db/2658492/Vimpelcom>,
        <https://1145.am/db/2659767/Vimpelcom>,
        <https://1145.am/db/2659847/Vimpelcom>,
        <https://1145.am/db/2661700/Vimpelcom>,
        <https://1145.am/db/2661979/Vimpelcom>,
        <https://1145.am/db/2662999/Vimpelcom>,
        <https://1145.am/db/2663844/Vimpelcom>,
        <https://1145.am/db/2664167/Vimpelcom>,
        <https://1145.am/db/2664571/Vimpelcom>,
        <https://1145.am/db/2664956/Vimpelcom>,
        <https://1145.am/db/2665182/Vimpelcom>,
        <https://1145.am/db/2665211/Vimpelcom>,
        <https://1145.am/db/2665345/Vimpelcom>,
        <https://1145.am/db/2665678/Vimpelcom>,
        <https://1145.am/db/2666025/Vimpelcom>,
        <https://1145.am/db/2666299/Vimpelcom>,
        <https://1145.am/db/2667105/Vimpelcom>,
        <https://1145.am/db/2668411/Vimpelcom>,
        <https://1145.am/db/2668429/Vimpelcom>,
        <https://1145.am/db/2669505/Vimpelcom>,
        <https://1145.am/db/2669683/Vimpelcom>,
        <https://1145.am/db/2670639/Vimpelcom>,
        <https://1145.am/db/2670685/Vimpelcom>,
        <https://1145.am/db/2671088/Vimpelcom>,
        <https://1145.am/db/2671104/Vimpelcom>,
        <https://1145.am/db/2671481/Vimpelcom>,
        <https://1145.am/db/2671812/Vimpelcom>,
        <https://1145.am/db/2671929/Vimpelcom>,
        <https://1145.am/db/2671975/Vimpelcom>,
        <https://1145.am/db/2672659/Vimpelcom>,
        <https://1145.am/db/2672667/Vimpelcom>,
        <https://1145.am/db/2672959/Vimpelcom>,
        <https://1145.am/db/2673845/Vimpelcom>,
        <https://1145.am/db/2674298/Vimpelcom>,
        <https://1145.am/db/2676518/Vimpelcom>,
        <https://1145.am/db/2676527/Vimpelcom>,
        <https://1145.am/db/2676659/Vimpelcom>,
        <https://1145.am/db/2678839/Vimpelcom>,
        <https://1145.am/db/2678849/Vimpelcom>,
        <https://1145.am/db/2679855/Vimpelcom>,
        <https://1145.am/db/2680662/Vimpelcom>,
        <https://1145.am/db/2683657/Vimpelcom>,
        <https://1145.am/db/2723235/Vimpelcom> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2660601/Telefonica> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:buyer <https://1145.am/db/2660601/Vivo_Acquisition> ;
    ns1:documentDate "2011-03-21T01:08:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Telefonica edges nearer to Vivo close" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/telefonica-edges-nearer-to-vivo-close> ;
    ns1:foundName "Telefonica" ;
    ns1:industry "telecom" ;
    ns1:investor <https://1145.am/db/2660601/Vivo_Acquisition> ;
    ns1:name "Telefonica" ;
    ns1:sameAsHigh <https://1145.am/db/1069736/Telefonica>,
        <https://1145.am/db/1104836/Telefonica>,
        <https://1145.am/db/1231195/Telefonica>,
        <https://1145.am/db/1285688/Telefonica>,
        <https://1145.am/db/1382369/Telefonica>,
        <https://1145.am/db/1671318/Telefonica>,
        <https://1145.am/db/1735164/Telefonica>,
        <https://1145.am/db/1739933/Telefnica>,
        <https://1145.am/db/1823997/Telefonica_Digital>,
        <https://1145.am/db/1847191/Telefonica_Digital>,
        <https://1145.am/db/2057136/Telefonica>,
        <https://1145.am/db/2108234/Telefonica>,
        <https://1145.am/db/2108651/Telefonica>,
        <https://1145.am/db/2109170/Telefonica>,
        <https://1145.am/db/2157611/Telefnica>,
        <https://1145.am/db/255451/Telefonica_Sa>,
        <https://1145.am/db/2600640/Telefonica>,
        <https://1145.am/db/2605344/Telefonica_Sa>,
        <https://1145.am/db/2608548/Teliasonera>,
        <https://1145.am/db/2608993/Telefonica>,
        <https://1145.am/db/2612255/Teliasonera>,
        <https://1145.am/db/2613016/Teliasonera>,
        <https://1145.am/db/2616820/Telefonica>,
        <https://1145.am/db/2617659/Telefonica>,
        <https://1145.am/db/2619705/Telefonica>,
        <https://1145.am/db/2623208/Telefonica>,
        <https://1145.am/db/2624908/Telefonica>,
        <https://1145.am/db/2640565/Teliasonera>,
        <https://1145.am/db/2648631/Telefnica>,
        <https://1145.am/db/2650838/Telefnica>,
        <https://1145.am/db/2651152/Telefonica>,
        <https://1145.am/db/2651361/Telefnica>,
        <https://1145.am/db/2651498/Telefnica>,
        <https://1145.am/db/2651739/Telefonica>,
        <https://1145.am/db/2651859/Teliasonera>,
        <https://1145.am/db/2651900/Telefnica>,
        <https://1145.am/db/2652052/Telefonica>,
        <https://1145.am/db/2652398/Telefnica>,
        <https://1145.am/db/2652795/Telefonica>,
        <https://1145.am/db/2652976/Teliasonera>,
        <https://1145.am/db/2653278/Teliasonera>,
        <https://1145.am/db/2653325/Teliasonera>,
        <https://1145.am/db/2653966/Telefnica>,
        <https://1145.am/db/2653986/Telefnica>,
        <https://1145.am/db/2654552/Teliasonera>,
        <https://1145.am/db/2656202/Telefonica>,
        <https://1145.am/db/2656915/Telefnica>,
        <https://1145.am/db/2657196/Telefonica>,
        <https://1145.am/db/2657718/Telefonica>,
        <https://1145.am/db/2658167/Teliasonera>,
        <https://1145.am/db/2658169/Telefonica>,
        <https://1145.am/db/2659115/Telefonica>,
        <https://1145.am/db/2660899/Teliasonera>,
        <https://1145.am/db/2661028/Teliasonera>,
        <https://1145.am/db/2661338/Telefonica>,
        <https://1145.am/db/2662436/Telefonica>,
        <https://1145.am/db/2663846/Teliasonera>,
        <https://1145.am/db/2664098/Telefonica>,
        <https://1145.am/db/2664196/Telefnica>,
        <https://1145.am/db/2664470/Telefnica>,
        <https://1145.am/db/2665863/Teliasonera>,
        <https://1145.am/db/2665887/Telefonica>,
        <https://1145.am/db/2666273/Teliasonera>,
        <https://1145.am/db/2666404/Telefnica>,
        <https://1145.am/db/2667338/Telefonica>,
        <https://1145.am/db/2668528/Telefnica_Uk>,
        <https://1145.am/db/2668530/Telefonica>,
        <https://1145.am/db/2670617/Telefnica>,
        <https://1145.am/db/2670729/Telefnica>,
        <https://1145.am/db/2670760/Telefnica>,
        <https://1145.am/db/2671847/Teliasonera>,
        <https://1145.am/db/2671938/Telefnica>,
        <https://1145.am/db/2671968/Telefnica>,
        <https://1145.am/db/2672143/Telefonica>,
        <https://1145.am/db/2673145/Telefnica>,
        <https://1145.am/db/2674214/Telefnica>,
        <https://1145.am/db/2674846/Teliasonera>,
        <https://1145.am/db/2675188/Teliasonera>,
        <https://1145.am/db/2675454/Telefnica>,
        <https://1145.am/db/2675459/Telefnica>,
        <https://1145.am/db/2676539/Telefnica>,
        <https://1145.am/db/2678311/Telefonica_Sa>,
        <https://1145.am/db/2678426/Teliasonera>,
        <https://1145.am/db/2679024/Telefnica>,
        <https://1145.am/db/2679056/Telefnica>,
        <https://1145.am/db/2681028/Telefonica>,
        <https://1145.am/db/2681824/Telefnica>,
        <https://1145.am/db/2683245/Telefonica>,
        <https://1145.am/db/2788675/Telefonica>,
        <https://1145.am/db/327861/Telefonica>,
        <https://1145.am/db/334351/Telefonica>,
        <https://1145.am/db/334414/Telefonica>,
        <https://1145.am/db/337315/Telefonica>,
        <https://1145.am/db/372003/Telefonica>,
        <https://1145.am/db/372697/Telefonica>,
        <https://1145.am/db/377907/Telefonica>,
        <https://1145.am/db/469415/Telefonica>,
        <https://1145.am/db/538065/Telefonica>,
        <https://1145.am/db/721139/Telefonica>,
        <https://1145.am/db/80982/Telefonica_Sa>,
        <https://1145.am/db/87823/Telefonica> ;
    ns1:sameAsMedium <https://1145.am/db/107126/Telefonica>,
        <https://1145.am/db/131936/Telefonica>,
        <https://1145.am/db/1681856/Telefonica>,
        <https://1145.am/db/1742133/Telefnica>,
        <https://1145.am/db/1757691/Telefonica>,
        <https://1145.am/db/1797744/Telefonica>,
        <https://1145.am/db/1817110/Telefonica>,
        <https://1145.am/db/1889714/Telefonica>,
        <https://1145.am/db/2165758/Telefonica_Sa>,
        <https://1145.am/db/2599743/Telefonica>,
        <https://1145.am/db/2602241/Telefonica_Uk>,
        <https://1145.am/db/2602311/Telefonica>,
        <https://1145.am/db/2605327/Telefonica>,
        <https://1145.am/db/2610778/Telefonica>,
        <https://1145.am/db/2613293/Telefonica>,
        <https://1145.am/db/2613788/Telefonica>,
        <https://1145.am/db/2615714/Telefonica>,
        <https://1145.am/db/2616305/Telefonica>,
        <https://1145.am/db/2616555/Telefonica>,
        <https://1145.am/db/2618904/Telefnica>,
        <https://1145.am/db/2621829/Telefonica>,
        <https://1145.am/db/2624439/Telefnica>,
        <https://1145.am/db/2624746/Telefonica>,
        <https://1145.am/db/2625430/Telefonica>,
        <https://1145.am/db/2625845/Telefnica>,
        <https://1145.am/db/2629007/Telefnica>,
        <https://1145.am/db/2632044/Telefnica>,
        <https://1145.am/db/2638379/Telefonica>,
        <https://1145.am/db/2640353/Telefonica>,
        <https://1145.am/db/2643386/Telefonica>,
        <https://1145.am/db/2648737/Telefnica>,
        <https://1145.am/db/2648747/Telefnica>,
        <https://1145.am/db/2650838/Telefonica>,
        <https://1145.am/db/2651408/Telefnica>,
        <https://1145.am/db/2651420/Telefnica>,
        <https://1145.am/db/2651770/Telefnica>,
        <https://1145.am/db/2651830/Telefnica>,
        <https://1145.am/db/2651853/Telefnica>,
        <https://1145.am/db/2651887/Telefnica>,
        <https://1145.am/db/2652365/Telefnica>,
        <https://1145.am/db/2652548/Telefnica>,
        <https://1145.am/db/2652760/Telefonica>,
        <https://1145.am/db/2653604/Telefonica>,
        <https://1145.am/db/2653961/Telefnica>,
        <https://1145.am/db/2654121/Telefnica>,
        <https://1145.am/db/2654161/Telefonica>,
        <https://1145.am/db/2654380/Telefonica>,
        <https://1145.am/db/2654609/Telefonica>,
        <https://1145.am/db/2654761/Telefnica>,
        <https://1145.am/db/2654874/Telefnica>,
        <https://1145.am/db/2654922/Telefnica>,
        <https://1145.am/db/2654999/Telefnica>,
        <https://1145.am/db/2655000/Telefnica>,
        <https://1145.am/db/2655251/Telefonica>,
        <https://1145.am/db/2655584/Telefonica>,
        <https://1145.am/db/2655826/Telefnica>,
        <https://1145.am/db/2656247/Telefonica_Sa>,
        <https://1145.am/db/2656800/Telefonica>,
        <https://1145.am/db/2657460/Telefonica>,
        <https://1145.am/db/2657816/Telefnica>,
        <https://1145.am/db/2657893/Telefnica>,
        <https://1145.am/db/2658441/Telefonica>,
        <https://1145.am/db/2658877/Telefnica>,
        <https://1145.am/db/2659845/Telefnica>,
        <https://1145.am/db/2659938/Telefnica>,
        <https://1145.am/db/2659970/Telefnica>,
        <https://1145.am/db/2660028/Telefonica>,
        <https://1145.am/db/2660250/Telefonica>,
        <https://1145.am/db/2660258/Telefonica>,
        <https://1145.am/db/2661936/Telefnica>,
        <https://1145.am/db/2661978/Telefnica>,
        <https://1145.am/db/2662037/Telefnica>,
        <https://1145.am/db/2662075/Telefnica>,
        <https://1145.am/db/2662686/Telefonica>,
        <https://1145.am/db/2662689/Telefnica>,
        <https://1145.am/db/2662695/Telefnica>,
        <https://1145.am/db/2663180/Telefnica>,
        <https://1145.am/db/2664227/Telefnica>,
        <https://1145.am/db/2665206/Telefnica>,
        <https://1145.am/db/2665345/Telefnica>,
        <https://1145.am/db/2665365/Telefnica>,
        <https://1145.am/db/2666285/Telefnica>,
        <https://1145.am/db/2666446/Telefonica>,
        <https://1145.am/db/2667500/Telefnica>,
        <https://1145.am/db/2667525/Telefnica>,
        <https://1145.am/db/2668412/Telefonica>,
        <https://1145.am/db/2668591/Telefnica>,
        <https://1145.am/db/2669513/Telefonica>,
        <https://1145.am/db/2670200/Telefonica>,
        <https://1145.am/db/2670631/Telefnica>,
        <https://1145.am/db/2670751/Telefnica>,
        <https://1145.am/db/2670756/Telefnica>,
        <https://1145.am/db/2670779/Telefnica>,
        <https://1145.am/db/2671810/Telefnica>,
        <https://1145.am/db/2671812/Telefnica>,
        <https://1145.am/db/2671856/Telefnica>,
        <https://1145.am/db/2671886/Telefnica>,
        <https://1145.am/db/2671930/Telefnica>,
        <https://1145.am/db/2674090/Telefonica>,
        <https://1145.am/db/2674172/Telefnica>,
        <https://1145.am/db/2674269/Telefnica>,
        <https://1145.am/db/2674289/Telefnica>,
        <https://1145.am/db/2675369/Telefnica>,
        <https://1145.am/db/2675482/Telefnica>,
        <https://1145.am/db/2676194/Telefonica>,
        <https://1145.am/db/2677796/Telefnica>,
        <https://1145.am/db/2677836/Telefnica>,
        <https://1145.am/db/2678648/Telefonica>,
        <https://1145.am/db/2678650/Telefnica>,
        <https://1145.am/db/2679002/Telefnica>,
        <https://1145.am/db/2679770/Telefnica>,
        <https://1145.am/db/2680055/Telefnica>,
        <https://1145.am/db/2680056/Telefnica>,
        <https://1145.am/db/2680806/Telefnica>,
        <https://1145.am/db/2680808/Telefonica>,
        <https://1145.am/db/2681079/Telefonica>,
        <https://1145.am/db/346196/Telefonica>,
        <https://1145.am/db/346206/Telefonica>,
        <https://1145.am/db/400633/Telefnica>,
        <https://1145.am/db/80938/Telefonica_Sa>,
        <https://1145.am/db/81375/Telefonica>,
        <https://1145.am/db/81437/Telefonica>,
        <https://1145.am/db/85758/Telefonica>,
        <https://1145.am/db/87741/Telefonica> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2685508/Nokia_Siemens_Networks_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-04-14T14:42:37+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Nokia (NYSE: NOK) and Siemens are considering selling off a controlling stake in their infrastructure joint venture Nokia Siemens Networks as the parent companies consider partnerships with private equity firms, according to a report in the Wall Street Journal." ;
    ns1:documentTitle "Report: Nokia, Siemens mull selling controlling stake in NSN" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-nokia-siemens-mull-selling-controlling-stake-nsn> ;
    ns1:foundName "partnerships",
        "selling off" ;
    ns1:name "partnerships",
        "selling off" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "stopped" ;
    ns1:target <https://1145.am/db/2685508/Nokia_Siemens_Networks>,
        <https://1145.am/db/2685508/Siemens> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Nokia Siemens Networks" ;
    ns1:valueRaw "$ 2 billion" ;
    ns1:vendor <https://1145.am/db/2685508/Nokia_Siemens_Networks>,
        <https://1145.am/db/2685508/Siemens> .

<https://1145.am/db/2685799/Leap_Wireless> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:buyer <https://1145.am/db/2685799/T-Mobile_Usa_Acquisition> ;
    ns1:description "flat-rate carriers" ;
    ns1:documentDate "2011-05-17T14:26:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MetroPCS, Leap open to scooping up divested AT&T/T-Mobile assets" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/metropcs-leap-open-to-scooping-up-divested-at-t-t-mobile-assets> ;
    ns1:foundName "Leap Wireless" ;
    ns1:name "Leap Wireless" ;
    ns1:sameAsMedium <https://1145.am/db/1836084/Leap_Wireless>,
        <https://1145.am/db/2173415/Leap_Wireless>,
        <https://1145.am/db/2625775/Leap_Wireless>,
        <https://1145.am/db/2631033/Leap_Wireless>,
        <https://1145.am/db/2637762/Leap_Wireless>,
        <https://1145.am/db/2639625/Leap_Wireless>,
        <https://1145.am/db/2647888/Leap_Wireless>,
        <https://1145.am/db/2655150/Leap_Wireless>,
        <https://1145.am/db/2658466/Leap_Wireless>,
        <https://1145.am/db/2661159/Leap_Wireless>,
        <https://1145.am/db/2661168/Leap_Wireless>,
        <https://1145.am/db/2662193/Leap_Wireless>,
        <https://1145.am/db/2662378/Leap_Wireless>,
        <https://1145.am/db/2664378/Leap_Wireless>,
        <https://1145.am/db/2664500/Leap_Wireless>,
        <https://1145.am/db/2665469/Leap_Wireless>,
        <https://1145.am/db/2669926/Leap_Wireless>,
        <https://1145.am/db/2674567/Leap_Wireless>,
        <https://1145.am/db/2676099/Leap_Wireless>,
        <https://1145.am/db/2678516/Leap_Wireless>,
        <https://1145.am/db/2680894/Leap_Wireless>,
        <https://1145.am/db/2680897/Leap_Wireless>,
        <https://1145.am/db/2680900/Leap_Wireless>,
        <https://1145.am/db/2680905/Leap_Wireless>,
        <https://1145.am/db/2680906/Leap_Wireless>,
        <https://1145.am/db/2681282/Leap_Wireless>,
        <https://1145.am/db/2681584/Leap_Wireless>,
        <https://1145.am/db/2681695/Leap_Wireless>,
        <https://1145.am/db/2681734/Leap_Wireless>,
        <https://1145.am/db/2682715/Leap_Wireless>,
        <https://1145.am/db/2684439/Leap_Wireless>,
        <https://1145.am/db/2685183/Leap_Wireless>,
        <https://1145.am/db/2685314/Leap_Wireless>,
        <https://1145.am/db/2686174/Leap_Wireless>,
        <https://1145.am/db/2686488/Leap_Wireless> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2685799/Metropcs> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:buyer <https://1145.am/db/2685799/T-Mobile_Usa_Acquisition> ;
    ns1:description "flat-rate carriers" ;
    ns1:documentDate "2011-05-17T14:26:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MetroPCS, Leap open to scooping up divested AT&T/T-Mobile assets" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/metropcs-leap-open-to-scooping-up-divested-at-t-t-mobile-assets> ;
    ns1:foundName "MetroPCS" ;
    ns1:investor <https://1145.am/db/2685799/T-Mobile_Usa_Acquisition> ;
    ns1:name "MetroPCS" ;
    ns1:sameAsHigh <https://1145.am/db/2659591/Metropcs>,
        <https://1145.am/db/2662860/Metropcs>,
        <https://1145.am/db/2669338/Metropcs>,
        <https://1145.am/db/2671585/Metropcs>,
        <https://1145.am/db/2676975/Metropcs>,
        <https://1145.am/db/2681584/Metropcs>,
        <https://1145.am/db/2683705/Metropcs> ;
    ns1:sameAsMedium <https://1145.am/db/2625808/Metropcs>,
        <https://1145.am/db/2626494/Metropcs>,
        <https://1145.am/db/2631033/Metropcs>,
        <https://1145.am/db/2640440/Metropcs>,
        <https://1145.am/db/2650228/Metropcs>,
        <https://1145.am/db/2656845/Metropcs>,
        <https://1145.am/db/2656851/Metropcs>,
        <https://1145.am/db/2658569/Metropcs>,
        <https://1145.am/db/2658575/Metropcs>,
        <https://1145.am/db/2658580/Metropcs>,
        <https://1145.am/db/2658589/Metropcs>,
        <https://1145.am/db/2659586/Metropcs>,
        <https://1145.am/db/2659597/Metropcs>,
        <https://1145.am/db/2659631/Metropcs>,
        <https://1145.am/db/2662872/Metropcs>,
        <https://1145.am/db/2663892/Metropcs>,
        <https://1145.am/db/2664500/Metropcs>,
        <https://1145.am/db/2664986/Metropcs>,
        <https://1145.am/db/2666714/Metropcs>,
        <https://1145.am/db/2668208/Metropcs>,
        <https://1145.am/db/2668226/Metropcs>,
        <https://1145.am/db/2669319/Metropcs>,
        <https://1145.am/db/2669321/Metropcs>,
        <https://1145.am/db/2670397/Metropcs>,
        <https://1145.am/db/2670454/Metropcs>,
        <https://1145.am/db/2671623/Metropcs>,
        <https://1145.am/db/2671629/Metropcs>,
        <https://1145.am/db/2673938/Metropcs>,
        <https://1145.am/db/2681282/Metropcs>,
        <https://1145.am/db/2681285/Metropcs>,
        <https://1145.am/db/2682450/Metropcs>,
        <https://1145.am/db/2685314/Metropcs>,
        <https://1145.am/db/2686488/Metropcs> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2686194/Gores_Group> a org:Organization ;
    ns1:buyer <https://1145.am/db/2686194/Nokia_Siemens_Networks_Stake_Acquisition> ;
    ns1:documentDate "2011-06-27T14:29:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Nokia, Siemens abandon private equity push for NSN" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-nokia-siemens-abandon-private-equity-push-for-nsn> ;
    ns1:foundName "Gores Group" ;
    ns1:investor <https://1145.am/db/2686194/Nokia_Siemens_Networks_Stake_Acquisition> ;
    ns1:name "Gores Group" ;
    ns1:sameAsMedium <https://1145.am/db/1001500/The_Gores_Group>,
        <https://1145.am/db/1157071/The_Gores_Group>,
        <https://1145.am/db/1157843/The_Gores_Group>,
        <https://1145.am/db/1249167/The_Gores_Group>,
        <https://1145.am/db/1578344/The_Gores_Group>,
        <https://1145.am/db/1579776/The_Gores_Group>,
        <https://1145.am/db/1890412/Gores_Group>,
        <https://1145.am/db/2294862/Gores_Group>,
        <https://1145.am/db/2583661/The_Gores_Group>,
        <https://1145.am/db/2588528/The_Gores_Group>,
        <https://1145.am/db/2604878/The_Gores_Group>,
        <https://1145.am/db/2608511/The_Gores_Group>,
        <https://1145.am/db/2683690/Gores_Group>,
        <https://1145.am/db/502502/The_Gores_Group>,
        <https://1145.am/db/696164/The_Gores_Group> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2686194/Kkr_And_Tpg> a org:Organization ;
    ns1:description "private equity firm" ;
    ns1:documentDate "2011-06-27T14:29:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Nokia, Siemens abandon private equity push for NSN" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-nokia-siemens-abandon-private-equity-push-for-nsn> ;
    ns1:foundName "KKR and TPG" ;
    ns1:investor <https://1145.am/db/2686194/Nokia_Siemens_Networks_Stake_Acquisition> ;
    ns1:name "KKR and TPG" ;
    ns1:sameAsHigh <https://1145.am/db/1087838/Tpg_Capital>,
        <https://1145.am/db/1155130/TPG>,
        <https://1145.am/db/1162348/TPG>,
        <https://1145.am/db/1294282/Tpg_Capital>,
        <https://1145.am/db/1378204/TPG>,
        <https://1145.am/db/1415588/Tpg_Capital>,
        <https://1145.am/db/1560437/Pag_Kkr___Co>,
        <https://1145.am/db/1581949/Tpg_Global>,
        <https://1145.am/db/164767/TPG>,
        <https://1145.am/db/1737934/Tpg_Capital>,
        <https://1145.am/db/1744790/TPG>,
        <https://1145.am/db/1805668/TPG>,
        <https://1145.am/db/1807001/TPG>,
        <https://1145.am/db/1959428/TPG>,
        <https://1145.am/db/1964151/TPG>,
        <https://1145.am/db/1976360/Tpg_Inc>,
        <https://1145.am/db/1978519/Tpg_Global>,
        <https://1145.am/db/1982009/Tpg_Incs>,
        <https://1145.am/db/2006652/TPG>,
        <https://1145.am/db/2008196/TPG>,
        <https://1145.am/db/2011805/Francisco_Partners_And_Tpg>,
        <https://1145.am/db/2020777/Tpg_Inc>,
        <https://1145.am/db/206449/TPG>,
        <https://1145.am/db/2065085/TPG>,
        <https://1145.am/db/2070436/Tpg_Inc>,
        <https://1145.am/db/2073035/TPG>,
        <https://1145.am/db/2087656/Tpg_Capital>,
        <https://1145.am/db/2096232/TPG>,
        <https://1145.am/db/2108960/TPG>,
        <https://1145.am/db/211185/TPG>,
        <https://1145.am/db/2159047/Tpg_Capital>,
        <https://1145.am/db/2171416/TPG>,
        <https://1145.am/db/2175476/TPG>,
        <https://1145.am/db/2181035/Tpg_Capital>,
        <https://1145.am/db/2182639/TPG>,
        <https://1145.am/db/2183308/Tpg_Capital>,
        <https://1145.am/db/2184940/Tpg_Capital>,
        <https://1145.am/db/2188868/Tpg_Capital>,
        <https://1145.am/db/2196851/Tpg_Capital>,
        <https://1145.am/db/2197483/TPG>,
        <https://1145.am/db/2290211/Tpg_Capital>,
        <https://1145.am/db/2305869/TPG>,
        <https://1145.am/db/2527205/Tpg_Capital>,
        <https://1145.am/db/254264/Tpg_Capital>,
        <https://1145.am/db/2568992/TPG>,
        <https://1145.am/db/2573913/TPG>,
        <https://1145.am/db/2614708/TPG>,
        <https://1145.am/db/2623581/Tpg_Capital>,
        <https://1145.am/db/2623582/Tpg_Capital>,
        <https://1145.am/db/2623607/Tpg_Capital>,
        <https://1145.am/db/2667112/Kohlberg_Kravis_Roberts_And_Co>,
        <https://1145.am/db/2674846/Tpg_Capital>,
        <https://1145.am/db/2686055/TPG>,
        <https://1145.am/db/2721631/Kkr_And_Tiga_Investments>,
        <https://1145.am/db/2721798/Tpg_Capital>,
        <https://1145.am/db/317747/Tpg_Capital>,
        <https://1145.am/db/322230/Tpg_Capital>,
        <https://1145.am/db/329444/TPG>,
        <https://1145.am/db/366659/TPG>,
        <https://1145.am/db/385073/Tpg_Capital>,
        <https://1145.am/db/385357/Tpg_Capital>,
        <https://1145.am/db/442655/Tpg_Capital>,
        <https://1145.am/db/619743/Tpg_Capital>,
        <https://1145.am/db/692055/TPG>,
        <https://1145.am/db/733889/TPG> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2686194/Platinum_Equity> a org:Organization ;
    ns1:documentDate "2011-06-27T14:29:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Nokia, Siemens abandon private equity push for NSN" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-nokia-siemens-abandon-private-equity-push-for-nsn> ;
    ns1:foundName "Platinum Equity" ;
    ns1:investor <https://1145.am/db/2686194/Nokia_Siemens_Networks_Stake_Acquisition> ;
    ns1:name "Platinum Equity" ;
    ns1:sameAsMedium <https://1145.am/db/1041774/Platinum_Equity>,
        <https://1145.am/db/1058285/Platinum_Equity_Llc>,
        <https://1145.am/db/1148282/Platinum_Equity>,
        <https://1145.am/db/1239839/Platinum_Equity>,
        <https://1145.am/db/1275936/Platinum_Equity>,
        <https://1145.am/db/1384024/Platinum_Equity>,
        <https://1145.am/db/1535520/Platinum_Equity>,
        <https://1145.am/db/1581363/Platinum_Equity>,
        <https://1145.am/db/1581380/Platinum_Equity>,
        <https://1145.am/db/1581381/Platinum_Equity>,
        <https://1145.am/db/166320/Platinum_Equity>,
        <https://1145.am/db/1882337/Platinum_Equity>,
        <https://1145.am/db/1891801/Platinum_Equity>,
        <https://1145.am/db/2135819/Platinum_Equity>,
        <https://1145.am/db/217750/Platinum_Equity>,
        <https://1145.am/db/2443167/Platinum_Equity>,
        <https://1145.am/db/2620290/Platinum_Equity>,
        <https://1145.am/db/2698867/Platinum_Equity>,
        <https://1145.am/db/304762/Platinum_Equity_Llc>,
        <https://1145.am/db/305672/Platinum_Equity_Llc>,
        <https://1145.am/db/353990/Platinum_Equity>,
        <https://1145.am/db/355252/Platinum_Equity>,
        <https://1145.am/db/371074/Platinum_Equity>,
        <https://1145.am/db/371503/Platinum_Equity>,
        <https://1145.am/db/371555/Platinum_Equity>,
        <https://1145.am/db/475901/Platinum_Equity>,
        <https://1145.am/db/493868/Platinum_Equity>,
        <https://1145.am/db/493900/Platinum_Equity>,
        <https://1145.am/db/520066/Platinum_Equity>,
        <https://1145.am/db/556395/Platinum_Equity>,
        <https://1145.am/db/567896/Platinum_Equity>,
        <https://1145.am/db/573461/Platinum_Equity>,
        <https://1145.am/db/578426/Platinum_Equity>,
        <https://1145.am/db/582171/Platinum_Equity>,
        <https://1145.am/db/589965/Platinum_Equity> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2171269/Npg_Cable_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "ipo" ;
    ns1:documentDate "2011-01-21T13:05:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Elsewhere in the world of telecommunications high finance, Suddenlink Communications has closed a private offering of $ 625 million, most of which will be used to fund the $ 350 million acquisition of NPG Cable.",
        "Suddenlink buys NPG Cable for $ 350 million." ;
    ns1:documentTitle "Money talks: Hughes Communications reported for sale; Suddenlink closes offering; Norsat snags Sinclair" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/money-talks-hughes-communications-reported-for-sale-suddenlink-closes-offering-norsat-snags> ;
    ns1:foundName "acquisition",
        "buys",
        "private offering" ;
    ns1:name "acquisition",
        "buys",
        "private offering" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2171269/Npg_Cable> ;
    ns1:targetName "NPG Cable" ;
    ns1:valueRaw "$ 350 million",
        "$ 625 million" ;
    ns1:vendor <https://1145.am/db/2171269/Suddenlink_Communications> .

<https://1145.am/db/2171269/Sinclair_Technologies_Holdings_Inc> a org:Organization ;
    ns1:basedInLowRaw "Great White North" ;
    ns1:description "providing antenna and RF conditioning products" ;
    ns1:documentDate "2011-01-21T13:05:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Money talks: Hughes Communications reported for sale; Suddenlink closes offering; Norsat snags Sinclair" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/money-talks-hughes-communications-reported-for-sale-suddenlink-closes-offering-norsat-snags> ;
    ns1:foundName "Sinclair Technologies Holdings Inc." ;
    ns1:industry "communications products" ;
    ns1:name "Sinclair Technologies Holdings Inc." ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2171269/Sinclair_Technologies_Holdings_Inc_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-01-21T13:05:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "And finally, the ever-shifting market even includes the Great White North where broadband communications products provider Norsat International is acquiring Sinclair Technologies Holdings Inc., a leading provider of antenna and RF conditioning products (and not to be confused with Sinclair Broadcast Group, a television stations owner and thorn in Time Warner Cable's side) for $ 19.25 million." ;
    ns1:documentTitle "Money talks: Hughes Communications reported for sale; Suddenlink closes offering; Norsat snags Sinclair" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/money-talks-hughes-communications-reported-for-sale-suddenlink-closes-offering-norsat-snags> ;
    ns1:foundName "acquiring" ;
    ns1:name "acquiring" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2171269/Sinclair_Technologies_Holdings_Inc> ;
    ns1:targetName "Sinclair Technologies Holdings Inc." ;
    ns1:valueRaw "$ 19.25 million" ;
    ns1:whereGeoName "White County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4136143/about.rdf> ;
    ns1:whereRaw "Great White North" .

<https://1145.am/db/2171269/Suddenlink_Communications> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2171269/Npg_Cable_Acquisition> ;
    ns1:documentDate "2011-01-21T13:05:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Money talks: Hughes Communications reported for sale; Suddenlink closes offering; Norsat snags Sinclair" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/money-talks-hughes-communications-reported-for-sale-suddenlink-closes-offering-norsat-snags> ;
    ns1:foundName "Suddenlink",
        "Suddenlink Communications" ;
    ns1:industry "telecommunications" ;
    ns1:name "Suddenlink",
        "Suddenlink Communications" ;
    ns1:sameAsHigh <https://1145.am/db/2160527/Suddenlink_Communications>,
        <https://1145.am/db/2162820/Suddenlink_Communications>,
        <https://1145.am/db/2165008/Suddenlink_Communications>,
        <https://1145.am/db/2171869/Suddenlink_Communications>,
        <https://1145.am/db/2176879/Suddenlink_Communications>,
        <https://1145.am/db/2176883/Suddenlink>,
        <https://1145.am/db/2176886/Suddenlink_Communications>,
        <https://1145.am/db/2176887/Suddenlink_Communications>,
        <https://1145.am/db/2176891/Suddenlink_Communications>,
        <https://1145.am/db/2176893/Suddenlink_Communications>,
        <https://1145.am/db/2176902/Suddenlink_Communications>,
        <https://1145.am/db/2176918/Suddenlink_Communications>,
        <https://1145.am/db/2617789/Suddenlink_Communications>,
        <https://1145.am/db/2653375/Suddenlink_Communications>,
        <https://1145.am/db/2655768/Suddenlink>,
        <https://1145.am/db/2658778/Suddenlink>,
        <https://1145.am/db/2660343/Suddenlink_Communications>,
        <https://1145.am/db/2666278/Suddenlink> ;
    ns1:sameAsMedium <https://1145.am/db/2160671/Suddenlink_Communications>,
        <https://1145.am/db/2168118/Suddenlink_Communications>,
        <https://1145.am/db/2169452/Suddenlink_Communications>,
        <https://1145.am/db/2174875/Suddenlink_Communications>,
        <https://1145.am/db/2670028/Suddenlink_Communications> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2176980/Cablemas> a org:Organization ;
    ns1:basedInHighGeoName "Mexico" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3996063/about.rdf> ;
    ns1:basedInHighRaw "Mexico" ;
    ns1:description "cable subscribers" ;
    ns1:documentDate "2011-04-04T14:06:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Liberty Global chases Ziggo ahead of IPO; Televisa buys Cablemas" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/liberty-global-chases-ziggo-ahead-ipo-televisa-buys-cablemas> ;
    ns1:foundName "Cablemas" ;
    ns1:name "Cablemas" ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2176980/Cablemas_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-04-04T14:06:26+00:00"^^xsd:dateTime ;
    ns1:documentExtract "In Mexico, Grupo Televisa is tidying things up by purchasing the 41.7 percent of Cablemas it does n't already own for $ 397 million, merging a company that has nearly 1 million cable subscribers, 360,000 HSD subs and 205,000 phone users into Televisa." ;
    ns1:documentTitle "Liberty Global chases Ziggo ahead of IPO; Televisa buys Cablemas" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/liberty-global-chases-ziggo-ahead-ipo-televisa-buys-cablemas> ;
    ns1:foundName "purchasing" ;
    ns1:name "purchasing" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2176980/Cablemas> ;
    ns1:targetName "Cablemas" ;
    ns1:valueRaw "$ 397 million" ;
    ns1:whereGeoName "Mexico" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3996063/about.rdf> ;
    ns1:whereRaw "Mexico" .

<https://1145.am/db/2176980/Unitymedia> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:documentDate "2011-04-04T14:06:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Liberty Global chases Ziggo ahead of IPO; Televisa buys Cablemas" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/liberty-global-chases-ziggo-ahead-ipo-televisa-buys-cablemas> ;
    ns1:foundName "Unitymedia and Kabel" ;
    ns1:name "Unitymedia" ;
    ns1:sameAsMedium <https://1145.am/db/2652362/Unitymedia> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2176980/Unitymedia_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-04-04T14:06:26+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Liberty Global (Nasdaq: LBTYA) , fresh off its acquisition of Germany's Unitymedia and Kabel, is now in the market to snap up the Netherlands top provider, Ziggo." ;
    ns1:documentTitle "Liberty Global chases Ziggo ahead of IPO; Televisa buys Cablemas" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/liberty-global-chases-ziggo-ahead-ipo-televisa-buys-cablemas> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2176980/Unitymedia> ;
    ns1:targetName "Unitymedia" ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "Germany" .

<https://1145.am/db/2176980/Ziggo> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of the Netherlands" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2750405/about.rdf> ;
    ns1:basedInHighRaw "Netherlands" ;
    ns1:description "telecom" ;
    ns1:documentDate "2011-04-04T14:06:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Liberty Global chases Ziggo ahead of IPO; Televisa buys Cablemas" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/liberty-global-chases-ziggo-ahead-ipo-televisa-buys-cablemas> ;
    ns1:foundName "Ziggo" ;
    ns1:name "Ziggo" ;
    ns1:sameAsMedium <https://1145.am/db/2157622/Ziggo>,
        <https://1145.am/db/2173439/Ziggo>,
        <https://1145.am/db/2663184/Ziggo>,
        <https://1145.am/db/2665363/Ziggo>,
        <https://1145.am/db/2669553/Ziggo>,
        <https://1145.am/db/2669561/Ziggo>,
        <https://1145.am/db/2671912/Ziggo> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2176980/Ziggo_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "ipo" ;
    ns1:documentDate "2011-04-04T14:06:26+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Liberty Global (Nasdaq: LBTYA) , fresh off its acquisition of Germany's Unitymedia and Kabel, is now in the market to snap up the Netherlands top provider, Ziggo.",
        "Liberty, which has been romping through Europe like the Allied Forces after D-Day, is making a preemptive move on Ziggo ahead of a potential IPO that would value the company at $ 9.97 billion." ;
    ns1:documentTitle "Liberty Global chases Ziggo ahead of IPO; Televisa buys Cablemas" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/liberty-global-chases-ziggo-ahead-ipo-televisa-buys-cablemas> ;
    ns1:foundName "IPO",
        "snap",
        "snap up" ;
    ns1:name "IPO",
        "snap",
        "snap up" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2176980/Ziggo> ;
    ns1:targetName "Ziggo" ;
    ns1:valueRaw "$ 9.97 billion" ;
    ns1:whereGeoName "Kingdom of the Netherlands" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2750405/about.rdf> ;
    ns1:whereRaw "Netherlands" .

<https://1145.am/db/2177634/Blockbuster> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "Blockbuster" ;
    ns1:documentDate "2011-04-11T12:01:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dish-Blockbuster deal gets DoJ, FTC approval" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/dish-blockbuster-deal-gets-doj-ftc-approval> ;
    ns1:foundName "Blockbuster" ;
    ns1:industry "movie rental" ;
    ns1:name "Blockbuster" ;
    ns1:sameAsHigh <https://1145.am/db/1873348/Blockbuster>,
        <https://1145.am/db/2170080/Blockbuster>,
        <https://1145.am/db/2170857/Blockbuster> ;
    ns1:sameAsMedium <https://1145.am/db/1706758/Blockbuster>,
        <https://1145.am/db/1869887/Blockbuster> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2177634/Blockbuster_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-04-11T12:01:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Dish Network's (Nasdaq: DISH) Blockbuster acquisition has received \"expeditious\" approval from the Department of Justice (DoJ) and Federal Trade Commission (FTC) and should close April 21, the satellite provider said in a news release." ;
    ns1:documentTitle "Dish-Blockbuster deal gets DoJ, FTC approval" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/dish-blockbuster-deal-gets-doj-ftc-approval> ;
    ns1:foundName "acquisition",
        "buy" ;
    ns1:name "acquisition",
        "buy" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2177634/Blockbuster> ;
    ns1:targetName "Blockbuster" ;
    ns1:valueRaw "$ 320 million" ;
    ns1:when "2011-04-21T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "April 21" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2217392/Carefx> a org:Organization ;
    ns1:basedInHighGeoName "Scottsdale" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5313457/about.rdf> ;
    ns1:basedInHighRaw "Scottsdale, AZ" ;
    ns1:description "Health care" ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "Carefx Corporation" ;
    ns1:industry "Health Care" ;
    ns1:name "Carefx" ;
    ns1:sameAsHigh <https://1145.am/db/1041802/Goodrx>,
        <https://1145.am/db/1043645/Goodrx>,
        <https://1145.am/db/1229122/Xp_Health>,
        <https://1145.am/db/1252538/Caredx_Inc>,
        <https://1145.am/db/1253870/Caredx_Inc>,
        <https://1145.am/db/1496080/Goodrx>,
        <https://1145.am/db/1791219/Crosschx>,
        <https://1145.am/db/1797561/Crosschx>,
        <https://1145.am/db/2233249/Healthagen>,
        <https://1145.am/db/2237260/Carefx_Corporation>,
        <https://1145.am/db/2238216/Imedx_Inc>,
        <https://1145.am/db/2238349/Imedx_Inc>,
        <https://1145.am/db/2241822/Imedx>,
        <https://1145.am/db/2249509/Imedx_Inc>,
        <https://1145.am/db/2249732/Imedx_Inc>,
        <https://1145.am/db/2256114/Healthagen>,
        <https://1145.am/db/2268568/Healthagen>,
        <https://1145.am/db/485932/GCX>,
        <https://1145.am/db/487324/GCX>,
        <https://1145.am/db/622381/Caringways>,
        <https://1145.am/db/702592/Performrx_Llc>,
        <https://1145.am/db/880972/Goodrx>,
        <https://1145.am/db/881918/Goodrx> ;
    ns1:sameAsMedium <https://1145.am/db/2217400/Carefx> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2217392/Evolution_Benefits> a org:Organization ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "Evolution Benefits" ;
    ns1:name "Evolution Benefits" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2217392/Medicity> a org:Organization ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "Medicity" ;
    ns1:industry "Health Care" ;
    ns1:name "Medicity" ;
    ns1:sameAsHigh <https://1145.am/db/1026534/Hospital_And_Large_Physician_Practices>,
        <https://1145.am/db/1075911/Apiary_Medical_Inc>,
        <https://1145.am/db/1223485/One_Medical>,
        <https://1145.am/db/1225219/One_Medical>,
        <https://1145.am/db/1225619/One_Medical>,
        <https://1145.am/db/1225725/One_Medical>,
        <https://1145.am/db/1281970/Medzed>,
        <https://1145.am/db/1282862/Medzed>,
        <https://1145.am/db/1293299/One_Medical>,
        <https://1145.am/db/1441714/National_Medical>,
        <https://1145.am/db/1473068/Care_Hospitals>,
        <https://1145.am/db/1677406/One_Medical>,
        <https://1145.am/db/1677884/One_Medical>,
        <https://1145.am/db/1677933/One_Medical>,
        <https://1145.am/db/1678927/One_Medical>,
        <https://1145.am/db/1693860/One_Medical>,
        <https://1145.am/db/1693863/One_Medical>,
        <https://1145.am/db/1697229/One_Medical>,
        <https://1145.am/db/1736278/Medefer>,
        <https://1145.am/db/1833657/One_Medical_Group>,
        <https://1145.am/db/1837663/One_Medical_Group>,
        <https://1145.am/db/1855887/Medivo>,
        <https://1145.am/db/1984072/10-4_Medical>,
        <https://1145.am/db/2154062/Gt_Medical>,
        <https://1145.am/db/2180343/One_Medical>,
        <https://1145.am/db/2180529/One_Medical>,
        <https://1145.am/db/2180909/One_Medical>,
        <https://1145.am/db/2181108/One_Medical>,
        <https://1145.am/db/2181397/One_Medical>,
        <https://1145.am/db/2181575/One_Medical>,
        <https://1145.am/db/2191166/One_Medical>,
        <https://1145.am/db/2192170/One_Medical>,
        <https://1145.am/db/2195374/One_Medical>,
        <https://1145.am/db/2196431/One_Medical>,
        <https://1145.am/db/2196868/One_Medical>,
        <https://1145.am/db/2206654/Medventive>,
        <https://1145.am/db/2208338/Symed>,
        <https://1145.am/db/2213150/The_Doctors>,
        <https://1145.am/db/2214135/Medicity>,
        <https://1145.am/db/2214933/One_Medical>,
        <https://1145.am/db/2215233/Meditech>,
        <https://1145.am/db/2224771/Medassurant>,
        <https://1145.am/db/2227720/Physicians_Hospital>,
        <https://1145.am/db/2228231/Medicalis>,
        <https://1145.am/db/2233501/Medventive>,
        <https://1145.am/db/2234808/Doctors_Medical_Center>,
        <https://1145.am/db/2249349/Conmed_Healthcare_Management>,
        <https://1145.am/db/2251632/Medicalis>,
        <https://1145.am/db/2270653/Medicity>,
        <https://1145.am/db/2275398/Medicity>,
        <https://1145.am/db/2281502/Related_Laborie>,
        <https://1145.am/db/2283723/Medicrea>,
        <https://1145.am/db/2286555/Hologic>,
        <https://1145.am/db/2287689/Atricure>,
        <https://1145.am/db/2289020/Hologic>,
        <https://1145.am/db/2289467/Theragenics>,
        <https://1145.am/db/2290283/Intuity_Medical>,
        <https://1145.am/db/2291976/Hologic>,
        <https://1145.am/db/2293088/Theragenics>,
        <https://1145.am/db/2293899/Medigroup>,
        <https://1145.am/db/2294267/Medivance>,
        <https://1145.am/db/2295490/Atricure>,
        <https://1145.am/db/2300717/Hologic>,
        <https://1145.am/db/2301475/Ethicon>,
        <https://1145.am/db/2321689/Mainstay_Medical>,
        <https://1145.am/db/2330324/Medtech_Sa>,
        <https://1145.am/db/2348901/Bioms_Medical_Corp>,
        <https://1145.am/db/252634/Advantage_Medical_Inc>,
        <https://1145.am/db/2592071/Bioms_Medical_Corp>,
        <https://1145.am/db/544970/Medsurvey>,
        <https://1145.am/db/679829/Us_Medical_Management>,
        <https://1145.am/db/683683/Biocare_Medical>,
        <https://1145.am/db/684397/Avation_Medical>,
        <https://1145.am/db/987870/Better_Health>,
        <https://1145.am/db/988426/Better_Health> ;
    ns1:sameAsMedium <https://1145.am/db/2203367/Medicity_Inc>,
        <https://1145.am/db/2213068/Medicity>,
        <https://1145.am/db/2214130/Medicity_Inc>,
        <https://1145.am/db/2240693/Medicity>,
        <https://1145.am/db/2245024/Medicity_Inc>,
        <https://1145.am/db/2269267/Medicity_Inc>,
        <https://1145.am/db/2574470/Medicity> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2223795/Airwatch> a org:Organization ;
    ns1:basedInHighGeoName "Atlanta",
        "City of Falls Church" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4180439/about.rdf>,
        <https://sws.geonames.org/4758398/about.rdf> ;
    ns1:basedInHighRaw "ATLANTA & FALLS CHURCH, Va." ;
    ns1:description "enterprise-grade smartphone and mobile device management (MDM) software" ;
    ns1:documentDate "2011-06-02T19:09:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AirWatch Provides a $100,000 Gift to Inova Health System to Fund Telemedicine Institute's Mobility Programs" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/airwatch-provides-a-100-000-gift-to-inova-health-system-to-fund-telemedicine-institute-s> ;
    ns1:foundName "AirWatch" ;
    ns1:name "AirWatch" ;
    ns1:sameAsHigh <https://1145.am/db/2657064/Airwatch>,
        <https://1145.am/db/2660082/Airwatch> ;
    ns1:sameAsMedium <https://1145.am/db/1810699/Airwatch>,
        <https://1145.am/db/1830622/Airwatch>,
        <https://1145.am/db/1831235/Airwatch>,
        <https://1145.am/db/1838167/Airwatch>,
        <https://1145.am/db/2653474/Airwatch> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2223795/Inova_Health_System> a org:Organization ;
    ns1:basedInHighGeoName "Northern Virginia" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/12216875/about.rdf> ;
    ns1:basedInHighRaw "Northern Virginia" ;
    ns1:description "Healthcare provider" ;
    ns1:documentDate "2011-06-02T19:09:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AirWatch Provides a $100,000 Gift to Inova Health System to Fund Telemedicine Institute's Mobility Programs" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/airwatch-provides-a-100-000-gift-to-inova-health-system-to-fund-telemedicine-institute-s> ;
    ns1:foundName "Inova",
        "Inova Health System" ;
    ns1:industry "Healthcare" ;
    ns1:name "Inova Health System" ;
    ns1:sameAsHigh <https://1145.am/db/1034465/Today_Innovaccer_Inc>,
        <https://1145.am/db/1175729/Innovage>,
        <https://1145.am/db/1234545/Innovaccer_Inc>,
        <https://1145.am/db/1234756/Innova_Medical_Group>,
        <https://1145.am/db/1387011/Innovaccer_Inc>,
        <https://1145.am/db/1464101/Innovaccer_Inc>,
        <https://1145.am/db/1486246/Innovacare_Health>,
        <https://1145.am/db/1762199/Innovaccer>,
        <https://1145.am/db/1783029/Innovaccer>,
        <https://1145.am/db/2057969/Innovacare_Health>,
        <https://1145.am/db/2185954/Innovaccer>,
        <https://1145.am/db/2186685/Inova>,
        <https://1145.am/db/2186950/Innovacare_Health>,
        <https://1145.am/db/2187613/Innovaccer>,
        <https://1145.am/db/218855/Innovacare_Health>,
        <https://1145.am/db/2205543/Ingenix>,
        <https://1145.am/db/2207501/Inovalon>,
        <https://1145.am/db/2224570/Ingenix>,
        <https://1145.am/db/2230828/Inovalon>,
        <https://1145.am/db/2249263/Ingenix>,
        <https://1145.am/db/2251157/Ingenix>,
        <https://1145.am/db/2259861/Inova>,
        <https://1145.am/db/2284483/Innovaccer>,
        <https://1145.am/db/2338799/Ingenix>,
        <https://1145.am/db/2581316/Ingenix>,
        <https://1145.am/db/365544/Innovacare_Health>,
        <https://1145.am/db/417100/Inovalon>,
        <https://1145.am/db/631896/Innovacare>,
        <https://1145.am/db/645045/Inova_Health_System>,
        <https://1145.am/db/648362/Inovalon>,
        <https://1145.am/db/700180/Innovaccer_Inc> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2223795/Telemedicine_Institute> a org:Organization ;
    ns1:basedInLowRaw "Va" ;
    ns1:description "healthcare provider" ;
    ns1:documentDate "2011-06-02T19:09:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AirWatch Provides a $100,000 Gift to Inova Health System to Fund Telemedicine Institute's Mobility Programs" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/airwatch-provides-a-100-000-gift-to-inova-health-system-to-fund-telemedicine-institute-s> ;
    ns1:foundName "Telemedicine Institute" ;
    ns1:industry "healthcare provider" ;
    ns1:name "Telemedicine Institute" ;
    ns1:sameAsHigh <https://1145.am/db/1003683/Teladoc_Health>,
        <https://1145.am/db/1133257/1800md>,
        <https://1145.am/db/1229921/Teladoc_Health>,
        <https://1145.am/db/1444536/Teladoc_Health>,
        <https://1145.am/db/1710398/Index_Health>,
        <https://1145.am/db/1736878/Nue_Life_Health>,
        <https://1145.am/db/174200/Workit_Health>,
        <https://1145.am/db/1744474/Alpha_Medical>,
        <https://1145.am/db/1748711/Twentyeight_Health>,
        <https://1145.am/db/2181961/Teladoc_Health>,
        <https://1145.am/db/2183352/Brightside_Health>,
        <https://1145.am/db/2186610/Mdecindirect>,
        <https://1145.am/db/2186610/Teladoc>,
        <https://1145.am/db/2186976/Teladoc>,
        <https://1145.am/db/2187962/Teladoc>,
        <https://1145.am/db/2188085/Intouch_Health>,
        <https://1145.am/db/2188085/Teladoc_Health>,
        <https://1145.am/db/2190528/Teladoc>,
        <https://1145.am/db/2190552/Teladoc>,
        <https://1145.am/db/2191526/Teladoc>,
        <https://1145.am/db/2192610/Teladoc>,
        <https://1145.am/db/2192612/Teladoc>,
        <https://1145.am/db/2193606/Teladoc>,
        <https://1145.am/db/2194185/Teladoc>,
        <https://1145.am/db/2194209/Teladoc>,
        <https://1145.am/db/2206103/Reach_Health>,
        <https://1145.am/db/2215217/Teladoc_Medical_Services>,
        <https://1145.am/db/2215768/Teladoc>,
        <https://1145.am/db/2230414/Teladoc>,
        <https://1145.am/db/2240575/Teladoc>,
        <https://1145.am/db/2287463/Teladoc>,
        <https://1145.am/db/2294927/Healthspot>,
        <https://1145.am/db/2363728/Compumed>,
        <https://1145.am/db/2369287/Compumed_Inc>,
        <https://1145.am/db/936559/Brightside_Health>,
        <https://1145.am/db/939279/Brightside_Health>,
        <https://1145.am/db/995703/Specialist_Telemed>,
        <https://1145.am/db/997007/Specialist_Telemed> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2227037/Essence_Group_Holdings_Corporation> a org:Organization ;
    ns1:basedInLowRaw "ST. LOUIS" ;
    ns1:description "Health care" ;
    ns1:documentDate "2011-07-19T13:30:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Essence Group Closes $61 Million Private Investment Round" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/essence-group-closes-61-million-private-investment-round> ;
    ns1:foundName "Essence Group Holdings Corporation" ;
    ns1:industry "health care" ;
    ns1:name "Essence Group Holdings Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/1850642/Essence_Group_Holdings_Corp>,
        <https://1145.am/db/2222737/Essence_Group_Holdings_Corporation> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2227037/Kleiner_Perkins_Caufield___Byers> a org:Organization ;
    ns1:basedInLowRaw "ST. LOUIS" ;
    ns1:documentDate "2011-07-19T13:30:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Essence Group Closes $61 Million Private Investment Round" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/essence-group-closes-61-million-private-investment-round> ;
    ns1:foundName "Kleiner Perkins Caufield & Byers" ;
    ns1:investor <https://1145.am/db/2227037/Investment_Camden_Partners_Essence_Group_Holdings_Corporation_Kleiner_Perkins_Caufield___Byers_Completed> ;
    ns1:name "Kleiner Perkins Caufield & Byers" ;
    ns1:sameAsMedium <https://1145.am/db/1697155/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1709036/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1714786/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1719362/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1792401/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1794049/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1794342/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1795003/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1796259/Kleiner_Perkins_Caufield_Byers>,
        <https://1145.am/db/1798154/Kleiner_Perkins_Caufield_Byers>,
        <https://1145.am/db/1802208/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1802525/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1805986/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1806158/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1808735/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1814186/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1816928/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1821378/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1824878/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1825866/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1826126/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1827381/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1830311/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1835647/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1838965/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1839326/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1840650/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1844931/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1845205/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1847021/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1849969/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850246/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850293/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850642/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1852048/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1852697/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1853217/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1853292/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/1854098/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1856424/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1858545/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1858646/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1859219/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860406/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860644/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1861870/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1864650/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1865436/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1868593/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1868958/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1870791/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1871768/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1872947/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/1872971/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1874419/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1876759/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1881582/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1883859/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1890121/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1891856/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1892105/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1892746/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1895292/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1906922/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1907771/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1915400/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2230414/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2288899/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2289585/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2291836/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2293308/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2300306/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2300337/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2305254/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2305256/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2310485/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2311540/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2312700/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2313567/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2316038/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2317750/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2317753/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2321949/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2325726/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2326444/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2326926/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2331026/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2331047/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2332010/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2336391/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2338251/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2338254/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2341484/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2341487/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2344782/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2349519/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2355531/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2355543/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2359987/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2362457/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2364035/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2367199/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2629526/Kleiner_Perkins_Caufield___Byers> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2232720/Acquisition_Aurora_(wis)_Health_Care_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-08-05T15:39:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> In yet another merger and acquisition, Aurora (Wis.) Health Care has purchased another Illinois physician group, reports the Business Journal." ;
    ns1:documentTitle "Doctors charged with $58M in false Medicare, Medicaid billing; DaVita's physician relationships under investigation;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/doctors-charged-58m-false-medicare-medicaid-billing-davita-s-physician-relationships> ;
    ns1:foundName "purchased" ;
    ns1:name "purchased" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:whereGeoName "Wisconsin" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5279468/about.rdf> ;
    ns1:whereRaw "Wisconsin" .

<https://1145.am/db/2232720/Merger_Aurora_(wis)_Health_Care_Aurora_(wis)_Health_Care_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2011-08-05T15:39:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> In yet another merger and acquisition, Aurora (Wis.) Health Care has purchased another Illinois physician group, reports the Business Journal." ;
    ns1:documentTitle "Doctors charged with $58M in false Medicare, Medicaid billing; DaVita's physician relationships under investigation;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/doctors-charged-58m-false-medicare-medicaid-billing-davita-s-physician-relationships> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:whereGeoName "Wisconsin" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5279468/about.rdf> ;
    ns1:whereRaw "Wisconsin" .

<https://1145.am/db/2233822/Health_Leads> a org:Organization ;
    ns1:basedInHighGeoName "Boston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4930956/about.rdf> ;
    ns1:basedInHighRaw "BOSTON" ;
    ns1:description "helping vulnerable families" ;
    ns1:documentDate "2011-05-10T14:21:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "The Physicians Foundation Awards $1 Million Grant to Health Leads" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/physicians-foundation-awards-1-million-grant-to-health-leads> ;
    ns1:foundName "Health Leads" ;
    ns1:industry "nonprofit" ;
    ns1:name "Health Leads" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2233822/Investment_Health_Leads_The_Physicians_Foundation_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-05-10T14:21:26+00:00"^^xsd:dateTime ;
    ns1:documentExtract "BOSTON- (BUSINESS WIRE) - The Physicians Foundation, a nonprofit organization that seeks to advance the work of practicing physicians and improve the quality of healthcare for all Americans, awarded a $ 1 million dollar grant to Health Leads, an organization devoted to helping vulnerable families by arranging for college volunteers to partner with physicians in hospitals across the country." ;
    ns1:documentTitle "The Physicians Foundation Awards $1 Million Grant to Health Leads" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/physicians-foundation-awards-1-million-grant-to-health-leads> ;
    ns1:foundName "grant" ;
    ns1:name "grant" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2233822/Health_Leads> ;
    ns1:valueRaw "$ 1 million dollar" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "America" .

<https://1145.am/db/2234558/Centrify_Corporation> a org:Organization ;
    ns1:basedInHighGeoName "Sunnyvale" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5400075/about.rdf> ;
    ns1:basedInHighRaw "SUNNYVALE, Calif." ;
    ns1:description "security and compliance solutions" ;
    ns1:documentDate "2011-08-17T12:20:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Centrify Secures $16M in Financing to Expand Distribution and Extend Its On-Premise and Cloud Security Offerings" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/centrify-secures-16m-financing-to-expand-distribution-and-extend-its-premise-and-cloud> ;
    ns1:foundName "Centrify Corporation" ;
    ns1:industry "security and compliance solutions" ;
    ns1:name "Centrify Corporation" ;
    ns1:sameAsMedium <https://1145.am/db/1852795/Centrify>,
        <https://1145.am/db/211869/Centrify> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2235176/Investment_First_5_La_Valley_Presbyterian_Hospital_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-08-18T16:20:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "VAN NUYS, Calif.- (BUSINESS WIRE) - First 5 LA announced today that it is awarding a grant of nearly $ 500,000 to Valley Presbyterian Hospital to improve the nutrition and health of the hospital's youngest patients by developing and maintaining policies and procedures to encourage increased breastfeeding among mothers of newborns." ;
    ns1:documentTitle "Valley Presbyterian Hospital Wins Grant for Breastfeeding Support" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/valley-presbyterian-hospital-wins-grant-for-breastfeeding-support> ;
    ns1:foundName "awarding",
        "grant" ;
    ns1:name "awarding",
        "grant" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2235176/Valley_Presbyterian_Hospital> ;
    ns1:valueRaw "nearly $ 500,000" ;
    ns1:whereGeoName "California" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:whereRaw "California" .

<https://1145.am/db/2235176/Valley_Presbyterian_Hospital> a org:Organization ;
    ns1:basedInHighGeoName "Van Nuys" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5405693/about.rdf> ;
    ns1:basedInHighRaw "VAN NUYS, Calif." ;
    ns1:description "Nursing" ;
    ns1:documentDate "2011-08-18T16:20:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Valley Presbyterian Hospital Wins Grant for Breastfeeding Support" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/valley-presbyterian-hospital-wins-grant-for-breastfeeding-support> ;
    ns1:foundName "Valley Presbyterian Hospital" ;
    ns1:industry "Hospital" ;
    ns1:name "Valley Presbyterian Hospital" ;
    ns1:sameAsHigh <https://1145.am/db/2239110/Valley_Presbyterian_Hospital>,
        <https://1145.am/db/2240122/Valley_Presbyterian_Hospital> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2239374/Chilton_Medical_Center> a org:Organization ;
    ns1:basedInHighGeoName "Clanton" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4055577/about.rdf> ;
    ns1:basedInHighRaw "Clanton, AL" ;
    ns1:description "patients" ;
    ns1:documentDate "2011-03-03T23:20:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SunLink Health Systems, Inc. Announces the Lease of Its Chilton Medical Center" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/sunlink-health-systems-inc-announces-lease-its-chilton-medical-center> ;
    ns1:foundName "Chilton Medical Center" ;
    ns1:industry "healthcare" ;
    ns1:name "Chilton Medical Center" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2239375/Institute_For_Child_And_Family_Health> a org:Organization ;
    ns1:basedInHighGeoName "Miami" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4164138/about.rdf> ;
    ns1:basedInHighRaw "MIAMI" ;
    ns1:description "Health care" ;
    ns1:documentDate "2011-03-04T12:20:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Institute for Child & Family Health (ICFH) Awarded $100,000 From Health Foundation of South Florida" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/institute-for-child-family-health-icfh-awarded-100-000-from-health-foundation-south> ;
    ns1:foundName "Institute for Child and Family Health" ;
    ns1:name "Institute for Child and Family Health" ;
    ns1:sameAsMedium <https://1145.am/db/1346789/Institute_For_Child___Family_Health> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2239375/Investment_Health_Foundation_Of_South_Florida_Institute_For_Child_And_Family_Health_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-03-04T12:20:41+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MIAMI, March 4, 2011 /PRNewswire-USNewswire/ - Institute for Child and Family Health (ICFH) received a $ 100,000 grant funding from Health Foundation of South Florida to support health information technology initiatives." ;
    ns1:documentTitle "Institute for Child & Family Health (ICFH) Awarded $100,000 From Health Foundation of South Florida" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/institute-for-child-family-health-icfh-awarded-100-000-from-health-foundation-south> ;
    ns1:foundName "funding",
        "grant" ;
    ns1:name "funding",
        "grant" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2239375/Institute_For_Child_And_Family_Health> ;
    ns1:valueRaw "$ 100,000" ;
    ns1:when "2011-03-04T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "March 4, 2011" ;
    ns1:whereGeoName "South Florida" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/12217087/about.rdf> ;
    ns1:whereRaw "South Florida" .

<https://1145.am/db/2240085/Genesis_Healthcare_Corporation> a org:Organization ;
    ns1:description "health care" ;
    ns1:documentDate "2011-03-07T22:20:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Health Care REIT, Inc. Completes $2.1 Billion in Concurrent Offerings of Common Stock and Cumulative Convertible Perpetual" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/health-care-reit-inc-completes-2-1-billion-concurrent-offerings-common-stock-and> ;
    ns1:foundName "Genesis HealthCare Corporation" ;
    ns1:industry "health care" ;
    ns1:name "Genesis HealthCare Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/1229215/Genesis_Innovation_Group>,
        <https://1145.am/db/1370577/Genesis_Research>,
        <https://1145.am/db/2236427/Genesis_Health_System>,
        <https://1145.am/db/2238687/Genesis_Healthcare>,
        <https://1145.am/db/2238691/Genesis_Healthcare_Corporation>,
        <https://1145.am/db/2239616/Genesis_Health_System>,
        <https://1145.am/db/2246571/Genesis_Healthcare>,
        <https://1145.am/db/2248737/Genesis_Healthcare>,
        <https://1145.am/db/2255692/Genesis_Health_System>,
        <https://1145.am/db/2275543/Genesis_Healthcare>,
        <https://1145.am/db/2564414/Genesiscare>,
        <https://1145.am/db/848903/Genesiscare>,
        <https://1145.am/db/849048/Genesiscare>,
        <https://1145.am/db/943176/Genesis_Integration_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2206999/Genesis_Healthcare>,
        <https://1145.am/db/2240360/Genesis_Healthcare>,
        <https://1145.am/db/736991/Genesis_Healthcare_Inc>,
        <https://1145.am/db/806964/Genesis_Healthcare> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2240085/Ipo_Health_Care_Reit_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "ipo" ;
    ns1:documentDate "2011-03-07T22:20:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "TOLEDO, Ohio- (BUSINESS WIRE) - Health Care REIT, Inc. (NYSE: HCN) today announced it has successfully completed its public offerings of 28.75 million shares of common stock at a price of $ 49.25 per share for total gross proceeds of $ 1.4 billion and $ 718.8 million (14.375 million shares) of 6.50 % cumulative convertible perpetual preferred stock." ;
    ns1:documentTitle "Health Care REIT, Inc. Completes $2.1 Billion in Concurrent Offerings of Common Stock and Cumulative Convertible Perpetual" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/health-care-reit-inc-completes-2-1-billion-concurrent-offerings-common-stock-and> ;
    ns1:foundName "public offerings" ;
    ns1:name "public offerings" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:valueRaw "$ 1.4 billion",
        "$ 718.8 million" ;
    ns1:whereGeoName "Ohio" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5165418/about.rdf> ;
    ns1:whereRaw "Ohio" .

<https://1145.am/db/2246449/St_Lukes_Hospital> a org:Organization ;
    ns1:basedInHighGeoName "Lucas County",
        "Maumee" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5161413/about.rdf>,
        <https://sws.geonames.org/5162137/about.rdf> ;
    ns1:basedInHighRaw "Lucas County, Ohio",
        "Maumee, Ohio" ;
    ns1:description "general acute-care inpatient hospital services",
        "patients" ;
    ns1:documentDate "2011-01-07T14:47:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "FTC and Ohio Attorney General Challenge ProMedica's Acquisition of St. Luke's Hospital" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/ftc-and-ohio-attorney-general-challenge-promedica-s-acquisition-st-luke-s-hospital> ;
    ns1:foundName "St. Luke's",
        "St. Luke's Hospital in Lucas County, Ohio" ;
    ns1:industry "healthcare",
        "hospital" ;
    ns1:name "St. Luke's",
        "St. Luke's Hospital" ;
    ns1:sameAsHigh <https://1145.am/db/2188700/Providence_St_Joseph_Health>,
        <https://1145.am/db/2190380/Providence_St_Joseph_Health>,
        <https://1145.am/db/2190771/Providence_St_Joseph_Health>,
        <https://1145.am/db/2190840/St_Marys_Medical_Center>,
        <https://1145.am/db/2191087/St_Joseph_Health_System>,
        <https://1145.am/db/2191509/Providence_St_Joseph_Health>,
        <https://1145.am/db/2192328/Providence_St_Joseph_Health>,
        <https://1145.am/db/2194492/St_Marys_Medical_Center>,
        <https://1145.am/db/2197204/Providence_St_Joseph_Health>,
        <https://1145.am/db/2197238/Providence_St_Joseph_Health>,
        <https://1145.am/db/2197868/Providence_St_Joseph_Health>,
        <https://1145.am/db/2227726/St_Johns_Hospital>,
        <https://1145.am/db/2231971/St_Joseph_Medical_Center>,
        <https://1145.am/db/2235362/St_Josephs_Mercy_Health_System>,
        <https://1145.am/db/2235381/St_Josephs_Mercy_Health_System>,
        <https://1145.am/db/2236580/St_Marys_Hospital>,
        <https://1145.am/db/2237939/St_Mary_Medical_Center>,
        <https://1145.am/db/2238692/St_Josephs_Hospital>,
        <https://1145.am/db/2238728/Saint_Josephs_Hospital>,
        <https://1145.am/db/2240451/Saint_Joseph_Health_System>,
        <https://1145.am/db/2241195/St_Marys_Hospital>,
        <https://1145.am/db/2242368/St_Joseph_Health_System>,
        <https://1145.am/db/2242446/Saint_Joseph_Mercy_Health_System>,
        <https://1145.am/db/2242448/Saint_Joseph_Mercy_Health_System>,
        <https://1145.am/db/2242987/St_Joseph_Medical_Center>,
        <https://1145.am/db/2243661/St_Anthony_Central_Hospital>,
        <https://1145.am/db/2244052/St_Lukes_Hospital>,
        <https://1145.am/db/2244184/St_Vincents_Hospital>,
        <https://1145.am/db/2245344/St_Joseph_Hospital>,
        <https://1145.am/db/2245692/St_Mary_Medical_Center>,
        <https://1145.am/db/2246977/St_Joseph_Health_System>,
        <https://1145.am/db/2247680/Saint_Marys_Hospital>,
        <https://1145.am/db/2249785/St_Joseph_Health_System>,
        <https://1145.am/db/2251918/St_Joseph_Medical_Center>,
        <https://1145.am/db/2254495/St_Marys_Hospital>,
        <https://1145.am/db/2254907/St_Marys_Medical_Center>,
        <https://1145.am/db/2256498/St_Joseph_Health_System>,
        <https://1145.am/db/2267653/St_Lukes_Hospital>,
        <https://1145.am/db/2269245/St_Josephs_Hospital>,
        <https://1145.am/db/2275053/St_Joseph_Health_System>,
        <https://1145.am/db/2276051/St_Lukes_Hospital>,
        <https://1145.am/db/499846/St_Bernard_Hospital> ;
    ns1:sameAsMedium <https://1145.am/db/2246455/St_Lukes_Hospital>,
        <https://1145.am/db/2254907/St_Lukes_Hospital>,
        <https://1145.am/db/2259150/St_Lukes_Medical_Center> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2246449/St_Lukes_Hospital_Control_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-01-07T14:47:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Continuing its efforts to protect healthcare consumers, the Federal Trade Commission today challenged ProMedica Health System, Inc.'s consummated acquisition of rival St. Luke's Hospital in Lucas County, Ohio.",
        "On August 31, 2010, ProMedica acquired control of St. Luke's, a formerly independent, not-for-profit general acute-care hospital in Maumee, Ohio." ;
    ns1:documentTitle "FTC and Ohio Attorney General Challenge ProMedica's Acquisition of St. Luke's Hospital" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/ftc-and-ohio-attorney-general-challenge-promedica-s-acquisition-st-luke-s-hospital> ;
    ns1:foundName "acquired",
        "acquisition" ;
    ns1:name "acquired",
        "acquisition" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2246449/St_Lukes_Hospital> ;
    ns1:targetDetails "control" ;
    ns1:targetName "St. Luke's",
        "St. Luke's Hospital" ;
    ns1:when "2010-08-31T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "August 31, 2010" ;
    ns1:whereGeoName "Maumee",
        "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5162137/about.rdf>,
        <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "Maumee, Ohio",
        "United States" .

<https://1145.am/db/2247240/Initiative_Capital_Romandie> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:documentDate "2011-07-05T14:20:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MyoPowers Closes Series B Investment of CHF 16 Million" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/myopowers-closes-series-b-investment-chf-16-million> ;
    ns1:foundName "Initiative Capital Romandie" ;
    ns1:investor <https://1145.am/db/2247240/Series_B_Investment_Blueocean_Ventures_Gran_Plasa_Sa_Initiative_Capital_Romandie_Myopowers_Medical_Technologies_Sa_Novartis_Venture_Funds_Truffle_Capital_Completed> ;
    ns1:name "Initiative Capital Romandie" ;
    ns1:sameAsMedium <https://1145.am/db/2292300/Initiative_Capital_Romandie>,
        <https://1145.am/db/2293270/Initiative_Capital_Romandie>,
        <https://1145.am/db/2298049/Initiative_Capital_Romandie>,
        <https://1145.am/db/2360125/Initiative_Capital_Romandie>,
        <https://1145.am/db/2360127/Initiative_Capital_Romandie>,
        <https://1145.am/db/2367257/Initiative_Capital_Romandie>,
        <https://1145.am/db/2367420/Initiative_Capital_Romandie> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2247240/Myopowers_Medical_Technologies_Sa> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:description "Business" ;
    ns1:documentDate "2011-07-05T14:20:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MyoPowers Closes Series B Investment of CHF 16 Million" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/myopowers-closes-series-b-investment-chf-16-million> ;
    ns1:foundName "MyoPowers Medical Technologies SA" ;
    ns1:industry "medical device" ;
    ns1:name "MyoPowers Medical Technologies SA" ;
    ns1:sameAsHigh <https://1145.am/db/2292300/Myopowers_Medical_Technologies> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2247240/Novartis_Venture_Funds> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:documentDate "2011-07-05T14:20:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MyoPowers Closes Series B Investment of CHF 16 Million" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/myopowers-closes-series-b-investment-chf-16-million> ;
    ns1:foundName "Novartis Venture Funds" ;
    ns1:investor <https://1145.am/db/2247240/Series_B_Investment_Blueocean_Ventures_Gran_Plasa_Sa_Initiative_Capital_Romandie_Myopowers_Medical_Technologies_Sa_Novartis_Venture_Funds_Truffle_Capital_Completed> ;
    ns1:name "Novartis Venture Funds" ;
    ns1:sameAsMedium <https://1145.am/db/1340338/Novartis_Venture_Fund>,
        <https://1145.am/db/1523031/Novartis_Venture_Fund>,
        <https://1145.am/db/207823/Novartis_Venture_Fund>,
        <https://1145.am/db/2152422/Novartis_Venture_Fund>,
        <https://1145.am/db/2289983/Novartis_Venture_Funds>,
        <https://1145.am/db/2292300/Novartis_Venture_Funds>,
        <https://1145.am/db/2292345/Novartis_Venture_Funds>,
        <https://1145.am/db/2297795/Novartis_Venture_Funds>,
        <https://1145.am/db/2298176/Novartis_Venture_Fund>,
        <https://1145.am/db/2307682/Novartis_Venture_Fund>,
        <https://1145.am/db/2310905/Novartis_Venture_Fund>,
        <https://1145.am/db/2310907/Novartis_Venture_Fund>,
        <https://1145.am/db/2313438/Novartis_Venture_Fund>,
        <https://1145.am/db/2315943/Novartis_Venture_Fund>,
        <https://1145.am/db/2315957/Novartis_Venture_Fund>,
        <https://1145.am/db/2317737/Novartis_Venture_Fund>,
        <https://1145.am/db/2323210/Novartis_Venture_Funds>,
        <https://1145.am/db/2323228/Novartis_Venture_Fund>,
        <https://1145.am/db/2323682/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2323683/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2326222/Novartis_Venture_Fund>,
        <https://1145.am/db/2327256/Novartis_Venture_Fund>,
        <https://1145.am/db/2327441/Novartis_Venture_Fund>,
        <https://1145.am/db/2327442/Novartis_Venture_Fund>,
        <https://1145.am/db/2330711/Novartis_Venture_Fund>,
        <https://1145.am/db/2331343/Novartis_Venture_Funds>,
        <https://1145.am/db/2331750/Novartis_Venture_Fund>,
        <https://1145.am/db/2331751/Novartis_Venture_Fund>,
        <https://1145.am/db/2332658/Novartis_Venture_Fund>,
        <https://1145.am/db/2332659/Novartis_Venture_Fund>,
        <https://1145.am/db/2335764/Novartis_Venture_Funds>,
        <https://1145.am/db/2336032/Novartis_Venture_Fund>,
        <https://1145.am/db/2336328/Novartis_Venture_Funds>,
        <https://1145.am/db/2337294/Novartis_Venture_Funds>,
        <https://1145.am/db/2337645/Novartis_Venture_Fund>,
        <https://1145.am/db/2338527/Novartis_Venture_Funds>,
        <https://1145.am/db/2339193/Novartis_Venture_Fund>,
        <https://1145.am/db/2339196/Novartis_Venture_Fund>,
        <https://1145.am/db/2340344/Novartis_Venture_Fund>,
        <https://1145.am/db/2340345/Novartis_Venture_Fund>,
        <https://1145.am/db/2340612/Novartis_Venture_Fund>,
        <https://1145.am/db/2340942/Novartis_Venture_Fund>,
        <https://1145.am/db/2343486/Novartis_Venture_Funds>,
        <https://1145.am/db/2343493/Novartis_Venture_Funds>,
        <https://1145.am/db/2343966/Novartis_Venture_Funds>,
        <https://1145.am/db/2344045/Novartis_Venture_Fund>,
        <https://1145.am/db/2348012/Novartis_Venture_Fund>,
        <https://1145.am/db/2348348/Novartis_Venture_Funds>,
        <https://1145.am/db/2348350/Novartis_Venture_Funds>,
        <https://1145.am/db/2351958/Novartis_Venture_Funds>,
        <https://1145.am/db/2351959/Novartis_Venture_Fund>,
        <https://1145.am/db/2352203/Novartis_Venture_Fund>,
        <https://1145.am/db/2352204/Novartis_Venture_Fund>,
        <https://1145.am/db/2352216/Novartis_Venture_Fund>,
        <https://1145.am/db/2353098/Novartis_Venture_Fund>,
        <https://1145.am/db/2356287/Novartis_Venture_Fund>,
        <https://1145.am/db/2356290/Novartis_Venture_Fund>,
        <https://1145.am/db/2356391/Novartis_Venture_Fund>,
        <https://1145.am/db/2356393/Novartis_Venture_Fund>,
        <https://1145.am/db/2356395/Novartis_Venture_Fund>,
        <https://1145.am/db/2356567/Novartis_Venture_Fund>,
        <https://1145.am/db/2358430/Novartis_Venture_Funds>,
        <https://1145.am/db/2358725/Novartis_Venture_Funds>,
        <https://1145.am/db/2358733/Novartis_Venture_Fund>,
        <https://1145.am/db/2361588/Novartis_Venture_Funds>,
        <https://1145.am/db/2362715/Novartis_Venture_Funds>,
        <https://1145.am/db/2363510/Novartis_Venture_Funds>,
        <https://1145.am/db/2363907/Novartis_Venture_Funds>,
        <https://1145.am/db/2367046/Novartis_Venture_Fund>,
        <https://1145.am/db/2369548/Novartis_Venture_Fund>,
        <https://1145.am/db/2551315/Novartis_Venture_Fund>,
        <https://1145.am/db/2570481/Novartis_Venture_Fund>,
        <https://1145.am/db/2570483/Novartis_Venture_Fund>,
        <https://1145.am/db/2578837/Novartis_Venture_Funds>,
        <https://1145.am/db/2592611/Novartis_Venture_Funds>,
        <https://1145.am/db/509733/Novartis_Venture_Fund>,
        <https://1145.am/db/866508/Novartis_Venture_Fund> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2258082/Amerihealth> a org:Organization ;
    ns1:basedInHighGeoName "Philadelphia" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4560349/about.rdf> ;
    ns1:basedInHighRaw "Philadelphia" ;
    ns1:description "Medicaid coverage" ;
    ns1:documentDate "2011-08-12T02:10:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blues plans spend $170M to expand into Medicaid" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/blues-plans-spend-170m-to-expand-into-medicaid> ;
    ns1:foundName "AmeriHealth Mercy Family of Companies",
        "the AmeriHealth" ;
    ns1:industry "healthcare" ;
    ns1:name "AmeriHealth" ;
    ns1:sameAsHigh <https://1145.am/db/1010061/Amwell>,
        <https://1145.am/db/1060960/Amn_Healthcare>,
        <https://1145.am/db/1063801/Amn_Healthcare>,
        <https://1145.am/db/1065910/Amwell>,
        <https://1145.am/db/1066998/Amwell>,
        <https://1145.am/db/1461816/Amn_Healthcare>,
        <https://1145.am/db/2027219/Amedisys>,
        <https://1145.am/db/2110693/Amerigroup_New_Jersey>,
        <https://1145.am/db/2214145/Amsplus>,
        <https://1145.am/db/2237211/Amsurg_Corp>,
        <https://1145.am/db/2246459/Amsplus>,
        <https://1145.am/db/2253494/Amerigroup>,
        <https://1145.am/db/2253495/Amerigroup>,
        <https://1145.am/db/2258956/Amerihealth>,
        <https://1145.am/db/2266016/Aetna>,
        <https://1145.am/db/2266915/Amerihealth>,
        <https://1145.am/db/2267701/Amerihealth>,
        <https://1145.am/db/2271851/Americhoice>,
        <https://1145.am/db/548416/Amn_Healthcare>,
        <https://1145.am/db/549179/Amn_Healthcare>,
        <https://1145.am/db/567184/Ambulnz_Inc>,
        <https://1145.am/db/892866/Amn_Healthcare>,
        <https://1145.am/db/893018/Amn_Healthcare> ;
    ns1:sameAsMedium <https://1145.am/db/2266902/Amerihealth> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2289564/Anc_Bio_Holdings> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Korea" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1835841/about.rdf> ;
    ns1:basedInHighRaw "South Korea" ;
    ns1:description "biomedical company" ;
    ns1:documentDate "2011-01-26T12:42:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CSA Medical snares $10M in first round" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/csa-medical-snares-10m-first-round> ;
    ns1:foundName "AND",
        "AnC Bio Holdings" ;
    ns1:industry "biomedical" ;
    ns1:investor <https://1145.am/db/2289564/Investment_Anc_Bio_Holdings_Bioheart_Completed> ;
    ns1:name "AnC Bio Holdings" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289564/Bioheart> a org:Organization ;
    ns1:basedInLowRaw "South Korea" ;
    ns1:description "cell therapies" ;
    ns1:documentDate "2011-01-26T12:42:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CSA Medical snares $10M in first round" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/csa-medical-snares-10m-first-round> ;
    ns1:foundName "Bioheart" ;
    ns1:industry "biomedical" ;
    ns1:name "Bioheart" ;
    ns1:sameAsMedium <https://1145.am/db/2307844/Bioheart>,
        <https://1145.am/db/2310081/Bioheart>,
        <https://1145.am/db/2322020/Bioheart> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289564/Csa_Medical> a org:Organization ;
    ns1:basedInHighGeoName "Baltimore County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4347790/about.rdf> ;
    ns1:basedInHighRaw "Baltimore" ;
    ns1:description "Cryotherapy" ;
    ns1:documentDate "2011-01-26T12:42:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CSA Medical snares $10M in first round" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/csa-medical-snares-10m-first-round> ;
    ns1:foundName "CSA Medical" ;
    ns1:industry "medical" ;
    ns1:name "CSA Medical" ;
    ns1:sameAsHigh <https://1145.am/db/2295654/Csa_Medical> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289564/Investment_Anc_Bio_Holdings_Bioheart_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-26T12:42:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "AND: South Korean biomedical company AnC Bio Holdings made a $ 4 million equity investment in Bioheart." ;
    ns1:documentTitle "CSA Medical snares $10M in first round" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/csa-medical-snares-10m-first-round> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2289564/Anc_Bio_Holdings>,
        <https://1145.am/db/2289564/Bioheart> ;
    ns1:targetName "Bioheart" ;
    ns1:valueRaw "$ 4 million" ;
    ns1:whereGeoName "Baltimore County",
        "Republic of Korea" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1835841/about.rdf>,
        <https://sws.geonames.org/4347790/about.rdf> ;
    ns1:whereRaw "Baltimore",
        "South Korea" .

<https://1145.am/db/2289564/Plus:_Nexstim_Oy> a org:Organization ;
    ns1:basedInLowRaw "Finland" ;
    ns1:description "noninvasive brain diagnostic and therapy technologies" ;
    ns1:documentDate "2011-01-26T12:42:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CSA Medical snares $10M in first round" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/csa-medical-snares-10m-first-round> ;
    ns1:foundName "PLUS: Nexstim Oy" ;
    ns1:name "PLUS: Nexstim Oy" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289564/Preferred_Stock_Investment_Csa_Medical_New_Markets_Venture_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-26T12:42:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "New Markets Venture Partners and existing investors led a $ 10 million Series A round of preferred stock financing for CSA Medical, a Baltimore - based company that develops spray cryotherapy devices." ;
    ns1:documentTitle "CSA Medical snares $10M in first round" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/csa-medical-snares-10m-first-round> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2289564/Csa_Medical> ;
    ns1:targetDetails "preferred stock" ;
    ns1:valueRaw "$ 10 million" ;
    ns1:whereGeoName "Baltimore County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4347790/about.rdf> ;
    ns1:whereRaw "Baltimore" .

<https://1145.am/db/2289591/Cellnovo> a org:Organization ;
    ns1:basedInHighGeoName "London" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:basedInHighRaw "London" ;
    ns1:description "diabetes" ;
    ns1:documentDate "2011-02-07T14:05:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cellnovo lands $48M for diabetes management system" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cellnovo-lands-48m-for-diabetes-management-system> ;
    ns1:foundName "Cellnovo" ;
    ns1:name "Cellnovo" ;
    ns1:sameAsHigh <https://1145.am/db/1802913/Glooko>,
        <https://1145.am/db/2190552/Livongo>,
        <https://1145.am/db/2277899/Cellnovo>,
        <https://1145.am/db/2280187/Eoflow>,
        <https://1145.am/db/2282840/Glooko>,
        <https://1145.am/db/2299867/Medingo>,
        <https://1145.am/db/2341621/Medingo>,
        <https://1145.am/db/2368522/Cellnovo_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289591/Edmond_De_Rothschild_Investment_Partners> a org:Organization ;
    ns1:basedInHighGeoName "London" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:basedInHighRaw "London" ;
    ns1:documentDate "2011-02-07T14:05:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cellnovo lands $48M for diabetes management system" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cellnovo-lands-48m-for-diabetes-management-system> ;
    ns1:foundName "Edmond de Rothschild Investment Partners" ;
    ns1:investor <https://1145.am/db/2289591/Series_B_Investment_Cellnovo_Edmond_De_Rothschild_Investment_Partners_Completed> ;
    ns1:name "Edmond de Rothschild Investment Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2297507/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2299423/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2301041/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2301096/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303210/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303641/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303642/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303849/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2313401/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2313410/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2320503/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2325831/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2336923/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2338023/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2338193/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2338196/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2348331/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2350101/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2351191/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2351192/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2353607/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2353610/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2356567/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2358268/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2358269/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2358541/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2363938/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2363941/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2367201/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2368740/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2369953/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2369982/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2369999/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2555540/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2701527/Edmond_De_Rothschild_Investment_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289591/Glaukos_Corp> a org:Organization ;
    ns1:basedInHighGeoName "Palo Alto County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4870630/about.rdf> ;
    ns1:basedInHighRaw "Palo Alto" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-02-07T14:05:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cellnovo lands $48M for diabetes management system" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cellnovo-lands-48m-for-diabetes-management-system> ;
    ns1:foundName "Glaukos Corp." ;
    ns1:name "Glaukos Corp." ;
    ns1:sameAsMedium <https://1145.am/db/2296275/Glaukos>,
        <https://1145.am/db/2367773/Glaukos>,
        <https://1145.am/db/252667/Glaukos_Corporation>,
        <https://1145.am/db/702818/Glaukos_Corporation>,
        <https://1145.am/db/711016/Glaukos_Corporation>,
        <https://1145.am/db/813286/Glaukos_Corporation>,
        <https://1145.am/db/814105/Glaukos_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289591/Series_B_Investment_Cellnovo_Edmond_De_Rothschild_Investment_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-02-07T14:05:59+00:00"^^xsd:dateTime ;
    ns1:documentExtract "London's Cellnovo, a maker of a diabetes monitoring system, has raised $ 48.4 million in a Series B financing led by Edmond de Rothschild Investment Partners." ;
    ns1:documentTitle "Cellnovo lands $48M for diabetes management system" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cellnovo-lands-48m-for-diabetes-management-system> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2289591/Cellnovo> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 48.4 million" ;
    ns1:whereGeoName "London" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:whereRaw "London" .

<https://1145.am/db/2289940/Airxpanders> a org:Organization ;
    ns1:basedInHighGeoName "Palo Alto" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5380748/about.rdf> ;
    ns1:basedInHighRaw "Palo Alto, CA" ;
    ns1:documentDate "2011-03-02T12:55:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CardioFocus raises $30.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiofocus-raises-30-6m> ;
    ns1:foundName "AirXpanders" ;
    ns1:name "AirXpanders" ;
    ns1:sameAsMedium <https://1145.am/db/2314049/Airxpanders>,
        <https://1145.am/db/2316127/Airxpanders>,
        <https://1145.am/db/2368763/Airxpanders_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289940/Cardiofocus> a org:Organization ;
    ns1:basedInHighGeoName "Marlborough" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4943170/about.rdf> ;
    ns1:basedInHighRaw "Marlborough, MA" ;
    ns1:documentDate "2011-03-02T12:55:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CardioFocus raises $30.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiofocus-raises-30-6m> ;
    ns1:foundName "CardioFocus" ;
    ns1:name "CardioFocus" ;
    ns1:sameAsMedium <https://1145.am/db/2300956/Cardiofocus> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289940/Investment_Airxpanders_Oxford_Finance_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-03-02T12:55:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "ALSO: Palo Alto, CA - based AirXpanders has another $ 8 million from two VC rounds, with $ 5 million led by GBS Ventures and another $ 3 million from Oxford Finance." ;
    ns1:documentTitle "CardioFocus raises $30.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiofocus-raises-30-6m> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2289940/Airxpanders> ;
    ns1:valueRaw "$ 5 million" ;
    ns1:whereGeoName "Marlborough" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4943170/about.rdf> ;
    ns1:whereRaw "Marlborough, MA" .

<https://1145.am/db/2289940/Oxford_Finance> a org:Organization ;
    ns1:basedInLowRaw "Palo Alto" ;
    ns1:documentDate "2011-03-02T12:55:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CardioFocus raises $30.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiofocus-raises-30-6m> ;
    ns1:foundName "Oxford Finance" ;
    ns1:investor <https://1145.am/db/2289940/Investment_Airxpanders_Oxford_Finance_Has_Not_Happened> ;
    ns1:name "Oxford Finance" ;
    ns1:sameAsMedium <https://1145.am/db/1100295/Oxford_Finance_Llc>,
        <https://1145.am/db/1100492/Oxford_Finance_Llc>,
        <https://1145.am/db/1101340/Oxford_Finance_Llc>,
        <https://1145.am/db/1152410/Oxford_Finance_Llc>,
        <https://1145.am/db/1318713/Oxford_Finance_Llc>,
        <https://1145.am/db/1422452/Oxford_Finance_Llc>,
        <https://1145.am/db/1433740/Oxford_Finance_Llc>,
        <https://1145.am/db/1434127/Oxford_Finance_Llc>,
        <https://1145.am/db/1459745/Oxford_Finance_Llc>,
        <https://1145.am/db/1506328/Oxford_Finance_Llc>,
        <https://1145.am/db/1508005/Oxford_Finance_Llc>,
        <https://1145.am/db/188641/Oxford_Finance_Llc>,
        <https://1145.am/db/2003353/Oxford_Finance_Llc>,
        <https://1145.am/db/2069388/Oxford_Finance>,
        <https://1145.am/db/2199361/Oxford_Finance_Corporation>,
        <https://1145.am/db/2288016/Oxford_Finance>,
        <https://1145.am/db/2292812/Oxford_Finance>,
        <https://1145.am/db/2293047/Oxford_Finance>,
        <https://1145.am/db/2302085/Oxford_Finance_Corporation>,
        <https://1145.am/db/2302707/Oxford_Finance_Corporation>,
        <https://1145.am/db/2305927/Oxford_Finance_Corporation>,
        <https://1145.am/db/2306687/Oxford_Finance_Corporation>,
        <https://1145.am/db/2311101/Oxford_Finance_Corporation>,
        <https://1145.am/db/2317145/Oxford_Finance_Corporation>,
        <https://1145.am/db/2319430/Oxford_Finance>,
        <https://1145.am/db/2324337/Oxford_Finance_Corporation>,
        <https://1145.am/db/2327464/Oxford_Finance>,
        <https://1145.am/db/2328500/Oxford_Finance_Corporation>,
        <https://1145.am/db/2328511/Oxford_Finance_Corporation>,
        <https://1145.am/db/2328616/Oxford_Finance_Corporation>,
        <https://1145.am/db/2331928/Oxford_Finance_Corporation>,
        <https://1145.am/db/2341182/Oxford_Finance_Llc>,
        <https://1145.am/db/2344565/Oxford_Finance_Corporation>,
        <https://1145.am/db/2346204/Oxford_Finance_Llc>,
        <https://1145.am/db/2348745/Oxford_Finance_Llc>,
        <https://1145.am/db/2358002/Oxford_Finance_Corporation>,
        <https://1145.am/db/2358116/Oxford_Finance_Llc>,
        <https://1145.am/db/2364404/Oxford_Finance_Corporation>,
        <https://1145.am/db/2365674/Oxford_Finance_Corporation>,
        <https://1145.am/db/2575677/Oxford_Finance>,
        <https://1145.am/db/2575679/Oxford_Finance>,
        <https://1145.am/db/2587375/Oxford_Finance>,
        <https://1145.am/db/520223/Oxford_Finance>,
        <https://1145.am/db/522518/Oxford_Finance>,
        <https://1145.am/db/593670/Oxford_Finance>,
        <https://1145.am/db/596524/Oxford_Finance_Llc>,
        <https://1145.am/db/604065/Oxford_Finance_Llc>,
        <https://1145.am/db/606420/Oxford_Finance_Llc>,
        <https://1145.am/db/704387/Oxford_Finance_Llc>,
        <https://1145.am/db/781786/Oxford_Finance>,
        <https://1145.am/db/815981/Oxford_Finance_Llc>,
        <https://1145.am/db/830736/Oxford_Finance_Llc>,
        <https://1145.am/db/847790/Oxford_Finance_Llc>,
        <https://1145.am/db/848458/Oxford_Finance_Llc>,
        <https://1145.am/db/928761/Oxford_Finance_Llc>,
        <https://1145.am/db/930408/Oxford_Finance_Llc>,
        <https://1145.am/db/955192/Oxford_Finance_Llc>,
        <https://1145.am/db/955875/Oxford_Finance_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289940/Retina_Implant> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "medical" ;
    ns1:documentDate "2011-03-02T12:55:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CardioFocus raises $30.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiofocus-raises-30-6m> ;
    ns1:foundName "Retina Implant" ;
    ns1:name "Retina Implant" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290405/Bionanomatrix> a org:Organization ;
    ns1:description "a developer of nanoscale, single-molecule imaging and analysis platforms designed to dramatically reduce the" ;
    ns1:documentDate "2011-03-18T01:13:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Finance, GE Capital give $20M senior credit facility to NeoVista" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/oxford-finance-ge-capital-give-20m-senior-credit-facility-to-neovista> ;
    ns1:foundName "BioNanomatrix" ;
    ns1:name "BioNanomatrix" ;
    ns1:sameAsMedium <https://1145.am/db/2200866/Bionanomatrix_Inc>,
        <https://1145.am/db/2314987/Bionanomatrix>,
        <https://1145.am/db/2321991/Bionanomatrix>,
        <https://1145.am/db/2325346/Bionanomatrix>,
        <https://1145.am/db/2353015/Bionanomatrix>,
        <https://1145.am/db/2357981/Bionanomatrix> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290405/Gund_Investment_Corporation> a org:Organization ;
    ns1:description "equity financing" ;
    ns1:documentDate "2011-03-18T01:13:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Finance, GE Capital give $20M senior credit facility to NeoVista" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/oxford-finance-ge-capital-give-20m-senior-credit-facility-to-neovista> ;
    ns1:foundName "Gund Investment Corporation" ;
    ns1:investor <https://1145.am/db/2290405/Equity_Investment_Battelle_Ventures_Bionanomatrix_Domain_Associates_Gund_Investment_Corporation_Innovation_Valley_Partners_Kt_Venture_Group_Completed> ;
    ns1:name "Gund Investment Corporation" ;
    ns1:sameAsMedium <https://1145.am/db/1708808/Gund_Investment>,
        <https://1145.am/db/2291344/Gund_Investment_Corporation>,
        <https://1145.am/db/2357981/Gund_Investment_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290405/Neovista> a org:Organization ;
    ns1:basedInHighGeoName "Newark" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5376803/about.rdf> ;
    ns1:basedInHighRaw "Newark, CA" ;
    ns1:documentDate "2011-03-18T01:13:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Finance, GE Capital give $20M senior credit facility to NeoVista" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/oxford-finance-ge-capital-give-20m-senior-credit-facility-to-neovista> ;
    ns1:foundName "NeoVista" ;
    ns1:industry "Healthcare" ;
    ns1:name "NeoVista" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2291344/Clal_Biotechnology_Industries> a org:Organization ;
    ns1:basedInHighGeoName "State of Israel" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:basedInHighRaw "Israel" ;
    ns1:documentDate "2011-05-12T13:06:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "WaveTec Vision secures $15.9M; EU to apply new hazardous materials regs to medical devices;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/wavetec-vision-secures-15-9m-eu-to-apply-new-hazardous-materials-regs-to-medical> ;
    ns1:foundName "> Clal Biotechnology Industries",
        "Clal Biotechnology Industries" ;
    ns1:industry "medical devices" ;
    ns1:investor <https://1145.am/db/2291344/Investment_Clal_Biotechnology_Industries_Has_Not_Happened> ;
    ns1:name "Clal Biotechnology Industries" ;
    ns1:sameAsMedium <https://1145.am/db/2305822/Clal_Biotechnology_Industries>,
        <https://1145.am/db/2319224/Clal_Biotechnology_Industries>,
        <https://1145.am/db/2335775/Clal_Biotechnology_Industries_Ltd>,
        <https://1145.am/db/2336157/Clal_Biotechnology_Industries_Ltd>,
        <https://1145.am/db/2337455/Clal_Biotechnology_Industries>,
        <https://1145.am/db/2341621/Clal_Biotechnology_Industries>,
        <https://1145.am/db/2584533/Clal_Biotechnology_Industries> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2291344/Gund_Investment_Corporation> a org:Organization ;
    ns1:basedInLowRaw "Aliso Viejo, CA" ;
    ns1:documentDate "2011-05-12T13:06:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "WaveTec Vision secures $15.9M; EU to apply new hazardous materials regs to medical devices;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/wavetec-vision-secures-15-9m-eu-to-apply-new-hazardous-materials-regs-to-medical> ;
    ns1:foundName "Gund Investment Corporation" ;
    ns1:investor <https://1145.am/db/2291344/Series_D_Investment_Accuitive_Medical_Ventures_De_Novo_Ventures_Gund_Investment_Corporation_Versant_Ventures_Completed> ;
    ns1:name "Gund Investment Corporation" ;
    ns1:sameAsMedium <https://1145.am/db/1708808/Gund_Investment>,
        <https://1145.am/db/2290405/Gund_Investment_Corporation>,
        <https://1145.am/db/2357981/Gund_Investment_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2291344/Investment_Clal_Biotechnology_Industries_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-05-12T13:06:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Clal Biotechnology Industries will soon make its first investment through the NIS 225 million ($ 64.5 million) medical devices investment fund that it is setting up with Israeli institutional investors." ;
    ns1:documentTitle "WaveTec Vision secures $15.9M; EU to apply new hazardous materials regs to medical devices;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/wavetec-vision-secures-15-9m-eu-to-apply-new-hazardous-materials-regs-to-medical> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2291344/Clal_Biotechnology_Industries>,
        <https://1145.am/db/2291344/Pi_R_Squared_Ltd> ;
    ns1:targetName "Pi R Squared Ltd." ;
    ns1:valueRaw "$ 64.5 million",
        "NIS 225 million",
        "several million dollars" ;
    ns1:whereGeoName "Aliso Viejo",
        "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/294640/about.rdf>,
        <https://sws.geonames.org/5323163/about.rdf> ;
    ns1:whereRaw "Aliso Viejo",
        "Israel" .

<https://1145.am/db/2291344/Pi_R_Squared_Ltd> a org:Organization ;
    ns1:basedInLowRaw "Israel" ;
    ns1:description "developing a treatment for calcification of coronary valves" ;
    ns1:documentDate "2011-05-12T13:06:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "WaveTec Vision secures $15.9M; EU to apply new hazardous materials regs to medical devices;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/wavetec-vision-secures-15-9m-eu-to-apply-new-hazardous-materials-regs-to-medical> ;
    ns1:foundName "Pi R Squared Ltd." ;
    ns1:industry "medical devices" ;
    ns1:name "Pi R Squared Ltd." ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2291344/Versant_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Aliso Viejo" ;
    ns1:documentDate "2011-05-12T13:06:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "WaveTec Vision secures $15.9M; EU to apply new hazardous materials regs to medical devices;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/wavetec-vision-secures-15-9m-eu-to-apply-new-hazardous-materials-regs-to-medical> ;
    ns1:foundName "Versant Ventures" ;
    ns1:investor <https://1145.am/db/2291344/Series_D_Investment_Accuitive_Medical_Ventures_De_Novo_Ventures_Gund_Investment_Corporation_Versant_Ventures_Completed> ;
    ns1:name "Versant Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1540787/Versant_Ventures>,
        <https://1145.am/db/1541055/Versant_Ventures>,
        <https://1145.am/db/1571794/Versant_Ventures>,
        <https://1145.am/db/1928388/Versant_Ventures>,
        <https://1145.am/db/1975490/Versant_Ventures>,
        <https://1145.am/db/2069394/Versant_Ventures>,
        <https://1145.am/db/2110276/Versant_Ventures>,
        <https://1145.am/db/2151802/Versant_Ventures>,
        <https://1145.am/db/2154338/Versant_Ventures>,
        <https://1145.am/db/2154566/Versant_Ventures>,
        <https://1145.am/db/2281211/Versant_Ventures>,
        <https://1145.am/db/2287023/Versant_Ventures>,
        <https://1145.am/db/2288016/Versant_Ventures>,
        <https://1145.am/db/2290283/Versant_Ventures>,
        <https://1145.am/db/2291315/Versant_Ventures>,
        <https://1145.am/db/2293059/Versant_Ventures>,
        <https://1145.am/db/2293893/Versant_Ventures>,
        <https://1145.am/db/2294202/Versant_Ventures>,
        <https://1145.am/db/2296209/Versant_Ventures>,
        <https://1145.am/db/2298176/Versant_Ventures>,
        <https://1145.am/db/2299080/Versant_Ventures>,
        <https://1145.am/db/2299776/Versant_Ventures>,
        <https://1145.am/db/2300337/Versant_Ventures>,
        <https://1145.am/db/2303767/Versant_Ventures>,
        <https://1145.am/db/2304598/Versant_Ventures>,
        <https://1145.am/db/2304606/Versant_Ventures>,
        <https://1145.am/db/2304769/Versant_Ventures>,
        <https://1145.am/db/2305015/Versant_Ventures>,
        <https://1145.am/db/2308758/Versant_Ventures>,
        <https://1145.am/db/2310285/Versant_Ventures>,
        <https://1145.am/db/2310302/Versant_Ventures>,
        <https://1145.am/db/2311353/Versant_Ventures>,
        <https://1145.am/db/2313143/Versant_Ventures>,
        <https://1145.am/db/2317750/Versant_Ventures>,
        <https://1145.am/db/2317753/Versant_Ventures>,
        <https://1145.am/db/2318733/Versant_Ventures>,
        <https://1145.am/db/2319784/Versant_Ventures>,
        <https://1145.am/db/2322646/Versant_Ventures>,
        <https://1145.am/db/2323226/Versant_Ventures>,
        <https://1145.am/db/2324226/Versant_Ventures>,
        <https://1145.am/db/2325681/Versant_Ventures>,
        <https://1145.am/db/2326361/Versant_Ventures>,
        <https://1145.am/db/2326373/Versant_Ventures>,
        <https://1145.am/db/2326903/Versant_Ventures>,
        <https://1145.am/db/2330075/Versant_Ventures>,
        <https://1145.am/db/2330712/Versant_Ventures>,
        <https://1145.am/db/2330852/Versant_Ventures>,
        <https://1145.am/db/2331754/Versant_Ventures>,
        <https://1145.am/db/2331868/Versant_Ventures>,
        <https://1145.am/db/2335675/Versant_Ventures>,
        <https://1145.am/db/2335760/Versant_Ventures>,
        <https://1145.am/db/2339885/Versant_Ventures>,
        <https://1145.am/db/2339886/Versant_Ventures>,
        <https://1145.am/db/2342445/Versant_Ventures>,
        <https://1145.am/db/2343184/Versant_Ventures>,
        <https://1145.am/db/2343185/Versant_Ventures>,
        <https://1145.am/db/2343206/Versant_Ventures>,
        <https://1145.am/db/2343467/Versant_Ventures>,
        <https://1145.am/db/2343547/Versant_Ventures>,
        <https://1145.am/db/2343641/Versant_Ventures>,
        <https://1145.am/db/2343647/Versant_Ventures>,
        <https://1145.am/db/2344915/Versant_Ventures>,
        <https://1145.am/db/2344916/Versant_Ventures>,
        <https://1145.am/db/2344922/Versant_Ventures>,
        <https://1145.am/db/2344926/Versant_Ventures>,
        <https://1145.am/db/2345769/Versant_Ventures>,
        <https://1145.am/db/2347368/Versant_Ventures>,
        <https://1145.am/db/2348012/Versant_Ventures>,
        <https://1145.am/db/2348857/Versant_Ventures>,
        <https://1145.am/db/2349233/Versant_Ventures>,
        <https://1145.am/db/2349834/Versant_Ventures>,
        <https://1145.am/db/2350917/Versant_Ventures>,
        <https://1145.am/db/2351904/Versant_Ventures>,
        <https://1145.am/db/2354296/Versant_Ventures>,
        <https://1145.am/db/2360189/Versant_Ventures>,
        <https://1145.am/db/2360191/Versant_Ventures>,
        <https://1145.am/db/2360415/Versant_Ventures>,
        <https://1145.am/db/2362457/Versant_Ventures>,
        <https://1145.am/db/2362527/Versant_Ventures>,
        <https://1145.am/db/2362528/Versant_Ventures>,
        <https://1145.am/db/2362565/Versant_Ventures>,
        <https://1145.am/db/2362566/Versant_Ventures>,
        <https://1145.am/db/2364480/Versant_Ventures>,
        <https://1145.am/db/2365134/Versant_Ventures>,
        <https://1145.am/db/2365135/Versant_Ventures>,
        <https://1145.am/db/2367275/Versant_Ventures>,
        <https://1145.am/db/2368517/Versant_Ventures>,
        <https://1145.am/db/2370609/Versant_Ventures>,
        <https://1145.am/db/2370782/Versant_Ventures>,
        <https://1145.am/db/2370799/Versant_Ventures>,
        <https://1145.am/db/2371160/Versant_Ventures>,
        <https://1145.am/db/2371163/Versant_Ventures>,
        <https://1145.am/db/2541575/Versant_Ventures>,
        <https://1145.am/db/2584561/Versant_Ventures>,
        <https://1145.am/db/456081/Versant_Ventures>,
        <https://1145.am/db/488687/Versant_Ventures>,
        <https://1145.am/db/547640/Versant_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2322429/Beringea> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:documentDate "2011-07-19T12:53:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Bioinformatics upstart Intervention Insights secures $7.2M" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/bioinformatics-upstart-intervention-insights-secures-7-2m> ;
    ns1:foundName "Beringea" ;
    ns1:investor <https://1145.am/db/2322429/Investment_Beringea_Chrysalis_Ventures_Hopen_Life_Sciences_Intervention_Insights_Michigan_Accelerator_Fund_I_Completed> ;
    ns1:name "Beringea" ;
    ns1:sameAsMedium <https://1145.am/db/1114659/Beringea>,
        <https://1145.am/db/1168925/Beringea>,
        <https://1145.am/db/1171251/Beringea>,
        <https://1145.am/db/1230379/Beringea>,
        <https://1145.am/db/150479/Beringea>,
        <https://1145.am/db/1707620/Beringea>,
        <https://1145.am/db/1760209/Beringea>,
        <https://1145.am/db/1764054/Beringea>,
        <https://1145.am/db/1784899/Beringea>,
        <https://1145.am/db/1795461/Beringea>,
        <https://1145.am/db/1797259/Beringea>,
        <https://1145.am/db/1801532/Beringea>,
        <https://1145.am/db/1950910/Beringea_Llc>,
        <https://1145.am/db/2050229/Beringea>,
        <https://1145.am/db/2252673/Beringea>,
        <https://1145.am/db/2323825/Beringea>,
        <https://1145.am/db/2363854/Beringea>,
        <https://1145.am/db/285942/Beringea>,
        <https://1145.am/db/474764/Beringea> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2322429/Chrysalis_Ventures> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:documentDate "2011-07-19T12:53:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Bioinformatics upstart Intervention Insights secures $7.2M" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/bioinformatics-upstart-intervention-insights-secures-7-2m> ;
    ns1:foundName "Chrysalis Ventures" ;
    ns1:investor <https://1145.am/db/2322429/Investment_Beringea_Chrysalis_Ventures_Hopen_Life_Sciences_Intervention_Insights_Michigan_Accelerator_Fund_I_Completed> ;
    ns1:name "Chrysalis Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1119554/Chrysalis_Ventures>,
        <https://1145.am/db/2246863/Chrysalis_Ventures>,
        <https://1145.am/db/2255605/Chrysalis_Ventures>,
        <https://1145.am/db/2363854/Chrysalis_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2322429/Hopen_Life_Sciences> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:documentDate "2011-07-19T12:53:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Bioinformatics upstart Intervention Insights secures $7.2M" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/bioinformatics-upstart-intervention-insights-secures-7-2m> ;
    ns1:foundName "Hopen Life Sciences" ;
    ns1:investor <https://1145.am/db/2322429/Investment_Beringea_Chrysalis_Ventures_Hopen_Life_Sciences_Intervention_Insights_Michigan_Accelerator_Fund_I_Completed> ;
    ns1:name "Hopen Life Sciences" ;
    ns1:sameAsMedium <https://1145.am/db/2363854/Hopen_Life_Sciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2322429/Michigan_Accelerator_Fund_I> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:documentDate "2011-07-19T12:53:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Bioinformatics upstart Intervention Insights secures $7.2M" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/bioinformatics-upstart-intervention-insights-secures-7-2m> ;
    ns1:foundName "Michigan Accelerator Fund I" ;
    ns1:investor <https://1145.am/db/2322429/Investment_Beringea_Chrysalis_Ventures_Hopen_Life_Sciences_Intervention_Insights_Michigan_Accelerator_Fund_I_Completed> ;
    ns1:name "Michigan Accelerator Fund I" ;
    ns1:sameAsMedium <https://1145.am/db/2363854/Michigan_Accelerator_Fund_I> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339295/Delenex> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:description "developing therapeutic antibody fragments" ;
    ns1:documentDate "2011-05-03T15:32:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Delenex extends its A round to CHF 30.2 million" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/delenex-extends-its-a-round-to-chf-30-2-million> ;
    ns1:foundName "Delenex Therapeutics AG" ;
    ns1:industry "biotech" ;
    ns1:name "Delenex" ;
    ns1:sameAsMedium <https://1145.am/db/2352383/Delenex> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339295/Hbm_Biocapital> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:description "venture equity investment" ;
    ns1:documentDate "2011-05-03T15:32:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Delenex extends its A round to CHF 30.2 million" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/delenex-extends-its-a-round-to-chf-30-2-million> ;
    ns1:foundName "HBM BioCapital" ;
    ns1:investor <https://1145.am/db/2339295/Series_A_Investment_Biomedinvest_Delenex_Hbm_Biocapital_Hbm_Bioventures_Novo_Ventures_Sv_Life_Sciences_Vi_Partners_Completed> ;
    ns1:name "HBM BioCapital" ;
    ns1:sameAsHigh <https://1145.am/db/2063805/Westlake_Village_Biopartners>,
        <https://1145.am/db/2313425/Bioam_Gestion>,
        <https://1145.am/db/2339295/Hbm_Bioventures> ;
    ns1:sameAsMedium <https://1145.am/db/2308422/Hbm_Biocapital_Lp>,
        <https://1145.am/db/2309368/Hbm_Biocapital_Lp>,
        <https://1145.am/db/2313322/Hbm_Biocapital>,
        <https://1145.am/db/2313438/Hbm_Biocapital>,
        <https://1145.am/db/2314397/Hbm_Biocapital>,
        <https://1145.am/db/2314400/Hbm_Biocapital>,
        <https://1145.am/db/2352382/Hbm_Biocapital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339295/Hbm_Bioventures> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:description "venture equity investment" ;
    ns1:documentDate "2011-05-03T15:32:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Delenex extends its A round to CHF 30.2 million" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/delenex-extends-its-a-round-to-chf-30-2-million> ;
    ns1:foundName "HBM BioVentures" ;
    ns1:investor <https://1145.am/db/2339295/Series_A_Investment_Biomedinvest_Delenex_Hbm_Biocapital_Hbm_Bioventures_Novo_Ventures_Sv_Life_Sciences_Vi_Partners_Completed> ;
    ns1:name "HBM BioVentures" ;
    ns1:sameAsHigh <https://1145.am/db/2063805/Westlake_Village_Biopartners>,
        <https://1145.am/db/2313425/Bioam_Gestion>,
        <https://1145.am/db/2339295/Hbm_Biocapital> ;
    ns1:sameAsMedium <https://1145.am/db/2292772/Hbm_Bioventures>,
        <https://1145.am/db/2301790/Hbm_Bioventures>,
        <https://1145.am/db/2302994/Hbm_Bioventures>,
        <https://1145.am/db/2302995/Hbm_Bioventures>,
        <https://1145.am/db/2303121/Hbm_Bioventures>,
        <https://1145.am/db/2304335/Hbm_Bioventures>,
        <https://1145.am/db/2304340/Hbm_Bioventures>,
        <https://1145.am/db/2313322/Hbm_Bioventures>,
        <https://1145.am/db/2313438/Hbm_Bioventures>,
        <https://1145.am/db/2324255/Hbm_Bioventures>,
        <https://1145.am/db/2325831/Hbm_Bioventures>,
        <https://1145.am/db/2326176/Hbm_Bioventures>,
        <https://1145.am/db/2329550/Hbm_Bioventures>,
        <https://1145.am/db/2332864/Hbm_Bioventures>,
        <https://1145.am/db/2335700/Hbm_Bioventures>,
        <https://1145.am/db/2349301/Hbm_Bioventures_Ltd>,
        <https://1145.am/db/2352382/Hbm_Bioventures>,
        <https://1145.am/db/2353607/Hbm_Bioventures>,
        <https://1145.am/db/2353610/Hbm_Bioventures>,
        <https://1145.am/db/2365748/Hbm_Bioventures>,
        <https://1145.am/db/2584056/Hbm_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339295/Vi_Partners> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:description "venture equity investment" ;
    ns1:documentDate "2011-05-03T15:32:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Delenex extends its A round to CHF 30.2 million" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/delenex-extends-its-a-round-to-chf-30-2-million> ;
    ns1:foundName "VI Partners" ;
    ns1:investor <https://1145.am/db/2339295/Series_A_Investment_Biomedinvest_Delenex_Hbm_Biocapital_Hbm_Bioventures_Novo_Ventures_Sv_Life_Sciences_Vi_Partners_Completed> ;
    ns1:name "VI Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1139643/Partners_Capital>,
        <https://1145.am/db/1512079/Forefront_Venture_Partners>,
        <https://1145.am/db/1712506/Us_Venture_Partners>,
        <https://1145.am/db/1758985/Us_Venture_Partners>,
        <https://1145.am/db/1763964/Us_Venture_Partners>,
        <https://1145.am/db/1786672/Insight_Venture_Partners>,
        <https://1145.am/db/1814404/Institutional_Venture_Partners>,
        <https://1145.am/db/1842350/Us_Venture_Partners>,
        <https://1145.am/db/1851689/Us_Venture_Partners>,
        <https://1145.am/db/1864900/Us_Venture_Partners>,
        <https://1145.am/db/2330758/Early_Stage_Partners>,
        <https://1145.am/db/769568/Vertical_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1386529/Vi_Partners>,
        <https://1145.am/db/1388463/Vi_Partners>,
        <https://1145.am/db/2154009/Vi_Partners>,
        <https://1145.am/db/2313124/Vi_Partners>,
        <https://1145.am/db/2313322/Vi_Partners>,
        <https://1145.am/db/2313438/Vi_Partners>,
        <https://1145.am/db/2322761/Vi_Partners>,
        <https://1145.am/db/2324792/Vi_Partners_Ag>,
        <https://1145.am/db/2341792/Vi_Partners>,
        <https://1145.am/db/2341800/Vi_Partners>,
        <https://1145.am/db/2347574/Vi_Partners_Ag>,
        <https://1145.am/db/2352382/Vi_Partners>,
        <https://1145.am/db/2352383/Vi_Partners>,
        <https://1145.am/db/2370979/Vi_Partners>,
        <https://1145.am/db/935322/Vi_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339616/Cognition_Therapeutics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Pittsburgh" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5206379/about.rdf> ;
    ns1:basedInHighRaw "Pittsburgh" ;
    ns1:description "Alzheimer's Disease",
        "drug discovery" ;
    ns1:documentDate "2011-01-20T15:50:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cognition Therapeutics Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cognition-therapeutics-completes-2-5m-series-a1-financing-to-advance-alzheimer-s-disease> ;
    ns1:foundName "Cognition Therapeutics",
        "Cognition Therapeutics Inc." ;
    ns1:industry "drug discovery" ;
    ns1:name "Cognition Therapeutics",
        "Cognition Therapeutics Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2339612/Cognition_Therapeutics>,
        <https://1145.am/db/2369299/Cognition_Life_Science>,
        <https://1145.am/db/535094/Cognition_Therapeutics>,
        <https://1145.am/db/542334/Cognition_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340172/Crown_Bioscience> a org:Organization ;
    ns1:basedInHighGeoName "Santa Clara" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3537906/about.rdf> ;
    ns1:basedInHighRaw "SANTA CLARA" ;
    ns1:description "R & D" ;
    ns1:documentDate "2011-05-06T13:21:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Crown Bioscience, Inc. Announces Closing of Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crown-bioscience-inc-announces-closing-of-series-c-financing> ;
    ns1:foundName "Crown Bioscience, Inc." ;
    ns1:name "Crown Bioscience" ;
    ns1:sameAsHigh <https://1145.am/db/2333346/Crown_Bioscience> ;
    ns1:sameAsMedium <https://1145.am/db/1232763/Crown_Bioscience>,
        <https://1145.am/db/1959035/Crown_Bioscience>,
        <https://1145.am/db/2282864/Crown_Bioscience>,
        <https://1145.am/db/2301434/Crown_Bioscience>,
        <https://1145.am/db/2323606/Crown_Bioscience>,
        <https://1145.am/db/2339243/Crown_Bioscience>,
        <https://1145.am/db/2362390/Crown_Bioscience>,
        <https://1145.am/db/2369286/Crown_Bioscience>,
        <https://1145.am/db/2370561/Crown_Bioscience>,
        <https://1145.am/db/2540991/Crown_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341068/Naurex_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Evanston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4891382/about.rdf> ;
    ns1:basedInHighRaw "EVANSTON, Ill." ;
    ns1:description "psychiatry and neurology" ;
    ns1:documentDate "2011-05-11T12:18:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $18 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-18-million-series-a-financing> ;
    ns1:foundName "Naurex Inc." ;
    ns1:name "Naurex Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2357487/Naurex_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2337253/Naurex>,
        <https://1145.am/db/2341074/Naurex>,
        <https://1145.am/db/2343793/Naurex>,
        <https://1145.am/db/2357494/Naurex>,
        <https://1145.am/db/2368702/Naurex>,
        <https://1145.am/db/2368707/Naurex>,
        <https://1145.am/db/2585617/Naurex_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341377/Investment_King_Pharmaceuticals_Pain_Therapeutics_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-28T14:09:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Pain Therapeutics Receives $ 5,000,000 Payment.",
        "SAN MATEO, Calif., Jan. 28, 2011 (GLOBE NEWSWIRE) - Pain Therapeutics, Inc. (Nasdaq: PTIE) today announced that it had received a $ 5,000,000 milestone payment from King Pharmaceuticals, Inc. (NYSE: KG) , its exclusive commercial partner for abuse-resistant prescription pain medications." ;
    ns1:documentTitle "Pain Therapeutics Receives $5,000,000 Payment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pain-therapeutics-receives-5-000-000-payment> ;
    ns1:foundName "payment" ;
    ns1:name "payment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2341377/Pain_Therapeutics> ;
    ns1:valueRaw "$ 5,000,000" ;
    ns1:when "2011-01-28T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Jan. 28, 2011" ;
    ns1:whereGeoName "Qarghayz-e Pn" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1467736/about.rdf> ;
    ns1:whereRaw "Pain Therapeutics" .

<https://1145.am/db/2341377/Pain_Therapeutics> a org:Organization ;
    ns1:description "a pharmaceutical company" ;
    ns1:documentDate "2011-01-28T14:09:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pain Therapeutics Receives $5,000,000 Payment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pain-therapeutics-receives-5-000-000-payment> ;
    ns1:foundName "Pain Therapeutics",
        "Pain Therapeutics, Inc" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Pain Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2327609/Pain_Therapeutics>,
        <https://1145.am/db/2337554/Pain_Therapeutics_Inc>,
        <https://1145.am/db/2341372/Pain_Therapeutics>,
        <https://1145.am/db/2348205/Pain_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342445/Ocular_Therapeutix> a org:Organization ;
    ns1:basedInHighGeoName "Bedford" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4930183/about.rdf> ;
    ns1:basedInHighRaw "Bedford, MA" ;
    ns1:description "a startup" ;
    ns1:documentDate "2011-02-03T15:22:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ocular Therapeutix garners $14M for mid-stage eye drug trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ocular-therapeutix-garners-14m-for-mid-stage-eye-drug-trials> ;
    ns1:foundName "Ocular",
        "Ocular Therapeutix" ;
    ns1:name "Ocular",
        "Ocular Therapeutix" ;
    ns1:sameAsMedium <https://1145.am/db/101611/Ocular_Therapeutix_Inc>,
        <https://1145.am/db/2343467/Ocular_Therapeutix>,
        <https://1145.am/db/2352911/Ocular_Therapeutix>,
        <https://1145.am/db/2353946/Ocular_Therapeutix>,
        <https://1145.am/db/2369288/Ocular_Therapeutix>,
        <https://1145.am/db/2580551/Ocular_Therapeutix>,
        <https://1145.am/db/505267/Ocular_Therapeutix> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342445/Versant_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Bedford, MA" ;
    ns1:documentDate "2011-02-03T15:22:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ocular Therapeutix garners $14M for mid-stage eye drug trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ocular-therapeutix-garners-14m-for-mid-stage-eye-drug-trials> ;
    ns1:foundName "Versant Ventures" ;
    ns1:investor <https://1145.am/db/2342445/Investment_Ascension_Health_Ventures_Ocular_Therapeutix_Polaris_Venture_Partners_Sv_Life_Sciences_Versant_Ventures_Completed> ;
    ns1:name "Versant Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1540787/Versant_Ventures>,
        <https://1145.am/db/1541055/Versant_Ventures>,
        <https://1145.am/db/1571794/Versant_Ventures>,
        <https://1145.am/db/1928388/Versant_Ventures>,
        <https://1145.am/db/1975490/Versant_Ventures>,
        <https://1145.am/db/2069394/Versant_Ventures>,
        <https://1145.am/db/2110276/Versant_Ventures>,
        <https://1145.am/db/2151802/Versant_Ventures>,
        <https://1145.am/db/2154338/Versant_Ventures>,
        <https://1145.am/db/2154566/Versant_Ventures>,
        <https://1145.am/db/2281211/Versant_Ventures>,
        <https://1145.am/db/2287023/Versant_Ventures>,
        <https://1145.am/db/2288016/Versant_Ventures>,
        <https://1145.am/db/2290283/Versant_Ventures>,
        <https://1145.am/db/2291315/Versant_Ventures>,
        <https://1145.am/db/2291344/Versant_Ventures>,
        <https://1145.am/db/2293059/Versant_Ventures>,
        <https://1145.am/db/2293893/Versant_Ventures>,
        <https://1145.am/db/2294202/Versant_Ventures>,
        <https://1145.am/db/2296209/Versant_Ventures>,
        <https://1145.am/db/2298176/Versant_Ventures>,
        <https://1145.am/db/2299080/Versant_Ventures>,
        <https://1145.am/db/2299776/Versant_Ventures>,
        <https://1145.am/db/2300337/Versant_Ventures>,
        <https://1145.am/db/2303767/Versant_Ventures>,
        <https://1145.am/db/2304598/Versant_Ventures>,
        <https://1145.am/db/2304606/Versant_Ventures>,
        <https://1145.am/db/2304769/Versant_Ventures>,
        <https://1145.am/db/2305015/Versant_Ventures>,
        <https://1145.am/db/2308758/Versant_Ventures>,
        <https://1145.am/db/2310285/Versant_Ventures>,
        <https://1145.am/db/2310302/Versant_Ventures>,
        <https://1145.am/db/2311353/Versant_Ventures>,
        <https://1145.am/db/2313143/Versant_Ventures>,
        <https://1145.am/db/2317750/Versant_Ventures>,
        <https://1145.am/db/2317753/Versant_Ventures>,
        <https://1145.am/db/2318733/Versant_Ventures>,
        <https://1145.am/db/2319784/Versant_Ventures>,
        <https://1145.am/db/2322646/Versant_Ventures>,
        <https://1145.am/db/2323226/Versant_Ventures>,
        <https://1145.am/db/2324226/Versant_Ventures>,
        <https://1145.am/db/2325681/Versant_Ventures>,
        <https://1145.am/db/2326361/Versant_Ventures>,
        <https://1145.am/db/2326373/Versant_Ventures>,
        <https://1145.am/db/2326903/Versant_Ventures>,
        <https://1145.am/db/2330075/Versant_Ventures>,
        <https://1145.am/db/2330712/Versant_Ventures>,
        <https://1145.am/db/2330852/Versant_Ventures>,
        <https://1145.am/db/2331754/Versant_Ventures>,
        <https://1145.am/db/2331868/Versant_Ventures>,
        <https://1145.am/db/2335675/Versant_Ventures>,
        <https://1145.am/db/2335760/Versant_Ventures>,
        <https://1145.am/db/2339885/Versant_Ventures>,
        <https://1145.am/db/2339886/Versant_Ventures>,
        <https://1145.am/db/2343184/Versant_Ventures>,
        <https://1145.am/db/2343185/Versant_Ventures>,
        <https://1145.am/db/2343206/Versant_Ventures>,
        <https://1145.am/db/2343467/Versant_Ventures>,
        <https://1145.am/db/2343547/Versant_Ventures>,
        <https://1145.am/db/2343641/Versant_Ventures>,
        <https://1145.am/db/2343647/Versant_Ventures>,
        <https://1145.am/db/2344915/Versant_Ventures>,
        <https://1145.am/db/2344916/Versant_Ventures>,
        <https://1145.am/db/2344922/Versant_Ventures>,
        <https://1145.am/db/2344926/Versant_Ventures>,
        <https://1145.am/db/2345769/Versant_Ventures>,
        <https://1145.am/db/2347368/Versant_Ventures>,
        <https://1145.am/db/2348012/Versant_Ventures>,
        <https://1145.am/db/2348857/Versant_Ventures>,
        <https://1145.am/db/2349233/Versant_Ventures>,
        <https://1145.am/db/2349834/Versant_Ventures>,
        <https://1145.am/db/2350917/Versant_Ventures>,
        <https://1145.am/db/2351904/Versant_Ventures>,
        <https://1145.am/db/2354296/Versant_Ventures>,
        <https://1145.am/db/2360189/Versant_Ventures>,
        <https://1145.am/db/2360191/Versant_Ventures>,
        <https://1145.am/db/2360415/Versant_Ventures>,
        <https://1145.am/db/2362457/Versant_Ventures>,
        <https://1145.am/db/2362527/Versant_Ventures>,
        <https://1145.am/db/2362528/Versant_Ventures>,
        <https://1145.am/db/2362565/Versant_Ventures>,
        <https://1145.am/db/2362566/Versant_Ventures>,
        <https://1145.am/db/2364480/Versant_Ventures>,
        <https://1145.am/db/2365134/Versant_Ventures>,
        <https://1145.am/db/2365135/Versant_Ventures>,
        <https://1145.am/db/2367275/Versant_Ventures>,
        <https://1145.am/db/2368517/Versant_Ventures>,
        <https://1145.am/db/2370609/Versant_Ventures>,
        <https://1145.am/db/2370782/Versant_Ventures>,
        <https://1145.am/db/2370799/Versant_Ventures>,
        <https://1145.am/db/2371160/Versant_Ventures>,
        <https://1145.am/db/2371163/Versant_Ventures>,
        <https://1145.am/db/2541575/Versant_Ventures>,
        <https://1145.am/db/2584561/Versant_Ventures>,
        <https://1145.am/db/456081/Versant_Ventures>,
        <https://1145.am/db/488687/Versant_Ventures>,
        <https://1145.am/db/547640/Versant_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344507/Apposite_Capital_Llp> a org:Organization ;
    ns1:basedInLowRaw "Ariz" ;
    ns1:documentDate "2011-02-09T12:47:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ulthera Announces $10.5 Million in Series C Venture Capital Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ulthera-announces-10-5-million-series-c-venture-capital-funding> ;
    ns1:foundName "Apposite Capital LLP" ;
    ns1:investor <https://1145.am/db/2344507/Venture_Investment_Apposite_Capital_Llp_New_Enterprise_Associates_Ulthera_Completed> ;
    ns1:name "Apposite Capital LLP" ;
    ns1:sameAsMedium <https://1145.am/db/2352436/Apposite_Capital_Llp>,
        <https://1145.am/db/2352441/Apposite_Capital>,
        <https://1145.am/db/2352442/Apposite_Capital_Llp>,
        <https://1145.am/db/2360415/Apposite_Capital>,
        <https://1145.am/db/2366860/Apposite_Capital>,
        <https://1145.am/db/612252/Apposite_Capital_Llp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344507/Ulthera> a org:Organization ;
    ns1:description "medical" ;
    ns1:documentDate "2011-02-09T12:47:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ulthera Announces $10.5 Million in Series C Venture Capital Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ulthera-announces-10-5-million-series-c-venture-capital-funding> ;
    ns1:foundName "Ulthera",
        "Ulthera, Inc." ;
    ns1:industry "medical" ;
    ns1:name "Ulthera" ;
    ns1:sameAsMedium <https://1145.am/db/2289377/Ulthera>,
        <https://1145.am/db/2289593/Ulthera>,
        <https://1145.am/db/2300253/Ulthera> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345206/Pfc_Pharma_Focus_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:description "contract research organization",
        "drug and medical device development services and regulatory consulting" ;
    ns1:documentDate "2011-05-23T13:55:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clinipace Worldwide Acquires Switzerland-Based PFC Pharma Focus Ltd." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clinipace-worldwide-acquires-switzerland-based-pfc-pharma-focus-ltd> ;
    ns1:foundName "PFC",
        "PFC Pharma Focus",
        "PFC Pharma Focus Ltd." ;
    ns1:industry "Life Sciences" ;
    ns1:name "PFC Pharma Focus",
        "PFC Pharma Focus Ltd." ;
    ns1:protagonist <https://1145.am/db/2345206/Pfc_Pharma_Focus_Ltd_Subsidiaries_Acquisition>,
        <https://1145.am/db/2345206/Subsidiaries_Acquisition_Clinipace_Worldwide_Pfc_Pharma_Focus_Ltd_Completed>,
        <https://1145.am/db/2345206/Subsidiaries_Merger_Clinipace_Worldwide_Clinipace_Worldwide_Pfc_Pharma_Focus_Ltd_Completed> ;
    ns1:sameAsMedium <https://1145.am/db/2321356/Pfc_Pharma_Focus> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/Bb_Biotech_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "BB Biotech AG",
        "BB Biotech Ventures" ;
    ns1:investor <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:name "BB Biotech",
        "BB Biotech Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2292345/Bb_Biotech_Ventures>,
        <https://1145.am/db/2293270/Bb_Biotech_Ventures_Iii>,
        <https://1145.am/db/2297795/Bb_Biotech_Ventures>,
        <https://1145.am/db/2298049/Bb_Biotech_Ventures_Iii>,
        <https://1145.am/db/2303009/Bb_Biotech_Ventures>,
        <https://1145.am/db/2306873/Bb_Biotech_Ventures>,
        <https://1145.am/db/2308887/Bb_Biotech_Ventures>,
        <https://1145.am/db/2309845/Bb_Biotech_Ventures>,
        <https://1145.am/db/2311011/Bb_Biotech_Ventures>,
        <https://1145.am/db/2315932/Bb_Biotech_Ventures>,
        <https://1145.am/db/2315934/Bb_Biotech_Ventures>,
        <https://1145.am/db/2318778/Bb_Biotech_Ventures>,
        <https://1145.am/db/2331661/Bb_Biotech_Ventures_Ii>,
        <https://1145.am/db/2331670/Bb_Biotech_Ventures_Ii>,
        <https://1145.am/db/2348506/Bb_Biotech_Ventures>,
        <https://1145.am/db/2348523/Bb_Biotech_Ventures>,
        <https://1145.am/db/2352172/Bb_Biotech_Ventures>,
        <https://1145.am/db/2352203/Bb_Biotech_Ventures>,
        <https://1145.am/db/2352204/Bb_Biotech_Ventures>,
        <https://1145.am/db/2352216/Bb_Biotech_Ventures>,
        <https://1145.am/db/2358026/Bb_Biotech_Ventures>,
        <https://1145.am/db/2363907/Bb_Biotech_Ventures>,
        <https://1145.am/db/2367218/Bb_Biotech_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/Oxford_Finance_Llc> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "Oxford Finance LLC" ;
    ns1:investor <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:name "Oxford Finance LLC" ;
    ns1:sameAsMedium <https://1145.am/db/1100295/Oxford_Finance_Llc>,
        <https://1145.am/db/1100492/Oxford_Finance_Llc>,
        <https://1145.am/db/1101340/Oxford_Finance_Llc>,
        <https://1145.am/db/1152410/Oxford_Finance_Llc>,
        <https://1145.am/db/1318713/Oxford_Finance_Llc>,
        <https://1145.am/db/1422452/Oxford_Finance_Llc>,
        <https://1145.am/db/1433740/Oxford_Finance_Llc>,
        <https://1145.am/db/1434127/Oxford_Finance_Llc>,
        <https://1145.am/db/1459745/Oxford_Finance_Llc>,
        <https://1145.am/db/1506328/Oxford_Finance_Llc>,
        <https://1145.am/db/1508005/Oxford_Finance_Llc>,
        <https://1145.am/db/188641/Oxford_Finance_Llc>,
        <https://1145.am/db/2003353/Oxford_Finance_Llc>,
        <https://1145.am/db/2069388/Oxford_Finance>,
        <https://1145.am/db/2199361/Oxford_Finance_Corporation>,
        <https://1145.am/db/2288016/Oxford_Finance>,
        <https://1145.am/db/2289940/Oxford_Finance>,
        <https://1145.am/db/2292812/Oxford_Finance>,
        <https://1145.am/db/2293047/Oxford_Finance>,
        <https://1145.am/db/2302085/Oxford_Finance_Corporation>,
        <https://1145.am/db/2302707/Oxford_Finance_Corporation>,
        <https://1145.am/db/2305927/Oxford_Finance_Corporation>,
        <https://1145.am/db/2306687/Oxford_Finance_Corporation>,
        <https://1145.am/db/2311101/Oxford_Finance_Corporation>,
        <https://1145.am/db/2317145/Oxford_Finance_Corporation>,
        <https://1145.am/db/2319430/Oxford_Finance>,
        <https://1145.am/db/2324337/Oxford_Finance_Corporation>,
        <https://1145.am/db/2327464/Oxford_Finance>,
        <https://1145.am/db/2328500/Oxford_Finance_Corporation>,
        <https://1145.am/db/2328511/Oxford_Finance_Corporation>,
        <https://1145.am/db/2328616/Oxford_Finance_Corporation>,
        <https://1145.am/db/2331928/Oxford_Finance_Corporation>,
        <https://1145.am/db/2341182/Oxford_Finance_Llc>,
        <https://1145.am/db/2344565/Oxford_Finance_Corporation>,
        <https://1145.am/db/2348745/Oxford_Finance_Llc>,
        <https://1145.am/db/2358002/Oxford_Finance_Corporation>,
        <https://1145.am/db/2358116/Oxford_Finance_Llc>,
        <https://1145.am/db/2364404/Oxford_Finance_Corporation>,
        <https://1145.am/db/2365674/Oxford_Finance_Corporation>,
        <https://1145.am/db/2575677/Oxford_Finance>,
        <https://1145.am/db/2575679/Oxford_Finance>,
        <https://1145.am/db/2587375/Oxford_Finance>,
        <https://1145.am/db/520223/Oxford_Finance>,
        <https://1145.am/db/522518/Oxford_Finance>,
        <https://1145.am/db/593670/Oxford_Finance>,
        <https://1145.am/db/596524/Oxford_Finance_Llc>,
        <https://1145.am/db/604065/Oxford_Finance_Llc>,
        <https://1145.am/db/606420/Oxford_Finance_Llc>,
        <https://1145.am/db/704387/Oxford_Finance_Llc>,
        <https://1145.am/db/781786/Oxford_Finance>,
        <https://1145.am/db/815981/Oxford_Finance_Llc>,
        <https://1145.am/db/830736/Oxford_Finance_Llc>,
        <https://1145.am/db/847790/Oxford_Finance_Llc>,
        <https://1145.am/db/848458/Oxford_Finance_Llc>,
        <https://1145.am/db/928761/Oxford_Finance_Llc>,
        <https://1145.am/db/930408/Oxford_Finance_Llc>,
        <https://1145.am/db/955192/Oxford_Finance_Llc>,
        <https://1145.am/db/955875/Oxford_Finance_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346204/Radius_Health_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:basedInLowRaw "United States" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "Radius",
        "Radius Health, Inc",
        "Radius Health, Inc." ;
    ns1:name "Radius Health",
        "Radius Health, Inc." ;
    ns1:protagonist <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:sameAsMedium <https://1145.am/db/1076059/Radius_Health_Inc>,
        <https://1145.am/db/1156145/Radius_Health>,
        <https://1145.am/db/1157508/Radius_Health>,
        <https://1145.am/db/1157615/Radius_Health>,
        <https://1145.am/db/1158644/Radius_Health>,
        <https://1145.am/db/1159902/Radius_Health>,
        <https://1145.am/db/1160656/Radius_Health>,
        <https://1145.am/db/1161401/Radius_Health>,
        <https://1145.am/db/1166101/Radius_Health>,
        <https://1145.am/db/1186635/Radius_Health>,
        <https://1145.am/db/1203594/Radius_Health>,
        <https://1145.am/db/1204941/Radius_Health>,
        <https://1145.am/db/1204986/Radius_Health>,
        <https://1145.am/db/1278945/Radius_Health>,
        <https://1145.am/db/2152927/Radius_Health>,
        <https://1145.am/db/2279738/Radius_Health>,
        <https://1145.am/db/2291409/Radius_Health>,
        <https://1145.am/db/2308887/Radius_Health>,
        <https://1145.am/db/2321020/Radius_Health>,
        <https://1145.am/db/2336183/Radius_Health>,
        <https://1145.am/db/2337687/Radius_Health>,
        <https://1145.am/db/2340685/Radius_Health>,
        <https://1145.am/db/2341182/Radius_Health>,
        <https://1145.am/db/2341186/Radius_Health>,
        <https://1145.am/db/2346205/Radius_Health>,
        <https://1145.am/db/2349447/Radius_Health>,
        <https://1145.am/db/2349449/Radius_Health>,
        <https://1145.am/db/2352172/Radius_Health>,
        <https://1145.am/db/2370073/Radius_Health> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346213/Nextech_Invest_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:description "Venture capital" ;
    ns1:documentDate "2011-05-24T15:59:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TetraLogic Closes $6 Million Series C-1 Investment with Nextech Invest Ltd." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tetralogic-closes-6-million-series-c-1-investment-nextech-invest-ltd> ;
    ns1:foundName "Nextech Invest Ltd",
        "Nextech Invest Ltd." ;
    ns1:investor <https://1145.am/db/2346213/Series_C-1_Investment_Nextech_Invest_Ltd_Tetralogic_Pharmaceuticals_Completed> ;
    ns1:name "Nextech Invest Ltd",
        "Nextech Invest Ltd." ;
    ns1:sameAsHigh <https://1145.am/db/1176018/Nextgen_Venture_Partners>,
        <https://1145.am/db/1334873/Nextgen_Venture_Partners>,
        <https://1145.am/db/1679879/Nextgen_Venture_Partners>,
        <https://1145.am/db/1743271/Next_Gear_Ventures>,
        <https://1145.am/db/1749670/Nextgen_Venture_Partners>,
        <https://1145.am/db/1753744/Nextgen_Venture_Partners>,
        <https://1145.am/db/1812689/Nextview_Ventures>,
        <https://1145.am/db/1877870/Nextview>,
        <https://1145.am/db/2346197/Nextech_Invest_Ltd>,
        <https://1145.am/db/511628/Nextequity_Partners>,
        <https://1145.am/db/765641/Next_Play_Ventures>,
        <https://1145.am/db/963508/Nextview_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Nextech_Invest>,
        <https://1145.am/db/1247997/Nextech_Invest>,
        <https://1145.am/db/2109798/Nextech_Invest>,
        <https://1145.am/db/2283431/Nextech_Invest>,
        <https://1145.am/db/2285762/Nextech_Invest>,
        <https://1145.am/db/2293667/Nextech_Invest>,
        <https://1145.am/db/2297604/Nextech_Invest>,
        <https://1145.am/db/2298642/Nextech_Invest>,
        <https://1145.am/db/2337294/Nextech_Invest>,
        <https://1145.am/db/2337976/Nextech_Invest>,
        <https://1145.am/db/2342754/Nextech_Invest_Ltd>,
        <https://1145.am/db/2342768/Nextech_Invest_Ltd>,
        <https://1145.am/db/2342771/Nextech_Invest>,
        <https://1145.am/db/2348350/Nextech_Invest>,
        <https://1145.am/db/2366561/Nextech_Invest>,
        <https://1145.am/db/425281/Nextech_Invest>,
        <https://1145.am/db/426160/Nextech_Invest>,
        <https://1145.am/db/490696/Nextech_Invest>,
        <https://1145.am/db/770684/Nextech_Invest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346213/Series_C-1_Investment_Nextech_Invest_Ltd_Tetralogic_Pharmaceuticals_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-05-24T15:59:27+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MALVERN, Pa., May 24, 2011 /PRNewswire/ - TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced that is has closed a $ 6 million investment with new investor Nextech Invest Ltd., a Zurich, Switzerland, based oncology focused venture capital fund.",
        "TetraLogic Closes $ 6 Million Series C-1 Investment with Nextech Invest Ltd." ;
    ns1:documentTitle "TetraLogic Closes $6 Million Series C-1 Investment with Nextech Invest Ltd." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tetralogic-closes-6-million-series-c-1-investment-nextech-invest-ltd> ;
    ns1:foundName "Investment",
        "investment" ;
    ns1:name "Investment",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2346213/Tetralogic_Pharmaceuticals> ;
    ns1:targetDetails "Series C-1" ;
    ns1:valueRaw "$ 6 Million",
        "$ 6 million" ;
    ns1:when "2011-05-24T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "May 24, 2011" ;
    ns1:whereGeoName "Switzerland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:whereRaw "Switzerland" .

<https://1145.am/db/2346213/Tetralogic_Pharmaceuticals> a org:Organization ;
    ns1:basedInHighGeoName "Malvern" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5199600/about.rdf> ;
    ns1:basedInHighRaw "MALVERN, Pa." ;
    ns1:description "developing novel small molecule drugs to treat cancer" ;
    ns1:documentDate "2011-05-24T15:59:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TetraLogic Closes $6 Million Series C-1 Investment with Nextech Invest Ltd." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tetralogic-closes-6-million-series-c-1-investment-nextech-invest-ltd> ;
    ns1:foundName "TetraLogic",
        "TetraLogic Pharmaceuticals" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "TetraLogic",
        "TetraLogic Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2346197/Tetralogic_Pharmaceuticals>,
        <https://1145.am/db/2346948/Tetralogic_Pharmaceuticals>,
        <https://1145.am/db/2352302/Tetralogic_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2358396/Tekmira_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2362530/Tetralogic>,
        <https://1145.am/db/2366291/Tetralogic_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2308022/Tetralogic_Pharmaceuticals>,
        <https://1145.am/db/2349717/Tetralogic_Pharmaceuticals>,
        <https://1145.am/db/2349722/Tetralogic_Pharmaceuticals>,
        <https://1145.am/db/2365171/Tetralogic_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346230/Q_Chip_Limited> a org:Organization ;
    ns1:basedInHighGeoName "Cardiff" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2653822/about.rdf> ;
    ns1:basedInHighRaw "CARDIFF, Wales" ;
    ns1:basedInLowRaw "US" ;
    ns1:description "developing innovative sustained-release drug formulations for cancer and other diseases" ;
    ns1:documentDate "2011-05-25T12:41:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Q Chip completes US$6 million funding round to expand its portfolio of drug formulations and establish a European facility" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/q-chip-completes-us-6-million-funding-round-to-expand-its-portfolio-of-drug-formulations> ;
    ns1:foundName "Q Chip",
        "Q Chip Limited" ;
    ns1:industry "bio-pharmaceutical" ;
    ns1:name "Q Chip",
        "Q Chip Limited" ;
    ns1:sameAsHigh <https://1145.am/db/2361231/Q_Chip_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/2350906/Q_Chip>,
        <https://1145.am/db/2350907/Q_Chip>,
        <https://1145.am/db/2350926/Q_Chip>,
        <https://1145.am/db/2586452/Q_Chip> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346523/Eye-Drug> a org:Organization ;
    ns1:basedInLowRaw "Israel" ;
    ns1:description "ophthalmology" ;
    ns1:documentDate "2011-02-14T13:14:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sanofi mulls $1.36B in eye drug deals as it nears Genzyme buy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sanofi-mulls-1-36b-eye-drug-deals-as-it-nears-genzyme-buy> ;
    ns1:foundName "eye-drug" ;
    ns1:industry "drugmaker" ;
    ns1:name "eye-drug" ;
    ns1:sameAsHigh <https://1145.am/db/1157791/Eyepoint_Pharmaceuticals>,
        <https://1145.am/db/1188455/Eyenovia>,
        <https://1145.am/db/1195796/Eyepoint_Pharmaceuticals>,
        <https://1145.am/db/1195924/Eyepoint_Pharmaceuticals_Inc>,
        <https://1145.am/db/1216801/Eyenovia>,
        <https://1145.am/db/1616372/Eyepoint_Pharmaceuticals>,
        <https://1145.am/db/2293419/Novartis>,
        <https://1145.am/db/2306164/Eyegate_Pharma>,
        <https://1145.am/db/2315547/Eyegate_Pharma>,
        <https://1145.am/db/2322162/Eyegate>,
        <https://1145.am/db/2331956/Eyegate_Pharma>,
        <https://1145.am/db/2337683/Eyegate_Pharmaceuticals>,
        <https://1145.am/db/2339669/Ophthotech>,
        <https://1145.am/db/2344947/Eyevensys>,
        <https://1145.am/db/2349068/Eyevensys>,
        <https://1145.am/db/2366298/Eyegate_Pharma>,
        <https://1145.am/db/2366467/Eyetech>,
        <https://1145.am/db/2366468/Eyetech>,
        <https://1145.am/db/2369057/Ophthotech_Corporation>,
        <https://1145.am/db/2370595/Eyegate_Pharmaceuticals>,
        <https://1145.am/db/2536832/Eyegate_Pharmaceuticals>,
        <https://1145.am/db/2572450/Eyetech>,
        <https://1145.am/db/2574001/Eyegate_Pharmaceuticals_Inc>,
        <https://1145.am/db/2595853/Eyetech_Inc>,
        <https://1145.am/db/403490/Eyegate_Pharmaceuticals>,
        <https://1145.am/db/628681/Eyepoint_Pharmaceuticals_Inc>,
        <https://1145.am/db/629638/Eyepoint_Pharmaceuticals_Inc>,
        <https://1145.am/db/634144/Eyepoint_Pharmaceuticals_Inc>,
        <https://1145.am/db/812277/Eyenovia>,
        <https://1145.am/db/877326/Eyenovia_Inc>,
        <https://1145.am/db/881652/Eyepoint_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346532/Canaan_Partners> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:description "Venture Partners" ;
    ns1:documentDate "2011-02-14T14:19:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Chimerix, Inc. Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/chimerix-inc-completes-45-million-financing-to-fund-further-development-of-novel-antiviral> ;
    ns1:foundName "Canaan Partners" ;
    ns1:investor <https://1145.am/db/2346532/Series_F_Investment_Alta_Partners_Asset_Management_Company_Canaan_Partners_Chimerix_Frazier_Healthcare_Ventures_Morningside_Group_New_Leaf_Venture_Partners_Pappas_Ventures_Sanderling_Ventures_Completed> ;
    ns1:name "Canaan Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1763795/Canaan>,
        <https://1145.am/db/2304587/Canaan_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1043342/Canaan_Partners>,
        <https://1145.am/db/146274/Canaan_Partners>,
        <https://1145.am/db/1695894/Canaan_Partners>,
        <https://1145.am/db/1696766/Canaan_Partners>,
        <https://1145.am/db/1697131/Canaan_Partners>,
        <https://1145.am/db/1702857/Canaan_Partners>,
        <https://1145.am/db/1711633/Canaan_Partners>,
        <https://1145.am/db/1724566/Canaan_Partners>,
        <https://1145.am/db/1734259/Canaan_Partners>,
        <https://1145.am/db/1741014/Canaan_Partners>,
        <https://1145.am/db/1741105/Canaan_Partners>,
        <https://1145.am/db/1741424/Canaan_Partners>,
        <https://1145.am/db/1749744/Canaan_Partners>,
        <https://1145.am/db/1754820/Canaan_Partners>,
        <https://1145.am/db/1768400/Canaan_Partners>,
        <https://1145.am/db/1770648/Canaan_Partners>,
        <https://1145.am/db/1791628/Canaan_Partners>,
        <https://1145.am/db/1792426/Canaan_Partners>,
        <https://1145.am/db/1793543/Canaan_Partners>,
        <https://1145.am/db/1796375/Canaan_Partners>,
        <https://1145.am/db/1814413/Canaan_Partners>,
        <https://1145.am/db/1819543/Canaan_Partners>,
        <https://1145.am/db/1827240/Canaan_Partners>,
        <https://1145.am/db/1829078/Canaan_Partners>,
        <https://1145.am/db/1829544/Canaan_Partners>,
        <https://1145.am/db/1836578/Canaan_Partners>,
        <https://1145.am/db/1842466/Canaan_Partners>,
        <https://1145.am/db/1845119/Canaan_Partners>,
        <https://1145.am/db/1852066/Canaan_Partners>,
        <https://1145.am/db/1858762/Canaan_Partners>,
        <https://1145.am/db/1863401/Canaan_Partners>,
        <https://1145.am/db/1866968/Canaan_Partners>,
        <https://1145.am/db/1894670/Canaan_Partners>,
        <https://1145.am/db/1897255/Canaan_Partners>,
        <https://1145.am/db/1900458/Canaan_Partners>,
        <https://1145.am/db/1906336/Canaan_Partners>,
        <https://1145.am/db/1907151/Canaan_Partners>,
        <https://1145.am/db/1907762/Canaan_Partners>,
        <https://1145.am/db/1910644/Canaan_Partners>,
        <https://1145.am/db/1919135/Canaan_Partners>,
        <https://1145.am/db/1920478/Canaan_Partners>,
        <https://1145.am/db/2164798/Canaan_Partners>,
        <https://1145.am/db/2164838/Canaan_Partners>,
        <https://1145.am/db/2210939/Canaan_Partners>,
        <https://1145.am/db/2238667/Canaan_Partners>,
        <https://1145.am/db/2287025/Canaan_Partners>,
        <https://1145.am/db/2287777/Canaan_Partners>,
        <https://1145.am/db/2297592/Canaan_Partners>,
        <https://1145.am/db/2298642/Canaan_Partners>,
        <https://1145.am/db/2301765/Canaan_Partners>,
        <https://1145.am/db/2304605/Canaan_Partners>,
        <https://1145.am/db/2306281/Canaan_Partners>,
        <https://1145.am/db/2308329/Canaan_Partners>,
        <https://1145.am/db/2309376/Canaan_Partners>,
        <https://1145.am/db/2309387/Canaan_Partners>,
        <https://1145.am/db/2313171/Canaan_Partners>,
        <https://1145.am/db/2320925/Canaan_Partners>,
        <https://1145.am/db/2322231/Canaan_Partners>,
        <https://1145.am/db/2329010/Canaan_Partners>,
        <https://1145.am/db/2329011/Canaan_Partners>,
        <https://1145.am/db/2329531/Canaan_Partners>,
        <https://1145.am/db/2332322/Canaan_Partners>,
        <https://1145.am/db/2337958/Canaan_Partners>,
        <https://1145.am/db/2337974/Canaan_Partners>,
        <https://1145.am/db/2347469/Canaan_Partners>,
        <https://1145.am/db/2351129/Canaan_Partners>,
        <https://1145.am/db/2351316/Canaan_Partners>,
        <https://1145.am/db/2351684/Canaan_Partners>,
        <https://1145.am/db/2353588/Canaan_Partners>,
        <https://1145.am/db/2353608/Canaan_Partners>,
        <https://1145.am/db/2355043/Canaan_Partners>,
        <https://1145.am/db/2355238/Canaan_Partners>,
        <https://1145.am/db/2355715/Canaan_Partners>,
        <https://1145.am/db/2358378/Canaan_Partners>,
        <https://1145.am/db/2359185/Canaan_Partners>,
        <https://1145.am/db/2360258/Canaan_Partners>,
        <https://1145.am/db/2360266/Canaan_Partners>,
        <https://1145.am/db/2360647/Canaan_Partners>,
        <https://1145.am/db/2363535/Canaan_Partners>,
        <https://1145.am/db/2365700/Canaan_Partners>,
        <https://1145.am/db/2366187/Canaan_Partners>,
        <https://1145.am/db/2366753/Canaan_Partners>,
        <https://1145.am/db/2368322/Canaan_Partners>,
        <https://1145.am/db/2368973/Canaan_Partners>,
        <https://1145.am/db/2368982/Canaan_Partners>,
        <https://1145.am/db/2370582/Canaan_Partners>,
        <https://1145.am/db/2370802/Canaan_Partners>,
        <https://1145.am/db/2370834/Canaan_Partners>,
        <https://1145.am/db/2572398/Canaan_Partners>,
        <https://1145.am/db/2583466/Canaan_Partners>,
        <https://1145.am/db/2635439/Canaan_Partners>,
        <https://1145.am/db/316299/Canaan_Partners>,
        <https://1145.am/db/319155/Canaan_Partners>,
        <https://1145.am/db/353476/Canaan_Partners>,
        <https://1145.am/db/411041/Canaan_Partners>,
        <https://1145.am/db/523179/Canaan_Partners>,
        <https://1145.am/db/564082/Canaan_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346532/Chimerix> a org:Organization ;
    ns1:description "Antiviral Therapeutics" ;
    ns1:documentDate "2011-02-14T14:19:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Chimerix, Inc. Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/chimerix-inc-completes-45-million-financing-to-fund-further-development-of-novel-antiviral> ;
    ns1:foundName "Chimerix, Inc." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Chimerix" ;
    ns1:sameAsHigh <https://1145.am/db/1264649/Chimerix>,
        <https://1145.am/db/1371886/Chimerix>,
        <https://1145.am/db/1371910/Chimerix>,
        <https://1145.am/db/2154033/Chimerix>,
        <https://1145.am/db/2304572/Chimerix_Inc>,
        <https://1145.am/db/2306276/Chimerix>,
        <https://1145.am/db/2306281/Chimerix>,
        <https://1145.am/db/2313760/Chimerabio>,
        <https://1145.am/db/2313762/Chimerabio>,
        <https://1145.am/db/2338305/Chimerix>,
        <https://1145.am/db/2340695/Chimerix>,
        <https://1145.am/db/2342610/Chimerix>,
        <https://1145.am/db/2342852/Chimerix>,
        <https://1145.am/db/2344665/Chimerix>,
        <https://1145.am/db/2346542/Chimerix>,
        <https://1145.am/db/2349123/Chimerix_Inc>,
        <https://1145.am/db/2349887/Chimerix>,
        <https://1145.am/db/2350957/Chimerix>,
        <https://1145.am/db/2361337/Chimerix>,
        <https://1145.am/db/2362323/Chimerix_Inc>,
        <https://1145.am/db/2362332/Chimerix_Inc>,
        <https://1145.am/db/2362551/Chimerix_Inc>,
        <https://1145.am/db/2363557/Chimerix_Inc>,
        <https://1145.am/db/2363568/Chimerix> ;
    ns1:sameAsMedium <https://1145.am/db/2303022/Chimerix>,
        <https://1145.am/db/2303823/Chimerix> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346534/Agechem_Venture_Fund> a org:Organization ;
    ns1:basedInHighGeoName "Montral" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6077246/about.rdf> ;
    ns1:basedInHighRaw "Montreal, Canada" ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-02-14T14:20:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Conatus Pharmaceuticals Inc. Completes $20 Million Series B Private Placement Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/conatus-pharmaceuticals-inc-completes-20-million-series-b-private-placement-financing> ;
    ns1:foundName "AgeChem Venture Fund of Montreal, Canada" ;
    ns1:investor <https://1145.am/db/2346534/Preferred_Stock_Investment_Aberdare_Ventures_Advent_Venture_Partners_Agechem_Venture_Fund_Bay_City_Capital_Conatus_Pharmaceuticals_Inc_Gilde_Healthcare_Partners_Roche_Venture_Fund_Completed> ;
    ns1:name "AgeChem Venture Fund" ;
    ns1:sameAsHigh <https://1145.am/db/2310073/Agechem_Venture_Fund_Cross_Creek_Capital>,
        <https://1145.am/db/2346542/Agechem_Venture_Fund>,
        <https://1145.am/db/2354752/Agechem_Venture_Fund>,
        <https://1145.am/db/2358031/Agechem_Venture_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2305729/Agechem_Venture_Fund>,
        <https://1145.am/db/2328030/Agechem_Venture_Fund_Lp>,
        <https://1145.am/db/2328034/Agechem_Venture_Fund_Lp>,
        <https://1145.am/db/2345002/Agechem_Venture_Fund>,
        <https://1145.am/db/2354770/Agechem_Venture_Fund>,
        <https://1145.am/db/2367046/Agechem_Venture_Fund>,
        <https://1145.am/db/2367047/Agechem_Venture_Fund>,
        <https://1145.am/db/2575232/Agechem_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346534/Bay_City_Capital> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:description "private placement financing" ;
    ns1:documentDate "2011-02-14T14:20:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Conatus Pharmaceuticals Inc. Completes $20 Million Series B Private Placement Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/conatus-pharmaceuticals-inc-completes-20-million-series-b-private-placement-financing> ;
    ns1:foundName "Bay City Capital" ;
    ns1:investor <https://1145.am/db/2346534/Preferred_Stock_Investment_Aberdare_Ventures_Advent_Venture_Partners_Agechem_Venture_Fund_Bay_City_Capital_Conatus_Pharmaceuticals_Inc_Gilde_Healthcare_Partners_Roche_Venture_Fund_Completed> ;
    ns1:name "Bay City Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2301824/Bay_City_Capital>,
        <https://1145.am/db/2311570/Bay_City_Capital>,
        <https://1145.am/db/2319822/Bay_City_Capital_Llc>,
        <https://1145.am/db/2320476/Bay_City_Capital>,
        <https://1145.am/db/2359185/Bay_City_Capital>,
        <https://1145.am/db/2360266/Bay_City_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2292334/Bay_City_Capital>,
        <https://1145.am/db/2292353/Bay_City_Capital>,
        <https://1145.am/db/2296810/Bay_City_Capital>,
        <https://1145.am/db/2302897/Bay_City_Capital>,
        <https://1145.am/db/2306568/Bay_City_Capital>,
        <https://1145.am/db/2308713/Bay_City_Capital>,
        <https://1145.am/db/2312435/Bay_City_Capital>,
        <https://1145.am/db/2314492/Bay_City_Capital>,
        <https://1145.am/db/2319965/Bay_City_Capital>,
        <https://1145.am/db/2324289/Bay_City_Capital>,
        <https://1145.am/db/2326903/Bay_City_Capital>,
        <https://1145.am/db/2329010/Bay_City_Capital>,
        <https://1145.am/db/2329011/Bay_City_Capital>,
        <https://1145.am/db/2331700/Bay_City_Capital>,
        <https://1145.am/db/2331784/Bay_City_Capital>,
        <https://1145.am/db/2336510/Bay_City_Capital>,
        <https://1145.am/db/2336511/Bay_City_Capital>,
        <https://1145.am/db/2337599/Bay_City_Capital>,
        <https://1145.am/db/2342864/Bay_City_Capital>,
        <https://1145.am/db/2350491/Bay_City_Capital>,
        <https://1145.am/db/2351129/Bay_City_Capital>,
        <https://1145.am/db/2356290/Bay_City_Capital>,
        <https://1145.am/db/2357418/Bay_City_Capital>,
        <https://1145.am/db/2358409/Bay_City_Capital>,
        <https://1145.am/db/2367022/Bay_City_Capital>,
        <https://1145.am/db/2367023/Bay_City_Capital>,
        <https://1145.am/db/2367026/Bay_City_Capital>,
        <https://1145.am/db/2583466/Bay_City_Capital>,
        <https://1145.am/db/2588372/Bay_City_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347571/Amunix> a org:Organization ;
    ns1:basedInLowRaw "MOUNTAIN VIEW, CA" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-02-16T15:02:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Versartis Completes $21 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/versartis-completes-21-million-series-b-financing-0> ;
    ns1:foundName "Amunix" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2347571/Series_B_Investment_Advent_Life_Sciences_Amunix_Index_Ventures_New_Leaf_Venture_Partners_Versartis_Completed> ;
    ns1:name "Amunix" ;
    ns1:sameAsHigh <https://1145.am/db/1006794/Elevate_Ventures>,
        <https://1145.am/db/1117048/Studio_Vc>,
        <https://1145.am/db/1140521/Elevation_Capital>,
        <https://1145.am/db/1213119/Fin_Capital>,
        <https://1145.am/db/1215930/Enavate_Sciences>,
        <https://1145.am/db/1219982/Thirty_Five_Ventures>,
        <https://1145.am/db/1230379/Advantage_Capital>,
        <https://1145.am/db/1307987/Venture_Highway>,
        <https://1145.am/db/1352420/Necessary_Ventures>,
        <https://1145.am/db/1504977/Advantage_Capital>,
        <https://1145.am/db/1668144/Applied_Ventures>,
        <https://1145.am/db/1688359/Necessary_Ventures>,
        <https://1145.am/db/1698464/Cathay_Innovation>,
        <https://1145.am/db/1702554/Main_Sequence_Ventures>,
        <https://1145.am/db/1719362/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1724979/Institutional_Venture_Partners>,
        <https://1145.am/db/1730174/Incubic_Venture_Capital>,
        <https://1145.am/db/1741725/Discovery_Ventures>,
        <https://1145.am/db/1746456/Active_Capital>,
        <https://1145.am/db/1747943/Firstround_Capital>,
        <https://1145.am/db/1749347/Main_Sequence_Ventures>,
        <https://1145.am/db/1752158/Hbcuvc>,
        <https://1145.am/db/1753744/Elevate_Ventures>,
        <https://1145.am/db/1754080/Cathay_Innovation>,
        <https://1145.am/db/1754580/Elevation_Capital>,
        <https://1145.am/db/1754765/Inventure>,
        <https://1145.am/db/1755479/Seed_Capital>,
        <https://1145.am/db/1760794/Appworks>,
        <https://1145.am/db/1761999/Access_Technology_Ventures>,
        <https://1145.am/db/1764278/Okta_Ventures>,
        <https://1145.am/db/1768909/Venture_Highway>,
        <https://1145.am/db/1769525/Seed_Capital>,
        <https://1145.am/db/1800466/Inventure>,
        <https://1145.am/db/1806610/Institutional_Venture_Partners>,
        <https://1145.am/db/1806644/Institutional_Venture_Partners>,
        <https://1145.am/db/1808735/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1809854/Institutional_Venture_Partners>,
        <https://1145.am/db/1810769/Institutional_Venture_Partners>,
        <https://1145.am/db/1811872/Seedcamp>,
        <https://1145.am/db/1821378/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1823230/Innovative_Venture_Fund_Investment>,
        <https://1145.am/db/1825866/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1826126/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1828008/Institutional_Venture_Partners>,
        <https://1145.am/db/1830014/Institutional_Venture_Partners>,
        <https://1145.am/db/1831764/Institutional_Venture_Partners>,
        <https://1145.am/db/1836984/Launch_Capital>,
        <https://1145.am/db/1844931/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1845205/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1849969/Institutional_Venture_Partners>,
        <https://1145.am/db/1849969/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1854098/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860406/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860644/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1868593/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1870791/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1872971/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1891856/Institutional_Venture_Partners>,
        <https://1145.am/db/1892105/Institutional_Venture_Partners>,
        <https://1145.am/db/1892105/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1896364/Launch_Capital>,
        <https://1145.am/db/1907771/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1911076/Ata_Ventures>,
        <https://1145.am/db/1932453/Framework_Ventures>,
        <https://1145.am/db/2144387/New_Age_Ventures>,
        <https://1145.am/db/2230414/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/229368/Essence_Ventures>,
        <https://1145.am/db/2305256/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2310485/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2312700/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2313567/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2326444/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2332010/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2339214/Adage_Capital>,
        <https://1145.am/db/2341487/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2343542/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2344530/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2348618/Amunix>,
        <https://1145.am/db/2348620/Amunix_Inc>,
        <https://1145.am/db/2349093/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2349307/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2350138/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2351335/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2355531/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2359987/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2364492/Bioventures>,
        <https://1145.am/db/2369359/Bioventures>,
        <https://1145.am/db/244100/Creative_Ventures>,
        <https://1145.am/db/2629526/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2656715/Institutional_Venture_Partners>,
        <https://1145.am/db/319155/Emergent_Ventures>,
        <https://1145.am/db/430525/Acapital>,
        <https://1145.am/db/449505/Elevate_Ventures>,
        <https://1145.am/db/491609/Emergent_Ventures>,
        <https://1145.am/db/517818/Cathay_Innovation>,
        <https://1145.am/db/626399/Embedded_Ventures>,
        <https://1145.am/db/674609/Main_Sequence_Ventures>,
        <https://1145.am/db/678162/Main_Sequence_Ventures>,
        <https://1145.am/db/696051/Framework_Ventures>,
        <https://1145.am/db/697473/Framework_Ventures>,
        <https://1145.am/db/718563/Creative_Ventures>,
        <https://1145.am/db/724376/Ten_Innovate>,
        <https://1145.am/db/730448/Seed_Capital>,
        <https://1145.am/db/734449/Evolve_Ventures>,
        <https://1145.am/db/751176/Core_Innovationcapital>,
        <https://1145.am/db/768154/Compound_Ventures>,
        <https://1145.am/db/830571/Okta_Ventures>,
        <https://1145.am/db/889658/Propel_Venture>,
        <https://1145.am/db/890529/Embedded_Ventures>,
        <https://1145.am/db/891145/Advantage_Capital>,
        <https://1145.am/db/937210/Cathay_Innovation>,
        <https://1145.am/db/971415/Firstround_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347574/Activaero_Gmbh> a org:Organization ;
    ns1:basedInHighGeoName "Gemnden (Wohra)" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6557835/about.rdf> ;
    ns1:basedInHighRaw "GEMNDEN / Wohra, Germany" ;
    ns1:description "controlled breathing inhalation devices" ;
    ns1:documentDate "2011-02-16T15:52:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Activaero Raises  5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/activaero-raises-%E2%82%AC-5-0-million-6-8-million-a-second-closing-series-a-round-led-by-lsp> ;
    ns1:foundName "Activaero",
        "Activaero GmbH" ;
    ns1:industry "Life Sciences" ;
    ns1:name "Activaero",
        "Activaero GmbH" ;
    ns1:sameAsHigh <https://1145.am/db/1016355/Esperion>,
        <https://1145.am/db/1087431/Umotif>,
        <https://1145.am/db/1157644/Sc1>,
        <https://1145.am/db/1158946/Sc1>,
        <https://1145.am/db/1320381/RXPX>,
        <https://1145.am/db/1524133/My01_Inc>,
        <https://1145.am/db/1672961/Catalent>,
        <https://1145.am/db/2020041/Benchsci>,
        <https://1145.am/db/2099443/Abcam>,
        <https://1145.am/db/2154080/Abcam>,
        <https://1145.am/db/2154380/Omniome>,
        <https://1145.am/db/2283202/SFL>,
        <https://1145.am/db/2289242/Cri>,
        <https://1145.am/db/2305858/Amri>,
        <https://1145.am/db/2308692/Accelrys>,
        <https://1145.am/db/2309489/Profibrix_Bv>,
        <https://1145.am/db/2313322/Esbatech>,
        <https://1145.am/db/2313438/Esbatech>,
        <https://1145.am/db/2332857/Nitromed>,
        <https://1145.am/db/2342352/Atterocor>,
        <https://1145.am/db/2343164/Abcam>,
        <https://1145.am/db/2361717/Obn>,
        <https://1145.am/db/2366385/Primeradx>,
        <https://1145.am/db/2368276/Obn>,
        <https://1145.am/db/2536909/Collbio_Limited>,
        <https://1145.am/db/2561653/Catalent>,
        <https://1145.am/db/2565911/Catalent>,
        <https://1145.am/db/2791820/Graticule>,
        <https://1145.am/db/572381/Cernostics>,
        <https://1145.am/db/607123/Seer_Inc>,
        <https://1145.am/db/660168/Seer_Inc>,
        <https://1145.am/db/879997/SFL>,
        <https://1145.am/db/909528/Seer_Inc>,
        <https://1145.am/db/996648/Escalent> ;
    ns1:sameAsMedium <https://1145.am/db/2324792/Activaero_Gmbh>,
        <https://1145.am/db/2324793/Activaero_Gmbh>,
        <https://1145.am/db/2357248/Activaero>,
        <https://1145.am/db/2357255/Activaero>,
        <https://1145.am/db/2357259/Activaero>,
        <https://1145.am/db/2537626/Activaero> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347574/Biomedpartners_Ag> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:description "advising BioMedInvest LP II" ;
    ns1:documentDate "2011-02-16T15:52:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Activaero Raises  5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/activaero-raises-%E2%82%AC-5-0-million-6-8-million-a-second-closing-series-a-round-led-by-lsp> ;
    ns1:foundName "BioMedPartners AG" ;
    ns1:industry "Life Sciences" ;
    ns1:investor <https://1145.am/db/2347574/Investment_Abalis_Finance_Ag_Activaero_Gmbh_Biomedpartners_Ag_Lsp_Life_Sciences_Partners_Medventure_Partners_Gmbh_Vi_Partners_Ag_Vesalius_Biocapital_I_Sicar_Sa_Completed> ;
    ns1:name "BioMedPartners AG" ;
    ns1:sameAsHigh <https://1145.am/db/2156117/Themis>,
        <https://1145.am/db/2286545/Senti_Biosciences>,
        <https://1145.am/db/2325875/Medicure_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2324792/Biomedpartners_Ag>,
        <https://1145.am/db/2363593/Biomedpartners>,
        <https://1145.am/db/2363597/Biomedpartners>,
        <https://1145.am/db/2367218/Biomedpartners>,
        <https://1145.am/db/426688/Biomedpartners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347574/Vi_Partners_Ag> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:description "Business" ;
    ns1:documentDate "2011-02-16T15:52:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Activaero Raises  5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/activaero-raises-%E2%82%AC-5-0-million-6-8-million-a-second-closing-series-a-round-led-by-lsp> ;
    ns1:foundName "VI Partners AG" ;
    ns1:investor <https://1145.am/db/2347574/Investment_Abalis_Finance_Ag_Activaero_Gmbh_Biomedpartners_Ag_Lsp_Life_Sciences_Partners_Medventure_Partners_Gmbh_Vi_Partners_Ag_Vesalius_Biocapital_I_Sicar_Sa_Completed> ;
    ns1:name "VI Partners AG" ;
    ns1:sameAsHigh <https://1145.am/db/2324792/Vi_Partners_Ag> ;
    ns1:sameAsMedium <https://1145.am/db/1386529/Vi_Partners>,
        <https://1145.am/db/1388463/Vi_Partners>,
        <https://1145.am/db/2154009/Vi_Partners>,
        <https://1145.am/db/2313124/Vi_Partners>,
        <https://1145.am/db/2313322/Vi_Partners>,
        <https://1145.am/db/2313438/Vi_Partners>,
        <https://1145.am/db/2322761/Vi_Partners>,
        <https://1145.am/db/2339295/Vi_Partners>,
        <https://1145.am/db/2341792/Vi_Partners>,
        <https://1145.am/db/2341800/Vi_Partners>,
        <https://1145.am/db/2352382/Vi_Partners>,
        <https://1145.am/db/2352383/Vi_Partners>,
        <https://1145.am/db/2370979/Vi_Partners>,
        <https://1145.am/db/935322/Vi_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348331/Edmond_De_Rothschild_Investment_Partners> a org:Organization ;
    ns1:basedInLowRaw "Netherlands" ;
    ns1:documentDate "2011-06-01T15:36:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sapiens raises  13m in a Series A financing to fund the development of a novel deep brain stimulation system" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sapiens-raises-%E2%82%AC-13m-a-series-a-financing-to-fund-development-of-a-novel-deep-brain> ;
    ns1:foundName "Edmond de Rothschild Investment Partners" ;
    ns1:investor <https://1145.am/db/2348331/Series_A_Investment_Edmond_De_Rothschild_Investment_Partners_Life_Sciences_Partners_Sapiens_Steering_Brain_Stimulation_Gmbh___Sapiens_Wellington_Partners_Completed> ;
    ns1:name "Edmond de Rothschild Investment Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2289591/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2297507/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2299423/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2301041/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2301096/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303210/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303641/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303642/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303849/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2313401/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2313410/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2320503/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2325831/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2336923/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2338023/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2338193/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2338196/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2350101/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2351191/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2351192/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2353607/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2353610/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2356567/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2358268/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2358269/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2358541/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2363938/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2363941/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2367201/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2368740/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2369953/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2369982/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2369999/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2555540/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2701527/Edmond_De_Rothschild_Investment_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348331/Sapiens_Steering_Brain_Stimulation_Gmbh___Sapiens> a org:Organization ;
    ns1:basedInHighGeoName "Gemeente Eindhoven" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2756252/about.rdf> ;
    ns1:basedInHighRaw "Eindhoven, the Netherlands" ;
    ns1:basedInLowRaw "Germany" ;
    ns1:description "Brain Stimulation",
        "medical" ;
    ns1:documentDate "2011-06-01T15:36:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sapiens raises  13m in a Series A financing to fund the development of a novel deep brain stimulation system" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sapiens-raises-%E2%82%AC-13m-a-series-a-financing-to-fund-development-of-a-novel-deep-brain> ;
    ns1:foundName "Sapiens Steering Brain Stimulation GmbH",
        "Sapiens Steering Brain Stimulation GmbH / Sapiens" ;
    ns1:industry "Life Sciences" ;
    ns1:name "Sapiens",
        "Sapiens Steering Brain Stimulation GmbH / Sapiens" ;
    ns1:sameAsHigh <https://1145.am/db/2291576/Sapiens_Steering_Brain_Stimulation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348618/Advent_Life_Sciences> a org:Organization ;
    ns1:basedInLowRaw "CA" ;
    ns1:documentDate "2011-02-22T13:27:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Versartis Completes $21 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/versartis-completes-21-million-series-b-financing> ;
    ns1:foundName "Advent Life Sciences" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2348618/Series_B_Investment_Advent_Life_Sciences_Amunix_Index_Ventures_New_Leaf_Venture_Partners_Versartis_Completed> ;
    ns1:name "Advent Life Sciences" ;
    ns1:sameAsHigh <https://1145.am/db/1048034/Exicure>,
        <https://1145.am/db/1054185/Exicure>,
        <https://1145.am/db/1064384/Celcuity_Inc>,
        <https://1145.am/db/1070403/Projenx_Inc>,
        <https://1145.am/db/1070709/Celularity_Inc>,
        <https://1145.am/db/1105043/Celularity>,
        <https://1145.am/db/1195567/Sqz_Biotechnologies>,
        <https://1145.am/db/1198717/Sqz_Biotechnologies>,
        <https://1145.am/db/1215930/Enavate_Sciences>,
        <https://1145.am/db/1322507/Gro_Biosciences_Inc>,
        <https://1145.am/db/1343489/Celcuity_Inc>,
        <https://1145.am/db/1354258/Cellistic>,
        <https://1145.am/db/1354263/Cellistic>,
        <https://1145.am/db/1359764/Aspect_Biosystems>,
        <https://1145.am/db/1360407/Aspect_Biosystems>,
        <https://1145.am/db/1381832/Coatue>,
        <https://1145.am/db/1382787/Coatue>,
        <https://1145.am/db/1415520/Obatala_Sciences>,
        <https://1145.am/db/1573937/Celcuity_Inc>,
        <https://1145.am/db/1621368/Celularity>,
        <https://1145.am/db/1683183/Exicure>,
        <https://1145.am/db/1945773/Morphimmune>,
        <https://1145.am/db/1966379/Dyve_Biosciences>,
        <https://1145.am/db/1984401/Exicure_Inc>,
        <https://1145.am/db/2021165/Exicure>,
        <https://1145.am/db/2052967/Morphimmune>,
        <https://1145.am/db/2095258/Exicure_Inc>,
        <https://1145.am/db/2114372/Actio_Biosciences>,
        <https://1145.am/db/2133590/Morphimmune>,
        <https://1145.am/db/2234316/Intercell_Ag>,
        <https://1145.am/db/2301876/Genizon_Biosciences>,
        <https://1145.am/db/2307362/Discovery_Laboratories_Inc>,
        <https://1145.am/db/2309472/Cel-Sci_Corporation>,
        <https://1145.am/db/2312827/Biotime_Inc>,
        <https://1145.am/db/2313884/Com)>,
        <https://1145.am/db/2321137/Le_@_P_Technology>,
        <https://1145.am/db/2334165/Genizon_Biosciences_Inc>,
        <https://1145.am/db/2336754/Biotime>,
        <https://1145.am/db/2337993/Progderm>,
        <https://1145.am/db/2338371/Inc>,
        <https://1145.am/db/2338373/Inc>,
        <https://1145.am/db/2339726/Discovery_Laboratories_Inc>,
        <https://1145.am/db/2340408/Group_Inc>,
        <https://1145.am/db/2341747/Techne_Corporation>,
        <https://1145.am/db/2343807/Cortice_Biosciences>,
        <https://1145.am/db/2347124/Orgenesis_Inc>,
        <https://1145.am/db/2347571/Advent_Life_Sciences>,
        <https://1145.am/db/2348868/Biotime_Inc>,
        <https://1145.am/db/2349406/Allocure>,
        <https://1145.am/db/2351955/Biotime>,
        <https://1145.am/db/2357417/Biotime_Inc>,
        <https://1145.am/db/2359274/Neostem_Inc>,
        <https://1145.am/db/2361237/Discovery_Laboratories>,
        <https://1145.am/db/2361671/Discovery_Laboratories_Inc>,
        <https://1145.am/db/2367144/Allocure_Inc>,
        <https://1145.am/db/2367147/Allocure_Inc>,
        <https://1145.am/db/2367461/Discovery_Laboratories_Inc>,
        <https://1145.am/db/2369874/Biotime>,
        <https://1145.am/db/2370050/M3_Biotechnology_Inc>,
        <https://1145.am/db/2581359/Group_Inc>,
        <https://1145.am/db/407158/Altasciences>,
        <https://1145.am/db/464787/Biosight_Ltd>,
        <https://1145.am/db/504446/Acrigen_Biosciences_Inc>,
        <https://1145.am/db/585936/Gro_Biosciences_Inc>,
        <https://1145.am/db/622178/Gro_Biosciences_Inc>,
        <https://1145.am/db/632040/Biosight>,
        <https://1145.am/db/660979/Celcuity>,
        <https://1145.am/db/683685/Gro_Biosciences_Inc>,
        <https://1145.am/db/704448/Biosight>,
        <https://1145.am/db/764965/Gro_Biosciences_Inc>,
        <https://1145.am/db/812748/Altasciences>,
        <https://1145.am/db/922231/Ocugen> ;
    ns1:sameAsMedium <https://1145.am/db/1169952/Advent_Life_Sciences>,
        <https://1145.am/db/1174901/Advent_Life_Sciences>,
        <https://1145.am/db/1281079/Advent_Life_Sciences>,
        <https://1145.am/db/1281647/Advent_Life_Sciences>,
        <https://1145.am/db/1426073/Advent_Life_Sciences>,
        <https://1145.am/db/1426943/Advent_Life_Sciences>,
        <https://1145.am/db/2182443/Advent_Life_Sciences>,
        <https://1145.am/db/2286277/Advent_Life_Sciences>,
        <https://1145.am/db/2290200/Advent_Life_Sciences>,
        <https://1145.am/db/2293893/Advent_Life_Sciences>,
        <https://1145.am/db/2296167/Advent_Life_Sciences>,
        <https://1145.am/db/2298978/Advent_Life_Sciences>,
        <https://1145.am/db/2335375/Advent_Life_Sciences>,
        <https://1145.am/db/2337664/Advent_Life_Sciences>,
        <https://1145.am/db/2338079/Advent_Life_Sciences>,
        <https://1145.am/db/2352059/Advent_Life_Sciences>,
        <https://1145.am/db/2355841/Advent_Life_Sciences>,
        <https://1145.am/db/2358630/Advent_Life_Sciences>,
        <https://1145.am/db/2361002/Advent_Life_Sciences>,
        <https://1145.am/db/2370626/Advent_Life_Sciences>,
        <https://1145.am/db/281538/Advent_Life_Sciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348618/Amunix> a org:Organization ;
    ns1:basedInLowRaw "CA" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-02-22T13:27:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Versartis Completes $21 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/versartis-completes-21-million-series-b-financing> ;
    ns1:foundName "Amunix" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2348618/Series_B_Investment_Advent_Life_Sciences_Amunix_Index_Ventures_New_Leaf_Venture_Partners_Versartis_Completed> ;
    ns1:name "Amunix" ;
    ns1:sameAsHigh <https://1145.am/db/1006794/Elevate_Ventures>,
        <https://1145.am/db/1117048/Studio_Vc>,
        <https://1145.am/db/1140521/Elevation_Capital>,
        <https://1145.am/db/1213119/Fin_Capital>,
        <https://1145.am/db/1215930/Enavate_Sciences>,
        <https://1145.am/db/1219982/Thirty_Five_Ventures>,
        <https://1145.am/db/1230379/Advantage_Capital>,
        <https://1145.am/db/1307987/Venture_Highway>,
        <https://1145.am/db/1352420/Necessary_Ventures>,
        <https://1145.am/db/1504977/Advantage_Capital>,
        <https://1145.am/db/1668144/Applied_Ventures>,
        <https://1145.am/db/1688359/Necessary_Ventures>,
        <https://1145.am/db/1698464/Cathay_Innovation>,
        <https://1145.am/db/1702554/Main_Sequence_Ventures>,
        <https://1145.am/db/1719362/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1724979/Institutional_Venture_Partners>,
        <https://1145.am/db/1730174/Incubic_Venture_Capital>,
        <https://1145.am/db/1741725/Discovery_Ventures>,
        <https://1145.am/db/1746456/Active_Capital>,
        <https://1145.am/db/1747943/Firstround_Capital>,
        <https://1145.am/db/1749347/Main_Sequence_Ventures>,
        <https://1145.am/db/1752158/Hbcuvc>,
        <https://1145.am/db/1753744/Elevate_Ventures>,
        <https://1145.am/db/1754080/Cathay_Innovation>,
        <https://1145.am/db/1754580/Elevation_Capital>,
        <https://1145.am/db/1754765/Inventure>,
        <https://1145.am/db/1755479/Seed_Capital>,
        <https://1145.am/db/1760794/Appworks>,
        <https://1145.am/db/1761999/Access_Technology_Ventures>,
        <https://1145.am/db/1764278/Okta_Ventures>,
        <https://1145.am/db/1768909/Venture_Highway>,
        <https://1145.am/db/1769525/Seed_Capital>,
        <https://1145.am/db/1800466/Inventure>,
        <https://1145.am/db/1806610/Institutional_Venture_Partners>,
        <https://1145.am/db/1806644/Institutional_Venture_Partners>,
        <https://1145.am/db/1808735/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1809854/Institutional_Venture_Partners>,
        <https://1145.am/db/1810769/Institutional_Venture_Partners>,
        <https://1145.am/db/1811872/Seedcamp>,
        <https://1145.am/db/1821378/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1823230/Innovative_Venture_Fund_Investment>,
        <https://1145.am/db/1825866/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1826126/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1828008/Institutional_Venture_Partners>,
        <https://1145.am/db/1830014/Institutional_Venture_Partners>,
        <https://1145.am/db/1831764/Institutional_Venture_Partners>,
        <https://1145.am/db/1836984/Launch_Capital>,
        <https://1145.am/db/1844931/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1845205/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1849969/Institutional_Venture_Partners>,
        <https://1145.am/db/1849969/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1854098/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860406/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860644/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1868593/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1870791/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1872971/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1891856/Institutional_Venture_Partners>,
        <https://1145.am/db/1892105/Institutional_Venture_Partners>,
        <https://1145.am/db/1892105/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1896364/Launch_Capital>,
        <https://1145.am/db/1907771/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1911076/Ata_Ventures>,
        <https://1145.am/db/1932453/Framework_Ventures>,
        <https://1145.am/db/2144387/New_Age_Ventures>,
        <https://1145.am/db/2230414/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/229368/Essence_Ventures>,
        <https://1145.am/db/2305256/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2310485/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2312700/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2313567/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2326444/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2332010/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2339214/Adage_Capital>,
        <https://1145.am/db/2341487/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2343542/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2344530/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2347571/Amunix>,
        <https://1145.am/db/2348620/Amunix_Inc>,
        <https://1145.am/db/2349093/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2349307/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2350138/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2351335/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2355531/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2359987/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2364492/Bioventures>,
        <https://1145.am/db/2369359/Bioventures>,
        <https://1145.am/db/244100/Creative_Ventures>,
        <https://1145.am/db/2629526/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2656715/Institutional_Venture_Partners>,
        <https://1145.am/db/319155/Emergent_Ventures>,
        <https://1145.am/db/430525/Acapital>,
        <https://1145.am/db/449505/Elevate_Ventures>,
        <https://1145.am/db/491609/Emergent_Ventures>,
        <https://1145.am/db/517818/Cathay_Innovation>,
        <https://1145.am/db/626399/Embedded_Ventures>,
        <https://1145.am/db/674609/Main_Sequence_Ventures>,
        <https://1145.am/db/678162/Main_Sequence_Ventures>,
        <https://1145.am/db/696051/Framework_Ventures>,
        <https://1145.am/db/697473/Framework_Ventures>,
        <https://1145.am/db/718563/Creative_Ventures>,
        <https://1145.am/db/724376/Ten_Innovate>,
        <https://1145.am/db/730448/Seed_Capital>,
        <https://1145.am/db/734449/Evolve_Ventures>,
        <https://1145.am/db/751176/Core_Innovationcapital>,
        <https://1145.am/db/768154/Compound_Ventures>,
        <https://1145.am/db/830571/Okta_Ventures>,
        <https://1145.am/db/889658/Propel_Venture>,
        <https://1145.am/db/890529/Embedded_Ventures>,
        <https://1145.am/db/891145/Advantage_Capital>,
        <https://1145.am/db/937210/Cathay_Innovation>,
        <https://1145.am/db/971415/Firstround_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350720/Arsanis_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Vienna" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2761369/about.rdf> ;
    ns1:basedInHighRaw "VIENNA" ;
    ns1:description "Life Sciences",
        "anti-infective monoclonal antibody therapeutics" ;
    ns1:documentDate "2011-02-28T16:41:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arsanis, Inc Announces Series A Financing with OrbiMed Advisors, Polaris Venture Partners and SV Life Sciences" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/arsanis-inc-announces-series-a-financing-orbimed-advisors-polaris-venture-partners-and-sv> ;
    ns1:foundName "Arsanis, Inc" ;
    ns1:industry "biotechnology" ;
    ns1:name "Arsanis",
        "Arsanis, Inc" ;
    ns1:sameAsHigh <https://1145.am/db/2350034/Arsanis_Inc>,
        <https://1145.am/db/2350692/Arsanis>,
        <https://1145.am/db/2367653/Arsanis> ;
    ns1:sameAsMedium <https://1145.am/db/2292255/Arsanis>,
        <https://1145.am/db/2300356/Arsanis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351734/Neurophage_Pharmaceuticals> a org:Organization ;
    ns1:description "Biotechnology" ;
    ns1:documentDate "2011-03-01T13:30:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NeuroPhage Pharmaceuticals closes $12.4M Series B round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/neurophage-pharmaceuticals-closes-12-4m-series-b-round-0> ;
    ns1:foundName "NeuroPhage Pharmaceuticals",
        "NeuroPhage Pharmaceuticals, Inc" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "NeuroPhage Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1377016/Neurocrine_Biosciences>,
        <https://1145.am/db/1631951/Neurotech_Pharmaceuticals_Inc>,
        <https://1145.am/db/2296526/Neuroderm>,
        <https://1145.am/db/2303308/Neuro-Hitech_Inc>,
        <https://1145.am/db/2303464/Neuromed_Pharmaceuticals>,
        <https://1145.am/db/2305157/Neuromed_Pharmaceuticals>,
        <https://1145.am/db/2305956/Neurogen>,
        <https://1145.am/db/2306726/Neurogen_Corporation>,
        <https://1145.am/db/2307114/Neurophage>,
        <https://1145.am/db/2309521/Neurogen>,
        <https://1145.am/db/2314313/Neuroscience_Pharmaceuticals>,
        <https://1145.am/db/2314563/Neurosearch>,
        <https://1145.am/db/2314820/Neurocrine_Biosciences_Inc>,
        <https://1145.am/db/2315317/Neuroscience_Pharmaceuticals_Inc>,
        <https://1145.am/db/2321184/Neurotech>,
        <https://1145.am/db/2322276/Neurocrine_Biosciences>,
        <https://1145.am/db/2322492/Neuropharm_Group_Plc>,
        <https://1145.am/db/2322639/Neurosearch>,
        <https://1145.am/db/2326209/Proximagen_Neuroscience_Plc>,
        <https://1145.am/db/2328039/Neurotherapeutics_Pharma>,
        <https://1145.am/db/2329093/Neurotherapeutics_Pharma>,
        <https://1145.am/db/2329848/Neurologix>,
        <https://1145.am/db/2331732/Neuromed_Pharmaceuticals>,
        <https://1145.am/db/2332947/Neuromed_Pharmaceuticals>,
        <https://1145.am/db/2333525/Neuromed_Pharmaceuticals>,
        <https://1145.am/db/2337344/Neurocrine_Biosciences_Inc>,
        <https://1145.am/db/2340127/Knopp_Neurosciences>,
        <https://1145.am/db/2340630/Nautilus_Neurosciences>,
        <https://1145.am/db/2340631/Nautilus_Neurosciences>,
        <https://1145.am/db/2340922/Neurotech_Pharmaceuticals>,
        <https://1145.am/db/2344202/Neurophage_Pharmaceuticals>,
        <https://1145.am/db/2344205/Neurophage_Pharmaceuticals>,
        <https://1145.am/db/2344651/Neurotrope_Bioscience>,
        <https://1145.am/db/2344651/Neurotrope_Inc>,
        <https://1145.am/db/2344664/Neurocrine_Biosciences>,
        <https://1145.am/db/2344667/Neurophage_Pharmaceuticals>,
        <https://1145.am/db/2344837/Neurotech_Pharmaceuticals>,
        <https://1145.am/db/2345731/Neuroderm_Ltd>,
        <https://1145.am/db/2347890/Neurotrope_Inc>,
        <https://1145.am/db/2348917/Neurotrope_Inc>,
        <https://1145.am/db/2349036/Neurotrope_Bioscience>,
        <https://1145.am/db/2349039/Neurotrope_Bioscience>,
        <https://1145.am/db/2349039/Neurotrope_Inc>,
        <https://1145.am/db/2351737/Neurophage_Pharmaceuticals>,
        <https://1145.am/db/2351754/Neurophage_Pharmaceuticals>,
        <https://1145.am/db/2352320/Neuralstem_Inc>,
        <https://1145.am/db/2354266/Neurophage_Pharmaceuticals>,
        <https://1145.am/db/2356122/Neurotherapeutics_Pharma>,
        <https://1145.am/db/2356124/Neurotherapeutics_Pharma>,
        <https://1145.am/db/2357163/Neurophage_Pharmaceuticals>,
        <https://1145.am/db/2358144/Neurop_Inc>,
        <https://1145.am/db/2358606/Neurocrine_Biosciences>,
        <https://1145.am/db/2359388/Neurophage_Pharmaceuticals>,
        <https://1145.am/db/2359398/Neurophage_Pharmaceuticals>,
        <https://1145.am/db/2360218/Neuroderm_Ltd>,
        <https://1145.am/db/2363142/Cns_Therapeutics>,
        <https://1145.am/db/2363145/Cns_Therapeutics>,
        <https://1145.am/db/2365319/Neurop>,
        <https://1145.am/db/2370127/Neuralstem>,
        <https://1145.am/db/2370135/Neuralstem>,
        <https://1145.am/db/2568701/Neurocrine_Biosciences>,
        <https://1145.am/db/2581057/Cns_Therapeutics>,
        <https://1145.am/db/569563/Alto_Neuroscience>,
        <https://1145.am/db/663779/Neurocrine_Biosciences>,
        <https://1145.am/db/972366/Alto_Neuroscience> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352441/Ambit_Biosciences> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "San Diego" ;
    ns1:documentDate "2011-06-10T14:41:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit bounces back from dropped IPO with $30M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-bounces-back-from-dropped-ipo-30m-round> ;
    ns1:foundName "Ambit",
        "Ambit Biosciences" ;
    ns1:industry "Biotech" ;
    ns1:name "Ambit",
        "Ambit Biosciences" ;
    ns1:sameAsHigh <https://1145.am/db/2315446/Amgen_Ventures>,
        <https://1145.am/db/2328748/Amgen>,
        <https://1145.am/db/2343250/Argen-X>,
        <https://1145.am/db/2343598/Argen-X>,
        <https://1145.am/db/2346035/Ambit_Biosciences>,
        <https://1145.am/db/2350288/Ambit_Biosciences> ;
    ns1:sameAsMedium <https://1145.am/db/2321248/Ambit_Biosciences>,
        <https://1145.am/db/2321254/Ambit_Biosciences>,
        <https://1145.am/db/2336763/Ambit_Biosciences>,
        <https://1145.am/db/2338641/Ambit_Biosciences_Inc>,
        <https://1145.am/db/2342017/Ambit_Biosciences>,
        <https://1145.am/db/2343542/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2344530/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2346030/Ambit_Biosciences_Inc>,
        <https://1145.am/db/2349093/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2349307/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2350138/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2351335/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2352436/Ambit_Biosciences>,
        <https://1145.am/db/2352442/Ambit_Biosciences>,
        <https://1145.am/db/2354434/Ambit_Biosciences>,
        <https://1145.am/db/2354455/Ambit_Biosciences>,
        <https://1145.am/db/2357387/Ambit_Biosciences_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352441/Apposite_Capital> a org:Organization ;
    ns1:documentDate "2011-06-10T14:41:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit bounces back from dropped IPO with $30M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-bounces-back-from-dropped-ipo-30m-round> ;
    ns1:foundName "Apposite Capital" ;
    ns1:investor <https://1145.am/db/2352441/Investment_Ambit_Biosciences_Apposite_Capital_Gimv_Genechem_Horizon_Technology_Finance_Novaquest_Orbimed_Advisors_Perseus-Soros_Biopharmaceutical_Fund_Completed> ;
    ns1:name "Apposite Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2344507/Apposite_Capital_Llp>,
        <https://1145.am/db/2352436/Apposite_Capital_Llp>,
        <https://1145.am/db/2352442/Apposite_Capital_Llp>,
        <https://1145.am/db/2360415/Apposite_Capital>,
        <https://1145.am/db/2366860/Apposite_Capital>,
        <https://1145.am/db/612252/Apposite_Capital_Llp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354540/Pappas_Ventures> a org:Organization ;
    ns1:basedInLowRaw "NOVATO" ;
    ns1:documentDate "2011-06-20T14:33:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ultragenyx Announces Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ultragenyx-announces-series-a-financing> ;
    ns1:foundName "Pappas Ventures" ;
    ns1:investor <https://1145.am/db/2354540/Series_A_Investment_Healthcap_Pappas_Ventures_Tpg_Biotech_And_Fidelity_Biosciences_Ultragenyx_Pharmaceutical_Inc_Completed> ;
    ns1:name "Pappas Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2289229/Pappas_Ventures>,
        <https://1145.am/db/2305706/Pappas_Ventures>,
        <https://1145.am/db/2305713/Pappas_Ventures>,
        <https://1145.am/db/2308329/Pappas_Ventures>,
        <https://1145.am/db/2312277/Pappas_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314492/Pappas_Ventures>,
        <https://1145.am/db/2319029/Pappas_Ventures>,
        <https://1145.am/db/2324289/Pappas_Ventures>,
        <https://1145.am/db/2328388/Pappas_Ventures>,
        <https://1145.am/db/2332753/Pappas_Ventures>,
        <https://1145.am/db/2341904/Pappas_Ventures>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346542/Pappas_Ventures>,
        <https://1145.am/db/2350779/Pappas_Ventures>,
        <https://1145.am/db/2350780/Pappas_Ventures>,
        <https://1145.am/db/2352805/Pappas_Ventures>,
        <https://1145.am/db/2352808/Pappas_Ventures>,
        <https://1145.am/db/2354537/Pappas_Ventures>,
        <https://1145.am/db/2355274/Pappas_Ventures>,
        <https://1145.am/db/2356216/Pappas_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2539913/Pappas_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354540/Ultragenyx_Pharmaceutical_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Novato" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5285048/about.rdf> ;
    ns1:basedInHighRaw "NOVATO, Calif." ;
    ns1:description "Pharmaceuticals",
        "rare disease therapeutics" ;
    ns1:documentDate "2011-06-20T14:33:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ultragenyx Announces Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ultragenyx-announces-series-a-financing> ;
    ns1:foundName "Ultragenyx",
        "Ultragenyx Pharmaceutical Inc." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Ultragenyx",
        "Ultragenyx Pharmaceutical Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1206173/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/1218109/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/1492184/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2279911/Ultragenyx>,
        <https://1145.am/db/2335687/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2340312/Ultragenyx_Pharmaceutical>,
        <https://1145.am/db/2350796/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2351964/Ultragenyx_Pharmaceutical>,
        <https://1145.am/db/2353954/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2354244/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2354537/Ultragenyx_Therapeutics>,
        <https://1145.am/db/2358607/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2359562/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2367797/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2367814/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2547355/Ultragenyx_Pharmaceutical>,
        <https://1145.am/db/998834/Ultragenyx_Pharmaceutical_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355543/Kleiner_Perkins_Caufield___Byers> a org:Organization ;
    ns1:basedInHighGeoName "Boston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4930956/about.rdf> ;
    ns1:basedInHighRaw "BOSTON" ;
    ns1:documentDate "2011-06-21T14:25:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tesaro-announces-101-million-series-b-financing-for-advancement-and-expansion-of-oncology> ;
    ns1:foundName "Kleiner Perkins Caufield & Byers" ;
    ns1:investor <https://1145.am/db/2355543/Series_B_Investment_Deerfield_Management_Interwest_Partners_Kleiner_Perkins_Caufield___Byers_Leerink_Swann_New_Enterprise_Associates_Oracle_Partners_T_Rowe_Price_Pappas_Ventures_T_Rowe_Price_Pappas_Ventures_Tesaro_Completed> ;
    ns1:name "Kleiner Perkins Caufield & Byers" ;
    ns1:sameAsMedium <https://1145.am/db/1697155/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1709036/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1714786/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1719362/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1792401/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1794049/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1794342/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1795003/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1796259/Kleiner_Perkins_Caufield_Byers>,
        <https://1145.am/db/1798154/Kleiner_Perkins_Caufield_Byers>,
        <https://1145.am/db/1802208/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1802525/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1805986/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1806158/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1808735/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1814186/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1816928/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1821378/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1824878/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1825866/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1826126/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1827381/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1830311/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1835647/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1838965/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1839326/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1840650/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1844931/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1845205/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1847021/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1849969/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850246/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850293/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1850642/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1852048/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1852697/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1853217/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1853292/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/1854098/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1856424/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1858545/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1858646/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1859219/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860406/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860644/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1861870/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1864650/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1865436/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1868593/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1868958/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1870791/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1871768/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1872947/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/1872971/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1874419/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1876759/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1881582/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1883859/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1890121/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1891856/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1892105/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1892746/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1895292/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1906922/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1907771/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1915400/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2227037/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2230414/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2288899/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2289585/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2291836/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2293308/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2300306/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2300337/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2305254/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2305256/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2310485/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2311540/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2312700/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2313567/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2316038/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2317750/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2317753/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2321949/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2325726/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2326444/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2326926/Kleiner_Perkins_Caulfield___Byers>,
        <https://1145.am/db/2331026/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2331047/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2332010/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2336391/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2338251/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2338254/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2341484/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2341487/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2344782/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2349519/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2355531/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2359987/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2362457/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2364035/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2367199/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2629526/Kleiner_Perkins_Caufield___Byers> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355543/Tesaro> a org:Organization ;
    ns1:basedInHighGeoName "Boston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4930956/about.rdf> ;
    ns1:basedInHighRaw "BOSTON" ;
    ns1:description "oncology" ;
    ns1:documentDate "2011-06-21T14:25:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tesaro-announces-101-million-series-b-financing-for-advancement-and-expansion-of-oncology> ;
    ns1:foundName "TESARO, Inc." ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "TESARO" ;
    ns1:sameAsHigh <https://1145.am/db/1244573/Tetris_Pharma>,
        <https://1145.am/db/1245052/Tetris_Pharma>,
        <https://1145.am/db/1371886/Tembexa>,
        <https://1145.am/db/2152045/Tesaro>,
        <https://1145.am/db/2341508/Tesaro>,
        <https://1145.am/db/2344012/Tesaro>,
        <https://1145.am/db/2354362/Tesaro>,
        <https://1145.am/db/2355531/Tesaro>,
        <https://1145.am/db/2356889/Tesaro_Inc>,
        <https://1145.am/db/2358225/Tesaro>,
        <https://1145.am/db/2358236/Tesaro>,
        <https://1145.am/db/2358242/Tesaro>,
        <https://1145.am/db/2368424/Tesaro>,
        <https://1145.am/db/2370580/Tesaro>,
        <https://1145.am/db/2371009/Tesaro>,
        <https://1145.am/db/2545242/Tesaro>,
        <https://1145.am/db/2545284/Tesaro>,
        <https://1145.am/db/2552598/Tesaro>,
        <https://1145.am/db/2554044/Tesaro>,
        <https://1145.am/db/2557200/Tesaro>,
        <https://1145.am/db/2566606/Tesaro>,
        <https://1145.am/db/2566825/Tesaro>,
        <https://1145.am/db/2567009/Tesaro> ;
    ns1:sameAsMedium <https://1145.am/db/2340777/Tesaro>,
        <https://1145.am/db/446194/Tesaro_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355904/Investment_Karolinska_Institutet_William_K_Bowes_Jr_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-03-15T11:19:31+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The Swedish medical university Karolinska Institutet has received a donation of USD 2 million from the Foundation of US venture capitalist William K. Bowes, Jr. for the establishment of an Accelerator Fund for Young Talented Scientists.",
        "US venture capitalist donates USD 2 million to Karolinska Institutet." ;
    ns1:documentTitle "US venture capitalist donates USD 2 million to Karolinska Institutet" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/us-venture-capitalist-donates-usd-2-million-to-karolinska-institutet> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2355904/Karolinska_Institutet> ;
    ns1:valueRaw "USD 2 million" ;
    ns1:whereGeoName "Kingdom of Sweden" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:whereRaw "Sweden" .

<https://1145.am/db/2355904/Karolinska_Institutet> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Sweden" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:basedInHighRaw "Sweden." ;
    ns1:description "medical research" ;
    ns1:documentDate "2011-03-15T11:19:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "US venture capitalist donates USD 2 million to Karolinska Institutet" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/us-venture-capitalist-donates-usd-2-million-to-karolinska-institutet> ;
    ns1:foundName "Karolinska Institutet" ;
    ns1:name "Karolinska Institutet" ;
    ns1:sameAsHigh <https://1145.am/db/2288192/Karolinska_Institutet> ;
    ns1:sameAsMedium <https://1145.am/db/2356903/Karolinska_Institutet> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358011/Synageva_Biopharma_Corp> a org:Organization ;
    ns1:basedInHighGeoName "Lexington" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4941935/about.rdf> ;
    ns1:basedInHighRaw "LEXINGTON, Mass." ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:description "developing drugs",
        "developing therapeutic products for rare disorders" ;
    ns1:documentDate "2011-03-21T14:33:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Synageva BioPharma Announces Additional $25 Million Funding to Support Rare Disease Product Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/synageva-biopharma-announces-additional-25-million-funding-to-support-rare-disease-product> ;
    ns1:foundName "Synageva BioPharma",
        "Synageva BioPharma Corp." ;
    ns1:industry "Biopharmaceutical" ;
    ns1:name "Synageva BioPharma",
        "Synageva BioPharma Corp" ;
    ns1:sameAsHigh <https://1145.am/db/1018912/Syneos_Health>,
        <https://1145.am/db/1130807/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/1142583/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/1418427/Syneos_Health>,
        <https://1145.am/db/1549319/Syndax_Pharmaceuticals>,
        <https://1145.am/db/1556582/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/1559723/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/1566029/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/1581300/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/1630772/Syneos_Health>,
        <https://1145.am/db/1651972/Synokem_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2290002/Synlogic>,
        <https://1145.am/db/2302213/Syndexa_Pharmaceuticals_Corp>,
        <https://1145.am/db/2308945/Synta_Pharmaceuticals>,
        <https://1145.am/db/2310275/Synvista_Therapeutics>,
        <https://1145.am/db/2310891/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2313221/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2319795/Synteract_Corporation>,
        <https://1145.am/db/2323676/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2324324/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2326590/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2328043/Synta_Pharmaceuticals>,
        <https://1145.am/db/2329577/Synta_Pharmaceuticals>,
        <https://1145.am/db/2329776/Syntonix_Pharmaceuticals>,
        <https://1145.am/db/2330601/Synta_Pharmaceuticals>,
        <https://1145.am/db/2332873/Synta_Pharmaceuticals>,
        <https://1145.am/db/2336266/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2342853/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2345412/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2346874/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347984/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347993/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2349211/Synta_Pharmaceuticals>,
        <https://1145.am/db/2349213/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2349994/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350262/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2352462/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2353622/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2354619/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2354673/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2355443/Synereca_Pharmaceuticals>,
        <https://1145.am/db/2356177/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2356706/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2357037/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2357438/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2358009/Synageva_Biopharma>,
        <https://1145.am/db/2360435/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2360728/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2365533/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2365922/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2365933/Synageva>,
        <https://1145.am/db/2366169/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2367544/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/2367558/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2369523/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2369837/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2370085/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2370094/Synlogic>,
        <https://1145.am/db/2370293/Synlogic>,
        <https://1145.am/db/2370319/Synlogic>,
        <https://1145.am/db/240858/Synedgen>,
        <https://1145.am/db/2576372/Synta_Pharmaceuticals>,
        <https://1145.am/db/2576382/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2595501/Synageva_Biopharma_Corp>,
        <https://1145.am/db/476676/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/705534/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/808631/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/868994/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/878342/Syndax_Pharmaceuticals_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2318634/Synageva_Biopharma>,
        <https://1145.am/db/2365965/Synageva_Biopharma> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358023/Cephalon_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Frazer" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5190421/about.rdf> ;
    ns1:basedInHighRaw "FRAZER, Pa" ;
    ns1:buyer <https://1145.am/db/2358023/Gemin_X_Pharmaceuticals_Acquisition> ;
    ns1:description "Biopharmaceutical" ;
    ns1:documentDate "2011-03-22T11:52:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cephalon Announces Definitive Agreement to Acquire Gemin X" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cephalon-announces-definitive-agreement-to-acquire-gemin-x> ;
    ns1:foundName "Cephalon, Inc" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Cephalon, Inc" ;
    ns1:sameAsHigh <https://1145.am/db/2301933/Cephalon>,
        <https://1145.am/db/2301947/Cephalon_Inc>,
        <https://1145.am/db/2302608/Cephalon>,
        <https://1145.am/db/2305244/Cephalon>,
        <https://1145.am/db/2306168/Cephalon_Inc>,
        <https://1145.am/db/2306283/Cephalon>,
        <https://1145.am/db/2311562/Cephalon_Inc>,
        <https://1145.am/db/2318093/Cephalon_Inc>,
        <https://1145.am/db/2321967/Cephalon>,
        <https://1145.am/db/2321976/Cephalon>,
        <https://1145.am/db/2323732/Cephalon>,
        <https://1145.am/db/2323733/Cephalon>,
        <https://1145.am/db/2330882/Cephalon>,
        <https://1145.am/db/2331204/Cephalon>,
        <https://1145.am/db/2331205/Cephalon>,
        <https://1145.am/db/2338474/Cephalon>,
        <https://1145.am/db/2338480/Cephalon>,
        <https://1145.am/db/2346543/Cephalon_Inc>,
        <https://1145.am/db/2350717/Cephalon>,
        <https://1145.am/db/2350721/Cephalon_Inc>,
        <https://1145.am/db/2356821/Cephalon>,
        <https://1145.am/db/2360144/Cephalon>,
        <https://1145.am/db/2361172/Cephalon>,
        <https://1145.am/db/2361190/Cephalon>,
        <https://1145.am/db/2362877/Cephalon>,
        <https://1145.am/db/2542509/Cephalon>,
        <https://1145.am/db/2571706/Cephalon>,
        <https://1145.am/db/2571717/Cephalon>,
        <https://1145.am/db/2571723/Cephalon>,
        <https://1145.am/db/2572533/Cephalon>,
        <https://1145.am/db/2572541/Cephalon>,
        <https://1145.am/db/2572542/Cephalon>,
        <https://1145.am/db/2573398/Cephalon>,
        <https://1145.am/db/2576440/Cephalon>,
        <https://1145.am/db/2578908/Cephalon>,
        <https://1145.am/db/2578932/Cephalon>,
        <https://1145.am/db/2580872/Cephalon>,
        <https://1145.am/db/2580875/Cephalon>,
        <https://1145.am/db/2586716/Cephalon>,
        <https://1145.am/db/2587261/Cephalon>,
        <https://1145.am/db/2587626/Cephalon>,
        <https://1145.am/db/2590292/Cephalon>,
        <https://1145.am/db/2590891/Cephalon>,
        <https://1145.am/db/2593831/Cephalon>,
        <https://1145.am/db/2594557/Cephalon>,
        <https://1145.am/db/2595287/Cephalon>,
        <https://1145.am/db/2595929/Cephalon>,
        <https://1145.am/db/2597223/Cephalon>,
        <https://1145.am/db/2598250/Cephalon>,
        <https://1145.am/db/2598261/Cephalon>,
        <https://1145.am/db/2598266/Cephalon>,
        <https://1145.am/db/2598433/Cephalon> ;
    ns1:sameAsMedium <https://1145.am/db/2199698/Cephalon_Inc>,
        <https://1145.am/db/2302692/Cephalon>,
        <https://1145.am/db/2306284/Cephalon>,
        <https://1145.am/db/2307936/Cephalon>,
        <https://1145.am/db/2310181/Cephalon>,
        <https://1145.am/db/2312417/Cephalon>,
        <https://1145.am/db/2319916/Cephalon>,
        <https://1145.am/db/2325473/Cephalon>,
        <https://1145.am/db/2353876/Cephalon_Inc>,
        <https://1145.am/db/2358020/Cephalon>,
        <https://1145.am/db/2363814/Cephalon>,
        <https://1145.am/db/2542518/Cephalon>,
        <https://1145.am/db/2546317/Cephalon>,
        <https://1145.am/db/2547670/Cephalon>,
        <https://1145.am/db/2573589/Cephalon>,
        <https://1145.am/db/2574480/Cephalon_Inc>,
        <https://1145.am/db/2575012/Cephalon>,
        <https://1145.am/db/2582406/Cephalon_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358023/Gemin_X_Pharmaceuticals> a org:Organization ;
    ns1:basedInHighGeoName "Frazer" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5190421/about.rdf> ;
    ns1:basedInHighRaw "FRAZER, Pa." ;
    ns1:description "cancer therapeutics" ;
    ns1:documentDate "2011-03-22T11:52:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cephalon Announces Definitive Agreement to Acquire Gemin X" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cephalon-announces-definitive-agreement-to-acquire-gemin-x> ;
    ns1:foundName "Gemin X Pharmaceuticals, Inc." ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Gemin X Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2251983/Gemin_X_Pharmaceuticals>,
        <https://1145.am/db/2303172/Gemin_X_Pharmaceuticals>,
        <https://1145.am/db/2305688/Gemin_X_Pharmaceuticals>,
        <https://1145.am/db/2305703/Gemin_X_Pharmaceuticals>,
        <https://1145.am/db/2338474/Gemin_X>,
        <https://1145.am/db/2339554/Gemmus_Pharma_Inc>,
        <https://1145.am/db/2343704/Gemin_X_Pharmaceuticals>,
        <https://1145.am/db/2343706/Gemin_X_Pharmaceuticals>,
        <https://1145.am/db/2348674/Gemin_X_Pharmaceuticals>,
        <https://1145.am/db/2358020/Gemin_X>,
        <https://1145.am/db/2589829/Gemmus_Pharma_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358023/Gemin_X_Pharmaceuticals_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-03-22T11:52:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "FRAZER, Pa., March 21, 2011 /PRNewswire/ - Cephalon, Inc. (Nasdaq: CEPH) announced today that it has signed a definitive merger agreement under which it will acquire all of the outstanding capital stock of Gemin X Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing first-in-class cancer therapeutics, for $ 225 million cash on a cash-free, debt-free basis." ;
    ns1:documentTitle "Cephalon Announces Definitive Agreement to Acquire Gemin X" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cephalon-announces-definitive-agreement-to-acquire-gemin-x> ;
    ns1:foundName "acquire",
        "merger" ;
    ns1:name "acquire",
        "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2358023/Gemin_X_Pharmaceuticals> ;
    ns1:targetName "Gemin X Pharmaceuticals" ;
    ns1:valueRaw "$ 225 million" ;
    ns1:whereGeoName "Frazer" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5190421/about.rdf> ;
    ns1:whereRaw "FRAZER, Pa." .

<https://1145.am/db/2358737/Lotus_Tissue_Repair_Inc> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "developing first-in-class protein replacement therapy for dystrophic epidermolysis bull" ;
    ns1:documentDate "2011-06-30T12:39:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lotus Tissue Repair, Inc. Secures $26 Million Series A Financing to Develop First-in-Class Protein Replacement Therapy for Dystr" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lotus-tissue-repair-inc-secures-26-million-series-a-financing-to-develop-first-class> ;
    ns1:foundName "Lotus Tissue Repair, Inc." ;
    ns1:industry "Life Sciences" ;
    ns1:name "Lotus Tissue Repair, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2361640/Lotus_Tissue_Repair_Inc>,
        <https://1145.am/db/2361641/Lotus_Tissue_Repair> ;
    ns1:sameAsMedium <https://1145.am/db/2339117/Lotus_Tissue_Repair>,
        <https://1145.am/db/2362744/Lotus_Tissue_Repair> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358737/Series_A_Investment_Lotus_Tissue_Repair_Inc_Third_Rock_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-06-30T12:39:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass.- (EON: Enhanced Online News) -Lotus Tissue Repair, Inc. today announced the closing of a $ 26 million Series A financing led by Third Rock Ventures.",
        "Lotus Tissue Repair, Inc. Secures $ 26 Million Series A Financing to Develop First-in-Class Protein Replacement Therapy for Dystrophic Epidermolysis Bullosa." ;
    ns1:documentTitle "Lotus Tissue Repair, Inc. Secures $26 Million Series A Financing to Develop First-in-Class Protein Replacement Therapy for Dystr" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lotus-tissue-repair-inc-secures-26-million-series-a-financing-to-develop-first-class> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2358737/Lotus_Tissue_Repair_Inc> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 26 Million",
        "$ 26 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2360090/Methylgene_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Montral" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6077246/about.rdf> ;
    ns1:basedInHighRaw "MONTREAL, QUEBEC" ;
    ns1:basedInLowRaw "Canada" ;
    ns1:description "Life science" ;
    ns1:documentDate "2011-03-25T12:38:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MethylGene Announces $34.5 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/methylgene-announces-34-5-million-private-placement> ;
    ns1:foundName "MethylGene",
        "MethylGene Inc",
        "MethylGene Inc." ;
    ns1:industry "life science" ;
    ns1:name "MethylGene",
        "MethylGene Inc",
        "MethylGene Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2342856/Methylgene_Inc>,
        <https://1145.am/db/2349122/Methylgene_Inc>,
        <https://1145.am/db/2355914/Methylgene_Inc>,
        <https://1145.am/db/2361256/Methylgene_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2348128/Methylgene_Inc>,
        <https://1145.am/db/2360091/Methylgene>,
        <https://1145.am/db/2363184/Methylgene_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360127/Anergis_Sa> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:description "immunotherapy" ;
    ns1:documentDate "2011-03-28T15:11:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Anergis Closes CHF 18 Million Series A Financing Round to Develop its Innovative Allergy Vaccines and Expands its Board of Direc" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anergis-closes-chf-18-million-series-a-financing-round-to-develop-its-innovative-allergy> ;
    ns1:foundName "Anergis",
        "Anergis SA" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Anergis",
        "Anergis SA" ;
    ns1:sameAsHigh <https://1145.am/db/2358617/Anergis> ;
    ns1:sameAsMedium <https://1145.am/db/2371021/Anergis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360127/Biomedinvest> a org:Organization ;
    ns1:basedInHighGeoName "Basel" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2661604/about.rdf> ;
    ns1:basedInHighRaw "Basel, Switzerland" ;
    ns1:description "Biotech" ;
    ns1:documentDate "2011-03-28T15:11:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Anergis Closes CHF 18 Million Series A Financing Round to Develop its Innovative Allergy Vaccines and Expands its Board of Direc" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anergis-closes-chf-18-million-series-a-financing-round-to-develop-its-innovative-allergy> ;
    ns1:foundName "BioMedInvest" ;
    ns1:investor <https://1145.am/db/2360127/Series_A_Investment_Anergis_Sa_Biomedinvest_Esperante_Initiative_Capital_Romandie_Sunstone_Capital_Vinci_Capital-Renaissance_Pme_Completed> ;
    ns1:name "BioMedInvest" ;
    ns1:sameAsHigh <https://1145.am/db/1441535/Micreos>,
        <https://1145.am/db/1629918/Novotech>,
        <https://1145.am/db/1634976/Biontech>,
        <https://1145.am/db/1696213/23andme_Inc>,
        <https://1145.am/db/1696213/Genentech>,
        <https://1145.am/db/1950266/Concentra_Biosciences>,
        <https://1145.am/db/2049549/Biogen>,
        <https://1145.am/db/2152261/Inventiva>,
        <https://1145.am/db/2154521/Baergic_Bio>,
        <https://1145.am/db/2156117/Themis>,
        <https://1145.am/db/2156304/Puretech>,
        <https://1145.am/db/2279108/Anaveon>,
        <https://1145.am/db/2279595/Erytech>,
        <https://1145.am/db/2279911/Genetx>,
        <https://1145.am/db/2280734/Forte_Biosciences>,
        <https://1145.am/db/2285390/Cellarity>,
        <https://1145.am/db/2290381/Life_Sciences>,
        <https://1145.am/db/2293654/Eleven_Bio>,
        <https://1145.am/db/2297083/Biogen_Idec>,
        <https://1145.am/db/2297963/Biogen>,
        <https://1145.am/db/2301170/Ablynx>,
        <https://1145.am/db/2301983/Biogen_Idec>,
        <https://1145.am/db/2302002/Biogen_Idec>,
        <https://1145.am/db/2308022/Cogenesys>,
        <https://1145.am/db/2313760/Sistemic_Ltd>,
        <https://1145.am/db/2315615/Anormed>,
        <https://1145.am/db/2320138/Biogen_Idec>,
        <https://1145.am/db/2325718/Biogen>,
        <https://1145.am/db/2326588/Gpc_Biotech>,
        <https://1145.am/db/2331994/3sbio>,
        <https://1145.am/db/2332003/Neose>,
        <https://1145.am/db/2332883/Gpc_Biotech>,
        <https://1145.am/db/2336383/Biocrates_Life_Sciences_Ag>,
        <https://1145.am/db/2341010/GTC>,
        <https://1145.am/db/2346300/Myr>,
        <https://1145.am/db/2355236/Stellar_Biotechnologies_Inc>,
        <https://1145.am/db/2355423/Biontech>,
        <https://1145.am/db/2357260/Inotrem>,
        <https://1145.am/db/2362543/Micurx>,
        <https://1145.am/db/2367816/Conkwest>,
        <https://1145.am/db/2369363/Volution>,
        <https://1145.am/db/2370806/Alvotech>,
        <https://1145.am/db/2538176/Matritech>,
        <https://1145.am/db/2542993/Biogen_Idec>,
        <https://1145.am/db/2546456/3sbio>,
        <https://1145.am/db/2550495/Bioatla>,
        <https://1145.am/db/2554066/Erytech>,
        <https://1145.am/db/2562577/Biogen>,
        <https://1145.am/db/540784/Coherus_Biosciences_Inc>,
        <https://1145.am/db/767994/Biotech_Prokidney_Lp>,
        <https://1145.am/db/940935/Mabxience> ;
    ns1:sameAsMedium <https://1145.am/db/2293270/Biomedinvest_Ag>,
        <https://1145.am/db/2298049/Biomedinvest_Ag>,
        <https://1145.am/db/2299180/Biomedinvest>,
        <https://1145.am/db/2307886/Biomedinvest_Ag>,
        <https://1145.am/db/2310922/Biomedinvest>,
        <https://1145.am/db/2313322/Biomedinvest>,
        <https://1145.am/db/2313438/Biomedinvest>,
        <https://1145.am/db/2318778/Biomedinvest>,
        <https://1145.am/db/2331946/Biomedinvest>,
        <https://1145.am/db/2332658/Biomedinvest>,
        <https://1145.am/db/2332659/Biomedinvest>,
        <https://1145.am/db/2337043/Biomedinvest>,
        <https://1145.am/db/2339295/Biomedinvest>,
        <https://1145.am/db/2352382/Biomedinvest>,
        <https://1145.am/db/2360125/Biomedinvest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360127/Initiative_Capital_Romandie> a org:Organization ;
    ns1:basedInHighGeoName "Lausanne" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2659994/about.rdf> ;
    ns1:basedInHighRaw "Lausanne, Switzerland" ;
    ns1:description "financing" ;
    ns1:documentDate "2011-03-28T15:11:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Anergis Closes CHF 18 Million Series A Financing Round to Develop its Innovative Allergy Vaccines and Expands its Board of Direc" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anergis-closes-chf-18-million-series-a-financing-round-to-develop-its-innovative-allergy> ;
    ns1:foundName "Initiative Capital Romandie" ;
    ns1:investor <https://1145.am/db/2360127/Series_A_Investment_Anergis_Sa_Biomedinvest_Esperante_Initiative_Capital_Romandie_Sunstone_Capital_Vinci_Capital-Renaissance_Pme_Completed> ;
    ns1:name "Initiative Capital Romandie" ;
    ns1:sameAsMedium <https://1145.am/db/2247240/Initiative_Capital_Romandie>,
        <https://1145.am/db/2292300/Initiative_Capital_Romandie>,
        <https://1145.am/db/2293270/Initiative_Capital_Romandie>,
        <https://1145.am/db/2298049/Initiative_Capital_Romandie>,
        <https://1145.am/db/2360125/Initiative_Capital_Romandie>,
        <https://1145.am/db/2367257/Initiative_Capital_Romandie>,
        <https://1145.am/db/2367420/Initiative_Capital_Romandie> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360127/Sunstone_Capital> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Denmark" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2623032/about.rdf> ;
    ns1:basedInHighRaw "Denmark" ;
    ns1:description "financing" ;
    ns1:documentDate "2011-03-28T15:11:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Anergis Closes CHF 18 Million Series A Financing Round to Develop its Innovative Allergy Vaccines and Expands its Board of Direc" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anergis-closes-chf-18-million-series-a-financing-round-to-develop-its-innovative-allergy> ;
    ns1:foundName "Sunstone Capital" ;
    ns1:investor <https://1145.am/db/2360127/Series_A_Investment_Anergis_Sa_Biomedinvest_Esperante_Initiative_Capital_Romandie_Sunstone_Capital_Vinci_Capital-Renaissance_Pme_Completed> ;
    ns1:name "Sunstone Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2329919/Sunstone_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1717714/Sunstone_Capital>,
        <https://1145.am/db/1776660/Sunstone_Capital>,
        <https://1145.am/db/1780157/Sunstone_Capital>,
        <https://1145.am/db/1791743/Sunstone_Capital>,
        <https://1145.am/db/1797413/Sunstone_Capital>,
        <https://1145.am/db/1800466/Sunstone_Capital>,
        <https://1145.am/db/1803787/Sunstone_Capital>,
        <https://1145.am/db/1808488/Sunstone_Capital>,
        <https://1145.am/db/1813404/Sunstone_Capital>,
        <https://1145.am/db/1821174/Sunstone_Capital>,
        <https://1145.am/db/1832434/Sunstone_Capital>,
        <https://1145.am/db/1833000/Sunstone_Capital>,
        <https://1145.am/db/1833646/Sunstone_Capital>,
        <https://1145.am/db/1850593/Sunstone_Capital>,
        <https://1145.am/db/1850760/Sunstone_Capital>,
        <https://1145.am/db/1854996/Sunstone_Capital>,
        <https://1145.am/db/1858818/Sunstone_Capital>,
        <https://1145.am/db/1859597/Sunstone_Capital>,
        <https://1145.am/db/1862019/Sunstone_Capital>,
        <https://1145.am/db/1868935/Sunstone_Capital>,
        <https://1145.am/db/1869517/Sunstone_Capital>,
        <https://1145.am/db/1870079/Sunstone_Capital>,
        <https://1145.am/db/1877786/Sunstone_Capital>,
        <https://1145.am/db/1879213/Sunstone_Capital>,
        <https://1145.am/db/1885147/Sunstone_Capital>,
        <https://1145.am/db/1888954/Sunstone_Capital>,
        <https://1145.am/db/2323700/Sunstone_Capital>,
        <https://1145.am/db/2336622/Sunstone_Capital>,
        <https://1145.am/db/2341942/Sunstone_Capital>,
        <https://1145.am/db/2346452/Sunstone_Capital>,
        <https://1145.am/db/2347980/Sunstone_Capital>,
        <https://1145.am/db/2348003/Sunstone_Capital>,
        <https://1145.am/db/2352203/Sunstone_Capital>,
        <https://1145.am/db/2352204/Sunstone_Capital>,
        <https://1145.am/db/2352216/Sunstone_Capital>,
        <https://1145.am/db/2355609/Sunstone_Capital>,
        <https://1145.am/db/2355841/Sunstone_Capital>,
        <https://1145.am/db/2360922/Sunstone_Capital>,
        <https://1145.am/db/2367218/Sunstone_Capital>,
        <https://1145.am/db/2569491/Sunstone_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360841/Investment_Northwest_Biotherapeutics_Richard_M_Schulze_Family_Foundation_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-08T13:22:14+00:00"^^xsd:dateTime ;
    ns1:documentExtract "BETHESDA, Md.- (BUSINESS WIRE) - Northwest Biotherapeutics (OTCBB: NWBO) (\"NWBT\") announced today a $ 4.55 million equity investment on June 28, 2011, by The Richard M. Schulze Family Foundation (the \"Foundation\") ." ;
    ns1:documentTitle "Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in t" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/family-foundation-of-business-leader-invests-4-55-million-northwest-biotherapeutics-for-0> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2360841/Northwest_Biotherapeutics> ;
    ns1:targetDetails "equity" ;
    ns1:targetName "Northwest Biotherapeutics" ;
    ns1:valueRaw "$ 4.55 million" ;
    ns1:when "2011-06-28T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "June 28, 2011" ;
    ns1:whereGeoName "Bethesda" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4348599/about.rdf> ;
    ns1:whereRaw "BETHESDA, Md" .

<https://1145.am/db/2360842/Equity_Investment_Northwest_Biotherapeutics_Richard_M_Schulze_Family_Foundation_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-08T13:22:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "BETHESDA, Md., July 8, 2011 /PRNewswire/ - Northwest Biotherapeutics (OTC Bulletin Board: NWBO) (\"NWBT\") announced today a $ 4.55 million equity investment on June 28, 2011, by The Richard M. Schulze Family Foundation (the \"Foundation\") ." ;
    ns1:documentTitle "Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/family-foundation-of-business-leader-invests-4-55-million-northwest-biotherapeutics-for-1> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2360842/Northwest_Biotherapeutics> ;
    ns1:targetDetails "equity" ;
    ns1:targetName "Northwest Biotherapeutics" ;
    ns1:valueRaw "$ 3 million",
        "$ 4.55 million" ;
    ns1:when "2011-06-28T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "June 28, 2011" ;
    ns1:whereGeoName "Bethesda" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4348599/about.rdf> ;
    ns1:whereRaw "BETHESDA, Md",
        "BETHESDA, Md." .

<https://1145.am/db/2360852/Equity_Investment_Whitebox_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-08T16:00:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Bethesda, MD, July 8, 2011 - Northwest Biotherapeutics (OTC Bulletin Board: NWBO) (\"NWBT\") announced today a $ 4.55 million equity investment on June 28, 2011, by The Richard M. Schulze Family Foundation (the \"Foundation\") ." ;
    ns1:documentTitle "Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics For Promising Clinical Trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/family-foundation-of-business-leader-invests-4-55-million-northwest-biotherapeutics-for> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:targetDetails "equity" ;
    ns1:valueRaw "$ 3 million" ;
    ns1:when "2011-06-28T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "June 28, 2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "US" .

<https://1145.am/db/2361204/Rxi_Pharmaceuticals_Corporation> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2361204/Apthera_Inc_Acquisition> ;
    ns1:description "RNAi - based therapeutic discovery and development" ;
    ns1:documentDate "2011-03-31T13:18:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RXi Pharmaceuticals Aggressively Moves into Late-Stage Clinical Development with the Agreement to Acquire Apthera, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rxi-pharmaceuticals-aggressively-moves-into-late-stage-clinical-development-agreement-to-0> ;
    ns1:foundName "RXi",
        "RXi Pharmaceuticals Corporation" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "RXi Pharmaceuticals Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2302151/Rxi_Pharmaceuticals>,
        <https://1145.am/db/2304261/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2308945/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2310568/Rxi_Pharmaceuticals>,
        <https://1145.am/db/2310584/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2313126/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2313214/Rexahn_Pharmaceuticals_Inc>,
        <https://1145.am/db/2316545/Trubion_Pharmaceuticals>,
        <https://1145.am/db/2317666/Rhei_Pharmaceuticals>,
        <https://1145.am/db/2318933/Rhei_Pharmaceuticals>,
        <https://1145.am/db/2328009/Rxi_Pharmaceuticals>,
        <https://1145.am/db/2329145/Trubion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330196/Trubion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330873/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2339602/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2344954/Reviva_Pharmaceuticals>,
        <https://1145.am/db/2350769/Trubion_Pharmaceuticals>,
        <https://1145.am/db/2350777/Trubion_Pharmaceuticals>,
        <https://1145.am/db/2352182/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353794/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2353795/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2358425/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2361205/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2361243/Rexahn_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363779/Rexahn_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364631/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2366292/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2366408/Rxi_Pharmaceuticals_Corporation> ;
    ns1:sameAsMedium <https://1145.am/db/2306610/Rxi_Pharmaceuticals>,
        <https://1145.am/db/2326917/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2327998/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353647/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2364206/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2365628/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2366102/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2367031/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2367209/Rxi_Pharmaceuticals_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361205/Rxi_Pharmaceuticals_Corporation> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2361205/Apthera_Inc_Acquisition> ;
    ns1:description "RNAi - based therapeutic discovery and development" ;
    ns1:documentDate "2011-03-31T13:18:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RXi Pharmaceuticals Aggressively Moves into Late-Stage Clinical Development with the Agreement to Acquire Apthera, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rxi-pharmaceuticals-aggressively-moves-into-late-stage-clinical-development-agreement-to> ;
    ns1:foundName "RXi",
        "RXi Pharmaceuticals Corporation" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "RXi Pharmaceuticals Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2302151/Rxi_Pharmaceuticals>,
        <https://1145.am/db/2304261/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2308945/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2310568/Rxi_Pharmaceuticals>,
        <https://1145.am/db/2310584/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2313126/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2313214/Rexahn_Pharmaceuticals_Inc>,
        <https://1145.am/db/2316545/Trubion_Pharmaceuticals>,
        <https://1145.am/db/2317666/Rhei_Pharmaceuticals>,
        <https://1145.am/db/2318933/Rhei_Pharmaceuticals>,
        <https://1145.am/db/2328009/Rxi_Pharmaceuticals>,
        <https://1145.am/db/2329145/Trubion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330196/Trubion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330873/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2339602/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2344954/Reviva_Pharmaceuticals>,
        <https://1145.am/db/2350769/Trubion_Pharmaceuticals>,
        <https://1145.am/db/2350777/Trubion_Pharmaceuticals>,
        <https://1145.am/db/2352182/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353794/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2353795/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2358425/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2361204/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2361243/Rexahn_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363779/Rexahn_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364631/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2366292/Rexahn_Pharmaceuticals>,
        <https://1145.am/db/2366408/Rxi_Pharmaceuticals_Corporation> ;
    ns1:sameAsMedium <https://1145.am/db/2306610/Rxi_Pharmaceuticals>,
        <https://1145.am/db/2326917/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2327998/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353647/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2364206/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2365628/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2366102/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2367031/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2367209/Rxi_Pharmaceuticals_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362871/Verastem> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "Cambridge, MA" ;
    ns1:description "cancer stem cells" ;
    ns1:documentDate "2011-07-14T13:23:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verastem snags $32M for drugs against cancer stem cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/verastem-snags-32m-for-drugs-against-cancer-stem-cells> ;
    ns1:foundName "Verastem" ;
    ns1:industry "biotech" ;
    ns1:name "Verastem" ;
    ns1:sameAsHigh <https://1145.am/db/1188139/Verastem_Oncology>,
        <https://1145.am/db/1582816/Verastem_Oncology>,
        <https://1145.am/db/1587065/Verastem_Oncology>,
        <https://1145.am/db/2011085/Verastem_Oncology>,
        <https://1145.am/db/202096/Verastem_Inc>,
        <https://1145.am/db/2039843/Verastem_Oncology>,
        <https://1145.am/db/2040117/Verastem_Oncology>,
        <https://1145.am/db/2152359/Verastem>,
        <https://1145.am/db/2319316/Verastem>,
        <https://1145.am/db/2320501/Verastem>,
        <https://1145.am/db/2325257/Macrogenics_Inc>,
        <https://1145.am/db/2325897/Stemcentrx>,
        <https://1145.am/db/2337820/Verastem>,
        <https://1145.am/db/2337887/Verastem>,
        <https://1145.am/db/2340826/Verastem_Inc>,
        <https://1145.am/db/2340852/Verastem_Inc>,
        <https://1145.am/db/2340879/Verastem_Inc>,
        <https://1145.am/db/2347448/Verastem>,
        <https://1145.am/db/2352247/Verastem_Inc>,
        <https://1145.am/db/2352480/Verastem>,
        <https://1145.am/db/2353404/Verastem>,
        <https://1145.am/db/2353413/Verastem>,
        <https://1145.am/db/2353415/Verastem>,
        <https://1145.am/db/2356228/Verastem_Inc>,
        <https://1145.am/db/2360077/Eclipse_Therapeutics_Inc>,
        <https://1145.am/db/2361987/Verastem>,
        <https://1145.am/db/2361989/Verastem>,
        <https://1145.am/db/2362101/Verastem_Inc>,
        <https://1145.am/db/2362632/Verastem>,
        <https://1145.am/db/2362661/Verastem>,
        <https://1145.am/db/2362868/Verastem>,
        <https://1145.am/db/2362869/Verastem>,
        <https://1145.am/db/2364641/Verastem>,
        <https://1145.am/db/2365545/Verastem>,
        <https://1145.am/db/2586849/Verastem_Inc>,
        <https://1145.am/db/2593705/Verastem>,
        <https://1145.am/db/360408/Verastem_Oncology>,
        <https://1145.am/db/378611/Verastem_Oncology>,
        <https://1145.am/db/490409/Verastem_Oncology>,
        <https://1145.am/db/498866/Verastem_Oncology>,
        <https://1145.am/db/499940/Verastem_Oncology>,
        <https://1145.am/db/571055/Verastem_Oncology>,
        <https://1145.am/db/75291/Verastem_Inc>,
        <https://1145.am/db/928527/Verastem_Oncology>,
        <https://1145.am/db/935085/Verastem_Oncology>,
        <https://1145.am/db/951789/Verastem_Oncology>,
        <https://1145.am/db/953535/Verastem_Oncology> ;
    ns1:sameAsMedium <https://1145.am/db/2338839/Verastem>,
        <https://1145.am/db/2339063/Verastem>,
        <https://1145.am/db/2340711/Verastem>,
        <https://1145.am/db/2352990/Verastem>,
        <https://1145.am/db/2356347/Verastem_Inc>,
        <https://1145.am/db/2357407/Verastem_Inc>,
        <https://1145.am/db/2362602/Verastem_Inc>,
        <https://1145.am/db/2362623/Verastem> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2363247/Ascletis> a org:Organization ;
    ns1:basedInHighGeoName "Chapel Hill" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4460162/about.rdf> ;
    ns1:basedInHighRaw "CHAPEL HILL, N.C." ;
    ns1:description "cancer and infectious disease therapeutics" ;
    ns1:documentDate "2011-04-06T13:59:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "US-China Based Ascletis, Inc. Raises $100 Million from Private Chinese Investors for Specialty Therapeutics Venture" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/us-china-based-ascletis-inc-raises-100-million-from-private-chinese-investors-for-specialty> ;
    ns1:foundName "Ascletis",
        "Ascletis, Inc." ;
    ns1:industry "life sciences" ;
    ns1:name "Ascletis" ;
    ns1:sameAsHigh <https://1145.am/db/2360860/Ascletis>,
        <https://1145.am/db/2363240/Ascletis>,
        <https://1145.am/db/2368258/Ascletis>,
        <https://1145.am/db/2545385/Ascletis> ;
    ns1:sameAsMedium <https://1145.am/db/2155814/Ascletis>,
        <https://1145.am/db/2288534/Ascletis>,
        <https://1145.am/db/2301611/Ascletis>,
        <https://1145.am/db/2546405/Ascletis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2363247/Investment_Ascletis_Hangzhou_Binjiang_Investment_Holding_Co_Ltd_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-06T13:59:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Ascletis has raised US $ 100 million in committed financing including a first tranche of US $ 50 million.",
        "CHAPEL HILL, N.C. & HANGZHOU, China- (EON: Enhanced Online News) -Ascletis, Inc., a U.S.-China specialty life sciences venture focused on cancer and infectious disease therapeutics, today announced the company's formation and completion of a Series A private equity financing." ;
    ns1:documentTitle "US-China Based Ascletis, Inc. Raises $100 Million from Private Chinese Investors for Specialty Therapeutics Venture" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/us-china-based-ascletis-inc-raises-100-million-from-private-chinese-investors-for-specialty> ;
    ns1:foundName "financing",
        "private" ;
    ns1:name "financing",
        "private" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2363247/Ascletis> ;
    ns1:targetDetails "Series A",
        "committed",
        "equity",
        "private equity" ;
    ns1:valueRaw "US $ 100 million",
        "US $ 50 million" ;
    ns1:whereGeoName "Peoples Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2363854/Beringea> a org:Organization ;
    ns1:basedInHighGeoName "Michigan" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5001836/about.rdf> ;
    ns1:basedInHighRaw "Michigan" ;
    ns1:description "venture and expansion-stage capital investor" ;
    ns1:documentDate "2011-07-19T12:32:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Beringea Invests in Healthcare IT Company Intervention Insights" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/beringea-invests-healthcare-it-company-intervention-insights> ;
    ns1:foundName "Beringea" ;
    ns1:industry "cancer care" ;
    ns1:investor <https://1145.am/db/2363854/Series_B_Investment_Beringea_Chrysalis_Ventures_Hopen_Life_Sciences_Intervention_Insights_Michigan_Accelerator_Fund_I_Completed> ;
    ns1:name "Beringea" ;
    ns1:sameAsHigh <https://1145.am/db/1168925/Beringea>,
        <https://1145.am/db/1171251/Beringea>,
        <https://1145.am/db/1760209/Beringea>,
        <https://1145.am/db/285942/Beringea> ;
    ns1:sameAsMedium <https://1145.am/db/1114659/Beringea>,
        <https://1145.am/db/1230379/Beringea>,
        <https://1145.am/db/150479/Beringea>,
        <https://1145.am/db/1707620/Beringea>,
        <https://1145.am/db/1764054/Beringea>,
        <https://1145.am/db/1784899/Beringea>,
        <https://1145.am/db/1795461/Beringea>,
        <https://1145.am/db/1797259/Beringea>,
        <https://1145.am/db/1801532/Beringea>,
        <https://1145.am/db/1950910/Beringea_Llc>,
        <https://1145.am/db/2050229/Beringea>,
        <https://1145.am/db/2252673/Beringea>,
        <https://1145.am/db/2322429/Beringea>,
        <https://1145.am/db/2323825/Beringea>,
        <https://1145.am/db/474764/Beringea> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2363854/Hopen_Life_Sciences> a org:Organization ;
    ns1:basedInLowRaw "Ky" ;
    ns1:documentDate "2011-07-19T12:32:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Beringea Invests in Healthcare IT Company Intervention Insights" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/beringea-invests-healthcare-it-company-intervention-insights> ;
    ns1:foundName "Hopen Life Sciences" ;
    ns1:industry "cancer care" ;
    ns1:investor <https://1145.am/db/2363854/Series_B_Investment_Beringea_Chrysalis_Ventures_Hopen_Life_Sciences_Intervention_Insights_Michigan_Accelerator_Fund_I_Completed> ;
    ns1:name "Hopen Life Sciences" ;
    ns1:sameAsMedium <https://1145.am/db/2322429/Hopen_Life_Sciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2363854/Michigan_Accelerator_Fund_I> a org:Organization ;
    ns1:basedInLowRaw "Ky" ;
    ns1:documentDate "2011-07-19T12:32:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Beringea Invests in Healthcare IT Company Intervention Insights" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/beringea-invests-healthcare-it-company-intervention-insights> ;
    ns1:foundName "Michigan Accelerator Fund I" ;
    ns1:investor <https://1145.am/db/2363854/Series_B_Investment_Beringea_Chrysalis_Ventures_Hopen_Life_Sciences_Intervention_Insights_Michigan_Accelerator_Fund_I_Completed> ;
    ns1:name "Michigan Accelerator Fund I" ;
    ns1:sameAsMedium <https://1145.am/db/2322429/Michigan_Accelerator_Fund_I> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2363871/Royalty_Investment_Cowen_Healthcare_Royalty_Partners_Ii_Zogenix_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-19T15:19:27+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SAN DIEGO, Jul 18, 2011 (GlobeNewswire via COMTEX) - Zogenix, Inc. ZGNX +1.49 %, a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, announced today that it closed its previously announced royalty financing with Cowen Healthcare Royalty Partners II, L.P. (\"Cowen Royalty\") .",
        "Zogenix Closes $ 30 Million Royalty Financing With Cowen Healthcare Royalty Partners II." ;
    ns1:documentTitle "Zogenix Closes $30 Million Royalty Financing With Cowen Healthcare Royalty Partners II Includes $1.5 Million Equity Investment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zogenix-closes-30-million-royalty-financing-cowen-healthcare-royalty-partners-ii-includes-1> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2363871/Zogenix> ;
    ns1:targetDetails "royalty" ;
    ns1:valueRaw "$ 1.5 Million",
        "$ 30 Million",
        "$ 30 million" ;
    ns1:when "2011-07-18T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Jul 18, 2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2363871/Zogenix> a org:Organization ;
    ns1:description "pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain" ;
    ns1:documentDate "2011-07-19T15:19:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zogenix Closes $30 Million Royalty Financing With Cowen Healthcare Royalty Partners II Includes $1.5 Million Equity Investment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zogenix-closes-30-million-royalty-financing-cowen-healthcare-royalty-partners-ii-includes-1> ;
    ns1:foundName "Zogenix",
        "Zogenix, Inc." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Zogenix" ;
    ns1:sameAsHigh <https://1145.am/db/2302008/Zogenix>,
        <https://1145.am/db/2302010/Zogenix>,
        <https://1145.am/db/2302292/Zogenix>,
        <https://1145.am/db/2311101/Zogenix>,
        <https://1145.am/db/2317145/Zogenix>,
        <https://1145.am/db/2317749/Zogenix_Inc>,
        <https://1145.am/db/2320299/Zogenix>,
        <https://1145.am/db/2335651/Zogenix>,
        <https://1145.am/db/2339199/$_Zgnx>,
        <https://1145.am/db/2341601/Zogenix_Inc>,
        <https://1145.am/db/2350250/Zogenix>,
        <https://1145.am/db/2363647/Zogenix>,
        <https://1145.am/db/2562552/Zogenix>,
        <https://1145.am/db/2564418/Zixin>,
        <https://1145.am/db/2569228/Zogenix>,
        <https://1145.am/db/2569431/Zogenix_Inc>,
        <https://1145.am/db/2569432/Zogenix_Inc>,
        <https://1145.am/db/2570309/Zogenix_Inc>,
        <https://1145.am/db/2573483/Zogenix_Inc>,
        <https://1145.am/db/2589255/Zogenix>,
        <https://1145.am/db/771062/Zogenix_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2320009/Zogenix>,
        <https://1145.am/db/2342312/Zogenix>,
        <https://1145.am/db/2349265/Zogenix>,
        <https://1145.am/db/2563511/Zogenix>,
        <https://1145.am/db/2593481/Zogenix>,
        <https://1145.am/db/768676/Zogenix>,
        <https://1145.am/db/769779/Zogenix>,
        <https://1145.am/db/769887/Zogenix>,
        <https://1145.am/db/774623/Zogenix>,
        <https://1145.am/db/784136/Zogenix>,
        <https://1145.am/db/797019/Zogenix> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364201/Cellular_Dynamics_International> a org:Organization ;
    ns1:basedInHighGeoName "Madison" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5261457/about.rdf> ;
    ns1:basedInHighRaw "MADISON, Wis." ;
    ns1:description "manufacturing" ;
    ns1:documentDate "2011-04-07T15:23:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cellular Dynamics Raises $30 Million to Expand Its Product Line of Human Stem Cells and Tissue Cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cellular-dynamics-raises-30-million-to-expand-its-product-line-of-human-stem-cells-and> ;
    ns1:foundName "Cellular Dynamics",
        "Cellular Dynamics International, Inc" ;
    ns1:industry "biomedical and pharmaceutical" ;
    ns1:name "Cellular Dynamics",
        "Cellular Dynamics International" ;
    ns1:sameAsHigh <https://1145.am/db/2303022/Cellular_Dynamics_International>,
        <https://1145.am/db/2345791/Cellular_Dynamics_International> ;
    ns1:sameAsMedium <https://1145.am/db/2342980/Cellular_Dynamics_International>,
        <https://1145.am/db/2342984/Cellular_Dynamics_International>,
        <https://1145.am/db/2345711/Cellular_Dynamics_International_Inc>,
        <https://1145.am/db/2345735/Cellular_Dynamics_International>,
        <https://1145.am/db/2345790/Cellular_Dynamics_International>,
        <https://1145.am/db/2364202/Cellular_Dynamics_International>,
        <https://1145.am/db/2537117/Cellular_Dynamics_International>,
        <https://1145.am/db/2537120/Cellular_Dynamics_International>,
        <https://1145.am/db/2538906/Cellular_Dynamics_International>,
        <https://1145.am/db/2550600/Cellular_Dynamics_International>,
        <https://1145.am/db/2550602/Cellular_Dynamics_International> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364216/Bergamo_Rights_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-04-08T13:09:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Amgen has purchased Brazilian pharma company Bergamo for $ 215 million in an effort to grow its reach in the country." ;
    ns1:documentTitle "Sanofi funds stalled Genzyme programs; Amgen broadens Brazilian reach;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sanofi-funds-stalled-genzyme-programs-amgen-broadens-brazilian-reach> ;
    ns1:foundName "purchased",
        "transfer" ;
    ns1:name "purchased",
        "transfer" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2364216/Bergamo> ;
    ns1:targetDetails "rights" ;
    ns1:targetName "Bergamo" ;
    ns1:valueRaw "$ 215 million" ;
    ns1:vendor <https://1145.am/db/2364216/Hypermarcas> ;
    ns1:whereGeoName "Federative Republic of Brazil" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:whereRaw "Brazil" .

<https://1145.am/db/2364216/Investment_Cadila_Healthcare_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-08T13:09:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Indian biotech Cadila Healthcare received FDA approval to start Phase I trials for ZYGK1, a type 2 diabetes treatment." ;
    ns1:documentTitle "Sanofi funds stalled Genzyme programs; Amgen broadens Brazilian reach;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sanofi-funds-stalled-genzyme-programs-amgen-broadens-brazilian-reach> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Republic of India" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:whereRaw "Indian" .

<https://1145.am/db/2364226/Mantecorp> a org:Organization ;
    ns1:basedInHighGeoName "Federative Republic of Brazil" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:basedInHighRaw "Brazil" ;
    ns1:description "pharmaceutical company" ;
    ns1:documentDate "2011-04-08T14:16:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen (AMGN) Establishes Commercial Operations in Brazil; Acquires Privately Held Brazilian Pharmaceutical Company Bergamo" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/amgen-amgn-establishes-commercial-operations-brazil-acquires-privately-held-brazilian> ;
    ns1:foundName "Mantecorp" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Mantecorp" ;
    ns1:sameAsHigh <https://1145.am/db/2576474/Mantecorp>,
        <https://1145.am/db/2595932/Mantecorp>,
        <https://1145.am/db/335420/Mandos_Llc>,
        <https://1145.am/db/367550/Mandos_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364240/Blueprint_Medicines> a org:Organization ;
    ns1:description "Molecular data" ;
    ns1:documentDate "2011-04-11T12:06:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blueprint Medicines Secures $40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/blueprint-medicines-secures-40-million-series-a-financing-to-translate-new-molecular-data> ;
    ns1:foundName "Blueprint Medicines" ;
    ns1:name "Blueprint Medicines" ;
    ns1:sameAsMedium <https://1145.am/db/2152005/Blueprint_Medicines>,
        <https://1145.am/db/2155620/Blueprint_Medicines>,
        <https://1145.am/db/2300981/Blueprint_Medicines>,
        <https://1145.am/db/2335652/Blueprint_Medicines>,
        <https://1145.am/db/2341940/Blueprint_Medicines>,
        <https://1145.am/db/2342754/Blueprint_Medicines>,
        <https://1145.am/db/2342768/Blueprint_Medicines>,
        <https://1145.am/db/2342771/Blueprint_Medicines>,
        <https://1145.am/db/2345682/Blueprint_Medicines>,
        <https://1145.am/db/2345683/Blueprint_Medicines>,
        <https://1145.am/db/2349136/Blueprint_Medicines>,
        <https://1145.am/db/2350235/Blueprint_Medicines>,
        <https://1145.am/db/2357722/Blueprint_Medicines>,
        <https://1145.am/db/2360971/Blueprint_Medicines>,
        <https://1145.am/db/2369044/Blueprint_Medicines>,
        <https://1145.am/db/2592780/Blueprint_Medicines> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364240/Series_A_Investment_Blueprint_Medicines_Third_Rock_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-11T12:06:22+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Blueprint Medicines Secures $ 40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments.",
        "CAMBRIDGE, Mass.- (BUSINESS WIRE) -Blueprint Medicines, a company harnessing the understanding of the molecular blueprint of cancer to develop personalized, highly-selective cancer therapies, today announced the closing of a $ 40 million Series A financing led by Third Rock Ventures." ;
    ns1:documentTitle "Blueprint Medicines Secures $40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/blueprint-medicines-secures-40-million-series-a-financing-to-translate-new-molecular-data> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2364240/Blueprint_Medicines> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 40 Million",
        "$ 40 million" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass" .

<https://1145.am/db/2365105/F-Star_Gmbh> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Austria" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2782113/about.rdf> ;
    ns1:basedInHighRaw "Austria" ;
    ns1:description "Biopharmaceutical",
        "Pharmaceuticals" ;
    ns1:documentDate "2011-04-13T10:20:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "f-star raises 15M in a New Financing led by SR One" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/f-star-raises-%E2%82%AC15m-a-new-financing-led-by-sr-one> ;
    ns1:foundName "f-star",
        "f-star GmbH" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "f-star",
        "f-star GmbH" ;
    ns1:sameAsHigh <https://1145.am/db/1041596/Fsd_Pharma_Inc>,
        <https://1145.am/db/1192323/F-Star>,
        <https://1145.am/db/1931162/F-Star>,
        <https://1145.am/db/2152487/F-Star>,
        <https://1145.am/db/2155696/F-Star>,
        <https://1145.am/db/2295742/F-Star>,
        <https://1145.am/db/2304215/F-Star>,
        <https://1145.am/db/2329919/Santaris_Pharma>,
        <https://1145.am/db/2341602/F-Star_Alpha_Ltd>,
        <https://1145.am/db/2365103/F-Star>,
        <https://1145.am/db/2365104/F-Star_Gmbh>,
        <https://1145.am/db/2367596/F-Star>,
        <https://1145.am/db/2595958/F-Star_Gmbh>,
        <https://1145.am/db/488496/Fsd_Pharma_Inc>,
        <https://1145.am/db/490633/Fsd_Pharma_Inc>,
        <https://1145.am/db/857970/Fsd_Pharma_Inc>,
        <https://1145.am/db/858543/Fsd_Pharma_Inc>,
        <https://1145.am/db/861614/Fsd_Pharma_Inc>,
        <https://1145.am/db/995401/Fsd_Pharma_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1161413/F-Star>,
        <https://1145.am/db/1191760/F-Star>,
        <https://1145.am/db/2155661/F-Star>,
        <https://1145.am/db/2304237/F-Star>,
        <https://1145.am/db/2355630/F-Star> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365105/Investment_Sr_One_F-Star_Gmbh_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-13T10:20:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Vienna, Austria, (13 April, 2011) - f-star GmbH, a biopharmaceutical company developing a new generation of antibody based products using its Modular Antibody Technology platform, today announced the closing of a EUR 15 Million financing.",
        "f-star raises 15M in a New Financing led by SR One." ;
    ns1:documentTitle "f-star raises 15M in a New Financing led by SR One" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/f-star-raises-%E2%82%AC15m-a-new-financing-led-by-sr-one> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2365105/F-Star_Gmbh> ;
    ns1:valueRaw "EUR 15 Million",
        "15M" ;
    ns1:when "2011-04-13T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "13 April, 2011" ;
    ns1:whereGeoName "Europe" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255148/about.rdf> ;
    ns1:whereRaw "Europe" .

<https://1145.am/db/2365109/Equity_Investment_Taris_Biomedical_Third_Rock_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-13T11:12:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "LEXINGTON, Mass.- (BUSINESS WIRE) -TARIS Biomedical, a specialty pharmaceutical company pioneering the development of innovative, targeted therapies using drug delivery to treat bladder diseases, announced today that it has raised $ 18.3 million of new capital in connection with its Series B equity financing.",
        "TARIS Closes $ 18.3 Million Series B Financing." ;
    ns1:documentTitle "TARIS Closes $18.3 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/taris-closes-18-3-million-series-b-financing-0> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2365109/Taris_Biomedical> ;
    ns1:targetDetails "Series B",
        "equity" ;
    ns1:valueRaw "$ 18.3 Million",
        "$ 18.3 million" ;
    ns1:whereGeoName "Lexington" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4941935/about.rdf> ;
    ns1:whereRaw "LEXINGTON, Mass" .

<https://1145.am/db/2365111/Equity_Investment_Taris_Biomedical_Third_Rock_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-13T11:20:38+00:00"^^xsd:dateTime ;
    ns1:documentExtract "LEXINGTON, Mass.- (BUSINESS WIRE) - TARIS Biomedical, a specialty pharmaceutical company pioneering the development of innovative, targeted therapies using drug delivery to treat bladder diseases, announced today that it has raised $ 18.3 million of new capital in connection with its Series B equity financing." ;
    ns1:documentTitle "TARIS Closes $18.3 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/taris-closes-18-3-million-series-b-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2365111/Taris_Biomedical> ;
    ns1:targetDetails "equity" ;
    ns1:valueRaw "$ 18.3 million" ;
    ns1:whereGeoName "Lexington" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4941935/about.rdf> ;
    ns1:whereRaw "Lexington, Mass" .

<https://1145.am/db/2365307/Alnara> a org:Organization ;
    ns1:basedInLowRaw "Denmark" ;
    ns1:documentDate "2011-01-03T15:56:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Longwood closes $85M biotech fund; FDA greenlights ESC trial for macular degeneration; Gottlieb castigates FDA;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/longwood-closes-85m-biotech-fund-fda-greenlights-esc-trial-for-macular-degeneration> ;
    ns1:foundName "Alnara" ;
    ns1:industry "biotech" ;
    ns1:name "Alnara" ;
    ns1:sameAsHigh <https://1145.am/db/1116501/Alvotech_Holdings_Sa>,
        <https://1145.am/db/1117630/Alvotech_Holdings_Sa>,
        <https://1145.am/db/1662033/Aldevron>,
        <https://1145.am/db/2154227/Alzheon>,
        <https://1145.am/db/2358227/Alnylam>,
        <https://1145.am/db/2370550/Albireo>,
        <https://1145.am/db/2546781/Aldevron>,
        <https://1145.am/db/677591/Alvotech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365307/Investment_Longwood_Founders_Management_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-03T15:56:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Bucking the trend, a trio of biotech veterans announced last week that they had closed an $ 85 million biotech fund for Longwood Founders Management." ;
    ns1:documentTitle "Longwood closes $85M biotech fund; FDA greenlights ESC trial for macular degeneration; Gottlieb castigates FDA;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/longwood-closes-85m-biotech-fund-fda-greenlights-esc-trial-for-macular-degeneration> ;
    ns1:foundName "closed",
        "invested" ;
    ns1:name "closed",
        "invested" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2365307/Alnara>,
        <https://1145.am/db/2365307/Longwood_Founders_Management> ;
    ns1:targetName "Alnara" ;
    ns1:valueRaw "$ 16 million",
        "$ 85 million" ;
    ns1:whereRaw "Longwood Founders Management" .

<https://1145.am/db/2365307/Investment_Longwood_Founders_Management_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-03T15:56:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Longwood has invested in Alnara and recently joined a $ 16 million round for Verastem." ;
    ns1:documentTitle "Longwood closes $85M biotech fund; FDA greenlights ESC trial for macular degeneration; Gottlieb castigates FDA;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/longwood-closes-85m-biotech-fund-fda-greenlights-esc-trial-for-macular-degeneration> ;
    ns1:foundName "invested" ;
    ns1:name "invested" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 16 million" ;
    ns1:whereRaw "Longwood Founders Management" .

<https://1145.am/db/2365307/Longwood_Founders_Management> a org:Organization ;
    ns1:documentDate "2011-01-03T15:56:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Longwood closes $85M biotech fund; FDA greenlights ESC trial for macular degeneration; Gottlieb castigates FDA;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/longwood-closes-85m-biotech-fund-fda-greenlights-esc-trial-for-macular-degeneration> ;
    ns1:foundName "Longwood",
        "Longwood Founders Management" ;
    ns1:investor <https://1145.am/db/2365307/Investment_Longwood_Founders_Management_Completed>,
        <https://1145.am/db/2365307/Investment_Longwood_Founders_Management_Has_Not_Happened> ;
    ns1:name "Longwood Founders Management" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365344/Novira_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Radnor" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5207490/about.rdf> ;
    ns1:basedInHighRaw "RADNOR, Pa." ;
    ns1:description "drug discovery" ;
    ns1:documentDate "2011-07-26T19:20:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novira Therapeutics, Inc. Completes Second Round of Seed Financing with Philadelphia Angel Syndicate" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/novira-therapeutics-inc-completes-second-round-of-seed-financing-philadelphia-angel> ;
    ns1:foundName "Novira Therapeutics, Inc." ;
    ns1:industry "drug discovery" ;
    ns1:name "Novira Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2344916/Novira_Therapeutics>,
        <https://1145.am/db/2347776/Novira_Therapeutics>,
        <https://1145.am/db/2359355/Novira_Therapeutics>,
        <https://1145.am/db/2361614/Novira_Therapeutics_Inc>,
        <https://1145.am/db/2367616/Novira> ;
    ns1:sameAsMedium <https://1145.am/db/2332322/Novira_Therapeutics_Inc>,
        <https://1145.am/db/2344915/Novira_Therapeutics>,
        <https://1145.am/db/2344922/Novira_Therapeutics>,
        <https://1145.am/db/2351683/Novira_Therapeutics>,
        <https://1145.am/db/2351684/Novira_Therapeutics_Inc>,
        <https://1145.am/db/2362653/Novira_Therapeutics_Inc>,
        <https://1145.am/db/2367617/Novira_Therapeutics>,
        <https://1145.am/db/2572398/Novira_Therapeutics_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365376/Cevec_Pharmaceuticals> a org:Organization ;
    ns1:basedInHighGeoName "Kln" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6553049/about.rdf> ;
    ns1:basedInHighRaw "Cologne, Germany" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-07-28T11:27:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CEVEC Pharma Raises $8.5 Million to Commercialize Human-Cell Expression Platform for Proteins and Vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cevec-pharma-raises-8-5-million-to-commercialize-human-cell-expression-platform-for> ;
    ns1:foundName "CEVEC Pharma",
        "CEVEC Pharmaceuticals" ;
    ns1:industry "Pharmaceutical",
        "Pharmaceuticals" ;
    ns1:name "CEVEC Pharma",
        "CEVEC Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1081367/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1192310/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1366554/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1396752/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2153295/Curzion_Pharmaceuticals>,
        <https://1145.am/db/2156297/Cerevel>,
        <https://1145.am/db/2285587/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2287377/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2301933/Ecr_Pharmaceuticals>,
        <https://1145.am/db/2301947/Ecr_Pharmaceuticals>,
        <https://1145.am/db/2302649/Ecr_Pharmaceuticals>,
        <https://1145.am/db/2309970/Eurand_Pharmaceuticals>,
        <https://1145.am/db/2311099/Celator_Pharmaceuticals>,
        <https://1145.am/db/2312778/Cerenis>,
        <https://1145.am/db/2313397/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2313471/Celator_Pharmaceuticals>,
        <https://1145.am/db/2314551/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2314554/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2320852/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2320853/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2322242/Cerimon_Pharmaceuticals>,
        <https://1145.am/db/2323370/Cerus>,
        <https://1145.am/db/2326327/Provectus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2328825/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2330539/Celator_Pharmaceuticals>,
        <https://1145.am/db/2338173/Celator_Pharmaceuticals>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2339182/Provectus_Pharmaceuticals>,
        <https://1145.am/db/2343805/Cempra>,
        <https://1145.am/db/2344274/Momenta_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353209/Celator_Pharmaceuticals>,
        <https://1145.am/db/2355936/Celator_Pharmaceuticals>,
        <https://1145.am/db/2355938/Celator_Pharmaceuticals>,
        <https://1145.am/db/2358532/Celator_Pharmaceuticals>,
        <https://1145.am/db/2361666/Celator_Pharmaceuticals>,
        <https://1145.am/db/2364675/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2364774/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2364776/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2365795/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2366302/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2367072/Provectus_Pharmaceuticals>,
        <https://1145.am/db/2367292/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2368333/Celator_Pharmaceuticals>,
        <https://1145.am/db/2537737/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2553248/Cenes_Pharmaceutical>,
        <https://1145.am/db/2569608/clat_Pharmaceuticals>,
        <https://1145.am/db/2574942/Celator_Pharmaceuticals>,
        <https://1145.am/db/958376/Cardior_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365651/Merrimack_Pharmaceuticals> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-04-14T14:31:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merrimack Pharmaceuticals Raises $77 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merrimack-pharmaceuticals-raises-77-million-private-financing> ;
    ns1:foundName "Merrimack Pharmaceuticals",
        "Merrimack Pharmaceuticals, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Merrimack Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2152227/Merrimack_Pharmaceuticals>,
        <https://1145.am/db/2288500/Merrimack_Pharmaceuticals>,
        <https://1145.am/db/2302012/Merrimack_Pharmaceuticals>,
        <https://1145.am/db/2311264/Merrimack_Pharmaceuticals>,
        <https://1145.am/db/2319334/Merrimack>,
        <https://1145.am/db/2326576/Merrimack_Pharmaceuticals>,
        <https://1145.am/db/2328360/Merrimack_Pharmaceuticals>,
        <https://1145.am/db/2341026/Merrimack_Pharmaceuticals>,
        <https://1145.am/db/2352979/Merrimack_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360741/Merrimack_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360862/Merrimack_Pharmaceuticals>,
        <https://1145.am/db/2369080/Merrimack_Pharmaceuticals>,
        <https://1145.am/db/2369082/Merrimack_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2544894/Merrimack_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365826/Dbv_Technologies> a org:Organization ;
    ns1:basedInLowRaw "PARIS" ;
    ns1:description "biotechnology" ;
    ns1:documentDate "2011-01-05T14:22:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DBV Technologies closes $25.5 (19,4) million Series 'C' financing round including new investors InnoBio, Lundbeckfond Ven" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dbv-technologies-closes-25-5-eu19-4-million-series-c-financing-round-including-new> ;
    ns1:foundName "DBV Technologies" ;
    ns1:industry "biotechnology" ;
    ns1:name "DBV Technologies" ;
    ns1:sameAsHigh <https://1145.am/db/1033140/Dbv_Technologies>,
        <https://1145.am/db/1121907/Dbv_Technologies>,
        <https://1145.am/db/1391253/Dbv_Technologies>,
        <https://1145.am/db/2304361/Dbv_Technologies>,
        <https://1145.am/db/2323102/Dbv_Technologies>,
        <https://1145.am/db/2366303/Dbv_Technologies>,
        <https://1145.am/db/2367416/Dbv_Technologies>,
        <https://1145.am/db/2369674/Dbv_Technologies>,
        <https://1145.am/db/2580380/Dbv_Technologies> ;
    ns1:sameAsMedium <https://1145.am/db/2153641/Dbv_Technologies>,
        <https://1145.am/db/2153651/Dbv_Technologies>,
        <https://1145.am/db/2154445/Dbv_Technologies>,
        <https://1145.am/db/2323100/Dbv_Technologies>,
        <https://1145.am/db/2363552/Dbv_Technologies>,
        <https://1145.am/db/2368417/Dbv_Technologies> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366539/Bluebird_Bio> a org:Organization ;
    ns1:description "biotechnology" ;
    ns1:documentDate "2011-04-20T11:04:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team New Financing Will Further A" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/bluebird-bio-secures-additional-30-million-financing-arch-venture-partners-joins-investor> ;
    ns1:foundName "bluebird bio" ;
    ns1:name "bluebird bio" ;
    ns1:sameAsMedium <https://1145.am/db/1333972/Bluebird_Bio>,
        <https://1145.am/db/1334694/Bluebird_Bio>,
        <https://1145.am/db/1540853/Bluebird_Bio>,
        <https://1145.am/db/1624189/Bluebird_Bio>,
        <https://1145.am/db/1624702/Bluebird_Bio>,
        <https://1145.am/db/1651952/Bluebird_Bio>,
        <https://1145.am/db/2154278/Bluebird_Bio>,
        <https://1145.am/db/2286093/Bluebird_Bio>,
        <https://1145.am/db/2335893/Bluebird_Bio>,
        <https://1145.am/db/2336126/Bluebird_Bio>,
        <https://1145.am/db/2338562/Bluebird_Bio>,
        <https://1145.am/db/2343096/Bluebird_Bio>,
        <https://1145.am/db/2343779/Bluebird_Bio>,
        <https://1145.am/db/2345724/Bluebird_Bio>,
        <https://1145.am/db/2349827/Bluebird_Bio>,
        <https://1145.am/db/2354276/Bluebird_Bio>,
        <https://1145.am/db/2358021/Bluebird_Bio>,
        <https://1145.am/db/2360737/Bluebird_Bio>,
        <https://1145.am/db/2360739/Bluebird_Bio>,
        <https://1145.am/db/2362395/Bluebird_Bio>,
        <https://1145.am/db/2785846/Bluebird_Bio>,
        <https://1145.am/db/457403/Bluebird_Bio> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366561/Nextech_Invest> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:description "Pharmaceuticals",
        "private venture round" ;
    ns1:documentDate "2011-04-20T16:19:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TRACON Pharmaceuticals Announces $22 Million Tranched Investment Led by JAFCO and Nextech to Fund TRC105 Phase 2 Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tracon-pharmaceuticals-announces-22-million-tranched-investment-led-by-jafco-and-nextech-to> ;
    ns1:foundName "Nextech",
        "Nextech Invest" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2366561/Investment_Arcus_Ventures_Bhp_Brookline_Investments_Jafco_Nextech_Invest_Tracon_Pharmaceuticals_Completed> ;
    ns1:name "Nextech",
        "Nextech Invest" ;
    ns1:sameAsHigh <https://1145.am/db/2313124/Nextech_Venture_Onc_Partners>,
        <https://1145.am/db/2342771/Nextech_Invest> ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Nextech_Invest>,
        <https://1145.am/db/1247997/Nextech_Invest>,
        <https://1145.am/db/2109798/Nextech_Invest>,
        <https://1145.am/db/2283431/Nextech_Invest>,
        <https://1145.am/db/2285762/Nextech_Invest>,
        <https://1145.am/db/2293667/Nextech_Invest>,
        <https://1145.am/db/2297604/Nextech_Invest>,
        <https://1145.am/db/2298642/Nextech_Invest>,
        <https://1145.am/db/2337294/Nextech_Invest>,
        <https://1145.am/db/2337976/Nextech_Invest>,
        <https://1145.am/db/2342754/Nextech_Invest_Ltd>,
        <https://1145.am/db/2342768/Nextech_Invest_Ltd>,
        <https://1145.am/db/2346197/Nextech_Invest_Ltd>,
        <https://1145.am/db/2346213/Nextech_Invest_Ltd>,
        <https://1145.am/db/2348350/Nextech_Invest>,
        <https://1145.am/db/425281/Nextech_Invest>,
        <https://1145.am/db/426160/Nextech_Invest>,
        <https://1145.am/db/490696/Nextech_Invest>,
        <https://1145.am/db/770684/Nextech_Invest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366561/Tracon_Pharmaceuticals> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2011-04-20T16:19:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TRACON Pharmaceuticals Announces $22 Million Tranched Investment Led by JAFCO and Nextech to Fund TRC105 Phase 2 Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tracon-pharmaceuticals-announces-22-million-tranched-investment-led-by-jafco-and-nextech-to> ;
    ns1:foundName "TRACON Pharmaceuticals",
        "TRACON Pharmaceuticals, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "TRACON Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1318899/Tracon_Pharmaceuticals>,
        <https://1145.am/db/1606145/Tracon_Pharmaceuticals>,
        <https://1145.am/db/2302151/Tracon_Pharmaceuticals>,
        <https://1145.am/db/2307644/Tragara_Pharmaceuticals_Inc>,
        <https://1145.am/db/2319721/Travanti_Pharma>,
        <https://1145.am/db/2319733/Travanti_Pharma_Inc>,
        <https://1145.am/db/2362398/Tracon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2371048/Tracon_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2335837/Tracon_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366744/Aratana_Therapeutics> a org:Organization ;
    ns1:description "animal health" ;
    ns1:documentDate "2011-01-07T14:54:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aratana Therapeutics Announces $20 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-therapeutics-announces-20-million-financing> ;
    ns1:foundName "Aratana Therapeutics" ;
    ns1:industry "animal health" ;
    ns1:name "Aratana Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2337545/Aratana_Therapeutics>,
        <https://1145.am/db/2342737/Aratana_Therapeutics>,
        <https://1145.am/db/2345299/Aratana_Therapeutics>,
        <https://1145.am/db/2345317/Aratana_Therapeutics>,
        <https://1145.am/db/2345318/Aratana_Therapeutics>,
        <https://1145.am/db/2359433/Aratana_Therapeutics_Inc>,
        <https://1145.am/db/2360046/Aratana_Therapeutics>,
        <https://1145.am/db/2363729/Aratana_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2342733/Aratana_Therapeutics>,
        <https://1145.am/db/2359431/Aratana_Therapeutics>,
        <https://1145.am/db/2369239/Aratana_Therapeutics>,
        <https://1145.am/db/2369321/Aratana_Therapeutics>,
        <https://1145.am/db/2585632/Aratana_Therapeutics>,
        <https://1145.am/db/2587577/Aratana_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366753/Canaan_Partners> a org:Organization ;
    ns1:basedInLowRaw "Chelsea" ;
    ns1:documentDate "2011-01-10T12:12:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $20 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/civitas-therapeutics-secures-20-million-series-a-financing> ;
    ns1:foundName "Canaan Partners" ;
    ns1:investor <https://1145.am/db/2366753/Series_A_Investment_Canaan_Partners_Civitas_Therapeutics_Longitude_Capital_Completed> ;
    ns1:name "Canaan Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1043342/Canaan_Partners>,
        <https://1145.am/db/146274/Canaan_Partners>,
        <https://1145.am/db/1695894/Canaan_Partners>,
        <https://1145.am/db/1696766/Canaan_Partners>,
        <https://1145.am/db/1697131/Canaan_Partners>,
        <https://1145.am/db/1702857/Canaan_Partners>,
        <https://1145.am/db/1711633/Canaan_Partners>,
        <https://1145.am/db/1724566/Canaan_Partners>,
        <https://1145.am/db/1734259/Canaan_Partners>,
        <https://1145.am/db/1741014/Canaan_Partners>,
        <https://1145.am/db/1741105/Canaan_Partners>,
        <https://1145.am/db/1741424/Canaan_Partners>,
        <https://1145.am/db/1749744/Canaan_Partners>,
        <https://1145.am/db/1754820/Canaan_Partners>,
        <https://1145.am/db/1768400/Canaan_Partners>,
        <https://1145.am/db/1770648/Canaan_Partners>,
        <https://1145.am/db/1791628/Canaan_Partners>,
        <https://1145.am/db/1792426/Canaan_Partners>,
        <https://1145.am/db/1793543/Canaan_Partners>,
        <https://1145.am/db/1796375/Canaan_Partners>,
        <https://1145.am/db/1814413/Canaan_Partners>,
        <https://1145.am/db/1819543/Canaan_Partners>,
        <https://1145.am/db/1827240/Canaan_Partners>,
        <https://1145.am/db/1829078/Canaan_Partners>,
        <https://1145.am/db/1829544/Canaan_Partners>,
        <https://1145.am/db/1836578/Canaan_Partners>,
        <https://1145.am/db/1842466/Canaan_Partners>,
        <https://1145.am/db/1845119/Canaan_Partners>,
        <https://1145.am/db/1852066/Canaan_Partners>,
        <https://1145.am/db/1858762/Canaan_Partners>,
        <https://1145.am/db/1863401/Canaan_Partners>,
        <https://1145.am/db/1866968/Canaan_Partners>,
        <https://1145.am/db/1894670/Canaan_Partners>,
        <https://1145.am/db/1897255/Canaan_Partners>,
        <https://1145.am/db/1900458/Canaan_Partners>,
        <https://1145.am/db/1906336/Canaan_Partners>,
        <https://1145.am/db/1907151/Canaan_Partners>,
        <https://1145.am/db/1907762/Canaan_Partners>,
        <https://1145.am/db/1910644/Canaan_Partners>,
        <https://1145.am/db/1919135/Canaan_Partners>,
        <https://1145.am/db/1920478/Canaan_Partners>,
        <https://1145.am/db/2164798/Canaan_Partners>,
        <https://1145.am/db/2164838/Canaan_Partners>,
        <https://1145.am/db/2210939/Canaan_Partners>,
        <https://1145.am/db/2238667/Canaan_Partners>,
        <https://1145.am/db/2287025/Canaan_Partners>,
        <https://1145.am/db/2287777/Canaan_Partners>,
        <https://1145.am/db/2297592/Canaan_Partners>,
        <https://1145.am/db/2298642/Canaan_Partners>,
        <https://1145.am/db/2301765/Canaan_Partners>,
        <https://1145.am/db/2304587/Canaan_Partners>,
        <https://1145.am/db/2304605/Canaan_Partners>,
        <https://1145.am/db/2306281/Canaan_Partners>,
        <https://1145.am/db/2308329/Canaan_Partners>,
        <https://1145.am/db/2309376/Canaan_Partners>,
        <https://1145.am/db/2309387/Canaan_Partners>,
        <https://1145.am/db/2313171/Canaan_Partners>,
        <https://1145.am/db/2320925/Canaan_Partners>,
        <https://1145.am/db/2322231/Canaan_Partners>,
        <https://1145.am/db/2329010/Canaan_Partners>,
        <https://1145.am/db/2329011/Canaan_Partners>,
        <https://1145.am/db/2329531/Canaan_Partners>,
        <https://1145.am/db/2332322/Canaan_Partners>,
        <https://1145.am/db/2337958/Canaan_Partners>,
        <https://1145.am/db/2337974/Canaan_Partners>,
        <https://1145.am/db/2346532/Canaan_Partners>,
        <https://1145.am/db/2347469/Canaan_Partners>,
        <https://1145.am/db/2351129/Canaan_Partners>,
        <https://1145.am/db/2351316/Canaan_Partners>,
        <https://1145.am/db/2351684/Canaan_Partners>,
        <https://1145.am/db/2353588/Canaan_Partners>,
        <https://1145.am/db/2353608/Canaan_Partners>,
        <https://1145.am/db/2355043/Canaan_Partners>,
        <https://1145.am/db/2355238/Canaan_Partners>,
        <https://1145.am/db/2355715/Canaan_Partners>,
        <https://1145.am/db/2358378/Canaan_Partners>,
        <https://1145.am/db/2359185/Canaan_Partners>,
        <https://1145.am/db/2360258/Canaan_Partners>,
        <https://1145.am/db/2360266/Canaan_Partners>,
        <https://1145.am/db/2360647/Canaan_Partners>,
        <https://1145.am/db/2363535/Canaan_Partners>,
        <https://1145.am/db/2365700/Canaan_Partners>,
        <https://1145.am/db/2366187/Canaan_Partners>,
        <https://1145.am/db/2368322/Canaan_Partners>,
        <https://1145.am/db/2368973/Canaan_Partners>,
        <https://1145.am/db/2368982/Canaan_Partners>,
        <https://1145.am/db/2370582/Canaan_Partners>,
        <https://1145.am/db/2370802/Canaan_Partners>,
        <https://1145.am/db/2370834/Canaan_Partners>,
        <https://1145.am/db/2572398/Canaan_Partners>,
        <https://1145.am/db/2583466/Canaan_Partners>,
        <https://1145.am/db/2635439/Canaan_Partners>,
        <https://1145.am/db/316299/Canaan_Partners>,
        <https://1145.am/db/319155/Canaan_Partners>,
        <https://1145.am/db/353476/Canaan_Partners>,
        <https://1145.am/db/411041/Canaan_Partners>,
        <https://1145.am/db/523179/Canaan_Partners>,
        <https://1145.am/db/564082/Canaan_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366753/Civitas_Therapeutics> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2011-01-10T12:12:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $20 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/civitas-therapeutics-secures-20-million-series-a-financing> ;
    ns1:foundName "Civitas Therapeutics",
        "Civitas Therapeutics, Inc." ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Civitas Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2336224/Civitas_Therapeutics>,
        <https://1145.am/db/2336227/Civitas_Therapeutics>,
        <https://1145.am/db/2339763/Civitas_Therapeutics>,
        <https://1145.am/db/2348922/Civitas_Therapeutics>,
        <https://1145.am/db/2351129/Civitas_Therapeutics>,
        <https://1145.am/db/2356842/Civitas_Therapeutics>,
        <https://1145.am/db/2356865/Civitas_Therapeutics>,
        <https://1145.am/db/2360266/Civitas_Therapeutics>,
        <https://1145.am/db/2360268/Civitas_Therapeutics>,
        <https://1145.am/db/2366757/Civitas_Therapeutics>,
        <https://1145.am/db/2558109/Civitas_Therapeutics>,
        <https://1145.am/db/2583466/Civitas_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2593166/Civitas_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366984/Acadia_Pharmaceuticals_Inc> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "SAN DIEGO" ;
    ns1:description "Drug discovery and clinical development" ;
    ns1:documentDate "2011-01-10T15:12:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ACADIA Pharmaceuticals, Inc. (ACAD) Announces $15 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/acadia-pharmaceuticals-inc-acad-announces-15-million-private-placement> ;
    ns1:foundName "ACADIA",
        "ACADIA Pharmaceuticals Inc" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "ACADIA Pharmaceuticals Inc",
        "ACADIA Pharmaceuticals Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2284072/Alliance_Pharma>,
        <https://1145.am/db/2321206/Alinea_Pharmaceuticals>,
        <https://1145.am/db/2339203/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2356414/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359583/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362996/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366775/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2368380/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2369296/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2369665/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2369849/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2369866/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2593731/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/443998/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/445086/Acadia_Pharmaceuticals_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1415440/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/1628726/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629475/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2067272/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2307993/Acadia_Pharmaceuticals>,
        <https://1145.am/db/2328713/Acadia_Pharmaceuticals>,
        <https://1145.am/db/2339231/Acadia_Pharmaceuticals>,
        <https://1145.am/db/2352879/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2355156/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2356408/Acadia_Pharmaceuticals>,
        <https://1145.am/db/582290/Acadia_Pharmaceuticals_Inc>,
        <https://1145.am/db/590137/Acadia_Pharmaceuticals_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367022/Bay_City_Capital> a org:Organization ;
    ns1:basedInLowRaw "CUPERTINO" ;
    ns1:documentDate "2011-01-12T12:55:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NextWave Pharmaceuticals Secures $45 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nextwave-pharmaceuticals-secures-45-million-financing> ;
    ns1:foundName "Bay City Capital" ;
    ns1:investor <https://1145.am/db/2367022/Series_C_Investment_Aisling_Capital_Bay_City_Capital_Fidelity_Biosciences_Kearny_Venture_Partners_Nextwave_Pharmaceuticals_Panorama_Capital_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Bay City Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2292334/Bay_City_Capital>,
        <https://1145.am/db/2292353/Bay_City_Capital>,
        <https://1145.am/db/2296810/Bay_City_Capital>,
        <https://1145.am/db/2301824/Bay_City_Capital>,
        <https://1145.am/db/2302897/Bay_City_Capital>,
        <https://1145.am/db/2306568/Bay_City_Capital>,
        <https://1145.am/db/2308713/Bay_City_Capital>,
        <https://1145.am/db/2311570/Bay_City_Capital>,
        <https://1145.am/db/2312435/Bay_City_Capital>,
        <https://1145.am/db/2314492/Bay_City_Capital>,
        <https://1145.am/db/2319822/Bay_City_Capital_Llc>,
        <https://1145.am/db/2319965/Bay_City_Capital>,
        <https://1145.am/db/2320476/Bay_City_Capital>,
        <https://1145.am/db/2324289/Bay_City_Capital>,
        <https://1145.am/db/2326903/Bay_City_Capital>,
        <https://1145.am/db/2329010/Bay_City_Capital>,
        <https://1145.am/db/2329011/Bay_City_Capital>,
        <https://1145.am/db/2331700/Bay_City_Capital>,
        <https://1145.am/db/2331784/Bay_City_Capital>,
        <https://1145.am/db/2336510/Bay_City_Capital>,
        <https://1145.am/db/2336511/Bay_City_Capital>,
        <https://1145.am/db/2337599/Bay_City_Capital>,
        <https://1145.am/db/2342864/Bay_City_Capital>,
        <https://1145.am/db/2346534/Bay_City_Capital>,
        <https://1145.am/db/2350491/Bay_City_Capital>,
        <https://1145.am/db/2351129/Bay_City_Capital>,
        <https://1145.am/db/2356290/Bay_City_Capital>,
        <https://1145.am/db/2357418/Bay_City_Capital>,
        <https://1145.am/db/2358409/Bay_City_Capital>,
        <https://1145.am/db/2359185/Bay_City_Capital>,
        <https://1145.am/db/2360266/Bay_City_Capital>,
        <https://1145.am/db/2367023/Bay_City_Capital>,
        <https://1145.am/db/2367026/Bay_City_Capital>,
        <https://1145.am/db/2583466/Bay_City_Capital>,
        <https://1145.am/db/2588372/Bay_City_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367022/Kearny_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CUPERTINO, Calif" ;
    ns1:documentDate "2011-01-12T12:55:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NextWave Pharmaceuticals Secures $45 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nextwave-pharmaceuticals-secures-45-million-financing> ;
    ns1:foundName "Kearny Venture Partners" ;
    ns1:investor <https://1145.am/db/2367022/Series_C_Investment_Aisling_Capital_Bay_City_Capital_Fidelity_Biosciences_Kearny_Venture_Partners_Nextwave_Pharmaceuticals_Panorama_Capital_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Kearny Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2300697/Kearny_Venture_Partners>,
        <https://1145.am/db/2303695/Kearny_Venture_Partners>,
        <https://1145.am/db/2306529/Kearny_Venture_Partners>,
        <https://1145.am/db/2335764/Kearny_Venture_Partners_Venture_Investors>,
        <https://1145.am/db/2354752/Kearny_Venture_Partners>,
        <https://1145.am/db/2354770/Kearny_Venture_Partners>,
        <https://1145.am/db/2361588/Kearny_Venture_Partners_Venture_Investors_Llc>,
        <https://1145.am/db/2367023/Kearny_Venture_Partners>,
        <https://1145.am/db/2367046/Kearny_Venture_Partners>,
        <https://1145.am/db/2367047/Kearny_Venture_Partners>,
        <https://1145.am/db/2575232/Kearny_Venture_Partners>,
        <https://1145.am/db/2588372/Kearny_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367022/Nextwave_Pharmaceuticals> a org:Organization ;
    ns1:description "developing and commercializing unique products utilizing proprietary drug delivery technology" ;
    ns1:documentDate "2011-01-12T12:55:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NextWave Pharmaceuticals Secures $45 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nextwave-pharmaceuticals-secures-45-million-financing> ;
    ns1:foundName "NextWave Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "NextWave Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/10328/Nextcure>,
        <https://1145.am/db/1152267/Nextcure>,
        <https://1145.am/db/1456096/Nextcure>,
        <https://1145.am/db/2307526/Nextpharma_Technologies_Holding_Limited>,
        <https://1145.am/db/2307529/Nextpharma>,
        <https://1145.am/db/2345013/Nextera>,
        <https://1145.am/db/2346959/Nextwave_Pharmaceuticals>,
        <https://1145.am/db/2357114/Nextcode_Health>,
        <https://1145.am/db/2367023/Nextwave_Pharmaceuticals>,
        <https://1145.am/db/2367026/Nextwave_Pharmaceuticals>,
        <https://1145.am/db/2561121/Nextpharma>,
        <https://1145.am/db/2573707/Nextwave_Pharmaceuticals>,
        <https://1145.am/db/2574687/Nextwave_Pharmaceuticals>,
        <https://1145.am/db/2574691/Nextwave_Pharmaceuticals>,
        <https://1145.am/db/2584210/Nextpharma>,
        <https://1145.am/db/2585908/Nextwave_Pharmaceuticals>,
        <https://1145.am/db/2588372/Nextwave_Pharmaceuticals>,
        <https://1145.am/db/2591101/Nextpharma_Technologies>,
        <https://1145.am/db/522134/Nextcure>,
        <https://1145.am/db/688785/Next_Frontier_Pharmaceuticals>,
        <https://1145.am/db/697733/Next_Frontier_Pharmaceuticals>,
        <https://1145.am/db/776091/Next_Frontier_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367043/Biogen_Idec> a org:Organization ;
    ns1:basedInHighGeoName "Park County",
        "Research",
        "Triangle" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2151718/about.rdf>,
        <https://sws.geonames.org/4790025/about.rdf>,
        <https://sws.geonames.org/5834587/about.rdf> ;
    ns1:basedInHighRaw "Research Triangle Park" ;
    ns1:documentDate "2011-04-26T14:47:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Nanopore raises $41M for DNA sequencing work; Biogen Idec ready to break ground on new manufacturing center;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/oxford-nanopore-raises-41m-for-dna-sequencing-work-biogen-idec-ready-to-break-ground-on-new> ;
    ns1:foundName "Biogen Idec" ;
    ns1:name "Biogen Idec" ;
    ns1:sameAsMedium <https://1145.am/db/2238762/Biogen_Idec>,
        <https://1145.am/db/2243599/Biogen_Idec>,
        <https://1145.am/db/2297083/Biogen_Idec>,
        <https://1145.am/db/2301684/Biogen_Idec_Inc>,
        <https://1145.am/db/2301691/Biogen_Idec>,
        <https://1145.am/db/2301809/Biogen_Idec>,
        <https://1145.am/db/2301844/Biogen_Idec>,
        <https://1145.am/db/2301977/Biogen_Idec_Inc>,
        <https://1145.am/db/2301979/Biogen_Idec_Inc>,
        <https://1145.am/db/2301983/Biogen_Idec>,
        <https://1145.am/db/2302002/Biogen_Idec>,
        <https://1145.am/db/2302112/Biogen_Idec>,
        <https://1145.am/db/2302275/Biogen_Idec>,
        <https://1145.am/db/2303415/Biogen_Idec>,
        <https://1145.am/db/2303604/Biogen_Idec>,
        <https://1145.am/db/2304017/Biogen_Idec_Inc>,
        <https://1145.am/db/2304845/Biogen_Idec>,
        <https://1145.am/db/2304924/Biogen_Idec>,
        <https://1145.am/db/2305209/Biogen_Idec>,
        <https://1145.am/db/2305210/Biogen_Idec>,
        <https://1145.am/db/2305215/Biogen_Idec>,
        <https://1145.am/db/2305804/Biogen_Idec>,
        <https://1145.am/db/2306117/Biogen_Idec>,
        <https://1145.am/db/2306662/Biogen_Idec>,
        <https://1145.am/db/2306935/Biogen_Idec>,
        <https://1145.am/db/2308142/Biogen_Idec>,
        <https://1145.am/db/2310216/Biogen_Idec>,
        <https://1145.am/db/2311233/Biogen_Idec>,
        <https://1145.am/db/2311264/Biogen_Idec>,
        <https://1145.am/db/2311545/Biogen_Idec>,
        <https://1145.am/db/2313448/Biogen_Idec>,
        <https://1145.am/db/2314822/Biogen_Idec>,
        <https://1145.am/db/2316066/Biogen_Idec>,
        <https://1145.am/db/2316356/Biogen_Idec>,
        <https://1145.am/db/2316720/Biogen_Idec>,
        <https://1145.am/db/2317000/Biogen_Idec>,
        <https://1145.am/db/2317136/Biogen_Idec_Inc>,
        <https://1145.am/db/2317505/Biogen_Idec>,
        <https://1145.am/db/2320138/Biogen_Idec>,
        <https://1145.am/db/2325714/Biogen_Idec>,
        <https://1145.am/db/2325717/Biogen_Idec>,
        <https://1145.am/db/2326219/Biogen_Idec>,
        <https://1145.am/db/2328437/Biogen_Idec>,
        <https://1145.am/db/2329776/Biogen_Idec>,
        <https://1145.am/db/2329848/Biogen_Idec>,
        <https://1145.am/db/2332651/Biogen_Idec>,
        <https://1145.am/db/2335838/Biogen_Idec>,
        <https://1145.am/db/2336274/Biogen_Idec>,
        <https://1145.am/db/2336983/Biogen_Idec>,
        <https://1145.am/db/2337745/Biogen_Idec>,
        <https://1145.am/db/2338836/Biogen_Idec>,
        <https://1145.am/db/2340610/Biogen_Idec>,
        <https://1145.am/db/2341549/Biogen_Idec>,
        <https://1145.am/db/2341558/Biogen_Idec>,
        <https://1145.am/db/2345027/Biogen_Idec>,
        <https://1145.am/db/2345999/Biogen_Idec>,
        <https://1145.am/db/2352069/Biogen_Idec>,
        <https://1145.am/db/2352070/Biogen_Idec>,
        <https://1145.am/db/2353066/Biogen_Idec>,
        <https://1145.am/db/2354694/Biogen_Idec>,
        <https://1145.am/db/2354701/Biogen_Idec>,
        <https://1145.am/db/2357123/Biogen_Idec>,
        <https://1145.am/db/2357932/Biogen_Idec>,
        <https://1145.am/db/2358296/Biogen_Idec>,
        <https://1145.am/db/2358301/Biogen_Idec>,
        <https://1145.am/db/2359499/Biogen_Idec>,
        <https://1145.am/db/2359505/Biogen_Idec>,
        <https://1145.am/db/2360274/Biogen_Idec>,
        <https://1145.am/db/2361297/Biogen_Idec>,
        <https://1145.am/db/2361405/Biogen_Idec>,
        <https://1145.am/db/2363538/Biogen_Idec>,
        <https://1145.am/db/2364095/Biogen_Idec>,
        <https://1145.am/db/2364671/Biogen_Idec>,
        <https://1145.am/db/2364672/Biogen_Idec>,
        <https://1145.am/db/2364678/Biogen_Idec>,
        <https://1145.am/db/2364681/Biogen_Idec>,
        <https://1145.am/db/2366338/Biogen_Idec>,
        <https://1145.am/db/2366915/Biogen_Idec>,
        <https://1145.am/db/2541239/Biogen_Idec>,
        <https://1145.am/db/2542993/Biogen_Idec>,
        <https://1145.am/db/2576156/Biogen_Idec>,
        <https://1145.am/db/2577183/Biogen_Idec>,
        <https://1145.am/db/2577184/Biogen_Idec>,
        <https://1145.am/db/2577382/Biogen_Idec>,
        <https://1145.am/db/2578528/Biogen_Idec>,
        <https://1145.am/db/2579483/Biogen_Idec>,
        <https://1145.am/db/2580963/Biogen_Idec>,
        <https://1145.am/db/2581855/Biogen_Idec>,
        <https://1145.am/db/2583839/Biogen_Idec>,
        <https://1145.am/db/2586117/Biogen_Idec>,
        <https://1145.am/db/2586160/Biogen_Idec>,
        <https://1145.am/db/2594877/Biogen_Idec>,
        <https://1145.am/db/2595511/Biogen_Idec>,
        <https://1145.am/db/2595513/Biogen_Idec>,
        <https://1145.am/db/2598449/Biogen_Idec> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367043/Oxford_Nanopore> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "DNA sequencing technology" ;
    ns1:documentDate "2011-04-26T14:47:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Oxford Nanopore raises $41M for DNA sequencing work; Biogen Idec ready to break ground on new manufacturing center;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/oxford-nanopore-raises-41m-for-dna-sequencing-work-biogen-idec-ready-to-break-ground-on-new> ;
    ns1:foundName "Oxford Nanopore" ;
    ns1:name "Oxford Nanopore" ;
    ns1:sameAsHigh <https://1145.am/db/2299566/Oxford_Nanopore_Technologies>,
        <https://1145.am/db/2320930/Oxford_Nanopore_Tech>,
        <https://1145.am/db/2327794/Oxford_Nanopore>,
        <https://1145.am/db/512413/Oxford_Nanopore_Technologies> ;
    ns1:sameAsMedium <https://1145.am/db/2155659/Oxford_Nanopore>,
        <https://1145.am/db/2289181/Oxford_Nanopore>,
        <https://1145.am/db/2299546/Oxford_Nanopore>,
        <https://1145.am/db/2306535/Oxford_Nanopore>,
        <https://1145.am/db/2311595/Oxford_Nanopore>,
        <https://1145.am/db/2322431/Oxford_Nanopore>,
        <https://1145.am/db/314588/Oxford_Nanopore>,
        <https://1145.am/db/323567/Oxford_Nanopore>,
        <https://1145.am/db/446047/Oxford_Nanopore>,
        <https://1145.am/db/460665/Oxford_Nanopore>,
        <https://1145.am/db/477851/Oxford_Nanopore>,
        <https://1145.am/db/522415/Oxford_Nanopore> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367046/Agechem_Venture_Fund> a org:Organization ;
    ns1:basedInLowRaw "OH" ;
    ns1:documentDate "2011-04-26T15:53:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Akebia Completes $22M Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/akebia-completes-22m-series-b-financing> ;
    ns1:foundName "AgeChem",
        "AgeChem Venture Fund" ;
    ns1:investor <https://1145.am/db/2367046/Series_B_Investment_Agechem_Venture_Fund_Akebia_Therapeutics_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Venture_Fund_Sigvion_Capital_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "AgeChem Venture Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2305729/Agechem_Venture_Fund>,
        <https://1145.am/db/2328030/Agechem_Venture_Fund_Lp>,
        <https://1145.am/db/2328034/Agechem_Venture_Fund_Lp>,
        <https://1145.am/db/2345002/Agechem_Venture_Fund>,
        <https://1145.am/db/2346534/Agechem_Venture_Fund>,
        <https://1145.am/db/2346542/Agechem_Venture_Fund>,
        <https://1145.am/db/2354752/Agechem_Venture_Fund>,
        <https://1145.am/db/2354770/Agechem_Venture_Fund>,
        <https://1145.am/db/2358031/Agechem_Venture_Fund>,
        <https://1145.am/db/2367047/Agechem_Venture_Fund>,
        <https://1145.am/db/2575232/Agechem_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367046/Akebia_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Cincinnati" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4508722/about.rdf> ;
    ns1:basedInHighRaw "CINCINNATI, OH" ;
    ns1:description "Pharmaceuticals",
        "pharmaceutical discovery and development" ;
    ns1:documentDate "2011-04-26T15:53:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Akebia Completes $22M Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/akebia-completes-22m-series-b-financing> ;
    ns1:foundName "Akebia",
        "Akebia Therapeutics, Inc." ;
    ns1:industry "pharmaceutical discovery and development" ;
    ns1:name "Akebia",
        "Akebia Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2303695/Akebia_Therapeutics>,
        <https://1145.am/db/2311729/Akebia_Therapeutics>,
        <https://1145.am/db/2340743/Akebia_Therapeutics>,
        <https://1145.am/db/2345827/Akebia_Therapeutics>,
        <https://1145.am/db/2360481/Akebia_Therapeutics>,
        <https://1145.am/db/2361588/Akebia_Therapeutics>,
        <https://1145.am/db/2367047/Akebia_Therapeutics>,
        <https://1145.am/db/791966/Akebia_Therapeutics_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2299413/Akebia_Therapeutics>,
        <https://1145.am/db/2349019/Akebia_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367046/Kearny_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "OH" ;
    ns1:documentDate "2011-04-26T15:53:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Akebia Completes $22M Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/akebia-completes-22m-series-b-financing> ;
    ns1:foundName "Kearny Venture Partners" ;
    ns1:investor <https://1145.am/db/2367046/Series_B_Investment_Agechem_Venture_Fund_Akebia_Therapeutics_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Venture_Fund_Sigvion_Capital_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Kearny Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2300697/Kearny_Venture_Partners>,
        <https://1145.am/db/2303695/Kearny_Venture_Partners>,
        <https://1145.am/db/2306529/Kearny_Venture_Partners>,
        <https://1145.am/db/2335764/Kearny_Venture_Partners_Venture_Investors>,
        <https://1145.am/db/2354752/Kearny_Venture_Partners>,
        <https://1145.am/db/2354770/Kearny_Venture_Partners>,
        <https://1145.am/db/2361588/Kearny_Venture_Partners_Venture_Investors_Llc>,
        <https://1145.am/db/2367022/Kearny_Venture_Partners>,
        <https://1145.am/db/2367023/Kearny_Venture_Partners>,
        <https://1145.am/db/2367047/Kearny_Venture_Partners>,
        <https://1145.am/db/2575232/Kearny_Venture_Partners>,
        <https://1145.am/db/2588372/Kearny_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367046/Novartis_Venture_Fund> a org:Organization ;
    ns1:basedInLowRaw "OH" ;
    ns1:documentDate "2011-04-26T15:53:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Akebia Completes $22M Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/akebia-completes-22m-series-b-financing> ;
    ns1:foundName "Novartis Venture Fund" ;
    ns1:investor <https://1145.am/db/2367046/Series_B_Investment_Agechem_Venture_Fund_Akebia_Therapeutics_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Venture_Fund_Sigvion_Capital_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Novartis Venture Fund" ;
    ns1:sameAsMedium <https://1145.am/db/1340338/Novartis_Venture_Fund>,
        <https://1145.am/db/1523031/Novartis_Venture_Fund>,
        <https://1145.am/db/207823/Novartis_Venture_Fund>,
        <https://1145.am/db/2152422/Novartis_Venture_Fund>,
        <https://1145.am/db/2247240/Novartis_Venture_Funds>,
        <https://1145.am/db/2289983/Novartis_Venture_Funds>,
        <https://1145.am/db/2292300/Novartis_Venture_Funds>,
        <https://1145.am/db/2292345/Novartis_Venture_Funds>,
        <https://1145.am/db/2297795/Novartis_Venture_Funds>,
        <https://1145.am/db/2298176/Novartis_Venture_Fund>,
        <https://1145.am/db/2307682/Novartis_Venture_Fund>,
        <https://1145.am/db/2310905/Novartis_Venture_Fund>,
        <https://1145.am/db/2310907/Novartis_Venture_Fund>,
        <https://1145.am/db/2313438/Novartis_Venture_Fund>,
        <https://1145.am/db/2315943/Novartis_Venture_Fund>,
        <https://1145.am/db/2315957/Novartis_Venture_Fund>,
        <https://1145.am/db/2317737/Novartis_Venture_Fund>,
        <https://1145.am/db/2323210/Novartis_Venture_Funds>,
        <https://1145.am/db/2323228/Novartis_Venture_Fund>,
        <https://1145.am/db/2323682/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2323683/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2326222/Novartis_Venture_Fund>,
        <https://1145.am/db/2327256/Novartis_Venture_Fund>,
        <https://1145.am/db/2327441/Novartis_Venture_Fund>,
        <https://1145.am/db/2327442/Novartis_Venture_Fund>,
        <https://1145.am/db/2330711/Novartis_Venture_Fund>,
        <https://1145.am/db/2331343/Novartis_Venture_Funds>,
        <https://1145.am/db/2331750/Novartis_Venture_Fund>,
        <https://1145.am/db/2331751/Novartis_Venture_Fund>,
        <https://1145.am/db/2332658/Novartis_Venture_Fund>,
        <https://1145.am/db/2332659/Novartis_Venture_Fund>,
        <https://1145.am/db/2335764/Novartis_Venture_Funds>,
        <https://1145.am/db/2336032/Novartis_Venture_Fund>,
        <https://1145.am/db/2336328/Novartis_Venture_Funds>,
        <https://1145.am/db/2337294/Novartis_Venture_Funds>,
        <https://1145.am/db/2337645/Novartis_Venture_Fund>,
        <https://1145.am/db/2338527/Novartis_Venture_Funds>,
        <https://1145.am/db/2339193/Novartis_Venture_Fund>,
        <https://1145.am/db/2339196/Novartis_Venture_Fund>,
        <https://1145.am/db/2340344/Novartis_Venture_Fund>,
        <https://1145.am/db/2340345/Novartis_Venture_Fund>,
        <https://1145.am/db/2340612/Novartis_Venture_Fund>,
        <https://1145.am/db/2340942/Novartis_Venture_Fund>,
        <https://1145.am/db/2343486/Novartis_Venture_Funds>,
        <https://1145.am/db/2343493/Novartis_Venture_Funds>,
        <https://1145.am/db/2343966/Novartis_Venture_Funds>,
        <https://1145.am/db/2344045/Novartis_Venture_Fund>,
        <https://1145.am/db/2348012/Novartis_Venture_Fund>,
        <https://1145.am/db/2348348/Novartis_Venture_Funds>,
        <https://1145.am/db/2348350/Novartis_Venture_Funds>,
        <https://1145.am/db/2351958/Novartis_Venture_Funds>,
        <https://1145.am/db/2351959/Novartis_Venture_Fund>,
        <https://1145.am/db/2352203/Novartis_Venture_Fund>,
        <https://1145.am/db/2352204/Novartis_Venture_Fund>,
        <https://1145.am/db/2352216/Novartis_Venture_Fund>,
        <https://1145.am/db/2353098/Novartis_Venture_Fund>,
        <https://1145.am/db/2356287/Novartis_Venture_Fund>,
        <https://1145.am/db/2356290/Novartis_Venture_Fund>,
        <https://1145.am/db/2356391/Novartis_Venture_Fund>,
        <https://1145.am/db/2356393/Novartis_Venture_Fund>,
        <https://1145.am/db/2356395/Novartis_Venture_Fund>,
        <https://1145.am/db/2356567/Novartis_Venture_Fund>,
        <https://1145.am/db/2358430/Novartis_Venture_Funds>,
        <https://1145.am/db/2358725/Novartis_Venture_Funds>,
        <https://1145.am/db/2358733/Novartis_Venture_Fund>,
        <https://1145.am/db/2361588/Novartis_Venture_Funds>,
        <https://1145.am/db/2362715/Novartis_Venture_Funds>,
        <https://1145.am/db/2363510/Novartis_Venture_Funds>,
        <https://1145.am/db/2363907/Novartis_Venture_Funds>,
        <https://1145.am/db/2369548/Novartis_Venture_Fund>,
        <https://1145.am/db/2551315/Novartis_Venture_Fund>,
        <https://1145.am/db/2570481/Novartis_Venture_Fund>,
        <https://1145.am/db/2570483/Novartis_Venture_Fund>,
        <https://1145.am/db/2578837/Novartis_Venture_Funds>,
        <https://1145.am/db/2592611/Novartis_Venture_Funds>,
        <https://1145.am/db/509733/Novartis_Venture_Fund>,
        <https://1145.am/db/866508/Novartis_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367053/Scout> a org:Organization ;
    ns1:basedInLowRaw "Kentucky" ;
    ns1:description "chemistry professors" ;
    ns1:documentDate "2011-04-27T12:49:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Potential diagnostic test for Alzheimer's would use cerebrospinal fluid" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/potential-diagnostic-test-for-alzheimer-s-would-use-cerebrospinal-fluid> ;
    ns1:foundName "Scout Diagnostics" ;
    ns1:name "Scout" ;
    ns1:sameAsMedium <https://1145.am/db/1373338/Scout>,
        <https://1145.am/db/1374162/Scout>,
        <https://1145.am/db/1376589/Scout>,
        <https://1145.am/db/726097/Scout> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367218/Bb_Biotech_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:documentDate "2011-01-12T20:16:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "VAXIMM Closes a CHF 7.8 Million Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vaximm-closes-a-chf-7-8-million-financing-round> ;
    ns1:foundName "BB Biotech Ventures" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2367218/Investment_Bb_Biotech_Ventures_Biomedpartners_Merck_Kgaa_Merck_Serono_Ventures_Sunstone_Capital_Vaximm_Ag_Completed> ;
    ns1:name "BB Biotech Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2283032/Morningside_Ventures>,
        <https://1145.am/db/2320503/Embl_Ventures>,
        <https://1145.am/db/2327405/Clarus_Ventures>,
        <https://1145.am/db/2343833/Amkey_Ventures>,
        <https://1145.am/db/2344915/Versant_Ventures>,
        <https://1145.am/db/2350917/Versant_Ventures>,
        <https://1145.am/db/2353256/Abs_Ventures>,
        <https://1145.am/db/2362475/Avalon_Ventures>,
        <https://1145.am/db/2362565/Versant_Ventures>,
        <https://1145.am/db/2367201/Google_Ventures>,
        <https://1145.am/db/2556160/Amplitude_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2292345/Bb_Biotech_Ventures>,
        <https://1145.am/db/2293270/Bb_Biotech_Ventures_Iii>,
        <https://1145.am/db/2297795/Bb_Biotech_Ventures>,
        <https://1145.am/db/2298049/Bb_Biotech_Ventures_Iii>,
        <https://1145.am/db/2303009/Bb_Biotech_Ventures>,
        <https://1145.am/db/2306873/Bb_Biotech_Ventures>,
        <https://1145.am/db/2308887/Bb_Biotech_Ventures>,
        <https://1145.am/db/2309845/Bb_Biotech_Ventures>,
        <https://1145.am/db/2311011/Bb_Biotech_Ventures>,
        <https://1145.am/db/2315932/Bb_Biotech_Ventures>,
        <https://1145.am/db/2315934/Bb_Biotech_Ventures>,
        <https://1145.am/db/2318778/Bb_Biotech_Ventures>,
        <https://1145.am/db/2331661/Bb_Biotech_Ventures_Ii>,
        <https://1145.am/db/2331670/Bb_Biotech_Ventures_Ii>,
        <https://1145.am/db/2346204/Bb_Biotech_Ventures>,
        <https://1145.am/db/2348506/Bb_Biotech_Ventures>,
        <https://1145.am/db/2348523/Bb_Biotech_Ventures>,
        <https://1145.am/db/2352172/Bb_Biotech_Ventures>,
        <https://1145.am/db/2352203/Bb_Biotech_Ventures>,
        <https://1145.am/db/2352204/Bb_Biotech_Ventures>,
        <https://1145.am/db/2352216/Bb_Biotech_Ventures>,
        <https://1145.am/db/2358026/Bb_Biotech_Ventures>,
        <https://1145.am/db/2363907/Bb_Biotech_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367218/Biomedpartners> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:documentDate "2011-01-12T20:16:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "VAXIMM Closes a CHF 7.8 Million Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vaximm-closes-a-chf-7-8-million-financing-round> ;
    ns1:foundName "BioMedPartners" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2367218/Investment_Bb_Biotech_Ventures_Biomedpartners_Merck_Kgaa_Merck_Serono_Ventures_Sunstone_Capital_Vaximm_Ag_Completed> ;
    ns1:name "BioMedPartners" ;
    ns1:sameAsHigh <https://1145.am/db/2363593/Biomedpartners> ;
    ns1:sameAsMedium <https://1145.am/db/2324792/Biomedpartners_Ag>,
        <https://1145.am/db/2347574/Biomedpartners_Ag>,
        <https://1145.am/db/2363597/Biomedpartners>,
        <https://1145.am/db/426688/Biomedpartners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367218/Sunstone_Capital> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:documentDate "2011-01-12T20:16:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "VAXIMM Closes a CHF 7.8 Million Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vaximm-closes-a-chf-7-8-million-financing-round> ;
    ns1:foundName "Sunstone Capital" ;
    ns1:investor <https://1145.am/db/2367218/Investment_Bb_Biotech_Ventures_Biomedpartners_Merck_Kgaa_Merck_Serono_Ventures_Sunstone_Capital_Vaximm_Ag_Completed> ;
    ns1:name "Sunstone Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1717714/Sunstone_Capital>,
        <https://1145.am/db/1776660/Sunstone_Capital>,
        <https://1145.am/db/1780157/Sunstone_Capital>,
        <https://1145.am/db/1791743/Sunstone_Capital>,
        <https://1145.am/db/1797413/Sunstone_Capital>,
        <https://1145.am/db/1800466/Sunstone_Capital>,
        <https://1145.am/db/1803787/Sunstone_Capital>,
        <https://1145.am/db/1808488/Sunstone_Capital>,
        <https://1145.am/db/1813404/Sunstone_Capital>,
        <https://1145.am/db/1821174/Sunstone_Capital>,
        <https://1145.am/db/1832434/Sunstone_Capital>,
        <https://1145.am/db/1833000/Sunstone_Capital>,
        <https://1145.am/db/1833646/Sunstone_Capital>,
        <https://1145.am/db/1850593/Sunstone_Capital>,
        <https://1145.am/db/1850760/Sunstone_Capital>,
        <https://1145.am/db/1854996/Sunstone_Capital>,
        <https://1145.am/db/1858818/Sunstone_Capital>,
        <https://1145.am/db/1859597/Sunstone_Capital>,
        <https://1145.am/db/1862019/Sunstone_Capital>,
        <https://1145.am/db/1868935/Sunstone_Capital>,
        <https://1145.am/db/1869517/Sunstone_Capital>,
        <https://1145.am/db/1870079/Sunstone_Capital>,
        <https://1145.am/db/1877786/Sunstone_Capital>,
        <https://1145.am/db/1879213/Sunstone_Capital>,
        <https://1145.am/db/1885147/Sunstone_Capital>,
        <https://1145.am/db/1888954/Sunstone_Capital>,
        <https://1145.am/db/2323700/Sunstone_Capital>,
        <https://1145.am/db/2329919/Sunstone_Capital>,
        <https://1145.am/db/2336622/Sunstone_Capital>,
        <https://1145.am/db/2341942/Sunstone_Capital>,
        <https://1145.am/db/2346452/Sunstone_Capital>,
        <https://1145.am/db/2347980/Sunstone_Capital>,
        <https://1145.am/db/2348003/Sunstone_Capital>,
        <https://1145.am/db/2352203/Sunstone_Capital>,
        <https://1145.am/db/2352204/Sunstone_Capital>,
        <https://1145.am/db/2352216/Sunstone_Capital>,
        <https://1145.am/db/2355609/Sunstone_Capital>,
        <https://1145.am/db/2355841/Sunstone_Capital>,
        <https://1145.am/db/2360127/Sunstone_Capital>,
        <https://1145.am/db/2360922/Sunstone_Capital>,
        <https://1145.am/db/2569491/Sunstone_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367218/Vaximm_Ag> a org:Organization ;
    ns1:basedInHighGeoName "Basel" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2661604/about.rdf> ;
    ns1:basedInHighRaw "Basel, Switzerland" ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:documentDate "2011-01-12T20:16:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "VAXIMM Closes a CHF 7.8 Million Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vaximm-closes-a-chf-7-8-million-financing-round> ;
    ns1:foundName "VAXIMM",
        "VAXIMM AG" ;
    ns1:industry "biotech" ;
    ns1:name "VAXIMM",
        "VAXIMM AG" ;
    ns1:sameAsHigh <https://1145.am/db/214466/Vaxess_Technologies>,
        <https://1145.am/db/2301686/Vaxinnate_Corporation>,
        <https://1145.am/db/2318656/Vaxinnate_Corporation>,
        <https://1145.am/db/2320354/Vaxart>,
        <https://1145.am/db/2337977/Vaxart>,
        <https://1145.am/db/2343852/Vaxart>,
        <https://1145.am/db/2353383/Vaxinnate_Corporation>,
        <https://1145.am/db/2355788/Vaxinnate>,
        <https://1145.am/db/2356866/Vaxinnate>,
        <https://1145.am/db/2362743/Vaxinnate_Corporation>,
        <https://1145.am/db/2365140/Vaxdesign>,
        <https://1145.am/db/2370019/Vaxart>,
        <https://1145.am/db/2553393/Vaxart>,
        <https://1145.am/db/2559922/Vaxart>,
        <https://1145.am/db/2580690/Vaxinnate_Corporation>,
        <https://1145.am/db/422783/Vaxart>,
        <https://1145.am/db/830323/Vaxart_Inc>,
        <https://1145.am/db/883423/Vaximm> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2577419/Alcon> a org:Organization ;
    ns1:description "eye care" ;
    ns1:documentDate "2010-12-23T12:50:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dealmaking goes from mega to mini" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dealmaking-goes-from-mega-to-mini> ;
    ns1:foundName "Alcon" ;
    ns1:industry "eye care" ;
    ns1:name "Alcon" ;
    ns1:sameAsHigh <https://1145.am/db/1077454/Alcon>,
        <https://1145.am/db/1078071/Alcon>,
        <https://1145.am/db/1294499/Alcon>,
        <https://1145.am/db/1294506/Alcon>,
        <https://1145.am/db/1295948/Alcon>,
        <https://1145.am/db/1296487/Alcon>,
        <https://1145.am/db/1520596/Alcon>,
        <https://1145.am/db/1520597/Alcon>,
        <https://1145.am/db/1521695/Alcon>,
        <https://1145.am/db/2291606/Alcon>,
        <https://1145.am/db/2293419/Alcon>,
        <https://1145.am/db/2305192/Alcon>,
        <https://1145.am/db/2308298/Alcon>,
        <https://1145.am/db/2314943/Alcon>,
        <https://1145.am/db/2314947/Alcon>,
        <https://1145.am/db/2321067/Alcon_Inc>,
        <https://1145.am/db/2360683/Alcon>,
        <https://1145.am/db/2552258/Alcon>,
        <https://1145.am/db/2553276/Alcon>,
        <https://1145.am/db/2553634/Alcon>,
        <https://1145.am/db/2572713/Alcon>,
        <https://1145.am/db/2573611/Alcon>,
        <https://1145.am/db/2575488/Alcon>,
        <https://1145.am/db/2579507/Alcon>,
        <https://1145.am/db/2579519/Alcon>,
        <https://1145.am/db/2580401/Alcon>,
        <https://1145.am/db/2581378/Alcon>,
        <https://1145.am/db/2581394/Alcon>,
        <https://1145.am/db/2582355/Alcon>,
        <https://1145.am/db/2582395/Alcon_Stock>,
        <https://1145.am/db/2582400/Alcon>,
        <https://1145.am/db/2582402/Alcon>,
        <https://1145.am/db/2584359/Alcon>,
        <https://1145.am/db/2587805/Alcon>,
        <https://1145.am/db/2590349/Alcon>,
        <https://1145.am/db/2594604/Alcon>,
        <https://1145.am/db/2598636/Alcon>,
        <https://1145.am/db/600939/Alcon>,
        <https://1145.am/db/600941/Alcon>,
        <https://1145.am/db/744985/Alcon> ;
    ns1:sameAsMedium <https://1145.am/db/1078074/Alcon_Inc>,
        <https://1145.am/db/1084233/Alcon_Inc>,
        <https://1145.am/db/1085993/Alcon_Inc>,
        <https://1145.am/db/1196175/Alcon_Inc>,
        <https://1145.am/db/1371279/Alcon_Inc>,
        <https://1145.am/db/1417348/Alcon_Inc>,
        <https://1145.am/db/1418572/Alcon_Inc>,
        <https://1145.am/db/1430057/Alcon_Inc>,
        <https://1145.am/db/1443334/Alcon>,
        <https://1145.am/db/1540449/Alcon_Inc>,
        <https://1145.am/db/2279276/Alcon>,
        <https://1145.am/db/2279686/Alcon>,
        <https://1145.am/db/2293431/Alcon>,
        <https://1145.am/db/2298871/Alcon>,
        <https://1145.am/db/2298902/Alcon>,
        <https://1145.am/db/2299847/Alcon>,
        <https://1145.am/db/2311754/Alcon>,
        <https://1145.am/db/2323188/Alcon>,
        <https://1145.am/db/2345114/Alcon_Inc>,
        <https://1145.am/db/2367207/Alcon>,
        <https://1145.am/db/2547283/Alcon>,
        <https://1145.am/db/2549760/Alcon>,
        <https://1145.am/db/2551680/Alcon>,
        <https://1145.am/db/2559797/Alcon>,
        <https://1145.am/db/2561268/Alcon>,
        <https://1145.am/db/2581397/Alcon>,
        <https://1145.am/db/2586661/Alcon>,
        <https://1145.am/db/2590140/Alcon>,
        <https://1145.am/db/2593443/Alcon>,
        <https://1145.am/db/2595924/Alcon_Inc>,
        <https://1145.am/db/2597135/Alcon> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2577419/Alcon_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2010-12-23T12:50:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The year's biggest deal-Novartis' ($ NVS) majority-stake buyout of Alcon ($ ACL) -was almost the exception that proved the rule." ;
    ns1:documentTitle "Dealmaking goes from mega to mini" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dealmaking-goes-from-mega-to-mini> ;
    ns1:foundName "buy" ;
    ns1:name "buy" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2577419/Alcon> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Alcon" ;
    ns1:valueRaw "$ 12.9 billion",
        "$ 28.1 billion" .

<https://1145.am/db/2577419/Biovail> a org:Organization ;
    ns1:documentDate "2010-12-23T12:50:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dealmaking goes from mega to mini" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dealmaking-goes-from-mega-to-mini> ;
    ns1:foundName "Biovail" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Biovail" ;
    ns1:protagonist <https://1145.am/db/2577419/Merger_Biovail_Valeant_Pharmaceuticals_Completed>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/1004139/Entrechem_Sl>,
        <https://1145.am/db/101302/Biotec_Pharmacon_Asa>,
        <https://1145.am/db/1037440/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/1043614/Pharmajet>,
        <https://1145.am/db/1046013/Pharmajet>,
        <https://1145.am/db/108359/Biogen_Inc>,
        <https://1145.am/db/1182119/Pharnext_Sa>,
        <https://1145.am/db/1196435/Infinity_Biologix_Llc>,
        <https://1145.am/db/1198542/Infinity_Biologix_Llc>,
        <https://1145.am/db/1263299/Biolab>,
        <https://1145.am/db/1265716/Bioivt>,
        <https://1145.am/db/1270730/Bioasis_Technologies_Inc>,
        <https://1145.am/db/1319248/Think_Bioscience>,
        <https://1145.am/db/1321358/Ichor_Life_Sciences>,
        <https://1145.am/db/1325997/Biopharma_Global>,
        <https://1145.am/db/1337532/Bioivt>,
        <https://1145.am/db/1345925/Innovation1_Biotech_Inc>,
        <https://1145.am/db/1376181/Flagship_Biosciences>,
        <https://1145.am/db/1380463/Vicapsys_Life_Sciences_Inc>,
        <https://1145.am/db/1397594/Rectify_Pharmaceuticals_Inc>,
        <https://1145.am/db/1402913/Biogen>,
        <https://1145.am/db/1405080/Ochre_Bio>,
        <https://1145.am/db/1406734/Bioneex>,
        <https://1145.am/db/1408996/Ochre_Bio>,
        <https://1145.am/db/1418668/Simcere_Pharmaceuticals>,
        <https://1145.am/db/1490051/Biogen>,
        <https://1145.am/db/1494850/Biogen_Inc>,
        <https://1145.am/db/1507989/Bionomics>,
        <https://1145.am/db/1522097/Bionomics_Limited>,
        <https://1145.am/db/1523985/Biocorrx_Pharmaceuticals_Inc>,
        <https://1145.am/db/1531806/Lifecore_Biomedical>,
        <https://1145.am/db/1545261/Cardior_Pharmaceuticals>,
        <https://1145.am/db/1563797/Be_Biopharma>,
        <https://1145.am/db/1576268/Bioasis_Technologies_Inc>,
        <https://1145.am/db/1619442/Hightide>,
        <https://1145.am/db/1628791/Atai_Life_Sciences>,
        <https://1145.am/db/1630569/Lifecore_Biomedical_Inc>,
        <https://1145.am/db/1659339/Biocon>,
        <https://1145.am/db/1680653/149_Bio>,
        <https://1145.am/db/1935113/Provention_Bio_Inc>,
        <https://1145.am/db/1957460/Pardes_Biosciences_Inc>,
        <https://1145.am/db/1979877/Biocon_Ltd>,
        <https://1145.am/db/1981295/Rectify_Pharmaceuticals_Inc>,
        <https://1145.am/db/1988637/Iveric_Bio>,
        <https://1145.am/db/1988943/Iveric_Bio_Inc>,
        <https://1145.am/db/2003152/Pharmacyte>,
        <https://1145.am/db/2004568/Medincell>,
        <https://1145.am/db/2017278/Erytech_Pharma>,
        <https://1145.am/db/2021869/Abionyx_Pharma>,
        <https://1145.am/db/2036830/Biogen>,
        <https://1145.am/db/2037970/Erytech_Pharma>,
        <https://1145.am/db/2056049/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2067011/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2090091/Concord_Biotech>,
        <https://1145.am/db/2152658/Atea_Pharmaceuticals>,
        <https://1145.am/db/2153005/Genentech>,
        <https://1145.am/db/2154198/Attune_Pharmaceuticals>,
        <https://1145.am/db/2154706/Biotage>,
        <https://1145.am/db/2155042/The_Medicines_Company>,
        <https://1145.am/db/2156114/X4_Pharmaceuticals>,
        <https://1145.am/db/2223218/United_Biosource_Corporation>,
        <https://1145.am/db/2230917/Scifluor_Life_Sciences>,
        <https://1145.am/db/2242573/Pharmarc>,
        <https://1145.am/db/2243599/Biogen_Idec>,
        <https://1145.am/db/2254330/Pharmathene>,
        <https://1145.am/db/2280215/Atea_Pharmaceuticals>,
        <https://1145.am/db/2280231/D___D_Pharmatech>,
        <https://1145.am/db/2280769/Iveric_Bio>,
        <https://1145.am/db/2282241/Be_Biopharma>,
        <https://1145.am/db/2282756/Isa_Pharmaceuticals>,
        <https://1145.am/db/2283468/Biohaven>,
        <https://1145.am/db/2284603/Biotech>,
        <https://1145.am/db/2285239/Bio>,
        <https://1145.am/db/2286092/Be_Biopharma>,
        <https://1145.am/db/2286404/Enthera_Pharmaceuticals>,
        <https://1145.am/db/2288191/Pharmaron>,
        <https://1145.am/db/2290480/Entera_Bio>,
        <https://1145.am/db/2291446/Roivant_Sciences>,
        <https://1145.am/db/2293310/Biogen>,
        <https://1145.am/db/2293696/Provention_Bio>,
        <https://1145.am/db/2295048/Proclara_Biosciences>,
        <https://1145.am/db/2296016/Ds_Biopharma>,
        <https://1145.am/db/2298167/Aetion>,
        <https://1145.am/db/2300489/Roivant_Sciences>,
        <https://1145.am/db/2301083/Biolinerx>,
        <https://1145.am/db/2301537/Proclara_Biosciences>,
        <https://1145.am/db/2301767/Bioxell_Spa>,
        <https://1145.am/db/2301820/Sciele_Pharma>,
        <https://1145.am/db/2301844/Biogen_Idec>,
        <https://1145.am/db/2302715/Biomimetic_Therapeutics>,
        <https://1145.am/db/2302897/Sagamore_Bioventures>,
        <https://1145.am/db/2303025/Profectus_Biosciences>,
        <https://1145.am/db/2303208/Biomarin_Pharmaceutical>,
        <https://1145.am/db/2303357/Biocon>,
        <https://1145.am/db/2303415/Biogen_Idec>,
        <https://1145.am/db/2303502/Accutest_Research_Laboratories>,
        <https://1145.am/db/2303937/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2304165/Bioclinica>,
        <https://1145.am/db/2304628/Bioreliance>,
        <https://1145.am/db/2304829/Pharming_Group_Nv>,
        <https://1145.am/db/2304919/Biovail>,
        <https://1145.am/db/2305020/Biodelivery>,
        <https://1145.am/db/2305559/Via_Pharmaceuticals>,
        <https://1145.am/db/2305822/D-Pharm>,
        <https://1145.am/db/2305956/Biotrove>,
        <https://1145.am/db/2306113/Pharming>,
        <https://1145.am/db/2306117/Biogen_Idec>,
        <https://1145.am/db/2306160/Pharminox_Limited>,
        <https://1145.am/db/2306464/Bioseek>,
        <https://1145.am/db/2306935/Biogen_Idec>,
        <https://1145.am/db/2307579/Biovectra>,
        <https://1145.am/db/2308761/Biolinerx>,
        <https://1145.am/db/2308916/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2309484/Biovail_Corporation>,
        <https://1145.am/db/230953/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2309736/Bioclinica>,
        <https://1145.am/db/2309970/Biomarin_Pharmaceutical>,
        <https://1145.am/db/2311264/Biogen_Idec>,
        <https://1145.am/db/2311476/Bioclinica>,
        <https://1145.am/db/2312358/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2313765/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2314230/Sciele_Pharma>,
        <https://1145.am/db/2314546/Combinature_Biopharm>,
        <https://1145.am/db/2314683/Pharming_Group_Nv>,
        <https://1145.am/db/2314688/Pharming_Group>,
        <https://1145.am/db/2315632/Synthetech>,
        <https://1145.am/db/2315688/Biovitrum>,
        <https://1145.am/db/2316356/Biogen_Idec>,
        <https://1145.am/db/2316481/Life_Technologies>,
        <https://1145.am/db/2316720/Biogen_Idec>,
        <https://1145.am/db/2316915/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2317508/Biovail>,
        <https://1145.am/db/2317680/Sciele_Pharma>,
        <https://1145.am/db/2318404/Almirall>,
        <https://1145.am/db/2318581/Sciele_Pharma>,
        <https://1145.am/db/2318644/Biovail_Corporation>,
        <https://1145.am/db/2318658/Biovail_Corporation>,
        <https://1145.am/db/2318658/Biovail_International_Laboratories_Srl>,
        <https://1145.am/db/2318766/Sciele>,
        <https://1145.am/db/2319577/Genentech>,
        <https://1145.am/db/2319587/Bioclinica>,
        <https://1145.am/db/2320110/Biovail>,
        <https://1145.am/db/2320163/Berna_Biotech>,
        <https://1145.am/db/2320648/Bioclinica>,
        <https://1145.am/db/2321134/Biomira>,
        <https://1145.am/db/2321911/Biovail_Corporation>,
        <https://1145.am/db/2322089/Biovail_Corporation>,
        <https://1145.am/db/2322091/Biovail>,
        <https://1145.am/db/2322093/Biovail>,
        <https://1145.am/db/2322189/Genentech>,
        <https://1145.am/db/2322201/Genentech>,
        <https://1145.am/db/2322295/Topgen_Esv>,
        <https://1145.am/db/2322805/Clinipace>,
        <https://1145.am/db/2322850/Clinipace>,
        <https://1145.am/db/2323097/Biovitrum_Ab>,
        <https://1145.am/db/2324079/Biostorage_Technologies>,
        <https://1145.am/db/2324234/Biothorpe_Pharmaceuticals>,
        <https://1145.am/db/2324755/Biomarin>,
        <https://1145.am/db/2326031/Bioclinica>,
        <https://1145.am/db/2326186/Sciele_Pharma>,
        <https://1145.am/db/2326815/Biovail_Corporation>,
        <https://1145.am/db/2326817/Biovail>,
        <https://1145.am/db/2326895/Biovitrum>,
        <https://1145.am/db/2327243/Bioenvision>,
        <https://1145.am/db/2328960/Biodel_Inc>,
        <https://1145.am/db/2328998/Via_Pharmaceuticals>,
        <https://1145.am/db/2330549/Celator_Pharmaceuticals>,
        <https://1145.am/db/2330782/Pharminggroup_Nv>,
        <https://1145.am/db/2330990/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2331044/Genentech>,
        <https://1145.am/db/2331511/Bioclinica>,
        <https://1145.am/db/2331622/Bioprocessors_Corporation>,
        <https://1145.am/db/2331991/Atrium_Biotechnologies>,
        <https://1145.am/db/2332200/Life_Technologies>,
        <https://1145.am/db/233261/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2332847/Atrium_Biotechnologies_Inc>,
        <https://1145.am/db/2333447/Eresearch_Technology>,
        <https://1145.am/db/2334032/Biooutsource>,
        <https://1145.am/db/2334133/Biorexis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2334181/Pharming>,
        <https://1145.am/db/2334589/Bioclinica>,
        <https://1145.am/db/2335029/Bioclinica>,
        <https://1145.am/db/2336028/Biolinerx>,
        <https://1145.am/db/2336041/Bioset>,
        <https://1145.am/db/2336113/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2336259/Coherus_Biosciences>,
        <https://1145.am/db/2337080/Medistem_Inc>,
        <https://1145.am/db/2337420/Chs_Pharma_Inc>,
        <https://1145.am/db/2338836/Biogen_Idec>,
        <https://1145.am/db/2340015/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340213/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340286/Pharmasset>,
        <https://1145.am/db/2340402/Biolinerx>,
        <https://1145.am/db/2341010/Lfb_Biotechnologies>,
        <https://1145.am/db/2341165/Pharmasset>,
        <https://1145.am/db/2342188/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342800/Theraclone_Sciences>,
        <https://1145.am/db/2342805/Theraclone_Sciences>,
        <https://1145.am/db/2343628/Galecto_Biotech_Ab>,
        <https://1145.am/db/2343817/Biomotiv>,
        <https://1145.am/db/2344078/Pharmathene>,
        <https://1145.am/db/2344192/Biologics>,
        <https://1145.am/db/2344318/Theraclone_Sciences>,
        <https://1145.am/db/2344560/Dmi_Biosciences_Inc>,
        <https://1145.am/db/2344940/Biodelivery_Sciences_International>,
        <https://1145.am/db/2345508/Pevion_Biotech_Ltd>,
        <https://1145.am/db/2346347/Biospecifics_Technologies_Corp>,
        <https://1145.am/db/2347256/Biocis_Pharma_Oy>,
        <https://1145.am/db/2347768/Biothera>,
        <https://1145.am/db/2347792/Biomarin>,
        <https://1145.am/db/2347799/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2348159/Biocon>,
        <https://1145.am/db/2348440/Cerulean_Pharma>,
        <https://1145.am/db/2348522/Am-Pharma>,
        <https://1145.am/db/2348776/Genentech>,
        <https://1145.am/db/2348923/Biothera>,
        <https://1145.am/db/2349891/Bioclinica>,
        <https://1145.am/db/2350127/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350245/Biodelivery_Sciences_International>,
        <https://1145.am/db/2351103/Genentech>,
        <https://1145.am/db/2351826/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2352246/Genentech>,
        <https://1145.am/db/2352261/Biodelivery_Sciences_International>,
        <https://1145.am/db/2353157/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2353325/Am-Pharma>,
        <https://1145.am/db/2353337/Am-Pharma>,
        <https://1145.am/db/2353644/Bionovo_Inc>,
        <https://1145.am/db/2353663/Biotie>,
        <https://1145.am/db/2353771/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2353789/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2353951/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/2353974/Acesion_Pharma>,
        <https://1145.am/db/2354079/Pharming>,
        <https://1145.am/db/2354084/Pharming_Group>,
        <https://1145.am/db/2354589/Biogen>,
        <https://1145.am/db/2354987/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2355177/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2355667/Pharmasset>,
        <https://1145.am/db/2356073/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2356186/Biothera>,
        <https://1145.am/db/2356597/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2356599/Biomarin>,
        <https://1145.am/db/2356945/Biovail_Laboratories_International_Srl>,
        <https://1145.am/db/2357049/Theravance>,
        <https://1145.am/db/2357068/Theravance_Inc>,
        <https://1145.am/db/2357123/Biogen_Idec>,
        <https://1145.am/db/2357508/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2358167/Alexion_Pharmaceuticals>,
        <https://1145.am/db/2358612/Bioclinica>,
        <https://1145.am/db/2358763/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2359141/Bioclinica>,
        <https://1145.am/db/2359286/Axim_Biotechnologies>,
        <https://1145.am/db/2360257/Aldea_Pharmaceuticals>,
        <https://1145.am/db/2360710/Xbiotech>,
        <https://1145.am/db/2360719/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/2360960/Pharmarc>,
        <https://1145.am/db/2361646/Biomarin>,
        <https://1145.am/db/2361667/Diamedica>,
        <https://1145.am/db/2361850/Provectus_Pharmaceuticals>,
        <https://1145.am/db/2362027/Biotie_Therapeutics>,
        <https://1145.am/db/2362341/Biontech_Ag>,
        <https://1145.am/db/2362901/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2363699/Prism_Pharma>,
        <https://1145.am/db/2364095/Biogen_Idec>,
        <https://1145.am/db/2364364/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364671/Biogen_Idec>,
        <https://1145.am/db/2364672/Biogen_Idec>,
        <https://1145.am/db/2364678/Biogen_Idec>,
        <https://1145.am/db/2364813/Biomarin>,
        <https://1145.am/db/2365199/Biovail>,
        <https://1145.am/db/2365200/Biovail>,
        <https://1145.am/db/2366353/Biodelivery_Sciences_International>,
        <https://1145.am/db/2366651/Pharming_Group_Nv>,
        <https://1145.am/db/2366688/Pharmagap_Inc>,
        <https://1145.am/db/2366933/Lux_Biosciences>,
        <https://1145.am/db/2367158/Lux_Biosciences>,
        <https://1145.am/db/2367182/Biotica>,
        <https://1145.am/db/2367612/Biota_Pharmaceuticals>,
        <https://1145.am/db/2368283/Eligo_Bioscience>,
        <https://1145.am/db/2368369/Biodelivery_Sciences_International>,
        <https://1145.am/db/2368429/Biodelivery_Sciences_International>,
        <https://1145.am/db/2368439/Biodelivery_Sciences_International>,
        <https://1145.am/db/2368457/Axovant_Sciences>,
        <https://1145.am/db/2368754/Biodelivery_Sciences_International>,
        <https://1145.am/db/2369234/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/2369490/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2369860/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2370706/Amo_Pharma>,
        <https://1145.am/db/2371179/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2371314/Genentech>,
        <https://1145.am/db/239789/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2537484/Sciele>,
        <https://1145.am/db/2538019/Biovitrum>,
        <https://1145.am/db/2540240/Biogen>,
        <https://1145.am/db/2541239/Biogen_Idec>,
        <https://1145.am/db/2541294/Ark_Biosciences>,
        <https://1145.am/db/2541703/A___C_Bio>,
        <https://1145.am/db/2543106/Biocon>,
        <https://1145.am/db/2543334/Mabspace_Biosciences>,
        <https://1145.am/db/2543721/Biocon_Biologics>,
        <https://1145.am/db/2543962/Quotient_Sciences>,
        <https://1145.am/db/2545015/Biovail>,
        <https://1145.am/db/2546113/Biodelivery_Sciences_International>,
        <https://1145.am/db/2546153/Coherus_Biosciences>,
        <https://1145.am/db/2547550/Bio_Pure_Technology>,
        <https://1145.am/db/2548022/Jsc_Biosintez>,
        <https://1145.am/db/2548151/Biocon>,
        <https://1145.am/db/2549670/Genentech>,
        <https://1145.am/db/2550148/Organon_Biosciences>,
        <https://1145.am/db/2550232/Xcelience>,
        <https://1145.am/db/2550837/Biohaven>,
        <https://1145.am/db/2551030/Biological_E>,
        <https://1145.am/db/2551075/Biosims>,
        <https://1145.am/db/2553491/Biomarin>,
        <https://1145.am/db/2553835/Biovail>,
        <https://1145.am/db/2559286/Biocon_Biologics>,
        <https://1145.am/db/2559490/Iveric_Bio>,
        <https://1145.am/db/2560880/Biovail>,
        <https://1145.am/db/2563423/Anthera_Pharmaceuticals>,
        <https://1145.am/db/2566088/Stellar_Biotechnologies>,
        <https://1145.am/db/2567129/Biocon_Biologics>,
        <https://1145.am/db/2567727/Biocon>,
        <https://1145.am/db/2567935/Medsenic>,
        <https://1145.am/db/2568444/Biogen>,
        <https://1145.am/db/2573593/Biotica>,
        <https://1145.am/db/2575552/Biovail>,
        <https://1145.am/db/2575644/Biodelivery_Sciences_International>,
        <https://1145.am/db/2576156/Biogen_Idec>,
        <https://1145.am/db/2580337/Biodelivery_Sciences_International>,
        <https://1145.am/db/2581394/Biocon>,
        <https://1145.am/db/2581855/Biogen_Idec>,
        <https://1145.am/db/2583414/Bioton>,
        <https://1145.am/db/2583783/Biomarin>,
        <https://1145.am/db/2585066/Advanced_Bio-Technologies>,
        <https://1145.am/db/2586160/Biogen_Idec>,
        <https://1145.am/db/2587981/Biochem>,
        <https://1145.am/db/2588178/Biovail>,
        <https://1145.am/db/2588378/Enlight_Biosciences>,
        <https://1145.am/db/2591550/Genentech>,
        <https://1145.am/db/2593529/Pharmstandard>,
        <https://1145.am/db/2593831/Biovail>,
        <https://1145.am/db/2594877/Biogen_Idec>,
        <https://1145.am/db/2595511/Biogen_Idec>,
        <https://1145.am/db/2595561/Biomarin_Pharmaceutical>,
        <https://1145.am/db/2597220/Biological_E>,
        <https://1145.am/db/2598558/Biovail>,
        <https://1145.am/db/2798422/Biomarin_Pharmaceutical>,
        <https://1145.am/db/291851/Altasciences>,
        <https://1145.am/db/317345/Realta_Life_Sciences>,
        <https://1145.am/db/345698/Flagship_Biosciences>,
        <https://1145.am/db/426688/Cardior_Pharmaceuticals>,
        <https://1145.am/db/427181/Cellect_Biotechnology_Ltd>,
        <https://1145.am/db/453079/Infinity_Pharmaceuticals>,
        <https://1145.am/db/486464/Aadi_Bioscience>,
        <https://1145.am/db/488591/Be_Biopharma>,
        <https://1145.am/db/522502/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/545988/Rectify_Pharmaceuticals>,
        <https://1145.am/db/556149/D___D_Pharmatech_Inc>,
        <https://1145.am/db/583231/D___D_Pharmatech>,
        <https://1145.am/db/662958/Biocina>,
        <https://1145.am/db/665573/Abionyx_Pharma>,
        <https://1145.am/db/674262/Abionyx_Pharma>,
        <https://1145.am/db/678224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/685681/Biocon_Ltd>,
        <https://1145.am/db/709723/Pardes_Biosciences>,
        <https://1145.am/db/712921/Replicel_Life_Sciences_Inc>,
        <https://1145.am/db/714643/Achieve_Life_Sciences>,
        <https://1145.am/db/722194/Biogen_Inc>,
        <https://1145.am/db/724168/Biogen_Inc>,
        <https://1145.am/db/726160/Biogen_Inc>,
        <https://1145.am/db/731137/Altasciences>,
        <https://1145.am/db/734635/Altasciences>,
        <https://1145.am/db/736861/Bionomics>,
        <https://1145.am/db/739339/Iveric_Bio>,
        <https://1145.am/db/832408/Biodelivery_Sciences_International>,
        <https://1145.am/db/833269/Biodelivery_Sciences_International>,
        <https://1145.am/db/840678/Gt_Biopharma>,
        <https://1145.am/db/862305/Biocon_Biologics>,
        <https://1145.am/db/862305/Biocon_Ltd>,
        <https://1145.am/db/866237/Cardior_Pharmaceuticals>,
        <https://1145.am/db/882284/Biofrontera_Inc>,
        <https://1145.am/db/901032/Achieve_Life_Sciences>,
        <https://1145.am/db/906534/Kither_Biotech>,
        <https://1145.am/db/926227/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/966626/Biogen>,
        <https://1145.am/db/973736/Biocorrx_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2305797/Biovail_Corporation>,
        <https://1145.am/db/2325321/Biovail>,
        <https://1145.am/db/2325331/Biovail_Corporation>,
        <https://1145.am/db/2325357/Biovail>,
        <https://1145.am/db/2544567/Biovail> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2577419/Chattem> a org:Organization ;
    ns1:basedInHighGeoName "United States" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:basedInHighRaw "U.S." ;
    ns1:description "consumer products" ;
    ns1:documentDate "2010-12-23T12:50:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dealmaking goes from mega to mini" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dealmaking-goes-from-mega-to-mini> ;
    ns1:foundName "Chattem" ;
    ns1:industry "consumer products" ;
    ns1:name "Chattem" ;
    ns1:sameAsMedium <https://1145.am/db/2304313/Chattem_Inc>,
        <https://1145.am/db/2322509/Chattem>,
        <https://1145.am/db/2562230/Chattem>,
        <https://1145.am/db/2579485/Chattem>,
        <https://1145.am/db/2579503/Chattem>,
        <https://1145.am/db/2581045/Chattem>,
        <https://1145.am/db/2582442/Chattem_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2577419/Chattem_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2010-12-23T12:50:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "So while Pfizer ($ PFE) and Merck ($ MRK) and Roche worked to integrate Wyeth and Schering-Plough and Genentech ($ DNA) , respectively, Sanofi-Aventis ($ SNY) snapped up the U.S. consumer products company Chattem for $ 1.9 billion and a Chinese consumer drugs company for $ 520 million." ;
    ns1:documentTitle "Dealmaking goes from mega to mini" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dealmaking-goes-from-mega-to-mini> ;
    ns1:foundName "snapped up" ;
    ns1:name "snapped up" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2577419/Chattem> ;
    ns1:targetName "Chattem" ;
    ns1:valueRaw "$ 1.9 billion",
        "$ 520 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S" .

<https://1145.am/db/2577419/Valeant_Pharmaceuticals> a org:Organization ;
    ns1:documentDate "2010-12-23T12:50:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dealmaking goes from mega to mini" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dealmaking-goes-from-mega-to-mini> ;
    ns1:foundName "Valeant Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Valeant Pharmaceuticals" ;
    ns1:protagonist <https://1145.am/db/2577419/Merger_Biovail_Valeant_Pharmaceuticals_Completed>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2294967/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2295456/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2302002/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2302007/Valeant_Canada_Limited>,
        <https://1145.am/db/2302007/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2302826/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2305757/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2305758/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2306724/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2306813/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2308734/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2312215/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2312221/Valeant>,
        <https://1145.am/db/2313272/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2313282/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2313320/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2313365/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2315100/Valeant>,
        <https://1145.am/db/2318350/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2318405/Valeant>,
        <https://1145.am/db/2319331/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2319722/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2322159/Valeant>,
        <https://1145.am/db/2322776/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2323106/Valeant>,
        <https://1145.am/db/2323111/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2324422/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2325692/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2325895/Valeant>,
        <https://1145.am/db/2330074/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2332074/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2335641/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2336083/Valeant>,
        <https://1145.am/db/2336258/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2336278/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2337634/Valeant>,
        <https://1145.am/db/2341518/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2346832/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2346833/Valeant_Canada_Limited>,
        <https://1145.am/db/2346833/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2348864/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2349239/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2349461/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2350907/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2353646/Valeant>,
        <https://1145.am/db/2354801/Valeant>,
        <https://1145.am/db/2354804/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2356945/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2357416/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2360703/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2361172/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2361190/Valeant>,
        <https://1145.am/db/2362893/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2362898/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2362898/Valeant_Pharmaceuticals_North_America_Llc>,
        <https://1145.am/db/2363430/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2365199/Valeant>,
        <https://1145.am/db/2365200/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2366467/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2366468/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2369037/Valeant>,
        <https://1145.am/db/2369371/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2369374/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2369618/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2538017/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2539802/Valeant>,
        <https://1145.am/db/2540219/Valeant>,
        <https://1145.am/db/2540467/Valeant>,
        <https://1145.am/db/2543893/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2543904/Valeant>,
        <https://1145.am/db/2544888/Valeant>,
        <https://1145.am/db/2545075/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2550867/Valeant>,
        <https://1145.am/db/2556458/Valeant>,
        <https://1145.am/db/2556718/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2556805/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2557472/Valeant>,
        <https://1145.am/db/2560716/Valeant>,
        <https://1145.am/db/2560770/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2566037/Valeant>,
        <https://1145.am/db/2568778/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2568799/Valeant_Canada>,
        <https://1145.am/db/2568808/Valeant_Canada>,
        <https://1145.am/db/2569148/Valeant>,
        <https://1145.am/db/2569149/Valeant>,
        <https://1145.am/db/2570033/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2570121/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2570390/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2571019/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2571068/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2572086/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2572449/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2572450/Valeant>,
        <https://1145.am/db/2572552/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2572553/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2572568/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2572605/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2572612/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2572932/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2573147/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2573199/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2573880/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2574433/Valeant>,
        <https://1145.am/db/2575134/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2575289/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2575552/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2575615/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2575800/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2576039/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2576047/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2576205/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2576478/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2576482/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2576956/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2576962/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2577145/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2577770/Valeant>,
        <https://1145.am/db/2577771/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2577774/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2577775/Valeant>,
        <https://1145.am/db/2577846/Valeant>,
        <https://1145.am/db/2577958/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2578188/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2578333/Valeant_Canada>,
        <https://1145.am/db/2578700/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2579147/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2580042/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2580047/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2580122/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2580140/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2580774/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2580775/Valeant>,
        <https://1145.am/db/2580831/Valeant>,
        <https://1145.am/db/2581225/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2582260/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2582935/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2583270/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2583732/Valeant>,
        <https://1145.am/db/2583843/Valeant_Pharmaceuticals_North_America>,
        <https://1145.am/db/2584209/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2584216/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2584226/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2584644/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2584750/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2584818/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2585746/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2586657/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2586658/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2587640/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2588178/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2589040/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2589223/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2589781/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2590589/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2591690/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2592575/And_Valeant>,
        <https://1145.am/db/2593443/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2593831/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594087/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594236/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594249/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594252/Valeant>,
        <https://1145.am/db/2594253/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2594281/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594413/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594414/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594557/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594858/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2595025/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2595150/Valeant>,
        <https://1145.am/db/2595287/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2595706/Valeant>,
        <https://1145.am/db/2595853/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2595929/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2596290/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2596891/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2597119/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597158/Valeant>,
        <https://1145.am/db/2597223/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597433/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597433/Valeant_Pharmaceuticals_North_America_Llc>,
        <https://1145.am/db/2597542/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2597746/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597769/Valeant>,
        <https://1145.am/db/2598012/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2598032/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2598205/Valeant>,
        <https://1145.am/db/2598266/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2598558/Valeant_Pharmaceuticals_International> ;
    ns1:sameAsMedium <https://1145.am/db/2598261/Valeant_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2591540/Bankruptcy_Genefar_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "bankruptcy" ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Hungary's Gedeon Richter said Genefar had been ordered to pay it $ 40 million for breach of contract in a dispute over the failed buyout of Polpharma." ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:valueRaw "$ 40 million" ;
    ns1:whereGeoName "Hungary" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/719819/about.rdf> ;
    ns1:whereRaw "Hungary" .

<https://1145.am/db/2591540/Kv_Pharmaceutical> a org:Organization ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:foundName "KV Pharmaceutical" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "KV Pharmaceutical" ;
    ns1:sameAsHigh <https://1145.am/db/2287178/Kronos_Bio>,
        <https://1145.am/db/2298017/Kleo_Pharmaceuticals>,
        <https://1145.am/db/2303393/Kv_Pharmaceutical>,
        <https://1145.am/db/2303412/Kv_Pharmaceutical>,
        <https://1145.am/db/2309826/Kv_Pharmaceutical>,
        <https://1145.am/db/2313872/Kv_Pharmaceutical>,
        <https://1145.am/db/2313881/Kv_Pharmaceutical_Company>,
        <https://1145.am/db/2321137/Koronis_Pharmaceuticals>,
        <https://1145.am/db/2324042/Koronis_Pharmaceuticals>,
        <https://1145.am/db/2341632/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2341635/Kv_Pharmaceutical>,
        <https://1145.am/db/2342502/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2343076/Kadmon_Pharmaceuticals>,
        <https://1145.am/db/2343087/Kadmon_Pharmaceuticals>,
        <https://1145.am/db/2357321/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2363493/Kv_Pharmaceutical_Company>,
        <https://1145.am/db/2581876/Kv_Pharmaceutical>,
        <https://1145.am/db/2581877/Kv_Pharmaceutical>,
        <https://1145.am/db/2584352/Keata_Pharma>,
        <https://1145.am/db/2585039/Kv_Pharmaceutical>,
        <https://1145.am/db/2586244/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2594329/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2595326/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2595368/Kadmon_Pharmaceuticals>,
        <https://1145.am/db/2597966/Karalex_Pharma_Llc>,
        <https://1145.am/db/2598514/K-V_Pharmaceutical>,
        <https://1145.am/db/2598521/K-V_Pharmaceutical_Company> ;
    ns1:sameAsMedium <https://1145.am/db/2367489/Kv_Kv_Pharmaceutical_Company>,
        <https://1145.am/db/2563450/Kv_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2591540/Salix_Pharmaceuticals> a org:Organization ;
    ns1:description "Gastrointestinal specialist" ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:foundName "Salix Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Salix Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2304616/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2304619/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2311289/Salix_Pharmaceuticals>,
        <https://1145.am/db/2314324/Salix_Pharmaceuticals>,
        <https://1145.am/db/2314325/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2320470/Salix_Pharmaceuticals>,
        <https://1145.am/db/2336083/Salix_Pharmaceuticals>,
        <https://1145.am/db/2337348/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2350833/Salix_Pharmaceuticals>,
        <https://1145.am/db/2359194/Salix_Pharmaceuticals>,
        <https://1145.am/db/2363430/Salix_Pharmaceuticals>,
        <https://1145.am/db/2364374/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2568778/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2569444/Salix_Pharmaceuticals>,
        <https://1145.am/db/2569465/Salix_Pharmaceuticals>,
        <https://1145.am/db/2570121/Salix_Pharmaceuticals>,
        <https://1145.am/db/2570958/Salix_Pharmaceuticals>,
        <https://1145.am/db/2570961/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2572965/Salix_Pharmaceuticals>,
        <https://1145.am/db/2573919/Salix_Pharmaceuticals>,
        <https://1145.am/db/2574443/Salix_Pharmaceuticals>,
        <https://1145.am/db/2577846/Salix_Pharmaceuticals>,
        <https://1145.am/db/2580318/Salix_Pharmaceuticals>,
        <https://1145.am/db/2583220/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2584250/Salix_Pharmaceuticals>,
        <https://1145.am/db/2584908/Salix_Pharmaceuticals>,
        <https://1145.am/db/2587094/Salix_Pharmaceuticals>,
        <https://1145.am/db/2594497/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2597158/Salix_Pharmaceuticals>,
        <https://1145.am/db/2597769/Salix_Pharmaceuticals>,
        <https://1145.am/db/354036/Sgd_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/2335641/Salix_Pharmaceuticals>,
        <https://1145.am/db/2342058/Salix_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2591540/Skyepharma> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:foundName "SkyePharma",
        "SkyePharma manufacturing" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "SkyePharma" ;
    ns1:sameAsHigh <https://1145.am/db/2011839/Skyepharma>,
        <https://1145.am/db/2080822/Skyepharma>,
        <https://1145.am/db/2288661/Skyepharma>,
        <https://1145.am/db/2305503/Skyepharma_Plc>,
        <https://1145.am/db/2323004/Skyepharma>,
        <https://1145.am/db/2330927/Skyepharma>,
        <https://1145.am/db/2351835/Skyepharma_Plc>,
        <https://1145.am/db/2358136/Skyepharma>,
        <https://1145.am/db/2370755/Skyepharma>,
        <https://1145.am/db/2537001/Skyepharma>,
        <https://1145.am/db/2553852/Skyepharma>,
        <https://1145.am/db/2593412/Skyepharma>,
        <https://1145.am/db/505757/Skye_Bioscience>,
        <https://1145.am/db/511637/Skye_Bioscience> ;
    ns1:sameAsMedium <https://1145.am/db/2321953/Skyepharma_Plc>,
        <https://1145.am/db/2347953/Skyepharma>,
        <https://1145.am/db/2593410/Skyepharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2591540/Skyepharma_Business_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Contract manufacturer Aenova plans to lease a SkyePharma manufacturing business near Lyon, France." ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:foundName "lease" ;
    ns1:name "lease" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2591540/Skyepharma> ;
    ns1:targetDetails "business" ;
    ns1:targetName "SkyePharma" ;
    ns1:whereGeoName "Republic of France" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:whereRaw "France" .

<https://1145.am/db/2591540/Unit_Acquisition_Kv_Pharmaceutical_Zydus_Pharmaceuticals_And_Zynesher_Pharmaceuticals_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> KV Pharmaceutical wrapped up the $ 60 million sale of its generics unit to Zydus Pharmaceuticals and Zynesher Pharmaceuticals." ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:foundName "sale" ;
    ns1:name "sale" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:targetDetails "unit" ;
    ns1:valueRaw "$ 60 million" ;
    ns1:vendor <https://1145.am/db/2591540/Kv_Pharmaceutical> .

<https://1145.am/db/2592467/Bilim_Ilac> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Turkey" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/298795/about.rdf> ;
    ns1:basedInHighRaw "Turkey" ;
    ns1:description "drugmakers" ;
    ns1:documentDate "2011-08-12T15:40:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Turkish private equity fund eyes stake in Bilim Ilac" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/turkish-private-equity-fund-eyes-stake-bilim-ilac> ;
    ns1:foundName "Bilim Ilac" ;
    ns1:industry "pharma company" ;
    ns1:name "Bilim Ilac" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2592467/Stake_Acquisition_Actera_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-08-12T15:40:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Reuters reports the pharma company is in talks to sell a stake to Actera, a Turkish - focused firm with a $ 500 million-plus fund devoted to investments in the country." ;
    ns1:documentTitle "Turkish private equity fund eyes stake in Bilim Ilac" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/turkish-private-equity-fund-eyes-stake-bilim-ilac> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "stake" ;
    ns1:whereRaw "Turkish" .

<https://1145.am/db/2593831/Biovail> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2011-03-30T13:50:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Investors boost Cephalon past Valeant's $5.7B offer" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/investors-boost-cephalon-past-valeant-s-5-7b-offer> ;
    ns1:foundName "Biovail" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Biovail" ;
    ns1:protagonist <https://1145.am/db/2593831/Cephalon_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/1004139/Entrechem_Sl>,
        <https://1145.am/db/101302/Biotec_Pharmacon_Asa>,
        <https://1145.am/db/1037440/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/1043614/Pharmajet>,
        <https://1145.am/db/1046013/Pharmajet>,
        <https://1145.am/db/108359/Biogen_Inc>,
        <https://1145.am/db/1182119/Pharnext_Sa>,
        <https://1145.am/db/1196435/Infinity_Biologix_Llc>,
        <https://1145.am/db/1198542/Infinity_Biologix_Llc>,
        <https://1145.am/db/1263299/Biolab>,
        <https://1145.am/db/1265716/Bioivt>,
        <https://1145.am/db/1270730/Bioasis_Technologies_Inc>,
        <https://1145.am/db/1319248/Think_Bioscience>,
        <https://1145.am/db/1321358/Ichor_Life_Sciences>,
        <https://1145.am/db/1325997/Biopharma_Global>,
        <https://1145.am/db/1337532/Bioivt>,
        <https://1145.am/db/1345925/Innovation1_Biotech_Inc>,
        <https://1145.am/db/1376181/Flagship_Biosciences>,
        <https://1145.am/db/1380463/Vicapsys_Life_Sciences_Inc>,
        <https://1145.am/db/1397594/Rectify_Pharmaceuticals_Inc>,
        <https://1145.am/db/1402913/Biogen>,
        <https://1145.am/db/1405080/Ochre_Bio>,
        <https://1145.am/db/1406734/Bioneex>,
        <https://1145.am/db/1408996/Ochre_Bio>,
        <https://1145.am/db/1418668/Simcere_Pharmaceuticals>,
        <https://1145.am/db/1490051/Biogen>,
        <https://1145.am/db/1494850/Biogen_Inc>,
        <https://1145.am/db/1507989/Bionomics>,
        <https://1145.am/db/1522097/Bionomics_Limited>,
        <https://1145.am/db/1523985/Biocorrx_Pharmaceuticals_Inc>,
        <https://1145.am/db/1531806/Lifecore_Biomedical>,
        <https://1145.am/db/1545261/Cardior_Pharmaceuticals>,
        <https://1145.am/db/1563797/Be_Biopharma>,
        <https://1145.am/db/1576268/Bioasis_Technologies_Inc>,
        <https://1145.am/db/1619442/Hightide>,
        <https://1145.am/db/1628791/Atai_Life_Sciences>,
        <https://1145.am/db/1630569/Lifecore_Biomedical_Inc>,
        <https://1145.am/db/1659339/Biocon>,
        <https://1145.am/db/1680653/149_Bio>,
        <https://1145.am/db/1935113/Provention_Bio_Inc>,
        <https://1145.am/db/1957460/Pardes_Biosciences_Inc>,
        <https://1145.am/db/1979877/Biocon_Ltd>,
        <https://1145.am/db/1981295/Rectify_Pharmaceuticals_Inc>,
        <https://1145.am/db/1988637/Iveric_Bio>,
        <https://1145.am/db/1988943/Iveric_Bio_Inc>,
        <https://1145.am/db/2003152/Pharmacyte>,
        <https://1145.am/db/2004568/Medincell>,
        <https://1145.am/db/2017278/Erytech_Pharma>,
        <https://1145.am/db/2021869/Abionyx_Pharma>,
        <https://1145.am/db/2036830/Biogen>,
        <https://1145.am/db/2037970/Erytech_Pharma>,
        <https://1145.am/db/2056049/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2067011/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2090091/Concord_Biotech>,
        <https://1145.am/db/2152658/Atea_Pharmaceuticals>,
        <https://1145.am/db/2153005/Genentech>,
        <https://1145.am/db/2154198/Attune_Pharmaceuticals>,
        <https://1145.am/db/2154706/Biotage>,
        <https://1145.am/db/2155042/The_Medicines_Company>,
        <https://1145.am/db/2156114/X4_Pharmaceuticals>,
        <https://1145.am/db/2223218/United_Biosource_Corporation>,
        <https://1145.am/db/2230917/Scifluor_Life_Sciences>,
        <https://1145.am/db/2242573/Pharmarc>,
        <https://1145.am/db/2243599/Biogen_Idec>,
        <https://1145.am/db/2254330/Pharmathene>,
        <https://1145.am/db/2280215/Atea_Pharmaceuticals>,
        <https://1145.am/db/2280231/D___D_Pharmatech>,
        <https://1145.am/db/2280769/Iveric_Bio>,
        <https://1145.am/db/2282241/Be_Biopharma>,
        <https://1145.am/db/2282756/Isa_Pharmaceuticals>,
        <https://1145.am/db/2283468/Biohaven>,
        <https://1145.am/db/2284603/Biotech>,
        <https://1145.am/db/2285239/Bio>,
        <https://1145.am/db/2286092/Be_Biopharma>,
        <https://1145.am/db/2286404/Enthera_Pharmaceuticals>,
        <https://1145.am/db/2288191/Pharmaron>,
        <https://1145.am/db/2290480/Entera_Bio>,
        <https://1145.am/db/2291446/Roivant_Sciences>,
        <https://1145.am/db/2293310/Biogen>,
        <https://1145.am/db/2293696/Provention_Bio>,
        <https://1145.am/db/2295048/Proclara_Biosciences>,
        <https://1145.am/db/2296016/Ds_Biopharma>,
        <https://1145.am/db/2298167/Aetion>,
        <https://1145.am/db/2300489/Roivant_Sciences>,
        <https://1145.am/db/2301083/Biolinerx>,
        <https://1145.am/db/2301537/Proclara_Biosciences>,
        <https://1145.am/db/2301767/Bioxell_Spa>,
        <https://1145.am/db/2301820/Sciele_Pharma>,
        <https://1145.am/db/2301844/Biogen_Idec>,
        <https://1145.am/db/2302715/Biomimetic_Therapeutics>,
        <https://1145.am/db/2302897/Sagamore_Bioventures>,
        <https://1145.am/db/2303025/Profectus_Biosciences>,
        <https://1145.am/db/2303208/Biomarin_Pharmaceutical>,
        <https://1145.am/db/2303357/Biocon>,
        <https://1145.am/db/2303415/Biogen_Idec>,
        <https://1145.am/db/2303502/Accutest_Research_Laboratories>,
        <https://1145.am/db/2303937/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2304165/Bioclinica>,
        <https://1145.am/db/2304628/Bioreliance>,
        <https://1145.am/db/2304829/Pharming_Group_Nv>,
        <https://1145.am/db/2304919/Biovail>,
        <https://1145.am/db/2305020/Biodelivery>,
        <https://1145.am/db/2305559/Via_Pharmaceuticals>,
        <https://1145.am/db/2305822/D-Pharm>,
        <https://1145.am/db/2305956/Biotrove>,
        <https://1145.am/db/2306113/Pharming>,
        <https://1145.am/db/2306117/Biogen_Idec>,
        <https://1145.am/db/2306160/Pharminox_Limited>,
        <https://1145.am/db/2306464/Bioseek>,
        <https://1145.am/db/2306935/Biogen_Idec>,
        <https://1145.am/db/2307579/Biovectra>,
        <https://1145.am/db/2308761/Biolinerx>,
        <https://1145.am/db/2308916/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2309484/Biovail_Corporation>,
        <https://1145.am/db/230953/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2309736/Bioclinica>,
        <https://1145.am/db/2309970/Biomarin_Pharmaceutical>,
        <https://1145.am/db/2311264/Biogen_Idec>,
        <https://1145.am/db/2311476/Bioclinica>,
        <https://1145.am/db/2312358/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2313765/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2314230/Sciele_Pharma>,
        <https://1145.am/db/2314546/Combinature_Biopharm>,
        <https://1145.am/db/2314683/Pharming_Group_Nv>,
        <https://1145.am/db/2314688/Pharming_Group>,
        <https://1145.am/db/2315632/Synthetech>,
        <https://1145.am/db/2315688/Biovitrum>,
        <https://1145.am/db/2316356/Biogen_Idec>,
        <https://1145.am/db/2316481/Life_Technologies>,
        <https://1145.am/db/2316720/Biogen_Idec>,
        <https://1145.am/db/2316915/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2317508/Biovail>,
        <https://1145.am/db/2317680/Sciele_Pharma>,
        <https://1145.am/db/2318404/Almirall>,
        <https://1145.am/db/2318581/Sciele_Pharma>,
        <https://1145.am/db/2318644/Biovail_Corporation>,
        <https://1145.am/db/2318658/Biovail_Corporation>,
        <https://1145.am/db/2318658/Biovail_International_Laboratories_Srl>,
        <https://1145.am/db/2318766/Sciele>,
        <https://1145.am/db/2319577/Genentech>,
        <https://1145.am/db/2319587/Bioclinica>,
        <https://1145.am/db/2320110/Biovail>,
        <https://1145.am/db/2320163/Berna_Biotech>,
        <https://1145.am/db/2320648/Bioclinica>,
        <https://1145.am/db/2321134/Biomira>,
        <https://1145.am/db/2321911/Biovail_Corporation>,
        <https://1145.am/db/2322089/Biovail_Corporation>,
        <https://1145.am/db/2322091/Biovail>,
        <https://1145.am/db/2322093/Biovail>,
        <https://1145.am/db/2322189/Genentech>,
        <https://1145.am/db/2322201/Genentech>,
        <https://1145.am/db/2322295/Topgen_Esv>,
        <https://1145.am/db/2322805/Clinipace>,
        <https://1145.am/db/2322850/Clinipace>,
        <https://1145.am/db/2323097/Biovitrum_Ab>,
        <https://1145.am/db/2324079/Biostorage_Technologies>,
        <https://1145.am/db/2324234/Biothorpe_Pharmaceuticals>,
        <https://1145.am/db/2324755/Biomarin>,
        <https://1145.am/db/2326031/Bioclinica>,
        <https://1145.am/db/2326186/Sciele_Pharma>,
        <https://1145.am/db/2326815/Biovail_Corporation>,
        <https://1145.am/db/2326817/Biovail>,
        <https://1145.am/db/2326895/Biovitrum>,
        <https://1145.am/db/2327243/Bioenvision>,
        <https://1145.am/db/2328960/Biodel_Inc>,
        <https://1145.am/db/2328998/Via_Pharmaceuticals>,
        <https://1145.am/db/2330549/Celator_Pharmaceuticals>,
        <https://1145.am/db/2330782/Pharminggroup_Nv>,
        <https://1145.am/db/2330990/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2331044/Genentech>,
        <https://1145.am/db/2331511/Bioclinica>,
        <https://1145.am/db/2331622/Bioprocessors_Corporation>,
        <https://1145.am/db/2331991/Atrium_Biotechnologies>,
        <https://1145.am/db/2332200/Life_Technologies>,
        <https://1145.am/db/233261/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2332847/Atrium_Biotechnologies_Inc>,
        <https://1145.am/db/2333447/Eresearch_Technology>,
        <https://1145.am/db/2334032/Biooutsource>,
        <https://1145.am/db/2334133/Biorexis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2334181/Pharming>,
        <https://1145.am/db/2334589/Bioclinica>,
        <https://1145.am/db/2335029/Bioclinica>,
        <https://1145.am/db/2336028/Biolinerx>,
        <https://1145.am/db/2336041/Bioset>,
        <https://1145.am/db/2336113/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2336259/Coherus_Biosciences>,
        <https://1145.am/db/2337080/Medistem_Inc>,
        <https://1145.am/db/2337420/Chs_Pharma_Inc>,
        <https://1145.am/db/2338836/Biogen_Idec>,
        <https://1145.am/db/2340015/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340213/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340286/Pharmasset>,
        <https://1145.am/db/2340402/Biolinerx>,
        <https://1145.am/db/2341010/Lfb_Biotechnologies>,
        <https://1145.am/db/2341165/Pharmasset>,
        <https://1145.am/db/2342188/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342800/Theraclone_Sciences>,
        <https://1145.am/db/2342805/Theraclone_Sciences>,
        <https://1145.am/db/2343628/Galecto_Biotech_Ab>,
        <https://1145.am/db/2343817/Biomotiv>,
        <https://1145.am/db/2344078/Pharmathene>,
        <https://1145.am/db/2344192/Biologics>,
        <https://1145.am/db/2344318/Theraclone_Sciences>,
        <https://1145.am/db/2344560/Dmi_Biosciences_Inc>,
        <https://1145.am/db/2344940/Biodelivery_Sciences_International>,
        <https://1145.am/db/2345508/Pevion_Biotech_Ltd>,
        <https://1145.am/db/2346347/Biospecifics_Technologies_Corp>,
        <https://1145.am/db/2347256/Biocis_Pharma_Oy>,
        <https://1145.am/db/2347768/Biothera>,
        <https://1145.am/db/2347792/Biomarin>,
        <https://1145.am/db/2347799/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2348159/Biocon>,
        <https://1145.am/db/2348440/Cerulean_Pharma>,
        <https://1145.am/db/2348522/Am-Pharma>,
        <https://1145.am/db/2348776/Genentech>,
        <https://1145.am/db/2348923/Biothera>,
        <https://1145.am/db/2349891/Bioclinica>,
        <https://1145.am/db/2350127/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350245/Biodelivery_Sciences_International>,
        <https://1145.am/db/2351103/Genentech>,
        <https://1145.am/db/2351826/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2352246/Genentech>,
        <https://1145.am/db/2352261/Biodelivery_Sciences_International>,
        <https://1145.am/db/2353157/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2353325/Am-Pharma>,
        <https://1145.am/db/2353337/Am-Pharma>,
        <https://1145.am/db/2353644/Bionovo_Inc>,
        <https://1145.am/db/2353663/Biotie>,
        <https://1145.am/db/2353771/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2353789/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2353951/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/2353974/Acesion_Pharma>,
        <https://1145.am/db/2354079/Pharming>,
        <https://1145.am/db/2354084/Pharming_Group>,
        <https://1145.am/db/2354589/Biogen>,
        <https://1145.am/db/2354987/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2355177/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2355667/Pharmasset>,
        <https://1145.am/db/2356073/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2356186/Biothera>,
        <https://1145.am/db/2356597/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2356599/Biomarin>,
        <https://1145.am/db/2356945/Biovail_Laboratories_International_Srl>,
        <https://1145.am/db/2357049/Theravance>,
        <https://1145.am/db/2357068/Theravance_Inc>,
        <https://1145.am/db/2357123/Biogen_Idec>,
        <https://1145.am/db/2357508/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2358167/Alexion_Pharmaceuticals>,
        <https://1145.am/db/2358612/Bioclinica>,
        <https://1145.am/db/2358763/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2359141/Bioclinica>,
        <https://1145.am/db/2359286/Axim_Biotechnologies>,
        <https://1145.am/db/2360257/Aldea_Pharmaceuticals>,
        <https://1145.am/db/2360710/Xbiotech>,
        <https://1145.am/db/2360719/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/2360960/Pharmarc>,
        <https://1145.am/db/2361646/Biomarin>,
        <https://1145.am/db/2361667/Diamedica>,
        <https://1145.am/db/2361850/Provectus_Pharmaceuticals>,
        <https://1145.am/db/2362027/Biotie_Therapeutics>,
        <https://1145.am/db/2362341/Biontech_Ag>,
        <https://1145.am/db/2362901/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2363699/Prism_Pharma>,
        <https://1145.am/db/2364095/Biogen_Idec>,
        <https://1145.am/db/2364364/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364671/Biogen_Idec>,
        <https://1145.am/db/2364672/Biogen_Idec>,
        <https://1145.am/db/2364678/Biogen_Idec>,
        <https://1145.am/db/2364813/Biomarin>,
        <https://1145.am/db/2365199/Biovail>,
        <https://1145.am/db/2365200/Biovail>,
        <https://1145.am/db/2366353/Biodelivery_Sciences_International>,
        <https://1145.am/db/2366651/Pharming_Group_Nv>,
        <https://1145.am/db/2366688/Pharmagap_Inc>,
        <https://1145.am/db/2366933/Lux_Biosciences>,
        <https://1145.am/db/2367158/Lux_Biosciences>,
        <https://1145.am/db/2367182/Biotica>,
        <https://1145.am/db/2367612/Biota_Pharmaceuticals>,
        <https://1145.am/db/2368283/Eligo_Bioscience>,
        <https://1145.am/db/2368369/Biodelivery_Sciences_International>,
        <https://1145.am/db/2368429/Biodelivery_Sciences_International>,
        <https://1145.am/db/2368439/Biodelivery_Sciences_International>,
        <https://1145.am/db/2368457/Axovant_Sciences>,
        <https://1145.am/db/2368754/Biodelivery_Sciences_International>,
        <https://1145.am/db/2369234/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/2369490/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2369860/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2370706/Amo_Pharma>,
        <https://1145.am/db/2371179/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2371314/Genentech>,
        <https://1145.am/db/239789/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2537484/Sciele>,
        <https://1145.am/db/2538019/Biovitrum>,
        <https://1145.am/db/2540240/Biogen>,
        <https://1145.am/db/2541239/Biogen_Idec>,
        <https://1145.am/db/2541294/Ark_Biosciences>,
        <https://1145.am/db/2541703/A___C_Bio>,
        <https://1145.am/db/2543106/Biocon>,
        <https://1145.am/db/2543334/Mabspace_Biosciences>,
        <https://1145.am/db/2543721/Biocon_Biologics>,
        <https://1145.am/db/2543962/Quotient_Sciences>,
        <https://1145.am/db/2545015/Biovail>,
        <https://1145.am/db/2546113/Biodelivery_Sciences_International>,
        <https://1145.am/db/2546153/Coherus_Biosciences>,
        <https://1145.am/db/2547550/Bio_Pure_Technology>,
        <https://1145.am/db/2548022/Jsc_Biosintez>,
        <https://1145.am/db/2548151/Biocon>,
        <https://1145.am/db/2549670/Genentech>,
        <https://1145.am/db/2550148/Organon_Biosciences>,
        <https://1145.am/db/2550232/Xcelience>,
        <https://1145.am/db/2550837/Biohaven>,
        <https://1145.am/db/2551030/Biological_E>,
        <https://1145.am/db/2551075/Biosims>,
        <https://1145.am/db/2553491/Biomarin>,
        <https://1145.am/db/2553835/Biovail>,
        <https://1145.am/db/2559286/Biocon_Biologics>,
        <https://1145.am/db/2559490/Iveric_Bio>,
        <https://1145.am/db/2560880/Biovail>,
        <https://1145.am/db/2563423/Anthera_Pharmaceuticals>,
        <https://1145.am/db/2566088/Stellar_Biotechnologies>,
        <https://1145.am/db/2567129/Biocon_Biologics>,
        <https://1145.am/db/2567727/Biocon>,
        <https://1145.am/db/2567935/Medsenic>,
        <https://1145.am/db/2568444/Biogen>,
        <https://1145.am/db/2573593/Biotica>,
        <https://1145.am/db/2575552/Biovail>,
        <https://1145.am/db/2575644/Biodelivery_Sciences_International>,
        <https://1145.am/db/2576156/Biogen_Idec>,
        <https://1145.am/db/2577419/Biovail>,
        <https://1145.am/db/2580337/Biodelivery_Sciences_International>,
        <https://1145.am/db/2581394/Biocon>,
        <https://1145.am/db/2581855/Biogen_Idec>,
        <https://1145.am/db/2583414/Bioton>,
        <https://1145.am/db/2583783/Biomarin>,
        <https://1145.am/db/2585066/Advanced_Bio-Technologies>,
        <https://1145.am/db/2586160/Biogen_Idec>,
        <https://1145.am/db/2587981/Biochem>,
        <https://1145.am/db/2588178/Biovail>,
        <https://1145.am/db/2588378/Enlight_Biosciences>,
        <https://1145.am/db/2591550/Genentech>,
        <https://1145.am/db/2593529/Pharmstandard>,
        <https://1145.am/db/2594877/Biogen_Idec>,
        <https://1145.am/db/2595511/Biogen_Idec>,
        <https://1145.am/db/2595561/Biomarin_Pharmaceutical>,
        <https://1145.am/db/2597220/Biological_E>,
        <https://1145.am/db/2598558/Biovail>,
        <https://1145.am/db/2798422/Biomarin_Pharmaceutical>,
        <https://1145.am/db/291851/Altasciences>,
        <https://1145.am/db/317345/Realta_Life_Sciences>,
        <https://1145.am/db/345698/Flagship_Biosciences>,
        <https://1145.am/db/426688/Cardior_Pharmaceuticals>,
        <https://1145.am/db/427181/Cellect_Biotechnology_Ltd>,
        <https://1145.am/db/453079/Infinity_Pharmaceuticals>,
        <https://1145.am/db/486464/Aadi_Bioscience>,
        <https://1145.am/db/488591/Be_Biopharma>,
        <https://1145.am/db/522502/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/545988/Rectify_Pharmaceuticals>,
        <https://1145.am/db/556149/D___D_Pharmatech_Inc>,
        <https://1145.am/db/583231/D___D_Pharmatech>,
        <https://1145.am/db/662958/Biocina>,
        <https://1145.am/db/665573/Abionyx_Pharma>,
        <https://1145.am/db/674262/Abionyx_Pharma>,
        <https://1145.am/db/678224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/685681/Biocon_Ltd>,
        <https://1145.am/db/709723/Pardes_Biosciences>,
        <https://1145.am/db/712921/Replicel_Life_Sciences_Inc>,
        <https://1145.am/db/714643/Achieve_Life_Sciences>,
        <https://1145.am/db/722194/Biogen_Inc>,
        <https://1145.am/db/724168/Biogen_Inc>,
        <https://1145.am/db/726160/Biogen_Inc>,
        <https://1145.am/db/731137/Altasciences>,
        <https://1145.am/db/734635/Altasciences>,
        <https://1145.am/db/736861/Bionomics>,
        <https://1145.am/db/739339/Iveric_Bio>,
        <https://1145.am/db/832408/Biodelivery_Sciences_International>,
        <https://1145.am/db/833269/Biodelivery_Sciences_International>,
        <https://1145.am/db/840678/Gt_Biopharma>,
        <https://1145.am/db/862305/Biocon_Biologics>,
        <https://1145.am/db/862305/Biocon_Ltd>,
        <https://1145.am/db/866237/Cardior_Pharmaceuticals>,
        <https://1145.am/db/882284/Biofrontera_Inc>,
        <https://1145.am/db/901032/Achieve_Life_Sciences>,
        <https://1145.am/db/906534/Kither_Biotech>,
        <https://1145.am/db/926227/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/966626/Biogen>,
        <https://1145.am/db/973736/Biocorrx_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2305797/Biovail_Corporation>,
        <https://1145.am/db/2325321/Biovail>,
        <https://1145.am/db/2325331/Biovail_Corporation>,
        <https://1145.am/db/2325357/Biovail>,
        <https://1145.am/db/2544567/Biovail> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593831/Valeant_Pharmaceuticals> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:buyer <https://1145.am/db/2593831/Cephalon_Acquisition> ;
    ns1:documentDate "2011-03-30T13:50:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Investors boost Cephalon past Valeant's $5.7B offer" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/investors-boost-cephalon-past-valeant-s-5-7b-offer> ;
    ns1:foundName "Valeant Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Valeant Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2294967/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2295456/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2302002/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2302007/Valeant_Canada_Limited>,
        <https://1145.am/db/2302007/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2302826/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2305757/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2305758/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2306724/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2306813/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2308734/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2312215/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2312221/Valeant>,
        <https://1145.am/db/2313272/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2313282/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2313320/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2313365/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2315100/Valeant>,
        <https://1145.am/db/2318350/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2318405/Valeant>,
        <https://1145.am/db/2319331/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2319722/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2322159/Valeant>,
        <https://1145.am/db/2322776/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2323106/Valeant>,
        <https://1145.am/db/2323111/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2324422/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2325692/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2325895/Valeant>,
        <https://1145.am/db/2330074/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2332074/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2335641/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2336083/Valeant>,
        <https://1145.am/db/2336258/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2336278/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2337634/Valeant>,
        <https://1145.am/db/2341518/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2346832/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2346833/Valeant_Canada_Limited>,
        <https://1145.am/db/2346833/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2348864/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2349239/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2349461/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2350907/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2353646/Valeant>,
        <https://1145.am/db/2354801/Valeant>,
        <https://1145.am/db/2354804/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2356945/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2357416/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2360703/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2361172/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2361190/Valeant>,
        <https://1145.am/db/2362893/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2362898/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2362898/Valeant_Pharmaceuticals_North_America_Llc>,
        <https://1145.am/db/2363430/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2365199/Valeant>,
        <https://1145.am/db/2365200/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2366467/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2366468/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2369037/Valeant>,
        <https://1145.am/db/2369371/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2369374/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2369618/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2538017/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2539802/Valeant>,
        <https://1145.am/db/2540219/Valeant>,
        <https://1145.am/db/2540467/Valeant>,
        <https://1145.am/db/2543893/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2543904/Valeant>,
        <https://1145.am/db/2544888/Valeant>,
        <https://1145.am/db/2545075/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2550867/Valeant>,
        <https://1145.am/db/2556458/Valeant>,
        <https://1145.am/db/2556718/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2556805/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2557472/Valeant>,
        <https://1145.am/db/2560716/Valeant>,
        <https://1145.am/db/2560770/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2566037/Valeant>,
        <https://1145.am/db/2568778/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2568799/Valeant_Canada>,
        <https://1145.am/db/2568808/Valeant_Canada>,
        <https://1145.am/db/2569148/Valeant>,
        <https://1145.am/db/2569149/Valeant>,
        <https://1145.am/db/2570033/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2570121/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2570390/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2571019/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2571068/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2572086/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2572449/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2572450/Valeant>,
        <https://1145.am/db/2572552/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2572553/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2572568/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2572605/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2572612/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2572932/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2573147/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2573199/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2573880/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2574433/Valeant>,
        <https://1145.am/db/2575134/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2575289/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2575552/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2575615/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2575800/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2576039/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2576047/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2576205/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2576478/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2576482/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2576956/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2576962/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2577145/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2577419/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2577770/Valeant>,
        <https://1145.am/db/2577771/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2577774/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2577775/Valeant>,
        <https://1145.am/db/2577846/Valeant>,
        <https://1145.am/db/2577958/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2578188/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2578333/Valeant_Canada>,
        <https://1145.am/db/2578700/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2579147/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2580042/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2580047/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2580122/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2580140/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2580774/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2580775/Valeant>,
        <https://1145.am/db/2580831/Valeant>,
        <https://1145.am/db/2581225/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2582260/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2582935/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2583270/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2583732/Valeant>,
        <https://1145.am/db/2583843/Valeant_Pharmaceuticals_North_America>,
        <https://1145.am/db/2584209/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2584216/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2584226/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2584644/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2584750/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2584818/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2585746/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2586657/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2586658/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2587640/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2588178/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2589040/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2589223/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2589781/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2590589/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2591690/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2592575/And_Valeant>,
        <https://1145.am/db/2593443/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594087/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594236/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594249/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594252/Valeant>,
        <https://1145.am/db/2594253/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2594281/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594413/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594414/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2594557/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2594858/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2595025/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2595150/Valeant>,
        <https://1145.am/db/2595287/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2595706/Valeant>,
        <https://1145.am/db/2595853/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2595929/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2596290/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2596891/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2597119/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597158/Valeant>,
        <https://1145.am/db/2597223/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597433/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597433/Valeant_Pharmaceuticals_North_America_Llc>,
        <https://1145.am/db/2597542/Valeant_Pharmaceuticals_International_Inc>,
        <https://1145.am/db/2597746/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2597769/Valeant>,
        <https://1145.am/db/2598012/Valeant_Pharmaceuticals>,
        <https://1145.am/db/2598032/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2598205/Valeant>,
        <https://1145.am/db/2598266/Valeant_Pharmaceuticals_International>,
        <https://1145.am/db/2598558/Valeant_Pharmaceuticals_International> ;
    ns1:sameAsMedium <https://1145.am/db/2598261/Valeant_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2598807/Business_Acquisition_Megapaths_Nextweb_Telepacific_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-04-04T15:42:09+00:00"^^xsd:dateTime ;
    ns1:documentExtract "TelePacific strikes deal to acquire MegaPath's fixed wireless business." ;
    ns1:documentTitle "TelePacific finishes acquisition of Covad's wireless unit" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/telepacific-finishes-acquisition-covad-s-wireless-unit> ;
    ns1:foundName "acquire" ;
    ns1:name "acquire" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "completed" ;
    ns1:targetDetails "business" ;
    ns1:vendor <https://1145.am/db/2598807/Megapaths_Nextweb> ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2598807/Centurylink> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2598807/Clec_One_Communications_Acquisition> ;
    ns1:description "M & A" ;
    ns1:documentDate "2011-04-04T15:42:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TelePacific finishes acquisition of Covad's wireless unit" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/telepacific-finishes-acquisition-covad-s-wireless-unit> ;
    ns1:foundName "CenturyLink" ;
    ns1:industry "telecom service provider" ;
    ns1:name "CenturyLink" ;
    ns1:sameAsHigh <https://1145.am/db/1726101/Centurylink>,
        <https://1145.am/db/2164963/Centurylink>,
        <https://1145.am/db/2170676/Centurylink>,
        <https://1145.am/db/2173631/Centurylink>,
        <https://1145.am/db/2174844/Centurylink>,
        <https://1145.am/db/2176128/Centurylink>,
        <https://1145.am/db/2598868/Centurylink>,
        <https://1145.am/db/2599592/Centurylink>,
        <https://1145.am/db/2600228/Centurylink>,
        <https://1145.am/db/2600830/Centurylink>,
        <https://1145.am/db/2601482/Centurylink>,
        <https://1145.am/db/2602203/Centurylink>,
        <https://1145.am/db/2602217/Centurylink>,
        <https://1145.am/db/2603475/Centurylink>,
        <https://1145.am/db/2603693/Centurylink>,
        <https://1145.am/db/2603762/Centurylink>,
        <https://1145.am/db/2604550/Centurylink>,
        <https://1145.am/db/2604884/Centurylink>,
        <https://1145.am/db/2605249/Centurylink>,
        <https://1145.am/db/2606652/Centurylink>,
        <https://1145.am/db/2606756/Centurylink>,
        <https://1145.am/db/2606782/Centurylink>,
        <https://1145.am/db/2607902/Centurylink>,
        <https://1145.am/db/2609460/Centurylink>,
        <https://1145.am/db/2609858/Centurylink>,
        <https://1145.am/db/2610372/Centurylink>,
        <https://1145.am/db/2610939/Centurylink>,
        <https://1145.am/db/2610946/Centurylink>,
        <https://1145.am/db/2610972/Centurylink>,
        <https://1145.am/db/2611180/Centurylink>,
        <https://1145.am/db/2612318/Centurylink>,
        <https://1145.am/db/2612700/Centurylink>,
        <https://1145.am/db/2613243/Centurylink>,
        <https://1145.am/db/2613533/Centurylink>,
        <https://1145.am/db/2613610/Centurylink>,
        <https://1145.am/db/2613795/Centurytel>,
        <https://1145.am/db/2614057/Centurylink>,
        <https://1145.am/db/2615666/Centurylink>,
        <https://1145.am/db/2616913/Centurylink>,
        <https://1145.am/db/2617606/Centurylink>,
        <https://1145.am/db/2618881/Centurylink>,
        <https://1145.am/db/2619046/Centurylink>,
        <https://1145.am/db/2662743/Centurylink> ;
    ns1:sameAsMedium <https://1145.am/db/1826002/Centurylink>,
        <https://1145.am/db/1853611/Centurylink>,
        <https://1145.am/db/2158821/Centurylink>,
        <https://1145.am/db/2160022/Centurylink>,
        <https://1145.am/db/2168049/Centurylink>,
        <https://1145.am/db/2168075/Centurylink>,
        <https://1145.am/db/2175230/Centurylink>,
        <https://1145.am/db/2175859/Centurylink>,
        <https://1145.am/db/2600200/Centurylink>,
        <https://1145.am/db/2600243/Centurylink>,
        <https://1145.am/db/2600354/Centurylink>,
        <https://1145.am/db/2600443/Centurylink>,
        <https://1145.am/db/2601150/Centurylink>,
        <https://1145.am/db/2601827/Centurylink>,
        <https://1145.am/db/2601955/Centurylink>,
        <https://1145.am/db/2602073/Centurylink>,
        <https://1145.am/db/2602780/Centurylink>,
        <https://1145.am/db/2602950/Centurylink>,
        <https://1145.am/db/2603230/Centurylink>,
        <https://1145.am/db/2603347/Centurylink>,
        <https://1145.am/db/2603384/Centurylink>,
        <https://1145.am/db/2603709/Centurylink>,
        <https://1145.am/db/2603774/Centurylink>,
        <https://1145.am/db/2604513/Centurylink>,
        <https://1145.am/db/2605134/Centurylink>,
        <https://1145.am/db/2605657/Centurylink>,
        <https://1145.am/db/2605852/Centurylink>,
        <https://1145.am/db/2606403/Centurylink>,
        <https://1145.am/db/2606522/Centurylink>,
        <https://1145.am/db/2606755/Centurylink>,
        <https://1145.am/db/2606758/Centurylink>,
        <https://1145.am/db/2607951/Centurylink>,
        <https://1145.am/db/2607971/Centurylink>,
        <https://1145.am/db/2608236/Centurylink>,
        <https://1145.am/db/2608799/Centurylink>,
        <https://1145.am/db/2608828/Centurylink>,
        <https://1145.am/db/2609143/Centurylink>,
        <https://1145.am/db/2609173/Centurylink>,
        <https://1145.am/db/2610327/Centurylink>,
        <https://1145.am/db/2610631/Centurylink>,
        <https://1145.am/db/2610971/Centurylink>,
        <https://1145.am/db/2610986/Centurylink>,
        <https://1145.am/db/2611152/Centurylink>,
        <https://1145.am/db/2611710/Centurylink>,
        <https://1145.am/db/2611955/Centurylink>,
        <https://1145.am/db/2612661/Centurylink>,
        <https://1145.am/db/2612672/Centurylink>,
        <https://1145.am/db/2614145/Centurylink>,
        <https://1145.am/db/2614371/Centurylink>,
        <https://1145.am/db/2614841/Centurylink>,
        <https://1145.am/db/2614932/Centurylink>,
        <https://1145.am/db/2615306/Centurylink>,
        <https://1145.am/db/2615496/Centurylink>,
        <https://1145.am/db/2615647/Centurylink>,
        <https://1145.am/db/2616350/Centurylink>,
        <https://1145.am/db/2617783/Centurylink>,
        <https://1145.am/db/2617940/Centurylink>,
        <https://1145.am/db/2617961/Centurylink>,
        <https://1145.am/db/2618678/Centurylink>,
        <https://1145.am/db/2619267/Centurylink>,
        <https://1145.am/db/2620516/Centurylink>,
        <https://1145.am/db/2621090/Centurylink>,
        <https://1145.am/db/2646328/Centurylink> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2598807/Covad_Wireless> a org:Organization ;
    ns1:basedInLowRaw "California" ;
    ns1:description "a pure wireless - based solution or a complementary backup element for their wireline" ;
    ns1:documentDate "2011-04-04T15:42:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TelePacific finishes acquisition of Covad's wireless unit" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/telepacific-finishes-acquisition-covad-s-wireless-unit> ;
    ns1:foundName "Covad Wireless" ;
    ns1:industry "telecom service provider" ;
    ns1:name "Covad Wireless" ;
    ns1:sameAsHigh <https://1145.am/db/2607121/Covad_Communications>,
        <https://1145.am/db/2619165/Covad_Communications>,
        <https://1145.am/db/2620290/Covad_Communications>,
        <https://1145.am/db/2636445/Covad_Communications> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2598807/Covad_Wireless_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-04-04T15:42:09+00:00"^^xsd:dateTime ;
    ns1:documentExtract "By wrapping up its acquisition of MegaPath's NextWeb wireless subsidiary Covad Wireless, TelePacific will have yet another weapon in its product arsenal to target new and existing customers that want a pure wireless - based solution or a complementary backup element for their wireline network service.",
        "Following CenturyLink's much expected closing of its merger with Qwest and EarthLink's deal to acquire CLEC One Communications, TelePacific's completion of its acquisition of MegaPath's NextWeb subsidiary Covad Wireless caps off what has been a busy week for telecom service provider M & A." ;
    ns1:documentTitle "TelePacific finishes acquisition of Covad's wireless unit" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/telepacific-finishes-acquisition-covad-s-wireless-unit> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2598807/Covad_Wireless> ;
    ns1:targetName "Covad Wireless" ;
    ns1:vendor <https://1145.am/db/2598807/Megapaths_Nextweb> ;
    ns1:whereGeoName "California" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:whereRaw "California" .

<https://1145.am/db/2598807/Qwest_And_Earthlink> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2598807/Clec_One_Communications_Acquisition> ;
    ns1:description "mergers" ;
    ns1:documentDate "2011-04-04T15:42:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TelePacific finishes acquisition of Covad's wireless unit" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/telepacific-finishes-acquisition-covad-s-wireless-unit> ;
    ns1:foundName "EarthLink",
        "Qwest",
        "Qwest and EarthLink" ;
    ns1:industry "telecom service provider" ;
    ns1:name "EarthLink",
        "Qwest",
        "Qwest and EarthLink" ;
    ns1:sameAsHigh <https://1145.am/db/2170783/Qwest_Communications>,
        <https://1145.am/db/2174844/Qwest_Communications>,
        <https://1145.am/db/2600228/Qwest>,
        <https://1145.am/db/2600243/Qwest>,
        <https://1145.am/db/2600830/Qwest>,
        <https://1145.am/db/2601482/Qwest>,
        <https://1145.am/db/2606652/Qwest>,
        <https://1145.am/db/2606756/Qwest>,
        <https://1145.am/db/2607927/Qwest>,
        <https://1145.am/db/2611180/Qwest>,
        <https://1145.am/db/2612700/Qwest>,
        <https://1145.am/db/2614530/Qwest_Communications>,
        <https://1145.am/db/2619145/Qwest>,
        <https://1145.am/db/2619262/Qwest>,
        <https://1145.am/db/2662284/Qwest_Communications>,
        <https://1145.am/db/2666626/Qwest_Communications> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2602193/Alog_Data_Centers> a org:Organization ;
    ns1:basedInHighGeoName "Federative Republic of Brazil" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:basedInHighRaw "Brazil" ;
    ns1:documentDate "2011-04-27T11:10:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Equinix gains instant Latin American presence by completing its ALOG acquisition" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/equinix-gains-instant-latin-american-presence-by-completing-its-alog-acquisition> ;
    ns1:foundName "ALOG",
        "ALOG Data Centers" ;
    ns1:industry "data center" ;
    ns1:name "ALOG",
        "ALOG Data Centers" ;
    ns1:sameAsHigh <https://1145.am/db/2601884/Alog_Data_Centers>,
        <https://1145.am/db/2617960/Alog_Data_Centers> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2606756/Centurylink> a org:Organization ;
    ns1:basedInLowRaw "New Mexico" ;
    ns1:buyer <https://1145.am/db/2606756/Joint_Venture_Centurylink_Qwest_Completed> ;
    ns1:documentDate "2011-07-13T12:19:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Citrix acquires Cloud.com; Apple's bet on TV, home automation could be $100B opportunity" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/citrix-acquires-cloud-com-apple-s-bet-tv-home-automation-could-be-100b-opportunity> ;
    ns1:foundName "CenturyLink" ;
    ns1:industry "telecom" ;
    ns1:name "CenturyLink" ;
    ns1:sameAsHigh <https://1145.am/db/1726101/Centurylink>,
        <https://1145.am/db/2164963/Centurylink>,
        <https://1145.am/db/2170676/Centurylink>,
        <https://1145.am/db/2173631/Centurylink>,
        <https://1145.am/db/2174844/Centurylink>,
        <https://1145.am/db/2176128/Centurylink>,
        <https://1145.am/db/2598807/Centurylink>,
        <https://1145.am/db/2598868/Centurylink>,
        <https://1145.am/db/2599592/Centurylink>,
        <https://1145.am/db/2600228/Centurylink>,
        <https://1145.am/db/2600830/Centurylink>,
        <https://1145.am/db/2601482/Centurylink>,
        <https://1145.am/db/2602203/Centurylink>,
        <https://1145.am/db/2603475/Centurylink>,
        <https://1145.am/db/2603762/Centurylink>,
        <https://1145.am/db/2604550/Centurylink>,
        <https://1145.am/db/2604884/Centurylink>,
        <https://1145.am/db/2605249/Centurylink>,
        <https://1145.am/db/2606652/Centurylink>,
        <https://1145.am/db/2606782/Centurylink>,
        <https://1145.am/db/2607902/Centurylink>,
        <https://1145.am/db/2609460/Centurylink>,
        <https://1145.am/db/2609858/Centurylink>,
        <https://1145.am/db/2610372/Centurylink>,
        <https://1145.am/db/2610939/Centurylink>,
        <https://1145.am/db/2610946/Centurylink>,
        <https://1145.am/db/2610972/Centurylink>,
        <https://1145.am/db/2611180/Centurylink>,
        <https://1145.am/db/2612318/Centurylink>,
        <https://1145.am/db/2612700/Centurylink>,
        <https://1145.am/db/2613243/Centurylink>,
        <https://1145.am/db/2613533/Centurylink>,
        <https://1145.am/db/2613610/Centurylink>,
        <https://1145.am/db/2613795/Centurytel>,
        <https://1145.am/db/2614057/Centurylink>,
        <https://1145.am/db/2615666/Centurylink>,
        <https://1145.am/db/2616913/Centurylink>,
        <https://1145.am/db/2617606/Centurylink>,
        <https://1145.am/db/2618881/Centurylink>,
        <https://1145.am/db/2619046/Centurylink>,
        <https://1145.am/db/2662743/Centurylink> ;
    ns1:sameAsMedium <https://1145.am/db/1826002/Centurylink>,
        <https://1145.am/db/1853611/Centurylink>,
        <https://1145.am/db/2158821/Centurylink>,
        <https://1145.am/db/2160022/Centurylink>,
        <https://1145.am/db/2168049/Centurylink>,
        <https://1145.am/db/2168075/Centurylink>,
        <https://1145.am/db/2175230/Centurylink>,
        <https://1145.am/db/2175859/Centurylink>,
        <https://1145.am/db/2600200/Centurylink>,
        <https://1145.am/db/2600243/Centurylink>,
        <https://1145.am/db/2600354/Centurylink>,
        <https://1145.am/db/2600443/Centurylink>,
        <https://1145.am/db/2601150/Centurylink>,
        <https://1145.am/db/2601827/Centurylink>,
        <https://1145.am/db/2601955/Centurylink>,
        <https://1145.am/db/2602073/Centurylink>,
        <https://1145.am/db/2602217/Centurylink>,
        <https://1145.am/db/2602780/Centurylink>,
        <https://1145.am/db/2602950/Centurylink>,
        <https://1145.am/db/2603230/Centurylink>,
        <https://1145.am/db/2603347/Centurylink>,
        <https://1145.am/db/2603384/Centurylink>,
        <https://1145.am/db/2603693/Centurylink>,
        <https://1145.am/db/2603709/Centurylink>,
        <https://1145.am/db/2603774/Centurylink>,
        <https://1145.am/db/2604513/Centurylink>,
        <https://1145.am/db/2605134/Centurylink>,
        <https://1145.am/db/2605657/Centurylink>,
        <https://1145.am/db/2605852/Centurylink>,
        <https://1145.am/db/2606403/Centurylink>,
        <https://1145.am/db/2606522/Centurylink>,
        <https://1145.am/db/2606755/Centurylink>,
        <https://1145.am/db/2606758/Centurylink>,
        <https://1145.am/db/2607951/Centurylink>,
        <https://1145.am/db/2607971/Centurylink>,
        <https://1145.am/db/2608236/Centurylink>,
        <https://1145.am/db/2608799/Centurylink>,
        <https://1145.am/db/2608828/Centurylink>,
        <https://1145.am/db/2609143/Centurylink>,
        <https://1145.am/db/2609173/Centurylink>,
        <https://1145.am/db/2610327/Centurylink>,
        <https://1145.am/db/2610631/Centurylink>,
        <https://1145.am/db/2610971/Centurylink>,
        <https://1145.am/db/2610986/Centurylink>,
        <https://1145.am/db/2611152/Centurylink>,
        <https://1145.am/db/2611710/Centurylink>,
        <https://1145.am/db/2611955/Centurylink>,
        <https://1145.am/db/2612661/Centurylink>,
        <https://1145.am/db/2612672/Centurylink>,
        <https://1145.am/db/2614145/Centurylink>,
        <https://1145.am/db/2614371/Centurylink>,
        <https://1145.am/db/2614841/Centurylink>,
        <https://1145.am/db/2614932/Centurylink>,
        <https://1145.am/db/2615306/Centurylink>,
        <https://1145.am/db/2615496/Centurylink>,
        <https://1145.am/db/2615647/Centurylink>,
        <https://1145.am/db/2616350/Centurylink>,
        <https://1145.am/db/2617783/Centurylink>,
        <https://1145.am/db/2617940/Centurylink>,
        <https://1145.am/db/2617961/Centurylink>,
        <https://1145.am/db/2618678/Centurylink>,
        <https://1145.am/db/2619267/Centurylink>,
        <https://1145.am/db/2620516/Centurylink>,
        <https://1145.am/db/2621090/Centurylink>,
        <https://1145.am/db/2646328/Centurylink> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2606756/Cloudcom> a org:Organization ;
    ns1:documentDate "2011-07-13T12:19:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Citrix acquires Cloud.com; Apple's bet on TV, home automation could be $100B opportunity" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/citrix-acquires-cloud-com-apple-s-bet-tv-home-automation-could-be-100b-opportunity> ;
    ns1:foundName "Cloud.com" ;
    ns1:name "Cloud.com" ;
    ns1:sameAsMedium <https://1145.am/db/1876258/Cloudcom> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2606756/Cloudcom_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-07-13T12:19:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Citrix Systems has acquired Cloud.com to become more of a competitive threat to VMware and Amazon." ;
    ns1:documentTitle "Citrix acquires Cloud.com; Apple's bet on TV, home automation could be $100B opportunity" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/citrix-acquires-cloud-com-apple-s-bet-tv-home-automation-could-be-100b-opportunity> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2606756/Cloudcom> ;
    ns1:targetName "Cloud.com" .

<https://1145.am/db/2606756/Investment_Swisscom_Winterthur_Public_Utilities_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-13T12:19:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Swisscom will invest 60 percent in Winterthur Public Utilities' (WPU) fiber network." ;
    ns1:documentTitle "Citrix acquires Cloud.com; Apple's bet on TV, home automation could be $100B opportunity" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/citrix-acquires-cloud-com-apple-s-bet-tv-home-automation-could-be-100b-opportunity> ;
    ns1:foundName "invest" ;
    ns1:name "invest" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2606756/Winterthur_Public_Utilities> ;
    ns1:targetName "Winterthur Public Utilities" ;
    ns1:whereGeoName "Mexico",
        "Switzerland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2658434/about.rdf>,
        <https://sws.geonames.org/3996063/about.rdf> ;
    ns1:whereRaw "New Mexico",
        "Switzerland" .

<https://1145.am/db/2606756/Qwest> a org:Organization ;
    ns1:basedInLowRaw "New Mexico" ;
    ns1:buyer <https://1145.am/db/2606756/Joint_Venture_Centurylink_Qwest_Completed> ;
    ns1:documentDate "2011-07-13T12:19:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Citrix acquires Cloud.com; Apple's bet on TV, home automation could be $100B opportunity" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/citrix-acquires-cloud-com-apple-s-bet-tv-home-automation-could-be-100b-opportunity> ;
    ns1:foundName "Qwest" ;
    ns1:industry "telecom" ;
    ns1:name "Qwest" ;
    ns1:sameAsHigh <https://1145.am/db/2170783/Qwest_Communications>,
        <https://1145.am/db/2174844/Qwest_Communications>,
        <https://1145.am/db/2598807/Qwest_And_Earthlink>,
        <https://1145.am/db/2600228/Qwest>,
        <https://1145.am/db/2600243/Qwest>,
        <https://1145.am/db/2600830/Qwest>,
        <https://1145.am/db/2601482/Qwest>,
        <https://1145.am/db/2606652/Qwest>,
        <https://1145.am/db/2607927/Qwest>,
        <https://1145.am/db/2611180/Qwest>,
        <https://1145.am/db/2612700/Qwest>,
        <https://1145.am/db/2614530/Qwest_Communications>,
        <https://1145.am/db/2619145/Qwest>,
        <https://1145.am/db/2619262/Qwest>,
        <https://1145.am/db/2662284/Qwest_Communications>,
        <https://1145.am/db/2666626/Qwest_Communications> ;
    ns1:sameAsMedium <https://1145.am/db/2158821/Qwest>,
        <https://1145.am/db/2599826/Qwest>,
        <https://1145.am/db/2600200/Qwest>,
        <https://1145.am/db/2602073/Qwest>,
        <https://1145.am/db/2602950/Qwest>,
        <https://1145.am/db/2603709/Qwest>,
        <https://1145.am/db/2605134/Qwest>,
        <https://1145.am/db/2605249/Qwest>,
        <https://1145.am/db/2610631/Qwest_Corp>,
        <https://1145.am/db/2611152/Qwest>,
        <https://1145.am/db/2611955/Qwest>,
        <https://1145.am/db/2612661/Qwest>,
        <https://1145.am/db/2612672/Qwest>,
        <https://1145.am/db/2613142/Qwest>,
        <https://1145.am/db/2614145/Qwest>,
        <https://1145.am/db/2614932/Qwest>,
        <https://1145.am/db/2615647/Qwest>,
        <https://1145.am/db/2615666/Qwest>,
        <https://1145.am/db/2617940/Qwest>,
        <https://1145.am/db/2617961/Qwest>,
        <https://1145.am/db/2618678/Qwest>,
        <https://1145.am/db/2619267/Qwest>,
        <https://1145.am/db/2662743/Qwest> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2606756/Winterthur_Public_Utilities> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:documentDate "2011-07-13T12:19:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Citrix acquires Cloud.com; Apple's bet on TV, home automation could be $100B opportunity" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/citrix-acquires-cloud-com-apple-s-bet-tv-home-automation-could-be-100b-opportunity> ;
    ns1:foundName "Winterthur Public Utilities" ;
    ns1:name "Winterthur Public Utilities" ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2618630/Bahamas_Telecom_Company_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-02-23T15:46:52+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cable & Wireless formalizes purchase of Bahamas Telecom Company." ;
    ns1:documentTitle "Cable & Wireless to sell off its Bermuda business" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/cable-wireless-to-sell-off-its-bermuda-business> ;
    ns1:foundName "purchase" ;
    ns1:name "purchase" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2618630/Bahamas_Telecom_Company> ;
    ns1:targetName "Bahamas Telecom Company" ;
    ns1:whereGeoName "Commonwealth of The Bahamas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3572887/about.rdf> ;
    ns1:whereRaw "Bahamas" .

<https://1145.am/db/2618630/Investment_Cable___Wireless_Worldwide_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-02-23T15:46:52+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cable & Wireless formalizes purchase of Bahamas Telecom Company." ;
    ns1:documentTitle "Cable & Wireless to sell off its Bermuda business" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/cable-wireless-to-sell-off-its-bermuda-business> ;
    ns1:foundName "purchase" ;
    ns1:name "purchase" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Commonwealth of The Bahamas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3572887/about.rdf> ;
    ns1:whereRaw "Bahamas" .

<https://1145.am/db/2655542/Inmarsat> a org:Organization ;
    ns1:basedInHighGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:basedInHighRaw "UK" ;
    ns1:description "satellite operator" ;
    ns1:documentDate "2011-02-08T01:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Finnish operators lack power; HTC acquires multimedia player" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-finnish-operators-lack-power-htc-acquires-multimedia-player> ;
    ns1:foundName "Inmarsat" ;
    ns1:industry "satellite operator" ;
    ns1:name "Inmarsat" ;
    ns1:sameAsHigh <https://1145.am/db/1084951/Inmarsat>,
        <https://1145.am/db/1096188/Inmarsat>,
        <https://1145.am/db/1120535/Inmarsat>,
        <https://1145.am/db/1132563/Inmarsat>,
        <https://1145.am/db/1153314/Inmarsat>,
        <https://1145.am/db/1240237/Inmarsat>,
        <https://1145.am/db/1348552/Inmarsat>,
        <https://1145.am/db/1420505/Inmarsat>,
        <https://1145.am/db/1429308/Inmarsat>,
        <https://1145.am/db/1705352/Inmarsat>,
        <https://1145.am/db/1710423/Inmarsat>,
        <https://1145.am/db/1999192/Inmarsat>,
        <https://1145.am/db/2620925/Inmarsat>,
        <https://1145.am/db/2635931/Inmarsat>,
        <https://1145.am/db/2642082/Inmarsat>,
        <https://1145.am/db/2642089/Inmarsat>,
        <https://1145.am/db/2669690/Inmarsat>,
        <https://1145.am/db/601860/Inmarsat> ;
    ns1:sameAsMedium <https://1145.am/db/1118237/Inmarsat>,
        <https://1145.am/db/1132192/Inmarsat>,
        <https://1145.am/db/1400989/Inmarsat>,
        <https://1145.am/db/1626553/Inmarsat>,
        <https://1145.am/db/1673636/Inmarsat>,
        <https://1145.am/db/1688858/Inmarsat>,
        <https://1145.am/db/2019158/Inmarsat>,
        <https://1145.am/db/246179/Inmarsat>,
        <https://1145.am/db/2642074/Inmarsat>,
        <https://1145.am/db/2646260/Inmarsat>,
        <https://1145.am/db/2647422/Inmarsat>,
        <https://1145.am/db/2648850/Inmarsat>,
        <https://1145.am/db/2653907/Inmarsat>,
        <https://1145.am/db/2684545/Inmarsat>,
        <https://1145.am/db/893758/Inmarsat_Plc>,
        <https://1145.am/db/895358/Inmarsat_Plc> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2655542/Saffron_Digital> a org:Organization ;
    ns1:basedInHighGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:basedInHighRaw "UK" ;
    ns1:description "digital multimedia" ;
    ns1:documentDate "2011-02-08T01:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Finnish operators lack power; HTC acquires multimedia player" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-finnish-operators-lack-power-htc-acquires-multimedia-player> ;
    ns1:foundName "Saffron Digital" ;
    ns1:industry "digital multimedia" ;
    ns1:name "Saffron Digital" ;
    ns1:sameAsHigh <https://1145.am/db/1878212/Saffron_Digital>,
        <https://1145.am/db/1883625/Saffron_Digital> ;
    ns1:sameAsMedium <https://1145.am/db/2686310/Saffron_Digital> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2655542/Saffron_Digital_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "ipo" ;
    ns1:documentDate "2011-02-08T01:00:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Taiwanese handset maker HTC has bought UK digital multimedia company Saffron Digital for 30m (35.5 million) ." ;
    ns1:documentTitle "Webwire: Finnish operators lack power; HTC acquires multimedia player" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-finnish-operators-lack-power-htc-acquires-multimedia-player> ;
    ns1:foundName "IPO",
        "bought",
        "selling" ;
    ns1:name "IPO",
        "bought",
        "selling" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2655542/Saffron_Digital> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Saffron Digital" ;
    ns1:valueRaw "$ 35 million",
        "30m",
        "25.7 million",
        "35.5 million",
        "484 million" ;
    ns1:vendor <https://1145.am/db/2655542/Aircel>,
        <https://1145.am/db/2655542/Harbinger_Capital> ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2655543/Megalan_Network> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Bulgaria" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/732800/about.rdf> ;
    ns1:basedInHighRaw "Bulgaria" ;
    ns1:description "fixed broadband, IPTV and convergent products" ;
    ns1:documentDate "2011-02-07T01:09:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Telekom Austria completes Bulgaria buys" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/telekom-austria-completes-bulgaria-buys> ;
    ns1:foundName "Megalan",
        "Megalan Network",
        "Megalan and Spectrum Net" ;
    ns1:industry "fixed-line operator" ;
    ns1:name "Megalan",
        "Megalan Network" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2660593/Orascom_Telecom> a org:Organization ;
    ns1:basedInHighGeoName "Arab Republic of Egypt" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/357994/about.rdf> ;
    ns1:basedInHighRaw "Egypt" ;
    ns1:description "cellular operations in Pakistan, Algeria, Tunisia, Bangladesh, Zimbabwe, Namibia, Bur" ;
    ns1:documentDate "2011-03-18T18:05:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vimpelcom becomes global player through $20bn Wind merger" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/vimpelcom-becomes-global-player-through-20bn-wind-merger> ;
    ns1:foundName "Orascom Telecom" ;
    ns1:name "Orascom Telecom" ;
    ns1:sameAsMedium <https://1145.am/db/2654421/Orascom_Telecom>,
        <https://1145.am/db/2655203/Orascom_Telecom>,
        <https://1145.am/db/2656676/Orascom_Telecom>,
        <https://1145.am/db/2657740/Orascom_Telecom>,
        <https://1145.am/db/2668326/Orascom_Telecom>,
        <https://1145.am/db/2671104/Orascom_Telecom>,
        <https://1145.am/db/2673027/Orascom_Telecom>,
        <https://1145.am/db/2675258/Orascom_Telecom>,
        <https://1145.am/db/2676643/Orascom_Telecom>,
        <https://1145.am/db/2676888/Orascom_Telecom>,
        <https://1145.am/db/2678993/Orascom_Telecom> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2660593/Orascom_Telecom_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-03-18T18:05:21+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The deal, which is expected to be finalised by mid-year, will see Vimpelcom own over 51 per cent of Egypt - based Orascom Telecom, which has cellular operations in Pakistan, Algeria, Tunisia, Bangladesh, Zimbabwe, Namibia, Burundi and Canada." ;
    ns1:documentTitle "Vimpelcom becomes global player through $20bn Wind merger" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/vimpelcom-becomes-global-player-through-20bn-wind-merger> ;
    ns1:foundName "own" ;
    ns1:name "own" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2660593/Orascom_Telecom> ;
    ns1:targetName "Orascom Telecom" ;
    ns1:whereGeoName "Arab Republic of Egypt" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/357994/about.rdf> ;
    ns1:whereRaw "Egypt" .

<https://1145.am/db/2660601/Vivo> a org:Organization ;
    ns1:basedInHighGeoName "Federative Republic of Brazil" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:basedInHighRaw "Brazil" ;
    ns1:description "Brazilian carrier" ;
    ns1:documentDate "2011-03-21T01:08:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Telefonica edges nearer to Vivo close" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/telefonica-edges-nearer-to-vivo-close> ;
    ns1:foundName "Vivo" ;
    ns1:industry "carrier" ;
    ns1:name "Vivo" ;
    ns1:sameAsHigh <https://1145.am/db/2652760/Vivo>,
        <https://1145.am/db/2664470/Vivo>,
        <https://1145.am/db/2678894/Vivo> ;
    ns1:sameAsMedium <https://1145.am/db/2653604/Vivo>,
        <https://1145.am/db/2661338/Vivo>,
        <https://1145.am/db/640741/Vivo>,
        <https://1145.am/db/7409/Vivo>,
        <https://1145.am/db/816470/Vivo> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2685799/T-Mobile_Usa> a org:Organization ;
    ns1:basedInLowRaw "USA" ;
    ns1:description "flat-rate carriers" ;
    ns1:documentDate "2011-05-17T14:26:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MetroPCS, Leap open to scooping up divested AT&T/T-Mobile assets" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/metropcs-leap-open-to-scooping-up-divested-at-t-t-mobile-assets> ;
    ns1:foundName "T-Mobile USA" ;
    ns1:name "T-Mobile USA" ;
    ns1:sameAsMedium <https://1145.am/db/1325578/T-Mobile_Us_Inc>,
        <https://1145.am/db/1333909/T-Mobile_Us>,
        <https://1145.am/db/1335192/T-Mobile_Usa>,
        <https://1145.am/db/1335249/T-Mobile_Usa>,
        <https://1145.am/db/1338725/T-Mobile_Us>,
        <https://1145.am/db/1673449/T-Mobile_Us>,
        <https://1145.am/db/1682956/T-Mobile_Us>,
        <https://1145.am/db/1845755/T-Mobile_Us>,
        <https://1145.am/db/1849778/T-Mobile_Usa>,
        <https://1145.am/db/1938719/T-Mobile_Us_Inc>,
        <https://1145.am/db/2050728/T-Mobile_Us>,
        <https://1145.am/db/2113124/T-Mobile_Usa>,
        <https://1145.am/db/2113624/T-Mobile_Us>,
        <https://1145.am/db/2156872/T-Mobile_Us>,
        <https://1145.am/db/2160856/T-Mobile_Us>,
        <https://1145.am/db/2624400/T-Mobile_Usa>,
        <https://1145.am/db/2625058/T-Mobile_Usa>,
        <https://1145.am/db/2625764/T-Mobile_Usa>,
        <https://1145.am/db/2625808/T-Mobile_Usa>,
        <https://1145.am/db/2627253/T-Mobile_Usa>,
        <https://1145.am/db/2627982/T-Mobile_Usa>,
        <https://1145.am/db/2628029/T-Mobile_Usa>,
        <https://1145.am/db/2628936/T-Mobile_Usa>,
        <https://1145.am/db/2628948/T-Mobile_Usa>,
        <https://1145.am/db/2629910/T-Mobile_Usa>,
        <https://1145.am/db/2630839/T-Mobile_Usa>,
        <https://1145.am/db/2639641/T-Mobile_Usa>,
        <https://1145.am/db/2640440/T-Mobile_Usa>,
        <https://1145.am/db/2640631/T-Mobile_Usa>,
        <https://1145.am/db/2643007/T-Mobile_Usa>,
        <https://1145.am/db/2644928/T-Mobile_Us>,
        <https://1145.am/db/2645879/T-Mobile_Us>,
        <https://1145.am/db/2650593/T-Mobile_Us>,
        <https://1145.am/db/2651447/T-Mobile_Usa>,
        <https://1145.am/db/2653683/T-Mobile_Us>,
        <https://1145.am/db/2653777/T-Mobile_Usa>,
        <https://1145.am/db/2654246/T-Mobile_Us>,
        <https://1145.am/db/2654263/T-Mobile_Us>,
        <https://1145.am/db/2655150/T-Mobile_Us>,
        <https://1145.am/db/2655154/T-Mobile_Us>,
        <https://1145.am/db/2656030/T-Mobile_Us>,
        <https://1145.am/db/2656226/T-Mobile_Us>,
        <https://1145.am/db/2656851/T-Mobile_Usa>,
        <https://1145.am/db/2657573/T-Mobile_Usa>,
        <https://1145.am/db/2658024/T-Mobile_Us>,
        <https://1145.am/db/2658043/T-Mobile_Us>,
        <https://1145.am/db/2658068/T-Mobile_Us>,
        <https://1145.am/db/2658213/T-Mobile_Us>,
        <https://1145.am/db/2658466/T-Mobile_Usa>,
        <https://1145.am/db/2658550/T-Mobile_Usa>,
        <https://1145.am/db/2658574/T-Mobile_Usa>,
        <https://1145.am/db/2658575/T-Mobile_Usa>,
        <https://1145.am/db/2659586/T-Mobile_Usa>,
        <https://1145.am/db/2659597/T-Mobile_Usa>,
        <https://1145.am/db/2661143/T-Mobile_Us>,
        <https://1145.am/db/2661274/T-Mobile_Usa>,
        <https://1145.am/db/2661290/T-Mobile_Usa>,
        <https://1145.am/db/2661405/T-Mobile_Us>,
        <https://1145.am/db/2661443/T-Mobile_Us>,
        <https://1145.am/db/2661680/T-Mobile_Usa>,
        <https://1145.am/db/2662808/T-Mobile_Usa>,
        <https://1145.am/db/2662860/T-Mobile_Usa>,
        <https://1145.am/db/2663146/T-Mobile_Us>,
        <https://1145.am/db/2663406/T-Mobile_Usa>,
        <https://1145.am/db/2663421/T-Mobile_Usa>,
        <https://1145.am/db/2663473/T-Mobile_Usa>,
        <https://1145.am/db/2663892/T-Mobile_Usa>,
        <https://1145.am/db/2664422/T-Mobile_Us>,
        <https://1145.am/db/2664500/T-Mobile_Usa>,
        <https://1145.am/db/2664505/T-Mobile_Usa>,
        <https://1145.am/db/2664517/T-Mobile_Usa>,
        <https://1145.am/db/2664547/T-Mobile_Usa>,
        <https://1145.am/db/2664692/T-Mobile_Us>,
        <https://1145.am/db/2665477/T-Mobile_Us>,
        <https://1145.am/db/2665579/T-Mobile_Usa>,
        <https://1145.am/db/2666714/T-Mobile_Usa>,
        <https://1145.am/db/2667620/T-Mobile_Us>,
        <https://1145.am/db/2668208/T-Mobile_Usa>,
        <https://1145.am/db/2668212/T-Mobile_Usa>,
        <https://1145.am/db/2668226/T-Mobile_Usa>,
        <https://1145.am/db/2668687/T-Mobile_Us>,
        <https://1145.am/db/2668814/T-Mobile_Usa>,
        <https://1145.am/db/2669319/T-Mobile_Usa>,
        <https://1145.am/db/2669321/T-Mobile_Usa>,
        <https://1145.am/db/2669338/T-Mobile_Usa>,
        <https://1145.am/db/2669512/T-Mobile_Us>,
        <https://1145.am/db/2669881/T-Mobile_Usa>,
        <https://1145.am/db/2669920/T-Mobile_Usa>,
        <https://1145.am/db/2669926/T-Mobile_Usa>,
        <https://1145.am/db/2670397/T-Mobile_Usa>,
        <https://1145.am/db/2671029/T-Mobile_Usa>,
        <https://1145.am/db/2671585/T-Mobile_Usa>,
        <https://1145.am/db/2671623/T-Mobile_Usa>,
        <https://1145.am/db/2671629/T-Mobile_Usa>,
        <https://1145.am/db/2672172/T-Mobile_Usa>,
        <https://1145.am/db/2672184/T-Mobile_Usa>,
        <https://1145.am/db/2673934/T-Mobile_Usa>,
        <https://1145.am/db/2674405/T-Mobile_Us>,
        <https://1145.am/db/2675647/T-Mobile_Us>,
        <https://1145.am/db/2676846/T-Mobile_Us>,
        <https://1145.am/db/2677262/T-Mobile_Usa>,
        <https://1145.am/db/2677564/T-Mobile_Us>,
        <https://1145.am/db/2677884/T-Mobile_Us>,
        <https://1145.am/db/2678023/T-Mobile_Us>,
        <https://1145.am/db/2679803/T-Mobile_Usa>,
        <https://1145.am/db/2679871/T-Mobile_Us>,
        <https://1145.am/db/2680365/T-Mobile_Usa>,
        <https://1145.am/db/2681282/T-Mobile_Usa>,
        <https://1145.am/db/2681407/T-Mobile_Us>,
        <https://1145.am/db/2681734/T-Mobile_Us>,
        <https://1145.am/db/2681889/T-Mobile_Us>,
        <https://1145.am/db/2682066/T-Mobile_Usa>,
        <https://1145.am/db/2682450/T-Mobile_Us>,
        <https://1145.am/db/2682698/T-Mobile_Usa>,
        <https://1145.am/db/2683912/T-Mobile_Usa>,
        <https://1145.am/db/2684079/T-Mobile_Usa>,
        <https://1145.am/db/2684148/T-Mobile_Us>,
        <https://1145.am/db/2684705/T-Mobile_Usa>,
        <https://1145.am/db/2685202/T-Mobile_Usa>,
        <https://1145.am/db/2685245/T-Mobile_Usa>,
        <https://1145.am/db/2685254/T-Mobile_Usa>,
        <https://1145.am/db/2685267/T-Mobile_Usa>,
        <https://1145.am/db/2685271/T-Mobile_Usa>,
        <https://1145.am/db/2685285/T-Mobile_Usa>,
        <https://1145.am/db/2685505/T-Mobile_Usa>,
        <https://1145.am/db/2685618/T-Mobile_Usa>,
        <https://1145.am/db/2685624/T-Mobile_Usa>,
        <https://1145.am/db/2685654/T-Mobile_Usa>,
        <https://1145.am/db/2685762/T-Mobile_Usa>,
        <https://1145.am/db/2685783/T-Mobile_Usa>,
        <https://1145.am/db/2685811/T-Mobile_Usa>,
        <https://1145.am/db/2685884/T-Mobile_Usa>,
        <https://1145.am/db/2685930/T-Mobile_Usa>,
        <https://1145.am/db/2685940/T-Mobile_Usa>,
        <https://1145.am/db/2686023/T-Mobile_Usa>,
        <https://1145.am/db/2686200/T-Mobile_Usa>,
        <https://1145.am/db/398217/T-Mobile_Us>,
        <https://1145.am/db/461272/T-Mobile_Us_Inc>,
        <https://1145.am/db/479322/T-Mobile_Us>,
        <https://1145.am/db/480217/T-Mobile_Us>,
        <https://1145.am/db/662586/T-Mobile_Usa>,
        <https://1145.am/db/665472/T-Mobile_Usa>,
        <https://1145.am/db/667175/T-Mobile_Usa>,
        <https://1145.am/db/97818/T-Mobile_Us> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2217392/Carefx_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NASHVILLE, Tenn.- (BUSINESS WIRE) - The Raymond James Health Care Investment Banking Group acted as financial advisor to Carefx Corporation in its sale to Harris Corporation (NYSE: HRS) ." ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "sale" ;
    ns1:name "sale" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2217392/Carefx> ;
    ns1:targetName "Carefx" ;
    ns1:whereGeoName "Scottsdale" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5313457/about.rdf> ;
    ns1:whereRaw "Scottsdale, AZ" .

<https://1145.am/db/2217392/Medicity_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentExtract "In the last fifteen months, Raymond James has also served as financial advisor to HLTH Corp. (NASDAQ: HLTH) in its merger with WebMD (NASDAQ: WBMD) ; the acquisition of AMICAS (NASDAQ: AMCS) by Merge Healthcare (NASDAQ: MRGE) ; the sale of Evolution Benefits to Genstar Capital; and the sale of Axolotl to Ingenix, a subsidiary of United Health Group (NYSE: UNH) ; and the sale of Medicity to Aetna (NYSE: AET) representing aggregate transaction value of approximately $ 2.4 billion." ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "sale" ;
    ns1:name "sale" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2217392/Medicity> ;
    ns1:targetName "Medicity" ;
    ns1:valueRaw "approximately $ 2.4 billion" .

<https://1145.am/db/2227037/Investment_Camden_Partners_Essence_Group_Holdings_Corporation_Kleiner_Perkins_Caufield___Byers_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-19T13:30:02+00:00"^^xsd:dateTime ;
    ns1:documentExtract "ST. LOUIS- (BUSINESS WIRE) - Essence Group Holdings Corporation (EGHC) today announced it has raised $ 61 million in a private funding round that includes new investors Camden Partners and Kleiner Perkins Caufield & Byers." ;
    ns1:documentTitle "Essence Group Closes $61 Million Private Investment Round" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/essence-group-closes-61-million-private-investment-round> ;
    ns1:foundName "funding",
        "raised" ;
    ns1:name "funding",
        "raised" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2227037/Essence_Group_Holdings_Corporation> ;
    ns1:valueRaw "$ 61 million" ;
    ns1:whereGeoName "Saint-Louis" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2246452/about.rdf> ;
    ns1:whereRaw "ST. LOUIS" .

<https://1145.am/db/2232720/Davita_Bankruptcy> a ns1:CorporateFinanceActivity ;
    ns1:activityType "bankruptcy" ;
    ns1:basedInHighGeoName "Denver" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5419384/about.rdf> ;
    ns1:basedInHighRaw "Denver" ;
    ns1:description "kidney dialysis" ;
    ns1:documentDate "2011-08-05T15:39:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> The U.S. Attorney's Office for the District of Colorado is investigating Denver - based kidney dialysis firm DaVita, reports the Denver Post." ;
    ns1:documentTitle "Doctors charged with $58M in false Medicare, Medicaid billing; DaVita's physician relationships under investigation;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/doctors-charged-58m-false-medicare-medicaid-billing-davita-s-physician-relationships> ;
    ns1:foundName "DaVita" ;
    ns1:industry "dialysis" ;
    ns1:name "DaVita" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "unknown" ;
    ns1:target <https://1145.am/db/2232720/Davita_Bankruptcy> ;
    ns1:targetName "DaVita" ;
    ns1:whereGeoName "Denver" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5419384/about.rdf> ;
    ns1:whereRaw "Denver" .

<https://1145.am/db/2233192/Operations_Acquisition_Dlp_Healthcare_Medcath_Partners_Medcath_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-05-05T12:21:23+00:00"^^xsd:dateTime ;
    ns1:documentExtract "DURHAM, N.C. & BRENTWOOD, Tenn.- (BUSINESS WIRE) - DLP Healthcare, LLC, a joint venture of Duke University Health System and LifePoint Hospitals, today announced that it has acquired the North Carolina cardiac catheterization operations of MedCath Partners, LLC, an affiliate of MedCath Corporation." ;
    ns1:documentTitle "DLP Healthcare Acquires Operations of MedCath Partners" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/dlp-healthcare-acquires-operations-medcath-partners> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:targetDetails "operations" ;
    ns1:whereGeoName "North Carolina" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4482348/about.rdf> ;
    ns1:whereRaw "North Carolina" .

<https://1145.am/db/2234558/Index_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Sunnyvale" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5400075/about.rdf> ;
    ns1:basedInHighRaw "SUNNYVALE, Calif." ;
    ns1:description "investment" ;
    ns1:documentDate "2011-08-17T12:20:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Centrify Secures $16M in Financing to Expand Distribution and Extend Its On-Premise and Cloud Security Offerings" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/centrify-secures-16m-financing-to-expand-distribution-and-extend-its-premise-and-cloud> ;
    ns1:foundName "Index Ventures" ;
    ns1:investor <https://1145.am/db/2234558/Series_D_Investment_Accel_Partners_Centrify_Corporation_Invesco_Private_Capital_Index_Ventures_Mayfield_Fund_Sigma_Partners_Completed> ;
    ns1:name "Index Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1247967/Index_Ventures>,
        <https://1145.am/db/1490485/Index_Ventures>,
        <https://1145.am/db/1704793/Index_Ventures>,
        <https://1145.am/db/1742878/Index_Ventures>,
        <https://1145.am/db/1746192/Index_Ventures>,
        <https://1145.am/db/1748621/Index_Ventures>,
        <https://1145.am/db/1766059/Index_Ventures>,
        <https://1145.am/db/1780507/Index_Ventures>,
        <https://1145.am/db/1799293/Index_Ventures>,
        <https://1145.am/db/1800172/Index_Ventures>,
        <https://1145.am/db/1849912/Index_Ventures>,
        <https://1145.am/db/1853547/Index_Ventures>,
        <https://1145.am/db/1856171/Index_Ventures>,
        <https://1145.am/db/1876014/Index_Ventures>,
        <https://1145.am/db/1876914/Index_Ventures>,
        <https://1145.am/db/1882301/Index_Ventures>,
        <https://1145.am/db/1893255/Index_Ventures>,
        <https://1145.am/db/1916868/Index_Ventures>,
        <https://1145.am/db/2028609/Index_Ventures>,
        <https://1145.am/db/2060465/Index_Ventures>,
        <https://1145.am/db/217906/Index_Ventures>,
        <https://1145.am/db/2290200/Index_Ventures>,
        <https://1145.am/db/2309847/Index_Ventures>,
        <https://1145.am/db/2327222/Index_Ventures>,
        <https://1145.am/db/2357169/Index_Ventures>,
        <https://1145.am/db/2362737/Index_Ventures>,
        <https://1145.am/db/2589317/Index_Ventures>,
        <https://1145.am/db/317470/Index_Ventures>,
        <https://1145.am/db/318142/Index_Ventures>,
        <https://1145.am/db/348633/Index_Ventures>,
        <https://1145.am/db/475105/Index_Ventures>,
        <https://1145.am/db/539919/Index_Ventures>,
        <https://1145.am/db/578277/Index_Ventures>,
        <https://1145.am/db/633695/Index_Ventures>,
        <https://1145.am/db/709798/Index_Ventures>,
        <https://1145.am/db/854512/Index_Ventures>,
        <https://1145.am/db/893076/Index_Ventures>,
        <https://1145.am/db/893316/Index_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1358814/Index_Ventures>,
        <https://1145.am/db/1493654/Index_Ventures>,
        <https://1145.am/db/1553352/Index_Ventures>,
        <https://1145.am/db/1693951/Index_Ventures>,
        <https://1145.am/db/1694279/Index_Ventures>,
        <https://1145.am/db/1699089/Index_Ventures>,
        <https://1145.am/db/1711587/Index_Ventures>,
        <https://1145.am/db/1711731/Index_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1712506/Index_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1717574/Index_Ventures>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1733028/Index_Ventures>,
        <https://1145.am/db/1735596/Index_Ventures>,
        <https://1145.am/db/1736117/Index_Ventures>,
        <https://1145.am/db/1737079/Index_Ventures>,
        <https://1145.am/db/1737527/Index_Ventures>,
        <https://1145.am/db/1737696/Index_Ventures>,
        <https://1145.am/db/1738402/Index_Ventures>,
        <https://1145.am/db/1738465/Index_Ventures>,
        <https://1145.am/db/1740781/Index_Ventures>,
        <https://1145.am/db/1744753/Index_Ventures>,
        <https://1145.am/db/1745368/Index_Ventures>,
        <https://1145.am/db/1745702/Index_Ventures>,
        <https://1145.am/db/1746800/Index_Ventures>,
        <https://1145.am/db/1746845/Index_Ventures>,
        <https://1145.am/db/1746947/Index_Ventures>,
        <https://1145.am/db/1747153/Index_Ventures>,
        <https://1145.am/db/1747208/Index_Ventures>,
        <https://1145.am/db/1748172/Index_Ventures>,
        <https://1145.am/db/1750406/Index_Ventures>,
        <https://1145.am/db/1750420/Index_Ventures>,
        <https://1145.am/db/1750828/Index_Ventures>,
        <https://1145.am/db/1752154/Index_Ventures>,
        <https://1145.am/db/1755398/Index_Ventures>,
        <https://1145.am/db/1755899/Index_Ventures>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756768/Index_Ventures>,
        <https://1145.am/db/1756873/Index_Ventures>,
        <https://1145.am/db/1758069/Index_Ventures>,
        <https://1145.am/db/1758834/Index_Ventures>,
        <https://1145.am/db/1759939/Index_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760954/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761664/Index_Ventures>,
        <https://1145.am/db/1762988/Index_Ventures>,
        <https://1145.am/db/1763352/Index_Ventures>,
        <https://1145.am/db/1765809/Index_Ventures>,
        <https://1145.am/db/1765870/Index_Ventures>,
        <https://1145.am/db/1766253/Index_Ventures>,
        <https://1145.am/db/1769654/Index_Ventures>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771672/Index_Ventures>,
        <https://1145.am/db/1771734/Index_Ventures>,
        <https://1145.am/db/1771773/Index_Ventures>,
        <https://1145.am/db/1775903/Index_Ventures>,
        <https://1145.am/db/1776139/Index_Ventures>,
        <https://1145.am/db/1776626/Index_Ventures>,
        <https://1145.am/db/1777546/Index_Ventures>,
        <https://1145.am/db/1778195/Index_Ventures>,
        <https://1145.am/db/1780733/Index_Ventures>,
        <https://1145.am/db/1783754/Index_Ventures>,
        <https://1145.am/db/1787471/Index_Ventures>,
        <https://1145.am/db/1787621/Index_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1790777/Index_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791667/Index_Ventures>,
        <https://1145.am/db/1791743/Index_Ventures>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1796201/Index_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1798836/Index_Ventures>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800998/Index_Ventures>,
        <https://1145.am/db/1805201/Index_Ventures>,
        <https://1145.am/db/1805473/Index_Ventures>,
        <https://1145.am/db/1807173/Index_Ventures>,
        <https://1145.am/db/1808484/Index_Ventures>,
        <https://1145.am/db/1809821/Index_Ventures>,
        <https://1145.am/db/1810000/Index_Ventures>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812038/Index_Ventures>,
        <https://1145.am/db/1812890/Index_Ventures>,
        <https://1145.am/db/1813037/Index_Ventures>,
        <https://1145.am/db/1813404/Index_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1819133/Index_Ventures>,
        <https://1145.am/db/1819302/Index_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1823078/Index_Ventures>,
        <https://1145.am/db/1823141/Index_Ventures>,
        <https://1145.am/db/1824561/Index_Ventures>,
        <https://1145.am/db/1828638/Index_Ventures>,
        <https://1145.am/db/1829991/Index_Ventures>,
        <https://1145.am/db/1830023/Index_Ventures>,
        <https://1145.am/db/1831440/Index_Ventures>,
        <https://1145.am/db/1832655/Index_Ventures>,
        <https://1145.am/db/1832808/Index_Ventures>,
        <https://1145.am/db/1832926/Index_Ventures>,
        <https://1145.am/db/1835321/Index_Ventures>,
        <https://1145.am/db/1835516/Index_Ventures>,
        <https://1145.am/db/1836455/Index_Ventures>,
        <https://1145.am/db/1836572/Index_Ventures>,
        <https://1145.am/db/1837081/Index_Ventures>,
        <https://1145.am/db/1837143/Index_Ventures>,
        <https://1145.am/db/1839663/Index_Ventures>,
        <https://1145.am/db/1840137/Index_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1845548/Index_Ventures>,
        <https://1145.am/db/1845841/Index_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846794/Index_Ventures>,
        <https://1145.am/db/1847483/Index_Ventures>,
        <https://1145.am/db/1848631/Index_Ventures>,
        <https://1145.am/db/1849844/Index_Ventures>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1850428/Index_Ventures>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851744/Index_Ventures>,
        <https://1145.am/db/1854191/Index_Ventures>,
        <https://1145.am/db/1856191/Index_Ventures>,
        <https://1145.am/db/1856802/Index_Ventures>,
        <https://1145.am/db/1856967/Index_Ventures>,
        <https://1145.am/db/1857638/Index_Ventures>,
        <https://1145.am/db/1858520/Index_Ventures>,
        <https://1145.am/db/1858521/Index_Ventures>,
        <https://1145.am/db/1862594/Index_Ventures>,
        <https://1145.am/db/1863500/Index_Ventures>,
        <https://1145.am/db/1865106/Index_Ventures>,
        <https://1145.am/db/1865524/Index_Ventures>,
        <https://1145.am/db/1866804/Index_Ventures>,
        <https://1145.am/db/1868923/Index_Ventures>,
        <https://1145.am/db/1868935/Index_Ventures>,
        <https://1145.am/db/1870074/Index_Ventures>,
        <https://1145.am/db/1870079/Index_Ventures>,
        <https://1145.am/db/1870810/Index_Ventures>,
        <https://1145.am/db/1871091/Index_Ventures>,
        <https://1145.am/db/1878630/Index_Ventures>,
        <https://1145.am/db/1880386/Index_Ventures>,
        <https://1145.am/db/1881391/Index_Ventures>,
        <https://1145.am/db/1881430/Index_Ventures>,
        <https://1145.am/db/1882686/Index_Ventures>,
        <https://1145.am/db/1884077/Index_Ventures>,
        <https://1145.am/db/1885147/Index_Ventures>,
        <https://1145.am/db/1890254/Index_Ventures>,
        <https://1145.am/db/1894621/Index_Ventures>,
        <https://1145.am/db/1894627/Index_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1899697/Index_Ventures>,
        <https://1145.am/db/1900904/Index_Ventures>,
        <https://1145.am/db/1902032/Index_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1910957/Index_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915168/Index_Ventures>,
        <https://1145.am/db/1916258/Index_Ventures>,
        <https://1145.am/db/1919238/Index_Ventures>,
        <https://1145.am/db/1967520/Index_Ventures>,
        <https://1145.am/db/1967683/Index_Ventures>,
        <https://1145.am/db/199212/Index_Ventures>,
        <https://1145.am/db/2062814/Index_Ventures>,
        <https://1145.am/db/2127786/Index_Ventures>,
        <https://1145.am/db/2198066/Index_Ventures>,
        <https://1145.am/db/2290088/Index_Ventures>,
        <https://1145.am/db/2297905/Index_Ventures>,
        <https://1145.am/db/2303009/Index_Ventures>,
        <https://1145.am/db/2303849/Index_Ventures>,
        <https://1145.am/db/2309490/Index_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2313410/Index_Ventures>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325147/Index_Ventures>,
        <https://1145.am/db/2333601/Index_Ventures>,
        <https://1145.am/db/2338079/Index_Ventures>,
        <https://1145.am/db/2338193/Index_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2344127/Index_Ventures>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2348012/Index_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2348620/Index_Ventures>,
        <https://1145.am/db/2350031/Index_Ventures>,
        <https://1145.am/db/2352142/Index_Ventures>,
        <https://1145.am/db/2352145/Index_Ventures>,
        <https://1145.am/db/2355609/Index_Ventures>,
        <https://1145.am/db/2355952/Index_Ventures>,
        <https://1145.am/db/2357356/Index_Ventures>,
        <https://1145.am/db/2358233/Index_Ventures>,
        <https://1145.am/db/2358246/Index_Ventures>,
        <https://1145.am/db/2362736/Index_Ventures>,
        <https://1145.am/db/2364597/Index_Ventures>,
        <https://1145.am/db/2364600/Index_Ventures>,
        <https://1145.am/db/2507691/Index_Ventures>,
        <https://1145.am/db/2555540/Index_Ventures>,
        <https://1145.am/db/2643797/Index_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/337401/Index_Ventures>,
        <https://1145.am/db/366983/Index_Ventures>,
        <https://1145.am/db/367008/Index_Ventures>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/707126/Index_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/768008/Index_Ventures>,
        <https://1145.am/db/789218/Index_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/868352/Index_Ventures>,
        <https://1145.am/db/909344/Index_Ventures>,
        <https://1145.am/db/957097/Index_Ventures>,
        <https://1145.am/db/980375/Index_Ventures>,
        <https://1145.am/db/981840/Index_Ventures> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2239374/Sunlink_Health_Systems> a org:Organization ;
    ns1:basedInHighGeoName "Atlanta" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4180439/about.rdf> ;
    ns1:basedInHighRaw "ATLANTA" ;
    ns1:description "health care" ;
    ns1:documentDate "2011-03-03T23:20:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SunLink Health Systems, Inc. Announces the Lease of Its Chilton Medical Center" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/sunlink-health-systems-inc-announces-lease-its-chilton-medical-center> ;
    ns1:foundName "SunLink Health Systems, Inc" ;
    ns1:industry "healthcare" ;
    ns1:name "SunLink Health Systems" ;
    ns1:sameAsHigh <https://1145.am/db/2067321/Sunlink_Health_Systems_Inc>,
        <https://1145.am/db/2230927/Sunlink_Health_Systems>,
        <https://1145.am/db/2231989/Sunlink_Health_Systems>,
        <https://1145.am/db/2232013/Sunlink_Health_Systems>,
        <https://1145.am/db/2237855/Sunlink_Health_Systems>,
        <https://1145.am/db/2242523/Sunlink_Health_Systems>,
        <https://1145.am/db/356847/Sunway>,
        <https://1145.am/db/356858/Sunway>,
        <https://1145.am/db/361200/Sunway_Berhad>,
        <https://1145.am/db/361200/Sunway_Healthcare> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2258082/Acquisition_Blue_Cross_Blue_Shield_Of_Michigan_Independence_Blue_Cross_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-08-12T02:10:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Hoping to significantly expand Medicaid coverage nationwide and increase the presence of Blues plans in the Medicaid market, Blue Cross Blue Shield of Michigan and Independence Blue Cross are jointly acquiring a top-ranked Medicaid HMO plan." ;
    ns1:documentTitle "Blues plans spend $170M to expand into Medicaid" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/blues-plans-spend-170m-to-expand-into-medicaid> ;
    ns1:foundName "acquiring" ;
    ns1:name "acquiring" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Michigan" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5001836/about.rdf> ;
    ns1:whereRaw "Michigan" .

<https://1145.am/db/2258082/Amerihealth_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-08-12T02:10:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The two Blues insurers will spend $ 170 million, of which Michigan Blues initially will pay $ 135 million, to acquire AmeriHealth Mercy Family of Companies, a Philadelphia - based insurer providing Medicaid coverage to recipients in Pennsylvania, South Carolina, and Indiana.",
        "Under the new arrangement, Independence will own 60 percent, and Michigan Blues will own 40 percent of the AmeriHealth, the Philadelphia Inquirer reports." ;
    ns1:documentTitle "Blues plans spend $170M to expand into Medicaid" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/blues-plans-spend-170m-to-expand-into-medicaid> ;
    ns1:foundName "acquire",
        "own" ;
    ns1:name "acquire",
        "own" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2258082/Amerihealth> ;
    ns1:targetName "AmeriHealth" ;
    ns1:valueRaw "$ 135 million",
        "$ 170 million" ;
    ns1:whereGeoName "Philadelphia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4560349/about.rdf> ;
    ns1:whereRaw "Philadelphia" .

<https://1145.am/db/2289564/Raindance_Technologies> a org:Organization ;
    ns1:basedInHighGeoName "Lexington" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4941935/about.rdf> ;
    ns1:basedInHighRaw "Lexington, MA" ;
    ns1:documentDate "2011-01-26T12:42:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CSA Medical snares $10M in first round" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/csa-medical-snares-10m-first-round> ;
    ns1:foundName "RainDance Technologies" ;
    ns1:industry "life science" ;
    ns1:name "RainDance Technologies" ;
    ns1:sameAsHigh <https://1145.am/db/1837464/Raindance>,
        <https://1145.am/db/2338153/Raindance_Technologies>,
        <https://1145.am/db/2340423/Raindance>,
        <https://1145.am/db/2370559/Raindance_Technologies> ;
    ns1:sameAsMedium <https://1145.am/db/2299625/Raindance_Technologies>,
        <https://1145.am/db/2306519/Raindance_Technologies>,
        <https://1145.am/db/2321707/Raindance_Technologies>,
        <https://1145.am/db/2321785/Raindance_Technologies>,
        <https://1145.am/db/2336262/Raindance_Technologies>,
        <https://1145.am/db/2340429/Raindance_Technologies>,
        <https://1145.am/db/2359729/Raindance_Technologies> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2322429/Intervention_Insights> a org:Organization ;
    ns1:description "a start-up" ;
    ns1:documentDate "2011-07-19T12:53:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Bioinformatics upstart Intervention Insights secures $7.2M" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/bioinformatics-upstart-intervention-insights-secures-7-2m> ;
    ns1:foundName "Intervention Insights" ;
    ns1:name "Intervention Insights" ;
    ns1:sameAsMedium <https://1145.am/db/2363854/Intervention_Insights> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339295/Biomedinvest> a org:Organization ;
    ns1:basedInLowRaw "Swiss" ;
    ns1:description "venture equity investment" ;
    ns1:documentDate "2011-05-03T15:32:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Delenex extends its A round to CHF 30.2 million" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/delenex-extends-its-a-round-to-chf-30-2-million> ;
    ns1:foundName "BioMedInvest" ;
    ns1:investor <https://1145.am/db/2339295/Series_A_Investment_Biomedinvest_Delenex_Hbm_Biocapital_Hbm_Bioventures_Novo_Ventures_Sv_Life_Sciences_Vi_Partners_Completed> ;
    ns1:name "BioMedInvest" ;
    ns1:sameAsHigh <https://1145.am/db/1223133/Bioadvance>,
        <https://1145.am/db/1223149/Bioadvance>,
        <https://1145.am/db/1422234/Forbion_Ventures>,
        <https://1145.am/db/1422725/Forbion_Ventures>,
        <https://1145.am/db/1867543/Tpg_Biotech>,
        <https://1145.am/db/1926411/Bioqube_Ventures>,
        <https://1145.am/db/1990861/Bioqube_Ventures>,
        <https://1145.am/db/2060484/Healthtech_Capital>,
        <https://1145.am/db/2155146/Biomatics_Capital_Partners>,
        <https://1145.am/db/2280492/Biovision_Ventures>,
        <https://1145.am/db/2285038/Time_Bioventures>,
        <https://1145.am/db/2286671/Forbion>,
        <https://1145.am/db/2298954/Biossom_Investment_Management>,
        <https://1145.am/db/2298978/Advent_Life_Sciences>,
        <https://1145.am/db/2301741/Bio_*_One_Capital>,
        <https://1145.am/db/2301792/Fonds_Bio-Innovation_Sec>,
        <https://1145.am/db/2302351/Medimmune_Ventures>,
        <https://1145.am/db/2305587/Medimmune_Ventures>,
        <https://1145.am/db/2309840/Bio_Fund>,
        <https://1145.am/db/2310285/Medventure_Associates>,
        <https://1145.am/db/2313322/Biomedinvest>,
        <https://1145.am/db/2313322/Hbm_Bioventures>,
        <https://1145.am/db/2313401/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2313438/Biomedinvest>,
        <https://1145.am/db/2313438/Hbm_Biocapital>,
        <https://1145.am/db/2313438/Hbm_Bioventures>,
        <https://1145.am/db/2313438/Sv_Life_Sciences>,
        <https://1145.am/db/2314400/Hbm_Biocapital>,
        <https://1145.am/db/2314515/Sv_Life_Sciences>,
        <https://1145.am/db/2314573/Avlar_Bioventures>,
        <https://1145.am/db/2316709/Bioadvance_Ventures>,
        <https://1145.am/db/2317737/Mc_Life_Sciences_Ventures>,
        <https://1145.am/db/2317779/Bio_*_One_Capital>,
        <https://1145.am/db/2319360/Medimmune_Ventures>,
        <https://1145.am/db/2321097/Healthcare_Ventures>,
        <https://1145.am/db/2323785/Medimmune_Ventures>,
        <https://1145.am/db/2324015/Medsciences_Capital>,
        <https://1145.am/db/2324195/Lotus_Bioscience_Ventures>,
        <https://1145.am/db/2325831/Bb_Biotech>,
        <https://1145.am/db/2325831/Hbm_Bioventures>,
        <https://1145.am/db/2336109/Biomed_Ventures>,
        <https://1145.am/db/2338673/Hopen_Life_Science_Ventures>,
        <https://1145.am/db/2345037/Biomed_Ventures>,
        <https://1145.am/db/2347571/Advent_Life_Sciences>,
        <https://1145.am/db/2352382/Biomedinvest>,
        <https://1145.am/db/2352633/Advanced_Biotechnologies_Venture_Fund>,
        <https://1145.am/db/2354295/Biomed_Ventures>,
        <https://1145.am/db/2359240/Frontline_Bioventures>,
        <https://1145.am/db/2364853/Medimmune_Ventures>,
        <https://1145.am/db/2365171/Healthcare_Ventures>,
        <https://1145.am/db/2366049/Biomed_Ventures>,
        <https://1145.am/db/2366055/Biomed_Ventures>,
        <https://1145.am/db/2366133/Biopacificventures>,
        <https://1145.am/db/2368251/Sv_Life_Sciences>,
        <https://1145.am/db/2369916/Biomed_Ventures>,
        <https://1145.am/db/363714/Palliare>,
        <https://1145.am/db/564585/Bioqube_Ventures>,
        <https://1145.am/db/566971/Bioqube_Ventures>,
        <https://1145.am/db/684123/Biourja_Ventures>,
        <https://1145.am/db/938108/Bioeconomy_Capital>,
        <https://1145.am/db/971939/I___I_Biotech_Fund>,
        <https://1145.am/db/975114/I___I_Biotech_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2293270/Biomedinvest_Ag>,
        <https://1145.am/db/2298049/Biomedinvest_Ag>,
        <https://1145.am/db/2299180/Biomedinvest>,
        <https://1145.am/db/2307886/Biomedinvest_Ag>,
        <https://1145.am/db/2310922/Biomedinvest>,
        <https://1145.am/db/2318778/Biomedinvest>,
        <https://1145.am/db/2331946/Biomedinvest>,
        <https://1145.am/db/2332658/Biomedinvest>,
        <https://1145.am/db/2332659/Biomedinvest>,
        <https://1145.am/db/2337043/Biomedinvest>,
        <https://1145.am/db/2360125/Biomedinvest>,
        <https://1145.am/db/2360127/Biomedinvest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339295/Sv_Life_Sciences> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:description "venture equity investment" ;
    ns1:documentDate "2011-05-03T15:32:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Delenex extends its A round to CHF 30.2 million" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/delenex-extends-its-a-round-to-chf-30-2-million> ;
    ns1:foundName "SV Life Sciences" ;
    ns1:investor <https://1145.am/db/2339295/Series_A_Investment_Biomedinvest_Delenex_Hbm_Biocapital_Hbm_Bioventures_Novo_Ventures_Sv_Life_Sciences_Vi_Partners_Completed> ;
    ns1:name "SV Life Sciences" ;
    ns1:sameAsHigh <https://1145.am/db/1136096/Biogenerator_Ventures>,
        <https://1145.am/db/2307676/Cdib_Bioscience_Venture_Management>,
        <https://1145.am/db/2322622/Biovest> ;
    ns1:sameAsMedium <https://1145.am/db/2236188/Sv_Life_Sciences>,
        <https://1145.am/db/2246177/Sv_Life_Sciences>,
        <https://1145.am/db/2293662/Sv_Life_Sciences>,
        <https://1145.am/db/2293765/Sv_Life_Sciences>,
        <https://1145.am/db/2297439/Sv_Life_Sciences>,
        <https://1145.am/db/2297604/Sv_Life_Sciences>,
        <https://1145.am/db/2298869/Sv_Life_Sciences>,
        <https://1145.am/db/2300322/Sv_Life_Sciences>,
        <https://1145.am/db/2302994/Sv_Life_Sciences>,
        <https://1145.am/db/2302995/Sv_Life_Sciences>,
        <https://1145.am/db/2305587/Sv_Life_Sciences>,
        <https://1145.am/db/2310485/Sv_Life_Sciences>,
        <https://1145.am/db/2311540/Sv_Life_Sciences>,
        <https://1145.am/db/2312831/Sv_Life_Sciences>,
        <https://1145.am/db/2312833/Sv_Life_Sciences>,
        <https://1145.am/db/2313287/Sv_Life_Sciences>,
        <https://1145.am/db/2313322/Sv_Life_Sciences>,
        <https://1145.am/db/2313438/Sv_Life_Sciences>,
        <https://1145.am/db/2314515/Sv_Life_Sciences>,
        <https://1145.am/db/2314625/Sv_Life_Sciences>,
        <https://1145.am/db/2316038/Sv_Life_Sciences>,
        <https://1145.am/db/2317635/Sv_Life_Sciences>,
        <https://1145.am/db/2319338/Sv_Life_Sciences>,
        <https://1145.am/db/2321713/Sv_Life_Sciences>,
        <https://1145.am/db/2321861/Sv_Life_Sciences>,
        <https://1145.am/db/2321870/Sv_Life_Sciences>,
        <https://1145.am/db/2327405/Sv_Life_Sciences>,
        <https://1145.am/db/2327677/Sv_Life_Sciences>,
        <https://1145.am/db/2328815/Sv_Life_Sciences>,
        <https://1145.am/db/2329550/Sv_Life_Sciences>,
        <https://1145.am/db/2336313/Sv_Life_Sciences>,
        <https://1145.am/db/2336890/Sv_Life_Sciences>,
        <https://1145.am/db/2337166/Sv_Life_Sciences>,
        <https://1145.am/db/2338193/Sv_Life_Sciences>,
        <https://1145.am/db/2338196/Sv_Life_Sciences>,
        <https://1145.am/db/2342260/Sv_Life_Sciences>,
        <https://1145.am/db/2342261/Sv_Life_Sciences>,
        <https://1145.am/db/2342266/Sv_Life_Sciences>,
        <https://1145.am/db/2342284/Sv_Life_Sciences>,
        <https://1145.am/db/2342445/Sv_Life_Sciences>,
        <https://1145.am/db/2342862/Sv_Life_Sciences>,
        <https://1145.am/db/2343467/Sv_Life_Sciences>,
        <https://1145.am/db/2343722/Sv_Life_Sciences>,
        <https://1145.am/db/2343725/Sv_Life_Sciences>,
        <https://1145.am/db/2343737/Sv_Life_Sciences>,
        <https://1145.am/db/2346832/Sv_Life_Sciences>,
        <https://1145.am/db/2347389/Sv_Life_Sciences>,
        <https://1145.am/db/2349406/Sv_Life_Sciences>,
        <https://1145.am/db/2349426/Sv_Life_Sciences>,
        <https://1145.am/db/2350034/Sv_Life_Sciences>,
        <https://1145.am/db/2350720/Sv_Life_Sciences>,
        <https://1145.am/db/2351394/Sv_Life_Sciences>,
        <https://1145.am/db/2351397/Sv_Life_Sciences>,
        <https://1145.am/db/2352382/Sv_Life_Sciences>,
        <https://1145.am/db/2352383/Sv_Life_Sciences>,
        <https://1145.am/db/2353098/Sv_Life_Sciences>,
        <https://1145.am/db/2353439/Sv_Life_Sciences>,
        <https://1145.am/db/2355586/Sv_Life_Sciences>,
        <https://1145.am/db/2356861/Sv_Life_Sciences>,
        <https://1145.am/db/2356876/Sv_Life_Sciences>,
        <https://1145.am/db/2358271/Sv_Life_Sciences>,
        <https://1145.am/db/2358272/Sv_Life_Sciences>,
        <https://1145.am/db/2359125/Sv_Life_Sciences>,
        <https://1145.am/db/2360756/Sv_Life_Sciences>,
        <https://1145.am/db/2360758/Sv_Life_Sciences>,
        <https://1145.am/db/2361065/Sv_Life_Sciences>,
        <https://1145.am/db/2365315/Sv_Life_Sciences>,
        <https://1145.am/db/2366519/Sv_Life_Sciences>,
        <https://1145.am/db/2366860/Sv_Life_Sciences>,
        <https://1145.am/db/2368251/Sv_Life_Sciences>,
        <https://1145.am/db/2368572/Sv_Life_Sciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340429/Raindance_Technologies> a org:Organization ;
    ns1:basedInLowRaw "India" ;
    ns1:description "Business" ;
    ns1:documentDate "2011-01-25T13:21:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RainDance Technologies Raises $37.5 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/raindance-technologies-raises-37-5-million-series-d-financing> ;
    ns1:foundName "RainDance Technologies",
        "RainDance Technologies, Inc." ;
    ns1:name "RainDance Technologies" ;
    ns1:sameAsHigh <https://1145.am/db/2321707/Raindance_Technologies>,
        <https://1145.am/db/2359729/Raindance_Technologies> ;
    ns1:sameAsMedium <https://1145.am/db/2289564/Raindance_Technologies>,
        <https://1145.am/db/2299625/Raindance_Technologies>,
        <https://1145.am/db/2306519/Raindance_Technologies>,
        <https://1145.am/db/2321785/Raindance_Technologies>,
        <https://1145.am/db/2336262/Raindance_Technologies>,
        <https://1145.am/db/2338153/Raindance_Technologies>,
        <https://1145.am/db/2370559/Raindance_Technologies> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341068/Shire> a org:Organization ;
    ns1:basedInLowRaw "Ill" ;
    ns1:description "psychiatry and neurology" ;
    ns1:documentDate "2011-05-11T12:18:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $18 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-18-million-series-a-financing> ;
    ns1:foundName "Shire" ;
    ns1:investor <https://1145.am/db/2341068/Series_A_Investment_Adams_Street_Partners_Druid_Bioventures_Genesys_Capital_Pathocapital_Lundbeck_Takeda_Venture_Latterell_Venture_Partners_Naurex_Inc_Pathocapital_Lundbeck_Takeda_Ventures_Inc_Shire_Completed> ;
    ns1:name "Shire" ;
    ns1:sameAsMedium <https://1145.am/db/142937/Shire_Plc>,
        <https://1145.am/db/2155273/Shire>,
        <https://1145.am/db/2225348/Shire_Plc>,
        <https://1145.am/db/2225352/Shire_Plc>,
        <https://1145.am/db/2288537/Shire>,
        <https://1145.am/db/2290932/Shire>,
        <https://1145.am/db/2291354/Shire>,
        <https://1145.am/db/2292991/Shire>,
        <https://1145.am/db/2293472/Shire>,
        <https://1145.am/db/2296208/Shire>,
        <https://1145.am/db/2296243/Shire>,
        <https://1145.am/db/2297066/Shire>,
        <https://1145.am/db/2298391/Shire>,
        <https://1145.am/db/2300483/Shire>,
        <https://1145.am/db/2302783/Shire_Limited>,
        <https://1145.am/db/2303789/Shire>,
        <https://1145.am/db/2305581/Shire_Plc>,
        <https://1145.am/db/2306762/Shire>,
        <https://1145.am/db/2310002/Shire>,
        <https://1145.am/db/2314408/Shire_Limited>,
        <https://1145.am/db/2320137/Shire>,
        <https://1145.am/db/2320509/Shire>,
        <https://1145.am/db/2324621/Shire_Plc>,
        <https://1145.am/db/2326381/Shire_Plc>,
        <https://1145.am/db/2328189/Shire>,
        <https://1145.am/db/2328788/Shire_Plc>,
        <https://1145.am/db/2331795/Shire_Plc>,
        <https://1145.am/db/2332620/Shire>,
        <https://1145.am/db/2333419/Shire>,
        <https://1145.am/db/2335641/Shire>,
        <https://1145.am/db/2336126/Shire_Plc>,
        <https://1145.am/db/2336575/Shire>,
        <https://1145.am/db/2336581/Shire>,
        <https://1145.am/db/2336708/Shire>,
        <https://1145.am/db/2338009/Shire>,
        <https://1145.am/db/2338011/Shire>,
        <https://1145.am/db/2339117/Shire>,
        <https://1145.am/db/2339733/Shire_Plc>,
        <https://1145.am/db/2340560/Shire>,
        <https://1145.am/db/2340566/Shire_Plc>,
        <https://1145.am/db/2340575/Shire>,
        <https://1145.am/db/2341074/Shire>,
        <https://1145.am/db/2341522/Shire>,
        <https://1145.am/db/2341828/Shire_Plc>,
        <https://1145.am/db/2341829/Shire>,
        <https://1145.am/db/2341838/Shire>,
        <https://1145.am/db/2341902/Shire>,
        <https://1145.am/db/2342514/Shire>,
        <https://1145.am/db/2342570/Shire>,
        <https://1145.am/db/2344160/Shire>,
        <https://1145.am/db/2344202/Shire>,
        <https://1145.am/db/2344205/Shire>,
        <https://1145.am/db/2344913/Shire>,
        <https://1145.am/db/2344914/Shire_Plc>,
        <https://1145.am/db/2344928/Shire_Plc>,
        <https://1145.am/db/2345096/Shire>,
        <https://1145.am/db/2345238/Shire>,
        <https://1145.am/db/2345248/Shire_Plc>,
        <https://1145.am/db/2345825/Shire_Plc>,
        <https://1145.am/db/2345826/Shire_Plc>,
        <https://1145.am/db/2346202/Shire>,
        <https://1145.am/db/2346640/Shire>,
        <https://1145.am/db/2346644/Shire_Plc>,
        <https://1145.am/db/2346646/Shire_Plc>,
        <https://1145.am/db/2346752/Shire_Plc>,
        <https://1145.am/db/2346863/Shire_Plc>,
        <https://1145.am/db/2346872/Shire_Plc>,
        <https://1145.am/db/2346879/Shire>,
        <https://1145.am/db/2347646/Shire_Plc>,
        <https://1145.am/db/2347772/Shire>,
        <https://1145.am/db/2348523/Shire>,
        <https://1145.am/db/2348661/Shire>,
        <https://1145.am/db/2348742/Shire>,
        <https://1145.am/db/2348750/Shire>,
        <https://1145.am/db/2348805/Shire>,
        <https://1145.am/db/2350265/Shire_Plc>,
        <https://1145.am/db/2351482/Shire>,
        <https://1145.am/db/2351483/Shire>,
        <https://1145.am/db/2351734/Shire_Llc>,
        <https://1145.am/db/2351737/Shire_Llc>,
        <https://1145.am/db/2351754/Shire>,
        <https://1145.am/db/2352906/Shire>,
        <https://1145.am/db/2353283/Shire_Plc>,
        <https://1145.am/db/2354266/Shire_Llc>,
        <https://1145.am/db/2354277/Shire>,
        <https://1145.am/db/2356384/Shire>,
        <https://1145.am/db/2357032/Shire>,
        <https://1145.am/db/2357116/Shire>,
        <https://1145.am/db/2357487/Shire>,
        <https://1145.am/db/2359634/Shire>,
        <https://1145.am/db/2359681/Shire>,
        <https://1145.am/db/2360712/Shire_Plc>,
        <https://1145.am/db/2361514/Shire_Plc>,
        <https://1145.am/db/2361640/Shire_Plc>,
        <https://1145.am/db/2361641/Shire>,
        <https://1145.am/db/2362744/Shire>,
        <https://1145.am/db/2364136/Shire_Plc>,
        <https://1145.am/db/2364149/Shire_Plc>,
        <https://1145.am/db/2364556/Shire>,
        <https://1145.am/db/2364813/Shire>,
        <https://1145.am/db/2365002/Shire_Plc>,
        <https://1145.am/db/2365826/Shire_Plc>,
        <https://1145.am/db/2366303/Shire>,
        <https://1145.am/db/2367132/Shire_Plc>,
        <https://1145.am/db/2367297/Shire>,
        <https://1145.am/db/2368144/Shire>,
        <https://1145.am/db/2368862/Shire>,
        <https://1145.am/db/2368885/Shire>,
        <https://1145.am/db/2368915/Shire>,
        <https://1145.am/db/2368936/Shire>,
        <https://1145.am/db/2369141/Shire>,
        <https://1145.am/db/2369701/Shire>,
        <https://1145.am/db/2369949/Shire>,
        <https://1145.am/db/2370010/Shire>,
        <https://1145.am/db/2370189/Shire>,
        <https://1145.am/db/2370358/Shire>,
        <https://1145.am/db/2370514/Shire>,
        <https://1145.am/db/2370740/Shire>,
        <https://1145.am/db/2371519/Shire>,
        <https://1145.am/db/2371522/Shire>,
        <https://1145.am/db/2537396/Shire>,
        <https://1145.am/db/2539292/Shire>,
        <https://1145.am/db/2541146/Shire>,
        <https://1145.am/db/2544223/Shire>,
        <https://1145.am/db/2544434/Shire>,
        <https://1145.am/db/2544459/Shire>,
        <https://1145.am/db/2544726/Shire>,
        <https://1145.am/db/2546262/Shire>,
        <https://1145.am/db/2546291/Shire>,
        <https://1145.am/db/2547036/Shire>,
        <https://1145.am/db/2547277/Shire>,
        <https://1145.am/db/2547575/Shire_Plc>,
        <https://1145.am/db/2548051/Shire>,
        <https://1145.am/db/2548805/Shire>,
        <https://1145.am/db/2548859/Shire>,
        <https://1145.am/db/2548979/Shire>,
        <https://1145.am/db/2550985/Shire>,
        <https://1145.am/db/2552180/Shire>,
        <https://1145.am/db/2552455/Shire>,
        <https://1145.am/db/2554269/Shire>,
        <https://1145.am/db/2554294/Shire>,
        <https://1145.am/db/2556988/Shire>,
        <https://1145.am/db/2558927/Shire>,
        <https://1145.am/db/2559769/Shire>,
        <https://1145.am/db/2561541/Shire>,
        <https://1145.am/db/2563175/Shire>,
        <https://1145.am/db/2564899/Shire>,
        <https://1145.am/db/2565613/Shire>,
        <https://1145.am/db/2566716/Shire>,
        <https://1145.am/db/2569388/Shire>,
        <https://1145.am/db/2569952/Shire>,
        <https://1145.am/db/2570020/Shire>,
        <https://1145.am/db/2570036/Shire>,
        <https://1145.am/db/2570363/Shire>,
        <https://1145.am/db/2570733/Shire_Plc>,
        <https://1145.am/db/2570807/Shire>,
        <https://1145.am/db/2571521/Shire>,
        <https://1145.am/db/2571526/Shire>,
        <https://1145.am/db/2572113/Shire_Plc>,
        <https://1145.am/db/2572335/Shire>,
        <https://1145.am/db/2572559/Shire>,
        <https://1145.am/db/2573463/Shire>,
        <https://1145.am/db/2573508/Shire>,
        <https://1145.am/db/2574443/Shire>,
        <https://1145.am/db/2574731/Shire>,
        <https://1145.am/db/2575050/Shire>,
        <https://1145.am/db/2575259/Shire>,
        <https://1145.am/db/2576815/Shire>,
        <https://1145.am/db/2576959/Shire>,
        <https://1145.am/db/2577114/Shire>,
        <https://1145.am/db/2577117/Shire>,
        <https://1145.am/db/2577176/Shire_Plc>,
        <https://1145.am/db/2577652/Shire_Plc>,
        <https://1145.am/db/2577793/Shire_Plc>,
        <https://1145.am/db/2578085/Shire_Plc>,
        <https://1145.am/db/2578319/Shire>,
        <https://1145.am/db/2578503/Shire>,
        <https://1145.am/db/2578568/Shire>,
        <https://1145.am/db/2579035/Shire_Plc>,
        <https://1145.am/db/2579062/Shire_Plc>,
        <https://1145.am/db/2580279/Shire>,
        <https://1145.am/db/2580603/Shire>,
        <https://1145.am/db/2580620/Shire>,
        <https://1145.am/db/2580622/Shire>,
        <https://1145.am/db/2580747/Shire>,
        <https://1145.am/db/2581261/Shire>,
        <https://1145.am/db/2582265/Shire>,
        <https://1145.am/db/2583177/Shire>,
        <https://1145.am/db/2583624/Shire_Plc>,
        <https://1145.am/db/2583662/Shire>,
        <https://1145.am/db/2584216/Shire>,
        <https://1145.am/db/2585066/Shire>,
        <https://1145.am/db/2585132/Shire>,
        <https://1145.am/db/2586132/Shire>,
        <https://1145.am/db/2586884/Shire>,
        <https://1145.am/db/2586889/Shire>,
        <https://1145.am/db/2587094/Shire>,
        <https://1145.am/db/2587511/Shire>,
        <https://1145.am/db/2588152/Shire>,
        <https://1145.am/db/2589981/Shire_Plc>,
        <https://1145.am/db/2591412/Shire>,
        <https://1145.am/db/2592333/Shire>,
        <https://1145.am/db/2592336/Shire>,
        <https://1145.am/db/2592562/Shire>,
        <https://1145.am/db/2595190/Shire>,
        <https://1145.am/db/2595210/Shire>,
        <https://1145.am/db/2597158/Shire>,
        <https://1145.am/db/2598205/Shire>,
        <https://1145.am/db/2976/Shire> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342445/Sv_Life_Sciences> a org:Organization ;
    ns1:basedInLowRaw "Bedford, MA" ;
    ns1:documentDate "2011-02-03T15:22:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ocular Therapeutix garners $14M for mid-stage eye drug trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ocular-therapeutix-garners-14m-for-mid-stage-eye-drug-trials> ;
    ns1:foundName "SV Life Sciences" ;
    ns1:investor <https://1145.am/db/2342445/Investment_Ascension_Health_Ventures_Ocular_Therapeutix_Polaris_Venture_Partners_Sv_Life_Sciences_Versant_Ventures_Completed> ;
    ns1:name "SV Life Sciences" ;
    ns1:sameAsMedium <https://1145.am/db/2236188/Sv_Life_Sciences>,
        <https://1145.am/db/2246177/Sv_Life_Sciences>,
        <https://1145.am/db/2293662/Sv_Life_Sciences>,
        <https://1145.am/db/2293765/Sv_Life_Sciences>,
        <https://1145.am/db/2297439/Sv_Life_Sciences>,
        <https://1145.am/db/2297604/Sv_Life_Sciences>,
        <https://1145.am/db/2298869/Sv_Life_Sciences>,
        <https://1145.am/db/2300322/Sv_Life_Sciences>,
        <https://1145.am/db/2302994/Sv_Life_Sciences>,
        <https://1145.am/db/2302995/Sv_Life_Sciences>,
        <https://1145.am/db/2305587/Sv_Life_Sciences>,
        <https://1145.am/db/2310485/Sv_Life_Sciences>,
        <https://1145.am/db/2311540/Sv_Life_Sciences>,
        <https://1145.am/db/2312831/Sv_Life_Sciences>,
        <https://1145.am/db/2312833/Sv_Life_Sciences>,
        <https://1145.am/db/2313287/Sv_Life_Sciences>,
        <https://1145.am/db/2313322/Sv_Life_Sciences>,
        <https://1145.am/db/2313438/Sv_Life_Sciences>,
        <https://1145.am/db/2314515/Sv_Life_Sciences>,
        <https://1145.am/db/2314625/Sv_Life_Sciences>,
        <https://1145.am/db/2316038/Sv_Life_Sciences>,
        <https://1145.am/db/2317635/Sv_Life_Sciences>,
        <https://1145.am/db/2319338/Sv_Life_Sciences>,
        <https://1145.am/db/2321713/Sv_Life_Sciences>,
        <https://1145.am/db/2321861/Sv_Life_Sciences>,
        <https://1145.am/db/2321870/Sv_Life_Sciences>,
        <https://1145.am/db/2327405/Sv_Life_Sciences>,
        <https://1145.am/db/2327677/Sv_Life_Sciences>,
        <https://1145.am/db/2328815/Sv_Life_Sciences>,
        <https://1145.am/db/2329550/Sv_Life_Sciences>,
        <https://1145.am/db/2336313/Sv_Life_Sciences>,
        <https://1145.am/db/2336890/Sv_Life_Sciences>,
        <https://1145.am/db/2337166/Sv_Life_Sciences>,
        <https://1145.am/db/2338193/Sv_Life_Sciences>,
        <https://1145.am/db/2338196/Sv_Life_Sciences>,
        <https://1145.am/db/2339295/Sv_Life_Sciences>,
        <https://1145.am/db/2342260/Sv_Life_Sciences>,
        <https://1145.am/db/2342261/Sv_Life_Sciences>,
        <https://1145.am/db/2342266/Sv_Life_Sciences>,
        <https://1145.am/db/2342284/Sv_Life_Sciences>,
        <https://1145.am/db/2342862/Sv_Life_Sciences>,
        <https://1145.am/db/2343467/Sv_Life_Sciences>,
        <https://1145.am/db/2343722/Sv_Life_Sciences>,
        <https://1145.am/db/2343725/Sv_Life_Sciences>,
        <https://1145.am/db/2343737/Sv_Life_Sciences>,
        <https://1145.am/db/2346832/Sv_Life_Sciences>,
        <https://1145.am/db/2347389/Sv_Life_Sciences>,
        <https://1145.am/db/2349406/Sv_Life_Sciences>,
        <https://1145.am/db/2349426/Sv_Life_Sciences>,
        <https://1145.am/db/2350034/Sv_Life_Sciences>,
        <https://1145.am/db/2350720/Sv_Life_Sciences>,
        <https://1145.am/db/2351394/Sv_Life_Sciences>,
        <https://1145.am/db/2351397/Sv_Life_Sciences>,
        <https://1145.am/db/2352382/Sv_Life_Sciences>,
        <https://1145.am/db/2352383/Sv_Life_Sciences>,
        <https://1145.am/db/2353098/Sv_Life_Sciences>,
        <https://1145.am/db/2353439/Sv_Life_Sciences>,
        <https://1145.am/db/2355586/Sv_Life_Sciences>,
        <https://1145.am/db/2356861/Sv_Life_Sciences>,
        <https://1145.am/db/2356876/Sv_Life_Sciences>,
        <https://1145.am/db/2358271/Sv_Life_Sciences>,
        <https://1145.am/db/2358272/Sv_Life_Sciences>,
        <https://1145.am/db/2359125/Sv_Life_Sciences>,
        <https://1145.am/db/2360756/Sv_Life_Sciences>,
        <https://1145.am/db/2360758/Sv_Life_Sciences>,
        <https://1145.am/db/2361065/Sv_Life_Sciences>,
        <https://1145.am/db/2365315/Sv_Life_Sciences>,
        <https://1145.am/db/2366519/Sv_Life_Sciences>,
        <https://1145.am/db/2366860/Sv_Life_Sciences>,
        <https://1145.am/db/2368251/Sv_Life_Sciences>,
        <https://1145.am/db/2368572/Sv_Life_Sciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344507/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInHighGeoName "Mesa" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5304391/about.rdf> ;
    ns1:basedInHighRaw "MESA, Ariz." ;
    ns1:documentDate "2011-02-09T12:47:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ulthera Announces $10.5 Million in Series C Venture Capital Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ulthera-announces-10-5-million-series-c-venture-capital-funding> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2344507/Venture_Investment_Apposite_Capital_Llp_New_Enterprise_Associates_Ulthera_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344507/Venture_Investment_Apposite_Capital_Llp_New_Enterprise_Associates_Ulthera_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-02-09T12:47:17+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MESA, Ariz., Feb. 8, 2011 /PRNewswire/ - Ulthera, Inc., developer of the Ulthera System, the first-ever ultrasound device approved by the FDA for aesthetics, announced today the recent completion of $ 10.5 million in Series C venture funding.",
        "Ulthera Announces $ 10.5 Million in Series C Venture Capital Funding." ;
    ns1:documentTitle "Ulthera Announces $10.5 Million in Series C Venture Capital Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ulthera-announces-10-5-million-series-c-venture-capital-funding> ;
    ns1:foundName "Funding",
        "funding" ;
    ns1:name "Funding",
        "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2344507/Ulthera> ;
    ns1:targetDetails "Venture Capital",
        "venture" ;
    ns1:valueRaw "$ 10.5 Million",
        "$ 10.5 million" ;
    ns1:when "2011-02-08T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Feb. 8, 2011" ;
    ns1:whereGeoName "Mesa" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5304391/about.rdf> ;
    ns1:whereRaw "MESA, Ariz" .

<https://1145.am/db/2345206/Subsidiaries_Acquisition_Clinipace_Worldwide_Pfc_Pharma_Focus_Ltd_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-05-23T13:55:58+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MORRISVILLE, N.C. & ZURICH, SWITZERLAND- (BUSINESS WIRE) -Clinipace Worldwide, a global digital clinical research organization (dCRO) , and Swiss - based PFC Pharma Focus (PFC) today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of privately-held PFC and its subsidiaries." ;
    ns1:documentTitle "Clinipace Worldwide Acquires Switzerland-Based PFC Pharma Focus Ltd." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clinipace-worldwide-acquires-switzerland-based-pfc-pharma-focus-ltd> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:targetDetails "subsidiaries" ;
    ns1:whereGeoName "Federal Republic of Germany",
        "Republic of India",
        "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf>,
        <https://sws.geonames.org/2921044/about.rdf>,
        <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Germany, Israel and India" .

<https://1145.am/db/2346204/Mpm_Capital> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "equity financing" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "MPM Capital" ;
    ns1:investor <https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> ;
    ns1:name "MPM Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2300455/Mpm_Capital>,
        <https://1145.am/db/2303855/Mpm_Capital>,
        <https://1145.am/db/2312309/Mpm_Capital>,
        <https://1145.am/db/2323563/Mpm_Capital>,
        <https://1145.am/db/2335701/Mpm_Capital>,
        <https://1145.am/db/2347469/Mpm_Capital>,
        <https://1145.am/db/2356396/Mpm_Capital>,
        <https://1145.am/db/2359001/Mpm_Capital>,
        <https://1145.am/db/2367199/Mpm_Capital>,
        <https://1145.am/db/2541350/Mpm_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1325968/Mpm_Capital>,
        <https://1145.am/db/1752458/Mpm_Capital>,
        <https://1145.am/db/2285876/Mpm_Capital>,
        <https://1145.am/db/2287191/Mpm_Capital>,
        <https://1145.am/db/2292334/Mpm_Capital>,
        <https://1145.am/db/2292353/Mpm_Capital>,
        <https://1145.am/db/2301901/Mpm_Capital>,
        <https://1145.am/db/2303391/Mpm_Capital>,
        <https://1145.am/db/2303833/Mpm_Capital>,
        <https://1145.am/db/2304634/Mpm_Capital>,
        <https://1145.am/db/2305503/Mpm_Capital>,
        <https://1145.am/db/2305656/Mpm_Capital>,
        <https://1145.am/db/2306705/Mpm_Capital>,
        <https://1145.am/db/2308887/Mpm_Capital>,
        <https://1145.am/db/2309845/Mpm_Capital>,
        <https://1145.am/db/2311551/Mpm_Capital>,
        <https://1145.am/db/2312285/Mpm_Capital>,
        <https://1145.am/db/2316391/Mpm_Capital>,
        <https://1145.am/db/2323055/Mpm_Capital>,
        <https://1145.am/db/2323066/Mpm_Capital>,
        <https://1145.am/db/2323094/Mpm_Capital>,
        <https://1145.am/db/2323568/Mpm_Capital>,
        <https://1145.am/db/2324195/Mpm_Capital>,
        <https://1145.am/db/2324226/Mpm_Capital>,
        <https://1145.am/db/2328338/Mpm_Capital>,
        <https://1145.am/db/2333119/Mpm_Capital>,
        <https://1145.am/db/2333525/Mpm_Capital>,
        <https://1145.am/db/2335714/Mpm_Capital>,
        <https://1145.am/db/2337140/Mpm_Capital>,
        <https://1145.am/db/2340957/Mpm_Capital>,
        <https://1145.am/db/2345299/Mpm_Capital>,
        <https://1145.am/db/2345318/Mpm_Capital>,
        <https://1145.am/db/2347140/Mpm_Capital>,
        <https://1145.am/db/2347984/Mpm_Capital>,
        <https://1145.am/db/2348484/Mpm_Capital>,
        <https://1145.am/db/2350030/Mpm_Capital>,
        <https://1145.am/db/2352172/Mpm_Capital>,
        <https://1145.am/db/2352362/Mpm_Capital>,
        <https://1145.am/db/2352899/Mpm_Capital>,
        <https://1145.am/db/2353365/Mpm_Capital>,
        <https://1145.am/db/2353404/Mpm_Capital>,
        <https://1145.am/db/2353413/Mpm_Capital>,
        <https://1145.am/db/2353415/Mpm_Capital>,
        <https://1145.am/db/2358979/Mpm_Capital>,
        <https://1145.am/db/2359873/Mpm_Capital>,
        <https://1145.am/db/2359875/Mpm_Capital>,
        <https://1145.am/db/2360526/Mpm_Capital>,
        <https://1145.am/db/2362871/Mpm_Capital>,
        <https://1145.am/db/2364492/Mpm_Capital>,
        <https://1145.am/db/2365098/Mpm_Capital>,
        <https://1145.am/db/2366744/Mpm_Capital>,
        <https://1145.am/db/2369202/Mpm_Capital>,
        <https://1145.am/db/2370582/Mpm_Capital>,
        <https://1145.am/db/677075/Mpm_Capital>,
        <https://1145.am/db/678997/Mpm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346532/New_Leaf_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:documentDate "2011-02-14T14:19:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Chimerix, Inc. Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/chimerix-inc-completes-45-million-financing-to-fund-further-development-of-novel-antiviral> ;
    ns1:foundName "New Leaf Venture Partners" ;
    ns1:investor <https://1145.am/db/2346532/Series_F_Investment_Alta_Partners_Asset_Management_Company_Canaan_Partners_Chimerix_Frazier_Healthcare_Ventures_Morningside_Group_New_Leaf_Venture_Partners_Pappas_Ventures_Sanderling_Ventures_Completed> ;
    ns1:name "New Leaf Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1287338/New_Leaf_Venture_Partners>,
        <https://1145.am/db/1749104/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2151983/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2155668/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2208603/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2289585/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2293765/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2298642/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2300322/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301824/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301828/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305507/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305514/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2307682/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2311595/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2312792/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315071/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315932/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315934/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2316674/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2317919/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318656/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318657/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325326/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325398/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334479/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334797/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2341003/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342925/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342937/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2343298/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345037/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345047/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346542/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347043/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347571/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347876/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347878/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348149/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348618/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2349120/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350164/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350167/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350491/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2352059/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2357356/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2359683/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2360174/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2361416/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362736/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362737/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2366860/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2569522/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2594141/New_Leaf_Venture_Partners>,
        <https://1145.am/db/425953/New_Leaf_Venture_Partners>,
        <https://1145.am/db/583528/New_Leaf_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347571/Advent_Life_Sciences> a org:Organization ;
    ns1:basedInLowRaw "MOUNTAIN VIEW, CA" ;
    ns1:description "Venture Capital" ;
    ns1:documentDate "2011-02-16T15:02:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Versartis Completes $21 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/versartis-completes-21-million-series-b-financing-0> ;
    ns1:foundName "Advent Life Sciences" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2347571/Series_B_Investment_Advent_Life_Sciences_Amunix_Index_Ventures_New_Leaf_Venture_Partners_Versartis_Completed> ;
    ns1:name "Advent Life Sciences" ;
    ns1:sameAsHigh <https://1145.am/db/1048034/Exicure>,
        <https://1145.am/db/1054185/Exicure>,
        <https://1145.am/db/1064384/Celcuity_Inc>,
        <https://1145.am/db/1070403/Projenx_Inc>,
        <https://1145.am/db/1070709/Celularity_Inc>,
        <https://1145.am/db/1105043/Celularity>,
        <https://1145.am/db/1195567/Sqz_Biotechnologies>,
        <https://1145.am/db/1198717/Sqz_Biotechnologies>,
        <https://1145.am/db/1215930/Enavate_Sciences>,
        <https://1145.am/db/1223133/Bioadvance>,
        <https://1145.am/db/1223149/Bioadvance>,
        <https://1145.am/db/1322507/Gro_Biosciences_Inc>,
        <https://1145.am/db/1343489/Celcuity_Inc>,
        <https://1145.am/db/1354258/Cellistic>,
        <https://1145.am/db/1354263/Cellistic>,
        <https://1145.am/db/1359764/Aspect_Biosystems>,
        <https://1145.am/db/1360407/Aspect_Biosystems>,
        <https://1145.am/db/1381832/Coatue>,
        <https://1145.am/db/1382787/Coatue>,
        <https://1145.am/db/1415520/Obatala_Sciences>,
        <https://1145.am/db/1422234/Forbion_Ventures>,
        <https://1145.am/db/1422725/Forbion_Ventures>,
        <https://1145.am/db/1573937/Celcuity_Inc>,
        <https://1145.am/db/1621368/Celularity>,
        <https://1145.am/db/1683183/Exicure>,
        <https://1145.am/db/1867543/Tpg_Biotech>,
        <https://1145.am/db/1926411/Bioqube_Ventures>,
        <https://1145.am/db/1945773/Morphimmune>,
        <https://1145.am/db/1966379/Dyve_Biosciences>,
        <https://1145.am/db/1984401/Exicure_Inc>,
        <https://1145.am/db/1990861/Bioqube_Ventures>,
        <https://1145.am/db/2021165/Exicure>,
        <https://1145.am/db/2052967/Morphimmune>,
        <https://1145.am/db/2060484/Healthtech_Capital>,
        <https://1145.am/db/2095258/Exicure_Inc>,
        <https://1145.am/db/2114372/Actio_Biosciences>,
        <https://1145.am/db/2133590/Morphimmune>,
        <https://1145.am/db/2155146/Biomatics_Capital_Partners>,
        <https://1145.am/db/2234316/Intercell_Ag>,
        <https://1145.am/db/2280492/Biovision_Ventures>,
        <https://1145.am/db/2285038/Time_Bioventures>,
        <https://1145.am/db/2286671/Forbion>,
        <https://1145.am/db/2298954/Biossom_Investment_Management>,
        <https://1145.am/db/2298978/Advent_Life_Sciences>,
        <https://1145.am/db/2301741/Bio_*_One_Capital>,
        <https://1145.am/db/2301792/Fonds_Bio-Innovation_Sec>,
        <https://1145.am/db/2301876/Genizon_Biosciences>,
        <https://1145.am/db/2302351/Medimmune_Ventures>,
        <https://1145.am/db/2305587/Medimmune_Ventures>,
        <https://1145.am/db/2307362/Discovery_Laboratories_Inc>,
        <https://1145.am/db/2309472/Cel-Sci_Corporation>,
        <https://1145.am/db/2309840/Bio_Fund>,
        <https://1145.am/db/2310285/Medventure_Associates>,
        <https://1145.am/db/2312827/Biotime_Inc>,
        <https://1145.am/db/2313322/Biomedinvest>,
        <https://1145.am/db/2313322/Hbm_Bioventures>,
        <https://1145.am/db/2313401/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2313438/Biomedinvest>,
        <https://1145.am/db/2313438/Hbm_Biocapital>,
        <https://1145.am/db/2313438/Hbm_Bioventures>,
        <https://1145.am/db/2313438/Sv_Life_Sciences>,
        <https://1145.am/db/2313884/Com)>,
        <https://1145.am/db/2314400/Hbm_Biocapital>,
        <https://1145.am/db/2314515/Sv_Life_Sciences>,
        <https://1145.am/db/2314573/Avlar_Bioventures>,
        <https://1145.am/db/2316709/Bioadvance_Ventures>,
        <https://1145.am/db/2317737/Mc_Life_Sciences_Ventures>,
        <https://1145.am/db/2317779/Bio_*_One_Capital>,
        <https://1145.am/db/2319360/Medimmune_Ventures>,
        <https://1145.am/db/2321097/Healthcare_Ventures>,
        <https://1145.am/db/2321137/Le_@_P_Technology>,
        <https://1145.am/db/2323785/Medimmune_Ventures>,
        <https://1145.am/db/2324015/Medsciences_Capital>,
        <https://1145.am/db/2324195/Lotus_Bioscience_Ventures>,
        <https://1145.am/db/2325831/Bb_Biotech>,
        <https://1145.am/db/2325831/Hbm_Bioventures>,
        <https://1145.am/db/2334165/Genizon_Biosciences_Inc>,
        <https://1145.am/db/2336109/Biomed_Ventures>,
        <https://1145.am/db/2336754/Biotime>,
        <https://1145.am/db/2337993/Progderm>,
        <https://1145.am/db/2338371/Inc>,
        <https://1145.am/db/2338373/Inc>,
        <https://1145.am/db/2338673/Hopen_Life_Science_Ventures>,
        <https://1145.am/db/2339295/Biomedinvest>,
        <https://1145.am/db/2339726/Discovery_Laboratories_Inc>,
        <https://1145.am/db/2340408/Group_Inc>,
        <https://1145.am/db/2341747/Techne_Corporation>,
        <https://1145.am/db/2343807/Cortice_Biosciences>,
        <https://1145.am/db/2345037/Biomed_Ventures>,
        <https://1145.am/db/2347124/Orgenesis_Inc>,
        <https://1145.am/db/2348618/Advent_Life_Sciences>,
        <https://1145.am/db/2348868/Biotime_Inc>,
        <https://1145.am/db/2349406/Allocure>,
        <https://1145.am/db/2351955/Biotime>,
        <https://1145.am/db/2352382/Biomedinvest>,
        <https://1145.am/db/2352633/Advanced_Biotechnologies_Venture_Fund>,
        <https://1145.am/db/2354295/Biomed_Ventures>,
        <https://1145.am/db/2357417/Biotime_Inc>,
        <https://1145.am/db/2359240/Frontline_Bioventures>,
        <https://1145.am/db/2359274/Neostem_Inc>,
        <https://1145.am/db/2361237/Discovery_Laboratories>,
        <https://1145.am/db/2361671/Discovery_Laboratories_Inc>,
        <https://1145.am/db/2364853/Medimmune_Ventures>,
        <https://1145.am/db/2365171/Healthcare_Ventures>,
        <https://1145.am/db/2366049/Biomed_Ventures>,
        <https://1145.am/db/2366055/Biomed_Ventures>,
        <https://1145.am/db/2366133/Biopacificventures>,
        <https://1145.am/db/2367144/Allocure_Inc>,
        <https://1145.am/db/2367147/Allocure_Inc>,
        <https://1145.am/db/2367461/Discovery_Laboratories_Inc>,
        <https://1145.am/db/2368251/Sv_Life_Sciences>,
        <https://1145.am/db/2369874/Biotime>,
        <https://1145.am/db/2369916/Biomed_Ventures>,
        <https://1145.am/db/2370050/M3_Biotechnology_Inc>,
        <https://1145.am/db/2581359/Group_Inc>,
        <https://1145.am/db/363714/Palliare>,
        <https://1145.am/db/407158/Altasciences>,
        <https://1145.am/db/464787/Biosight_Ltd>,
        <https://1145.am/db/504446/Acrigen_Biosciences_Inc>,
        <https://1145.am/db/564585/Bioqube_Ventures>,
        <https://1145.am/db/566971/Bioqube_Ventures>,
        <https://1145.am/db/585936/Gro_Biosciences_Inc>,
        <https://1145.am/db/622178/Gro_Biosciences_Inc>,
        <https://1145.am/db/632040/Biosight>,
        <https://1145.am/db/660979/Celcuity>,
        <https://1145.am/db/683685/Gro_Biosciences_Inc>,
        <https://1145.am/db/684123/Biourja_Ventures>,
        <https://1145.am/db/704448/Biosight>,
        <https://1145.am/db/764965/Gro_Biosciences_Inc>,
        <https://1145.am/db/812748/Altasciences>,
        <https://1145.am/db/922231/Ocugen>,
        <https://1145.am/db/938108/Bioeconomy_Capital>,
        <https://1145.am/db/971939/I___I_Biotech_Fund>,
        <https://1145.am/db/975114/I___I_Biotech_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/1169952/Advent_Life_Sciences>,
        <https://1145.am/db/1174901/Advent_Life_Sciences>,
        <https://1145.am/db/1281079/Advent_Life_Sciences>,
        <https://1145.am/db/1281647/Advent_Life_Sciences>,
        <https://1145.am/db/1426073/Advent_Life_Sciences>,
        <https://1145.am/db/1426943/Advent_Life_Sciences>,
        <https://1145.am/db/2182443/Advent_Life_Sciences>,
        <https://1145.am/db/2286277/Advent_Life_Sciences>,
        <https://1145.am/db/2290200/Advent_Life_Sciences>,
        <https://1145.am/db/2293893/Advent_Life_Sciences>,
        <https://1145.am/db/2296167/Advent_Life_Sciences>,
        <https://1145.am/db/2335375/Advent_Life_Sciences>,
        <https://1145.am/db/2337664/Advent_Life_Sciences>,
        <https://1145.am/db/2338079/Advent_Life_Sciences>,
        <https://1145.am/db/2352059/Advent_Life_Sciences>,
        <https://1145.am/db/2355841/Advent_Life_Sciences>,
        <https://1145.am/db/2358630/Advent_Life_Sciences>,
        <https://1145.am/db/2361002/Advent_Life_Sciences>,
        <https://1145.am/db/2370626/Advent_Life_Sciences>,
        <https://1145.am/db/281538/Advent_Life_Sciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347571/New_Leaf_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "MOUNTAIN VIEW, CA" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-02-16T15:02:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Versartis Completes $21 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/versartis-completes-21-million-series-b-financing-0> ;
    ns1:foundName "New Leaf Venture Partners" ;
    ns1:investor <https://1145.am/db/2347571/Series_B_Investment_Advent_Life_Sciences_Amunix_Index_Ventures_New_Leaf_Venture_Partners_Versartis_Completed> ;
    ns1:name "New Leaf Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1749104/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2151983/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2182517/New_Mountain_Capital>,
        <https://1145.am/db/2301824/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305507/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2312792/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325326/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325398/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334797/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342925/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342937/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2343298/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347043/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347876/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348618/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2359683/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2360174/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2361416/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362737/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2594141/New_Leaf_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1287338/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2155668/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2208603/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2289585/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2293765/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2298642/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2300322/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301828/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305514/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2307682/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2311595/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315071/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315932/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315934/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2316674/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2317919/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318656/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318657/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334479/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2341003/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345037/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345047/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346532/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346542/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347878/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348149/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2349120/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350164/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350167/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350491/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2352059/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2357356/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362736/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2366860/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2569522/New_Leaf_Venture_Partners>,
        <https://1145.am/db/425953/New_Leaf_Venture_Partners>,
        <https://1145.am/db/583528/New_Leaf_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347571/Versartis> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2011-02-16T15:02:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Versartis Completes $21 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/versartis-completes-21-million-series-b-financing-0> ;
    ns1:foundName "Versartis",
        "Versartis, Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "Versartis" ;
    ns1:sameAsHigh <https://1145.am/db/1219612/Versanis_Bio>,
        <https://1145.am/db/2284615/Versanis_Bio>,
        <https://1145.am/db/2325147/Versartis_Inc>,
        <https://1145.am/db/2343678/Versartis_Inc>,
        <https://1145.am/db/2347739/Versartis>,
        <https://1145.am/db/2348618/Versartis>,
        <https://1145.am/db/2348620/Versartis_Inc>,
        <https://1145.am/db/2352059/Versartis>,
        <https://1145.am/db/2352331/Versartis>,
        <https://1145.am/db/2357241/Versartis>,
        <https://1145.am/db/2357356/Versartis>,
        <https://1145.am/db/2359361/Versartis>,
        <https://1145.am/db/2359375/Versartis>,
        <https://1145.am/db/2362737/Versartis>,
        <https://1145.am/db/2370072/Versartis_Inc>,
        <https://1145.am/db/2589317/Versartis>,
        <https://1145.am/db/2592575/Versapharm> ;
    ns1:sameAsMedium <https://1145.am/db/2325140/Versartis_Inc>,
        <https://1145.am/db/2340691/Versartis_Inc>,
        <https://1145.am/db/2347568/Versartis>,
        <https://1145.am/db/2357360/Versartis>,
        <https://1145.am/db/2362736/Versartis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348618/New_Leaf_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CA" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-02-22T13:27:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Versartis Completes $21 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/versartis-completes-21-million-series-b-financing> ;
    ns1:foundName "New",
        "New Leaf Venture Partners" ;
    ns1:investor <https://1145.am/db/2348618/Series_B_Investment_Advent_Life_Sciences_Amunix_Index_Ventures_New_Leaf_Venture_Partners_Versartis_Completed> ;
    ns1:name "New Leaf Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1749104/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2151983/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2182517/New_Mountain_Capital>,
        <https://1145.am/db/2301824/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305507/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2312792/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325326/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325398/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334797/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342925/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342937/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2343298/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347043/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347571/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347876/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2359683/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2360174/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2361416/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362737/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2594141/New_Leaf_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1287338/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2155668/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2208603/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2289585/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2293765/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2298642/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2300322/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301828/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305514/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2307682/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2311595/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315071/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315932/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315934/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2316674/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2317919/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318656/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318657/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334479/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2341003/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345037/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345047/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346532/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346542/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347878/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348149/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2349120/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350164/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350167/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350491/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2352059/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2357356/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362736/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2366860/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2569522/New_Leaf_Venture_Partners>,
        <https://1145.am/db/425953/New_Leaf_Venture_Partners>,
        <https://1145.am/db/583528/New_Leaf_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348618/Versartis> a org:Organization ;
    ns1:description "endocrine disorders" ;
    ns1:documentDate "2011-02-22T13:27:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Versartis Completes $21 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/versartis-completes-21-million-series-b-financing> ;
    ns1:foundName "Versartis",
        "Versartis, Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "Versartis" ;
    ns1:sameAsHigh <https://1145.am/db/1219612/Versanis_Bio>,
        <https://1145.am/db/2347571/Versartis>,
        <https://1145.am/db/2347739/Versartis>,
        <https://1145.am/db/2348620/Versartis_Inc>,
        <https://1145.am/db/2352059/Versartis>,
        <https://1145.am/db/2352331/Versartis>,
        <https://1145.am/db/2357241/Versartis>,
        <https://1145.am/db/2357356/Versartis>,
        <https://1145.am/db/2359361/Versartis>,
        <https://1145.am/db/2359375/Versartis>,
        <https://1145.am/db/2362737/Versartis>,
        <https://1145.am/db/2370072/Versartis_Inc>,
        <https://1145.am/db/2589317/Versartis> ;
    ns1:sameAsMedium <https://1145.am/db/2325140/Versartis_Inc>,
        <https://1145.am/db/2325147/Versartis_Inc>,
        <https://1145.am/db/2340691/Versartis_Inc>,
        <https://1145.am/db/2343678/Versartis_Inc>,
        <https://1145.am/db/2347568/Versartis>,
        <https://1145.am/db/2357360/Versartis>,
        <https://1145.am/db/2362736/Versartis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350720/Series_A_Investment_Arsanis_Inc_Orbimed_Sv_Life_Sciences_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-02-28T16:41:05+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Arsanis, Inc Announces Series A Financing with OrbiMed Advisors, Polaris Venture Partners and SV Life Sciences.",
        "VIENNA- (BUSINESS WIRE) -Arsanis, Inc, a recently founded biotechnology company dedicated to the development of anti-infective monoclonal antibody therapeutics, today announced the closing of a Series A financing with a total funding amount of $ 10 million." ;
    ns1:documentTitle "Arsanis, Inc Announces Series A Financing with OrbiMed Advisors, Polaris Venture Partners and SV Life Sciences" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/arsanis-inc-announces-series-a-financing-orbimed-advisors-polaris-venture-partners-and-sv> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2350720/Arsanis_Inc> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 10 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2350720/Sv_Life_Sciences> a org:Organization ;
    ns1:description "Life Sciences" ;
    ns1:documentDate "2011-02-28T16:41:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arsanis, Inc Announces Series A Financing with OrbiMed Advisors, Polaris Venture Partners and SV Life Sciences" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/arsanis-inc-announces-series-a-financing-orbimed-advisors-polaris-venture-partners-and-sv> ;
    ns1:foundName "SV Life Sciences" ;
    ns1:industry "Life Sciences" ;
    ns1:investor <https://1145.am/db/2350720/Series_A_Investment_Arsanis_Inc_Orbimed_Sv_Life_Sciences_Has_Not_Happened> ;
    ns1:name "SV Life Sciences" ;
    ns1:sameAsHigh <https://1145.am/db/2297439/Sv_Life_Sciences>,
        <https://1145.am/db/2305587/Sv_Life_Sciences>,
        <https://1145.am/db/2310485/Sv_Life_Sciences>,
        <https://1145.am/db/2311540/Sv_Life_Sciences>,
        <https://1145.am/db/2314625/Sv_Life_Sciences>,
        <https://1145.am/db/2316038/Sv_Life_Sciences>,
        <https://1145.am/db/2319338/Sv_Life_Sciences>,
        <https://1145.am/db/2321713/Sv_Life_Sciences>,
        <https://1145.am/db/2321870/Sv_Life_Sciences>,
        <https://1145.am/db/2327405/Sv_Life_Sciences>,
        <https://1145.am/db/2327677/Sv_Life_Sciences>,
        <https://1145.am/db/2328815/Sv_Life_Sciences>,
        <https://1145.am/db/2329550/Sv_Life_Sciences>,
        <https://1145.am/db/2336313/Sv_Life_Sciences>,
        <https://1145.am/db/2337166/Sv_Life_Sciences>,
        <https://1145.am/db/2342284/Sv_Life_Sciences>,
        <https://1145.am/db/2343725/Sv_Life_Sciences>,
        <https://1145.am/db/2353098/Sv_Life_Sciences> ;
    ns1:sameAsMedium <https://1145.am/db/2236188/Sv_Life_Sciences>,
        <https://1145.am/db/2246177/Sv_Life_Sciences>,
        <https://1145.am/db/2293662/Sv_Life_Sciences>,
        <https://1145.am/db/2293765/Sv_Life_Sciences>,
        <https://1145.am/db/2297604/Sv_Life_Sciences>,
        <https://1145.am/db/2298869/Sv_Life_Sciences>,
        <https://1145.am/db/2300322/Sv_Life_Sciences>,
        <https://1145.am/db/2302994/Sv_Life_Sciences>,
        <https://1145.am/db/2302995/Sv_Life_Sciences>,
        <https://1145.am/db/2312831/Sv_Life_Sciences>,
        <https://1145.am/db/2312833/Sv_Life_Sciences>,
        <https://1145.am/db/2313287/Sv_Life_Sciences>,
        <https://1145.am/db/2313322/Sv_Life_Sciences>,
        <https://1145.am/db/2313438/Sv_Life_Sciences>,
        <https://1145.am/db/2314515/Sv_Life_Sciences>,
        <https://1145.am/db/2317635/Sv_Life_Sciences>,
        <https://1145.am/db/2321861/Sv_Life_Sciences>,
        <https://1145.am/db/2336890/Sv_Life_Sciences>,
        <https://1145.am/db/2338193/Sv_Life_Sciences>,
        <https://1145.am/db/2338196/Sv_Life_Sciences>,
        <https://1145.am/db/2339295/Sv_Life_Sciences>,
        <https://1145.am/db/2342260/Sv_Life_Sciences>,
        <https://1145.am/db/2342261/Sv_Life_Sciences>,
        <https://1145.am/db/2342266/Sv_Life_Sciences>,
        <https://1145.am/db/2342445/Sv_Life_Sciences>,
        <https://1145.am/db/2342862/Sv_Life_Sciences>,
        <https://1145.am/db/2343467/Sv_Life_Sciences>,
        <https://1145.am/db/2343722/Sv_Life_Sciences>,
        <https://1145.am/db/2343737/Sv_Life_Sciences>,
        <https://1145.am/db/2346832/Sv_Life_Sciences>,
        <https://1145.am/db/2347389/Sv_Life_Sciences>,
        <https://1145.am/db/2349406/Sv_Life_Sciences>,
        <https://1145.am/db/2349426/Sv_Life_Sciences>,
        <https://1145.am/db/2350034/Sv_Life_Sciences>,
        <https://1145.am/db/2351394/Sv_Life_Sciences>,
        <https://1145.am/db/2351397/Sv_Life_Sciences>,
        <https://1145.am/db/2352382/Sv_Life_Sciences>,
        <https://1145.am/db/2352383/Sv_Life_Sciences>,
        <https://1145.am/db/2353439/Sv_Life_Sciences>,
        <https://1145.am/db/2355586/Sv_Life_Sciences>,
        <https://1145.am/db/2356861/Sv_Life_Sciences>,
        <https://1145.am/db/2356876/Sv_Life_Sciences>,
        <https://1145.am/db/2358271/Sv_Life_Sciences>,
        <https://1145.am/db/2358272/Sv_Life_Sciences>,
        <https://1145.am/db/2359125/Sv_Life_Sciences>,
        <https://1145.am/db/2360756/Sv_Life_Sciences>,
        <https://1145.am/db/2360758/Sv_Life_Sciences>,
        <https://1145.am/db/2361065/Sv_Life_Sciences>,
        <https://1145.am/db/2365315/Sv_Life_Sciences>,
        <https://1145.am/db/2366519/Sv_Life_Sciences>,
        <https://1145.am/db/2366860/Sv_Life_Sciences>,
        <https://1145.am/db/2368251/Sv_Life_Sciences>,
        <https://1145.am/db/2368572/Sv_Life_Sciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351734/Series_B_Investment_Mrieux_Dveloppement_Neurophage_Pharmaceuticals_Shire_Llc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-03-01T13:30:07+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, MA, February 18 /PRNewswire/ - NeuroPhage Pharmaceuticals, Inc. (NeuroPhage) , a privately held biotechnology company developing a protein disaggregation platform for treatment of neurodegenerative diseases, announced today that it has secured $ 12.4 million in Series B financing, which will be mostly directed to the IND-enabling activities in preparation of a Phase 1 clinical trial for NPT001, NeuroPhage's lead product candidate for the treatment of Alzheimer's disease, and include further work to expand the platform.",
        "NeuroPhage Pharmaceuticals closes $ 12.4M Series B round." ;
    ns1:documentTitle "NeuroPhage Pharmaceuticals closes $12.4M Series B round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/neurophage-pharmaceuticals-closes-12-4m-series-b-round-0> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2351734/Neurophage_Pharmaceuticals> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 12.4 million",
        "$ 12.4M" ;
    ns1:when "2011-02-18T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "February 18" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, MA" .

<https://1145.am/db/2351734/Shire_Llc> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, MA" ;
    ns1:documentDate "2011-03-01T13:30:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NeuroPhage Pharmaceuticals closes $12.4M Series B round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/neurophage-pharmaceuticals-closes-12-4m-series-b-round-0> ;
    ns1:foundName "Shire LLC" ;
    ns1:investor <https://1145.am/db/2351734/Series_B_Investment_Mrieux_Dveloppement_Neurophage_Pharmaceuticals_Shire_Llc_Completed> ;
    ns1:name "Shire LLC" ;
    ns1:sameAsMedium <https://1145.am/db/142937/Shire_Plc>,
        <https://1145.am/db/2155273/Shire>,
        <https://1145.am/db/2225348/Shire_Plc>,
        <https://1145.am/db/2225352/Shire_Plc>,
        <https://1145.am/db/2288537/Shire>,
        <https://1145.am/db/2290932/Shire>,
        <https://1145.am/db/2291354/Shire>,
        <https://1145.am/db/2292991/Shire>,
        <https://1145.am/db/2293472/Shire>,
        <https://1145.am/db/2296208/Shire>,
        <https://1145.am/db/2296243/Shire>,
        <https://1145.am/db/2297066/Shire>,
        <https://1145.am/db/2298391/Shire>,
        <https://1145.am/db/2300483/Shire>,
        <https://1145.am/db/2302783/Shire_Limited>,
        <https://1145.am/db/2303789/Shire>,
        <https://1145.am/db/2305581/Shire_Plc>,
        <https://1145.am/db/2306762/Shire>,
        <https://1145.am/db/2310002/Shire>,
        <https://1145.am/db/2314408/Shire_Limited>,
        <https://1145.am/db/2320137/Shire>,
        <https://1145.am/db/2320509/Shire>,
        <https://1145.am/db/2324621/Shire_Plc>,
        <https://1145.am/db/2326381/Shire_Plc>,
        <https://1145.am/db/2328189/Shire>,
        <https://1145.am/db/2328788/Shire_Plc>,
        <https://1145.am/db/2331795/Shire_Plc>,
        <https://1145.am/db/2332620/Shire>,
        <https://1145.am/db/2333419/Shire>,
        <https://1145.am/db/2335641/Shire>,
        <https://1145.am/db/2336126/Shire_Plc>,
        <https://1145.am/db/2336575/Shire>,
        <https://1145.am/db/2336581/Shire>,
        <https://1145.am/db/2336708/Shire>,
        <https://1145.am/db/2338009/Shire>,
        <https://1145.am/db/2338011/Shire>,
        <https://1145.am/db/2339117/Shire>,
        <https://1145.am/db/2339733/Shire_Plc>,
        <https://1145.am/db/2340560/Shire>,
        <https://1145.am/db/2340566/Shire_Plc>,
        <https://1145.am/db/2340575/Shire>,
        <https://1145.am/db/2341068/Shire>,
        <https://1145.am/db/2341074/Shire>,
        <https://1145.am/db/2341522/Shire>,
        <https://1145.am/db/2341828/Shire_Plc>,
        <https://1145.am/db/2341829/Shire>,
        <https://1145.am/db/2341838/Shire>,
        <https://1145.am/db/2341902/Shire>,
        <https://1145.am/db/2342514/Shire>,
        <https://1145.am/db/2342570/Shire>,
        <https://1145.am/db/2344160/Shire>,
        <https://1145.am/db/2344202/Shire>,
        <https://1145.am/db/2344205/Shire>,
        <https://1145.am/db/2344913/Shire>,
        <https://1145.am/db/2344914/Shire_Plc>,
        <https://1145.am/db/2344928/Shire_Plc>,
        <https://1145.am/db/2345096/Shire>,
        <https://1145.am/db/2345238/Shire>,
        <https://1145.am/db/2345248/Shire_Plc>,
        <https://1145.am/db/2345825/Shire_Plc>,
        <https://1145.am/db/2345826/Shire_Plc>,
        <https://1145.am/db/2346202/Shire>,
        <https://1145.am/db/2346640/Shire>,
        <https://1145.am/db/2346644/Shire_Plc>,
        <https://1145.am/db/2346646/Shire_Plc>,
        <https://1145.am/db/2346752/Shire_Plc>,
        <https://1145.am/db/2346863/Shire_Plc>,
        <https://1145.am/db/2346872/Shire_Plc>,
        <https://1145.am/db/2346879/Shire>,
        <https://1145.am/db/2347646/Shire_Plc>,
        <https://1145.am/db/2347772/Shire>,
        <https://1145.am/db/2348523/Shire>,
        <https://1145.am/db/2348661/Shire>,
        <https://1145.am/db/2348742/Shire>,
        <https://1145.am/db/2348750/Shire>,
        <https://1145.am/db/2348805/Shire>,
        <https://1145.am/db/2350265/Shire_Plc>,
        <https://1145.am/db/2351482/Shire>,
        <https://1145.am/db/2351483/Shire>,
        <https://1145.am/db/2351737/Shire_Llc>,
        <https://1145.am/db/2351754/Shire>,
        <https://1145.am/db/2352906/Shire>,
        <https://1145.am/db/2353283/Shire_Plc>,
        <https://1145.am/db/2354266/Shire_Llc>,
        <https://1145.am/db/2354277/Shire>,
        <https://1145.am/db/2356384/Shire>,
        <https://1145.am/db/2357032/Shire>,
        <https://1145.am/db/2357116/Shire>,
        <https://1145.am/db/2357487/Shire>,
        <https://1145.am/db/2359634/Shire>,
        <https://1145.am/db/2359681/Shire>,
        <https://1145.am/db/2360712/Shire_Plc>,
        <https://1145.am/db/2361514/Shire_Plc>,
        <https://1145.am/db/2361640/Shire_Plc>,
        <https://1145.am/db/2361641/Shire>,
        <https://1145.am/db/2362744/Shire>,
        <https://1145.am/db/2364136/Shire_Plc>,
        <https://1145.am/db/2364149/Shire_Plc>,
        <https://1145.am/db/2364556/Shire>,
        <https://1145.am/db/2364813/Shire>,
        <https://1145.am/db/2365002/Shire_Plc>,
        <https://1145.am/db/2365826/Shire_Plc>,
        <https://1145.am/db/2366303/Shire>,
        <https://1145.am/db/2367132/Shire_Plc>,
        <https://1145.am/db/2367297/Shire>,
        <https://1145.am/db/2368144/Shire>,
        <https://1145.am/db/2368862/Shire>,
        <https://1145.am/db/2368885/Shire>,
        <https://1145.am/db/2368915/Shire>,
        <https://1145.am/db/2368936/Shire>,
        <https://1145.am/db/2369141/Shire>,
        <https://1145.am/db/2369701/Shire>,
        <https://1145.am/db/2369949/Shire>,
        <https://1145.am/db/2370010/Shire>,
        <https://1145.am/db/2370189/Shire>,
        <https://1145.am/db/2370358/Shire>,
        <https://1145.am/db/2370514/Shire>,
        <https://1145.am/db/2370740/Shire>,
        <https://1145.am/db/2371519/Shire>,
        <https://1145.am/db/2371522/Shire>,
        <https://1145.am/db/2537396/Shire>,
        <https://1145.am/db/2539292/Shire>,
        <https://1145.am/db/2541146/Shire>,
        <https://1145.am/db/2544223/Shire>,
        <https://1145.am/db/2544434/Shire>,
        <https://1145.am/db/2544459/Shire>,
        <https://1145.am/db/2544726/Shire>,
        <https://1145.am/db/2546262/Shire>,
        <https://1145.am/db/2546291/Shire>,
        <https://1145.am/db/2547036/Shire>,
        <https://1145.am/db/2547277/Shire>,
        <https://1145.am/db/2547575/Shire_Plc>,
        <https://1145.am/db/2548051/Shire>,
        <https://1145.am/db/2548805/Shire>,
        <https://1145.am/db/2548859/Shire>,
        <https://1145.am/db/2548979/Shire>,
        <https://1145.am/db/2550985/Shire>,
        <https://1145.am/db/2552180/Shire>,
        <https://1145.am/db/2552455/Shire>,
        <https://1145.am/db/2554269/Shire>,
        <https://1145.am/db/2554294/Shire>,
        <https://1145.am/db/2556988/Shire>,
        <https://1145.am/db/2558927/Shire>,
        <https://1145.am/db/2559769/Shire>,
        <https://1145.am/db/2561541/Shire>,
        <https://1145.am/db/2563175/Shire>,
        <https://1145.am/db/2564899/Shire>,
        <https://1145.am/db/2565613/Shire>,
        <https://1145.am/db/2566716/Shire>,
        <https://1145.am/db/2569388/Shire>,
        <https://1145.am/db/2569952/Shire>,
        <https://1145.am/db/2570020/Shire>,
        <https://1145.am/db/2570036/Shire>,
        <https://1145.am/db/2570363/Shire>,
        <https://1145.am/db/2570733/Shire_Plc>,
        <https://1145.am/db/2570807/Shire>,
        <https://1145.am/db/2571521/Shire>,
        <https://1145.am/db/2571526/Shire>,
        <https://1145.am/db/2572113/Shire_Plc>,
        <https://1145.am/db/2572335/Shire>,
        <https://1145.am/db/2572559/Shire>,
        <https://1145.am/db/2573463/Shire>,
        <https://1145.am/db/2573508/Shire>,
        <https://1145.am/db/2574443/Shire>,
        <https://1145.am/db/2574731/Shire>,
        <https://1145.am/db/2575050/Shire>,
        <https://1145.am/db/2575259/Shire>,
        <https://1145.am/db/2576815/Shire>,
        <https://1145.am/db/2576959/Shire>,
        <https://1145.am/db/2577114/Shire>,
        <https://1145.am/db/2577117/Shire>,
        <https://1145.am/db/2577176/Shire_Plc>,
        <https://1145.am/db/2577652/Shire_Plc>,
        <https://1145.am/db/2577793/Shire_Plc>,
        <https://1145.am/db/2578085/Shire_Plc>,
        <https://1145.am/db/2578319/Shire>,
        <https://1145.am/db/2578503/Shire>,
        <https://1145.am/db/2578568/Shire>,
        <https://1145.am/db/2579035/Shire_Plc>,
        <https://1145.am/db/2579062/Shire_Plc>,
        <https://1145.am/db/2580279/Shire>,
        <https://1145.am/db/2580603/Shire>,
        <https://1145.am/db/2580620/Shire>,
        <https://1145.am/db/2580622/Shire>,
        <https://1145.am/db/2580747/Shire>,
        <https://1145.am/db/2581261/Shire>,
        <https://1145.am/db/2582265/Shire>,
        <https://1145.am/db/2583177/Shire>,
        <https://1145.am/db/2583624/Shire_Plc>,
        <https://1145.am/db/2583662/Shire>,
        <https://1145.am/db/2584216/Shire>,
        <https://1145.am/db/2585066/Shire>,
        <https://1145.am/db/2585132/Shire>,
        <https://1145.am/db/2586132/Shire>,
        <https://1145.am/db/2586884/Shire>,
        <https://1145.am/db/2586889/Shire>,
        <https://1145.am/db/2587094/Shire>,
        <https://1145.am/db/2587511/Shire>,
        <https://1145.am/db/2588152/Shire>,
        <https://1145.am/db/2589981/Shire_Plc>,
        <https://1145.am/db/2591412/Shire>,
        <https://1145.am/db/2592333/Shire>,
        <https://1145.am/db/2592336/Shire>,
        <https://1145.am/db/2592562/Shire>,
        <https://1145.am/db/2595190/Shire>,
        <https://1145.am/db/2595210/Shire>,
        <https://1145.am/db/2597158/Shire>,
        <https://1145.am/db/2598205/Shire>,
        <https://1145.am/db/2976/Shire> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355543/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInHighGeoName "Boston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4930956/about.rdf> ;
    ns1:basedInHighRaw "BOSTON" ;
    ns1:description "investing" ;
    ns1:documentDate "2011-06-21T14:25:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tesaro-announces-101-million-series-b-financing-for-advancement-and-expansion-of-oncology> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2355543/Series_B_Investment_Deerfield_Management_Interwest_Partners_Kleiner_Perkins_Caufield___Byers_Leerink_Swann_New_Enterprise_Associates_Oracle_Partners_T_Rowe_Price_Pappas_Ventures_T_Rowe_Price_Pappas_Ventures_Tesaro_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsHigh <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360841/Richard_M_Schulze_Family_Foundation> a org:Organization ;
    ns1:basedInLowRaw "BETHESDA, Md" ;
    ns1:description "game-changing medical research and treatment breakthroughs" ;
    ns1:documentDate "2011-07-08T13:22:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in t" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/family-foundation-of-business-leader-invests-4-55-million-northwest-biotherapeutics-for-0> ;
    ns1:foundName "The Richard M. Schulze Family Foundation" ;
    ns1:investor <https://1145.am/db/2360841/Investment_Northwest_Biotherapeutics_Richard_M_Schulze_Family_Foundation_Completed> ;
    ns1:name "Richard M. Schulze Family Foundation" ;
    ns1:sameAsHigh <https://1145.am/db/2360842/Richard_M_Schulze_Family_Foundation>,
        <https://1145.am/db/2360852/Richard_M_Schulze_Family_Foundation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360842/Richard_M_Schulze_Family_Foundation> a org:Organization ;
    ns1:basedInLowRaw "BETHESDA, Md" ;
    ns1:description "game-changing medical research and treatment breakthroughs" ;
    ns1:documentDate "2011-07-08T13:22:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/family-foundation-of-business-leader-invests-4-55-million-northwest-biotherapeutics-for-1> ;
    ns1:foundName "The Richard M. Schulze Family Foundation" ;
    ns1:investor <https://1145.am/db/2360842/Equity_Investment_Northwest_Biotherapeutics_Richard_M_Schulze_Family_Foundation_Completed> ;
    ns1:name "Richard M. Schulze Family Foundation" ;
    ns1:sameAsHigh <https://1145.am/db/2360841/Richard_M_Schulze_Family_Foundation>,
        <https://1145.am/db/2360852/Richard_M_Schulze_Family_Foundation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360852/Investment_Family_Foundation_Of_Business_Leader_Northwest_Biotherapeutics_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-08T16:00:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Bethesda, MD, July 8, 2011 - Northwest Biotherapeutics (OTC Bulletin Board: NWBO) (\"NWBT\") announced today a $ 4.55 million equity investment on June 28, 2011, by The Richard M. Schulze Family Foundation (the \"Foundation\") .",
        "Family Foundation of Business Leader Invests $ 4.55 Million In Northwest Biotherapeutics For Promising Clinical Trials In The US and Europe." ;
    ns1:documentTitle "Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics For Promising Clinical Trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/family-foundation-of-business-leader-invests-4-55-million-northwest-biotherapeutics-for> ;
    ns1:foundName "Invests",
        "investment" ;
    ns1:name "Invests",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2360852/Northwest_Biotherapeutics> ;
    ns1:targetDetails "equity" ;
    ns1:valueRaw "$ 4.55 Million",
        "$ 4.55 million" ;
    ns1:when "2011-06-28T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "June 28, 2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "US" .

<https://1145.am/db/2360852/Richard_M_Schulze_Family_Foundation> a org:Organization ;
    ns1:basedInHighGeoName "Bethesda" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4348599/about.rdf> ;
    ns1:basedInHighRaw "Bethesda, MD" ;
    ns1:description "game-changing medical research and treatment breakthroughs" ;
    ns1:documentDate "2011-07-08T16:00:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics For Promising Clinical Trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/family-foundation-of-business-leader-invests-4-55-million-northwest-biotherapeutics-for> ;
    ns1:foundName "The Richard M. Schulze Family Foundation" ;
    ns1:investor <https://1145.am/db/2360852/Investment_Family_Foundation_Of_Business_Leader_Northwest_Biotherapeutics_Completed> ;
    ns1:name "Richard M. Schulze Family Foundation" ;
    ns1:sameAsHigh <https://1145.am/db/2360841/Richard_M_Schulze_Family_Foundation>,
        <https://1145.am/db/2360842/Richard_M_Schulze_Family_Foundation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361204/Apthera_Inc> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2361204/Apthera_Inc_Acquisition> ;
    ns1:description "developing a pipeline of peptide - based immunotherapies" ;
    ns1:documentDate "2011-03-31T13:18:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RXi Pharmaceuticals Aggressively Moves into Late-Stage Clinical Development with the Agreement to Acquire Apthera, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rxi-pharmaceuticals-aggressively-moves-into-late-stage-clinical-development-agreement-to-0> ;
    ns1:foundName "Apthera",
        "Apthera, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Apthera",
        "Apthera, Inc." ;
    ns1:protagonist <https://1145.am/db/2361204/Apthera_Inc_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/1468175/Aristea_Therapeutics>,
        <https://1145.am/db/2126619/Alfasigma_Spa>,
        <https://1145.am/db/2147923/Alfasigma_Spa>,
        <https://1145.am/db/2301066/Akcea>,
        <https://1145.am/db/2338987/Ario_Pharma>,
        <https://1145.am/db/2361205/Apthera_Inc>,
        <https://1145.am/db/2540527/Arixtra>,
        <https://1145.am/db/2542503/Arixtra>,
        <https://1145.am/db/2560880/Arius_Research>,
        <https://1145.am/db/2799540/Alfasigma> ;
    ns1:sameAsMedium <https://1145.am/db/2364206/Apthera>,
        <https://1145.am/db/2365628/Apthera> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361205/Apthera_Inc> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2361205/Apthera_Inc_Acquisition> ;
    ns1:description "developing a pipeline of peptide - based immunotherapies" ;
    ns1:documentDate "2011-03-31T13:18:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RXi Pharmaceuticals Aggressively Moves into Late-Stage Clinical Development with the Agreement to Acquire Apthera, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rxi-pharmaceuticals-aggressively-moves-into-late-stage-clinical-development-agreement-to> ;
    ns1:foundName "Apthera",
        "Apthera, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Apthera",
        "Apthera, Inc." ;
    ns1:protagonist <https://1145.am/db/2361205/Apthera_Inc_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/1468175/Aristea_Therapeutics>,
        <https://1145.am/db/2126619/Alfasigma_Spa>,
        <https://1145.am/db/2147923/Alfasigma_Spa>,
        <https://1145.am/db/2301066/Akcea>,
        <https://1145.am/db/2338987/Ario_Pharma>,
        <https://1145.am/db/2361204/Apthera_Inc>,
        <https://1145.am/db/2540527/Arixtra>,
        <https://1145.am/db/2542503/Arixtra>,
        <https://1145.am/db/2560880/Arius_Research>,
        <https://1145.am/db/2799540/Alfasigma> ;
    ns1:sameAsMedium <https://1145.am/db/2364206/Apthera>,
        <https://1145.am/db/2365628/Apthera> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362871/Mpm_Capital> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-07-14T13:23:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verastem snags $32M for drugs against cancer stem cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/verastem-snags-32m-for-drugs-against-cancer-stem-cells> ;
    ns1:foundName "MPM Capital" ;
    ns1:investor <https://1145.am/db/2362871/Series_B_Investment_Advanced_Technology_Ventures_Astellas_Venture_Management_Bessemer_Venture_Partners_Cardinal_Partners_Longwood_Founders_Fund_Mpm_Capital_Verastem_Completed> ;
    ns1:name "MPM Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1070429/Mhs_Capital>,
        <https://1145.am/db/1070486/Mhs_Capital>,
        <https://1145.am/db/1296944/Mbx_Capital>,
        <https://1145.am/db/1297060/Mbx_Capital>,
        <https://1145.am/db/1325968/Mpm_Capital>,
        <https://1145.am/db/1406509/Mu_Ventures>,
        <https://1145.am/db/1545994/Mjc_Partners>,
        <https://1145.am/db/1547281/Mjc_Partners>,
        <https://1145.am/db/1632028/Mpm_Capital_Management>,
        <https://1145.am/db/1632156/Mpm_Capital_Management>,
        <https://1145.am/db/1739285/Massmutual_Ventures>,
        <https://1145.am/db/1764784/Massmutual_Ventures>,
        <https://1145.am/db/1791838/Double_M_Partners>,
        <https://1145.am/db/1821600/MMC>,
        <https://1145.am/db/1855703/Mbm_Capital_Partners>,
        <https://1145.am/db/1857563/Mhs_Capital>,
        <https://1145.am/db/1990861/M_Ventures>,
        <https://1145.am/db/2051518/M_Ventures>,
        <https://1145.am/db/2064074/M_Venture_Partners>,
        <https://1145.am/db/577856/Pm_Equity_Partner>,
        <https://1145.am/db/615337/Massmutual_Ventures>,
        <https://1145.am/db/734867/Massmutual_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1752458/Mpm_Capital>,
        <https://1145.am/db/2285876/Mpm_Capital>,
        <https://1145.am/db/2287191/Mpm_Capital>,
        <https://1145.am/db/2292334/Mpm_Capital>,
        <https://1145.am/db/2292353/Mpm_Capital>,
        <https://1145.am/db/2300455/Mpm_Capital>,
        <https://1145.am/db/2301901/Mpm_Capital>,
        <https://1145.am/db/2303391/Mpm_Capital>,
        <https://1145.am/db/2303833/Mpm_Capital>,
        <https://1145.am/db/2303855/Mpm_Capital>,
        <https://1145.am/db/2304634/Mpm_Capital>,
        <https://1145.am/db/2305503/Mpm_Capital>,
        <https://1145.am/db/2305656/Mpm_Capital>,
        <https://1145.am/db/2306705/Mpm_Capital>,
        <https://1145.am/db/2308887/Mpm_Capital>,
        <https://1145.am/db/2309845/Mpm_Capital>,
        <https://1145.am/db/2311551/Mpm_Capital>,
        <https://1145.am/db/2312285/Mpm_Capital>,
        <https://1145.am/db/2312309/Mpm_Capital>,
        <https://1145.am/db/2316391/Mpm_Capital>,
        <https://1145.am/db/2323055/Mpm_Capital>,
        <https://1145.am/db/2323066/Mpm_Capital>,
        <https://1145.am/db/2323094/Mpm_Capital>,
        <https://1145.am/db/2323563/Mpm_Capital>,
        <https://1145.am/db/2323568/Mpm_Capital>,
        <https://1145.am/db/2324195/Mpm_Capital>,
        <https://1145.am/db/2324226/Mpm_Capital>,
        <https://1145.am/db/2328338/Mpm_Capital>,
        <https://1145.am/db/2333119/Mpm_Capital>,
        <https://1145.am/db/2333525/Mpm_Capital>,
        <https://1145.am/db/2335701/Mpm_Capital>,
        <https://1145.am/db/2335714/Mpm_Capital>,
        <https://1145.am/db/2337140/Mpm_Capital>,
        <https://1145.am/db/2340957/Mpm_Capital>,
        <https://1145.am/db/2345299/Mpm_Capital>,
        <https://1145.am/db/2345318/Mpm_Capital>,
        <https://1145.am/db/2346204/Mpm_Capital>,
        <https://1145.am/db/2347140/Mpm_Capital>,
        <https://1145.am/db/2347469/Mpm_Capital>,
        <https://1145.am/db/2347984/Mpm_Capital>,
        <https://1145.am/db/2348484/Mpm_Capital>,
        <https://1145.am/db/2350030/Mpm_Capital>,
        <https://1145.am/db/2352172/Mpm_Capital>,
        <https://1145.am/db/2352362/Mpm_Capital>,
        <https://1145.am/db/2352899/Mpm_Capital>,
        <https://1145.am/db/2353365/Mpm_Capital>,
        <https://1145.am/db/2353404/Mpm_Capital>,
        <https://1145.am/db/2353413/Mpm_Capital>,
        <https://1145.am/db/2353415/Mpm_Capital>,
        <https://1145.am/db/2356396/Mpm_Capital>,
        <https://1145.am/db/2358979/Mpm_Capital>,
        <https://1145.am/db/2359001/Mpm_Capital>,
        <https://1145.am/db/2359873/Mpm_Capital>,
        <https://1145.am/db/2359875/Mpm_Capital>,
        <https://1145.am/db/2360526/Mpm_Capital>,
        <https://1145.am/db/2364492/Mpm_Capital>,
        <https://1145.am/db/2365098/Mpm_Capital>,
        <https://1145.am/db/2366744/Mpm_Capital>,
        <https://1145.am/db/2367199/Mpm_Capital>,
        <https://1145.am/db/2369202/Mpm_Capital>,
        <https://1145.am/db/2370582/Mpm_Capital>,
        <https://1145.am/db/2541350/Mpm_Capital>,
        <https://1145.am/db/677075/Mpm_Capital>,
        <https://1145.am/db/678997/Mpm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2363854/Intervention_Insights> a org:Organization ;
    ns1:basedInHighGeoName "Grand Rapids" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4994358/about.rdf> ;
    ns1:basedInHighRaw "Grand Rapids" ;
    ns1:basedInLowRaw "Ky" ;
    ns1:description "healthcare information technology" ;
    ns1:documentDate "2011-07-19T12:32:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Beringea Invests in Healthcare IT Company Intervention Insights" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/beringea-invests-healthcare-it-company-intervention-insights> ;
    ns1:foundName "Intervention Insight",
        "Intervention Insights" ;
    ns1:industry "cancer care",
        "healthcare information technology" ;
    ns1:name "Intervention Insight",
        "Intervention Insights" ;
    ns1:sameAsMedium <https://1145.am/db/2322429/Intervention_Insights> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364216/Bergamo> a org:Organization ;
    ns1:basedInHighGeoName "Federative Republic of Brazil" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:basedInHighRaw "Brazil" ;
    ns1:description "pharma" ;
    ns1:documentDate "2011-04-08T13:09:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sanofi funds stalled Genzyme programs; Amgen broadens Brazilian reach;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sanofi-funds-stalled-genzyme-programs-amgen-broadens-brazilian-reach> ;
    ns1:foundName "Bergamo" ;
    ns1:industry "pharma" ;
    ns1:name "Bergamo" ;
    ns1:sameAsHigh <https://1145.am/db/2364219/Bergamo>,
        <https://1145.am/db/2364226/Bergamo>,
        <https://1145.am/db/2595297/Bergamo>,
        <https://1145.am/db/2595930/Bergamo> ;
    ns1:sameAsMedium <https://1145.am/db/2350471/Bergamo> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364216/Hypermarcas> a org:Organization ;
    ns1:basedInHighGeoName "Federative Republic of Brazil" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:basedInHighRaw "Brazil" ;
    ns1:documentDate "2011-04-08T13:09:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sanofi funds stalled Genzyme programs; Amgen broadens Brazilian reach;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sanofi-funds-stalled-genzyme-programs-amgen-broadens-brazilian-reach> ;
    ns1:foundName "Hypermarcas" ;
    ns1:industry "pharma" ;
    ns1:name "Hypermarcas" ;
    ns1:sameAsHigh <https://1145.am/db/2364219/Hypermarcas>,
        <https://1145.am/db/2364226/Hypermarcas>,
        <https://1145.am/db/2556957/Hyperion_Pharma_Co_Ltd>,
        <https://1145.am/db/2595297/Hypermarcas>,
        <https://1145.am/db/2595932/Bergamo> ;
    ns1:sameAsMedium <https://1145.am/db/2564462/Hypermarcas>,
        <https://1145.am/db/2570564/Hypermarcas>,
        <https://1145.am/db/2576474/Hypermarcas>,
        <https://1145.am/db/2578498/Hypermarcas_Sa> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364226/Bergamo> a org:Organization ;
    ns1:basedInHighGeoName "Federative Republic of Brazil" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:basedInHighRaw "Brazil" ;
    ns1:buyer <https://1145.am/db/2364226/Bergamo_Rights_Investment>,
        <https://1145.am/db/2364226/Rights_Acquisition_Bergamo_Hypermarcas_Has_Not_Happened> ;
    ns1:description "Pharmaceutical" ;
    ns1:documentDate "2011-04-08T14:16:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen (AMGN) Establishes Commercial Operations in Brazil; Acquires Privately Held Brazilian Pharmaceutical Company Bergamo" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/amgen-amgn-establishes-commercial-operations-brazil-acquires-privately-held-brazilian> ;
    ns1:foundName "Amgen",
        "Bergamo" ;
    ns1:industry "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2364226/Bergamo_Rights_Investment> ;
    ns1:name "Bergamo" ;
    ns1:sameAsHigh <https://1145.am/db/2364216/Bergamo>,
        <https://1145.am/db/2364219/Bergamo>,
        <https://1145.am/db/2595297/Bergamo>,
        <https://1145.am/db/2595930/Bergamo> ;
    ns1:sameAsMedium <https://1145.am/db/2350471/Bergamo> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364226/Hypermarcas> a org:Organization ;
    ns1:basedInHighGeoName "Federative Republic of Brazil" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:basedInHighRaw "Brazil" ;
    ns1:buyer <https://1145.am/db/2364226/Rights_Acquisition_Bergamo_Hypermarcas_Has_Not_Happened> ;
    ns1:documentDate "2011-04-08T14:16:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen (AMGN) Establishes Commercial Operations in Brazil; Acquires Privately Held Brazilian Pharmaceutical Company Bergamo" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/amgen-amgn-establishes-commercial-operations-brazil-acquires-privately-held-brazilian> ;
    ns1:foundName "Hypermarcas",
        "Hypermarcas)" ;
    ns1:industry "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2364226/Bergamo_Rights_Investment> ;
    ns1:name "Hypermarcas" ;
    ns1:sameAsHigh <https://1145.am/db/2364216/Hypermarcas>,
        <https://1145.am/db/2364219/Hypermarcas>,
        <https://1145.am/db/2556957/Hyperion_Pharma_Co_Ltd>,
        <https://1145.am/db/2595297/Hypermarcas>,
        <https://1145.am/db/2595932/Bergamo> ;
    ns1:sameAsMedium <https://1145.am/db/2564462/Hypermarcas>,
        <https://1145.am/db/2570564/Hypermarcas>,
        <https://1145.am/db/2576474/Hypermarcas>,
        <https://1145.am/db/2578498/Hypermarcas_Sa> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364226/Rights_Acquisition_Bergamo_Hypermarcas_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-04-08T14:16:56+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Amgen has also agreed to reacquire rights in Brazil to its products that were previously granted to Mantecorp (subsequently acquired by Hypermarcas) ." ;
    ns1:documentTitle "Amgen (AMGN) Establishes Commercial Operations in Brazil; Acquires Privately Held Brazilian Pharmaceutical Company Bergamo" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/amgen-amgn-establishes-commercial-operations-brazil-acquires-privately-held-brazilian> ;
    ns1:foundName "reacquire" ;
    ns1:name "reacquire" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "rights" ;
    ns1:whereGeoName "Federative Republic of Brazil" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:whereRaw "Brazil" .

<https://1145.am/db/2365109/Taris_Biomedical> a org:Organization ;
    ns1:basedInHighGeoName "Lexington" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4941935/about.rdf> ;
    ns1:basedInHighRaw "LEXINGTON, Mass." ;
    ns1:description "developing innovative, targeted therapies using drug delivery to treat bladder diseases",
        "venture capital" ;
    ns1:documentDate "2011-04-13T11:12:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TARIS Closes $18.3 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/taris-closes-18-3-million-series-b-financing-0> ;
    ns1:foundName "TARIS",
        "TARIS Biomedical" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "TARIS",
        "TARIS Biomedical" ;
    ns1:sameAsHigh <https://1145.am/db/2303879/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2304127/Taro_Pharmaceutical>,
        <https://1145.am/db/2307738/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2307859/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2316028/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2316529/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2317682/Taro>,
        <https://1145.am/db/2319800/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2321137/Taro_Pharmaceutical_Industries>,
        <https://1145.am/db/2324243/Taro_Pharmaceutical_Industries>,
        <https://1145.am/db/2325227/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2328501/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2328513/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2330617/Taris_Biomedical>,
        <https://1145.am/db/2332824/Taro_Pharmaceutical_Industries>,
        <https://1145.am/db/2338620/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2341453/Taris_Biomedical>,
        <https://1145.am/db/2346988/Taris>,
        <https://1145.am/db/2365111/Taris_Biomedical>,
        <https://1145.am/db/2538647/Taro_Pharmaceuticals>,
        <https://1145.am/db/2539462/Taro_Pharmaceutical>,
        <https://1145.am/db/2549705/Taro_Pharmaceutical>,
        <https://1145.am/db/2563423/Taro_Pharma>,
        <https://1145.am/db/2571648/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2573447/Taro_Pharmaceutical>,
        <https://1145.am/db/2578262/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2579495/Taro_Pharmaceutical_Industries>,
        <https://1145.am/db/2583089/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2585238/Taro_Pharmaceutical_Industries>,
        <https://1145.am/db/2586229/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2586399/Taris_Biomedical>,
        <https://1145.am/db/2595055/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2595688/Taro>,
        <https://1145.am/db/2597197/Taro_Pharmaceuticals>,
        <https://1145.am/db/2597320/Taro_Pharmaceuticals>,
        <https://1145.am/db/376971/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/665392/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/667006/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/849790/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/865475/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/870656/Taro_Pharmaceutical_Industries_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/2154521/Taris_Biomedical>,
        <https://1145.am/db/2330623/Taris_Biomedical>,
        <https://1145.am/db/2371435/Taris_Biomedical>,
        <https://1145.am/db/2590269/Taris_Biomedical> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365111/Taris_Biomedical> a org:Organization ;
    ns1:basedInHighGeoName "Lexington" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4941935/about.rdf> ;
    ns1:basedInHighRaw "LEXINGTON, Mass." ;
    ns1:description "a pharmaceutical company" ;
    ns1:documentDate "2011-04-13T11:20:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TARIS Closes $18.3 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/taris-closes-18-3-million-series-b-financing> ;
    ns1:foundName "TARIS Biomedical" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "TARIS Biomedical" ;
    ns1:sameAsHigh <https://1145.am/db/2303879/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2304127/Taro_Pharmaceutical>,
        <https://1145.am/db/2307738/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2307859/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2316028/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2316529/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2317682/Taro>,
        <https://1145.am/db/2319800/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2321137/Taro_Pharmaceutical_Industries>,
        <https://1145.am/db/2324243/Taro_Pharmaceutical_Industries>,
        <https://1145.am/db/2325227/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2328501/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2328513/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2330617/Taris_Biomedical>,
        <https://1145.am/db/2332824/Taro_Pharmaceutical_Industries>,
        <https://1145.am/db/2338620/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2341453/Taris_Biomedical>,
        <https://1145.am/db/2346988/Taris>,
        <https://1145.am/db/2365109/Taris_Biomedical>,
        <https://1145.am/db/2538647/Taro_Pharmaceuticals>,
        <https://1145.am/db/2539462/Taro_Pharmaceutical>,
        <https://1145.am/db/2549705/Taro_Pharmaceutical>,
        <https://1145.am/db/2563423/Taro_Pharma>,
        <https://1145.am/db/2571648/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2573447/Taro_Pharmaceutical>,
        <https://1145.am/db/2578262/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2579495/Taro_Pharmaceutical_Industries>,
        <https://1145.am/db/2583089/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2585238/Taro_Pharmaceutical_Industries>,
        <https://1145.am/db/2586229/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2586399/Taris_Biomedical>,
        <https://1145.am/db/2595055/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/2595688/Taro>,
        <https://1145.am/db/2597197/Taro_Pharmaceuticals>,
        <https://1145.am/db/2597320/Taro_Pharmaceuticals>,
        <https://1145.am/db/376971/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/665392/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/667006/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/849790/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/865475/Taro_Pharmaceutical_Industries_Ltd>,
        <https://1145.am/db/870656/Taro_Pharmaceutical_Industries_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/2154521/Taris_Biomedical>,
        <https://1145.am/db/2330623/Taris_Biomedical>,
        <https://1145.am/db/2371435/Taris_Biomedical>,
        <https://1145.am/db/2590269/Taris_Biomedical> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365826/Shire_Plc> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:documentDate "2011-01-05T14:22:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DBV Technologies closes $25.5 (19,4) million Series 'C' financing round including new investors InnoBio, Lundbeckfond Ven" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dbv-technologies-closes-25-5-eu19-4-million-series-c-financing-round-including-new> ;
    ns1:foundName "Shire plc" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2365826/Series_C_Investment_Alk_Abello_Alto_Invest_Dbv_Technologies_Innobio_Fund_Lundbeckfond_Ventures_Shire_Plc_Sofinnova_Partners_Completed> ;
    ns1:name "Shire plc" ;
    ns1:sameAsHigh <https://1145.am/db/2361640/Shire_Plc>,
        <https://1145.am/db/2371522/Shire>,
        <https://1145.am/db/2592336/Shire> ;
    ns1:sameAsMedium <https://1145.am/db/142937/Shire_Plc>,
        <https://1145.am/db/2155273/Shire>,
        <https://1145.am/db/2225348/Shire_Plc>,
        <https://1145.am/db/2225352/Shire_Plc>,
        <https://1145.am/db/2288537/Shire>,
        <https://1145.am/db/2290932/Shire>,
        <https://1145.am/db/2291354/Shire>,
        <https://1145.am/db/2292991/Shire>,
        <https://1145.am/db/2293472/Shire>,
        <https://1145.am/db/2296208/Shire>,
        <https://1145.am/db/2296243/Shire>,
        <https://1145.am/db/2297066/Shire>,
        <https://1145.am/db/2298391/Shire>,
        <https://1145.am/db/2300483/Shire>,
        <https://1145.am/db/2302783/Shire_Limited>,
        <https://1145.am/db/2303789/Shire>,
        <https://1145.am/db/2305581/Shire_Plc>,
        <https://1145.am/db/2306762/Shire>,
        <https://1145.am/db/2310002/Shire>,
        <https://1145.am/db/2314408/Shire_Limited>,
        <https://1145.am/db/2320137/Shire>,
        <https://1145.am/db/2320509/Shire>,
        <https://1145.am/db/2324621/Shire_Plc>,
        <https://1145.am/db/2326381/Shire_Plc>,
        <https://1145.am/db/2328189/Shire>,
        <https://1145.am/db/2328788/Shire_Plc>,
        <https://1145.am/db/2331795/Shire_Plc>,
        <https://1145.am/db/2332620/Shire>,
        <https://1145.am/db/2333419/Shire>,
        <https://1145.am/db/2335641/Shire>,
        <https://1145.am/db/2336126/Shire_Plc>,
        <https://1145.am/db/2336575/Shire>,
        <https://1145.am/db/2336581/Shire>,
        <https://1145.am/db/2336708/Shire>,
        <https://1145.am/db/2338009/Shire>,
        <https://1145.am/db/2338011/Shire>,
        <https://1145.am/db/2339117/Shire>,
        <https://1145.am/db/2339733/Shire_Plc>,
        <https://1145.am/db/2340560/Shire>,
        <https://1145.am/db/2340566/Shire_Plc>,
        <https://1145.am/db/2340575/Shire>,
        <https://1145.am/db/2341068/Shire>,
        <https://1145.am/db/2341074/Shire>,
        <https://1145.am/db/2341522/Shire>,
        <https://1145.am/db/2341828/Shire_Plc>,
        <https://1145.am/db/2341829/Shire>,
        <https://1145.am/db/2341838/Shire>,
        <https://1145.am/db/2341902/Shire>,
        <https://1145.am/db/2342514/Shire>,
        <https://1145.am/db/2342570/Shire>,
        <https://1145.am/db/2344160/Shire>,
        <https://1145.am/db/2344202/Shire>,
        <https://1145.am/db/2344205/Shire>,
        <https://1145.am/db/2344913/Shire>,
        <https://1145.am/db/2344914/Shire_Plc>,
        <https://1145.am/db/2344928/Shire_Plc>,
        <https://1145.am/db/2345096/Shire>,
        <https://1145.am/db/2345238/Shire>,
        <https://1145.am/db/2345248/Shire_Plc>,
        <https://1145.am/db/2345825/Shire_Plc>,
        <https://1145.am/db/2345826/Shire_Plc>,
        <https://1145.am/db/2346202/Shire>,
        <https://1145.am/db/2346640/Shire>,
        <https://1145.am/db/2346644/Shire_Plc>,
        <https://1145.am/db/2346646/Shire_Plc>,
        <https://1145.am/db/2346752/Shire_Plc>,
        <https://1145.am/db/2346863/Shire_Plc>,
        <https://1145.am/db/2346872/Shire_Plc>,
        <https://1145.am/db/2346879/Shire>,
        <https://1145.am/db/2347646/Shire_Plc>,
        <https://1145.am/db/2347772/Shire>,
        <https://1145.am/db/2348523/Shire>,
        <https://1145.am/db/2348661/Shire>,
        <https://1145.am/db/2348742/Shire>,
        <https://1145.am/db/2348750/Shire>,
        <https://1145.am/db/2348805/Shire>,
        <https://1145.am/db/2350265/Shire_Plc>,
        <https://1145.am/db/2351482/Shire>,
        <https://1145.am/db/2351483/Shire>,
        <https://1145.am/db/2351734/Shire_Llc>,
        <https://1145.am/db/2351737/Shire_Llc>,
        <https://1145.am/db/2351754/Shire>,
        <https://1145.am/db/2352906/Shire>,
        <https://1145.am/db/2353283/Shire_Plc>,
        <https://1145.am/db/2354266/Shire_Llc>,
        <https://1145.am/db/2354277/Shire>,
        <https://1145.am/db/2356384/Shire>,
        <https://1145.am/db/2357032/Shire>,
        <https://1145.am/db/2357116/Shire>,
        <https://1145.am/db/2357487/Shire>,
        <https://1145.am/db/2359634/Shire>,
        <https://1145.am/db/2359681/Shire>,
        <https://1145.am/db/2360712/Shire_Plc>,
        <https://1145.am/db/2361514/Shire_Plc>,
        <https://1145.am/db/2361641/Shire>,
        <https://1145.am/db/2362744/Shire>,
        <https://1145.am/db/2364136/Shire_Plc>,
        <https://1145.am/db/2364149/Shire_Plc>,
        <https://1145.am/db/2364556/Shire>,
        <https://1145.am/db/2364813/Shire>,
        <https://1145.am/db/2365002/Shire_Plc>,
        <https://1145.am/db/2366303/Shire>,
        <https://1145.am/db/2367132/Shire_Plc>,
        <https://1145.am/db/2367297/Shire>,
        <https://1145.am/db/2368144/Shire>,
        <https://1145.am/db/2368862/Shire>,
        <https://1145.am/db/2368885/Shire>,
        <https://1145.am/db/2368915/Shire>,
        <https://1145.am/db/2368936/Shire>,
        <https://1145.am/db/2369141/Shire>,
        <https://1145.am/db/2369701/Shire>,
        <https://1145.am/db/2369949/Shire>,
        <https://1145.am/db/2370010/Shire>,
        <https://1145.am/db/2370189/Shire>,
        <https://1145.am/db/2370358/Shire>,
        <https://1145.am/db/2370514/Shire>,
        <https://1145.am/db/2370740/Shire>,
        <https://1145.am/db/2371519/Shire>,
        <https://1145.am/db/2537396/Shire>,
        <https://1145.am/db/2539292/Shire>,
        <https://1145.am/db/2541146/Shire>,
        <https://1145.am/db/2544223/Shire>,
        <https://1145.am/db/2544434/Shire>,
        <https://1145.am/db/2544459/Shire>,
        <https://1145.am/db/2544726/Shire>,
        <https://1145.am/db/2546262/Shire>,
        <https://1145.am/db/2546291/Shire>,
        <https://1145.am/db/2547036/Shire>,
        <https://1145.am/db/2547277/Shire>,
        <https://1145.am/db/2547575/Shire_Plc>,
        <https://1145.am/db/2548051/Shire>,
        <https://1145.am/db/2548805/Shire>,
        <https://1145.am/db/2548859/Shire>,
        <https://1145.am/db/2548979/Shire>,
        <https://1145.am/db/2550985/Shire>,
        <https://1145.am/db/2552180/Shire>,
        <https://1145.am/db/2552455/Shire>,
        <https://1145.am/db/2554269/Shire>,
        <https://1145.am/db/2554294/Shire>,
        <https://1145.am/db/2556988/Shire>,
        <https://1145.am/db/2558927/Shire>,
        <https://1145.am/db/2559769/Shire>,
        <https://1145.am/db/2561541/Shire>,
        <https://1145.am/db/2563175/Shire>,
        <https://1145.am/db/2564899/Shire>,
        <https://1145.am/db/2565613/Shire>,
        <https://1145.am/db/2566716/Shire>,
        <https://1145.am/db/2569388/Shire>,
        <https://1145.am/db/2569952/Shire>,
        <https://1145.am/db/2570020/Shire>,
        <https://1145.am/db/2570036/Shire>,
        <https://1145.am/db/2570363/Shire>,
        <https://1145.am/db/2570733/Shire_Plc>,
        <https://1145.am/db/2570807/Shire>,
        <https://1145.am/db/2571521/Shire>,
        <https://1145.am/db/2571526/Shire>,
        <https://1145.am/db/2572113/Shire_Plc>,
        <https://1145.am/db/2572335/Shire>,
        <https://1145.am/db/2572559/Shire>,
        <https://1145.am/db/2573463/Shire>,
        <https://1145.am/db/2573508/Shire>,
        <https://1145.am/db/2574443/Shire>,
        <https://1145.am/db/2574731/Shire>,
        <https://1145.am/db/2575050/Shire>,
        <https://1145.am/db/2575259/Shire>,
        <https://1145.am/db/2576815/Shire>,
        <https://1145.am/db/2576959/Shire>,
        <https://1145.am/db/2577114/Shire>,
        <https://1145.am/db/2577117/Shire>,
        <https://1145.am/db/2577176/Shire_Plc>,
        <https://1145.am/db/2577652/Shire_Plc>,
        <https://1145.am/db/2577793/Shire_Plc>,
        <https://1145.am/db/2578085/Shire_Plc>,
        <https://1145.am/db/2578319/Shire>,
        <https://1145.am/db/2578503/Shire>,
        <https://1145.am/db/2578568/Shire>,
        <https://1145.am/db/2579035/Shire_Plc>,
        <https://1145.am/db/2579062/Shire_Plc>,
        <https://1145.am/db/2580279/Shire>,
        <https://1145.am/db/2580603/Shire>,
        <https://1145.am/db/2580620/Shire>,
        <https://1145.am/db/2580622/Shire>,
        <https://1145.am/db/2580747/Shire>,
        <https://1145.am/db/2581261/Shire>,
        <https://1145.am/db/2582265/Shire>,
        <https://1145.am/db/2583177/Shire>,
        <https://1145.am/db/2583624/Shire_Plc>,
        <https://1145.am/db/2583662/Shire>,
        <https://1145.am/db/2584216/Shire>,
        <https://1145.am/db/2585066/Shire>,
        <https://1145.am/db/2585132/Shire>,
        <https://1145.am/db/2586132/Shire>,
        <https://1145.am/db/2586884/Shire>,
        <https://1145.am/db/2586889/Shire>,
        <https://1145.am/db/2587094/Shire>,
        <https://1145.am/db/2587511/Shire>,
        <https://1145.am/db/2588152/Shire>,
        <https://1145.am/db/2589981/Shire_Plc>,
        <https://1145.am/db/2591412/Shire>,
        <https://1145.am/db/2592333/Shire>,
        <https://1145.am/db/2592562/Shire>,
        <https://1145.am/db/2595190/Shire>,
        <https://1145.am/db/2595210/Shire>,
        <https://1145.am/db/2597158/Shire>,
        <https://1145.am/db/2598205/Shire>,
        <https://1145.am/db/2976/Shire> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366744/Mpm_Capital> a org:Organization ;
    ns1:basedInLowRaw "KANSAS CITY, Kan" ;
    ns1:documentDate "2011-01-07T14:54:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aratana Therapeutics Announces $20 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-therapeutics-announces-20-million-financing> ;
    ns1:foundName "MPM Capital" ;
    ns1:investor <https://1145.am/db/2366744/Series_A_Investment_Aratana_Therapeutics_Avalon_Ventures_Mpm_Capital_Completed> ;
    ns1:name "MPM Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1325968/Mpm_Capital>,
        <https://1145.am/db/1752458/Mpm_Capital>,
        <https://1145.am/db/2285876/Mpm_Capital>,
        <https://1145.am/db/2287191/Mpm_Capital>,
        <https://1145.am/db/2292334/Mpm_Capital>,
        <https://1145.am/db/2292353/Mpm_Capital>,
        <https://1145.am/db/2300455/Mpm_Capital>,
        <https://1145.am/db/2301901/Mpm_Capital>,
        <https://1145.am/db/2303391/Mpm_Capital>,
        <https://1145.am/db/2303833/Mpm_Capital>,
        <https://1145.am/db/2303855/Mpm_Capital>,
        <https://1145.am/db/2304634/Mpm_Capital>,
        <https://1145.am/db/2305503/Mpm_Capital>,
        <https://1145.am/db/2305656/Mpm_Capital>,
        <https://1145.am/db/2306705/Mpm_Capital>,
        <https://1145.am/db/2308887/Mpm_Capital>,
        <https://1145.am/db/2309845/Mpm_Capital>,
        <https://1145.am/db/2311551/Mpm_Capital>,
        <https://1145.am/db/2312285/Mpm_Capital>,
        <https://1145.am/db/2312309/Mpm_Capital>,
        <https://1145.am/db/2316391/Mpm_Capital>,
        <https://1145.am/db/2323055/Mpm_Capital>,
        <https://1145.am/db/2323066/Mpm_Capital>,
        <https://1145.am/db/2323094/Mpm_Capital>,
        <https://1145.am/db/2323563/Mpm_Capital>,
        <https://1145.am/db/2323568/Mpm_Capital>,
        <https://1145.am/db/2324195/Mpm_Capital>,
        <https://1145.am/db/2324226/Mpm_Capital>,
        <https://1145.am/db/2328338/Mpm_Capital>,
        <https://1145.am/db/2333119/Mpm_Capital>,
        <https://1145.am/db/2333525/Mpm_Capital>,
        <https://1145.am/db/2335701/Mpm_Capital>,
        <https://1145.am/db/2335714/Mpm_Capital>,
        <https://1145.am/db/2337140/Mpm_Capital>,
        <https://1145.am/db/2340957/Mpm_Capital>,
        <https://1145.am/db/2345299/Mpm_Capital>,
        <https://1145.am/db/2345318/Mpm_Capital>,
        <https://1145.am/db/2346204/Mpm_Capital>,
        <https://1145.am/db/2347140/Mpm_Capital>,
        <https://1145.am/db/2347469/Mpm_Capital>,
        <https://1145.am/db/2347984/Mpm_Capital>,
        <https://1145.am/db/2348484/Mpm_Capital>,
        <https://1145.am/db/2350030/Mpm_Capital>,
        <https://1145.am/db/2352172/Mpm_Capital>,
        <https://1145.am/db/2352362/Mpm_Capital>,
        <https://1145.am/db/2352899/Mpm_Capital>,
        <https://1145.am/db/2353365/Mpm_Capital>,
        <https://1145.am/db/2353404/Mpm_Capital>,
        <https://1145.am/db/2353413/Mpm_Capital>,
        <https://1145.am/db/2353415/Mpm_Capital>,
        <https://1145.am/db/2356396/Mpm_Capital>,
        <https://1145.am/db/2358979/Mpm_Capital>,
        <https://1145.am/db/2359001/Mpm_Capital>,
        <https://1145.am/db/2359873/Mpm_Capital>,
        <https://1145.am/db/2359875/Mpm_Capital>,
        <https://1145.am/db/2360526/Mpm_Capital>,
        <https://1145.am/db/2362871/Mpm_Capital>,
        <https://1145.am/db/2364492/Mpm_Capital>,
        <https://1145.am/db/2365098/Mpm_Capital>,
        <https://1145.am/db/2367199/Mpm_Capital>,
        <https://1145.am/db/2369202/Mpm_Capital>,
        <https://1145.am/db/2370582/Mpm_Capital>,
        <https://1145.am/db/2541350/Mpm_Capital>,
        <https://1145.am/db/677075/Mpm_Capital>,
        <https://1145.am/db/678997/Mpm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366744/Series_A_Investment_Aratana_Therapeutics_Avalon_Ventures_Mpm_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-07T14:54:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aratana Therapeutics Announces $ 20 Million Financing.",
        "KANSAS CITY, Kan., Jan. 7, 2011 /PRNewswire/ - Aratana Therapeutics, a newly-formed company focused on the development of innovative therapies for the animal health industry, today announced that it has closed a $ 20 million Series A financing led by MPM Capital and Avalon Ventures." ;
    ns1:documentTitle "Aratana Therapeutics Announces $20 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-therapeutics-announces-20-million-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2366744/Aratana_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 20 Million",
        "$ 20 million" ;
    ns1:when "2011-01-07T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Jan. 7, 2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2366753/Series_A_Investment_Canaan_Partners_Civitas_Therapeutics_Longitude_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-10T12:12:44+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Chelsea, MA - January xx, 2011 - Civitas Therapeutics, Inc., a privately held biopharmaceutical company focused on developing transformative pulmonary delivery therapies, announced today that it has secured a $ 20 million Series A financing from founding investor, Longitude Capital, along with co-lead Canaan Partners.",
        "Civitas Therapeutics Secures $ 20 Million Series A Financing." ;
    ns1:documentTitle "Civitas Therapeutics Secures $20 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/civitas-therapeutics-secures-20-million-series-a-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2366753/Civitas_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 20 Million",
        "$ 20 million" ;
    ns1:whenRaw "January xx, 2011" ;
    ns1:whereGeoName "Chelsea" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/8673938/about.rdf> ;
    ns1:whereRaw "Chelsea" .

<https://1145.am/db/2366984/Investment_Acadia_Pharmaceuticals_Inc_New_Enterprise_Associates_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-10T15:12:27+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SAN DIEGO- (BUSINESS WIRE) - ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD - News) , a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has entered into a securities purchase agreement for a private placement financing with a select group of institutional investors, including New Enterprise Associates and Venrock." ;
    ns1:documentTitle "ACADIA Pharmaceuticals, Inc. (ACAD) Announces $15 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/acadia-pharmaceuticals-inc-acad-announces-15-million-private-placement> ;
    ns1:foundName "private placement",
        "sale" ;
    ns1:name "private placement",
        "sale" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2366984/Acadia_Pharmaceuticals_Inc> ;
    ns1:valueRaw "$ 15.0 million",
        "12.57 million units" ;
    ns1:whereGeoName "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "SAN DIEGO" .

<https://1145.am/db/2366984/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2011-01-10T15:12:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ACADIA Pharmaceuticals, Inc. (ACAD) Announces $15 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/acadia-pharmaceuticals-inc-acad-announces-15-million-private-placement> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2366984/Investment_Acadia_Pharmaceuticals_Inc_New_Enterprise_Associates_Has_Not_Happened> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2577419/Merger_Biovail_Valeant_Pharmaceuticals_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2010-12-23T12:50:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Biovail ($ BVF) and Valeant Pharmaceuticals ($ VRX) merged in a $ 3.2 billion deal." ;
    ns1:documentTitle "Dealmaking goes from mega to mini" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dealmaking-goes-from-mega-to-mini> ;
    ns1:foundName "merged" ;
    ns1:name "merged" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:valueRaw "$ 3.2 billion" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2591540/Polpharma_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "bankruptcy" ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Hungary's Gedeon Richter said Genefar had been ordered to pay it $ 40 million for breach of contract in a dispute over the failed buyout of Polpharma." ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:foundName "buyout" ;
    ns1:name "buyout" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "stopped" ;
    ns1:target <https://1145.am/db/2591540/Polpharma> ;
    ns1:targetName "Polpharma" ;
    ns1:valueRaw "$ 40 million" ;
    ns1:whereGeoName "Hungary" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/719819/about.rdf> ;
    ns1:whereRaw "Hungary" .

<https://1145.am/db/2592467/Bilim_Ilac_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-08-12T15:40:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Actera is said to be buying a 10 % stake in the company in a deal that would value Bilim Ilac at more than $ 900 million.",
        "Turkish drugmaker Bilim Ilac may have found a private-equity investor." ;
    ns1:documentTitle "Turkish private equity fund eyes stake in Bilim Ilac" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/turkish-private-equity-fund-eyes-stake-bilim-ilac> ;
    ns1:foundName "buying",
        "sell" ;
    ns1:name "buying",
        "sell" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2592467/Bilim_Ilac> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Bilim Ilac" ;
    ns1:valueRaw "$ 500 million",
        "more than $ 900 million" ;
    ns1:whereRaw "Turkish" .

<https://1145.am/db/2593831/Cephalon> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2011-03-30T13:50:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Investors boost Cephalon past Valeant's $5.7B offer" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/investors-boost-cephalon-past-valeant-s-5-7b-offer> ;
    ns1:foundName "Cephalon" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Cephalon" ;
    ns1:sameAsHigh <https://1145.am/db/2301933/Cephalon>,
        <https://1145.am/db/2301947/Cephalon_Inc>,
        <https://1145.am/db/2302608/Cephalon>,
        <https://1145.am/db/2305244/Cephalon>,
        <https://1145.am/db/2306168/Cephalon_Inc>,
        <https://1145.am/db/2306283/Cephalon>,
        <https://1145.am/db/2311562/Cephalon_Inc>,
        <https://1145.am/db/2318093/Cephalon_Inc>,
        <https://1145.am/db/2321967/Cephalon>,
        <https://1145.am/db/2321976/Cephalon>,
        <https://1145.am/db/2323732/Cephalon>,
        <https://1145.am/db/2323733/Cephalon>,
        <https://1145.am/db/2330882/Cephalon>,
        <https://1145.am/db/2331204/Cephalon>,
        <https://1145.am/db/2331205/Cephalon>,
        <https://1145.am/db/2338474/Cephalon>,
        <https://1145.am/db/2338480/Cephalon>,
        <https://1145.am/db/2346543/Cephalon_Inc>,
        <https://1145.am/db/2350717/Cephalon>,
        <https://1145.am/db/2350721/Cephalon_Inc>,
        <https://1145.am/db/2356821/Cephalon>,
        <https://1145.am/db/2358023/Cephalon_Inc>,
        <https://1145.am/db/2360144/Cephalon>,
        <https://1145.am/db/2361172/Cephalon>,
        <https://1145.am/db/2361190/Cephalon>,
        <https://1145.am/db/2362877/Cephalon>,
        <https://1145.am/db/2542509/Cephalon>,
        <https://1145.am/db/2571706/Cephalon>,
        <https://1145.am/db/2571717/Cephalon>,
        <https://1145.am/db/2571723/Cephalon>,
        <https://1145.am/db/2572533/Cephalon>,
        <https://1145.am/db/2572541/Cephalon>,
        <https://1145.am/db/2572542/Cephalon>,
        <https://1145.am/db/2573398/Cephalon>,
        <https://1145.am/db/2576440/Cephalon>,
        <https://1145.am/db/2578908/Cephalon>,
        <https://1145.am/db/2578932/Cephalon>,
        <https://1145.am/db/2580872/Cephalon>,
        <https://1145.am/db/2580875/Cephalon>,
        <https://1145.am/db/2586716/Cephalon>,
        <https://1145.am/db/2587261/Cephalon>,
        <https://1145.am/db/2587626/Cephalon>,
        <https://1145.am/db/2590292/Cephalon>,
        <https://1145.am/db/2590891/Cephalon>,
        <https://1145.am/db/2594557/Cephalon>,
        <https://1145.am/db/2595287/Cephalon>,
        <https://1145.am/db/2595929/Cephalon>,
        <https://1145.am/db/2597223/Cephalon>,
        <https://1145.am/db/2598250/Cephalon>,
        <https://1145.am/db/2598261/Cephalon>,
        <https://1145.am/db/2598266/Cephalon>,
        <https://1145.am/db/2598433/Cephalon> ;
    ns1:sameAsMedium <https://1145.am/db/2199698/Cephalon_Inc>,
        <https://1145.am/db/2302692/Cephalon>,
        <https://1145.am/db/2306284/Cephalon>,
        <https://1145.am/db/2307936/Cephalon>,
        <https://1145.am/db/2310181/Cephalon>,
        <https://1145.am/db/2312417/Cephalon>,
        <https://1145.am/db/2319916/Cephalon>,
        <https://1145.am/db/2325473/Cephalon>,
        <https://1145.am/db/2353876/Cephalon_Inc>,
        <https://1145.am/db/2358020/Cephalon>,
        <https://1145.am/db/2363814/Cephalon>,
        <https://1145.am/db/2542518/Cephalon>,
        <https://1145.am/db/2546317/Cephalon>,
        <https://1145.am/db/2547670/Cephalon>,
        <https://1145.am/db/2573589/Cephalon>,
        <https://1145.am/db/2574480/Cephalon_Inc>,
        <https://1145.am/db/2575012/Cephalon>,
        <https://1145.am/db/2582406/Cephalon_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593831/Cephalon_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-03-30T13:50:57+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Just nine months after a $ 4 billion merger with Biovail, Valeant Pharmaceuticals ($ VRX) is looking to buy Cephalon ($ CEPH) for $ 5.7 billion, or $ 73 per share." ;
    ns1:documentTitle "Investors boost Cephalon past Valeant's $5.7B offer" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/investors-boost-cephalon-past-valeant-s-5-7b-offer> ;
    ns1:foundName "buy",
        "merger" ;
    ns1:name "buy",
        "merger" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2593831/Cephalon> ;
    ns1:targetName "Cephalon" ;
    ns1:valueRaw "$ 5.7 billion" .

<https://1145.am/db/2601480/Bahamas_Telecommunications_Company_Stake_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-04-09T18:34:13+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cable & Wireless Communications has put the final touches of its acquisition of a 51 percent stake in the Bahamas Telecommunications Company (BTC) .",
        "Cable & Wireless formalizes purchase of Bahamas Telecom Company." ;
    ns1:documentTitle "Cable & Wireless completes acquisition of stake in the Bahamas Telecom Company" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/cable-wireless-completes-acquisition-stake-bahamas-telecom-company> ;
    ns1:foundName "acquisition",
        "purchase" ;
    ns1:name "acquisition",
        "purchase" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2601480/Bahamas_Telecommunications_Company> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Bahamas Telecommunications",
        "Bahamas Telecommunications Company" ;
    ns1:valueRaw "$ 14.3 million",
        "$ 210 million" ;
    ns1:whereGeoName "Commonwealth of The Bahamas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3572887/about.rdf> ;
    ns1:whereRaw "Bahamas" .

<https://1145.am/db/2601480/Cable___Wireless_Communications> a org:Organization ;
    ns1:basedInLowRaw "Bahamas",
        "Bermuda" ;
    ns1:buyer <https://1145.am/db/2601480/Bahamas_Telecommunications_Company_Stake_Investment> ;
    ns1:description "telecommunications" ;
    ns1:documentDate "2011-04-09T18:34:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cable & Wireless completes acquisition of stake in the Bahamas Telecom Company" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/cable-wireless-completes-acquisition-stake-bahamas-telecom-company> ;
    ns1:foundName "Cable & Wireless",
        "Cable & Wireless Communications" ;
    ns1:industry "telecommunications" ;
    ns1:investor <https://1145.am/db/2601480/Bahamas_Telecommunications_Company_Stake_Investment> ;
    ns1:name "Cable & Wireless",
        "Cable & Wireless Communications" ;
    ns1:sameAsHigh <https://1145.am/db/2159394/The_Society_Of_Cable_Telecommunications_Engineers>,
        <https://1145.am/db/2161554/Cablecom>,
        <https://1145.am/db/2171269/Npg_Cable>,
        <https://1145.am/db/2599495/J:_Com>,
        <https://1145.am/db/2599515/J:_Com>,
        <https://1145.am/db/2601443/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2602679/Cablecom>,
        <https://1145.am/db/2605253/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2607479/Cable___Wireless_Communications>,
        <https://1145.am/db/2614188/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2617542/Cablelabs>,
        <https://1145.am/db/2617934/Cable___Wireless_Communications>,
        <https://1145.am/db/2618630/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2618856/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2619256/Cable___Wireless>,
        <https://1145.am/db/2619431/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2619973/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2619998/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2649437/Mediacom_Communications>,
        <https://1145.am/db/2666765/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2672886/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2673796/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2673808/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2673830/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2673851/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2674384/Cable___Wireless>,
        <https://1145.am/db/2674986/Cable___Wireless_Worldwide> ;
    ns1:sameAsMedium <https://1145.am/db/2162111/Cable___Wireless_Communications>,
        <https://1145.am/db/2611272/Cable___Wireless_Communications>,
        <https://1145.am/db/2614188/Cable___Wireless_Communications>,
        <https://1145.am/db/2618598/Cable___Wireless_Communications>,
        <https://1145.am/db/2657880/Cable___Wireless_Communications>,
        <https://1145.am/db/2659958/Cable___Wireless_Communications>,
        <https://1145.am/db/2662077/Cable___Wireless_Communications>,
        <https://1145.am/db/2664151/Cable___Wireless_Communications>,
        <https://1145.am/db/2667523/Cable___Wireless_Communications>,
        <https://1145.am/db/2679067/Cable___Wireless_Communications> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2606756/Joint_Venture_Centurylink_Qwest_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "joint venture" ;
    ns1:documentDate "2011-07-13T12:19:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> CenturyLink has completed Qwest's $ 258 million upgrade of New Mexico's telecom infrastructure to extend broadband coverage to 85 percent of the state's population." ;
    ns1:documentTitle "Citrix acquires Cloud.com; Apple's bet on TV, home automation could be $100B opportunity" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/citrix-acquires-cloud-com-apple-s-bet-tv-home-automation-could-be-100b-opportunity> ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "completed" ;
    ns1:valueRaw "$ 258 million" ;
    ns1:whereGeoName "Mexico" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3996063/about.rdf> ;
    ns1:whereRaw "New Mexico" .

<https://1145.am/db/2655542/Aircel> a org:Organization ;
    ns1:basedInLowRaw "India" ;
    ns1:description "Wi-Fi" ;
    ns1:documentDate "2011-02-08T01:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Finnish operators lack power; HTC acquires multimedia player" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-finnish-operators-lack-power-htc-acquires-multimedia-player> ;
    ns1:foundName "Aircel" ;
    ns1:name "Aircel" ;
    ns1:sameAsHigh <https://1145.am/db/1191614/Airties> ;
    ns1:sameAsMedium <https://1145.am/db/2659741/Aircel>,
        <https://1145.am/db/2675798/Aircel>,
        <https://1145.am/db/2678419/Aircel> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2655542/Harbinger_Capital> a org:Organization ;
    ns1:basedInHighGeoName "United States" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:basedInHighRaw "US" ;
    ns1:documentDate "2011-02-08T01:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Finnish operators lack power; HTC acquires multimedia player" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-finnish-operators-lack-power-htc-acquires-multimedia-player> ;
    ns1:foundName "Harbinger",
        "Harbinger Capital" ;
    ns1:industry "investment fund" ;
    ns1:name "Harbinger Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1383196/Hn_Capital_Partners>,
        <https://1145.am/db/1540263/Vestar_Capital_Partners>,
        <https://1145.am/db/328545/Harbright_Ventures> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2660601/Vivo_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-03-21T01:08:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Telefonica is a step closer to completing its acquisition of Brazilian carrier Vivo, after concluding a tender to purchase outstanding shares in the operator." ;
    ns1:documentTitle "Telefonica edges nearer to Vivo close" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/telefonica-edges-nearer-to-vivo-close> ;
    ns1:foundName "acquisition",
        "purchase" ;
    ns1:name "acquisition",
        "purchase" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2660601/Vivo> ;
    ns1:targetName "Vivo" ;
    ns1:valueRaw "1.27 billion Brazilian reais",
        "536 million" ;
    ns1:whereGeoName "Federative Republic of Brazil" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:whereRaw "Brazil" .

<https://1145.am/db/2171269/Npg_Cable> a org:Organization ;
    ns1:documentDate "2011-01-21T13:05:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Money talks: Hughes Communications reported for sale; Suddenlink closes offering; Norsat snags Sinclair" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/money-talks-hughes-communications-reported-for-sale-suddenlink-closes-offering-norsat-snags> ;
    ns1:foundName "NPG Cable" ;
    ns1:industry "telecommunications" ;
    ns1:name "NPG Cable" ;
    ns1:sameAsHigh <https://1145.am/db/2159394/The_Society_Of_Cable_Telecommunications_Engineers>,
        <https://1145.am/db/2599495/J:_Com>,
        <https://1145.am/db/2599515/J:_Com>,
        <https://1145.am/db/2601480/Cable___Wireless_Communications>,
        <https://1145.am/db/2607479/Cable___Wireless_Communications>,
        <https://1145.am/db/2617542/Cablelabs>,
        <https://1145.am/db/2617934/Cable___Wireless_Communications>,
        <https://1145.am/db/2618630/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2649437/Mediacom_Communications>,
        <https://1145.am/db/2672886/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2673796/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2674986/Cable___Wireless_Worldwide> ;
    ns1:sameAsMedium <https://1145.am/db/2167428/Npg_Cable_Inc>,
        <https://1145.am/db/2168118/Npg_Cable> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2217392/Evolution_Benefits_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentExtract "In the last fifteen months, Raymond James has also served as financial advisor to HLTH Corp. (NASDAQ: HLTH) in its merger with WebMD (NASDAQ: WBMD) ; the acquisition of AMICAS (NASDAQ: AMCS) by Merge Healthcare (NASDAQ: MRGE) ; the sale of Evolution Benefits to Genstar Capital; and the sale of Axolotl to Ingenix, a subsidiary of United Health Group (NYSE: UNH) ; and the sale of Medicity to Aetna (NYSE: AET) representing aggregate transaction value of approximately $ 2.4 billion." ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "sale" ;
    ns1:name "sale" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2217392/Evolution_Benefits> ;
    ns1:targetName "Evolution Benefits" ;
    ns1:valueRaw "approximately $ 2.4 billion" .

<https://1145.am/db/2233192/Operations_Acquisition_Dlp_Healthcare_Duke_University_Health_System_Medcath_Partners_Medcath_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2011-05-05T12:21:23+00:00"^^xsd:dateTime ;
    ns1:documentExtract "DURHAM, N.C. & BRENTWOOD, Tenn.- (BUSINESS WIRE) - DLP Healthcare, LLC, a joint venture of Duke University Health System and LifePoint Hospitals, today announced that it has acquired the North Carolina cardiac catheterization operations of MedCath Partners, LLC, an affiliate of MedCath Corporation." ;
    ns1:documentTitle "DLP Healthcare Acquires Operations of MedCath Partners" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/dlp-healthcare-acquires-operations-medcath-partners> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:targetDetails "operations" ;
    ns1:whereGeoName "North Carolina" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4482348/about.rdf> ;
    ns1:whereRaw "North Carolina" .

<https://1145.am/db/2239374/Chilton_Medical_Center_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-03-03T23:20:42+00:00"^^xsd:dateTime ;
    ns1:documentExtract "ATLANTA- (BUSINESS WIRE) - SunLink Health Systems, Inc. (NYSE Amex Equities: SSY) today announced that effective March 1st it transferred operation of, and leased its Chilton Medical Center in Clanton, AL, to a subsidiary of Carraway Medical Systems, LLC." ;
    ns1:documentTitle "SunLink Health Systems, Inc. Announces the Lease of Its Chilton Medical Center" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/sunlink-health-systems-inc-announces-lease-its-chilton-medical-center> ;
    ns1:foundName "purchase",
        "transferred" ;
    ns1:name "purchase",
        "transferred" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2239374/Chilton_Medical_Center>,
        <https://1145.am/db/2239374/Sunlink_Health_Systems> ;
    ns1:targetName "Chilton Medical Center" ;
    ns1:vendor <https://1145.am/db/2239374/Sunlink_Health_Systems> ;
    ns1:when "2011-03-01T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "March 1st" ;
    ns1:whereGeoName "Clanton" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4055577/about.rdf> ;
    ns1:whereRaw "Clanton, AL" .

<https://1145.am/db/2289940/Investment_Cardiofocus_First_Alliance___Capital_Invest_Fletcher_Spaght_Ventures_Manatuck_Hill_Partners_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-03-02T12:55:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CardioFocus' investors include first-timers Fletcher Spaght Ventures, Manatuck Hill Partners and First Alliance & Capital Invest, as well as a laundry list of previous investors.",
        "Marlborough, MA - based CardioFocus has landed $ 30.6 million in private financing to support development of its CardioFocus Endoscopic Ablation System." ;
    ns1:documentTitle "CardioFocus raises $30.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiofocus-raises-30-6m> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2289940/Cardiofocus> ;
    ns1:valueRaw "$ 30.6 million" ;
    ns1:whereGeoName "Marlborough" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4943170/about.rdf> ;
    ns1:whereRaw "Marlborough, MA" .

<https://1145.am/db/2345206/Pfc_Pharma_Focus_Ltd_Subsidiaries_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-05-23T13:55:58+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Clinipace Worldwide Acquires Switzerland - Based PFC Pharma Focus Ltd.",
        "MORRISVILLE, N.C. & ZURICH, SWITZERLAND- (BUSINESS WIRE) -Clinipace Worldwide, a global digital clinical research organization (dCRO) , and Swiss - based PFC Pharma Focus (PFC) today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of privately-held PFC and its subsidiaries." ;
    ns1:documentTitle "Clinipace Worldwide Acquires Switzerland-Based PFC Pharma Focus Ltd." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clinipace-worldwide-acquires-switzerland-based-pfc-pharma-focus-ltd> ;
    ns1:foundName "Acquires",
        "acquired",
        "merger" ;
    ns1:name "Acquires",
        "acquired",
        "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2345206/Pfc_Pharma_Focus_Ltd> ;
    ns1:targetDetails "subsidiaries" ;
    ns1:targetName "PFC Pharma Focus",
        "PFC Pharma Focus Ltd." ;
    ns1:whereGeoName "Switzerland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:whereRaw "Switzerland" .

<https://1145.am/db/2345206/Subsidiaries_Merger_Clinipace_Worldwide_Clinipace_Worldwide_Pfc_Pharma_Focus_Ltd_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2011-05-23T13:55:58+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MORRISVILLE, N.C. & ZURICH, SWITZERLAND- (BUSINESS WIRE) -Clinipace Worldwide, a global digital clinical research organization (dCRO) , and Swiss - based PFC Pharma Focus (PFC) today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of privately-held PFC and its subsidiaries." ;
    ns1:documentTitle "Clinipace Worldwide Acquires Switzerland-Based PFC Pharma Focus Ltd." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clinipace-worldwide-acquires-switzerland-based-pfc-pharma-focus-ltd> ;
    ns1:foundName "merger" ;
    ns1:name "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:targetDetails "subsidiaries" ;
    ns1:whereGeoName "Federal Republic of Germany",
        "Republic of India",
        "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf>,
        <https://sws.geonames.org/2921044/about.rdf>,
        <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Germany, Israel and India" .

<https://1145.am/db/2346230/Series_C_Investment_Finance_Wales_Limburg_Ventures_Nedermaas_Hightech_Ventures_Q_Chip_Limited_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-05-25T12:41:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CARDIFF, Wales, 18 May 2011 - Q Chip Limited, an emerging bio-pharmaceutical company developing innovative sustained-release drug formulations for cancer and other diseases, announced today it has completed its US $ 6 million Series C financing round (the first close was in September 2010) .",
        "Q Chip completes US $ 6 million (3.6 million) funding round to expand its portfolio of drug formulations and establish a European manufacturing facility." ;
    ns1:documentTitle "Q Chip completes US$6 million funding round to expand its portfolio of drug formulations and establish a European facility" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/q-chip-completes-us-6-million-funding-round-to-expand-its-portfolio-of-drug-formulations> ;
    ns1:foundName "financing",
        "funding" ;
    ns1:name "financing",
        "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2346230/Q_Chip_Limited> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "US $ 6 million",
        "3.6 million" ;
    ns1:when "2011-05-18T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "18 May 2011" ;
    ns1:whereGeoName "Europe" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255148/about.rdf> ;
    ns1:whereRaw "Europe" .

<https://1145.am/db/2346534/Conatus_Pharmaceuticals_Inc> a org:Organization ;
    ns1:documentDate "2011-02-14T14:20:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Conatus Pharmaceuticals Inc. Completes $20 Million Series B Private Placement Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/conatus-pharmaceuticals-inc-completes-20-million-series-b-private-placement-financing> ;
    ns1:foundName "Conatus Pharmaceuticals Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Conatus Pharmaceuticals Inc." ;
    ns1:sameAsHigh <https://1145.am/db/101025/Scpharmaceuticals_Inc>,
        <https://1145.am/db/101329/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1031042/Intomics>,
        <https://1145.am/db/1033561/Hs_Pharmaceuticals>,
        <https://1145.am/db/1054457/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/1054503/Hs_Pharmaceuticals>,
        <https://1145.am/db/1061901/Pharmaessentia_Corporation>,
        <https://1145.am/db/1070158/Biognosys>,
        <https://1145.am/db/1079560/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1080385/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1092000/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/11010/Progenics_Pharmaceuticals>,
        <https://1145.am/db/1104169/20045078>,
        <https://1145.am/db/1118439/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1141704/Inmed_Pharmaceuticals>,
        <https://1145.am/db/1174705/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1176480/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1185008/TDV>,
        <https://1145.am/db/1186876/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1216583/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1291286/Vital_Pharmaceuticals_Inc>,
        <https://1145.am/db/1294499/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1294506/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1295948/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1296487/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1307419/X4_Pharmaceuticals>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1329779/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1339033/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1343020/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/1370859/Bioivt>,
        <https://1145.am/db/1371279/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1387773/Aspire_Pharma>,
        <https://1145.am/db/1390741/Nexus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1409143/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417723/Altasciences>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443334/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443968/Pharmajet>,
        <https://1145.am/db/1445613/Pharmajet>,
        <https://1145.am/db/1487706/Phathom_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497210/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1497218/Opiant_Pharmaceuticals>,
        <https://1145.am/db/1500616/Indivior_Plc>,
        <https://1145.am/db/1500616/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1502096/Indivior_Plc>,
        <https://1145.am/db/1502096/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1505968/Escient_Pharmaceuticals>,
        <https://1145.am/db/1508407/Escient_Pharmaceuticals>,
        <https://1145.am/db/1515279/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1520596/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1520597/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521624/Scpharmaceuticals>,
        <https://1145.am/db/1521695/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521941/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1523220/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1533327/Escient_Pharmaceuticals>,
        <https://1145.am/db/1533685/Escient_Pharmaceuticals>,
        <https://1145.am/db/1537336/Pharmajet>,
        <https://1145.am/db/1538786/Pharmajet>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1541946/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1548955/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1557072/Essential_Pharma>,
        <https://1145.am/db/1559882/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1571078/Organon>,
        <https://1145.am/db/1585097/Scpharmaceuticals_Inc>,
        <https://1145.am/db/158742/Biogen_Inc>,
        <https://1145.am/db/1595580/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1613688/Pharmalex>,
        <https://1145.am/db/1624479/Indivior_Plc>,
        <https://1145.am/db/1624479/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1625532/Indivior_Plc>,
        <https://1145.am/db/1625532/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629605/Biogen>,
        <https://1145.am/db/1629663/Biogen>,
        <https://1145.am/db/1632411/Scipher_Medicine>,
        <https://1145.am/db/1632862/Scipher_Medicine>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1680583/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/1687234/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/180589/Servier>,
        <https://1145.am/db/1955684/Eip_Pharma_Inc>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2038168/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039291/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039678/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2045820/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2049603/Inova_Pharmaceuticals>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2062156/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2066480/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2071248/Biogen>,
        <https://1145.am/db/2074741/Biogen_Inc>,
        <https://1145.am/db/2092442/Leo_Pharma>,
        <https://1145.am/db/2093802/Meitheal_Pharmaceuticals>,
        <https://1145.am/db/2100253/Biogen_Inc>,
        <https://1145.am/db/2101006/Leo_Pharma_A_S>,
        <https://1145.am/db/2138834/Altasciences>,
        <https://1145.am/db/2151781/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152434/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2153727/Amunix_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154118/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154527/The_Medicines_Company>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155006/Medicines_Company>,
        <https://1145.am/db/2155312/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155622/Isa_Pharmaceuticals>,
        <https://1145.am/db/2155792/Ucb_Pharma>,
        <https://1145.am/db/2155798/Ucb_Pharma>,
        <https://1145.am/db/2155994/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2198945/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2201094/Pharmadeals_Ltd>,
        <https://1145.am/db/2204969/Organon_Biosciences>,
        <https://1145.am/db/2207034/Cequent_Pharmaceuticals>,
        <https://1145.am/db/221697/Gw_Pharmaceuticals>,
        <https://1145.am/db/2217819/Pharmacopeia>,
        <https://1145.am/db/221787/Gw_Pharmaceuticals>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2224859/Biologics>,
        <https://1145.am/db/2229191/Biologics>,
        <https://1145.am/db/2279276/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2279648/Organon>,
        <https://1145.am/db/2280123/Casi_Pharmaceuticals>,
        <https://1145.am/db/2280153/Pharming>,
        <https://1145.am/db/2281547/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2283570/Pherin_Pharmaceuticals>,
        <https://1145.am/db/2284358/Escient_Pharmaceuticals>,
        <https://1145.am/db/2285117/Immedica>,
        <https://1145.am/db/2285495/Bioivt>,
        <https://1145.am/db/2287224/Escient_Pharmaceuticals>,
        <https://1145.am/db/2287505/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2287572/T3_Pharmaceuticals>,
        <https://1145.am/db/2288192/Servier>,
        <https://1145.am/db/2290842/X4_Pharmaceuticals>,
        <https://1145.am/db/2291791/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2294547/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2294570/Pharmatek>,
        <https://1145.am/db/2296094/Biogen>,
        <https://1145.am/db/2297534/Bio>,
        <https://1145.am/db/2298037/Ethicon>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2299414/Biogen>,
        <https://1145.am/db/2301089/Cerulean_Pharma>,
        <https://1145.am/db/2301346/Pharmaron>,
        <https://1145.am/db/2301718/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2301735/Idera_Pharmaceuticals>,
        <https://1145.am/db/2301764/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302275/Map_Pharmaceuticals>,
        <https://1145.am/db/2302426/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302431/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2302574/Via_Pharmaceuticals>,
        <https://1145.am/db/2302579/Via_Pharmaceuticals>,
        <https://1145.am/db/2302587/Access_Pharmaceuticals>,
        <https://1145.am/db/2302658/Biotie>,
        <https://1145.am/db/2302707/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2302774/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302779/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302890/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2302897/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303121/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303131/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303182/Pharmexa>,
        <https://1145.am/db/2303208/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303674/Cerulean_Pharma>,
        <https://1145.am/db/2303792/Access_Pharmaceuticals>,
        <https://1145.am/db/2303934/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2304044/Novamed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2304097/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2304135/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2304610/Pharmos_Corp>,
        <https://1145.am/db/2304745/Critical_Pharmaceuticals>,
        <https://1145.am/db/2304831/Pharmion_Corporation>,
        <https://1145.am/db/2304934/Medicure>,
        <https://1145.am/db/2304985/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2305742/Mh_Pharma_Uk>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2305927/Entremed>,
        <https://1145.am/db/2305956/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2306299/Verily>,
        <https://1145.am/db/2306641/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2306962/Pharmaron>,
        <https://1145.am/db/2307239/Pharmaxis_Ltd>,
        <https://1145.am/db/2307246/Pharmaxis>,
        <https://1145.am/db/2307254/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2307651/Organon>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307871/Access_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2307897/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2308446/Pharmathene>,
        <https://1145.am/db/2308922/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308964/Slate_Pharmaceuticals>,
        <https://1145.am/db/2309001/Biocon>,
        <https://1145.am/db/2309301/Inc>,
        <https://1145.am/db/2309923/Diasome_Pharmaceuticals>,
        <https://1145.am/db/2310002/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2310002/Map_Pharmaceuticals>,
        <https://1145.am/db/2310045/Slate_Pharmaceuticals>,
        <https://1145.am/db/2310071/Encysive_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310200/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2310219/Docpharma>,
        <https://1145.am/db/2310232/Genaissance_Pharmaceuticals>,
        <https://1145.am/db/2310471/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/2310473/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310476/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2310480/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310790/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310993/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2311166/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2311202/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311217/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2311264/Medicure>,
        <https://1145.am/db/2311726/Inc>,
        <https://1145.am/db/2312088/Cerulean_Pharma>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312193/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2312344/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2312416/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2312476/Nps_Pharmaceuticals>,
        <https://1145.am/db/2312479/Nps_Pharmaceuticals>,
        <https://1145.am/db/2313305/Tetraphase_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313306/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313320/Ore_Pharmaceuticals>,
        <https://1145.am/db/2313323/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313336/Sound_Pharmaceuticals>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2313501/Bioalliance_Pharma>,
        <https://1145.am/db/2313527/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2313528/Us_Pharmaceutical_Company>,
        <https://1145.am/db/2314217/Sciele_Pharma>,
        <https://1145.am/db/2314271/Biomarck_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2314277/Biomarck_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314375/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314680/Pharming>,
        <https://1145.am/db/2314816/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314837/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2315159/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2315192/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315485/Polpharma>,
        <https://1145.am/db/2315571/Sciele_Pharma>,
        <https://1145.am/db/2315624/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315624/Pharmos>,
        <https://1145.am/db/2315925/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316239/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2316418/Pharmaventures_Ltd>,
        <https://1145.am/db/2316435/Pharmaventures_Ltd>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317337/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2317344/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2317635/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2317762/Pharmathene>,
        <https://1145.am/db/2317826/Anormed>,
        <https://1145.am/db/2317826/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2317842/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317895/Esprit_Pharma>,
        <https://1145.am/db/2317929/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2318105/Pharma_Inc>,
        <https://1145.am/db/2318114/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318248/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318285/Pht_Corporation>,
        <https://1145.am/db/2318469/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2318554/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318574/Idera_Pharmaceuticals>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2318743/Pharmos_Corporation>,
        <https://1145.am/db/2318808/Pharmathene>,
        <https://1145.am/db/2318986/Corgentech>,
        <https://1145.am/db/2318994/Cornerstone_Biopharma>,
        <https://1145.am/db/2319208/Osi_Pharmaceuticals>,
        <https://1145.am/db/2319687/Advisys>,
        <https://1145.am/db/2319790/Pharmacyclics>,
        <https://1145.am/db/2319806/Satori_Pharmaceuticals>,
        <https://1145.am/db/2319809/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320009/Map_Pharmaceuticals>,
        <https://1145.am/db/2320025/Am-Pharma>,
        <https://1145.am/db/2320025/Esprit_Pharma>,
        <https://1145.am/db/2320461/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320767/Via_Pharmaceuticals>,
        <https://1145.am/db/2320903/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2320949/Medicines_Company>,
        <https://1145.am/db/2321148/Savient_Pharmaceuticals>,
        <https://1145.am/db/2321157/Access_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321565/2009-2010>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2321860/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2321861/Astion_Pharma>,
        <https://1145.am/db/2321871/Astion_Pharma>,
        <https://1145.am/db/2321899/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2322135/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322235/Pharmacopeia>,
        <https://1145.am/db/2322291/Polpharma>,
        <https://1145.am/db/2322481/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322632/Savient_Pharmaceuticals>,
        <https://1145.am/db/2322942/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2322953/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2323173/Pharmacopeia>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323225/Arqule>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323358/Organon_Biosciences>,
        <https://1145.am/db/2324017/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2324024/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2324243/Arqule>,
        <https://1145.am/db/2324417/Biomimetic_Pharmaceuticals>,
        <https://1145.am/db/2324753/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2324838/Biogen>,
        <https://1145.am/db/2325070/The_Medicines_Company>,
        <https://1145.am/db/2325074/The_Medicines_Company>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2325725/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326025/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2326148/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2326286/Idera_Pharmaceuticals>,
        <https://1145.am/db/2326403/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2326466/Macromed>,
        <https://1145.am/db/2326474/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327450/York_Pharma>,
        <https://1145.am/db/2327480/Transdel_Pharmaceuticals>,
        <https://1145.am/db/2327649/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2327849/Pharmacia_Corporation>,
        <https://1145.am/db/2328043/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/2328220/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2328222/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2328616/Map_Pharmaceuticals>,
        <https://1145.am/db/2328650/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2328729/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2328988/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2328990/Mdrna>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329309/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2329643/Pharmaceuticals_Inc>,
        <https://1145.am/db/2329756/Provid_Pharmaceuticals>,
        <https://1145.am/db/2329814/Map_Pharmaceuticals>,
        <https://1145.am/db/2329816/Map_Pharmaceuticals>,
        <https://1145.am/db/2330057/Pharmathene>,
        <https://1145.am/db/2330086/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330094/Idera_Pharmaceuticals>,
        <https://1145.am/db/2330207/Bioxell>,
        <https://1145.am/db/2330207/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2330534/Pharmion>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330667/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330880/Access_Pharmaceuticals>,
        <https://1145.am/db/2330880/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330989/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331745/Elan_Pharmaceuticals>,
        <https://1145.am/db/2331756/Pro-Pharmaceuticals>,
        <https://1145.am/db/2331875/Bioalliance_Pharma>,
        <https://1145.am/db/2332473/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2332596/Esprit_Pharma>,
        <https://1145.am/db/2332777/S_*_Bio>,
        <https://1145.am/db/2332974/Osi_Pharmaceuticals>,
        <https://1145.am/db/2332980/Pharmos_Corporation>,
        <https://1145.am/db/2333492/Access_Pharmaceuticals>,
        <https://1145.am/db/2333569/Ception>,
        <https://1145.am/db/2333624/Pharmos>,
        <https://1145.am/db/2334034/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2334119/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334121/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334183/Idera_Pharmaceuticals>,
        <https://1145.am/db/2335077/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336160/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2336293/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2336378/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336442/Bionor_Pharma_Asa>,
        <https://1145.am/db/2336452/Pharmaxis_Ltd>,
        <https://1145.am/db/2336503/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336505/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336506/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2336524/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336934/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337345/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337348/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2337547/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337986/Pharmagen_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2338390/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338401/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2338430/Pharmacyclics>,
        <https://1145.am/db/2338551/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338735/Map_Pharmaceuticals>,
        <https://1145.am/db/2338877/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2339019/Isa_Pharmaceuticals_Bv>,
        <https://1145.am/db/2339186/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2339570/Map_Pharmaceuticals>,
        <https://1145.am/db/2339718/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2339727/Pharmacyclics_Inc>,
        <https://1145.am/db/2339787/Pharmalink_Ab>,
        <https://1145.am/db/2339892/Pharmacyclics>,
        <https://1145.am/db/2339907/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2339910/Biomed_Pharmaceuticals>,
        <https://1145.am/db/2339922/Pharmaform>,
        <https://1145.am/db/2339979/Theravance>,
        <https://1145.am/db/2340000/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340224/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340291/Pharmasset>,
        <https://1145.am/db/2340373/Nps_Pharmaceuticals>,
        <https://1145.am/db/2340431/Savient_Pharmaceuticals>,
        <https://1145.am/db/2341523/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2341742/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2341752/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2341998/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342469/Pharmadel>,
        <https://1145.am/db/2342687/Bioalliance_Pharma>,
        <https://1145.am/db/2342800/Pharmathene>,
        <https://1145.am/db/2342805/Pharmathene>,
        <https://1145.am/db/2342918/Pharmalink_Ab>,
        <https://1145.am/db/2343264/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2343277/Pharmasset>,
        <https://1145.am/db/2343826/The_Medicines_Company>,
        <https://1145.am/db/2343837/Medicines_Co>,
        <https://1145.am/db/2343966/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2344011/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344076/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344079/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344131/Pharmascience_Inc>,
        <https://1145.am/db/2344207/Entremed>,
        <https://1145.am/db/2344624/Pharmagen_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344739/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344939/Theravance>,
        <https://1145.am/db/2344955/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2345106/Map_Pharmaceuticals>,
        <https://1145.am/db/2345474/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345902/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346542/Conatus_Pharmaceuticals>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2346800/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346807/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2346951/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346964/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2347127/Pharmacyte_Biotech>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347227/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2347272/Pharmascience>,
        <https://1145.am/db/2347519/Pharmadeals_Ltd>,
        <https://1145.am/db/2347644/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347648/Pharminox_Limited>,
        <https://1145.am/db/2347659/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347982/Epicept>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348506/Am-Pharma_Bv>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348763/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2348864/Vital_Science_Corp>,
        <https://1145.am/db/2349103/Biota_Pharmaceuticals>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349348/R-Pharm>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349965/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350440/Ethicon>,
        <https://1145.am/db/2350852/Isa_Pharmaceuticals>,
        <https://1145.am/db/2351091/Biomotiv>,
        <https://1145.am/db/2351471/Mymetics_Corporation>,
        <https://1145.am/db/2351818/Biocon>,
        <https://1145.am/db/2352046/Costim_Pharmaceuticals>,
        <https://1145.am/db/2352165/Bio>,
        <https://1145.am/db/2352177/Theravance_Inc>,
        <https://1145.am/db/2352180/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2352333/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2352538/Biota_Pharmaceuticals>,
        <https://1145.am/db/2352659/Nps_Pharmaceuticals>,
        <https://1145.am/db/2352784/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2352805/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2352808/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353006/Radient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353093/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353098/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353254/Pharma_Inc>,
        <https://1145.am/db/2353262/Sound_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2353364/Am-Pharma>,
        <https://1145.am/db/2353651/Pharmathene>,
        <https://1145.am/db/2353668/Biotie>,
        <https://1145.am/db/2354002/N30_Pharmaceuticals>,
        <https://1145.am/db/2354062/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354064/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354083/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354086/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354124/Uk>,
        <https://1145.am/db/2354146/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2354376/Aspireo_Pharmaceuticals>,
        <https://1145.am/db/2354380/Pharmaxis>,
        <https://1145.am/db/2354388/Pharmaxis>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354406/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354804/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2354836/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354913/Bionor_Pharma_Asa>,
        <https://1145.am/db/2355099/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355109/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355324/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2355678/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2355721/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2355884/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355941/Theratechnologies>,
        <https://1145.am/db/2355974/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2356294/Company>,
        <https://1145.am/db/2356294/Inc>,
        <https://1145.am/db/2356391/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2357329/Pharmalink_Ab>,
        <https://1145.am/db/2357333/Pharmalink>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357636/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2358047/Entremed>,
        <https://1145.am/db/2358405/Pharmagen_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358732/Osi_Pharmaceuticals>,
        <https://1145.am/db/2358877/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359266/D-Pharm>,
        <https://1145.am/db/2359401/Scpharmaceuticals_Inc>,
        <https://1145.am/db/2359438/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2359474/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359668/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2359882/Biotie>,
        <https://1145.am/db/2359926/Entremed>,
        <https://1145.am/db/2360155/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2360489/Medac_Pharma>,
        <https://1145.am/db/2360588/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360697/Medgenics>,
        <https://1145.am/db/2360739/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2360945/Entremed>,
        <https://1145.am/db/2361244/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2361516/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362456/Action_Pharma_A_S>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2362593/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363186/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363285/Phenex_Pharmaceuticals_Ag>,
        <https://1145.am/db/2363340/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363387/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2363425/The_Medicines_Company>,
        <https://1145.am/db/2363433/The_Medicines_Company>,
        <https://1145.am/db/2363452/Pharmasum_Therapeutics_As>,
        <https://1145.am/db/2363530/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2363955/Savient_Pharmaceuticals>,
        <https://1145.am/db/2364093/Biotie>,
        <https://1145.am/db/2364252/Nps_Pharmaceuticals>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364276/S_*_Bio>,
        <https://1145.am/db/2364494/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2364495/Bioalliance_Pharma>,
        <https://1145.am/db/2364538/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2364541/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2364585/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364593/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364601/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364774/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364884/Entremed_Inc>,
        <https://1145.am/db/2365030/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2365098/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365224/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2365423/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2365724/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365763/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2366139/Prism_Pharmaceuticals>,
        <https://1145.am/db/2366388/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366521/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367021/Biotie>,
        <https://1145.am/db/2367070/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2367280/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2367438/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2367483/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367496/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367951/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2367962/Catalyst_Pharmaceuticals>,
        <https://1145.am/db/2368070/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2368339/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2368420/Intec_Pharma>,
        <https://1145.am/db/2368593/Bioquiddity_Incorporated>,
        <https://1145.am/db/2368632/Pharmacyclics>,
        <https://1145.am/db/2368739/Novartis_Pharmaceuticals>,
        <https://1145.am/db/2368826/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369004/Biogen>,
        <https://1145.am/db/2369037/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369144/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369233/Biopharmx_Corporation>,
        <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2369812/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2369931/Biogen>,
        <https://1145.am/db/2370022/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2370078/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2370082/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2370089/Abide_Therapeutics>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370637/Medgenics_Inc>,
        <https://1145.am/db/2370797/Pharmanest>,
        <https://1145.am/db/2370798/Pharmalink_Ab>,
        <https://1145.am/db/2370946/Biogen>,
        <https://1145.am/db/2371015/M_Pharma>,
        <https://1145.am/db/2371016/M_Pharma>,
        <https://1145.am/db/2371279/Biomunex_Pharmaceuticals>,
        <https://1145.am/db/2371491/Biopharmx_Corporation>,
        <https://1145.am/db/2536754/Oramed_Pharma>,
        <https://1145.am/db/2536756/Zao>,
        <https://1145.am/db/2537468/Pharmascience_Inc>,
        <https://1145.am/db/2538171/Biomeda_Group>,
        <https://1145.am/db/2538567/Upm_Pharmaceuticals>,
        <https://1145.am/db/2538861/Par_Pharmaceuticals>,
        <https://1145.am/db/2538901/The_Harvard_Drug_Group>,
        <https://1145.am/db/2539516/Par_Pharmaceuticals>,
        <https://1145.am/db/2539568/Zao>,
        <https://1145.am/db/2540193/Pharmanest>,
        <https://1145.am/db/2540449/Biocon>,
        <https://1145.am/db/2540951/Rytary>,
        <https://1145.am/db/2541039/Elan_Pharmaceuticals>,
        <https://1145.am/db/2541239/Pharmstar>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541717/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2541810/British_Pharma>,
        <https://1145.am/db/2542218/Pharmacyclics>,
        <https://1145.am/db/2543839/British_Pharma>,
        <https://1145.am/db/2544111/Unique_Pharmaceuticals>,
        <https://1145.am/db/2544358/Mundipharma>,
        <https://1145.am/db/2544596/Polpharma>,
        <https://1145.am/db/2544679/Neopharma>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2545143/Mundipharma>,
        <https://1145.am/db/2545411/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2546441/Intas_Pharmaceuticals>,
        <https://1145.am/db/2546529/Pharma_Tech_Industries>,
        <https://1145.am/db/2546629/Par_Pharmaceutical>,
        <https://1145.am/db/2547189/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2548585/Par_Pharmaceuticals>,
        <https://1145.am/db/2548674/Sopharma>,
        <https://1145.am/db/2549477/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2549520/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2549919/Pharmathen>,
        <https://1145.am/db/2550212/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2550471/Pharmaform>,
        <https://1145.am/db/2550523/Pharmaron>,
        <https://1145.am/db/2550685/Upm_Pharmaceuticals>,
        <https://1145.am/db/2551427/Pharmablock_Sciences>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552169/Alembic_Pharmaceuticals>,
        <https://1145.am/db/2552465/Medis>,
        <https://1145.am/db/2552641/Plethico_Pharmaceuticals>,
        <https://1145.am/db/2552642/Mankind_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2552794/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553276/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553512/Pharmax_Pharmaceuticals>,
        <https://1145.am/db/2553708/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2554237/Intas_Pharmaceuticals>,
        <https://1145.am/db/2554810/Continuus_Pharmaceuticals>,
        <https://1145.am/db/2554814/Globalpharma>,
        <https://1145.am/db/2554858/Medicure_Usa_Inc>,
        <https://1145.am/db/2555338/Pharmacore>,
        <https://1145.am/db/2555890/Pharmalucence>,
        <https://1145.am/db/2555896/Pharmalucence>,
        <https://1145.am/db/2556805/Medicis_Pharmaceuticals>,
        <https://1145.am/db/2557303/Pharmaron>,
        <https://1145.am/db/2557538/Neopharma>,
        <https://1145.am/db/2558025/Pharmaxis>,
        <https://1145.am/db/2558026/Pharmaxis>,
        <https://1145.am/db/2558970/Biostar_Pharmaceuticals>,
        <https://1145.am/db/2559783/Polpharma>,
        <https://1145.am/db/2560083/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561100/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561312/Oxford_Pharmaceuticals>,
        <https://1145.am/db/2561438/Pharmacia___Upjohn>,
        <https://1145.am/db/2561978/Biomarin_Pharmaceuticals>,
        <https://1145.am/db/2562199/Novartis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562500/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2563255/Active_Pharmaceutical_Ingredients>,
        <https://1145.am/db/2563497/Creo_Pharmaceuticals>,
        <https://1145.am/db/2563497/Polpharma>,
        <https://1145.am/db/2564196/Pharmaron>,
        <https://1145.am/db/2564713/C2_Pharma>,
        <https://1145.am/db/2567007/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2567055/Sovereign_Pharmaceuticals>,
        <https://1145.am/db/2567283/The_Pharma_Giant>,
        <https://1145.am/db/2567438/Biogen>,
        <https://1145.am/db/2567651/Indivior>,
        <https://1145.am/db/2567651/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2568205/Biogen>,
        <https://1145.am/db/2568375/Biogen>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569187/Pharmacyclics>,
        <https://1145.am/db/2569370/Co>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569729/The_Medicines_Company>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570068/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2570289/Pharmacyclics>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570449/Biocon>,
        <https://1145.am/db/2570741/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570807/Pharmacyclics>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2572200/The_Medicines_Company>,
        <https://1145.am/db/2572870/Hi-Tech_Pharmaceuticals>,
        <https://1145.am/db/2573057/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2573058/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2573147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2573271/Physician_Therapeutics>,
        <https://1145.am/db/2573391/Url_Pharma>,
        <https://1145.am/db/2573392/Url_Pharma>,
        <https://1145.am/db/2573887/Biogen>,
        <https://1145.am/db/2574679/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2574891/Pharmacyclics>,
        <https://1145.am/db/2575222/Map_Pharmaceuticals>,
        <https://1145.am/db/2575242/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2575462/Paras_Pharmaceuticals>,
        <https://1145.am/db/2575623/Inova_Pharmaceuticals>,
        <https://1145.am/db/2576205/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2577145/Medicis_Pharmaceutical>,
        <https://1145.am/db/2577259/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals>,
        <https://1145.am/db/2577675/Biogen>,
        <https://1145.am/db/2577684/Biogen>,
        <https://1145.am/db/2577894/Huvepharma_Ad>,
        <https://1145.am/db/2577934/Pharmascience>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578319/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2578473/Aa_Pharma>,
        <https://1145.am/db/2578481/Aa_Pharma_Inc>,
        <https://1145.am/db/2579147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2579211/Eusa_Pharma>,
        <https://1145.am/db/2579538/Pharmaforce>,
        <https://1145.am/db/2580123/Savient_Pharmaceuticals>,
        <https://1145.am/db/2580479/Pharmaxis>,
        <https://1145.am/db/2581225/Inova_Pharmaceuticals>,
        <https://1145.am/db/2582110/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582153/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2582174/Pharmasset>,
        <https://1145.am/db/2582320/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2583013/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583022/Url_Pharma>,
        <https://1145.am/db/2583220/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2583270/Pharmaswiss>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583402/Osi_Pharmaceuticals>,
        <https://1145.am/db/2583414/Polpharma>,
        <https://1145.am/db/2583769/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2584209/Pharmaswiss_Sa>,
        <https://1145.am/db/2584226/Pharmaswiss_Sa>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2585281/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2585887/Pharma_Inc>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587155/Millennium_Pharma>,
        <https://1145.am/db/2587616/Pharmaq>,
        <https://1145.am/db/2587696/R-Pharm>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588718/Pharmacyclics>,
        <https://1145.am/db/2588884/Map_Pharmaceuticals>,
        <https://1145.am/db/2589884/Map_Pharmaceuticals>,
        <https://1145.am/db/2590159/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2590195/Pro-Tect_Pharmaceuticals>,
        <https://1145.am/db/2590409/Biogen>,
        <https://1145.am/db/2590910/Savient_Pharmaceuticals>,
        <https://1145.am/db/2591540/Polpharma>,
        <https://1145.am/db/2591690/Medicis_Pharmaceutical>,
        <https://1145.am/db/2591938/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2593142/Access_Pharmaceuticals>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594042/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594116/Pharmerica>,
        <https://1145.am/db/2594602/Osi_Pharma>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2595190/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595210/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595413/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596307/Savient_Pharmaceuticals>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596369/Pharmadeals_Ltd>,
        <https://1145.am/db/2596818/Pharmasset>,
        <https://1145.am/db/2597158/Nps_Pharmaceuticals>,
        <https://1145.am/db/2597180/Prism_Pharmaceuticals>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2597935/Osi_Pharmaceuticals>,
        <https://1145.am/db/2598027/Nps_Pharmaceuticals>,
        <https://1145.am/db/2598099/Paras_Pharmaceuticals>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598195/Pharmatech>,
        <https://1145.am/db/2598605/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2765310/Biogen>,
        <https://1145.am/db/281576/Mymd_Pharmaceuticals>,
        <https://1145.am/db/307255/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/324642/Mundipharma>,
        <https://1145.am/db/367137/Biomat>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/380389/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/407888/Quoin_Pharmaceuticals>,
        <https://1145.am/db/410129/Catalyst_Pharmaceuticals_Inc>,
        <https://1145.am/db/427157/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/431169/Pharmablock>,
        <https://1145.am/db/4491/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/452957/Aerie_Pharmaceuticals>,
        <https://1145.am/db/468221/Aerie_Pharmaceuticals>,
        <https://1145.am/db/481129/Biocon_Ltd>,
        <https://1145.am/db/485351/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/486302/Phathom_Pharmaceuticals>,
        <https://1145.am/db/487010/Scipher_Medicine>,
        <https://1145.am/db/488564/Aerie_Pharmaceuticals>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/538112/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/545583/Citius_Pharmaceuticals>,
        <https://1145.am/db/546391/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/567789/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/585607/Am-Pharma>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/662016/Prestige_Biopharma_Limited>,
        <https://1145.am/db/668495/Scipher_Medicine>,
        <https://1145.am/db/669775/Scipher_Medicine>,
        <https://1145.am/db/693128/Ascensus_Specialties>,
        <https://1145.am/db/700482/Novartis_Pharmaceuticals>,
        <https://1145.am/db/712037/Amunix_Pharmaceuticals>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/713105/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/713736/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/714923/Betterlife_Pharma_Inc>,
        <https://1145.am/db/715385/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/718008/Pharnext_Sa>,
        <https://1145.am/db/723883/Mymd_Pharmaceuticals>,
        <https://1145.am/db/724999/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/734669/Escient_Pharmaceuticals>,
        <https://1145.am/db/742794/Hr_Pharmaceuticals_Inc>,
        <https://1145.am/db/771062/Gw_Pharmaceuticals>,
        <https://1145.am/db/793071/Biogen_Inc>,
        <https://1145.am/db/835485/Pharmaessentia_Corporation>,
        <https://1145.am/db/854026/Aerie_Pharmaceuticals>,
        <https://1145.am/db/883896/Biontech>,
        <https://1145.am/db/884665/Pharmaceutical_Institute>,
        <https://1145.am/db/887575/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/889331/Tha_Pharma>,
        <https://1145.am/db/912469/Aerie_Pharmaceuticals>,
        <https://1145.am/db/913730/Aerie_Pharmaceuticals>,
        <https://1145.am/db/922740/Grand_Pharma>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2340755/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346602/Conatus_Pharmaceuticals>,
        <https://1145.am/db/2360709/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2367807/Conatus_Pharmaceuticals_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348331/Series_A_Investment_Edmond_De_Rothschild_Investment_Partners_Life_Sciences_Partners_Sapiens_Steering_Brain_Stimulation_Gmbh___Sapiens_Wellington_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-06-01T15:36:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Eindhoven, the Netherlands, Munich, Germany, June 1st, 2011 - Sapiens Steering Brain Stimulation GmbH ('Sapiens' ), a spin off from Philips Research, announces today that it has raised 13 million in a Series A round co - led by Wellington Partners (WP) and Edmond de Rothschild Investment Partners (EdRIP) with additional financing from Life Sciences Partners (LSP) .",
        "Sapiens Steering Brain Stimulation GmbH / Sapiens raises  13m in a Series A financing to fund the development of a novel deep brain stimulation system." ;
    ns1:documentTitle "Sapiens raises  13m in a Series A financing to fund the development of a novel deep brain stimulation system" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sapiens-raises-%E2%82%AC-13m-a-series-a-financing-to-fund-development-of-a-novel-deep-brain> ;
    ns1:foundName "financing",
        "raises" ;
    ns1:name "financing",
        "raises" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2348331/Sapiens_Steering_Brain_Stimulation_Gmbh___Sapiens> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw " 13m",
        "13 million" ;
    ns1:when "2011-06-01T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "June 1st, 2011" ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "Germany" .

<https://1145.am/db/2354540/Series_A_Investment_Healthcap_Pappas_Ventures_Tpg_Biotech_And_Fidelity_Biosciences_Ultragenyx_Pharmaceutical_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-06-20T14:33:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NOVATO, Calif.- (EON: Enhanced Online News) -Ultragenyx Pharmaceutical Inc. today announced the closing of a $ 45 million Series A financing to support the development of rare disease therapeutics.",
        "Ultragenyx Announces Series A Financing. $ 45 million to support development of rare disease therapeutics." ;
    ns1:documentTitle "Ultragenyx Announces Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ultragenyx-announces-series-a-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2354540/Ultragenyx_Pharmaceutical_Inc> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 45 million" ;
    ns1:whereGeoName "Daylight",
        "Time" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3134627/about.rdf>,
        <https://sws.geonames.org/4617522/about.rdf> ;
    ns1:whereRaw "Eastern Daylight Time" .

<https://1145.am/db/2360841/Northwest_Biotherapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Bethesda" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4348599/about.rdf> ;
    ns1:basedInHighRaw "BETHESDA, Md." ;
    ns1:description "game-changing medical research and treatment breakthroughs" ;
    ns1:documentDate "2011-07-08T13:22:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in t" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/family-foundation-of-business-leader-invests-4-55-million-northwest-biotherapeutics-for-0> ;
    ns1:foundName "Northwest Biotherapeutics" ;
    ns1:name "Northwest Biotherapeutics" ;
    ns1:sameAsMedium <https://1145.am/db/2317631/Northwest_Biotherapeutics>,
        <https://1145.am/db/2329687/Northwest_Biotherapeutics_Inc>,
        <https://1145.am/db/2338074/Northwest_Biotherapeutics>,
        <https://1145.am/db/2344032/Northwest_Biotherapeutics>,
        <https://1145.am/db/2344036/Northwest_Biotherapeutics>,
        <https://1145.am/db/2344857/Northwest_Biotherapeutics>,
        <https://1145.am/db/2346758/Northwest_Biotherapeutics>,
        <https://1145.am/db/2346762/Northwest_Biotherapeutics>,
        <https://1145.am/db/2348793/Northwest_Biotherapeutics>,
        <https://1145.am/db/2350349/Northwest_Biotherapeutics>,
        <https://1145.am/db/2350354/Northwest_Biotherapeutics>,
        <https://1145.am/db/2351401/Northwest_Biotherapeutics>,
        <https://1145.am/db/2351442/Northwest_Biotherapeutics>,
        <https://1145.am/db/2352422/Northwest_Biotherapeutics>,
        <https://1145.am/db/2360842/Northwest_Biotherapeutics>,
        <https://1145.am/db/2360852/Northwest_Biotherapeutics>,
        <https://1145.am/db/2361085/Northwest_Biotherapeutics>,
        <https://1145.am/db/2361104/Northwest_Biotherapeutics_Gmbh>,
        <https://1145.am/db/2363528/Northwest_Biotherapeutics>,
        <https://1145.am/db/2558852/Northwest_Biotherapeutics>,
        <https://1145.am/db/659619/Northwest_Biotherapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360842/Northwest_Biotherapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Bethesda" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4348599/about.rdf> ;
    ns1:basedInHighRaw "BETHESDA, Md." ;
    ns1:documentDate "2011-07-08T13:22:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/family-foundation-of-business-leader-invests-4-55-million-northwest-biotherapeutics-for-1> ;
    ns1:foundName "Northwest Biotherapeutics" ;
    ns1:name "Northwest Biotherapeutics" ;
    ns1:sameAsMedium <https://1145.am/db/2317631/Northwest_Biotherapeutics>,
        <https://1145.am/db/2329687/Northwest_Biotherapeutics_Inc>,
        <https://1145.am/db/2338074/Northwest_Biotherapeutics>,
        <https://1145.am/db/2344032/Northwest_Biotherapeutics>,
        <https://1145.am/db/2344036/Northwest_Biotherapeutics>,
        <https://1145.am/db/2344857/Northwest_Biotherapeutics>,
        <https://1145.am/db/2346758/Northwest_Biotherapeutics>,
        <https://1145.am/db/2346762/Northwest_Biotherapeutics>,
        <https://1145.am/db/2348793/Northwest_Biotherapeutics>,
        <https://1145.am/db/2350349/Northwest_Biotherapeutics>,
        <https://1145.am/db/2350354/Northwest_Biotherapeutics>,
        <https://1145.am/db/2351401/Northwest_Biotherapeutics>,
        <https://1145.am/db/2351442/Northwest_Biotherapeutics>,
        <https://1145.am/db/2352422/Northwest_Biotherapeutics>,
        <https://1145.am/db/2360841/Northwest_Biotherapeutics>,
        <https://1145.am/db/2360852/Northwest_Biotherapeutics>,
        <https://1145.am/db/2361085/Northwest_Biotherapeutics>,
        <https://1145.am/db/2361104/Northwest_Biotherapeutics_Gmbh>,
        <https://1145.am/db/2363528/Northwest_Biotherapeutics>,
        <https://1145.am/db/2558852/Northwest_Biotherapeutics>,
        <https://1145.am/db/659619/Northwest_Biotherapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360852/Northwest_Biotherapeutics> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:description "Clinical Trials" ;
    ns1:documentDate "2011-07-08T16:00:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics For Promising Clinical Trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/family-foundation-of-business-leader-invests-4-55-million-northwest-biotherapeutics-for> ;
    ns1:foundName "Northwest Biotherapeutics" ;
    ns1:name "Northwest Biotherapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1396319/Science_37_Holdings_Inc>,
        <https://1145.am/db/2295289/Science_37>,
        <https://1145.am/db/2300367/Science_37>,
        <https://1145.am/db/2314111/Kells_Medical_Research_Group>,
        <https://1145.am/db/2317631/Northwest_Biotherapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2329687/Northwest_Biotherapeutics_Inc>,
        <https://1145.am/db/2338074/Northwest_Biotherapeutics>,
        <https://1145.am/db/2344032/Northwest_Biotherapeutics>,
        <https://1145.am/db/2344036/Northwest_Biotherapeutics>,
        <https://1145.am/db/2344857/Northwest_Biotherapeutics>,
        <https://1145.am/db/2346758/Northwest_Biotherapeutics>,
        <https://1145.am/db/2346762/Northwest_Biotherapeutics>,
        <https://1145.am/db/2348793/Northwest_Biotherapeutics>,
        <https://1145.am/db/2350349/Northwest_Biotherapeutics>,
        <https://1145.am/db/2350354/Northwest_Biotherapeutics>,
        <https://1145.am/db/2351401/Northwest_Biotherapeutics>,
        <https://1145.am/db/2351442/Northwest_Biotherapeutics>,
        <https://1145.am/db/2352422/Northwest_Biotherapeutics>,
        <https://1145.am/db/2360841/Northwest_Biotherapeutics>,
        <https://1145.am/db/2360842/Northwest_Biotherapeutics>,
        <https://1145.am/db/2361085/Northwest_Biotherapeutics>,
        <https://1145.am/db/2361104/Northwest_Biotherapeutics_Gmbh>,
        <https://1145.am/db/2363528/Northwest_Biotherapeutics>,
        <https://1145.am/db/2558852/Northwest_Biotherapeutics>,
        <https://1145.am/db/659619/Northwest_Biotherapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361204/Apthera_Inc_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-03-31T13:18:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "RXi Pharmaceuticals Corporation (Nasdaq: RXII) , a recognized leader in RNAi - based therapeutic discovery and development, and Apthera, Inc., a private biotechnology company developing a pipeline of peptide - based immunotherapies for the adjuvant treatment of HER2-positive breast and other cancers, announced today the signing of a definitive merger agreement under which RXi will acquire Apthera." ;
    ns1:documentTitle "RXi Pharmaceuticals Aggressively Moves into Late-Stage Clinical Development with the Agreement to Acquire Apthera, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rxi-pharmaceuticals-aggressively-moves-into-late-stage-clinical-development-agreement-to-0> ;
    ns1:foundName "acquire",
        "merger" ;
    ns1:name "acquire",
        "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2361204/Apthera_Inc> ;
    ns1:targetName "Apthera, Inc." .

<https://1145.am/db/2361205/Apthera_Inc_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-03-31T13:18:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "RXi Pharmaceuticals Corporation (Nasdaq: RXII) , a recognized leader in RNAi - based therapeutic discovery and development, and Apthera, Inc., a private biotechnology company developing a pipeline of peptide - based immunotherapies for the adjuvant treatment of HER2-positive breast and other cancers, announced today the signing of a definitive merger agreement under which RXi will acquire Apthera." ;
    ns1:documentTitle "RXi Pharmaceuticals Aggressively Moves into Late-Stage Clinical Development with the Agreement to Acquire Apthera, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rxi-pharmaceuticals-aggressively-moves-into-late-stage-clinical-development-agreement-to> ;
    ns1:foundName "acquire",
        "merger" ;
    ns1:name "acquire",
        "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2361205/Apthera_Inc> ;
    ns1:targetName "Apthera, Inc." .

<https://1145.am/db/2364201/Investment_Cellular_Dynamics_International_G_Force_Investments_Llc_Sam_Zells_Equity_Group_Investments_Llc_Sixth_Floor_Investors_Lp_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-07T15:23:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cellular Dynamics Raises $ 30 Million to Expand Its Product Line of Human Stem Cells and Tissue Cells.",
        "MADISON, Wis., April 7, 2011 /PRNewswire/ - Cellular Dynamics International, Inc. (CDI) , the world's only industrial manufacturer of human induced pluripotent stem cells (iPSCs) and tissue cells, has closed on a $ 30 million private equity round." ;
    ns1:documentTitle "Cellular Dynamics Raises $30 Million to Expand Its Product Line of Human Stem Cells and Tissue Cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cellular-dynamics-raises-30-million-to-expand-its-product-line-of-human-stem-cells-and> ;
    ns1:foundName "Raises",
        "private equity" ;
    ns1:name "Raises",
        "private equity" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2364201/Cellular_Dynamics_International> ;
    ns1:valueRaw "$ 30 Million",
        "$ 30 million" ;
    ns1:when "2011-04-07T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "April 7, 2011" ;
    ns1:whereRaw "Cellular Dynamics" .

<https://1145.am/db/2364226/Bergamo_Rights_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-04-08T14:16:56+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Amgen (AMGN) Establishes Commercial Operations in Brazil; Acquires Privately Held Brazilian Pharmaceutical Company Bergamo and Agrees to Reacquire Rights to Certain Amgen Products in Brazil from Hypermarcas.",
        "THOUSAND OAKS, Calif., April 8, 2011 /PRNewswire/ - Amgen (NASDAQ: AMGN - News) , the world's largest biotechnology company, announced today the expansion of its operations in Brazil, including the acquisition of Bergamo, a privately-held Brazilian pharmaceutical company." ;
    ns1:documentTitle "Amgen (AMGN) Establishes Commercial Operations in Brazil; Acquires Privately Held Brazilian Pharmaceutical Company Bergamo" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/amgen-amgn-establishes-commercial-operations-brazil-acquires-privately-held-brazilian> ;
    ns1:foundName "Acquires",
        "acquisition" ;
    ns1:name "Acquires",
        "acquisition" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2364226/Bergamo>,
        <https://1145.am/db/2364226/Mantecorp> ;
    ns1:targetDetails "rights" ;
    ns1:targetName "Bergamo" ;
    ns1:vendor <https://1145.am/db/2364226/Hypermarcas> ;
    ns1:whereGeoName "Federative Republic of Brazil" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:whereRaw "Brazil" .

<https://1145.am/db/2365344/Seed_Investment_Delaware_Crossing_Investor_Group_Mid-Atlantic_Angel_Group_Fund_Ii_Novira_Therapeutics_Robin_Hood_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-26T19:20:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "RADNOR, Pa.- (BUSINESS WIRE) - Novira Therapeutics, Inc., a privately held antiviral drug discovery company developing innovative, first-in-class therapeutics for the treatment of viral diseases, including HBV and HIV, announced that it has completed a second round of seed financing that brings the company's early financing to approximately $ 2.5 million, with another $ 1.0 million obtained in non-dilutive grants." ;
    ns1:documentTitle "Novira Therapeutics, Inc. Completes Second Round of Seed Financing with Philadelphia Angel Syndicate" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/novira-therapeutics-inc-completes-second-round-of-seed-financing-philadelphia-angel> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2365344/Novira_Therapeutics> ;
    ns1:targetDetails "seed" ;
    ns1:valueRaw "$ 1.0 million",
        "another",
        "approximately $ 2.5 million" ;
    ns1:whereGeoName "Radnor" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5207490/about.rdf> ;
    ns1:whereRaw "RADNOR, Pa" .

<https://1145.am/db/2577419/Osi_Pharmaceuticals> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:documentDate "2010-12-23T12:50:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dealmaking goes from mega to mini" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dealmaking-goes-from-mega-to-mini> ;
    ns1:foundName "OSI Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "OSI Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/101025/Scpharmaceuticals_Inc>,
        <https://1145.am/db/101329/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1031042/Intomics>,
        <https://1145.am/db/1033561/Hs_Pharmaceuticals>,
        <https://1145.am/db/1054457/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/1054503/Hs_Pharmaceuticals>,
        <https://1145.am/db/1061901/Pharmaessentia_Corporation>,
        <https://1145.am/db/1070158/Biognosys>,
        <https://1145.am/db/1079560/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1080385/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1092000/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/11010/Progenics_Pharmaceuticals>,
        <https://1145.am/db/1104169/20045078>,
        <https://1145.am/db/1118439/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1141704/Inmed_Pharmaceuticals>,
        <https://1145.am/db/1174705/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1176480/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1185008/TDV>,
        <https://1145.am/db/1186876/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1216583/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1291286/Vital_Pharmaceuticals_Inc>,
        <https://1145.am/db/1294499/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1294506/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1295948/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1296487/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1307419/X4_Pharmaceuticals>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1329779/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1339033/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1343020/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/1370859/Bioivt>,
        <https://1145.am/db/1371279/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1387773/Aspire_Pharma>,
        <https://1145.am/db/1390741/Nexus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1409143/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417723/Altasciences>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443334/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443968/Pharmajet>,
        <https://1145.am/db/1445613/Pharmajet>,
        <https://1145.am/db/1487706/Phathom_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497210/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1497218/Opiant_Pharmaceuticals>,
        <https://1145.am/db/1500616/Indivior_Plc>,
        <https://1145.am/db/1500616/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1502096/Indivior_Plc>,
        <https://1145.am/db/1502096/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1505968/Escient_Pharmaceuticals>,
        <https://1145.am/db/1508407/Escient_Pharmaceuticals>,
        <https://1145.am/db/1515279/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1520596/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1520597/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521624/Scpharmaceuticals>,
        <https://1145.am/db/1521695/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521941/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1523220/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1533327/Escient_Pharmaceuticals>,
        <https://1145.am/db/1533685/Escient_Pharmaceuticals>,
        <https://1145.am/db/1537336/Pharmajet>,
        <https://1145.am/db/1538786/Pharmajet>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1541946/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1548955/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1557072/Essential_Pharma>,
        <https://1145.am/db/1559882/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1571078/Organon>,
        <https://1145.am/db/1585097/Scpharmaceuticals_Inc>,
        <https://1145.am/db/158742/Biogen_Inc>,
        <https://1145.am/db/1595580/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1613688/Pharmalex>,
        <https://1145.am/db/1624479/Indivior_Plc>,
        <https://1145.am/db/1624479/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1625532/Indivior_Plc>,
        <https://1145.am/db/1625532/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629605/Biogen>,
        <https://1145.am/db/1629663/Biogen>,
        <https://1145.am/db/1632411/Scipher_Medicine>,
        <https://1145.am/db/1632862/Scipher_Medicine>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1680583/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/1687234/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/180589/Servier>,
        <https://1145.am/db/1955684/Eip_Pharma_Inc>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2038168/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039291/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039678/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2045820/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2049603/Inova_Pharmaceuticals>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2062156/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2066480/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2071248/Biogen>,
        <https://1145.am/db/2074741/Biogen_Inc>,
        <https://1145.am/db/2092442/Leo_Pharma>,
        <https://1145.am/db/2093802/Meitheal_Pharmaceuticals>,
        <https://1145.am/db/2100253/Biogen_Inc>,
        <https://1145.am/db/2101006/Leo_Pharma_A_S>,
        <https://1145.am/db/2138834/Altasciences>,
        <https://1145.am/db/2151781/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152434/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2153727/Amunix_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154118/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154527/The_Medicines_Company>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155006/Medicines_Company>,
        <https://1145.am/db/2155312/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155622/Isa_Pharmaceuticals>,
        <https://1145.am/db/2155792/Ucb_Pharma>,
        <https://1145.am/db/2155798/Ucb_Pharma>,
        <https://1145.am/db/2155994/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2198945/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2201094/Pharmadeals_Ltd>,
        <https://1145.am/db/2204969/Organon_Biosciences>,
        <https://1145.am/db/2207034/Cequent_Pharmaceuticals>,
        <https://1145.am/db/221697/Gw_Pharmaceuticals>,
        <https://1145.am/db/2217819/Pharmacopeia>,
        <https://1145.am/db/221787/Gw_Pharmaceuticals>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2224859/Biologics>,
        <https://1145.am/db/2229191/Biologics>,
        <https://1145.am/db/2279276/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2279648/Organon>,
        <https://1145.am/db/2280123/Casi_Pharmaceuticals>,
        <https://1145.am/db/2280153/Pharming>,
        <https://1145.am/db/2281547/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2283570/Pherin_Pharmaceuticals>,
        <https://1145.am/db/2284358/Escient_Pharmaceuticals>,
        <https://1145.am/db/2285117/Immedica>,
        <https://1145.am/db/2285495/Bioivt>,
        <https://1145.am/db/2287224/Escient_Pharmaceuticals>,
        <https://1145.am/db/2287505/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2287572/T3_Pharmaceuticals>,
        <https://1145.am/db/2288192/Servier>,
        <https://1145.am/db/2290842/X4_Pharmaceuticals>,
        <https://1145.am/db/2291791/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2294547/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2294570/Pharmatek>,
        <https://1145.am/db/2296094/Biogen>,
        <https://1145.am/db/2297534/Bio>,
        <https://1145.am/db/2298037/Ethicon>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2299414/Biogen>,
        <https://1145.am/db/2301089/Cerulean_Pharma>,
        <https://1145.am/db/2301346/Pharmaron>,
        <https://1145.am/db/2301718/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2301735/Idera_Pharmaceuticals>,
        <https://1145.am/db/2301764/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302275/Map_Pharmaceuticals>,
        <https://1145.am/db/2302426/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302431/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2302574/Via_Pharmaceuticals>,
        <https://1145.am/db/2302579/Via_Pharmaceuticals>,
        <https://1145.am/db/2302587/Access_Pharmaceuticals>,
        <https://1145.am/db/2302658/Biotie>,
        <https://1145.am/db/2302707/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2302774/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302779/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302890/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2302897/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303121/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303131/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303182/Pharmexa>,
        <https://1145.am/db/2303208/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303674/Cerulean_Pharma>,
        <https://1145.am/db/2303792/Access_Pharmaceuticals>,
        <https://1145.am/db/2303934/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2304044/Novamed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2304097/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2304135/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2304610/Pharmos_Corp>,
        <https://1145.am/db/2304745/Critical_Pharmaceuticals>,
        <https://1145.am/db/2304831/Pharmion_Corporation>,
        <https://1145.am/db/2304934/Medicure>,
        <https://1145.am/db/2304985/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2305742/Mh_Pharma_Uk>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2305927/Entremed>,
        <https://1145.am/db/2305956/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2306299/Verily>,
        <https://1145.am/db/2306641/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2306962/Pharmaron>,
        <https://1145.am/db/2307239/Pharmaxis_Ltd>,
        <https://1145.am/db/2307246/Pharmaxis>,
        <https://1145.am/db/2307254/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2307651/Organon>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307871/Access_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2307897/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2308446/Pharmathene>,
        <https://1145.am/db/2308922/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308964/Slate_Pharmaceuticals>,
        <https://1145.am/db/2309001/Biocon>,
        <https://1145.am/db/2309301/Inc>,
        <https://1145.am/db/2309923/Diasome_Pharmaceuticals>,
        <https://1145.am/db/2310002/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2310002/Map_Pharmaceuticals>,
        <https://1145.am/db/2310045/Slate_Pharmaceuticals>,
        <https://1145.am/db/2310071/Encysive_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310200/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2310219/Docpharma>,
        <https://1145.am/db/2310232/Genaissance_Pharmaceuticals>,
        <https://1145.am/db/2310471/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/2310473/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310476/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2310480/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310790/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310993/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2311166/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2311202/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311217/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2311264/Medicure>,
        <https://1145.am/db/2311726/Inc>,
        <https://1145.am/db/2312088/Cerulean_Pharma>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312193/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2312344/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2312416/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2312476/Nps_Pharmaceuticals>,
        <https://1145.am/db/2312479/Nps_Pharmaceuticals>,
        <https://1145.am/db/2313305/Tetraphase_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313306/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313320/Ore_Pharmaceuticals>,
        <https://1145.am/db/2313323/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313336/Sound_Pharmaceuticals>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2313501/Bioalliance_Pharma>,
        <https://1145.am/db/2313527/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2313528/Us_Pharmaceutical_Company>,
        <https://1145.am/db/2314217/Sciele_Pharma>,
        <https://1145.am/db/2314271/Biomarck_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2314277/Biomarck_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314375/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314680/Pharming>,
        <https://1145.am/db/2314816/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314837/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2315159/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2315192/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315485/Polpharma>,
        <https://1145.am/db/2315571/Sciele_Pharma>,
        <https://1145.am/db/2315624/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315624/Pharmos>,
        <https://1145.am/db/2315925/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316239/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2316418/Pharmaventures_Ltd>,
        <https://1145.am/db/2316435/Pharmaventures_Ltd>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317337/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2317344/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2317635/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2317762/Pharmathene>,
        <https://1145.am/db/2317826/Anormed>,
        <https://1145.am/db/2317826/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2317842/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317895/Esprit_Pharma>,
        <https://1145.am/db/2317929/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2318105/Pharma_Inc>,
        <https://1145.am/db/2318114/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318248/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318285/Pht_Corporation>,
        <https://1145.am/db/2318469/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2318554/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318574/Idera_Pharmaceuticals>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2318743/Pharmos_Corporation>,
        <https://1145.am/db/2318808/Pharmathene>,
        <https://1145.am/db/2318986/Corgentech>,
        <https://1145.am/db/2318994/Cornerstone_Biopharma>,
        <https://1145.am/db/2319208/Osi_Pharmaceuticals>,
        <https://1145.am/db/2319687/Advisys>,
        <https://1145.am/db/2319790/Pharmacyclics>,
        <https://1145.am/db/2319806/Satori_Pharmaceuticals>,
        <https://1145.am/db/2319809/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320009/Map_Pharmaceuticals>,
        <https://1145.am/db/2320025/Am-Pharma>,
        <https://1145.am/db/2320025/Esprit_Pharma>,
        <https://1145.am/db/2320461/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320767/Via_Pharmaceuticals>,
        <https://1145.am/db/2320903/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2320949/Medicines_Company>,
        <https://1145.am/db/2321148/Savient_Pharmaceuticals>,
        <https://1145.am/db/2321157/Access_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321565/2009-2010>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2321860/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2321861/Astion_Pharma>,
        <https://1145.am/db/2321871/Astion_Pharma>,
        <https://1145.am/db/2321899/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2322135/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322235/Pharmacopeia>,
        <https://1145.am/db/2322291/Polpharma>,
        <https://1145.am/db/2322481/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322632/Savient_Pharmaceuticals>,
        <https://1145.am/db/2322942/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2322953/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2323173/Pharmacopeia>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323225/Arqule>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323358/Organon_Biosciences>,
        <https://1145.am/db/2324017/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2324024/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2324243/Arqule>,
        <https://1145.am/db/2324417/Biomimetic_Pharmaceuticals>,
        <https://1145.am/db/2324753/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2324838/Biogen>,
        <https://1145.am/db/2325070/The_Medicines_Company>,
        <https://1145.am/db/2325074/The_Medicines_Company>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2325725/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326025/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2326148/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2326286/Idera_Pharmaceuticals>,
        <https://1145.am/db/2326403/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2326466/Macromed>,
        <https://1145.am/db/2326474/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327450/York_Pharma>,
        <https://1145.am/db/2327480/Transdel_Pharmaceuticals>,
        <https://1145.am/db/2327649/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2327849/Pharmacia_Corporation>,
        <https://1145.am/db/2328043/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/2328220/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2328222/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2328616/Map_Pharmaceuticals>,
        <https://1145.am/db/2328650/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2328729/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2328988/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2328990/Mdrna>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329309/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2329643/Pharmaceuticals_Inc>,
        <https://1145.am/db/2329756/Provid_Pharmaceuticals>,
        <https://1145.am/db/2329814/Map_Pharmaceuticals>,
        <https://1145.am/db/2329816/Map_Pharmaceuticals>,
        <https://1145.am/db/2330057/Pharmathene>,
        <https://1145.am/db/2330086/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330094/Idera_Pharmaceuticals>,
        <https://1145.am/db/2330207/Bioxell>,
        <https://1145.am/db/2330207/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2330534/Pharmion>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330667/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330880/Access_Pharmaceuticals>,
        <https://1145.am/db/2330880/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330989/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331745/Elan_Pharmaceuticals>,
        <https://1145.am/db/2331756/Pro-Pharmaceuticals>,
        <https://1145.am/db/2331875/Bioalliance_Pharma>,
        <https://1145.am/db/2332473/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2332596/Esprit_Pharma>,
        <https://1145.am/db/2332777/S_*_Bio>,
        <https://1145.am/db/2332974/Osi_Pharmaceuticals>,
        <https://1145.am/db/2332980/Pharmos_Corporation>,
        <https://1145.am/db/2333492/Access_Pharmaceuticals>,
        <https://1145.am/db/2333569/Ception>,
        <https://1145.am/db/2333624/Pharmos>,
        <https://1145.am/db/2334034/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2334119/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334121/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334183/Idera_Pharmaceuticals>,
        <https://1145.am/db/2335077/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336160/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2336293/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2336378/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336442/Bionor_Pharma_Asa>,
        <https://1145.am/db/2336452/Pharmaxis_Ltd>,
        <https://1145.am/db/2336503/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336505/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336506/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2336524/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336934/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337345/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337348/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2337547/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337986/Pharmagen_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2338390/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338401/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2338430/Pharmacyclics>,
        <https://1145.am/db/2338551/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338735/Map_Pharmaceuticals>,
        <https://1145.am/db/2338877/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2339019/Isa_Pharmaceuticals_Bv>,
        <https://1145.am/db/2339186/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2339570/Map_Pharmaceuticals>,
        <https://1145.am/db/2339718/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2339727/Pharmacyclics_Inc>,
        <https://1145.am/db/2339787/Pharmalink_Ab>,
        <https://1145.am/db/2339892/Pharmacyclics>,
        <https://1145.am/db/2339907/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2339910/Biomed_Pharmaceuticals>,
        <https://1145.am/db/2339922/Pharmaform>,
        <https://1145.am/db/2339979/Theravance>,
        <https://1145.am/db/2340000/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340224/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340291/Pharmasset>,
        <https://1145.am/db/2340373/Nps_Pharmaceuticals>,
        <https://1145.am/db/2340431/Savient_Pharmaceuticals>,
        <https://1145.am/db/2341523/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2341742/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2341752/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2341998/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342469/Pharmadel>,
        <https://1145.am/db/2342687/Bioalliance_Pharma>,
        <https://1145.am/db/2342800/Pharmathene>,
        <https://1145.am/db/2342805/Pharmathene>,
        <https://1145.am/db/2342918/Pharmalink_Ab>,
        <https://1145.am/db/2343264/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2343277/Pharmasset>,
        <https://1145.am/db/2343826/The_Medicines_Company>,
        <https://1145.am/db/2343837/Medicines_Co>,
        <https://1145.am/db/2343966/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2344011/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344076/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344079/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344131/Pharmascience_Inc>,
        <https://1145.am/db/2344207/Entremed>,
        <https://1145.am/db/2344624/Pharmagen_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344739/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344939/Theravance>,
        <https://1145.am/db/2344955/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2345106/Map_Pharmaceuticals>,
        <https://1145.am/db/2345474/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345902/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346534/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346542/Conatus_Pharmaceuticals>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2346800/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346807/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2346951/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346964/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2347127/Pharmacyte_Biotech>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347227/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2347272/Pharmascience>,
        <https://1145.am/db/2347519/Pharmadeals_Ltd>,
        <https://1145.am/db/2347644/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347648/Pharminox_Limited>,
        <https://1145.am/db/2347659/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347982/Epicept>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348506/Am-Pharma_Bv>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348763/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2348864/Vital_Science_Corp>,
        <https://1145.am/db/2349103/Biota_Pharmaceuticals>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349348/R-Pharm>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349965/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350440/Ethicon>,
        <https://1145.am/db/2350852/Isa_Pharmaceuticals>,
        <https://1145.am/db/2351091/Biomotiv>,
        <https://1145.am/db/2351471/Mymetics_Corporation>,
        <https://1145.am/db/2351818/Biocon>,
        <https://1145.am/db/2352046/Costim_Pharmaceuticals>,
        <https://1145.am/db/2352165/Bio>,
        <https://1145.am/db/2352177/Theravance_Inc>,
        <https://1145.am/db/2352180/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2352333/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2352538/Biota_Pharmaceuticals>,
        <https://1145.am/db/2352659/Nps_Pharmaceuticals>,
        <https://1145.am/db/2352784/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2352805/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2352808/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353006/Radient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353093/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353098/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353254/Pharma_Inc>,
        <https://1145.am/db/2353262/Sound_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2353364/Am-Pharma>,
        <https://1145.am/db/2353651/Pharmathene>,
        <https://1145.am/db/2353668/Biotie>,
        <https://1145.am/db/2354002/N30_Pharmaceuticals>,
        <https://1145.am/db/2354062/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354064/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354083/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354086/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354124/Uk>,
        <https://1145.am/db/2354146/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2354376/Aspireo_Pharmaceuticals>,
        <https://1145.am/db/2354380/Pharmaxis>,
        <https://1145.am/db/2354388/Pharmaxis>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354406/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354804/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2354836/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354913/Bionor_Pharma_Asa>,
        <https://1145.am/db/2355099/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355109/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355324/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2355678/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2355721/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2355884/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355941/Theratechnologies>,
        <https://1145.am/db/2355974/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2356294/Company>,
        <https://1145.am/db/2356294/Inc>,
        <https://1145.am/db/2356391/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2357329/Pharmalink_Ab>,
        <https://1145.am/db/2357333/Pharmalink>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357636/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2358047/Entremed>,
        <https://1145.am/db/2358405/Pharmagen_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358732/Osi_Pharmaceuticals>,
        <https://1145.am/db/2358877/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359266/D-Pharm>,
        <https://1145.am/db/2359401/Scpharmaceuticals_Inc>,
        <https://1145.am/db/2359438/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2359474/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359668/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2359882/Biotie>,
        <https://1145.am/db/2359926/Entremed>,
        <https://1145.am/db/2360155/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2360489/Medac_Pharma>,
        <https://1145.am/db/2360588/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360697/Medgenics>,
        <https://1145.am/db/2360739/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2360945/Entremed>,
        <https://1145.am/db/2361244/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2361516/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362456/Action_Pharma_A_S>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2362593/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363186/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363285/Phenex_Pharmaceuticals_Ag>,
        <https://1145.am/db/2363340/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363387/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2363425/The_Medicines_Company>,
        <https://1145.am/db/2363433/The_Medicines_Company>,
        <https://1145.am/db/2363452/Pharmasum_Therapeutics_As>,
        <https://1145.am/db/2363530/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2363955/Savient_Pharmaceuticals>,
        <https://1145.am/db/2364093/Biotie>,
        <https://1145.am/db/2364252/Nps_Pharmaceuticals>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364276/S_*_Bio>,
        <https://1145.am/db/2364494/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2364495/Bioalliance_Pharma>,
        <https://1145.am/db/2364538/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2364541/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2364585/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364593/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364601/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364774/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364884/Entremed_Inc>,
        <https://1145.am/db/2365030/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2365098/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365224/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2365423/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2365724/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365763/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2366139/Prism_Pharmaceuticals>,
        <https://1145.am/db/2366388/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366521/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367021/Biotie>,
        <https://1145.am/db/2367070/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2367280/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2367438/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2367483/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367496/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367951/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2367962/Catalyst_Pharmaceuticals>,
        <https://1145.am/db/2368070/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2368339/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2368420/Intec_Pharma>,
        <https://1145.am/db/2368593/Bioquiddity_Incorporated>,
        <https://1145.am/db/2368632/Pharmacyclics>,
        <https://1145.am/db/2368739/Novartis_Pharmaceuticals>,
        <https://1145.am/db/2368826/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369004/Biogen>,
        <https://1145.am/db/2369037/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369144/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369233/Biopharmx_Corporation>,
        <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2369812/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2369931/Biogen>,
        <https://1145.am/db/2370022/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2370078/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2370082/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2370089/Abide_Therapeutics>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370637/Medgenics_Inc>,
        <https://1145.am/db/2370797/Pharmanest>,
        <https://1145.am/db/2370798/Pharmalink_Ab>,
        <https://1145.am/db/2370946/Biogen>,
        <https://1145.am/db/2371015/M_Pharma>,
        <https://1145.am/db/2371016/M_Pharma>,
        <https://1145.am/db/2371279/Biomunex_Pharmaceuticals>,
        <https://1145.am/db/2371491/Biopharmx_Corporation>,
        <https://1145.am/db/2536754/Oramed_Pharma>,
        <https://1145.am/db/2536756/Zao>,
        <https://1145.am/db/2537468/Pharmascience_Inc>,
        <https://1145.am/db/2538171/Biomeda_Group>,
        <https://1145.am/db/2538567/Upm_Pharmaceuticals>,
        <https://1145.am/db/2538861/Par_Pharmaceuticals>,
        <https://1145.am/db/2538901/The_Harvard_Drug_Group>,
        <https://1145.am/db/2539516/Par_Pharmaceuticals>,
        <https://1145.am/db/2539568/Zao>,
        <https://1145.am/db/2540193/Pharmanest>,
        <https://1145.am/db/2540449/Biocon>,
        <https://1145.am/db/2540951/Rytary>,
        <https://1145.am/db/2541039/Elan_Pharmaceuticals>,
        <https://1145.am/db/2541239/Pharmstar>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541717/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2541810/British_Pharma>,
        <https://1145.am/db/2542218/Pharmacyclics>,
        <https://1145.am/db/2543839/British_Pharma>,
        <https://1145.am/db/2544111/Unique_Pharmaceuticals>,
        <https://1145.am/db/2544358/Mundipharma>,
        <https://1145.am/db/2544596/Polpharma>,
        <https://1145.am/db/2544679/Neopharma>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2545143/Mundipharma>,
        <https://1145.am/db/2545411/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2546441/Intas_Pharmaceuticals>,
        <https://1145.am/db/2546529/Pharma_Tech_Industries>,
        <https://1145.am/db/2546629/Par_Pharmaceutical>,
        <https://1145.am/db/2547189/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2548585/Par_Pharmaceuticals>,
        <https://1145.am/db/2548674/Sopharma>,
        <https://1145.am/db/2549477/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2549520/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2549919/Pharmathen>,
        <https://1145.am/db/2550212/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2550471/Pharmaform>,
        <https://1145.am/db/2550523/Pharmaron>,
        <https://1145.am/db/2550685/Upm_Pharmaceuticals>,
        <https://1145.am/db/2551427/Pharmablock_Sciences>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552169/Alembic_Pharmaceuticals>,
        <https://1145.am/db/2552465/Medis>,
        <https://1145.am/db/2552641/Plethico_Pharmaceuticals>,
        <https://1145.am/db/2552642/Mankind_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2552794/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553276/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553512/Pharmax_Pharmaceuticals>,
        <https://1145.am/db/2553708/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2554237/Intas_Pharmaceuticals>,
        <https://1145.am/db/2554810/Continuus_Pharmaceuticals>,
        <https://1145.am/db/2554814/Globalpharma>,
        <https://1145.am/db/2554858/Medicure_Usa_Inc>,
        <https://1145.am/db/2555338/Pharmacore>,
        <https://1145.am/db/2555890/Pharmalucence>,
        <https://1145.am/db/2555896/Pharmalucence>,
        <https://1145.am/db/2556805/Medicis_Pharmaceuticals>,
        <https://1145.am/db/2557303/Pharmaron>,
        <https://1145.am/db/2557538/Neopharma>,
        <https://1145.am/db/2558025/Pharmaxis>,
        <https://1145.am/db/2558026/Pharmaxis>,
        <https://1145.am/db/2558970/Biostar_Pharmaceuticals>,
        <https://1145.am/db/2559783/Polpharma>,
        <https://1145.am/db/2560083/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561100/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561312/Oxford_Pharmaceuticals>,
        <https://1145.am/db/2561438/Pharmacia___Upjohn>,
        <https://1145.am/db/2561978/Biomarin_Pharmaceuticals>,
        <https://1145.am/db/2562199/Novartis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562500/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2563255/Active_Pharmaceutical_Ingredients>,
        <https://1145.am/db/2563497/Creo_Pharmaceuticals>,
        <https://1145.am/db/2563497/Polpharma>,
        <https://1145.am/db/2564196/Pharmaron>,
        <https://1145.am/db/2564713/C2_Pharma>,
        <https://1145.am/db/2567007/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2567055/Sovereign_Pharmaceuticals>,
        <https://1145.am/db/2567283/The_Pharma_Giant>,
        <https://1145.am/db/2567438/Biogen>,
        <https://1145.am/db/2567651/Indivior>,
        <https://1145.am/db/2567651/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2568205/Biogen>,
        <https://1145.am/db/2568375/Biogen>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569187/Pharmacyclics>,
        <https://1145.am/db/2569370/Co>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569729/The_Medicines_Company>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570068/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2570289/Pharmacyclics>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570449/Biocon>,
        <https://1145.am/db/2570741/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570807/Pharmacyclics>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2572200/The_Medicines_Company>,
        <https://1145.am/db/2572870/Hi-Tech_Pharmaceuticals>,
        <https://1145.am/db/2573057/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2573058/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2573147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2573271/Physician_Therapeutics>,
        <https://1145.am/db/2573391/Url_Pharma>,
        <https://1145.am/db/2573392/Url_Pharma>,
        <https://1145.am/db/2573887/Biogen>,
        <https://1145.am/db/2574679/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2574891/Pharmacyclics>,
        <https://1145.am/db/2575222/Map_Pharmaceuticals>,
        <https://1145.am/db/2575242/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2575462/Paras_Pharmaceuticals>,
        <https://1145.am/db/2575623/Inova_Pharmaceuticals>,
        <https://1145.am/db/2576205/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2577145/Medicis_Pharmaceutical>,
        <https://1145.am/db/2577259/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2577675/Biogen>,
        <https://1145.am/db/2577684/Biogen>,
        <https://1145.am/db/2577894/Huvepharma_Ad>,
        <https://1145.am/db/2577934/Pharmascience>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578319/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2578473/Aa_Pharma>,
        <https://1145.am/db/2578481/Aa_Pharma_Inc>,
        <https://1145.am/db/2579147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2579211/Eusa_Pharma>,
        <https://1145.am/db/2579538/Pharmaforce>,
        <https://1145.am/db/2580123/Savient_Pharmaceuticals>,
        <https://1145.am/db/2580479/Pharmaxis>,
        <https://1145.am/db/2581225/Inova_Pharmaceuticals>,
        <https://1145.am/db/2582110/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582153/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2582174/Pharmasset>,
        <https://1145.am/db/2582320/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2583013/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583022/Url_Pharma>,
        <https://1145.am/db/2583220/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2583270/Pharmaswiss>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583402/Osi_Pharmaceuticals>,
        <https://1145.am/db/2583414/Polpharma>,
        <https://1145.am/db/2583769/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2584209/Pharmaswiss_Sa>,
        <https://1145.am/db/2584226/Pharmaswiss_Sa>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2585281/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2585887/Pharma_Inc>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587155/Millennium_Pharma>,
        <https://1145.am/db/2587616/Pharmaq>,
        <https://1145.am/db/2587696/R-Pharm>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588718/Pharmacyclics>,
        <https://1145.am/db/2588884/Map_Pharmaceuticals>,
        <https://1145.am/db/2589884/Map_Pharmaceuticals>,
        <https://1145.am/db/2590159/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2590195/Pro-Tect_Pharmaceuticals>,
        <https://1145.am/db/2590409/Biogen>,
        <https://1145.am/db/2590910/Savient_Pharmaceuticals>,
        <https://1145.am/db/2591540/Polpharma>,
        <https://1145.am/db/2591690/Medicis_Pharmaceutical>,
        <https://1145.am/db/2591938/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2593142/Access_Pharmaceuticals>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594042/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594116/Pharmerica>,
        <https://1145.am/db/2594602/Osi_Pharma>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2595190/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595210/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595413/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596307/Savient_Pharmaceuticals>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596369/Pharmadeals_Ltd>,
        <https://1145.am/db/2596818/Pharmasset>,
        <https://1145.am/db/2597158/Nps_Pharmaceuticals>,
        <https://1145.am/db/2597180/Prism_Pharmaceuticals>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2597935/Osi_Pharmaceuticals>,
        <https://1145.am/db/2598027/Nps_Pharmaceuticals>,
        <https://1145.am/db/2598099/Paras_Pharmaceuticals>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598195/Pharmatech>,
        <https://1145.am/db/2598605/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2765310/Biogen>,
        <https://1145.am/db/281576/Mymd_Pharmaceuticals>,
        <https://1145.am/db/307255/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/324642/Mundipharma>,
        <https://1145.am/db/367137/Biomat>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/380389/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/407888/Quoin_Pharmaceuticals>,
        <https://1145.am/db/410129/Catalyst_Pharmaceuticals_Inc>,
        <https://1145.am/db/427157/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/431169/Pharmablock>,
        <https://1145.am/db/4491/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/452957/Aerie_Pharmaceuticals>,
        <https://1145.am/db/468221/Aerie_Pharmaceuticals>,
        <https://1145.am/db/481129/Biocon_Ltd>,
        <https://1145.am/db/485351/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/486302/Phathom_Pharmaceuticals>,
        <https://1145.am/db/487010/Scipher_Medicine>,
        <https://1145.am/db/488564/Aerie_Pharmaceuticals>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/538112/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/545583/Citius_Pharmaceuticals>,
        <https://1145.am/db/546391/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/567789/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/585607/Am-Pharma>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/662016/Prestige_Biopharma_Limited>,
        <https://1145.am/db/668495/Scipher_Medicine>,
        <https://1145.am/db/669775/Scipher_Medicine>,
        <https://1145.am/db/693128/Ascensus_Specialties>,
        <https://1145.am/db/700482/Novartis_Pharmaceuticals>,
        <https://1145.am/db/712037/Amunix_Pharmaceuticals>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/713105/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/713736/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/714923/Betterlife_Pharma_Inc>,
        <https://1145.am/db/715385/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/718008/Pharnext_Sa>,
        <https://1145.am/db/723883/Mymd_Pharmaceuticals>,
        <https://1145.am/db/724999/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/734669/Escient_Pharmaceuticals>,
        <https://1145.am/db/742794/Hr_Pharmaceuticals_Inc>,
        <https://1145.am/db/771062/Gw_Pharmaceuticals>,
        <https://1145.am/db/793071/Biogen_Inc>,
        <https://1145.am/db/835485/Pharmaessentia_Corporation>,
        <https://1145.am/db/854026/Aerie_Pharmaceuticals>,
        <https://1145.am/db/883896/Biontech>,
        <https://1145.am/db/884665/Pharmaceutical_Institute>,
        <https://1145.am/db/887575/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/889331/Tha_Pharma>,
        <https://1145.am/db/912469/Aerie_Pharmaceuticals>,
        <https://1145.am/db/913730/Aerie_Pharmaceuticals>,
        <https://1145.am/db/922740/Grand_Pharma>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2315693/Osi_Pharmaceuticals>,
        <https://1145.am/db/2319239/Osi_Pharmaceuticals>,
        <https://1145.am/db/2362425/Osi_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2591540/Polpharma> a org:Organization ;
    ns1:basedInHighGeoName "Hungary" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/719819/about.rdf> ;
    ns1:basedInHighRaw "Hungary" ;
    ns1:documentDate "2011-08-09T12:46:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "KV Pharma completes generics-unit sale; Gedeon Richter wins dispute over buyout;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/kv-pharma-completes-generics-unit-sale-gedeon-richter-wins-dispute-over-buyout> ;
    ns1:foundName "Polpharma" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Polpharma" ;
    ns1:sameAsHigh <https://1145.am/db/101025/Scpharmaceuticals_Inc>,
        <https://1145.am/db/101329/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1031042/Intomics>,
        <https://1145.am/db/1033561/Hs_Pharmaceuticals>,
        <https://1145.am/db/1054457/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/1054503/Hs_Pharmaceuticals>,
        <https://1145.am/db/1061901/Pharmaessentia_Corporation>,
        <https://1145.am/db/1070158/Biognosys>,
        <https://1145.am/db/1079560/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1080385/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1092000/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/11010/Progenics_Pharmaceuticals>,
        <https://1145.am/db/1104169/20045078>,
        <https://1145.am/db/1118439/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1141704/Inmed_Pharmaceuticals>,
        <https://1145.am/db/1174705/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1176480/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1185008/TDV>,
        <https://1145.am/db/1186876/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1216583/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1291286/Vital_Pharmaceuticals_Inc>,
        <https://1145.am/db/1294499/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1294506/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1295948/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1296487/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1307419/X4_Pharmaceuticals>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1329779/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1339033/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1343020/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/1370859/Bioivt>,
        <https://1145.am/db/1371279/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1387773/Aspire_Pharma>,
        <https://1145.am/db/1390741/Nexus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1409143/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417723/Altasciences>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443334/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443968/Pharmajet>,
        <https://1145.am/db/1445613/Pharmajet>,
        <https://1145.am/db/1487706/Phathom_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497210/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1497218/Opiant_Pharmaceuticals>,
        <https://1145.am/db/1500616/Indivior_Plc>,
        <https://1145.am/db/1500616/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1502096/Indivior_Plc>,
        <https://1145.am/db/1502096/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1505968/Escient_Pharmaceuticals>,
        <https://1145.am/db/1508407/Escient_Pharmaceuticals>,
        <https://1145.am/db/1515279/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1520596/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1520597/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521624/Scpharmaceuticals>,
        <https://1145.am/db/1521695/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521941/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1523220/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1533327/Escient_Pharmaceuticals>,
        <https://1145.am/db/1533685/Escient_Pharmaceuticals>,
        <https://1145.am/db/1537336/Pharmajet>,
        <https://1145.am/db/1538786/Pharmajet>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1541946/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1548955/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1557072/Essential_Pharma>,
        <https://1145.am/db/1559882/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1571078/Organon>,
        <https://1145.am/db/1585097/Scpharmaceuticals_Inc>,
        <https://1145.am/db/158742/Biogen_Inc>,
        <https://1145.am/db/1595580/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1613688/Pharmalex>,
        <https://1145.am/db/1624479/Indivior_Plc>,
        <https://1145.am/db/1624479/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1625532/Indivior_Plc>,
        <https://1145.am/db/1625532/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629605/Biogen>,
        <https://1145.am/db/1629663/Biogen>,
        <https://1145.am/db/1632411/Scipher_Medicine>,
        <https://1145.am/db/1632862/Scipher_Medicine>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1680583/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/1687234/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/180589/Servier>,
        <https://1145.am/db/1955684/Eip_Pharma_Inc>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2038168/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039291/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039678/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2045820/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2049603/Inova_Pharmaceuticals>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2062156/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2066480/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2071248/Biogen>,
        <https://1145.am/db/2074741/Biogen_Inc>,
        <https://1145.am/db/2092442/Leo_Pharma>,
        <https://1145.am/db/2093802/Meitheal_Pharmaceuticals>,
        <https://1145.am/db/2100253/Biogen_Inc>,
        <https://1145.am/db/2101006/Leo_Pharma_A_S>,
        <https://1145.am/db/2138834/Altasciences>,
        <https://1145.am/db/2151781/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152434/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2153727/Amunix_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154118/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154527/The_Medicines_Company>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155006/Medicines_Company>,
        <https://1145.am/db/2155312/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155622/Isa_Pharmaceuticals>,
        <https://1145.am/db/2155792/Ucb_Pharma>,
        <https://1145.am/db/2155798/Ucb_Pharma>,
        <https://1145.am/db/2155994/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2198945/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2201094/Pharmadeals_Ltd>,
        <https://1145.am/db/2204969/Organon_Biosciences>,
        <https://1145.am/db/2207034/Cequent_Pharmaceuticals>,
        <https://1145.am/db/221697/Gw_Pharmaceuticals>,
        <https://1145.am/db/2217819/Pharmacopeia>,
        <https://1145.am/db/221787/Gw_Pharmaceuticals>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2224859/Biologics>,
        <https://1145.am/db/2229191/Biologics>,
        <https://1145.am/db/2279276/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2279648/Organon>,
        <https://1145.am/db/2280123/Casi_Pharmaceuticals>,
        <https://1145.am/db/2280153/Pharming>,
        <https://1145.am/db/2281547/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2283570/Pherin_Pharmaceuticals>,
        <https://1145.am/db/2284358/Escient_Pharmaceuticals>,
        <https://1145.am/db/2285117/Immedica>,
        <https://1145.am/db/2285495/Bioivt>,
        <https://1145.am/db/2287224/Escient_Pharmaceuticals>,
        <https://1145.am/db/2287505/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2287572/T3_Pharmaceuticals>,
        <https://1145.am/db/2288192/Servier>,
        <https://1145.am/db/2290842/X4_Pharmaceuticals>,
        <https://1145.am/db/2291791/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2294547/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2294570/Pharmatek>,
        <https://1145.am/db/2296094/Biogen>,
        <https://1145.am/db/2297534/Bio>,
        <https://1145.am/db/2298037/Ethicon>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2299414/Biogen>,
        <https://1145.am/db/2301089/Cerulean_Pharma>,
        <https://1145.am/db/2301346/Pharmaron>,
        <https://1145.am/db/2301718/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2301735/Idera_Pharmaceuticals>,
        <https://1145.am/db/2301764/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302275/Map_Pharmaceuticals>,
        <https://1145.am/db/2302426/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302431/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2302574/Via_Pharmaceuticals>,
        <https://1145.am/db/2302579/Via_Pharmaceuticals>,
        <https://1145.am/db/2302587/Access_Pharmaceuticals>,
        <https://1145.am/db/2302658/Biotie>,
        <https://1145.am/db/2302707/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2302774/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302779/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302890/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2302897/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303121/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303131/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303182/Pharmexa>,
        <https://1145.am/db/2303208/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303674/Cerulean_Pharma>,
        <https://1145.am/db/2303792/Access_Pharmaceuticals>,
        <https://1145.am/db/2303934/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2304044/Novamed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2304097/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2304135/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2304610/Pharmos_Corp>,
        <https://1145.am/db/2304745/Critical_Pharmaceuticals>,
        <https://1145.am/db/2304831/Pharmion_Corporation>,
        <https://1145.am/db/2304934/Medicure>,
        <https://1145.am/db/2304985/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2305742/Mh_Pharma_Uk>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2305927/Entremed>,
        <https://1145.am/db/2305956/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2306299/Verily>,
        <https://1145.am/db/2306641/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2306962/Pharmaron>,
        <https://1145.am/db/2307239/Pharmaxis_Ltd>,
        <https://1145.am/db/2307246/Pharmaxis>,
        <https://1145.am/db/2307254/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2307651/Organon>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307871/Access_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2307897/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2308446/Pharmathene>,
        <https://1145.am/db/2308922/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308964/Slate_Pharmaceuticals>,
        <https://1145.am/db/2309001/Biocon>,
        <https://1145.am/db/2309301/Inc>,
        <https://1145.am/db/2309923/Diasome_Pharmaceuticals>,
        <https://1145.am/db/2310002/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2310002/Map_Pharmaceuticals>,
        <https://1145.am/db/2310045/Slate_Pharmaceuticals>,
        <https://1145.am/db/2310071/Encysive_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310200/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2310219/Docpharma>,
        <https://1145.am/db/2310232/Genaissance_Pharmaceuticals>,
        <https://1145.am/db/2310471/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/2310473/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310476/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2310480/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310790/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310993/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2311166/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2311202/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311217/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2311264/Medicure>,
        <https://1145.am/db/2311726/Inc>,
        <https://1145.am/db/2312088/Cerulean_Pharma>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312193/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2312344/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2312416/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2312476/Nps_Pharmaceuticals>,
        <https://1145.am/db/2312479/Nps_Pharmaceuticals>,
        <https://1145.am/db/2313305/Tetraphase_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313306/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313320/Ore_Pharmaceuticals>,
        <https://1145.am/db/2313323/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313336/Sound_Pharmaceuticals>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2313501/Bioalliance_Pharma>,
        <https://1145.am/db/2313527/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2313528/Us_Pharmaceutical_Company>,
        <https://1145.am/db/2314217/Sciele_Pharma>,
        <https://1145.am/db/2314271/Biomarck_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2314277/Biomarck_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314375/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314680/Pharming>,
        <https://1145.am/db/2314816/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314837/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2315159/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2315192/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315485/Polpharma>,
        <https://1145.am/db/2315571/Sciele_Pharma>,
        <https://1145.am/db/2315624/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315624/Pharmos>,
        <https://1145.am/db/2315925/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316239/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2316418/Pharmaventures_Ltd>,
        <https://1145.am/db/2316435/Pharmaventures_Ltd>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317337/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2317344/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2317635/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2317762/Pharmathene>,
        <https://1145.am/db/2317826/Anormed>,
        <https://1145.am/db/2317826/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2317842/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317895/Esprit_Pharma>,
        <https://1145.am/db/2317929/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2318105/Pharma_Inc>,
        <https://1145.am/db/2318114/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318248/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318285/Pht_Corporation>,
        <https://1145.am/db/2318469/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2318554/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318574/Idera_Pharmaceuticals>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2318743/Pharmos_Corporation>,
        <https://1145.am/db/2318808/Pharmathene>,
        <https://1145.am/db/2318986/Corgentech>,
        <https://1145.am/db/2318994/Cornerstone_Biopharma>,
        <https://1145.am/db/2319208/Osi_Pharmaceuticals>,
        <https://1145.am/db/2319687/Advisys>,
        <https://1145.am/db/2319790/Pharmacyclics>,
        <https://1145.am/db/2319806/Satori_Pharmaceuticals>,
        <https://1145.am/db/2319809/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320009/Map_Pharmaceuticals>,
        <https://1145.am/db/2320025/Am-Pharma>,
        <https://1145.am/db/2320025/Esprit_Pharma>,
        <https://1145.am/db/2320461/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320767/Via_Pharmaceuticals>,
        <https://1145.am/db/2320903/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2320949/Medicines_Company>,
        <https://1145.am/db/2321148/Savient_Pharmaceuticals>,
        <https://1145.am/db/2321157/Access_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321565/2009-2010>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2321860/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2321861/Astion_Pharma>,
        <https://1145.am/db/2321871/Astion_Pharma>,
        <https://1145.am/db/2321899/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2322135/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322235/Pharmacopeia>,
        <https://1145.am/db/2322291/Polpharma>,
        <https://1145.am/db/2322481/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322632/Savient_Pharmaceuticals>,
        <https://1145.am/db/2322942/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2322953/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2323173/Pharmacopeia>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323225/Arqule>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323358/Organon_Biosciences>,
        <https://1145.am/db/2324017/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2324024/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2324243/Arqule>,
        <https://1145.am/db/2324417/Biomimetic_Pharmaceuticals>,
        <https://1145.am/db/2324753/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2324838/Biogen>,
        <https://1145.am/db/2325070/The_Medicines_Company>,
        <https://1145.am/db/2325074/The_Medicines_Company>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2325725/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326025/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2326148/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2326286/Idera_Pharmaceuticals>,
        <https://1145.am/db/2326403/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2326466/Macromed>,
        <https://1145.am/db/2326474/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327450/York_Pharma>,
        <https://1145.am/db/2327480/Transdel_Pharmaceuticals>,
        <https://1145.am/db/2327649/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2327849/Pharmacia_Corporation>,
        <https://1145.am/db/2328043/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/2328220/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2328222/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2328616/Map_Pharmaceuticals>,
        <https://1145.am/db/2328650/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2328729/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2328988/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2328990/Mdrna>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329309/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2329643/Pharmaceuticals_Inc>,
        <https://1145.am/db/2329756/Provid_Pharmaceuticals>,
        <https://1145.am/db/2329814/Map_Pharmaceuticals>,
        <https://1145.am/db/2329816/Map_Pharmaceuticals>,
        <https://1145.am/db/2330057/Pharmathene>,
        <https://1145.am/db/2330086/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330094/Idera_Pharmaceuticals>,
        <https://1145.am/db/2330207/Bioxell>,
        <https://1145.am/db/2330207/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2330534/Pharmion>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330667/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330880/Access_Pharmaceuticals>,
        <https://1145.am/db/2330880/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330989/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331745/Elan_Pharmaceuticals>,
        <https://1145.am/db/2331756/Pro-Pharmaceuticals>,
        <https://1145.am/db/2331875/Bioalliance_Pharma>,
        <https://1145.am/db/2332473/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2332596/Esprit_Pharma>,
        <https://1145.am/db/2332777/S_*_Bio>,
        <https://1145.am/db/2332974/Osi_Pharmaceuticals>,
        <https://1145.am/db/2332980/Pharmos_Corporation>,
        <https://1145.am/db/2333492/Access_Pharmaceuticals>,
        <https://1145.am/db/2333569/Ception>,
        <https://1145.am/db/2333624/Pharmos>,
        <https://1145.am/db/2334034/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2334119/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334121/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334183/Idera_Pharmaceuticals>,
        <https://1145.am/db/2335077/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336160/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2336293/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2336378/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336442/Bionor_Pharma_Asa>,
        <https://1145.am/db/2336452/Pharmaxis_Ltd>,
        <https://1145.am/db/2336503/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336505/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336506/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2336524/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336934/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337345/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337348/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2337547/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337986/Pharmagen_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2338390/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338401/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2338430/Pharmacyclics>,
        <https://1145.am/db/2338551/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338735/Map_Pharmaceuticals>,
        <https://1145.am/db/2338877/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2339019/Isa_Pharmaceuticals_Bv>,
        <https://1145.am/db/2339186/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2339570/Map_Pharmaceuticals>,
        <https://1145.am/db/2339718/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2339727/Pharmacyclics_Inc>,
        <https://1145.am/db/2339787/Pharmalink_Ab>,
        <https://1145.am/db/2339892/Pharmacyclics>,
        <https://1145.am/db/2339907/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2339910/Biomed_Pharmaceuticals>,
        <https://1145.am/db/2339922/Pharmaform>,
        <https://1145.am/db/2339979/Theravance>,
        <https://1145.am/db/2340000/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340224/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340291/Pharmasset>,
        <https://1145.am/db/2340373/Nps_Pharmaceuticals>,
        <https://1145.am/db/2340431/Savient_Pharmaceuticals>,
        <https://1145.am/db/2341523/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2341742/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2341752/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2341998/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342469/Pharmadel>,
        <https://1145.am/db/2342687/Bioalliance_Pharma>,
        <https://1145.am/db/2342800/Pharmathene>,
        <https://1145.am/db/2342805/Pharmathene>,
        <https://1145.am/db/2342918/Pharmalink_Ab>,
        <https://1145.am/db/2343264/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2343277/Pharmasset>,
        <https://1145.am/db/2343826/The_Medicines_Company>,
        <https://1145.am/db/2343837/Medicines_Co>,
        <https://1145.am/db/2343966/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2344011/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344076/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344079/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344131/Pharmascience_Inc>,
        <https://1145.am/db/2344207/Entremed>,
        <https://1145.am/db/2344624/Pharmagen_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344739/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344939/Theravance>,
        <https://1145.am/db/2344955/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2345106/Map_Pharmaceuticals>,
        <https://1145.am/db/2345474/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345902/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346534/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346542/Conatus_Pharmaceuticals>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2346800/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346807/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2346951/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346964/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2347127/Pharmacyte_Biotech>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347227/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2347272/Pharmascience>,
        <https://1145.am/db/2347519/Pharmadeals_Ltd>,
        <https://1145.am/db/2347644/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347648/Pharminox_Limited>,
        <https://1145.am/db/2347659/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347982/Epicept>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348506/Am-Pharma_Bv>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348763/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2348864/Vital_Science_Corp>,
        <https://1145.am/db/2349103/Biota_Pharmaceuticals>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349348/R-Pharm>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349965/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350440/Ethicon>,
        <https://1145.am/db/2350852/Isa_Pharmaceuticals>,
        <https://1145.am/db/2351091/Biomotiv>,
        <https://1145.am/db/2351471/Mymetics_Corporation>,
        <https://1145.am/db/2351818/Biocon>,
        <https://1145.am/db/2352046/Costim_Pharmaceuticals>,
        <https://1145.am/db/2352165/Bio>,
        <https://1145.am/db/2352177/Theravance_Inc>,
        <https://1145.am/db/2352180/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2352333/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2352538/Biota_Pharmaceuticals>,
        <https://1145.am/db/2352659/Nps_Pharmaceuticals>,
        <https://1145.am/db/2352784/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2352805/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2352808/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353006/Radient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353093/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353098/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353254/Pharma_Inc>,
        <https://1145.am/db/2353262/Sound_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2353364/Am-Pharma>,
        <https://1145.am/db/2353651/Pharmathene>,
        <https://1145.am/db/2353668/Biotie>,
        <https://1145.am/db/2354002/N30_Pharmaceuticals>,
        <https://1145.am/db/2354062/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354064/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354083/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354086/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354124/Uk>,
        <https://1145.am/db/2354146/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2354376/Aspireo_Pharmaceuticals>,
        <https://1145.am/db/2354380/Pharmaxis>,
        <https://1145.am/db/2354388/Pharmaxis>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354406/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354804/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2354836/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354913/Bionor_Pharma_Asa>,
        <https://1145.am/db/2355099/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355109/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355324/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2355678/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2355721/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2355884/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355941/Theratechnologies>,
        <https://1145.am/db/2355974/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2356294/Company>,
        <https://1145.am/db/2356294/Inc>,
        <https://1145.am/db/2356391/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2357329/Pharmalink_Ab>,
        <https://1145.am/db/2357333/Pharmalink>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357636/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2358047/Entremed>,
        <https://1145.am/db/2358405/Pharmagen_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358732/Osi_Pharmaceuticals>,
        <https://1145.am/db/2358877/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359266/D-Pharm>,
        <https://1145.am/db/2359401/Scpharmaceuticals_Inc>,
        <https://1145.am/db/2359438/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2359474/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359668/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2359882/Biotie>,
        <https://1145.am/db/2359926/Entremed>,
        <https://1145.am/db/2360155/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2360489/Medac_Pharma>,
        <https://1145.am/db/2360588/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360697/Medgenics>,
        <https://1145.am/db/2360739/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2360945/Entremed>,
        <https://1145.am/db/2361244/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2361516/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362456/Action_Pharma_A_S>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2362593/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363186/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363285/Phenex_Pharmaceuticals_Ag>,
        <https://1145.am/db/2363340/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363387/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2363425/The_Medicines_Company>,
        <https://1145.am/db/2363433/The_Medicines_Company>,
        <https://1145.am/db/2363452/Pharmasum_Therapeutics_As>,
        <https://1145.am/db/2363530/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2363955/Savient_Pharmaceuticals>,
        <https://1145.am/db/2364093/Biotie>,
        <https://1145.am/db/2364252/Nps_Pharmaceuticals>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364276/S_*_Bio>,
        <https://1145.am/db/2364494/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2364495/Bioalliance_Pharma>,
        <https://1145.am/db/2364538/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2364541/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2364585/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364593/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364601/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364774/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364884/Entremed_Inc>,
        <https://1145.am/db/2365030/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2365098/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365224/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2365423/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2365724/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365763/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2366139/Prism_Pharmaceuticals>,
        <https://1145.am/db/2366388/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366521/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367021/Biotie>,
        <https://1145.am/db/2367070/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2367280/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2367438/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2367483/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367496/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367951/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2367962/Catalyst_Pharmaceuticals>,
        <https://1145.am/db/2368070/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2368339/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2368420/Intec_Pharma>,
        <https://1145.am/db/2368593/Bioquiddity_Incorporated>,
        <https://1145.am/db/2368632/Pharmacyclics>,
        <https://1145.am/db/2368739/Novartis_Pharmaceuticals>,
        <https://1145.am/db/2368826/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369004/Biogen>,
        <https://1145.am/db/2369037/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369144/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369233/Biopharmx_Corporation>,
        <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2369812/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2369931/Biogen>,
        <https://1145.am/db/2370022/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2370078/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2370082/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2370089/Abide_Therapeutics>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370637/Medgenics_Inc>,
        <https://1145.am/db/2370797/Pharmanest>,
        <https://1145.am/db/2370798/Pharmalink_Ab>,
        <https://1145.am/db/2370946/Biogen>,
        <https://1145.am/db/2371015/M_Pharma>,
        <https://1145.am/db/2371016/M_Pharma>,
        <https://1145.am/db/2371279/Biomunex_Pharmaceuticals>,
        <https://1145.am/db/2371491/Biopharmx_Corporation>,
        <https://1145.am/db/2536754/Oramed_Pharma>,
        <https://1145.am/db/2536756/Zao>,
        <https://1145.am/db/2537468/Pharmascience_Inc>,
        <https://1145.am/db/2538171/Biomeda_Group>,
        <https://1145.am/db/2538567/Upm_Pharmaceuticals>,
        <https://1145.am/db/2538861/Par_Pharmaceuticals>,
        <https://1145.am/db/2538901/The_Harvard_Drug_Group>,
        <https://1145.am/db/2539516/Par_Pharmaceuticals>,
        <https://1145.am/db/2539568/Zao>,
        <https://1145.am/db/2540193/Pharmanest>,
        <https://1145.am/db/2540449/Biocon>,
        <https://1145.am/db/2540951/Rytary>,
        <https://1145.am/db/2541039/Elan_Pharmaceuticals>,
        <https://1145.am/db/2541239/Pharmstar>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541717/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2541810/British_Pharma>,
        <https://1145.am/db/2542218/Pharmacyclics>,
        <https://1145.am/db/2543839/British_Pharma>,
        <https://1145.am/db/2544111/Unique_Pharmaceuticals>,
        <https://1145.am/db/2544358/Mundipharma>,
        <https://1145.am/db/2544596/Polpharma>,
        <https://1145.am/db/2544679/Neopharma>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2545143/Mundipharma>,
        <https://1145.am/db/2545411/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2546441/Intas_Pharmaceuticals>,
        <https://1145.am/db/2546529/Pharma_Tech_Industries>,
        <https://1145.am/db/2546629/Par_Pharmaceutical>,
        <https://1145.am/db/2547189/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2548585/Par_Pharmaceuticals>,
        <https://1145.am/db/2548674/Sopharma>,
        <https://1145.am/db/2549477/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2549520/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2549919/Pharmathen>,
        <https://1145.am/db/2550212/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2550471/Pharmaform>,
        <https://1145.am/db/2550523/Pharmaron>,
        <https://1145.am/db/2550685/Upm_Pharmaceuticals>,
        <https://1145.am/db/2551427/Pharmablock_Sciences>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552169/Alembic_Pharmaceuticals>,
        <https://1145.am/db/2552465/Medis>,
        <https://1145.am/db/2552641/Plethico_Pharmaceuticals>,
        <https://1145.am/db/2552642/Mankind_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2552794/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553276/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553512/Pharmax_Pharmaceuticals>,
        <https://1145.am/db/2553708/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2554237/Intas_Pharmaceuticals>,
        <https://1145.am/db/2554810/Continuus_Pharmaceuticals>,
        <https://1145.am/db/2554814/Globalpharma>,
        <https://1145.am/db/2554858/Medicure_Usa_Inc>,
        <https://1145.am/db/2555338/Pharmacore>,
        <https://1145.am/db/2555890/Pharmalucence>,
        <https://1145.am/db/2555896/Pharmalucence>,
        <https://1145.am/db/2556805/Medicis_Pharmaceuticals>,
        <https://1145.am/db/2557303/Pharmaron>,
        <https://1145.am/db/2557538/Neopharma>,
        <https://1145.am/db/2558025/Pharmaxis>,
        <https://1145.am/db/2558026/Pharmaxis>,
        <https://1145.am/db/2558970/Biostar_Pharmaceuticals>,
        <https://1145.am/db/2559783/Polpharma>,
        <https://1145.am/db/2560083/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561100/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561312/Oxford_Pharmaceuticals>,
        <https://1145.am/db/2561438/Pharmacia___Upjohn>,
        <https://1145.am/db/2561978/Biomarin_Pharmaceuticals>,
        <https://1145.am/db/2562199/Novartis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562500/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2563255/Active_Pharmaceutical_Ingredients>,
        <https://1145.am/db/2563497/Creo_Pharmaceuticals>,
        <https://1145.am/db/2563497/Polpharma>,
        <https://1145.am/db/2564196/Pharmaron>,
        <https://1145.am/db/2564713/C2_Pharma>,
        <https://1145.am/db/2567007/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2567055/Sovereign_Pharmaceuticals>,
        <https://1145.am/db/2567283/The_Pharma_Giant>,
        <https://1145.am/db/2567438/Biogen>,
        <https://1145.am/db/2567651/Indivior>,
        <https://1145.am/db/2567651/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2568205/Biogen>,
        <https://1145.am/db/2568375/Biogen>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569187/Pharmacyclics>,
        <https://1145.am/db/2569370/Co>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569729/The_Medicines_Company>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570068/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2570289/Pharmacyclics>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570449/Biocon>,
        <https://1145.am/db/2570741/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570807/Pharmacyclics>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2572200/The_Medicines_Company>,
        <https://1145.am/db/2572870/Hi-Tech_Pharmaceuticals>,
        <https://1145.am/db/2573057/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2573058/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2573147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2573271/Physician_Therapeutics>,
        <https://1145.am/db/2573391/Url_Pharma>,
        <https://1145.am/db/2573392/Url_Pharma>,
        <https://1145.am/db/2573887/Biogen>,
        <https://1145.am/db/2574679/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2574891/Pharmacyclics>,
        <https://1145.am/db/2575222/Map_Pharmaceuticals>,
        <https://1145.am/db/2575242/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2575462/Paras_Pharmaceuticals>,
        <https://1145.am/db/2575623/Inova_Pharmaceuticals>,
        <https://1145.am/db/2576205/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2577145/Medicis_Pharmaceutical>,
        <https://1145.am/db/2577259/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals>,
        <https://1145.am/db/2577675/Biogen>,
        <https://1145.am/db/2577684/Biogen>,
        <https://1145.am/db/2577894/Huvepharma_Ad>,
        <https://1145.am/db/2577934/Pharmascience>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578319/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2578473/Aa_Pharma>,
        <https://1145.am/db/2578481/Aa_Pharma_Inc>,
        <https://1145.am/db/2579147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2579211/Eusa_Pharma>,
        <https://1145.am/db/2579538/Pharmaforce>,
        <https://1145.am/db/2580123/Savient_Pharmaceuticals>,
        <https://1145.am/db/2580479/Pharmaxis>,
        <https://1145.am/db/2581225/Inova_Pharmaceuticals>,
        <https://1145.am/db/2582110/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582153/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2582174/Pharmasset>,
        <https://1145.am/db/2582320/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2583013/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583022/Url_Pharma>,
        <https://1145.am/db/2583220/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2583270/Pharmaswiss>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583402/Osi_Pharmaceuticals>,
        <https://1145.am/db/2583414/Polpharma>,
        <https://1145.am/db/2583769/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2584209/Pharmaswiss_Sa>,
        <https://1145.am/db/2584226/Pharmaswiss_Sa>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2585281/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2585887/Pharma_Inc>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587155/Millennium_Pharma>,
        <https://1145.am/db/2587616/Pharmaq>,
        <https://1145.am/db/2587696/R-Pharm>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588718/Pharmacyclics>,
        <https://1145.am/db/2588884/Map_Pharmaceuticals>,
        <https://1145.am/db/2589884/Map_Pharmaceuticals>,
        <https://1145.am/db/2590159/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2590195/Pro-Tect_Pharmaceuticals>,
        <https://1145.am/db/2590409/Biogen>,
        <https://1145.am/db/2590910/Savient_Pharmaceuticals>,
        <https://1145.am/db/2591690/Medicis_Pharmaceutical>,
        <https://1145.am/db/2591938/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2593142/Access_Pharmaceuticals>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594042/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594116/Pharmerica>,
        <https://1145.am/db/2594602/Osi_Pharma>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2595190/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595210/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595413/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596307/Savient_Pharmaceuticals>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596369/Pharmadeals_Ltd>,
        <https://1145.am/db/2596818/Pharmasset>,
        <https://1145.am/db/2597158/Nps_Pharmaceuticals>,
        <https://1145.am/db/2597180/Prism_Pharmaceuticals>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2597935/Osi_Pharmaceuticals>,
        <https://1145.am/db/2598027/Nps_Pharmaceuticals>,
        <https://1145.am/db/2598099/Paras_Pharmaceuticals>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598195/Pharmatech>,
        <https://1145.am/db/2598605/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2765310/Biogen>,
        <https://1145.am/db/281576/Mymd_Pharmaceuticals>,
        <https://1145.am/db/307255/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/324642/Mundipharma>,
        <https://1145.am/db/367137/Biomat>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/380389/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/407888/Quoin_Pharmaceuticals>,
        <https://1145.am/db/410129/Catalyst_Pharmaceuticals_Inc>,
        <https://1145.am/db/427157/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/431169/Pharmablock>,
        <https://1145.am/db/4491/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/452957/Aerie_Pharmaceuticals>,
        <https://1145.am/db/468221/Aerie_Pharmaceuticals>,
        <https://1145.am/db/481129/Biocon_Ltd>,
        <https://1145.am/db/485351/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/486302/Phathom_Pharmaceuticals>,
        <https://1145.am/db/487010/Scipher_Medicine>,
        <https://1145.am/db/488564/Aerie_Pharmaceuticals>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/538112/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/545583/Citius_Pharmaceuticals>,
        <https://1145.am/db/546391/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/567789/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/585607/Am-Pharma>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/662016/Prestige_Biopharma_Limited>,
        <https://1145.am/db/668495/Scipher_Medicine>,
        <https://1145.am/db/669775/Scipher_Medicine>,
        <https://1145.am/db/693128/Ascensus_Specialties>,
        <https://1145.am/db/700482/Novartis_Pharmaceuticals>,
        <https://1145.am/db/712037/Amunix_Pharmaceuticals>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/713105/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/713736/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/714923/Betterlife_Pharma_Inc>,
        <https://1145.am/db/715385/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/718008/Pharnext_Sa>,
        <https://1145.am/db/723883/Mymd_Pharmaceuticals>,
        <https://1145.am/db/724999/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/734669/Escient_Pharmaceuticals>,
        <https://1145.am/db/742794/Hr_Pharmaceuticals_Inc>,
        <https://1145.am/db/771062/Gw_Pharmaceuticals>,
        <https://1145.am/db/793071/Biogen_Inc>,
        <https://1145.am/db/835485/Pharmaessentia_Corporation>,
        <https://1145.am/db/854026/Aerie_Pharmaceuticals>,
        <https://1145.am/db/883896/Biontech>,
        <https://1145.am/db/884665/Pharmaceutical_Institute>,
        <https://1145.am/db/887575/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/889331/Tha_Pharma>,
        <https://1145.am/db/912469/Aerie_Pharmaceuticals>,
        <https://1145.am/db/913730/Aerie_Pharmaceuticals>,
        <https://1145.am/db/922740/Grand_Pharma>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/771669/Polpharma>,
        <https://1145.am/db/771701/Polpharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2598807/Megapaths_Nextweb> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "NextWeb is a subsidiary of MegaPath, a company that provides Internet services" ;
    ns1:documentDate "2011-04-04T15:42:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TelePacific finishes acquisition of Covad's wireless unit" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/telepacific-finishes-acquisition-covad-s-wireless-unit> ;
    ns1:foundName "MegaPath" ;
    ns1:industry "telecom service provider" ;
    ns1:name "MegaPath's NextWeb" ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2601480/Bahamas_Telecommunications_Company> a org:Organization ;
    ns1:basedInHighGeoName "Commonwealth of The Bahamas" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3572887/about.rdf> ;
    ns1:basedInHighRaw "Bahamas" ;
    ns1:basedInLowRaw "Bermuda" ;
    ns1:description "business" ;
    ns1:documentDate "2011-04-09T18:34:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cable & Wireless completes acquisition of stake in the Bahamas Telecom Company" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/cable-wireless-completes-acquisition-stake-bahamas-telecom-company> ;
    ns1:foundName "Bahamas Telecom Company",
        "the Bahamas Telecommunications Company" ;
    ns1:name "Bahamas Telecommunications",
        "Bahamas Telecommunications Company" ;
    ns1:sameAsHigh <https://1145.am/db/2614188/Bahamas_Telecommunications>,
        <https://1145.am/db/2617934/The_Bahamas_Telecommunications_Company> ;
    ns1:sameAsMedium <https://1145.am/db/2618630/Bahamas_Telecom_Company>,
        <https://1145.am/db/2618630/The_Bahamas_Telecommunications_Company>,
        <https://1145.am/db/2619256/Bahamas_Telecommunications> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2602193/Alog_Data_Centers_Major_Stake_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-04-27T11:10:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Equinix (Nasdaq: EQIX) , together with private equity partner Riverwood Capital, has completed its acquisition of a major stake in Brazil - based ALOG Data Centers.",
        "Equinix targets Latin America by purchasing piece of Brazil - based ALOG." ;
    ns1:documentTitle "Equinix gains instant Latin American presence by completing its ALOG acquisition" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/equinix-gains-instant-latin-american-presence-by-completing-its-alog-acquisition> ;
    ns1:foundName "acquisition",
        "purchasing" ;
    ns1:name "acquisition",
        "purchasing" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2602193/Alog_Data_Centers> ;
    ns1:targetDetails "major stake" ;
    ns1:targetName "ALOG",
        "ALOG Data Centers" ;
    ns1:valueRaw "about $ 15 million",
        "about $ 68 million",
        "about $ 83 million" ;
    ns1:whereGeoName "Federative Republic of Brazil" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:whereRaw "Brazil" .

<https://1145.am/db/2618630/Bahamas_Telecom_Company> a org:Organization ;
    ns1:basedInHighGeoName "Commonwealth of The Bahamas" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3572887/about.rdf> ;
    ns1:basedInHighRaw "Bahamas." ;
    ns1:documentDate "2011-02-23T15:46:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cable & Wireless to sell off its Bermuda business" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/cable-wireless-to-sell-off-its-bermuda-business> ;
    ns1:foundName "Bahamas Telecom Company" ;
    ns1:name "Bahamas Telecom Company" ;
    ns1:sameAsMedium <https://1145.am/db/2601480/Bahamas_Telecommunications_Company>,
        <https://1145.am/db/2614188/Bahamas_Telecommunications>,
        <https://1145.am/db/2617934/The_Bahamas_Telecommunications_Company>,
        <https://1145.am/db/2618630/The_Bahamas_Telecommunications_Company>,
        <https://1145.am/db/2619256/Bahamas_Telecommunications> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2618630/The_Bahamas_Telecommunications_Company> a org:Organization ;
    ns1:basedInLowRaw "Bahamas" ;
    ns1:documentDate "2011-02-23T15:46:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cable & Wireless to sell off its Bermuda business" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/cable-wireless-to-sell-off-its-bermuda-business> ;
    ns1:foundName "The Bahamas Telecommunications Company" ;
    ns1:industry "telco and cable operator" ;
    ns1:name "The Bahamas Telecommunications Company" ;
    ns1:sameAsMedium <https://1145.am/db/2601480/Bahamas_Telecommunications_Company>,
        <https://1145.am/db/2614188/Bahamas_Telecommunications>,
        <https://1145.am/db/2617934/The_Bahamas_Telecommunications_Company>,
        <https://1145.am/db/2618630/Bahamas_Telecom_Company>,
        <https://1145.am/db/2619256/Bahamas_Telecommunications> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2618630/The_Bahamas_Telecommunications_Company_Operations_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-02-23T15:46:52+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cable & Wireless (LSE: CW.L) has decided that it needs to realign its Caribbean operations, so it's selling off its Bermuda operations to Canadian - based telco and cable operator Bragg Group.",
        "Cable & Wireless formalizes purchase of Bahamas Telecom Company." ;
    ns1:documentTitle "Cable & Wireless to sell off its Bermuda business" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/cable-wireless-to-sell-off-its-bermuda-business> ;
    ns1:foundName "bid",
        "purchase",
        "selling off" ;
    ns1:name "bid",
        "purchase",
        "selling off" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "has not happened",
        "stopped" ;
    ns1:target <https://1145.am/db/2618630/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2618630/The_Bahamas_Telecommunications_Company> ;
    ns1:targetDetails "operations",
        "stake" ;
    ns1:targetName "Cable & Wireless Worldwide",
        "The Bahamas Telecommunications Company" ;
    ns1:valueRaw "$ 70 million" ;
    ns1:vendor <https://1145.am/db/2618630/Cable___Wireless_Worldwide> ;
    ns1:whereGeoName "Commonwealth of The Bahamas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3572887/about.rdf> ;
    ns1:whereRaw "Bahamas" .

<https://1145.am/db/2655543/Megalan_Network_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-02-07T01:09:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Telekom Austria has moved a step closer to tapping into growing demand for broadband services in Bulgaria, completing its acquisition of fixed-line operator Megalan Network.",
        "Telekom Austria revealed in September it would spend up to 72 million to acquire Megalan and Spectrum Net as it seeks to tap into predicted growth in fixed broadband, IPTV and convergent products in the country.",
        "The operator's local subsidiary Mobitel acquired 80 % of Megalan Network late last week, and will acquire the remaining 20 % of the firm by end March 2012." ;
    ns1:documentTitle "Telekom Austria completes Bulgaria buys" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/telekom-austria-completes-bulgaria-buys> ;
    ns1:foundName "acquire",
        "acquired",
        "acquisition" ;
    ns1:name "acquire",
        "acquired",
        "acquisition" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2655543/Megalan_Network> ;
    ns1:targetName "Megalan",
        "Megalan Network" ;
    ns1:valueRaw "up to 72 million" ;
    ns1:whereGeoName "Republic of Bulgaria" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/732800/about.rdf> ;
    ns1:whereRaw "Bulgaria" .

<https://1145.am/db/2685508/Nokia_Siemens_Networks> a org:Organization ;
    ns1:basedInLowRaw "Finland" ;
    ns1:description "Nokia Siemens Networks",
        "infrastructure" ;
    ns1:documentDate "2011-04-14T14:42:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Nokia, Siemens mull selling controlling stake in NSN" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-nokia-siemens-mull-selling-controlling-stake-nsn> ;
    ns1:foundName "Nokia",
        "Nokia Siemens Networks" ;
    ns1:name "Nokia",
        "Nokia Siemens Networks" ;
    ns1:sameAsHigh <https://1145.am/db/1714727/Nokia_Corp>,
        <https://1145.am/db/1717164/Nokia_Siemens>,
        <https://1145.am/db/1867044/Nokia_Siemens_Networks>,
        <https://1145.am/db/1906036/Nokia>,
        <https://1145.am/db/2599088/Nokia>,
        <https://1145.am/db/2600870/Nokia>,
        <https://1145.am/db/2604506/Nokia_Siemens_Networks>,
        <https://1145.am/db/2604506/Siemens>,
        <https://1145.am/db/2604853/Nokia_Siemens_Networks>,
        <https://1145.am/db/2606778/Nokia_Siemens_Networks>,
        <https://1145.am/db/2611268/Nokia_Siemens_Networks>,
        <https://1145.am/db/2611289/Nokia_Siemens_Networks>,
        <https://1145.am/db/2614782/Nokia>,
        <https://1145.am/db/2618843/Nokia_Siemens_Networks>,
        <https://1145.am/db/2619160/Nokia_Siemens_Networks>,
        <https://1145.am/db/2621187/Nokia>,
        <https://1145.am/db/2622268/Nokia_Siemens_Networks>,
        <https://1145.am/db/2624696/Nokia>,
        <https://1145.am/db/2629903/Nokia_Siemens_Networks>,
        <https://1145.am/db/2631730/Nokia_Siemens_Networks>,
        <https://1145.am/db/2635003/Nokia>,
        <https://1145.am/db/2637962/Nokia_Siemens_Networks>,
        <https://1145.am/db/2638937/Nokia_Siemens_Networks>,
        <https://1145.am/db/2638938/Nokia_Siemens_Networks>,
        <https://1145.am/db/2639419/Nokia_Siemens_Networks>,
        <https://1145.am/db/2643132/Nokia_Siemens_Networks>,
        <https://1145.am/db/2643438/Nokia_Siemens_Networks>,
        <https://1145.am/db/2647330/Nokia_Siemens>,
        <https://1145.am/db/2648177/Nokia_Siemens_Networks>,
        <https://1145.am/db/2651254/Nokia_Siemens>,
        <https://1145.am/db/2651364/Nokia_Networks>,
        <https://1145.am/db/2651897/Nokia_Solutions_And_Networks>,
        <https://1145.am/db/2653481/Nokia_Solutions_And_Networks>,
        <https://1145.am/db/2654614/Nokia_Siemens_Networks>,
        <https://1145.am/db/2654922/Nokia_Siemens_Networks>,
        <https://1145.am/db/2656598/Nokia_Siemens_Networks>,
        <https://1145.am/db/2656673/Nokia_Siemens_Networks>,
        <https://1145.am/db/2656920/Nokia>,
        <https://1145.am/db/2658913/Nokia>,
        <https://1145.am/db/2659204/Nokia_Siemens_Networks>,
        <https://1145.am/db/2660228/Nokia_Siemens_Networks>,
        <https://1145.am/db/2660256/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662032/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662041/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662048/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662061/Nokia_Solutions_And_Networks>,
        <https://1145.am/db/2662406/Nokia_Siemens_Networks>,
        <https://1145.am/db/2663837/Nokia_Siemens>,
        <https://1145.am/db/2665681/Nokia_Siemens_Networks>,
        <https://1145.am/db/2670700/Nokia_Siemens_Networks>,
        <https://1145.am/db/2672328/Nokia>,
        <https://1145.am/db/2672497/Nokia_Siemens_Networks>,
        <https://1145.am/db/2672581/Nokia_Siemens_Networks>,
        <https://1145.am/db/2672582/Nokia_Siemens_Networks>,
        <https://1145.am/db/2673516/Nokia>,
        <https://1145.am/db/2673703/Nokia_Siemens_Networks>,
        <https://1145.am/db/2673792/Nokia_Siemens>,
        <https://1145.am/db/2674307/Nokia>,
        <https://1145.am/db/2674670/Nokia>,
        <https://1145.am/db/2676312/Nokia_Siemens_Networks>,
        <https://1145.am/db/2676415/Nokia_Siemens_Networks>,
        <https://1145.am/db/2677609/Nokia_Siemens_Networks>,
        <https://1145.am/db/2679325/Nokia_Siemens_Networks>,
        <https://1145.am/db/2680041/Nokia>,
        <https://1145.am/db/2680048/Nokia_Siemens_Networks>,
        <https://1145.am/db/2680713/Nokia_Siemens_Networks>,
        <https://1145.am/db/2683690/Nokia_Siemens_Networks>,
        <https://1145.am/db/2684551/Nokia_Siemens_Networks>,
        <https://1145.am/db/2685152/Nokia_Siemens>,
        <https://1145.am/db/2685812/Nokia_Siemens> ;
    ns1:sameAsMedium <https://1145.am/db/1865517/Nokia_Siemens_Networks>,
        <https://1145.am/db/1866965/Nokia_Siemens_Networks>,
        <https://1145.am/db/1893323/Nokia_Siemens_Networks>,
        <https://1145.am/db/2600044/Nokia_Siemens_Networks>,
        <https://1145.am/db/2604319/Nokia_Siemens_Networks>,
        <https://1145.am/db/2607155/Nokia_Siemens_Networks>,
        <https://1145.am/db/2607408/Nokia_Siemens_Networks>,
        <https://1145.am/db/2608234/Nokia_Siemens_Networks>,
        <https://1145.am/db/2608675/Nokia_Siemens_Networks>,
        <https://1145.am/db/2611280/Nokia_Siemens_Networks>,
        <https://1145.am/db/2612831/Nokia_Siemens_Networks>,
        <https://1145.am/db/2613146/Nokia_Siemens_Networks>,
        <https://1145.am/db/2613169/Nokia_Siemens_Networks>,
        <https://1145.am/db/2614294/Nokia_Siemens_Networks>,
        <https://1145.am/db/2615021/Nokia_Siemens_Networks>,
        <https://1145.am/db/2616502/Nokia_Siemens_Networks>,
        <https://1145.am/db/2616957/Nokia_Siemens_Networks>,
        <https://1145.am/db/2616995/Nokia_Siemens_Networks>,
        <https://1145.am/db/2617005/Nokia_Siemens_Networks>,
        <https://1145.am/db/2617493/Nokia_Siemens_Networks>,
        <https://1145.am/db/2617657/Nokia_Siemens_Networks>,
        <https://1145.am/db/2619460/Nokia_Siemens_Networks>,
        <https://1145.am/db/2619788/Nokia_Siemens_Networks>,
        <https://1145.am/db/2625103/Nokia_Siemens_Networks>,
        <https://1145.am/db/2625106/Nokia_Siemens_Networks>,
        <https://1145.am/db/2630841/Nokia_Siemens_Networks>,
        <https://1145.am/db/2635511/Nokia_Siemens_Networks>,
        <https://1145.am/db/2635545/Nokia_Siemens_Networks>,
        <https://1145.am/db/2636044/Nokia_Siemens_Networks>,
        <https://1145.am/db/2636463/Nokia_Siemens_Networks>,
        <https://1145.am/db/2639425/Nokia_Siemens_Networks>,
        <https://1145.am/db/2640432/Nokia_Siemens_Networks>,
        <https://1145.am/db/2642116/Nokia_Siemens_Networks>,
        <https://1145.am/db/2647326/Nokia_Siemens_Networks>,
        <https://1145.am/db/2648187/Nokia_Siemens_Networks>,
        <https://1145.am/db/2650490/Nokia_Siemens_Networks>,
        <https://1145.am/db/2651649/Nokia_Siemens_Networks>,
        <https://1145.am/db/2651664/Nokia_Siemens_Networks>,
        <https://1145.am/db/2651668/Nokia_Siemens_Networks>,
        <https://1145.am/db/2652178/Nokia_Siemens_Networks>,
        <https://1145.am/db/2652962/Nokia_Siemens_Networks>,
        <https://1145.am/db/2653862/Nokia_Siemens_Networks>,
        <https://1145.am/db/2654893/Nokia_Siemens_Networks>,
        <https://1145.am/db/2657431/Nokia_Siemens_Networks>,
        <https://1145.am/db/2657486/Nokia_Siemens_Networks>,
        <https://1145.am/db/2657523/Nokia_Siemens_Networks>,
        <https://1145.am/db/2659506/Nokia_Siemens_Networks>,
        <https://1145.am/db/2659682/Nokia_Siemens_Networks>,
        <https://1145.am/db/2660248/Nokia_Siemens_Networks>,
        <https://1145.am/db/2660261/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662059/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662625/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662689/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662865/Nokia_Siemens_Networks>,
        <https://1145.am/db/2663834/Nokia_Siemens_Networks>,
        <https://1145.am/db/2664171/Nokia_Siemens_Networks>,
        <https://1145.am/db/2665073/Nokia_Siemens_Networks>,
        <https://1145.am/db/2665701/Nokia_Siemens_Networks>,
        <https://1145.am/db/2665980/Nokia_Siemens_Networks>,
        <https://1145.am/db/2666063/Nokia_Siemens_Networks>,
        <https://1145.am/db/2666090/Nokia_Siemens_Networks>,
        <https://1145.am/db/2666165/Nokia_Siemens_Networks>,
        <https://1145.am/db/2666167/Nokia_Siemens_Networks>,
        <https://1145.am/db/2666782/Nokia_Siemens_Networks>,
        <https://1145.am/db/2667192/Nokia_Siemens_Networks>,
        <https://1145.am/db/2668320/Nokia_Siemens_Networks>,
        <https://1145.am/db/2668329/Nokia_Siemens_Networks>,
        <https://1145.am/db/2668820/Nokia_Siemens_Networks>,
        <https://1145.am/db/2669368/Nokia_Siemens_Networks>,
        <https://1145.am/db/2670327/Nokia_Siemens_Networks>,
        <https://1145.am/db/2672513/Nokia_Siemens_Networks>,
        <https://1145.am/db/2673757/Nokia_Siemens_Networks>,
        <https://1145.am/db/2674536/Nokia_Siemens_Networks>,
        <https://1145.am/db/2674934/Nokia_Siemens_Networks>,
        <https://1145.am/db/2674950/Nokia_Siemens_Networks>,
        <https://1145.am/db/2675256/Nokia_Siemens_Networks>,
        <https://1145.am/db/2675276/Nokia_Siemens_Networks>,
        <https://1145.am/db/2676115/Nokia_Siemens_Networks>,
        <https://1145.am/db/2677266/Nokia_Siemens_Networks>,
        <https://1145.am/db/2677518/Nokia_Siemens_Networks>,
        <https://1145.am/db/2678837/Nokia_Siemens_Networks>,
        <https://1145.am/db/2679545/Nokia_Siemens_Networks>,
        <https://1145.am/db/2679741/Nokia_Siemens_Networks>,
        <https://1145.am/db/2679877/Nokia_Siemens_Networks>,
        <https://1145.am/db/2680720/Nokia_Siemens_Networks>,
        <https://1145.am/db/2682371/Nokia_Siemens_Networks>,
        <https://1145.am/db/2685124/Nokia_Siemens_Networks>,
        <https://1145.am/db/2685394/Nokia_Siemens_Networks>,
        <https://1145.am/db/2685558/Nokia_Siemens_Networks>,
        <https://1145.am/db/2686194/Nokia_Siemens_Networks> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2685508/Siemens> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:documentDate "2011-04-14T14:42:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Nokia, Siemens mull selling controlling stake in NSN" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-nokia-siemens-mull-selling-controlling-stake-nsn> ;
    ns1:foundName "Siemens" ;
    ns1:name "Siemens" ;
    ns1:sameAsMedium <https://1145.am/db/1075888/Siemens>,
        <https://1145.am/db/1165094/Siemens>,
        <https://1145.am/db/1166647/Siemens>,
        <https://1145.am/db/1166933/Siemens_Ag>,
        <https://1145.am/db/132708/Siemens>,
        <https://1145.am/db/1467416/Siemens>,
        <https://1145.am/db/1681794/Siemens>,
        <https://1145.am/db/1689000/Siemens_Ag>,
        <https://1145.am/db/1703564/Siemens>,
        <https://1145.am/db/1715713/Siemens>,
        <https://1145.am/db/1738976/Siemens>,
        <https://1145.am/db/1752181/Siemens>,
        <https://1145.am/db/1771078/Siemens>,
        <https://1145.am/db/1771396/Siemens>,
        <https://1145.am/db/1776036/Siemens>,
        <https://1145.am/db/1857982/Siemens>,
        <https://1145.am/db/1872498/Siemens>,
        <https://1145.am/db/1928635/Siemens_Ag>,
        <https://1145.am/db/1930723/Siemens_Ag>,
        <https://1145.am/db/2036828/Siemens>,
        <https://1145.am/db/2210167/Siemens>,
        <https://1145.am/db/2213344/Siemens>,
        <https://1145.am/db/2220921/Siemens>,
        <https://1145.am/db/2222399/Siemens>,
        <https://1145.am/db/2226763/Siemens>,
        <https://1145.am/db/2247513/Siemens>,
        <https://1145.am/db/2287784/Siemens>,
        <https://1145.am/db/228811/Siemens>,
        <https://1145.am/db/2289427/Siemens>,
        <https://1145.am/db/2290671/Siemens>,
        <https://1145.am/db/2293219/Siemens>,
        <https://1145.am/db/2293973/Siemens>,
        <https://1145.am/db/2294479/Siemens>,
        <https://1145.am/db/2296530/Siemens>,
        <https://1145.am/db/2297769/Siemens>,
        <https://1145.am/db/2298756/Siemens>,
        <https://1145.am/db/2298848/Siemens>,
        <https://1145.am/db/2301652/Siemens>,
        <https://1145.am/db/2310148/Siemens>,
        <https://1145.am/db/2310168/Siemens>,
        <https://1145.am/db/2343808/Siemens>,
        <https://1145.am/db/2454110/Siemens>,
        <https://1145.am/db/2602219/Siemens>,
        <https://1145.am/db/2604506/Siemens>,
        <https://1145.am/db/2612583/Siemens>,
        <https://1145.am/db/2623455/Siemens>,
        <https://1145.am/db/2624733/Siemens>,
        <https://1145.am/db/2627938/Siemens>,
        <https://1145.am/db/2637775/Siemens>,
        <https://1145.am/db/2647326/Siemens>,
        <https://1145.am/db/2651127/Siemens>,
        <https://1145.am/db/2651897/Siemens>,
        <https://1145.am/db/2657363/Siemens>,
        <https://1145.am/db/2667192/Siemens>,
        <https://1145.am/db/2676115/Siemens>,
        <https://1145.am/db/2677518/Siemens>,
        <https://1145.am/db/2679119/Siemens>,
        <https://1145.am/db/2679877/Siemens>,
        <https://1145.am/db/2680041/Siemens>,
        <https://1145.am/db/2680048/Siemens>,
        <https://1145.am/db/2680066/Siemens>,
        <https://1145.am/db/2681746/Siemens>,
        <https://1145.am/db/2682593/Siemens>,
        <https://1145.am/db/2683272/Siemens>,
        <https://1145.am/db/2683690/Siemens>,
        <https://1145.am/db/2686194/Siemens>,
        <https://1145.am/db/2786046/Siemens_Ag>,
        <https://1145.am/db/2786046/Siemens_Ltd>,
        <https://1145.am/db/2792945/Siemens>,
        <https://1145.am/db/2793288/Siemens>,
        <https://1145.am/db/2796865/Siemens_Ag>,
        <https://1145.am/db/2796865/Siemens_Ltd>,
        <https://1145.am/db/334937/Siemens>,
        <https://1145.am/db/336095/Siemens_Ag>,
        <https://1145.am/db/553007/Siemens>,
        <https://1145.am/db/767649/Siemens>,
        <https://1145.am/db/817821/Siemens>,
        <https://1145.am/db/820046/Siemens>,
        <https://1145.am/db/820051/Siemens> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2685799/T-Mobile_Usa_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-05-17T14:26:45+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Executives from flat-rate carriers MetroPCS (NASDAQ: PCS) and Leap Wireless (NASDAQ: LEAP) each said they would consider buying spectrum and other network assets that AT & T (NYSE: T) might be forced to divest as a condition on its proposed $ 39 billion acquisition of T-Mobile USA." ;
    ns1:documentTitle "MetroPCS, Leap open to scooping up divested AT&T/T-Mobile assets" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/metropcs-leap-open-to-scooping-up-divested-at-t-t-mobile-assets> ;
    ns1:foundName "acquisition",
        "buying" ;
    ns1:name "acquisition",
        "buying" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2685799/T-Mobile_Usa> ;
    ns1:targetName "T-Mobile USA" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "USA" .

<https://1145.am/db/2686194/Nokia_Siemens_Networks> a org:Organization ;
    ns1:basedInLowRaw "Finland",
        "Germany" ;
    ns1:description "Nokia spokesman James Etheridge" ;
    ns1:documentDate "2011-06-27T14:29:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Nokia, Siemens abandon private equity push for NSN" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-nokia-siemens-abandon-private-equity-push-for-nsn> ;
    ns1:foundName "Nokia",
        "Nokia Siemens Networks" ;
    ns1:name "Nokia",
        "Nokia Siemens Networks" ;
    ns1:sameAsMedium <https://1145.am/db/1865517/Nokia_Siemens_Networks>,
        <https://1145.am/db/1866965/Nokia_Siemens_Networks>,
        <https://1145.am/db/1867044/Nokia_Siemens_Networks>,
        <https://1145.am/db/1893323/Nokia_Siemens_Networks>,
        <https://1145.am/db/2600044/Nokia_Siemens_Networks>,
        <https://1145.am/db/2604319/Nokia_Siemens_Networks>,
        <https://1145.am/db/2604506/Nokia_Siemens_Networks>,
        <https://1145.am/db/2604853/Nokia_Siemens_Networks>,
        <https://1145.am/db/2606778/Nokia_Siemens_Networks>,
        <https://1145.am/db/2607155/Nokia_Siemens_Networks>,
        <https://1145.am/db/2607408/Nokia_Siemens_Networks>,
        <https://1145.am/db/2608234/Nokia_Siemens_Networks>,
        <https://1145.am/db/2608675/Nokia_Siemens_Networks>,
        <https://1145.am/db/2611268/Nokia_Siemens_Networks>,
        <https://1145.am/db/2611280/Nokia_Siemens_Networks>,
        <https://1145.am/db/2611289/Nokia_Siemens_Networks>,
        <https://1145.am/db/2612831/Nokia_Siemens_Networks>,
        <https://1145.am/db/2613146/Nokia_Siemens_Networks>,
        <https://1145.am/db/2613169/Nokia_Siemens_Networks>,
        <https://1145.am/db/2614294/Nokia_Siemens_Networks>,
        <https://1145.am/db/2615021/Nokia_Siemens_Networks>,
        <https://1145.am/db/2616502/Nokia_Siemens_Networks>,
        <https://1145.am/db/2616957/Nokia_Siemens_Networks>,
        <https://1145.am/db/2616995/Nokia_Siemens_Networks>,
        <https://1145.am/db/2617005/Nokia_Siemens_Networks>,
        <https://1145.am/db/2617493/Nokia_Siemens_Networks>,
        <https://1145.am/db/2617657/Nokia_Siemens_Networks>,
        <https://1145.am/db/2618843/Nokia_Siemens_Networks>,
        <https://1145.am/db/2619160/Nokia_Siemens_Networks>,
        <https://1145.am/db/2619460/Nokia_Siemens_Networks>,
        <https://1145.am/db/2619788/Nokia_Siemens_Networks>,
        <https://1145.am/db/2622268/Nokia_Siemens_Networks>,
        <https://1145.am/db/2625103/Nokia_Siemens_Networks>,
        <https://1145.am/db/2625106/Nokia_Siemens_Networks>,
        <https://1145.am/db/2629903/Nokia_Siemens_Networks>,
        <https://1145.am/db/2630841/Nokia_Siemens_Networks>,
        <https://1145.am/db/2631730/Nokia_Siemens_Networks>,
        <https://1145.am/db/2635511/Nokia_Siemens_Networks>,
        <https://1145.am/db/2635545/Nokia_Siemens_Networks>,
        <https://1145.am/db/2636044/Nokia_Siemens_Networks>,
        <https://1145.am/db/2636463/Nokia_Siemens_Networks>,
        <https://1145.am/db/2637962/Nokia_Siemens_Networks>,
        <https://1145.am/db/2638937/Nokia_Siemens_Networks>,
        <https://1145.am/db/2638938/Nokia_Siemens_Networks>,
        <https://1145.am/db/2639419/Nokia_Siemens_Networks>,
        <https://1145.am/db/2639425/Nokia_Siemens_Networks>,
        <https://1145.am/db/2640432/Nokia_Siemens_Networks>,
        <https://1145.am/db/2642116/Nokia_Siemens_Networks>,
        <https://1145.am/db/2643132/Nokia_Siemens_Networks>,
        <https://1145.am/db/2643438/Nokia_Siemens_Networks>,
        <https://1145.am/db/2647326/Nokia_Siemens_Networks>,
        <https://1145.am/db/2648177/Nokia_Siemens_Networks>,
        <https://1145.am/db/2648187/Nokia_Siemens_Networks>,
        <https://1145.am/db/2650490/Nokia_Siemens_Networks>,
        <https://1145.am/db/2651649/Nokia_Siemens_Networks>,
        <https://1145.am/db/2651664/Nokia_Siemens_Networks>,
        <https://1145.am/db/2651668/Nokia_Siemens_Networks>,
        <https://1145.am/db/2652178/Nokia_Siemens_Networks>,
        <https://1145.am/db/2652962/Nokia_Siemens_Networks>,
        <https://1145.am/db/2653862/Nokia_Siemens_Networks>,
        <https://1145.am/db/2654614/Nokia_Siemens_Networks>,
        <https://1145.am/db/2654893/Nokia_Siemens_Networks>,
        <https://1145.am/db/2654922/Nokia_Siemens_Networks>,
        <https://1145.am/db/2656598/Nokia_Siemens_Networks>,
        <https://1145.am/db/2656673/Nokia_Siemens_Networks>,
        <https://1145.am/db/2657431/Nokia_Siemens_Networks>,
        <https://1145.am/db/2657486/Nokia_Siemens_Networks>,
        <https://1145.am/db/2657523/Nokia_Siemens_Networks>,
        <https://1145.am/db/2659204/Nokia_Siemens_Networks>,
        <https://1145.am/db/2659506/Nokia_Siemens_Networks>,
        <https://1145.am/db/2659682/Nokia_Siemens_Networks>,
        <https://1145.am/db/2660228/Nokia_Siemens_Networks>,
        <https://1145.am/db/2660248/Nokia_Siemens_Networks>,
        <https://1145.am/db/2660256/Nokia_Siemens_Networks>,
        <https://1145.am/db/2660261/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662032/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662041/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662048/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662059/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662406/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662625/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662689/Nokia_Siemens_Networks>,
        <https://1145.am/db/2662865/Nokia_Siemens_Networks>,
        <https://1145.am/db/2663834/Nokia_Siemens_Networks>,
        <https://1145.am/db/2664171/Nokia_Siemens_Networks>,
        <https://1145.am/db/2665073/Nokia_Siemens_Networks>,
        <https://1145.am/db/2665681/Nokia_Siemens_Networks>,
        <https://1145.am/db/2665701/Nokia_Siemens_Networks>,
        <https://1145.am/db/2665980/Nokia_Siemens_Networks>,
        <https://1145.am/db/2666063/Nokia_Siemens_Networks>,
        <https://1145.am/db/2666090/Nokia_Siemens_Networks>,
        <https://1145.am/db/2666165/Nokia_Siemens_Networks>,
        <https://1145.am/db/2666167/Nokia_Siemens_Networks>,
        <https://1145.am/db/2666782/Nokia_Siemens_Networks>,
        <https://1145.am/db/2667192/Nokia_Siemens_Networks>,
        <https://1145.am/db/2668320/Nokia_Siemens_Networks>,
        <https://1145.am/db/2668329/Nokia_Siemens_Networks>,
        <https://1145.am/db/2668820/Nokia_Siemens_Networks>,
        <https://1145.am/db/2669368/Nokia_Siemens_Networks>,
        <https://1145.am/db/2670327/Nokia_Siemens_Networks>,
        <https://1145.am/db/2670700/Nokia_Siemens_Networks>,
        <https://1145.am/db/2672497/Nokia_Siemens_Networks>,
        <https://1145.am/db/2672513/Nokia_Siemens_Networks>,
        <https://1145.am/db/2672581/Nokia_Siemens_Networks>,
        <https://1145.am/db/2672582/Nokia_Siemens_Networks>,
        <https://1145.am/db/2673703/Nokia_Siemens_Networks>,
        <https://1145.am/db/2673757/Nokia_Siemens_Networks>,
        <https://1145.am/db/2674536/Nokia_Siemens_Networks>,
        <https://1145.am/db/2674934/Nokia_Siemens_Networks>,
        <https://1145.am/db/2674950/Nokia_Siemens_Networks>,
        <https://1145.am/db/2675256/Nokia_Siemens_Networks>,
        <https://1145.am/db/2675276/Nokia_Siemens_Networks>,
        <https://1145.am/db/2676115/Nokia_Siemens_Networks>,
        <https://1145.am/db/2676312/Nokia_Siemens_Networks>,
        <https://1145.am/db/2676415/Nokia_Siemens_Networks>,
        <https://1145.am/db/2677266/Nokia_Siemens_Networks>,
        <https://1145.am/db/2677518/Nokia_Siemens_Networks>,
        <https://1145.am/db/2677609/Nokia_Siemens_Networks>,
        <https://1145.am/db/2678837/Nokia_Siemens_Networks>,
        <https://1145.am/db/2679325/Nokia_Siemens_Networks>,
        <https://1145.am/db/2679545/Nokia_Siemens_Networks>,
        <https://1145.am/db/2679741/Nokia_Siemens_Networks>,
        <https://1145.am/db/2679877/Nokia_Siemens_Networks>,
        <https://1145.am/db/2680048/Nokia_Siemens_Networks>,
        <https://1145.am/db/2680713/Nokia_Siemens_Networks>,
        <https://1145.am/db/2680720/Nokia_Siemens_Networks>,
        <https://1145.am/db/2682371/Nokia_Siemens_Networks>,
        <https://1145.am/db/2683690/Nokia_Siemens_Networks>,
        <https://1145.am/db/2684551/Nokia_Siemens_Networks>,
        <https://1145.am/db/2685124/Nokia_Siemens_Networks>,
        <https://1145.am/db/2685394/Nokia_Siemens_Networks>,
        <https://1145.am/db/2685508/Nokia_Siemens_Networks>,
        <https://1145.am/db/2685558/Nokia_Siemens_Networks> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2686194/Siemens> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:description "private equity firms" ;
    ns1:documentDate "2011-06-27T14:29:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Nokia, Siemens abandon private equity push for NSN" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-nokia-siemens-abandon-private-equity-push-for-nsn> ;
    ns1:foundName "Siemens" ;
    ns1:name "Siemens" ;
    ns1:sameAsHigh <https://1145.am/db/2676115/Siemens> ;
    ns1:sameAsMedium <https://1145.am/db/1075888/Siemens>,
        <https://1145.am/db/1165094/Siemens>,
        <https://1145.am/db/1166647/Siemens>,
        <https://1145.am/db/1166933/Siemens_Ag>,
        <https://1145.am/db/132708/Siemens>,
        <https://1145.am/db/1467416/Siemens>,
        <https://1145.am/db/1681794/Siemens>,
        <https://1145.am/db/1689000/Siemens_Ag>,
        <https://1145.am/db/1703564/Siemens>,
        <https://1145.am/db/1715713/Siemens>,
        <https://1145.am/db/1738976/Siemens>,
        <https://1145.am/db/1752181/Siemens>,
        <https://1145.am/db/1771078/Siemens>,
        <https://1145.am/db/1771396/Siemens>,
        <https://1145.am/db/1776036/Siemens>,
        <https://1145.am/db/1857982/Siemens>,
        <https://1145.am/db/1872498/Siemens>,
        <https://1145.am/db/1928635/Siemens_Ag>,
        <https://1145.am/db/1930723/Siemens_Ag>,
        <https://1145.am/db/2036828/Siemens>,
        <https://1145.am/db/2210167/Siemens>,
        <https://1145.am/db/2213344/Siemens>,
        <https://1145.am/db/2220921/Siemens>,
        <https://1145.am/db/2222399/Siemens>,
        <https://1145.am/db/2226763/Siemens>,
        <https://1145.am/db/2247513/Siemens>,
        <https://1145.am/db/2287784/Siemens>,
        <https://1145.am/db/228811/Siemens>,
        <https://1145.am/db/2289427/Siemens>,
        <https://1145.am/db/2290671/Siemens>,
        <https://1145.am/db/2293219/Siemens>,
        <https://1145.am/db/2293973/Siemens>,
        <https://1145.am/db/2294479/Siemens>,
        <https://1145.am/db/2296530/Siemens>,
        <https://1145.am/db/2297769/Siemens>,
        <https://1145.am/db/2298756/Siemens>,
        <https://1145.am/db/2298848/Siemens>,
        <https://1145.am/db/2301652/Siemens>,
        <https://1145.am/db/2310148/Siemens>,
        <https://1145.am/db/2310168/Siemens>,
        <https://1145.am/db/2343808/Siemens>,
        <https://1145.am/db/2454110/Siemens>,
        <https://1145.am/db/2602219/Siemens>,
        <https://1145.am/db/2604506/Siemens>,
        <https://1145.am/db/2612583/Siemens>,
        <https://1145.am/db/2623455/Siemens>,
        <https://1145.am/db/2624733/Siemens>,
        <https://1145.am/db/2627938/Siemens>,
        <https://1145.am/db/2637775/Siemens>,
        <https://1145.am/db/2647326/Siemens>,
        <https://1145.am/db/2651127/Siemens>,
        <https://1145.am/db/2651897/Siemens>,
        <https://1145.am/db/2657363/Siemens>,
        <https://1145.am/db/2667192/Siemens>,
        <https://1145.am/db/2677518/Siemens>,
        <https://1145.am/db/2679119/Siemens>,
        <https://1145.am/db/2679877/Siemens>,
        <https://1145.am/db/2680041/Siemens>,
        <https://1145.am/db/2680048/Siemens>,
        <https://1145.am/db/2680066/Siemens>,
        <https://1145.am/db/2681746/Siemens>,
        <https://1145.am/db/2682593/Siemens>,
        <https://1145.am/db/2683272/Siemens>,
        <https://1145.am/db/2683690/Siemens>,
        <https://1145.am/db/2685508/Siemens>,
        <https://1145.am/db/2786046/Siemens_Ag>,
        <https://1145.am/db/2786046/Siemens_Ltd>,
        <https://1145.am/db/2792945/Siemens>,
        <https://1145.am/db/2793288/Siemens>,
        <https://1145.am/db/2796865/Siemens_Ag>,
        <https://1145.am/db/2796865/Siemens_Ltd>,
        <https://1145.am/db/334937/Siemens>,
        <https://1145.am/db/336095/Siemens_Ag>,
        <https://1145.am/db/553007/Siemens>,
        <https://1145.am/db/767649/Siemens>,
        <https://1145.am/db/817821/Siemens>,
        <https://1145.am/db/820046/Siemens>,
        <https://1145.am/db/820051/Siemens> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2291344/Series_D_Investment_Accuitive_Medical_Ventures_De_Novo_Ventures_Gund_Investment_Corporation_Versant_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-05-12T13:06:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Aliso Viejo, CA - based WaveTec Vision has closed its Series D financing, securing $ 15.9 million from existing and new investors." ;
    ns1:documentTitle "WaveTec Vision secures $15.9M; EU to apply new hazardous materials regs to medical devices;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/wavetec-vision-secures-15-9m-eu-to-apply-new-hazardous-materials-regs-to-medical> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "$ 15.9 million" ;
    ns1:whereGeoName "Aliso Viejo" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5323163/about.rdf> ;
    ns1:whereRaw "Aliso Viejo" .

<https://1145.am/db/2322429/Investment_Beringea_Chrysalis_Ventures_Hopen_Life_Sciences_Intervention_Insights_Michigan_Accelerator_Fund_I_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-19T12:53:18+00:00"^^xsd:dateTime ;
    ns1:documentExtract "As community oncologists tackle the challenge of matching their patients with a growing menu of targeted drugs, start-up Intervention Insights has landed $ 7.2 million in venture financing to advance the commercialization of an informatics platform designed to aid doctors in providing such personalized cancer care.",
        "Grand Rapids, MI - based Intervention Insights, which hatched in 2009 with technology from the Van Ander Research Institute, raised the Series B funds from co-lead investors Beringea and Chrysalis Ventures as well as other backers such as Hopen Life Sciences and Michigan Accelerator Fund I." ;
    ns1:documentTitle "Bioinformatics upstart Intervention Insights secures $7.2M" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/bioinformatics-upstart-intervention-insights-secures-7-2m> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2322429/Intervention_Insights> ;
    ns1:targetDetails "venture" ;
    ns1:valueRaw "$ 7.2 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S" .

<https://1145.am/db/2340429/Mohr_Davidow_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-01-25T13:21:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RainDance Technologies Raises $37.5 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/raindance-technologies-raises-37-5-million-series-d-financing> ;
    ns1:foundName "Mohr Davidow Ventures" ;
    ns1:investor <https://1145.am/db/2340429/Series_D_Investment_Acadia_Woods_Alloy_Ventures_Mohr_Davidow_Ventures_Quaker_Bioventures_Raindance_Technologies_Completed> ;
    ns1:name "Mohr Davidow Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1006252/Menlo_Ventures>,
        <https://1145.am/db/1006262/Com_Prelude_Ventures>,
        <https://1145.am/db/1006574/Integr8d_Capital>,
        <https://1145.am/db/1006880/Root_Ventures>,
        <https://1145.am/db/1007193/Capital_One_Ventures>,
        <https://1145.am/db/1007527/Integr8d_Capital>,
        <https://1145.am/db/1008085/Root_Ventures>,
        <https://1145.am/db/1008260/Servicenow_Ventures>,
        <https://1145.am/db/1010064/Greatpoint_Ventures>,
        <https://1145.am/db/1010064/Maverick_Ventures>,
        <https://1145.am/db/1010199/One9_Ventures>,
        <https://1145.am/db/102038/Allegion_Ventures>,
        <https://1145.am/db/102038/Pathbreaker_Ventures>,
        <https://1145.am/db/102038/West_Ventures>,
        <https://1145.am/db/1023252/Digitalbridge_Ventures>,
        <https://1145.am/db/1024247/Digitalbridge_Ventures>,
        <https://1145.am/db/1024483/Investbridge_Capital>,
        <https://1145.am/db/1026319/Able_Partners>,
        <https://1145.am/db/1034591/Valia_Ventures>,
        <https://1145.am/db/1041601/Kineo_Finance>,
        <https://1145.am/db/1042250/Kineo_Finance>,
        <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043342/Root_Ventures>,
        <https://1145.am/db/1043516/Kineo_Finance>,
        <https://1145.am/db/1045242/Dipalo_Ventures>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1051115/Dn_Capital>,
        <https://1145.am/db/1051644/Vestigo_Ventures>,
        <https://1145.am/db/1052155/Gate_Ventures>,
        <https://1145.am/db/1059993/Tera_Ventures>,
        <https://1145.am/db/1060146/Ulu_Ventures>,
        <https://1145.am/db/1061824/Bluebird_Ventures>,
        <https://1145.am/db/1061911/Ulu_Ventures>,
        <https://1145.am/db/1065366/Applied_Ventures_Llc>,
        <https://1145.am/db/1065544/Menlo_Ventures>,
        <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1081490/Vinco_Ventures>,
        <https://1145.am/db/1081888/Ggv_Capital>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/1082719/Dorilton_Ventures>,
        <https://1145.am/db/1082814/Cathexis_Ventures>,
        <https://1145.am/db/1082814/Promus_Ventures>,
        <https://1145.am/db/1082814/Type_One_Ventures>,
        <https://1145.am/db/1084014/Ret_Ventures>,
        <https://1145.am/db/1085867/Ret_Ventures>,
        <https://1145.am/db/1086604/Alerion_Ventures>,
        <https://1145.am/db/1086673/Wintrust_Ventures>,
        <https://1145.am/db/1089416/Nexo_Ventures>,
        <https://1145.am/db/1090643/Argon_Ventures>,
        <https://1145.am/db/1090643/Glasswing_Ventures>,
        <https://1145.am/db/1101244/Acequia_Capital>,
        <https://1145.am/db/1103270/Acequia_Capital>,
        <https://1145.am/db/1106082/Northpond_Ventures>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1111505/Nissay_Capital>,
        <https://1145.am/db/1111505/Remiges_Ventures>,
        <https://1145.am/db/1112074/Nissay_Capital>,
        <https://1145.am/db/1112074/Remiges_Ventures>,
        <https://1145.am/db/1114979/Catapult_Ventures>,
        <https://1145.am/db/1115103/Northpond_Ventures>,
        <https://1145.am/db/1119456/Truist_Ventures>,
        <https://1145.am/db/1119699/Prelude_Ventures>,
        <https://1145.am/db/1120030/Morpheus_Ventures>,
        <https://1145.am/db/1120030/Point72_Ventures>,
        <https://1145.am/db/1120071/Morpheus_Ventures>,
        <https://1145.am/db/1120071/Point72_Ventures>,
        <https://1145.am/db/1122750/Prelude_Ventures>,
        <https://1145.am/db/1129561/Redbeard_Ventures>,
        <https://1145.am/db/1130744/Redbeard_Ventures>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1134165/Boldstart_Ventures>,
        <https://1145.am/db/1136173/Boldstart_Ventures>,
        <https://1145.am/db/1137178/CRV>,
        <https://1145.am/db/1138154/Ggv_Capital>,
        <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1140286/Origin_Ventures>,
        <https://1145.am/db/1141736/Redpoint_Ventures>,
        <https://1145.am/db/1150154/Riv_Capital>,
        <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1150529/Solasta_Ventures>,
        <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1151736/True_Ventures>,
        <https://1145.am/db/1152929/Aperiamventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1154242/True_Ventures>,
        <https://1145.am/db/1163139/Sentiero_Ventures>,
        <https://1145.am/db/1163139/Skyriver_Ventures>,
        <https://1145.am/db/1164299/Lavrock_Ventures>,
        <https://1145.am/db/1164299/Progress_Ventures>,
        <https://1145.am/db/1164688/Abstract_Ventures>,
        <https://1145.am/db/1164688/Spacecadet_Ventures>,
        <https://1145.am/db/1164845/Lavrock_Ventures>,
        <https://1145.am/db/1164845/Progress_Ventures>,
        <https://1145.am/db/1165515/G2_Group_Ventures>,
        <https://1145.am/db/1166154/Allos_Ventures>,
        <https://1145.am/db/1166957/Seedil_Ventures>,
        <https://1145.am/db/1168757/Accomplice_Ventures>,
        <https://1145.am/db/1169687/Artiman_Ventures>,
        <https://1145.am/db/1169687/J_Ventures>,
        <https://1145.am/db/1169687/Nd_Capital>,
        <https://1145.am/db/1169815/Accomplice_Ventures>,
        <https://1145.am/db/1170971/Equinor_Ventures>,
        <https://1145.am/db/1173428/Equinor_Ventures>,
        <https://1145.am/db/1175576/Divcowest_Ventures>,
        <https://1145.am/db/1175576/Point72_Ventures>,
        <https://1145.am/db/1175576/Signia_Ventures>,
        <https://1145.am/db/1176018/First_Star_Ventures>,
        <https://1145.am/db/1187600/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/11887/Adv>,
        <https://1145.am/db/1190097/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/1190127/Animo_Ventures>,
        <https://1145.am/db/1190127/Chaac_Ventures>,
        <https://1145.am/db/1190127/Ulu_Ventures>,
        <https://1145.am/db/1196068/Arthur_Ventures>,
        <https://1145.am/db/1196728/Greatpoint_Ventures>,
        <https://1145.am/db/1199177/Greatpoint_Ventures>,
        <https://1145.am/db/1199182/Boxone_Ventures>,
        <https://1145.am/db/1202673/Basecamp_Ventures>,
        <https://1145.am/db/1203180/Basecamp_Ventures>,
        <https://1145.am/db/1206820/Tenoneten_Ventures>,
        <https://1145.am/db/1208519/Tappanhill_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1208749/Keshif_Ventures>,
        <https://1145.am/db/1208749/Tenoneten_Ventures>,
        <https://1145.am/db/1213076/Equinor_Ventures>,
        <https://1145.am/db/1213076/Scf_Ventures>,
        <https://1145.am/db/1213119/Nevcaut_Ventures>,
        <https://1145.am/db/1215930/Northpond_Ventures>,
        <https://1145.am/db/1219982/Soma_Ventures>,
        <https://1145.am/db/1221237/C2_Ventures>,
        <https://1145.am/db/1222789/Glasswing_Ventures>,
        <https://1145.am/db/1232497/Droia_Ventures>,
        <https://1145.am/db/1232497/Gv>,
        <https://1145.am/db/1233314/Citta_Capital>,
        <https://1145.am/db/1236549/Adit_Ventures>,
        <https://1145.am/db/1247755/Sinewave_Ventures>,
        <https://1145.am/db/1247761/Clear_Ventures>,
        <https://1145.am/db/1248631/Sinewave_Ventures>,
        <https://1145.am/db/1252447/Gaingels>,
        <https://1145.am/db/1256269/Ampd_Ventures_Inc>,
        <https://1145.am/db/1264028/K3_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1268150/Pender_Ventures>,
        <https://1145.am/db/1269968/Abstract_Ventures>,
        <https://1145.am/db/1272468/Launchpad_Capital>,
        <https://1145.am/db/1279264/Roosh_Ventures>,
        <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1282820/Agya_Ventures>,
        <https://1145.am/db/1286872/Morevc>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1297417/Bitkraft_Ventures>,
        <https://1145.am/db/1299578/Seedtob_Capital>,
        <https://1145.am/db/1307620/Inventus_Capital_Partners>,
        <https://1145.am/db/1311917/Avid_Ventures>,
        <https://1145.am/db/1311917/Canapi_Ventures>,
        <https://1145.am/db/1322441/Solana_Ventures>,
        <https://1145.am/db/1326376/Dexcom_Ventures>,
        <https://1145.am/db/1329887/Peter_Nagar>,
        <https://1145.am/db/1331691/Pelion_Ventures>,
        <https://1145.am/db/1332798/Acrobator_Ventures>,
        <https://1145.am/db/1334186/First_Ascent_Ventures>,
        <https://1145.am/db/1334193/Version_One_Ventures>,
        <https://1145.am/db/1334395/Gv>,
        <https://1145.am/db/1334895/Soleus_Capital>,
        <https://1145.am/db/1335073/Yl_Ventures>,
        <https://1145.am/db/1335080/Dorilton_Ventures>,
        <https://1145.am/db/1344240/Neotribe_Ventures>,
        <https://1145.am/db/1352420/Vamos_Ventures>,
        <https://1145.am/db/1353145/Infinity_Ventures>,
        <https://1145.am/db/1362743/Cobalt_Ventures>,
        <https://1145.am/db/1373683/BGV>,
        <https://1145.am/db/1375916/J2_Ventures>,
        <https://1145.am/db/1376353/J2_Ventures>,
        <https://1145.am/db/1378599/Menlo_Ventures>,
        <https://1145.am/db/1381832/Northpond_Ventures>,
        <https://1145.am/db/1382787/Northpond_Ventures>,
        <https://1145.am/db/1383818/Newlin_Ventures>,
        <https://1145.am/db/1387557/Naventures>,
        <https://1145.am/db/138878/Metacartel_Ventures>,
        <https://1145.am/db/1398057/Owen_Van_Natta_Temaris___Associates>,
        <https://1145.am/db/1398917/Trousdale_Ventures>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1407614/C2_Ventures>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1411934/Riptide_Ventures>,
        <https://1145.am/db/1425749/Menlo_Ventures>,
        <https://1145.am/db/1425749/Se_Ventures>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1445378/Mvp_Ventures>,
        <https://1145.am/db/1445935/Verissimo_Ventures>,
        <https://1145.am/db/1449316/+Nd_Capital>,
        <https://1145.am/db/1449740/Mistral_Ventures>,
        <https://1145.am/db/1452107/Abstract_Ventures>,
        <https://1145.am/db/1455216/Engage_Ventures>,
        <https://1145.am/db/1455616/Abstract_Ventures>,
        <https://1145.am/db/1463829/1sharpe_Ventures>,
        <https://1145.am/db/1467693/Preseed_Ventures>,
        <https://1145.am/db/1467892/M_Ventures>,
        <https://1145.am/db/1467932/Sequoia_Capital_Gv>,
        <https://1145.am/db/1468981/Preseed_Ventures>,
        <https://1145.am/db/1476448/Origin_Ventures>,
        <https://1145.am/db/1480152/True_Ventures>,
        <https://1145.am/db/1480651/Glasswing_Ventures>,
        <https://1145.am/db/1480989/Infinity_Ventures>,
        <https://1145.am/db/1481875/Infinity_Ventures>,
        <https://1145.am/db/1482705/Oif_Ventures>,
        <https://1145.am/db/1484103/Boxone_Ventures>,
        <https://1145.am/db/1484857/Iu_Ventures>,
        <https://1145.am/db/1488858/Alkeon_Capital>,
        <https://1145.am/db/1490126/Seedtob_Capital>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490978/Seedtob_Capital>,
        <https://1145.am/db/1492889/Future_Ventures>,
        <https://1145.am/db/1492889/Radical_Ventures>,
        <https://1145.am/db/1494028/Alkeon_Capital>,
        <https://1145.am/db/1496360/Realist_Ventures>,
        <https://1145.am/db/1503768/Nevateam_Partners>,
        <https://1145.am/db/1508325/Aramco_Ventures>,
        <https://1145.am/db/1509462/F7_Ventures>,
        <https://1145.am/db/1512891/Acme_Capital>,
        <https://1145.am/db/1515109/Cmfg_Ventures>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1520070/Menlo_Ventures>,
        <https://1145.am/db/1520070/Northpond_Ventures>,
        <https://1145.am/db/1520772/January_Ventures>,
        <https://1145.am/db/1537166/Catalio_Capital_Management>,
        <https://1145.am/db/1537970/Catalio_Capital_Management>,
        <https://1145.am/db/1541308/Panoramic_Ventures>,
        <https://1145.am/db/1541797/G1_Ventures>,
        <https://1145.am/db/1545833/Alerion_Ventures>,
        <https://1145.am/db/1545994/Noemis_Ventures>,
        <https://1145.am/db/1546945/Alerion_Ventures>,
        <https://1145.am/db/1546965/Citi_Ventures>,
        <https://1145.am/db/1546965/Truist_Ventures>,
        <https://1145.am/db/1547281/Noemis_Ventures>,
        <https://1145.am/db/1548592/Gopoint_Ventures>,
        <https://1145.am/db/1556397/Dnx_Ventures>,
        <https://1145.am/db/1556442/C16_Ventures>,
        <https://1145.am/db/1557877/Embark_Ventures>,
        <https://1145.am/db/1559824/Embark_Ventures>,
        <https://1145.am/db/1560704/Breaktrail_Ventures>,
        <https://1145.am/db/1563623/Amex_Ventures>,
        <https://1145.am/db/1564049/Amex_Ventures>,
        <https://1145.am/db/1571330/Seae_Ventures>,
        <https://1145.am/db/1571330/Venturesouth>,
        <https://1145.am/db/1572216/Seae_Ventures>,
        <https://1145.am/db/1572216/Venturesouth>,
        <https://1145.am/db/1574557/True_Ventures>,
        <https://1145.am/db/1574647/Vanterra_Ventures>,
        <https://1145.am/db/1575612/Interlace_Ventures>,
        <https://1145.am/db/1575612/Valia_Ventures>,
        <https://1145.am/db/1578178/N49p>,
        <https://1145.am/db/1578178/Naventures>,
        <https://1145.am/db/1578327/Crit_Ventures>,
        <https://1145.am/db/1578327/Nextview_Ventures>,
        <https://1145.am/db/1579770/Schams_Ventures>,
        <https://1145.am/db/1579792/Crit_Ventures>,
        <https://1145.am/db/1579792/Nextview_Ventures>,
        <https://1145.am/db/1580468/Cohort_Ventures>,
        <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1582111/Forepont_Capital_Partners>,
        <https://1145.am/db/1583413/Navigare_Ventures>,
        <https://1145.am/db/1615195/Digitalis_Ventures>,
        <https://1145.am/db/1616990/Digitalis_Ventures>,
        <https://1145.am/db/1632002/Catalio_Capital_Management>,
        <https://1145.am/db/1632028/Catalio_Capital_Management>,
        <https://1145.am/db/1632131/Catalio_Capital_Management>,
        <https://1145.am/db/1632156/Catalio_Capital_Management>,
        <https://1145.am/db/1638640/1digi_Ventures>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1653506/Ascendum_Capital>,
        <https://1145.am/db/1653506/Citta_Capital>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1664837/Civilization_Ventures>,
        <https://1145.am/db/1664948/Dreamit_Ventures>,
        <https://1145.am/db/1669908/Aviso_Ventures>,
        <https://1145.am/db/1670128/Primary_Ventures>,
        <https://1145.am/db/1676513/Connect_Ventures>,
        <https://1145.am/db/1685482/Lavrock_Ventures>,
        <https://1145.am/db/1690703/Arkam_Ventures>,
        <https://1145.am/db/1690703/Prosus_Ventures>,
        <https://1145.am/db/1691060/Veblen_Ventures>,
        <https://1145.am/db/1691364/Ts_Ventures>,
        <https://1145.am/db/1693592/Cventures>,
        <https://1145.am/db/1693668/Sunny_Side_Ventures>,
        <https://1145.am/db/1693981/Boldstart_Ventures>,
        <https://1145.am/db/1694241/True_Ventures>,
        <https://1145.am/db/1694301/Dn_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1694448/Presidio_Ventures>,
        <https://1145.am/db/1694592/Credo_Ventures>,
        <https://1145.am/db/1694592/Susa_Ventures>,
        <https://1145.am/db/1694798/Udc_Ventures>,
        <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1695849/Salesforce_Ventures>,
        <https://1145.am/db/1695885/True_Ventures>,
        <https://1145.am/db/1697044/Palomar_Ventures>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697373/Lerer_Ventures>,
        <https://1145.am/db/1697910/Entrepia_Ventures>,
        <https://1145.am/db/1697910/Innovacom>,
        <https://1145.am/db/1698516/Engage_Ventures>,
        <https://1145.am/db/1698516/Tyh_Ventures>,
        <https://1145.am/db/1698644/Inovia_Capital>,
        <https://1145.am/db/1699263/Contour_Venture_Partners>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1700572/Contour_Venture_Partners>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702003/Ventures_West>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1702472/Chiratae_Ventures>,
        <https://1145.am/db/1702483/Sure_Ventures_Usvp>,
        <https://1145.am/db/1702517/Prime_Ventures>,
        <https://1145.am/db/1702871/Charles_River_Ventures>,
        <https://1145.am/db/1703120/Point72_Ventures>,
        <https://1145.am/db/1703551/People_Ventures>,
        <https://1145.am/db/1703907/T-Venture>,
        <https://1145.am/db/1704404/True_Ventures>,
        <https://1145.am/db/1704740/T-Venture>,
        <https://1145.am/db/1704842/Se_Ventures>,
        <https://1145.am/db/1704871/Yl_Ventures>,
        <https://1145.am/db/1705825/Ventures_Platform>,
        <https://1145.am/db/1707227/Schams_Ventures>,
        <https://1145.am/db/1707540/Prosus_Ventures>,
        <https://1145.am/db/1707567/Contour_Venture_Partners>,
        <https://1145.am/db/1707567/Reign_Ventures>,
        <https://1145.am/db/1707637/Resolute_Ventures>,
        <https://1145.am/db/1707736/Artiman_Ventures>,
        <https://1145.am/db/1708555/20vc>,
        <https://1145.am/db/1708903/Kaedan_Capital>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1710027/Contour_Venture_Partners>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1711383/Aviso_Ventures>,
        <https://1145.am/db/1711383/Pelion_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1711790/CRV>,
        <https://1145.am/db/1711849/K20_Ventures>,
        <https://1145.am/db/1712471/Cervin_Ventures>,
        <https://1145.am/db/1713712/Grotech_Ventures>,
        <https://1145.am/db/1714098/Charles_River_Ventures>,
        <https://1145.am/db/1714148/Ulu_Ventures>,
        <https://1145.am/db/1714624/Abstract_Ventures>,
        <https://1145.am/db/1714630/January_Ventures>,
        <https://1145.am/db/1716124/Appian_Ventures>,
        <https://1145.am/db/1716168/Onset_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1718012/Presidio_Ventures>,
        <https://1145.am/db/1718018/Ggv_Capital>,
        <https://1145.am/db/1718081/Jafco_Ventures>,
        <https://1145.am/db/1718748/Truist_Ventures>,
        <https://1145.am/db/1718787/J_Ventures>,
        <https://1145.am/db/1719362/True_Ventures>,
        <https://1145.am/db/1719370/Bv_Capital>,
        <https://1145.am/db/1720145/Bessemer_Ventures>,
        <https://1145.am/db/1720182/Convivialit_Ventures>,
        <https://1145.am/db/1720441/Origin_Ventures>,
        <https://1145.am/db/1721171/Citi_Ventures>,
        <https://1145.am/db/1721392/Redpoint_Ventures>,
        <https://1145.am/db/1721393/Trinity_Ventures>,
        <https://1145.am/db/1721548/Ggv_Capital>,
        <https://1145.am/db/1721548/Menlo_Ventures>,
        <https://1145.am/db/1722252/Onset_Ventures>,
        <https://1145.am/db/1723165/Menlo_Ventures>,
        <https://1145.am/db/1723664/T-Venture>,
        <https://1145.am/db/1723932/Citi_Ventures>,
        <https://1145.am/db/1724979/Jafco_Ventures>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726088/Zeev_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1726544/Ei_Ventures>,
        <https://1145.am/db/1727288/Sozo_Ventures>,
        <https://1145.am/db/1728569/Redpoint_Ventures>,
        <https://1145.am/db/1729186/Catamount_Ventures>,
        <https://1145.am/db/1731187/Rho_Ventures>,
        <https://1145.am/db/1731419/Redpoint_Ventures>,
        <https://1145.am/db/1734104/Alpana_Ventures>,
        <https://1145.am/db/1734104/Highsage_Ventures>,
        <https://1145.am/db/1734728/Talis_Capital>,
        <https://1145.am/db/1735194/Eqt_Ventures>,
        <https://1145.am/db/1735248/Corigin_Ventures>,
        <https://1145.am/db/1735726/Nextview_Ventures>,
        <https://1145.am/db/1735755/Firebolt_Ventures>,
        <https://1145.am/db/1735774/Alpha4_Ventures>,
        <https://1145.am/db/1736136/Ggv_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1737392/Moxxie_Ventures>,
        <https://1145.am/db/1737979/CRV>,
        <https://1145.am/db/1738162/3one4_Capital>,
        <https://1145.am/db/1738300/Chryscapital>,
        <https://1145.am/db/1738415/Capnamic_Ventures>,
        <https://1145.am/db/1738444/Prosus_Ventures>,
        <https://1145.am/db/1738776/Illuminate_Ventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1739042/Experior_Venture_Fund>,
        <https://1145.am/db/1739064/Jsw_Ventures>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1739630/Redsea_Ventures>,
        <https://1145.am/db/1739719/Seedplus>,
        <https://1145.am/db/1739851/Signum_Capital>,
        <https://1145.am/db/1739909/Root_Ventures>,
        <https://1145.am/db/1739946/Dn_Capital>,
        <https://1145.am/db/1740077/3one4_Capital>,
        <https://1145.am/db/1740665/First_Bridge_Ventures>,
        <https://1145.am/db/1740832/J_Ventures>,
        <https://1145.am/db/1740832/Susa_Ventures>,
        <https://1145.am/db/1740859/Ggv_Capital>,
        <https://1145.am/db/1741357/Dn_Capital>,
        <https://1145.am/db/1741575/Addventure>,
        <https://1145.am/db/1741635/Zeev_Ventures>,
        <https://1145.am/db/1742267/Firebolt_Ventures>,
        <https://1145.am/db/1742267/Point72_Ventures>,
        <https://1145.am/db/1743271/Liil_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1743409/Dreamit_Ventures>,
        <https://1145.am/db/1743737/Regah_Ventures>,
        <https://1145.am/db/1744229/R7>,
        <https://1145.am/db/1744775/Point72_Ventures>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1744922/Agla_Ventures>,
        <https://1145.am/db/1745326/Eqt_Ventures>,
        <https://1145.am/db/1745326/Lios_Ventures>,
        <https://1145.am/db/1745326/Prime_Ventures>,
        <https://1145.am/db/1745746/Garuda_Ventures>,
        <https://1145.am/db/1745746/Starling_Ventures>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1747252/Citi_Ventures>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747400/Eqt_Ventures>,
        <https://1145.am/db/1747503/Brighteye_Ventures>,
        <https://1145.am/db/1747722/Shinhan_Capital>,
        <https://1145.am/db/1747943/Altai_Ventures>,
        <https://1145.am/db/1748417/Zeev_Ventures>,
        <https://1145.am/db/1749226/Dn_Capital>,
        <https://1145.am/db/1749425/Ac_Ventures>,
        <https://1145.am/db/1749651/Colle_Capital>,
        <https://1145.am/db/1749911/Khwarizmi_Ventures>,
        <https://1145.am/db/1750942/Celesta_Capital>,
        <https://1145.am/db/1750942/Chiratae_Ventures>,
        <https://1145.am/db/1751135/Inovia_Capital>,
        <https://1145.am/db/1751312/Abstract_Ventures>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1751506/Ggv_Capital>,
        <https://1145.am/db/1751551/Gaingels>,
        <https://1145.am/db/1751553/Canapi_Ventures>,
        <https://1145.am/db/1751743/Intudo_Ventures>,
        <https://1145.am/db/1751800/Morpheus_Ventures>,
        <https://1145.am/db/1751954/Novastar_Ventures>,
        <https://1145.am/db/1752102/Origin_Ventures>,
        <https://1145.am/db/1752403/Yl_Ventures>,
        <https://1145.am/db/1752998/Agla_Ventures>,
        <https://1145.am/db/1753704/Apex_Ventures>,
        <https://1145.am/db/1753721/Financial_Venture_Studio>,
        <https://1145.am/db/1753721/Resolute_Ventures>,
        <https://1145.am/db/1753745/2i_Ventures>,
        <https://1145.am/db/1754211/Citi_Ventures>,
        <https://1145.am/db/1754211/Menlo_Ventures>,
        <https://1145.am/db/1754242/Gsv_Ventures>,
        <https://1145.am/db/1754595/Global_Ventures>,
        <https://1145.am/db/1754595/Otg_Ventures>,
        <https://1145.am/db/1754751/Menlo_Ventures>,
        <https://1145.am/db/1754787/Letsventure>,
        <https://1145.am/db/1754997/Alkeon_Capital>,
        <https://1145.am/db/1755086/Kollective_Ventures>,
        <https://1145.am/db/1755278/Zeev_Ventures>,
        <https://1145.am/db/1755704/Promus_Ventures>,
        <https://1145.am/db/1755828/Future_Ventures>,
        <https://1145.am/db/1755860/Dg_Ventures>,
        <https://1145.am/db/1755860/Intudo_Ventures>,
        <https://1145.am/db/1756040/Altos_Ventures>,
        <https://1145.am/db/1756094/CRV>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1756326/Neotribe_Ventures>,
        <https://1145.am/db/1756384/Abstract_Ventures>,
        <https://1145.am/db/1756384/Lightspeed_Ventures>,
        <https://1145.am/db/1756599/True_Ventures>,
        <https://1145.am/db/1757035/Vectr_Ventures>,
        <https://1145.am/db/1757365/Will_Ventures>,
        <https://1145.am/db/1757382/Gl_Ventures>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1757772/Lorimer_Ventures>,
        <https://1145.am/db/1758193/Tenoneten_Ventures>,
        <https://1145.am/db/1758193/Valia_Ventures>,
        <https://1145.am/db/1758313/Venture_Field>,
        <https://1145.am/db/1758622/Oca_Ventures>,
        <https://1145.am/db/1759048/Avid_Ventures>,
        <https://1145.am/db/1759048/Lightspeed_Ventures>,
        <https://1145.am/db/1759567/J_Ventures>,
        <https://1145.am/db/1759922/Verance_Capital>,
        <https://1145.am/db/1760383/True_Ventures>,
        <https://1145.am/db/1760520/Prologis_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1760985/Frontier_Ventures>,
        <https://1145.am/db/1761126/Redpoint_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761607/Menlo_Ventures>,
        <https://1145.am/db/1761607/Sinewave_Ventures>,
        <https://1145.am/db/1761957/Alkeon_Capital>,
        <https://1145.am/db/1761999/Ggv_Capital>,
        <https://1145.am/db/1762031/Menlo_Ventures>,
        <https://1145.am/db/1762055/Altos_Ventures>,
        <https://1145.am/db/1762277/Ac_Ventures>,
        <https://1145.am/db/1762453/Line_Ventures>,
        <https://1145.am/db/1762561/Grotech_Ventures>,
        <https://1145.am/db/1762669/Creandum>,
        <https://1145.am/db/1762844/Signum_Capital>,
        <https://1145.am/db/1763356/Agla_Ventures>,
        <https://1145.am/db/1763371/Spacecadet_Ventures>,
        <https://1145.am/db/1763395/Idc_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763774/Ggv_Capital>,
        <https://1145.am/db/1763795/Ventures_Platform>,
        <https://1145.am/db/1763795/Xyz_Ventures>,
        <https://1145.am/db/1763875/Golden_Gate_Ventures>,
        <https://1145.am/db/1764027/Menlo_Ventures>,
        <https://1145.am/db/1764255/Pathbreaker_Ventures>,
        <https://1145.am/db/1764255/Stageone_Ventures>,
        <https://1145.am/db/1764345/Talis_Capital>,
        <https://1145.am/db/1764527/Presidio_Ventures>,
        <https://1145.am/db/1764527/Yl_Ventures>,
        <https://1145.am/db/1765273/Adevinta_Ventures>,
        <https://1145.am/db/1765273/Venturefriends>,
        <https://1145.am/db/1765372/Irobot_Ventures>,
        <https://1145.am/db/1765377/Redpoint_Ventures>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1765646/Amiti_Ventures>,
        <https://1145.am/db/1765673/Salesforce_Ventures>,
        <https://1145.am/db/1766091/Inreach_Ventures>,
        <https://1145.am/db/1766096/Borealis_Ventures>,
        <https://1145.am/db/1766096/Northpond_Ventures>,
        <https://1145.am/db/1766253/Redpoint_Ventures>,
        <https://1145.am/db/1766253/True_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1766978/Rga_Ventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1768363/Golden_Gate_Ventures>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1770139/Victress_Capital>,
        <https://1145.am/db/1770265/Techstars_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1770372/Korelya_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1770982/Gv>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771011/Ggv_Capital>,
        <https://1145.am/db/1771548/Seekdource_Capital>,
        <https://1145.am/db/1771613/Creandum>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1772004/Raed_Ventures>,
        <https://1145.am/db/1772004/Seed_Equity_Venture_Partners>,
        <https://1145.am/db/1772381/Altos_Ventures>,
        <https://1145.am/db/1772452/Connect_Ventures>,
        <https://1145.am/db/1773130/Capnamic_Ventures>,
        <https://1145.am/db/1773143/Venturefriends>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1774348/True_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1774535/Susa_Ventures>,
        <https://1145.am/db/1774658/Gv>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776340/Ggv_Capital>,
        <https://1145.am/db/1776340/Menlo_Ventures>,
        <https://1145.am/db/1776537/Origin_Ventures>,
        <https://1145.am/db/1776537/Tekton_Ventures>,
        <https://1145.am/db/1776621/Redpoint_Ventures>,
        <https://1145.am/db/1777289/Dn_Capital>,
        <https://1145.am/db/1777563/Evolv_Ventures>,
        <https://1145.am/db/1777563/Ggv_Capital>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1778935/Oryzn_Capital>,
        <https://1145.am/db/1780024/Partech_Ventures>,
        <https://1145.am/db/1782098/Addventure>,
        <https://1145.am/db/1782221/Point72_Ventures>,
        <https://1145.am/db/1783189/Citi_Ventures>,
        <https://1145.am/db/1784644/Creathor_Ventures>,
        <https://1145.am/db/1784964/Clear_Ventures>,
        <https://1145.am/db/1785361/M_Ventures>,
        <https://1145.am/db/1786249/Redpoint_Ventures>,
        <https://1145.am/db/1786249/Resolute_Ventures>,
        <https://1145.am/db/1786663/Edenred_Capital_Partners>,
        <https://1145.am/db/1786663/Eqt_Ventures>,
        <https://1145.am/db/1787249/Kpn_Ventures>,
        <https://1145.am/db/1787342/Korelya_Capital>,
        <https://1145.am/db/1787536/Point72_Ventures>,
        <https://1145.am/db/1787791/True_Ventures>,
        <https://1145.am/db/1787886/True_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1788726/Redbeat_Capital>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789754/Advancit_Capital>,
        <https://1145.am/db/1790280/Arthur_Ventures>,
        <https://1145.am/db/1790399/Capnamic_Ventures>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1790574/Red_Swan_Ventures>,
        <https://1145.am/db/1790574/Sherpa_Ventures>,
        <https://1145.am/db/1790641/Dn_Capital>,
        <https://1145.am/db/1790771/Redpoint_Ventures>,
        <https://1145.am/db/1790777/Connect_Ventures>,
        <https://1145.am/db/1791216/True_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1791838/Advancit_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792771/Softtechvc>,
        <https://1145.am/db/1792887/Kaedan_Capital>,
        <https://1145.am/db/1792887/Stageone_Ventures>,
        <https://1145.am/db/1794699/Ws_Ventures>,
        <https://1145.am/db/1794935/Intervest_Co_Ltd>,
        <https://1145.am/db/1795020/Redpoint_Ventures>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1795538/Skystar_Capital>,
        <https://1145.am/db/1796109/Contour_Venture_Partners>,
        <https://1145.am/db/1796593/Tenoneten_Ventures>,
        <https://1145.am/db/1796901/Red_Swan_Ventures>,
        <https://1145.am/db/1796922/Cagni_Ventures>,
        <https://1145.am/db/1797209/Kdwc_Ventures>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797899/Brave_Ventures>,
        <https://1145.am/db/1797999/Redpoint_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1799099/Inovia_Capital>,
        <https://1145.am/db/1799184/Ggv_Capital>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800929/Ventureast>,
        <https://1145.am/db/1802086/High_Line_Ventures>,
        <https://1145.am/db/1802227/Advancit_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802336/Capnamic_Ventures>,
        <https://1145.am/db/1804102/True_Ventures>,
        <https://1145.am/db/1804247/Holtzbrinck_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1804476/True_Ventures>,
        <https://1145.am/db/1804992/Talis_Capital>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1805604/Connect_Ventures>,
        <https://1145.am/db/1805604/Inreach_Ventures>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1806739/Golden_Gate_Ventures>,
        <https://1145.am/db/1808047/Salesforce_Ventures>,
        <https://1145.am/db/1808505/Helion_Ventures>,
        <https://1145.am/db/1808723/Mindworks_Ventures>,
        <https://1145.am/db/1808735/Commonangels_Ventures>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809844/Real_Ventures>,
        <https://1145.am/db/1809862/Acequia_Capital>,
        <https://1145.am/db/1810384/Starstrike_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1810714/Catalus_Capital>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1812856/Exfinity_Ventures>,
        <https://1145.am/db/1813375/Creandum>,
        <https://1145.am/db/1813575/Ggv_Capital>,
        <https://1145.am/db/1813944/Menlo_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1814643/Corigin_Ventures>,
        <https://1145.am/db/1814643/Launchcapital>,
        <https://1145.am/db/1815038/Plus_Ventures>,
        <https://1145.am/db/1815507/Globis_Capital_Partners>,
        <https://1145.am/db/1815697/Cherubic_Ventures>,
        <https://1145.am/db/1815701/True_Ventures>,
        <https://1145.am/db/1815886/Teneleven_Ventures>,
        <https://1145.am/db/1816491/Grotech_Ventures>,
        <https://1145.am/db/1818174/Advancit_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1819374/Rothenberg_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1820882/Inven_Capital>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1821711/Winton_Ventures>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1823162/True_Ventures>,
        <https://1145.am/db/1823217/Kdc_Ventures>,
        <https://1145.am/db/1823217/Nbm_Ventures>,
        <https://1145.am/db/1823684/Dcm_Ventures>,
        <https://1145.am/db/1823684/Idg_Ventures>,
        <https://1145.am/db/1824252/Allos_Ventures>,
        <https://1145.am/db/1824253/Trinity_Ventures>,
        <https://1145.am/db/1824944/True_Ventures>,
        <https://1145.am/db/1825465/Ben_Narasin>,
        <https://1145.am/db/1825713/Menlo_Ventures>,
        <https://1145.am/db/1825946/Lerer_Ventures>,
        <https://1145.am/db/1826265/Idg_Ventures>,
        <https://1145.am/db/1826648/True_Ventures>,
        <https://1145.am/db/1826922/Ggv_Capital>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828036/Redpoint_Ventures>,
        <https://1145.am/db/1828092/Eden_Ventures>,
        <https://1145.am/db/1828251/Golden_Gate_Ventures>,
        <https://1145.am/db/1828455/Quotidien_Ventures>,
        <https://1145.am/db/1828658/Focus_Ventures>,
        <https://1145.am/db/1828663/Great_Oaks_Ventures>,
        <https://1145.am/db/1828663/Inovia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1829422/Rothenberg_Ventures>,
        <https://1145.am/db/1829612/Lerer_Ventures>,
        <https://1145.am/db/1830502/Frontline_Ventures>,
        <https://1145.am/db/1830613/True_Ventures>,
        <https://1145.am/db/1830809/Numecent>,
        <https://1145.am/db/1830809/T-Ventures>,
        <https://1145.am/db/1830817/Charles_River_Ventures>,
        <https://1145.am/db/1831577/Artiman_Ventures>,
        <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832038/True_Ventures>,
        <https://1145.am/db/1832316/Partech_Ventures>,
        <https://1145.am/db/1832316/Scentan_Ventures>,
        <https://1145.am/db/1832316/Startcaps_Ventures>,
        <https://1145.am/db/1832856/Grotech_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834224/Orix_Ventures>,
        <https://1145.am/db/1834305/Charles_River_Ventures>,
        <https://1145.am/db/1834334/Altos_Ventures>,
        <https://1145.am/db/1834334/Baseline_Ventures>,
        <https://1145.am/db/1834334/Firebolt_Ventures>,
        <https://1145.am/db/1834334/Lazerow_Ventures>,
        <https://1145.am/db/1834520/Ben_Horowitz>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1834708/Sherpa_Ventures>,
        <https://1145.am/db/1834965/Lerer_Ventures>,
        <https://1145.am/db/1835229/Lerer_Ventures>,
        <https://1145.am/db/1835229/Trinity_Ventures>,
        <https://1145.am/db/1835229/Xg_Ventures>,
        <https://1145.am/db/1835740/Lerer_Ventures>,
        <https://1145.am/db/1835749/Gree_Ventures>,
        <https://1145.am/db/1835825/Focus_Ventures>,
        <https://1145.am/db/1836984/Siemer_Ventures>,
        <https://1145.am/db/1836984/Tekton_Ventures>,
        <https://1145.am/db/1837741/Menlo_Ventures>,
        <https://1145.am/db/1838026/Plus_Ventures>,
        <https://1145.am/db/1840775/Ggv_Capital>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1840881/Trinity_Ventures>,
        <https://1145.am/db/1841176/Lerer_Ventures>,
        <https://1145.am/db/1841176/True_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1842402/Redpoint_Ventures>,
        <https://1145.am/db/1842898/Grotech_Ventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1843449/Redpoint_Ventures>,
        <https://1145.am/db/1843602/Nextview_Ventures>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844143/Inovia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1844737/True_Ventures>,
        <https://1145.am/db/1844931/Charles_River_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1845960/Lerer_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846483/Inovia_Capital>,
        <https://1145.am/db/1847463/Prism_Ventureworks>,
        <https://1145.am/db/1847752/T-Venture>,
        <https://1145.am/db/1848523/Trinity_Ventures>,
        <https://1145.am/db/1849673/Inventure_Partners>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849949/Holtzbrinck_Ventures>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850668/True_Ventures>,
        <https://1145.am/db/1850989/Artiman_Ventures>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851035/Acequia_Capital>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851035/Redpoint_Ventures>,
        <https://1145.am/db/1851705/Promus_Ventures>,
        <https://1145.am/db/1851854/Partech_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1852308/Plus_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Trestle_Ventures>,
        <https://1145.am/db/1852556/Dave_Morin>,
        <https://1145.am/db/1852806/Redpoint_Ventures>,
        <https://1145.am/db/1852870/Golden_Gate_Ventures>,
        <https://1145.am/db/1852870/Siemer_Ventures>,
        <https://1145.am/db/1853417/Catamount_Ventures>,
        <https://1145.am/db/1853496/T-Ventures>,
        <https://1145.am/db/1854200/Ggv_Capital>,
        <https://1145.am/db/1854201/Charles_River_Ventures>,
        <https://1145.am/db/1854786/Eden_Ventures>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1854874/Sherpa_Ventures>,
        <https://1145.am/db/1854874/Softtech>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1855363/True_Ventures>,
        <https://1145.am/db/1855403/Rho_Ventures>,
        <https://1145.am/db/1855780/Bds_Ventures>,
        <https://1145.am/db/1855780/Ggv_Capital>,
        <https://1145.am/db/1856191/Creandum>,
        <https://1145.am/db/1856380/Softtech>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1856616/Redpoint_Ventures>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1857635/Rikard_Steiber>,
        <https://1145.am/db/1857659/Revolution_Ventures>,
        <https://1145.am/db/1857930/Inovia_Capital>,
        <https://1145.am/db/1857930/Version_One_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858592/Apex_Venture_Partners>,
        <https://1145.am/db/1858592/Origin_Ventures>,
        <https://1145.am/db/1858991/Capnamic_Ventures>,
        <https://1145.am/db/1859199/True_Ventures>,
        <https://1145.am/db/1859314/Version_One_Ventures>,
        <https://1145.am/db/1860163/Inovia_Capital>,
        <https://1145.am/db/1860345/Commonangels>,
        <https://1145.am/db/1860345/Launchcapital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1861355/Rho_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1863147/Apex_Venture_Partners>,
        <https://1145.am/db/1864601/Trinity_Ventures>,
        <https://1145.am/db/1864646/Inventus_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sherpalo_Ventures>,
        <https://1145.am/db/1866032/Launchcapital>,
        <https://1145.am/db/1866134/Embarcadero_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866155/Presidio_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867599/Cava_Capital>,
        <https://1145.am/db/1868107/Redpoint_Ventures>,
        <https://1145.am/db/1868109/Charles_River_Ventures>,
        <https://1145.am/db/1868178/True_Ventures>,
        <https://1145.am/db/1870015/Redpoint_Ventures>,
        <https://1145.am/db/1870465/Nextview_Ventures>,
        <https://1145.am/db/1871221/True_Ventures>,
        <https://1145.am/db/1871574/Redpoint_Ventures>,
        <https://1145.am/db/1871777/Charles_River_Ventures>,
        <https://1145.am/db/1871784/Charles_River_Ventures>,
        <https://1145.am/db/1871888/Charles_River_Ventures>,
        <https://1145.am/db/1873191/El_Dorado_Ventures>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1873680/Lerer_Ventures>,
        <https://1145.am/db/1873680/Xg_Ventures>,
        <https://1145.am/db/1874749/True_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1877283/Northzone_Ventures>,
        <https://1145.am/db/1877473/True_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878620/Ggv_Capital>,
        <https://1145.am/db/1879279/High_Line_Ventures>,
        <https://1145.am/db/1879759/T-Venture>,
        <https://1145.am/db/1880679/Northzone_Ventures>,
        <https://1145.am/db/1881464/Ggv_Capital>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1882330/New_World_Ventures>,
        <https://1145.am/db/1882727/Charles_River_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1883568/Eden_Ventures>,
        <https://1145.am/db/1883572/Astutia_Ventures>,
        <https://1145.am/db/1886402/New_Atlantic_Ventures>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1889394/Focus_Ventures>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1890000/Lerer_Ventures>,
        <https://1145.am/db/1890122/East_Ventures>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1890133/Focus_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/1890208/Menlo_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890839/Inovia_Capital>,
        <https://1145.am/db/1890903/Miven_Ventures>,
        <https://1145.am/db/1891615/Holtzbrinck_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891913/New_World_Ventures>,
        <https://1145.am/db/1891913/Oca_Ventures>,
        <https://1145.am/db/1891926/New_World_Ventures>,
        <https://1145.am/db/1892050/Charles_River_Ventures>,
        <https://1145.am/db/1892105/Crosscreek_Capital>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1892106/Altos_Ventures>,
        <https://1145.am/db/1892106/Illuminate_Ventures>,
        <https://1145.am/db/1892620/True_Ventures>,
        <https://1145.am/db/1892674/Appian_Ventures>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1892955/Guy_Gamzu>,
        <https://1145.am/db/1895072/Nextview_Ventures>,
        <https://1145.am/db/1895951/Windward_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1896379/Redpoint_Ventures>,
        <https://1145.am/db/1896419/True_Ventures>,
        <https://1145.am/db/1902330/Baseline_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1909430/Menlo_Ventures>,
        <https://1145.am/db/1909651/Revolution_Ventures>,
        <https://1145.am/db/1910694/True_Ventures>,
        <https://1145.am/db/1910922/Charles_River_Ventures>,
        <https://1145.am/db/1912684/Charles_River_Ventures>,
        <https://1145.am/db/1913863/Tl_Ventures>,
        <https://1145.am/db/1913874/Redpoint_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1915862/Focus_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1920478/Dawntreader_Ventures>,
        <https://1145.am/db/1920837/Onset_Ventures>,
        <https://1145.am/db/1927817/Trm_Ventures>,
        <https://1145.am/db/1939926/Cobalt_Ventures>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/1947303/Cavallo_Ventures>,
        <https://1145.am/db/1947312/Boldstart_Ventures>,
        <https://1145.am/db/1952989/Singularity_Ventures>,
        <https://1145.am/db/1954147/Accomplice_Ventures>,
        <https://1145.am/db/1957179/Sozo_Ventures>,
        <https://1145.am/db/1958963/Prosus_Ventures>,
        <https://1145.am/db/1959001/Capital_Technology_Ventures>,
        <https://1145.am/db/1959001/Glasswing_Ventures>,
        <https://1145.am/db/1962819/Connetic_Ventures>,
        <https://1145.am/db/1967592/Firebolt_Ventures>,
        <https://1145.am/db/1967683/Dig_Ventures_Vine_Ventures>,
        <https://1145.am/db/1975490/Northview_Ventures>,
        <https://1145.am/db/1975547/Nanban_Ventures>,
        <https://1145.am/db/1975547/Sinewave_Ventures>,
        <https://1145.am/db/1986122/Menlo_Ventures>,
        <https://1145.am/db/1995926/Neotribe_Ventures>,
        <https://1145.am/db/1998196/Gni_Group_Ltd>,
        <https://1145.am/db/1999771/Servicenow_Ventures>,
        <https://1145.am/db/2004427/Convivialit_Ventures>,
        <https://1145.am/db/2005131/Wwventures>,
        <https://1145.am/db/2007132/Nventures>,
        <https://1145.am/db/2020041/Inovia_Capital>,
        <https://1145.am/db/2020041/TCV>,
        <https://1145.am/db/2023596/Salesforce_Ventures>,
        <https://1145.am/db/2025081/True_Ventures>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2035454/Gv>,
        <https://1145.am/db/2036021/Clear_Ventures>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/2039177/Stellantis_Ventures>,
        <https://1145.am/db/2041480/Brunnur_Ventures>,
        <https://1145.am/db/2042858/Gv>,
        <https://1145.am/db/2044380/20sales>,
        <https://1145.am/db/2045587/Veritec_Ventures>,
        <https://1145.am/db/2050229/Nventures>,
        <https://1145.am/db/2050359/At_One_Ventures>,
        <https://1145.am/db/2051164/Aviso_Ventures>,
        <https://1145.am/db/2053027/Glasswing_Ventures>,
        <https://1145.am/db/2055707/Globis_Capital_Partners>,
        <https://1145.am/db/2056931/We_Ventures>,
        <https://1145.am/db/2060003/Crit_Ventures_100___100_Ventures>,
        <https://1145.am/db/2061278/Incisive_Ventures>,
        <https://1145.am/db/2061278/Volo_Ventures>,
        <https://1145.am/db/2063642/Clear_Bridge_Ventures>,
        <https://1145.am/db/2063967/Vsquared_Ventures>,
        <https://1145.am/db/2069147/Boldstart_Ventures>,
        <https://1145.am/db/2069147/Pelion_Ventures>,
        <https://1145.am/db/2069147/Salesforce_Ventures>,
        <https://1145.am/db/2069495/Intermountain_Ventures>,
        <https://1145.am/db/2069495/Northpond_Ventures>,
        <https://1145.am/db/2073129/Abstract_Ventures>,
        <https://1145.am/db/2073132/Idc_Ventures>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2075625/Rocketship_Ventures>,
        <https://1145.am/db/2081180/S4s_Ventures>,
        <https://1145.am/db/2081674/Capital_One_Ventures>,
        <https://1145.am/db/2082068/Arctern_Ventures>,
        <https://1145.am/db/2082068/Prelude_Ventures>,
        <https://1145.am/db/2083987/Vanterra_Ventures>,
        <https://1145.am/db/2087289/Jven_Capital>,
        <https://1145.am/db/2087289/Northpond_Ventures>,
        <https://1145.am/db/2089206/Crescendo_Venture_Partners>,
        <https://1145.am/db/2093427/Yl_Ventures>,
        <https://1145.am/db/2093713/Yl_Ventures>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2100116/Epic_Ventures>,
        <https://1145.am/db/2107533/Globis_Capital_Partners>,
        <https://1145.am/db/2109529/Point72_Ventures>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2109932/Catalio_Capital_Management>,
        <https://1145.am/db/2109932/Epic_Ventures>,
        <https://1145.am/db/2109932/Intermountain_Ventures>,
        <https://1145.am/db/2109932/North_South_Ventures>,
        <https://1145.am/db/2116769/Celesta_Capital>,
        <https://1145.am/db/2116769/Chiratae_Ventures>,
        <https://1145.am/db/2123953/Amex_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2123953/Infinity_Ventures>,
        <https://1145.am/db/2124766/P1_Ventures>,
        <https://1145.am/db/2125182/Nevcaut_Ventures>,
        <https://1145.am/db/2125182/Ulu_Ventures>,
        <https://1145.am/db/2125927/1984_Ventures>,
        <https://1145.am/db/2127882/Akkadian_Ventures>,
        <https://1145.am/db/2134989/Clear_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2141183/S_Ventures>,
        <https://1145.am/db/2141328/Connetic_Ventures>,
        <https://1145.am/db/2143438/Scorpio_Capital>,
        <https://1145.am/db/2147767/Catapult_Ventures>,
        <https://1145.am/db/2147767/Tenoneten_Ventures>,
        <https://1145.am/db/2151983/CRV>,
        <https://1145.am/db/2151983/Greatpoint_Ventures>,
        <https://1145.am/db/2155426/Brighteyes_Ventures>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2164121/Menlo_Ventures>,
        <https://1145.am/db/2169799/Nwise_Ventures>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2182443/Global_Ventures>,
        <https://1145.am/db/2183352/Optum_Ventures>,
        <https://1145.am/db/2186568/Frist_Cressey_Ventures>,
        <https://1145.am/db/2186568/Springrock_Ventures>,
        <https://1145.am/db/2186949/Greatpoint_Ventures_And_Cross_Creek>,
        <https://1145.am/db/2186949/Springrock_Ventures>,
        <https://1145.am/db/2190141/Link_Ventures>,
        <https://1145.am/db/2192636/TCV>,
        <https://1145.am/db/219311/Origin_Ventures>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2208603/McKesson_Ventures>,
        <https://1145.am/db/2210557/True_Ventures>,
        <https://1145.am/db/221321/Ggv_Capital>,
        <https://1145.am/db/2214690/Idg_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2264763/True_Ventures>,
        <https://1145.am/db/2283006/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Northpond_Ventures>,
        <https://1145.am/db/2284412/Soleus_Capital>,
        <https://1145.am/db/2286665/Shanda_Group>,
        <https://1145.am/db/2288209/Echelon_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2293172/Prospect_Ventures>,
        <https://1145.am/db/2294202/Trinitas_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2295253/Arkitekt_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2296249/Proxima_Ventures>,
        <https://1145.am/db/2296869/Dcm_Ventures>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2298897/Eshelman_Ventures>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2302351/Rho_Ventures>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2302897/Ventures_West_Capital>,
        <https://1145.am/db/2303098/Seaflower_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304606/Prism_Ventureworks>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2306568/Cmea_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2309507/Rho_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2312792/Onset_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2314380/Puretech_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314515/Apjohnventures>,
        <https://1145.am/db/2315754/Arcturus_Capital>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2321856/Ventures_West_Capital_Ltd>,
        <https://1145.am/db/2323785/Eshelman_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2325015/True_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325257/Ventures_West>,
        <https://1145.am/db/2325337/Resolvyx>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/2326362/Nextech_Venture>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2328585/Cmea_Ventures>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2338023/Cipla_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338703/Wavepoint_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341942/High-Tech_Grnderfonds>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2343184/Jven_Capital>,
        <https://1145.am/db/2345017/Venture_Investments>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2346300/High-Tech_Grnderfonds>,
        <https://1145.am/db/2346452/Aescap_Venture>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346978/Ventures_West_Capital>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2357487/Savitr_Capital>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2358747/Solon_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/2362638/Launchpad_Venture_Group>,
        <https://1145.am/db/2363460/Rho_Ventures>,
        <https://1145.am/db/2363854/Chrysalis_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365103/Aescap_Venture>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/238282/Carnrite_Ventures>,
        <https://1145.am/db/2400536/Capital_One_Ventures>,
        <https://1145.am/db/2423653/Venturewell>,
        <https://1145.am/db/253438/Esplanade_Ventures>,
        <https://1145.am/db/254357/Ulu_Ventures>,
        <https://1145.am/db/2549491/Ktb_Ventures>,
        <https://1145.am/db/2552636/Morningside_Ventures>,
        <https://1145.am/db/2569491/High-Tech_Grnderfonds>,
        <https://1145.am/db/2570138/Sherpa_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2603254/Salesforce_Ventures>,
        <https://1145.am/db/2628424/Verana_Networks>,
        <https://1145.am/db/2628848/Neocarta_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2638432/Nissay_Capital>,
        <https://1145.am/db/2641337/Promus_Ventures>,
        <https://1145.am/db/2641337/True_Ventures>,
        <https://1145.am/db/2654391/Biggell_Finance>,
        <https://1145.am/db/265532/Ulu_Ventures>,
        <https://1145.am/db/2702871/Inovia_Capital>,
        <https://1145.am/db/274170/G1_Ventures>,
        <https://1145.am/db/2754677/Golden_Gate_Ventures>,
        <https://1145.am/db/2765022/Garuda_Ventures>,
        <https://1145.am/db/2765030/Daniel_Ventures>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/2786411/Allegion_Ventures>,
        <https://1145.am/db/2788052/Rx_Ventures>,
        <https://1145.am/db/2790064/Novastar_Ventures>,
        <https://1145.am/db/2794396/Snowpoint_Ventures>,
        <https://1145.am/db/2797562/Menlo_Ventures>,
        <https://1145.am/db/283272/Salesforce_Ventures>,
        <https://1145.am/db/283607/Salesforce_Ventures>,
        <https://1145.am/db/293715/Signum_Capital>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/293891/Ggv_Capital>,
        <https://1145.am/db/299738/Steadfast_Capital_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/319155/Bgv_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/341984/Salesforce_Ventures>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Salesforce_Ventures>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/343459/F7_Ventures>,
        <https://1145.am/db/346598/Salesforce_Ventures>,
        <https://1145.am/db/348442/Triventures>,
        <https://1145.am/db/348659/Launchpad_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/364168/Alerion_Ventures>,
        <https://1145.am/db/367592/Gv>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/388551/Vestigo_Ventures>,
        <https://1145.am/db/396305/Real_Ventures>,
        <https://1145.am/db/402103/1776_Ventures>,
        <https://1145.am/db/402701/January_Ventures>,
        <https://1145.am/db/403810/Riverstone_Ventures>,
        <https://1145.am/db/410322/Gv>,
        <https://1145.am/db/410473/Celesta_Capital>,
        <https://1145.am/db/410473/Lytical_Ventures_And_Nepenthe_Capital>,
        <https://1145.am/db/410529/Goodyear_Ventures>,
        <https://1145.am/db/411539/Zeev_Ventures>,
        <https://1145.am/db/412020/Defi_Ventures_Inc>,
        <https://1145.am/db/415322/CRV>,
        <https://1145.am/db/416041/Akkadian_Ventures>,
        <https://1145.am/db/416041/Signia_Ventures>,
        <https://1145.am/db/416041/Zeev_Ventures>,
        <https://1145.am/db/419489/Point72_Ventures>,
        <https://1145.am/db/424877/North_First_Ventures>,
        <https://1145.am/db/425262/Yl_Ventures>,
        <https://1145.am/db/425423/True_Ventures>,
        <https://1145.am/db/425973/Will_Ventures>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/429179/C5_Capital>,
        <https://1145.am/db/430986/Cortado_Ventures>,
        <https://1145.am/db/434334/1up_Ventures>,
        <https://1145.am/db/435691/Klick_Ventures>,
        <https://1145.am/db/439819/Cavu_Ventures>,
        <https://1145.am/db/441319/Celesta_Capital>,
        <https://1145.am/db/444105/Exfinity_Ventures>,
        <https://1145.am/db/445365/Revolution_Ventures>,
        <https://1145.am/db/446341/Sinewave_Ventures>,
        <https://1145.am/db/455558/Intudo_Ventures>,
        <https://1145.am/db/457435/Alerce>,
        <https://1145.am/db/457435/Clin>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/471253/Gv>,
        <https://1145.am/db/471436/Citi_Ventures>,
        <https://1145.am/db/471504/Canapi_Ventures>,
        <https://1145.am/db/473030/Highsage_Ventures>,
        <https://1145.am/db/474928/Susa_Ventures>,
        <https://1145.am/db/478049/Worldquant_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/479113/Menlo_Ventures>,
        <https://1145.am/db/485616/K3_Ventures>,
        <https://1145.am/db/486858/Gaingels>,
        <https://1145.am/db/486901/Gaingels>,
        <https://1145.am/db/488743/Salesforce_Ventures>,
        <https://1145.am/db/491130/Raiven_Capital>,
        <https://1145.am/db/491338/Raiven_Capital>,
        <https://1145.am/db/493560/Tyh_Ventures>,
        <https://1145.am/db/495912/Regah_Ventures>,
        <https://1145.am/db/506588/Trinity_Ventures>,
        <https://1145.am/db/508145/Sora_Finance>,
        <https://1145.am/db/508161/Sora_Finance>,
        <https://1145.am/db/510565/Epic_Ventures>,
        <https://1145.am/db/513305/Avid_Ventures>,
        <https://1145.am/db/513305/Canapi_Ventures>,
        <https://1145.am/db/513897/Rlc_Ventures>,
        <https://1145.am/db/514151/Rlc_Ventures>,
        <https://1145.am/db/516396/Acequia_Capital>,
        <https://1145.am/db/517213/Acequia_Capital>,
        <https://1145.am/db/523349/Osf_Ventures>,
        <https://1145.am/db/523776/Root_Ventures>,
        <https://1145.am/db/525285/Inventum_Ventures>,
        <https://1145.am/db/525285/Optima_Ventures>,
        <https://1145.am/db/526109/Ggv_Capital>,
        <https://1145.am/db/526175/Ridgeline_Ventures>,
        <https://1145.am/db/529812/Inventum_Ventures>,
        <https://1145.am/db/529812/Optima_Ventures>,
        <https://1145.am/db/532016/Id_Ventures>,
        <https://1145.am/db/539571/Origin_Ventures>,
        <https://1145.am/db/545843/Capital_One_Ventures>,
        <https://1145.am/db/545852/Boxone_Ventures>,
        <https://1145.am/db/545852/Panache_Ventures>,
        <https://1145.am/db/547770/BGV>,
        <https://1145.am/db/547944/BGV>,
        <https://1145.am/db/554552/Konvoy_Ventures>,
        <https://1145.am/db/555193/Illumina_Ventures>,
        <https://1145.am/db/555193/Technology_Venture_Partners>,
        <https://1145.am/db/556705/Congress_Ave_Ventures>,
        <https://1145.am/db/558005/Illumina_Ventures>,
        <https://1145.am/db/558005/Technology_Venture_Partners>,
        <https://1145.am/db/558877/Falabella_Ventures>,
        <https://1145.am/db/559220/Ulu_Ventures>,
        <https://1145.am/db/561662/Redpoint_Ventures>,
        <https://1145.am/db/561662/Vandelay_Ventures>,
        <https://1145.am/db/562745/Vinmar_Ventures>,
        <https://1145.am/db/563575/Celesta_Capital>,
        <https://1145.am/db/564008/D1_Ventures>,
        <https://1145.am/db/571769/Illumina_Ventures>,
        <https://1145.am/db/571769/M_Ventures>,
        <https://1145.am/db/572097/Menlo_Ventures>,
        <https://1145.am/db/572097/Teneleven_Ventures>,
        <https://1145.am/db/575249/TCV>,
        <https://1145.am/db/576186/Konvoy_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/586525/Tenoneten_Ventures>,
        <https://1145.am/db/587038/Coparion>,
        <https://1145.am/db/591566/Morningside_Ventures>,
        <https://1145.am/db/596145/Anorak_Ventures>,
        <https://1145.am/db/596564/Anorak_Ventures>,
        <https://1145.am/db/601455/Morningside_Ventures>,
        <https://1145.am/db/603725/Ignitexl_Ventures>,
        <https://1145.am/db/606074/Fiscus_Ventures>,
        <https://1145.am/db/606144/Ggv_Capital>,
        <https://1145.am/db/615337/Companyon_Ventures>,
        <https://1145.am/db/619284/Scf_Ventures>,
        <https://1145.am/db/619366/Capital_One_Ventures>,
        <https://1145.am/db/619736/Lightspeed_Ventures>,
        <https://1145.am/db/623178/Array_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/626781/Dnx_Ventures>,
        <https://1145.am/db/627030/Launchpad_Capital>,
        <https://1145.am/db/628654/Prologis_Ventures>,
        <https://1145.am/db/633238/True_Ventures>,
        <https://1145.am/db/633869/Skywell_Capital_Partners>,
        <https://1145.am/db/633869/Stageone_Ventures>,
        <https://1145.am/db/640939/Ggv_Capital>,
        <https://1145.am/db/642123/Charles_River_Ventures>,
        <https://1145.am/db/642518/Network_Ventures>,
        <https://1145.am/db/643600/Vinco_Ventures>,
        <https://1145.am/db/648552/True_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/659675/Gv>,
        <https://1145.am/db/661747/Adit_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/665129/Ac_Ventures>,
        <https://1145.am/db/665776/Firstime_Ventures>,
        <https://1145.am/db/676217/Steelsky_Ventures>,
        <https://1145.am/db/676869/Ggv_Capital>,
        <https://1145.am/db/678140/Ggv_Capital>,
        <https://1145.am/db/678587/Lightshed_Ventures>,
        <https://1145.am/db/678593/Solana_Ventures>,
        <https://1145.am/db/687538/Kayyak_Ventures>,
        <https://1145.am/db/689460/True_Ventures>,
        <https://1145.am/db/694513/Authentic_Ventures>,
        <https://1145.am/db/694924/Avid_Ventures>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/700327/Menlo_Ventures>,
        <https://1145.am/db/700877/Gaingels>,
        <https://1145.am/db/703983/Eqventure>,
        <https://1145.am/db/704489/Eqventure>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/704753/Menlo_Ventures>,
        <https://1145.am/db/704793/Quidnet_Ventures>,
        <https://1145.am/db/704991/Gaingels>,
        <https://1145.am/db/709633/Connetic_Ventures>,
        <https://1145.am/db/726461/Contour_Ventures>,
        <https://1145.am/db/729628/Kyber_Ventures>,
        <https://1145.am/db/729628/Signum_Capital>,
        <https://1145.am/db/738920/Oca_Ventures>,
        <https://1145.am/db/738920/Susa_Ventures>,
        <https://1145.am/db/739538/Morpheus_Ventures>,
        <https://1145.am/db/739538/Oca_Ventures>,
        <https://1145.am/db/739538/Susa_Ventures>,
        <https://1145.am/db/747051/Tenoneten_Ventures>,
        <https://1145.am/db/747771/Ta_Ventures>,
        <https://1145.am/db/749147/1984_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/1984_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/750305/Yl_Ventures>,
        <https://1145.am/db/750725/Vestigo_Ventures>,
        <https://1145.am/db/751176/Maverick_Ventures>,
        <https://1145.am/db/751176/Susa_Ventures>,
        <https://1145.am/db/751387/Menlo_Ventures>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/753251/Savantus_Ventures>,
        <https://1145.am/db/753913/Brunnur_Ventures>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/758206/Great_North_Ventures>,
        <https://1145.am/db/758206/Grotech_Ventures>,
        <https://1145.am/db/759749/Cava_Capital>,
        <https://1145.am/db/763083/Gaingels>,
        <https://1145.am/db/764875/Rev1_Ventures>,
        <https://1145.am/db/764896/Rev1_Ventures>,
        <https://1145.am/db/765216/True_Ventures>,
        <https://1145.am/db/768172/Gaingels>,
        <https://1145.am/db/768172/Type_One_Ventures>,
        <https://1145.am/db/768349/Salesforce_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769568/Axon_Ventures>,
        <https://1145.am/db/772099/Array_Ventures>,
        <https://1145.am/db/773235/Prelude_Ventures>,
        <https://1145.am/db/773684/Fulgur_Ventures>,
        <https://1145.am/db/773794/Array_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/778423/Sentiero_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/779867/Genesis_Block_Ventures>,
        <https://1145.am/db/780272/East_Ventures>,
        <https://1145.am/db/780289/East_Ventures>,
        <https://1145.am/db/783431/Cathay_Venture_Inc>,
        <https://1145.am/db/784093/Boldstart_Ventures>,
        <https://1145.am/db/787806/Boldstart_Ventures>,
        <https://1145.am/db/788016/Boldstart_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796250/Sp_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/797597/Lansdowne_Partners>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/800101/Gaingels>,
        <https://1145.am/db/803541/Credo_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/8045/Greatpoint_Ventures>,
        <https://1145.am/db/806828/Promus_Ventures>,
        <https://1145.am/db/806994/Companyon_Ventures>,
        <https://1145.am/db/807080/K3_Ventures>,
        <https://1145.am/db/808020/Starlight_Ventures>,
        <https://1145.am/db/808020/Valo_Ventures>,
        <https://1145.am/db/8146/Rev1_Ventures>,
        <https://1145.am/db/817162/Orbia_Ventures>,
        <https://1145.am/db/818444/1984_Ventures>,
        <https://1145.am/db/821135/Se_Ventures>,
        <https://1145.am/db/823763/Infinity_Ventures>,
        <https://1145.am/db/828716/Idc_Ventures>,
        <https://1145.am/db/829118/Salesforce_Ventures>,
        <https://1145.am/db/830571/Company_Ventures>,
        <https://1145.am/db/830689/Soleus_Capital>,
        <https://1145.am/db/832264/Salesforce_Ventures>,
        <https://1145.am/db/832573/Solasta_Ventures>,
        <https://1145.am/db/834864/Ggv_Capital>,
        <https://1145.am/db/834864/K3_Ventures>,
        <https://1145.am/db/836848/Technexus_Venture_Collaborative>,
        <https://1145.am/db/836908/Frontier_Ventures>,
        <https://1145.am/db/837034/Redpoint_Ventures>,
        <https://1145.am/db/838138/Root_Ventures>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/847157/Signum_Capital>,
        <https://1145.am/db/847862/Wise_Ventures>,
        <https://1145.am/db/854001/Gv>,
        <https://1145.am/db/854589/Verance_Capital>,
        <https://1145.am/db/854654/Mrtnz_Ventures>,
        <https://1145.am/db/854795/Menlo_Ventures>,
        <https://1145.am/db/867865/Applied_Ventures>,
        <https://1145.am/db/868093/Cobro_Ventures>,
        <https://1145.am/db/869652/Forever_Ventures>,
        <https://1145.am/db/874394/Nextview_Ventures>,
        <https://1145.am/db/874394/True_Ventures>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/881298/At_One_Ventures>,
        <https://1145.am/db/882723/At_One_Ventures>,
        <https://1145.am/db/884787/Foresite_Capital>,
        <https://1145.am/db/884787/Gv>,
        <https://1145.am/db/884787/Northpond_Ventures>,
        <https://1145.am/db/886445/Gv>,
        <https://1145.am/db/887062/Panoramic_Ventures>,
        <https://1145.am/db/889246/At_One_Ventures>,
        <https://1145.am/db/890271/Panoramic_Ventures>,
        <https://1145.am/db/891162/Emergingvc>,
        <https://1145.am/db/891162/Launchpad_Venture_Group>,
        <https://1145.am/db/903689/Vectr_Ventures>,
        <https://1145.am/db/904276/Nextview_Ventures>,
        <https://1145.am/db/906393/East_Ventures>,
        <https://1145.am/db/907844/Argon_Ventures>,
        <https://1145.am/db/907844/Glasswing_Ventures>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/913678/Sandbridge_Capital>,
        <https://1145.am/db/919636/Menlo_Ventures>,
        <https://1145.am/db/921704/Scop_Ventures>,
        <https://1145.am/db/92200/Knoll_Ventures>,
        <https://1145.am/db/922066/Irrvrnt_Vc>,
        <https://1145.am/db/922192/Gv>,
        <https://1145.am/db/922498/Sozo_Ventures>,
        <https://1145.am/db/923723/Scop_Ventures>,
        <https://1145.am/db/928711/Frontline_Ventures>,
        <https://1145.am/db/934946/Ggv_Capital>,
        <https://1145.am/db/935046/Origin_Ventures>,
        <https://1145.am/db/935249/Victress_Capital>,
        <https://1145.am/db/935322/Alpana_Ventures>,
        <https://1145.am/db/935322/M_Ventures>,
        <https://1145.am/db/935796/Salesforce_Ventures>,
        <https://1145.am/db/935962/Digitalbridge_Ventures>,
        <https://1145.am/db/936045/Lpc_Ventures>,
        <https://1145.am/db/936057/Noemis_Ventures>,
        <https://1145.am/db/936154/Salesforce_Ventures>,
        <https://1145.am/db/936448/Ggv_Capital>,
        <https://1145.am/db/936862/Lool_Ventures>,
        <https://1145.am/db/936906/Neotribe_Ventures>,
        <https://1145.am/db/937210/Citi_Ventures>,
        <https://1145.am/db/937210/Firebolt_Ventures>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/938108/Conti_Ventures>,
        <https://1145.am/db/938555/Digitalbridge_Ventures>,
        <https://1145.am/db/938586/Venturesouth>,
        <https://1145.am/db/938921/Redpoint_Ventures>,
        <https://1145.am/db/938975/Ggv_Capital>,
        <https://1145.am/db/939163/Goodyear_Ventures>,
        <https://1145.am/db/940740/Agnc_Ventures>,
        <https://1145.am/db/940913/True_Ventures>,
        <https://1145.am/db/941816/Radical_Ventures>,
        <https://1145.am/db/942825/Argon_Ventures>,
        <https://1145.am/db/946710/Citi_Ventures>,
        <https://1145.am/db/947238/Kyros_Ventures>,
        <https://1145.am/db/952434/Verissimo_Ventures>,
        <https://1145.am/db/955201/Gv>,
        <https://1145.am/db/960022/Verance_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/970950/Ulu_Ventures>,
        <https://1145.am/db/971415/Altai_Ventures>,
        <https://1145.am/db/971450/Allon_Ventures>,
        <https://1145.am/db/971939/Formic_Ventures>,
        <https://1145.am/db/975114/Formic_Ventures>,
        <https://1145.am/db/979753/Menlo_Ventures>,
        <https://1145.am/db/980678/Menlo_Ventures>,
        <https://1145.am/db/984645/Vinco_Ventures>,
        <https://1145.am/db/987688/Brightspark_Ventures>,
        <https://1145.am/db/987700/Infinityvc>,
        <https://1145.am/db/988084/Abstract_Ventures>,
        <https://1145.am/db/988084/Blank_Ventures>,
        <https://1145.am/db/988318/Arthur_Ventures>,
        <https://1145.am/db/988482/Brightspark_Ventures>,
        <https://1145.am/db/988979/Infinityvc>,
        <https://1145.am/db/989392/Arthur_Ventures>,
        <https://1145.am/db/990085/Radical_Ventures>,
        <https://1145.am/db/995593/Raiven_Capital>,
        <https://1145.am/db/995737/Nuoyan_Capital>,
        <https://1145.am/db/996563/Raiven_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1704643/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1713745/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1825596/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1846737/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1861044/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866492/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1872463/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1873191/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1876054/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1880666/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1884011/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890172/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1894610/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1906154/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1911282/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1911316/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2206261/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2206263/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2292797/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2293308/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2312700/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2340423/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2349519/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2362862/Mohr_Davidow_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340429/Series_D_Investment_Acadia_Woods_Alloy_Ventures_Mohr_Davidow_Ventures_Quaker_Bioventures_Raindance_Technologies_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-25T13:21:26+00:00"^^xsd:dateTime ;
    ns1:documentExtract "LEXINGTON, Mass., January 25, 2011 - RainDance Technologies, Inc., the leading provider of microdroplet - based solutions for single molecule and single cell analysis, today announced that it has closed a Series D financing round of $ 37.5 million.",
        "RainDance Technologies Raises $ 37.5 Million in Series D Financing.",
        "RainDance Technologies, the leading provider of microdroplet - based solutions for single molecule and single cell analysis, today announced that it has closed a Series D financing round of $ 37.5 million." ;
    ns1:documentTitle "RainDance Technologies Raises $37.5 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/raindance-technologies-raises-37-5-million-series-d-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2340429/Raindance_Technologies> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "$ 37.5 Million",
        "$ 37.5 million" ;
    ns1:when "2011-01-25T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "January 25, 2011" ;
    ns1:whereGeoName "Lexington" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4941935/about.rdf> ;
    ns1:whereRaw "LEXINGTON, Mass" .

<https://1145.am/db/2342445/Investment_Ascension_Health_Ventures_Ocular_Therapeutix_Polaris_Venture_Partners_Sv_Life_Sciences_Versant_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-02-03T15:22:43+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Bedford, MA - based Ocular Therapeutix has raised an additional $ 14 million in its fourth round, according to a report from Xconomy's Ryan McBride.",
        "Ocular has now raised more than $ 41 million as it plots mid-stage work on new therapies for pink eye and glaucoma." ;
    ns1:documentTitle "Ocular Therapeutix garners $14M for mid-stage eye drug trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ocular-therapeutix-garners-14m-for-mid-stage-eye-drug-trials> ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "stopped" ;
    ns1:target <https://1145.am/db/2342445/Ocular_Therapeutix> ;
    ns1:valueRaw "$ 14 million" ;
    ns1:whereGeoName "Bedford" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4930183/about.rdf> ;
    ns1:whereRaw "Bedford, MA" .

<https://1145.am/db/2347571/Series_B_Investment_Advent_Life_Sciences_Amunix_Index_Ventures_New_Leaf_Venture_Partners_Versartis_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-02-16T15:02:22+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MOUNTAIN VIEW, CA- (Marketwire - February 16, 2011) - Versartis, Inc., an emerging biotechnology company developing novel therapeutics for patients with endocrine disorders, today announced completion of a $ 21 million Series B financing.",
        "Versartis Completes $ 21 Million Series B Financing." ;
    ns1:documentTitle "Versartis Completes $21 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/versartis-completes-21-million-series-b-financing-0> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2347571/Versartis> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 21 Million",
        "$ 21 million" ;
    ns1:when "2011-02-16T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "February 16, 2011" ;
    ns1:whereGeoName "Mountain View" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5375480/about.rdf> ;
    ns1:whereRaw "MOUNTAIN VIEW, CA" .

<https://1145.am/db/2348618/Series_B_Investment_Advent_Life_Sciences_Amunix_Index_Ventures_New_Leaf_Venture_Partners_Versartis_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-02-22T13:27:41+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Mountain View, CA - February 16, 2011 - Versartis, Inc., an emerging biotechnology company developing novel therapeutics for patients with endocrine disorders, today announced completion of a $ 21 million Series B financing.",
        "Versartis Completes $ 21 Million Series B Financing." ;
    ns1:documentTitle "Versartis Completes $21 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/versartis-completes-21-million-series-b-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2348618/Versartis> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 21 Million",
        "$ 21 million" ;
    ns1:when "2011-02-16T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "February 16, 2011" ;
    ns1:whereGeoName "Mountain View" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5375480/about.rdf> ;
    ns1:whereRaw "Mountain View, CA" .

<https://1145.am/db/2358737/Third_Rock_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:description "a venture capitalist" ;
    ns1:documentDate "2011-06-30T12:39:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lotus Tissue Repair, Inc. Secures $26 Million Series A Financing to Develop First-in-Class Protein Replacement Therapy for Dystr" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lotus-tissue-repair-inc-secures-26-million-series-a-financing-to-develop-first-class> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:industry "life sciences" ;
    ns1:investor <https://1145.am/db/2358737/Series_A_Investment_Lotus_Tissue_Repair_Inc_Third_Rock_Ventures_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/1782938/Third_Kind_Venture_Capital>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2339925/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359865/Third_Rock>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2365109/Third_Rock_Ventures>,
        <https://1145.am/db/2365111/Third_Rock_Ventures>,
        <https://1145.am/db/2368501/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/2371304/Third_Rock>,
        <https://1145.am/db/572554/Third_Rock_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2338625/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2341792/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354307/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2359987/Third_Rock_Ventures>,
        <https://1145.am/db/2360006/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2364240/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366539/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2369202/Third_Rock_Ventures>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2363854/Series_B_Investment_Beringea_Chrysalis_Ventures_Hopen_Life_Sciences_Intervention_Insights_Michigan_Accelerator_Fund_I_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-19T12:32:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "FARMINGTON HILLS, Mich. - Beringea, Michigan's largest and most active venture and expansion-stage capital investor, has invested in Intervention Insights, a Grand Rapids - based healthcare information technology company which helps community oncologists develop individualized patient treatment plans.",
        "The investment was part of Intervention Insight's $ 7.2 million Series B financing round, co - led by Beringea and Louisville, Ky. - based Chrysalis Ventures, and joined by Hopen Life Sciences, Michigan Accelerator Fund I and other existing investors." ;
    ns1:documentTitle "Beringea Invests in Healthcare IT Company Intervention Insights" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/beringea-invests-healthcare-it-company-intervention-insights> ;
    ns1:foundName "financing",
        "invested" ;
    ns1:name "financing",
        "invested" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2363854/Intervention_Insights> ;
    ns1:targetDetails "Series B" ;
    ns1:targetName "Intervention Insights" ;
    ns1:valueRaw "$ 7.2 million" ;
    ns1:whereGeoName "Kentucky",
        "Michigan" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5001836/about.rdf>,
        <https://sws.geonames.org/6254925/about.rdf> ;
    ns1:whereRaw "Kentucky",
        "Michigan" .

<https://1145.am/db/2364240/Third_Rock_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:documentDate "2011-04-11T12:06:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blueprint Medicines Secures $40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/blueprint-medicines-secures-40-million-series-a-financing-to-translate-new-molecular-data> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:investor <https://1145.am/db/2364240/Series_A_Investment_Blueprint_Medicines_Third_Rock_Ventures_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2338625/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339925/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2341792/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354307/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2358737/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2359987/Third_Rock_Ventures>,
        <https://1145.am/db/2360006/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365109/Third_Rock_Ventures>,
        <https://1145.am/db/2365111/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366539/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2368501/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2369202/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/572554/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365109/Third_Rock_Ventures> a org:Organization ;
    ns1:basedInLowRaw "LEXINGTON" ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-04-13T11:12:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TARIS Closes $18.3 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/taris-closes-18-3-million-series-b-financing-0> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:investor <https://1145.am/db/2365109/Equity_Investment_Taris_Biomedical_Third_Rock_Ventures_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/1782938/Third_Kind_Venture_Capital>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2339925/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2358737/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2365111/Third_Rock_Ventures>,
        <https://1145.am/db/2368501/Third_Rock_Ventures>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/572554/Third_Rock_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2338625/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2341792/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354307/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2359987/Third_Rock_Ventures>,
        <https://1145.am/db/2360006/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2364240/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366539/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2369202/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365111/Third_Rock_Ventures> a org:Organization ;
    ns1:basedInLowRaw "LEXINGTON" ;
    ns1:description "Investing" ;
    ns1:documentDate "2011-04-13T11:20:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TARIS Closes $18.3 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/taris-closes-18-3-million-series-b-financing> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:investor <https://1145.am/db/2365111/Equity_Investment_Taris_Biomedical_Third_Rock_Ventures_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/1782938/Third_Kind_Venture_Capital>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2339925/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2358737/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2365109/Third_Rock_Ventures>,
        <https://1145.am/db/2368501/Third_Rock_Ventures>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/572554/Third_Rock_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2338625/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2341792/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354307/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2359987/Third_Rock_Ventures>,
        <https://1145.am/db/2360006/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2364240/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366539/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2369202/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365376/Investment_Cevec_Pharmaceuticals_Creathor_Venture_Fonds_Kfw_Bank_Kfw_Bank_Nrwbank_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-28T11:27:16+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CEVEC Pharma Raises $ 8.5 Million to Commercialize Human-Cell Expression Platform for Proteins and Vaccines.",
        "Cologne, Germany, July 25, 2011 / B3C newswire / - CEVEC Pharmaceuticals, licensing its human CAP Technology based expression system for proteins and vaccines, today announced the closing of a 6M financing round." ;
    ns1:documentTitle "CEVEC Pharma Raises $8.5 Million to Commercialize Human-Cell Expression Platform for Proteins and Vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cevec-pharma-raises-8-5-million-to-commercialize-human-cell-expression-platform-for> ;
    ns1:foundName "Raises",
        "financing" ;
    ns1:name "Raises",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2365376/Cevec_Pharmaceuticals> ;
    ns1:valueRaw "$ 8.5 Million",
        "6M" ;
    ns1:when "2011-07-25T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "July 25, 2011" ;
    ns1:whereGeoName "Pharma" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/10678659/about.rdf> ;
    ns1:whereRaw "CEVEC Pharma" .

<https://1145.am/db/2366539/Third_Rock_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2011-04-20T11:04:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team New Financing Will Further A" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/bluebird-bio-secures-additional-30-million-financing-arch-venture-partners-joins-investor> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:investor <https://1145.am/db/2366539/Investment_Arch_Venture_Partners_Easton_Capital_Investment_Group_Forbion_Capital_Partners_Tvm_Capital_Third_Rock_Ventures_Bluebird_Bio_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2338625/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339925/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2341792/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354307/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2358737/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2359987/Third_Rock_Ventures>,
        <https://1145.am/db/2360006/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2364240/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365109/Third_Rock_Ventures>,
        <https://1145.am/db/2365111/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2368501/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2369202/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/572554/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2577419/Osi_Pharmaceuticals_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2010-12-23T12:50:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Biovail ($ BVF) and Valeant Pharmaceuticals ($ VRX) merged in a $ 3.2 billion deal.",
        "Japan's Astellas Pharma bought OSI Pharmaceuticals for $ 4 billion." ;
    ns1:documentTitle "Dealmaking goes from mega to mini" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/dealmaking-goes-from-mega-to-mini> ;
    ns1:foundName "bought",
        "merged" ;
    ns1:name "bought",
        "merged" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2577419/Osi_Pharmaceuticals> ;
    ns1:targetName "OSI Pharmaceuticals" ;
    ns1:valueRaw "$ 3.2 billion",
        "$ 4 billion" ;
    ns1:whereGeoName "Japan" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1861060/about.rdf> ;
    ns1:whereRaw "Japan" .

<https://1145.am/db/2598807/Clec_One_Communications_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:description "telecom service provider" ;
    ns1:documentDate "2011-04-04T15:42:09+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Following CenturyLink's much expected closing of its merger with Qwest and EarthLink's deal to acquire CLEC One Communications, TelePacific's completion of its acquisition of MegaPath's NextWeb subsidiary Covad Wireless caps off what has been a busy week for telecom service provider M & A." ;
    ns1:documentTitle "TelePacific finishes acquisition of Covad's wireless unit" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/telepacific-finishes-acquisition-covad-s-wireless-unit> ;
    ns1:foundName "CLEC One Communications",
        "acquire",
        "merger" ;
    ns1:industry "telecom service provider" ;
    ns1:name "CLEC One Communications",
        "acquire",
        "merger" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2598807/Clec_One_Communications_Acquisition> ;
    ns1:targetName "CLEC One Communications" ;
    ns1:vendor <https://1145.am/db/2598807/Megapaths_Nextweb> .

<https://1145.am/db/2618630/Cable___Wireless_Worldwide> a org:Organization ;
    ns1:basedInLowRaw "Bermuda",
        "SingTel" ;
    ns1:description "telecommunications" ;
    ns1:documentDate "2011-02-23T15:46:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cable & Wireless to sell off its Bermuda business" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/cable-wireless-to-sell-off-its-bermuda-business> ;
    ns1:foundName "Cable & Wireless",
        "Cable & Wireless Worldwide" ;
    ns1:industry "telecommunications" ;
    ns1:investor <https://1145.am/db/2618630/Bahamas_Telecom_Company_Investment>,
        <https://1145.am/db/2618630/Investment_Cable___Wireless_Worldwide_Has_Not_Happened> ;
    ns1:name "Cable & Wireless",
        "Cable & Wireless Worldwide" ;
    ns1:sameAsHigh <https://1145.am/db/2159394/The_Society_Of_Cable_Telecommunications_Engineers>,
        <https://1145.am/db/2161554/Cablecom>,
        <https://1145.am/db/2171269/Npg_Cable>,
        <https://1145.am/db/2599495/J:_Com>,
        <https://1145.am/db/2599515/J:_Com>,
        <https://1145.am/db/2601443/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2601480/Cable___Wireless_Communications>,
        <https://1145.am/db/2602679/Cablecom>,
        <https://1145.am/db/2605253/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2607479/Cable___Wireless_Communications>,
        <https://1145.am/db/2614188/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2617542/Cablelabs>,
        <https://1145.am/db/2617934/Cable___Wireless_Communications>,
        <https://1145.am/db/2618856/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2619256/Cable___Wireless>,
        <https://1145.am/db/2619431/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2619973/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2619998/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2649437/Mediacom_Communications>,
        <https://1145.am/db/2666765/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2672886/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2673796/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2673808/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2673830/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2673851/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2674384/Cable___Wireless>,
        <https://1145.am/db/2674986/Cable___Wireless_Worldwide> ;
    ns1:sameAsMedium <https://1145.am/db/1896956/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2602132/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2618135/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2618871/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2620930/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2620945/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2651481/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2667028/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2667032/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2668097/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2670315/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2672664/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2673809/Cable___Wireless_Worldwide>,
        <https://1145.am/db/2680795/Cable___Wireless_Worldwide> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2686194/Nokia_Siemens_Networks_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2011-06-27T14:29:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Nokia (NYSE: NOK) and Germany's Siemens have decided to stop attempting to sell a controlling stake in Nokia Siemens Networks to private equity firms, according to a report in the Wall Street Journal." ;
    ns1:documentTitle "Report: Nokia, Siemens abandon private equity push for NSN" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-nokia-siemens-abandon-private-equity-push-for-nsn> ;
    ns1:foundName "purchase",
        "sell" ;
    ns1:name "purchase",
        "sell" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "stopped" ;
    ns1:target <https://1145.am/db/2686194/Nokia_Siemens_Networks>,
        <https://1145.am/db/2686194/Siemens> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Nokia Siemens Networks" ;
    ns1:vendor <https://1145.am/db/2686194/Nokia_Siemens_Networks>,
        <https://1145.am/db/2686194/Siemens> ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "Germany" .

<https://1145.am/db/2234558/Series_D_Investment_Accel_Partners_Centrify_Corporation_Invesco_Private_Capital_Index_Ventures_Mayfield_Fund_Sigma_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-08-17T12:20:40+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SUNNYVALE, Calif., Aug. 17, 2011 /PRNewswire/ - Centrify Corporation, the leading provider of security and compliance solutions that centrally control, secure and audit both on-premise and cloud - based systems and applications, today announced that it has closed its Series D round of financing." ;
    ns1:documentTitle "Centrify Secures $16M in Financing to Expand Distribution and Extend Its On-Premise and Cloud Security Offerings" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/centrify-secures-16m-financing-to-expand-distribution-and-extend-its-premise-and-cloud> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2234558/Centrify_Corporation> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "$ 16 million" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "Sunnyvale" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5400075/about.rdf> ;
    ns1:whereRaw "SUNNYVALE, Calif" .

<https://1145.am/db/2247240/Series_B_Investment_Blueocean_Ventures_Gran_Plasa_Sa_Initiative_Capital_Romandie_Myopowers_Medical_Technologies_Sa_Novartis_Venture_Funds_Truffle_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-05T14:20:38+00:00"^^xsd:dateTime ;
    ns1:documentExtract "LAUSANNE, Switzerland- (BUSINESS WIRE) - MyoPowers Medical Technologies SA (www.myopowers.com) , a Swiss medical device startup developing artificial muscle technologies to treat sphincter dysfunction and incontinences, announced today that it has closed a CHF 16 million Series B investment round led by Truffle Capital." ;
    ns1:documentTitle "MyoPowers Closes Series B Investment of CHF 16 Million" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/myopowers-closes-series-b-investment-chf-16-million> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2247240/Myopowers_Medical_Technologies_Sa> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "CHF 16 million" ;
    ns1:whereGeoName "Switzerland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:whereRaw "Switzerland" .

<https://1145.am/db/2290405/Equity_Investment_Battelle_Ventures_Bionanomatrix_Domain_Associates_Gund_Investment_Corporation_Innovation_Valley_Partners_Kt_Venture_Group_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-03-18T01:13:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "BioNanomatrix, a developer of nanoscale, single-molecule imaging and analysis platforms designed to dramatically reduce the time and cost needed to analyze the genome, has closed a $ 23.3 million Series B round of equity financing." ;
    ns1:documentTitle "Oxford Finance, GE Capital give $20M senior credit facility to NeoVista" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/oxford-finance-ge-capital-give-20m-senior-credit-facility-to-neovista> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2290405/Bionanomatrix> ;
    ns1:targetDetails "equity" ;
    ns1:valueRaw "$ 23.3 million" ;
    ns1:whereGeoName "Newark" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5376803/about.rdf> ;
    ns1:whereRaw "Newark, CA" .

<https://1145.am/db/2346532/Pappas_Ventures> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-02-14T14:19:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Chimerix, Inc. Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/chimerix-inc-completes-45-million-financing-to-fund-further-development-of-novel-antiviral> ;
    ns1:foundName "Pappas Ventures" ;
    ns1:investor <https://1145.am/db/2346532/Series_F_Investment_Alta_Partners_Asset_Management_Company_Canaan_Partners_Chimerix_Frazier_Healthcare_Ventures_Morningside_Group_New_Leaf_Venture_Partners_Pappas_Ventures_Sanderling_Ventures_Completed> ;
    ns1:name "Pappas Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1006252/Menlo_Ventures>,
        <https://1145.am/db/1006262/Com_Prelude_Ventures>,
        <https://1145.am/db/1006574/Integr8d_Capital>,
        <https://1145.am/db/1006880/Root_Ventures>,
        <https://1145.am/db/1007193/Capital_One_Ventures>,
        <https://1145.am/db/1007527/Integr8d_Capital>,
        <https://1145.am/db/1008085/Root_Ventures>,
        <https://1145.am/db/1008260/Servicenow_Ventures>,
        <https://1145.am/db/1010064/Greatpoint_Ventures>,
        <https://1145.am/db/1010064/Maverick_Ventures>,
        <https://1145.am/db/1010199/One9_Ventures>,
        <https://1145.am/db/102038/Allegion_Ventures>,
        <https://1145.am/db/102038/Pathbreaker_Ventures>,
        <https://1145.am/db/102038/West_Ventures>,
        <https://1145.am/db/1023252/Digitalbridge_Ventures>,
        <https://1145.am/db/1024247/Digitalbridge_Ventures>,
        <https://1145.am/db/1024483/Investbridge_Capital>,
        <https://1145.am/db/1026319/Able_Partners>,
        <https://1145.am/db/1034591/Valia_Ventures>,
        <https://1145.am/db/1041601/Kineo_Finance>,
        <https://1145.am/db/1042250/Kineo_Finance>,
        <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043342/Root_Ventures>,
        <https://1145.am/db/1043516/Kineo_Finance>,
        <https://1145.am/db/1045242/Dipalo_Ventures>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1051115/Dn_Capital>,
        <https://1145.am/db/1051644/Vestigo_Ventures>,
        <https://1145.am/db/1052155/Gate_Ventures>,
        <https://1145.am/db/1059993/Tera_Ventures>,
        <https://1145.am/db/1060146/Ulu_Ventures>,
        <https://1145.am/db/1061824/Bluebird_Ventures>,
        <https://1145.am/db/1061911/Ulu_Ventures>,
        <https://1145.am/db/1065366/Applied_Ventures_Llc>,
        <https://1145.am/db/1065544/Menlo_Ventures>,
        <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1081490/Vinco_Ventures>,
        <https://1145.am/db/1081888/Ggv_Capital>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/1082719/Dorilton_Ventures>,
        <https://1145.am/db/1082814/Cathexis_Ventures>,
        <https://1145.am/db/1082814/Promus_Ventures>,
        <https://1145.am/db/1082814/Type_One_Ventures>,
        <https://1145.am/db/1084014/Ret_Ventures>,
        <https://1145.am/db/1085867/Ret_Ventures>,
        <https://1145.am/db/1086604/Alerion_Ventures>,
        <https://1145.am/db/1086673/Wintrust_Ventures>,
        <https://1145.am/db/1089416/Nexo_Ventures>,
        <https://1145.am/db/1090643/Argon_Ventures>,
        <https://1145.am/db/1090643/Glasswing_Ventures>,
        <https://1145.am/db/1101244/Acequia_Capital>,
        <https://1145.am/db/1103270/Acequia_Capital>,
        <https://1145.am/db/1106082/Northpond_Ventures>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1111505/Nissay_Capital>,
        <https://1145.am/db/1111505/Remiges_Ventures>,
        <https://1145.am/db/1112074/Nissay_Capital>,
        <https://1145.am/db/1112074/Remiges_Ventures>,
        <https://1145.am/db/1114979/Catapult_Ventures>,
        <https://1145.am/db/1115103/Northpond_Ventures>,
        <https://1145.am/db/1119456/Truist_Ventures>,
        <https://1145.am/db/1119699/Prelude_Ventures>,
        <https://1145.am/db/1120030/Morpheus_Ventures>,
        <https://1145.am/db/1120030/Point72_Ventures>,
        <https://1145.am/db/1120071/Morpheus_Ventures>,
        <https://1145.am/db/1120071/Point72_Ventures>,
        <https://1145.am/db/1122750/Prelude_Ventures>,
        <https://1145.am/db/1129561/Redbeard_Ventures>,
        <https://1145.am/db/1130744/Redbeard_Ventures>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1134165/Boldstart_Ventures>,
        <https://1145.am/db/1136173/Boldstart_Ventures>,
        <https://1145.am/db/1137178/CRV>,
        <https://1145.am/db/1138154/Ggv_Capital>,
        <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1140286/Origin_Ventures>,
        <https://1145.am/db/1141736/Redpoint_Ventures>,
        <https://1145.am/db/1150154/Riv_Capital>,
        <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1150529/Solasta_Ventures>,
        <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1151736/True_Ventures>,
        <https://1145.am/db/1152929/Aperiamventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1154242/True_Ventures>,
        <https://1145.am/db/1163139/Sentiero_Ventures>,
        <https://1145.am/db/1163139/Skyriver_Ventures>,
        <https://1145.am/db/1164299/Lavrock_Ventures>,
        <https://1145.am/db/1164299/Progress_Ventures>,
        <https://1145.am/db/1164688/Abstract_Ventures>,
        <https://1145.am/db/1164688/Spacecadet_Ventures>,
        <https://1145.am/db/1164845/Lavrock_Ventures>,
        <https://1145.am/db/1164845/Progress_Ventures>,
        <https://1145.am/db/1165515/G2_Group_Ventures>,
        <https://1145.am/db/1166154/Allos_Ventures>,
        <https://1145.am/db/1166957/Seedil_Ventures>,
        <https://1145.am/db/1168757/Accomplice_Ventures>,
        <https://1145.am/db/1169687/Artiman_Ventures>,
        <https://1145.am/db/1169687/J_Ventures>,
        <https://1145.am/db/1169687/Nd_Capital>,
        <https://1145.am/db/1169815/Accomplice_Ventures>,
        <https://1145.am/db/1170971/Equinor_Ventures>,
        <https://1145.am/db/1173428/Equinor_Ventures>,
        <https://1145.am/db/1175576/Divcowest_Ventures>,
        <https://1145.am/db/1175576/Point72_Ventures>,
        <https://1145.am/db/1175576/Signia_Ventures>,
        <https://1145.am/db/1176018/First_Star_Ventures>,
        <https://1145.am/db/1187600/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/11887/Adv>,
        <https://1145.am/db/1190097/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/1190127/Animo_Ventures>,
        <https://1145.am/db/1190127/Chaac_Ventures>,
        <https://1145.am/db/1190127/Ulu_Ventures>,
        <https://1145.am/db/1196068/Arthur_Ventures>,
        <https://1145.am/db/1196728/Greatpoint_Ventures>,
        <https://1145.am/db/1199177/Greatpoint_Ventures>,
        <https://1145.am/db/1199182/Boxone_Ventures>,
        <https://1145.am/db/1202673/Basecamp_Ventures>,
        <https://1145.am/db/1203180/Basecamp_Ventures>,
        <https://1145.am/db/1206820/Tenoneten_Ventures>,
        <https://1145.am/db/1208519/Tappanhill_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1208749/Keshif_Ventures>,
        <https://1145.am/db/1208749/Tenoneten_Ventures>,
        <https://1145.am/db/1213076/Equinor_Ventures>,
        <https://1145.am/db/1213076/Scf_Ventures>,
        <https://1145.am/db/1213119/Nevcaut_Ventures>,
        <https://1145.am/db/1215930/Northpond_Ventures>,
        <https://1145.am/db/1219982/Soma_Ventures>,
        <https://1145.am/db/1221237/C2_Ventures>,
        <https://1145.am/db/1222789/Glasswing_Ventures>,
        <https://1145.am/db/1232497/Droia_Ventures>,
        <https://1145.am/db/1232497/Gv>,
        <https://1145.am/db/1233314/Citta_Capital>,
        <https://1145.am/db/1236549/Adit_Ventures>,
        <https://1145.am/db/1247755/Sinewave_Ventures>,
        <https://1145.am/db/1247761/Clear_Ventures>,
        <https://1145.am/db/1248631/Sinewave_Ventures>,
        <https://1145.am/db/1252447/Gaingels>,
        <https://1145.am/db/1256269/Ampd_Ventures_Inc>,
        <https://1145.am/db/1264028/K3_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1268150/Pender_Ventures>,
        <https://1145.am/db/1269968/Abstract_Ventures>,
        <https://1145.am/db/1272468/Launchpad_Capital>,
        <https://1145.am/db/1279264/Roosh_Ventures>,
        <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1282820/Agya_Ventures>,
        <https://1145.am/db/1286872/Morevc>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1297417/Bitkraft_Ventures>,
        <https://1145.am/db/1299578/Seedtob_Capital>,
        <https://1145.am/db/1307620/Inventus_Capital_Partners>,
        <https://1145.am/db/1311917/Avid_Ventures>,
        <https://1145.am/db/1311917/Canapi_Ventures>,
        <https://1145.am/db/1322441/Solana_Ventures>,
        <https://1145.am/db/1326376/Dexcom_Ventures>,
        <https://1145.am/db/1329887/Peter_Nagar>,
        <https://1145.am/db/1331691/Pelion_Ventures>,
        <https://1145.am/db/1332798/Acrobator_Ventures>,
        <https://1145.am/db/1334186/First_Ascent_Ventures>,
        <https://1145.am/db/1334193/Version_One_Ventures>,
        <https://1145.am/db/1334395/Gv>,
        <https://1145.am/db/1334895/Soleus_Capital>,
        <https://1145.am/db/1335073/Yl_Ventures>,
        <https://1145.am/db/1335080/Dorilton_Ventures>,
        <https://1145.am/db/1344240/Neotribe_Ventures>,
        <https://1145.am/db/1352420/Vamos_Ventures>,
        <https://1145.am/db/1353145/Infinity_Ventures>,
        <https://1145.am/db/1362743/Cobalt_Ventures>,
        <https://1145.am/db/1373683/BGV>,
        <https://1145.am/db/1375916/J2_Ventures>,
        <https://1145.am/db/1376353/J2_Ventures>,
        <https://1145.am/db/1378599/Menlo_Ventures>,
        <https://1145.am/db/1381832/Northpond_Ventures>,
        <https://1145.am/db/1382787/Northpond_Ventures>,
        <https://1145.am/db/1383818/Newlin_Ventures>,
        <https://1145.am/db/1387557/Naventures>,
        <https://1145.am/db/138878/Metacartel_Ventures>,
        <https://1145.am/db/1398057/Owen_Van_Natta_Temaris___Associates>,
        <https://1145.am/db/1398917/Trousdale_Ventures>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1407614/C2_Ventures>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1411934/Riptide_Ventures>,
        <https://1145.am/db/1425749/Menlo_Ventures>,
        <https://1145.am/db/1425749/Se_Ventures>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1445378/Mvp_Ventures>,
        <https://1145.am/db/1445935/Verissimo_Ventures>,
        <https://1145.am/db/1449316/+Nd_Capital>,
        <https://1145.am/db/1449740/Mistral_Ventures>,
        <https://1145.am/db/1452107/Abstract_Ventures>,
        <https://1145.am/db/1455216/Engage_Ventures>,
        <https://1145.am/db/1455616/Abstract_Ventures>,
        <https://1145.am/db/1463829/1sharpe_Ventures>,
        <https://1145.am/db/1467693/Preseed_Ventures>,
        <https://1145.am/db/1467892/M_Ventures>,
        <https://1145.am/db/1467932/Sequoia_Capital_Gv>,
        <https://1145.am/db/1468981/Preseed_Ventures>,
        <https://1145.am/db/1476448/Origin_Ventures>,
        <https://1145.am/db/1480152/True_Ventures>,
        <https://1145.am/db/1480651/Glasswing_Ventures>,
        <https://1145.am/db/1480989/Infinity_Ventures>,
        <https://1145.am/db/1481875/Infinity_Ventures>,
        <https://1145.am/db/1482705/Oif_Ventures>,
        <https://1145.am/db/1484103/Boxone_Ventures>,
        <https://1145.am/db/1484857/Iu_Ventures>,
        <https://1145.am/db/1488858/Alkeon_Capital>,
        <https://1145.am/db/1490126/Seedtob_Capital>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490978/Seedtob_Capital>,
        <https://1145.am/db/1492889/Future_Ventures>,
        <https://1145.am/db/1492889/Radical_Ventures>,
        <https://1145.am/db/1494028/Alkeon_Capital>,
        <https://1145.am/db/1496360/Realist_Ventures>,
        <https://1145.am/db/1503768/Nevateam_Partners>,
        <https://1145.am/db/1508325/Aramco_Ventures>,
        <https://1145.am/db/1509462/F7_Ventures>,
        <https://1145.am/db/1512891/Acme_Capital>,
        <https://1145.am/db/1515109/Cmfg_Ventures>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1520070/Menlo_Ventures>,
        <https://1145.am/db/1520070/Northpond_Ventures>,
        <https://1145.am/db/1520772/January_Ventures>,
        <https://1145.am/db/1537166/Catalio_Capital_Management>,
        <https://1145.am/db/1537970/Catalio_Capital_Management>,
        <https://1145.am/db/1541308/Panoramic_Ventures>,
        <https://1145.am/db/1541797/G1_Ventures>,
        <https://1145.am/db/1545833/Alerion_Ventures>,
        <https://1145.am/db/1545994/Noemis_Ventures>,
        <https://1145.am/db/1546945/Alerion_Ventures>,
        <https://1145.am/db/1546965/Citi_Ventures>,
        <https://1145.am/db/1546965/Truist_Ventures>,
        <https://1145.am/db/1547281/Noemis_Ventures>,
        <https://1145.am/db/1548592/Gopoint_Ventures>,
        <https://1145.am/db/1556397/Dnx_Ventures>,
        <https://1145.am/db/1556442/C16_Ventures>,
        <https://1145.am/db/1557877/Embark_Ventures>,
        <https://1145.am/db/1559824/Embark_Ventures>,
        <https://1145.am/db/1560704/Breaktrail_Ventures>,
        <https://1145.am/db/1563623/Amex_Ventures>,
        <https://1145.am/db/1564049/Amex_Ventures>,
        <https://1145.am/db/1571330/Seae_Ventures>,
        <https://1145.am/db/1571330/Venturesouth>,
        <https://1145.am/db/1572216/Seae_Ventures>,
        <https://1145.am/db/1572216/Venturesouth>,
        <https://1145.am/db/1574557/True_Ventures>,
        <https://1145.am/db/1574647/Vanterra_Ventures>,
        <https://1145.am/db/1575612/Interlace_Ventures>,
        <https://1145.am/db/1575612/Valia_Ventures>,
        <https://1145.am/db/1578178/N49p>,
        <https://1145.am/db/1578178/Naventures>,
        <https://1145.am/db/1578327/Crit_Ventures>,
        <https://1145.am/db/1578327/Nextview_Ventures>,
        <https://1145.am/db/1579770/Schams_Ventures>,
        <https://1145.am/db/1579792/Crit_Ventures>,
        <https://1145.am/db/1579792/Nextview_Ventures>,
        <https://1145.am/db/1580468/Cohort_Ventures>,
        <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1582111/Forepont_Capital_Partners>,
        <https://1145.am/db/1583413/Navigare_Ventures>,
        <https://1145.am/db/1615195/Digitalis_Ventures>,
        <https://1145.am/db/1616990/Digitalis_Ventures>,
        <https://1145.am/db/1632002/Catalio_Capital_Management>,
        <https://1145.am/db/1632028/Catalio_Capital_Management>,
        <https://1145.am/db/1632131/Catalio_Capital_Management>,
        <https://1145.am/db/1632156/Catalio_Capital_Management>,
        <https://1145.am/db/1638640/1digi_Ventures>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1653506/Ascendum_Capital>,
        <https://1145.am/db/1653506/Citta_Capital>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1664837/Civilization_Ventures>,
        <https://1145.am/db/1664948/Dreamit_Ventures>,
        <https://1145.am/db/1669908/Aviso_Ventures>,
        <https://1145.am/db/1670128/Primary_Ventures>,
        <https://1145.am/db/1676513/Connect_Ventures>,
        <https://1145.am/db/1685482/Lavrock_Ventures>,
        <https://1145.am/db/1690703/Arkam_Ventures>,
        <https://1145.am/db/1690703/Prosus_Ventures>,
        <https://1145.am/db/1691060/Veblen_Ventures>,
        <https://1145.am/db/1691364/Ts_Ventures>,
        <https://1145.am/db/1693592/Cventures>,
        <https://1145.am/db/1693668/Sunny_Side_Ventures>,
        <https://1145.am/db/1693981/Boldstart_Ventures>,
        <https://1145.am/db/1694241/True_Ventures>,
        <https://1145.am/db/1694301/Dn_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1694448/Presidio_Ventures>,
        <https://1145.am/db/1694592/Credo_Ventures>,
        <https://1145.am/db/1694592/Susa_Ventures>,
        <https://1145.am/db/1694798/Udc_Ventures>,
        <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1695849/Salesforce_Ventures>,
        <https://1145.am/db/1695885/True_Ventures>,
        <https://1145.am/db/1697044/Palomar_Ventures>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697373/Lerer_Ventures>,
        <https://1145.am/db/1697910/Entrepia_Ventures>,
        <https://1145.am/db/1697910/Innovacom>,
        <https://1145.am/db/1698516/Engage_Ventures>,
        <https://1145.am/db/1698516/Tyh_Ventures>,
        <https://1145.am/db/1698644/Inovia_Capital>,
        <https://1145.am/db/1699263/Contour_Venture_Partners>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1700572/Contour_Venture_Partners>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702003/Ventures_West>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1702472/Chiratae_Ventures>,
        <https://1145.am/db/1702483/Sure_Ventures_Usvp>,
        <https://1145.am/db/1702517/Prime_Ventures>,
        <https://1145.am/db/1702871/Charles_River_Ventures>,
        <https://1145.am/db/1703120/Point72_Ventures>,
        <https://1145.am/db/1703551/People_Ventures>,
        <https://1145.am/db/1703907/T-Venture>,
        <https://1145.am/db/1704404/True_Ventures>,
        <https://1145.am/db/1704740/T-Venture>,
        <https://1145.am/db/1704842/Se_Ventures>,
        <https://1145.am/db/1704871/Yl_Ventures>,
        <https://1145.am/db/1705825/Ventures_Platform>,
        <https://1145.am/db/1707227/Schams_Ventures>,
        <https://1145.am/db/1707540/Prosus_Ventures>,
        <https://1145.am/db/1707567/Contour_Venture_Partners>,
        <https://1145.am/db/1707567/Reign_Ventures>,
        <https://1145.am/db/1707637/Resolute_Ventures>,
        <https://1145.am/db/1707736/Artiman_Ventures>,
        <https://1145.am/db/1708555/20vc>,
        <https://1145.am/db/1708903/Kaedan_Capital>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1710027/Contour_Venture_Partners>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1711383/Aviso_Ventures>,
        <https://1145.am/db/1711383/Pelion_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1711790/CRV>,
        <https://1145.am/db/1711849/K20_Ventures>,
        <https://1145.am/db/1712471/Cervin_Ventures>,
        <https://1145.am/db/1713712/Grotech_Ventures>,
        <https://1145.am/db/1714098/Charles_River_Ventures>,
        <https://1145.am/db/1714148/Ulu_Ventures>,
        <https://1145.am/db/1714624/Abstract_Ventures>,
        <https://1145.am/db/1714630/January_Ventures>,
        <https://1145.am/db/1716124/Appian_Ventures>,
        <https://1145.am/db/1716168/Onset_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1718012/Presidio_Ventures>,
        <https://1145.am/db/1718018/Ggv_Capital>,
        <https://1145.am/db/1718081/Jafco_Ventures>,
        <https://1145.am/db/1718748/Truist_Ventures>,
        <https://1145.am/db/1718787/J_Ventures>,
        <https://1145.am/db/1719362/True_Ventures>,
        <https://1145.am/db/1719370/Bv_Capital>,
        <https://1145.am/db/1720145/Bessemer_Ventures>,
        <https://1145.am/db/1720182/Convivialit_Ventures>,
        <https://1145.am/db/1720441/Origin_Ventures>,
        <https://1145.am/db/1721171/Citi_Ventures>,
        <https://1145.am/db/1721392/Redpoint_Ventures>,
        <https://1145.am/db/1721393/Trinity_Ventures>,
        <https://1145.am/db/1721548/Ggv_Capital>,
        <https://1145.am/db/1721548/Menlo_Ventures>,
        <https://1145.am/db/1722252/Onset_Ventures>,
        <https://1145.am/db/1723165/Menlo_Ventures>,
        <https://1145.am/db/1723664/T-Venture>,
        <https://1145.am/db/1723932/Citi_Ventures>,
        <https://1145.am/db/1724979/Jafco_Ventures>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726088/Zeev_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1726544/Ei_Ventures>,
        <https://1145.am/db/1727288/Sozo_Ventures>,
        <https://1145.am/db/1728569/Redpoint_Ventures>,
        <https://1145.am/db/1729186/Catamount_Ventures>,
        <https://1145.am/db/1731187/Rho_Ventures>,
        <https://1145.am/db/1731419/Redpoint_Ventures>,
        <https://1145.am/db/1734104/Alpana_Ventures>,
        <https://1145.am/db/1734104/Highsage_Ventures>,
        <https://1145.am/db/1734728/Talis_Capital>,
        <https://1145.am/db/1735194/Eqt_Ventures>,
        <https://1145.am/db/1735248/Corigin_Ventures>,
        <https://1145.am/db/1735726/Nextview_Ventures>,
        <https://1145.am/db/1735755/Firebolt_Ventures>,
        <https://1145.am/db/1735774/Alpha4_Ventures>,
        <https://1145.am/db/1736136/Ggv_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1737392/Moxxie_Ventures>,
        <https://1145.am/db/1737979/CRV>,
        <https://1145.am/db/1738162/3one4_Capital>,
        <https://1145.am/db/1738300/Chryscapital>,
        <https://1145.am/db/1738415/Capnamic_Ventures>,
        <https://1145.am/db/1738444/Prosus_Ventures>,
        <https://1145.am/db/1738776/Illuminate_Ventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1739042/Experior_Venture_Fund>,
        <https://1145.am/db/1739064/Jsw_Ventures>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1739630/Redsea_Ventures>,
        <https://1145.am/db/1739719/Seedplus>,
        <https://1145.am/db/1739851/Signum_Capital>,
        <https://1145.am/db/1739909/Root_Ventures>,
        <https://1145.am/db/1739946/Dn_Capital>,
        <https://1145.am/db/1740077/3one4_Capital>,
        <https://1145.am/db/1740665/First_Bridge_Ventures>,
        <https://1145.am/db/1740832/J_Ventures>,
        <https://1145.am/db/1740832/Susa_Ventures>,
        <https://1145.am/db/1740859/Ggv_Capital>,
        <https://1145.am/db/1741357/Dn_Capital>,
        <https://1145.am/db/1741575/Addventure>,
        <https://1145.am/db/1741635/Zeev_Ventures>,
        <https://1145.am/db/1742267/Firebolt_Ventures>,
        <https://1145.am/db/1742267/Point72_Ventures>,
        <https://1145.am/db/1743271/Liil_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1743409/Dreamit_Ventures>,
        <https://1145.am/db/1743737/Regah_Ventures>,
        <https://1145.am/db/1744229/R7>,
        <https://1145.am/db/1744775/Point72_Ventures>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1744922/Agla_Ventures>,
        <https://1145.am/db/1745326/Eqt_Ventures>,
        <https://1145.am/db/1745326/Lios_Ventures>,
        <https://1145.am/db/1745326/Prime_Ventures>,
        <https://1145.am/db/1745746/Garuda_Ventures>,
        <https://1145.am/db/1745746/Starling_Ventures>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1747252/Citi_Ventures>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747400/Eqt_Ventures>,
        <https://1145.am/db/1747503/Brighteye_Ventures>,
        <https://1145.am/db/1747722/Shinhan_Capital>,
        <https://1145.am/db/1747943/Altai_Ventures>,
        <https://1145.am/db/1748417/Zeev_Ventures>,
        <https://1145.am/db/1749226/Dn_Capital>,
        <https://1145.am/db/1749425/Ac_Ventures>,
        <https://1145.am/db/1749651/Colle_Capital>,
        <https://1145.am/db/1749911/Khwarizmi_Ventures>,
        <https://1145.am/db/1750942/Celesta_Capital>,
        <https://1145.am/db/1750942/Chiratae_Ventures>,
        <https://1145.am/db/1751135/Inovia_Capital>,
        <https://1145.am/db/1751312/Abstract_Ventures>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1751506/Ggv_Capital>,
        <https://1145.am/db/1751551/Gaingels>,
        <https://1145.am/db/1751553/Canapi_Ventures>,
        <https://1145.am/db/1751743/Intudo_Ventures>,
        <https://1145.am/db/1751800/Morpheus_Ventures>,
        <https://1145.am/db/1751954/Novastar_Ventures>,
        <https://1145.am/db/1752102/Origin_Ventures>,
        <https://1145.am/db/1752403/Yl_Ventures>,
        <https://1145.am/db/1752998/Agla_Ventures>,
        <https://1145.am/db/1753704/Apex_Ventures>,
        <https://1145.am/db/1753721/Financial_Venture_Studio>,
        <https://1145.am/db/1753721/Resolute_Ventures>,
        <https://1145.am/db/1753745/2i_Ventures>,
        <https://1145.am/db/1754211/Citi_Ventures>,
        <https://1145.am/db/1754211/Menlo_Ventures>,
        <https://1145.am/db/1754242/Gsv_Ventures>,
        <https://1145.am/db/1754595/Global_Ventures>,
        <https://1145.am/db/1754595/Otg_Ventures>,
        <https://1145.am/db/1754751/Menlo_Ventures>,
        <https://1145.am/db/1754787/Letsventure>,
        <https://1145.am/db/1754997/Alkeon_Capital>,
        <https://1145.am/db/1755086/Kollective_Ventures>,
        <https://1145.am/db/1755278/Zeev_Ventures>,
        <https://1145.am/db/1755704/Promus_Ventures>,
        <https://1145.am/db/1755828/Future_Ventures>,
        <https://1145.am/db/1755860/Dg_Ventures>,
        <https://1145.am/db/1755860/Intudo_Ventures>,
        <https://1145.am/db/1756040/Altos_Ventures>,
        <https://1145.am/db/1756094/CRV>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1756326/Neotribe_Ventures>,
        <https://1145.am/db/1756384/Abstract_Ventures>,
        <https://1145.am/db/1756384/Lightspeed_Ventures>,
        <https://1145.am/db/1756599/True_Ventures>,
        <https://1145.am/db/1757035/Vectr_Ventures>,
        <https://1145.am/db/1757365/Will_Ventures>,
        <https://1145.am/db/1757382/Gl_Ventures>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1757772/Lorimer_Ventures>,
        <https://1145.am/db/1758193/Tenoneten_Ventures>,
        <https://1145.am/db/1758193/Valia_Ventures>,
        <https://1145.am/db/1758313/Venture_Field>,
        <https://1145.am/db/1758622/Oca_Ventures>,
        <https://1145.am/db/1759048/Avid_Ventures>,
        <https://1145.am/db/1759048/Lightspeed_Ventures>,
        <https://1145.am/db/1759567/J_Ventures>,
        <https://1145.am/db/1759922/Verance_Capital>,
        <https://1145.am/db/1760383/True_Ventures>,
        <https://1145.am/db/1760520/Prologis_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1760985/Frontier_Ventures>,
        <https://1145.am/db/1761126/Redpoint_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761607/Menlo_Ventures>,
        <https://1145.am/db/1761607/Sinewave_Ventures>,
        <https://1145.am/db/1761957/Alkeon_Capital>,
        <https://1145.am/db/1761999/Ggv_Capital>,
        <https://1145.am/db/1762031/Menlo_Ventures>,
        <https://1145.am/db/1762055/Altos_Ventures>,
        <https://1145.am/db/1762277/Ac_Ventures>,
        <https://1145.am/db/1762453/Line_Ventures>,
        <https://1145.am/db/1762561/Grotech_Ventures>,
        <https://1145.am/db/1762669/Creandum>,
        <https://1145.am/db/1762844/Signum_Capital>,
        <https://1145.am/db/1763356/Agla_Ventures>,
        <https://1145.am/db/1763371/Spacecadet_Ventures>,
        <https://1145.am/db/1763395/Idc_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763774/Ggv_Capital>,
        <https://1145.am/db/1763795/Ventures_Platform>,
        <https://1145.am/db/1763795/Xyz_Ventures>,
        <https://1145.am/db/1763875/Golden_Gate_Ventures>,
        <https://1145.am/db/1764027/Menlo_Ventures>,
        <https://1145.am/db/1764255/Pathbreaker_Ventures>,
        <https://1145.am/db/1764255/Stageone_Ventures>,
        <https://1145.am/db/1764345/Talis_Capital>,
        <https://1145.am/db/1764527/Presidio_Ventures>,
        <https://1145.am/db/1764527/Yl_Ventures>,
        <https://1145.am/db/1765273/Adevinta_Ventures>,
        <https://1145.am/db/1765273/Venturefriends>,
        <https://1145.am/db/1765372/Irobot_Ventures>,
        <https://1145.am/db/1765377/Redpoint_Ventures>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1765646/Amiti_Ventures>,
        <https://1145.am/db/1765673/Salesforce_Ventures>,
        <https://1145.am/db/1766091/Inreach_Ventures>,
        <https://1145.am/db/1766096/Borealis_Ventures>,
        <https://1145.am/db/1766096/Northpond_Ventures>,
        <https://1145.am/db/1766253/Redpoint_Ventures>,
        <https://1145.am/db/1766253/True_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1766978/Rga_Ventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1768363/Golden_Gate_Ventures>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1770139/Victress_Capital>,
        <https://1145.am/db/1770265/Techstars_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1770372/Korelya_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1770982/Gv>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771011/Ggv_Capital>,
        <https://1145.am/db/1771548/Seekdource_Capital>,
        <https://1145.am/db/1771613/Creandum>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1772004/Raed_Ventures>,
        <https://1145.am/db/1772004/Seed_Equity_Venture_Partners>,
        <https://1145.am/db/1772381/Altos_Ventures>,
        <https://1145.am/db/1772452/Connect_Ventures>,
        <https://1145.am/db/1773130/Capnamic_Ventures>,
        <https://1145.am/db/1773143/Venturefriends>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1774348/True_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1774535/Susa_Ventures>,
        <https://1145.am/db/1774658/Gv>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776340/Ggv_Capital>,
        <https://1145.am/db/1776340/Menlo_Ventures>,
        <https://1145.am/db/1776537/Origin_Ventures>,
        <https://1145.am/db/1776537/Tekton_Ventures>,
        <https://1145.am/db/1776621/Redpoint_Ventures>,
        <https://1145.am/db/1777289/Dn_Capital>,
        <https://1145.am/db/1777563/Evolv_Ventures>,
        <https://1145.am/db/1777563/Ggv_Capital>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1778935/Oryzn_Capital>,
        <https://1145.am/db/1780024/Partech_Ventures>,
        <https://1145.am/db/1782098/Addventure>,
        <https://1145.am/db/1782221/Point72_Ventures>,
        <https://1145.am/db/1783189/Citi_Ventures>,
        <https://1145.am/db/1784644/Creathor_Ventures>,
        <https://1145.am/db/1784964/Clear_Ventures>,
        <https://1145.am/db/1785361/M_Ventures>,
        <https://1145.am/db/1786249/Redpoint_Ventures>,
        <https://1145.am/db/1786249/Resolute_Ventures>,
        <https://1145.am/db/1786663/Edenred_Capital_Partners>,
        <https://1145.am/db/1786663/Eqt_Ventures>,
        <https://1145.am/db/1787249/Kpn_Ventures>,
        <https://1145.am/db/1787342/Korelya_Capital>,
        <https://1145.am/db/1787536/Point72_Ventures>,
        <https://1145.am/db/1787791/True_Ventures>,
        <https://1145.am/db/1787886/True_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1788726/Redbeat_Capital>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789754/Advancit_Capital>,
        <https://1145.am/db/1790280/Arthur_Ventures>,
        <https://1145.am/db/1790399/Capnamic_Ventures>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1790574/Red_Swan_Ventures>,
        <https://1145.am/db/1790574/Sherpa_Ventures>,
        <https://1145.am/db/1790641/Dn_Capital>,
        <https://1145.am/db/1790771/Redpoint_Ventures>,
        <https://1145.am/db/1790777/Connect_Ventures>,
        <https://1145.am/db/1791216/True_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1791838/Advancit_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792771/Softtechvc>,
        <https://1145.am/db/1792887/Kaedan_Capital>,
        <https://1145.am/db/1792887/Stageone_Ventures>,
        <https://1145.am/db/1794699/Ws_Ventures>,
        <https://1145.am/db/1794935/Intervest_Co_Ltd>,
        <https://1145.am/db/1795020/Redpoint_Ventures>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1795538/Skystar_Capital>,
        <https://1145.am/db/1796109/Contour_Venture_Partners>,
        <https://1145.am/db/1796593/Tenoneten_Ventures>,
        <https://1145.am/db/1796901/Red_Swan_Ventures>,
        <https://1145.am/db/1796922/Cagni_Ventures>,
        <https://1145.am/db/1797209/Kdwc_Ventures>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797899/Brave_Ventures>,
        <https://1145.am/db/1797999/Redpoint_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1799099/Inovia_Capital>,
        <https://1145.am/db/1799184/Ggv_Capital>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800929/Ventureast>,
        <https://1145.am/db/1802086/High_Line_Ventures>,
        <https://1145.am/db/1802227/Advancit_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802336/Capnamic_Ventures>,
        <https://1145.am/db/1804102/True_Ventures>,
        <https://1145.am/db/1804247/Holtzbrinck_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1804476/True_Ventures>,
        <https://1145.am/db/1804992/Talis_Capital>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1805604/Connect_Ventures>,
        <https://1145.am/db/1805604/Inreach_Ventures>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1806739/Golden_Gate_Ventures>,
        <https://1145.am/db/1808047/Salesforce_Ventures>,
        <https://1145.am/db/1808505/Helion_Ventures>,
        <https://1145.am/db/1808723/Mindworks_Ventures>,
        <https://1145.am/db/1808735/Commonangels_Ventures>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809844/Real_Ventures>,
        <https://1145.am/db/1809862/Acequia_Capital>,
        <https://1145.am/db/1810384/Starstrike_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1810714/Catalus_Capital>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1812856/Exfinity_Ventures>,
        <https://1145.am/db/1813375/Creandum>,
        <https://1145.am/db/1813575/Ggv_Capital>,
        <https://1145.am/db/1813944/Menlo_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1814643/Corigin_Ventures>,
        <https://1145.am/db/1814643/Launchcapital>,
        <https://1145.am/db/1815038/Plus_Ventures>,
        <https://1145.am/db/1815507/Globis_Capital_Partners>,
        <https://1145.am/db/1815697/Cherubic_Ventures>,
        <https://1145.am/db/1815701/True_Ventures>,
        <https://1145.am/db/1815886/Teneleven_Ventures>,
        <https://1145.am/db/1816491/Grotech_Ventures>,
        <https://1145.am/db/1818174/Advancit_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1819374/Rothenberg_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1820882/Inven_Capital>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1821711/Winton_Ventures>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1823162/True_Ventures>,
        <https://1145.am/db/1823217/Kdc_Ventures>,
        <https://1145.am/db/1823217/Nbm_Ventures>,
        <https://1145.am/db/1823684/Dcm_Ventures>,
        <https://1145.am/db/1823684/Idg_Ventures>,
        <https://1145.am/db/1824252/Allos_Ventures>,
        <https://1145.am/db/1824253/Trinity_Ventures>,
        <https://1145.am/db/1824944/True_Ventures>,
        <https://1145.am/db/1825465/Ben_Narasin>,
        <https://1145.am/db/1825713/Menlo_Ventures>,
        <https://1145.am/db/1825946/Lerer_Ventures>,
        <https://1145.am/db/1826265/Idg_Ventures>,
        <https://1145.am/db/1826648/True_Ventures>,
        <https://1145.am/db/1826922/Ggv_Capital>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828036/Redpoint_Ventures>,
        <https://1145.am/db/1828092/Eden_Ventures>,
        <https://1145.am/db/1828251/Golden_Gate_Ventures>,
        <https://1145.am/db/1828455/Quotidien_Ventures>,
        <https://1145.am/db/1828658/Focus_Ventures>,
        <https://1145.am/db/1828663/Great_Oaks_Ventures>,
        <https://1145.am/db/1828663/Inovia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1829422/Rothenberg_Ventures>,
        <https://1145.am/db/1829612/Lerer_Ventures>,
        <https://1145.am/db/1830502/Frontline_Ventures>,
        <https://1145.am/db/1830613/True_Ventures>,
        <https://1145.am/db/1830809/Numecent>,
        <https://1145.am/db/1830809/T-Ventures>,
        <https://1145.am/db/1830817/Charles_River_Ventures>,
        <https://1145.am/db/1831577/Artiman_Ventures>,
        <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832038/True_Ventures>,
        <https://1145.am/db/1832316/Partech_Ventures>,
        <https://1145.am/db/1832316/Scentan_Ventures>,
        <https://1145.am/db/1832316/Startcaps_Ventures>,
        <https://1145.am/db/1832856/Grotech_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834224/Orix_Ventures>,
        <https://1145.am/db/1834305/Charles_River_Ventures>,
        <https://1145.am/db/1834334/Altos_Ventures>,
        <https://1145.am/db/1834334/Baseline_Ventures>,
        <https://1145.am/db/1834334/Firebolt_Ventures>,
        <https://1145.am/db/1834334/Lazerow_Ventures>,
        <https://1145.am/db/1834520/Ben_Horowitz>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1834708/Sherpa_Ventures>,
        <https://1145.am/db/1834965/Lerer_Ventures>,
        <https://1145.am/db/1835229/Lerer_Ventures>,
        <https://1145.am/db/1835229/Trinity_Ventures>,
        <https://1145.am/db/1835229/Xg_Ventures>,
        <https://1145.am/db/1835740/Lerer_Ventures>,
        <https://1145.am/db/1835749/Gree_Ventures>,
        <https://1145.am/db/1835825/Focus_Ventures>,
        <https://1145.am/db/1836984/Siemer_Ventures>,
        <https://1145.am/db/1836984/Tekton_Ventures>,
        <https://1145.am/db/1837741/Menlo_Ventures>,
        <https://1145.am/db/1838026/Plus_Ventures>,
        <https://1145.am/db/1840775/Ggv_Capital>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1840881/Trinity_Ventures>,
        <https://1145.am/db/1841176/Lerer_Ventures>,
        <https://1145.am/db/1841176/True_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1842402/Redpoint_Ventures>,
        <https://1145.am/db/1842898/Grotech_Ventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1843449/Redpoint_Ventures>,
        <https://1145.am/db/1843602/Nextview_Ventures>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844143/Inovia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1844737/True_Ventures>,
        <https://1145.am/db/1844931/Charles_River_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1845960/Lerer_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846483/Inovia_Capital>,
        <https://1145.am/db/1847463/Prism_Ventureworks>,
        <https://1145.am/db/1847752/T-Venture>,
        <https://1145.am/db/1848523/Trinity_Ventures>,
        <https://1145.am/db/1849673/Inventure_Partners>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849949/Holtzbrinck_Ventures>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850668/True_Ventures>,
        <https://1145.am/db/1850989/Artiman_Ventures>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851035/Acequia_Capital>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851035/Redpoint_Ventures>,
        <https://1145.am/db/1851705/Promus_Ventures>,
        <https://1145.am/db/1851854/Partech_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1852308/Plus_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Trestle_Ventures>,
        <https://1145.am/db/1852556/Dave_Morin>,
        <https://1145.am/db/1852806/Redpoint_Ventures>,
        <https://1145.am/db/1852870/Golden_Gate_Ventures>,
        <https://1145.am/db/1852870/Siemer_Ventures>,
        <https://1145.am/db/1853417/Catamount_Ventures>,
        <https://1145.am/db/1853496/T-Ventures>,
        <https://1145.am/db/1854200/Ggv_Capital>,
        <https://1145.am/db/1854201/Charles_River_Ventures>,
        <https://1145.am/db/1854786/Eden_Ventures>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1854874/Sherpa_Ventures>,
        <https://1145.am/db/1854874/Softtech>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1855363/True_Ventures>,
        <https://1145.am/db/1855403/Rho_Ventures>,
        <https://1145.am/db/1855780/Bds_Ventures>,
        <https://1145.am/db/1855780/Ggv_Capital>,
        <https://1145.am/db/1856191/Creandum>,
        <https://1145.am/db/1856380/Softtech>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1856616/Redpoint_Ventures>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1857635/Rikard_Steiber>,
        <https://1145.am/db/1857659/Revolution_Ventures>,
        <https://1145.am/db/1857930/Inovia_Capital>,
        <https://1145.am/db/1857930/Version_One_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858592/Apex_Venture_Partners>,
        <https://1145.am/db/1858592/Origin_Ventures>,
        <https://1145.am/db/1858991/Capnamic_Ventures>,
        <https://1145.am/db/1859199/True_Ventures>,
        <https://1145.am/db/1859314/Version_One_Ventures>,
        <https://1145.am/db/1860163/Inovia_Capital>,
        <https://1145.am/db/1860345/Commonangels>,
        <https://1145.am/db/1860345/Launchcapital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1861355/Rho_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1863147/Apex_Venture_Partners>,
        <https://1145.am/db/1864601/Trinity_Ventures>,
        <https://1145.am/db/1864646/Inventus_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sherpalo_Ventures>,
        <https://1145.am/db/1866032/Launchcapital>,
        <https://1145.am/db/1866134/Embarcadero_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866155/Presidio_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867599/Cava_Capital>,
        <https://1145.am/db/1868107/Redpoint_Ventures>,
        <https://1145.am/db/1868109/Charles_River_Ventures>,
        <https://1145.am/db/1868178/True_Ventures>,
        <https://1145.am/db/1870015/Redpoint_Ventures>,
        <https://1145.am/db/1870465/Nextview_Ventures>,
        <https://1145.am/db/1871221/True_Ventures>,
        <https://1145.am/db/1871574/Redpoint_Ventures>,
        <https://1145.am/db/1871777/Charles_River_Ventures>,
        <https://1145.am/db/1871784/Charles_River_Ventures>,
        <https://1145.am/db/1871888/Charles_River_Ventures>,
        <https://1145.am/db/1873191/El_Dorado_Ventures>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1873680/Lerer_Ventures>,
        <https://1145.am/db/1873680/Xg_Ventures>,
        <https://1145.am/db/1874749/True_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1877283/Northzone_Ventures>,
        <https://1145.am/db/1877473/True_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878620/Ggv_Capital>,
        <https://1145.am/db/1879279/High_Line_Ventures>,
        <https://1145.am/db/1879759/T-Venture>,
        <https://1145.am/db/1880679/Northzone_Ventures>,
        <https://1145.am/db/1881464/Ggv_Capital>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1882330/New_World_Ventures>,
        <https://1145.am/db/1882727/Charles_River_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1883568/Eden_Ventures>,
        <https://1145.am/db/1883572/Astutia_Ventures>,
        <https://1145.am/db/1886402/New_Atlantic_Ventures>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1889394/Focus_Ventures>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1890000/Lerer_Ventures>,
        <https://1145.am/db/1890122/East_Ventures>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1890133/Focus_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/1890208/Menlo_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890839/Inovia_Capital>,
        <https://1145.am/db/1890903/Miven_Ventures>,
        <https://1145.am/db/1891615/Holtzbrinck_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891913/New_World_Ventures>,
        <https://1145.am/db/1891913/Oca_Ventures>,
        <https://1145.am/db/1891926/New_World_Ventures>,
        <https://1145.am/db/1892050/Charles_River_Ventures>,
        <https://1145.am/db/1892105/Crosscreek_Capital>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1892106/Altos_Ventures>,
        <https://1145.am/db/1892106/Illuminate_Ventures>,
        <https://1145.am/db/1892620/True_Ventures>,
        <https://1145.am/db/1892674/Appian_Ventures>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1892955/Guy_Gamzu>,
        <https://1145.am/db/1895072/Nextview_Ventures>,
        <https://1145.am/db/1895951/Windward_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1896379/Redpoint_Ventures>,
        <https://1145.am/db/1896419/True_Ventures>,
        <https://1145.am/db/1902330/Baseline_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1909430/Menlo_Ventures>,
        <https://1145.am/db/1909651/Revolution_Ventures>,
        <https://1145.am/db/1910694/True_Ventures>,
        <https://1145.am/db/1910922/Charles_River_Ventures>,
        <https://1145.am/db/1912684/Charles_River_Ventures>,
        <https://1145.am/db/1913863/Tl_Ventures>,
        <https://1145.am/db/1913874/Redpoint_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1915862/Focus_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1920478/Dawntreader_Ventures>,
        <https://1145.am/db/1920837/Onset_Ventures>,
        <https://1145.am/db/1927817/Trm_Ventures>,
        <https://1145.am/db/1939926/Cobalt_Ventures>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/1947303/Cavallo_Ventures>,
        <https://1145.am/db/1947312/Boldstart_Ventures>,
        <https://1145.am/db/1952989/Singularity_Ventures>,
        <https://1145.am/db/1954147/Accomplice_Ventures>,
        <https://1145.am/db/1957179/Sozo_Ventures>,
        <https://1145.am/db/1958963/Prosus_Ventures>,
        <https://1145.am/db/1959001/Capital_Technology_Ventures>,
        <https://1145.am/db/1959001/Glasswing_Ventures>,
        <https://1145.am/db/1962819/Connetic_Ventures>,
        <https://1145.am/db/1967592/Firebolt_Ventures>,
        <https://1145.am/db/1967683/Dig_Ventures_Vine_Ventures>,
        <https://1145.am/db/1975490/Northview_Ventures>,
        <https://1145.am/db/1975547/Nanban_Ventures>,
        <https://1145.am/db/1975547/Sinewave_Ventures>,
        <https://1145.am/db/1986122/Menlo_Ventures>,
        <https://1145.am/db/1995926/Neotribe_Ventures>,
        <https://1145.am/db/1998196/Gni_Group_Ltd>,
        <https://1145.am/db/1999771/Servicenow_Ventures>,
        <https://1145.am/db/2004427/Convivialit_Ventures>,
        <https://1145.am/db/2005131/Wwventures>,
        <https://1145.am/db/2007132/Nventures>,
        <https://1145.am/db/2020041/Inovia_Capital>,
        <https://1145.am/db/2020041/TCV>,
        <https://1145.am/db/2023596/Salesforce_Ventures>,
        <https://1145.am/db/2025081/True_Ventures>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2035454/Gv>,
        <https://1145.am/db/2036021/Clear_Ventures>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/2039177/Stellantis_Ventures>,
        <https://1145.am/db/2041480/Brunnur_Ventures>,
        <https://1145.am/db/2042858/Gv>,
        <https://1145.am/db/2044380/20sales>,
        <https://1145.am/db/2045587/Veritec_Ventures>,
        <https://1145.am/db/2050229/Nventures>,
        <https://1145.am/db/2050359/At_One_Ventures>,
        <https://1145.am/db/2051164/Aviso_Ventures>,
        <https://1145.am/db/2053027/Glasswing_Ventures>,
        <https://1145.am/db/2055707/Globis_Capital_Partners>,
        <https://1145.am/db/2056931/We_Ventures>,
        <https://1145.am/db/2060003/Crit_Ventures_100___100_Ventures>,
        <https://1145.am/db/2061278/Incisive_Ventures>,
        <https://1145.am/db/2061278/Volo_Ventures>,
        <https://1145.am/db/2063642/Clear_Bridge_Ventures>,
        <https://1145.am/db/2063967/Vsquared_Ventures>,
        <https://1145.am/db/2069147/Boldstart_Ventures>,
        <https://1145.am/db/2069147/Pelion_Ventures>,
        <https://1145.am/db/2069147/Salesforce_Ventures>,
        <https://1145.am/db/2069495/Intermountain_Ventures>,
        <https://1145.am/db/2069495/Northpond_Ventures>,
        <https://1145.am/db/2073129/Abstract_Ventures>,
        <https://1145.am/db/2073132/Idc_Ventures>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2075625/Rocketship_Ventures>,
        <https://1145.am/db/2081180/S4s_Ventures>,
        <https://1145.am/db/2081674/Capital_One_Ventures>,
        <https://1145.am/db/2082068/Arctern_Ventures>,
        <https://1145.am/db/2082068/Prelude_Ventures>,
        <https://1145.am/db/2083987/Vanterra_Ventures>,
        <https://1145.am/db/2087289/Jven_Capital>,
        <https://1145.am/db/2087289/Northpond_Ventures>,
        <https://1145.am/db/2089206/Crescendo_Venture_Partners>,
        <https://1145.am/db/2093427/Yl_Ventures>,
        <https://1145.am/db/2093713/Yl_Ventures>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2100116/Epic_Ventures>,
        <https://1145.am/db/2107533/Globis_Capital_Partners>,
        <https://1145.am/db/2109529/Point72_Ventures>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2109932/Catalio_Capital_Management>,
        <https://1145.am/db/2109932/Epic_Ventures>,
        <https://1145.am/db/2109932/Intermountain_Ventures>,
        <https://1145.am/db/2109932/North_South_Ventures>,
        <https://1145.am/db/2116769/Celesta_Capital>,
        <https://1145.am/db/2116769/Chiratae_Ventures>,
        <https://1145.am/db/2123953/Amex_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2123953/Infinity_Ventures>,
        <https://1145.am/db/2124766/P1_Ventures>,
        <https://1145.am/db/2125182/Nevcaut_Ventures>,
        <https://1145.am/db/2125182/Ulu_Ventures>,
        <https://1145.am/db/2125927/1984_Ventures>,
        <https://1145.am/db/2127882/Akkadian_Ventures>,
        <https://1145.am/db/2134989/Clear_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2141183/S_Ventures>,
        <https://1145.am/db/2141328/Connetic_Ventures>,
        <https://1145.am/db/2143438/Scorpio_Capital>,
        <https://1145.am/db/2147767/Catapult_Ventures>,
        <https://1145.am/db/2147767/Tenoneten_Ventures>,
        <https://1145.am/db/2151983/CRV>,
        <https://1145.am/db/2151983/Greatpoint_Ventures>,
        <https://1145.am/db/2155426/Brighteyes_Ventures>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2164121/Menlo_Ventures>,
        <https://1145.am/db/2169799/Nwise_Ventures>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2182443/Global_Ventures>,
        <https://1145.am/db/2183352/Optum_Ventures>,
        <https://1145.am/db/2186568/Frist_Cressey_Ventures>,
        <https://1145.am/db/2186568/Springrock_Ventures>,
        <https://1145.am/db/2186949/Greatpoint_Ventures_And_Cross_Creek>,
        <https://1145.am/db/2186949/Springrock_Ventures>,
        <https://1145.am/db/2190141/Link_Ventures>,
        <https://1145.am/db/2192636/TCV>,
        <https://1145.am/db/219311/Origin_Ventures>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2208603/McKesson_Ventures>,
        <https://1145.am/db/2210557/True_Ventures>,
        <https://1145.am/db/221321/Ggv_Capital>,
        <https://1145.am/db/2214690/Idg_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2264763/True_Ventures>,
        <https://1145.am/db/2283006/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Northpond_Ventures>,
        <https://1145.am/db/2284412/Soleus_Capital>,
        <https://1145.am/db/2286665/Shanda_Group>,
        <https://1145.am/db/2288209/Echelon_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2293172/Prospect_Ventures>,
        <https://1145.am/db/2294202/Trinitas_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2295253/Arkitekt_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2296249/Proxima_Ventures>,
        <https://1145.am/db/2296869/Dcm_Ventures>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2298897/Eshelman_Ventures>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2302351/Rho_Ventures>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2302897/Ventures_West_Capital>,
        <https://1145.am/db/2303098/Seaflower_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304606/Prism_Ventureworks>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2306568/Cmea_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2309507/Rho_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2312792/Onset_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2314380/Puretech_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314515/Apjohnventures>,
        <https://1145.am/db/2315754/Arcturus_Capital>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2321856/Ventures_West_Capital_Ltd>,
        <https://1145.am/db/2323785/Eshelman_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2325015/True_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325257/Ventures_West>,
        <https://1145.am/db/2325337/Resolvyx>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/2326362/Nextech_Venture>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2328585/Cmea_Ventures>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2338023/Cipla_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338703/Wavepoint_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341942/High-Tech_Grnderfonds>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2343184/Jven_Capital>,
        <https://1145.am/db/2345017/Venture_Investments>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2346300/High-Tech_Grnderfonds>,
        <https://1145.am/db/2346452/Aescap_Venture>,
        <https://1145.am/db/2346978/Ventures_West_Capital>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2357487/Savitr_Capital>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2358747/Solon_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/2362638/Launchpad_Venture_Group>,
        <https://1145.am/db/2363460/Rho_Ventures>,
        <https://1145.am/db/2363854/Chrysalis_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365103/Aescap_Venture>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/238282/Carnrite_Ventures>,
        <https://1145.am/db/2400536/Capital_One_Ventures>,
        <https://1145.am/db/2423653/Venturewell>,
        <https://1145.am/db/253438/Esplanade_Ventures>,
        <https://1145.am/db/254357/Ulu_Ventures>,
        <https://1145.am/db/2549491/Ktb_Ventures>,
        <https://1145.am/db/2552636/Morningside_Ventures>,
        <https://1145.am/db/2569491/High-Tech_Grnderfonds>,
        <https://1145.am/db/2570138/Sherpa_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2603254/Salesforce_Ventures>,
        <https://1145.am/db/2628424/Verana_Networks>,
        <https://1145.am/db/2628848/Neocarta_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2638432/Nissay_Capital>,
        <https://1145.am/db/2641337/Promus_Ventures>,
        <https://1145.am/db/2641337/True_Ventures>,
        <https://1145.am/db/2654391/Biggell_Finance>,
        <https://1145.am/db/265532/Ulu_Ventures>,
        <https://1145.am/db/2702871/Inovia_Capital>,
        <https://1145.am/db/274170/G1_Ventures>,
        <https://1145.am/db/2754677/Golden_Gate_Ventures>,
        <https://1145.am/db/2765022/Garuda_Ventures>,
        <https://1145.am/db/2765030/Daniel_Ventures>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/2786411/Allegion_Ventures>,
        <https://1145.am/db/2788052/Rx_Ventures>,
        <https://1145.am/db/2790064/Novastar_Ventures>,
        <https://1145.am/db/2794396/Snowpoint_Ventures>,
        <https://1145.am/db/2797562/Menlo_Ventures>,
        <https://1145.am/db/283272/Salesforce_Ventures>,
        <https://1145.am/db/283607/Salesforce_Ventures>,
        <https://1145.am/db/293715/Signum_Capital>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/293891/Ggv_Capital>,
        <https://1145.am/db/299738/Steadfast_Capital_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/319155/Bgv_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/341984/Salesforce_Ventures>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Salesforce_Ventures>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/343459/F7_Ventures>,
        <https://1145.am/db/346598/Salesforce_Ventures>,
        <https://1145.am/db/348442/Triventures>,
        <https://1145.am/db/348659/Launchpad_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/364168/Alerion_Ventures>,
        <https://1145.am/db/367592/Gv>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/388551/Vestigo_Ventures>,
        <https://1145.am/db/396305/Real_Ventures>,
        <https://1145.am/db/402103/1776_Ventures>,
        <https://1145.am/db/402701/January_Ventures>,
        <https://1145.am/db/403810/Riverstone_Ventures>,
        <https://1145.am/db/410322/Gv>,
        <https://1145.am/db/410473/Celesta_Capital>,
        <https://1145.am/db/410473/Lytical_Ventures_And_Nepenthe_Capital>,
        <https://1145.am/db/410529/Goodyear_Ventures>,
        <https://1145.am/db/411539/Zeev_Ventures>,
        <https://1145.am/db/412020/Defi_Ventures_Inc>,
        <https://1145.am/db/415322/CRV>,
        <https://1145.am/db/416041/Akkadian_Ventures>,
        <https://1145.am/db/416041/Signia_Ventures>,
        <https://1145.am/db/416041/Zeev_Ventures>,
        <https://1145.am/db/419489/Point72_Ventures>,
        <https://1145.am/db/424877/North_First_Ventures>,
        <https://1145.am/db/425262/Yl_Ventures>,
        <https://1145.am/db/425423/True_Ventures>,
        <https://1145.am/db/425973/Will_Ventures>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/429179/C5_Capital>,
        <https://1145.am/db/430986/Cortado_Ventures>,
        <https://1145.am/db/434334/1up_Ventures>,
        <https://1145.am/db/435691/Klick_Ventures>,
        <https://1145.am/db/439819/Cavu_Ventures>,
        <https://1145.am/db/441319/Celesta_Capital>,
        <https://1145.am/db/444105/Exfinity_Ventures>,
        <https://1145.am/db/445365/Revolution_Ventures>,
        <https://1145.am/db/446341/Sinewave_Ventures>,
        <https://1145.am/db/455558/Intudo_Ventures>,
        <https://1145.am/db/457435/Alerce>,
        <https://1145.am/db/457435/Clin>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/471253/Gv>,
        <https://1145.am/db/471436/Citi_Ventures>,
        <https://1145.am/db/471504/Canapi_Ventures>,
        <https://1145.am/db/473030/Highsage_Ventures>,
        <https://1145.am/db/474928/Susa_Ventures>,
        <https://1145.am/db/478049/Worldquant_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/479113/Menlo_Ventures>,
        <https://1145.am/db/485616/K3_Ventures>,
        <https://1145.am/db/486858/Gaingels>,
        <https://1145.am/db/486901/Gaingels>,
        <https://1145.am/db/488743/Salesforce_Ventures>,
        <https://1145.am/db/491130/Raiven_Capital>,
        <https://1145.am/db/491338/Raiven_Capital>,
        <https://1145.am/db/493560/Tyh_Ventures>,
        <https://1145.am/db/495912/Regah_Ventures>,
        <https://1145.am/db/506588/Trinity_Ventures>,
        <https://1145.am/db/508145/Sora_Finance>,
        <https://1145.am/db/508161/Sora_Finance>,
        <https://1145.am/db/510565/Epic_Ventures>,
        <https://1145.am/db/513305/Avid_Ventures>,
        <https://1145.am/db/513305/Canapi_Ventures>,
        <https://1145.am/db/513897/Rlc_Ventures>,
        <https://1145.am/db/514151/Rlc_Ventures>,
        <https://1145.am/db/516396/Acequia_Capital>,
        <https://1145.am/db/517213/Acequia_Capital>,
        <https://1145.am/db/523349/Osf_Ventures>,
        <https://1145.am/db/523776/Root_Ventures>,
        <https://1145.am/db/525285/Inventum_Ventures>,
        <https://1145.am/db/525285/Optima_Ventures>,
        <https://1145.am/db/526109/Ggv_Capital>,
        <https://1145.am/db/526175/Ridgeline_Ventures>,
        <https://1145.am/db/529812/Inventum_Ventures>,
        <https://1145.am/db/529812/Optima_Ventures>,
        <https://1145.am/db/532016/Id_Ventures>,
        <https://1145.am/db/539571/Origin_Ventures>,
        <https://1145.am/db/545843/Capital_One_Ventures>,
        <https://1145.am/db/545852/Boxone_Ventures>,
        <https://1145.am/db/545852/Panache_Ventures>,
        <https://1145.am/db/547770/BGV>,
        <https://1145.am/db/547944/BGV>,
        <https://1145.am/db/554552/Konvoy_Ventures>,
        <https://1145.am/db/555193/Illumina_Ventures>,
        <https://1145.am/db/555193/Technology_Venture_Partners>,
        <https://1145.am/db/556705/Congress_Ave_Ventures>,
        <https://1145.am/db/558005/Illumina_Ventures>,
        <https://1145.am/db/558005/Technology_Venture_Partners>,
        <https://1145.am/db/558877/Falabella_Ventures>,
        <https://1145.am/db/559220/Ulu_Ventures>,
        <https://1145.am/db/561662/Redpoint_Ventures>,
        <https://1145.am/db/561662/Vandelay_Ventures>,
        <https://1145.am/db/562745/Vinmar_Ventures>,
        <https://1145.am/db/563575/Celesta_Capital>,
        <https://1145.am/db/564008/D1_Ventures>,
        <https://1145.am/db/571769/Illumina_Ventures>,
        <https://1145.am/db/571769/M_Ventures>,
        <https://1145.am/db/572097/Menlo_Ventures>,
        <https://1145.am/db/572097/Teneleven_Ventures>,
        <https://1145.am/db/575249/TCV>,
        <https://1145.am/db/576186/Konvoy_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/586525/Tenoneten_Ventures>,
        <https://1145.am/db/587038/Coparion>,
        <https://1145.am/db/591566/Morningside_Ventures>,
        <https://1145.am/db/596145/Anorak_Ventures>,
        <https://1145.am/db/596564/Anorak_Ventures>,
        <https://1145.am/db/601455/Morningside_Ventures>,
        <https://1145.am/db/603725/Ignitexl_Ventures>,
        <https://1145.am/db/606074/Fiscus_Ventures>,
        <https://1145.am/db/606144/Ggv_Capital>,
        <https://1145.am/db/615337/Companyon_Ventures>,
        <https://1145.am/db/619284/Scf_Ventures>,
        <https://1145.am/db/619366/Capital_One_Ventures>,
        <https://1145.am/db/619736/Lightspeed_Ventures>,
        <https://1145.am/db/623178/Array_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/626781/Dnx_Ventures>,
        <https://1145.am/db/627030/Launchpad_Capital>,
        <https://1145.am/db/628654/Prologis_Ventures>,
        <https://1145.am/db/633238/True_Ventures>,
        <https://1145.am/db/633869/Skywell_Capital_Partners>,
        <https://1145.am/db/633869/Stageone_Ventures>,
        <https://1145.am/db/640939/Ggv_Capital>,
        <https://1145.am/db/642123/Charles_River_Ventures>,
        <https://1145.am/db/642518/Network_Ventures>,
        <https://1145.am/db/643600/Vinco_Ventures>,
        <https://1145.am/db/648552/True_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/659675/Gv>,
        <https://1145.am/db/661747/Adit_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/665129/Ac_Ventures>,
        <https://1145.am/db/665776/Firstime_Ventures>,
        <https://1145.am/db/676217/Steelsky_Ventures>,
        <https://1145.am/db/676869/Ggv_Capital>,
        <https://1145.am/db/678140/Ggv_Capital>,
        <https://1145.am/db/678587/Lightshed_Ventures>,
        <https://1145.am/db/678593/Solana_Ventures>,
        <https://1145.am/db/687538/Kayyak_Ventures>,
        <https://1145.am/db/689460/True_Ventures>,
        <https://1145.am/db/694513/Authentic_Ventures>,
        <https://1145.am/db/694924/Avid_Ventures>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/700327/Menlo_Ventures>,
        <https://1145.am/db/700877/Gaingels>,
        <https://1145.am/db/703983/Eqventure>,
        <https://1145.am/db/704489/Eqventure>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/704753/Menlo_Ventures>,
        <https://1145.am/db/704793/Quidnet_Ventures>,
        <https://1145.am/db/704991/Gaingels>,
        <https://1145.am/db/709633/Connetic_Ventures>,
        <https://1145.am/db/726461/Contour_Ventures>,
        <https://1145.am/db/729628/Kyber_Ventures>,
        <https://1145.am/db/729628/Signum_Capital>,
        <https://1145.am/db/738920/Oca_Ventures>,
        <https://1145.am/db/738920/Susa_Ventures>,
        <https://1145.am/db/739538/Morpheus_Ventures>,
        <https://1145.am/db/739538/Oca_Ventures>,
        <https://1145.am/db/739538/Susa_Ventures>,
        <https://1145.am/db/747051/Tenoneten_Ventures>,
        <https://1145.am/db/747771/Ta_Ventures>,
        <https://1145.am/db/749147/1984_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/1984_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/750305/Yl_Ventures>,
        <https://1145.am/db/750725/Vestigo_Ventures>,
        <https://1145.am/db/751176/Maverick_Ventures>,
        <https://1145.am/db/751176/Susa_Ventures>,
        <https://1145.am/db/751387/Menlo_Ventures>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/753251/Savantus_Ventures>,
        <https://1145.am/db/753913/Brunnur_Ventures>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/758206/Great_North_Ventures>,
        <https://1145.am/db/758206/Grotech_Ventures>,
        <https://1145.am/db/759749/Cava_Capital>,
        <https://1145.am/db/763083/Gaingels>,
        <https://1145.am/db/764875/Rev1_Ventures>,
        <https://1145.am/db/764896/Rev1_Ventures>,
        <https://1145.am/db/765216/True_Ventures>,
        <https://1145.am/db/768172/Gaingels>,
        <https://1145.am/db/768172/Type_One_Ventures>,
        <https://1145.am/db/768349/Salesforce_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769568/Axon_Ventures>,
        <https://1145.am/db/772099/Array_Ventures>,
        <https://1145.am/db/773235/Prelude_Ventures>,
        <https://1145.am/db/773684/Fulgur_Ventures>,
        <https://1145.am/db/773794/Array_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/778423/Sentiero_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/779867/Genesis_Block_Ventures>,
        <https://1145.am/db/780272/East_Ventures>,
        <https://1145.am/db/780289/East_Ventures>,
        <https://1145.am/db/783431/Cathay_Venture_Inc>,
        <https://1145.am/db/784093/Boldstart_Ventures>,
        <https://1145.am/db/787806/Boldstart_Ventures>,
        <https://1145.am/db/788016/Boldstart_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796250/Sp_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/797597/Lansdowne_Partners>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/800101/Gaingels>,
        <https://1145.am/db/803541/Credo_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/8045/Greatpoint_Ventures>,
        <https://1145.am/db/806828/Promus_Ventures>,
        <https://1145.am/db/806994/Companyon_Ventures>,
        <https://1145.am/db/807080/K3_Ventures>,
        <https://1145.am/db/808020/Starlight_Ventures>,
        <https://1145.am/db/808020/Valo_Ventures>,
        <https://1145.am/db/8146/Rev1_Ventures>,
        <https://1145.am/db/817162/Orbia_Ventures>,
        <https://1145.am/db/818444/1984_Ventures>,
        <https://1145.am/db/821135/Se_Ventures>,
        <https://1145.am/db/823763/Infinity_Ventures>,
        <https://1145.am/db/828716/Idc_Ventures>,
        <https://1145.am/db/829118/Salesforce_Ventures>,
        <https://1145.am/db/830571/Company_Ventures>,
        <https://1145.am/db/830689/Soleus_Capital>,
        <https://1145.am/db/832264/Salesforce_Ventures>,
        <https://1145.am/db/832573/Solasta_Ventures>,
        <https://1145.am/db/834864/Ggv_Capital>,
        <https://1145.am/db/834864/K3_Ventures>,
        <https://1145.am/db/836848/Technexus_Venture_Collaborative>,
        <https://1145.am/db/836908/Frontier_Ventures>,
        <https://1145.am/db/837034/Redpoint_Ventures>,
        <https://1145.am/db/838138/Root_Ventures>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/847157/Signum_Capital>,
        <https://1145.am/db/847862/Wise_Ventures>,
        <https://1145.am/db/854001/Gv>,
        <https://1145.am/db/854589/Verance_Capital>,
        <https://1145.am/db/854654/Mrtnz_Ventures>,
        <https://1145.am/db/854795/Menlo_Ventures>,
        <https://1145.am/db/867865/Applied_Ventures>,
        <https://1145.am/db/868093/Cobro_Ventures>,
        <https://1145.am/db/869652/Forever_Ventures>,
        <https://1145.am/db/874394/Nextview_Ventures>,
        <https://1145.am/db/874394/True_Ventures>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/881298/At_One_Ventures>,
        <https://1145.am/db/882723/At_One_Ventures>,
        <https://1145.am/db/884787/Foresite_Capital>,
        <https://1145.am/db/884787/Gv>,
        <https://1145.am/db/884787/Northpond_Ventures>,
        <https://1145.am/db/886445/Gv>,
        <https://1145.am/db/887062/Panoramic_Ventures>,
        <https://1145.am/db/889246/At_One_Ventures>,
        <https://1145.am/db/890271/Panoramic_Ventures>,
        <https://1145.am/db/891162/Emergingvc>,
        <https://1145.am/db/891162/Launchpad_Venture_Group>,
        <https://1145.am/db/903689/Vectr_Ventures>,
        <https://1145.am/db/904276/Nextview_Ventures>,
        <https://1145.am/db/906393/East_Ventures>,
        <https://1145.am/db/907844/Argon_Ventures>,
        <https://1145.am/db/907844/Glasswing_Ventures>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/913678/Sandbridge_Capital>,
        <https://1145.am/db/919636/Menlo_Ventures>,
        <https://1145.am/db/921704/Scop_Ventures>,
        <https://1145.am/db/92200/Knoll_Ventures>,
        <https://1145.am/db/922066/Irrvrnt_Vc>,
        <https://1145.am/db/922192/Gv>,
        <https://1145.am/db/922498/Sozo_Ventures>,
        <https://1145.am/db/923723/Scop_Ventures>,
        <https://1145.am/db/928711/Frontline_Ventures>,
        <https://1145.am/db/934946/Ggv_Capital>,
        <https://1145.am/db/935046/Origin_Ventures>,
        <https://1145.am/db/935249/Victress_Capital>,
        <https://1145.am/db/935322/Alpana_Ventures>,
        <https://1145.am/db/935322/M_Ventures>,
        <https://1145.am/db/935796/Salesforce_Ventures>,
        <https://1145.am/db/935962/Digitalbridge_Ventures>,
        <https://1145.am/db/936045/Lpc_Ventures>,
        <https://1145.am/db/936057/Noemis_Ventures>,
        <https://1145.am/db/936154/Salesforce_Ventures>,
        <https://1145.am/db/936448/Ggv_Capital>,
        <https://1145.am/db/936862/Lool_Ventures>,
        <https://1145.am/db/936906/Neotribe_Ventures>,
        <https://1145.am/db/937210/Citi_Ventures>,
        <https://1145.am/db/937210/Firebolt_Ventures>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/938108/Conti_Ventures>,
        <https://1145.am/db/938555/Digitalbridge_Ventures>,
        <https://1145.am/db/938586/Venturesouth>,
        <https://1145.am/db/938921/Redpoint_Ventures>,
        <https://1145.am/db/938975/Ggv_Capital>,
        <https://1145.am/db/939163/Goodyear_Ventures>,
        <https://1145.am/db/940740/Agnc_Ventures>,
        <https://1145.am/db/940913/True_Ventures>,
        <https://1145.am/db/941816/Radical_Ventures>,
        <https://1145.am/db/942825/Argon_Ventures>,
        <https://1145.am/db/946710/Citi_Ventures>,
        <https://1145.am/db/947238/Kyros_Ventures>,
        <https://1145.am/db/952434/Verissimo_Ventures>,
        <https://1145.am/db/955201/Gv>,
        <https://1145.am/db/960022/Verance_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/970950/Ulu_Ventures>,
        <https://1145.am/db/971415/Altai_Ventures>,
        <https://1145.am/db/971450/Allon_Ventures>,
        <https://1145.am/db/971939/Formic_Ventures>,
        <https://1145.am/db/975114/Formic_Ventures>,
        <https://1145.am/db/979753/Menlo_Ventures>,
        <https://1145.am/db/980678/Menlo_Ventures>,
        <https://1145.am/db/984645/Vinco_Ventures>,
        <https://1145.am/db/987688/Brightspark_Ventures>,
        <https://1145.am/db/987700/Infinityvc>,
        <https://1145.am/db/988084/Abstract_Ventures>,
        <https://1145.am/db/988084/Blank_Ventures>,
        <https://1145.am/db/988318/Arthur_Ventures>,
        <https://1145.am/db/988482/Brightspark_Ventures>,
        <https://1145.am/db/988979/Infinityvc>,
        <https://1145.am/db/989392/Arthur_Ventures>,
        <https://1145.am/db/990085/Radical_Ventures>,
        <https://1145.am/db/995593/Raiven_Capital>,
        <https://1145.am/db/995737/Nuoyan_Capital>,
        <https://1145.am/db/996563/Raiven_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2289229/Pappas_Ventures>,
        <https://1145.am/db/2305706/Pappas_Ventures>,
        <https://1145.am/db/2305713/Pappas_Ventures>,
        <https://1145.am/db/2308329/Pappas_Ventures>,
        <https://1145.am/db/2312277/Pappas_Ventures>,
        <https://1145.am/db/2314492/Pappas_Ventures>,
        <https://1145.am/db/2319029/Pappas_Ventures>,
        <https://1145.am/db/2324289/Pappas_Ventures>,
        <https://1145.am/db/2328388/Pappas_Ventures>,
        <https://1145.am/db/2332753/Pappas_Ventures>,
        <https://1145.am/db/2341904/Pappas_Ventures>,
        <https://1145.am/db/2346542/Pappas_Ventures>,
        <https://1145.am/db/2350779/Pappas_Ventures>,
        <https://1145.am/db/2350780/Pappas_Ventures>,
        <https://1145.am/db/2352805/Pappas_Ventures>,
        <https://1145.am/db/2352808/Pappas_Ventures>,
        <https://1145.am/db/2354537/Pappas_Ventures>,
        <https://1145.am/db/2354540/Pappas_Ventures>,
        <https://1145.am/db/2355274/Pappas_Ventures>,
        <https://1145.am/db/2356216/Pappas_Ventures>,
        <https://1145.am/db/2539913/Pappas_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347571/Index_Ventures> a org:Organization ;
    ns1:basedInLowRaw "MOUNTAIN VIEW, CA" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-02-16T15:02:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Versartis Completes $21 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/versartis-completes-21-million-series-b-financing-0> ;
    ns1:foundName "Index Ventures" ;
    ns1:investor <https://1145.am/db/2347571/Series_B_Investment_Advent_Life_Sciences_Amunix_Index_Ventures_New_Leaf_Venture_Partners_Versartis_Completed> ;
    ns1:name "Index Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1006252/Menlo_Ventures>,
        <https://1145.am/db/1006262/Com_Prelude_Ventures>,
        <https://1145.am/db/1006574/Integr8d_Capital>,
        <https://1145.am/db/1006880/Root_Ventures>,
        <https://1145.am/db/1007193/Capital_One_Ventures>,
        <https://1145.am/db/1007527/Integr8d_Capital>,
        <https://1145.am/db/1008085/Root_Ventures>,
        <https://1145.am/db/1008260/Servicenow_Ventures>,
        <https://1145.am/db/1010064/Greatpoint_Ventures>,
        <https://1145.am/db/1010064/Maverick_Ventures>,
        <https://1145.am/db/1010199/One9_Ventures>,
        <https://1145.am/db/102038/Allegion_Ventures>,
        <https://1145.am/db/102038/Pathbreaker_Ventures>,
        <https://1145.am/db/102038/West_Ventures>,
        <https://1145.am/db/1023252/Digitalbridge_Ventures>,
        <https://1145.am/db/1024247/Digitalbridge_Ventures>,
        <https://1145.am/db/1024483/Investbridge_Capital>,
        <https://1145.am/db/1026319/Able_Partners>,
        <https://1145.am/db/1034591/Valia_Ventures>,
        <https://1145.am/db/1041601/Kineo_Finance>,
        <https://1145.am/db/1042250/Kineo_Finance>,
        <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043342/Root_Ventures>,
        <https://1145.am/db/1043516/Kineo_Finance>,
        <https://1145.am/db/1045242/Dipalo_Ventures>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1051115/Dn_Capital>,
        <https://1145.am/db/1051644/Vestigo_Ventures>,
        <https://1145.am/db/1052155/Gate_Ventures>,
        <https://1145.am/db/1059993/Tera_Ventures>,
        <https://1145.am/db/1060146/Ulu_Ventures>,
        <https://1145.am/db/1061824/Bluebird_Ventures>,
        <https://1145.am/db/1061911/Ulu_Ventures>,
        <https://1145.am/db/1065366/Applied_Ventures_Llc>,
        <https://1145.am/db/1065544/Menlo_Ventures>,
        <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1081490/Vinco_Ventures>,
        <https://1145.am/db/1081888/Ggv_Capital>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/1082719/Dorilton_Ventures>,
        <https://1145.am/db/1082814/Cathexis_Ventures>,
        <https://1145.am/db/1082814/Promus_Ventures>,
        <https://1145.am/db/1082814/Type_One_Ventures>,
        <https://1145.am/db/1084014/Ret_Ventures>,
        <https://1145.am/db/1085867/Ret_Ventures>,
        <https://1145.am/db/1086604/Alerion_Ventures>,
        <https://1145.am/db/1086673/Wintrust_Ventures>,
        <https://1145.am/db/1089416/Nexo_Ventures>,
        <https://1145.am/db/1090643/Argon_Ventures>,
        <https://1145.am/db/1090643/Glasswing_Ventures>,
        <https://1145.am/db/1101244/Acequia_Capital>,
        <https://1145.am/db/1103270/Acequia_Capital>,
        <https://1145.am/db/1106082/Northpond_Ventures>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1111505/Nissay_Capital>,
        <https://1145.am/db/1111505/Remiges_Ventures>,
        <https://1145.am/db/1112074/Nissay_Capital>,
        <https://1145.am/db/1112074/Remiges_Ventures>,
        <https://1145.am/db/1114979/Catapult_Ventures>,
        <https://1145.am/db/1115103/Northpond_Ventures>,
        <https://1145.am/db/1119456/Truist_Ventures>,
        <https://1145.am/db/1119699/Prelude_Ventures>,
        <https://1145.am/db/1120030/Morpheus_Ventures>,
        <https://1145.am/db/1120030/Point72_Ventures>,
        <https://1145.am/db/1120071/Morpheus_Ventures>,
        <https://1145.am/db/1120071/Point72_Ventures>,
        <https://1145.am/db/1122750/Prelude_Ventures>,
        <https://1145.am/db/1129561/Redbeard_Ventures>,
        <https://1145.am/db/1130744/Redbeard_Ventures>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1134165/Boldstart_Ventures>,
        <https://1145.am/db/1136173/Boldstart_Ventures>,
        <https://1145.am/db/1137178/CRV>,
        <https://1145.am/db/1138154/Ggv_Capital>,
        <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1140286/Origin_Ventures>,
        <https://1145.am/db/1141736/Redpoint_Ventures>,
        <https://1145.am/db/1150154/Riv_Capital>,
        <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1150529/Solasta_Ventures>,
        <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1151736/True_Ventures>,
        <https://1145.am/db/1152929/Aperiamventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1154242/True_Ventures>,
        <https://1145.am/db/1163139/Sentiero_Ventures>,
        <https://1145.am/db/1163139/Skyriver_Ventures>,
        <https://1145.am/db/1164299/Lavrock_Ventures>,
        <https://1145.am/db/1164299/Progress_Ventures>,
        <https://1145.am/db/1164688/Abstract_Ventures>,
        <https://1145.am/db/1164688/Spacecadet_Ventures>,
        <https://1145.am/db/1164845/Lavrock_Ventures>,
        <https://1145.am/db/1164845/Progress_Ventures>,
        <https://1145.am/db/1165515/G2_Group_Ventures>,
        <https://1145.am/db/1166154/Allos_Ventures>,
        <https://1145.am/db/1166957/Seedil_Ventures>,
        <https://1145.am/db/1168757/Accomplice_Ventures>,
        <https://1145.am/db/1169687/Artiman_Ventures>,
        <https://1145.am/db/1169687/J_Ventures>,
        <https://1145.am/db/1169687/Nd_Capital>,
        <https://1145.am/db/1169815/Accomplice_Ventures>,
        <https://1145.am/db/1170971/Equinor_Ventures>,
        <https://1145.am/db/1173428/Equinor_Ventures>,
        <https://1145.am/db/1175576/Divcowest_Ventures>,
        <https://1145.am/db/1175576/Point72_Ventures>,
        <https://1145.am/db/1175576/Signia_Ventures>,
        <https://1145.am/db/1176018/First_Star_Ventures>,
        <https://1145.am/db/1187600/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/11887/Adv>,
        <https://1145.am/db/1190097/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/1190127/Animo_Ventures>,
        <https://1145.am/db/1190127/Chaac_Ventures>,
        <https://1145.am/db/1190127/Ulu_Ventures>,
        <https://1145.am/db/1196068/Arthur_Ventures>,
        <https://1145.am/db/1196728/Greatpoint_Ventures>,
        <https://1145.am/db/1199177/Greatpoint_Ventures>,
        <https://1145.am/db/1199182/Boxone_Ventures>,
        <https://1145.am/db/1202673/Basecamp_Ventures>,
        <https://1145.am/db/1203180/Basecamp_Ventures>,
        <https://1145.am/db/1206820/Tenoneten_Ventures>,
        <https://1145.am/db/1208519/Tappanhill_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1208749/Keshif_Ventures>,
        <https://1145.am/db/1208749/Tenoneten_Ventures>,
        <https://1145.am/db/1213076/Equinor_Ventures>,
        <https://1145.am/db/1213076/Scf_Ventures>,
        <https://1145.am/db/1213119/Nevcaut_Ventures>,
        <https://1145.am/db/1215930/Northpond_Ventures>,
        <https://1145.am/db/1219982/Soma_Ventures>,
        <https://1145.am/db/1221237/C2_Ventures>,
        <https://1145.am/db/1222789/Glasswing_Ventures>,
        <https://1145.am/db/1232497/Droia_Ventures>,
        <https://1145.am/db/1232497/Gv>,
        <https://1145.am/db/1233314/Citta_Capital>,
        <https://1145.am/db/1236549/Adit_Ventures>,
        <https://1145.am/db/1247755/Sinewave_Ventures>,
        <https://1145.am/db/1247761/Clear_Ventures>,
        <https://1145.am/db/1248631/Sinewave_Ventures>,
        <https://1145.am/db/1252447/Gaingels>,
        <https://1145.am/db/1256269/Ampd_Ventures_Inc>,
        <https://1145.am/db/1264028/K3_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1268150/Pender_Ventures>,
        <https://1145.am/db/1269968/Abstract_Ventures>,
        <https://1145.am/db/1272468/Launchpad_Capital>,
        <https://1145.am/db/1279264/Roosh_Ventures>,
        <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1282820/Agya_Ventures>,
        <https://1145.am/db/1286872/Morevc>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1297417/Bitkraft_Ventures>,
        <https://1145.am/db/1299578/Seedtob_Capital>,
        <https://1145.am/db/1307620/Inventus_Capital_Partners>,
        <https://1145.am/db/1311917/Avid_Ventures>,
        <https://1145.am/db/1311917/Canapi_Ventures>,
        <https://1145.am/db/1322441/Solana_Ventures>,
        <https://1145.am/db/1326376/Dexcom_Ventures>,
        <https://1145.am/db/1329887/Peter_Nagar>,
        <https://1145.am/db/1331691/Pelion_Ventures>,
        <https://1145.am/db/1332798/Acrobator_Ventures>,
        <https://1145.am/db/1334186/First_Ascent_Ventures>,
        <https://1145.am/db/1334193/Version_One_Ventures>,
        <https://1145.am/db/1334395/Gv>,
        <https://1145.am/db/1334895/Soleus_Capital>,
        <https://1145.am/db/1335073/Yl_Ventures>,
        <https://1145.am/db/1335080/Dorilton_Ventures>,
        <https://1145.am/db/1344240/Neotribe_Ventures>,
        <https://1145.am/db/1352420/Vamos_Ventures>,
        <https://1145.am/db/1353145/Infinity_Ventures>,
        <https://1145.am/db/1362743/Cobalt_Ventures>,
        <https://1145.am/db/1373683/BGV>,
        <https://1145.am/db/1375916/J2_Ventures>,
        <https://1145.am/db/1376353/J2_Ventures>,
        <https://1145.am/db/1378599/Menlo_Ventures>,
        <https://1145.am/db/1381832/Northpond_Ventures>,
        <https://1145.am/db/1382787/Northpond_Ventures>,
        <https://1145.am/db/1383818/Newlin_Ventures>,
        <https://1145.am/db/1387557/Naventures>,
        <https://1145.am/db/138878/Metacartel_Ventures>,
        <https://1145.am/db/1398057/Owen_Van_Natta_Temaris___Associates>,
        <https://1145.am/db/1398917/Trousdale_Ventures>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1407614/C2_Ventures>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1411934/Riptide_Ventures>,
        <https://1145.am/db/1425749/Menlo_Ventures>,
        <https://1145.am/db/1425749/Se_Ventures>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1445378/Mvp_Ventures>,
        <https://1145.am/db/1445935/Verissimo_Ventures>,
        <https://1145.am/db/1449316/+Nd_Capital>,
        <https://1145.am/db/1449740/Mistral_Ventures>,
        <https://1145.am/db/1452107/Abstract_Ventures>,
        <https://1145.am/db/1455216/Engage_Ventures>,
        <https://1145.am/db/1455616/Abstract_Ventures>,
        <https://1145.am/db/1463829/1sharpe_Ventures>,
        <https://1145.am/db/1467693/Preseed_Ventures>,
        <https://1145.am/db/1467892/M_Ventures>,
        <https://1145.am/db/1467932/Sequoia_Capital_Gv>,
        <https://1145.am/db/1468981/Preseed_Ventures>,
        <https://1145.am/db/1476448/Origin_Ventures>,
        <https://1145.am/db/1480152/True_Ventures>,
        <https://1145.am/db/1480651/Glasswing_Ventures>,
        <https://1145.am/db/1480989/Infinity_Ventures>,
        <https://1145.am/db/1481875/Infinity_Ventures>,
        <https://1145.am/db/1482705/Oif_Ventures>,
        <https://1145.am/db/1484103/Boxone_Ventures>,
        <https://1145.am/db/1484857/Iu_Ventures>,
        <https://1145.am/db/1488858/Alkeon_Capital>,
        <https://1145.am/db/1490126/Seedtob_Capital>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490978/Seedtob_Capital>,
        <https://1145.am/db/1492889/Future_Ventures>,
        <https://1145.am/db/1492889/Radical_Ventures>,
        <https://1145.am/db/1494028/Alkeon_Capital>,
        <https://1145.am/db/1496360/Realist_Ventures>,
        <https://1145.am/db/1503768/Nevateam_Partners>,
        <https://1145.am/db/1508325/Aramco_Ventures>,
        <https://1145.am/db/1509462/F7_Ventures>,
        <https://1145.am/db/1512891/Acme_Capital>,
        <https://1145.am/db/1515109/Cmfg_Ventures>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1520070/Menlo_Ventures>,
        <https://1145.am/db/1520070/Northpond_Ventures>,
        <https://1145.am/db/1520772/January_Ventures>,
        <https://1145.am/db/1537166/Catalio_Capital_Management>,
        <https://1145.am/db/1537970/Catalio_Capital_Management>,
        <https://1145.am/db/1541308/Panoramic_Ventures>,
        <https://1145.am/db/1541797/G1_Ventures>,
        <https://1145.am/db/1545833/Alerion_Ventures>,
        <https://1145.am/db/1545994/Noemis_Ventures>,
        <https://1145.am/db/1546945/Alerion_Ventures>,
        <https://1145.am/db/1546965/Citi_Ventures>,
        <https://1145.am/db/1546965/Truist_Ventures>,
        <https://1145.am/db/1547281/Noemis_Ventures>,
        <https://1145.am/db/1548592/Gopoint_Ventures>,
        <https://1145.am/db/1556397/Dnx_Ventures>,
        <https://1145.am/db/1556442/C16_Ventures>,
        <https://1145.am/db/1557877/Embark_Ventures>,
        <https://1145.am/db/1559824/Embark_Ventures>,
        <https://1145.am/db/1560704/Breaktrail_Ventures>,
        <https://1145.am/db/1563623/Amex_Ventures>,
        <https://1145.am/db/1564049/Amex_Ventures>,
        <https://1145.am/db/1571330/Seae_Ventures>,
        <https://1145.am/db/1571330/Venturesouth>,
        <https://1145.am/db/1572216/Seae_Ventures>,
        <https://1145.am/db/1572216/Venturesouth>,
        <https://1145.am/db/1574557/True_Ventures>,
        <https://1145.am/db/1574647/Vanterra_Ventures>,
        <https://1145.am/db/1575612/Interlace_Ventures>,
        <https://1145.am/db/1575612/Valia_Ventures>,
        <https://1145.am/db/1578178/N49p>,
        <https://1145.am/db/1578178/Naventures>,
        <https://1145.am/db/1578327/Crit_Ventures>,
        <https://1145.am/db/1578327/Nextview_Ventures>,
        <https://1145.am/db/1579770/Schams_Ventures>,
        <https://1145.am/db/1579792/Crit_Ventures>,
        <https://1145.am/db/1579792/Nextview_Ventures>,
        <https://1145.am/db/1580468/Cohort_Ventures>,
        <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1582111/Forepont_Capital_Partners>,
        <https://1145.am/db/1583413/Navigare_Ventures>,
        <https://1145.am/db/1615195/Digitalis_Ventures>,
        <https://1145.am/db/1616990/Digitalis_Ventures>,
        <https://1145.am/db/1632002/Catalio_Capital_Management>,
        <https://1145.am/db/1632028/Catalio_Capital_Management>,
        <https://1145.am/db/1632131/Catalio_Capital_Management>,
        <https://1145.am/db/1632156/Catalio_Capital_Management>,
        <https://1145.am/db/1638640/1digi_Ventures>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1653506/Ascendum_Capital>,
        <https://1145.am/db/1653506/Citta_Capital>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1664837/Civilization_Ventures>,
        <https://1145.am/db/1664948/Dreamit_Ventures>,
        <https://1145.am/db/1669908/Aviso_Ventures>,
        <https://1145.am/db/1670128/Primary_Ventures>,
        <https://1145.am/db/1676513/Connect_Ventures>,
        <https://1145.am/db/1685482/Lavrock_Ventures>,
        <https://1145.am/db/1690703/Arkam_Ventures>,
        <https://1145.am/db/1690703/Prosus_Ventures>,
        <https://1145.am/db/1691060/Veblen_Ventures>,
        <https://1145.am/db/1691364/Ts_Ventures>,
        <https://1145.am/db/1693592/Cventures>,
        <https://1145.am/db/1693668/Sunny_Side_Ventures>,
        <https://1145.am/db/1693981/Boldstart_Ventures>,
        <https://1145.am/db/1694241/True_Ventures>,
        <https://1145.am/db/1694301/Dn_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1694448/Presidio_Ventures>,
        <https://1145.am/db/1694592/Credo_Ventures>,
        <https://1145.am/db/1694592/Susa_Ventures>,
        <https://1145.am/db/1694798/Udc_Ventures>,
        <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1695849/Salesforce_Ventures>,
        <https://1145.am/db/1695885/True_Ventures>,
        <https://1145.am/db/1697044/Palomar_Ventures>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697373/Lerer_Ventures>,
        <https://1145.am/db/1697910/Entrepia_Ventures>,
        <https://1145.am/db/1697910/Innovacom>,
        <https://1145.am/db/1698516/Engage_Ventures>,
        <https://1145.am/db/1698516/Tyh_Ventures>,
        <https://1145.am/db/1698644/Inovia_Capital>,
        <https://1145.am/db/1699263/Contour_Venture_Partners>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1700572/Contour_Venture_Partners>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702003/Ventures_West>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1702472/Chiratae_Ventures>,
        <https://1145.am/db/1702483/Sure_Ventures_Usvp>,
        <https://1145.am/db/1702517/Prime_Ventures>,
        <https://1145.am/db/1702871/Charles_River_Ventures>,
        <https://1145.am/db/1703120/Point72_Ventures>,
        <https://1145.am/db/1703551/People_Ventures>,
        <https://1145.am/db/1703907/T-Venture>,
        <https://1145.am/db/1704404/True_Ventures>,
        <https://1145.am/db/1704740/T-Venture>,
        <https://1145.am/db/1704842/Se_Ventures>,
        <https://1145.am/db/1704871/Yl_Ventures>,
        <https://1145.am/db/1705825/Ventures_Platform>,
        <https://1145.am/db/1707227/Schams_Ventures>,
        <https://1145.am/db/1707540/Prosus_Ventures>,
        <https://1145.am/db/1707567/Contour_Venture_Partners>,
        <https://1145.am/db/1707567/Reign_Ventures>,
        <https://1145.am/db/1707637/Resolute_Ventures>,
        <https://1145.am/db/1707736/Artiman_Ventures>,
        <https://1145.am/db/1708555/20vc>,
        <https://1145.am/db/1708903/Kaedan_Capital>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1710027/Contour_Venture_Partners>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1711383/Aviso_Ventures>,
        <https://1145.am/db/1711383/Pelion_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1711790/CRV>,
        <https://1145.am/db/1711849/K20_Ventures>,
        <https://1145.am/db/1712471/Cervin_Ventures>,
        <https://1145.am/db/1713712/Grotech_Ventures>,
        <https://1145.am/db/1714098/Charles_River_Ventures>,
        <https://1145.am/db/1714148/Ulu_Ventures>,
        <https://1145.am/db/1714624/Abstract_Ventures>,
        <https://1145.am/db/1714630/January_Ventures>,
        <https://1145.am/db/1716124/Appian_Ventures>,
        <https://1145.am/db/1716168/Onset_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1718012/Presidio_Ventures>,
        <https://1145.am/db/1718018/Ggv_Capital>,
        <https://1145.am/db/1718081/Jafco_Ventures>,
        <https://1145.am/db/1718748/Truist_Ventures>,
        <https://1145.am/db/1718787/J_Ventures>,
        <https://1145.am/db/1719362/True_Ventures>,
        <https://1145.am/db/1719370/Bv_Capital>,
        <https://1145.am/db/1720145/Bessemer_Ventures>,
        <https://1145.am/db/1720182/Convivialit_Ventures>,
        <https://1145.am/db/1720441/Origin_Ventures>,
        <https://1145.am/db/1721171/Citi_Ventures>,
        <https://1145.am/db/1721392/Redpoint_Ventures>,
        <https://1145.am/db/1721393/Trinity_Ventures>,
        <https://1145.am/db/1721548/Ggv_Capital>,
        <https://1145.am/db/1721548/Menlo_Ventures>,
        <https://1145.am/db/1722252/Onset_Ventures>,
        <https://1145.am/db/1723165/Menlo_Ventures>,
        <https://1145.am/db/1723664/T-Venture>,
        <https://1145.am/db/1723932/Citi_Ventures>,
        <https://1145.am/db/1724979/Jafco_Ventures>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726088/Zeev_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1726544/Ei_Ventures>,
        <https://1145.am/db/1727288/Sozo_Ventures>,
        <https://1145.am/db/1728569/Redpoint_Ventures>,
        <https://1145.am/db/1729186/Catamount_Ventures>,
        <https://1145.am/db/1731187/Rho_Ventures>,
        <https://1145.am/db/1731419/Redpoint_Ventures>,
        <https://1145.am/db/1734104/Alpana_Ventures>,
        <https://1145.am/db/1734104/Highsage_Ventures>,
        <https://1145.am/db/1734728/Talis_Capital>,
        <https://1145.am/db/1735194/Eqt_Ventures>,
        <https://1145.am/db/1735248/Corigin_Ventures>,
        <https://1145.am/db/1735726/Nextview_Ventures>,
        <https://1145.am/db/1735755/Firebolt_Ventures>,
        <https://1145.am/db/1735774/Alpha4_Ventures>,
        <https://1145.am/db/1736136/Ggv_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1737392/Moxxie_Ventures>,
        <https://1145.am/db/1737979/CRV>,
        <https://1145.am/db/1738162/3one4_Capital>,
        <https://1145.am/db/1738300/Chryscapital>,
        <https://1145.am/db/1738415/Capnamic_Ventures>,
        <https://1145.am/db/1738444/Prosus_Ventures>,
        <https://1145.am/db/1738776/Illuminate_Ventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1739042/Experior_Venture_Fund>,
        <https://1145.am/db/1739064/Jsw_Ventures>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1739630/Redsea_Ventures>,
        <https://1145.am/db/1739719/Seedplus>,
        <https://1145.am/db/1739851/Signum_Capital>,
        <https://1145.am/db/1739909/Root_Ventures>,
        <https://1145.am/db/1739946/Dn_Capital>,
        <https://1145.am/db/1740077/3one4_Capital>,
        <https://1145.am/db/1740665/First_Bridge_Ventures>,
        <https://1145.am/db/1740832/J_Ventures>,
        <https://1145.am/db/1740832/Susa_Ventures>,
        <https://1145.am/db/1740859/Ggv_Capital>,
        <https://1145.am/db/1741357/Dn_Capital>,
        <https://1145.am/db/1741575/Addventure>,
        <https://1145.am/db/1741635/Zeev_Ventures>,
        <https://1145.am/db/1742267/Firebolt_Ventures>,
        <https://1145.am/db/1742267/Point72_Ventures>,
        <https://1145.am/db/1743271/Liil_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1743409/Dreamit_Ventures>,
        <https://1145.am/db/1743737/Regah_Ventures>,
        <https://1145.am/db/1744229/R7>,
        <https://1145.am/db/1744775/Point72_Ventures>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1744922/Agla_Ventures>,
        <https://1145.am/db/1745326/Eqt_Ventures>,
        <https://1145.am/db/1745326/Lios_Ventures>,
        <https://1145.am/db/1745326/Prime_Ventures>,
        <https://1145.am/db/1745746/Garuda_Ventures>,
        <https://1145.am/db/1745746/Starling_Ventures>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1747252/Citi_Ventures>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747400/Eqt_Ventures>,
        <https://1145.am/db/1747503/Brighteye_Ventures>,
        <https://1145.am/db/1747722/Shinhan_Capital>,
        <https://1145.am/db/1747943/Altai_Ventures>,
        <https://1145.am/db/1748417/Zeev_Ventures>,
        <https://1145.am/db/1749226/Dn_Capital>,
        <https://1145.am/db/1749425/Ac_Ventures>,
        <https://1145.am/db/1749651/Colle_Capital>,
        <https://1145.am/db/1749911/Khwarizmi_Ventures>,
        <https://1145.am/db/1750942/Celesta_Capital>,
        <https://1145.am/db/1750942/Chiratae_Ventures>,
        <https://1145.am/db/1751135/Inovia_Capital>,
        <https://1145.am/db/1751312/Abstract_Ventures>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1751506/Ggv_Capital>,
        <https://1145.am/db/1751551/Gaingels>,
        <https://1145.am/db/1751553/Canapi_Ventures>,
        <https://1145.am/db/1751743/Intudo_Ventures>,
        <https://1145.am/db/1751800/Morpheus_Ventures>,
        <https://1145.am/db/1751954/Novastar_Ventures>,
        <https://1145.am/db/1752102/Origin_Ventures>,
        <https://1145.am/db/1752403/Yl_Ventures>,
        <https://1145.am/db/1752998/Agla_Ventures>,
        <https://1145.am/db/1753704/Apex_Ventures>,
        <https://1145.am/db/1753721/Financial_Venture_Studio>,
        <https://1145.am/db/1753721/Resolute_Ventures>,
        <https://1145.am/db/1753745/2i_Ventures>,
        <https://1145.am/db/1754211/Citi_Ventures>,
        <https://1145.am/db/1754211/Menlo_Ventures>,
        <https://1145.am/db/1754242/Gsv_Ventures>,
        <https://1145.am/db/1754595/Global_Ventures>,
        <https://1145.am/db/1754595/Otg_Ventures>,
        <https://1145.am/db/1754751/Menlo_Ventures>,
        <https://1145.am/db/1754787/Letsventure>,
        <https://1145.am/db/1754997/Alkeon_Capital>,
        <https://1145.am/db/1755086/Kollective_Ventures>,
        <https://1145.am/db/1755278/Zeev_Ventures>,
        <https://1145.am/db/1755704/Promus_Ventures>,
        <https://1145.am/db/1755828/Future_Ventures>,
        <https://1145.am/db/1755860/Dg_Ventures>,
        <https://1145.am/db/1755860/Intudo_Ventures>,
        <https://1145.am/db/1756040/Altos_Ventures>,
        <https://1145.am/db/1756094/CRV>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1756326/Neotribe_Ventures>,
        <https://1145.am/db/1756384/Abstract_Ventures>,
        <https://1145.am/db/1756384/Lightspeed_Ventures>,
        <https://1145.am/db/1756599/True_Ventures>,
        <https://1145.am/db/1757035/Vectr_Ventures>,
        <https://1145.am/db/1757365/Will_Ventures>,
        <https://1145.am/db/1757382/Gl_Ventures>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1757772/Lorimer_Ventures>,
        <https://1145.am/db/1758193/Tenoneten_Ventures>,
        <https://1145.am/db/1758193/Valia_Ventures>,
        <https://1145.am/db/1758313/Venture_Field>,
        <https://1145.am/db/1758622/Oca_Ventures>,
        <https://1145.am/db/1759048/Avid_Ventures>,
        <https://1145.am/db/1759048/Lightspeed_Ventures>,
        <https://1145.am/db/1759567/J_Ventures>,
        <https://1145.am/db/1759922/Verance_Capital>,
        <https://1145.am/db/1760383/True_Ventures>,
        <https://1145.am/db/1760520/Prologis_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1760985/Frontier_Ventures>,
        <https://1145.am/db/1761126/Redpoint_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761607/Menlo_Ventures>,
        <https://1145.am/db/1761607/Sinewave_Ventures>,
        <https://1145.am/db/1761957/Alkeon_Capital>,
        <https://1145.am/db/1761999/Ggv_Capital>,
        <https://1145.am/db/1762031/Menlo_Ventures>,
        <https://1145.am/db/1762055/Altos_Ventures>,
        <https://1145.am/db/1762277/Ac_Ventures>,
        <https://1145.am/db/1762453/Line_Ventures>,
        <https://1145.am/db/1762561/Grotech_Ventures>,
        <https://1145.am/db/1762669/Creandum>,
        <https://1145.am/db/1762844/Signum_Capital>,
        <https://1145.am/db/1763356/Agla_Ventures>,
        <https://1145.am/db/1763371/Spacecadet_Ventures>,
        <https://1145.am/db/1763395/Idc_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763774/Ggv_Capital>,
        <https://1145.am/db/1763795/Ventures_Platform>,
        <https://1145.am/db/1763795/Xyz_Ventures>,
        <https://1145.am/db/1763875/Golden_Gate_Ventures>,
        <https://1145.am/db/1764027/Menlo_Ventures>,
        <https://1145.am/db/1764255/Pathbreaker_Ventures>,
        <https://1145.am/db/1764255/Stageone_Ventures>,
        <https://1145.am/db/1764345/Talis_Capital>,
        <https://1145.am/db/1764527/Presidio_Ventures>,
        <https://1145.am/db/1764527/Yl_Ventures>,
        <https://1145.am/db/1765273/Adevinta_Ventures>,
        <https://1145.am/db/1765273/Venturefriends>,
        <https://1145.am/db/1765372/Irobot_Ventures>,
        <https://1145.am/db/1765377/Redpoint_Ventures>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1765646/Amiti_Ventures>,
        <https://1145.am/db/1765673/Salesforce_Ventures>,
        <https://1145.am/db/1766091/Inreach_Ventures>,
        <https://1145.am/db/1766096/Borealis_Ventures>,
        <https://1145.am/db/1766096/Northpond_Ventures>,
        <https://1145.am/db/1766253/Redpoint_Ventures>,
        <https://1145.am/db/1766253/True_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1766978/Rga_Ventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1768363/Golden_Gate_Ventures>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1770139/Victress_Capital>,
        <https://1145.am/db/1770265/Techstars_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1770372/Korelya_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1770982/Gv>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771011/Ggv_Capital>,
        <https://1145.am/db/1771548/Seekdource_Capital>,
        <https://1145.am/db/1771613/Creandum>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1772004/Raed_Ventures>,
        <https://1145.am/db/1772004/Seed_Equity_Venture_Partners>,
        <https://1145.am/db/1772381/Altos_Ventures>,
        <https://1145.am/db/1772452/Connect_Ventures>,
        <https://1145.am/db/1773130/Capnamic_Ventures>,
        <https://1145.am/db/1773143/Venturefriends>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1774348/True_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1774535/Susa_Ventures>,
        <https://1145.am/db/1774658/Gv>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776340/Ggv_Capital>,
        <https://1145.am/db/1776340/Menlo_Ventures>,
        <https://1145.am/db/1776537/Origin_Ventures>,
        <https://1145.am/db/1776537/Tekton_Ventures>,
        <https://1145.am/db/1776621/Redpoint_Ventures>,
        <https://1145.am/db/1777289/Dn_Capital>,
        <https://1145.am/db/1777563/Evolv_Ventures>,
        <https://1145.am/db/1777563/Ggv_Capital>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1778935/Oryzn_Capital>,
        <https://1145.am/db/1780024/Partech_Ventures>,
        <https://1145.am/db/1782098/Addventure>,
        <https://1145.am/db/1782221/Point72_Ventures>,
        <https://1145.am/db/1783189/Citi_Ventures>,
        <https://1145.am/db/1784644/Creathor_Ventures>,
        <https://1145.am/db/1784964/Clear_Ventures>,
        <https://1145.am/db/1785361/M_Ventures>,
        <https://1145.am/db/1786249/Redpoint_Ventures>,
        <https://1145.am/db/1786249/Resolute_Ventures>,
        <https://1145.am/db/1786663/Edenred_Capital_Partners>,
        <https://1145.am/db/1786663/Eqt_Ventures>,
        <https://1145.am/db/1787249/Kpn_Ventures>,
        <https://1145.am/db/1787342/Korelya_Capital>,
        <https://1145.am/db/1787536/Point72_Ventures>,
        <https://1145.am/db/1787791/True_Ventures>,
        <https://1145.am/db/1787886/True_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1788726/Redbeat_Capital>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789754/Advancit_Capital>,
        <https://1145.am/db/1790280/Arthur_Ventures>,
        <https://1145.am/db/1790399/Capnamic_Ventures>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1790574/Red_Swan_Ventures>,
        <https://1145.am/db/1790574/Sherpa_Ventures>,
        <https://1145.am/db/1790641/Dn_Capital>,
        <https://1145.am/db/1790771/Redpoint_Ventures>,
        <https://1145.am/db/1790777/Connect_Ventures>,
        <https://1145.am/db/1791216/True_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1791838/Advancit_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792771/Softtechvc>,
        <https://1145.am/db/1792887/Kaedan_Capital>,
        <https://1145.am/db/1792887/Stageone_Ventures>,
        <https://1145.am/db/1794699/Ws_Ventures>,
        <https://1145.am/db/1794935/Intervest_Co_Ltd>,
        <https://1145.am/db/1795020/Redpoint_Ventures>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1795538/Skystar_Capital>,
        <https://1145.am/db/1796109/Contour_Venture_Partners>,
        <https://1145.am/db/1796593/Tenoneten_Ventures>,
        <https://1145.am/db/1796901/Red_Swan_Ventures>,
        <https://1145.am/db/1796922/Cagni_Ventures>,
        <https://1145.am/db/1797209/Kdwc_Ventures>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797899/Brave_Ventures>,
        <https://1145.am/db/1797999/Redpoint_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1799099/Inovia_Capital>,
        <https://1145.am/db/1799184/Ggv_Capital>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800929/Ventureast>,
        <https://1145.am/db/1802086/High_Line_Ventures>,
        <https://1145.am/db/1802227/Advancit_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802336/Capnamic_Ventures>,
        <https://1145.am/db/1804102/True_Ventures>,
        <https://1145.am/db/1804247/Holtzbrinck_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1804476/True_Ventures>,
        <https://1145.am/db/1804992/Talis_Capital>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1805604/Connect_Ventures>,
        <https://1145.am/db/1805604/Inreach_Ventures>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1806739/Golden_Gate_Ventures>,
        <https://1145.am/db/1808047/Salesforce_Ventures>,
        <https://1145.am/db/1808505/Helion_Ventures>,
        <https://1145.am/db/1808723/Mindworks_Ventures>,
        <https://1145.am/db/1808735/Commonangels_Ventures>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809844/Real_Ventures>,
        <https://1145.am/db/1809862/Acequia_Capital>,
        <https://1145.am/db/1810384/Starstrike_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1810714/Catalus_Capital>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1812856/Exfinity_Ventures>,
        <https://1145.am/db/1813375/Creandum>,
        <https://1145.am/db/1813575/Ggv_Capital>,
        <https://1145.am/db/1813944/Menlo_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1814643/Corigin_Ventures>,
        <https://1145.am/db/1814643/Launchcapital>,
        <https://1145.am/db/1815038/Plus_Ventures>,
        <https://1145.am/db/1815507/Globis_Capital_Partners>,
        <https://1145.am/db/1815697/Cherubic_Ventures>,
        <https://1145.am/db/1815701/True_Ventures>,
        <https://1145.am/db/1815886/Teneleven_Ventures>,
        <https://1145.am/db/1816491/Grotech_Ventures>,
        <https://1145.am/db/1818174/Advancit_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1819374/Rothenberg_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1820882/Inven_Capital>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1821711/Winton_Ventures>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1823162/True_Ventures>,
        <https://1145.am/db/1823217/Kdc_Ventures>,
        <https://1145.am/db/1823217/Nbm_Ventures>,
        <https://1145.am/db/1823684/Dcm_Ventures>,
        <https://1145.am/db/1823684/Idg_Ventures>,
        <https://1145.am/db/1824252/Allos_Ventures>,
        <https://1145.am/db/1824253/Trinity_Ventures>,
        <https://1145.am/db/1824944/True_Ventures>,
        <https://1145.am/db/1825465/Ben_Narasin>,
        <https://1145.am/db/1825713/Menlo_Ventures>,
        <https://1145.am/db/1825946/Lerer_Ventures>,
        <https://1145.am/db/1826265/Idg_Ventures>,
        <https://1145.am/db/1826648/True_Ventures>,
        <https://1145.am/db/1826922/Ggv_Capital>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828036/Redpoint_Ventures>,
        <https://1145.am/db/1828092/Eden_Ventures>,
        <https://1145.am/db/1828251/Golden_Gate_Ventures>,
        <https://1145.am/db/1828455/Quotidien_Ventures>,
        <https://1145.am/db/1828658/Focus_Ventures>,
        <https://1145.am/db/1828663/Great_Oaks_Ventures>,
        <https://1145.am/db/1828663/Inovia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1829422/Rothenberg_Ventures>,
        <https://1145.am/db/1829612/Lerer_Ventures>,
        <https://1145.am/db/1830502/Frontline_Ventures>,
        <https://1145.am/db/1830613/True_Ventures>,
        <https://1145.am/db/1830809/Numecent>,
        <https://1145.am/db/1830809/T-Ventures>,
        <https://1145.am/db/1830817/Charles_River_Ventures>,
        <https://1145.am/db/1831577/Artiman_Ventures>,
        <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832038/True_Ventures>,
        <https://1145.am/db/1832316/Partech_Ventures>,
        <https://1145.am/db/1832316/Scentan_Ventures>,
        <https://1145.am/db/1832316/Startcaps_Ventures>,
        <https://1145.am/db/1832856/Grotech_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834224/Orix_Ventures>,
        <https://1145.am/db/1834305/Charles_River_Ventures>,
        <https://1145.am/db/1834334/Altos_Ventures>,
        <https://1145.am/db/1834334/Baseline_Ventures>,
        <https://1145.am/db/1834334/Firebolt_Ventures>,
        <https://1145.am/db/1834334/Lazerow_Ventures>,
        <https://1145.am/db/1834520/Ben_Horowitz>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1834708/Sherpa_Ventures>,
        <https://1145.am/db/1834965/Lerer_Ventures>,
        <https://1145.am/db/1835229/Lerer_Ventures>,
        <https://1145.am/db/1835229/Trinity_Ventures>,
        <https://1145.am/db/1835229/Xg_Ventures>,
        <https://1145.am/db/1835740/Lerer_Ventures>,
        <https://1145.am/db/1835749/Gree_Ventures>,
        <https://1145.am/db/1835825/Focus_Ventures>,
        <https://1145.am/db/1836984/Siemer_Ventures>,
        <https://1145.am/db/1836984/Tekton_Ventures>,
        <https://1145.am/db/1837741/Menlo_Ventures>,
        <https://1145.am/db/1838026/Plus_Ventures>,
        <https://1145.am/db/1840775/Ggv_Capital>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1840881/Trinity_Ventures>,
        <https://1145.am/db/1841176/Lerer_Ventures>,
        <https://1145.am/db/1841176/True_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1842402/Redpoint_Ventures>,
        <https://1145.am/db/1842898/Grotech_Ventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1843449/Redpoint_Ventures>,
        <https://1145.am/db/1843602/Nextview_Ventures>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844143/Inovia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1844737/True_Ventures>,
        <https://1145.am/db/1844931/Charles_River_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1845960/Lerer_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846483/Inovia_Capital>,
        <https://1145.am/db/1847463/Prism_Ventureworks>,
        <https://1145.am/db/1847752/T-Venture>,
        <https://1145.am/db/1848523/Trinity_Ventures>,
        <https://1145.am/db/1849673/Inventure_Partners>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849949/Holtzbrinck_Ventures>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850668/True_Ventures>,
        <https://1145.am/db/1850989/Artiman_Ventures>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851035/Acequia_Capital>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851035/Redpoint_Ventures>,
        <https://1145.am/db/1851705/Promus_Ventures>,
        <https://1145.am/db/1851854/Partech_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1852308/Plus_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Trestle_Ventures>,
        <https://1145.am/db/1852556/Dave_Morin>,
        <https://1145.am/db/1852806/Redpoint_Ventures>,
        <https://1145.am/db/1852870/Golden_Gate_Ventures>,
        <https://1145.am/db/1852870/Siemer_Ventures>,
        <https://1145.am/db/1853417/Catamount_Ventures>,
        <https://1145.am/db/1853496/T-Ventures>,
        <https://1145.am/db/1854200/Ggv_Capital>,
        <https://1145.am/db/1854201/Charles_River_Ventures>,
        <https://1145.am/db/1854786/Eden_Ventures>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1854874/Sherpa_Ventures>,
        <https://1145.am/db/1854874/Softtech>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1855363/True_Ventures>,
        <https://1145.am/db/1855403/Rho_Ventures>,
        <https://1145.am/db/1855780/Bds_Ventures>,
        <https://1145.am/db/1855780/Ggv_Capital>,
        <https://1145.am/db/1856191/Creandum>,
        <https://1145.am/db/1856380/Softtech>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1856616/Redpoint_Ventures>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1857635/Rikard_Steiber>,
        <https://1145.am/db/1857659/Revolution_Ventures>,
        <https://1145.am/db/1857930/Inovia_Capital>,
        <https://1145.am/db/1857930/Version_One_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858592/Apex_Venture_Partners>,
        <https://1145.am/db/1858592/Origin_Ventures>,
        <https://1145.am/db/1858991/Capnamic_Ventures>,
        <https://1145.am/db/1859199/True_Ventures>,
        <https://1145.am/db/1859314/Version_One_Ventures>,
        <https://1145.am/db/1860163/Inovia_Capital>,
        <https://1145.am/db/1860345/Commonangels>,
        <https://1145.am/db/1860345/Launchcapital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1861355/Rho_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1863147/Apex_Venture_Partners>,
        <https://1145.am/db/1864601/Trinity_Ventures>,
        <https://1145.am/db/1864646/Inventus_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sherpalo_Ventures>,
        <https://1145.am/db/1866032/Launchcapital>,
        <https://1145.am/db/1866134/Embarcadero_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866155/Presidio_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867599/Cava_Capital>,
        <https://1145.am/db/1868107/Redpoint_Ventures>,
        <https://1145.am/db/1868109/Charles_River_Ventures>,
        <https://1145.am/db/1868178/True_Ventures>,
        <https://1145.am/db/1870015/Redpoint_Ventures>,
        <https://1145.am/db/1870465/Nextview_Ventures>,
        <https://1145.am/db/1871221/True_Ventures>,
        <https://1145.am/db/1871574/Redpoint_Ventures>,
        <https://1145.am/db/1871777/Charles_River_Ventures>,
        <https://1145.am/db/1871784/Charles_River_Ventures>,
        <https://1145.am/db/1871888/Charles_River_Ventures>,
        <https://1145.am/db/1873191/El_Dorado_Ventures>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1873680/Lerer_Ventures>,
        <https://1145.am/db/1873680/Xg_Ventures>,
        <https://1145.am/db/1874749/True_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1877283/Northzone_Ventures>,
        <https://1145.am/db/1877473/True_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878620/Ggv_Capital>,
        <https://1145.am/db/1879279/High_Line_Ventures>,
        <https://1145.am/db/1879759/T-Venture>,
        <https://1145.am/db/1880679/Northzone_Ventures>,
        <https://1145.am/db/1881464/Ggv_Capital>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1882330/New_World_Ventures>,
        <https://1145.am/db/1882727/Charles_River_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1883568/Eden_Ventures>,
        <https://1145.am/db/1883572/Astutia_Ventures>,
        <https://1145.am/db/1886402/New_Atlantic_Ventures>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1889394/Focus_Ventures>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1890000/Lerer_Ventures>,
        <https://1145.am/db/1890122/East_Ventures>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1890133/Focus_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/1890208/Menlo_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890839/Inovia_Capital>,
        <https://1145.am/db/1890903/Miven_Ventures>,
        <https://1145.am/db/1891615/Holtzbrinck_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891913/New_World_Ventures>,
        <https://1145.am/db/1891913/Oca_Ventures>,
        <https://1145.am/db/1891926/New_World_Ventures>,
        <https://1145.am/db/1892050/Charles_River_Ventures>,
        <https://1145.am/db/1892105/Crosscreek_Capital>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1892106/Altos_Ventures>,
        <https://1145.am/db/1892106/Illuminate_Ventures>,
        <https://1145.am/db/1892620/True_Ventures>,
        <https://1145.am/db/1892674/Appian_Ventures>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1892955/Guy_Gamzu>,
        <https://1145.am/db/1895072/Nextview_Ventures>,
        <https://1145.am/db/1895951/Windward_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1896379/Redpoint_Ventures>,
        <https://1145.am/db/1896419/True_Ventures>,
        <https://1145.am/db/1902330/Baseline_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1909430/Menlo_Ventures>,
        <https://1145.am/db/1909651/Revolution_Ventures>,
        <https://1145.am/db/1910694/True_Ventures>,
        <https://1145.am/db/1910922/Charles_River_Ventures>,
        <https://1145.am/db/1912684/Charles_River_Ventures>,
        <https://1145.am/db/1913863/Tl_Ventures>,
        <https://1145.am/db/1913874/Redpoint_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1915862/Focus_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1920478/Dawntreader_Ventures>,
        <https://1145.am/db/1920837/Onset_Ventures>,
        <https://1145.am/db/1927817/Trm_Ventures>,
        <https://1145.am/db/1939926/Cobalt_Ventures>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/1947303/Cavallo_Ventures>,
        <https://1145.am/db/1947312/Boldstart_Ventures>,
        <https://1145.am/db/1952989/Singularity_Ventures>,
        <https://1145.am/db/1954147/Accomplice_Ventures>,
        <https://1145.am/db/1957179/Sozo_Ventures>,
        <https://1145.am/db/1958963/Prosus_Ventures>,
        <https://1145.am/db/1959001/Capital_Technology_Ventures>,
        <https://1145.am/db/1959001/Glasswing_Ventures>,
        <https://1145.am/db/1962819/Connetic_Ventures>,
        <https://1145.am/db/1967592/Firebolt_Ventures>,
        <https://1145.am/db/1967683/Dig_Ventures_Vine_Ventures>,
        <https://1145.am/db/1975490/Northview_Ventures>,
        <https://1145.am/db/1975547/Nanban_Ventures>,
        <https://1145.am/db/1975547/Sinewave_Ventures>,
        <https://1145.am/db/1986122/Menlo_Ventures>,
        <https://1145.am/db/1995926/Neotribe_Ventures>,
        <https://1145.am/db/1998196/Gni_Group_Ltd>,
        <https://1145.am/db/1999771/Servicenow_Ventures>,
        <https://1145.am/db/2004427/Convivialit_Ventures>,
        <https://1145.am/db/2005131/Wwventures>,
        <https://1145.am/db/2007132/Nventures>,
        <https://1145.am/db/2020041/Inovia_Capital>,
        <https://1145.am/db/2020041/TCV>,
        <https://1145.am/db/2023596/Salesforce_Ventures>,
        <https://1145.am/db/2025081/True_Ventures>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2035454/Gv>,
        <https://1145.am/db/2036021/Clear_Ventures>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/2039177/Stellantis_Ventures>,
        <https://1145.am/db/2041480/Brunnur_Ventures>,
        <https://1145.am/db/2042858/Gv>,
        <https://1145.am/db/2044380/20sales>,
        <https://1145.am/db/2045587/Veritec_Ventures>,
        <https://1145.am/db/2050229/Nventures>,
        <https://1145.am/db/2050359/At_One_Ventures>,
        <https://1145.am/db/2051164/Aviso_Ventures>,
        <https://1145.am/db/2053027/Glasswing_Ventures>,
        <https://1145.am/db/2055707/Globis_Capital_Partners>,
        <https://1145.am/db/2056931/We_Ventures>,
        <https://1145.am/db/2060003/Crit_Ventures_100___100_Ventures>,
        <https://1145.am/db/2061278/Incisive_Ventures>,
        <https://1145.am/db/2061278/Volo_Ventures>,
        <https://1145.am/db/2063642/Clear_Bridge_Ventures>,
        <https://1145.am/db/2063967/Vsquared_Ventures>,
        <https://1145.am/db/2069147/Boldstart_Ventures>,
        <https://1145.am/db/2069147/Pelion_Ventures>,
        <https://1145.am/db/2069147/Salesforce_Ventures>,
        <https://1145.am/db/2069495/Intermountain_Ventures>,
        <https://1145.am/db/2069495/Northpond_Ventures>,
        <https://1145.am/db/2073129/Abstract_Ventures>,
        <https://1145.am/db/2073132/Idc_Ventures>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2075625/Rocketship_Ventures>,
        <https://1145.am/db/2081180/S4s_Ventures>,
        <https://1145.am/db/2081674/Capital_One_Ventures>,
        <https://1145.am/db/2082068/Arctern_Ventures>,
        <https://1145.am/db/2082068/Prelude_Ventures>,
        <https://1145.am/db/2083987/Vanterra_Ventures>,
        <https://1145.am/db/2087289/Jven_Capital>,
        <https://1145.am/db/2087289/Northpond_Ventures>,
        <https://1145.am/db/2089206/Crescendo_Venture_Partners>,
        <https://1145.am/db/2093427/Yl_Ventures>,
        <https://1145.am/db/2093713/Yl_Ventures>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2100116/Epic_Ventures>,
        <https://1145.am/db/2107533/Globis_Capital_Partners>,
        <https://1145.am/db/2109529/Point72_Ventures>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2109932/Catalio_Capital_Management>,
        <https://1145.am/db/2109932/Epic_Ventures>,
        <https://1145.am/db/2109932/Intermountain_Ventures>,
        <https://1145.am/db/2109932/North_South_Ventures>,
        <https://1145.am/db/2116769/Celesta_Capital>,
        <https://1145.am/db/2116769/Chiratae_Ventures>,
        <https://1145.am/db/2123953/Amex_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2123953/Infinity_Ventures>,
        <https://1145.am/db/2124766/P1_Ventures>,
        <https://1145.am/db/2125182/Nevcaut_Ventures>,
        <https://1145.am/db/2125182/Ulu_Ventures>,
        <https://1145.am/db/2125927/1984_Ventures>,
        <https://1145.am/db/2127882/Akkadian_Ventures>,
        <https://1145.am/db/2134989/Clear_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2141183/S_Ventures>,
        <https://1145.am/db/2141328/Connetic_Ventures>,
        <https://1145.am/db/2143438/Scorpio_Capital>,
        <https://1145.am/db/2147767/Catapult_Ventures>,
        <https://1145.am/db/2147767/Tenoneten_Ventures>,
        <https://1145.am/db/2151983/CRV>,
        <https://1145.am/db/2151983/Greatpoint_Ventures>,
        <https://1145.am/db/2155426/Brighteyes_Ventures>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2164121/Menlo_Ventures>,
        <https://1145.am/db/2169799/Nwise_Ventures>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2182443/Global_Ventures>,
        <https://1145.am/db/2183352/Optum_Ventures>,
        <https://1145.am/db/2186568/Frist_Cressey_Ventures>,
        <https://1145.am/db/2186568/Springrock_Ventures>,
        <https://1145.am/db/2186949/Greatpoint_Ventures_And_Cross_Creek>,
        <https://1145.am/db/2186949/Springrock_Ventures>,
        <https://1145.am/db/2190141/Link_Ventures>,
        <https://1145.am/db/2192636/TCV>,
        <https://1145.am/db/219311/Origin_Ventures>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2208603/McKesson_Ventures>,
        <https://1145.am/db/2210557/True_Ventures>,
        <https://1145.am/db/221321/Ggv_Capital>,
        <https://1145.am/db/2214690/Idg_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2264763/True_Ventures>,
        <https://1145.am/db/2283006/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Northpond_Ventures>,
        <https://1145.am/db/2284412/Soleus_Capital>,
        <https://1145.am/db/2286665/Shanda_Group>,
        <https://1145.am/db/2288209/Echelon_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2293172/Prospect_Ventures>,
        <https://1145.am/db/2294202/Trinitas_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2295253/Arkitekt_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2296249/Proxima_Ventures>,
        <https://1145.am/db/2296869/Dcm_Ventures>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2298897/Eshelman_Ventures>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2302351/Rho_Ventures>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2302897/Ventures_West_Capital>,
        <https://1145.am/db/2303098/Seaflower_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304606/Prism_Ventureworks>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2306568/Cmea_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2309507/Rho_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2312792/Onset_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2314380/Puretech_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314515/Apjohnventures>,
        <https://1145.am/db/2315754/Arcturus_Capital>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2321856/Ventures_West_Capital_Ltd>,
        <https://1145.am/db/2323785/Eshelman_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2325015/True_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325257/Ventures_West>,
        <https://1145.am/db/2325337/Resolvyx>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/2326362/Nextech_Venture>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2328585/Cmea_Ventures>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2338023/Cipla_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338703/Wavepoint_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341942/High-Tech_Grnderfonds>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2343184/Jven_Capital>,
        <https://1145.am/db/2345017/Venture_Investments>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2346300/High-Tech_Grnderfonds>,
        <https://1145.am/db/2346452/Aescap_Venture>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346978/Ventures_West_Capital>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2357487/Savitr_Capital>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2358747/Solon_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/2362638/Launchpad_Venture_Group>,
        <https://1145.am/db/2363460/Rho_Ventures>,
        <https://1145.am/db/2363854/Chrysalis_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365103/Aescap_Venture>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/238282/Carnrite_Ventures>,
        <https://1145.am/db/2400536/Capital_One_Ventures>,
        <https://1145.am/db/2423653/Venturewell>,
        <https://1145.am/db/253438/Esplanade_Ventures>,
        <https://1145.am/db/254357/Ulu_Ventures>,
        <https://1145.am/db/2549491/Ktb_Ventures>,
        <https://1145.am/db/2552636/Morningside_Ventures>,
        <https://1145.am/db/2569491/High-Tech_Grnderfonds>,
        <https://1145.am/db/2570138/Sherpa_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2603254/Salesforce_Ventures>,
        <https://1145.am/db/2628424/Verana_Networks>,
        <https://1145.am/db/2628848/Neocarta_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2638432/Nissay_Capital>,
        <https://1145.am/db/2641337/Promus_Ventures>,
        <https://1145.am/db/2641337/True_Ventures>,
        <https://1145.am/db/2654391/Biggell_Finance>,
        <https://1145.am/db/265532/Ulu_Ventures>,
        <https://1145.am/db/2702871/Inovia_Capital>,
        <https://1145.am/db/274170/G1_Ventures>,
        <https://1145.am/db/2754677/Golden_Gate_Ventures>,
        <https://1145.am/db/2765022/Garuda_Ventures>,
        <https://1145.am/db/2765030/Daniel_Ventures>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/2786411/Allegion_Ventures>,
        <https://1145.am/db/2788052/Rx_Ventures>,
        <https://1145.am/db/2790064/Novastar_Ventures>,
        <https://1145.am/db/2794396/Snowpoint_Ventures>,
        <https://1145.am/db/2797562/Menlo_Ventures>,
        <https://1145.am/db/283272/Salesforce_Ventures>,
        <https://1145.am/db/283607/Salesforce_Ventures>,
        <https://1145.am/db/293715/Signum_Capital>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/293891/Ggv_Capital>,
        <https://1145.am/db/299738/Steadfast_Capital_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/319155/Bgv_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/341984/Salesforce_Ventures>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Salesforce_Ventures>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/343459/F7_Ventures>,
        <https://1145.am/db/346598/Salesforce_Ventures>,
        <https://1145.am/db/348442/Triventures>,
        <https://1145.am/db/348659/Launchpad_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/364168/Alerion_Ventures>,
        <https://1145.am/db/367592/Gv>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/388551/Vestigo_Ventures>,
        <https://1145.am/db/396305/Real_Ventures>,
        <https://1145.am/db/402103/1776_Ventures>,
        <https://1145.am/db/402701/January_Ventures>,
        <https://1145.am/db/403810/Riverstone_Ventures>,
        <https://1145.am/db/410322/Gv>,
        <https://1145.am/db/410473/Celesta_Capital>,
        <https://1145.am/db/410473/Lytical_Ventures_And_Nepenthe_Capital>,
        <https://1145.am/db/410529/Goodyear_Ventures>,
        <https://1145.am/db/411539/Zeev_Ventures>,
        <https://1145.am/db/412020/Defi_Ventures_Inc>,
        <https://1145.am/db/415322/CRV>,
        <https://1145.am/db/416041/Akkadian_Ventures>,
        <https://1145.am/db/416041/Signia_Ventures>,
        <https://1145.am/db/416041/Zeev_Ventures>,
        <https://1145.am/db/419489/Point72_Ventures>,
        <https://1145.am/db/424877/North_First_Ventures>,
        <https://1145.am/db/425262/Yl_Ventures>,
        <https://1145.am/db/425423/True_Ventures>,
        <https://1145.am/db/425973/Will_Ventures>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/429179/C5_Capital>,
        <https://1145.am/db/430986/Cortado_Ventures>,
        <https://1145.am/db/434334/1up_Ventures>,
        <https://1145.am/db/435691/Klick_Ventures>,
        <https://1145.am/db/439819/Cavu_Ventures>,
        <https://1145.am/db/441319/Celesta_Capital>,
        <https://1145.am/db/444105/Exfinity_Ventures>,
        <https://1145.am/db/445365/Revolution_Ventures>,
        <https://1145.am/db/446341/Sinewave_Ventures>,
        <https://1145.am/db/455558/Intudo_Ventures>,
        <https://1145.am/db/457435/Alerce>,
        <https://1145.am/db/457435/Clin>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/471253/Gv>,
        <https://1145.am/db/471436/Citi_Ventures>,
        <https://1145.am/db/471504/Canapi_Ventures>,
        <https://1145.am/db/473030/Highsage_Ventures>,
        <https://1145.am/db/474928/Susa_Ventures>,
        <https://1145.am/db/478049/Worldquant_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/479113/Menlo_Ventures>,
        <https://1145.am/db/485616/K3_Ventures>,
        <https://1145.am/db/486858/Gaingels>,
        <https://1145.am/db/486901/Gaingels>,
        <https://1145.am/db/488743/Salesforce_Ventures>,
        <https://1145.am/db/491130/Raiven_Capital>,
        <https://1145.am/db/491338/Raiven_Capital>,
        <https://1145.am/db/493560/Tyh_Ventures>,
        <https://1145.am/db/495912/Regah_Ventures>,
        <https://1145.am/db/506588/Trinity_Ventures>,
        <https://1145.am/db/508145/Sora_Finance>,
        <https://1145.am/db/508161/Sora_Finance>,
        <https://1145.am/db/510565/Epic_Ventures>,
        <https://1145.am/db/513305/Avid_Ventures>,
        <https://1145.am/db/513305/Canapi_Ventures>,
        <https://1145.am/db/513897/Rlc_Ventures>,
        <https://1145.am/db/514151/Rlc_Ventures>,
        <https://1145.am/db/516396/Acequia_Capital>,
        <https://1145.am/db/517213/Acequia_Capital>,
        <https://1145.am/db/523349/Osf_Ventures>,
        <https://1145.am/db/523776/Root_Ventures>,
        <https://1145.am/db/525285/Inventum_Ventures>,
        <https://1145.am/db/525285/Optima_Ventures>,
        <https://1145.am/db/526109/Ggv_Capital>,
        <https://1145.am/db/526175/Ridgeline_Ventures>,
        <https://1145.am/db/529812/Inventum_Ventures>,
        <https://1145.am/db/529812/Optima_Ventures>,
        <https://1145.am/db/532016/Id_Ventures>,
        <https://1145.am/db/539571/Origin_Ventures>,
        <https://1145.am/db/545843/Capital_One_Ventures>,
        <https://1145.am/db/545852/Boxone_Ventures>,
        <https://1145.am/db/545852/Panache_Ventures>,
        <https://1145.am/db/547770/BGV>,
        <https://1145.am/db/547944/BGV>,
        <https://1145.am/db/554552/Konvoy_Ventures>,
        <https://1145.am/db/555193/Illumina_Ventures>,
        <https://1145.am/db/555193/Technology_Venture_Partners>,
        <https://1145.am/db/556705/Congress_Ave_Ventures>,
        <https://1145.am/db/558005/Illumina_Ventures>,
        <https://1145.am/db/558005/Technology_Venture_Partners>,
        <https://1145.am/db/558877/Falabella_Ventures>,
        <https://1145.am/db/559220/Ulu_Ventures>,
        <https://1145.am/db/561662/Redpoint_Ventures>,
        <https://1145.am/db/561662/Vandelay_Ventures>,
        <https://1145.am/db/562745/Vinmar_Ventures>,
        <https://1145.am/db/563575/Celesta_Capital>,
        <https://1145.am/db/564008/D1_Ventures>,
        <https://1145.am/db/571769/Illumina_Ventures>,
        <https://1145.am/db/571769/M_Ventures>,
        <https://1145.am/db/572097/Menlo_Ventures>,
        <https://1145.am/db/572097/Teneleven_Ventures>,
        <https://1145.am/db/575249/TCV>,
        <https://1145.am/db/576186/Konvoy_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/586525/Tenoneten_Ventures>,
        <https://1145.am/db/587038/Coparion>,
        <https://1145.am/db/591566/Morningside_Ventures>,
        <https://1145.am/db/596145/Anorak_Ventures>,
        <https://1145.am/db/596564/Anorak_Ventures>,
        <https://1145.am/db/601455/Morningside_Ventures>,
        <https://1145.am/db/603725/Ignitexl_Ventures>,
        <https://1145.am/db/606074/Fiscus_Ventures>,
        <https://1145.am/db/606144/Ggv_Capital>,
        <https://1145.am/db/615337/Companyon_Ventures>,
        <https://1145.am/db/619284/Scf_Ventures>,
        <https://1145.am/db/619366/Capital_One_Ventures>,
        <https://1145.am/db/619736/Lightspeed_Ventures>,
        <https://1145.am/db/623178/Array_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/626781/Dnx_Ventures>,
        <https://1145.am/db/627030/Launchpad_Capital>,
        <https://1145.am/db/628654/Prologis_Ventures>,
        <https://1145.am/db/633238/True_Ventures>,
        <https://1145.am/db/633869/Skywell_Capital_Partners>,
        <https://1145.am/db/633869/Stageone_Ventures>,
        <https://1145.am/db/640939/Ggv_Capital>,
        <https://1145.am/db/642123/Charles_River_Ventures>,
        <https://1145.am/db/642518/Network_Ventures>,
        <https://1145.am/db/643600/Vinco_Ventures>,
        <https://1145.am/db/648552/True_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/659675/Gv>,
        <https://1145.am/db/661747/Adit_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/665129/Ac_Ventures>,
        <https://1145.am/db/665776/Firstime_Ventures>,
        <https://1145.am/db/676217/Steelsky_Ventures>,
        <https://1145.am/db/676869/Ggv_Capital>,
        <https://1145.am/db/678140/Ggv_Capital>,
        <https://1145.am/db/678587/Lightshed_Ventures>,
        <https://1145.am/db/678593/Solana_Ventures>,
        <https://1145.am/db/687538/Kayyak_Ventures>,
        <https://1145.am/db/689460/True_Ventures>,
        <https://1145.am/db/694513/Authentic_Ventures>,
        <https://1145.am/db/694924/Avid_Ventures>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/700327/Menlo_Ventures>,
        <https://1145.am/db/700877/Gaingels>,
        <https://1145.am/db/703983/Eqventure>,
        <https://1145.am/db/704489/Eqventure>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/704753/Menlo_Ventures>,
        <https://1145.am/db/704793/Quidnet_Ventures>,
        <https://1145.am/db/704991/Gaingels>,
        <https://1145.am/db/709633/Connetic_Ventures>,
        <https://1145.am/db/726461/Contour_Ventures>,
        <https://1145.am/db/729628/Kyber_Ventures>,
        <https://1145.am/db/729628/Signum_Capital>,
        <https://1145.am/db/738920/Oca_Ventures>,
        <https://1145.am/db/738920/Susa_Ventures>,
        <https://1145.am/db/739538/Morpheus_Ventures>,
        <https://1145.am/db/739538/Oca_Ventures>,
        <https://1145.am/db/739538/Susa_Ventures>,
        <https://1145.am/db/747051/Tenoneten_Ventures>,
        <https://1145.am/db/747771/Ta_Ventures>,
        <https://1145.am/db/749147/1984_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/1984_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/750305/Yl_Ventures>,
        <https://1145.am/db/750725/Vestigo_Ventures>,
        <https://1145.am/db/751176/Maverick_Ventures>,
        <https://1145.am/db/751176/Susa_Ventures>,
        <https://1145.am/db/751387/Menlo_Ventures>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/753251/Savantus_Ventures>,
        <https://1145.am/db/753913/Brunnur_Ventures>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/758206/Great_North_Ventures>,
        <https://1145.am/db/758206/Grotech_Ventures>,
        <https://1145.am/db/759749/Cava_Capital>,
        <https://1145.am/db/763083/Gaingels>,
        <https://1145.am/db/764875/Rev1_Ventures>,
        <https://1145.am/db/764896/Rev1_Ventures>,
        <https://1145.am/db/765216/True_Ventures>,
        <https://1145.am/db/768172/Gaingels>,
        <https://1145.am/db/768172/Type_One_Ventures>,
        <https://1145.am/db/768349/Salesforce_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769568/Axon_Ventures>,
        <https://1145.am/db/772099/Array_Ventures>,
        <https://1145.am/db/773235/Prelude_Ventures>,
        <https://1145.am/db/773684/Fulgur_Ventures>,
        <https://1145.am/db/773794/Array_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/778423/Sentiero_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/779867/Genesis_Block_Ventures>,
        <https://1145.am/db/780272/East_Ventures>,
        <https://1145.am/db/780289/East_Ventures>,
        <https://1145.am/db/783431/Cathay_Venture_Inc>,
        <https://1145.am/db/784093/Boldstart_Ventures>,
        <https://1145.am/db/787806/Boldstart_Ventures>,
        <https://1145.am/db/788016/Boldstart_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796250/Sp_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/797597/Lansdowne_Partners>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/800101/Gaingels>,
        <https://1145.am/db/803541/Credo_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/8045/Greatpoint_Ventures>,
        <https://1145.am/db/806828/Promus_Ventures>,
        <https://1145.am/db/806994/Companyon_Ventures>,
        <https://1145.am/db/807080/K3_Ventures>,
        <https://1145.am/db/808020/Starlight_Ventures>,
        <https://1145.am/db/808020/Valo_Ventures>,
        <https://1145.am/db/8146/Rev1_Ventures>,
        <https://1145.am/db/817162/Orbia_Ventures>,
        <https://1145.am/db/818444/1984_Ventures>,
        <https://1145.am/db/821135/Se_Ventures>,
        <https://1145.am/db/823763/Infinity_Ventures>,
        <https://1145.am/db/828716/Idc_Ventures>,
        <https://1145.am/db/829118/Salesforce_Ventures>,
        <https://1145.am/db/830571/Company_Ventures>,
        <https://1145.am/db/830689/Soleus_Capital>,
        <https://1145.am/db/832264/Salesforce_Ventures>,
        <https://1145.am/db/832573/Solasta_Ventures>,
        <https://1145.am/db/834864/Ggv_Capital>,
        <https://1145.am/db/834864/K3_Ventures>,
        <https://1145.am/db/836848/Technexus_Venture_Collaborative>,
        <https://1145.am/db/836908/Frontier_Ventures>,
        <https://1145.am/db/837034/Redpoint_Ventures>,
        <https://1145.am/db/838138/Root_Ventures>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/847157/Signum_Capital>,
        <https://1145.am/db/847862/Wise_Ventures>,
        <https://1145.am/db/854001/Gv>,
        <https://1145.am/db/854589/Verance_Capital>,
        <https://1145.am/db/854654/Mrtnz_Ventures>,
        <https://1145.am/db/854795/Menlo_Ventures>,
        <https://1145.am/db/867865/Applied_Ventures>,
        <https://1145.am/db/868093/Cobro_Ventures>,
        <https://1145.am/db/869652/Forever_Ventures>,
        <https://1145.am/db/874394/Nextview_Ventures>,
        <https://1145.am/db/874394/True_Ventures>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/881298/At_One_Ventures>,
        <https://1145.am/db/882723/At_One_Ventures>,
        <https://1145.am/db/884787/Foresite_Capital>,
        <https://1145.am/db/884787/Gv>,
        <https://1145.am/db/884787/Northpond_Ventures>,
        <https://1145.am/db/886445/Gv>,
        <https://1145.am/db/887062/Panoramic_Ventures>,
        <https://1145.am/db/889246/At_One_Ventures>,
        <https://1145.am/db/890271/Panoramic_Ventures>,
        <https://1145.am/db/891162/Emergingvc>,
        <https://1145.am/db/891162/Launchpad_Venture_Group>,
        <https://1145.am/db/903689/Vectr_Ventures>,
        <https://1145.am/db/904276/Nextview_Ventures>,
        <https://1145.am/db/906393/East_Ventures>,
        <https://1145.am/db/907844/Argon_Ventures>,
        <https://1145.am/db/907844/Glasswing_Ventures>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/913678/Sandbridge_Capital>,
        <https://1145.am/db/919636/Menlo_Ventures>,
        <https://1145.am/db/921704/Scop_Ventures>,
        <https://1145.am/db/92200/Knoll_Ventures>,
        <https://1145.am/db/922066/Irrvrnt_Vc>,
        <https://1145.am/db/922192/Gv>,
        <https://1145.am/db/922498/Sozo_Ventures>,
        <https://1145.am/db/923723/Scop_Ventures>,
        <https://1145.am/db/928711/Frontline_Ventures>,
        <https://1145.am/db/934946/Ggv_Capital>,
        <https://1145.am/db/935046/Origin_Ventures>,
        <https://1145.am/db/935249/Victress_Capital>,
        <https://1145.am/db/935322/Alpana_Ventures>,
        <https://1145.am/db/935322/M_Ventures>,
        <https://1145.am/db/935796/Salesforce_Ventures>,
        <https://1145.am/db/935962/Digitalbridge_Ventures>,
        <https://1145.am/db/936045/Lpc_Ventures>,
        <https://1145.am/db/936057/Noemis_Ventures>,
        <https://1145.am/db/936154/Salesforce_Ventures>,
        <https://1145.am/db/936448/Ggv_Capital>,
        <https://1145.am/db/936862/Lool_Ventures>,
        <https://1145.am/db/936906/Neotribe_Ventures>,
        <https://1145.am/db/937210/Citi_Ventures>,
        <https://1145.am/db/937210/Firebolt_Ventures>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/938108/Conti_Ventures>,
        <https://1145.am/db/938555/Digitalbridge_Ventures>,
        <https://1145.am/db/938586/Venturesouth>,
        <https://1145.am/db/938921/Redpoint_Ventures>,
        <https://1145.am/db/938975/Ggv_Capital>,
        <https://1145.am/db/939163/Goodyear_Ventures>,
        <https://1145.am/db/940740/Agnc_Ventures>,
        <https://1145.am/db/940913/True_Ventures>,
        <https://1145.am/db/941816/Radical_Ventures>,
        <https://1145.am/db/942825/Argon_Ventures>,
        <https://1145.am/db/946710/Citi_Ventures>,
        <https://1145.am/db/947238/Kyros_Ventures>,
        <https://1145.am/db/952434/Verissimo_Ventures>,
        <https://1145.am/db/955201/Gv>,
        <https://1145.am/db/960022/Verance_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/970950/Ulu_Ventures>,
        <https://1145.am/db/971415/Altai_Ventures>,
        <https://1145.am/db/971450/Allon_Ventures>,
        <https://1145.am/db/971939/Formic_Ventures>,
        <https://1145.am/db/975114/Formic_Ventures>,
        <https://1145.am/db/979753/Menlo_Ventures>,
        <https://1145.am/db/980678/Menlo_Ventures>,
        <https://1145.am/db/984645/Vinco_Ventures>,
        <https://1145.am/db/987688/Brightspark_Ventures>,
        <https://1145.am/db/987700/Infinityvc>,
        <https://1145.am/db/988084/Abstract_Ventures>,
        <https://1145.am/db/988084/Blank_Ventures>,
        <https://1145.am/db/988318/Arthur_Ventures>,
        <https://1145.am/db/988482/Brightspark_Ventures>,
        <https://1145.am/db/988979/Infinityvc>,
        <https://1145.am/db/989392/Arthur_Ventures>,
        <https://1145.am/db/990085/Radical_Ventures>,
        <https://1145.am/db/995593/Raiven_Capital>,
        <https://1145.am/db/995737/Nuoyan_Capital>,
        <https://1145.am/db/996563/Raiven_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1247967/Index_Ventures>,
        <https://1145.am/db/1358814/Index_Ventures>,
        <https://1145.am/db/1490485/Index_Ventures>,
        <https://1145.am/db/1493654/Index_Ventures>,
        <https://1145.am/db/1553352/Index_Ventures>,
        <https://1145.am/db/1693951/Index_Ventures>,
        <https://1145.am/db/1694279/Index_Ventures>,
        <https://1145.am/db/1699089/Index_Ventures>,
        <https://1145.am/db/1704793/Index_Ventures>,
        <https://1145.am/db/1711587/Index_Ventures>,
        <https://1145.am/db/1711731/Index_Ventures>,
        <https://1145.am/db/1712506/Index_Ventures>,
        <https://1145.am/db/1717574/Index_Ventures>,
        <https://1145.am/db/1733028/Index_Ventures>,
        <https://1145.am/db/1735596/Index_Ventures>,
        <https://1145.am/db/1736117/Index_Ventures>,
        <https://1145.am/db/1737079/Index_Ventures>,
        <https://1145.am/db/1737527/Index_Ventures>,
        <https://1145.am/db/1737696/Index_Ventures>,
        <https://1145.am/db/1738402/Index_Ventures>,
        <https://1145.am/db/1738465/Index_Ventures>,
        <https://1145.am/db/1740781/Index_Ventures>,
        <https://1145.am/db/1742878/Index_Ventures>,
        <https://1145.am/db/1744753/Index_Ventures>,
        <https://1145.am/db/1745368/Index_Ventures>,
        <https://1145.am/db/1745702/Index_Ventures>,
        <https://1145.am/db/1746192/Index_Ventures>,
        <https://1145.am/db/1746800/Index_Ventures>,
        <https://1145.am/db/1746845/Index_Ventures>,
        <https://1145.am/db/1746947/Index_Ventures>,
        <https://1145.am/db/1747153/Index_Ventures>,
        <https://1145.am/db/1747208/Index_Ventures>,
        <https://1145.am/db/1748172/Index_Ventures>,
        <https://1145.am/db/1748621/Index_Ventures>,
        <https://1145.am/db/1750406/Index_Ventures>,
        <https://1145.am/db/1750420/Index_Ventures>,
        <https://1145.am/db/1750828/Index_Ventures>,
        <https://1145.am/db/1752154/Index_Ventures>,
        <https://1145.am/db/1755398/Index_Ventures>,
        <https://1145.am/db/1755899/Index_Ventures>,
        <https://1145.am/db/1756768/Index_Ventures>,
        <https://1145.am/db/1756873/Index_Ventures>,
        <https://1145.am/db/1758069/Index_Ventures>,
        <https://1145.am/db/1758834/Index_Ventures>,
        <https://1145.am/db/1759939/Index_Ventures>,
        <https://1145.am/db/1760954/Index_Ventures>,
        <https://1145.am/db/1761664/Index_Ventures>,
        <https://1145.am/db/1762988/Index_Ventures>,
        <https://1145.am/db/1763352/Index_Ventures>,
        <https://1145.am/db/1765809/Index_Ventures>,
        <https://1145.am/db/1765870/Index_Ventures>,
        <https://1145.am/db/1766059/Index_Ventures>,
        <https://1145.am/db/1766253/Index_Ventures>,
        <https://1145.am/db/1769654/Index_Ventures>,
        <https://1145.am/db/1771672/Index_Ventures>,
        <https://1145.am/db/1771734/Index_Ventures>,
        <https://1145.am/db/1771773/Index_Ventures>,
        <https://1145.am/db/1775903/Index_Ventures>,
        <https://1145.am/db/1776139/Index_Ventures>,
        <https://1145.am/db/1776626/Index_Ventures>,
        <https://1145.am/db/1777546/Index_Ventures>,
        <https://1145.am/db/1778195/Index_Ventures>,
        <https://1145.am/db/1780507/Index_Ventures>,
        <https://1145.am/db/1780733/Index_Ventures>,
        <https://1145.am/db/1783754/Index_Ventures>,
        <https://1145.am/db/1787471/Index_Ventures>,
        <https://1145.am/db/1787621/Index_Ventures>,
        <https://1145.am/db/1790777/Index_Ventures>,
        <https://1145.am/db/1791667/Index_Ventures>,
        <https://1145.am/db/1791743/Index_Ventures>,
        <https://1145.am/db/1796201/Index_Ventures>,
        <https://1145.am/db/1798836/Index_Ventures>,
        <https://1145.am/db/1799293/Index_Ventures>,
        <https://1145.am/db/1800172/Index_Ventures>,
        <https://1145.am/db/1800998/Index_Ventures>,
        <https://1145.am/db/1805201/Index_Ventures>,
        <https://1145.am/db/1805473/Index_Ventures>,
        <https://1145.am/db/1807173/Index_Ventures>,
        <https://1145.am/db/1808484/Index_Ventures>,
        <https://1145.am/db/1809821/Index_Ventures>,
        <https://1145.am/db/1810000/Index_Ventures>,
        <https://1145.am/db/1812038/Index_Ventures>,
        <https://1145.am/db/1812890/Index_Ventures>,
        <https://1145.am/db/1813037/Index_Ventures>,
        <https://1145.am/db/1813404/Index_Ventures>,
        <https://1145.am/db/1819133/Index_Ventures>,
        <https://1145.am/db/1819302/Index_Ventures>,
        <https://1145.am/db/1823078/Index_Ventures>,
        <https://1145.am/db/1823141/Index_Ventures>,
        <https://1145.am/db/1824561/Index_Ventures>,
        <https://1145.am/db/1828638/Index_Ventures>,
        <https://1145.am/db/1829991/Index_Ventures>,
        <https://1145.am/db/1830023/Index_Ventures>,
        <https://1145.am/db/1831440/Index_Ventures>,
        <https://1145.am/db/1832655/Index_Ventures>,
        <https://1145.am/db/1832808/Index_Ventures>,
        <https://1145.am/db/1832926/Index_Ventures>,
        <https://1145.am/db/1835321/Index_Ventures>,
        <https://1145.am/db/1835516/Index_Ventures>,
        <https://1145.am/db/1836455/Index_Ventures>,
        <https://1145.am/db/1836572/Index_Ventures>,
        <https://1145.am/db/1837081/Index_Ventures>,
        <https://1145.am/db/1837143/Index_Ventures>,
        <https://1145.am/db/1839663/Index_Ventures>,
        <https://1145.am/db/1840137/Index_Ventures>,
        <https://1145.am/db/1845548/Index_Ventures>,
        <https://1145.am/db/1845841/Index_Ventures>,
        <https://1145.am/db/1846794/Index_Ventures>,
        <https://1145.am/db/1847483/Index_Ventures>,
        <https://1145.am/db/1848631/Index_Ventures>,
        <https://1145.am/db/1849844/Index_Ventures>,
        <https://1145.am/db/1849912/Index_Ventures>,
        <https://1145.am/db/1850428/Index_Ventures>,
        <https://1145.am/db/1851744/Index_Ventures>,
        <https://1145.am/db/1853547/Index_Ventures>,
        <https://1145.am/db/1854191/Index_Ventures>,
        <https://1145.am/db/1856171/Index_Ventures>,
        <https://1145.am/db/1856191/Index_Ventures>,
        <https://1145.am/db/1856802/Index_Ventures>,
        <https://1145.am/db/1856967/Index_Ventures>,
        <https://1145.am/db/1857638/Index_Ventures>,
        <https://1145.am/db/1858520/Index_Ventures>,
        <https://1145.am/db/1858521/Index_Ventures>,
        <https://1145.am/db/1862594/Index_Ventures>,
        <https://1145.am/db/1863500/Index_Ventures>,
        <https://1145.am/db/1865106/Index_Ventures>,
        <https://1145.am/db/1865524/Index_Ventures>,
        <https://1145.am/db/1866804/Index_Ventures>,
        <https://1145.am/db/1868923/Index_Ventures>,
        <https://1145.am/db/1868935/Index_Ventures>,
        <https://1145.am/db/1870074/Index_Ventures>,
        <https://1145.am/db/1870079/Index_Ventures>,
        <https://1145.am/db/1870810/Index_Ventures>,
        <https://1145.am/db/1871091/Index_Ventures>,
        <https://1145.am/db/1876014/Index_Ventures>,
        <https://1145.am/db/1876914/Index_Ventures>,
        <https://1145.am/db/1878630/Index_Ventures>,
        <https://1145.am/db/1880386/Index_Ventures>,
        <https://1145.am/db/1881391/Index_Ventures>,
        <https://1145.am/db/1881430/Index_Ventures>,
        <https://1145.am/db/1882301/Index_Ventures>,
        <https://1145.am/db/1882686/Index_Ventures>,
        <https://1145.am/db/1884077/Index_Ventures>,
        <https://1145.am/db/1885147/Index_Ventures>,
        <https://1145.am/db/1890254/Index_Ventures>,
        <https://1145.am/db/1893255/Index_Ventures>,
        <https://1145.am/db/1894621/Index_Ventures>,
        <https://1145.am/db/1894627/Index_Ventures>,
        <https://1145.am/db/1899697/Index_Ventures>,
        <https://1145.am/db/1900904/Index_Ventures>,
        <https://1145.am/db/1902032/Index_Ventures>,
        <https://1145.am/db/1910957/Index_Ventures>,
        <https://1145.am/db/1915168/Index_Ventures>,
        <https://1145.am/db/1916258/Index_Ventures>,
        <https://1145.am/db/1916868/Index_Ventures>,
        <https://1145.am/db/1919238/Index_Ventures>,
        <https://1145.am/db/1967520/Index_Ventures>,
        <https://1145.am/db/1967683/Index_Ventures>,
        <https://1145.am/db/199212/Index_Ventures>,
        <https://1145.am/db/2028609/Index_Ventures>,
        <https://1145.am/db/2060465/Index_Ventures>,
        <https://1145.am/db/2062814/Index_Ventures>,
        <https://1145.am/db/2127786/Index_Ventures>,
        <https://1145.am/db/217906/Index_Ventures>,
        <https://1145.am/db/2198066/Index_Ventures>,
        <https://1145.am/db/2234558/Index_Ventures>,
        <https://1145.am/db/2290088/Index_Ventures>,
        <https://1145.am/db/2290200/Index_Ventures>,
        <https://1145.am/db/2297905/Index_Ventures>,
        <https://1145.am/db/2303009/Index_Ventures>,
        <https://1145.am/db/2303849/Index_Ventures>,
        <https://1145.am/db/2309490/Index_Ventures>,
        <https://1145.am/db/2309847/Index_Ventures>,
        <https://1145.am/db/2313410/Index_Ventures>,
        <https://1145.am/db/2325147/Index_Ventures>,
        <https://1145.am/db/2327222/Index_Ventures>,
        <https://1145.am/db/2333601/Index_Ventures>,
        <https://1145.am/db/2338079/Index_Ventures>,
        <https://1145.am/db/2338193/Index_Ventures>,
        <https://1145.am/db/2344127/Index_Ventures>,
        <https://1145.am/db/2348012/Index_Ventures>,
        <https://1145.am/db/2348620/Index_Ventures>,
        <https://1145.am/db/2350031/Index_Ventures>,
        <https://1145.am/db/2352142/Index_Ventures>,
        <https://1145.am/db/2352145/Index_Ventures>,
        <https://1145.am/db/2355609/Index_Ventures>,
        <https://1145.am/db/2355952/Index_Ventures>,
        <https://1145.am/db/2357169/Index_Ventures>,
        <https://1145.am/db/2357356/Index_Ventures>,
        <https://1145.am/db/2358233/Index_Ventures>,
        <https://1145.am/db/2358246/Index_Ventures>,
        <https://1145.am/db/2362736/Index_Ventures>,
        <https://1145.am/db/2362737/Index_Ventures>,
        <https://1145.am/db/2364597/Index_Ventures>,
        <https://1145.am/db/2364600/Index_Ventures>,
        <https://1145.am/db/2507691/Index_Ventures>,
        <https://1145.am/db/2555540/Index_Ventures>,
        <https://1145.am/db/2589317/Index_Ventures>,
        <https://1145.am/db/2643797/Index_Ventures>,
        <https://1145.am/db/317470/Index_Ventures>,
        <https://1145.am/db/318142/Index_Ventures>,
        <https://1145.am/db/337401/Index_Ventures>,
        <https://1145.am/db/348633/Index_Ventures>,
        <https://1145.am/db/366983/Index_Ventures>,
        <https://1145.am/db/367008/Index_Ventures>,
        <https://1145.am/db/475105/Index_Ventures>,
        <https://1145.am/db/539919/Index_Ventures>,
        <https://1145.am/db/578277/Index_Ventures>,
        <https://1145.am/db/633695/Index_Ventures>,
        <https://1145.am/db/707126/Index_Ventures>,
        <https://1145.am/db/709798/Index_Ventures>,
        <https://1145.am/db/768008/Index_Ventures>,
        <https://1145.am/db/789218/Index_Ventures>,
        <https://1145.am/db/854512/Index_Ventures>,
        <https://1145.am/db/868352/Index_Ventures>,
        <https://1145.am/db/893076/Index_Ventures>,
        <https://1145.am/db/893316/Index_Ventures>,
        <https://1145.am/db/909344/Index_Ventures>,
        <https://1145.am/db/957097/Index_Ventures>,
        <https://1145.am/db/980375/Index_Ventures>,
        <https://1145.am/db/981840/Index_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348618/Index_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Mountain View, CA" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-02-22T13:27:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Versartis Completes $21 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/versartis-completes-21-million-series-b-financing> ;
    ns1:foundName "Index Ventures" ;
    ns1:investor <https://1145.am/db/2348618/Series_B_Investment_Advent_Life_Sciences_Amunix_Index_Ventures_New_Leaf_Venture_Partners_Versartis_Completed> ;
    ns1:name "Index Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1006252/Menlo_Ventures>,
        <https://1145.am/db/1006262/Com_Prelude_Ventures>,
        <https://1145.am/db/1006574/Integr8d_Capital>,
        <https://1145.am/db/1006880/Root_Ventures>,
        <https://1145.am/db/1007193/Capital_One_Ventures>,
        <https://1145.am/db/1007527/Integr8d_Capital>,
        <https://1145.am/db/1008085/Root_Ventures>,
        <https://1145.am/db/1008260/Servicenow_Ventures>,
        <https://1145.am/db/1010064/Greatpoint_Ventures>,
        <https://1145.am/db/1010064/Maverick_Ventures>,
        <https://1145.am/db/1010199/One9_Ventures>,
        <https://1145.am/db/102038/Allegion_Ventures>,
        <https://1145.am/db/102038/Pathbreaker_Ventures>,
        <https://1145.am/db/102038/West_Ventures>,
        <https://1145.am/db/1023252/Digitalbridge_Ventures>,
        <https://1145.am/db/1024247/Digitalbridge_Ventures>,
        <https://1145.am/db/1024483/Investbridge_Capital>,
        <https://1145.am/db/1026319/Able_Partners>,
        <https://1145.am/db/1034591/Valia_Ventures>,
        <https://1145.am/db/1041601/Kineo_Finance>,
        <https://1145.am/db/1042250/Kineo_Finance>,
        <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043342/Root_Ventures>,
        <https://1145.am/db/1043516/Kineo_Finance>,
        <https://1145.am/db/1045242/Dipalo_Ventures>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1051115/Dn_Capital>,
        <https://1145.am/db/1051644/Vestigo_Ventures>,
        <https://1145.am/db/1052155/Gate_Ventures>,
        <https://1145.am/db/1059993/Tera_Ventures>,
        <https://1145.am/db/1060146/Ulu_Ventures>,
        <https://1145.am/db/1061824/Bluebird_Ventures>,
        <https://1145.am/db/1061911/Ulu_Ventures>,
        <https://1145.am/db/1065366/Applied_Ventures_Llc>,
        <https://1145.am/db/1065544/Menlo_Ventures>,
        <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1081490/Vinco_Ventures>,
        <https://1145.am/db/1081888/Ggv_Capital>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/1082719/Dorilton_Ventures>,
        <https://1145.am/db/1082814/Cathexis_Ventures>,
        <https://1145.am/db/1082814/Promus_Ventures>,
        <https://1145.am/db/1082814/Type_One_Ventures>,
        <https://1145.am/db/1084014/Ret_Ventures>,
        <https://1145.am/db/1085867/Ret_Ventures>,
        <https://1145.am/db/1086604/Alerion_Ventures>,
        <https://1145.am/db/1086673/Wintrust_Ventures>,
        <https://1145.am/db/1089416/Nexo_Ventures>,
        <https://1145.am/db/1090643/Argon_Ventures>,
        <https://1145.am/db/1090643/Glasswing_Ventures>,
        <https://1145.am/db/1101244/Acequia_Capital>,
        <https://1145.am/db/1103270/Acequia_Capital>,
        <https://1145.am/db/1106082/Northpond_Ventures>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1111505/Nissay_Capital>,
        <https://1145.am/db/1111505/Remiges_Ventures>,
        <https://1145.am/db/1112074/Nissay_Capital>,
        <https://1145.am/db/1112074/Remiges_Ventures>,
        <https://1145.am/db/1114979/Catapult_Ventures>,
        <https://1145.am/db/1115103/Northpond_Ventures>,
        <https://1145.am/db/1119456/Truist_Ventures>,
        <https://1145.am/db/1119699/Prelude_Ventures>,
        <https://1145.am/db/1120030/Morpheus_Ventures>,
        <https://1145.am/db/1120030/Point72_Ventures>,
        <https://1145.am/db/1120071/Morpheus_Ventures>,
        <https://1145.am/db/1120071/Point72_Ventures>,
        <https://1145.am/db/1122750/Prelude_Ventures>,
        <https://1145.am/db/1129561/Redbeard_Ventures>,
        <https://1145.am/db/1130744/Redbeard_Ventures>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1134165/Boldstart_Ventures>,
        <https://1145.am/db/1136173/Boldstart_Ventures>,
        <https://1145.am/db/1137178/CRV>,
        <https://1145.am/db/1138154/Ggv_Capital>,
        <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1140286/Origin_Ventures>,
        <https://1145.am/db/1141736/Redpoint_Ventures>,
        <https://1145.am/db/1150154/Riv_Capital>,
        <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1150529/Solasta_Ventures>,
        <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1151736/True_Ventures>,
        <https://1145.am/db/1152929/Aperiamventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1154242/True_Ventures>,
        <https://1145.am/db/1163139/Sentiero_Ventures>,
        <https://1145.am/db/1163139/Skyriver_Ventures>,
        <https://1145.am/db/1164299/Lavrock_Ventures>,
        <https://1145.am/db/1164299/Progress_Ventures>,
        <https://1145.am/db/1164688/Abstract_Ventures>,
        <https://1145.am/db/1164688/Spacecadet_Ventures>,
        <https://1145.am/db/1164845/Lavrock_Ventures>,
        <https://1145.am/db/1164845/Progress_Ventures>,
        <https://1145.am/db/1165515/G2_Group_Ventures>,
        <https://1145.am/db/1166154/Allos_Ventures>,
        <https://1145.am/db/1166957/Seedil_Ventures>,
        <https://1145.am/db/1168757/Accomplice_Ventures>,
        <https://1145.am/db/1169687/Artiman_Ventures>,
        <https://1145.am/db/1169687/J_Ventures>,
        <https://1145.am/db/1169687/Nd_Capital>,
        <https://1145.am/db/1169815/Accomplice_Ventures>,
        <https://1145.am/db/1170971/Equinor_Ventures>,
        <https://1145.am/db/1173428/Equinor_Ventures>,
        <https://1145.am/db/1175576/Divcowest_Ventures>,
        <https://1145.am/db/1175576/Point72_Ventures>,
        <https://1145.am/db/1175576/Signia_Ventures>,
        <https://1145.am/db/1176018/First_Star_Ventures>,
        <https://1145.am/db/1187600/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/11887/Adv>,
        <https://1145.am/db/1190097/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/1190127/Animo_Ventures>,
        <https://1145.am/db/1190127/Chaac_Ventures>,
        <https://1145.am/db/1190127/Ulu_Ventures>,
        <https://1145.am/db/1196068/Arthur_Ventures>,
        <https://1145.am/db/1196728/Greatpoint_Ventures>,
        <https://1145.am/db/1199177/Greatpoint_Ventures>,
        <https://1145.am/db/1199182/Boxone_Ventures>,
        <https://1145.am/db/1202673/Basecamp_Ventures>,
        <https://1145.am/db/1203180/Basecamp_Ventures>,
        <https://1145.am/db/1206820/Tenoneten_Ventures>,
        <https://1145.am/db/1208519/Tappanhill_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1208749/Keshif_Ventures>,
        <https://1145.am/db/1208749/Tenoneten_Ventures>,
        <https://1145.am/db/1213076/Equinor_Ventures>,
        <https://1145.am/db/1213076/Scf_Ventures>,
        <https://1145.am/db/1213119/Nevcaut_Ventures>,
        <https://1145.am/db/1215930/Northpond_Ventures>,
        <https://1145.am/db/1219982/Soma_Ventures>,
        <https://1145.am/db/1221237/C2_Ventures>,
        <https://1145.am/db/1222789/Glasswing_Ventures>,
        <https://1145.am/db/1232497/Droia_Ventures>,
        <https://1145.am/db/1232497/Gv>,
        <https://1145.am/db/1233314/Citta_Capital>,
        <https://1145.am/db/1236549/Adit_Ventures>,
        <https://1145.am/db/1247755/Sinewave_Ventures>,
        <https://1145.am/db/1247761/Clear_Ventures>,
        <https://1145.am/db/1248631/Sinewave_Ventures>,
        <https://1145.am/db/1252447/Gaingels>,
        <https://1145.am/db/1256269/Ampd_Ventures_Inc>,
        <https://1145.am/db/1264028/K3_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1268150/Pender_Ventures>,
        <https://1145.am/db/1269968/Abstract_Ventures>,
        <https://1145.am/db/1272468/Launchpad_Capital>,
        <https://1145.am/db/1279264/Roosh_Ventures>,
        <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1282820/Agya_Ventures>,
        <https://1145.am/db/1286872/Morevc>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1297417/Bitkraft_Ventures>,
        <https://1145.am/db/1299578/Seedtob_Capital>,
        <https://1145.am/db/1307620/Inventus_Capital_Partners>,
        <https://1145.am/db/1311917/Avid_Ventures>,
        <https://1145.am/db/1311917/Canapi_Ventures>,
        <https://1145.am/db/1322441/Solana_Ventures>,
        <https://1145.am/db/1326376/Dexcom_Ventures>,
        <https://1145.am/db/1329887/Peter_Nagar>,
        <https://1145.am/db/1331691/Pelion_Ventures>,
        <https://1145.am/db/1332798/Acrobator_Ventures>,
        <https://1145.am/db/1334186/First_Ascent_Ventures>,
        <https://1145.am/db/1334193/Version_One_Ventures>,
        <https://1145.am/db/1334395/Gv>,
        <https://1145.am/db/1334895/Soleus_Capital>,
        <https://1145.am/db/1335073/Yl_Ventures>,
        <https://1145.am/db/1335080/Dorilton_Ventures>,
        <https://1145.am/db/1344240/Neotribe_Ventures>,
        <https://1145.am/db/1352420/Vamos_Ventures>,
        <https://1145.am/db/1353145/Infinity_Ventures>,
        <https://1145.am/db/1362743/Cobalt_Ventures>,
        <https://1145.am/db/1373683/BGV>,
        <https://1145.am/db/1375916/J2_Ventures>,
        <https://1145.am/db/1376353/J2_Ventures>,
        <https://1145.am/db/1378599/Menlo_Ventures>,
        <https://1145.am/db/1381832/Northpond_Ventures>,
        <https://1145.am/db/1382787/Northpond_Ventures>,
        <https://1145.am/db/1383818/Newlin_Ventures>,
        <https://1145.am/db/1387557/Naventures>,
        <https://1145.am/db/138878/Metacartel_Ventures>,
        <https://1145.am/db/1398057/Owen_Van_Natta_Temaris___Associates>,
        <https://1145.am/db/1398917/Trousdale_Ventures>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1407614/C2_Ventures>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1411934/Riptide_Ventures>,
        <https://1145.am/db/1425749/Menlo_Ventures>,
        <https://1145.am/db/1425749/Se_Ventures>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1445378/Mvp_Ventures>,
        <https://1145.am/db/1445935/Verissimo_Ventures>,
        <https://1145.am/db/1449316/+Nd_Capital>,
        <https://1145.am/db/1449740/Mistral_Ventures>,
        <https://1145.am/db/1452107/Abstract_Ventures>,
        <https://1145.am/db/1455216/Engage_Ventures>,
        <https://1145.am/db/1455616/Abstract_Ventures>,
        <https://1145.am/db/1463829/1sharpe_Ventures>,
        <https://1145.am/db/1467693/Preseed_Ventures>,
        <https://1145.am/db/1467892/M_Ventures>,
        <https://1145.am/db/1467932/Sequoia_Capital_Gv>,
        <https://1145.am/db/1468981/Preseed_Ventures>,
        <https://1145.am/db/1476448/Origin_Ventures>,
        <https://1145.am/db/1480152/True_Ventures>,
        <https://1145.am/db/1480651/Glasswing_Ventures>,
        <https://1145.am/db/1480989/Infinity_Ventures>,
        <https://1145.am/db/1481875/Infinity_Ventures>,
        <https://1145.am/db/1482705/Oif_Ventures>,
        <https://1145.am/db/1484103/Boxone_Ventures>,
        <https://1145.am/db/1484857/Iu_Ventures>,
        <https://1145.am/db/1488858/Alkeon_Capital>,
        <https://1145.am/db/1490126/Seedtob_Capital>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490978/Seedtob_Capital>,
        <https://1145.am/db/1492889/Future_Ventures>,
        <https://1145.am/db/1492889/Radical_Ventures>,
        <https://1145.am/db/1494028/Alkeon_Capital>,
        <https://1145.am/db/1496360/Realist_Ventures>,
        <https://1145.am/db/1503768/Nevateam_Partners>,
        <https://1145.am/db/1508325/Aramco_Ventures>,
        <https://1145.am/db/1509462/F7_Ventures>,
        <https://1145.am/db/1512891/Acme_Capital>,
        <https://1145.am/db/1515109/Cmfg_Ventures>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1520070/Menlo_Ventures>,
        <https://1145.am/db/1520070/Northpond_Ventures>,
        <https://1145.am/db/1520772/January_Ventures>,
        <https://1145.am/db/1537166/Catalio_Capital_Management>,
        <https://1145.am/db/1537970/Catalio_Capital_Management>,
        <https://1145.am/db/1541308/Panoramic_Ventures>,
        <https://1145.am/db/1541797/G1_Ventures>,
        <https://1145.am/db/1545833/Alerion_Ventures>,
        <https://1145.am/db/1545994/Noemis_Ventures>,
        <https://1145.am/db/1546945/Alerion_Ventures>,
        <https://1145.am/db/1546965/Citi_Ventures>,
        <https://1145.am/db/1546965/Truist_Ventures>,
        <https://1145.am/db/1547281/Noemis_Ventures>,
        <https://1145.am/db/1548592/Gopoint_Ventures>,
        <https://1145.am/db/1556397/Dnx_Ventures>,
        <https://1145.am/db/1556442/C16_Ventures>,
        <https://1145.am/db/1557877/Embark_Ventures>,
        <https://1145.am/db/1559824/Embark_Ventures>,
        <https://1145.am/db/1560704/Breaktrail_Ventures>,
        <https://1145.am/db/1563623/Amex_Ventures>,
        <https://1145.am/db/1564049/Amex_Ventures>,
        <https://1145.am/db/1571330/Seae_Ventures>,
        <https://1145.am/db/1571330/Venturesouth>,
        <https://1145.am/db/1572216/Seae_Ventures>,
        <https://1145.am/db/1572216/Venturesouth>,
        <https://1145.am/db/1574557/True_Ventures>,
        <https://1145.am/db/1574647/Vanterra_Ventures>,
        <https://1145.am/db/1575612/Interlace_Ventures>,
        <https://1145.am/db/1575612/Valia_Ventures>,
        <https://1145.am/db/1578178/N49p>,
        <https://1145.am/db/1578178/Naventures>,
        <https://1145.am/db/1578327/Crit_Ventures>,
        <https://1145.am/db/1578327/Nextview_Ventures>,
        <https://1145.am/db/1579770/Schams_Ventures>,
        <https://1145.am/db/1579792/Crit_Ventures>,
        <https://1145.am/db/1579792/Nextview_Ventures>,
        <https://1145.am/db/1580468/Cohort_Ventures>,
        <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1582111/Forepont_Capital_Partners>,
        <https://1145.am/db/1583413/Navigare_Ventures>,
        <https://1145.am/db/1615195/Digitalis_Ventures>,
        <https://1145.am/db/1616990/Digitalis_Ventures>,
        <https://1145.am/db/1632002/Catalio_Capital_Management>,
        <https://1145.am/db/1632028/Catalio_Capital_Management>,
        <https://1145.am/db/1632131/Catalio_Capital_Management>,
        <https://1145.am/db/1632156/Catalio_Capital_Management>,
        <https://1145.am/db/1638640/1digi_Ventures>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1653506/Ascendum_Capital>,
        <https://1145.am/db/1653506/Citta_Capital>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1664837/Civilization_Ventures>,
        <https://1145.am/db/1664948/Dreamit_Ventures>,
        <https://1145.am/db/1669908/Aviso_Ventures>,
        <https://1145.am/db/1670128/Primary_Ventures>,
        <https://1145.am/db/1676513/Connect_Ventures>,
        <https://1145.am/db/1685482/Lavrock_Ventures>,
        <https://1145.am/db/1690703/Arkam_Ventures>,
        <https://1145.am/db/1690703/Prosus_Ventures>,
        <https://1145.am/db/1691060/Veblen_Ventures>,
        <https://1145.am/db/1691364/Ts_Ventures>,
        <https://1145.am/db/1693592/Cventures>,
        <https://1145.am/db/1693668/Sunny_Side_Ventures>,
        <https://1145.am/db/1693981/Boldstart_Ventures>,
        <https://1145.am/db/1694241/True_Ventures>,
        <https://1145.am/db/1694301/Dn_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1694448/Presidio_Ventures>,
        <https://1145.am/db/1694592/Credo_Ventures>,
        <https://1145.am/db/1694592/Susa_Ventures>,
        <https://1145.am/db/1694798/Udc_Ventures>,
        <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1695849/Salesforce_Ventures>,
        <https://1145.am/db/1695885/True_Ventures>,
        <https://1145.am/db/1697044/Palomar_Ventures>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697373/Lerer_Ventures>,
        <https://1145.am/db/1697910/Entrepia_Ventures>,
        <https://1145.am/db/1697910/Innovacom>,
        <https://1145.am/db/1698516/Engage_Ventures>,
        <https://1145.am/db/1698516/Tyh_Ventures>,
        <https://1145.am/db/1698644/Inovia_Capital>,
        <https://1145.am/db/1699263/Contour_Venture_Partners>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1700572/Contour_Venture_Partners>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702003/Ventures_West>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1702472/Chiratae_Ventures>,
        <https://1145.am/db/1702483/Sure_Ventures_Usvp>,
        <https://1145.am/db/1702517/Prime_Ventures>,
        <https://1145.am/db/1702871/Charles_River_Ventures>,
        <https://1145.am/db/1703120/Point72_Ventures>,
        <https://1145.am/db/1703551/People_Ventures>,
        <https://1145.am/db/1703907/T-Venture>,
        <https://1145.am/db/1704404/True_Ventures>,
        <https://1145.am/db/1704740/T-Venture>,
        <https://1145.am/db/1704842/Se_Ventures>,
        <https://1145.am/db/1704871/Yl_Ventures>,
        <https://1145.am/db/1705825/Ventures_Platform>,
        <https://1145.am/db/1707227/Schams_Ventures>,
        <https://1145.am/db/1707540/Prosus_Ventures>,
        <https://1145.am/db/1707567/Contour_Venture_Partners>,
        <https://1145.am/db/1707567/Reign_Ventures>,
        <https://1145.am/db/1707637/Resolute_Ventures>,
        <https://1145.am/db/1707736/Artiman_Ventures>,
        <https://1145.am/db/1708555/20vc>,
        <https://1145.am/db/1708903/Kaedan_Capital>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1710027/Contour_Venture_Partners>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1711383/Aviso_Ventures>,
        <https://1145.am/db/1711383/Pelion_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1711790/CRV>,
        <https://1145.am/db/1711849/K20_Ventures>,
        <https://1145.am/db/1712471/Cervin_Ventures>,
        <https://1145.am/db/1713712/Grotech_Ventures>,
        <https://1145.am/db/1714098/Charles_River_Ventures>,
        <https://1145.am/db/1714148/Ulu_Ventures>,
        <https://1145.am/db/1714624/Abstract_Ventures>,
        <https://1145.am/db/1714630/January_Ventures>,
        <https://1145.am/db/1716124/Appian_Ventures>,
        <https://1145.am/db/1716168/Onset_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1718012/Presidio_Ventures>,
        <https://1145.am/db/1718018/Ggv_Capital>,
        <https://1145.am/db/1718081/Jafco_Ventures>,
        <https://1145.am/db/1718748/Truist_Ventures>,
        <https://1145.am/db/1718787/J_Ventures>,
        <https://1145.am/db/1719362/True_Ventures>,
        <https://1145.am/db/1719370/Bv_Capital>,
        <https://1145.am/db/1720145/Bessemer_Ventures>,
        <https://1145.am/db/1720182/Convivialit_Ventures>,
        <https://1145.am/db/1720441/Origin_Ventures>,
        <https://1145.am/db/1721171/Citi_Ventures>,
        <https://1145.am/db/1721392/Redpoint_Ventures>,
        <https://1145.am/db/1721393/Trinity_Ventures>,
        <https://1145.am/db/1721548/Ggv_Capital>,
        <https://1145.am/db/1721548/Menlo_Ventures>,
        <https://1145.am/db/1722252/Onset_Ventures>,
        <https://1145.am/db/1723165/Menlo_Ventures>,
        <https://1145.am/db/1723664/T-Venture>,
        <https://1145.am/db/1723932/Citi_Ventures>,
        <https://1145.am/db/1724979/Jafco_Ventures>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726088/Zeev_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1726544/Ei_Ventures>,
        <https://1145.am/db/1727288/Sozo_Ventures>,
        <https://1145.am/db/1728569/Redpoint_Ventures>,
        <https://1145.am/db/1729186/Catamount_Ventures>,
        <https://1145.am/db/1731187/Rho_Ventures>,
        <https://1145.am/db/1731419/Redpoint_Ventures>,
        <https://1145.am/db/1734104/Alpana_Ventures>,
        <https://1145.am/db/1734104/Highsage_Ventures>,
        <https://1145.am/db/1734728/Talis_Capital>,
        <https://1145.am/db/1735194/Eqt_Ventures>,
        <https://1145.am/db/1735248/Corigin_Ventures>,
        <https://1145.am/db/1735726/Nextview_Ventures>,
        <https://1145.am/db/1735755/Firebolt_Ventures>,
        <https://1145.am/db/1735774/Alpha4_Ventures>,
        <https://1145.am/db/1736136/Ggv_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1737392/Moxxie_Ventures>,
        <https://1145.am/db/1737979/CRV>,
        <https://1145.am/db/1738162/3one4_Capital>,
        <https://1145.am/db/1738300/Chryscapital>,
        <https://1145.am/db/1738415/Capnamic_Ventures>,
        <https://1145.am/db/1738444/Prosus_Ventures>,
        <https://1145.am/db/1738776/Illuminate_Ventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1739042/Experior_Venture_Fund>,
        <https://1145.am/db/1739064/Jsw_Ventures>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1739630/Redsea_Ventures>,
        <https://1145.am/db/1739719/Seedplus>,
        <https://1145.am/db/1739851/Signum_Capital>,
        <https://1145.am/db/1739909/Root_Ventures>,
        <https://1145.am/db/1739946/Dn_Capital>,
        <https://1145.am/db/1740077/3one4_Capital>,
        <https://1145.am/db/1740665/First_Bridge_Ventures>,
        <https://1145.am/db/1740832/J_Ventures>,
        <https://1145.am/db/1740832/Susa_Ventures>,
        <https://1145.am/db/1740859/Ggv_Capital>,
        <https://1145.am/db/1741357/Dn_Capital>,
        <https://1145.am/db/1741575/Addventure>,
        <https://1145.am/db/1741635/Zeev_Ventures>,
        <https://1145.am/db/1742267/Firebolt_Ventures>,
        <https://1145.am/db/1742267/Point72_Ventures>,
        <https://1145.am/db/1743271/Liil_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1743409/Dreamit_Ventures>,
        <https://1145.am/db/1743737/Regah_Ventures>,
        <https://1145.am/db/1744229/R7>,
        <https://1145.am/db/1744775/Point72_Ventures>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1744922/Agla_Ventures>,
        <https://1145.am/db/1745326/Eqt_Ventures>,
        <https://1145.am/db/1745326/Lios_Ventures>,
        <https://1145.am/db/1745326/Prime_Ventures>,
        <https://1145.am/db/1745746/Garuda_Ventures>,
        <https://1145.am/db/1745746/Starling_Ventures>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1747252/Citi_Ventures>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747400/Eqt_Ventures>,
        <https://1145.am/db/1747503/Brighteye_Ventures>,
        <https://1145.am/db/1747722/Shinhan_Capital>,
        <https://1145.am/db/1747943/Altai_Ventures>,
        <https://1145.am/db/1748417/Zeev_Ventures>,
        <https://1145.am/db/1749226/Dn_Capital>,
        <https://1145.am/db/1749425/Ac_Ventures>,
        <https://1145.am/db/1749651/Colle_Capital>,
        <https://1145.am/db/1749911/Khwarizmi_Ventures>,
        <https://1145.am/db/1750942/Celesta_Capital>,
        <https://1145.am/db/1750942/Chiratae_Ventures>,
        <https://1145.am/db/1751135/Inovia_Capital>,
        <https://1145.am/db/1751312/Abstract_Ventures>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1751506/Ggv_Capital>,
        <https://1145.am/db/1751551/Gaingels>,
        <https://1145.am/db/1751553/Canapi_Ventures>,
        <https://1145.am/db/1751743/Intudo_Ventures>,
        <https://1145.am/db/1751800/Morpheus_Ventures>,
        <https://1145.am/db/1751954/Novastar_Ventures>,
        <https://1145.am/db/1752102/Origin_Ventures>,
        <https://1145.am/db/1752403/Yl_Ventures>,
        <https://1145.am/db/1752998/Agla_Ventures>,
        <https://1145.am/db/1753704/Apex_Ventures>,
        <https://1145.am/db/1753721/Financial_Venture_Studio>,
        <https://1145.am/db/1753721/Resolute_Ventures>,
        <https://1145.am/db/1753745/2i_Ventures>,
        <https://1145.am/db/1754211/Citi_Ventures>,
        <https://1145.am/db/1754211/Menlo_Ventures>,
        <https://1145.am/db/1754242/Gsv_Ventures>,
        <https://1145.am/db/1754595/Global_Ventures>,
        <https://1145.am/db/1754595/Otg_Ventures>,
        <https://1145.am/db/1754751/Menlo_Ventures>,
        <https://1145.am/db/1754787/Letsventure>,
        <https://1145.am/db/1754997/Alkeon_Capital>,
        <https://1145.am/db/1755086/Kollective_Ventures>,
        <https://1145.am/db/1755278/Zeev_Ventures>,
        <https://1145.am/db/1755704/Promus_Ventures>,
        <https://1145.am/db/1755828/Future_Ventures>,
        <https://1145.am/db/1755860/Dg_Ventures>,
        <https://1145.am/db/1755860/Intudo_Ventures>,
        <https://1145.am/db/1756040/Altos_Ventures>,
        <https://1145.am/db/1756094/CRV>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1756326/Neotribe_Ventures>,
        <https://1145.am/db/1756384/Abstract_Ventures>,
        <https://1145.am/db/1756384/Lightspeed_Ventures>,
        <https://1145.am/db/1756599/True_Ventures>,
        <https://1145.am/db/1757035/Vectr_Ventures>,
        <https://1145.am/db/1757365/Will_Ventures>,
        <https://1145.am/db/1757382/Gl_Ventures>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1757772/Lorimer_Ventures>,
        <https://1145.am/db/1758193/Tenoneten_Ventures>,
        <https://1145.am/db/1758193/Valia_Ventures>,
        <https://1145.am/db/1758313/Venture_Field>,
        <https://1145.am/db/1758622/Oca_Ventures>,
        <https://1145.am/db/1759048/Avid_Ventures>,
        <https://1145.am/db/1759048/Lightspeed_Ventures>,
        <https://1145.am/db/1759567/J_Ventures>,
        <https://1145.am/db/1759922/Verance_Capital>,
        <https://1145.am/db/1760383/True_Ventures>,
        <https://1145.am/db/1760520/Prologis_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1760985/Frontier_Ventures>,
        <https://1145.am/db/1761126/Redpoint_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761607/Menlo_Ventures>,
        <https://1145.am/db/1761607/Sinewave_Ventures>,
        <https://1145.am/db/1761957/Alkeon_Capital>,
        <https://1145.am/db/1761999/Ggv_Capital>,
        <https://1145.am/db/1762031/Menlo_Ventures>,
        <https://1145.am/db/1762055/Altos_Ventures>,
        <https://1145.am/db/1762277/Ac_Ventures>,
        <https://1145.am/db/1762453/Line_Ventures>,
        <https://1145.am/db/1762561/Grotech_Ventures>,
        <https://1145.am/db/1762669/Creandum>,
        <https://1145.am/db/1762844/Signum_Capital>,
        <https://1145.am/db/1763356/Agla_Ventures>,
        <https://1145.am/db/1763371/Spacecadet_Ventures>,
        <https://1145.am/db/1763395/Idc_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763774/Ggv_Capital>,
        <https://1145.am/db/1763795/Ventures_Platform>,
        <https://1145.am/db/1763795/Xyz_Ventures>,
        <https://1145.am/db/1763875/Golden_Gate_Ventures>,
        <https://1145.am/db/1764027/Menlo_Ventures>,
        <https://1145.am/db/1764255/Pathbreaker_Ventures>,
        <https://1145.am/db/1764255/Stageone_Ventures>,
        <https://1145.am/db/1764345/Talis_Capital>,
        <https://1145.am/db/1764527/Presidio_Ventures>,
        <https://1145.am/db/1764527/Yl_Ventures>,
        <https://1145.am/db/1765273/Adevinta_Ventures>,
        <https://1145.am/db/1765273/Venturefriends>,
        <https://1145.am/db/1765372/Irobot_Ventures>,
        <https://1145.am/db/1765377/Redpoint_Ventures>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1765646/Amiti_Ventures>,
        <https://1145.am/db/1765673/Salesforce_Ventures>,
        <https://1145.am/db/1766091/Inreach_Ventures>,
        <https://1145.am/db/1766096/Borealis_Ventures>,
        <https://1145.am/db/1766096/Northpond_Ventures>,
        <https://1145.am/db/1766253/Redpoint_Ventures>,
        <https://1145.am/db/1766253/True_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1766978/Rga_Ventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1768363/Golden_Gate_Ventures>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1770139/Victress_Capital>,
        <https://1145.am/db/1770265/Techstars_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1770372/Korelya_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1770982/Gv>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771011/Ggv_Capital>,
        <https://1145.am/db/1771548/Seekdource_Capital>,
        <https://1145.am/db/1771613/Creandum>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1772004/Raed_Ventures>,
        <https://1145.am/db/1772004/Seed_Equity_Venture_Partners>,
        <https://1145.am/db/1772381/Altos_Ventures>,
        <https://1145.am/db/1772452/Connect_Ventures>,
        <https://1145.am/db/1773130/Capnamic_Ventures>,
        <https://1145.am/db/1773143/Venturefriends>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1774348/True_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1774535/Susa_Ventures>,
        <https://1145.am/db/1774658/Gv>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776340/Ggv_Capital>,
        <https://1145.am/db/1776340/Menlo_Ventures>,
        <https://1145.am/db/1776537/Origin_Ventures>,
        <https://1145.am/db/1776537/Tekton_Ventures>,
        <https://1145.am/db/1776621/Redpoint_Ventures>,
        <https://1145.am/db/1777289/Dn_Capital>,
        <https://1145.am/db/1777563/Evolv_Ventures>,
        <https://1145.am/db/1777563/Ggv_Capital>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1778935/Oryzn_Capital>,
        <https://1145.am/db/1780024/Partech_Ventures>,
        <https://1145.am/db/1782098/Addventure>,
        <https://1145.am/db/1782221/Point72_Ventures>,
        <https://1145.am/db/1783189/Citi_Ventures>,
        <https://1145.am/db/1784644/Creathor_Ventures>,
        <https://1145.am/db/1784964/Clear_Ventures>,
        <https://1145.am/db/1785361/M_Ventures>,
        <https://1145.am/db/1786249/Redpoint_Ventures>,
        <https://1145.am/db/1786249/Resolute_Ventures>,
        <https://1145.am/db/1786663/Edenred_Capital_Partners>,
        <https://1145.am/db/1786663/Eqt_Ventures>,
        <https://1145.am/db/1787249/Kpn_Ventures>,
        <https://1145.am/db/1787342/Korelya_Capital>,
        <https://1145.am/db/1787536/Point72_Ventures>,
        <https://1145.am/db/1787791/True_Ventures>,
        <https://1145.am/db/1787886/True_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1788726/Redbeat_Capital>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789754/Advancit_Capital>,
        <https://1145.am/db/1790280/Arthur_Ventures>,
        <https://1145.am/db/1790399/Capnamic_Ventures>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1790574/Red_Swan_Ventures>,
        <https://1145.am/db/1790574/Sherpa_Ventures>,
        <https://1145.am/db/1790641/Dn_Capital>,
        <https://1145.am/db/1790771/Redpoint_Ventures>,
        <https://1145.am/db/1790777/Connect_Ventures>,
        <https://1145.am/db/1791216/True_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1791838/Advancit_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792771/Softtechvc>,
        <https://1145.am/db/1792887/Kaedan_Capital>,
        <https://1145.am/db/1792887/Stageone_Ventures>,
        <https://1145.am/db/1794699/Ws_Ventures>,
        <https://1145.am/db/1794935/Intervest_Co_Ltd>,
        <https://1145.am/db/1795020/Redpoint_Ventures>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1795538/Skystar_Capital>,
        <https://1145.am/db/1796109/Contour_Venture_Partners>,
        <https://1145.am/db/1796593/Tenoneten_Ventures>,
        <https://1145.am/db/1796901/Red_Swan_Ventures>,
        <https://1145.am/db/1796922/Cagni_Ventures>,
        <https://1145.am/db/1797209/Kdwc_Ventures>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797899/Brave_Ventures>,
        <https://1145.am/db/1797999/Redpoint_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1799099/Inovia_Capital>,
        <https://1145.am/db/1799184/Ggv_Capital>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800929/Ventureast>,
        <https://1145.am/db/1802086/High_Line_Ventures>,
        <https://1145.am/db/1802227/Advancit_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802336/Capnamic_Ventures>,
        <https://1145.am/db/1804102/True_Ventures>,
        <https://1145.am/db/1804247/Holtzbrinck_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1804476/True_Ventures>,
        <https://1145.am/db/1804992/Talis_Capital>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1805604/Connect_Ventures>,
        <https://1145.am/db/1805604/Inreach_Ventures>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1806739/Golden_Gate_Ventures>,
        <https://1145.am/db/1808047/Salesforce_Ventures>,
        <https://1145.am/db/1808505/Helion_Ventures>,
        <https://1145.am/db/1808723/Mindworks_Ventures>,
        <https://1145.am/db/1808735/Commonangels_Ventures>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809844/Real_Ventures>,
        <https://1145.am/db/1809862/Acequia_Capital>,
        <https://1145.am/db/1810384/Starstrike_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1810714/Catalus_Capital>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1812856/Exfinity_Ventures>,
        <https://1145.am/db/1813375/Creandum>,
        <https://1145.am/db/1813575/Ggv_Capital>,
        <https://1145.am/db/1813944/Menlo_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1814643/Corigin_Ventures>,
        <https://1145.am/db/1814643/Launchcapital>,
        <https://1145.am/db/1815038/Plus_Ventures>,
        <https://1145.am/db/1815507/Globis_Capital_Partners>,
        <https://1145.am/db/1815697/Cherubic_Ventures>,
        <https://1145.am/db/1815701/True_Ventures>,
        <https://1145.am/db/1815886/Teneleven_Ventures>,
        <https://1145.am/db/1816491/Grotech_Ventures>,
        <https://1145.am/db/1818174/Advancit_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1819374/Rothenberg_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1820882/Inven_Capital>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1821711/Winton_Ventures>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1823162/True_Ventures>,
        <https://1145.am/db/1823217/Kdc_Ventures>,
        <https://1145.am/db/1823217/Nbm_Ventures>,
        <https://1145.am/db/1823684/Dcm_Ventures>,
        <https://1145.am/db/1823684/Idg_Ventures>,
        <https://1145.am/db/1824252/Allos_Ventures>,
        <https://1145.am/db/1824253/Trinity_Ventures>,
        <https://1145.am/db/1824944/True_Ventures>,
        <https://1145.am/db/1825465/Ben_Narasin>,
        <https://1145.am/db/1825713/Menlo_Ventures>,
        <https://1145.am/db/1825946/Lerer_Ventures>,
        <https://1145.am/db/1826265/Idg_Ventures>,
        <https://1145.am/db/1826648/True_Ventures>,
        <https://1145.am/db/1826922/Ggv_Capital>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828036/Redpoint_Ventures>,
        <https://1145.am/db/1828092/Eden_Ventures>,
        <https://1145.am/db/1828251/Golden_Gate_Ventures>,
        <https://1145.am/db/1828455/Quotidien_Ventures>,
        <https://1145.am/db/1828658/Focus_Ventures>,
        <https://1145.am/db/1828663/Great_Oaks_Ventures>,
        <https://1145.am/db/1828663/Inovia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1829422/Rothenberg_Ventures>,
        <https://1145.am/db/1829612/Lerer_Ventures>,
        <https://1145.am/db/1830502/Frontline_Ventures>,
        <https://1145.am/db/1830613/True_Ventures>,
        <https://1145.am/db/1830809/Numecent>,
        <https://1145.am/db/1830809/T-Ventures>,
        <https://1145.am/db/1830817/Charles_River_Ventures>,
        <https://1145.am/db/1831577/Artiman_Ventures>,
        <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832038/True_Ventures>,
        <https://1145.am/db/1832316/Partech_Ventures>,
        <https://1145.am/db/1832316/Scentan_Ventures>,
        <https://1145.am/db/1832316/Startcaps_Ventures>,
        <https://1145.am/db/1832856/Grotech_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834224/Orix_Ventures>,
        <https://1145.am/db/1834305/Charles_River_Ventures>,
        <https://1145.am/db/1834334/Altos_Ventures>,
        <https://1145.am/db/1834334/Baseline_Ventures>,
        <https://1145.am/db/1834334/Firebolt_Ventures>,
        <https://1145.am/db/1834334/Lazerow_Ventures>,
        <https://1145.am/db/1834520/Ben_Horowitz>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1834708/Sherpa_Ventures>,
        <https://1145.am/db/1834965/Lerer_Ventures>,
        <https://1145.am/db/1835229/Lerer_Ventures>,
        <https://1145.am/db/1835229/Trinity_Ventures>,
        <https://1145.am/db/1835229/Xg_Ventures>,
        <https://1145.am/db/1835740/Lerer_Ventures>,
        <https://1145.am/db/1835749/Gree_Ventures>,
        <https://1145.am/db/1835825/Focus_Ventures>,
        <https://1145.am/db/1836984/Siemer_Ventures>,
        <https://1145.am/db/1836984/Tekton_Ventures>,
        <https://1145.am/db/1837741/Menlo_Ventures>,
        <https://1145.am/db/1838026/Plus_Ventures>,
        <https://1145.am/db/1840775/Ggv_Capital>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1840881/Trinity_Ventures>,
        <https://1145.am/db/1841176/Lerer_Ventures>,
        <https://1145.am/db/1841176/True_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1842402/Redpoint_Ventures>,
        <https://1145.am/db/1842898/Grotech_Ventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1843449/Redpoint_Ventures>,
        <https://1145.am/db/1843602/Nextview_Ventures>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844143/Inovia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1844737/True_Ventures>,
        <https://1145.am/db/1844931/Charles_River_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1845960/Lerer_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846483/Inovia_Capital>,
        <https://1145.am/db/1847463/Prism_Ventureworks>,
        <https://1145.am/db/1847752/T-Venture>,
        <https://1145.am/db/1848523/Trinity_Ventures>,
        <https://1145.am/db/1849673/Inventure_Partners>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849949/Holtzbrinck_Ventures>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850668/True_Ventures>,
        <https://1145.am/db/1850989/Artiman_Ventures>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851035/Acequia_Capital>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851035/Redpoint_Ventures>,
        <https://1145.am/db/1851705/Promus_Ventures>,
        <https://1145.am/db/1851854/Partech_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1852308/Plus_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Trestle_Ventures>,
        <https://1145.am/db/1852556/Dave_Morin>,
        <https://1145.am/db/1852806/Redpoint_Ventures>,
        <https://1145.am/db/1852870/Golden_Gate_Ventures>,
        <https://1145.am/db/1852870/Siemer_Ventures>,
        <https://1145.am/db/1853417/Catamount_Ventures>,
        <https://1145.am/db/1853496/T-Ventures>,
        <https://1145.am/db/1854200/Ggv_Capital>,
        <https://1145.am/db/1854201/Charles_River_Ventures>,
        <https://1145.am/db/1854786/Eden_Ventures>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1854874/Sherpa_Ventures>,
        <https://1145.am/db/1854874/Softtech>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1855363/True_Ventures>,
        <https://1145.am/db/1855403/Rho_Ventures>,
        <https://1145.am/db/1855780/Bds_Ventures>,
        <https://1145.am/db/1855780/Ggv_Capital>,
        <https://1145.am/db/1856191/Creandum>,
        <https://1145.am/db/1856380/Softtech>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1856616/Redpoint_Ventures>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1857635/Rikard_Steiber>,
        <https://1145.am/db/1857659/Revolution_Ventures>,
        <https://1145.am/db/1857930/Inovia_Capital>,
        <https://1145.am/db/1857930/Version_One_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858592/Apex_Venture_Partners>,
        <https://1145.am/db/1858592/Origin_Ventures>,
        <https://1145.am/db/1858991/Capnamic_Ventures>,
        <https://1145.am/db/1859199/True_Ventures>,
        <https://1145.am/db/1859314/Version_One_Ventures>,
        <https://1145.am/db/1860163/Inovia_Capital>,
        <https://1145.am/db/1860345/Commonangels>,
        <https://1145.am/db/1860345/Launchcapital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1861355/Rho_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1863147/Apex_Venture_Partners>,
        <https://1145.am/db/1864601/Trinity_Ventures>,
        <https://1145.am/db/1864646/Inventus_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sherpalo_Ventures>,
        <https://1145.am/db/1866032/Launchcapital>,
        <https://1145.am/db/1866134/Embarcadero_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866155/Presidio_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867599/Cava_Capital>,
        <https://1145.am/db/1868107/Redpoint_Ventures>,
        <https://1145.am/db/1868109/Charles_River_Ventures>,
        <https://1145.am/db/1868178/True_Ventures>,
        <https://1145.am/db/1870015/Redpoint_Ventures>,
        <https://1145.am/db/1870465/Nextview_Ventures>,
        <https://1145.am/db/1871221/True_Ventures>,
        <https://1145.am/db/1871574/Redpoint_Ventures>,
        <https://1145.am/db/1871777/Charles_River_Ventures>,
        <https://1145.am/db/1871784/Charles_River_Ventures>,
        <https://1145.am/db/1871888/Charles_River_Ventures>,
        <https://1145.am/db/1873191/El_Dorado_Ventures>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1873680/Lerer_Ventures>,
        <https://1145.am/db/1873680/Xg_Ventures>,
        <https://1145.am/db/1874749/True_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1877283/Northzone_Ventures>,
        <https://1145.am/db/1877473/True_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878620/Ggv_Capital>,
        <https://1145.am/db/1879279/High_Line_Ventures>,
        <https://1145.am/db/1879759/T-Venture>,
        <https://1145.am/db/1880679/Northzone_Ventures>,
        <https://1145.am/db/1881464/Ggv_Capital>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1882330/New_World_Ventures>,
        <https://1145.am/db/1882727/Charles_River_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1883568/Eden_Ventures>,
        <https://1145.am/db/1883572/Astutia_Ventures>,
        <https://1145.am/db/1886402/New_Atlantic_Ventures>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1889394/Focus_Ventures>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1890000/Lerer_Ventures>,
        <https://1145.am/db/1890122/East_Ventures>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1890133/Focus_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/1890208/Menlo_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890839/Inovia_Capital>,
        <https://1145.am/db/1890903/Miven_Ventures>,
        <https://1145.am/db/1891615/Holtzbrinck_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891913/New_World_Ventures>,
        <https://1145.am/db/1891913/Oca_Ventures>,
        <https://1145.am/db/1891926/New_World_Ventures>,
        <https://1145.am/db/1892050/Charles_River_Ventures>,
        <https://1145.am/db/1892105/Crosscreek_Capital>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1892106/Altos_Ventures>,
        <https://1145.am/db/1892106/Illuminate_Ventures>,
        <https://1145.am/db/1892620/True_Ventures>,
        <https://1145.am/db/1892674/Appian_Ventures>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1892955/Guy_Gamzu>,
        <https://1145.am/db/1895072/Nextview_Ventures>,
        <https://1145.am/db/1895951/Windward_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1896379/Redpoint_Ventures>,
        <https://1145.am/db/1896419/True_Ventures>,
        <https://1145.am/db/1902330/Baseline_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1909430/Menlo_Ventures>,
        <https://1145.am/db/1909651/Revolution_Ventures>,
        <https://1145.am/db/1910694/True_Ventures>,
        <https://1145.am/db/1910922/Charles_River_Ventures>,
        <https://1145.am/db/1912684/Charles_River_Ventures>,
        <https://1145.am/db/1913863/Tl_Ventures>,
        <https://1145.am/db/1913874/Redpoint_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1915862/Focus_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1920478/Dawntreader_Ventures>,
        <https://1145.am/db/1920837/Onset_Ventures>,
        <https://1145.am/db/1927817/Trm_Ventures>,
        <https://1145.am/db/1939926/Cobalt_Ventures>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/1947303/Cavallo_Ventures>,
        <https://1145.am/db/1947312/Boldstart_Ventures>,
        <https://1145.am/db/1952989/Singularity_Ventures>,
        <https://1145.am/db/1954147/Accomplice_Ventures>,
        <https://1145.am/db/1957179/Sozo_Ventures>,
        <https://1145.am/db/1958963/Prosus_Ventures>,
        <https://1145.am/db/1959001/Capital_Technology_Ventures>,
        <https://1145.am/db/1959001/Glasswing_Ventures>,
        <https://1145.am/db/1962819/Connetic_Ventures>,
        <https://1145.am/db/1967592/Firebolt_Ventures>,
        <https://1145.am/db/1967683/Dig_Ventures_Vine_Ventures>,
        <https://1145.am/db/1975490/Northview_Ventures>,
        <https://1145.am/db/1975547/Nanban_Ventures>,
        <https://1145.am/db/1975547/Sinewave_Ventures>,
        <https://1145.am/db/1986122/Menlo_Ventures>,
        <https://1145.am/db/1995926/Neotribe_Ventures>,
        <https://1145.am/db/1998196/Gni_Group_Ltd>,
        <https://1145.am/db/1999771/Servicenow_Ventures>,
        <https://1145.am/db/2004427/Convivialit_Ventures>,
        <https://1145.am/db/2005131/Wwventures>,
        <https://1145.am/db/2007132/Nventures>,
        <https://1145.am/db/2020041/Inovia_Capital>,
        <https://1145.am/db/2020041/TCV>,
        <https://1145.am/db/2023596/Salesforce_Ventures>,
        <https://1145.am/db/2025081/True_Ventures>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2035454/Gv>,
        <https://1145.am/db/2036021/Clear_Ventures>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/2039177/Stellantis_Ventures>,
        <https://1145.am/db/2041480/Brunnur_Ventures>,
        <https://1145.am/db/2042858/Gv>,
        <https://1145.am/db/2044380/20sales>,
        <https://1145.am/db/2045587/Veritec_Ventures>,
        <https://1145.am/db/2050229/Nventures>,
        <https://1145.am/db/2050359/At_One_Ventures>,
        <https://1145.am/db/2051164/Aviso_Ventures>,
        <https://1145.am/db/2053027/Glasswing_Ventures>,
        <https://1145.am/db/2055707/Globis_Capital_Partners>,
        <https://1145.am/db/2056931/We_Ventures>,
        <https://1145.am/db/2060003/Crit_Ventures_100___100_Ventures>,
        <https://1145.am/db/2061278/Incisive_Ventures>,
        <https://1145.am/db/2061278/Volo_Ventures>,
        <https://1145.am/db/2063642/Clear_Bridge_Ventures>,
        <https://1145.am/db/2063967/Vsquared_Ventures>,
        <https://1145.am/db/2069147/Boldstart_Ventures>,
        <https://1145.am/db/2069147/Pelion_Ventures>,
        <https://1145.am/db/2069147/Salesforce_Ventures>,
        <https://1145.am/db/2069495/Intermountain_Ventures>,
        <https://1145.am/db/2069495/Northpond_Ventures>,
        <https://1145.am/db/2073129/Abstract_Ventures>,
        <https://1145.am/db/2073132/Idc_Ventures>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2075625/Rocketship_Ventures>,
        <https://1145.am/db/2081180/S4s_Ventures>,
        <https://1145.am/db/2081674/Capital_One_Ventures>,
        <https://1145.am/db/2082068/Arctern_Ventures>,
        <https://1145.am/db/2082068/Prelude_Ventures>,
        <https://1145.am/db/2083987/Vanterra_Ventures>,
        <https://1145.am/db/2087289/Jven_Capital>,
        <https://1145.am/db/2087289/Northpond_Ventures>,
        <https://1145.am/db/2089206/Crescendo_Venture_Partners>,
        <https://1145.am/db/2093427/Yl_Ventures>,
        <https://1145.am/db/2093713/Yl_Ventures>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2100116/Epic_Ventures>,
        <https://1145.am/db/2107533/Globis_Capital_Partners>,
        <https://1145.am/db/2109529/Point72_Ventures>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2109932/Catalio_Capital_Management>,
        <https://1145.am/db/2109932/Epic_Ventures>,
        <https://1145.am/db/2109932/Intermountain_Ventures>,
        <https://1145.am/db/2109932/North_South_Ventures>,
        <https://1145.am/db/2116769/Celesta_Capital>,
        <https://1145.am/db/2116769/Chiratae_Ventures>,
        <https://1145.am/db/2123953/Amex_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2123953/Infinity_Ventures>,
        <https://1145.am/db/2124766/P1_Ventures>,
        <https://1145.am/db/2125182/Nevcaut_Ventures>,
        <https://1145.am/db/2125182/Ulu_Ventures>,
        <https://1145.am/db/2125927/1984_Ventures>,
        <https://1145.am/db/2127882/Akkadian_Ventures>,
        <https://1145.am/db/2134989/Clear_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2141183/S_Ventures>,
        <https://1145.am/db/2141328/Connetic_Ventures>,
        <https://1145.am/db/2143438/Scorpio_Capital>,
        <https://1145.am/db/2147767/Catapult_Ventures>,
        <https://1145.am/db/2147767/Tenoneten_Ventures>,
        <https://1145.am/db/2151983/CRV>,
        <https://1145.am/db/2151983/Greatpoint_Ventures>,
        <https://1145.am/db/2155426/Brighteyes_Ventures>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2164121/Menlo_Ventures>,
        <https://1145.am/db/2169799/Nwise_Ventures>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2182443/Global_Ventures>,
        <https://1145.am/db/2183352/Optum_Ventures>,
        <https://1145.am/db/2186568/Frist_Cressey_Ventures>,
        <https://1145.am/db/2186568/Springrock_Ventures>,
        <https://1145.am/db/2186949/Greatpoint_Ventures_And_Cross_Creek>,
        <https://1145.am/db/2186949/Springrock_Ventures>,
        <https://1145.am/db/2190141/Link_Ventures>,
        <https://1145.am/db/2192636/TCV>,
        <https://1145.am/db/219311/Origin_Ventures>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2208603/McKesson_Ventures>,
        <https://1145.am/db/2210557/True_Ventures>,
        <https://1145.am/db/221321/Ggv_Capital>,
        <https://1145.am/db/2214690/Idg_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2264763/True_Ventures>,
        <https://1145.am/db/2283006/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Northpond_Ventures>,
        <https://1145.am/db/2284412/Soleus_Capital>,
        <https://1145.am/db/2286665/Shanda_Group>,
        <https://1145.am/db/2288209/Echelon_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2293172/Prospect_Ventures>,
        <https://1145.am/db/2294202/Trinitas_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2295253/Arkitekt_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2296249/Proxima_Ventures>,
        <https://1145.am/db/2296869/Dcm_Ventures>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2298897/Eshelman_Ventures>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2302351/Rho_Ventures>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2302897/Ventures_West_Capital>,
        <https://1145.am/db/2303098/Seaflower_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304606/Prism_Ventureworks>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2306568/Cmea_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2309507/Rho_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2312792/Onset_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2314380/Puretech_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314515/Apjohnventures>,
        <https://1145.am/db/2315754/Arcturus_Capital>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2321856/Ventures_West_Capital_Ltd>,
        <https://1145.am/db/2323785/Eshelman_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2325015/True_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325257/Ventures_West>,
        <https://1145.am/db/2325337/Resolvyx>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/2326362/Nextech_Venture>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2328585/Cmea_Ventures>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2338023/Cipla_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338703/Wavepoint_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341942/High-Tech_Grnderfonds>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2343184/Jven_Capital>,
        <https://1145.am/db/2345017/Venture_Investments>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2346300/High-Tech_Grnderfonds>,
        <https://1145.am/db/2346452/Aescap_Venture>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346978/Ventures_West_Capital>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2357487/Savitr_Capital>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2358747/Solon_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/2362638/Launchpad_Venture_Group>,
        <https://1145.am/db/2363460/Rho_Ventures>,
        <https://1145.am/db/2363854/Chrysalis_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365103/Aescap_Venture>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/238282/Carnrite_Ventures>,
        <https://1145.am/db/2400536/Capital_One_Ventures>,
        <https://1145.am/db/2423653/Venturewell>,
        <https://1145.am/db/253438/Esplanade_Ventures>,
        <https://1145.am/db/254357/Ulu_Ventures>,
        <https://1145.am/db/2549491/Ktb_Ventures>,
        <https://1145.am/db/2552636/Morningside_Ventures>,
        <https://1145.am/db/2569491/High-Tech_Grnderfonds>,
        <https://1145.am/db/2570138/Sherpa_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2603254/Salesforce_Ventures>,
        <https://1145.am/db/2628424/Verana_Networks>,
        <https://1145.am/db/2628848/Neocarta_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2638432/Nissay_Capital>,
        <https://1145.am/db/2641337/Promus_Ventures>,
        <https://1145.am/db/2641337/True_Ventures>,
        <https://1145.am/db/2654391/Biggell_Finance>,
        <https://1145.am/db/265532/Ulu_Ventures>,
        <https://1145.am/db/2702871/Inovia_Capital>,
        <https://1145.am/db/274170/G1_Ventures>,
        <https://1145.am/db/2754677/Golden_Gate_Ventures>,
        <https://1145.am/db/2765022/Garuda_Ventures>,
        <https://1145.am/db/2765030/Daniel_Ventures>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/2786411/Allegion_Ventures>,
        <https://1145.am/db/2788052/Rx_Ventures>,
        <https://1145.am/db/2790064/Novastar_Ventures>,
        <https://1145.am/db/2794396/Snowpoint_Ventures>,
        <https://1145.am/db/2797562/Menlo_Ventures>,
        <https://1145.am/db/283272/Salesforce_Ventures>,
        <https://1145.am/db/283607/Salesforce_Ventures>,
        <https://1145.am/db/293715/Signum_Capital>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/293891/Ggv_Capital>,
        <https://1145.am/db/299738/Steadfast_Capital_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/319155/Bgv_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/341984/Salesforce_Ventures>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Salesforce_Ventures>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/343459/F7_Ventures>,
        <https://1145.am/db/346598/Salesforce_Ventures>,
        <https://1145.am/db/348442/Triventures>,
        <https://1145.am/db/348659/Launchpad_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/364168/Alerion_Ventures>,
        <https://1145.am/db/367592/Gv>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/388551/Vestigo_Ventures>,
        <https://1145.am/db/396305/Real_Ventures>,
        <https://1145.am/db/402103/1776_Ventures>,
        <https://1145.am/db/402701/January_Ventures>,
        <https://1145.am/db/403810/Riverstone_Ventures>,
        <https://1145.am/db/410322/Gv>,
        <https://1145.am/db/410473/Celesta_Capital>,
        <https://1145.am/db/410473/Lytical_Ventures_And_Nepenthe_Capital>,
        <https://1145.am/db/410529/Goodyear_Ventures>,
        <https://1145.am/db/411539/Zeev_Ventures>,
        <https://1145.am/db/412020/Defi_Ventures_Inc>,
        <https://1145.am/db/415322/CRV>,
        <https://1145.am/db/416041/Akkadian_Ventures>,
        <https://1145.am/db/416041/Signia_Ventures>,
        <https://1145.am/db/416041/Zeev_Ventures>,
        <https://1145.am/db/419489/Point72_Ventures>,
        <https://1145.am/db/424877/North_First_Ventures>,
        <https://1145.am/db/425262/Yl_Ventures>,
        <https://1145.am/db/425423/True_Ventures>,
        <https://1145.am/db/425973/Will_Ventures>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/429179/C5_Capital>,
        <https://1145.am/db/430986/Cortado_Ventures>,
        <https://1145.am/db/434334/1up_Ventures>,
        <https://1145.am/db/435691/Klick_Ventures>,
        <https://1145.am/db/439819/Cavu_Ventures>,
        <https://1145.am/db/441319/Celesta_Capital>,
        <https://1145.am/db/444105/Exfinity_Ventures>,
        <https://1145.am/db/445365/Revolution_Ventures>,
        <https://1145.am/db/446341/Sinewave_Ventures>,
        <https://1145.am/db/455558/Intudo_Ventures>,
        <https://1145.am/db/457435/Alerce>,
        <https://1145.am/db/457435/Clin>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/471253/Gv>,
        <https://1145.am/db/471436/Citi_Ventures>,
        <https://1145.am/db/471504/Canapi_Ventures>,
        <https://1145.am/db/473030/Highsage_Ventures>,
        <https://1145.am/db/474928/Susa_Ventures>,
        <https://1145.am/db/478049/Worldquant_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/479113/Menlo_Ventures>,
        <https://1145.am/db/485616/K3_Ventures>,
        <https://1145.am/db/486858/Gaingels>,
        <https://1145.am/db/486901/Gaingels>,
        <https://1145.am/db/488743/Salesforce_Ventures>,
        <https://1145.am/db/491130/Raiven_Capital>,
        <https://1145.am/db/491338/Raiven_Capital>,
        <https://1145.am/db/493560/Tyh_Ventures>,
        <https://1145.am/db/495912/Regah_Ventures>,
        <https://1145.am/db/506588/Trinity_Ventures>,
        <https://1145.am/db/508145/Sora_Finance>,
        <https://1145.am/db/508161/Sora_Finance>,
        <https://1145.am/db/510565/Epic_Ventures>,
        <https://1145.am/db/513305/Avid_Ventures>,
        <https://1145.am/db/513305/Canapi_Ventures>,
        <https://1145.am/db/513897/Rlc_Ventures>,
        <https://1145.am/db/514151/Rlc_Ventures>,
        <https://1145.am/db/516396/Acequia_Capital>,
        <https://1145.am/db/517213/Acequia_Capital>,
        <https://1145.am/db/523349/Osf_Ventures>,
        <https://1145.am/db/523776/Root_Ventures>,
        <https://1145.am/db/525285/Inventum_Ventures>,
        <https://1145.am/db/525285/Optima_Ventures>,
        <https://1145.am/db/526109/Ggv_Capital>,
        <https://1145.am/db/526175/Ridgeline_Ventures>,
        <https://1145.am/db/529812/Inventum_Ventures>,
        <https://1145.am/db/529812/Optima_Ventures>,
        <https://1145.am/db/532016/Id_Ventures>,
        <https://1145.am/db/539571/Origin_Ventures>,
        <https://1145.am/db/545843/Capital_One_Ventures>,
        <https://1145.am/db/545852/Boxone_Ventures>,
        <https://1145.am/db/545852/Panache_Ventures>,
        <https://1145.am/db/547770/BGV>,
        <https://1145.am/db/547944/BGV>,
        <https://1145.am/db/554552/Konvoy_Ventures>,
        <https://1145.am/db/555193/Illumina_Ventures>,
        <https://1145.am/db/555193/Technology_Venture_Partners>,
        <https://1145.am/db/556705/Congress_Ave_Ventures>,
        <https://1145.am/db/558005/Illumina_Ventures>,
        <https://1145.am/db/558005/Technology_Venture_Partners>,
        <https://1145.am/db/558877/Falabella_Ventures>,
        <https://1145.am/db/559220/Ulu_Ventures>,
        <https://1145.am/db/561662/Redpoint_Ventures>,
        <https://1145.am/db/561662/Vandelay_Ventures>,
        <https://1145.am/db/562745/Vinmar_Ventures>,
        <https://1145.am/db/563575/Celesta_Capital>,
        <https://1145.am/db/564008/D1_Ventures>,
        <https://1145.am/db/571769/Illumina_Ventures>,
        <https://1145.am/db/571769/M_Ventures>,
        <https://1145.am/db/572097/Menlo_Ventures>,
        <https://1145.am/db/572097/Teneleven_Ventures>,
        <https://1145.am/db/575249/TCV>,
        <https://1145.am/db/576186/Konvoy_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/586525/Tenoneten_Ventures>,
        <https://1145.am/db/587038/Coparion>,
        <https://1145.am/db/591566/Morningside_Ventures>,
        <https://1145.am/db/596145/Anorak_Ventures>,
        <https://1145.am/db/596564/Anorak_Ventures>,
        <https://1145.am/db/601455/Morningside_Ventures>,
        <https://1145.am/db/603725/Ignitexl_Ventures>,
        <https://1145.am/db/606074/Fiscus_Ventures>,
        <https://1145.am/db/606144/Ggv_Capital>,
        <https://1145.am/db/615337/Companyon_Ventures>,
        <https://1145.am/db/619284/Scf_Ventures>,
        <https://1145.am/db/619366/Capital_One_Ventures>,
        <https://1145.am/db/619736/Lightspeed_Ventures>,
        <https://1145.am/db/623178/Array_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/626781/Dnx_Ventures>,
        <https://1145.am/db/627030/Launchpad_Capital>,
        <https://1145.am/db/628654/Prologis_Ventures>,
        <https://1145.am/db/633238/True_Ventures>,
        <https://1145.am/db/633869/Skywell_Capital_Partners>,
        <https://1145.am/db/633869/Stageone_Ventures>,
        <https://1145.am/db/640939/Ggv_Capital>,
        <https://1145.am/db/642123/Charles_River_Ventures>,
        <https://1145.am/db/642518/Network_Ventures>,
        <https://1145.am/db/643600/Vinco_Ventures>,
        <https://1145.am/db/648552/True_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/659675/Gv>,
        <https://1145.am/db/661747/Adit_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/665129/Ac_Ventures>,
        <https://1145.am/db/665776/Firstime_Ventures>,
        <https://1145.am/db/676217/Steelsky_Ventures>,
        <https://1145.am/db/676869/Ggv_Capital>,
        <https://1145.am/db/678140/Ggv_Capital>,
        <https://1145.am/db/678587/Lightshed_Ventures>,
        <https://1145.am/db/678593/Solana_Ventures>,
        <https://1145.am/db/687538/Kayyak_Ventures>,
        <https://1145.am/db/689460/True_Ventures>,
        <https://1145.am/db/694513/Authentic_Ventures>,
        <https://1145.am/db/694924/Avid_Ventures>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/700327/Menlo_Ventures>,
        <https://1145.am/db/700877/Gaingels>,
        <https://1145.am/db/703983/Eqventure>,
        <https://1145.am/db/704489/Eqventure>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/704753/Menlo_Ventures>,
        <https://1145.am/db/704793/Quidnet_Ventures>,
        <https://1145.am/db/704991/Gaingels>,
        <https://1145.am/db/709633/Connetic_Ventures>,
        <https://1145.am/db/726461/Contour_Ventures>,
        <https://1145.am/db/729628/Kyber_Ventures>,
        <https://1145.am/db/729628/Signum_Capital>,
        <https://1145.am/db/738920/Oca_Ventures>,
        <https://1145.am/db/738920/Susa_Ventures>,
        <https://1145.am/db/739538/Morpheus_Ventures>,
        <https://1145.am/db/739538/Oca_Ventures>,
        <https://1145.am/db/739538/Susa_Ventures>,
        <https://1145.am/db/747051/Tenoneten_Ventures>,
        <https://1145.am/db/747771/Ta_Ventures>,
        <https://1145.am/db/749147/1984_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/1984_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/750305/Yl_Ventures>,
        <https://1145.am/db/750725/Vestigo_Ventures>,
        <https://1145.am/db/751176/Maverick_Ventures>,
        <https://1145.am/db/751176/Susa_Ventures>,
        <https://1145.am/db/751387/Menlo_Ventures>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/753251/Savantus_Ventures>,
        <https://1145.am/db/753913/Brunnur_Ventures>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/758206/Great_North_Ventures>,
        <https://1145.am/db/758206/Grotech_Ventures>,
        <https://1145.am/db/759749/Cava_Capital>,
        <https://1145.am/db/763083/Gaingels>,
        <https://1145.am/db/764875/Rev1_Ventures>,
        <https://1145.am/db/764896/Rev1_Ventures>,
        <https://1145.am/db/765216/True_Ventures>,
        <https://1145.am/db/768172/Gaingels>,
        <https://1145.am/db/768172/Type_One_Ventures>,
        <https://1145.am/db/768349/Salesforce_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769568/Axon_Ventures>,
        <https://1145.am/db/772099/Array_Ventures>,
        <https://1145.am/db/773235/Prelude_Ventures>,
        <https://1145.am/db/773684/Fulgur_Ventures>,
        <https://1145.am/db/773794/Array_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/778423/Sentiero_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/779867/Genesis_Block_Ventures>,
        <https://1145.am/db/780272/East_Ventures>,
        <https://1145.am/db/780289/East_Ventures>,
        <https://1145.am/db/783431/Cathay_Venture_Inc>,
        <https://1145.am/db/784093/Boldstart_Ventures>,
        <https://1145.am/db/787806/Boldstart_Ventures>,
        <https://1145.am/db/788016/Boldstart_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796250/Sp_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/797597/Lansdowne_Partners>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/800101/Gaingels>,
        <https://1145.am/db/803541/Credo_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/8045/Greatpoint_Ventures>,
        <https://1145.am/db/806828/Promus_Ventures>,
        <https://1145.am/db/806994/Companyon_Ventures>,
        <https://1145.am/db/807080/K3_Ventures>,
        <https://1145.am/db/808020/Starlight_Ventures>,
        <https://1145.am/db/808020/Valo_Ventures>,
        <https://1145.am/db/8146/Rev1_Ventures>,
        <https://1145.am/db/817162/Orbia_Ventures>,
        <https://1145.am/db/818444/1984_Ventures>,
        <https://1145.am/db/821135/Se_Ventures>,
        <https://1145.am/db/823763/Infinity_Ventures>,
        <https://1145.am/db/828716/Idc_Ventures>,
        <https://1145.am/db/829118/Salesforce_Ventures>,
        <https://1145.am/db/830571/Company_Ventures>,
        <https://1145.am/db/830689/Soleus_Capital>,
        <https://1145.am/db/832264/Salesforce_Ventures>,
        <https://1145.am/db/832573/Solasta_Ventures>,
        <https://1145.am/db/834864/Ggv_Capital>,
        <https://1145.am/db/834864/K3_Ventures>,
        <https://1145.am/db/836848/Technexus_Venture_Collaborative>,
        <https://1145.am/db/836908/Frontier_Ventures>,
        <https://1145.am/db/837034/Redpoint_Ventures>,
        <https://1145.am/db/838138/Root_Ventures>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/847157/Signum_Capital>,
        <https://1145.am/db/847862/Wise_Ventures>,
        <https://1145.am/db/854001/Gv>,
        <https://1145.am/db/854589/Verance_Capital>,
        <https://1145.am/db/854654/Mrtnz_Ventures>,
        <https://1145.am/db/854795/Menlo_Ventures>,
        <https://1145.am/db/867865/Applied_Ventures>,
        <https://1145.am/db/868093/Cobro_Ventures>,
        <https://1145.am/db/869652/Forever_Ventures>,
        <https://1145.am/db/874394/Nextview_Ventures>,
        <https://1145.am/db/874394/True_Ventures>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/881298/At_One_Ventures>,
        <https://1145.am/db/882723/At_One_Ventures>,
        <https://1145.am/db/884787/Foresite_Capital>,
        <https://1145.am/db/884787/Gv>,
        <https://1145.am/db/884787/Northpond_Ventures>,
        <https://1145.am/db/886445/Gv>,
        <https://1145.am/db/887062/Panoramic_Ventures>,
        <https://1145.am/db/889246/At_One_Ventures>,
        <https://1145.am/db/890271/Panoramic_Ventures>,
        <https://1145.am/db/891162/Emergingvc>,
        <https://1145.am/db/891162/Launchpad_Venture_Group>,
        <https://1145.am/db/903689/Vectr_Ventures>,
        <https://1145.am/db/904276/Nextview_Ventures>,
        <https://1145.am/db/906393/East_Ventures>,
        <https://1145.am/db/907844/Argon_Ventures>,
        <https://1145.am/db/907844/Glasswing_Ventures>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/913678/Sandbridge_Capital>,
        <https://1145.am/db/919636/Menlo_Ventures>,
        <https://1145.am/db/921704/Scop_Ventures>,
        <https://1145.am/db/92200/Knoll_Ventures>,
        <https://1145.am/db/922066/Irrvrnt_Vc>,
        <https://1145.am/db/922192/Gv>,
        <https://1145.am/db/922498/Sozo_Ventures>,
        <https://1145.am/db/923723/Scop_Ventures>,
        <https://1145.am/db/928711/Frontline_Ventures>,
        <https://1145.am/db/934946/Ggv_Capital>,
        <https://1145.am/db/935046/Origin_Ventures>,
        <https://1145.am/db/935249/Victress_Capital>,
        <https://1145.am/db/935322/Alpana_Ventures>,
        <https://1145.am/db/935322/M_Ventures>,
        <https://1145.am/db/935796/Salesforce_Ventures>,
        <https://1145.am/db/935962/Digitalbridge_Ventures>,
        <https://1145.am/db/936045/Lpc_Ventures>,
        <https://1145.am/db/936057/Noemis_Ventures>,
        <https://1145.am/db/936154/Salesforce_Ventures>,
        <https://1145.am/db/936448/Ggv_Capital>,
        <https://1145.am/db/936862/Lool_Ventures>,
        <https://1145.am/db/936906/Neotribe_Ventures>,
        <https://1145.am/db/937210/Citi_Ventures>,
        <https://1145.am/db/937210/Firebolt_Ventures>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/938108/Conti_Ventures>,
        <https://1145.am/db/938555/Digitalbridge_Ventures>,
        <https://1145.am/db/938586/Venturesouth>,
        <https://1145.am/db/938921/Redpoint_Ventures>,
        <https://1145.am/db/938975/Ggv_Capital>,
        <https://1145.am/db/939163/Goodyear_Ventures>,
        <https://1145.am/db/940740/Agnc_Ventures>,
        <https://1145.am/db/940913/True_Ventures>,
        <https://1145.am/db/941816/Radical_Ventures>,
        <https://1145.am/db/942825/Argon_Ventures>,
        <https://1145.am/db/946710/Citi_Ventures>,
        <https://1145.am/db/947238/Kyros_Ventures>,
        <https://1145.am/db/952434/Verissimo_Ventures>,
        <https://1145.am/db/955201/Gv>,
        <https://1145.am/db/960022/Verance_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/970950/Ulu_Ventures>,
        <https://1145.am/db/971415/Altai_Ventures>,
        <https://1145.am/db/971450/Allon_Ventures>,
        <https://1145.am/db/971939/Formic_Ventures>,
        <https://1145.am/db/975114/Formic_Ventures>,
        <https://1145.am/db/979753/Menlo_Ventures>,
        <https://1145.am/db/980678/Menlo_Ventures>,
        <https://1145.am/db/984645/Vinco_Ventures>,
        <https://1145.am/db/987688/Brightspark_Ventures>,
        <https://1145.am/db/987700/Infinityvc>,
        <https://1145.am/db/988084/Abstract_Ventures>,
        <https://1145.am/db/988084/Blank_Ventures>,
        <https://1145.am/db/988318/Arthur_Ventures>,
        <https://1145.am/db/988482/Brightspark_Ventures>,
        <https://1145.am/db/988979/Infinityvc>,
        <https://1145.am/db/989392/Arthur_Ventures>,
        <https://1145.am/db/990085/Radical_Ventures>,
        <https://1145.am/db/995593/Raiven_Capital>,
        <https://1145.am/db/995737/Nuoyan_Capital>,
        <https://1145.am/db/996563/Raiven_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1247967/Index_Ventures>,
        <https://1145.am/db/1358814/Index_Ventures>,
        <https://1145.am/db/1490485/Index_Ventures>,
        <https://1145.am/db/1493654/Index_Ventures>,
        <https://1145.am/db/1553352/Index_Ventures>,
        <https://1145.am/db/1693951/Index_Ventures>,
        <https://1145.am/db/1694279/Index_Ventures>,
        <https://1145.am/db/1699089/Index_Ventures>,
        <https://1145.am/db/1704793/Index_Ventures>,
        <https://1145.am/db/1711587/Index_Ventures>,
        <https://1145.am/db/1711731/Index_Ventures>,
        <https://1145.am/db/1712506/Index_Ventures>,
        <https://1145.am/db/1717574/Index_Ventures>,
        <https://1145.am/db/1733028/Index_Ventures>,
        <https://1145.am/db/1735596/Index_Ventures>,
        <https://1145.am/db/1736117/Index_Ventures>,
        <https://1145.am/db/1737079/Index_Ventures>,
        <https://1145.am/db/1737527/Index_Ventures>,
        <https://1145.am/db/1737696/Index_Ventures>,
        <https://1145.am/db/1738402/Index_Ventures>,
        <https://1145.am/db/1738465/Index_Ventures>,
        <https://1145.am/db/1740781/Index_Ventures>,
        <https://1145.am/db/1742878/Index_Ventures>,
        <https://1145.am/db/1744753/Index_Ventures>,
        <https://1145.am/db/1745368/Index_Ventures>,
        <https://1145.am/db/1745702/Index_Ventures>,
        <https://1145.am/db/1746192/Index_Ventures>,
        <https://1145.am/db/1746800/Index_Ventures>,
        <https://1145.am/db/1746845/Index_Ventures>,
        <https://1145.am/db/1746947/Index_Ventures>,
        <https://1145.am/db/1747153/Index_Ventures>,
        <https://1145.am/db/1747208/Index_Ventures>,
        <https://1145.am/db/1748172/Index_Ventures>,
        <https://1145.am/db/1748621/Index_Ventures>,
        <https://1145.am/db/1750406/Index_Ventures>,
        <https://1145.am/db/1750420/Index_Ventures>,
        <https://1145.am/db/1750828/Index_Ventures>,
        <https://1145.am/db/1752154/Index_Ventures>,
        <https://1145.am/db/1755398/Index_Ventures>,
        <https://1145.am/db/1755899/Index_Ventures>,
        <https://1145.am/db/1756768/Index_Ventures>,
        <https://1145.am/db/1756873/Index_Ventures>,
        <https://1145.am/db/1758069/Index_Ventures>,
        <https://1145.am/db/1758834/Index_Ventures>,
        <https://1145.am/db/1759939/Index_Ventures>,
        <https://1145.am/db/1760954/Index_Ventures>,
        <https://1145.am/db/1761664/Index_Ventures>,
        <https://1145.am/db/1762988/Index_Ventures>,
        <https://1145.am/db/1763352/Index_Ventures>,
        <https://1145.am/db/1765809/Index_Ventures>,
        <https://1145.am/db/1765870/Index_Ventures>,
        <https://1145.am/db/1766059/Index_Ventures>,
        <https://1145.am/db/1766253/Index_Ventures>,
        <https://1145.am/db/1769654/Index_Ventures>,
        <https://1145.am/db/1771672/Index_Ventures>,
        <https://1145.am/db/1771734/Index_Ventures>,
        <https://1145.am/db/1771773/Index_Ventures>,
        <https://1145.am/db/1775903/Index_Ventures>,
        <https://1145.am/db/1776139/Index_Ventures>,
        <https://1145.am/db/1776626/Index_Ventures>,
        <https://1145.am/db/1777546/Index_Ventures>,
        <https://1145.am/db/1778195/Index_Ventures>,
        <https://1145.am/db/1780507/Index_Ventures>,
        <https://1145.am/db/1780733/Index_Ventures>,
        <https://1145.am/db/1783754/Index_Ventures>,
        <https://1145.am/db/1787471/Index_Ventures>,
        <https://1145.am/db/1787621/Index_Ventures>,
        <https://1145.am/db/1790777/Index_Ventures>,
        <https://1145.am/db/1791667/Index_Ventures>,
        <https://1145.am/db/1791743/Index_Ventures>,
        <https://1145.am/db/1796201/Index_Ventures>,
        <https://1145.am/db/1798836/Index_Ventures>,
        <https://1145.am/db/1799293/Index_Ventures>,
        <https://1145.am/db/1800172/Index_Ventures>,
        <https://1145.am/db/1800998/Index_Ventures>,
        <https://1145.am/db/1805201/Index_Ventures>,
        <https://1145.am/db/1805473/Index_Ventures>,
        <https://1145.am/db/1807173/Index_Ventures>,
        <https://1145.am/db/1808484/Index_Ventures>,
        <https://1145.am/db/1809821/Index_Ventures>,
        <https://1145.am/db/1810000/Index_Ventures>,
        <https://1145.am/db/1812038/Index_Ventures>,
        <https://1145.am/db/1812890/Index_Ventures>,
        <https://1145.am/db/1813037/Index_Ventures>,
        <https://1145.am/db/1813404/Index_Ventures>,
        <https://1145.am/db/1819133/Index_Ventures>,
        <https://1145.am/db/1819302/Index_Ventures>,
        <https://1145.am/db/1823078/Index_Ventures>,
        <https://1145.am/db/1823141/Index_Ventures>,
        <https://1145.am/db/1824561/Index_Ventures>,
        <https://1145.am/db/1828638/Index_Ventures>,
        <https://1145.am/db/1829991/Index_Ventures>,
        <https://1145.am/db/1830023/Index_Ventures>,
        <https://1145.am/db/1831440/Index_Ventures>,
        <https://1145.am/db/1832655/Index_Ventures>,
        <https://1145.am/db/1832808/Index_Ventures>,
        <https://1145.am/db/1832926/Index_Ventures>,
        <https://1145.am/db/1835321/Index_Ventures>,
        <https://1145.am/db/1835516/Index_Ventures>,
        <https://1145.am/db/1836455/Index_Ventures>,
        <https://1145.am/db/1836572/Index_Ventures>,
        <https://1145.am/db/1837081/Index_Ventures>,
        <https://1145.am/db/1837143/Index_Ventures>,
        <https://1145.am/db/1839663/Index_Ventures>,
        <https://1145.am/db/1840137/Index_Ventures>,
        <https://1145.am/db/1845548/Index_Ventures>,
        <https://1145.am/db/1845841/Index_Ventures>,
        <https://1145.am/db/1846794/Index_Ventures>,
        <https://1145.am/db/1847483/Index_Ventures>,
        <https://1145.am/db/1848631/Index_Ventures>,
        <https://1145.am/db/1849844/Index_Ventures>,
        <https://1145.am/db/1849912/Index_Ventures>,
        <https://1145.am/db/1850428/Index_Ventures>,
        <https://1145.am/db/1851744/Index_Ventures>,
        <https://1145.am/db/1853547/Index_Ventures>,
        <https://1145.am/db/1854191/Index_Ventures>,
        <https://1145.am/db/1856171/Index_Ventures>,
        <https://1145.am/db/1856191/Index_Ventures>,
        <https://1145.am/db/1856802/Index_Ventures>,
        <https://1145.am/db/1856967/Index_Ventures>,
        <https://1145.am/db/1857638/Index_Ventures>,
        <https://1145.am/db/1858520/Index_Ventures>,
        <https://1145.am/db/1858521/Index_Ventures>,
        <https://1145.am/db/1862594/Index_Ventures>,
        <https://1145.am/db/1863500/Index_Ventures>,
        <https://1145.am/db/1865106/Index_Ventures>,
        <https://1145.am/db/1865524/Index_Ventures>,
        <https://1145.am/db/1866804/Index_Ventures>,
        <https://1145.am/db/1868923/Index_Ventures>,
        <https://1145.am/db/1868935/Index_Ventures>,
        <https://1145.am/db/1870074/Index_Ventures>,
        <https://1145.am/db/1870079/Index_Ventures>,
        <https://1145.am/db/1870810/Index_Ventures>,
        <https://1145.am/db/1871091/Index_Ventures>,
        <https://1145.am/db/1876014/Index_Ventures>,
        <https://1145.am/db/1876914/Index_Ventures>,
        <https://1145.am/db/1878630/Index_Ventures>,
        <https://1145.am/db/1880386/Index_Ventures>,
        <https://1145.am/db/1881391/Index_Ventures>,
        <https://1145.am/db/1881430/Index_Ventures>,
        <https://1145.am/db/1882301/Index_Ventures>,
        <https://1145.am/db/1882686/Index_Ventures>,
        <https://1145.am/db/1884077/Index_Ventures>,
        <https://1145.am/db/1885147/Index_Ventures>,
        <https://1145.am/db/1890254/Index_Ventures>,
        <https://1145.am/db/1893255/Index_Ventures>,
        <https://1145.am/db/1894621/Index_Ventures>,
        <https://1145.am/db/1894627/Index_Ventures>,
        <https://1145.am/db/1899697/Index_Ventures>,
        <https://1145.am/db/1900904/Index_Ventures>,
        <https://1145.am/db/1902032/Index_Ventures>,
        <https://1145.am/db/1910957/Index_Ventures>,
        <https://1145.am/db/1915168/Index_Ventures>,
        <https://1145.am/db/1916258/Index_Ventures>,
        <https://1145.am/db/1916868/Index_Ventures>,
        <https://1145.am/db/1919238/Index_Ventures>,
        <https://1145.am/db/1967520/Index_Ventures>,
        <https://1145.am/db/1967683/Index_Ventures>,
        <https://1145.am/db/199212/Index_Ventures>,
        <https://1145.am/db/2028609/Index_Ventures>,
        <https://1145.am/db/2060465/Index_Ventures>,
        <https://1145.am/db/2062814/Index_Ventures>,
        <https://1145.am/db/2127786/Index_Ventures>,
        <https://1145.am/db/217906/Index_Ventures>,
        <https://1145.am/db/2198066/Index_Ventures>,
        <https://1145.am/db/2234558/Index_Ventures>,
        <https://1145.am/db/2290088/Index_Ventures>,
        <https://1145.am/db/2290200/Index_Ventures>,
        <https://1145.am/db/2297905/Index_Ventures>,
        <https://1145.am/db/2303009/Index_Ventures>,
        <https://1145.am/db/2303849/Index_Ventures>,
        <https://1145.am/db/2309490/Index_Ventures>,
        <https://1145.am/db/2309847/Index_Ventures>,
        <https://1145.am/db/2313410/Index_Ventures>,
        <https://1145.am/db/2325147/Index_Ventures>,
        <https://1145.am/db/2327222/Index_Ventures>,
        <https://1145.am/db/2333601/Index_Ventures>,
        <https://1145.am/db/2338079/Index_Ventures>,
        <https://1145.am/db/2338193/Index_Ventures>,
        <https://1145.am/db/2344127/Index_Ventures>,
        <https://1145.am/db/2348012/Index_Ventures>,
        <https://1145.am/db/2348620/Index_Ventures>,
        <https://1145.am/db/2350031/Index_Ventures>,
        <https://1145.am/db/2352142/Index_Ventures>,
        <https://1145.am/db/2352145/Index_Ventures>,
        <https://1145.am/db/2355609/Index_Ventures>,
        <https://1145.am/db/2355952/Index_Ventures>,
        <https://1145.am/db/2357169/Index_Ventures>,
        <https://1145.am/db/2357356/Index_Ventures>,
        <https://1145.am/db/2358233/Index_Ventures>,
        <https://1145.am/db/2358246/Index_Ventures>,
        <https://1145.am/db/2362736/Index_Ventures>,
        <https://1145.am/db/2362737/Index_Ventures>,
        <https://1145.am/db/2364597/Index_Ventures>,
        <https://1145.am/db/2364600/Index_Ventures>,
        <https://1145.am/db/2507691/Index_Ventures>,
        <https://1145.am/db/2555540/Index_Ventures>,
        <https://1145.am/db/2589317/Index_Ventures>,
        <https://1145.am/db/2643797/Index_Ventures>,
        <https://1145.am/db/317470/Index_Ventures>,
        <https://1145.am/db/318142/Index_Ventures>,
        <https://1145.am/db/337401/Index_Ventures>,
        <https://1145.am/db/348633/Index_Ventures>,
        <https://1145.am/db/366983/Index_Ventures>,
        <https://1145.am/db/367008/Index_Ventures>,
        <https://1145.am/db/475105/Index_Ventures>,
        <https://1145.am/db/539919/Index_Ventures>,
        <https://1145.am/db/578277/Index_Ventures>,
        <https://1145.am/db/633695/Index_Ventures>,
        <https://1145.am/db/707126/Index_Ventures>,
        <https://1145.am/db/709798/Index_Ventures>,
        <https://1145.am/db/768008/Index_Ventures>,
        <https://1145.am/db/789218/Index_Ventures>,
        <https://1145.am/db/854512/Index_Ventures>,
        <https://1145.am/db/868352/Index_Ventures>,
        <https://1145.am/db/893076/Index_Ventures>,
        <https://1145.am/db/893316/Index_Ventures>,
        <https://1145.am/db/909344/Index_Ventures>,
        <https://1145.am/db/957097/Index_Ventures>,
        <https://1145.am/db/980375/Index_Ventures>,
        <https://1145.am/db/981840/Index_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360127/Series_A_Investment_Anergis_Sa_Biomedinvest_Esperante_Initiative_Capital_Romandie_Sunstone_Capital_Vinci_Capital-Renaissance_Pme_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-03-28T15:11:09+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Anergis Closes CHF 18 Million Series A Financing Round to Develop its Innovative Allergy Vaccines and Expands its Board of Directors.",
        "LAUSANNE, Switzerland - March 28th, 2011 - Anergis SA announced today that it has closed a Series A financing round raising CHF 18 millions from European biotech funds and private local investors." ;
    ns1:documentTitle "Anergis Closes CHF 18 Million Series A Financing Round to Develop its Innovative Allergy Vaccines and Expands its Board of Direc" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anergis-closes-chf-18-million-series-a-financing-round-to-develop-its-innovative-allergy> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2360127/Anergis_Sa> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "CHF 18 Million",
        "CHF 18 millions" ;
    ns1:when "2011-03-28T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "March 28th, 2011" ;
    ns1:whereGeoName "Switzerland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:whereRaw "Switzerland" .

<https://1145.am/db/2363854/Chrysalis_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Louisville" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4299276/about.rdf> ;
    ns1:basedInHighRaw "Louisville, Ky." ;
    ns1:description "venture capital" ;
    ns1:documentDate "2011-07-19T12:32:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Beringea Invests in Healthcare IT Company Intervention Insights" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/beringea-invests-healthcare-it-company-intervention-insights> ;
    ns1:foundName "Chrysalis Ventures" ;
    ns1:investor <https://1145.am/db/2363854/Series_B_Investment_Beringea_Chrysalis_Ventures_Hopen_Life_Sciences_Intervention_Insights_Michigan_Accelerator_Fund_I_Completed> ;
    ns1:name "Chrysalis Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1006252/Menlo_Ventures>,
        <https://1145.am/db/1006262/Com_Prelude_Ventures>,
        <https://1145.am/db/1006574/Integr8d_Capital>,
        <https://1145.am/db/1006880/Root_Ventures>,
        <https://1145.am/db/1007193/Capital_One_Ventures>,
        <https://1145.am/db/1007527/Integr8d_Capital>,
        <https://1145.am/db/1008085/Root_Ventures>,
        <https://1145.am/db/1008260/Servicenow_Ventures>,
        <https://1145.am/db/1010064/Greatpoint_Ventures>,
        <https://1145.am/db/1010064/Maverick_Ventures>,
        <https://1145.am/db/1010199/One9_Ventures>,
        <https://1145.am/db/102038/Allegion_Ventures>,
        <https://1145.am/db/102038/Pathbreaker_Ventures>,
        <https://1145.am/db/102038/West_Ventures>,
        <https://1145.am/db/1023252/Digitalbridge_Ventures>,
        <https://1145.am/db/1024247/Digitalbridge_Ventures>,
        <https://1145.am/db/1024483/Investbridge_Capital>,
        <https://1145.am/db/1026319/Able_Partners>,
        <https://1145.am/db/1034591/Valia_Ventures>,
        <https://1145.am/db/1041601/Kineo_Finance>,
        <https://1145.am/db/1042250/Kineo_Finance>,
        <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043342/Root_Ventures>,
        <https://1145.am/db/1043516/Kineo_Finance>,
        <https://1145.am/db/1045242/Dipalo_Ventures>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1051115/Dn_Capital>,
        <https://1145.am/db/1051644/Vestigo_Ventures>,
        <https://1145.am/db/1052155/Gate_Ventures>,
        <https://1145.am/db/1059993/Tera_Ventures>,
        <https://1145.am/db/1060146/Ulu_Ventures>,
        <https://1145.am/db/1061824/Bluebird_Ventures>,
        <https://1145.am/db/1061911/Ulu_Ventures>,
        <https://1145.am/db/1065366/Applied_Ventures_Llc>,
        <https://1145.am/db/1065544/Menlo_Ventures>,
        <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1081490/Vinco_Ventures>,
        <https://1145.am/db/1081888/Ggv_Capital>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/1082719/Dorilton_Ventures>,
        <https://1145.am/db/1082814/Cathexis_Ventures>,
        <https://1145.am/db/1082814/Promus_Ventures>,
        <https://1145.am/db/1082814/Type_One_Ventures>,
        <https://1145.am/db/1084014/Ret_Ventures>,
        <https://1145.am/db/1085867/Ret_Ventures>,
        <https://1145.am/db/1086604/Alerion_Ventures>,
        <https://1145.am/db/1086673/Wintrust_Ventures>,
        <https://1145.am/db/1089416/Nexo_Ventures>,
        <https://1145.am/db/1090643/Argon_Ventures>,
        <https://1145.am/db/1090643/Glasswing_Ventures>,
        <https://1145.am/db/1101244/Acequia_Capital>,
        <https://1145.am/db/1103270/Acequia_Capital>,
        <https://1145.am/db/1106082/Northpond_Ventures>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1111505/Nissay_Capital>,
        <https://1145.am/db/1111505/Remiges_Ventures>,
        <https://1145.am/db/1112074/Nissay_Capital>,
        <https://1145.am/db/1112074/Remiges_Ventures>,
        <https://1145.am/db/1114979/Catapult_Ventures>,
        <https://1145.am/db/1115103/Northpond_Ventures>,
        <https://1145.am/db/1119456/Truist_Ventures>,
        <https://1145.am/db/1119699/Prelude_Ventures>,
        <https://1145.am/db/1120030/Morpheus_Ventures>,
        <https://1145.am/db/1120030/Point72_Ventures>,
        <https://1145.am/db/1120071/Morpheus_Ventures>,
        <https://1145.am/db/1120071/Point72_Ventures>,
        <https://1145.am/db/1122750/Prelude_Ventures>,
        <https://1145.am/db/1129561/Redbeard_Ventures>,
        <https://1145.am/db/1130744/Redbeard_Ventures>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1134165/Boldstart_Ventures>,
        <https://1145.am/db/1136173/Boldstart_Ventures>,
        <https://1145.am/db/1137178/CRV>,
        <https://1145.am/db/1138154/Ggv_Capital>,
        <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1140286/Origin_Ventures>,
        <https://1145.am/db/1141736/Redpoint_Ventures>,
        <https://1145.am/db/1150154/Riv_Capital>,
        <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1150529/Solasta_Ventures>,
        <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1151736/True_Ventures>,
        <https://1145.am/db/1152929/Aperiamventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1154242/True_Ventures>,
        <https://1145.am/db/1163139/Sentiero_Ventures>,
        <https://1145.am/db/1163139/Skyriver_Ventures>,
        <https://1145.am/db/1164299/Lavrock_Ventures>,
        <https://1145.am/db/1164299/Progress_Ventures>,
        <https://1145.am/db/1164688/Abstract_Ventures>,
        <https://1145.am/db/1164688/Spacecadet_Ventures>,
        <https://1145.am/db/1164845/Lavrock_Ventures>,
        <https://1145.am/db/1164845/Progress_Ventures>,
        <https://1145.am/db/1165515/G2_Group_Ventures>,
        <https://1145.am/db/1166154/Allos_Ventures>,
        <https://1145.am/db/1166957/Seedil_Ventures>,
        <https://1145.am/db/1168757/Accomplice_Ventures>,
        <https://1145.am/db/1169687/Artiman_Ventures>,
        <https://1145.am/db/1169687/J_Ventures>,
        <https://1145.am/db/1169687/Nd_Capital>,
        <https://1145.am/db/1169815/Accomplice_Ventures>,
        <https://1145.am/db/1170971/Equinor_Ventures>,
        <https://1145.am/db/1173428/Equinor_Ventures>,
        <https://1145.am/db/1175576/Divcowest_Ventures>,
        <https://1145.am/db/1175576/Point72_Ventures>,
        <https://1145.am/db/1175576/Signia_Ventures>,
        <https://1145.am/db/1176018/First_Star_Ventures>,
        <https://1145.am/db/1187600/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/11887/Adv>,
        <https://1145.am/db/1190097/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/1190127/Animo_Ventures>,
        <https://1145.am/db/1190127/Chaac_Ventures>,
        <https://1145.am/db/1190127/Ulu_Ventures>,
        <https://1145.am/db/1196068/Arthur_Ventures>,
        <https://1145.am/db/1196728/Greatpoint_Ventures>,
        <https://1145.am/db/1199177/Greatpoint_Ventures>,
        <https://1145.am/db/1199182/Boxone_Ventures>,
        <https://1145.am/db/1202673/Basecamp_Ventures>,
        <https://1145.am/db/1203180/Basecamp_Ventures>,
        <https://1145.am/db/1206820/Tenoneten_Ventures>,
        <https://1145.am/db/1208519/Tappanhill_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1208749/Keshif_Ventures>,
        <https://1145.am/db/1208749/Tenoneten_Ventures>,
        <https://1145.am/db/1213076/Equinor_Ventures>,
        <https://1145.am/db/1213076/Scf_Ventures>,
        <https://1145.am/db/1213119/Nevcaut_Ventures>,
        <https://1145.am/db/1215930/Northpond_Ventures>,
        <https://1145.am/db/1219982/Soma_Ventures>,
        <https://1145.am/db/1221237/C2_Ventures>,
        <https://1145.am/db/1222789/Glasswing_Ventures>,
        <https://1145.am/db/1232497/Droia_Ventures>,
        <https://1145.am/db/1232497/Gv>,
        <https://1145.am/db/1233314/Citta_Capital>,
        <https://1145.am/db/1236549/Adit_Ventures>,
        <https://1145.am/db/1247755/Sinewave_Ventures>,
        <https://1145.am/db/1247761/Clear_Ventures>,
        <https://1145.am/db/1248631/Sinewave_Ventures>,
        <https://1145.am/db/1252447/Gaingels>,
        <https://1145.am/db/1256269/Ampd_Ventures_Inc>,
        <https://1145.am/db/1264028/K3_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1268150/Pender_Ventures>,
        <https://1145.am/db/1269968/Abstract_Ventures>,
        <https://1145.am/db/1272468/Launchpad_Capital>,
        <https://1145.am/db/1279264/Roosh_Ventures>,
        <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1282820/Agya_Ventures>,
        <https://1145.am/db/1286872/Morevc>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1297417/Bitkraft_Ventures>,
        <https://1145.am/db/1299578/Seedtob_Capital>,
        <https://1145.am/db/1307620/Inventus_Capital_Partners>,
        <https://1145.am/db/1311917/Avid_Ventures>,
        <https://1145.am/db/1311917/Canapi_Ventures>,
        <https://1145.am/db/1322441/Solana_Ventures>,
        <https://1145.am/db/1326376/Dexcom_Ventures>,
        <https://1145.am/db/1329887/Peter_Nagar>,
        <https://1145.am/db/1331691/Pelion_Ventures>,
        <https://1145.am/db/1332798/Acrobator_Ventures>,
        <https://1145.am/db/1334186/First_Ascent_Ventures>,
        <https://1145.am/db/1334193/Version_One_Ventures>,
        <https://1145.am/db/1334395/Gv>,
        <https://1145.am/db/1334895/Soleus_Capital>,
        <https://1145.am/db/1335073/Yl_Ventures>,
        <https://1145.am/db/1335080/Dorilton_Ventures>,
        <https://1145.am/db/1344240/Neotribe_Ventures>,
        <https://1145.am/db/1352420/Vamos_Ventures>,
        <https://1145.am/db/1353145/Infinity_Ventures>,
        <https://1145.am/db/1362743/Cobalt_Ventures>,
        <https://1145.am/db/1373683/BGV>,
        <https://1145.am/db/1375916/J2_Ventures>,
        <https://1145.am/db/1376353/J2_Ventures>,
        <https://1145.am/db/1378599/Menlo_Ventures>,
        <https://1145.am/db/1381832/Northpond_Ventures>,
        <https://1145.am/db/1382787/Northpond_Ventures>,
        <https://1145.am/db/1383818/Newlin_Ventures>,
        <https://1145.am/db/1387557/Naventures>,
        <https://1145.am/db/138878/Metacartel_Ventures>,
        <https://1145.am/db/1398057/Owen_Van_Natta_Temaris___Associates>,
        <https://1145.am/db/1398917/Trousdale_Ventures>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1407614/C2_Ventures>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1411934/Riptide_Ventures>,
        <https://1145.am/db/1425749/Menlo_Ventures>,
        <https://1145.am/db/1425749/Se_Ventures>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1445378/Mvp_Ventures>,
        <https://1145.am/db/1445935/Verissimo_Ventures>,
        <https://1145.am/db/1449316/+Nd_Capital>,
        <https://1145.am/db/1449740/Mistral_Ventures>,
        <https://1145.am/db/1452107/Abstract_Ventures>,
        <https://1145.am/db/1455216/Engage_Ventures>,
        <https://1145.am/db/1455616/Abstract_Ventures>,
        <https://1145.am/db/1463829/1sharpe_Ventures>,
        <https://1145.am/db/1467693/Preseed_Ventures>,
        <https://1145.am/db/1467892/M_Ventures>,
        <https://1145.am/db/1467932/Sequoia_Capital_Gv>,
        <https://1145.am/db/1468981/Preseed_Ventures>,
        <https://1145.am/db/1476448/Origin_Ventures>,
        <https://1145.am/db/1480152/True_Ventures>,
        <https://1145.am/db/1480651/Glasswing_Ventures>,
        <https://1145.am/db/1480989/Infinity_Ventures>,
        <https://1145.am/db/1481875/Infinity_Ventures>,
        <https://1145.am/db/1482705/Oif_Ventures>,
        <https://1145.am/db/1484103/Boxone_Ventures>,
        <https://1145.am/db/1484857/Iu_Ventures>,
        <https://1145.am/db/1488858/Alkeon_Capital>,
        <https://1145.am/db/1490126/Seedtob_Capital>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490978/Seedtob_Capital>,
        <https://1145.am/db/1492889/Future_Ventures>,
        <https://1145.am/db/1492889/Radical_Ventures>,
        <https://1145.am/db/1494028/Alkeon_Capital>,
        <https://1145.am/db/1496360/Realist_Ventures>,
        <https://1145.am/db/1503768/Nevateam_Partners>,
        <https://1145.am/db/1508325/Aramco_Ventures>,
        <https://1145.am/db/1509462/F7_Ventures>,
        <https://1145.am/db/1512891/Acme_Capital>,
        <https://1145.am/db/1515109/Cmfg_Ventures>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1520070/Menlo_Ventures>,
        <https://1145.am/db/1520070/Northpond_Ventures>,
        <https://1145.am/db/1520772/January_Ventures>,
        <https://1145.am/db/1537166/Catalio_Capital_Management>,
        <https://1145.am/db/1537970/Catalio_Capital_Management>,
        <https://1145.am/db/1541308/Panoramic_Ventures>,
        <https://1145.am/db/1541797/G1_Ventures>,
        <https://1145.am/db/1545833/Alerion_Ventures>,
        <https://1145.am/db/1545994/Noemis_Ventures>,
        <https://1145.am/db/1546945/Alerion_Ventures>,
        <https://1145.am/db/1546965/Citi_Ventures>,
        <https://1145.am/db/1546965/Truist_Ventures>,
        <https://1145.am/db/1547281/Noemis_Ventures>,
        <https://1145.am/db/1548592/Gopoint_Ventures>,
        <https://1145.am/db/1556397/Dnx_Ventures>,
        <https://1145.am/db/1556442/C16_Ventures>,
        <https://1145.am/db/1557877/Embark_Ventures>,
        <https://1145.am/db/1559824/Embark_Ventures>,
        <https://1145.am/db/1560704/Breaktrail_Ventures>,
        <https://1145.am/db/1563623/Amex_Ventures>,
        <https://1145.am/db/1564049/Amex_Ventures>,
        <https://1145.am/db/1571330/Seae_Ventures>,
        <https://1145.am/db/1571330/Venturesouth>,
        <https://1145.am/db/1572216/Seae_Ventures>,
        <https://1145.am/db/1572216/Venturesouth>,
        <https://1145.am/db/1574557/True_Ventures>,
        <https://1145.am/db/1574647/Vanterra_Ventures>,
        <https://1145.am/db/1575612/Interlace_Ventures>,
        <https://1145.am/db/1575612/Valia_Ventures>,
        <https://1145.am/db/1578178/N49p>,
        <https://1145.am/db/1578178/Naventures>,
        <https://1145.am/db/1578327/Crit_Ventures>,
        <https://1145.am/db/1578327/Nextview_Ventures>,
        <https://1145.am/db/1579770/Schams_Ventures>,
        <https://1145.am/db/1579792/Crit_Ventures>,
        <https://1145.am/db/1579792/Nextview_Ventures>,
        <https://1145.am/db/1580468/Cohort_Ventures>,
        <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1582111/Forepont_Capital_Partners>,
        <https://1145.am/db/1583413/Navigare_Ventures>,
        <https://1145.am/db/1615195/Digitalis_Ventures>,
        <https://1145.am/db/1616990/Digitalis_Ventures>,
        <https://1145.am/db/1632002/Catalio_Capital_Management>,
        <https://1145.am/db/1632028/Catalio_Capital_Management>,
        <https://1145.am/db/1632131/Catalio_Capital_Management>,
        <https://1145.am/db/1632156/Catalio_Capital_Management>,
        <https://1145.am/db/1638640/1digi_Ventures>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1653506/Ascendum_Capital>,
        <https://1145.am/db/1653506/Citta_Capital>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1664837/Civilization_Ventures>,
        <https://1145.am/db/1664948/Dreamit_Ventures>,
        <https://1145.am/db/1669908/Aviso_Ventures>,
        <https://1145.am/db/1670128/Primary_Ventures>,
        <https://1145.am/db/1676513/Connect_Ventures>,
        <https://1145.am/db/1685482/Lavrock_Ventures>,
        <https://1145.am/db/1690703/Arkam_Ventures>,
        <https://1145.am/db/1690703/Prosus_Ventures>,
        <https://1145.am/db/1691060/Veblen_Ventures>,
        <https://1145.am/db/1691364/Ts_Ventures>,
        <https://1145.am/db/1693592/Cventures>,
        <https://1145.am/db/1693668/Sunny_Side_Ventures>,
        <https://1145.am/db/1693981/Boldstart_Ventures>,
        <https://1145.am/db/1694241/True_Ventures>,
        <https://1145.am/db/1694301/Dn_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1694448/Presidio_Ventures>,
        <https://1145.am/db/1694592/Credo_Ventures>,
        <https://1145.am/db/1694592/Susa_Ventures>,
        <https://1145.am/db/1694798/Udc_Ventures>,
        <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1695849/Salesforce_Ventures>,
        <https://1145.am/db/1695885/True_Ventures>,
        <https://1145.am/db/1697044/Palomar_Ventures>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697373/Lerer_Ventures>,
        <https://1145.am/db/1697910/Entrepia_Ventures>,
        <https://1145.am/db/1697910/Innovacom>,
        <https://1145.am/db/1698516/Engage_Ventures>,
        <https://1145.am/db/1698516/Tyh_Ventures>,
        <https://1145.am/db/1698644/Inovia_Capital>,
        <https://1145.am/db/1699263/Contour_Venture_Partners>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1700572/Contour_Venture_Partners>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702003/Ventures_West>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1702472/Chiratae_Ventures>,
        <https://1145.am/db/1702483/Sure_Ventures_Usvp>,
        <https://1145.am/db/1702517/Prime_Ventures>,
        <https://1145.am/db/1702871/Charles_River_Ventures>,
        <https://1145.am/db/1703120/Point72_Ventures>,
        <https://1145.am/db/1703551/People_Ventures>,
        <https://1145.am/db/1703907/T-Venture>,
        <https://1145.am/db/1704404/True_Ventures>,
        <https://1145.am/db/1704740/T-Venture>,
        <https://1145.am/db/1704842/Se_Ventures>,
        <https://1145.am/db/1704871/Yl_Ventures>,
        <https://1145.am/db/1705825/Ventures_Platform>,
        <https://1145.am/db/1707227/Schams_Ventures>,
        <https://1145.am/db/1707540/Prosus_Ventures>,
        <https://1145.am/db/1707567/Contour_Venture_Partners>,
        <https://1145.am/db/1707567/Reign_Ventures>,
        <https://1145.am/db/1707637/Resolute_Ventures>,
        <https://1145.am/db/1707736/Artiman_Ventures>,
        <https://1145.am/db/1708555/20vc>,
        <https://1145.am/db/1708903/Kaedan_Capital>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1710027/Contour_Venture_Partners>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1711383/Aviso_Ventures>,
        <https://1145.am/db/1711383/Pelion_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1711790/CRV>,
        <https://1145.am/db/1711849/K20_Ventures>,
        <https://1145.am/db/1712471/Cervin_Ventures>,
        <https://1145.am/db/1713712/Grotech_Ventures>,
        <https://1145.am/db/1714098/Charles_River_Ventures>,
        <https://1145.am/db/1714148/Ulu_Ventures>,
        <https://1145.am/db/1714624/Abstract_Ventures>,
        <https://1145.am/db/1714630/January_Ventures>,
        <https://1145.am/db/1716124/Appian_Ventures>,
        <https://1145.am/db/1716168/Onset_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1718012/Presidio_Ventures>,
        <https://1145.am/db/1718018/Ggv_Capital>,
        <https://1145.am/db/1718081/Jafco_Ventures>,
        <https://1145.am/db/1718748/Truist_Ventures>,
        <https://1145.am/db/1718787/J_Ventures>,
        <https://1145.am/db/1719362/True_Ventures>,
        <https://1145.am/db/1719370/Bv_Capital>,
        <https://1145.am/db/1720145/Bessemer_Ventures>,
        <https://1145.am/db/1720182/Convivialit_Ventures>,
        <https://1145.am/db/1720441/Origin_Ventures>,
        <https://1145.am/db/1721171/Citi_Ventures>,
        <https://1145.am/db/1721392/Redpoint_Ventures>,
        <https://1145.am/db/1721393/Trinity_Ventures>,
        <https://1145.am/db/1721548/Ggv_Capital>,
        <https://1145.am/db/1721548/Menlo_Ventures>,
        <https://1145.am/db/1722252/Onset_Ventures>,
        <https://1145.am/db/1723165/Menlo_Ventures>,
        <https://1145.am/db/1723664/T-Venture>,
        <https://1145.am/db/1723932/Citi_Ventures>,
        <https://1145.am/db/1724979/Jafco_Ventures>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726088/Zeev_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1726544/Ei_Ventures>,
        <https://1145.am/db/1727288/Sozo_Ventures>,
        <https://1145.am/db/1728569/Redpoint_Ventures>,
        <https://1145.am/db/1729186/Catamount_Ventures>,
        <https://1145.am/db/1731187/Rho_Ventures>,
        <https://1145.am/db/1731419/Redpoint_Ventures>,
        <https://1145.am/db/1734104/Alpana_Ventures>,
        <https://1145.am/db/1734104/Highsage_Ventures>,
        <https://1145.am/db/1734728/Talis_Capital>,
        <https://1145.am/db/1735194/Eqt_Ventures>,
        <https://1145.am/db/1735248/Corigin_Ventures>,
        <https://1145.am/db/1735726/Nextview_Ventures>,
        <https://1145.am/db/1735755/Firebolt_Ventures>,
        <https://1145.am/db/1735774/Alpha4_Ventures>,
        <https://1145.am/db/1736136/Ggv_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1737392/Moxxie_Ventures>,
        <https://1145.am/db/1737979/CRV>,
        <https://1145.am/db/1738162/3one4_Capital>,
        <https://1145.am/db/1738300/Chryscapital>,
        <https://1145.am/db/1738415/Capnamic_Ventures>,
        <https://1145.am/db/1738444/Prosus_Ventures>,
        <https://1145.am/db/1738776/Illuminate_Ventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1739042/Experior_Venture_Fund>,
        <https://1145.am/db/1739064/Jsw_Ventures>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1739630/Redsea_Ventures>,
        <https://1145.am/db/1739719/Seedplus>,
        <https://1145.am/db/1739851/Signum_Capital>,
        <https://1145.am/db/1739909/Root_Ventures>,
        <https://1145.am/db/1739946/Dn_Capital>,
        <https://1145.am/db/1740077/3one4_Capital>,
        <https://1145.am/db/1740665/First_Bridge_Ventures>,
        <https://1145.am/db/1740832/J_Ventures>,
        <https://1145.am/db/1740832/Susa_Ventures>,
        <https://1145.am/db/1740859/Ggv_Capital>,
        <https://1145.am/db/1741357/Dn_Capital>,
        <https://1145.am/db/1741575/Addventure>,
        <https://1145.am/db/1741635/Zeev_Ventures>,
        <https://1145.am/db/1742267/Firebolt_Ventures>,
        <https://1145.am/db/1742267/Point72_Ventures>,
        <https://1145.am/db/1743271/Liil_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1743409/Dreamit_Ventures>,
        <https://1145.am/db/1743737/Regah_Ventures>,
        <https://1145.am/db/1744229/R7>,
        <https://1145.am/db/1744775/Point72_Ventures>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1744922/Agla_Ventures>,
        <https://1145.am/db/1745326/Eqt_Ventures>,
        <https://1145.am/db/1745326/Lios_Ventures>,
        <https://1145.am/db/1745326/Prime_Ventures>,
        <https://1145.am/db/1745746/Garuda_Ventures>,
        <https://1145.am/db/1745746/Starling_Ventures>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1747252/Citi_Ventures>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747400/Eqt_Ventures>,
        <https://1145.am/db/1747503/Brighteye_Ventures>,
        <https://1145.am/db/1747722/Shinhan_Capital>,
        <https://1145.am/db/1747943/Altai_Ventures>,
        <https://1145.am/db/1748417/Zeev_Ventures>,
        <https://1145.am/db/1749226/Dn_Capital>,
        <https://1145.am/db/1749425/Ac_Ventures>,
        <https://1145.am/db/1749651/Colle_Capital>,
        <https://1145.am/db/1749911/Khwarizmi_Ventures>,
        <https://1145.am/db/1750942/Celesta_Capital>,
        <https://1145.am/db/1750942/Chiratae_Ventures>,
        <https://1145.am/db/1751135/Inovia_Capital>,
        <https://1145.am/db/1751312/Abstract_Ventures>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1751506/Ggv_Capital>,
        <https://1145.am/db/1751551/Gaingels>,
        <https://1145.am/db/1751553/Canapi_Ventures>,
        <https://1145.am/db/1751743/Intudo_Ventures>,
        <https://1145.am/db/1751800/Morpheus_Ventures>,
        <https://1145.am/db/1751954/Novastar_Ventures>,
        <https://1145.am/db/1752102/Origin_Ventures>,
        <https://1145.am/db/1752403/Yl_Ventures>,
        <https://1145.am/db/1752998/Agla_Ventures>,
        <https://1145.am/db/1753704/Apex_Ventures>,
        <https://1145.am/db/1753721/Financial_Venture_Studio>,
        <https://1145.am/db/1753721/Resolute_Ventures>,
        <https://1145.am/db/1753745/2i_Ventures>,
        <https://1145.am/db/1754211/Citi_Ventures>,
        <https://1145.am/db/1754211/Menlo_Ventures>,
        <https://1145.am/db/1754242/Gsv_Ventures>,
        <https://1145.am/db/1754595/Global_Ventures>,
        <https://1145.am/db/1754595/Otg_Ventures>,
        <https://1145.am/db/1754751/Menlo_Ventures>,
        <https://1145.am/db/1754787/Letsventure>,
        <https://1145.am/db/1754997/Alkeon_Capital>,
        <https://1145.am/db/1755086/Kollective_Ventures>,
        <https://1145.am/db/1755278/Zeev_Ventures>,
        <https://1145.am/db/1755704/Promus_Ventures>,
        <https://1145.am/db/1755828/Future_Ventures>,
        <https://1145.am/db/1755860/Dg_Ventures>,
        <https://1145.am/db/1755860/Intudo_Ventures>,
        <https://1145.am/db/1756040/Altos_Ventures>,
        <https://1145.am/db/1756094/CRV>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1756326/Neotribe_Ventures>,
        <https://1145.am/db/1756384/Abstract_Ventures>,
        <https://1145.am/db/1756384/Lightspeed_Ventures>,
        <https://1145.am/db/1756599/True_Ventures>,
        <https://1145.am/db/1757035/Vectr_Ventures>,
        <https://1145.am/db/1757365/Will_Ventures>,
        <https://1145.am/db/1757382/Gl_Ventures>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1757772/Lorimer_Ventures>,
        <https://1145.am/db/1758193/Tenoneten_Ventures>,
        <https://1145.am/db/1758193/Valia_Ventures>,
        <https://1145.am/db/1758313/Venture_Field>,
        <https://1145.am/db/1758622/Oca_Ventures>,
        <https://1145.am/db/1759048/Avid_Ventures>,
        <https://1145.am/db/1759048/Lightspeed_Ventures>,
        <https://1145.am/db/1759567/J_Ventures>,
        <https://1145.am/db/1759922/Verance_Capital>,
        <https://1145.am/db/1760383/True_Ventures>,
        <https://1145.am/db/1760520/Prologis_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1760985/Frontier_Ventures>,
        <https://1145.am/db/1761126/Redpoint_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761607/Menlo_Ventures>,
        <https://1145.am/db/1761607/Sinewave_Ventures>,
        <https://1145.am/db/1761957/Alkeon_Capital>,
        <https://1145.am/db/1761999/Ggv_Capital>,
        <https://1145.am/db/1762031/Menlo_Ventures>,
        <https://1145.am/db/1762055/Altos_Ventures>,
        <https://1145.am/db/1762277/Ac_Ventures>,
        <https://1145.am/db/1762453/Line_Ventures>,
        <https://1145.am/db/1762561/Grotech_Ventures>,
        <https://1145.am/db/1762669/Creandum>,
        <https://1145.am/db/1762844/Signum_Capital>,
        <https://1145.am/db/1763356/Agla_Ventures>,
        <https://1145.am/db/1763371/Spacecadet_Ventures>,
        <https://1145.am/db/1763395/Idc_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763774/Ggv_Capital>,
        <https://1145.am/db/1763795/Ventures_Platform>,
        <https://1145.am/db/1763795/Xyz_Ventures>,
        <https://1145.am/db/1763875/Golden_Gate_Ventures>,
        <https://1145.am/db/1764027/Menlo_Ventures>,
        <https://1145.am/db/1764255/Pathbreaker_Ventures>,
        <https://1145.am/db/1764255/Stageone_Ventures>,
        <https://1145.am/db/1764345/Talis_Capital>,
        <https://1145.am/db/1764527/Presidio_Ventures>,
        <https://1145.am/db/1764527/Yl_Ventures>,
        <https://1145.am/db/1765273/Adevinta_Ventures>,
        <https://1145.am/db/1765273/Venturefriends>,
        <https://1145.am/db/1765372/Irobot_Ventures>,
        <https://1145.am/db/1765377/Redpoint_Ventures>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1765646/Amiti_Ventures>,
        <https://1145.am/db/1765673/Salesforce_Ventures>,
        <https://1145.am/db/1766091/Inreach_Ventures>,
        <https://1145.am/db/1766096/Borealis_Ventures>,
        <https://1145.am/db/1766096/Northpond_Ventures>,
        <https://1145.am/db/1766253/Redpoint_Ventures>,
        <https://1145.am/db/1766253/True_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1766978/Rga_Ventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1768363/Golden_Gate_Ventures>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1770139/Victress_Capital>,
        <https://1145.am/db/1770265/Techstars_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1770372/Korelya_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1770982/Gv>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771011/Ggv_Capital>,
        <https://1145.am/db/1771548/Seekdource_Capital>,
        <https://1145.am/db/1771613/Creandum>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1772004/Raed_Ventures>,
        <https://1145.am/db/1772004/Seed_Equity_Venture_Partners>,
        <https://1145.am/db/1772381/Altos_Ventures>,
        <https://1145.am/db/1772452/Connect_Ventures>,
        <https://1145.am/db/1773130/Capnamic_Ventures>,
        <https://1145.am/db/1773143/Venturefriends>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1774348/True_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1774535/Susa_Ventures>,
        <https://1145.am/db/1774658/Gv>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776340/Ggv_Capital>,
        <https://1145.am/db/1776340/Menlo_Ventures>,
        <https://1145.am/db/1776537/Origin_Ventures>,
        <https://1145.am/db/1776537/Tekton_Ventures>,
        <https://1145.am/db/1776621/Redpoint_Ventures>,
        <https://1145.am/db/1777289/Dn_Capital>,
        <https://1145.am/db/1777563/Evolv_Ventures>,
        <https://1145.am/db/1777563/Ggv_Capital>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1778935/Oryzn_Capital>,
        <https://1145.am/db/1780024/Partech_Ventures>,
        <https://1145.am/db/1782098/Addventure>,
        <https://1145.am/db/1782221/Point72_Ventures>,
        <https://1145.am/db/1783189/Citi_Ventures>,
        <https://1145.am/db/1784644/Creathor_Ventures>,
        <https://1145.am/db/1784964/Clear_Ventures>,
        <https://1145.am/db/1785361/M_Ventures>,
        <https://1145.am/db/1786249/Redpoint_Ventures>,
        <https://1145.am/db/1786249/Resolute_Ventures>,
        <https://1145.am/db/1786663/Edenred_Capital_Partners>,
        <https://1145.am/db/1786663/Eqt_Ventures>,
        <https://1145.am/db/1787249/Kpn_Ventures>,
        <https://1145.am/db/1787342/Korelya_Capital>,
        <https://1145.am/db/1787536/Point72_Ventures>,
        <https://1145.am/db/1787791/True_Ventures>,
        <https://1145.am/db/1787886/True_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1788726/Redbeat_Capital>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789754/Advancit_Capital>,
        <https://1145.am/db/1790280/Arthur_Ventures>,
        <https://1145.am/db/1790399/Capnamic_Ventures>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1790574/Red_Swan_Ventures>,
        <https://1145.am/db/1790574/Sherpa_Ventures>,
        <https://1145.am/db/1790641/Dn_Capital>,
        <https://1145.am/db/1790771/Redpoint_Ventures>,
        <https://1145.am/db/1790777/Connect_Ventures>,
        <https://1145.am/db/1791216/True_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1791838/Advancit_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792771/Softtechvc>,
        <https://1145.am/db/1792887/Kaedan_Capital>,
        <https://1145.am/db/1792887/Stageone_Ventures>,
        <https://1145.am/db/1794699/Ws_Ventures>,
        <https://1145.am/db/1794935/Intervest_Co_Ltd>,
        <https://1145.am/db/1795020/Redpoint_Ventures>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1795538/Skystar_Capital>,
        <https://1145.am/db/1796109/Contour_Venture_Partners>,
        <https://1145.am/db/1796593/Tenoneten_Ventures>,
        <https://1145.am/db/1796901/Red_Swan_Ventures>,
        <https://1145.am/db/1796922/Cagni_Ventures>,
        <https://1145.am/db/1797209/Kdwc_Ventures>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797899/Brave_Ventures>,
        <https://1145.am/db/1797999/Redpoint_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1799099/Inovia_Capital>,
        <https://1145.am/db/1799184/Ggv_Capital>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800929/Ventureast>,
        <https://1145.am/db/1802086/High_Line_Ventures>,
        <https://1145.am/db/1802227/Advancit_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802336/Capnamic_Ventures>,
        <https://1145.am/db/1804102/True_Ventures>,
        <https://1145.am/db/1804247/Holtzbrinck_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1804476/True_Ventures>,
        <https://1145.am/db/1804992/Talis_Capital>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1805604/Connect_Ventures>,
        <https://1145.am/db/1805604/Inreach_Ventures>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1806739/Golden_Gate_Ventures>,
        <https://1145.am/db/1808047/Salesforce_Ventures>,
        <https://1145.am/db/1808505/Helion_Ventures>,
        <https://1145.am/db/1808723/Mindworks_Ventures>,
        <https://1145.am/db/1808735/Commonangels_Ventures>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809844/Real_Ventures>,
        <https://1145.am/db/1809862/Acequia_Capital>,
        <https://1145.am/db/1810384/Starstrike_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1810714/Catalus_Capital>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1812856/Exfinity_Ventures>,
        <https://1145.am/db/1813375/Creandum>,
        <https://1145.am/db/1813575/Ggv_Capital>,
        <https://1145.am/db/1813944/Menlo_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1814643/Corigin_Ventures>,
        <https://1145.am/db/1814643/Launchcapital>,
        <https://1145.am/db/1815038/Plus_Ventures>,
        <https://1145.am/db/1815507/Globis_Capital_Partners>,
        <https://1145.am/db/1815697/Cherubic_Ventures>,
        <https://1145.am/db/1815701/True_Ventures>,
        <https://1145.am/db/1815886/Teneleven_Ventures>,
        <https://1145.am/db/1816491/Grotech_Ventures>,
        <https://1145.am/db/1818174/Advancit_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1819374/Rothenberg_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1820882/Inven_Capital>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1821711/Winton_Ventures>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1823162/True_Ventures>,
        <https://1145.am/db/1823217/Kdc_Ventures>,
        <https://1145.am/db/1823217/Nbm_Ventures>,
        <https://1145.am/db/1823684/Dcm_Ventures>,
        <https://1145.am/db/1823684/Idg_Ventures>,
        <https://1145.am/db/1824252/Allos_Ventures>,
        <https://1145.am/db/1824253/Trinity_Ventures>,
        <https://1145.am/db/1824944/True_Ventures>,
        <https://1145.am/db/1825465/Ben_Narasin>,
        <https://1145.am/db/1825713/Menlo_Ventures>,
        <https://1145.am/db/1825946/Lerer_Ventures>,
        <https://1145.am/db/1826265/Idg_Ventures>,
        <https://1145.am/db/1826648/True_Ventures>,
        <https://1145.am/db/1826922/Ggv_Capital>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828036/Redpoint_Ventures>,
        <https://1145.am/db/1828092/Eden_Ventures>,
        <https://1145.am/db/1828251/Golden_Gate_Ventures>,
        <https://1145.am/db/1828455/Quotidien_Ventures>,
        <https://1145.am/db/1828658/Focus_Ventures>,
        <https://1145.am/db/1828663/Great_Oaks_Ventures>,
        <https://1145.am/db/1828663/Inovia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1829422/Rothenberg_Ventures>,
        <https://1145.am/db/1829612/Lerer_Ventures>,
        <https://1145.am/db/1830502/Frontline_Ventures>,
        <https://1145.am/db/1830613/True_Ventures>,
        <https://1145.am/db/1830809/Numecent>,
        <https://1145.am/db/1830809/T-Ventures>,
        <https://1145.am/db/1830817/Charles_River_Ventures>,
        <https://1145.am/db/1831577/Artiman_Ventures>,
        <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832038/True_Ventures>,
        <https://1145.am/db/1832316/Partech_Ventures>,
        <https://1145.am/db/1832316/Scentan_Ventures>,
        <https://1145.am/db/1832316/Startcaps_Ventures>,
        <https://1145.am/db/1832856/Grotech_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834224/Orix_Ventures>,
        <https://1145.am/db/1834305/Charles_River_Ventures>,
        <https://1145.am/db/1834334/Altos_Ventures>,
        <https://1145.am/db/1834334/Baseline_Ventures>,
        <https://1145.am/db/1834334/Firebolt_Ventures>,
        <https://1145.am/db/1834334/Lazerow_Ventures>,
        <https://1145.am/db/1834520/Ben_Horowitz>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1834708/Sherpa_Ventures>,
        <https://1145.am/db/1834965/Lerer_Ventures>,
        <https://1145.am/db/1835229/Lerer_Ventures>,
        <https://1145.am/db/1835229/Trinity_Ventures>,
        <https://1145.am/db/1835229/Xg_Ventures>,
        <https://1145.am/db/1835740/Lerer_Ventures>,
        <https://1145.am/db/1835749/Gree_Ventures>,
        <https://1145.am/db/1835825/Focus_Ventures>,
        <https://1145.am/db/1836984/Siemer_Ventures>,
        <https://1145.am/db/1836984/Tekton_Ventures>,
        <https://1145.am/db/1837741/Menlo_Ventures>,
        <https://1145.am/db/1838026/Plus_Ventures>,
        <https://1145.am/db/1840775/Ggv_Capital>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1840881/Trinity_Ventures>,
        <https://1145.am/db/1841176/Lerer_Ventures>,
        <https://1145.am/db/1841176/True_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1842402/Redpoint_Ventures>,
        <https://1145.am/db/1842898/Grotech_Ventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1843449/Redpoint_Ventures>,
        <https://1145.am/db/1843602/Nextview_Ventures>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844143/Inovia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1844737/True_Ventures>,
        <https://1145.am/db/1844931/Charles_River_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1845960/Lerer_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846483/Inovia_Capital>,
        <https://1145.am/db/1847463/Prism_Ventureworks>,
        <https://1145.am/db/1847752/T-Venture>,
        <https://1145.am/db/1848523/Trinity_Ventures>,
        <https://1145.am/db/1849673/Inventure_Partners>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849949/Holtzbrinck_Ventures>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850668/True_Ventures>,
        <https://1145.am/db/1850989/Artiman_Ventures>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851035/Acequia_Capital>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851035/Redpoint_Ventures>,
        <https://1145.am/db/1851705/Promus_Ventures>,
        <https://1145.am/db/1851854/Partech_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1852308/Plus_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Trestle_Ventures>,
        <https://1145.am/db/1852556/Dave_Morin>,
        <https://1145.am/db/1852806/Redpoint_Ventures>,
        <https://1145.am/db/1852870/Golden_Gate_Ventures>,
        <https://1145.am/db/1852870/Siemer_Ventures>,
        <https://1145.am/db/1853417/Catamount_Ventures>,
        <https://1145.am/db/1853496/T-Ventures>,
        <https://1145.am/db/1854200/Ggv_Capital>,
        <https://1145.am/db/1854201/Charles_River_Ventures>,
        <https://1145.am/db/1854786/Eden_Ventures>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1854874/Sherpa_Ventures>,
        <https://1145.am/db/1854874/Softtech>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1855363/True_Ventures>,
        <https://1145.am/db/1855403/Rho_Ventures>,
        <https://1145.am/db/1855780/Bds_Ventures>,
        <https://1145.am/db/1855780/Ggv_Capital>,
        <https://1145.am/db/1856191/Creandum>,
        <https://1145.am/db/1856380/Softtech>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1856616/Redpoint_Ventures>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1857635/Rikard_Steiber>,
        <https://1145.am/db/1857659/Revolution_Ventures>,
        <https://1145.am/db/1857930/Inovia_Capital>,
        <https://1145.am/db/1857930/Version_One_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858592/Apex_Venture_Partners>,
        <https://1145.am/db/1858592/Origin_Ventures>,
        <https://1145.am/db/1858991/Capnamic_Ventures>,
        <https://1145.am/db/1859199/True_Ventures>,
        <https://1145.am/db/1859314/Version_One_Ventures>,
        <https://1145.am/db/1860163/Inovia_Capital>,
        <https://1145.am/db/1860345/Commonangels>,
        <https://1145.am/db/1860345/Launchcapital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1861355/Rho_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1863147/Apex_Venture_Partners>,
        <https://1145.am/db/1864601/Trinity_Ventures>,
        <https://1145.am/db/1864646/Inventus_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sherpalo_Ventures>,
        <https://1145.am/db/1866032/Launchcapital>,
        <https://1145.am/db/1866134/Embarcadero_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866155/Presidio_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867599/Cava_Capital>,
        <https://1145.am/db/1868107/Redpoint_Ventures>,
        <https://1145.am/db/1868109/Charles_River_Ventures>,
        <https://1145.am/db/1868178/True_Ventures>,
        <https://1145.am/db/1870015/Redpoint_Ventures>,
        <https://1145.am/db/1870465/Nextview_Ventures>,
        <https://1145.am/db/1871221/True_Ventures>,
        <https://1145.am/db/1871574/Redpoint_Ventures>,
        <https://1145.am/db/1871777/Charles_River_Ventures>,
        <https://1145.am/db/1871784/Charles_River_Ventures>,
        <https://1145.am/db/1871888/Charles_River_Ventures>,
        <https://1145.am/db/1873191/El_Dorado_Ventures>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1873680/Lerer_Ventures>,
        <https://1145.am/db/1873680/Xg_Ventures>,
        <https://1145.am/db/1874749/True_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1877283/Northzone_Ventures>,
        <https://1145.am/db/1877473/True_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878620/Ggv_Capital>,
        <https://1145.am/db/1879279/High_Line_Ventures>,
        <https://1145.am/db/1879759/T-Venture>,
        <https://1145.am/db/1880679/Northzone_Ventures>,
        <https://1145.am/db/1881464/Ggv_Capital>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1882330/New_World_Ventures>,
        <https://1145.am/db/1882727/Charles_River_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1883568/Eden_Ventures>,
        <https://1145.am/db/1883572/Astutia_Ventures>,
        <https://1145.am/db/1886402/New_Atlantic_Ventures>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1889394/Focus_Ventures>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1890000/Lerer_Ventures>,
        <https://1145.am/db/1890122/East_Ventures>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1890133/Focus_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/1890208/Menlo_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890839/Inovia_Capital>,
        <https://1145.am/db/1890903/Miven_Ventures>,
        <https://1145.am/db/1891615/Holtzbrinck_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891913/New_World_Ventures>,
        <https://1145.am/db/1891913/Oca_Ventures>,
        <https://1145.am/db/1891926/New_World_Ventures>,
        <https://1145.am/db/1892050/Charles_River_Ventures>,
        <https://1145.am/db/1892105/Crosscreek_Capital>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1892106/Altos_Ventures>,
        <https://1145.am/db/1892106/Illuminate_Ventures>,
        <https://1145.am/db/1892620/True_Ventures>,
        <https://1145.am/db/1892674/Appian_Ventures>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1892955/Guy_Gamzu>,
        <https://1145.am/db/1895072/Nextview_Ventures>,
        <https://1145.am/db/1895951/Windward_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1896379/Redpoint_Ventures>,
        <https://1145.am/db/1896419/True_Ventures>,
        <https://1145.am/db/1902330/Baseline_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1909430/Menlo_Ventures>,
        <https://1145.am/db/1909651/Revolution_Ventures>,
        <https://1145.am/db/1910694/True_Ventures>,
        <https://1145.am/db/1910922/Charles_River_Ventures>,
        <https://1145.am/db/1912684/Charles_River_Ventures>,
        <https://1145.am/db/1913863/Tl_Ventures>,
        <https://1145.am/db/1913874/Redpoint_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1915862/Focus_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1920478/Dawntreader_Ventures>,
        <https://1145.am/db/1920837/Onset_Ventures>,
        <https://1145.am/db/1927817/Trm_Ventures>,
        <https://1145.am/db/1939926/Cobalt_Ventures>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/1947303/Cavallo_Ventures>,
        <https://1145.am/db/1947312/Boldstart_Ventures>,
        <https://1145.am/db/1952989/Singularity_Ventures>,
        <https://1145.am/db/1954147/Accomplice_Ventures>,
        <https://1145.am/db/1957179/Sozo_Ventures>,
        <https://1145.am/db/1958963/Prosus_Ventures>,
        <https://1145.am/db/1959001/Capital_Technology_Ventures>,
        <https://1145.am/db/1959001/Glasswing_Ventures>,
        <https://1145.am/db/1962819/Connetic_Ventures>,
        <https://1145.am/db/1967592/Firebolt_Ventures>,
        <https://1145.am/db/1967683/Dig_Ventures_Vine_Ventures>,
        <https://1145.am/db/1975490/Northview_Ventures>,
        <https://1145.am/db/1975547/Nanban_Ventures>,
        <https://1145.am/db/1975547/Sinewave_Ventures>,
        <https://1145.am/db/1986122/Menlo_Ventures>,
        <https://1145.am/db/1995926/Neotribe_Ventures>,
        <https://1145.am/db/1998196/Gni_Group_Ltd>,
        <https://1145.am/db/1999771/Servicenow_Ventures>,
        <https://1145.am/db/2004427/Convivialit_Ventures>,
        <https://1145.am/db/2005131/Wwventures>,
        <https://1145.am/db/2007132/Nventures>,
        <https://1145.am/db/2020041/Inovia_Capital>,
        <https://1145.am/db/2020041/TCV>,
        <https://1145.am/db/2023596/Salesforce_Ventures>,
        <https://1145.am/db/2025081/True_Ventures>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2035454/Gv>,
        <https://1145.am/db/2036021/Clear_Ventures>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/2039177/Stellantis_Ventures>,
        <https://1145.am/db/2041480/Brunnur_Ventures>,
        <https://1145.am/db/2042858/Gv>,
        <https://1145.am/db/2044380/20sales>,
        <https://1145.am/db/2045587/Veritec_Ventures>,
        <https://1145.am/db/2050229/Nventures>,
        <https://1145.am/db/2050359/At_One_Ventures>,
        <https://1145.am/db/2051164/Aviso_Ventures>,
        <https://1145.am/db/2053027/Glasswing_Ventures>,
        <https://1145.am/db/2055707/Globis_Capital_Partners>,
        <https://1145.am/db/2056931/We_Ventures>,
        <https://1145.am/db/2060003/Crit_Ventures_100___100_Ventures>,
        <https://1145.am/db/2061278/Incisive_Ventures>,
        <https://1145.am/db/2061278/Volo_Ventures>,
        <https://1145.am/db/2063642/Clear_Bridge_Ventures>,
        <https://1145.am/db/2063967/Vsquared_Ventures>,
        <https://1145.am/db/2069147/Boldstart_Ventures>,
        <https://1145.am/db/2069147/Pelion_Ventures>,
        <https://1145.am/db/2069147/Salesforce_Ventures>,
        <https://1145.am/db/2069495/Intermountain_Ventures>,
        <https://1145.am/db/2069495/Northpond_Ventures>,
        <https://1145.am/db/2073129/Abstract_Ventures>,
        <https://1145.am/db/2073132/Idc_Ventures>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2075625/Rocketship_Ventures>,
        <https://1145.am/db/2081180/S4s_Ventures>,
        <https://1145.am/db/2081674/Capital_One_Ventures>,
        <https://1145.am/db/2082068/Arctern_Ventures>,
        <https://1145.am/db/2082068/Prelude_Ventures>,
        <https://1145.am/db/2083987/Vanterra_Ventures>,
        <https://1145.am/db/2087289/Jven_Capital>,
        <https://1145.am/db/2087289/Northpond_Ventures>,
        <https://1145.am/db/2089206/Crescendo_Venture_Partners>,
        <https://1145.am/db/2093427/Yl_Ventures>,
        <https://1145.am/db/2093713/Yl_Ventures>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2100116/Epic_Ventures>,
        <https://1145.am/db/2107533/Globis_Capital_Partners>,
        <https://1145.am/db/2109529/Point72_Ventures>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2109932/Catalio_Capital_Management>,
        <https://1145.am/db/2109932/Epic_Ventures>,
        <https://1145.am/db/2109932/Intermountain_Ventures>,
        <https://1145.am/db/2109932/North_South_Ventures>,
        <https://1145.am/db/2116769/Celesta_Capital>,
        <https://1145.am/db/2116769/Chiratae_Ventures>,
        <https://1145.am/db/2123953/Amex_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2123953/Infinity_Ventures>,
        <https://1145.am/db/2124766/P1_Ventures>,
        <https://1145.am/db/2125182/Nevcaut_Ventures>,
        <https://1145.am/db/2125182/Ulu_Ventures>,
        <https://1145.am/db/2125927/1984_Ventures>,
        <https://1145.am/db/2127882/Akkadian_Ventures>,
        <https://1145.am/db/2134989/Clear_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2141183/S_Ventures>,
        <https://1145.am/db/2141328/Connetic_Ventures>,
        <https://1145.am/db/2143438/Scorpio_Capital>,
        <https://1145.am/db/2147767/Catapult_Ventures>,
        <https://1145.am/db/2147767/Tenoneten_Ventures>,
        <https://1145.am/db/2151983/CRV>,
        <https://1145.am/db/2151983/Greatpoint_Ventures>,
        <https://1145.am/db/2155426/Brighteyes_Ventures>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2164121/Menlo_Ventures>,
        <https://1145.am/db/2169799/Nwise_Ventures>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2182443/Global_Ventures>,
        <https://1145.am/db/2183352/Optum_Ventures>,
        <https://1145.am/db/2186568/Frist_Cressey_Ventures>,
        <https://1145.am/db/2186568/Springrock_Ventures>,
        <https://1145.am/db/2186949/Greatpoint_Ventures_And_Cross_Creek>,
        <https://1145.am/db/2186949/Springrock_Ventures>,
        <https://1145.am/db/2190141/Link_Ventures>,
        <https://1145.am/db/2192636/TCV>,
        <https://1145.am/db/219311/Origin_Ventures>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2208603/McKesson_Ventures>,
        <https://1145.am/db/2210557/True_Ventures>,
        <https://1145.am/db/221321/Ggv_Capital>,
        <https://1145.am/db/2214690/Idg_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2264763/True_Ventures>,
        <https://1145.am/db/2283006/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Northpond_Ventures>,
        <https://1145.am/db/2284412/Soleus_Capital>,
        <https://1145.am/db/2286665/Shanda_Group>,
        <https://1145.am/db/2288209/Echelon_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2293172/Prospect_Ventures>,
        <https://1145.am/db/2294202/Trinitas_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2295253/Arkitekt_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2296249/Proxima_Ventures>,
        <https://1145.am/db/2296869/Dcm_Ventures>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2298897/Eshelman_Ventures>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2302351/Rho_Ventures>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2302897/Ventures_West_Capital>,
        <https://1145.am/db/2303098/Seaflower_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304606/Prism_Ventureworks>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2306568/Cmea_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2309507/Rho_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2312792/Onset_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2314380/Puretech_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314515/Apjohnventures>,
        <https://1145.am/db/2315754/Arcturus_Capital>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2321856/Ventures_West_Capital_Ltd>,
        <https://1145.am/db/2323785/Eshelman_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2325015/True_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325257/Ventures_West>,
        <https://1145.am/db/2325337/Resolvyx>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/2326362/Nextech_Venture>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2328585/Cmea_Ventures>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2338023/Cipla_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338703/Wavepoint_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341942/High-Tech_Grnderfonds>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2343184/Jven_Capital>,
        <https://1145.am/db/2345017/Venture_Investments>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2346300/High-Tech_Grnderfonds>,
        <https://1145.am/db/2346452/Aescap_Venture>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346978/Ventures_West_Capital>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2357487/Savitr_Capital>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2358747/Solon_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/2362638/Launchpad_Venture_Group>,
        <https://1145.am/db/2363460/Rho_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365103/Aescap_Venture>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/238282/Carnrite_Ventures>,
        <https://1145.am/db/2400536/Capital_One_Ventures>,
        <https://1145.am/db/2423653/Venturewell>,
        <https://1145.am/db/253438/Esplanade_Ventures>,
        <https://1145.am/db/254357/Ulu_Ventures>,
        <https://1145.am/db/2549491/Ktb_Ventures>,
        <https://1145.am/db/2552636/Morningside_Ventures>,
        <https://1145.am/db/2569491/High-Tech_Grnderfonds>,
        <https://1145.am/db/2570138/Sherpa_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2603254/Salesforce_Ventures>,
        <https://1145.am/db/2628424/Verana_Networks>,
        <https://1145.am/db/2628848/Neocarta_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2638432/Nissay_Capital>,
        <https://1145.am/db/2641337/Promus_Ventures>,
        <https://1145.am/db/2641337/True_Ventures>,
        <https://1145.am/db/2654391/Biggell_Finance>,
        <https://1145.am/db/265532/Ulu_Ventures>,
        <https://1145.am/db/2702871/Inovia_Capital>,
        <https://1145.am/db/274170/G1_Ventures>,
        <https://1145.am/db/2754677/Golden_Gate_Ventures>,
        <https://1145.am/db/2765022/Garuda_Ventures>,
        <https://1145.am/db/2765030/Daniel_Ventures>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/2786411/Allegion_Ventures>,
        <https://1145.am/db/2788052/Rx_Ventures>,
        <https://1145.am/db/2790064/Novastar_Ventures>,
        <https://1145.am/db/2794396/Snowpoint_Ventures>,
        <https://1145.am/db/2797562/Menlo_Ventures>,
        <https://1145.am/db/283272/Salesforce_Ventures>,
        <https://1145.am/db/283607/Salesforce_Ventures>,
        <https://1145.am/db/293715/Signum_Capital>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/293891/Ggv_Capital>,
        <https://1145.am/db/299738/Steadfast_Capital_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/319155/Bgv_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/341984/Salesforce_Ventures>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Salesforce_Ventures>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/343459/F7_Ventures>,
        <https://1145.am/db/346598/Salesforce_Ventures>,
        <https://1145.am/db/348442/Triventures>,
        <https://1145.am/db/348659/Launchpad_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/364168/Alerion_Ventures>,
        <https://1145.am/db/367592/Gv>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/388551/Vestigo_Ventures>,
        <https://1145.am/db/396305/Real_Ventures>,
        <https://1145.am/db/402103/1776_Ventures>,
        <https://1145.am/db/402701/January_Ventures>,
        <https://1145.am/db/403810/Riverstone_Ventures>,
        <https://1145.am/db/410322/Gv>,
        <https://1145.am/db/410473/Celesta_Capital>,
        <https://1145.am/db/410473/Lytical_Ventures_And_Nepenthe_Capital>,
        <https://1145.am/db/410529/Goodyear_Ventures>,
        <https://1145.am/db/411539/Zeev_Ventures>,
        <https://1145.am/db/412020/Defi_Ventures_Inc>,
        <https://1145.am/db/415322/CRV>,
        <https://1145.am/db/416041/Akkadian_Ventures>,
        <https://1145.am/db/416041/Signia_Ventures>,
        <https://1145.am/db/416041/Zeev_Ventures>,
        <https://1145.am/db/419489/Point72_Ventures>,
        <https://1145.am/db/424877/North_First_Ventures>,
        <https://1145.am/db/425262/Yl_Ventures>,
        <https://1145.am/db/425423/True_Ventures>,
        <https://1145.am/db/425973/Will_Ventures>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/429179/C5_Capital>,
        <https://1145.am/db/430986/Cortado_Ventures>,
        <https://1145.am/db/434334/1up_Ventures>,
        <https://1145.am/db/435691/Klick_Ventures>,
        <https://1145.am/db/439819/Cavu_Ventures>,
        <https://1145.am/db/441319/Celesta_Capital>,
        <https://1145.am/db/444105/Exfinity_Ventures>,
        <https://1145.am/db/445365/Revolution_Ventures>,
        <https://1145.am/db/446341/Sinewave_Ventures>,
        <https://1145.am/db/455558/Intudo_Ventures>,
        <https://1145.am/db/457435/Alerce>,
        <https://1145.am/db/457435/Clin>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/471253/Gv>,
        <https://1145.am/db/471436/Citi_Ventures>,
        <https://1145.am/db/471504/Canapi_Ventures>,
        <https://1145.am/db/473030/Highsage_Ventures>,
        <https://1145.am/db/474928/Susa_Ventures>,
        <https://1145.am/db/478049/Worldquant_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/479113/Menlo_Ventures>,
        <https://1145.am/db/485616/K3_Ventures>,
        <https://1145.am/db/486858/Gaingels>,
        <https://1145.am/db/486901/Gaingels>,
        <https://1145.am/db/488743/Salesforce_Ventures>,
        <https://1145.am/db/491130/Raiven_Capital>,
        <https://1145.am/db/491338/Raiven_Capital>,
        <https://1145.am/db/493560/Tyh_Ventures>,
        <https://1145.am/db/495912/Regah_Ventures>,
        <https://1145.am/db/506588/Trinity_Ventures>,
        <https://1145.am/db/508145/Sora_Finance>,
        <https://1145.am/db/508161/Sora_Finance>,
        <https://1145.am/db/510565/Epic_Ventures>,
        <https://1145.am/db/513305/Avid_Ventures>,
        <https://1145.am/db/513305/Canapi_Ventures>,
        <https://1145.am/db/513897/Rlc_Ventures>,
        <https://1145.am/db/514151/Rlc_Ventures>,
        <https://1145.am/db/516396/Acequia_Capital>,
        <https://1145.am/db/517213/Acequia_Capital>,
        <https://1145.am/db/523349/Osf_Ventures>,
        <https://1145.am/db/523776/Root_Ventures>,
        <https://1145.am/db/525285/Inventum_Ventures>,
        <https://1145.am/db/525285/Optima_Ventures>,
        <https://1145.am/db/526109/Ggv_Capital>,
        <https://1145.am/db/526175/Ridgeline_Ventures>,
        <https://1145.am/db/529812/Inventum_Ventures>,
        <https://1145.am/db/529812/Optima_Ventures>,
        <https://1145.am/db/532016/Id_Ventures>,
        <https://1145.am/db/539571/Origin_Ventures>,
        <https://1145.am/db/545843/Capital_One_Ventures>,
        <https://1145.am/db/545852/Boxone_Ventures>,
        <https://1145.am/db/545852/Panache_Ventures>,
        <https://1145.am/db/547770/BGV>,
        <https://1145.am/db/547944/BGV>,
        <https://1145.am/db/554552/Konvoy_Ventures>,
        <https://1145.am/db/555193/Illumina_Ventures>,
        <https://1145.am/db/555193/Technology_Venture_Partners>,
        <https://1145.am/db/556705/Congress_Ave_Ventures>,
        <https://1145.am/db/558005/Illumina_Ventures>,
        <https://1145.am/db/558005/Technology_Venture_Partners>,
        <https://1145.am/db/558877/Falabella_Ventures>,
        <https://1145.am/db/559220/Ulu_Ventures>,
        <https://1145.am/db/561662/Redpoint_Ventures>,
        <https://1145.am/db/561662/Vandelay_Ventures>,
        <https://1145.am/db/562745/Vinmar_Ventures>,
        <https://1145.am/db/563575/Celesta_Capital>,
        <https://1145.am/db/564008/D1_Ventures>,
        <https://1145.am/db/571769/Illumina_Ventures>,
        <https://1145.am/db/571769/M_Ventures>,
        <https://1145.am/db/572097/Menlo_Ventures>,
        <https://1145.am/db/572097/Teneleven_Ventures>,
        <https://1145.am/db/575249/TCV>,
        <https://1145.am/db/576186/Konvoy_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/586525/Tenoneten_Ventures>,
        <https://1145.am/db/587038/Coparion>,
        <https://1145.am/db/591566/Morningside_Ventures>,
        <https://1145.am/db/596145/Anorak_Ventures>,
        <https://1145.am/db/596564/Anorak_Ventures>,
        <https://1145.am/db/601455/Morningside_Ventures>,
        <https://1145.am/db/603725/Ignitexl_Ventures>,
        <https://1145.am/db/606074/Fiscus_Ventures>,
        <https://1145.am/db/606144/Ggv_Capital>,
        <https://1145.am/db/615337/Companyon_Ventures>,
        <https://1145.am/db/619284/Scf_Ventures>,
        <https://1145.am/db/619366/Capital_One_Ventures>,
        <https://1145.am/db/619736/Lightspeed_Ventures>,
        <https://1145.am/db/623178/Array_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/626781/Dnx_Ventures>,
        <https://1145.am/db/627030/Launchpad_Capital>,
        <https://1145.am/db/628654/Prologis_Ventures>,
        <https://1145.am/db/633238/True_Ventures>,
        <https://1145.am/db/633869/Skywell_Capital_Partners>,
        <https://1145.am/db/633869/Stageone_Ventures>,
        <https://1145.am/db/640939/Ggv_Capital>,
        <https://1145.am/db/642123/Charles_River_Ventures>,
        <https://1145.am/db/642518/Network_Ventures>,
        <https://1145.am/db/643600/Vinco_Ventures>,
        <https://1145.am/db/648552/True_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/659675/Gv>,
        <https://1145.am/db/661747/Adit_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/665129/Ac_Ventures>,
        <https://1145.am/db/665776/Firstime_Ventures>,
        <https://1145.am/db/676217/Steelsky_Ventures>,
        <https://1145.am/db/676869/Ggv_Capital>,
        <https://1145.am/db/678140/Ggv_Capital>,
        <https://1145.am/db/678587/Lightshed_Ventures>,
        <https://1145.am/db/678593/Solana_Ventures>,
        <https://1145.am/db/687538/Kayyak_Ventures>,
        <https://1145.am/db/689460/True_Ventures>,
        <https://1145.am/db/694513/Authentic_Ventures>,
        <https://1145.am/db/694924/Avid_Ventures>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/700327/Menlo_Ventures>,
        <https://1145.am/db/700877/Gaingels>,
        <https://1145.am/db/703983/Eqventure>,
        <https://1145.am/db/704489/Eqventure>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/704753/Menlo_Ventures>,
        <https://1145.am/db/704793/Quidnet_Ventures>,
        <https://1145.am/db/704991/Gaingels>,
        <https://1145.am/db/709633/Connetic_Ventures>,
        <https://1145.am/db/726461/Contour_Ventures>,
        <https://1145.am/db/729628/Kyber_Ventures>,
        <https://1145.am/db/729628/Signum_Capital>,
        <https://1145.am/db/738920/Oca_Ventures>,
        <https://1145.am/db/738920/Susa_Ventures>,
        <https://1145.am/db/739538/Morpheus_Ventures>,
        <https://1145.am/db/739538/Oca_Ventures>,
        <https://1145.am/db/739538/Susa_Ventures>,
        <https://1145.am/db/747051/Tenoneten_Ventures>,
        <https://1145.am/db/747771/Ta_Ventures>,
        <https://1145.am/db/749147/1984_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/1984_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/750305/Yl_Ventures>,
        <https://1145.am/db/750725/Vestigo_Ventures>,
        <https://1145.am/db/751176/Maverick_Ventures>,
        <https://1145.am/db/751176/Susa_Ventures>,
        <https://1145.am/db/751387/Menlo_Ventures>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/753251/Savantus_Ventures>,
        <https://1145.am/db/753913/Brunnur_Ventures>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/758206/Great_North_Ventures>,
        <https://1145.am/db/758206/Grotech_Ventures>,
        <https://1145.am/db/759749/Cava_Capital>,
        <https://1145.am/db/763083/Gaingels>,
        <https://1145.am/db/764875/Rev1_Ventures>,
        <https://1145.am/db/764896/Rev1_Ventures>,
        <https://1145.am/db/765216/True_Ventures>,
        <https://1145.am/db/768172/Gaingels>,
        <https://1145.am/db/768172/Type_One_Ventures>,
        <https://1145.am/db/768349/Salesforce_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769568/Axon_Ventures>,
        <https://1145.am/db/772099/Array_Ventures>,
        <https://1145.am/db/773235/Prelude_Ventures>,
        <https://1145.am/db/773684/Fulgur_Ventures>,
        <https://1145.am/db/773794/Array_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/778423/Sentiero_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/779867/Genesis_Block_Ventures>,
        <https://1145.am/db/780272/East_Ventures>,
        <https://1145.am/db/780289/East_Ventures>,
        <https://1145.am/db/783431/Cathay_Venture_Inc>,
        <https://1145.am/db/784093/Boldstart_Ventures>,
        <https://1145.am/db/787806/Boldstart_Ventures>,
        <https://1145.am/db/788016/Boldstart_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796250/Sp_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/797597/Lansdowne_Partners>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/800101/Gaingels>,
        <https://1145.am/db/803541/Credo_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/8045/Greatpoint_Ventures>,
        <https://1145.am/db/806828/Promus_Ventures>,
        <https://1145.am/db/806994/Companyon_Ventures>,
        <https://1145.am/db/807080/K3_Ventures>,
        <https://1145.am/db/808020/Starlight_Ventures>,
        <https://1145.am/db/808020/Valo_Ventures>,
        <https://1145.am/db/8146/Rev1_Ventures>,
        <https://1145.am/db/817162/Orbia_Ventures>,
        <https://1145.am/db/818444/1984_Ventures>,
        <https://1145.am/db/821135/Se_Ventures>,
        <https://1145.am/db/823763/Infinity_Ventures>,
        <https://1145.am/db/828716/Idc_Ventures>,
        <https://1145.am/db/829118/Salesforce_Ventures>,
        <https://1145.am/db/830571/Company_Ventures>,
        <https://1145.am/db/830689/Soleus_Capital>,
        <https://1145.am/db/832264/Salesforce_Ventures>,
        <https://1145.am/db/832573/Solasta_Ventures>,
        <https://1145.am/db/834864/Ggv_Capital>,
        <https://1145.am/db/834864/K3_Ventures>,
        <https://1145.am/db/836848/Technexus_Venture_Collaborative>,
        <https://1145.am/db/836908/Frontier_Ventures>,
        <https://1145.am/db/837034/Redpoint_Ventures>,
        <https://1145.am/db/838138/Root_Ventures>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/847157/Signum_Capital>,
        <https://1145.am/db/847862/Wise_Ventures>,
        <https://1145.am/db/854001/Gv>,
        <https://1145.am/db/854589/Verance_Capital>,
        <https://1145.am/db/854654/Mrtnz_Ventures>,
        <https://1145.am/db/854795/Menlo_Ventures>,
        <https://1145.am/db/867865/Applied_Ventures>,
        <https://1145.am/db/868093/Cobro_Ventures>,
        <https://1145.am/db/869652/Forever_Ventures>,
        <https://1145.am/db/874394/Nextview_Ventures>,
        <https://1145.am/db/874394/True_Ventures>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/881298/At_One_Ventures>,
        <https://1145.am/db/882723/At_One_Ventures>,
        <https://1145.am/db/884787/Foresite_Capital>,
        <https://1145.am/db/884787/Gv>,
        <https://1145.am/db/884787/Northpond_Ventures>,
        <https://1145.am/db/886445/Gv>,
        <https://1145.am/db/887062/Panoramic_Ventures>,
        <https://1145.am/db/889246/At_One_Ventures>,
        <https://1145.am/db/890271/Panoramic_Ventures>,
        <https://1145.am/db/891162/Emergingvc>,
        <https://1145.am/db/891162/Launchpad_Venture_Group>,
        <https://1145.am/db/903689/Vectr_Ventures>,
        <https://1145.am/db/904276/Nextview_Ventures>,
        <https://1145.am/db/906393/East_Ventures>,
        <https://1145.am/db/907844/Argon_Ventures>,
        <https://1145.am/db/907844/Glasswing_Ventures>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/913678/Sandbridge_Capital>,
        <https://1145.am/db/919636/Menlo_Ventures>,
        <https://1145.am/db/921704/Scop_Ventures>,
        <https://1145.am/db/92200/Knoll_Ventures>,
        <https://1145.am/db/922066/Irrvrnt_Vc>,
        <https://1145.am/db/922192/Gv>,
        <https://1145.am/db/922498/Sozo_Ventures>,
        <https://1145.am/db/923723/Scop_Ventures>,
        <https://1145.am/db/928711/Frontline_Ventures>,
        <https://1145.am/db/934946/Ggv_Capital>,
        <https://1145.am/db/935046/Origin_Ventures>,
        <https://1145.am/db/935249/Victress_Capital>,
        <https://1145.am/db/935322/Alpana_Ventures>,
        <https://1145.am/db/935322/M_Ventures>,
        <https://1145.am/db/935796/Salesforce_Ventures>,
        <https://1145.am/db/935962/Digitalbridge_Ventures>,
        <https://1145.am/db/936045/Lpc_Ventures>,
        <https://1145.am/db/936057/Noemis_Ventures>,
        <https://1145.am/db/936154/Salesforce_Ventures>,
        <https://1145.am/db/936448/Ggv_Capital>,
        <https://1145.am/db/936862/Lool_Ventures>,
        <https://1145.am/db/936906/Neotribe_Ventures>,
        <https://1145.am/db/937210/Citi_Ventures>,
        <https://1145.am/db/937210/Firebolt_Ventures>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/938108/Conti_Ventures>,
        <https://1145.am/db/938555/Digitalbridge_Ventures>,
        <https://1145.am/db/938586/Venturesouth>,
        <https://1145.am/db/938921/Redpoint_Ventures>,
        <https://1145.am/db/938975/Ggv_Capital>,
        <https://1145.am/db/939163/Goodyear_Ventures>,
        <https://1145.am/db/940740/Agnc_Ventures>,
        <https://1145.am/db/940913/True_Ventures>,
        <https://1145.am/db/941816/Radical_Ventures>,
        <https://1145.am/db/942825/Argon_Ventures>,
        <https://1145.am/db/946710/Citi_Ventures>,
        <https://1145.am/db/947238/Kyros_Ventures>,
        <https://1145.am/db/952434/Verissimo_Ventures>,
        <https://1145.am/db/955201/Gv>,
        <https://1145.am/db/960022/Verance_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/970950/Ulu_Ventures>,
        <https://1145.am/db/971415/Altai_Ventures>,
        <https://1145.am/db/971450/Allon_Ventures>,
        <https://1145.am/db/971939/Formic_Ventures>,
        <https://1145.am/db/975114/Formic_Ventures>,
        <https://1145.am/db/979753/Menlo_Ventures>,
        <https://1145.am/db/980678/Menlo_Ventures>,
        <https://1145.am/db/984645/Vinco_Ventures>,
        <https://1145.am/db/987688/Brightspark_Ventures>,
        <https://1145.am/db/987700/Infinityvc>,
        <https://1145.am/db/988084/Abstract_Ventures>,
        <https://1145.am/db/988084/Blank_Ventures>,
        <https://1145.am/db/988318/Arthur_Ventures>,
        <https://1145.am/db/988482/Brightspark_Ventures>,
        <https://1145.am/db/988979/Infinityvc>,
        <https://1145.am/db/989392/Arthur_Ventures>,
        <https://1145.am/db/990085/Radical_Ventures>,
        <https://1145.am/db/995593/Raiven_Capital>,
        <https://1145.am/db/995737/Nuoyan_Capital>,
        <https://1145.am/db/996563/Raiven_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1119554/Chrysalis_Ventures>,
        <https://1145.am/db/2246863/Chrysalis_Ventures>,
        <https://1145.am/db/2255605/Chrysalis_Ventures>,
        <https://1145.am/db/2322429/Chrysalis_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2366539/Investment_Arch_Venture_Partners_Easton_Capital_Investment_Group_Forbion_Capital_Partners_Tvm_Capital_Third_Rock_Ventures_Bluebird_Bio_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-20T11:04:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., Apr 20, 2011 (BUSINESS WIRE) - bluebird bio, an emerging leader in the development of innovative gene therapies for severe genetic disorders, today announced that the company has secured an additional $ 30 million in financing.",
        "bluebird bio Secures Additional $ 30 Million in Financing; ARCH Venture Partners Joins Investor Team New Financing Will Further Advance the Beta-Thalassemia, Sickle Cell Anemia and ALD Clinical Programs While Accelerating the Product Platform Build." ;
    ns1:documentTitle "bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team New Financing Will Further A" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/bluebird-bio-secures-additional-30-million-financing-arch-venture-partners-joins-investor> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2366539/Bluebird_Bio> ;
    ns1:valueRaw "$ 30 Million",
        "$ 30 million" ;
    ns1:when "2011-04-20T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Apr 20, 2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2366561/Investment_Arcus_Ventures_Bhp_Brookline_Investments_Jafco_Nextech_Invest_Tracon_Pharmaceuticals_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-20T16:19:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SAN DIEGO, April 20, 2011 (GLOBE NEWSWIRE) - TRACON Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on the development of cancer therapeutics, announced the successful 1st tranche closing of a $ 14 million private venture round from new investors.",
        "TRACON Pharmaceuticals Announces $ 22 Million Tranched Investment Led by JAFCO and Nextech to Fund TRC105 Phase 2 Development." ;
    ns1:documentTitle "TRACON Pharmaceuticals Announces $22 Million Tranched Investment Led by JAFCO and Nextech to Fund TRC105 Phase 2 Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tracon-pharmaceuticals-announces-22-million-tranched-investment-led-by-jafco-and-nextech-to> ;
    ns1:foundName "Investment",
        "private venture" ;
    ns1:name "Investment",
        "private venture" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2366561/Tracon_Pharmaceuticals> ;
    ns1:targetDetails "private venture" ;
    ns1:valueRaw "$ 14 million",
        "$ 22 Million" ;
    ns1:when "2011-04-20T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "April 20, 2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2367043/Investment_Ip_Group_Illumina_Invesco_Perpetual_Lansdowne_Partners_Oxford_Nanopore_Redmile_Group_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-26T14:47:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> The UK's Oxford Nanopore has raised $ 41 million in new funds from a group of investors." ;
    ns1:documentTitle "Oxford Nanopore raises $41M for DNA sequencing work; Biogen Idec ready to break ground on new manufacturing center;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/oxford-nanopore-raises-41m-for-dna-sequencing-work-biogen-idec-ready-to-break-ground-on-new> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2367043/Oxford_Nanopore> ;
    ns1:valueRaw "$ 41 million" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2367218/Investment_Bb_Biotech_Ventures_Biomedpartners_Merck_Kgaa_Merck_Serono_Ventures_Sunstone_Capital_Vaximm_Ag_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-12T20:16:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Basel, Switzerland and Mannheim, Germany, January 11, 2011 / b3c newswire / - Swiss biotech firm and Merck KGaA spin-off VAXIMM AG announced today the closing of a private financing round totaling CHF 7.8 million from new and existing investors.",
        "VAXIMM Closes a CHF 7.8 Million Financing Round." ;
    ns1:documentTitle "VAXIMM Closes a CHF 7.8 Million Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vaximm-closes-a-chf-7-8-million-financing-round> ;
    ns1:foundName "Financing",
        "financing",
        "private" ;
    ns1:name "Financing",
        "financing",
        "private" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2367218/Vaximm_Ag> ;
    ns1:valueRaw "CHF 7.8 Million",
        "CHF 7.8 million" ;
    ns1:when "2011-01-11T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "January 11, 2011" ;
    ns1:whereGeoName "Switzerland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:whereRaw "Switzerland" .

<https://1145.am/db/2217392/Axolotl_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2011-02-22T16:30:01+00:00"^^xsd:dateTime ;
    ns1:documentExtract "In the last fifteen months, Raymond James has also served as financial advisor to HLTH Corp. (NASDAQ: HLTH) in its merger with WebMD (NASDAQ: WBMD) ; the acquisition of AMICAS (NASDAQ: AMCS) by Merge Healthcare (NASDAQ: MRGE) ; the sale of Evolution Benefits to Genstar Capital; and the sale of Axolotl to Ingenix, a subsidiary of United Health Group (NYSE: UNH) ; and the sale of Medicity to Aetna (NYSE: AET) representing aggregate transaction value of approximately $ 2.4 billion." ;
    ns1:documentTitle "Raymond James Health Care Investment Banking Group Advises Carefx on $155 Million Acquisition by Harris Corporation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/raymond-james-health-care-investment-banking-group-advises-carefx-155-million-acquisition-by> ;
    ns1:foundName "AMICAS",
        "Axolotl",
        "acquisition",
        "merger",
        "sale" ;
    ns1:name "Axolotl",
        "acquisition",
        "merger",
        "sale" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2217392/Axolotl_Acquisition> ;
    ns1:targetName "Axolotl" ;
    ns1:valueRaw "approximately $ 2.4 billion" .

<https://1145.am/db/2339295/Series_A_Investment_Biomedinvest_Delenex_Hbm_Biocapital_Hbm_Bioventures_Novo_Ventures_Sv_Life_Sciences_Vi_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-05-03T15:32:59+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Delenex Therapeutics AG (\"Delenex\") , a Swiss biotech company developing therapeutic antibody fragments for diseases with high unmet need, has extended its Series A venture equity investment round securing an additional CHF 16.7 million (USD 19.3 mio, EUR 13.0 mio) providing a total A Round investment of CHF 30.2 million (USD 34.8 mio, EUR 23.5 mio) .",
        "Delenex Therapeutics AG (\"Delenex\") , a Swiss biotech company developing therapeutic antibody fragments for diseases with high unmet need, has extended its Series A venture equity investment round securing an additional CHF 16.7 million (USD 19.3 mio, EUR 13.0 mio) providing a total A Round investment of CHF 30.2 million (USD 34.8 mio, EUR 23.5 mio)." ;
    ns1:documentTitle "Delenex extends its A round to CHF 30.2 million" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/delenex-extends-its-a-round-to-chf-30-2-million> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2339295/Delenex> ;
    ns1:targetDetails "Series A",
        "venture equity" ;
    ns1:valueRaw "CHF 16.7 million",
        "CHF 30.2 million",
        "EUR 13.0 mio",
        "EUR 23.5 mio",
        "USD 19.3 mio",
        "USD 34.8 mio" ;
    ns1:whereGeoName "Switzerland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:whereRaw "Switzerland" .

<https://1145.am/db/2341068/Series_A_Investment_Adams_Street_Partners_Druid_Bioventures_Genesys_Capital_Pathocapital_Lundbeck_Takeda_Venture_Latterell_Venture_Partners_Naurex_Inc_Pathocapital_Lundbeck_Takeda_Ventures_Inc_Shire_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-05-11T12:18:04+00:00"^^xsd:dateTime ;
    ns1:documentExtract "EVANSTON, Ill., May 11, 2011 /PRNewswire/ - Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of an $ 18 million Series A financing led by Adams Street Partners and Latterell Venture Partners." ;
    ns1:documentTitle "Naurex Completes $18 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-18-million-series-a-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2341068/Naurex_Inc> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 18 million" ;
    ns1:when "2011-05-11T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "May 11, 2011" ;
    ns1:whereGeoName "Evanston" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4891382/about.rdf> ;
    ns1:whereRaw "EVANSTON, Ill." .

<https://1145.am/db/2346534/Preferred_Stock_Investment_Aberdare_Ventures_Advent_Venture_Partners_Agechem_Venture_Fund_Bay_City_Capital_Conatus_Pharmaceuticals_Inc_Gilde_Healthcare_Partners_Roche_Venture_Fund_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-02-14T14:20:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Conatus Pharmaceuticals Inc. Completes $ 20 Million Series B Private Placement Financing.",
        "SAN DIEGO, Feb. 11, 2011 /PRNewswire/ - Conatus Pharmaceuticals Inc. today announced the closing of a $ 20 million Series B Preferred Stock private placement financing." ;
    ns1:documentTitle "Conatus Pharmaceuticals Inc. Completes $20 Million Series B Private Placement Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/conatus-pharmaceuticals-inc-completes-20-million-series-b-private-placement-financing> ;
    ns1:foundName "Financing",
        "Placement",
        "financing",
        "private placement" ;
    ns1:name "Financing",
        "Placement",
        "financing",
        "private placement" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2346534/Conatus_Pharmaceuticals_Inc> ;
    ns1:targetDetails "Preferred Stock",
        "Private",
        "Series B" ;
    ns1:valueRaw "$ 20 Million",
        "$ 20 million" ;
    ns1:when "2011-02-11T00:00:00"^^xsd:dateTime,
        "2011-02-14T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2/14/2011",
        "2011",
        "Feb. 11, 2011" ;
    ns1:whereGeoName "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "SAN DIEGO" .

<https://1145.am/db/2347574/Investment_Abalis_Finance_Ag_Activaero_Gmbh_Biomedpartners_Ag_Lsp_Life_Sciences_Partners_Medventure_Partners_Gmbh_Vi_Partners_Ag_Vesalius_Biocapital_I_Sicar_Sa_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-02-16T15:52:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Activaero Raises  5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP.",
        "GEMNDEN / Wohra, Germany- (BUSINESS WIRE) -Activaero GmbH, a technology leader in controlled breathing inhalation devices, today announced that it has closed a further financing round of  5.0 million ($ 6.8 million) ." ;
    ns1:documentTitle "Activaero Raises  5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/activaero-raises-%E2%82%AC-5-0-million-6-8-million-a-second-closing-series-a-round-led-by-lsp> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2347574/Activaero_Gmbh> ;
    ns1:targetDetails "Series a" ;
    ns1:valueRaw "$ 6.8 Million",
        "$ 6.8 million",
        " 1.5 million",
        " 3.5 million",
        " 5.0 Million",
        " 5.0 million" ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "Germany" .

<https://1145.am/db/2362871/Series_B_Investment_Advanced_Technology_Ventures_Astellas_Venture_Management_Bessemer_Venture_Partners_Cardinal_Partners_Longwood_Founders_Fund_Mpm_Capital_Verastem_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-07-14T13:23:30+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Start-up Verastem has closed a $ 32 million Series B round of financing with plans to advance its first drug against cancer stem cells into the clinic next year." ;
    ns1:documentTitle "Verastem snags $32M for drugs against cancer stem cells" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/verastem-snags-32m-for-drugs-against-cancer-stem-cells> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2362871/Verastem> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 32 million" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "Cambridge, MA" .

<https://1145.am/db/2365826/Series_C_Investment_Alk_Abello_Alto_Invest_Dbv_Technologies_Innobio_Fund_Lundbeckfond_Ventures_Shire_Plc_Sofinnova_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-05T14:22:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "PARIS- (BUSINESS WIRE) - DBV Technologies, an emerging biotechnology company, announced today that it has secured $ 25.5 million (19,4 million) in a Series C financing round." ;
    ns1:documentTitle "DBV Technologies closes $25.5 (19,4) million Series 'C' financing round including new investors InnoBio, Lundbeckfond Ven" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/dbv-technologies-closes-25-5-eu19-4-million-series-c-financing-round-including-new> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2365826/Dbv_Technologies> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 25.5 million",
        "19,4 million" ;
    ns1:whereGeoName "Paris" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2988507/about.rdf> ;
    ns1:whereRaw "Paris" .

<https://1145.am/db/2339616/Series_A1_Investment_Cognition_Therapeutics_Inc_Golden_Seeds_Innovation_Works_M5invest_Ogden_Cap_Associates_Pittsburgh_Life_Sciences_Greenhouse_Tmc_Investment_Company_The_Breedlove_Limited_Family_Partnership_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-20T15:50:14+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cognition Therapeutics Completes $ 2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program.",
        "PITTSBURGH, Jan. 20, 2011 /PRNewswire/ - Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $ 2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status." ;
    ns1:documentTitle "Cognition Therapeutics Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cognition-therapeutics-completes-2-5m-series-a1-financing-to-advance-alzheimer-s-disease> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2339616/Cognition_Therapeutics_Inc> ;
    ns1:targetDetails "Series A1" ;
    ns1:valueRaw "$ 2.5 million",
        "$ 2.5M" ;
    ns1:when "2011-01-20T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Jan. 20, 2011" ;
    ns1:whereGeoName "Pittsburgh" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5206379/about.rdf> ;
    ns1:whereRaw "Pittsburgh" .

<https://1145.am/db/2340172/Series_C_Investment_Argonaut_Private_Equity_Cdib_Capital_Investment_Cid_Group_Crci_Crown_Bioscience_Ibt_Orbimed_Advisors_Caduceus_Asia_Partners_Fund_Qiming_Venture_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-05-06T13:21:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SANTA CLARA, Calif., May 4, 2011 /PRNewswire/ - Crown Bioscience, Inc., a leading company in innovative oncology R & D partnership and services, today announced the closing of a US $ 28.8 million Series C financing." ;
    ns1:documentTitle "Crown Bioscience, Inc. Announces Closing of Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crown-bioscience-inc-announces-closing-of-series-c-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2340172/Crown_Bioscience> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "US $ 28.8 million" ;
    ns1:when "2011-05-04T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "May 4, 2011" ;
    ns1:whereGeoName "Santa Clara County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5393021/about.rdf> ;
    ns1:whereRaw "SANTA CLARA, Calif" .

<https://1145.am/db/2346532/Series_F_Investment_Alta_Partners_Asset_Management_Company_Canaan_Partners_Chimerix_Frazier_Healthcare_Ventures_Morningside_Group_New_Leaf_Venture_Partners_Pappas_Ventures_Sanderling_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-02-14T14:19:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Chimerix, Inc. Completes $ 45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157.",
        "DURHAM, N.C., Feb. 14, 2011 /PRNewswire/ - Chimerix, Inc., a pharmaceutical company developing orally-available broad spectrum antiviral therapeutics, today announced the completion of a $ 45 million Series F financing." ;
    ns1:documentTitle "Chimerix, Inc. Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/chimerix-inc-completes-45-million-financing-to-fund-further-development-of-novel-antiviral> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2346532/Chimerix> ;
    ns1:targetDetails "Series F" ;
    ns1:valueRaw "$ 45 Million",
        "$ 45 million" ;
    ns1:when "2011-02-14T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2/14/2011",
        "Feb. 14, 2011" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2352441/Investment_Ambit_Biosciences_Apposite_Capital_Gimv_Genechem_Horizon_Technology_Finance_Novaquest_Orbimed_Advisors_Perseus-Soros_Biopharmaceutical_Fund_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-06-10T14:41:59+00:00"^^xsd:dateTime ;
    ns1:documentExtract "A day after word that Ambit Biosciences had dropped plans for an $ 86 million IPO, venture investors have swooped in and replenished the cancer drug developer's coffers with a $ 30 million equity financing, the company says." ;
    ns1:documentTitle "Ambit bounces back from dropped IPO with $30M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-bounces-back-from-dropped-ipo-30m-round> ;
    ns1:foundName "IPO",
        "financing" ;
    ns1:name "IPO",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "stopped" ;
    ns1:target <https://1145.am/db/2352441/Ambit_Biosciences> ;
    ns1:valueRaw "$ 30 million",
        "$ 86 million" ;
    ns1:whereGeoName "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "San Diego" .

<https://1145.am/db/2355543/Series_B_Investment_Deerfield_Management_Interwest_Partners_Kleiner_Perkins_Caufield___Byers_Leerink_Swann_New_Enterprise_Associates_Oracle_Partners_T_Rowe_Price_Pappas_Ventures_T_Rowe_Price_Pappas_Ventures_Tesaro_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-06-21T14:25:43+00:00"^^xsd:dateTime ;
    ns1:documentExtract "BOSTON, Jun 21, 2011 (BUSINESS WIRE) - TESARO, Inc., an oncology - focused biopharmaceutical company, today announced that it has secured $ 101 million in a Series B financing to advance and expand the Company's cancer product portfolio." ;
    ns1:documentTitle "TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tesaro-announces-101-million-series-b-financing-for-advancement-and-expansion-of-oncology> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2355543/Tesaro> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 101 million" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "Boston" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4930956/about.rdf> ;
    ns1:whereRaw "BOSTON" .

<https://1145.am/db/2367022/Series_C_Investment_Aisling_Capital_Bay_City_Capital_Fidelity_Biosciences_Kearny_Venture_Partners_Nextwave_Pharmaceuticals_Panorama_Capital_Sofinnova_Ventures_Vivo_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-01-12T12:55:16+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CUPERTINO, Calif.- (BUSINESS WIRE) - NextWave Pharmaceuticals, an emerging specialty pharmaceutical company that develops and commercializes unique products utilizing proprietary drug delivery technology, today announced it has secured $ 45 million in a Series C financing.",
        "NextWave Pharmaceuticals Secures $ 45 Million in Financing." ;
    ns1:documentTitle "NextWave Pharmaceuticals Secures $45 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nextwave-pharmaceuticals-secures-45-million-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2367022/Nextwave_Pharmaceuticals> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 45 Million",
        "$ 45 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2367046/Series_B_Investment_Agechem_Venture_Fund_Akebia_Therapeutics_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Venture_Fund_Sigvion_Capital_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2011-04-26T15:53:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Akebia Completes $ 22M Series B Financing. Funds Will Allow Completion of Phase 2 Studies of AKB-6548 for Treatment of Anemia.",
        "CINCINNATI, OH- (Marketwire - Apr 26, 2011) - Akebia Therapeutics, Inc., a pharmaceutical discovery and development company focused on anemia and vascular disorders, today announced that it has closed a Series B Preferred stock financing totaling $ 22 million." ;
    ns1:documentTitle "Akebia Completes $22M Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/akebia-completes-22m-series-b-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2367046/Akebia_Therapeutics> ;
    ns1:targetDetails "Preferred stock",
        "Series B" ;
    ns1:valueRaw "$ 22 million",
        "$ 22M" ;
    ns1:whenRaw "2011" ;
    ns1:whereGeoName "Cincinnati" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4508722/about.rdf> ;
    ns1:whereRaw "CINCINNATI, OH" .

<https://1145.am/db/2346204/Equity_Investment_Bb_Biotech_Ventures_Brookside_Capital_Ge_Capital_Healthcare_Financial_Services_Healthcare_Ventures_Ipsen_Mpm_Bio_Iv_Nvs_Strategic_Fund_Mpm_Capital_Nordic_Bioscience_Oxford_Finance_Llc_Radius_Health_Inc_Saints_Capital_Scottish_Widows_Investment_Partnership_The_Wellcome_Trust_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment",
        "merger" ;
    ns1:documentDate "2011-05-24T13:35:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., May 24, 2011 /PRNewswire/ - Radius Health, Inc. (\"Radius\") today announced that the company has raised approximately $ 91 million in its third financing round, including $ 66 million in equity financing and a commitment by GE Capital, Healthcare Financial Services and Oxford Finance LLC to a $ 25 million multi-draw term loan facility.",
        "Radius also announced today that immediately following the initial closing of the equity financing, it merged with MPM Acquisition Corp. (\"MAC\") , an unlisted public reporting shell company." ;
    ns1:documentTitle "Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/radius-announces-closing-of-91-million-financing-to-advance-ba058-injection-into-phase-3> ;
    ns1:foundName "financing",
        "merged" ;
    ns1:name "financing",
        "merged" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2346204/Radius_Health_Inc> ;
    ns1:targetDetails "equity",
        "term loan" ;
    ns1:targetName "Radius Health, Inc." ;
    ns1:valueRaw "$ 25 million",
        "$ 66 million",
        "approximately $ 91 million" ;
    ns1:when "2011-05-24T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "May 24, 2011" ;
    ns1:whereGeoName "Cambridge",
        "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf>,
        <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass.",
        "United States" .

